inhibitors|mesh-ancestor
6733274|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733275|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733276|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
6733277|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6733278|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733279|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733280|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6733281|NCT01915277|Analgesics|analgesics|mesh-ancestor
6733282|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
6733283|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733284|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6733285|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6733286|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6733287|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
6733288|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733289|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733290|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
6733291|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6733292|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6733293|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6733294|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733295|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733296|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
6733297|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733298|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733299|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6733300|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733301|NCT01915472|Irinotecan|irinotecan|mesh-list
6733302|NCT01915472|Labetuzumab|labetuzumab|mesh-list
6733303|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
6733304|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
6733305|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733306|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6733307|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6733308|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733309|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733310|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733311|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6733312|NCT01915537|Infliximab|infliximab|mesh-list
6733313|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
6733314|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6733315|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6733316|NCT01915550|Insulin|insulin|mesh-list
6733317|NCT01915550|Metformin|metformin|mesh-list
6733318|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6733319|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
6733320|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6733321|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733322|NCT01915602|Sorafenib|sorafenib|mesh-list
6733323|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733324|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6733325|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733326|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733327|NCT01915758|Clindamycin|clindamycin|mesh-list
6733328|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
6733329|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
6733330|NCT01915758|Tretinoin|tretinoin|mesh-list
6733331|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6733332|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733333|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6733334|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733335|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733336|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733337|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
6733338|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
6733339|NCT01915810|Nicotine|nicotine|mesh-list
6733340|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6733341|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
6733342|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733343|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733344|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6733345|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6733346|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
6733347|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733348|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733349|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6733350|NCT01915901|Bismuth|bismuth|mesh-list
6733351|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6733352|NCT01915901|Antacids|antacids|mesh-ancestor
6733353|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733354|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6733355|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
6733356|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6733357|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
6733358|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733359|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
6733360|NCT01915979|Betamethasone|betamethasone|mesh-list
6733361|NCT01915979|Mitogens|mitogens|mesh-list
6733362|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
6733363|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733364|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6733365|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
6733366|NCT01915979|Hormones|hormones|mesh-ancestor
6733367|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6733368|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733369|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6733370|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
6733371|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6733372|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6733373|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733374|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6733375|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6733376|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733377|NCT01916174|Insulin|insulin|mesh-list
6733378|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6733379|NCT01916174|Liraglutide|liraglutide|mesh-list
6733380|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
6733381|NCT01916174|Xultophy|xultophy|mesh-list
6733382|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6733383|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733384|NCT01916174|Incretins|incretins|mesh-ancestor
6733385|NCT01916174|Hormones|hormones|mesh-ancestor
6733386|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6733387|NCT01916187|Imetelstat|imetelstat|mesh-list
6733388|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
6733389|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733390|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733391|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6733392|NCT01916200|Paroxetine|paroxetine|mesh-list
6733393|NCT01916200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6733394|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6733395|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733396|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733397|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733398|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
6733399|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733400|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6733401|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
6733402|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6733403|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6733404|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6733405|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733406|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
6733407|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6733408|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
6733409|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733410|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
6733411|NCT01916213|Protective Agents|protective agents|mesh-ancestor
6733412|NCT01916252|Dexamethasone|dexamethasone|mesh-list
6733413|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
6733414|NCT01916252|Lenalidomide|lenalidomide|mesh-list
6733415|NCT01916252|Bortezomib|bortezomib|mesh-list
6733416|NCT01916252|Melphalan|melphalan|mesh-list
6733417|NCT01916252|Busulfan|busulfan|mesh-list
6733418|NCT01916252|BB 1101|bb 1101|mesh-list
6733419|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6733420|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
6733421|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
6733422|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733423|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733424|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6733425|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
6733426|NCT01916252|Hormones|hormones|mesh-ancestor
6733427|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6733428|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6733429|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733430|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
6733431|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6733432|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6733433|NCT01916252|Growth Substances|growth substances|mesh-ancestor
6733434|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
6733435|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6733436|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
6733437|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733438|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6733439|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6733440|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
6733441|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733442|NCT01916265|Glucagon|glucagon|mesh-list
6733443|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6733444|NCT01916265|Hormones|hormones|mesh-ancestor
6733445|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6733446|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733447|NCT01916278|Lidocaine|lidocaine|mesh-list
6733448|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
6733449|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
6733450|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733451|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733452|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
6733453|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733454|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6733455|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6733456|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6733457|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733458|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733459|NCT01916317|Lidocaine|lidocaine|mesh-list
6733460|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
6733461|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
6733462|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733463|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733464|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
6733465|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733466|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6733467|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6733468|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6733469|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733470|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733471|NCT01916382|Nitisinone|nitisinone|mesh-list
6733472|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733473|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733474|NCT01916395|Sumatriptan|sumatriptan|mesh-list
6733475|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6733476|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6733477|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6733478|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
6733479|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733480|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733481|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733482|NCT01916408|Wobenzym|wobenzym|mesh-list
6733483|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6733484|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
6733485|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733486|NCT01916447|Bevacizumab|bevacizumab|mesh-list
6733487|NCT01916447|Irinotecan|irinotecan|mesh-list
6733488|NCT01916447|Camptothecin|camptothecin|mesh-list
6733489|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6733490|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733491|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6733492|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6733493|NCT01916447|Growth Substances|growth substances|mesh-ancestor
6733494|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733495|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
6733496|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6733497|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6733498|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733499|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733500|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6733501|NCT01916577|Plerixafor|plerixafor|mesh-list
6733502|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6733503|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6733504|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
6733505|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785717|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
6785718|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6785719|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
6785720|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785721|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6785722|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6785723|NCT02210117|Growth Substances|growth substances|mesh-ancestor
6785724|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785725|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
6785726|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
6785727|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6785728|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785729|NCT02210156|Micronutrients|micronutrients|mesh-list
6785730|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785731|NCT02210169|Vancomycin|vancomycin|mesh-list
6785732|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6785733|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785734|NCT02210182|Pentamidine|pentamidine|mesh-list
6785735|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
6785736|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785737|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6785738|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6785739|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6785740|NCT02210260|Heroin|heroin|mesh-list
6785741|NCT02210260|Bupivacaine|bupivacaine|mesh-list
6785742|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
6785743|NCT02210260|Anesthetics|anesthetics|mesh-list
6785744|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785745|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785746|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
6785747|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785748|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6785749|NCT02210260|Narcotics|narcotics|mesh-ancestor
6785750|NCT02210260|Analgesics|analgesics|mesh-ancestor
6785751|NCT02210325|Azithromycin|azithromycin|mesh-list
6785752|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
6785753|NCT02210325|Solithromycin|solithromycin|mesh-list
6785754|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6785755|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785756|NCT02210364|Capecitabine|capecitabine|mesh-list
6785757|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6785758|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
6785759|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785760|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733506|NCT01916642|Lidocaine|lidocaine|mesh-list
6733507|NCT01916642|Etomidate|etomidate|mesh-list
6733508|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
6733509|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
6733510|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733511|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733512|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
6733513|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733514|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6733515|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6733516|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6733517|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733518|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733519|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6733520|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6733521|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
6733522|NCT01916707|Enoxaparin|enoxaparin|mesh-list
6733523|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
6733524|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6733525|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6733526|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733527|NCT01916733|Insulin|insulin|mesh-list
6733528|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6733529|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733530|NCT01916785|Dasatinib|dasatinib|mesh-list
6733531|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733532|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6733533|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733534|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733535|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6733536|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6733537|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6733538|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6733539|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6733540|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6733541|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733542|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6733543|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733544|NCT01916863|Canagliflozin|canagliflozin|mesh-list
6733545|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6733546|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6733547|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733548|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6733549|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733550|NCT01916902|Ticagrelor|ticagrelor|mesh-list
6733551|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6733552|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6733553|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6733554|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6733555|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
6733556|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733557|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733558|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733559|NCT01916915|Tramadol|tramadol|mesh-list
6733560|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
6733561|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6733562|NCT01916915|Narcotics|narcotics|mesh-ancestor
6733563|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733564|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733565|NCT01916915|Analgesics|analgesics|mesh-ancestor
6733566|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
6733567|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733568|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
6733569|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
6733570|NCT01916954|Lumefantrine|lumefantrine|mesh-list
6733571|NCT01916954|Artemether|artemether|mesh-list
6733572|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6733573|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
6733574|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6733575|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6785761|NCT02210559|Gemcitabine|gemcitabine|mesh-list
6733576|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733577|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
6733578|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6733579|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733580|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733581|NCT01917032|Folic Acid|folic acid|mesh-list
6733582|NCT01917032|Vitamin A|vitamin a|mesh-list
6733583|NCT01917032|Micronutrients|micronutrients|mesh-list
6733584|NCT01917032|Trace Elements|trace elements|mesh-list
6733585|NCT01917032|Tretinoin|tretinoin|mesh-list
6733586|NCT01917032|Vitamins|vitamins|mesh-ancestor
6733587|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733588|NCT01917032|Hematinics|hematinics|mesh-ancestor
6733589|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
6733590|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733591|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
6733592|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
6733593|NCT01917045|Sufentanil|sufentanil|mesh-list
6733594|NCT01917045|Morphine|morphine|mesh-list
6733595|NCT01917045|Dsuvia|dsuvia|mesh-list
6733596|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6733597|NCT01917045|Narcotics|narcotics|mesh-ancestor
6733598|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733599|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733600|NCT01917045|Analgesics|analgesics|mesh-ancestor
6733601|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
6733602|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733603|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6733604|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6733605|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
6733606|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
6733607|NCT01917058|Abatacept|abatacept|mesh-list
6733608|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6733609|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733610|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733611|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6733612|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
6733613|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733614|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6733615|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
6733616|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6733617|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733618|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733619|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6733620|NCT01917097|Analgesics|analgesics|mesh-ancestor
6733621|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
6733622|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733623|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6733624|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6733625|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6733626|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
6733627|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733628|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733629|NCT01917149|Metoprolol|metoprolol|mesh-list
6733630|NCT01917149|Valsartan|valsartan|mesh-list
6733631|NCT01917149|Benazepril|benazepril|mesh-list
6733632|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6733633|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6733634|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6733635|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733636|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6733637|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
6733638|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
6733639|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733640|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733641|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6733642|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6733643|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6733644|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
6733645|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733646|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6733647|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
6733648|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733649|NCT01917279|Docetaxel|docetaxel|mesh-list
6733650|NCT01917279|Capecitabine|capecitabine|mesh-list
6733651|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733652|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
6733653|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
6733654|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
6733655|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733656|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6733657|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
6733658|NCT01917318|Iloperidone|iloperidone|mesh-list
6733659|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6733660|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6733661|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733662|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733663|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6733664|NCT01917331|Beclomethasone|beclomethasone|mesh-list
6733665|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
6733666|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
6733667|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6733668|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
6733669|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733670|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733671|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6733672|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
6733673|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6733674|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6733675|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6733676|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
6733677|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733678|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733679|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6733680|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6733681|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6733682|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
6733683|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6733684|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
6733685|NCT01917331|Hormones|hormones|mesh-ancestor
6733686|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6733687|NCT01917448|Morphine|morphine|mesh-list
6733688|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6733689|NCT01917448|Narcotics|narcotics|mesh-ancestor
6733690|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733691|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733692|NCT01917448|Analgesics|analgesics|mesh-ancestor
6733693|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
6733694|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733695|NCT01917552|Capecitabine|capecitabine|mesh-list
6733696|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6733697|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
6733698|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733699|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733700|NCT01917578|Paclitaxel|paclitaxel|mesh-list
6733701|NCT01917578|Docetaxel|docetaxel|mesh-list
6733702|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6733703|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
6733704|NCT01917578|Carboplatin|carboplatin|mesh-list
6733705|NCT01917578|Doxorubicin|doxorubicin|mesh-list
6733706|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6733707|NCT01917578|Fluorouracil|fluorouracil|mesh-list
6733708|NCT01917578|Trastuzumab|trastuzumab|mesh-list
6733709|NCT01917578|Epirubicin|epirubicin|mesh-list
6733710|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6733711|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733712|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
6733713|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
6733714|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
6733715|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733716|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6733717|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
6733718|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733719|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6733720|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6733721|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
6733722|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6733723|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6733724|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6733725|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6733726|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733727|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
6733728|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6733729|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6733730|NCT01917617|Gemcitabine|gemcitabine|mesh-list
6733731|NCT01917617|Cisplatin|cisplatin|mesh-list
6733732|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6733733|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733734|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6733735|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
6733736|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733737|NCT01917617|Antiviral Agents|antiviral agents|mesh-ancestor
6733738|NCT01917617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733739|NCT01917617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733740|NCT01917617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6733741|NCT01917617|Immunologic Factors|immunologic factors|mesh-ancestor
6733742|NCT01917617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733743|NCT01917708|Abatacept|abatacept|mesh-list
6733744|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6733745|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733746|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733747|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6733748|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
6733749|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733750|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6733751|NCT01917721|Doxycycline|doxycycline|mesh-list
6733752|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6733753|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733754|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
6733755|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6733756|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6733757|NCT01917799|Aspirin|aspirin|mesh-list
6733758|NCT01917799|Heparin|heparin|mesh-list
6733759|NCT01917799|Enoxaparin|enoxaparin|mesh-list
6733760|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6733761|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6733762|NCT01917799|Analgesics|analgesics|mesh-ancestor
6733763|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
6733764|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733765|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733766|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6733767|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6733768|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6733769|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6733770|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733771|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6733772|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6733773|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733774|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
6733775|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
6733776|NCT01917877|Dexamethasone|dexamethasone|mesh-list
6733777|NCT01917877|Bevacizumab|bevacizumab|mesh-list
6733778|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6733779|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733780|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6733781|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6733782|NCT01917877|Growth Substances|growth substances|mesh-ancestor
6733783|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733784|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
6733785|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6733786|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
6733787|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
6733788|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733789|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6733790|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
6733791|NCT01917877|Hormones|hormones|mesh-ancestor
6733792|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6733793|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6733794|NCT01917890|Curcumin|curcumin|mesh-list
6733795|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6733796|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6733797|NCT01917890|Analgesics|analgesics|mesh-ancestor
6733798|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
6733799|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733800|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733801|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6733802|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6733803|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733804|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733805|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733806|NCT01918098|Oxycodone|oxycodone|mesh-list
6733807|NCT01918098|Naloxone|naloxone|mesh-list
6733808|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6733809|NCT01918098|Narcotics|narcotics|mesh-ancestor
6733810|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733811|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733812|NCT01918098|Analgesics|analgesics|mesh-ancestor
6733813|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
6733814|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733815|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6733816|NCT01918111|Adenosine|adenosine|mesh-list
6733817|NCT01918111|Analgesics|analgesics|mesh-ancestor
6733818|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
6733819|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733820|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733821|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6733822|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
6733823|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6733824|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
6733825|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
6733826|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6733827|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733828|NCT01918124|Paclitaxel|paclitaxel|mesh-list
6733829|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
6733830|NCT01918124|Cisplatin|cisplatin|mesh-list
6733831|NCT01918124|Carboplatin|carboplatin|mesh-list
6733832|NCT01918124|Doxorubicin|doxorubicin|mesh-list
6733833|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6733834|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733835|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
6733836|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
6733837|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
6733838|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733839|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6733840|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
6733841|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733842|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6733843|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6733844|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
6733845|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6733846|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6733847|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6733848|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6733849|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733850|NCT01918150|Cobalt|cobalt|mesh-list
6733851|NCT01918150|Chromium|chromium|mesh-list
6733852|NCT01918150|Trace Elements|trace elements|mesh-ancestor
6733853|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
6733854|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733855|NCT01918176|Palbociclib|palbociclib|mesh-list
6733856|NCT01918176|Rabeprazole|rabeprazole|mesh-list
6733857|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733858|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6733859|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733860|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733861|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6733862|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6733863|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6733864|NCT01918241|Lenograstim|lenograstim|mesh-list
6733865|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6733866|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
6733867|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733868|NCT01918254|Paclitaxel|paclitaxel|mesh-list
6733869|NCT01918254|Pertuzumab|pertuzumab|mesh-list
6733870|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6733871|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733872|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
6733873|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
6733874|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
6733875|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733876|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6785762|NCT02210559|Paclitaxel|paclitaxel|mesh-list
6785763|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6785764|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785765|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
6785766|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
6785767|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
6785768|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785769|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6785770|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
6785771|NCT02210559|Antiviral Agents|antiviral agents|mesh-ancestor
6785772|NCT02210559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785773|NCT02210559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785774|NCT02210559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6785775|NCT02210559|Immunologic Factors|immunologic factors|mesh-ancestor
6785776|NCT02210559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785777|NCT02210598|Oxytocin|oxytocin|mesh-list
6785778|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
6785779|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6785780|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785781|NCT02210663|Veliparib|veliparib|mesh-list
6785782|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6785783|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785784|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785785|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785786|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6785787|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6785788|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6785789|NCT02210702|Norethindrone|norethindrone|mesh-list
6785790|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
6785791|NCT02210702|Estradiol|estradiol|mesh-list
6785792|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6785793|NCT02210702|Estrogens|estrogens|mesh-ancestor
6785794|NCT02210702|Hormones|hormones|mesh-ancestor
6785795|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6785796|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785797|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6785798|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
6785799|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6785800|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6785801|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6733877|NCT01918358|Valsartan|valsartan|mesh-list
6733878|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6733879|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6733880|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6733881|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
6733882|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733883|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6733884|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6733885|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733886|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6733887|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6733888|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6733889|NCT01918384|Arbekacin|arbekacin|mesh-list
6733890|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733891|NCT01918397|Levofloxacin|levofloxacin|mesh-list
6733892|NCT01918397|Ofloxacin|ofloxacin|mesh-list
6733893|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6733894|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733895|NCT01918397|Renal Agents|renal agents|mesh-ancestor
6733896|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6733897|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6733898|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6733899|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733900|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733901|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733902|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6733903|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6733904|NCT01918475|Carbetocin|carbetocin|mesh-list
6733905|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
6733906|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6733907|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733908|NCT01918488|Amiloride|amiloride|mesh-list
6733909|NCT01918488|Triamterene|triamterene|mesh-list
6733910|NCT01918488|Diuretics|diuretics|mesh-ancestor
6733911|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
6733912|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733913|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6733914|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6733915|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733916|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733917|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6733918|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6733919|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
6733920|NCT01918514|Analgesics|analgesics|mesh-ancestor
6733921|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
6733922|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6733923|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733924|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
6733925|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6733926|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6733927|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
6733928|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6733929|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6733930|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733931|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6733932|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
6733933|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6733934|NCT01918527|Capecitabine|capecitabine|mesh-list
6733935|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
6733936|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6733937|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
6733938|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733939|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733940|NCT01918631|Tenofovir|tenofovir|mesh-list
6733941|NCT01918631|Entecavir|entecavir|mesh-list
6733942|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
6733943|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733944|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6733945|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6733946|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733947|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733948|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6733949|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6733950|NCT01918644|Capecitabine|capecitabine|mesh-list
6733951|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6733952|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
6733953|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733954|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733955|NCT01918709|Valsartan|valsartan|mesh-list
6733956|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6733957|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6733958|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6733959|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
6733960|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733961|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6733962|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6733963|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733964|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6733965|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6733966|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6733967|NCT01918813|Vancomycin|vancomycin|mesh-list
6733968|NCT01918813|Mupirocin|mupirocin|mesh-list
6733969|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6733970|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6733971|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6733972|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6733973|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733974|NCT01918852|Bevacizumab|bevacizumab|mesh-list
6733975|NCT01918852|Capecitabine|capecitabine|mesh-list
6733976|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6733977|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733978|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6733979|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6733980|NCT01918852|Growth Substances|growth substances|mesh-ancestor
6733981|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733982|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
6733983|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6733984|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
6733985|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6733986|NCT01918865|Metformin|metformin|mesh-list
6733987|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6733988|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733989|NCT01918878|Aflibercept|aflibercept|mesh-list
6733990|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6733991|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6733992|NCT01918878|Growth Substances|growth substances|mesh-ancestor
6733993|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6733994|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
6733995|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6733996|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
6733997|NCT01918904|Antidotes|antidotes|mesh-ancestor
6733998|NCT01918904|Protective Agents|protective agents|mesh-ancestor
6733999|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734000|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
6734001|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734002|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
6734003|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6734004|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734005|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
6734006|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
6734007|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
6734008|NCT01918917|Morphine|morphine|mesh-list
6734009|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
6734010|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6734011|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734012|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734013|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6734014|NCT01918917|Analgesics|analgesics|mesh-ancestor
6734015|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
6734016|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734017|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6734018|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6734019|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6734020|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
6734021|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734022|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734023|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6734024|NCT01918917|Narcotics|narcotics|mesh-ancestor
6734025|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
6734026|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
6734027|NCT01918995|Regadenoson|regadenoson|mesh-list
6734028|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6734029|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6734030|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
6734031|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
6734032|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734033|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734034|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734035|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6734036|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
6734037|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6734038|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6734039|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6734040|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734041|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734042|NCT01919047|Mirabegron|mirabegron|mesh-list
6734043|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6734044|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6734045|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6734046|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
6734047|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734048|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734049|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734050|NCT01919047|Urological Agents|urological agents|mesh-ancestor
6734051|NCT01919086|Dexamethasone|dexamethasone|mesh-list
6734052|NCT01919086|Lenalidomide|lenalidomide|mesh-list
6734053|NCT01919086|Bortezomib|bortezomib|mesh-list
6734054|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734055|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
6734056|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
6734057|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734058|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734059|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6734060|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
6734061|NCT01919086|Hormones|hormones|mesh-ancestor
6734062|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734063|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6734064|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734065|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
6734066|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6734067|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6734068|NCT01919086|Growth Substances|growth substances|mesh-ancestor
6734069|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
6734070|NCT01919203|Remifentanil|remifentanil|mesh-list
6734071|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6734072|NCT01919203|Narcotics|narcotics|mesh-ancestor
6734073|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734074|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734075|NCT01919203|Analgesics|analgesics|mesh-ancestor
6734076|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
6734077|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734078|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
6734079|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
6734080|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
6734081|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
6734082|NCT01919255|Citric Acid|citric acid|mesh-list
6734083|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
6734084|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6734085|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
6734086|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
6734087|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734088|NCT01919255|Cathartics|cathartics|mesh-ancestor
6734089|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6734090|NCT01919255|Antacids|antacids|mesh-ancestor
6734091|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
6734092|NCT01919294|Testosterone|testosterone|mesh-list
6734093|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
6734094|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
6734095|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6734096|NCT01919294|Androgens|androgens|mesh-ancestor
6734097|NCT01919294|Hormones|hormones|mesh-ancestor
6734098|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734099|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734100|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6734101|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734102|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
6734103|NCT01919346|Eculizumab|eculizumab|mesh-list
6734104|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6734105|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6734106|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
6734107|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734108|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
6734109|NCT01919424|Miotics|miotics|mesh-ancestor
6734110|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
6734111|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734112|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734113|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6734114|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6734115|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
6734116|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6734117|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6734118|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
6734119|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734120|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734121|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
6734122|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6734123|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
6734124|NCT01919593|Povidone|povidone|mesh-list
6734125|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6734126|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734127|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
6734128|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
6734129|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
6734130|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
6734131|NCT01919619|Lenalidomide|lenalidomide|mesh-list
6734132|NCT01919619|Ipilimumab|ipilimumab|mesh-list
6734133|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
6734134|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734135|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6734136|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6734137|NCT01919619|Growth Substances|growth substances|mesh-ancestor
6734138|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
6734139|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734140|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6734141|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6734142|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734143|NCT01919788|Insulin|insulin|mesh-list
6734144|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6734145|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734146|NCT01919879|Cetuximab|cetuximab|mesh-list
6734147|NCT01919879|Afatinib|afatinib|mesh-list
6734148|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6734149|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734150|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6734151|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734152|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734153|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
6734154|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
6734155|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6734156|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734157|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734158|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
6734159|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6734160|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734161|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734162|NCT01919905|Vitamin D|vitamin d|mesh-list
6734163|NCT01919905|Vitamins|vitamins|mesh-ancestor
6734164|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
6734165|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734166|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6785802|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6785803|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6785804|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
6785805|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6785806|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6785807|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
6785808|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785809|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6785810|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6785811|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785812|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785813|NCT02210728|Methylphenidate|methylphenidate|mesh-list
6785814|NCT02210728|Amphetamine|amphetamine|mesh-list
6785815|NCT02210728|Adderall|adderall|mesh-list
6785816|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
6785817|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6785818|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785819|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6785820|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6785821|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6785822|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785823|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
6785824|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785825|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
6785826|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
6785827|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785828|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
6785829|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6785830|NCT02210754|Menthol|menthol|mesh-list
6785831|NCT02210754|Nicotine|nicotine|mesh-list
6785832|NCT02210754|Glycerol|glycerol|mesh-list
6785833|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6785834|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
6785835|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785836|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785837|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6785838|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6785839|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
6785840|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785841|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785842|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
6785843|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
6785844|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6785845|NCT02210754|Protective Agents|protective agents|mesh-ancestor
6785846|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
6785847|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6785848|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
6785849|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6785850|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
6785851|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734167|NCT01919918|Adenosine|adenosine|mesh-list
6734168|NCT01919918|Analgesics|analgesics|mesh-ancestor
6734169|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
6734170|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734171|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734172|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6734173|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
6734174|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6734175|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
6734176|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
6734177|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734178|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734179|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
6734180|NCT01920022|Mifepristone|mifepristone|mesh-list
6734181|NCT01920022|Etonogestrel|etonogestrel|mesh-list
6734182|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6734183|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734184|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6734185|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
6734186|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6734187|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6734188|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6734189|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6734190|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6734191|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
6734192|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734193|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
6734194|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6734195|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6734196|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
6734197|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
6734198|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
6734199|NCT01920113|Remifentanil|remifentanil|mesh-list
6734200|NCT01920113|Propofol|propofol|mesh-list
6734201|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6734202|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734203|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734204|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6734205|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
6734206|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
6734207|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6734208|NCT01920113|Analgesics|analgesics|mesh-ancestor
6734209|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
6734210|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734211|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6734212|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6734213|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6734214|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
6734215|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734216|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734217|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6734218|NCT01920113|Narcotics|narcotics|mesh-ancestor
6734219|NCT01920191|Poly ICLC|poly iclc|mesh-list
6734220|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
6734221|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
6734222|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734223|NCT01920204|Midostaurin|midostaurin|mesh-list
6734224|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734225|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6734226|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734227|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734228|NCT01920269|Mitomycins|mitomycins|mesh-list
6734229|NCT01920269|Mitomycin|mitomycin|mesh-list
6734230|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6734231|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734232|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
6734233|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734234|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6734235|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734236|NCT01920334|Zolpidem|zolpidem|mesh-list
6734237|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6734238|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6734239|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734240|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734241|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6734242|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
6734243|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
6734244|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734245|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734246|NCT01920386|Acetaminophen|acetaminophen|mesh-list
6734247|NCT01920386|Tramadol|tramadol|mesh-list
6734248|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6734249|NCT01920386|Analgesics|analgesics|mesh-ancestor
6734250|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
6734251|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734252|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734253|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
6734254|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6734255|NCT01920386|Narcotics|narcotics|mesh-ancestor
6734256|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734257|NCT01920503|Doxorubicin|doxorubicin|mesh-list
6734258|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6734259|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734260|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6734261|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6734262|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734263|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734264|NCT01920516|Melphalan|melphalan|mesh-list
6734265|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6734266|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
6734267|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734268|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734269|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6734270|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6734271|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
6734272|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734273|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
6734274|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6734275|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734276|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734277|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6734278|NCT01920542|Analgesics|analgesics|mesh-ancestor
6734279|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
6734280|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734281|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6734282|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6734283|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6734284|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
6734285|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734286|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734287|NCT01920737|Leucovorin|leucovorin|mesh-list
6734288|NCT01920737|Cytarabine|cytarabine|mesh-list
6734289|NCT01920737|Dexamethasone|dexamethasone|mesh-list
6734290|NCT01920737|Prednisone|prednisone|mesh-list
6734291|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
6734292|NCT01920737|Methotrexate|methotrexate|mesh-list
6734293|NCT01920737|Vincristine|vincristine|mesh-list
6734294|NCT01920737|Daunorubicin|daunorubicin|mesh-list
6734295|NCT01920737|Asparaginase|asparaginase|mesh-list
6734296|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
6734297|NCT01920737|Pegaspargase|pegaspargase|mesh-list
6734298|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6734299|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
6734300|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734301|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6734302|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6734303|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
6734304|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734305|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734306|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6734307|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734308|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
6734309|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
6734310|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734311|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6734312|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
6734313|NCT01920737|Hormones|hormones|mesh-ancestor
6734314|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734315|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6734316|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6734317|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
6734318|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6734319|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6734320|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
6734321|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
6734322|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734323|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6734324|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6734325|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
6734326|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734327|NCT01920737|Antidotes|antidotes|mesh-ancestor
6734328|NCT01920737|Protective Agents|protective agents|mesh-ancestor
6734329|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
6734330|NCT01920737|Vitamins|vitamins|mesh-ancestor
6734331|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
6734332|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6734333|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
6734334|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
6734335|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
6734336|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6734337|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6734338|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6734339|NCT01920919|Dexamethasone|dexamethasone|mesh-list
6734340|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734341|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
6734342|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
6734343|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734344|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734345|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6734346|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
6734347|NCT01920919|Hormones|hormones|mesh-ancestor
6734348|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734349|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6734350|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734351|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6734352|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6734353|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6734354|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734355|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734356|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6734357|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6734358|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734359|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
6734360|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734361|NCT01920984|Bevacizumab|bevacizumab|mesh-list
6734362|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6734363|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734364|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6734365|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6734366|NCT01920984|Growth Substances|growth substances|mesh-ancestor
6734367|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734368|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
6734369|NCT01921010|Niacin|niacin|mesh-list
6734370|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
6734371|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6734372|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
6734373|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734374|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6734375|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
6734376|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
6734377|NCT01921010|Vitamins|vitamins|mesh-ancestor
6734378|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
6734379|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734380|NCT01921192|Folic Acid|folic acid|mesh-list
6734381|NCT01921192|Hematinics|hematinics|mesh-ancestor
6734382|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
6734383|NCT01921192|Vitamins|vitamins|mesh-ancestor
6734384|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
6734385|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734386|NCT01921218|Cyclosporine|cyclosporine|mesh-list
6734387|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
6734388|NCT01921218|Prednisone|prednisone|mesh-list
6734389|NCT01921218|Abatacept|abatacept|mesh-list
6734390|NCT01921218|Tacrolimus|tacrolimus|mesh-list
6734391|NCT01921218|Cyclosporins|cyclosporins|mesh-list
6734392|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6734393|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734394|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
6734395|NCT01921218|Hormones|hormones|mesh-ancestor
6734396|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734397|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734398|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6734399|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734400|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6734401|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
6734402|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734403|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734404|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
6734405|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734406|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
6734407|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6734408|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6734409|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6734410|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
6734411|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6734412|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6734413|NCT01921231|Bupivacaine|bupivacaine|mesh-list
6734414|NCT01921231|Prilocaine|prilocaine|mesh-list
6734415|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
6734416|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
6734417|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734418|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734419|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
6734420|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734421|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
6734422|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
6734423|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6734424|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734425|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734426|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6734427|NCT01921361|Analgesics|analgesics|mesh-ancestor
6734428|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
6734429|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734430|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6734431|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6734432|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6734433|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
6734434|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734435|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734436|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
6734437|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
6734438|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
6734439|NCT01921374|Interferons|interferons|mesh-list
6734440|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
6734441|NCT01921374|Interleukin-2|interleukin-2|mesh-list
6734442|NCT01921374|Interleukin-4|interleukin-4|mesh-list
6734443|NCT01921374|Dinoprostone|dinoprostone|mesh-list
6734444|NCT01921374|Hormones|hormones|mesh-list
6734445|NCT01921374|Estradiol|estradiol|mesh-list
6734446|NCT01921374|Testosterone|testosterone|mesh-list
6734447|NCT01921374|Progesterone|progesterone|mesh-list
6734448|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6734449|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6734450|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6734451|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
6734452|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6734453|NCT01921374|Antibodies|antibodies|mesh-list
6734454|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
6734455|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
6734456|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
6734457|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
6734458|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
6734459|NCT01921374|Uric Acid|uric acid|mesh-list
6734460|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734461|NCT01921374|Vitamins|vitamins|mesh-ancestor
6734462|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
6734463|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734464|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
6734465|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734466|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734467|NCT01921374|Estrogens|estrogens|mesh-ancestor
6734468|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6734469|NCT01921374|Androgens|androgens|mesh-ancestor
6734470|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
6734471|NCT01921374|Progestins|progestins|mesh-ancestor
6734472|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6734473|NCT01921374|Analgesics|analgesics|mesh-ancestor
6734474|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
6734475|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734476|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
6734477|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734478|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734479|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
6734480|NCT01921374|Protective Agents|protective agents|mesh-ancestor
6734481|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
6734482|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6734483|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6734484|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
6734485|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
6734486|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734487|NCT01921426|Protective Agents|protective agents|mesh-ancestor
6734488|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734489|NCT01921582|Methylphenidate|methylphenidate|mesh-list
6734490|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6734491|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734492|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6734493|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6734494|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6734495|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734496|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
6734497|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785852|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785853|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
6785854|NCT02210858|Tipifarnib|tipifarnib|mesh-list
6785855|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785856|NCT02210884|Vitamin D|vitamin d|mesh-list
6785857|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
6785858|NCT02210884|Vitamins|vitamins|mesh-list
6785859|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
6785860|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785861|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6785862|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6785863|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
6785864|NCT02210949|Hematinics|hematinics|mesh-ancestor
6785865|NCT02211066|Clopidogrel|clopidogrel|mesh-list
6785866|NCT02211066|Ticagrelor|ticagrelor|mesh-list
6785867|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6785868|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6785869|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6785870|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6785871|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
6785872|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785873|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785874|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785875|NCT02211079|Tolbutamide|tolbutamide|mesh-list
6785876|NCT02211079|Midazolam|midazolam|mesh-list
6785877|NCT02211079|Caffeine|caffeine|mesh-list
6785878|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6785879|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6785880|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785881|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785882|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6785883|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6785884|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6785885|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6785886|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
6785887|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
6785888|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
6785889|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
6785890|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785891|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785892|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6785893|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6734498|NCT01921647|Amoxicillin|amoxicillin|mesh-list
6734499|NCT01921647|Clarithromycin|clarithromycin|mesh-list
6734500|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6734501|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734502|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6734503|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734504|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734505|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6734506|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6734507|NCT01921673|Docetaxel|docetaxel|mesh-list
6734508|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734509|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
6734510|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
6734511|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
6734512|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734513|NCT01921738|Azithromycin|azithromycin|mesh-list
6734514|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6734515|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734516|NCT01921790|Gemcitabine|gemcitabine|mesh-list
6734517|NCT01921790|Dexamethasone|dexamethasone|mesh-list
6734518|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
6734519|NCT01921790|Bevacizumab|bevacizumab|mesh-list
6734520|NCT01921790|Pegaspargase|pegaspargase|mesh-list
6734521|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734522|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
6734523|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
6734524|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734525|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734526|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6734527|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
6734528|NCT01921790|Hormones|hormones|mesh-ancestor
6734529|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734530|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6734531|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734532|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6734533|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
6734534|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734535|NCT01921790|Antiviral Agents|antiviral agents|mesh-ancestor
6734536|NCT01921790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734537|NCT01921790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734538|NCT01921790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6734539|NCT01921790|Immunologic Factors|immunologic factors|mesh-ancestor
6734540|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6734541|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6734542|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6734543|NCT01921790|Growth Substances|growth substances|mesh-ancestor
6734544|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
6734545|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
6734546|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6734547|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
6734548|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
6734549|NCT01921868|Vitamins|vitamins|mesh-ancestor
6734550|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
6734551|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734552|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
6734553|NCT01921920|Omeprazole|omeprazole|mesh-list
6734554|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6734555|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6734556|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6734557|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734558|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734559|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6734560|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6734561|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6734562|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
6734563|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734564|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6734565|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6734566|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734567|NCT01921972|Memantine|memantine|mesh-list
6734568|NCT01921972|Galantamine|galantamine|mesh-list
6734569|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6734570|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6734571|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
6734572|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785894|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734573|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734574|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734575|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6734576|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6734577|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6734578|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734579|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
6734580|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6734581|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
6734582|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734583|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
6734584|NCT01921985|Terlipressin|terlipressin|mesh-list
6734585|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6734586|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6734587|NCT01922141|Amlodipine|amlodipine|mesh-list
6734588|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6734589|NCT01922141|Ramipril|ramipril|mesh-list
6734590|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6734591|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6734592|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6734593|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734594|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6734595|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734596|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
6734597|NCT01922141|Diuretics|diuretics|mesh-ancestor
6734598|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
6734599|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6734600|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6734601|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
6734602|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734603|NCT01922154|Ranibizumab|ranibizumab|mesh-list
6734604|NCT01922154|Mitomycin|mitomycin|mesh-list
6734605|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6734606|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6734607|NCT01922154|Growth Substances|growth substances|mesh-ancestor
6734608|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734609|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
6734610|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734611|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
6734612|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734613|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6734614|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6734615|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734616|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6734617|NCT01922193|Hormones|hormones|mesh-ancestor
6734618|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734619|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734620|NCT01922375|Naftopidil|naftopidil|mesh-list
6734621|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6734622|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6734623|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
6734624|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734625|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734626|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734627|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6734628|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6734629|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6734630|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6734631|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6734632|NCT01922427|RNS60|rns60|mesh-list
6734633|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6734634|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6734635|NCT01922427|Analgesics|analgesics|mesh-ancestor
6734636|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
6734637|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734638|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734639|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734640|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6734641|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6734642|NCT01922440|Parathyroid Hormone|parathyroid hormone|mesh-list
6734643|NCT01922440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6734644|NCT01922440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734645|NCT01922466|Loxoprofen|loxoprofen|mesh-list
6734646|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6734647|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6734648|NCT01922466|Analgesics|analgesics|mesh-ancestor
6734649|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
6734650|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734651|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734652|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734653|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6734654|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6734655|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734656|NCT01922596|Ropivacaine|ropivacaine|mesh-list
6734657|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
6734658|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
6734659|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734660|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734661|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
6734662|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734663|NCT01922687|Amlodipine|amlodipine|mesh-list
6734664|NCT01922687|Atorvastatin|atorvastatin|mesh-list
6734665|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6734666|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6734667|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
6734668|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734669|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6734670|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6734671|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734672|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6734673|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6734674|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6734675|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6734676|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734677|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
6734678|NCT01922713|Vitamin A|vitamin a|mesh-list
6734679|NCT01922713|Beta Carotene|beta carotene|mesh-list
6734680|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
6734681|NCT01922713|Vitamins|vitamins|mesh-ancestor
6734682|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
6734683|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734684|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
6734685|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734686|NCT01922713|Protective Agents|protective agents|mesh-ancestor
6734687|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6734688|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734689|NCT01922713|Provitamins|provitamins|mesh-ancestor
6734690|NCT01922765|Amoxicillin|amoxicillin|mesh-list
6734691|NCT01922765|Metronidazole|metronidazole|mesh-list
6734692|NCT01922765|Clarithromycin|clarithromycin|mesh-list
6734693|NCT01922765|Rabeprazole|rabeprazole|mesh-list
6734694|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6734695|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734696|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6734697|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6734698|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6734699|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734700|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734701|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6734702|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6734703|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6734704|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6734705|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6734706|NCT01922804|Vitamins|vitamins|mesh-list
6734707|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
6734708|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734709|NCT01922817|Saxagliptin|saxagliptin|mesh-list
6734710|NCT01922817|Incretins|incretins|mesh-ancestor
6734711|NCT01922817|Hormones|hormones|mesh-ancestor
6734712|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734713|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734714|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6734715|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
6734716|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734717|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734718|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6734719|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
6734720|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6734721|NCT01922921|Trastuzumab|trastuzumab|mesh-list
6734722|NCT01922921|Pertuzumab|pertuzumab|mesh-list
6734723|NCT01922921|Antibodies|antibodies|mesh-list
6734724|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
6734725|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6734726|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
6734727|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734728|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734729|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6734730|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6734731|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
6734732|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734733|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
6734734|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6734735|NCT01922921|Protective Agents|protective agents|mesh-ancestor
6734736|NCT01922999|Melatonin|melatonin|mesh-list
6734737|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
6734738|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734739|NCT01922999|Protective Agents|protective agents|mesh-ancestor
6734740|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734741|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734742|NCT01923012|Vitamin K|vitamin k|mesh-list
6734743|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
6734744|NCT01923012|Vitamins|vitamins|mesh-ancestor
6734745|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
6734746|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734747|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6734748|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6734749|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734750|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
6734751|NCT01923012|Coagulants|coagulants|mesh-ancestor
6734752|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
6734753|NCT01923064|Polidocanol|polidocanol|mesh-list
6734754|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734755|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6734756|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6734757|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6734758|NCT01923077|Simvastatin|simvastatin|mesh-list
6734759|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6734760|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6734761|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
6734762|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734763|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6734764|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6734765|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734766|NCT01923090|Finasteride|finasteride|mesh-list
6734767|NCT01923090|Dutasteride|dutasteride|mesh-list
6734768|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6734769|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6734770|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734771|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734772|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
6734773|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734774|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734775|NCT01923090|Urological Agents|urological agents|mesh-ancestor
6734776|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6734777|NCT01923194|Hormones|hormones|mesh-ancestor
6734778|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734779|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785895|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6785896|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6785897|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
6785898|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6785899|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
6785900|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6785901|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785902|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785903|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6785904|NCT02211118|Analgesics|analgesics|mesh-ancestor
6785905|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
6785906|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785907|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6785908|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6785909|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6785910|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
6785911|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6785912|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785913|NCT02211222|Lenvatinib|lenvatinib|mesh-list
6785914|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785915|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6785916|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785917|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785918|NCT02211326|Warfarin|warfarin|mesh-list
6785919|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
6785920|NCT02211391|Caseins|caseins|mesh-list
6785921|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
6785922|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
6785923|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785924|NCT02211417|Mineral Oil|mineral oil|mesh-list
6785925|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
6785926|NCT02211417|Emollients|emollients|mesh-ancestor
6785927|NCT02211443|Cetuximab|cetuximab|mesh-list
6785928|NCT02211443|Antibodies|antibodies|mesh-list
6785929|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6785930|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
6785931|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785932|NCT02211443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6785933|NCT02211443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734780|NCT01923259|Donepezil|donepezil|mesh-list
6734781|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6734782|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734783|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734784|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
6734785|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734786|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734787|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
6734788|NCT01923337|Irinotecan|irinotecan|mesh-list
6734789|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6734790|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6734791|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734792|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734793|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734794|NCT01923376|Lactulose|lactulose|mesh-list
6734795|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6734796|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6734797|NCT01923376|Laxatives|laxatives|mesh-ancestor
6734798|NCT01923454|Acetazolamide|acetazolamide|mesh-list
6734799|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
6734800|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6734801|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734802|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734803|NCT01923454|Diuretics|diuretics|mesh-ancestor
6734804|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
6734805|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734806|NCT01923545|Lenograstim|lenograstim|mesh-list
6734807|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6734808|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
6734809|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734810|NCT01923558|Donepezil|donepezil|mesh-list
6734811|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6734812|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734813|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734814|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
6734815|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6734816|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734817|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
6734818|NCT01923584|Ubiquinone|ubiquinone|mesh-list
6734819|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
6734820|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734821|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6734822|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
6734823|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734824|NCT01923597|Protective Agents|protective agents|mesh-ancestor
6734825|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734826|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6734827|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6734828|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734829|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6734830|NCT01923623|Ropivacaine|ropivacaine|mesh-list
6734831|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
6734832|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
6734833|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734834|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734835|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
6734836|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734837|NCT01923649|Lanreotide|lanreotide|mesh-list
6734838|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734839|NCT01923818|Aspirin|aspirin|mesh-list
6734840|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
6734841|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6734842|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6734843|NCT01923818|Analgesics|analgesics|mesh-ancestor
6734844|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
6734845|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734846|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734847|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734848|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6734849|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6734850|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6734851|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734852|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6734853|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6734854|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734855|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
6734856|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6734857|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
6734858|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6734859|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
6734860|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
6734861|NCT01923831|Dexamethasone|dexamethasone|mesh-list
6734862|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
6734863|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734864|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
6734865|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
6734866|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734867|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734868|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6734869|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
6734870|NCT01923831|Hormones|hormones|mesh-ancestor
6734871|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734872|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6734873|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734874|NCT01923831|Analgesics|analgesics|mesh-ancestor
6734875|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
6734876|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
6734877|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734878|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6734879|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
6734880|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6734881|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6734882|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734883|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6734884|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
6734885|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6734886|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6734887|NCT01923844|Beractant|beractant|mesh-list
6734888|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
6734889|NCT01923857|Enclomiphene|enclomiphene|mesh-list
6734890|NCT01923857|Clomiphene|clomiphene|mesh-list
6734891|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
6734892|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6734893|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
6734894|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734895|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734896|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6734897|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
6734898|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6734899|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6734900|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6734901|NCT01923870|Enclomiphene|enclomiphene|mesh-list
6734902|NCT01923870|Clomiphene|clomiphene|mesh-list
6734903|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
6734904|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6734905|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
6734906|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734907|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734908|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6734909|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
6734910|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6734911|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6734912|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6734913|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6734914|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734915|NCT01923935|Melphalan|melphalan|mesh-list
6734916|NCT01923935|Busulfan|busulfan|mesh-list
6734917|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6734918|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
6734919|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734920|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734921|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6734922|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6734923|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
6734924|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734925|NCT01923948|Pregabalin|pregabalin|mesh-list
6734926|NCT01923948|Analgesics|analgesics|mesh-ancestor
6734927|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
6734928|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734929|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734930|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
6785934|NCT02211482|Lamivudine|lamivudine|mesh-list
6734931|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6734932|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6734933|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734934|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6734935|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6734936|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6734937|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734938|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6734939|NCT01923974|Melatonin|melatonin|mesh-list
6734940|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
6734941|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734942|NCT01923974|Protective Agents|protective agents|mesh-ancestor
6734943|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734944|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6734945|NCT01923987|Cetuximab|cetuximab|mesh-list
6734946|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6734947|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734948|NCT01924000|Minoxidil|minoxidil|mesh-list
6734949|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6734950|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
6734951|NCT01924013|Vitamin D|vitamin d|mesh-list
6734952|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
6734953|NCT01924013|Vitamins|vitamins|mesh-ancestor
6734954|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
6734955|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734956|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6734957|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6734958|NCT01924052|Calcitonin|calcitonin|mesh-list
6734959|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6734960|NCT01924052|Katacalcin|katacalcin|mesh-list
6734961|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6734962|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734963|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6734964|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
6734965|NCT01924065|Anticoagulants|anticoagulants|mesh-list
6734966|NCT01924078|Capecitabine|capecitabine|mesh-list
6734967|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6734968|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6734969|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
6734970|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6734971|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6734972|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6734973|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6734974|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6734975|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
6734976|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6734977|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734978|NCT01924091|Dapivirine|dapivirine|mesh-list
6734979|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6734980|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6734981|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
6734982|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6734983|NCT01924104|Aspirin|aspirin|mesh-list
6734984|NCT01924104|Heparin|heparin|mesh-list
6734985|NCT01924104|Calcium heparin|calcium heparin|mesh-list
6734986|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6734987|NCT01924104|Tinzaparin|tinzaparin|mesh-list
6734988|NCT01924104|Dalteparin|dalteparin|mesh-list
6734989|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6734990|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6734991|NCT01924104|Analgesics|analgesics|mesh-ancestor
6734992|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
6734993|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6734994|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6734995|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6734996|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6734997|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6734998|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6734999|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735000|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6735001|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6735002|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735003|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
6735004|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
6735005|NCT01924234|Morphine|morphine|mesh-list
6735006|NCT01924234|Remifentanil|remifentanil|mesh-list
6735007|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6735008|NCT01924234|Narcotics|narcotics|mesh-ancestor
6735009|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6735010|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735011|NCT01924234|Analgesics|analgesics|mesh-ancestor
6735012|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
6735013|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735014|NCT01924260|Gemcitabine|gemcitabine|mesh-list
6735015|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6735016|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
6735017|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735018|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735019|NCT01924260|Antiviral Agents|antiviral agents|mesh-ancestor
6735020|NCT01924260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735021|NCT01924260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735022|NCT01924260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735023|NCT01924260|Immunologic Factors|immunologic factors|mesh-ancestor
6735024|NCT01924260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735025|NCT01924273|Talaporfin|talaporfin|mesh-list
6735026|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735027|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6735028|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
6735029|NCT01924286|Prednisone|prednisone|mesh-list
6735030|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6735031|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
6735032|NCT01924286|Hormones|hormones|mesh-ancestor
6735033|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735034|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735035|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6735036|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735037|NCT01924325|Aspirin|aspirin|mesh-list
6735038|NCT01924325|Apixaban|apixaban|mesh-list
6735039|NCT01924325|Clopidogrel|clopidogrel|mesh-list
6735040|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6735041|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6735042|NCT01924325|Analgesics|analgesics|mesh-ancestor
6735043|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
6735044|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735045|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735046|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6735047|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6735048|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6735049|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6735050|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735051|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6735052|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6735053|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735054|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
6735055|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6735056|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6735057|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6735058|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
6735059|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735060|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6735061|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
6735062|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6735063|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
6735064|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
6735065|NCT01924468|Haloperidol|haloperidol|mesh-list
6735066|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
6735067|NCT01924468|Methylphenidate|methylphenidate|mesh-list
6735068|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6735069|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735070|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6735071|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6735072|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6735073|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735074|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
6735075|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735076|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
6735077|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
6735078|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735079|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6735080|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6735081|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6735082|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6735083|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6735084|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6735085|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6735086|NCT01924481|Theobromine|theobromine|mesh-list
6735087|NCT01924481|Caffeine|caffeine|mesh-list
6735088|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6735089|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735090|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6735091|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735092|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735093|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6735094|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6735095|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
6735096|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735097|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6735098|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
6735099|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735100|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6735101|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
6735102|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
6735103|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6735104|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
6735105|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6735106|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6735107|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6735108|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6735109|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735110|NCT01924624|Thalidomide|thalidomide|mesh-list
6735111|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735112|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
6735113|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735114|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
6735115|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6735116|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735117|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6735118|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6735119|NCT01924624|Growth Substances|growth substances|mesh-ancestor
6735120|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
6735121|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735122|NCT01924637|Insulin|insulin|mesh-list
6735123|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6735124|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
6735125|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
6735126|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6735127|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6735128|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735129|NCT01924676|Oxycodone|oxycodone|mesh-list
6735130|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6735131|NCT01924676|Narcotics|narcotics|mesh-ancestor
6735132|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6735133|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735134|NCT01924676|Analgesics|analgesics|mesh-ancestor
6735135|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
6735136|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735137|NCT01924819|Leucovorin|leucovorin|mesh-list
6735138|NCT01924819|Cisplatin|cisplatin|mesh-list
6735139|NCT01924819|Docetaxel|docetaxel|mesh-list
6735140|NCT01924819|Fluorouracil|fluorouracil|mesh-list
6735141|NCT01924819|Capecitabine|capecitabine|mesh-list
6735142|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
6735143|NCT01924819|Epirubicin|epirubicin|mesh-list
6735144|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735145|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
6735146|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
6735147|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
6735148|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735149|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
6735150|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6735151|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735152|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
6735153|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735154|NCT01924819|Antidotes|antidotes|mesh-ancestor
6735155|NCT01924819|Protective Agents|protective agents|mesh-ancestor
6735156|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
6735157|NCT01924819|Vitamins|vitamins|mesh-ancestor
6735158|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
6735159|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6735160|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6735161|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6735162|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735163|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6735164|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
6735165|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735166|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
6735167|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735168|NCT01924910|Vitamin D|vitamin d|mesh-list
6735169|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
6735170|NCT01924910|Vitamins|vitamins|mesh-ancestor
6735171|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
6735172|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735173|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6735174|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6785935|NCT02211482|Dolutegravir|dolutegravir|mesh-list
6785936|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6785937|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6785938|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785939|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785940|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
6785941|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785942|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6785943|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6785944|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6785945|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6785946|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
6785947|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6785948|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
6785949|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785950|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
6785951|NCT02211521|Protective Agents|protective agents|mesh-ancestor
6785952|NCT02211625|Oxycodone|oxycodone|mesh-list
6785953|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6785954|NCT02211625|Narcotics|narcotics|mesh-ancestor
6785955|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6785956|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785957|NCT02211625|Analgesics|analgesics|mesh-ancestor
6785958|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
6785959|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6785960|NCT02211690|Tenofovir|tenofovir|mesh-list
6785961|NCT02211690|Emtricitabine|emtricitabine|mesh-list
6785962|NCT02211690|Dolutegravir|dolutegravir|mesh-list
6785963|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
6785964|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785965|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6785966|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6785967|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785968|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785969|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6785970|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6785971|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6785972|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6785973|NCT02211729|Azithromycin|azithromycin|mesh-list
6785974|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
6785975|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
6785976|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6785977|NCT02211729|Amodiaquine|amodiaquine|mesh-list
6785978|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6785979|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6785980|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
6785981|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6785982|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6785983|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6785984|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785985|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785986|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6785987|NCT02211729|Renal Agents|renal agents|mesh-ancestor
6785988|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
6785989|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6785990|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785991|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6735175|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6735176|NCT01925027|Sirolimus|sirolimus|mesh-list
6735177|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6735178|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735179|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6735180|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735181|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
6735182|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735183|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
6735184|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735185|NCT01925066|Vancomycin|vancomycin|mesh-list
6735186|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6735187|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735188|NCT01925092|Mifepristone|mifepristone|mesh-list
6735189|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6735190|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
6735191|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6735192|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735193|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6735194|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6735195|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6735196|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
6735197|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6735198|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6735199|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
6735200|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735201|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
6735202|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6735203|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6735204|NCT01925131|Prednisone|prednisone|mesh-list
6735205|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
6735206|NCT01925131|Vincristine|vincristine|mesh-list
6735207|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
6735208|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735209|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
6735210|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735211|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6735212|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6735213|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
6735214|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735215|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735216|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6735217|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6735218|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
6735219|NCT01925131|Hormones|hormones|mesh-ancestor
6735220|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735221|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6735222|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6735223|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
6735224|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
6735225|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
6735226|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6735227|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6735228|NCT01925287|Curcumin|curcumin|mesh-list
6735229|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6735230|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6735231|NCT01925287|Analgesics|analgesics|mesh-ancestor
6735232|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
6735233|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735234|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735235|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6735236|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6735237|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735238|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735239|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735240|NCT01925300|Bisoprolol|bisoprolol|mesh-list
6735241|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6735242|NCT01925300|Calcium|calcium|mesh-list
6735243|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6735244|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735245|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6735246|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6735247|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
6735248|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735249|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6735250|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6735251|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735252|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6735253|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
6735254|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
6735255|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735256|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6735257|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6735258|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6735259|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
6735260|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735261|NCT01925352|Mitogens|mitogens|mesh-list
6735262|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
6735263|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735264|NCT01925378|Nelfinavir|nelfinavir|mesh-list
6735265|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6735266|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6735267|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
6735268|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735269|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735270|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6735271|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6735272|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
6735273|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735274|NCT01925456|Fesoterodine|fesoterodine|mesh-list
6735275|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6735276|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6735277|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
6735278|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735279|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735280|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735281|NCT01925456|Urological Agents|urological agents|mesh-ancestor
6735282|NCT01925547|Curcumin|curcumin|mesh-list
6735283|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6735284|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6735285|NCT01925547|Analgesics|analgesics|mesh-ancestor
6735286|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
6735287|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735288|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735289|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6735290|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6735291|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735292|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735293|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735294|NCT01925638|Ketoconazole|ketoconazole|mesh-list
6735295|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
6735296|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735297|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6735298|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6735299|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735300|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735301|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6735302|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
6735303|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735304|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735305|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6735306|NCT01925729|Phenylephrine|phenylephrine|mesh-list
6735307|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
6735308|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
6735309|NCT01925729|Ephedrine|ephedrine|mesh-list
6735310|NCT01925729|Histamine|histamine|mesh-list
6735311|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6735312|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
6735313|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735314|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735315|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6735316|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
6735317|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
6735318|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6735319|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6735320|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
6735321|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
6735322|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735323|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735324|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6735325|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6735326|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6735327|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
6735328|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6735329|NCT01925729|Protective Agents|protective agents|mesh-ancestor
6735330|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
6735331|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
6735332|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
6735333|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6735334|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
6735335|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6735336|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
6735337|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735338|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735339|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
6735340|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6735341|NCT01925820|Entecavir|entecavir|mesh-list
6735342|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
6735343|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735344|NCT01925859|Dexamethasone|dexamethasone|mesh-list
6735345|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
6735346|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6735347|NCT01925859|BB 1101|bb 1101|mesh-list
6735348|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6735349|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
6735350|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
6735351|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735352|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735353|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6735354|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
6735355|NCT01925859|Hormones|hormones|mesh-ancestor
6735356|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735357|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6735358|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735359|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
6735360|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735361|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735362|NCT01925898|Midazolam|midazolam|mesh-list
6735363|NCT01925898|Ketamine|ketamine|mesh-list
6735364|NCT01925898|Analgesics|analgesics|mesh-ancestor
6735365|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
6735366|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735367|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735368|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6735369|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6735370|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
6735371|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
6735372|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6735373|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6735374|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6735375|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735376|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735377|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6735378|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6735379|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6735380|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6735381|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6735382|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
6735383|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
6735384|NCT01925911|Midazolam|midazolam|mesh-list
6735385|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6735386|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6735387|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6735388|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735389|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6735390|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6735391|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6735392|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6735393|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
6735394|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
6735395|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
6735396|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
6735397|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735398|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735399|NCT01925937|Ubiquinone|ubiquinone|mesh-list
6735400|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
6735401|NCT01925937|Atorvastatin|atorvastatin|mesh-list
6735402|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6735403|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6735404|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
6735405|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735406|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6735407|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6735408|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735409|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
6735410|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735411|NCT01925937|Vitamins|vitamins|mesh-ancestor
6735412|NCT01926041|Varenicline|varenicline|mesh-list
6735413|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6735414|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6735415|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
6735416|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735417|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735418|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735419|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
6735420|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
6735421|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735422|NCT01926132|Protective Agents|protective agents|mesh-ancestor
6735423|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735424|NCT01926132|Vitamins|vitamins|mesh-ancestor
6735425|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
6735426|NCT01926158|Denosumab|denosumab|mesh-list
6735427|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6735428|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735429|NCT01926197|Leucovorin|leucovorin|mesh-list
6735430|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
6735431|NCT01926197|Irinotecan|irinotecan|mesh-list
6735432|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735433|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6735434|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6735435|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735436|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735437|NCT01926197|Antidotes|antidotes|mesh-ancestor
6735438|NCT01926197|Protective Agents|protective agents|mesh-ancestor
6735439|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735440|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
6735441|NCT01926197|Vitamins|vitamins|mesh-ancestor
6735442|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
6735443|NCT01926210|Letrozole|letrozole|mesh-list
6735444|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735445|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6735446|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6735447|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735448|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735449|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6735450|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
6735451|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735452|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735453|NCT01926236|Leucovorin|leucovorin|mesh-list
6735454|NCT01926236|Folic Acid|folic acid|mesh-list
6735455|NCT01926236|Fluorouracil|fluorouracil|mesh-list
6735456|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
6735457|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
6735458|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
6735459|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735460|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6735461|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735462|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735463|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
6735464|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735465|NCT01926236|Antidotes|antidotes|mesh-ancestor
6735466|NCT01926236|Protective Agents|protective agents|mesh-ancestor
6735467|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
6735468|NCT01926236|Vitamins|vitamins|mesh-ancestor
6735469|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
6735470|NCT01926236|Hematinics|hematinics|mesh-ancestor
6735471|NCT01926288|Entecavir|entecavir|mesh-list
6735472|NCT01926288|Maleic acid|maleic acid|mesh-list
6735473|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735474|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735475|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
6735476|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735477|NCT01926379|Isoniazid|isoniazid|mesh-list
6735478|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
6735479|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6735480|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735481|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6735482|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6735483|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
6735484|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735485|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6735486|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
6735487|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6735488|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6735489|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735490|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6735491|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6735492|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
6735493|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6735494|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
6735495|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735496|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6735497|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735498|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735499|NCT01926587|Azacitidine|azacitidine|mesh-list
6735500|NCT01926587|ON 01910|on 01910|mesh-list
6735501|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6735502|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
6735503|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735504|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735505|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735506|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6735507|NCT01926639|Rituximab|rituximab|mesh-list
6735508|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6735509|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735510|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
6735511|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735512|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6735513|NCT01926652|Amlodipine|amlodipine|mesh-list
6735514|NCT01926652|Candesartan|candesartan|mesh-list
6735515|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
6735516|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6735517|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6735518|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6735519|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735520|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6735521|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735522|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
6735523|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6735524|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6785992|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6785993|NCT02211833|Pemetrexed|pemetrexed|mesh-list
6785994|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6785995|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6785996|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6785997|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6785998|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6785999|NCT02211846|Mirabegron|mirabegron|mesh-list
6786000|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6786001|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6786002|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6786003|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
6786004|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786005|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786006|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786007|NCT02211846|Urological Agents|urological agents|mesh-ancestor
6786008|NCT02211911|Bisacodyl|bisacodyl|mesh-list
6786009|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
6735525|NCT01926665|Dexamethasone|dexamethasone|mesh-list
6735526|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6735527|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
6735528|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
6735529|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735530|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735531|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6735532|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
6735533|NCT01926665|Hormones|hormones|mesh-ancestor
6735534|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735535|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6735536|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735537|NCT01926769|Metformin|metformin|mesh-list
6735538|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6735539|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735540|NCT01926821|Sizofiran|sizofiran|mesh-list
6735541|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6735542|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
6735543|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735544|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6735545|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735546|NCT01926847|Riociguat|riociguat|mesh-list
6735547|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
6735548|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735549|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6735550|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
6735551|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735552|NCT01926899|Bortezomib|bortezomib|mesh-list
6735553|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735554|NCT01927029|Progesterone|progesterone|mesh-list
6735555|NCT01927029|Progestins|progestins|mesh-ancestor
6735556|NCT01927029|Hormones|hormones|mesh-ancestor
6735557|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735558|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735559|NCT01927068|Paclitaxel|paclitaxel|mesh-list
6735560|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6735561|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735562|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
6735563|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
6735564|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
6735565|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735566|NCT01927224|Nifurtimox|nifurtimox|mesh-list
6735567|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6735568|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6735569|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6735570|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735571|NCT01927263|Infliximab|infliximab|mesh-list
6735572|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
6735573|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6735574|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6735575|NCT01927315|Fenofibrate|fenofibrate|mesh-list
6735576|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6735577|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
6735578|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735579|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6735580|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6735581|NCT01927328|Hematinics|hematinics|mesh-ancestor
6735582|NCT01927406|Timolol|timolol|mesh-list
6735583|NCT01927406|Bimatoprost|bimatoprost|mesh-list
6735584|NCT01927406|Travoprost|travoprost|mesh-list
6735585|NCT01927406|Latanoprost|latanoprost|mesh-list
6735586|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6735587|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6735588|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
6735589|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735590|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735591|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735592|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6735593|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6735594|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6735595|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6735596|NCT01927484|Methotrexate|methotrexate|mesh-list
6735597|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6735598|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
6735599|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6735600|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735601|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6735602|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
6735603|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735604|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735605|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
6735606|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735607|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6735608|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735609|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
6735610|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6735611|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6735612|NCT01927588|Prednisone|prednisone|mesh-list
6735613|NCT01927588|Everolimus|everolimus|mesh-list
6735614|NCT01927588|Tacrolimus|tacrolimus|mesh-list
6735615|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6735616|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
6735617|NCT01927588|Hormones|hormones|mesh-ancestor
6735618|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735619|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735620|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6735621|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735622|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735623|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
6735624|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6735625|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735626|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735627|NCT01927640|Cocaine|cocaine|mesh-list
6735628|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
6735629|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6735630|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6735631|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735632|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6735633|NCT01927640|Analgesics|analgesics|mesh-ancestor
6735634|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
6735635|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735636|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6735637|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6735638|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6735639|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
6735640|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735641|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735642|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
6735643|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
6735644|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6735645|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6735646|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6735647|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6735648|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
6735649|NCT01927679|Vitamin E|vitamin e|mesh-list
6735650|NCT01927679|Antioxidants|antioxidants|mesh-list
6735651|NCT01927679|Vitamins|vitamins|mesh-ancestor
6735652|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
6735653|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735654|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735655|NCT01927679|Protective Agents|protective agents|mesh-ancestor
6735656|NCT01927835|Vaccines|vaccines|mesh-list
6735657|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
6735658|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735659|NCT01927874|Bupivacaine|bupivacaine|mesh-list
6735660|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
6735661|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
6735662|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6735663|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735664|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
6735665|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735666|NCT01927913|Deferasirox|deferasirox|mesh-list
6735667|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6735668|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
6735669|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
6735670|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735671|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
6735672|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6735673|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
6735674|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735675|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735676|NCT01928043|Curcumin|curcumin|mesh-list
6735677|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6735678|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6735679|NCT01928043|Analgesics|analgesics|mesh-ancestor
6735680|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
6735681|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735682|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735683|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6735684|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6735685|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735686|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735687|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735688|NCT01928056|Montelukast|montelukast|mesh-list
6735689|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6735690|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
6735691|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6735692|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
6735693|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735694|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735695|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6735696|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6735697|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735698|NCT01928069|Montelukast|montelukast|mesh-list
6735699|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6735700|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
6735701|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6735702|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
6735703|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735704|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735705|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6735706|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6735707|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735708|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
6735709|NCT01928134|Calcium|calcium|mesh-list
6735710|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6735711|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735712|NCT01928134|Antacids|antacids|mesh-ancestor
6735713|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735714|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6735715|NCT01928160|Carboplatin|carboplatin|mesh-list
6735716|NCT01928160|Pemetrexed|pemetrexed|mesh-list
6735717|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6735718|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735719|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735720|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735721|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6735722|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6735723|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6735724|NCT01928316|Mizolastine|mizolastine|mesh-list
6735725|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6735726|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6735727|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
6735728|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
6735729|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735730|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735731|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786010|NCT02211911|Cathartics|cathartics|mesh-ancestor
6786011|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6786012|NCT02211911|Laxatives|laxatives|mesh-ancestor
6786013|NCT02211950|Acarbose|acarbose|mesh-list
6786014|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6786015|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786016|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786017|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6786018|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786019|NCT02211976|Bisacodyl|bisacodyl|mesh-list
6786020|NCT02211976|Cathartics|cathartics|mesh-ancestor
6786021|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6786022|NCT02211976|Laxatives|laxatives|mesh-ancestor
6786023|NCT02212015|Paclitaxel|paclitaxel|mesh-list
6786024|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6786025|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786026|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
6786027|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
6786028|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
6786029|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735732|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6735733|NCT01928407|Darunavir|darunavir|mesh-list
6735734|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6735735|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6735736|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
6735737|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735738|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735739|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6735740|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6735741|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
6735742|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735743|NCT01928459|Infigratinib|infigratinib|mesh-list
6735744|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735745|NCT01928498|Paclitaxel|paclitaxel|mesh-list
6735746|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6735747|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735748|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
6735749|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
6735750|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
6735751|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735752|NCT01928511|Interferons|interferons|mesh-list
6735753|NCT01928511|Tenofovir|tenofovir|mesh-list
6735754|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
6735755|NCT01928511|Lamivudine|lamivudine|mesh-list
6735756|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
6735757|NCT01928511|Entecavir|entecavir|mesh-list
6735758|NCT01928511|Adefovir|adefovir|mesh-list
6735759|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6735760|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735761|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
6735762|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735763|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6735764|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6735765|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735766|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735767|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6735768|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6735769|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
6735770|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735771|NCT01928537|ON 01910|on 01910|mesh-list
6735772|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735773|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6735774|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735775|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735776|NCT01928563|Udenafil|udenafil|mesh-list
6735777|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6735778|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6735779|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735780|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735781|NCT01928576|Nivolumab|nivolumab|mesh-list
6735782|NCT01928576|Azacitidine|azacitidine|mesh-list
6735783|NCT01928576|Entinostat|entinostat|mesh-list
6735784|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6735785|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735786|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6735787|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735788|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6735789|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
6735790|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735791|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6735792|NCT01928628|Valsartan|valsartan|mesh-list
6735793|NCT01928628|Lercanidipine|lercanidipine|mesh-list
6735794|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6735795|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6735796|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6735797|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735798|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6735799|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6735800|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6735801|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735802|NCT01928823|Cycloserine|cycloserine|mesh-list
6735803|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6735804|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735805|NCT01928823|Renal Agents|renal agents|mesh-ancestor
6735806|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6735807|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
6735808|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6735809|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
6735810|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735811|NCT01928875|Anesthetics|anesthetics|mesh-list
6735812|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6735813|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735814|NCT01928888|Famotidine|famotidine|mesh-list
6735815|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
6735816|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6735817|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6735818|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6735819|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
6735820|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
6735821|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735822|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735823|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735824|NCT01928888|Antacids|antacids|mesh-ancestor
6735825|NCT01928901|Thymol|thymol|mesh-list
6735826|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735827|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6735828|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
6735829|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
6735830|NCT01928914|Tafenoquine|tafenoquine|mesh-list
6735831|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6735832|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735833|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6735834|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6735835|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735836|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735837|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735838|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
6735839|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6735840|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6735841|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6735842|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6735843|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6735844|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
6735845|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735846|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6735847|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6735848|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735849|NCT01929096|Edaravone|edaravone|mesh-list
6735850|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6735851|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
6735852|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735853|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6735854|NCT01929096|Protective Agents|protective agents|mesh-ancestor
6735855|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735856|NCT01929161|Oxytocin|oxytocin|mesh-list
6735857|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
6735858|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6735859|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735860|NCT01929187|Amorolfine|amorolfine|mesh-list
6735861|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
6735862|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735863|NCT01929213|Bosentan|bosentan|mesh-list
6735864|NCT01929213|Udenafil|udenafil|mesh-list
6735865|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6735866|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6735867|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735868|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6735869|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6735870|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735871|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
6735872|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
6735873|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6735874|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6735875|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735876|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6735877|NCT01929252|Analgesics|analgesics|mesh-ancestor
6735878|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
6735879|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6735880|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6735881|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6735882|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6735883|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
6735884|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6735885|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735886|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
6735887|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
6735888|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6735889|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6735890|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
6735891|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735892|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735893|NCT01929278|Clindamycin|clindamycin|mesh-list
6735894|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
6735895|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
6735896|NCT01929278|Tretinoin|tretinoin|mesh-list
6735897|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6735898|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735899|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6735900|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735901|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735902|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735903|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
6735904|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
6735905|NCT01929330|Dutasteride|dutasteride|mesh-list
6735906|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6735907|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6735908|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735909|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735910|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
6735911|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6735912|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735913|NCT01929382|Interferons|interferons|mesh-list
6735914|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
6735915|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735916|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
6735917|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735918|NCT01929421|Gemcitabine|gemcitabine|mesh-list
6735919|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6735920|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
6735921|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735922|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735923|NCT01929421|Antiviral Agents|antiviral agents|mesh-ancestor
6735924|NCT01929421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735925|NCT01929421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735926|NCT01929421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735927|NCT01929421|Immunologic Factors|immunologic factors|mesh-ancestor
6735928|NCT01929421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735929|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
6735930|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735931|NCT01929512|Metformin|metformin|mesh-list
6735932|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6735933|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6735934|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735935|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6735936|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6735937|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
6735938|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735939|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6735940|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6735941|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735942|NCT01929577|Peficitinib|peficitinib|mesh-list
6735943|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735944|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735945|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735946|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
6735947|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735948|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6735949|NCT01929590|Laxatives|laxatives|mesh-ancestor
6735950|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6735951|NCT01929603|Rifampin|rifampin|mesh-list
6735952|NCT01929603|Olaparib|olaparib|mesh-list
6735953|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6735954|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735955|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735956|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735957|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6735958|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
6735959|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6735960|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6735961|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
6735962|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6735963|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6735964|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6735965|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6735966|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6735967|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6735968|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6735969|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6735970|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735971|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
6735972|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
6735973|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735974|NCT01929668|Protective Agents|protective agents|mesh-ancestor
6735975|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735976|NCT01929668|Vitamins|vitamins|mesh-ancestor
6735977|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
6735978|NCT01929746|Daclizumab|daclizumab|mesh-list
6735979|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6735980|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
6735981|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735982|NCT01929798|Pancrelipase|pancrelipase|mesh-list
6735983|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6735984|NCT01929811|Metformin|metformin|mesh-list
6735985|NCT01929811|Docetaxel|docetaxel|mesh-list
6735986|NCT01929811|Epirubicin|epirubicin|mesh-list
6735987|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6735988|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6735989|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6735990|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
6735991|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
6735992|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
6735993|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6735994|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6735995|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6735996|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6735997|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6735998|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
6735999|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6736000|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
6736001|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736002|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736003|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6736004|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
6736005|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6736006|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
6736007|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736008|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736009|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6736010|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
6736011|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
6736012|NCT01929824|Protective Agents|protective agents|mesh-ancestor
6736013|NCT01929915|Fentanyl|fentanyl|mesh-list
6736014|NCT01929915|Morphine|morphine|mesh-list
6736015|NCT01929915|Bupivacaine|bupivacaine|mesh-list
6736016|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
6736017|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
6736018|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736019|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736020|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
6736021|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736022|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6736023|NCT01929915|Narcotics|narcotics|mesh-ancestor
6736024|NCT01929915|Analgesics|analgesics|mesh-ancestor
6736025|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6736026|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6736027|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
6736028|NCT01929941|Gemcitabine|gemcitabine|mesh-list
6736029|NCT01929941|Paclitaxel|paclitaxel|mesh-list
6736030|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6736031|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736032|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
6736033|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
6736034|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
6736035|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736036|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6736037|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
6736038|NCT01929941|Antiviral Agents|antiviral agents|mesh-ancestor
6736039|NCT01929941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736040|NCT01929941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736041|NCT01929941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6736042|NCT01929941|Immunologic Factors|immunologic factors|mesh-ancestor
6736043|NCT01929941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736044|NCT01930019|Thiopental|thiopental|mesh-list
6736045|NCT01930019|Etomidate|etomidate|mesh-list
6736046|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
6736047|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736048|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736049|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6736050|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6736051|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
6736052|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
6736053|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
6736054|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
6736055|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736056|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736057|NCT01930201|Anesthetics|anesthetics|mesh-list
6736058|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736059|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736060|NCT01930292|Paclitaxel|paclitaxel|mesh-list
6736061|NCT01930292|Carboplatin|carboplatin|mesh-list
6736062|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6736063|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736064|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
6736065|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
6736066|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
6736067|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736068|NCT01930318|Parecoxib|parecoxib|mesh-list
6736069|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6736070|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6736071|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736072|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736073|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6736074|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6736075|NCT01930318|Analgesics|analgesics|mesh-ancestor
6736076|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
6736077|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736078|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736079|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6736080|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6736081|NCT01930331|Piperaquine|piperaquine|mesh-list
6736082|NCT01930331|Artenimol|artenimol|mesh-list
6736083|NCT01930331|Artemisinins|artemisinins|mesh-list
6736084|NCT01930331|Artemisinin|artemisinin|mesh-list
6736085|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
6736086|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6736087|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6736088|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786030|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
6786031|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6786032|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6786033|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786034|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
6786035|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786036|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786037|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
6786038|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6786039|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6786040|NCT02212210|Prednisolone|prednisolone|mesh-list
6786041|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
6786042|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6786043|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
6786044|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6786045|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
6786046|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
6786047|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786048|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786049|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6786050|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
6786051|NCT02212210|Hormones|hormones|mesh-ancestor
6786052|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786053|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6786054|NCT02212210|Protective Agents|protective agents|mesh-ancestor
6786055|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6786056|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786057|NCT02212223|Vitamin D|vitamin d|mesh-list
6786058|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
6786059|NCT02212223|Vitamins|vitamins|mesh-ancestor
6786060|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
6786061|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786062|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6736089|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6736090|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
6736091|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
6736092|NCT01930396|Heparin|heparin|mesh-list
6736093|NCT01930396|Calcium heparin|calcium heparin|mesh-list
6736094|NCT01930396|Tinzaparin|tinzaparin|mesh-list
6736095|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6736096|NCT01930396|Dalteparin|dalteparin|mesh-list
6736097|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
6736098|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6736099|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6736100|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736101|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
6736102|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736103|NCT01930552|Leucovorin|leucovorin|mesh-list
6736104|NCT01930552|Fluorouracil|fluorouracil|mesh-list
6736105|NCT01930552|Irinotecan|irinotecan|mesh-list
6736106|NCT01930552|Aflibercept|aflibercept|mesh-list
6736107|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
6736108|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736109|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6736110|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736111|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6736112|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
6736113|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736114|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6736115|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6736116|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736117|NCT01930552|Antidotes|antidotes|mesh-ancestor
6736118|NCT01930552|Protective Agents|protective agents|mesh-ancestor
6736119|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
6736120|NCT01930552|Vitamins|vitamins|mesh-ancestor
6736121|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
6736122|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6736123|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6736124|NCT01930552|Growth Substances|growth substances|mesh-ancestor
6736125|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
6736126|NCT01930591|Clopidogrel|clopidogrel|mesh-list
6736127|NCT01930591|Ticagrelor|ticagrelor|mesh-list
6736128|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6736129|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6736130|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6736131|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6736132|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
6736133|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736134|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736135|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736136|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6736137|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6736138|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6736139|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6736140|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736141|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736142|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6736143|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6736144|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736145|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
6736146|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736147|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6736148|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6736149|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6736150|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6736151|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736152|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6736153|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
6736154|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6736155|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
6736156|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736157|NCT01930734|Dobutamine|dobutamine|mesh-list
6736158|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6736159|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
6736160|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
6736161|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736162|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736163|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6736164|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6736165|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6736166|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
6736167|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736168|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736169|NCT01930734|Protective Agents|protective agents|mesh-ancestor
6736170|NCT01930773|Clopidogrel|clopidogrel|mesh-list
6736171|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6736172|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6736173|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6736174|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6736175|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
6736176|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736177|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736178|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736179|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
6736180|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6736181|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6736182|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6736183|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6736184|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736185|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
6736186|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736187|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736188|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6736189|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736190|NCT01930812|Listerine|listerine|mesh-list
6736191|NCT01930812|Fluorides|fluorides|mesh-list
6736192|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
6736193|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
6736194|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
6736195|NCT01930812|Protective Agents|protective agents|mesh-ancestor
6736196|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736197|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6736198|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736199|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6736200|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736201|NCT01930864|Metformin|metformin|mesh-list
6736202|NCT01930864|Irinotecan|irinotecan|mesh-list
6736203|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6736204|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736205|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6736206|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6736207|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736208|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736209|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736210|NCT01930877|Lidocaine|lidocaine|mesh-list
6736211|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
6736212|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
6736213|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736214|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736215|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
6736216|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736217|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6736218|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6736219|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6736220|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6736221|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736222|NCT01930916|Anticoagulants|anticoagulants|mesh-list
6736223|NCT01930916|Antibodies|antibodies|mesh-list
6736224|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
6736225|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
6736226|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
6736227|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736228|NCT01930955|Amoxicillin|amoxicillin|mesh-list
6736229|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6736230|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736231|NCT01931033|Oxytocin|oxytocin|mesh-list
6736232|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
6736233|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6736234|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736235|NCT01931085|Triclabendazole|triclabendazole|mesh-list
6736236|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6736237|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
6736238|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6736239|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736240|NCT01931098|Topotecan|topotecan|mesh-list
6736241|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6736242|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6736243|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736244|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736245|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736246|NCT01931137|Insulin|insulin|mesh-list
6736247|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6736248|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736249|NCT01931189|Infliximab|infliximab|mesh-list
6736250|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
6736251|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6736252|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6736253|NCT01931215|Clonidine|clonidine|mesh-list
6736254|NCT01931215|Morphine|morphine|mesh-list
6736255|NCT01931215|Ropivacaine|ropivacaine|mesh-list
6736256|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
6736257|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736258|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736259|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6736260|NCT01931215|Narcotics|narcotics|mesh-ancestor
6736261|NCT01931215|Analgesics|analgesics|mesh-ancestor
6736262|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
6736263|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736264|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
6736265|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6736266|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
6736267|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
6736268|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6736269|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6736270|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6736271|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
6736272|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736273|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736274|NCT01931293|Folic Acid|folic acid|mesh-list
6736275|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
6736276|NCT01931293|Vitamins|vitamins|mesh-ancestor
6736277|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
6736278|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736279|NCT01931293|Hematinics|hematinics|mesh-ancestor
6736280|NCT01931306|Afatinib|afatinib|mesh-list
6736281|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736282|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6736283|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736284|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736285|NCT01931319|Baclofen|baclofen|mesh-list
6736286|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6736287|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736288|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6736289|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736290|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6736291|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
6736292|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
6736293|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736294|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736295|NCT01931332|Heroin|heroin|mesh-list
6736296|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6736297|NCT01931332|Narcotics|narcotics|mesh-ancestor
6736298|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736299|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736300|NCT01931332|Analgesics|analgesics|mesh-ancestor
6736301|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
6736302|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736303|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6736304|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6736305|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736306|NCT01931410|Misoprostol|misoprostol|mesh-list
6736307|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6736308|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
6736309|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6736310|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736311|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6736312|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6736313|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
6736314|NCT01931501|Montelukast|montelukast|mesh-list
6736315|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6736316|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
6736317|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6736318|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
6736319|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6736320|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736321|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6736322|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6736323|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736324|NCT01931514|Montelukast|montelukast|mesh-list
6736325|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6736326|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
6736327|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6736328|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
6736329|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6736330|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736331|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6736332|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6736333|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736334|NCT01931592|Gentamicins|gentamicins|mesh-list
6736335|NCT01931592|Colistin|colistin|mesh-list
6736336|NCT01931592|Fosfomycin|fosfomycin|mesh-list
6736337|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6736338|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736339|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6736340|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736341|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736342|NCT01931657|Mifepristone|mifepristone|mesh-list
6736343|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
6736344|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6736345|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
6736346|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6736347|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736348|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6736349|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6736350|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6736351|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
6736352|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6736353|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6736354|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
6736355|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6736356|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
6736357|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6736358|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6736359|NCT01931683|Remifentanil|remifentanil|mesh-list
6736360|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6736361|NCT01931683|Narcotics|narcotics|mesh-ancestor
6736362|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736363|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736364|NCT01931683|Analgesics|analgesics|mesh-ancestor
6736365|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
6736366|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736367|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
6736368|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
6736369|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736370|NCT01931787|Protective Agents|protective agents|mesh-ancestor
6736371|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736372|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
6736373|NCT01931787|Vitamins|vitamins|mesh-ancestor
6736374|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
6786063|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6786064|NCT02212340|Remifentanil|remifentanil|mesh-list
6786065|NCT02212340|Desflurane|desflurane|mesh-list
6786066|NCT02212340|Propofol|propofol|mesh-list
6786067|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6786068|NCT02212340|Narcotics|narcotics|mesh-ancestor
6786069|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6786070|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786071|NCT02212340|Analgesics|analgesics|mesh-ancestor
6786072|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
6786073|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786074|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6786075|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
6786076|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
6786077|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6786078|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6786079|NCT02212392|Meropenem|meropenem|mesh-list
6786080|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786081|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786082|NCT02212431|Cysteamine|cysteamine|mesh-list
6786083|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6786084|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786085|NCT02212535|Plerixafor|plerixafor|mesh-list
6786086|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6786087|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6786088|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
6786089|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786090|NCT02212561|Vidarabine|vidarabine|mesh-list
6786091|NCT02212561|Cytarabine|cytarabine|mesh-list
6786092|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
6786093|NCT02212561|Methotrexate|methotrexate|mesh-list
6786094|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
6786095|NCT02212561|Fludarabine|fludarabine|mesh-list
6786096|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6786097|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
6736375|NCT01931982|Liraglutide|liraglutide|mesh-list
6736376|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6736377|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736378|NCT01931982|Incretins|incretins|mesh-ancestor
6736379|NCT01931982|Hormones|hormones|mesh-ancestor
6736380|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6736381|NCT01932151|Terlipressin|terlipressin|mesh-list
6736382|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6736383|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6736384|NCT01932177|Everolimus|everolimus|mesh-list
6736385|NCT01932177|Sorafenib|sorafenib|mesh-list
6736386|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736387|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6736388|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
6736389|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736390|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6736391|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736392|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736393|NCT01932203|Aspirin|aspirin|mesh-list
6736394|NCT01932203|Cilostazol|cilostazol|mesh-list
6736395|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6736396|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6736397|NCT01932203|Analgesics|analgesics|mesh-ancestor
6736398|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
6736399|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736400|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736401|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6736402|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6736403|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6736404|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6736405|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736406|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6736407|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6736408|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736409|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
6736410|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6736411|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
6736412|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6736413|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
6736414|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
6736415|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6736416|NCT01932203|Protective Agents|protective agents|mesh-ancestor
6736417|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6736418|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6736419|NCT01932229|Afatinib|afatinib|mesh-list
6736420|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736421|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6736422|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736423|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736424|NCT01932268|Rifampin|rifampin|mesh-list
6736425|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6736426|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
6736427|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6736428|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736429|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
6736430|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6736431|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736432|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736433|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6736434|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6736435|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6736436|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6736437|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6736438|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6736439|NCT01932320|Ketoconazole|ketoconazole|mesh-list
6736440|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
6736441|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736442|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6736443|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6736444|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736445|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736446|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6736447|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
6736448|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6736449|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736450|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6736451|NCT01932372|Etanercept|etanercept|mesh-list
6736452|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
6736453|NCT01932372|Tofacitinib|tofacitinib|mesh-list
6736454|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6736455|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6736456|NCT01932372|Analgesics|analgesics|mesh-ancestor
6736457|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
6736458|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736459|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736460|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6736461|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6736462|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6736463|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
6736464|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6736465|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736466|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736467|NCT01932385|Sorafenib|sorafenib|mesh-list
6736468|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736469|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6736470|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736471|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736472|NCT01932424|Propofol|propofol|mesh-list
6736473|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6736474|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736475|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736476|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6736477|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
6736478|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
6736479|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
6736480|NCT01932502|Clobazam|clobazam|mesh-list
6736481|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
6736482|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6736483|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6736484|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736485|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736486|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6736487|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6736488|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
6736489|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
6736490|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736491|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736492|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6736493|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6736494|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6736495|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736496|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736497|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6736498|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6736499|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6736500|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6736501|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
6736502|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736503|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736504|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6736505|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6736506|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
6736507|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6736508|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6736509|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
6736510|NCT01932554|Ibuprofen|ibuprofen|mesh-list
6736511|NCT01932554|Fentanyl|fentanyl|mesh-list
6736512|NCT01932554|Morphine|morphine|mesh-list
6736513|NCT01932554|Hydromorphone|hydromorphone|mesh-list
6736514|NCT01932554|Narcotics|narcotics|mesh-list
6736515|NCT01932554|Abciximab|abciximab|mesh-list
6736516|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6736517|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736518|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736519|NCT01932554|Analgesics|analgesics|mesh-ancestor
6736520|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
6736521|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736522|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6736523|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6736524|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
6736525|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
6736526|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6736527|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6736528|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6736529|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6736530|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6736531|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736532|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736533|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
6736534|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6736535|NCT01932580|Docetaxel|docetaxel|mesh-list
6736536|NCT01932580|Fluorouracil|fluorouracil|mesh-list
6736537|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
6736538|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736539|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
6736540|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
6736541|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
6736542|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736543|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
6736544|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6736545|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6736546|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
6736547|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736548|NCT01932918|Ketorolac|ketorolac|mesh-list
6736549|NCT01932918|Morphine|morphine|mesh-list
6736550|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6736551|NCT01932918|Narcotics|narcotics|mesh-ancestor
6736552|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736553|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736554|NCT01932918|Analgesics|analgesics|mesh-ancestor
6736555|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
6736556|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736557|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6736558|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6736559|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6736560|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6736561|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6736562|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736563|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736564|NCT01932931|Vitamin D|vitamin d|mesh-list
6736565|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
6736566|NCT01932931|Vitamins|vitamins|mesh-ancestor
6736567|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
6736568|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736569|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6736570|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6736571|NCT01933022|Leuprolide|leuprolide|mesh-list
6736572|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6736573|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
6736574|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6736575|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736576|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6736577|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736578|NCT01933061|Paclitaxel|paclitaxel|mesh-list
6736579|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6736580|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6736581|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736582|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
6736583|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
6736584|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
6736585|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736586|NCT01933152|Ranibizumab|ranibizumab|mesh-list
6736587|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6736588|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6736589|NCT01933152|Growth Substances|growth substances|mesh-ancestor
6736590|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736591|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
6736592|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736593|NCT01933347|Gefitinib|gefitinib|mesh-list
6736594|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736595|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6736596|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736597|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736598|NCT01933360|Misoprostol|misoprostol|mesh-list
6736599|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6736600|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
6736601|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6736602|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736603|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6736604|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6736605|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
6736606|NCT01933412|Vaccines|vaccines|mesh-list
6736607|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
6736608|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736609|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
6736610|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6736611|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736612|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
6736613|NCT01933503|Cathartics|cathartics|mesh-ancestor
6736614|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6736615|NCT01933516|Rituximab|rituximab|mesh-list
6736616|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6736617|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736618|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
6736619|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736620|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6736621|NCT01933542|Morphine|morphine|mesh-list
6736622|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
6736623|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6736624|NCT01933542|Narcotics|narcotics|mesh-ancestor
6736625|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736626|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736627|NCT01933542|Analgesics|analgesics|mesh-ancestor
6736628|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
6736629|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736630|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6736631|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6736632|NCT01933568|Cisplatin|cisplatin|mesh-list
6736633|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786098|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6786099|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786100|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6786101|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
6786102|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786103|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786104|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
6786105|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786106|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6786107|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786108|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
6786109|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6786110|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6786111|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
6786112|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786113|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6786114|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
6786115|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
6786116|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786117|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786118|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786119|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
6786120|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
6786121|NCT02212639|Digoxin|digoxin|mesh-list
6786122|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6786123|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6786124|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786125|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786126|NCT02212639|Protective Agents|protective agents|mesh-ancestor
6786127|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786128|NCT02212652|Vitamin D|vitamin d|mesh-list
6786129|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
6786130|NCT02212652|Vitamins|vitamins|mesh-list
6786131|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
6786132|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786133|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6786134|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6786135|NCT02212756|Metformin|metformin|mesh-list
6786136|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6786137|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786138|NCT02212769|Losartan|losartan|mesh-list
6786139|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6786140|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6786141|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6786142|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6786143|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786144|NCT02212782|Linagliptin|linagliptin|mesh-list
6786145|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6786146|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736634|NCT01933698|Amoxicillin|amoxicillin|mesh-list
6736635|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6736636|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736637|NCT01933711|Rituximab|rituximab|mesh-list
6736638|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6736639|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736640|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
6736641|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736642|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6736643|NCT01933724|Prednisone|prednisone|mesh-list
6736644|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
6736645|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6736646|NCT01933724|Hormones|hormones|mesh-ancestor
6736647|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6736648|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736649|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6736650|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736651|NCT01933815|Bevacizumab|bevacizumab|mesh-list
6736652|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6736653|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736654|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6736655|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6736656|NCT01933815|Growth Substances|growth substances|mesh-ancestor
6736657|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736658|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
6736659|NCT01933906|Interferons|interferons|mesh-list
6736660|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
6736661|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
6736662|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6736663|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736664|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
6736665|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736666|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
6736667|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736668|NCT01933945|Sorafenib|sorafenib|mesh-list
6736669|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736670|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6736671|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736672|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736673|NCT01933971|Lenograstim|lenograstim|mesh-list
6736674|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6736675|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
6736676|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736677|NCT01933997|Pyridoxine|pyridoxine|mesh-list
6736678|NCT01933997|Metadoxine|metadoxine|mesh-list
6736679|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6736680|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
6736681|NCT01933997|Vitamins|vitamins|mesh-ancestor
6736682|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
6736683|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736684|NCT01934023|Varenicline|varenicline|mesh-list
6736685|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6736686|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6736687|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
6736688|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736689|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736690|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736691|NCT01934049|Anesthetics|anesthetics|mesh-list
6736692|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736693|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736694|NCT01934088|Fentanyl|fentanyl|mesh-list
6736695|NCT01934088|Midazolam|midazolam|mesh-list
6736696|NCT01934088|Propofol|propofol|mesh-list
6736697|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6736698|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736699|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736700|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6736701|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
6736702|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
6736703|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6736704|NCT01934088|Narcotics|narcotics|mesh-ancestor
6736705|NCT01934088|Analgesics|analgesics|mesh-ancestor
6736706|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
6736707|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736708|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6736709|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6736710|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6736711|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6736712|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
6736713|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
6736714|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736715|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736716|NCT01934127|Vaccines|vaccines|mesh-list
6736717|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
6736718|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736719|NCT01934166|Nalmefene|nalmefene|mesh-list
6736720|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6736721|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736722|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
6736723|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736724|NCT01934361|Carboplatin|carboplatin|mesh-list
6736725|NCT01934361|Lomustine|lomustine|mesh-list
6736726|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736727|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6736728|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
6736729|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736730|NCT01934569|Losartan|losartan|mesh-list
6736731|NCT01934569|Midazolam|midazolam|mesh-list
6736732|NCT01934569|Caffeine|caffeine|mesh-list
6736733|NCT01934569|Omeprazole|omeprazole|mesh-list
6736734|NCT01934569|Pravastatin|pravastatin|mesh-list
6736735|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6736736|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6736737|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736738|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736739|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6736740|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6736741|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6736742|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6736743|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
6736744|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
6736745|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
6736746|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
6736747|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736748|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736749|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6736750|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6736751|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6736752|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6736753|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6736754|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6736755|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6736756|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736757|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6736758|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6736759|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6736760|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6736761|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
6736762|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6736763|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6736764|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
6736765|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6736766|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6736767|NCT01934634|Gemcitabine|gemcitabine|mesh-list
6736768|NCT01934634|Paclitaxel|paclitaxel|mesh-list
6736769|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6736770|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736771|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
6736772|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
6736773|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
6736774|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736775|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6736776|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
6736777|NCT01934634|Antiviral Agents|antiviral agents|mesh-ancestor
6736778|NCT01934634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736779|NCT01934634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736780|NCT01934634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6736781|NCT01934634|Immunologic Factors|immunologic factors|mesh-ancestor
6736782|NCT01934634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736783|NCT01934712|Insulin|insulin|mesh-list
6736784|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6736785|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
6736786|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
6736787|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6736788|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6736789|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736790|NCT01934777|Vitamin E|vitamin e|mesh-list
6736791|NCT01934777|Choline|choline|mesh-list
6736792|NCT01934777|Vitamins|vitamins|mesh-ancestor
6736793|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
6736794|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736795|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
6736796|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736797|NCT01934777|Protective Agents|protective agents|mesh-ancestor
6736798|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
6736799|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6736800|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
6736801|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6736802|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6736803|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
6736804|NCT01934816|Liraglutide|liraglutide|mesh-list
6736805|NCT01934816|Exenatide|exenatide|mesh-list
6736806|NCT01934816|Glucagon|glucagon|mesh-list
6736807|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6736808|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6736809|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736810|NCT01934816|Incretins|incretins|mesh-ancestor
6736811|NCT01934816|Hormones|hormones|mesh-ancestor
6736812|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6736813|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6736814|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6736815|NCT01934829|Sorafenib|sorafenib|mesh-list
6736816|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736817|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6736818|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736819|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736820|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6736821|NCT01934933|Celecoxib|celecoxib|mesh-list
6736822|NCT01934933|Etanercept|etanercept|mesh-list
6736823|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6736824|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6736825|NCT01934933|Analgesics|analgesics|mesh-ancestor
6736826|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
6736827|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736828|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736829|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6736830|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6736831|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6736832|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6736833|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736834|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736835|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6736836|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6736837|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
6736838|NCT01935063|Lidocaine|lidocaine|mesh-list
6736839|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
6736840|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
6736841|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736842|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736843|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
6736844|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736845|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6736846|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6736847|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6736848|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6736849|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736850|NCT01935089|Interferons|interferons|mesh-list
6736851|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
6736852|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
6736853|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6736854|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736855|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
6736856|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6736857|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
6736858|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736859|NCT01935115|Ketamine|ketamine|mesh-list
6736860|NCT01935115|Propofol|propofol|mesh-list
6736861|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6736862|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6736863|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736864|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6736865|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
6736866|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
6736867|NCT01935115|Analgesics|analgesics|mesh-ancestor
6736868|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
6736869|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736870|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6736871|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6736872|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6736873|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736874|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736875|NCT01935128|Everolimus|everolimus|mesh-list
6736876|NCT01935128|Tacrolimus|tacrolimus|mesh-list
6736877|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6736878|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
6736879|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736880|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6736881|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736882|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736883|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736884|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
6736885|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6736886|NCT01935141|Growth Substances|growth substances|mesh-ancestor
6736887|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736888|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
6736889|NCT01935193|Analgesics|analgesics|mesh-ancestor
6736890|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
6736891|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736892|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736893|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6736894|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6736895|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6736896|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6736897|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6736898|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6736899|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736900|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736901|NCT01935206|Naloxone|naloxone|mesh-list
6736902|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6736903|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736904|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
6736905|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786147|NCT02212782|Incretins|incretins|mesh-ancestor
6786148|NCT02212782|Hormones|hormones|mesh-ancestor
6786149|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786150|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6786151|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
6786152|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786153|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786154|NCT02212795|Levofloxacin|levofloxacin|mesh-list
6786155|NCT02212795|Ofloxacin|ofloxacin|mesh-list
6786156|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
6786157|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6786158|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786159|NCT02212795|Renal Agents|renal agents|mesh-ancestor
6786160|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786161|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6786162|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6786163|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786164|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786165|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786166|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6786167|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6786168|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6786169|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
6736906|NCT01935310|Imiquimod|imiquimod|mesh-list
6736907|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6736908|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
6736909|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736910|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736911|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
6736912|NCT01935492|Paclitaxel|paclitaxel|mesh-list
6736913|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6736914|NCT01935492|Bevacizumab|bevacizumab|mesh-list
6736915|NCT01935492|Doxorubicin|doxorubicin|mesh-list
6736916|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6736917|NCT01935492|Capecitabine|capecitabine|mesh-list
6736918|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6736919|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6736920|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
6736921|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
6736922|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
6736923|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736924|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6736925|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6736926|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6736927|NCT01935492|Growth Substances|growth substances|mesh-ancestor
6736928|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736929|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
6736930|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6736931|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6736932|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6736933|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736934|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6736935|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
6736936|NCT01935505|Bupropion|bupropion|mesh-list
6736937|NCT01935505|Nicotine|nicotine|mesh-list
6736938|NCT01935505|Varenicline|varenicline|mesh-list
6736939|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6736940|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
6736941|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736942|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736943|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6736944|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6736945|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
6736946|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736947|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736948|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6736949|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
6736950|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6736951|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6736952|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6736953|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6736954|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
6736955|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6736956|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6736957|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736958|NCT01935518|Fasudil|fasudil|mesh-list
6736959|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6736960|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6736961|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736962|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6736963|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736964|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
6736965|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6736966|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736967|NCT01935531|Diclofenac|diclofenac|mesh-list
6736968|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
6736969|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6736970|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6736971|NCT01935531|Analgesics|analgesics|mesh-ancestor
6736972|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
6736973|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6736974|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736975|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6736976|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6736977|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6736978|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6736979|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736980|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6736981|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
6736982|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
6736983|NCT01935531|Protective Agents|protective agents|mesh-ancestor
6736984|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
6736985|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6736986|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6736987|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736988|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
6736989|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6736990|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6736991|NCT01935557|Heparin|heparin|mesh-list
6736992|NCT01935557|Calcium heparin|calcium heparin|mesh-list
6736993|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
6736994|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6736995|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6736996|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6736997|NCT01935596|Ropivacaine|ropivacaine|mesh-list
6736998|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
6736999|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
6737000|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
6737001|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737002|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737003|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
6737004|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737005|NCT01935648|Ropivacaine|ropivacaine|mesh-list
6737006|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
6737007|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
6737008|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737009|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737010|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
6737011|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737012|NCT01935674|Ritonavir|ritonavir|mesh-list
6737013|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6737014|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6737015|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6737016|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
6737017|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737018|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737019|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6737020|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6737021|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
6737022|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737023|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6737024|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6737025|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6737026|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6737027|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
6737028|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6737029|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6737030|NCT01935713|Nicotine|nicotine|mesh-list
6737031|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6737032|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
6737033|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737034|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737035|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6737036|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6737037|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
6737038|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737039|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737040|NCT01935778|Docetaxel|docetaxel|mesh-list
6737041|NCT01935778|Capecitabine|capecitabine|mesh-list
6737042|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
6737043|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737044|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
6737045|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
6737046|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
6737047|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737048|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6737049|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
6737050|NCT01935804|Metformin|metformin|mesh-list
6737051|NCT01935804|Pioglitazone|pioglitazone|mesh-list
6737052|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6737053|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737054|NCT01935817|Vitamin E|vitamin e|mesh-list
6737055|NCT01935817|Silybin|silybin|mesh-list
6737056|NCT01935817|Vitamins|vitamins|mesh-ancestor
6737057|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
6737058|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737059|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
6737060|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737061|NCT01935817|Protective Agents|protective agents|mesh-ancestor
6737062|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6737063|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737064|NCT01935830|Ritonavir|ritonavir|mesh-list
6737065|NCT01935830|Efavirenz|efavirenz|mesh-list
6737066|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6737067|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6737068|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
6737069|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737070|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737071|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6737072|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6737073|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
6737074|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737075|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6737076|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6737077|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6737078|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6737079|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6737080|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6737081|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6737082|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6737083|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6737084|NCT01935869|Petrolatum|petrolatum|mesh-list
6737085|NCT01935869|Emollients|emollients|mesh-ancestor
6737086|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
6737087|NCT01935882|Lumefantrine|lumefantrine|mesh-list
6737088|NCT01935882|Artemether|artemether|mesh-list
6737089|NCT01935882|Primaquine|primaquine|mesh-list
6737090|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6737091|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
6737092|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6737093|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6737094|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737095|NCT01935908|Levetiracetam|levetiracetam|mesh-list
6737096|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
6737097|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
6737098|NCT01935973|Trametinib|trametinib|mesh-list
6737099|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737100|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6737101|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737102|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737103|NCT01936012|Lisinopril|lisinopril|mesh-list
6737104|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6737105|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
6737106|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737107|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737108|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6737109|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6737110|NCT01936012|Protective Agents|protective agents|mesh-ancestor
6737111|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737112|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6737113|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
6737114|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6737115|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737116|NCT01936025|Incretins|incretins|mesh-ancestor
6737117|NCT01936025|Hormones|hormones|mesh-ancestor
6737118|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6737119|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6737120|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
6737121|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737122|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737123|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
6737124|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
6737125|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6737126|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6737127|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737128|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
6737129|NCT01936064|Epirubicin|epirubicin|mesh-list
6737130|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6737131|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
6737132|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737133|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737134|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6737135|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
6737136|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737137|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737138|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6737139|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6737140|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6737141|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6737142|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737143|NCT01936090|Bortezomib|bortezomib|mesh-list
6737144|NCT01936090|Melphalan|melphalan|mesh-list
6737145|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737146|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6737147|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
6737148|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737149|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6737150|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6737151|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
6737152|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737153|NCT01936103|Atorvastatin|atorvastatin|mesh-list
6737154|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6737155|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6737156|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
6737157|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737158|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6737159|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6737160|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737161|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
6737162|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
6737163|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6737164|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
6737165|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737166|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6737167|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737168|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
6737169|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6737170|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737171|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737172|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6737173|NCT01936233|Aspirin|aspirin|mesh-list
6737174|NCT01936233|Lamivudine|lamivudine|mesh-list
6737175|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6737176|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6737177|NCT01936233|Analgesics|analgesics|mesh-ancestor
6737178|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
6737179|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737180|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737181|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6737182|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737183|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6737184|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6737185|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737186|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6737187|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6737188|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737189|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
6737190|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6737191|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6737192|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
6737193|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737194|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6737195|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6737196|NCT01936285|Colchicine|colchicine|mesh-list
6737197|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
6737198|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737199|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
6737200|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
6737201|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
6737202|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737203|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737204|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
6737205|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
6737206|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6737207|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6737208|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737209|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737210|NCT01936350|Urological Agents|urological agents|mesh-ancestor
6737211|NCT01936532|Dexamethasone|dexamethasone|mesh-list
6737212|NCT01936532|Lenalidomide|lenalidomide|mesh-list
6737213|NCT01936532|Ixazomib|ixazomib|mesh-list
6737214|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6737215|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
6737216|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
6737217|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737218|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737219|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6737220|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
6737221|NCT01936532|Hormones|hormones|mesh-ancestor
6737222|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6737223|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6737224|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737225|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
6737226|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6737227|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6737228|NCT01936532|Growth Substances|growth substances|mesh-ancestor
6737229|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
6737230|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
6737231|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737232|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737233|NCT01936545|Propofol|propofol|mesh-list
6737234|NCT01936545|Desflurane|desflurane|mesh-list
6737235|NCT01936545|Liver Extracts|liver extracts|mesh-list
6737236|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6737237|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737238|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737239|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6737240|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
6737241|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
6737242|NCT01936545|Hematinics|hematinics|mesh-ancestor
6737243|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6737244|NCT01936636|Fentanyl|fentanyl|mesh-list
6737245|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6737246|NCT01936636|Narcotics|narcotics|mesh-ancestor
6737247|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737248|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737249|NCT01936636|Analgesics|analgesics|mesh-ancestor
6737250|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
6737251|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737252|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6737253|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6737254|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
6737255|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
6737256|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6737257|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6737258|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6737259|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
6737260|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737261|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6737262|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6737263|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786170|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6786171|NCT02212821|Erythromycin|erythromycin|mesh-list
6786172|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
6786173|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6786174|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
6786175|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786176|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737264|NCT01936961|Antibodies|antibodies|mesh-list
6737265|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
6737266|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737267|NCT01937013|Oxytocin|oxytocin|mesh-list
6737268|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
6737269|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6737270|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737271|NCT01937078|Famotidine|famotidine|mesh-list
6737272|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6737273|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6737274|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6737275|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
6737276|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
6737277|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737278|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737279|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737280|NCT01937104|Remifentanil|remifentanil|mesh-list
6737281|NCT01937104|Desflurane|desflurane|mesh-list
6737282|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6737283|NCT01937104|Narcotics|narcotics|mesh-ancestor
6737284|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737285|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737286|NCT01937104|Analgesics|analgesics|mesh-ancestor
6737287|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
6737288|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737289|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6737290|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
6737291|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
6737292|NCT01937156|Granisetron|granisetron|mesh-list
6737293|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
6737294|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
6737295|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737296|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737297|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6737298|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6737299|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
6737300|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737301|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737302|NCT01937169|Levodopa|levodopa|mesh-list
6737303|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6737304|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6737305|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
6737306|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737307|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737308|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737309|NCT01937182|Citalopram|citalopram|mesh-list
6737310|NCT01937182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6737311|NCT01937182|Serotonin|serotonin|mesh-list
6737312|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6737313|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6737314|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737315|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737316|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
6737317|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737318|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6737319|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
6737320|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6737321|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6737322|NCT01937234|Metoclopramide|metoclopramide|mesh-list
6737323|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
6737324|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
6737325|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737326|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737327|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6737328|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6737329|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6737330|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
6737331|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737332|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737333|NCT01937325|Ivacaftor|ivacaftor|mesh-list
6737334|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6737335|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6737336|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737337|NCT01937338|AZD7624|azd7624|mesh-list
6737338|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6737339|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737340|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737341|NCT01937442|Thalidomide|thalidomide|mesh-list
6737342|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6737343|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
6737344|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737345|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
6737346|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6737347|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737348|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6737349|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6737350|NCT01937442|Growth Substances|growth substances|mesh-ancestor
6737351|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
6737352|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737353|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
6737354|NCT01937494|Histamine|histamine|mesh-list
6737355|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
6737356|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
6737357|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737358|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737359|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737360|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
6737361|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
6737362|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737363|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
6737364|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737365|NCT01937611|Midazolam|midazolam|mesh-list
6737366|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
6737367|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6737368|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737369|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737370|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6737371|NCT01937611|Analgesics|analgesics|mesh-ancestor
6737372|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
6737373|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737374|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6737375|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6737376|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6737377|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
6737378|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737379|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737380|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6737381|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6737382|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6737383|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6737384|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6737385|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
6737386|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
6737387|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
6737388|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
6737389|NCT01937650|Metronidazole|metronidazole|mesh-list
6737390|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737391|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6737392|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6737393|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6737394|NCT01937728|Interferons|interferons|mesh-list
6737395|NCT01937728|Ribavirin|ribavirin|mesh-list
6737396|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
6737397|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
6737398|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6737399|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737400|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
6737401|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737402|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
6737403|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737404|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
6737405|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737406|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
6737407|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6737408|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
6737409|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737410|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737411|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6737412|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
6737413|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6737414|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
6737415|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737416|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737417|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6737418|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
6737419|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
6737420|NCT01937754|Protective Agents|protective agents|mesh-ancestor
6737421|NCT01937767|Fentanyl|fentanyl|mesh-list
6737422|NCT01937767|Remifentanil|remifentanil|mesh-list
6737423|NCT01937767|Propofol|propofol|mesh-list
6737424|NCT01937767|Sevoflurane|sevoflurane|mesh-list
6737425|NCT01937767|Rocuronium|rocuronium|mesh-list
6737426|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6737427|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737428|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737429|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6737430|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
6737431|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
6737432|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6737433|NCT01937767|Narcotics|narcotics|mesh-ancestor
6737434|NCT01937767|Analgesics|analgesics|mesh-ancestor
6737435|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
6737436|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737437|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6737438|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6737439|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6737440|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6737441|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6737442|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6737443|NCT01937806|Tenofovir|tenofovir|mesh-list
6737444|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
6737445|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737446|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6737447|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6737448|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737449|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737450|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6737451|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6737452|NCT01937832|Ertapenem|ertapenem|mesh-list
6737453|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6737454|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737455|NCT01938092|Diazepam|diazepam|mesh-list
6737456|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6737457|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
6737458|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
6737459|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
6737460|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737461|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737462|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6737463|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6737464|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737465|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6737466|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6737467|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6737468|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6737469|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6737470|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6737471|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
6737472|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
6737473|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
6737474|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
6737475|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737476|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737477|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
6737478|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6737479|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737480|NCT01938144|Acetaminophen|acetaminophen|mesh-list
6737481|NCT01938144|Ibuprofen|ibuprofen|mesh-list
6737482|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6737483|NCT01938144|Analgesics|analgesics|mesh-ancestor
6737484|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
6737485|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737486|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737487|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
6737488|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6737489|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6737490|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737491|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6737492|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737493|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737494|NCT01938183|Metronidazole|metronidazole|mesh-list
6737495|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737496|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6737497|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6737498|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6737499|NCT01938235|Exenatide|exenatide|mesh-list
6737500|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6737501|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737502|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6737503|NCT01938235|Incretins|incretins|mesh-ancestor
6737504|NCT01938235|Hormones|hormones|mesh-ancestor
6737505|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6737506|NCT01938248|Aspirin|aspirin|mesh-list
6737507|NCT01938248|Apixaban|apixaban|mesh-list
6737508|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6737509|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6737510|NCT01938248|Analgesics|analgesics|mesh-ancestor
6737511|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
6737512|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737513|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737514|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6737515|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737516|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6737517|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6737518|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737519|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6737520|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6737521|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737522|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
6737523|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6737524|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
6737525|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6737526|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
6737527|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
6737528|NCT01938261|Acetaminophen|acetaminophen|mesh-list
6737529|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6737530|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6737531|NCT01938261|Analgesics|analgesics|mesh-ancestor
6737532|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
6737533|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737534|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737535|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
6737536|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
6737537|NCT01938300|Analgesics|analgesics|mesh-ancestor
6737538|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
6737539|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737540|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737541|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
6737542|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737543|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6737544|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
6737545|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6737546|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6737547|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737548|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6737549|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
6737550|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6737551|NCT01938417|Tobramycin|tobramycin|mesh-list
6737552|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6737553|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737554|NCT01938443|Trametinib|trametinib|mesh-list
6737555|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737556|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6737557|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737558|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737559|NCT01938456|Docetaxel|docetaxel|mesh-list
6737560|NCT01938456|Trametinib|trametinib|mesh-list
6737561|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737562|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
6737563|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
6737564|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
6737565|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737566|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6737567|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737568|NCT01938508|Minocycline|minocycline|mesh-list
6737569|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6737570|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737571|NCT01938547|Clevidipine|clevidipine|mesh-list
6737572|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6737573|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6737574|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737575|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6737576|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737577|NCT01938612|Durvalumab|durvalumab|mesh-list
6737578|NCT01938612|Tremelimumab|tremelimumab|mesh-list
6737579|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6737580|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786177|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6786178|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6786179|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786180|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786181|NCT02212990|Acetaminophen|acetaminophen|mesh-list
6786182|NCT02212990|Ibuprofen|ibuprofen|mesh-list
6786183|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6786184|NCT02212990|Analgesics|analgesics|mesh-ancestor
6786185|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
6786186|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786187|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786188|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
6786189|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6786190|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6786191|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737581|NCT01938729|Gemcitabine|gemcitabine|mesh-list
6737582|NCT01938729|Dexamethasone|dexamethasone|mesh-list
6737583|NCT01938729|Floxuridine|floxuridine|mesh-list
6737584|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6737585|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
6737586|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
6737587|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737588|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737589|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6737590|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
6737591|NCT01938729|Hormones|hormones|mesh-ancestor
6737592|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6737593|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6737594|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737595|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6737596|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
6737597|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737598|NCT01938729|Antiviral Agents|antiviral agents|mesh-ancestor
6737599|NCT01938729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737600|NCT01938729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737601|NCT01938729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6737602|NCT01938729|Immunologic Factors|immunologic factors|mesh-ancestor
6737603|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
6737604|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
6737605|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
6737606|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737607|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737608|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
6737609|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737610|NCT01938781|Entecavir|entecavir|mesh-list
6737611|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
6737612|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737613|NCT01938820|Entecavir|entecavir|mesh-list
6737614|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
6737615|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737616|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6737617|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
6737618|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6737619|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6737620|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6737621|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737622|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737623|NCT01938872|Paclitaxel|paclitaxel|mesh-list
6737624|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6737625|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737626|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
6737627|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
6737628|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
6737629|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737630|NCT01938911|Oxytocin|oxytocin|mesh-list
6737631|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
6737632|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6737633|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737634|NCT01939054|Docetaxel|docetaxel|mesh-list
6737635|NCT01939054|Capecitabine|capecitabine|mesh-list
6737636|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
6737637|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737638|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
6737639|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
6737640|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
6737641|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737642|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6737643|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
6737644|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6737645|NCT01939093|Thiamine|thiamine|mesh-list
6737646|NCT01939093|Cinnarizine|cinnarizine|mesh-list
6737647|NCT01939093|Diazepam|diazepam|mesh-list
6737648|NCT01939093|Vitamins|vitamins|mesh-ancestor
6737649|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
6737650|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737651|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
6737652|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6737653|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
6737654|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
6737655|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
6737656|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737657|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6737658|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6737659|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737660|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6737661|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6737662|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6737663|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6737664|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6737665|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6737666|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
6737667|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
6737668|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
6737669|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
6737670|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737671|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737672|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6737673|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6737674|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6737675|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6737676|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
6737677|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
6737678|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
6737679|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
6737680|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737681|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6737682|NCT01939327|Rituximab|rituximab|mesh-list
6737683|NCT01939327|Lenalidomide|lenalidomide|mesh-list
6737684|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6737685|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737686|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
6737687|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737688|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737689|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6737690|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6737691|NCT01939327|Growth Substances|growth substances|mesh-ancestor
6737692|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
6737693|NCT01939379|Acetaminophen|acetaminophen|mesh-list
6737694|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6737695|NCT01939379|Morphine|morphine|mesh-list
6737696|NCT01939379|Oxycodone|oxycodone|mesh-list
6737697|NCT01939379|Analgesics|analgesics|mesh-list
6737698|NCT01939379|Ropivacaine|ropivacaine|mesh-list
6737699|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6737700|NCT01939379|Narcotics|narcotics|mesh-ancestor
6737701|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737702|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737703|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
6737704|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737705|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
6737706|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
6737707|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6737708|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6737709|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6737710|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737711|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
6737712|NCT01939418|Gemcitabine|gemcitabine|mesh-list
6737713|NCT01939418|Everolimus|everolimus|mesh-list
6737714|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737715|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6737716|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
6737717|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737718|NCT01939418|Antiviral Agents|antiviral agents|mesh-ancestor
6737719|NCT01939418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737720|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737721|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6737722|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
6737723|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737724|NCT01939444|Naloxone|naloxone|mesh-list
6737725|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6737726|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737727|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
6737728|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737729|NCT01939457|Misoprostol|misoprostol|mesh-list
6737730|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6737731|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
6737732|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6737733|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737734|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6737735|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6737736|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
6737737|NCT01939483|Irinotecan|irinotecan|mesh-list
6737738|NCT01939483|Camptothecin|camptothecin|mesh-list
6737739|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6737740|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6737741|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737742|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737743|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737744|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6737745|NCT01939509|Atenolol|atenolol|mesh-list
6737746|NCT01939509|Bisoprolol|bisoprolol|mesh-list
6737747|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6737748|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6737749|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
6737750|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
6737751|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737752|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737753|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6737754|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6737755|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6737756|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
6737757|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737758|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737759|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6737760|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
6737761|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737762|NCT01939561|Lamotrigine|lamotrigine|mesh-list
6737763|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
6737764|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6737765|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6737766|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737767|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6737768|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737769|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6737770|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6737771|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737772|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6737773|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6737774|NCT01939574|Bevacizumab|bevacizumab|mesh-list
6737775|NCT01939574|Temozolomide|temozolomide|mesh-list
6737776|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6737777|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737778|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6737779|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6737780|NCT01939574|Growth Substances|growth substances|mesh-ancestor
6737781|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737782|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
6737783|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6737784|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
6737785|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737786|NCT01939639|Oxytocin|oxytocin|mesh-list
6737787|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
6737788|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6737789|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737790|NCT01939691|Prednisolone|prednisolone|mesh-list
6737791|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6737792|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
6737793|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6737794|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
6737795|NCT01939691|Nepafenac|nepafenac|mesh-list
6737796|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6737797|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
6737798|NCT01939691|Difluprednate|difluprednate|mesh-list
6737799|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6737800|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
6737801|NCT01939691|Hormones|hormones|mesh-ancestor
6737802|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6737803|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737804|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6737805|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737806|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
6737807|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
6737808|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737809|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6737810|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6737811|NCT01939691|Protective Agents|protective agents|mesh-ancestor
6737812|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6737813|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6737814|NCT01939691|Analgesics|analgesics|mesh-ancestor
6737815|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
6737816|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737817|NCT01939730|Rituximab|rituximab|mesh-list
6737818|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6737819|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737820|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
6737821|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737822|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737823|NCT01939743|Diclofenac|diclofenac|mesh-list
6737824|NCT01939743|Lidocaine|lidocaine|mesh-list
6737825|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
6737826|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
6737827|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737828|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737829|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
6737830|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737831|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6737832|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6737833|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6737834|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6737835|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737836|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6737837|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6737838|NCT01939743|Analgesics|analgesics|mesh-ancestor
6737839|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6737840|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6737841|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6737842|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737843|NCT01939834|Insulin|insulin|mesh-list
6737844|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6737845|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737846|NCT01939886|Artesunate|artesunate|mesh-list
6737847|NCT01939886|Lumefantrine|lumefantrine|mesh-list
6737848|NCT01939886|Artemether|artemether|mesh-list
6737849|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6737850|NCT01939886|Mefloquine|mefloquine|mesh-list
6737851|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
6737852|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6737853|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6737854|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6737855|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737856|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
6737857|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
6737858|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6737859|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
6737860|NCT01939912|Adenosine|adenosine|mesh-list
6737861|NCT01939912|Analgesics|analgesics|mesh-ancestor
6737862|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
6737863|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737864|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737865|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6737866|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
6737867|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6737868|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
6737869|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
6737870|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737871|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737872|NCT01939990|Nebivolol|nebivolol|mesh-list
6737873|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6737874|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
6737875|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6737876|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6737877|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6737878|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
6737879|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737880|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737881|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737882|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6737883|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737884|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737885|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737886|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6737887|NCT01940172|Conatumumab|conatumumab|mesh-list
6737888|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6737889|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737890|NCT01940224|Pregabalin|pregabalin|mesh-list
6737891|NCT01940224|Morphine|morphine|mesh-list
6737892|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6737893|NCT01940224|Narcotics|narcotics|mesh-ancestor
6737894|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737895|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737896|NCT01940224|Analgesics|analgesics|mesh-ancestor
6737897|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
6737898|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737899|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
6737900|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6737901|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6737902|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737903|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6737904|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6737905|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6737906|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6737907|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
6737908|NCT01940250|Analgesics|analgesics|mesh-ancestor
6737909|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
6737910|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6737911|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737912|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
6737913|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6737914|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6737915|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
6737916|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6737917|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6737918|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737919|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6737920|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
6737921|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6786192|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6786193|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786194|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786195|NCT02213029|Oxytocin|oxytocin|mesh-list
6786196|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
6786197|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6737922|NCT01940393|Cetirizine|cetirizine|mesh-list
6737923|NCT01940393|Fexofenadine|fexofenadine|mesh-list
6737924|NCT01940393|Desloratadine|desloratadine|mesh-list
6737925|NCT01940393|Ebastine|ebastine|mesh-list
6737926|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6737927|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6737928|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6737929|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
6737930|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
6737931|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737932|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737933|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737934|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6737935|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
6737936|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
6737937|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6737938|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6737939|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737940|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
6737941|NCT01940419|Coagulants|coagulants|mesh-ancestor
6737942|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
6737943|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6737944|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6737945|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737946|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
6737947|NCT01940536|Coagulants|coagulants|mesh-ancestor
6737948|NCT01940601|Lenograstim|lenograstim|mesh-list
6737949|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6737950|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
6737951|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737952|NCT01940627|Ubiquinone|ubiquinone|mesh-list
6737953|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
6737954|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
6737955|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737956|NCT01940627|Vitamins|vitamins|mesh-ancestor
6737957|NCT01940653|Estradiol|estradiol|mesh-list
6737958|NCT01940653|Progesterone|progesterone|mesh-list
6737959|NCT01940653|Estrogens|estrogens|mesh-ancestor
6737960|NCT01940653|Hormones|hormones|mesh-ancestor
6737961|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6737962|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737963|NCT01940653|Progestins|progestins|mesh-ancestor
6737964|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
6737965|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6737966|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6737967|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737968|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
6737969|NCT01940692|Coagulants|coagulants|mesh-ancestor
6737970|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
6737971|NCT01940718|Testosterone|testosterone|mesh-list
6737972|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
6737973|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
6737974|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6737975|NCT01940718|Androgens|androgens|mesh-ancestor
6737976|NCT01940718|Hormones|hormones|mesh-ancestor
6737977|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6737978|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737979|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6737980|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737981|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
6737982|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6737983|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6737984|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6737985|NCT01940952|Donepezil|donepezil|mesh-list
6737986|NCT01940952|Udenafil|udenafil|mesh-list
6737987|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6737988|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6737989|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6737990|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
6737991|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6737992|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6737993|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
6737994|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6737995|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6737996|NCT01940965|Lixisenatide|lixisenatide|mesh-list
6737997|NCT01940965|Biguanides|biguanides|mesh-list
6737998|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6737999|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738000|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
6738001|NCT01940978|Methylphenidate|methylphenidate|mesh-list
6738002|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6738003|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738004|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6738005|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6738006|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6738007|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738008|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
6738009|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738010|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
6738011|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
6738012|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6738013|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6738014|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
6738015|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
6738016|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6738017|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
6738018|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6738019|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6738020|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6738021|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738022|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6738023|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
6738024|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738025|NCT01941056|Vaccines|vaccines|mesh-list
6738026|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
6738027|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738028|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
6738029|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6738030|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6738031|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
6738032|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
6738033|NCT01941134|Estradiol|estradiol|mesh-list
6738034|NCT01941134|Estrogens|estrogens|mesh-ancestor
6738035|NCT01941134|Hormones|hormones|mesh-ancestor
6738036|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738037|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738038|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6738039|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6738040|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6738041|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6738042|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6738043|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6738044|NCT01941173|Leucovorin|leucovorin|mesh-list
6738045|NCT01941173|Fluorouracil|fluorouracil|mesh-list
6738046|NCT01941173|Irinotecan|irinotecan|mesh-list
6738047|NCT01941173|Aflibercept|aflibercept|mesh-list
6738048|NCT01941173|Calcium|calcium|mesh-list
6738049|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
6738050|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
6738051|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6738052|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738053|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
6738054|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738055|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6738056|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738057|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6738058|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
6738059|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6738060|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6738061|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738062|NCT01941173|Antidotes|antidotes|mesh-ancestor
6738063|NCT01941173|Protective Agents|protective agents|mesh-ancestor
6738064|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
6738065|NCT01941173|Vitamins|vitamins|mesh-ancestor
6738066|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
6738067|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6738068|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6738069|NCT01941173|Growth Substances|growth substances|mesh-ancestor
6738070|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
6738071|NCT01941199|Metformin|metformin|mesh-list
6738072|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6738073|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738074|NCT01941225|Iloprost|iloprost|mesh-list
6738075|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6738076|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
6738077|NCT01941264|Lumefantrine|lumefantrine|mesh-list
6738078|NCT01941264|Artemether|artemether|mesh-list
6738079|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6738080|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
6738081|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6738082|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6738083|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738084|NCT01941316|Irinotecan|irinotecan|mesh-list
6738085|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6738086|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6738087|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738088|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738089|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738090|NCT01941329|Ranibizumab|ranibizumab|mesh-list
6738091|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6738092|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6738093|NCT01941329|Growth Substances|growth substances|mesh-ancestor
6738094|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738095|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
6738096|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738097|NCT01941407|Bevacizumab|bevacizumab|mesh-list
6738098|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6738099|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738100|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6738101|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6738102|NCT01941407|Growth Substances|growth substances|mesh-ancestor
6738103|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738104|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
6738105|NCT01941524|Poractant alfa|poractant alfa|mesh-list
6738106|NCT01941524|Beractant|beractant|mesh-list
6738107|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6738108|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
6738109|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6738110|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
6738111|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738112|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
6738113|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6738114|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6738115|NCT01941589|Prednisolone|prednisolone|mesh-list
6738116|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
6738117|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
6738118|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6738119|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6738120|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6738121|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6738122|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
6738123|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6738124|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
6738125|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
6738126|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738127|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738128|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6738129|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
6738130|NCT01941589|Hormones|hormones|mesh-ancestor
6738131|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738132|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6738133|NCT01941589|Protective Agents|protective agents|mesh-ancestor
6738134|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6738135|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738136|NCT01941602|Enoxaparin|enoxaparin|mesh-list
6738137|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
6738138|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6738139|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6738140|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738141|NCT01941641|Capecitabine|capecitabine|mesh-list
6738142|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6738143|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
6738144|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738145|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738146|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
6738147|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
6738148|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6738149|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6738150|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786198|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738151|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738152|NCT01941732|Urological Agents|urological agents|mesh-ancestor
6738153|NCT01941758|Vaccines|vaccines|mesh-list
6738154|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
6738155|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738156|NCT01941771|Capecitabine|capecitabine|mesh-list
6738157|NCT01941771|Vinorelbine|vinorelbine|mesh-list
6738158|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6738159|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
6738160|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738161|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738162|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6738163|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
6738164|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
6738165|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
6738166|NCT01941810|Lactoferrin|lactoferrin|mesh-list
6738167|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738168|NCT01941875|Progesterone|progesterone|mesh-list
6738169|NCT01941875|Progestins|progestins|mesh-ancestor
6738170|NCT01941875|Hormones|hormones|mesh-ancestor
6738171|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738172|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738173|NCT01941888|Midazolam|midazolam|mesh-list
6738174|NCT01941888|Propofol|propofol|mesh-list
6738175|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6738176|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738177|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738178|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6738179|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
6738180|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
6738181|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6738182|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6738183|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6738184|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6738185|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
6738186|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
6738187|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738188|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738189|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
6738190|NCT01941901|Bleomycin|bleomycin|mesh-list
6738191|NCT01941901|Calcium|calcium|mesh-list
6738192|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6738193|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738194|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6738195|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6738196|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738197|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
6738198|NCT01941914|Calcium|calcium|mesh-list
6738199|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6738200|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738201|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6738202|NCT01941953|Metformin|metformin|mesh-list
6738203|NCT01941953|Fluorouracil|fluorouracil|mesh-list
6738204|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6738205|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738206|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
6738207|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738208|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6738209|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738210|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6738211|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
6738212|NCT01941966|Capecitabine|capecitabine|mesh-list
6738213|NCT01941966|Mitomycins|mitomycins|mesh-list
6738214|NCT01941966|Mitomycin|mitomycin|mesh-list
6738215|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6738216|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
6738217|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738218|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738219|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6738220|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
6738221|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6738222|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738223|NCT01941979|Leucovorin|leucovorin|mesh-list
6738224|NCT01941979|Capecitabine|capecitabine|mesh-list
6738225|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
6738226|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6738227|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
6738228|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738229|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738230|NCT01941979|Antidotes|antidotes|mesh-ancestor
6738231|NCT01941979|Protective Agents|protective agents|mesh-ancestor
6738232|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738233|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
6738234|NCT01941979|Vitamins|vitamins|mesh-ancestor
6738235|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
6738236|NCT01942070|Everolimus|everolimus|mesh-list
6738237|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738238|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6738239|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
6738240|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786199|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
6786200|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6786201|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
6786202|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6786203|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786204|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6786205|NCT02213107|Dutasteride|dutasteride|mesh-list
6786206|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6786207|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6786208|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786209|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786210|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
6786211|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786212|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786213|NCT02213146|Insulin|insulin|mesh-list
6786214|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
6786215|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6786216|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6786217|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786218|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
6786219|NCT02213159|Morphine|morphine|mesh-list
6786220|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6786221|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6786222|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786223|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6786224|NCT02213159|Analgesics|analgesics|mesh-ancestor
6786225|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
6786226|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786227|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6786228|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6786229|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6786230|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
6786231|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786232|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786233|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6786234|NCT02213159|Narcotics|narcotics|mesh-ancestor
6786235|NCT02213211|Lumefantrine|lumefantrine|mesh-list
6786236|NCT02213211|Artemether|artemether|mesh-list
6786237|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6786238|NCT02213211|Artemisinins|artemisinins|mesh-list
6786239|NCT02213211|Artemisinin|artemisinin|mesh-list
6786240|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
6786241|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6786242|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6786243|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786244|NCT02213224|Amlodipine|amlodipine|mesh-list
6786245|NCT02213224|Telmisartan|telmisartan|mesh-list
6786246|NCT02213224|Perindopril|perindopril|mesh-list
6786247|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6786248|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6786249|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6786250|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786251|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6786252|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786253|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
6786254|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6738241|NCT01942109|Torsemide|torsemide|mesh-list
6738242|NCT01942109|Furosemide|furosemide|mesh-list
6738243|NCT01942109|Diuretics|diuretics|mesh-ancestor
6738244|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
6738245|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738246|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6738247|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6738248|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738249|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6738250|NCT01942174|Methotrexate|methotrexate|mesh-list
6738251|NCT01942174|Vaccines|vaccines|mesh-list
6738252|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6738253|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6738254|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
6738255|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6738256|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738257|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6738258|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
6738259|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738260|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738261|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
6738262|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738263|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6738264|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6738265|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
6738266|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6738267|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6738268|NCT01942187|Aripiprazole|aripiprazole|mesh-list
6738269|NCT01942187|Bupropion|bupropion|mesh-list
6738270|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6738271|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
6738272|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6738273|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6738274|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6738275|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6738276|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738277|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
6738278|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738279|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738280|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6738281|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6738282|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738283|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6738284|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6738285|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738286|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
6738287|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6738288|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6738289|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
6738290|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6738291|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6738292|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6738293|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6738294|NCT01942291|Niacin|niacin|mesh-list
6738295|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
6738296|NCT01942291|Vitamins|vitamins|mesh-ancestor
6738297|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
6738298|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738299|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
6738300|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6738301|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
6738302|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738303|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6738304|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
6738305|NCT01942304|Calcium|calcium|mesh-list
6738306|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6738307|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738308|NCT01942343|Droperidol|droperidol|mesh-list
6738309|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6738310|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
6738311|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
6738312|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738313|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738314|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6738315|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6738316|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6738317|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738318|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6738319|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6738320|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6738321|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
6738322|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738323|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738324|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6738325|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
6738326|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6738327|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
6738328|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6738329|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738330|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6738331|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6738332|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738333|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6738334|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6738335|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6738336|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738337|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738338|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6738339|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6738340|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6738341|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
6738342|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738343|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738344|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6738345|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6738346|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
6738347|NCT01942447|Vancomycin|vancomycin|mesh-list
6738348|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6738349|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738350|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6738351|NCT01942460|Hematinics|hematinics|mesh-ancestor
6738352|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6738353|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6738354|NCT01942551|Tadalafil|tadalafil|mesh-list
6738355|NCT01942551|Dutasteride|dutasteride|mesh-list
6738356|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
6738357|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6738358|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6738359|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738360|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738361|NCT01942551|Urological Agents|urological agents|mesh-ancestor
6738362|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6738363|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6738364|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
6738365|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738366|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738367|NCT01942577|Protective Agents|protective agents|mesh-list
6738368|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738369|NCT01942681|Propiverine|propiverine|mesh-list
6738370|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
6738371|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
6738372|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738373|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738374|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6738375|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6738376|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
6738377|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738378|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738379|NCT01942681|Urological Agents|urological agents|mesh-ancestor
6738380|NCT01942889|Antioxidants|antioxidants|mesh-list
6738381|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738382|NCT01942889|Protective Agents|protective agents|mesh-ancestor
6738383|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738384|NCT01943019|Linagliptin|linagliptin|mesh-list
6738385|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6738386|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738387|NCT01943019|Incretins|incretins|mesh-ancestor
6738388|NCT01943019|Hormones|hormones|mesh-ancestor
6738389|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738390|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6738391|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
6738392|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738393|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738394|NCT01943058|Megestrol|megestrol|mesh-list
6738395|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
6738396|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
6738397|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6738398|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
6738399|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6738400|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738401|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6738402|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6738403|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6738404|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6738405|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6738406|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738407|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
6738408|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6738409|NCT01943136|Mupirocin|mupirocin|mesh-list
6738410|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6738411|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738412|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6738413|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738414|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738415|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
6738416|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6738417|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
6738418|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738419|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6738420|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6738421|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
6738422|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738423|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738424|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6738425|NCT01943240|Ropivacaine|ropivacaine|mesh-list
6738426|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
6738427|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
6738428|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738429|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738430|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
6738431|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738432|NCT01943305|Vaccines|vaccines|mesh-list
6738433|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
6738434|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738435|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6738436|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6738437|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6738438|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6738439|NCT01943422|Interferons|interferons|mesh-list
6738440|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
6738441|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
6738442|NCT01943422|Vemurafenib|vemurafenib|mesh-list
6738443|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738444|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
6738445|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738446|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
6738447|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738448|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6738449|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738450|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738451|NCT01943487|Verapamil|verapamil|mesh-list
6738452|NCT01943487|Tamsulosin|tamsulosin|mesh-list
6738453|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
6738454|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6738455|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6738456|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6738457|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
6738458|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738459|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738460|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738461|NCT01943487|Urological Agents|urological agents|mesh-ancestor
6738462|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6738463|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6738464|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
6738465|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6738466|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6738467|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6738468|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6738469|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
6738470|NCT01943526|Natalizumab|natalizumab|mesh-list
6738471|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
6738472|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738473|NCT01943617|Entecavir|entecavir|mesh-list
6738474|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
6738475|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738476|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
6738477|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6738478|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
6738479|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738480|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738481|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6738482|NCT01943630|Protective Agents|protective agents|mesh-ancestor
6738483|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6738484|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6738485|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738486|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738487|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
6738488|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786255|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6786256|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6786257|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
6786258|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786259|NCT02213302|Midazolam|midazolam|mesh-list
6786260|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6786261|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6786262|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6786263|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786264|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6786265|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6786266|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6786267|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6786268|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
6786269|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
6786270|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
6786271|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
6786272|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786273|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786274|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
6786275|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6786276|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6786277|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
6786278|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786279|NCT02213328|Tenofovir|tenofovir|mesh-list
6786280|NCT02213328|Emtricitabine|emtricitabine|mesh-list
6786281|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6786282|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
6786283|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786284|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6786285|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6786286|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786287|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786288|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6786289|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6786290|NCT02213419|Ethanol|ethanol|mesh-list
6786291|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6786292|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786293|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6786294|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786295|NCT02213432|Vaccines|vaccines|mesh-list
6786296|NCT02213432|Immunologic Factors|immunologic factors|mesh-ancestor
6786297|NCT02213432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786298|NCT02213497|Paclitaxel|paclitaxel|mesh-list
6786299|NCT02213497|Carboplatin|carboplatin|mesh-list
6786300|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6786301|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6738489|NCT01943760|Tramadol|tramadol|mesh-list
6738490|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6738491|NCT01943760|Narcotics|narcotics|mesh-ancestor
6738492|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738493|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738494|NCT01943760|Analgesics|analgesics|mesh-ancestor
6738495|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
6738496|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738497|NCT01943786|Cetuximab|cetuximab|mesh-list
6738498|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6738499|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738500|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6738501|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6738502|NCT01943812|Estradiol|estradiol|mesh-list
6738503|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6738504|NCT01943812|Progesterone|progesterone|mesh-list
6738505|NCT01943812|Estrogens|estrogens|mesh-ancestor
6738506|NCT01943812|Hormones|hormones|mesh-ancestor
6738507|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738508|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738509|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6738510|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
6738511|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6738512|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6738513|NCT01943812|Progestins|progestins|mesh-ancestor
6738514|NCT01943877|Propolis|propolis|mesh-list
6738515|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738516|NCT01943942|Montelukast|montelukast|mesh-list
6738517|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6738518|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
6738519|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6738520|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
6738521|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738522|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738523|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6738524|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6738525|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738526|NCT01943994|Psilocybin|psilocybin|mesh-list
6738527|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
6738528|NCT01943994|Nicotine|nicotine|mesh-list
6738529|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6738530|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
6738531|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738532|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738533|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6738534|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6738535|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
6738536|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738537|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738538|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
6738539|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6738540|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6738541|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
6738542|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6738543|NCT01944033|Terbutaline|terbutaline|mesh-list
6738544|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6738545|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
6738546|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738547|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738548|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6738549|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
6738550|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
6738551|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
6738552|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6738553|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6738554|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6738555|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6738556|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
6738557|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738558|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738559|NCT01944085|Acetaminophen|acetaminophen|mesh-list
6738560|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
6738561|NCT01944085|Ibuprofen|ibuprofen|mesh-list
6738562|NCT01944085|Vitamins|vitamins|mesh-ancestor
6738563|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
6738564|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738565|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6738566|NCT01944085|Analgesics|analgesics|mesh-ancestor
6738567|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
6738568|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738569|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
6738570|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6738571|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6738572|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6738573|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6738574|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738575|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738576|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
6738577|NCT01944085|Protective Agents|protective agents|mesh-ancestor
6738578|NCT01944176|Simvastatin|simvastatin|mesh-list
6738579|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6738580|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6738581|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
6738582|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738583|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6738584|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6738585|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738586|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6738587|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
6738588|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6738589|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6738590|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738591|NCT01944215|Caffeine|caffeine|mesh-list
6738592|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6738593|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738594|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6738595|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738596|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738597|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6738598|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6738599|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
6738600|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738601|NCT01944384|Spironolactone|spironolactone|mesh-list
6738602|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6738603|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
6738604|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738605|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738606|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6738607|NCT01944384|Diuretics|diuretics|mesh-ancestor
6738608|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
6738609|NCT01944410|Mitogens|mitogens|mesh-list
6738610|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
6738611|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738612|NCT01944436|Rivastigmine|rivastigmine|mesh-list
6738613|NCT01944436|Donepezil|donepezil|mesh-list
6738614|NCT01944436|Galantamine|galantamine|mesh-list
6738615|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
6738616|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738617|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738618|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
6738619|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738620|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738621|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
6738622|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6738623|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
6738624|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738625|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6738626|NCT01944436|Protective Agents|protective agents|mesh-ancestor
6738627|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
6738628|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6738629|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738630|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6738631|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738632|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
6738633|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6738634|NCT01944683|Midazolam|midazolam|mesh-list
6738635|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6738636|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6738637|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738638|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738639|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6738640|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6738641|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6738642|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6738643|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
6738644|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
6738645|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
6738646|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
6738647|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738648|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738649|NCT01944735|Mannitol|mannitol|mesh-list
6738650|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6738651|NCT01944735|Diuretics|diuretics|mesh-ancestor
6738652|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
6738653|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738654|NCT01944800|Ticagrelor|ticagrelor|mesh-list
6738655|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6738656|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6738657|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6738658|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6738659|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6738660|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
6738661|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738662|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738663|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738664|NCT01944852|Icodextrin|icodextrin|mesh-list
6738665|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
6738666|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6786302|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786303|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
6786304|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
6786305|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
6786306|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786307|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6786308|NCT02213588|Antioxidants|antioxidants|mesh-list
6786309|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786310|NCT02213588|Protective Agents|protective agents|mesh-ancestor
6786311|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786312|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
6786313|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
6786314|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6786315|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786316|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786317|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
6786318|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6786319|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6786320|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786321|NCT02213627|Menotropins|menotropins|mesh-list
6786322|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6786323|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
6786324|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6786325|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786326|NCT02213653|Iron|iron|mesh-list
6786327|NCT02213653|Trace Elements|trace elements|mesh-ancestor
6786328|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
6786329|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786330|NCT02213718|Sufentanil|sufentanil|mesh-list
6786331|NCT02213718|Propofol|propofol|mesh-list
6786332|NCT02213718|Desflurane|desflurane|mesh-list
6786333|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6786334|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6786335|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786336|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6786337|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
6786338|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
6786339|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6786340|NCT02213718|Narcotics|narcotics|mesh-ancestor
6786341|NCT02213718|Analgesics|analgesics|mesh-ancestor
6786342|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
6786343|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786344|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6738667|NCT01945021|Crizotinib|crizotinib|mesh-list
6738668|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738669|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6738670|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738671|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738672|NCT01945047|Midazolam|midazolam|mesh-list
6738673|NCT01945047|Ketamine|ketamine|mesh-list
6738674|NCT01945047|Analgesics|analgesics|mesh-ancestor
6738675|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
6738676|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738677|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738678|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6738679|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6738680|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
6738681|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
6738682|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738683|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6738684|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6738685|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738686|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738687|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6738688|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6738689|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6738690|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6738691|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6738692|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
6738693|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
6738694|NCT01945099|Insulin|insulin|mesh-list
6738695|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6738696|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738697|NCT01945268|Vaccines|vaccines|mesh-list
6738698|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
6738699|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786345|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6738700|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
6738701|NCT01945437|Analgesics|analgesics|mesh-ancestor
6738702|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
6738703|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738704|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738705|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
6738706|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738707|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6738708|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
6738709|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6738710|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6738711|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738712|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6738713|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
6738714|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6738715|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6738716|NCT01945450|Clindamycin|clindamycin|mesh-list
6738717|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
6738718|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
6738719|NCT01945450|Gentamicins|gentamicins|mesh-list
6738720|NCT01945450|Ampicillin|ampicillin|mesh-list
6738721|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738722|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6738723|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738724|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738725|NCT01945476|Midazolam|midazolam|mesh-list
6738726|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6738727|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6738728|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738729|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738730|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6738731|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6738732|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6738733|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6738734|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
6738735|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
6738736|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
6738737|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
6738738|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738739|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738740|NCT01945528|Lidocaine|lidocaine|mesh-list
6738741|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
6738742|NCT01945528|Anesthetics|anesthetics|mesh-list
6738743|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738744|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738745|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
6738746|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738747|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6738748|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6738749|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6738750|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6738751|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738752|NCT01945554|Bupivacaine|bupivacaine|mesh-list
6738753|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
6738754|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
6738755|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738756|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738757|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
6738758|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738759|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
6738760|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6738761|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6738762|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6738763|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6738764|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738765|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
6738766|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738767|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738768|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6738769|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738770|NCT01945736|Methadone|methadone|mesh-list
6738771|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6738772|NCT01945736|Narcotics|narcotics|mesh-ancestor
6786346|NCT02213744|Gemcitabine|gemcitabine|mesh-list
6738773|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738774|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738775|NCT01945736|Analgesics|analgesics|mesh-ancestor
6738776|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
6738777|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738778|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
6738779|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
6738780|NCT01945788|Teriparatide|teriparatide|mesh-list
6738781|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6738782|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738783|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6738784|NCT01945801|Furosemide|furosemide|mesh-list
6738785|NCT01945801|Spironolactone|spironolactone|mesh-list
6738786|NCT01945801|Diuretics|diuretics|mesh-ancestor
6738787|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
6738788|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738789|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6738790|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6738791|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738792|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6738793|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
6738794|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738795|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6738796|NCT01945840|Hormones|hormones|mesh-list
6738797|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738798|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738799|NCT01945879|Heparin|heparin|mesh-list
6738800|NCT01945879|Enoxaparin|enoxaparin|mesh-list
6738801|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6738802|NCT01945879|Tinzaparin|tinzaparin|mesh-list
6738803|NCT01945879|Dalteparin|dalteparin|mesh-list
6738804|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
6738805|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6738806|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6738807|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738808|NCT01945892|Dexamethasone|dexamethasone|mesh-list
6738809|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6738810|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
6738811|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
6738812|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738813|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738814|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6738815|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
6738816|NCT01945892|Hormones|hormones|mesh-ancestor
6738817|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738818|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6738819|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738820|NCT01945957|Oxytocin|oxytocin|mesh-list
6738821|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
6738822|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6738823|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738824|NCT01945983|Norepinephrine|norepinephrine|mesh-list
6738825|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6738826|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6738827|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
6738828|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738829|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738830|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738831|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
6738832|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
6738833|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738834|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6738835|NCT01946009|Cidofovir|cidofovir|mesh-list
6738836|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
6738837|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738838|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738839|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738840|NCT01946035|Doxazosin|doxazosin|mesh-list
6738841|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6738842|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6738843|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6738844|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6738845|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
6738846|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738847|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738848|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738849|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
6738850|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738851|NCT01946074|Paclitaxel|paclitaxel|mesh-list
6738852|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6738853|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738854|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
6738855|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
6738856|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
6738857|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738858|NCT01946256|Amoxicillin|amoxicillin|mesh-list
6738859|NCT01946256|Erythromycin|erythromycin|mesh-list
6738860|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
6738861|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6738862|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
6738863|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6738864|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738865|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6738866|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6738867|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6738868|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738869|NCT01946295|Famotidine|famotidine|mesh-list
6738870|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6738871|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6738872|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6738873|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
6738874|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
6738875|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738876|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738877|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738878|NCT01946373|Vidarabine|vidarabine|mesh-list
6738879|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
6738880|NCT01946373|Fludarabine|fludarabine|mesh-list
6738881|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
6738882|NCT01946373|Interleukin-2|interleukin-2|mesh-list
6738883|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6738884|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
6738885|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738886|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6738887|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6738888|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
6738889|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738890|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738891|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6738892|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6738893|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
6738894|NCT01946373|Antiviral Agents|antiviral agents|mesh-ancestor
6738895|NCT01946373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738896|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6738897|NCT01946373|Analgesics|analgesics|mesh-ancestor
6738898|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
6738899|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738900|NCT01946386|Betamethasone|betamethasone|mesh-list
6738901|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
6738902|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6738903|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
6738904|NCT01946386|Clobetasol|clobetasol|mesh-list
6738905|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6738906|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6738907|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
6738908|NCT01946386|Hormones|hormones|mesh-ancestor
6738909|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738910|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738911|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6738912|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
6738913|NCT01946399|Dexamethasone|dexamethasone|mesh-list
6738914|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6738915|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
6738916|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
6738917|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738918|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738919|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6738920|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
6738921|NCT01946399|Hormones|hormones|mesh-ancestor
6786347|NCT02213744|Capecitabine|capecitabine|mesh-list
6738922|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738923|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6738924|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6738925|NCT01946555|Fentanyl|fentanyl|mesh-list
6738926|NCT01946555|Morphine|morphine|mesh-list
6738927|NCT01946555|Oxycodone|oxycodone|mesh-list
6738928|NCT01946555|Buprenorphine|buprenorphine|mesh-list
6738929|NCT01946555|Methadone|methadone|mesh-list
6738930|NCT01946555|Hydromorphone|hydromorphone|mesh-list
6738931|NCT01946555|Tapentadol|tapentadol|mesh-list
6738932|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6738933|NCT01946555|Narcotics|narcotics|mesh-ancestor
6738934|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6738935|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738936|NCT01946555|Analgesics|analgesics|mesh-ancestor
6738937|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
6738938|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738939|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6738940|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6738941|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
6738942|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
6738943|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6738944|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
6738945|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
6738946|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6738947|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6738948|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6738949|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738950|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
6738951|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738952|NCT01946568|Dalbavancin|dalbavancin|mesh-list
6738953|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6738954|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6738955|NCT01946594|Acetaminophen|acetaminophen|mesh-list
6738956|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6738957|NCT01946594|Analgesics|analgesics|mesh-ancestor
6738958|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
6738959|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738960|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738961|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
6738962|NCT01946607|Citalopram|citalopram|mesh-list
6738963|NCT01946607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6738964|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6738965|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6738966|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738967|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738968|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
6738969|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738970|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6738971|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
6738972|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6738973|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
6738974|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6738975|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
6738976|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738977|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738978|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6738979|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
6738980|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6738981|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6738982|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6738983|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
6738984|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6738985|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6738986|NCT01946711|Budesonide|budesonide|mesh-list
6738987|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6738988|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6738989|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
6738990|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6738991|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6738992|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6738993|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
6738994|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
6738995|NCT01946711|Hormones|hormones|mesh-ancestor
6738996|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6738997|NCT01946815|Atorvastatin|atorvastatin|mesh-list
6738998|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6738999|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6739000|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
6739001|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739002|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6739003|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6739004|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739005|NCT01946906|Rifaximin|rifaximin|mesh-list
6739006|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6739007|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739008|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6739009|NCT01946971|Lansoprazole|lansoprazole|mesh-list
6739010|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
6739011|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6739012|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6739013|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6739014|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739015|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739016|NCT01946984|Diclofenac|diclofenac|mesh-list
6739017|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
6739018|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6739019|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6739020|NCT01946984|Analgesics|analgesics|mesh-ancestor
6739021|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
6739022|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739023|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739024|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6739025|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6739026|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6739027|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739028|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739029|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6739030|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
6739031|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739032|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
6739033|NCT01947062|Cisplatin|cisplatin|mesh-list
6739034|NCT01947062|Etoposide|etoposide|mesh-list
6739035|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
6739036|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6739037|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
6739038|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739039|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6739040|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6739041|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
6739042|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739043|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739044|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6739045|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6739046|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6739047|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6739048|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786348|NCT02213744|Trastuzumab|trastuzumab|mesh-list
6786349|NCT02213744|Vinorelbine|vinorelbine|mesh-list
6786350|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6786351|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
6786352|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786353|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786354|NCT02213744|Antiviral Agents|antiviral agents|mesh-ancestor
6786355|NCT02213744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786356|NCT02213744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786357|NCT02213744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786358|NCT02213744|Immunologic Factors|immunologic factors|mesh-ancestor
6739049|NCT01947114|Ketamine|ketamine|mesh-list
6739050|NCT01947114|Remifentanil|remifentanil|mesh-list
6739051|NCT01947114|Propofol|propofol|mesh-list
6739052|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6739053|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739054|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739055|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6739056|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
6739057|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
6739058|NCT01947114|Analgesics|analgesics|mesh-ancestor
6739059|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
6739060|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739061|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6739062|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6739063|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6739064|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739065|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739066|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6739067|NCT01947114|Narcotics|narcotics|mesh-ancestor
6739068|NCT01947140|Romidepsin|romidepsin|mesh-list
6739069|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6739070|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739071|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
6739072|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6739073|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739074|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
6739075|NCT01947205|Acetaminophen|acetaminophen|mesh-list
6739076|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6739077|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6739078|NCT01947205|Analgesics|analgesics|mesh-ancestor
6739079|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
6739080|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739081|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739082|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
6739083|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6739084|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6739085|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6739086|NCT01947309|Lenalidomide|lenalidomide|mesh-list
6739087|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
6739088|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739089|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6739090|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6739091|NCT01947309|Growth Substances|growth substances|mesh-ancestor
6739092|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
6739093|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739094|NCT01947465|Vaccines|vaccines|mesh-list
6739095|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
6739096|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739097|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
6739098|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6739099|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739100|NCT01947608|Ceritinib|ceritinib|mesh-list
6739101|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739102|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6739103|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739104|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739105|NCT01947660|Anesthetics|anesthetics|mesh-list
6739106|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739107|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739108|NCT01947699|Glyburide|glyburide|mesh-list
6739109|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6739110|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739111|NCT01947777|Rifampin|rifampin|mesh-list
6739112|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6739113|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
6739114|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6739115|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739116|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
6739117|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6739118|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739119|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739120|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6739121|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6739122|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6739123|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6739124|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6739125|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6739126|NCT01947790|Metformin|metformin|mesh-list
6739127|NCT01947790|Pioglitazone|pioglitazone|mesh-list
6739128|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6739129|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739130|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6739131|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6739132|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6739133|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739134|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739135|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6739136|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6739137|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6739138|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
6739139|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739140|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739141|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6739142|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6739143|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
6739144|NCT01947920|Tramadol|tramadol|mesh-list
6739145|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6739146|NCT01947920|Narcotics|narcotics|mesh-ancestor
6739147|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739148|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739149|NCT01947920|Analgesics|analgesics|mesh-ancestor
6739150|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
6739151|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739152|NCT01947933|Mirikizumab|mirikizumab|mesh-list
6739153|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6739154|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6739155|NCT01947933|Analgesics|analgesics|mesh-ancestor
6739156|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
6739157|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739158|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739159|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6739160|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6739161|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6739162|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6739163|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
6739164|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6739165|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
6739166|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6739167|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
6739168|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739169|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739170|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
6739171|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
6739172|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6739173|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
6739174|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6739175|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
6739176|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739177|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739178|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
6739179|NCT01947998|Warfarin|warfarin|mesh-list
6739180|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
6739181|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
6739182|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
6739183|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6739184|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
6739185|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6739186|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
6739187|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739188|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739189|NCT01948011|Racecadotril|racecadotril|mesh-list
6739190|NCT01948011|Thiorphan|thiorphan|mesh-list
6739191|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
6739192|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6739193|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
6739194|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739195|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739196|NCT01948024|Asenapine|asenapine|mesh-list
6739197|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6739198|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6739199|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739200|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739201|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6739202|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
6739203|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6739204|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
6739205|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
6739206|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739207|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739208|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6739209|NCT01948115|Analgesics|analgesics|mesh-ancestor
6739210|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
6739211|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739212|NCT01948128|Vitamin D|vitamin d|mesh-list
6739213|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
6739214|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
6739215|NCT01948128|Vitamins|vitamins|mesh-list
6739216|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
6739217|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739218|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6739219|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6739220|NCT01948232|Perindopril|perindopril|mesh-list
6739221|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6739222|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
6739223|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739224|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739225|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6739226|NCT01948245|Taurolidine|taurolidine|mesh-list
6739227|NCT01948245|Heparin|heparin|mesh-list
6739228|NCT01948245|Calcium heparin|calcium heparin|mesh-list
6739229|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
6739230|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739231|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6739232|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6739233|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739234|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6739235|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739236|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
6739237|NCT01948336|Ketamine|ketamine|mesh-list
6739238|NCT01948336|Propofol|propofol|mesh-list
6739239|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6739240|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739241|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739242|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6739243|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
6739244|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
6739245|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6739246|NCT01948336|Analgesics|analgesics|mesh-ancestor
6739247|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
6739248|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739249|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6739250|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6739251|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6739252|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
6739253|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739254|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739255|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6739256|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6739257|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6739258|NCT01948362|Sulforaphane|sulforaphane|mesh-list
6739259|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6739260|NCT01948362|Protective Agents|protective agents|mesh-ancestor
6739261|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739262|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739263|NCT01948401|Prednisolone|prednisolone|mesh-list
6739264|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6739265|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
6739266|NCT01948401|Hormones|hormones|mesh-ancestor
6739267|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6739268|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739269|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6739270|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739271|NCT01948505|Acetaminophen|acetaminophen|mesh-list
6739272|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6739273|NCT01948505|Analgesics|analgesics|mesh-ancestor
6739274|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
6739275|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739276|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739277|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
6739278|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
6739279|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6739280|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
6739281|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739282|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
6739283|NCT01948583|Protective Agents|protective agents|mesh-ancestor
6739284|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6739285|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6739286|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6739287|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
6739288|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739289|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6786359|NCT02213744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786360|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6786361|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6786362|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
6786363|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
6786364|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
6786365|NCT02213757|Estrogens|estrogens|mesh-list
6786366|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6786367|NCT02213757|Hormones|hormones|mesh-ancestor
6786368|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786369|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786370|NCT02213783|Imipenem|imipenem|mesh-list
6786371|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786372|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786373|NCT02213796|Meropenem|meropenem|mesh-list
6786374|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786375|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786376|NCT02213848|Calcium|calcium|mesh-list
6786377|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6786378|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786379|NCT02213887|Pantoprazole|pantoprazole|mesh-list
6786380|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6786381|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6786382|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6786383|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786384|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786385|NCT02213913|Prednisone|prednisone|mesh-list
6786386|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
6786387|NCT02213913|Rituximab|rituximab|mesh-list
6786388|NCT02213913|Doxorubicin|doxorubicin|mesh-list
6786389|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6786390|NCT02213913|Etoposide|etoposide|mesh-list
6786391|NCT02213913|Vincristine|vincristine|mesh-list
6786392|NCT02213913|Lenalidomide|lenalidomide|mesh-list
6786393|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
6786394|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786395|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
6786396|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786397|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6786398|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6786399|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
6786400|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739290|NCT01948765|Propofol|propofol|mesh-list
6739291|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6739292|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739293|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739294|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6739295|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
6739296|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
6739297|NCT01948804|Letrozole|letrozole|mesh-list
6739298|NCT01948804|Clomiphene|clomiphene|mesh-list
6739299|NCT01948804|Cetrorelix|cetrorelix|mesh-list
6739300|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6739301|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739302|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6739303|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6739304|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739305|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739306|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6739307|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
6739308|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6739309|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739310|NCT01948804|Hormones|hormones|mesh-ancestor
6739311|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6739312|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
6739313|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6739314|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6739315|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6739316|NCT01948817|Deferasirox|deferasirox|mesh-list
6739317|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6739318|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
6739319|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
6739320|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739321|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6739322|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6739323|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6739324|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6739325|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739326|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739327|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739328|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
6739329|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6739330|NCT01948921|Meperidine|meperidine|mesh-list
6739331|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6739332|NCT01948921|Narcotics|narcotics|mesh-ancestor
6739333|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739334|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739335|NCT01948921|Analgesics|analgesics|mesh-ancestor
6739336|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
6739337|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739338|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6739339|NCT01948960|Everolimus|everolimus|mesh-list
6739340|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739341|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6739342|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
6739343|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739344|NCT01948999|Anesthetics|anesthetics|mesh-list
6739345|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739346|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739347|NCT01949038|Alprazolam|alprazolam|mesh-list
6739348|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6739349|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739350|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739351|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6739352|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6739353|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6739354|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
6739355|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
6739356|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739357|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739358|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
6739359|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739360|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
6739361|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
6739362|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
6739363|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
6739364|NCT01949129|Busulfan|busulfan|mesh-list
6739365|NCT01949129|Thiotepa|thiotepa|mesh-list
6739366|NCT01949129|Treosulfan|treosulfan|mesh-list
6739367|NCT01949129|Fludarabine|fludarabine|mesh-list
6739368|NCT01949129|Etoposide|etoposide|mesh-list
6739369|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
6739370|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6739371|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
6739372|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6739373|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
6739374|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739375|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6739376|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6739377|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
6739378|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739379|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739380|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6739381|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6739382|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6739383|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6739384|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739385|NCT01949168|Ribavirin|ribavirin|mesh-list
6739386|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6739387|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
6739388|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739389|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
6739390|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739391|NCT01949233|Doxycycline|doxycycline|mesh-list
6739392|NCT01949233|Irbesartan|irbesartan|mesh-list
6739393|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6739394|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739395|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
6739396|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6739397|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6739398|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6739399|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6739400|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6739401|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739402|NCT01949363|Cefixime|cefixime|mesh-list
6739403|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6739404|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739405|NCT01949454|Fluorometholone|fluorometholone|mesh-list
6739406|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6739407|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
6739408|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6739409|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6739410|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
6739411|NCT01949454|Hormones|hormones|mesh-ancestor
6739412|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6739413|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739414|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6739415|NCT01949519|Lycopene|lycopene|mesh-list
6739416|NCT01949519|Docetaxel|docetaxel|mesh-list
6739417|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739418|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
6739419|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
6739420|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
6739421|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739422|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6739423|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
6739424|NCT01949519|Protective Agents|protective agents|mesh-ancestor
6739425|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739426|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6739427|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6739428|NCT01949571|Mirtazapine|mirtazapine|mesh-list
6739429|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
6739430|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6739431|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6739432|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
6739433|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
6739434|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739435|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739436|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739437|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6739438|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6739439|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739440|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6739441|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6739442|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6739443|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
6739444|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6739445|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6739446|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
6739447|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6739448|NCT01949675|Vaccines|vaccines|mesh-list
6739449|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
6739450|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739451|NCT01949714|Epinephrine|epinephrine|mesh-list
6739452|NCT01949714|Racepinephrine|racepinephrine|mesh-list
6739453|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
6739454|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6739455|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6739456|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
6739457|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739458|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739459|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739460|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6739461|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6739462|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
6739463|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739464|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6739465|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
6739466|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
6739467|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
6739468|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6739469|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6739470|NCT01949766|Glycerol|glycerol|mesh-list
6739471|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6739472|NCT01949766|Protective Agents|protective agents|mesh-ancestor
6739473|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739474|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739475|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
6739476|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6739477|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
6739478|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739479|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
6739480|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739481|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739482|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6739483|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
6739484|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739485|NCT01949818|Prednisone|prednisone|mesh-list
6739486|NCT01949818|Prednisolone|prednisolone|mesh-list
6739487|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
6739488|NCT01949818|Doxorubicin|doxorubicin|mesh-list
6739489|NCT01949818|Vincristine|vincristine|mesh-list
6739490|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6739491|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
6739492|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739493|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6739494|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6739495|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
6739496|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739497|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739498|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6739499|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6739500|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6739501|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6739502|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739503|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6739504|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
6739505|NCT01949818|Hormones|hormones|mesh-ancestor
6739506|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6739507|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6739508|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6739509|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
6739510|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
6739511|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
6739512|NCT01949857|Vaccines|vaccines|mesh-list
6739513|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
6739514|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739515|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
6739516|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6739517|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
6739518|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739519|NCT01949935|Mupirocin|mupirocin|mesh-list
6739520|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6739521|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739522|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6739523|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739524|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739525|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6739526|NCT01949948|Tenecteplase|tenecteplase|mesh-list
6739527|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6739528|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6739529|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739530|NCT01950000|Fentanyl|fentanyl|mesh-list
6739531|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6739532|NCT01950000|Narcotics|narcotics|mesh-ancestor
6739533|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739534|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739535|NCT01950000|Analgesics|analgesics|mesh-ancestor
6739536|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
6739537|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739538|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6739539|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6739540|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
6739541|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
6739542|NCT01950182|Tamoxifen|tamoxifen|mesh-list
6739543|NCT01950182|Gemcitabine|gemcitabine|mesh-list
6739544|NCT01950182|Capecitabine|capecitabine|mesh-list
6739545|NCT01950182|Trastuzumab|trastuzumab|mesh-list
6739546|NCT01950182|Vinorelbine|vinorelbine|mesh-list
6739547|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6739548|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6739549|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
6739550|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739551|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739552|NCT01950182|Antiviral Agents|antiviral agents|mesh-ancestor
6739553|NCT01950182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739554|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739555|NCT01950182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6739556|NCT01950182|Immunologic Factors|immunologic factors|mesh-ancestor
6739557|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739558|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6739559|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6739560|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
6739561|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
6739562|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
6739563|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6739564|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
6739565|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6739566|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6739567|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6739568|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6739569|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6739570|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6739571|NCT01950195|Ipilimumab|ipilimumab|mesh-list
6739572|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6739573|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739574|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6739575|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739576|NCT01950403|Linaclotide|linaclotide|mesh-list
6739577|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6739578|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
6739579|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739580|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6739581|NCT01950416|Clopidogrel|clopidogrel|mesh-list
6739582|NCT01950416|Ticagrelor|ticagrelor|mesh-list
6739583|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6739584|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6739585|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6739586|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6739587|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
6739588|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739589|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739590|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786401|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786402|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6786403|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6786404|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6786405|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6786406|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6786407|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786408|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6786409|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
6786410|NCT02213913|Hormones|hormones|mesh-ancestor
6786411|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786412|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6786413|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6786414|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
6786415|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
6786416|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
6786417|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6786418|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6786419|NCT02213913|Growth Substances|growth substances|mesh-ancestor
6786420|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
6786421|NCT02214004|Trastuzumab|trastuzumab|mesh-list
6786422|NCT02214004|Letrozole|letrozole|mesh-list
6739591|NCT01950481|Ceritinib|ceritinib|mesh-list
6739592|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739593|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6739594|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739595|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739596|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
6739597|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6739598|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739599|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
6739600|NCT01950507|Fluconazole|fluconazole|mesh-list
6739601|NCT01950507|Voriconazole|voriconazole|mesh-list
6739602|NCT01950507|Micafungin|micafungin|mesh-list
6739603|NCT01950507|Budesonide|budesonide|mesh-list
6739604|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6739605|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6739606|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
6739607|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739608|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739609|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6739610|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
6739611|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
6739612|NCT01950507|Hormones|hormones|mesh-ancestor
6739613|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6739614|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
6739615|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739616|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6739617|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6739618|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739619|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739620|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6739621|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
6739622|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6739623|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6739624|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6739625|NCT01950520|Topiramate|topiramate|mesh-list
6739626|NCT01950520|Phentermine|phentermine|mesh-list
6739627|NCT01950520|Propranolol|propranolol|mesh-list
6739628|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
6739629|NCT01950520|Pindolol|pindolol|mesh-list
6739630|NCT01950520|Naltrexone|naltrexone|mesh-list
6739631|NCT01950520|Caffeine|caffeine|mesh-list
6739632|NCT01950520|Dantrolene|dantrolene|mesh-list
6739633|NCT01950520|Mirabegron|mirabegron|mesh-list
6739634|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6739635|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6739636|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739637|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
6739638|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739639|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6739640|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6739641|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739642|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739643|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6739644|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6739645|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
6739646|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739647|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6739648|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6739649|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
6739650|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6739651|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6739652|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
6739653|NCT01950520|Analgesics|analgesics|mesh-ancestor
6739654|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
6739655|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739656|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
6739657|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6739658|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6739659|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6739660|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
6739661|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6739662|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6739663|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6739664|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6739665|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6739666|NCT01950520|Urological Agents|urological agents|mesh-ancestor
6739667|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
6739668|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6739669|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
6739670|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
6739671|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6739672|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
6739673|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6739674|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6739675|NCT01950546|Fluorides|fluorides|mesh-list
6739676|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
6739677|NCT01950546|Protective Agents|protective agents|mesh-ancestor
6739678|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739679|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
6739680|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739681|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
6739682|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739683|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739684|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6739685|NCT01950611|Bortezomib|bortezomib|mesh-list
6739686|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739687|NCT01950689|Nimorazole|nimorazole|mesh-list
6739688|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6739689|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6739690|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6739691|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739692|NCT01950793|Triamcinolone|triamcinolone|mesh-list
6739693|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6739694|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6739695|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
6739696|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6739697|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6739698|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
6739699|NCT01950793|Hormones|hormones|mesh-ancestor
6739700|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6739701|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739702|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6739703|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
6739704|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739705|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739706|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6739707|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
6739708|NCT01950793|Protective Agents|protective agents|mesh-ancestor
6739709|NCT01950884|Ezetimibe|ezetimibe|mesh-list
6739710|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6739711|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6739712|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
6739713|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739714|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6739715|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
6739716|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739717|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
6739718|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6739719|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6739720|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739721|NCT01950923|Urological Agents|urological agents|mesh-ancestor
6739722|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6739723|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
6739724|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
6739725|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6739726|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6739727|NCT01951027|Lenograstim|lenograstim|mesh-list
6739728|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6739729|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
6739730|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739731|NCT01951053|Citalopram|citalopram|mesh-list
6739732|NCT01951053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6739733|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6739734|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6739735|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739736|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739737|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
6739738|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739739|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6739740|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
6739741|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6739742|NCT01951079|Digoxin|digoxin|mesh-list
6739743|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6739744|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6739745|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739746|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739747|NCT01951079|Protective Agents|protective agents|mesh-ancestor
6739748|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739749|NCT01951144|Lorazepam|lorazepam|mesh-list
6739750|NCT01951144|PF-06372865|pf-06372865|mesh-list
6739751|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
6739752|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
6739753|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
6739754|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739755|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739756|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6739757|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6739758|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739759|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6739760|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6739761|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6739762|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
6739763|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
6739764|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739765|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739766|NCT01951209|Rifaximin|rifaximin|mesh-list
6739767|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6739768|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739769|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6739770|NCT01951404|Allopurinol|allopurinol|mesh-list
6739771|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
6739772|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739773|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739774|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
6739775|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6739776|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6739777|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
6739778|NCT01951404|Protective Agents|protective agents|mesh-ancestor
6739779|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739780|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6739781|NCT01951430|Cephalosporins|cephalosporins|mesh-list
6739782|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6739783|NCT01951430|Itraconazole|itraconazole|mesh-list
6739784|NCT01951430|Fluconazole|fluconazole|mesh-list
6739785|NCT01951430|Posaconazole|posaconazole|mesh-list
6739786|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
6739787|NCT01951430|Clotrimazole|clotrimazole|mesh-list
6739788|NCT01951430|Miconazole|miconazole|mesh-list
6739789|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739790|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6739791|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6739792|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739793|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739794|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6739795|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
6739796|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6739797|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739798|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6739799|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6739800|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6739801|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6739802|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6739803|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6739804|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6739805|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6739806|NCT01951430|Renal Agents|renal agents|mesh-ancestor
6739807|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
6739808|NCT01951482|Bevacizumab|bevacizumab|mesh-list
6739809|NCT01951482|Cisplatin|cisplatin|mesh-list
6739810|NCT01951482|Pemetrexed|pemetrexed|mesh-list
6739811|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6739812|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739813|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6739814|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6739815|NCT01951482|Growth Substances|growth substances|mesh-ancestor
6739816|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739817|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
6739818|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739819|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739820|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6739821|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6739822|NCT01951508|Methylphenidate|methylphenidate|mesh-list
6739823|NCT01951508|Modafinil|modafinil|mesh-list
6739824|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6739825|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739826|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6739827|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6739828|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6739829|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739830|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
6739831|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739832|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6739833|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6739834|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6739835|NCT01951560|Valproic Acid|valproic acid|mesh-list
6739836|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
6739837|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739838|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739839|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
6739840|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739841|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739842|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
6739843|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6739844|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739845|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6739846|NCT01951599|Osimertinib|osimertinib|mesh-list
6739847|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739848|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6739849|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739850|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739851|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6739852|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
6739853|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739854|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6739855|NCT01951677|Antacids|antacids|mesh-ancestor
6739856|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739857|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6739858|NCT01951729|Atropine|atropine|mesh-list
6739859|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6739860|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6739861|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6739862|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
6739863|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739864|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739865|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6739866|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
6739867|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
6739868|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
6739869|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6739870|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6739871|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
6739872|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739873|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739874|NCT01951846|Nintedanib|nintedanib|mesh-list
6739875|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739876|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6739877|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739878|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739879|NCT01951872|Caffeine|caffeine|mesh-list
6739880|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6739881|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739882|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6739883|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739884|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739885|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6739886|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6739887|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
6739888|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739889|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
6739890|NCT01951885|Methotrexate|methotrexate|mesh-list
6739891|NCT01951885|Tacrolimus|tacrolimus|mesh-list
6739892|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6739893|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
6739894|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6739895|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739896|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6739897|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
6739898|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739899|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6739900|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
6739901|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739902|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6739903|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6739904|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
6739905|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6739906|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6739907|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6739908|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6739909|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6739910|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
6739911|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6739912|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739913|NCT01951898|Montelukast|montelukast|mesh-list
6739914|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6739915|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
6739916|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6739917|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
6739918|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6739919|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739920|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6739921|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6739922|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739923|NCT01951911|Ketamine|ketamine|mesh-list
6739924|NCT01951911|Analgesics|analgesics|mesh-ancestor
6739925|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
6739926|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739927|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739928|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6739929|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6739930|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
6739931|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
6739932|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739933|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6739934|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6739935|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739936|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739937|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
6739938|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6739939|NCT01951924|Antibodies|antibodies|mesh-list
6739940|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
6739941|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
6739942|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739943|NCT01952314|Naftopidil|naftopidil|mesh-list
6739944|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6739945|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6739946|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
6739947|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739948|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739949|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739950|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6739951|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6739952|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6739953|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6739954|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6786423|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6786424|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786425|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6786426|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6786427|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786428|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786429|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6786430|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
6786431|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786432|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786433|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6786434|NCT02214368|Propofol|propofol|mesh-list
6786435|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6786436|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6786437|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786438|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6786439|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
6786440|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
6786441|NCT02214381|Paclitaxel|paclitaxel|mesh-list
6786442|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
6786443|NCT02214381|Doxorubicin|doxorubicin|mesh-list
6786444|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6786445|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786446|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
6786447|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
6786448|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
6786449|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786450|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786451|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
6786452|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786453|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6786454|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6786455|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
6786456|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6786457|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6786458|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6786459|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6786460|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786461|NCT02214433|Pantoprazole|pantoprazole|mesh-list
6786462|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6786463|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6786464|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6786465|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6786466|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786467|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786468|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6786469|NCT02214498|Enalapril|enalapril|mesh-list
6786470|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6786471|NCT02214498|Diuretics|diuretics|mesh-ancestor
6786472|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
6786473|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739955|NCT01952561|Dapivirine|dapivirine|mesh-list
6739956|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6739957|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6739958|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
6739959|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6739960|NCT01952626|Ondansetron|ondansetron|mesh-list
6739961|NCT01952626|Palonosetron|palonosetron|mesh-list
6739962|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
6739963|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
6739964|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739965|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739966|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6739967|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
6739968|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
6739969|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6739970|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
6739971|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6739972|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739973|NCT01952626|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6739974|NCT01952626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6739975|NCT01952626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739976|NCT01952626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6739977|NCT01952626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6739978|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6739979|NCT01952652|Naproxen|naproxen|mesh-list
6739980|NCT01952652|Codeine|codeine|mesh-list
6739981|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6739982|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6739983|NCT01952652|Analgesics|analgesics|mesh-ancestor
6739984|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
6739985|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6739986|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6739987|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6739988|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6739989|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
6739990|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6739991|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6739992|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6739993|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6739994|NCT01952652|Narcotics|narcotics|mesh-ancestor
6739995|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6739996|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
6739997|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
6739998|NCT01952756|Cilostazol|cilostazol|mesh-list
6739999|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6740000|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
6740001|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740002|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740003|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6740004|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
6740005|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6740006|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6740007|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740008|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6740009|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
6740010|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6740011|NCT01952756|Protective Agents|protective agents|mesh-ancestor
6740012|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6740013|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6740014|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740015|NCT01952769|Pidilizumab|pidilizumab|mesh-list
6740016|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6740017|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740018|NCT01952782|Naloxone|naloxone|mesh-list
6740019|NCT01952782|Hormones|hormones|mesh-list
6740020|NCT01952782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740021|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740022|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6740023|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
6740024|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740025|NCT01952886|Ondansetron|ondansetron|mesh-list
6740026|NCT01952886|Granisetron|granisetron|mesh-list
6740027|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
6740028|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
6740029|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740030|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740031|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6740032|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
6740033|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
6740034|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6740035|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
6740036|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740037|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740038|NCT01952886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6740039|NCT01952886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6740040|NCT01952886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6740041|NCT01952886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6740042|NCT01952886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6740043|NCT01952951|Fluorouracil|fluorouracil|mesh-list
6740044|NCT01952951|Capecitabine|capecitabine|mesh-list
6740045|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
6740046|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
6740047|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740048|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6740049|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740050|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740051|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
6740052|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740053|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
6740054|NCT01953107|Trace Elements|trace elements|mesh-ancestor
6740055|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
6740056|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740057|NCT01953120|Abatacept|abatacept|mesh-list
6740058|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6740059|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740060|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740061|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740062|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
6740063|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740064|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6740065|NCT01953172|Tocotrienols|tocotrienols|mesh-list
6740066|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
6740067|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
6740068|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740069|NCT01953172|Protective Agents|protective agents|mesh-ancestor
6740070|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740071|NCT01953172|Vitamins|vitamins|mesh-ancestor
6740072|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
6740073|NCT01953367|Tobramycin|tobramycin|mesh-list
6740074|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6740075|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740076|NCT01953406|Fluorouracil|fluorouracil|mesh-list
6740077|NCT01953406|Mitomycins|mitomycins|mesh-list
6740078|NCT01953406|Mitomycin|mitomycin|mesh-list
6740079|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
6740080|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740081|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6740082|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740083|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740084|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
6740085|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740086|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6740087|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
6740088|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6740089|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740090|NCT01953419|Pemetrexed|pemetrexed|mesh-list
6740091|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740092|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740093|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740094|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6740095|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6740096|NCT01953445|Paclitaxel|paclitaxel|mesh-list
6740097|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6740098|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740099|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
6740100|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
6740101|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
6740102|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740103|NCT01953510|Vaccines|vaccines|mesh-list
6740104|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6740105|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
6740106|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740107|NCT01953536|Folic Acid|folic acid|mesh-list
6740108|NCT01953536|Paclitaxel|paclitaxel|mesh-list
6740109|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6740110|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6740111|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740112|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
6740113|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
6740114|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
6740115|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740116|NCT01953536|Hematinics|hematinics|mesh-ancestor
6740117|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
6740118|NCT01953536|Vitamins|vitamins|mesh-ancestor
6740119|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
6740120|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740121|NCT01953588|Fulvestrant|fulvestrant|mesh-list
6740122|NCT01953588|Anastrozole|anastrozole|mesh-list
6740123|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6740124|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740125|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6740126|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6740127|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
6740128|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740129|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740130|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6740131|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6740132|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740133|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740134|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
6740135|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6740136|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
6740137|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6740138|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740139|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6740140|NCT01953731|Rifampin|rifampin|mesh-list
6740141|NCT01953731|Palbociclib|palbociclib|mesh-list
6740142|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740143|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6740144|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740145|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740146|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6740147|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
6740148|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6740149|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740150|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
6740151|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6740152|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6740153|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6740154|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6740155|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6740156|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6740157|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6740158|NCT01953744|Fluconazole|fluconazole|mesh-list
6740159|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
6740160|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
6740161|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740162|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6740163|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6740164|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740165|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740166|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6740167|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
6740168|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740169|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740170|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6740171|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6740172|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6740173|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6740174|NCT01953757|Vitamins|vitamins|mesh-list
6740175|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
6740176|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
6740177|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
6740178|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
6740179|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740180|NCT01953757|Hematinics|hematinics|mesh-ancestor
6740181|NCT01953770|Cytarabine|cytarabine|mesh-list
6740182|NCT01953770|Prednisone|prednisone|mesh-list
6740183|NCT01953770|Methotrexate|methotrexate|mesh-list
6740184|NCT01953770|Daunorubicin|daunorubicin|mesh-list
6740185|NCT01953770|Asparaginase|asparaginase|mesh-list
6740186|NCT01953770|Pegaspargase|pegaspargase|mesh-list
6740187|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6740188|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
6740189|NCT01953770|Hormones|hormones|mesh-ancestor
6740190|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740191|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740192|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6740193|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740194|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6740195|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
6740196|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6740197|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6740198|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
6740199|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740200|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
6740201|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740202|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6740203|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740204|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
6740205|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6740206|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6740207|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
6740208|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740209|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6740210|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6740211|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6740212|NCT01953796|Clomiphene|clomiphene|mesh-list
6740213|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6740214|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
6740215|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740216|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740217|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6740218|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
6740219|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6740220|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6740221|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6740222|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6740223|NCT01953835|Simvastatin|simvastatin|mesh-list
6740224|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6740225|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6740226|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
6740227|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740228|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6740229|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6740230|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740231|NCT01953848|Tamsulosin|tamsulosin|mesh-list
6740232|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
6740233|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6740234|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6740235|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6740236|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
6740237|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740238|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740239|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740240|NCT01953848|Urological Agents|urological agents|mesh-ancestor
6740241|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6740242|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6740243|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
6740244|NCT01953887|Tamsulosin|tamsulosin|mesh-list
6740245|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
6740246|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6740247|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6740248|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6740249|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
6740250|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740251|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740252|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740253|NCT01953887|Urological Agents|urological agents|mesh-ancestor
6740254|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6740255|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6740256|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
6740257|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
6740258|NCT01953900|Fludarabine|fludarabine|mesh-list
6740259|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740260|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
6740261|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740262|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6740263|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6740264|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
6740265|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740266|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740267|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6740268|NCT01953952|Cisplatin|cisplatin|mesh-list
6740269|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740270|NCT01953978|Acetaminophen|acetaminophen|mesh-list
6740271|NCT01953978|Dexamethasone|dexamethasone|mesh-list
6740272|NCT01953978|Ibuprofen|ibuprofen|mesh-list
6740273|NCT01953978|Morphine|morphine|mesh-list
6740274|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6740275|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
6740276|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
6740277|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740278|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740279|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6740280|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
6740281|NCT01953978|Hormones|hormones|mesh-ancestor
6740282|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740283|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6740284|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740285|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6740286|NCT01953978|Narcotics|narcotics|mesh-ancestor
6740287|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6740288|NCT01953978|Analgesics|analgesics|mesh-ancestor
6740289|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
6740290|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6740291|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6740292|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6740293|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6740294|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740295|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740296|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
6740297|NCT01954030|Bevacizumab|bevacizumab|mesh-list
6740298|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
6740299|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6740300|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740301|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6740302|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6740303|NCT01954030|Growth Substances|growth substances|mesh-ancestor
6740304|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740305|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
6740306|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6740307|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6740308|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740309|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6740310|NCT01954043|Rifampin|rifampin|mesh-list
6740311|NCT01954043|Dabrafenib|dabrafenib|mesh-list
6740312|NCT01954043|Rabeprazole|rabeprazole|mesh-list
6740313|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6740314|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6740315|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6740316|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740317|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740318|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6740319|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
6740320|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6740321|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740322|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
6740323|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6740324|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6740325|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6740326|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6740327|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6740328|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6740329|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6740330|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740331|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6740332|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
6740333|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6740334|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
6740335|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740336|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
6740337|NCT01954108|Protective Agents|protective agents|mesh-ancestor
6786474|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6786475|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6786476|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786477|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6786478|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
6786479|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786480|NCT02214563|Vitamin D|vitamin d|mesh-list
6786481|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
6786482|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
6786483|NCT02214563|Vitamins|vitamins|mesh-list
6786484|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
6786485|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786486|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6786487|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6786488|NCT02214602|Doxorubicin|doxorubicin|mesh-list
6786489|NCT02214602|Epirubicin|epirubicin|mesh-list
6786490|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6786491|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786492|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6786493|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6786494|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786495|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786496|NCT02214680|Timolol|timolol|mesh-list
6786497|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6786498|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
6786499|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6786500|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6786501|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
6786502|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786503|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740338|NCT01954186|Oxytocin|oxytocin|mesh-list
6740339|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
6740340|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6740341|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740342|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
6740343|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6740344|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
6740345|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6740346|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
6740347|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740348|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740349|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
6740350|NCT01954290|Mannitol|mannitol|mesh-list
6740351|NCT01954290|Conivaptan|conivaptan|mesh-list
6740352|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6740353|NCT01954290|Diuretics|diuretics|mesh-ancestor
6740354|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
6740355|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740356|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6740357|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740358|NCT01954355|Paclitaxel|paclitaxel|mesh-list
6740359|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6740360|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740361|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
6740362|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
6740363|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
6740364|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740365|NCT01954368|Sufentanil|sufentanil|mesh-list
6740366|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6740367|NCT01954368|Narcotics|narcotics|mesh-ancestor
6740368|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6740369|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740370|NCT01954368|Analgesics|analgesics|mesh-ancestor
6740371|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
6740372|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740373|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6740374|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6740375|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
6740376|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
6740377|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
6740378|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
6740379|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6740380|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6740381|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740382|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740383|NCT01954524|Urological Agents|urological agents|mesh-ancestor
6740384|NCT01954693|Everolimus|everolimus|mesh-list
6740385|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740386|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740387|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
6740388|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740389|NCT01954732|Metformin|metformin|mesh-list
6740390|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6740391|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740392|NCT01954784|Cyclosporine|cyclosporine|mesh-list
6740393|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
6740394|NCT01954784|Fludarabine|fludarabine|mesh-list
6740395|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
6740396|NCT01954784|Lenalidomide|lenalidomide|mesh-list
6740397|NCT01954784|Bortezomib|bortezomib|mesh-list
6740398|NCT01954784|Cyclosporins|cyclosporins|mesh-list
6740399|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740400|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6740401|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
6740402|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740403|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740404|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
6740405|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740406|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740407|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
6740408|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740409|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
6740410|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6740411|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6740412|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6740413|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6740414|NCT01954784|Growth Substances|growth substances|mesh-ancestor
6740415|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
6740416|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6740417|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6740418|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
6740419|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6740420|NCT01954914|Plerixafor|plerixafor|mesh-list
6740421|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6740422|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6740423|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
6740424|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740425|NCT01954966|Progesterone|progesterone|mesh-list
6740426|NCT01954966|Progestins|progestins|mesh-ancestor
6740427|NCT01954966|Hormones|hormones|mesh-ancestor
6740428|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740429|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740430|NCT01954992|Fluorouracil|fluorouracil|mesh-list
6740431|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
6740432|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740433|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6740434|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740435|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740436|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
6740437|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740438|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
6740439|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
6740440|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740441|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
6740442|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740443|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740444|NCT01955070|Ketamine|ketamine|mesh-list
6740445|NCT01955070|Analgesics|analgesics|mesh-ancestor
6740446|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
6740447|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740448|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740449|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6740450|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6740451|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
6740452|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
6740453|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6740454|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6740455|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6740456|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740457|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740458|NCT01955135|Ketamine|ketamine|mesh-list
6740459|NCT01955135|Propofol|propofol|mesh-list
6740460|NCT01955135|Sevoflurane|sevoflurane|mesh-list
6740461|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6740462|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6740463|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740464|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6740465|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
6740466|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
6740467|NCT01955135|Analgesics|analgesics|mesh-ancestor
6740468|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
6740469|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740470|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6740471|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6740472|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6740473|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740474|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740475|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6740476|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6740477|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
6740478|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6740479|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6740480|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740481|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
6740482|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740483|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740484|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
6740485|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6740486|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6740487|NCT01955187|Prednisolone|prednisolone|mesh-list
6740488|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
6740489|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
6740490|NCT01955187|Rituximab|rituximab|mesh-list
6740491|NCT01955187|Tacrolimus|tacrolimus|mesh-list
6740492|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6740493|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
6740494|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740495|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
6740496|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740497|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6740498|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6740499|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
6740500|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740501|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740502|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6740503|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6740504|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6740505|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740506|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6740507|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
6740508|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
6740509|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740510|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6740511|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
6740512|NCT01955187|Hormones|hormones|mesh-ancestor
6740513|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740514|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6740515|NCT01955187|Protective Agents|protective agents|mesh-ancestor
6740516|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6740517|NCT01955200|Cilostazol|cilostazol|mesh-list
6740518|NCT01955200|Clopidogrel|clopidogrel|mesh-list
6740519|NCT01955200|Ticagrelor|ticagrelor|mesh-list
6740520|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6740521|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6740522|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6740523|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6740524|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
6740525|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740526|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740527|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740528|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6740529|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
6740530|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740531|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6740532|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
6740533|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6740534|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6740535|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
6740536|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6740537|NCT01955200|Protective Agents|protective agents|mesh-ancestor
6740538|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6740539|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6740540|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740541|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
6740542|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6740543|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740544|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
6740545|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740546|NCT01955252|Azithromycin|azithromycin|mesh-list
6740547|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6740548|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740549|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
6740550|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6740551|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740552|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
6740553|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
6740554|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
6740555|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740556|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740557|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740558|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6740559|NCT01955421|Gefitinib|gefitinib|mesh-list
6740560|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740561|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6740562|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740563|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740564|NCT01955460|Aldesleukin|aldesleukin|mesh-list
6740565|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
6740566|NCT01955460|Fludarabine|fludarabine|mesh-list
6740567|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
6740568|NCT01955460|Interleukin-2|interleukin-2|mesh-list
6740569|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740570|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
6740571|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740572|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6740573|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6740574|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
6740575|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740576|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740577|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6740578|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6740579|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
6740580|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6740581|NCT01955460|Analgesics|analgesics|mesh-ancestor
6740582|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
6740583|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740584|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6740585|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6740586|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
6740587|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740588|NCT01955512|Clopidogrel|clopidogrel|mesh-list
6740589|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6740590|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6740591|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6740592|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6740593|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
6740594|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740595|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740596|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740597|NCT01955577|Vitamin D|vitamin d|mesh-list
6740598|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
6740599|NCT01955577|Vitamins|vitamins|mesh-ancestor
6740600|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
6740601|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740602|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6740603|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6740604|NCT01955642|Clopidogrel|clopidogrel|mesh-list
6740605|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6740606|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6740607|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6740608|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6740609|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
6740610|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740611|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740612|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740613|NCT01955655|Baclofen|baclofen|mesh-list
6740614|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6740615|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740616|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6740617|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740618|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6740619|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
6740620|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
6740621|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740622|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740623|NCT01955694|Eplerenone|eplerenone|mesh-list
6740624|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6740625|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
6740626|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740627|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740628|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6740629|NCT01955694|Diuretics|diuretics|mesh-ancestor
6740630|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
6740631|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6740632|NCT01955759|Amiodarone|amiodarone|mesh-list
6740633|NCT01955759|Bisoprolol|bisoprolol|mesh-list
6740634|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6740635|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6740636|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6740637|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6740638|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
6740639|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740640|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6740641|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6740642|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740643|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6740644|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
6740645|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6740646|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6740647|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6740648|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6740649|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6740650|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6740651|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6740652|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6740653|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6740654|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
6740655|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740656|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740657|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6740658|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
6740659|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
6740660|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740661|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6786504|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786505|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6786506|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6786507|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6786508|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6786509|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6786510|NCT02214706|Sirolimus|sirolimus|mesh-list
6786511|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786512|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786513|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6786514|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786515|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
6786516|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786517|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
6786518|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786519|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
6786520|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786521|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786522|NCT02214810|Bupivacaine|bupivacaine|mesh-list
6786523|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
6786524|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
6786525|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6786526|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786527|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
6786528|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786529|NCT02214966|Telmisartan|telmisartan|mesh-list
6786530|NCT02214966|Ramipril|ramipril|mesh-list
6786531|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6786532|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6786533|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6786534|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786535|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6786536|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
6786537|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786538|NCT02214979|Telmisartan|telmisartan|mesh-list
6786539|NCT02214979|Ramipril|ramipril|mesh-list
6786540|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6786541|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6786542|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6786543|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786544|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6786545|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
6786546|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786547|NCT02214992|Telmisartan|telmisartan|mesh-list
6786548|NCT02214992|Ramipril|ramipril|mesh-list
6786549|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6786550|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6786551|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6786552|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786553|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6786554|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
6786555|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786556|NCT02215005|Telmisartan|telmisartan|mesh-list
6786557|NCT02215005|Ramipril|ramipril|mesh-list
6786558|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6786559|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6786560|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6786561|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786562|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6786563|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
6786564|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786565|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6786566|NCT02215044|Gemcitabine|gemcitabine|mesh-list
6786567|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6786568|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
6786569|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786570|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786571|NCT02215044|Antiviral Agents|antiviral agents|mesh-ancestor
6786572|NCT02215044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740662|NCT01955824|Lidocaine|lidocaine|mesh-list
6740663|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
6740664|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
6740665|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6740666|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740667|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
6740668|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740669|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6740670|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6740671|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6740672|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6740673|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740674|NCT01955967|Lidocaine|lidocaine|mesh-list
6740675|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
6740676|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
6740677|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6740678|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740679|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
6740680|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740681|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6740682|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6740683|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6740684|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6740685|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740686|NCT01955980|Budesonide|budesonide|mesh-list
6740687|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6740688|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6740689|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
6740690|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740691|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740692|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6740693|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
6740694|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
6740695|NCT01955980|Hormones|hormones|mesh-ancestor
6740696|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740697|NCT01956006|Milrinone|milrinone|mesh-list
6740698|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6740699|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6740700|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
6740701|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6740702|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6740703|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740704|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740705|NCT01956006|Protective Agents|protective agents|mesh-ancestor
6740706|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740707|NCT01956201|Atorvastatin|atorvastatin|mesh-list
6740708|NCT01956201|Fenofibrate|fenofibrate|mesh-list
6740709|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6740710|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6740711|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
6740712|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740713|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6740714|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6740715|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740716|NCT01956305|Metformin|metformin|mesh-list
6740717|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6740718|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740719|NCT01956474|Riboflavin|riboflavin|mesh-list
6740720|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
6740721|NCT01956474|Vitamins|vitamins|mesh-ancestor
6740722|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
6740723|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740724|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6740725|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
6740726|NCT01956487|Propafenone|propafenone|mesh-list
6740727|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6740728|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6740729|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6740730|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6740731|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740732|NCT01956591|Oxybutynin|oxybutynin|mesh-list
6740733|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
6740734|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
6740735|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740736|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740737|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6740738|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6740739|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
6740740|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740741|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740742|NCT01956591|Urological Agents|urological agents|mesh-ancestor
6740743|NCT01956604|Clonidine|clonidine|mesh-list
6740744|NCT01956604|Analgesics|analgesics|mesh-ancestor
6740745|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
6740746|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740747|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740748|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6740749|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
6740750|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
6740751|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6740752|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6740753|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6740754|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
6740755|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740756|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740757|NCT01956695|Rituximab|rituximab|mesh-list
6740758|NCT01956695|Lenalidomide|lenalidomide|mesh-list
6740759|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6740760|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740761|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
6740762|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740763|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6740764|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6740765|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6740766|NCT01956695|Growth Substances|growth substances|mesh-ancestor
6740767|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
6740768|NCT01956734|Temozolomide|temozolomide|mesh-list
6740769|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6740770|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
6740771|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740772|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740773|NCT01956786|Amlodipine|amlodipine|mesh-list
6740774|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6740775|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6740776|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6740777|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740778|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6740779|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740780|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
6740781|NCT01956864|Vitamin D|vitamin d|mesh-list
6740782|NCT01956864|Vitamins|vitamins|mesh-ancestor
6740783|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
6740784|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740785|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6740786|NCT01956929|Metformin|metformin|mesh-list
6740787|NCT01956929|Lactulose|lactulose|mesh-list
6740788|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6740789|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740790|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6740791|NCT01956955|Heparin|heparin|mesh-list
6740792|NCT01956955|Enoxaparin|enoxaparin|mesh-list
6740793|NCT01956955|Calcium heparin|calcium heparin|mesh-list
6740794|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6740795|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
6740796|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6740797|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6740798|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740799|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
6740800|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
6740801|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6740802|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6740803|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740804|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6740805|NCT01956981|Analgesics|analgesics|mesh-ancestor
6740806|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
6740807|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740808|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6740809|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6740810|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6740811|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
6740812|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740813|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740814|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
6740815|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6740816|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
6740817|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6740818|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6740819|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6740820|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
6740821|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6740822|NCT01957007|Docetaxel|docetaxel|mesh-list
6740823|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740824|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
6740825|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
6740826|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
6740827|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740828|NCT01957046|Laxatives|laxatives|mesh-list
6740829|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6740830|NCT01957189|Tamsulosin|tamsulosin|mesh-list
6740831|NCT01957189|Dutasteride|dutasteride|mesh-list
6740832|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6740833|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6740834|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6740835|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
6740836|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740837|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740838|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740839|NCT01957189|Urological Agents|urological agents|mesh-ancestor
6740840|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6740841|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6740842|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740843|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
6740844|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740845|NCT01957293|Albuterol|albuterol|mesh-list
6740846|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6740847|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
6740848|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740849|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740850|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6740851|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
6740852|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
6740853|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6740854|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6740855|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6740856|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6740857|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
6740858|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740859|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740860|NCT01957319|Vitamin E|vitamin e|mesh-list
6740861|NCT01957319|Silybin|silybin|mesh-list
6740862|NCT01957319|Vitamins|vitamins|mesh-ancestor
6740863|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
6740864|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740865|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
6740866|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740867|NCT01957319|Protective Agents|protective agents|mesh-ancestor
6740868|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6740869|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786573|NCT02215044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786574|NCT02215044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786575|NCT02215044|Immunologic Factors|immunologic factors|mesh-ancestor
6786576|NCT02215044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786577|NCT02215057|Lidocaine|lidocaine|mesh-list
6786578|NCT02215057|Anesthetics|anesthetics|mesh-list
6786579|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
6786580|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6786581|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786582|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
6786583|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786584|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6786585|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6786586|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6740870|NCT01957436|Docetaxel|docetaxel|mesh-list
6740871|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
6740872|NCT01957436|Androgens|androgens|mesh-list
6740873|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740874|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
6740875|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
6740876|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
6740877|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740878|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6740879|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740880|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
6740881|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740882|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740883|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6740884|NCT01957436|Hormones|hormones|mesh-ancestor
6740885|NCT01957449|Propranolol|propranolol|mesh-list
6740886|NCT01957449|Metoprolol|metoprolol|mesh-list
6740887|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6740888|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6740889|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
6740890|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740891|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740892|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740893|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6740894|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6740895|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
6740896|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
6740897|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
6740898|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740899|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6740900|NCT01957540|Ticagrelor|ticagrelor|mesh-list
6740901|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6740902|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6740903|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6740904|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6740905|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6740906|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
6740907|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740908|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740909|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740910|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
6740911|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6740912|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6740913|NCT01957631|Prednisolone|prednisolone|mesh-list
6740914|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
6740915|NCT01957631|Bupivacaine|bupivacaine|mesh-list
6740916|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6740917|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
6740918|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
6740919|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
6740920|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6740921|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740922|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
6740923|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6740924|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6740925|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
6740926|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
6740927|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6740928|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
6740929|NCT01957631|Hormones|hormones|mesh-ancestor
6740930|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6740931|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6740932|NCT01957631|Protective Agents|protective agents|mesh-ancestor
6740933|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6740934|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740935|NCT01957839|Cabergoline|cabergoline|mesh-list
6740936|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6740937|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6740938|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
6740939|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
6740940|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6740941|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740942|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740943|NCT01957852|Thrombin|thrombin|mesh-list
6740944|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
6740945|NCT01957852|Coagulants|coagulants|mesh-ancestor
6740946|NCT01957943|SMOFlipid|smoflipid|mesh-list
6740947|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6740948|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6740949|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6740950|NCT01957956|Temozolomide|temozolomide|mesh-list
6740951|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6740952|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
6740953|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740954|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740955|NCT01957995|Docetaxel|docetaxel|mesh-list
6740956|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740957|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
6740958|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
6740959|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
6740960|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740961|NCT01958138|Propofol|propofol|mesh-list
6740962|NCT01958138|Isoflurane|isoflurane|mesh-list
6740963|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6740964|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6740965|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740966|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6740967|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
6740968|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
6740969|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6740970|NCT01958190|Sirolimus|sirolimus|mesh-list
6740971|NCT01958190|Tacrolimus|tacrolimus|mesh-list
6740972|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6740973|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
6740974|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6740975|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6740976|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740977|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740978|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6740979|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6740980|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6740981|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740982|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
6740983|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
6740984|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
6740985|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6740986|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6740987|NCT01958372|Etoposide|etoposide|mesh-list
6740988|NCT01958372|Pemetrexed|pemetrexed|mesh-list
6740989|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6740990|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6740991|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6740992|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6740993|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6740994|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6740995|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6740996|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6740997|NCT01958580|Gemcitabine|gemcitabine|mesh-list
6740998|NCT01958580|Docetaxel|docetaxel|mesh-list
6740999|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6741000|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
6741001|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741002|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741003|NCT01958580|Antiviral Agents|antiviral agents|mesh-ancestor
6741004|NCT01958580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6741005|NCT01958580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741006|NCT01958580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6741007|NCT01958580|Immunologic Factors|immunologic factors|mesh-ancestor
6741008|NCT01958580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741009|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
6741010|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
6741011|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
6741012|NCT01958684|Copper|copper|mesh-list
6741013|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
6741014|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6741015|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
6741016|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6741017|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741018|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6741019|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6741020|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6741021|NCT01958684|Trace Elements|trace elements|mesh-ancestor
6741022|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
6741023|NCT01958775|Glucagon|glucagon|mesh-list
6741024|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6741025|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6741026|NCT01958775|Hormones|hormones|mesh-ancestor
6741027|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6741028|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741029|NCT01958775|Incretins|incretins|mesh-ancestor
6741030|NCT01958814|Albuterol|albuterol|mesh-list
6741031|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6741032|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
6741033|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741034|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741035|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6741036|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
6741037|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
6741038|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6741039|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6741040|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6741041|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6741042|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
6741043|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741044|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741045|NCT01958866|Acetaminophen|acetaminophen|mesh-list
6741046|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6741047|NCT01958866|Analgesics|analgesics|mesh-ancestor
6741048|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
6741049|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741050|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741051|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
6741052|NCT01958905|Lumefantrine|lumefantrine|mesh-list
6741053|NCT01958905|Artemether|artemether|mesh-list
6741054|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6741055|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
6741056|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6741057|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6741058|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6741059|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
6741060|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6741061|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
6741062|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741063|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741064|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6741065|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
6741066|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6741067|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
6741068|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741069|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741070|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6741071|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
6741072|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
6741073|NCT01958944|Protective Agents|protective agents|mesh-ancestor
6741074|NCT01958996|Idarubicin|idarubicin|mesh-list
6741075|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6741076|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741077|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6741078|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6741079|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741080|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741081|NCT01959022|Doxazosin|doxazosin|mesh-list
6741082|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6741083|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6741084|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6741085|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6741086|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
6741087|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741088|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741089|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741090|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
6741091|NCT01959061|Raltitrexed|raltitrexed|mesh-list
6741092|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
6741093|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741094|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6741095|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
6741096|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741097|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6741098|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741099|NCT01959074|Aceclofenac|aceclofenac|mesh-list
6741100|NCT01959074|Naftopidil|naftopidil|mesh-list
6741101|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6741102|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6741103|NCT01959074|Analgesics|analgesics|mesh-ancestor
6741104|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
6741105|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741106|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741107|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6741108|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6741109|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6741110|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6741111|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
6741112|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741113|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741114|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6741115|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6741116|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6741117|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6741118|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6741119|NCT01959100|Azithromycin|azithromycin|mesh-list
6741120|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6741121|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6741122|NCT01959152|Imidacloprid|imidacloprid|mesh-list
6741123|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
6741124|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741125|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741126|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741127|NCT01959191|Aspirin|aspirin|mesh-list
6741128|NCT01959191|Clopidogrel|clopidogrel|mesh-list
6741129|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6741130|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6741131|NCT01959191|Analgesics|analgesics|mesh-ancestor
6741132|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
6741133|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741134|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741135|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6741136|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6741137|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6741138|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6741139|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741140|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6741141|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6741142|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741143|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
6741144|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6741145|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6741146|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6741147|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
6741148|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741149|NCT01959204|Oxycodone|oxycodone|mesh-list
6741150|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6741151|NCT01959204|Narcotics|narcotics|mesh-ancestor
6741152|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741153|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741154|NCT01959204|Analgesics|analgesics|mesh-ancestor
6741155|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
6741156|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786587|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6786588|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786589|NCT02215096|GSK2636771|gsk2636771|mesh-list
6786590|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786591|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6786592|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786593|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786594|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6786595|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6786596|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
6786597|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786598|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786599|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6786600|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
6786601|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
6786602|NCT02215122|Hormones|hormones|mesh-ancestor
6786603|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786604|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
6786605|NCT02215148|Tolvaptan|tolvaptan|mesh-list
6786606|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6786607|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786608|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
6786609|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786610|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6786611|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6786612|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6786613|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
6786614|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786615|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6786616|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6786617|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786618|NCT02215213|Vitamin D|vitamin d|mesh-list
6786619|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
6786620|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
6786621|NCT02215213|Vitamins|vitamins|mesh-list
6786622|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
6786623|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786624|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6786625|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6786626|NCT02215265|Cisplatin|cisplatin|mesh-list
6786627|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786628|NCT02215330|Eplerenone|eplerenone|mesh-list
6786629|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6786630|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
6786631|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786632|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786633|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6786634|NCT02215330|Diuretics|diuretics|mesh-ancestor
6741157|NCT01959386|Trastuzumab|trastuzumab|mesh-list
6741158|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6741159|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741160|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6741161|NCT01959399|Peficitinib|peficitinib|mesh-list
6741162|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6741163|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6741164|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
6741165|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741166|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6741167|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6741168|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741169|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6741170|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
6741171|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741172|NCT01959438|Selenious Acid|selenious acid|mesh-list
6741173|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
6741174|NCT01959438|Trace Elements|trace elements|mesh-ancestor
6741175|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
6741176|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741177|NCT01959451|Clopidogrel|clopidogrel|mesh-list
6741178|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6741179|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6741180|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6741181|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6741182|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6741183|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
6741184|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741185|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741186|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741187|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
6741188|NCT01959477|Busulfan|busulfan|mesh-list
6741189|NCT01959477|Etoposide|etoposide|mesh-list
6741190|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
6741191|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6741192|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
6741193|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741194|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6741195|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6741196|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
6741197|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741198|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741199|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6741200|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6741201|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6741202|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6741203|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741204|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
6741205|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6741206|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
6741207|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741208|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741209|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6741210|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
6741211|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6741212|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
6741213|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741214|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741215|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6741216|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
6741217|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
6741218|NCT01959828|Protective Agents|protective agents|mesh-ancestor
6741219|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6741220|NCT01959854|Laxatives|laxatives|mesh-ancestor
6741221|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6741222|NCT01960023|Cetuximab|cetuximab|mesh-list
6741223|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6741224|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741225|NCT01960049|Ropivacaine|ropivacaine|mesh-list
6741226|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741227|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
6741228|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741229|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741230|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
6786635|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
6741231|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741232|NCT01960153|Tadalafil|tadalafil|mesh-list
6741233|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
6741234|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6741235|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6741236|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741237|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741238|NCT01960153|Urological Agents|urological agents|mesh-ancestor
6741239|NCT01960179|Lixisenatide|lixisenatide|mesh-list
6741240|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6741241|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741242|NCT01960205|Metformin|metformin|mesh-list
6741243|NCT01960205|Saxagliptin|saxagliptin|mesh-list
6741244|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6741245|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741246|NCT01960205|Incretins|incretins|mesh-ancestor
6741247|NCT01960205|Hormones|hormones|mesh-ancestor
6741248|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6741249|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6741250|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
6741251|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741252|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741253|NCT01960283|Methotrexate|methotrexate|mesh-list
6741254|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6741255|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
6741256|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6741257|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741258|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6741259|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
6741260|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741261|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741262|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
6741263|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741264|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6741265|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6741266|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
6741267|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6741268|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6741269|NCT01960426|Adalimumab|adalimumab|mesh-list
6741270|NCT01960426|Infliximab|infliximab|mesh-list
6741271|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6741272|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6741273|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
6741274|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6741275|NCT01960543|Fentanyl|fentanyl|mesh-list
6741276|NCT01960543|Bupivacaine|bupivacaine|mesh-list
6741277|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
6741278|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741279|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
6741280|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741281|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741282|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
6741283|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741284|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6741285|NCT01960543|Narcotics|narcotics|mesh-ancestor
6741286|NCT01960543|Analgesics|analgesics|mesh-ancestor
6741287|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6741288|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6741289|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
6741290|NCT01960569|Hirudins|hirudins|mesh-list
6741291|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
6741292|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6741293|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
6741294|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741295|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741296|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
6741297|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6741298|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6741299|NCT01960595|Fentanyl|fentanyl|mesh-list
6741300|NCT01960595|Bupivacaine|bupivacaine|mesh-list
6741301|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741302|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
6741303|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741304|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741305|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
6741306|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741307|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6741308|NCT01960595|Narcotics|narcotics|mesh-ancestor
6741309|NCT01960595|Analgesics|analgesics|mesh-ancestor
6741310|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6741311|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6741312|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
6741313|NCT01960647|Paclitaxel|paclitaxel|mesh-list
6741314|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6741315|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741316|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
6741317|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
6741318|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
6741319|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741320|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6741321|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6741322|NCT01960829|Everolimus|everolimus|mesh-list
6741323|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741324|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6741325|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
6741326|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741327|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6741328|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6741329|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6741330|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
6741331|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6741332|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
6741333|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741334|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741335|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
6741336|NCT01961154|Hormones|hormones|mesh-ancestor
6741337|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6741338|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
6741339|NCT01961180|Citalopram|citalopram|mesh-list
6741340|NCT01961180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6741341|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6741342|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6741343|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741344|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741345|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
6741346|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741347|NCT01961180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6741348|NCT01961180|Antidepressive Agents|antidepressive agents|mesh-ancestor
6741349|NCT01961180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6741350|NCT01961193|Silicon|silicon|mesh-list
6741351|NCT01961193|Trace Elements|trace elements|mesh-ancestor
6741352|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
6741353|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741354|NCT01961219|Anesthetics|anesthetics|mesh-list
6741355|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741356|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786636|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6741357|NCT01961336|Testosterone|testosterone|mesh-list
6741358|NCT01961336|Androgens|androgens|mesh-ancestor
6741359|NCT01961336|Hormones|hormones|mesh-ancestor
6741360|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6741361|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741362|NCT01961388|Metformin|metformin|mesh-list
6741363|NCT01961388|Acarbose|acarbose|mesh-list
6741364|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6741365|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741366|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6741367|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741368|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741369|NCT01961414|Aflibercept|aflibercept|mesh-list
6741370|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6741371|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6741372|NCT01961414|Growth Substances|growth substances|mesh-ancestor
6741373|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741374|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
6741375|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741376|NCT01961453|Isosorbide|isosorbide|mesh-list
6741377|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6741378|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6741379|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6741380|NCT01961453|Diuretics|diuretics|mesh-ancestor
6741381|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
6741382|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741383|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
6741384|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6741385|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741386|NCT01961635|Cimetidine|cimetidine|mesh-list
6741387|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6741388|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6741389|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6741390|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
6741391|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
6741392|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741393|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741394|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741395|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6741396|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6741397|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741398|NCT01961739|Lidocaine|lidocaine|mesh-list
6741399|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741400|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
6741401|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741402|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741403|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
6741404|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741405|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6741406|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6741407|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6741408|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6741409|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741410|NCT01961752|Triamcinolone|triamcinolone|mesh-list
6741411|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6741412|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6741413|NCT01961752|Bupivacaine|bupivacaine|mesh-list
6741414|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6741415|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741416|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
6741417|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741418|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741419|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
6741420|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741421|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6741422|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
6741423|NCT01961752|Hormones|hormones|mesh-ancestor
6741424|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6741425|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6741426|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
6741427|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741428|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741429|NCT01961830|Arbekacin|arbekacin|mesh-list
6741430|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6741431|NCT01961843|Prednisone|prednisone|mesh-list
6741432|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
6741433|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6741434|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
6741435|NCT01961843|Hormones|hormones|mesh-ancestor
6741436|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6741437|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741438|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6741439|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741440|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6741441|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741442|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741443|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
6741444|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6741445|NCT01961856|Clopidogrel|clopidogrel|mesh-list
6741446|NCT01961856|Ticagrelor|ticagrelor|mesh-list
6741447|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6741448|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6741449|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6741450|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6741451|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
6741452|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741453|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741454|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741455|NCT01961947|Vaccines|vaccines|mesh-list
6741456|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
6741457|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741458|NCT01962116|Heparin|heparin|mesh-list
6741459|NCT01962116|Calcium heparin|calcium heparin|mesh-list
6741460|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
6741461|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741462|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6741463|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6741464|NCT01962181|Methylphenidate|methylphenidate|mesh-list
6741465|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6741466|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741467|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6741468|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6741469|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6741470|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741471|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
6741472|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741473|NCT01962285|Propofol|propofol|mesh-list
6741474|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6741475|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741476|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741477|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6741478|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
6741479|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
6741480|NCT01962363|Tocotrienols|tocotrienols|mesh-list
6741481|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
6741482|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
6741483|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741484|NCT01962363|Protective Agents|protective agents|mesh-ancestor
6741485|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741486|NCT01962363|Vitamins|vitamins|mesh-ancestor
6741487|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
6741488|NCT01962376|Bevacizumab|bevacizumab|mesh-list
6741489|NCT01962376|Capecitabine|capecitabine|mesh-list
6741490|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
6741491|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6741492|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741493|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6741494|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6741495|NCT01962376|Growth Substances|growth substances|mesh-ancestor
6741496|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741497|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
6741498|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6741499|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
6741500|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741501|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
6741502|NCT01962454|Testosterone|testosterone|mesh-list
6741503|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
6741504|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
6741505|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6741506|NCT01962454|Androgens|androgens|mesh-ancestor
6741507|NCT01962454|Hormones|hormones|mesh-ancestor
6741508|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6741509|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741510|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6741511|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741512|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
6741513|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
6741514|NCT01962571|Hematinics|hematinics|mesh-ancestor
6741515|NCT01962636|Cyclosporine|cyclosporine|mesh-list
6741516|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
6741517|NCT01962636|Fludarabine|fludarabine|mesh-list
6741518|NCT01962636|Cyclosporins|cyclosporins|mesh-list
6741519|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6741520|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
6741521|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741522|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6741523|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6741524|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
6741525|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741526|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741527|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6741528|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741529|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
6741530|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6741531|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
6741532|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6741533|NCT01962831|Dinoprostone|dinoprostone|mesh-list
6741534|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
6741535|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6741536|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741537|NCT01962948|Paclitaxel|paclitaxel|mesh-list
6741538|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6741539|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741540|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
6741541|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
6741542|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
6741543|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786637|NCT02215382|Atropine|atropine|mesh-list
6786638|NCT02215382|Neostigmine|neostigmine|mesh-list
6786639|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6786640|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6786641|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6786642|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
6786643|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786644|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786645|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6786646|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
6786647|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
6786648|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
6786649|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6786650|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6786651|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
6786652|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786653|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786654|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6786655|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786656|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6786657|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6786658|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
6786659|NCT02215395|Estradiol|estradiol|mesh-list
6786660|NCT02215395|Estrogens|estrogens|mesh-ancestor
6786661|NCT02215395|Hormones|hormones|mesh-ancestor
6786662|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786663|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786664|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6786665|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6786666|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6786667|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6786668|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6786669|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
6786670|NCT02215434|Testosterone|testosterone|mesh-list
6786671|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
6786672|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
6786673|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6786674|NCT02215434|Androgens|androgens|mesh-ancestor
6786675|NCT02215434|Hormones|hormones|mesh-ancestor
6786676|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786677|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786678|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6786679|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786680|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
6786681|NCT02215447|Paclitaxel|paclitaxel|mesh-list
6786682|NCT02215447|Carboplatin|carboplatin|mesh-list
6786683|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6786684|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786685|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
6786686|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
6786687|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
6741544|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6741545|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
6741546|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6741547|NCT01963039|Protective Agents|protective agents|mesh-ancestor
6741548|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741549|NCT01963182|Irinotecan|irinotecan|mesh-list
6741550|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6741551|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6741552|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741553|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741554|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741555|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6741556|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6741557|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741558|NCT01963299|Clonidine|clonidine|mesh-list
6741559|NCT01963299|Ropivacaine|ropivacaine|mesh-list
6741560|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741561|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
6741562|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741563|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741564|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
6741565|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741566|NCT01963299|Analgesics|analgesics|mesh-ancestor
6741567|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6741568|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
6741569|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
6741570|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6741571|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6741572|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6741573|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
6741574|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741575|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741576|NCT01963325|Paclitaxel|paclitaxel|mesh-list
6741577|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6741578|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6741579|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741580|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
6741581|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
6741582|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
6741583|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741584|NCT01963390|Testosterone|testosterone|mesh-list
6741585|NCT01963390|Androgens|androgens|mesh-ancestor
6741586|NCT01963390|Hormones|hormones|mesh-ancestor
6741587|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6741588|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741589|NCT01963416|Micronutrients|micronutrients|mesh-list
6741590|NCT01963416|Trace Elements|trace elements|mesh-list
6741591|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741592|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6741593|NCT01963442|Lactams|lactams|mesh-list
6741594|NCT01963442|beta-Lactams|beta-lactams|mesh-list
6741595|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6741596|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6741597|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6741598|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741599|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741600|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
6741601|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741602|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741603|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6741604|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6741605|NCT01963546|Analgesics|analgesics|mesh-ancestor
6741606|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
6741607|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741608|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6741609|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6741610|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6741611|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
6741612|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741613|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741614|NCT01963559|Lidocaine|lidocaine|mesh-list
6741615|NCT01963559|Prilocaine|prilocaine|mesh-list
6741616|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6741617|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741618|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
6741619|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741620|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741621|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
6741622|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741623|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6741624|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6741625|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6741626|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6741627|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741628|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6741629|NCT01963663|Metformin|metformin|mesh-list
6741630|NCT01963663|Pioglitazone|pioglitazone|mesh-list
6741631|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6741632|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741633|NCT01963702|Capecitabine|capecitabine|mesh-list
6741634|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
6741635|NCT01963702|Docetaxel|docetaxel|mesh-list
6741636|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6741637|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
6741638|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741639|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741640|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
6741641|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
6741642|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
6741643|NCT01963741|Histamine|histamine|mesh-list
6741644|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
6741645|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
6741646|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741647|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741648|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741649|NCT01963754|Epinephrine|epinephrine|mesh-list
6741650|NCT01963754|Racepinephrine|racepinephrine|mesh-list
6741651|NCT01963754|Anesthetics|anesthetics|mesh-list
6741652|NCT01963754|Carticaine|carticaine|mesh-list
6741653|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
6741654|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741655|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741656|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6741657|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6741658|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
6741659|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741660|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741661|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6741662|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6741663|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
6741664|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741665|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6741666|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
6741667|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
6741668|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
6741669|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6741670|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741671|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
6741672|NCT01963832|Fluoxetine|fluoxetine|mesh-list
6741673|NCT01963832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6741674|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6741675|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6741676|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741677|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741678|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
6741679|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741680|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6741681|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
6741682|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6741683|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6741684|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6741685|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741686|NCT01963910|Mannitol|mannitol|mesh-list
6741687|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6741688|NCT01963910|Diuretics|diuretics|mesh-ancestor
6741689|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
6741690|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741691|NCT01963962|Copper|copper|mesh-list
6741692|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
6741693|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6741694|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
6741695|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6741696|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741697|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6741698|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6741699|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6741700|NCT01963962|Trace Elements|trace elements|mesh-ancestor
6741701|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
6741702|NCT01964001|Vitamins|vitamins|mesh-list
6741703|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
6741704|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
6741705|NCT01964001|Pyridoxal|pyridoxal|mesh-list
6741706|NCT01964001|Pyridoxine|pyridoxine|mesh-list
6741707|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
6741708|NCT01964001|Ubiquinone|ubiquinone|mesh-list
6741709|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
6741710|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741711|NCT01964027|Irinotecan|irinotecan|mesh-list
6741712|NCT01964027|Epirubicin|epirubicin|mesh-list
6741713|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6741714|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6741715|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741716|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741717|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741718|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6741719|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6741720|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
6741721|NCT01964040|Bupivacaine|bupivacaine|mesh-list
6741722|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741723|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
6741724|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741725|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741726|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
6741727|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741728|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6741729|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6741730|NCT01964040|Analgesics|analgesics|mesh-ancestor
6741731|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6741732|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6741733|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6741734|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
6741735|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741736|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741737|NCT01964079|Losartan|losartan|mesh-list
6741738|NCT01964079|Amlodipine|amlodipine|mesh-list
6741739|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6741740|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6741741|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6741742|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741743|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6741744|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741745|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
6741746|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6741747|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6741748|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6741749|NCT01964157|Ceritinib|ceritinib|mesh-list
6741750|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741751|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6741752|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741753|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741754|NCT01964170|Goserelin|goserelin|mesh-list
6741755|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6741756|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741757|NCT01964183|Mirabegron|mirabegron|mesh-list
6741758|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
6741759|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6741760|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6741761|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6741762|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
6741763|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741764|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741765|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741766|NCT01964183|Urological Agents|urological agents|mesh-ancestor
6741767|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6741768|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6741769|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
6741770|NCT01964248|Lidocaine|lidocaine|mesh-list
6741771|NCT01964248|Prilocaine|prilocaine|mesh-list
6741772|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
6741773|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741774|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
6741775|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741776|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741777|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
6741778|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741779|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6741780|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6741781|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6741782|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6741783|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741784|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
6741785|NCT01964287|Leucovorin|leucovorin|mesh-list
6741786|NCT01964287|Gemcitabine|gemcitabine|mesh-list
6741787|NCT01964287|Paclitaxel|paclitaxel|mesh-list
6741788|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
6741789|NCT01964287|Irinotecan|irinotecan|mesh-list
6741790|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6741791|NCT01964287|Folfirinox|folfirinox|mesh-list
6741792|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6741793|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741794|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
6741795|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
6741796|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
6741797|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741798|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6741799|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
6741800|NCT01964287|Antiviral Agents|antiviral agents|mesh-ancestor
6741801|NCT01964287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6741802|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741803|NCT01964287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6741804|NCT01964287|Immunologic Factors|immunologic factors|mesh-ancestor
6741805|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741806|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6741807|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6741808|NCT01964287|Antidotes|antidotes|mesh-ancestor
6741809|NCT01964287|Protective Agents|protective agents|mesh-ancestor
6741810|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
6741811|NCT01964287|Vitamins|vitamins|mesh-ancestor
6741812|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
6741813|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
6741814|NCT01964365|Fenofibrate|fenofibrate|mesh-list
6741815|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6741816|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6741817|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
6741818|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741819|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6741820|NCT01964391|Paclitaxel|paclitaxel|mesh-list
6741821|NCT01964391|Docetaxel|docetaxel|mesh-list
6741822|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
6741823|NCT01964391|Carboplatin|carboplatin|mesh-list
6741824|NCT01964391|Doxorubicin|doxorubicin|mesh-list
6741825|NCT01964391|Trastuzumab|trastuzumab|mesh-list
6741826|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6741827|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741828|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
6741829|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
6741830|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
6741831|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741832|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6741833|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
6741834|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741835|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6741836|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6741837|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
6741838|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6741839|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6741840|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6741841|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6741842|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741843|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6741844|NCT01964404|Dronabinol|dronabinol|mesh-list
6741845|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
6741846|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741847|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6741848|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6741849|NCT01964404|Analgesics|analgesics|mesh-ancestor
6741850|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
6741851|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741852|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6741853|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6741854|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741855|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741856|NCT01964404|Hormones|hormones|mesh-ancestor
6741857|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6741858|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6741859|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6741860|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6741861|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
6741862|NCT01964534|Gemcitabine|gemcitabine|mesh-list
6741863|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6741864|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6741865|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
6741866|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741867|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741868|NCT01964534|Antiviral Agents|antiviral agents|mesh-ancestor
6741869|NCT01964534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6741870|NCT01964534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741871|NCT01964534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6741872|NCT01964534|Immunologic Factors|immunologic factors|mesh-ancestor
6741873|NCT01964534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741874|NCT01964573|Rotigotine|rotigotine|mesh-list
6741875|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
6741876|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
6741877|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741878|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741879|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741880|NCT01964586|Lidocaine|lidocaine|mesh-list
6741881|NCT01964586|Epinephrine|epinephrine|mesh-list
6741882|NCT01964586|Racepinephrine|racepinephrine|mesh-list
6741883|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
6741884|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
6741885|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741886|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
6741887|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741888|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741889|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
6741890|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741891|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6741892|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6741893|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6741894|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6741895|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741896|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6741897|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6741898|NCT01964586|Analgesics|analgesics|mesh-ancestor
6741899|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6741900|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6741901|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6741902|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
6741903|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741904|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6741905|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6741906|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
6741907|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6741908|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
6741909|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
6741910|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
6741911|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6741912|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
6741913|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741914|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786688|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786689|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
6786690|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6786691|NCT02215460|Azithromycin|azithromycin|mesh-list
6786692|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6786693|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786694|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
6786695|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
6786696|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786697|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
6786698|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6786699|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6786700|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786701|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
6786702|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
6786703|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
6786704|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6786705|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6786706|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
6786707|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
6786708|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6786709|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786710|NCT02215538|Methylphenidate|methylphenidate|mesh-list
6786711|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6741915|NCT01964781|Epinephrine|epinephrine|mesh-list
6741916|NCT01964781|Racepinephrine|racepinephrine|mesh-list
6741917|NCT01964781|Bupivacaine|bupivacaine|mesh-list
6741918|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
6741919|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
6741920|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741921|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
6741922|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741923|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741924|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
6741925|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741926|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6741927|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6741928|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741929|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
6741930|NCT01964781|Coagulants|coagulants|mesh-ancestor
6741931|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6741932|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6741933|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
6741934|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6741935|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6741936|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6741937|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
6741938|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6741939|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
6741940|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
6741941|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
6741942|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6741943|NCT01964846|Curcumin|curcumin|mesh-list
6741944|NCT01964846|Resveratrol|resveratrol|mesh-list
6741945|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6741946|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6741947|NCT01964846|Analgesics|analgesics|mesh-ancestor
6741948|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
6741949|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741950|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741951|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6741952|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6741953|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741954|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741955|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741956|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
6741957|NCT01964846|Protective Agents|protective agents|mesh-ancestor
6741958|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6741959|NCT01964911|Ropivacaine|ropivacaine|mesh-list
6741960|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741961|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
6741962|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741963|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741964|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
6741965|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741966|NCT01965041|Aflibercept|aflibercept|mesh-list
6741967|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6741968|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6741969|NCT01965041|Growth Substances|growth substances|mesh-ancestor
6741970|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741971|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
6741972|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741973|NCT01965080|Exemestane|exemestane|mesh-list
6741974|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741975|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6741976|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6741977|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741978|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741979|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6741980|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
6741981|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6741982|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741983|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6741984|NCT01965275|Gefitinib|gefitinib|mesh-list
6741985|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6741986|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6741987|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6741988|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6741989|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
6741990|NCT01965301|Promethazine|promethazine|mesh-list
6741991|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6741992|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6741993|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6741994|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6741995|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
6741996|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
6741997|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
6741998|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6741999|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
6742000|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
6742001|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6742002|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6742003|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
6742004|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
6742005|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742006|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742007|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6742008|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
6742009|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
6742010|NCT01965353|Dexamethasone|dexamethasone|mesh-list
6742011|NCT01965353|Lenalidomide|lenalidomide|mesh-list
6742012|NCT01965353|Bortezomib|bortezomib|mesh-list
6742013|NCT01965353|Panobinostat|panobinostat|mesh-list
6742014|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6742015|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
6742016|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
6742017|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742018|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742019|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6742020|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
6742021|NCT01965353|Hormones|hormones|mesh-ancestor
6742022|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742023|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6742024|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742025|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
6742026|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6742027|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6742028|NCT01965353|Growth Substances|growth substances|mesh-ancestor
6742029|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
6742030|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6742031|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742032|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742033|NCT01965405|Bupropion|bupropion|mesh-list
6742034|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6742035|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
6742036|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6742037|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6742038|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6742039|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6742040|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742041|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
6742042|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742043|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742044|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6742045|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6742046|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742047|NCT01965522|Vitamin D|vitamin d|mesh-list
6742048|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
6742049|NCT01965522|Vitamins|vitamins|mesh-list
6742050|NCT01965522|Melatonin|melatonin|mesh-list
6742051|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
6742052|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742053|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6742054|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6742055|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
6742056|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742057|NCT01965522|Protective Agents|protective agents|mesh-ancestor
6742058|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742059|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
6742060|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6742061|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
6742062|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6742063|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742064|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6742065|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6742066|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6742067|NCT01965626|Oseltamivir|oseltamivir|mesh-list
6742068|NCT01965626|Dexamethasone|dexamethasone|mesh-list
6742069|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6742070|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
6742071|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
6742072|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742073|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742074|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6742075|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
6742076|NCT01965626|Hormones|hormones|mesh-ancestor
6742077|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742078|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6742079|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742080|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
6742081|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742082|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742083|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742084|NCT01965704|Ondansetron|ondansetron|mesh-list
6742085|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
6742086|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
6742087|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742088|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742089|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6742090|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
6742091|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
6742092|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6742093|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
6742094|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742095|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742096|NCT01965704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6742097|NCT01965704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6742098|NCT01965704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742099|NCT01965704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6742100|NCT01965704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6742101|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
6742102|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6742103|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6742104|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742105|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
6742106|NCT01965730|Coagulants|coagulants|mesh-ancestor
6742107|NCT01965925|Modafinil|modafinil|mesh-list
6742108|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6742109|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742110|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6742111|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6742112|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6742113|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742114|NCT01965977|Bortezomib|bortezomib|mesh-list
6742115|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742116|NCT01966055|Solithromycin|solithromycin|mesh-list
6742117|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6742118|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742119|NCT01966133|Doxorubicin|doxorubicin|mesh-list
6742120|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6742121|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
6742122|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6742123|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742124|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6742125|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6742126|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742127|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742128|NCT01966172|Acetaminophen|acetaminophen|mesh-list
6742129|NCT01966172|Ibuprofen|ibuprofen|mesh-list
6742130|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6742131|NCT01966172|Morphine|morphine|mesh-list
6742132|NCT01966172|Gabapentin|gabapentin|mesh-list
6742133|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6742134|NCT01966172|Narcotics|narcotics|mesh-ancestor
6742135|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742136|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742137|NCT01966172|Analgesics|analgesics|mesh-ancestor
6742138|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
6742139|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742140|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6742141|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6742142|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6742143|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6742144|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742145|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742146|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
6742147|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
6742148|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6742149|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6742150|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6742151|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6742152|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6742153|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742154|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
6742155|NCT01966263|Epinephrine|epinephrine|mesh-list
6742156|NCT01966263|Racepinephrine|racepinephrine|mesh-list
6742157|NCT01966263|Ropivacaine|ropivacaine|mesh-list
6742158|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
6742159|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
6742160|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
6742161|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742162|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742163|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
6742164|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742165|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6742166|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6742167|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
6742168|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742169|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742170|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6742171|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6742172|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
6742173|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6742174|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
6742175|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
6742176|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
6742177|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6742178|NCT01966276|Methylphenidate|methylphenidate|mesh-list
6742179|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6742180|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742181|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6742182|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6742183|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6742184|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742185|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
6742186|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742187|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
6742188|NCT01966289|Guadecitabine|guadecitabine|mesh-list
6742189|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
6742190|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742191|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6742192|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6742193|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6742194|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
6742195|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742196|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742197|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6742198|NCT01966302|Beraprost|beraprost|mesh-list
6742199|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6742200|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
6742201|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6742202|NCT01966341|Laxatives|laxatives|mesh-list
6742203|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
6742204|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742205|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6742206|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
6742207|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742208|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742209|NCT01966484|Succinylcholine|succinylcholine|mesh-list
6742210|NCT01966484|Mivacurium|mivacurium|mesh-list
6742211|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6742212|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6742213|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6742214|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742215|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742216|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6742217|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6742218|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
6742219|NCT01966575|Progestins|progestins|mesh-list
6742220|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6742221|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6742222|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6742223|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
6742224|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6742225|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742226|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6742227|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6742228|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6742229|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6742230|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742231|NCT01966575|Hormones|hormones|mesh-ancestor
6742232|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742233|NCT01966627|Liver Extracts|liver extracts|mesh-list
6742234|NCT01966627|Hematinics|hematinics|mesh-ancestor
6786712|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786713|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6786714|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6786715|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6786716|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786717|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
6786718|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786719|NCT02215720|Sirolimus|sirolimus|mesh-list
6786720|NCT02215720|Cetuximab|cetuximab|mesh-list
6786721|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6786722|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786723|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786724|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786725|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6786726|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
6786727|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786728|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
6786729|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786730|NCT02215733|Telmisartan|telmisartan|mesh-list
6786731|NCT02215733|Diuretics|diuretics|mesh-list
6786732|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
6786733|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6786734|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6786735|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6786736|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786737|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
6786738|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786739|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6786740|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
6786741|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786742|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6786743|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6786744|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6786745|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6786746|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786747|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786748|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786749|NCT02215798|Analgesics|analgesics|mesh-ancestor
6786750|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
6786751|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786752|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
6786753|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6786754|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
6786755|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6786756|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
6786757|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786758|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
6786759|NCT02215876|Doxorubicin|doxorubicin|mesh-list
6786760|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786761|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
6786762|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786763|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6786764|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6742235|NCT01966653|Fosfomycin|fosfomycin|mesh-list
6742236|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
6742237|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6742238|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742239|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6742240|NCT01966653|Renal Agents|renal agents|mesh-ancestor
6742241|NCT01966692|Fluticasone|fluticasone|mesh-list
6742242|NCT01966692|Xhance|xhance|mesh-list
6742243|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6742244|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6742245|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
6742246|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742247|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742248|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6742249|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
6742250|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
6742251|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6742252|NCT01966783|Budesonide|budesonide|mesh-list
6742253|NCT01966783|Mesalamine|mesalamine|mesh-list
6742254|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6742255|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6742256|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
6742257|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742258|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742259|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6742260|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
6742261|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
6742262|NCT01966783|Hormones|hormones|mesh-ancestor
6742263|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742264|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6742265|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6742266|NCT01966783|Analgesics|analgesics|mesh-ancestor
6742267|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
6742268|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6742269|NCT01966822|Ritonavir|ritonavir|mesh-list
6742270|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
6742271|NCT01966822|Dolutegravir|dolutegravir|mesh-list
6742272|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
6742273|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6742274|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742275|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742276|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6742277|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6742278|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
6742279|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742280|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6742281|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6742282|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6742283|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6742284|NCT01966913|Bevacizumab|bevacizumab|mesh-list
6742285|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6742286|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742287|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6742288|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6742289|NCT01966913|Growth Substances|growth substances|mesh-ancestor
6742290|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742291|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
6742292|NCT01967017|Lidocaine|lidocaine|mesh-list
6742293|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
6742294|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
6742295|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742296|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742297|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
6742298|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742299|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6742300|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6742301|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6742302|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6742303|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742304|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6742305|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742306|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6742307|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742308|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742309|NCT01967199|Paclitaxel|paclitaxel|mesh-list
6742310|NCT01967199|Everolimus|everolimus|mesh-list
6742311|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6742312|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742313|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
6742314|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
6742315|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
6742316|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742317|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6742318|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
6742319|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742320|NCT01967238|Vaccines|vaccines|mesh-list
6742321|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
6742322|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742323|NCT01967251|Udenafil|udenafil|mesh-list
6742324|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6742325|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6742326|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742327|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742328|NCT01967264|Udenafil|udenafil|mesh-list
6742329|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6742330|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6742331|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742332|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742333|NCT01967368|Vaccines|vaccines|mesh-list
6742334|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
6742335|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742336|NCT01967381|Methamphetamine|methamphetamine|mesh-list
6742337|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6742338|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742339|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
6742340|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
6742341|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742342|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
6742343|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742344|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742345|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
6742346|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6742347|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6742348|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6742349|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6742350|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
6742351|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6742352|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742353|NCT01967459|Vitamins|vitamins|mesh-ancestor
6742354|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
6742355|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6742356|NCT01967472|Artesunate|artesunate|mesh-list
6742357|NCT01967472|Lumefantrine|lumefantrine|mesh-list
6742358|NCT01967472|Artemether|artemether|mesh-list
6742359|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6742360|NCT01967472|Amodiaquine|amodiaquine|mesh-list
6742361|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
6742362|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6742363|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6742364|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742365|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742366|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
6742367|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
6742368|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6742369|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
6742370|NCT01967498|Montelukast|montelukast|mesh-list
6742371|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6742372|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
6742373|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6742374|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
6742375|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742376|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742377|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6742378|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6742379|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742380|NCT01967524|Ropivacaine|ropivacaine|mesh-list
6742381|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6742382|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
6742383|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6742384|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
6742385|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
6742386|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742387|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742388|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
6742389|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742390|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6742391|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6742392|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742393|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
6742394|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742395|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6742396|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6742397|NCT01967758|Amoxicillin|amoxicillin|mesh-list
6742398|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6742399|NCT01967758|Trimethoprim|trimethoprim|mesh-list
6742400|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
6742401|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742402|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6742403|NCT01967758|Renal Agents|renal agents|mesh-ancestor
6742404|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
6742405|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6742406|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6742407|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6742408|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742409|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742410|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6742411|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6742412|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6742413|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6742414|NCT01967823|Aldesleukin|aldesleukin|mesh-list
6742415|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
6742416|NCT01967823|Fludarabine|fludarabine|mesh-list
6742417|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6742418|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
6742419|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742420|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6742421|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6742422|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
6742423|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742424|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742425|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6742426|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6742427|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6742428|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
6742429|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742430|NCT01967875|Docetaxel|docetaxel|mesh-list
6742431|NCT01967875|Capecitabine|capecitabine|mesh-list
6742432|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742433|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
6742434|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
6742435|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
6742436|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742437|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6742438|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
6742439|NCT01967927|Imidazole|imidazole|mesh-list
6742440|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742441|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742442|NCT01967979|Itraconazole|itraconazole|mesh-list
6742443|NCT01967979|Fluoxetine|fluoxetine|mesh-list
6742444|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
6742445|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742446|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6742447|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6742448|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742449|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742450|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6742451|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
6742452|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742453|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742454|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6742455|NCT01967979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6742456|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6742457|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6742458|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742459|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
6742460|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6742461|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
6742462|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6742463|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6742464|NCT01968005|Etodolac|etodolac|mesh-list
6742465|NCT01968005|Lidocaine|lidocaine|mesh-list
6742466|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
6742467|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
6742468|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742469|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742470|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
6742471|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742472|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6742473|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6742474|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6742475|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6742476|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742477|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6742478|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6742479|NCT01968005|Analgesics|analgesics|mesh-ancestor
6742480|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6742481|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6742482|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6742483|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6742484|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742485|NCT01968018|Acetaminophen|acetaminophen|mesh-list
6742486|NCT01968018|Tramadol|tramadol|mesh-list
6742487|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6742488|NCT01968018|Analgesics|analgesics|mesh-ancestor
6742489|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
6742490|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742491|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742492|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
6742493|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6742494|NCT01968018|Narcotics|narcotics|mesh-ancestor
6742495|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742496|NCT01968044|Linagliptin|linagliptin|mesh-list
6742497|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6742498|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742499|NCT01968044|Incretins|incretins|mesh-ancestor
6742500|NCT01968044|Hormones|hormones|mesh-ancestor
6742501|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742502|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6742503|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
6742504|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742505|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742506|NCT01968083|Vaccines|vaccines|mesh-list
6742507|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
6742508|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742509|NCT01968161|Asenapine|asenapine|mesh-list
6742510|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6742511|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6742512|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742513|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742514|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6742515|NCT01968200|Enalapril|enalapril|mesh-list
6742516|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6742517|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
6742518|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742519|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742520|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6742521|NCT01968239|Ranibizumab|ranibizumab|mesh-list
6742522|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6742523|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6742524|NCT01968239|Growth Substances|growth substances|mesh-ancestor
6742525|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742526|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
6742527|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742528|NCT01968395|Caspofungin|caspofungin|mesh-list
6742529|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
6742530|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742531|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742532|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742533|NCT01968460|Pramipexole|pramipexole|mesh-list
6742534|NCT01968460|Rasagiline|rasagiline|mesh-list
6742535|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
6742536|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742537|NCT01968460|Protective Agents|protective agents|mesh-ancestor
6742538|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742539|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6742540|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6742541|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
6742542|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
6742543|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742544|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6742545|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742546|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6742547|NCT01968486|Ranibizumab|ranibizumab|mesh-list
6742548|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6742549|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6742550|NCT01968486|Growth Substances|growth substances|mesh-ancestor
6742551|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742552|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
6742553|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742554|NCT01968564|Curcumin|curcumin|mesh-list
6742555|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6742556|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6742557|NCT01968564|Analgesics|analgesics|mesh-ancestor
6742558|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
6742559|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742560|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742561|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6742562|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6742563|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742564|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742565|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786765|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
6786766|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786767|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786768|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6786769|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6786770|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6786771|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6786772|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786773|NCT02215980|Dexamethasone|dexamethasone|mesh-list
6786774|NCT02215980|Lenalidomide|lenalidomide|mesh-list
6786775|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6786776|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
6786777|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
6786778|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786779|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786780|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6786781|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
6786782|NCT02215980|Hormones|hormones|mesh-ancestor
6786783|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786784|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6786785|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786786|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
6786787|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6786788|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6786789|NCT02215980|Growth Substances|growth substances|mesh-ancestor
6786790|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
6786791|NCT02215993|Ticagrelor|ticagrelor|mesh-list
6786792|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6786793|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6786794|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6786795|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6786796|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6786797|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
6786798|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786799|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786800|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786801|NCT02216045|Ribavirin|ribavirin|mesh-list
6786802|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6786803|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
6786804|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
6786805|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786806|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
6786807|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786808|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
6786809|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786810|NCT02216058|Sirolimus|sirolimus|mesh-list
6786811|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786812|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786813|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6786814|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786815|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
6786816|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786817|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
6786818|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786819|NCT02216149|Capecitabine|capecitabine|mesh-list
6786820|NCT02216149|Tegafur|tegafur|mesh-list
6786821|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
6786822|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6786823|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
6786824|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786825|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786826|NCT02216227|Iodine|iodine|mesh-list
6786827|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
6786828|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6742566|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6742567|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6742568|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6742569|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
6742570|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742571|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6742572|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6742573|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742574|NCT01968590|Vitamin D|vitamin d|mesh-list
6742575|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
6742576|NCT01968590|Vitamins|vitamins|mesh-ancestor
6742577|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
6742578|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742579|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6742580|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6742581|NCT01968616|Ranibizumab|ranibizumab|mesh-list
6742582|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6742583|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6742584|NCT01968616|Growth Substances|growth substances|mesh-ancestor
6742585|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742586|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
6742587|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742588|NCT01968655|Factor VIII|factor viii|mesh-list
6742589|NCT01968655|Coagulants|coagulants|mesh-ancestor
6742590|NCT01968759|Ramipril|ramipril|mesh-list
6742591|NCT01968759|Irbesartan|irbesartan|mesh-list
6742592|NCT01968759|Sevelamer|sevelamer|mesh-list
6742593|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6742594|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
6742595|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742596|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742597|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6742598|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6742599|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6742600|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
6742601|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
6742602|NCT01968798|Aspirin|aspirin|mesh-list
6742603|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6742604|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6742605|NCT01968798|Analgesics|analgesics|mesh-ancestor
6742606|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
6742607|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742608|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742609|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6742610|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6742611|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6742612|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6742613|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742614|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6742615|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6742616|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742617|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
6742618|NCT01968850|Vitamin D|vitamin d|mesh-list
6742619|NCT01968850|Alendronate|alendronate|mesh-list
6742620|NCT01968850|Vitamins|vitamins|mesh-ancestor
6742621|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
6742622|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742623|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6742624|NCT01968915|Paclitaxel|paclitaxel|mesh-list
6742625|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6742626|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742627|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
6742628|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
6742629|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
6742630|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742631|NCT01969006|Bupivacaine|bupivacaine|mesh-list
6742632|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
6742633|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
6742634|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742635|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742636|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
6742637|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742638|NCT01969019|Prednisone|prednisone|mesh-list
6742639|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
6742640|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6742641|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6742642|NCT01969019|Prednisolone|prednisolone|mesh-list
6742643|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
6742644|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6742645|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
6742646|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6742647|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
6742648|NCT01969019|Hormones|hormones|mesh-ancestor
6742649|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742650|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742651|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6742652|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742653|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
6742654|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
6742655|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742656|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6742657|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6742658|NCT01969019|Protective Agents|protective agents|mesh-ancestor
6742659|NCT01969032|Paclitaxel|paclitaxel|mesh-list
6742660|NCT01969032|Doxorubicin|doxorubicin|mesh-list
6742661|NCT01969032|Capecitabine|capecitabine|mesh-list
6742662|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
6742663|NCT01969032|Carboplatin|carboplatin|mesh-list
6742664|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6742665|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742666|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
6742667|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
6742668|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
6742669|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742670|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6742671|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6742672|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6742673|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742674|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6742675|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
6742676|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6742677|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
6742678|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742679|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6742680|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6742681|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
6742682|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6742683|NCT01969071|Simendan|simendan|mesh-list
6742684|NCT01969071|Dobutamine|dobutamine|mesh-list
6742685|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6742686|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
6742687|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6742688|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6742689|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742690|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742691|NCT01969071|Protective Agents|protective agents|mesh-ancestor
6742692|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742693|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
6742694|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
6742695|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742696|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6742697|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6742698|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6742699|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
6742700|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742701|NCT01969149|Insulin|insulin|mesh-list
6742702|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6742703|NCT01969149|Exenatide|exenatide|mesh-list
6742704|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
6742705|NCT01969149|Incretins|incretins|mesh-list
6742706|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6742707|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742708|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6742709|NCT01969149|Hormones|hormones|mesh-ancestor
6742710|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742711|NCT01969227|Ketamine|ketamine|mesh-list
6742712|NCT01969227|Analgesics|analgesics|mesh-ancestor
6742713|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
6742714|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742715|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742716|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6742717|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6742718|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
6742719|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
6742720|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742721|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6742722|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6742723|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742724|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742725|NCT01969318|Metformin|metformin|mesh-list
6742726|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6742727|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742728|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6742729|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6742730|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742731|NCT01969357|Incretins|incretins|mesh-ancestor
6742732|NCT01969357|Hormones|hormones|mesh-ancestor
6742733|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742734|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6742735|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
6742736|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742737|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742738|NCT01969578|Paclitaxel|paclitaxel|mesh-list
6742739|NCT01969578|Carboplatin|carboplatin|mesh-list
6742740|NCT01969578|Doxorubicin|doxorubicin|mesh-list
6742741|NCT01969578|Bicalutamide|bicalutamide|mesh-list
6742742|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6742743|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6742744|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742745|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
6742746|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
6742747|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
6742748|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742749|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6742750|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6742751|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6742752|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742753|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
6742754|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
6742755|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742756|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742757|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
6742758|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6742759|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
6742760|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6742761|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6742762|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6742763|NCT01969617|Naltrexone|naltrexone|mesh-list
6742764|NCT01969617|Nalmefene|nalmefene|mesh-list
6742765|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6742766|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742767|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
6742768|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742769|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6742770|NCT01969656|Calcitriol|calcitriol|mesh-list
6742771|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6742772|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742773|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6742774|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6742775|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742776|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6742777|NCT01969656|Vitamins|vitamins|mesh-ancestor
6742778|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
6742779|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6742780|NCT01969669|Ketoconazole|ketoconazole|mesh-list
6742781|NCT01969669|Venetoclax|venetoclax|mesh-list
6742782|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742783|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
6742784|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742785|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6742786|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6742787|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742788|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742789|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6742790|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
6742791|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742792|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742793|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6742794|NCT01969682|Rifampin|rifampin|mesh-list
6742795|NCT01969682|Venetoclax|venetoclax|mesh-list
6742796|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742797|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6742798|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
6742799|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6742800|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742801|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
6742802|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6742803|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742804|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742805|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6742806|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6742807|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6742808|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6742809|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6742810|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6742811|NCT01969695|Venetoclax|venetoclax|mesh-list
6742812|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742813|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
6742814|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6742815|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6742816|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6742817|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6742818|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742819|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
6742820|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742821|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742822|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6742823|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742824|NCT01969877|Cetuximab|cetuximab|mesh-list
6742825|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742826|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6742827|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
6742828|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6742829|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742830|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742831|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6742832|NCT01969903|Analgesics|analgesics|mesh-ancestor
6742833|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
6742834|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742835|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6742836|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6742837|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6742838|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
6742839|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742840|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742841|NCT01969942|Melphalan|melphalan|mesh-list
6742842|NCT01969942|Busulfan|busulfan|mesh-list
6742843|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6742844|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
6742845|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742846|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742847|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6742848|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6742849|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
6742850|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742851|NCT01969955|Paclitaxel|paclitaxel|mesh-list
6742852|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6742853|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6742854|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742855|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
6742856|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
6742857|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
6742858|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742859|NCT01970046|Metformin|metformin|mesh-list
6742860|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6742861|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742862|NCT01970059|Metoprolol|metoprolol|mesh-list
6742863|NCT01970059|Carvedilol|carvedilol|mesh-list
6742864|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6742865|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6742866|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
6742867|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
6742868|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6742869|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742870|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6742871|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6742872|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6742873|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
6742874|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742875|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742876|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
6742877|NCT01970059|Protective Agents|protective agents|mesh-ancestor
6742878|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6742879|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6742880|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6742881|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
6742882|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6742883|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6742884|NCT01970072|Midazolam|midazolam|mesh-list
6742885|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6742886|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6742887|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6742888|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742889|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6742890|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6742891|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6742892|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6742893|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
6742894|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
6742895|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
6742896|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
6742897|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742898|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742899|NCT01970202|Enoxaparin|enoxaparin|mesh-list
6742900|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
6742901|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
6742902|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6742903|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6742904|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742905|NCT01970215|Atorvastatin|atorvastatin|mesh-list
6742906|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6742907|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6742908|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6742909|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
6742910|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742911|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6742912|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6742913|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742914|NCT01970280|Enoxaparin|enoxaparin|mesh-list
6742915|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
6742916|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6742917|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6742918|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786829|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
6786830|NCT02216227|Vancomycin|vancomycin|mesh-list
6786831|NCT02216227|Cefazolin|cefazolin|mesh-list
6786832|NCT02216227|Mupirocin|mupirocin|mesh-list
6786833|NCT02216227|Povidone|povidone|mesh-list
6786834|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6786835|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786836|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
6786837|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
6786838|NCT02216227|Trace Elements|trace elements|mesh-ancestor
6786839|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
6786840|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786841|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786842|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
6786843|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
6786844|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6786845|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786846|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786847|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6786848|NCT02216266|Physostigmine|physostigmine|mesh-list
6786849|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6786850|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786851|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786852|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
6786853|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6786854|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786855|NCT02216266|Miotics|miotics|mesh-ancestor
6786856|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
6786857|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786858|NCT02216331|Rifampin|rifampin|mesh-list
6786859|NCT02216331|Rifapentine|rifapentine|mesh-list
6786860|NCT02216331|Bedaquiline|bedaquiline|mesh-list
6786861|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6786862|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
6786863|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6786864|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742919|NCT01970345|Mecasermin|mecasermin|mesh-list
6742920|NCT01970345|Growth Substances|growth substances|mesh-ancestor
6742921|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742922|NCT01970358|Poly ICLC|poly iclc|mesh-list
6742923|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
6742924|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
6742925|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742926|NCT01970449|Vaccines|vaccines|mesh-list
6742927|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
6742928|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742929|NCT01970553|Gemcitabine|gemcitabine|mesh-list
6742930|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6742931|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
6742932|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742933|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742934|NCT01970553|Antiviral Agents|antiviral agents|mesh-ancestor
6742935|NCT01970553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742936|NCT01970553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742937|NCT01970553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6742938|NCT01970553|Immunologic Factors|immunologic factors|mesh-ancestor
6742939|NCT01970553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742940|NCT01970579|Paclitaxel|paclitaxel|mesh-list
6742941|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6742942|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742943|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
6742944|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
6742945|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
6742946|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742947|NCT01970722|Gemcitabine|gemcitabine|mesh-list
6742948|NCT01970722|Paclitaxel|paclitaxel|mesh-list
6742949|NCT01970722|Cisplatin|cisplatin|mesh-list
6742950|NCT01970722|Carboplatin|carboplatin|mesh-list
6742951|NCT01970722|Doxorubicin|doxorubicin|mesh-list
6742952|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6742953|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6742954|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6742955|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742956|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
6742957|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
6742958|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
6742959|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742960|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6742961|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
6742962|NCT01970722|Antiviral Agents|antiviral agents|mesh-ancestor
6742963|NCT01970722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742964|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6742965|NCT01970722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6742966|NCT01970722|Immunologic Factors|immunologic factors|mesh-ancestor
6742967|NCT01970722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742968|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6742969|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6742970|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6742971|NCT01970748|Propranolol|propranolol|mesh-list
6742972|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6742973|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6742974|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
6742975|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6742976|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742977|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742978|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6742979|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6742980|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
6742981|NCT01970800|Hormones|hormones|mesh-list
6742982|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6742983|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6742984|NCT01970904|Ribavirin|ribavirin|mesh-list
6742985|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6742986|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
6742987|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6742988|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
6742989|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6742990|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6742991|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6742992|NCT01971034|Metformin|metformin|mesh-list
6742993|NCT01971034|Paclitaxel|paclitaxel|mesh-list
6742994|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6786865|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
6742995|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6742996|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
6742997|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
6742998|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
6742999|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743000|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6743001|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743002|NCT01971047|Insulin|insulin|mesh-list
6743003|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
6743004|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6743005|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6743006|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743007|NCT01971190|Aflibercept|aflibercept|mesh-list
6743008|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6743009|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6743010|NCT01971190|Growth Substances|growth substances|mesh-ancestor
6743011|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743012|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
6743013|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743014|NCT01971242|Exenatide|exenatide|mesh-list
6743015|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6743016|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743017|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6743018|NCT01971242|Incretins|incretins|mesh-ancestor
6743019|NCT01971242|Hormones|hormones|mesh-ancestor
6743020|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743021|NCT01971268|Cimetidine|cimetidine|mesh-list
6743022|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6743023|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743024|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6743025|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
6743026|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
6743027|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6743028|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743029|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743030|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6743031|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6743032|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743033|NCT01971281|Gemcitabine|gemcitabine|mesh-list
6743034|NCT01971281|Paclitaxel|paclitaxel|mesh-list
6743035|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6743036|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743037|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
6743038|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
6743039|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
6743040|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743041|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6743042|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
6743043|NCT01971281|Antiviral Agents|antiviral agents|mesh-ancestor
6743044|NCT01971281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743045|NCT01971281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743046|NCT01971281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6743047|NCT01971281|Immunologic Factors|immunologic factors|mesh-ancestor
6743048|NCT01971281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743049|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
6743050|NCT01971411|Vitamin D|vitamin d|mesh-list
6743051|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
6743052|NCT01971411|Vitamins|vitamins|mesh-list
6743053|NCT01971411|Calcium|calcium|mesh-list
6743054|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
6743055|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743056|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6743057|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6743058|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
6743059|NCT01971424|Antacids|antacids|mesh-ancestor
6743060|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743061|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743062|NCT01971450|Iloprost|iloprost|mesh-list
6743063|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6743064|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
6743065|NCT01971489|Gemcitabine|gemcitabine|mesh-list
6743066|NCT01971489|Cisplatin|cisplatin|mesh-list
6743067|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743068|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6743069|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
6743070|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743071|NCT01971489|Antiviral Agents|antiviral agents|mesh-ancestor
6743072|NCT01971489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743073|NCT01971489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743074|NCT01971489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6743075|NCT01971489|Immunologic Factors|immunologic factors|mesh-ancestor
6743076|NCT01971489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743077|NCT01971515|Tamoxifen|tamoxifen|mesh-list
6743078|NCT01971515|Trastuzumab|trastuzumab|mesh-list
6743079|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6743080|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743081|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6743082|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
6743083|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743084|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743085|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6743086|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6743087|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6743088|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6743089|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6743090|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6743091|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6743092|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
6743093|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743094|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6743095|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6743096|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743097|NCT01971632|Oxycodone|oxycodone|mesh-list
6743098|NCT01971632|Naloxone|naloxone|mesh-list
6743099|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6743100|NCT01971632|Narcotics|narcotics|mesh-ancestor
6743101|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743102|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743103|NCT01971632|Analgesics|analgesics|mesh-ancestor
6743104|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
6743105|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743106|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6743107|NCT01971658|Thalidomide|thalidomide|mesh-list
6743108|NCT01971658|Dexamethasone|dexamethasone|mesh-list
6743109|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
6743110|NCT01971658|Bortezomib|bortezomib|mesh-list
6743111|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6743112|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
6743113|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743114|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6743115|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6743116|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
6743117|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743118|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743119|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6743120|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6743121|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
6743122|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
6743123|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743124|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743125|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
6743126|NCT01971658|Hormones|hormones|mesh-ancestor
6743127|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743128|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6743129|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
6743130|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6743131|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743132|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6743133|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6743134|NCT01971658|Growth Substances|growth substances|mesh-ancestor
6743135|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
6743136|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
6743137|NCT01971684|Sirolimus|sirolimus|mesh-list
6743138|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
6743139|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743140|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
6743141|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743142|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6743143|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6743144|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
6743145|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6743146|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743147|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743148|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743149|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
6743150|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6743151|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
6743152|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6743153|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6743154|NCT01971801|Vitamin D|vitamin d|mesh-list
6743155|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
6743156|NCT01971801|Vitamins|vitamins|mesh-ancestor
6743157|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
6743158|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743159|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6743160|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6743161|NCT01971814|Infliximab|infliximab|mesh-list
6743162|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
6743163|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743164|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6743165|NCT01971918|Antibodies|antibodies|mesh-list
6743166|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
6743167|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743168|NCT01972035|Valacyclovir|valacyclovir|mesh-list
6743169|NCT01972035|Valganciclovir|valganciclovir|mesh-list
6743170|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
6743171|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6786866|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6786867|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786868|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786869|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6786870|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6786871|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6786872|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6786873|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6786874|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6786875|NCT02216383|Oxytocin|oxytocin|mesh-list
6786876|NCT02216383|Carbetocin|carbetocin|mesh-list
6786877|NCT02216383|Syntometrine|syntometrine|mesh-list
6786878|NCT02216383|Ergonovine|ergonovine|mesh-list
6786879|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
6786880|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6786881|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786882|NCT02216409|Magrolimab|magrolimab|mesh-list
6786883|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6786884|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786885|NCT02216487|Irinotecan|irinotecan|mesh-list
6786886|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6786887|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6743172|NCT01972113|Vitamins|vitamins|mesh-list
6743173|NCT01972113|Vitamin K|vitamin k|mesh-list
6743174|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
6743175|NCT01972113|Vitamin MK 7|vitamin mk 7|mesh-list
6743176|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
6743177|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743178|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6743179|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6743180|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743181|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
6743182|NCT01972113|Coagulants|coagulants|mesh-ancestor
6743183|NCT01972230|Remifentanil|remifentanil|mesh-list
6743184|NCT01972230|Sevoflurane|sevoflurane|mesh-list
6743185|NCT01972230|Propofol|propofol|mesh-list
6743186|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6743187|NCT01972230|Narcotics|narcotics|mesh-ancestor
6743188|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743189|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743190|NCT01972230|Analgesics|analgesics|mesh-ancestor
6743191|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
6743192|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743193|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6743194|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6743195|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
6743196|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
6743197|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6743198|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6743199|NCT01972269|Lidocaine|lidocaine|mesh-list
6743200|NCT01972269|Fentanyl|fentanyl|mesh-list
6743201|NCT01972269|Bupivacaine|bupivacaine|mesh-list
6743202|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
6743203|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
6743204|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743205|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743206|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
6743207|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743208|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6743209|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6743210|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6743211|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6743212|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743213|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6743214|NCT01972269|Narcotics|narcotics|mesh-ancestor
6743215|NCT01972269|Analgesics|analgesics|mesh-ancestor
6743216|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6743217|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6743218|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
6743219|NCT01972347|Trametinib|trametinib|mesh-list
6743220|NCT01972347|Dabrafenib|dabrafenib|mesh-list
6743221|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743222|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6743223|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743224|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743225|NCT01972373|Bevacizumab|bevacizumab|mesh-list
6743226|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6743227|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743228|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6743229|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6743230|NCT01972373|Growth Substances|growth substances|mesh-ancestor
6743231|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743232|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
6743233|NCT01972490|Bevacizumab|bevacizumab|mesh-list
6743234|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6743235|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743236|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6743237|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6743238|NCT01972490|Growth Substances|growth substances|mesh-ancestor
6743239|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743240|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
6743241|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
6743242|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743243|NCT01972620|Bupivacaine|bupivacaine|mesh-list
6743244|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
6743245|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
6743246|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743247|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743248|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
6786888|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743249|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743250|NCT01972711|Amisulpride|amisulpride|mesh-list
6743251|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6743252|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6743253|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743254|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743255|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6743256|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6743257|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
6743258|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6743259|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743260|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6743261|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
6743262|NCT01972763|Ranibizumab|ranibizumab|mesh-list
6743263|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6743264|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6743265|NCT01972763|Growth Substances|growth substances|mesh-ancestor
6743266|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743267|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
6743268|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743269|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
6743270|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
6743271|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
6743272|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
6743273|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6743274|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743275|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6743276|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743277|NCT01972906|Ibuprofen|ibuprofen|mesh-list
6743278|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6743279|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6743280|NCT01972906|Analgesics|analgesics|mesh-ancestor
6743281|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
6743282|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743283|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743284|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6743285|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6743286|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6743287|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743288|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743289|NCT01972984|Anastrozole|anastrozole|mesh-list
6743290|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6743291|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743292|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6743293|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6743294|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743295|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743296|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6743297|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
6743298|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743299|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743300|NCT01973010|Ibuprofen|ibuprofen|mesh-list
6743301|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6743302|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6743303|NCT01973010|Analgesics|analgesics|mesh-ancestor
6743304|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
6743305|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743306|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743307|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6743308|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6743309|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6743310|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743311|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743312|NCT01973101|Gemcitabine|gemcitabine|mesh-list
6743313|NCT01973101|Cisplatin|cisplatin|mesh-list
6743314|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743315|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6743316|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
6743317|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743318|NCT01973101|Antiviral Agents|antiviral agents|mesh-ancestor
6743319|NCT01973101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743320|NCT01973101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743321|NCT01973101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6743322|NCT01973101|Immunologic Factors|immunologic factors|mesh-ancestor
6743323|NCT01973101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743324|NCT01973114|Latanoprost|latanoprost|mesh-list
6743325|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6743326|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6743327|NCT01973140|Tolvaptan|tolvaptan|mesh-list
6743328|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6743329|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743330|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
6743331|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743332|NCT01973309|Paclitaxel|paclitaxel|mesh-list
6743333|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6743334|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743335|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
6743336|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
6743337|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
6743338|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743339|NCT01973322|Vaccines|vaccines|mesh-list
6743340|NCT01973322|Complement Factor H|complement factor h|mesh-list
6743341|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
6743342|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743343|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6743344|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6743345|NCT01973400|Tocotrienols|tocotrienols|mesh-list
6743346|NCT01973400|Vitamin E|vitamin e|mesh-list
6743347|NCT01973400|Tocopherols|tocopherols|mesh-list
6743348|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
6743349|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743350|NCT01973400|Protective Agents|protective agents|mesh-ancestor
6743351|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743352|NCT01973400|Vitamins|vitamins|mesh-ancestor
6743353|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
6743354|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6743355|NCT01973517|Hematinics|hematinics|mesh-ancestor
6743356|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6743357|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6743358|NCT01973660|Tamoxifen|tamoxifen|mesh-list
6743359|NCT01973660|Paclitaxel|paclitaxel|mesh-list
6743360|NCT01973660|Trastuzumab|trastuzumab|mesh-list
6743361|NCT01973660|Letrozole|letrozole|mesh-list
6743362|NCT01973660|Lapatinib|lapatinib|mesh-list
6743363|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6743364|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743365|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
6743366|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
6743367|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
6743368|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743369|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6743370|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6743371|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6743372|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743373|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6743374|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
6743375|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743376|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743377|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6743378|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6743379|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6743380|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6743381|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6743382|NCT01973751|Budesonide|budesonide|mesh-list
6743383|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6743384|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6743385|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
6743386|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743387|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743388|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6743389|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
6743390|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
6743391|NCT01973751|Hormones|hormones|mesh-ancestor
6743392|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743393|NCT01973790|Z 338|z 338|mesh-list
6743394|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6743395|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743396|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743397|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
6743398|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6743399|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743400|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743401|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
6743402|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6743403|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6743404|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6743405|NCT01973816|Estradiol|estradiol|mesh-list
6743406|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6743407|NCT01973816|Cyproterone|cyproterone|mesh-list
6743408|NCT01973816|Estrogens|estrogens|mesh-ancestor
6743409|NCT01973816|Hormones|hormones|mesh-ancestor
6743410|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743411|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743412|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6743413|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
6743414|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6743415|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6743416|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
6743417|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
6743418|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743419|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6743420|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
6743421|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6743422|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6743423|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
6743424|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6743425|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
6743426|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6743427|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743428|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6743429|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6743430|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743431|NCT01973855|Ribavirin|ribavirin|mesh-list
6743432|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
6743433|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743434|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
6743435|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743436|NCT01973868|Cetuximab|cetuximab|mesh-list
6743437|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6743438|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786889|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786890|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786891|NCT02216513|Deferoxamine|deferoxamine|mesh-list
6786892|NCT02216513|Siderophores|siderophores|mesh-ancestor
6786893|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6786894|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
6786895|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
6786896|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786897|NCT02216552|Resveratrol|resveratrol|mesh-list
6786898|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
6786899|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786900|NCT02216552|Protective Agents|protective agents|mesh-ancestor
6786901|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786902|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786903|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6786904|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6786905|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6786906|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6786907|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786908|NCT02216617|Docetaxel|docetaxel|mesh-list
6786909|NCT02216617|Afatinib|afatinib|mesh-list
6786910|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786911|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
6786912|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
6786913|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
6786914|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786915|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6786916|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786917|NCT02216656|Cinacalcet|cinacalcet|mesh-list
6786918|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6743439|NCT01973920|Insulin|insulin|mesh-list
6743440|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6743441|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743442|NCT01973933|Metformin|metformin|mesh-list
6743443|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
6743444|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6743445|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743446|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
6743447|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6743448|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6743449|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743450|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6743451|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743452|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743453|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
6743454|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6743455|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6743456|NCT01974024|Prednisolone|prednisolone|mesh-list
6743457|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
6743458|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6743459|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
6743460|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6743461|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
6743462|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
6743463|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743464|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743465|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743466|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
6743467|NCT01974024|Hormones|hormones|mesh-ancestor
6743468|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743469|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6743470|NCT01974024|Protective Agents|protective agents|mesh-ancestor
6743471|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6743472|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743473|NCT01974037|Capsaicin|capsaicin|mesh-list
6743474|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
6743475|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
6743476|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
6743477|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743478|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743479|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
6743480|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6743481|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
6743482|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6743483|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743484|NCT01974167|Vitamins|vitamins|mesh-ancestor
6743485|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
6743486|NCT01974258|Vemurafenib|vemurafenib|mesh-list
6743487|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743488|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6743489|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743490|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743491|NCT01974297|Atorvastatin|atorvastatin|mesh-list
6743492|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
6743493|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6743494|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6743495|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
6743496|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743497|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6743498|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6743499|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743500|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6743501|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6743502|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743503|NCT01974375|Fluconazole|fluconazole|mesh-list
6743504|NCT01974375|Micafungin|micafungin|mesh-list
6743505|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
6743506|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743507|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6743508|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6743509|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743510|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743511|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6743512|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
6743513|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743514|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743515|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6743516|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6743517|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
6743518|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6743519|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743520|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
6743521|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
6743522|NCT01974518|Rituximab|rituximab|mesh-list
6743523|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6743524|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
6743525|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743526|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6743527|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6743528|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
6743529|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743530|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743531|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6743532|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6743533|NCT01974609|Acetaminophen|acetaminophen|mesh-list
6743534|NCT01974609|Ibuprofen|ibuprofen|mesh-list
6743535|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6743536|NCT01974609|Hydrocodone|hydrocodone|mesh-list
6743537|NCT01974609|Narcotics|narcotics|mesh-list
6743538|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6743539|NCT01974609|Analgesics|analgesics|mesh-ancestor
6743540|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
6743541|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743542|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743543|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
6743544|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6743545|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6743546|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6743547|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6743548|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743549|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743550|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6743551|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743552|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
6743553|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
6743554|NCT01974622|Verteporfin|verteporfin|mesh-list
6743555|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6743556|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
6743557|NCT01974648|Remifentanil|remifentanil|mesh-list
6743558|NCT01974648|Propofol|propofol|mesh-list
6743559|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6743560|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743561|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743562|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6743563|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
6743564|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
6743565|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6743566|NCT01974648|Narcotics|narcotics|mesh-ancestor
6743567|NCT01974648|Analgesics|analgesics|mesh-ancestor
6743568|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
6743569|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743570|NCT01974843|Bupivacaine|bupivacaine|mesh-list
6743571|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
6743572|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
6743573|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
6743574|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743575|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743576|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
6743577|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743578|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6743579|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6743580|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6743581|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6743582|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743583|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6743584|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743585|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
6743586|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6743587|NCT01975012|Rilpivirine|rilpivirine|mesh-list
6743588|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6743589|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6743590|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743591|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743592|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
6743593|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743594|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6743595|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6743596|NCT01975051|Miltefosine|miltefosine|mesh-list
6743597|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
6743598|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743599|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743600|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6743601|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6743602|NCT01975064|Propofol|propofol|mesh-list
6743603|NCT01975064|Sevoflurane|sevoflurane|mesh-list
6743604|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6743605|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743606|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743607|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6743608|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
6743609|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
6743610|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6743611|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6743612|NCT01975129|Oxytocin|oxytocin|mesh-list
6743613|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
6743614|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6743615|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743616|NCT01975142|Trastuzumab|trastuzumab|mesh-list
6743617|NCT01975142|Maytansine|maytansine|mesh-list
6743618|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6743619|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743620|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6743621|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
6743622|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
6743623|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
6743624|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743625|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6743626|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6743627|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6743628|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
6743629|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743630|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6743631|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6743632|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743633|NCT01975259|Glucagon|glucagon|mesh-list
6743634|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
6743635|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6743636|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743637|NCT01975259|Hormones|hormones|mesh-ancestor
6743638|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743639|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743640|NCT01975259|Incretins|incretins|mesh-ancestor
6743641|NCT01975272|Iron|iron|mesh-list
6743642|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
6743643|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
6743644|NCT01975272|Trace Elements|trace elements|mesh-ancestor
6743645|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
6743646|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743647|NCT01975272|Hematinics|hematinics|mesh-ancestor
6743648|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
6743649|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6743650|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6743651|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743652|NCT01975363|Curcumin|curcumin|mesh-list
6743653|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6743654|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6743655|NCT01975363|Analgesics|analgesics|mesh-ancestor
6743656|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
6743657|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743658|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743659|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6743660|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6743661|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743662|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743663|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743664|NCT01975441|Ivermectin|ivermectin|mesh-list
6743665|NCT01975441|Albendazole|albendazole|mesh-list
6743666|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
6743667|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6743668|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743669|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
6743670|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
6743671|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6743672|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6743673|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
6743674|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
6743675|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
6743676|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743677|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743678|NCT01975441|Filaricides|filaricides|mesh-ancestor
6743679|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
6743680|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6743681|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743682|NCT01975454|Capecitabine|capecitabine|mesh-list
6743683|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
6743684|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6743685|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
6743686|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743687|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743688|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6743689|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6743690|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6743691|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6743692|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743693|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6743694|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743695|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
6743696|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6786919|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786920|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6786921|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
6786922|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786923|NCT02216669|Imidazole|imidazole|mesh-list
6786924|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786925|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786926|NCT02216747|Prednisone|prednisone|mesh-list
6786927|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6786928|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
6786929|NCT02216747|Hormones|hormones|mesh-ancestor
6786930|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786931|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786932|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6786933|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786934|NCT02216786|Everolimus|everolimus|mesh-list
6786935|NCT02216786|Fulvestrant|fulvestrant|mesh-list
6786936|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786937|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786938|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
6786939|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786940|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6786941|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6786942|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6786943|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
6786944|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786945|NCT02216799|Insulin|insulin|mesh-list
6786946|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6786947|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
6786948|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6786949|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786950|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
6786951|NCT02216877|Antacids|antacids|mesh-ancestor
6786952|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786953|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743697|NCT01975662|Vancomycin|vancomycin|mesh-list
6743698|NCT01975662|Daptomycin|daptomycin|mesh-list
6743699|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6743700|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743701|NCT01975688|Nabiximols|nabiximols|mesh-list
6743702|NCT01975688|Analgesics|analgesics|mesh-ancestor
6743703|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
6743704|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743705|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743706|NCT01975714|Bimatoprost|bimatoprost|mesh-list
6743707|NCT01975714|Latanoprost|latanoprost|mesh-list
6743708|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6743709|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6743710|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6743711|NCT01975727|Dexamethasone|dexamethasone|mesh-list
6743712|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
6743713|NCT01975727|BB 1101|bb 1101|mesh-list
6743714|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6743715|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
6743716|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
6743717|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743718|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743719|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743720|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
6743721|NCT01975727|Hormones|hormones|mesh-ancestor
6743722|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743723|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6743724|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743725|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
6743726|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743727|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743728|NCT01975753|Fentanyl|fentanyl|mesh-list
6743729|NCT01975753|Morphine|morphine|mesh-list
6743730|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6743731|NCT01975753|Narcotics|narcotics|mesh-ancestor
6743732|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743733|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743734|NCT01975753|Analgesics|analgesics|mesh-ancestor
6743735|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
6743736|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743737|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6743738|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6743739|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
6743740|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
6743741|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
6743742|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6743743|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
6743744|NCT01975805|Povidone|povidone|mesh-list
6743745|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6743746|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743747|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
6743748|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
6743749|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
6743750|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
6743751|NCT01975961|Telmisartan|telmisartan|mesh-list
6743752|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6743753|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6743754|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6743755|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
6743756|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743757|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6743758|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6743759|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743760|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6743761|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6743762|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6743763|NCT01976078|Midazolam|midazolam|mesh-list
6743764|NCT01976078|Esomeprazole|esomeprazole|mesh-list
6743765|NCT01976078|Ranitidine|ranitidine|mesh-list
6743766|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6743767|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6743768|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6743769|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743770|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743771|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6743772|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6743773|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6743774|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6743775|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
6743776|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
6743777|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
6743778|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
6743779|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6743780|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743781|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6743782|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743783|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6743784|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743785|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6743786|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
6743787|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
6743788|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
6743789|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743790|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6743791|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6743792|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743793|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743794|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
6743795|NCT01976182|Methotrexate|methotrexate|mesh-list
6743796|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6743797|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
6743798|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743799|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6743800|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6743801|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
6743802|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743803|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743804|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6743805|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6743806|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
6743807|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6743808|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6743809|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
6743810|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
6743811|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743812|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6743813|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6743814|NCT01976195|Thalidomide|thalidomide|mesh-list
6743815|NCT01976195|Dexamethasone|dexamethasone|mesh-list
6743816|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6743817|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
6743818|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
6743819|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743820|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743821|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743822|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
6743823|NCT01976195|Hormones|hormones|mesh-ancestor
6743824|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6743825|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6743826|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743827|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6743828|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
6743829|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
6743830|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6743831|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743832|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6743833|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6743834|NCT01976195|Growth Substances|growth substances|mesh-ancestor
6743835|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
6743836|NCT01976208|Omalizumab|omalizumab|mesh-list
6743837|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6743838|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6743839|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
6743840|NCT01976520|Vaccines|vaccines|mesh-list
6743841|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
6743842|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743843|NCT01976585|Poly ICLC|poly iclc|mesh-list
6743844|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
6743845|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
6743846|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743847|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
6743848|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6743849|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6743850|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6743851|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6743852|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743853|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
6743854|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6743855|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743856|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6743857|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743858|NCT01976676|Folic Acid|folic acid|mesh-list
6743859|NCT01976676|Hematinics|hematinics|mesh-ancestor
6743860|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
6743861|NCT01976676|Vitamins|vitamins|mesh-ancestor
6743862|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
6743863|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743864|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
6743865|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6743866|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743867|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743868|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6743869|NCT01976754|Analgesics|analgesics|mesh-ancestor
6743870|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
6743871|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743872|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6743873|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6743874|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6743875|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
6743876|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6743877|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743878|NCT01976780|Artesunate|artesunate|mesh-list
6743879|NCT01976780|Lumefantrine|lumefantrine|mesh-list
6743880|NCT01976780|Artemether|artemether|mesh-list
6743881|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6743882|NCT01976780|Mefloquine|mefloquine|mesh-list
6743883|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
6743884|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6743885|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6743886|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743887|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743888|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
6743889|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
6743890|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6743891|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
6743892|NCT01976923|Bevacizumab|bevacizumab|mesh-list
6743893|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6743894|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743895|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6743896|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6743897|NCT01976923|Growth Substances|growth substances|mesh-ancestor
6743898|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743899|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
6743900|NCT01976936|Lovastatin|lovastatin|mesh-list
6743901|NCT01976936|L 647318|l 647318|mesh-list
6743902|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
6743903|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6743904|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6743905|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
6743906|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743907|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6743908|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6743909|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743910|NCT01977118|Streptokinase|streptokinase|mesh-list
6743911|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6743912|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6743913|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743914|NCT01977209|Gossypol|gossypol|mesh-list
6743915|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6743916|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
6743917|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6743918|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743919|NCT01977235|Irinotecan|irinotecan|mesh-list
6743920|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6743921|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6743922|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6743923|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743924|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743925|NCT01977300|Valproic Acid|valproic acid|mesh-list
6743926|NCT01977300|Olanzapine|olanzapine|mesh-list
6743927|NCT01977300|Risperidone|risperidone|mesh-list
6743928|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
6743929|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6743930|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
6743931|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6743932|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743933|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743934|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6743935|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6743936|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743937|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6743938|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6743939|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
6743940|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
6743941|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
6743942|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743943|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6743944|NCT01977300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6743945|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6743946|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6743947|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
6743948|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6743949|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
6743950|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
6743951|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
6743952|NCT01977339|Bupivacaine|bupivacaine|mesh-list
6743953|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
6743954|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
6743955|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6743956|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743957|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
6743958|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743959|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6743960|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6743961|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6743962|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6743963|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6743964|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743965|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6743966|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743967|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6743968|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
6743969|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6743970|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6743971|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6743972|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6743973|NCT01977417|Analgesics|analgesics|mesh-ancestor
6743974|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
6743975|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6743976|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743977|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6743978|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6786954|NCT02216994|Mineral Oil|mineral oil|mesh-list
6786955|NCT02216994|Lactulose|lactulose|mesh-list
6786956|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6786957|NCT02216994|Emollients|emollients|mesh-ancestor
6786958|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
6786959|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
6786960|NCT02217007|Acamprosate|acamprosate|mesh-list
6786961|NCT02217007|Calcium|calcium|mesh-list
6786962|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6786963|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786964|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6786965|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6786966|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
6786967|NCT02217020|Irinotecan|irinotecan|mesh-list
6786968|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786969|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6743979|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6743980|NCT01977430|Furosemide|furosemide|mesh-list
6743981|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6743982|NCT01977430|Diuretics|diuretics|mesh-ancestor
6743983|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
6743984|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743985|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6743986|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6743987|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6743988|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6743989|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6743990|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6743991|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
6743992|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
6743993|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6743994|NCT01977989|Vancomycin|vancomycin|mesh-list
6743995|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6743996|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6743997|NCT01978015|Timolol|timolol|mesh-list
6743998|NCT01978015|Bimatoprost|bimatoprost|mesh-list
6743999|NCT01978015|Travoprost|travoprost|mesh-list
6744000|NCT01978015|Dextrans|dextrans|mesh-list
6744001|NCT01978015|Latanoprost|latanoprost|mesh-list
6744002|NCT01978015|Maleic acid|maleic acid|mesh-list
6744003|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6744004|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6744005|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
6744006|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744007|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744008|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744009|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6744010|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6744011|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744012|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6744013|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6744014|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
6744015|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
6744016|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
6744017|NCT01978041|Fluorides|fluorides|mesh-list
6744018|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
6744019|NCT01978041|Protective Agents|protective agents|mesh-ancestor
6744020|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744021|NCT01978301|Triamcinolone|triamcinolone|mesh-list
6744022|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6744023|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6744024|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6744025|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6744026|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
6744027|NCT01978301|Hormones|hormones|mesh-ancestor
6744028|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744029|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744030|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6744031|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
6744032|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744033|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744034|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
6744035|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
6744036|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744037|NCT01978405|Protective Agents|protective agents|mesh-ancestor
6744038|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744039|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
6744040|NCT01978405|Vitamins|vitamins|mesh-ancestor
6744041|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
6744042|NCT01978418|Albuterol|albuterol|mesh-list
6744043|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6744044|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
6744045|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744046|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744047|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6744048|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
6744049|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
6744050|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6744051|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6744052|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6744053|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6744054|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
6744055|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744056|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744057|NCT01978431|Cocaine|cocaine|mesh-list
6744058|NCT01978431|Methylphenidate|methylphenidate|mesh-list
6744059|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6744060|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744061|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6744062|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6744063|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6744064|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744065|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
6744066|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744067|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
6744068|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
6744069|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744070|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
6744071|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744072|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6744073|NCT01978457|Propranolol|propranolol|mesh-list
6744074|NCT01978457|Cocaine|cocaine|mesh-list
6744075|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6744076|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6744077|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
6744078|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744079|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744080|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744081|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6744082|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6744083|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
6744084|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
6744085|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
6744086|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744087|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
6744088|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744089|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6744090|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6744091|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6744092|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6744093|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
6744094|NCT01978483|Denosumab|denosumab|mesh-list
6744095|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6744096|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744097|NCT01978496|Eletriptan|eletriptan|mesh-list
6744098|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6744099|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
6744100|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744101|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744102|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744103|NCT01978665|Prednisone|prednisone|mesh-list
6744104|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6744105|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
6744106|NCT01978665|Hormones|hormones|mesh-ancestor
6744107|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744108|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744109|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6744110|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744111|NCT01978678|Budesonide|budesonide|mesh-list
6744112|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6744113|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6744114|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
6744115|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744116|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744117|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6744118|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
6744119|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
6744120|NCT01978678|Hormones|hormones|mesh-ancestor
6744121|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744122|NCT01978704|Insulin|insulin|mesh-list
6744123|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6744124|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6744125|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744126|NCT01978717|Anesthetics|anesthetics|mesh-list
6744127|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744128|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744129|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
6744130|NCT01978782|Citalopram|citalopram|mesh-list
6744131|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6744132|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6744133|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
6744134|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744135|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6744136|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6744137|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744138|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744139|NCT01978782|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6744140|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6744141|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6744142|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744143|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
6744144|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744145|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6744146|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
6744147|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6744148|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
6744149|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
6744150|NCT01978873|Androgens|androgens|mesh-list
6744151|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6744152|NCT01978873|Hormones|hormones|mesh-ancestor
6744153|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744154|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744155|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
6744156|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744157|NCT01978873|Protective Agents|protective agents|mesh-ancestor
6744158|NCT01978873|Vitamins|vitamins|mesh-ancestor
6744159|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
6744160|NCT01978873|Estrogens|estrogens|mesh-ancestor
6744161|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6744162|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744163|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
6744164|NCT01979211|Cetuximab|cetuximab|mesh-list
6744165|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6744166|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786970|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6786971|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6786972|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786973|NCT02217163|Dexamethasone|dexamethasone|mesh-list
6786974|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
6786975|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6786976|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
6786977|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786978|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6786979|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6786980|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
6786981|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6786982|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6786983|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6786984|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6786985|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
6786986|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
6786987|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6786988|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6786989|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
6786990|NCT02217163|Hormones|hormones|mesh-ancestor
6786991|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6786992|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6786993|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
6786994|NCT02217189|Astringents|astringents|mesh-ancestor
6786995|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6786996|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
6786997|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6786998|NCT02217202|Laxatives|laxatives|mesh-ancestor
6786999|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787000|NCT02217267|Lidocaine|lidocaine|mesh-list
6787001|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
6787002|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
6787003|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787004|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787005|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
6787006|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787007|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6787008|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6787009|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6787010|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6787011|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787012|NCT02217319|Sevoflurane|sevoflurane|mesh-list
6787013|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6787014|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6744167|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6744168|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6744169|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744170|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
6744171|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6744172|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
6744173|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6744174|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6744175|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6744176|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744177|NCT01979354|Morphine|morphine|mesh-list
6744178|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6744179|NCT01979354|Narcotics|narcotics|mesh-ancestor
6744180|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744181|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744182|NCT01979354|Analgesics|analgesics|mesh-ancestor
6744183|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
6744184|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744185|NCT01979406|Vaccines|vaccines|mesh-list
6744186|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
6744187|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744188|NCT01979510|Acetaminophen|acetaminophen|mesh-list
6744189|NCT01979510|Etoricoxib|etoricoxib|mesh-list
6744190|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6744191|NCT01979510|Analgesics|analgesics|mesh-ancestor
6744192|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
6744193|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744194|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744195|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
6744196|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6744197|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6744198|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6744199|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6744200|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6744201|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744202|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744203|NCT01979653|Midazolam|midazolam|mesh-list
6744204|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
6744205|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6744206|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744207|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744208|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6744209|NCT01979653|Analgesics|analgesics|mesh-ancestor
6744210|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
6744211|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744212|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6744213|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6744214|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6744215|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
6744216|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744217|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744218|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6744219|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6744220|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6744221|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6744222|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6744223|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
6744224|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
6744225|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
6744226|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
6744227|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6744228|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6744229|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6744230|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744231|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744232|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6744233|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6744234|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6744235|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6744236|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
6744237|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744238|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744239|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6744240|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6744241|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
6744242|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6744243|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6744244|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
6744245|NCT01979796|Nicotine|nicotine|mesh-list
6744246|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6744247|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
6744248|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744249|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744250|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6744251|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6744252|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
6744253|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744254|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744255|NCT01979965|Ranolazine|ranolazine|mesh-list
6744256|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6744257|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6744258|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744259|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
6744260|NCT01980004|Diuretics|diuretics|mesh-ancestor
6744261|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
6744262|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744263|NCT01980004|Expectorants|expectorants|mesh-ancestor
6744264|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
6744265|NCT01980069|Neostigmine|neostigmine|mesh-list
6744266|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6744267|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744268|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744269|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
6744270|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744271|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744272|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6744273|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
6744274|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744275|NCT01980082|Cefazolin|cefazolin|mesh-list
6744276|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6744277|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744278|NCT01980277|Paclitaxel|paclitaxel|mesh-list
6744279|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6744280|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744281|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
6744282|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
6744283|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
6744284|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744285|NCT01980303|Esketamine|esketamine|mesh-list
6744286|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
6744287|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6744288|NCT01980316|Heparin|heparin|mesh-list
6744289|NCT01980316|Calcium heparin|calcium heparin|mesh-list
6744290|NCT01980316|Argatroban|argatroban|mesh-list
6744291|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
6744292|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6744293|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6744294|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744295|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
6744296|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6744297|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
6744298|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744299|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6744300|NCT01980329|Maraviroc|maraviroc|mesh-list
6744301|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6744302|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6744303|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744304|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6744305|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6744306|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
6744307|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744308|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6744309|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
6744310|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6744311|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6744312|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744313|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
6744314|NCT01980355|Coagulants|coagulants|mesh-ancestor
6744315|NCT01980407|Leucovorin|leucovorin|mesh-list
6744316|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
6744317|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
6744318|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744319|NCT01980407|Antidotes|antidotes|mesh-ancestor
6744320|NCT01980407|Protective Agents|protective agents|mesh-ancestor
6744321|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744322|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
6744323|NCT01980407|Vitamins|vitamins|mesh-ancestor
6744324|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
6744325|NCT01980472|Paclitaxel|paclitaxel|mesh-list
6744326|NCT01980472|Bevacizumab|bevacizumab|mesh-list
6744327|NCT01980472|Carboplatin|carboplatin|mesh-list
6744328|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6744329|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744330|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
6744331|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
6744332|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
6744333|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744334|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6744335|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6744336|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6744337|NCT01980472|Growth Substances|growth substances|mesh-ancestor
6744338|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744339|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
6744340|NCT01980498|Fentanyl|fentanyl|mesh-list
6744341|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6744342|NCT01980498|Narcotics|narcotics|mesh-ancestor
6744343|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744344|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744345|NCT01980498|Analgesics|analgesics|mesh-ancestor
6744346|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
6744347|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744348|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6744349|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6744350|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
6744351|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
6744352|NCT01980550|Nicotine|nicotine|mesh-list
6744353|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6744354|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
6744355|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744356|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744357|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6744358|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6744359|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
6744360|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744361|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744362|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6744363|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6744364|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
6744365|NCT01980667|Cisplatin|cisplatin|mesh-list
6744366|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744367|NCT01980680|Estradiol|estradiol|mesh-list
6744368|NCT01980680|Progesterone|progesterone|mesh-list
6744369|NCT01980680|Estrogens|estrogens|mesh-ancestor
6744370|NCT01980680|Hormones|hormones|mesh-ancestor
6744371|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744372|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744373|NCT01980680|Progestins|progestins|mesh-ancestor
6744374|NCT01980745|Chloroquine|chloroquine|mesh-list
6744375|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6744376|NCT01980745|Amebicides|amebicides|mesh-ancestor
6744377|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6744378|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6744379|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744380|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
6744381|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6744382|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6744383|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6744384|NCT01980745|Analgesics|analgesics|mesh-ancestor
6744385|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
6744386|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744387|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744388|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6744389|NCT01980745|Filaricides|filaricides|mesh-ancestor
6744390|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
6744391|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
6787015|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
6787016|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
6787017|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787018|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787019|NCT02217514|Midazolam|midazolam|mesh-list
6744392|NCT01980810|Paclitaxel|paclitaxel|mesh-list
6744393|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6744394|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6744395|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744396|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
6744397|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
6744398|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
6744399|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744400|NCT01980823|Metformin|metformin|mesh-list
6744401|NCT01980823|Atorvastatin|atorvastatin|mesh-list
6744402|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6744403|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744404|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6744405|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6744406|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
6744407|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744408|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6744409|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6744410|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744411|NCT01980849|Nadroparin|nadroparin|mesh-list
6744412|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
6744413|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6744414|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6744415|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744416|NCT01980966|Oseltamivir|oseltamivir|mesh-list
6744417|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
6744418|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744419|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744420|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744421|NCT01980979|Treprostinil|treprostinil|mesh-list
6744422|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6744423|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
6744424|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6744425|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744426|NCT01981278|Tapentadol|tapentadol|mesh-list
6744427|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6744428|NCT01981278|Narcotics|narcotics|mesh-ancestor
6744429|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744430|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744431|NCT01981278|Analgesics|analgesics|mesh-ancestor
6744432|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
6744433|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744434|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6744435|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6744436|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6744437|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744438|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
6744439|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744440|NCT01981291|Anesthetics|anesthetics|mesh-list
6744441|NCT01981291|Mepivacaine|mepivacaine|mesh-list
6744442|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
6744443|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744444|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744445|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
6744446|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744447|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
6744448|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6744449|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
6744450|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744451|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
6744452|NCT01981330|Protective Agents|protective agents|mesh-ancestor
6744453|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
6744454|NCT01981369|Propofol|propofol|mesh-list
6744455|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6744456|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744457|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744458|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6744459|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
6744460|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
6744461|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6744462|NCT01981369|Analgesics|analgesics|mesh-ancestor
6744463|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
6744464|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744465|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6744466|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6744467|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6744468|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
6744469|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744470|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744471|NCT01981447|Lacosamide|lacosamide|mesh-list
6744472|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
6744473|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6744474|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6744475|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6744476|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744477|NCT01981460|Methylene Blue|methylene blue|mesh-list
6744478|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744479|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744480|NCT01981499|Cetirizine|cetirizine|mesh-list
6744481|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6744482|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6744483|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6744484|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
6744485|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
6744486|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744487|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744488|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744489|NCT01981525|Metformin|metformin|mesh-list
6744490|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6744491|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744492|NCT01981707|Choline|choline|mesh-list
6744493|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
6744494|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6744495|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
6744496|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744497|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6744498|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6744499|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
6744500|NCT01981746|Ropivacaine|ropivacaine|mesh-list
6744501|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
6744502|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
6744503|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744504|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744505|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
6744506|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744507|NCT01981811|Aripiprazole|aripiprazole|mesh-list
6744508|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
6744509|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6744510|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6744511|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6744512|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744513|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744514|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
6744515|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
6744516|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744517|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744518|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6744519|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6744520|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
6744521|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6744522|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6744523|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6744524|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6744525|NCT01981889|Prednisone|prednisone|mesh-list
6744526|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6744527|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
6744528|NCT01981889|Hormones|hormones|mesh-ancestor
6744529|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744530|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744531|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6744532|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744533|NCT01981941|Gabapentin|gabapentin|mesh-list
6744534|NCT01981941|Analgesics|analgesics|mesh-ancestor
6744535|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
6744536|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744537|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744538|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
6744539|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6744540|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6744541|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744542|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6744543|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6744544|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6744545|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744546|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744547|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
6744548|NCT01982019|Hormones|hormones|mesh-list
6744549|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744550|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744551|NCT01982071|Micafungin|micafungin|mesh-list
6744552|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
6744553|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744554|NCT01982097|Sorafenib|sorafenib|mesh-list
6744555|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744556|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6744557|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744558|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744559|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
6744560|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6744561|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744562|NCT01982201|Lesinurad|lesinurad|mesh-list
6744563|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
6744564|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6744565|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
6744566|NCT01982201|Renal Agents|renal agents|mesh-ancestor
6744567|NCT01982396|Lamivudine|lamivudine|mesh-list
6744568|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6744569|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6744570|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744571|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744572|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
6744573|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744574|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6744575|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6744576|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6744577|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6744578|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6744579|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
6744580|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744581|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6744582|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6744583|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744584|NCT01982578|Genistein|genistein|mesh-list
6744585|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6744586|NCT01982578|Protective Agents|protective agents|mesh-ancestor
6744587|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744588|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744589|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6744590|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744591|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744592|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
6744593|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6744594|NCT01982578|Estrogens|estrogens|mesh-ancestor
6744595|NCT01982578|Hormones|hormones|mesh-ancestor
6744596|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787020|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6787021|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6787022|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787023|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787024|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6787025|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6787026|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6787027|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6787028|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
6787029|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
6787030|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
6787031|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
6744597|NCT01982734|Curcumin|curcumin|mesh-list
6744598|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6744599|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6744600|NCT01982734|Analgesics|analgesics|mesh-ancestor
6744601|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
6744602|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744603|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744604|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6744605|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6744606|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744607|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744608|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744609|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6744610|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
6744611|NCT01982760|Coagulants|coagulants|mesh-ancestor
6744612|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6744613|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
6744614|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744615|NCT01982799|Acetaminophen|acetaminophen|mesh-list
6744616|NCT01982799|Ibuprofen|ibuprofen|mesh-list
6744617|NCT01982799|Naproxen|naproxen|mesh-list
6744618|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6744619|NCT01982799|Hydrocodone|hydrocodone|mesh-list
6744620|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6744621|NCT01982799|Analgesics|analgesics|mesh-ancestor
6744622|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
6744623|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744624|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744625|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
6744626|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6744627|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6744628|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6744629|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6744630|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744631|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744632|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
6744633|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6744634|NCT01982799|Narcotics|narcotics|mesh-ancestor
6744635|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744636|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
6744637|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
6744638|NCT01982864|Gentamicins|gentamicins|mesh-list
6744639|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6744640|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744641|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6744642|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744643|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744644|NCT01982929|Epinephrine|epinephrine|mesh-list
6744645|NCT01982929|Bupivacaine|bupivacaine|mesh-list
6744646|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
6744647|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
6744648|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744649|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744650|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
6744651|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744652|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6744653|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6744654|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
6744655|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744656|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744657|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6744658|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6744659|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
6744660|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6744661|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
6744662|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
6744663|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
6744664|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6744665|NCT01983124|Vemurafenib|vemurafenib|mesh-list
6744666|NCT01983124|Fotemustine|fotemustine|mesh-list
6744667|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744668|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6744669|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744670|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744671|NCT01983137|Oxycodone|oxycodone|mesh-list
6744672|NCT01983137|Naloxone|naloxone|mesh-list
6744673|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6744674|NCT01983137|Narcotics|narcotics|mesh-ancestor
6744675|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744676|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744677|NCT01983137|Analgesics|analgesics|mesh-ancestor
6744678|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
6744679|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744680|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6744681|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6744682|NCT01983371|Hematinics|hematinics|mesh-ancestor
6744683|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6744684|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6744685|NCT01983384|Anesthetics|anesthetics|mesh-list
6744686|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744687|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744688|NCT01983449|Dexamethasone|dexamethasone|mesh-list
6744689|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
6744690|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6744691|NCT01983449|BB 1101|bb 1101|mesh-list
6744692|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6744693|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
6744694|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
6744695|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744696|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744697|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6744698|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
6744699|NCT01983449|Hormones|hormones|mesh-ancestor
6744700|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744701|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6744702|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744703|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
6744704|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744705|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744706|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6744707|NCT01983462|Clonidine|clonidine|mesh-list
6744708|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6744709|NCT01983462|Diuretics|diuretics|mesh-ancestor
6744710|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
6744711|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744712|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6744713|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6744714|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744715|NCT01983462|Analgesics|analgesics|mesh-ancestor
6744716|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
6744717|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744718|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
6744719|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
6744720|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6744721|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6744722|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6744723|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
6744724|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744725|NCT01983475|Denosumab|denosumab|mesh-list
6744726|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6744727|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744728|NCT01983501|Tucatinib|tucatinib|mesh-list
6744729|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744730|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744731|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6744732|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744733|NCT01983514|Oxytocin|oxytocin|mesh-list
6744734|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
6744735|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6744736|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744737|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
6744738|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6744739|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6744740|NCT01983527|Prednisolone|prednisolone|mesh-list
6744741|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
6744742|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6744743|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
6744744|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6744745|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
6744746|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
6744747|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744748|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744749|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6744750|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
6744751|NCT01983527|Hormones|hormones|mesh-ancestor
6744752|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744753|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6744754|NCT01983527|Protective Agents|protective agents|mesh-ancestor
6744755|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6744756|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744757|NCT01983540|Vaccines|vaccines|mesh-list
6744758|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6744759|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
6744760|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744761|NCT01983579|Bevacizumab|bevacizumab|mesh-list
6744762|NCT01983579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6744763|NCT01983579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744764|NCT01983579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6744765|NCT01983579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6744766|NCT01983579|Growth Substances|growth substances|mesh-ancestor
6744767|NCT01983579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744768|NCT01983579|Growth Inhibitors|growth inhibitors|mesh-ancestor
6744769|NCT01983657|Molgramostim|molgramostim|mesh-list
6744770|NCT01983657|Sargramostim|sargramostim|mesh-list
6744771|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
6744772|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744773|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744774|NCT01983722|Stiripentol|stiripentol|mesh-list
6744775|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
6744776|NCT01983735|Niacin|niacin|mesh-list
6744777|NCT01983735|Amlodipine|amlodipine|mesh-list
6744778|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6744779|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6744780|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6744781|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744782|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6744783|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744784|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
6744785|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6744786|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
6744787|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6744788|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
6744789|NCT01983735|Vitamins|vitamins|mesh-ancestor
6744790|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
6744791|NCT01983761|Vidarabine|vidarabine|mesh-list
6744792|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
6744793|NCT01983761|Fludarabine|fludarabine|mesh-list
6744794|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
6744795|NCT01983761|Melphalan|melphalan|mesh-list
6744796|NCT01983761|Busulfan|busulfan|mesh-list
6744797|NCT01983761|Clofarabine|clofarabine|mesh-list
6744798|NCT01983761|Tacrolimus|tacrolimus|mesh-list
6744799|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744800|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
6744801|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744802|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6744803|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
6744804|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744805|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6744806|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
6744807|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744808|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6744809|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744810|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6744811|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6744812|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
6744813|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6744814|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6744815|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
6744816|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6744817|NCT01983800|Midazolam|midazolam|mesh-list
6744818|NCT01983800|Propofol|propofol|mesh-list
6744819|NCT01983800|Isoflurane|isoflurane|mesh-list
6744820|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6744821|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744822|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744823|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6744824|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
6744825|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
6744826|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6744827|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6744828|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6744829|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6744830|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
6744831|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
6744832|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744833|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744834|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6744835|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
6744836|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744837|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
6744838|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744839|NCT01983943|Protective Agents|protective agents|mesh-ancestor
6744840|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744841|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6744842|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
6744843|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
6744844|NCT01984008|Citric Acid|citric acid|mesh-list
6744845|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
6744846|NCT01984008|Cathartics|cathartics|mesh-ancestor
6744847|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6744848|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
6744849|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6744850|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
6744851|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
6744852|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744853|NCT01984008|Antacids|antacids|mesh-ancestor
6744854|NCT01984073|Niacin|niacin|mesh-list
6744855|NCT01984073|Niacinamide|niacinamide|mesh-list
6744856|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
6744857|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6744858|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
6744859|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744860|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6744861|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
6744862|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
6744863|NCT01984073|Vitamins|vitamins|mesh-ancestor
6744864|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
6744865|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744866|NCT01984086|Albuterol|albuterol|mesh-list
6744867|NCT01984086|Charcoal|charcoal|mesh-list
6744868|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6744869|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
6744870|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744871|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744872|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6744873|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
6744874|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
6744875|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6744876|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6744877|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6744878|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6744879|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
6744880|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744881|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744882|NCT01984086|Antidotes|antidotes|mesh-ancestor
6744883|NCT01984086|Protective Agents|protective agents|mesh-ancestor
6744884|NCT01984099|Folic Acid|folic acid|mesh-list
6744885|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
6744886|NCT01984099|Methotrexate|methotrexate|mesh-list
6744887|NCT01984099|Vitamins|vitamins|mesh-ancestor
6744888|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
6744889|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744890|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6744891|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
6744892|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6744893|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6744894|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
6744895|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744896|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744897|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
6744898|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744899|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6744900|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6744901|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
6744902|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6744903|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6744904|NCT01984099|Hematinics|hematinics|mesh-ancestor
6744905|NCT01984138|Estradiol|estradiol|mesh-list
6744906|NCT01984138|Estrogens|estrogens|mesh-ancestor
6744907|NCT01984138|Hormones|hormones|mesh-ancestor
6744908|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744909|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744910|NCT01984177|Hormones|hormones|mesh-list
6744911|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6744912|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
6744913|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744914|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744915|NCT01984255|Ipilimumab|ipilimumab|mesh-list
6744916|NCT01984255|Bavituximab|bavituximab|mesh-list
6744917|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6744918|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744919|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6744920|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787032|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787033|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787034|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
6787035|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6787036|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787037|NCT02217553|Vitamins|vitamins|mesh-ancestor
6787038|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
6787039|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6787040|NCT02217631|Prednisolone|prednisolone|mesh-list
6787041|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6787042|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
6787043|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6787044|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
6787045|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6787046|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
6787047|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6787048|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
6787049|NCT02217631|Hormones|hormones|mesh-ancestor
6787050|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787051|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787052|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6787053|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787054|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
6787055|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
6787056|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787057|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787058|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6787059|NCT02217631|Protective Agents|protective agents|mesh-ancestor
6787060|NCT02217670|Metformin|metformin|mesh-list
6787061|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6787062|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787063|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
6787064|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6787065|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
6787066|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787067|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787068|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6787069|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
6787070|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6787071|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
6787072|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787073|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787074|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6787075|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
6787076|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
6787077|NCT02217683|Protective Agents|protective agents|mesh-ancestor
6787078|NCT02217709|Phenelzine|phenelzine|mesh-list
6787079|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
6787080|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6787081|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6787082|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787083|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787084|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6787085|NCT02217722|Amoxicillin|amoxicillin|mesh-list
6787086|NCT02217722|Metronidazole|metronidazole|mesh-list
6787087|NCT02217722|Doxycycline|doxycycline|mesh-list
6787088|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787089|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6744921|NCT01984372|Insulin|insulin|mesh-list
6744922|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6744923|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744924|NCT01984463|Fentanyl|fentanyl|mesh-list
6744925|NCT01984463|Morphine|morphine|mesh-list
6744926|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6744927|NCT01984463|Narcotics|narcotics|mesh-ancestor
6744928|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744929|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744930|NCT01984463|Analgesics|analgesics|mesh-ancestor
6744931|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
6744932|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744933|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6744934|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6744935|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
6744936|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
6744937|NCT01984567|Vitamin E|vitamin e|mesh-list
6744938|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
6744939|NCT01984567|Vitamins|vitamins|mesh-ancestor
6744940|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
6744941|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744942|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
6744943|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744944|NCT01984567|Protective Agents|protective agents|mesh-ancestor
6744945|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
6744946|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6744947|NCT01984606|Empagliflozin|empagliflozin|mesh-list
6744948|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6744949|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744950|NCT01984606|Incretins|incretins|mesh-ancestor
6744951|NCT01984606|Hormones|hormones|mesh-ancestor
6744952|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6744953|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6744954|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
6744955|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744956|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744957|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6744958|NCT01984749|Febuxostat|febuxostat|mesh-list
6744959|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
6744960|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6744961|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
6744962|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6744963|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6744964|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6744965|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6744966|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744967|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744968|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6744969|NCT01984931|Medazepam|medazepam|mesh-list
6744970|NCT01984931|Metoclopramide|metoclopramide|mesh-list
6744971|NCT01984931|Bromazepam|bromazepam|mesh-list
6744972|NCT01984931|Simethicone|simethicone|mesh-list
6744973|NCT01984931|Trimebutine|trimebutine|mesh-list
6744974|NCT01984931|Mosapride|mosapride|mesh-list
6744975|NCT01984931|Maleic acid|maleic acid|mesh-list
6744976|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6744977|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6744978|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
6744979|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
6744980|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6744981|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6744982|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6744983|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6744984|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6744985|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
6744986|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6744987|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
6744988|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6744989|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
6744990|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
6744991|NCT01984931|Emollients|emollients|mesh-ancestor
6744992|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
6744993|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6744994|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6744995|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6744996|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6744997|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
6744998|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
6744999|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
6745000|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6745001|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6745002|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6745003|NCT01985061|Busulfan|busulfan|mesh-list
6745004|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
6745005|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745006|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6745007|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
6745008|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745009|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6745010|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745011|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6745012|NCT01985087|Temozolomide|temozolomide|mesh-list
6745013|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6745014|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
6745015|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745016|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745017|NCT01985152|Choline|choline|mesh-list
6745018|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6745019|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6745020|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6745021|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745022|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
6745023|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6745024|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
6745025|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745026|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6745027|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
6745028|NCT01985256|Flucytosine|flucytosine|mesh-list
6745029|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
6745030|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745031|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
6745032|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745033|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
6745034|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6745035|NCT01985373|Antibodies|antibodies|mesh-list
6745036|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
6745037|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6745038|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
6745039|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745040|NCT01985451|Temozolomide|temozolomide|mesh-list
6745041|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6745042|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
6745043|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745044|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745045|NCT01985477|Dexamethasone|dexamethasone|mesh-list
6745046|NCT01985477|Lenalidomide|lenalidomide|mesh-list
6745047|NCT01985477|Tretinoin|tretinoin|mesh-list
6745048|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6745049|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
6745050|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
6745051|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745052|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745053|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745054|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
6745055|NCT01985477|Hormones|hormones|mesh-ancestor
6745056|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745057|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6745058|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242772|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6242773|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6242774|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6242775|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
6242776|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
6242777|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6242778|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6242779|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745059|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
6745060|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6745061|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6745062|NCT01985477|Growth Substances|growth substances|mesh-ancestor
6745063|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
6745064|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
6745065|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
6745066|NCT01985594|Nifedipine|nifedipine|mesh-list
6745067|NCT01985594|Progesterone|progesterone|mesh-list
6745068|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6745069|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745070|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745071|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6745072|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745073|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
6745074|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
6745075|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6745076|NCT01985594|Progestins|progestins|mesh-ancestor
6745077|NCT01985594|Hormones|hormones|mesh-ancestor
6745078|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745079|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
6745080|NCT01985724|Docetaxel|docetaxel|mesh-list
6745081|NCT01985724|Epirubicin|epirubicin|mesh-list
6745082|NCT01985724|Fluorouracil|fluorouracil|mesh-list
6745083|NCT01985724|Mitogens|mitogens|mesh-list
6745084|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6745085|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
6745086|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745087|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6745088|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6745089|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
6745090|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745091|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745092|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6745093|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
6745094|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
6745095|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
6745096|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6745097|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6745098|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6745099|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745100|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
6745101|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6745102|NCT01985750|Cycloserine|cycloserine|mesh-list
6745103|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6745104|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745105|NCT01985750|Renal Agents|renal agents|mesh-ancestor
6745106|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6745107|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
6745108|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6745109|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
6745110|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745111|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
6745112|NCT01985789|Promethazine|promethazine|mesh-list
6745113|NCT01985789|Cetirizine|cetirizine|mesh-list
6745114|NCT01985789|Desloratadine|desloratadine|mesh-list
6745115|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6745116|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6745117|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745118|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745119|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
6745120|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
6745121|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
6745122|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745123|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
6745124|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
6745125|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745126|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6745127|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
6745128|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
6745129|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745130|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745131|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6745132|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
6745133|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
6745134|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6745135|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6745136|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
6745137|NCT01985828|Androgens|androgens|mesh-list
6745138|NCT01985828|Hormones|hormones|mesh-ancestor
6745139|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745140|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745141|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
6745142|NCT01985841|Docetaxel|docetaxel|mesh-list
6745143|NCT01985841|Fluorouracil|fluorouracil|mesh-list
6745144|NCT01985841|Epirubicin|epirubicin|mesh-list
6745145|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6745146|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
6745147|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745148|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6745149|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6745150|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
6745151|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745152|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745153|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6745154|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
6745155|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
6745156|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
6745157|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
6745158|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6745159|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6745160|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6745161|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6745162|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787090|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6787091|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
6787092|NCT02217787|PF-06372865|pf-06372865|mesh-list
6787093|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
6787094|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
6787095|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787096|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787097|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787098|NCT02217826|Octreotide|octreotide|mesh-list
6787099|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787100|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6787101|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787102|NCT02217839|Octreotide|octreotide|mesh-list
6787103|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787104|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6787105|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787106|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6787107|NCT02217852|Captopril|captopril|mesh-list
6787108|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
6787109|NCT02217852|Nitrendipine|nitrendipine|mesh-list
6787110|NCT02217852|Diuretics|diuretics|mesh-ancestor
6787111|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
6787112|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787113|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6787114|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745163|NCT01985854|Propofol|propofol|mesh-list
6745164|NCT01985854|Desflurane|desflurane|mesh-list
6745165|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6745166|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745167|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745168|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6745169|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
6745170|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
6745171|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6745172|NCT01985893|Trastuzumab|trastuzumab|mesh-list
6745173|NCT01985893|Lapatinib|lapatinib|mesh-list
6745174|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6745175|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745176|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6745177|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745178|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745179|NCT01986036|Calcium|calcium|mesh-list
6745180|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6745181|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745182|NCT01986049|Bupivacaine|bupivacaine|mesh-list
6745183|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
6745184|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
6745185|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745186|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745187|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
6745188|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745189|NCT01986088|Sumatriptan|sumatriptan|mesh-list
6745190|NCT01986088|Eletriptan|eletriptan|mesh-list
6745191|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6745192|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6745193|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6745194|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
6745195|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745196|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745197|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745198|NCT01986127|Adalimumab|adalimumab|mesh-list
6745199|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6745200|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6745201|NCT01986192|Warfarin|warfarin|mesh-list
6745202|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
6745203|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
6745204|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6745205|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
6745206|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6745207|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
6745208|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745209|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745210|NCT01986270|Sumatriptan|sumatriptan|mesh-list
6745211|NCT01986270|Eletriptan|eletriptan|mesh-list
6745212|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6745213|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6745214|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6745215|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
6745216|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745217|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745218|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745219|NCT01986283|Oxycodone|oxycodone|mesh-list
6745220|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6745221|NCT01986283|Narcotics|narcotics|mesh-ancestor
6745222|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745223|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745224|NCT01986283|Analgesics|analgesics|mesh-ancestor
6745225|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
6745226|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745227|NCT01986309|Lidocaine|lidocaine|mesh-list
6745228|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
6745229|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
6745230|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745231|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745232|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
6745233|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745234|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6745235|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6745236|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6745237|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745238|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745239|NCT01986322|Vaccines|vaccines|mesh-list
6745240|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
6745241|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745242|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
6745243|NCT01986426|Ipilimumab|ipilimumab|mesh-list
6745244|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6745245|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745246|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6745247|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745248|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6745249|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
6745250|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6745251|NCT01986465|Prednisolone|prednisolone|mesh-list
6745252|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
6745253|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6745254|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
6745255|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6745256|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
6745257|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
6745258|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745259|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745260|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745261|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
6745262|NCT01986465|Hormones|hormones|mesh-ancestor
6745263|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745264|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6745265|NCT01986465|Protective Agents|protective agents|mesh-ancestor
6745266|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6745267|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745268|NCT01986556|Lesinurad|lesinurad|mesh-list
6745269|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
6745270|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6745271|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
6745272|NCT01986556|Renal Agents|renal agents|mesh-ancestor
6745273|NCT01986582|Phenylephrine|phenylephrine|mesh-list
6745274|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
6745275|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6745276|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6745277|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
6745278|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745279|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745280|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745281|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
6745282|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
6745283|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745284|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
6745285|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6745286|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
6745287|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6745288|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
6745289|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6745290|NCT01986582|Protective Agents|protective agents|mesh-ancestor
6745291|NCT01986608|Lacosamide|lacosamide|mesh-list
6745292|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
6745293|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6745294|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6745295|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745296|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745297|NCT01986660|Ibuprofen|ibuprofen|mesh-list
6745298|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6745299|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6745300|NCT01986660|Analgesics|analgesics|mesh-ancestor
6745301|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
6745302|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745303|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745304|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6745305|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6745306|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6745307|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745308|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745309|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
6745310|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
6745311|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6745312|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6745313|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745314|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745315|NCT01986673|Urological Agents|urological agents|mesh-ancestor
6745316|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6745317|NCT01986764|Estradiol|estradiol|mesh-list
6745318|NCT01986764|Estrogens|estrogens|mesh-list
6745319|NCT01986764|Hormones|hormones|mesh-ancestor
6745320|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745321|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745322|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6745323|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6745324|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6745325|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745326|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745327|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
6745328|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745329|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6745330|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6745331|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745332|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6745333|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6745334|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745335|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745336|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
6745337|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745338|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
6745339|NCT01986894|Thalidomide|thalidomide|mesh-list
6745340|NCT01986894|Pomalidomide|pomalidomide|mesh-list
6745341|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6745342|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745343|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6745344|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6745345|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745346|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745347|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745348|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745349|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
6745350|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6745351|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6745352|NCT01986894|Growth Substances|growth substances|mesh-ancestor
6745353|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
6745354|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6745355|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
6745356|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
6745357|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6745358|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6745359|NCT01986998|Prednisolone|prednisolone|mesh-list
6745360|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
6745361|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6745362|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
6745363|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6745364|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
6745365|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
6745366|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745367|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745368|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745369|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
6745370|NCT01986998|Hormones|hormones|mesh-ancestor
6745371|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745372|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6745373|NCT01986998|Protective Agents|protective agents|mesh-ancestor
6745374|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6745375|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745376|NCT01987076|Prednisone|prednisone|mesh-list
6745377|NCT01987076|Clobetasol|clobetasol|mesh-list
6745378|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6745379|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
6745380|NCT01987076|Hormones|hormones|mesh-ancestor
6745381|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745382|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745383|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6745384|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745385|NCT01987128|Ropivacaine|ropivacaine|mesh-list
6745386|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
6745387|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
6745388|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745389|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745390|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
6745391|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745392|NCT01987154|Caseins|caseins|mesh-list
6745393|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
6745394|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
6745395|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745396|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6745397|NCT01987167|Hormones|hormones|mesh-ancestor
6745398|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745399|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745400|NCT01987297|Cytarabine|cytarabine|mesh-list
6745401|NCT01987297|Daunorubicin|daunorubicin|mesh-list
6745402|NCT01987297|Idarubicin|idarubicin|mesh-list
6745403|NCT01987297|Tretinoin|tretinoin|mesh-list
6745404|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
6745405|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6745406|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
6745407|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745408|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745409|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
6745410|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745411|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6745412|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
6745413|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745414|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6745415|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6745416|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6745417|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745418|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
6745419|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
6745420|NCT01987310|Atorvastatin|atorvastatin|mesh-list
6745421|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6745422|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6745423|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
6745424|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745425|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6745426|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6745427|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745428|NCT01987323|Latanoprost|latanoprost|mesh-list
6745429|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6745430|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6745431|NCT01987375|Cetuximab|cetuximab|mesh-list
6745432|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6745433|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745434|NCT01987570|Allopurinol|allopurinol|mesh-list
6745435|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
6745436|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745437|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745438|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
6745439|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6745440|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6745441|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
6745442|NCT01987570|Protective Agents|protective agents|mesh-ancestor
6745443|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787115|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787116|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6787117|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
6787118|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787119|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6787120|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6787121|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
6787122|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
6787123|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6787124|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787125|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6787126|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6787127|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787128|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787129|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787130|NCT02217956|Bevacizumab|bevacizumab|mesh-list
6787131|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6787132|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787133|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6787134|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6787135|NCT02217956|Growth Substances|growth substances|mesh-ancestor
6787136|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787137|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
6787138|NCT02218021|Oxycodone|oxycodone|mesh-list
6787139|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6745444|NCT01987739|Zolpidem|zolpidem|mesh-list
6745445|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6745446|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6745447|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745448|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745449|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6745450|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
6745451|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
6745452|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745453|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745454|NCT01987804|Oxytocin|oxytocin|mesh-list
6745455|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
6745456|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6745457|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745458|NCT01988077|Ipilimumab|ipilimumab|mesh-list
6745459|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6745460|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745461|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6745462|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745463|NCT01988116|Calcitriol|calcitriol|mesh-list
6745464|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6745465|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745466|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6745467|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745468|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745469|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6745470|NCT01988116|Vitamins|vitamins|mesh-ancestor
6745471|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
6745472|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6745473|NCT01988298|Acetaminophen|acetaminophen|mesh-list
6745474|NCT01988298|Ibuprofen|ibuprofen|mesh-list
6745475|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6745476|NCT01988298|Analgesics|analgesics|mesh-ancestor
6745477|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
6745478|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745479|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745480|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
6745481|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6745482|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6745483|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6745484|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6745485|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745486|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745487|NCT01988311|Psilocybin|psilocybin|mesh-list
6745488|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
6745489|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745490|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6745491|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
6745492|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6745493|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745494|NCT01988506|Interleukin-2|interleukin-2|mesh-list
6745495|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745496|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6745497|NCT01988506|Analgesics|analgesics|mesh-ancestor
6745498|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
6745499|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745500|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745501|NCT01988545|Exenatide|exenatide|mesh-list
6745502|NCT01988545|Glucagon|glucagon|mesh-list
6745503|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6745504|NCT01988545|Incretins|incretins|mesh-ancestor
6745505|NCT01988545|Hormones|hormones|mesh-ancestor
6745506|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745507|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745508|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745509|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6745510|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6745511|NCT01988610|Mifepristone|mifepristone|mesh-list
6745512|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6745513|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
6745514|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6745515|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745516|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6745517|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6745518|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6745519|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
6745520|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6745521|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6745522|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
6745523|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745524|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
6745525|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6745526|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6745527|NCT01988649|Oxytocin|oxytocin|mesh-list
6745528|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
6745529|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6745530|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745531|NCT01988831|Propranolol|propranolol|mesh-list
6745532|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6745533|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6745534|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
6745535|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745536|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745537|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745538|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6745539|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6745540|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
6745541|NCT01988896|Atezolizumab|atezolizumab|mesh-list
6745542|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745543|NCT01988961|Golimumab|golimumab|mesh-list
6745544|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6745545|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6745546|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6745547|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
6745548|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745549|NCT01989000|Gemcitabine|gemcitabine|mesh-list
6745550|NCT01989000|Imidazole|imidazole|mesh-list
6745551|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6745552|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
6745553|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745554|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745555|NCT01989000|Antiviral Agents|antiviral agents|mesh-ancestor
6745556|NCT01989000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745557|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745558|NCT01989000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6745559|NCT01989000|Immunologic Factors|immunologic factors|mesh-ancestor
6745560|NCT01989000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745561|NCT01989052|Lomustine|lomustine|mesh-list
6745562|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
6745563|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6745564|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
6745565|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745566|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745567|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6745568|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745569|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6745570|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745571|NCT01989078|Losartan|losartan|mesh-list
6745572|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6745573|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6745574|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6745575|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6745576|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745577|NCT01989091|Heparin|heparin|mesh-list
6745578|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
6745579|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6745580|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6745581|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745582|NCT01989312|Lidocaine|lidocaine|mesh-list
6745583|NCT01989312|Epinephrine|epinephrine|mesh-list
6745584|NCT01989312|Midazolam|midazolam|mesh-list
6745585|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
6745586|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
6745587|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
6745588|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745589|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745590|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
6745591|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745592|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6745593|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6745594|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6745595|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745596|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745597|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6745598|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6745599|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6745600|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6745601|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6745602|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6745603|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
6745604|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
6745605|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
6745606|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745607|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6745608|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6745609|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
6745610|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6745611|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6745612|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
6745613|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6745614|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
6745615|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
6745616|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
6745617|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6745618|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
6745619|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6745620|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6745621|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745622|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
6745623|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
6787140|NCT02218021|Narcotics|narcotics|mesh-ancestor
6787141|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787142|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787143|NCT02218021|Analgesics|analgesics|mesh-ancestor
6787144|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
6787145|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787146|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
6787147|NCT02218034|Tazarotene|tazarotene|mesh-list
6787148|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
6787149|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
6787150|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
6787151|NCT02218034|Vitamins|vitamins|mesh-ancestor
6787152|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
6787153|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787154|NCT02218047|Interferons|interferons|mesh-list
6787155|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
6787156|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
6787157|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787158|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
6745624|NCT01989507|Nicotine|nicotine|mesh-list
6745625|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6745626|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
6745627|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745628|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745629|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6745630|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6745631|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
6745632|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745633|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745634|NCT01989559|Vaccines|vaccines|mesh-list
6745635|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
6745636|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745637|NCT01989598|Trametinib|trametinib|mesh-list
6745638|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745639|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6745640|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745641|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745642|NCT01989611|Tenofovir|tenofovir|mesh-list
6745643|NCT01989611|Emtricitabine|emtricitabine|mesh-list
6745644|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
6745645|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745646|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6745647|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6745648|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745649|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745650|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6745651|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6745652|NCT01989663|Tenofovir|tenofovir|mesh-list
6745653|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
6745654|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745655|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6745656|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6745657|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745658|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745659|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6745660|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6745661|NCT01989676|Paclitaxel|paclitaxel|mesh-list
6745662|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6745663|NCT01989676|Trastuzumab|trastuzumab|mesh-list
6745664|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6745665|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745666|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
6745667|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
6745668|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
6745669|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745670|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6745671|NCT01989780|Paclitaxel|paclitaxel|mesh-list
6745672|NCT01989780|Bevacizumab|bevacizumab|mesh-list
6745673|NCT01989780|Letrozole|letrozole|mesh-list
6745674|NCT01989780|Fulvestrant|fulvestrant|mesh-list
6745675|NCT01989780|Anastrozole|anastrozole|mesh-list
6745676|NCT01989780|Exemestane|exemestane|mesh-list
6745677|NCT01989780|Goserelin|goserelin|mesh-list
6745678|NCT01989780|Leuprolide|leuprolide|mesh-list
6745679|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6745680|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6745681|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745682|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
6745683|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
6745684|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
6745685|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745686|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6745687|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6745688|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6745689|NCT01989780|Growth Substances|growth substances|mesh-ancestor
6745690|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745691|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
6745692|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6745693|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745694|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6745695|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
6745696|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745697|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6745698|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6745699|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6745700|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
6745701|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6745702|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
6745703|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6745704|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
6745705|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6745706|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
6745707|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745708|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745709|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
6745710|NCT01989884|IDN 5109|idn 5109|mesh-list
6745711|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745712|NCT01989897|Phenol|phenol|mesh-list
6745713|NCT01989897|Histamine|histamine|mesh-list
6745714|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
6745715|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
6745716|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745717|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745718|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745719|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6745720|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745721|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
6745722|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6745723|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6745724|NCT01989923|Nicotine|nicotine|mesh-list
6745725|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6745726|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
6745727|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745728|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745729|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6745730|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6745731|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
6745732|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745733|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745734|NCT01989936|Eletriptan|eletriptan|mesh-list
6745735|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6745736|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
6745737|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745738|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745739|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745740|NCT01990079|Bupropion|bupropion|mesh-list
6745741|NCT01990079|Nicotine|nicotine|mesh-list
6745742|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6745743|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
6745744|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745745|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745746|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6745747|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6745748|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
6745749|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745750|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745751|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6745752|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
6745753|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6745754|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6745755|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6745756|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745757|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
6745758|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6745759|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6745760|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745761|NCT01990118|Cyclosporine|cyclosporine|mesh-list
6745762|NCT01990118|Cyclosporins|cyclosporins|mesh-list
6745763|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745764|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745765|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6745766|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
6745767|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745768|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
6745769|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745770|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
6745771|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6745772|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6745773|NCT01990144|Rituximab|rituximab|mesh-list
6745774|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6745775|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6745776|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745777|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
6745778|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745779|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6745780|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6745781|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
6745782|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745783|NCT01990196|Dasatinib|dasatinib|mesh-list
6745784|NCT01990196|Trametinib|trametinib|mesh-list
6745785|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745786|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6745787|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745788|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745789|NCT01990352|Doxorubicin|doxorubicin|mesh-list
6745790|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6745791|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6745792|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745793|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6745794|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6745795|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745796|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745797|NCT01990378|Rabeprazole|rabeprazole|mesh-list
6745798|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6745799|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745800|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6745801|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745802|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745803|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
6745804|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6745805|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
6745806|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
6745807|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745808|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745809|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6745810|NCT01990404|Analgesics|analgesics|mesh-ancestor
6745811|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
6745812|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745813|NCT01990443|Reslizumab|reslizumab|mesh-list
6745814|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6745815|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
6745816|NCT01990586|Rabeprazole|rabeprazole|mesh-list
6745817|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6745818|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745819|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6745820|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745821|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745822|NCT01990690|Antioxidants|antioxidants|mesh-list
6745823|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745824|NCT01990690|Protective Agents|protective agents|mesh-ancestor
6745825|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745826|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
6745827|NCT01990755|Olanzapine|olanzapine|mesh-list
6745828|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
6745829|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
6745830|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745831|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745832|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745833|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6745834|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6745835|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745836|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6745837|NCT01990755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6745838|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6745839|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745840|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745841|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745842|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
6745843|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
6745844|NCT01990781|Dexamethasone|dexamethasone|mesh-list
6745845|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
6745846|NCT01990781|Lidocaine|lidocaine|mesh-list
6745847|NCT01990781|BB 1101|bb 1101|mesh-list
6745848|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6745849|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
6745850|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
6745851|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745852|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745853|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745854|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
6745855|NCT01990781|Hormones|hormones|mesh-ancestor
6745856|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745857|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6745858|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745859|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
6745860|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745861|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745862|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
6745863|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
6745864|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745865|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
6745866|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6745867|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6745868|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6745869|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745870|NCT01990807|Idarubicin|idarubicin|mesh-list
6745871|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6745872|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745873|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6745874|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6745875|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745876|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745877|NCT01990872|Vitamin D|vitamin d|mesh-list
6745878|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
6745879|NCT01990872|Vitamins|vitamins|mesh-ancestor
6745880|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
6745881|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745882|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6745883|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6745884|NCT01990911|Diuretics|diuretics|mesh-list
6745885|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
6745886|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745887|NCT01990937|Midazolam|midazolam|mesh-list
6745888|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6745889|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6745890|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745891|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745892|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6745893|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6745894|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6745895|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6745896|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
6745897|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
6745898|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
6745899|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
6745900|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745901|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745902|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6745903|NCT01991054|Vitamin D|vitamin d|mesh-list
6745904|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
6745905|NCT01991054|Vitamins|vitamins|mesh-ancestor
6745906|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
6745907|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745908|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6745909|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6745910|NCT01991119|Dronedarone|dronedarone|mesh-list
6745911|NCT01991119|Propafenone|propafenone|mesh-list
6745912|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6745913|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6745914|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6745915|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6745916|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787159|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787160|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
6787161|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787162|NCT02218177|Ranibizumab|ranibizumab|mesh-list
6787163|NCT02218177|Aflibercept|aflibercept|mesh-list
6787164|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6745917|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
6745918|NCT01991145|Hematinics|hematinics|mesh-ancestor
6745919|NCT01991158|Gemcitabine|gemcitabine|mesh-list
6745920|NCT01991158|Dexamethasone|dexamethasone|mesh-list
6745921|NCT01991158|Methotrexate|methotrexate|mesh-list
6745922|NCT01991158|Pegaspargase|pegaspargase|mesh-list
6745923|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6745924|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
6745925|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
6745926|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745927|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745928|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6745929|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
6745930|NCT01991158|Hormones|hormones|mesh-ancestor
6745931|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745932|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6745933|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745934|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6745935|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
6745936|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745937|NCT01991158|Antiviral Agents|antiviral agents|mesh-ancestor
6745938|NCT01991158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6745939|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745940|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6745941|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
6745942|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6745943|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
6745944|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6745945|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
6745946|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6745947|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6745948|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6745949|NCT01991275|Morphine|morphine|mesh-list
6745950|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6745951|NCT01991275|Narcotics|narcotics|mesh-ancestor
6745952|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745953|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745954|NCT01991275|Analgesics|analgesics|mesh-ancestor
6745955|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
6745956|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745957|NCT01991288|Epinephrine|epinephrine|mesh-list
6745958|NCT01991288|Racepinephrine|racepinephrine|mesh-list
6745959|NCT01991288|Bupivacaine|bupivacaine|mesh-list
6745960|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
6745961|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
6745962|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
6745963|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
6745964|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6745965|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745966|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
6745967|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6745968|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6745969|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6745970|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
6745971|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6745972|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745973|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6745974|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6745975|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
6745976|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6745977|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
6745978|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
6745979|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
6745980|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6745981|NCT01991327|Enclomiphene|enclomiphene|mesh-list
6745982|NCT01991327|Clomiphene|clomiphene|mesh-list
6745983|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
6745984|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6745985|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
6745986|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6745987|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6745988|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6745989|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
6745990|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6745991|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6745992|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6745993|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
6745994|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6745995|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6745996|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6745997|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6745998|NCT01991457|Fludarabine|fludarabine|mesh-list
6745999|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746000|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6746001|NCT01991561|Vaccines|vaccines|mesh-list
6746002|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
6746003|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746004|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6746005|NCT01991561|Antacids|antacids|mesh-ancestor
6746006|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746007|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6746008|NCT01991574|Calcium|calcium|mesh-list
6746009|NCT01991574|Calcium acetate|calcium acetate|mesh-list
6746010|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6746011|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746012|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
6746013|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
6746014|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746015|NCT01991587|Vaccines|vaccines|mesh-list
6746016|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
6746017|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746018|NCT01991626|Iron|iron|mesh-list
6746019|NCT01991626|Trace Elements|trace elements|mesh-list
6746020|NCT01991626|Micronutrients|micronutrients|mesh-list
6746021|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746022|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
6746023|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746024|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6746025|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6746026|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746027|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746028|NCT01991834|Cefazolin|cefazolin|mesh-list
6746029|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6746030|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746031|NCT01991873|Leucovorin|leucovorin|mesh-list
6746032|NCT01991873|Folic Acid|folic acid|mesh-list
6746033|NCT01991873|Fluorouracil|fluorouracil|mesh-list
6746034|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
6746035|NCT01991873|Panitumumab|panitumumab|mesh-list
6746036|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
6746037|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
6746038|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746039|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6746040|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746041|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6746042|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
6746043|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746044|NCT01991873|Antidotes|antidotes|mesh-ancestor
6746045|NCT01991873|Protective Agents|protective agents|mesh-ancestor
6746046|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
6746047|NCT01991873|Vitamins|vitamins|mesh-ancestor
6746048|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
6746049|NCT01991873|Hematinics|hematinics|mesh-ancestor
6746050|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6746051|NCT01991951|Warfarin|warfarin|mesh-list
6746052|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
6746053|NCT01992133|Vitamin D|vitamin d|mesh-list
6746054|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
6746055|NCT01992133|Vitamins|vitamins|mesh-ancestor
6746056|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
6746057|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746058|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6746059|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6746060|NCT01992146|Naloxone|naloxone|mesh-list
6746061|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6746062|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746063|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
6746064|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746065|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
6746066|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6746067|NCT01992198|Metronidazole|metronidazole|mesh-list
6746068|NCT01992198|Meropenem|meropenem|mesh-list
6746069|NCT01992198|Cefoperazone|cefoperazone|mesh-list
6746070|NCT01992198|Sulperazone|sulperazone|mesh-list
6746071|NCT01992198|Somatostatin|somatostatin|mesh-list
6746072|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6746073|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746074|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
6746075|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
6746076|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6746077|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6746078|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6746079|NCT01992198|Hormones|hormones|mesh-ancestor
6746080|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6746081|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746082|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6746083|NCT01992198|Renal Agents|renal agents|mesh-ancestor
6746084|NCT01992211|Metformin|metformin|mesh-list
6746085|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6746086|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6746087|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746088|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6746089|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6746090|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
6746091|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746092|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6746093|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6746094|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746095|NCT01992263|Vitamin D|vitamin d|mesh-list
6746096|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
6746097|NCT01992263|Vitamins|vitamins|mesh-list
6746098|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
6746099|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746100|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6746101|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6746102|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
6746103|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6746104|NCT01992328|Antibodies|antibodies|mesh-list
6746105|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
6746106|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
6746107|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6746108|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
6746109|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746110|NCT01992341|Paclitaxel|paclitaxel|mesh-list
6746111|NCT01992341|Trebananib|trebananib|mesh-list
6746112|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6746113|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746114|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
6746115|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
6746116|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
6746117|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746118|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6746119|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6746120|NCT01992341|Growth Substances|growth substances|mesh-ancestor
6746121|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746122|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
6746123|NCT01992562|Ziconotide|ziconotide|mesh-list
6746124|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6746125|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746126|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746127|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6746128|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746129|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6746130|NCT01992562|Protective Agents|protective agents|mesh-ancestor
6746131|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6746132|NCT01992562|Analgesics|analgesics|mesh-ancestor
6746133|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
6746134|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746135|NCT01992588|Insulin|insulin|mesh-list
6746136|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6746137|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
6746138|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
6746139|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6746140|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6746141|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746142|NCT01992601|Telmisartan|telmisartan|mesh-list
6746143|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6746144|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6746145|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6746146|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
6746147|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746148|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6746149|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6746150|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746151|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6746152|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6746153|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6746154|NCT01992653|Prednisone|prednisone|mesh-list
6746155|NCT01992653|Prednisolone|prednisolone|mesh-list
6746156|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
6746157|NCT01992653|Rituximab|rituximab|mesh-list
6746158|NCT01992653|Doxorubicin|doxorubicin|mesh-list
6746159|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
6746160|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6746161|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
6746162|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746163|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6746164|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6746165|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
6746166|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746167|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746168|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6746169|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6746170|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6746171|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6746172|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6746173|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746174|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6746175|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
6746176|NCT01992653|Hormones|hormones|mesh-ancestor
6746177|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6746178|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6746179|NCT01992705|Fluorouracil|fluorouracil|mesh-list
6746180|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
6746181|NCT01992705|Irinotecan|irinotecan|mesh-list
6746182|NCT01992705|Folfirinox|folfirinox|mesh-list
6746183|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
6746184|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746185|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6746186|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746187|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6746188|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
6746189|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746190|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6746191|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6746192|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746193|NCT01992796|Telmisartan|telmisartan|mesh-list
6746194|NCT01992796|Candesartan|candesartan|mesh-list
6746195|NCT01992796|Olmesartan|olmesartan|mesh-list
6746196|NCT01992796|Irbesartan|irbesartan|mesh-list
6746197|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6746198|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6746199|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6746200|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787165|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6787166|NCT02218177|Growth Substances|growth substances|mesh-ancestor
6787167|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787168|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
6787169|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787170|NCT02218359|Amikacin|amikacin|mesh-list
6787171|NCT02218359|Fosfomycin|fosfomycin|mesh-list
6787172|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6787173|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6787174|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787175|NCT02218398|Albuterol|albuterol|mesh-list
6787176|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6787177|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
6787178|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787179|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787180|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6787181|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
6787182|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
6787183|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6787184|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6787185|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6787186|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6787187|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
6787188|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787189|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787190|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
6787191|NCT02218476|Vitamins|vitamins|mesh-ancestor
6787192|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
6787193|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787194|NCT02218606|Prednisone|prednisone|mesh-list
6787195|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
6787196|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6787197|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
6787198|NCT02218606|Hormones|hormones|mesh-ancestor
6787199|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787200|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787201|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6787202|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787203|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6787204|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787205|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787206|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
6787207|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6746201|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
6746202|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6746203|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6746204|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746205|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
6746206|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
6746207|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746208|NCT01992900|Piperaquine|piperaquine|mesh-list
6746209|NCT01992900|Artenimol|artenimol|mesh-list
6746210|NCT01992900|Artemisinins|artemisinins|mesh-list
6746211|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
6746212|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6746213|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6746214|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746215|NCT01992952|Fulvestrant|fulvestrant|mesh-list
6746216|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6746217|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746218|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6746219|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6746220|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
6746221|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6746222|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746223|NCT01993134|Cefazolin|cefazolin|mesh-list
6746224|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6746225|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746226|NCT01993173|Vaccines|vaccines|mesh-list
6746227|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
6746228|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746229|NCT01993212|Enclomiphene|enclomiphene|mesh-list
6746230|NCT01993212|Testosterone|testosterone|mesh-list
6746231|NCT01993212|Androgens|androgens|mesh-ancestor
6746232|NCT01993212|Hormones|hormones|mesh-ancestor
6746233|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6746234|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746235|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6746236|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
6746237|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6746238|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
6746239|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6746240|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6746241|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6746242|NCT01993225|Enclomiphene|enclomiphene|mesh-list
6746243|NCT01993225|Testosterone|testosterone|mesh-list
6746244|NCT01993225|Androgens|androgens|mesh-ancestor
6746245|NCT01993225|Hormones|hormones|mesh-ancestor
6746246|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6746247|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746248|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6746249|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
6746250|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6746251|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
6746252|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6746253|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6746254|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6746255|NCT01993251|Melatonin|melatonin|mesh-list
6746256|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
6746257|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746258|NCT01993251|Protective Agents|protective agents|mesh-ancestor
6746259|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746260|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746261|NCT01993290|Ropivacaine|ropivacaine|mesh-list
6746262|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
6746263|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
6746264|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746265|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746266|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
6746267|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746268|NCT01993459|Midazolam|midazolam|mesh-list
6746269|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6746270|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6746271|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6746272|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746273|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746274|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6746275|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6746276|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6746277|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6746278|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
6746279|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
6746280|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
6746281|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
6746282|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746283|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746284|NCT01993472|Andrographolide|andrographolide|mesh-list
6746285|NCT01993472|Capecitabine|capecitabine|mesh-list
6746286|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6746287|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
6746288|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746289|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746290|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6746291|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6746292|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6746293|NCT01993472|Analgesics|analgesics|mesh-ancestor
6746294|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
6746295|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746296|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746297|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6746298|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6746299|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6746300|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746301|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
6746302|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6746303|NCT01993537|Vitamin D|vitamin d|mesh-list
6746304|NCT01993537|Vitamins|vitamins|mesh-ancestor
6746305|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
6746306|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746307|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6746308|NCT01993589|Acetaminophen|acetaminophen|mesh-list
6746309|NCT01993589|Analgesics|analgesics|mesh-list
6746310|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6746311|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
6746312|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746313|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746314|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
6746315|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
6746316|NCT01993680|Bromides|bromides|mesh-list
6746317|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6746318|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
6746319|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6746320|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746321|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746322|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
6746323|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746324|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746325|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6746326|NCT01993771|Anesthetics|anesthetics|mesh-list
6746327|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746328|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746329|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
6746330|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6746331|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746332|NCT01993810|Paclitaxel|paclitaxel|mesh-list
6746333|NCT01993810|Etoposide|etoposide|mesh-list
6746334|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
6746335|NCT01993810|Cisplatin|cisplatin|mesh-list
6746336|NCT01993810|Carboplatin|carboplatin|mesh-list
6746337|NCT01993810|Pemetrexed|pemetrexed|mesh-list
6746338|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6746339|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
6746340|NCT01993810|Durvalumab|durvalumab|mesh-list
6746341|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
6746342|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6746343|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
6746344|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6746345|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746346|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
6746347|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
6746348|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
6746349|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746350|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6746351|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6746352|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746353|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6746354|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6746355|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6746356|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
6746357|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746358|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
6746359|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
6746360|NCT01993979|Gemcitabine|gemcitabine|mesh-list
6746361|NCT01993979|Cisplatin|cisplatin|mesh-list
6746362|NCT01993979|Carboplatin|carboplatin|mesh-list
6746363|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746364|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6746365|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
6746366|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746367|NCT01993979|Antiviral Agents|antiviral agents|mesh-ancestor
6746368|NCT01993979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746369|NCT01993979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746370|NCT01993979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6746371|NCT01993979|Immunologic Factors|immunologic factors|mesh-ancestor
6746372|NCT01993979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746373|NCT01994031|Paclitaxel|paclitaxel|mesh-list
6746374|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6746375|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6746376|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746377|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
6746378|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
6746379|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
6746380|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746381|NCT01994070|Procainamide|procainamide|mesh-list
6746382|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6746383|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6746384|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6746385|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746386|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746387|NCT01994096|Caspofungin|caspofungin|mesh-list
6746388|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
6746389|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746390|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746391|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746392|NCT01994265|Warfarin|warfarin|mesh-list
6746393|NCT01994265|Dabigatran|dabigatran|mesh-list
6746394|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
6746395|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
6746396|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6746397|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
6746398|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746399|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746400|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6746401|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
6746402|NCT01994330|Coagulants|coagulants|mesh-ancestor
6746403|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6746404|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
6746405|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746406|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
6746407|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6746408|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787208|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6787209|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
6787210|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787211|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6787212|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787213|NCT02218645|Brotizolam|brotizolam|mesh-list
6787214|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6787215|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787216|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787217|NCT02218658|Brotizolam|brotizolam|mesh-list
6787218|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6787219|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787220|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787221|NCT02218671|Brotizolam|brotizolam|mesh-list
6787222|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6787223|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787224|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787225|NCT02218684|Telmisartan|telmisartan|mesh-list
6787226|NCT02218684|Lacidipine|lacidipine|mesh-list
6787227|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6787228|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6787229|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6787230|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787231|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6787232|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6787233|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6787234|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787235|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6746409|NCT01994460|Linezolid|linezolid|mesh-list
6746410|NCT01994460|Ethambutol|ethambutol|mesh-list
6746411|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6746412|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746413|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6746414|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746415|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746416|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
6746417|NCT01994525|Vaccines|vaccines|mesh-list
6746418|NCT01994525|Immunologic Factors|immunologic factors|mesh-ancestor
6746419|NCT01994525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746420|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
6746421|NCT01994642|Dexamethasone|dexamethasone|mesh-list
6746422|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
6746423|NCT01994642|BB 1101|bb 1101|mesh-list
6746424|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6746425|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
6746426|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
6746427|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746428|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746429|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6746430|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
6746431|NCT01994642|Hormones|hormones|mesh-ancestor
6746432|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6746433|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6746434|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746435|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
6746436|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746437|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746438|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6746439|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746440|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6746441|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6746442|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6746443|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6746444|NCT01994668|Lorazepam|lorazepam|mesh-list
6746445|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
6746446|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
6746447|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
6746448|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746449|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746450|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6746451|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6746452|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746453|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6746454|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6746455|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6746456|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
6746457|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
6746458|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746459|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746460|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
6746461|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
6746462|NCT01994733|Calcium|calcium|mesh-list
6746463|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6746464|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746465|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6746466|NCT01994733|Antacids|antacids|mesh-ancestor
6746467|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746468|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6746469|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
6746470|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6746471|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6746472|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
6746473|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
6746474|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746475|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746476|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6746477|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
6746478|NCT01994759|Hormones|hormones|mesh-ancestor
6787236|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
6746479|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6746480|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6746481|NCT01994759|Protective Agents|protective agents|mesh-ancestor
6746482|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
6746483|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6746484|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
6746485|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746486|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6746487|NCT01994941|Clopidogrel|clopidogrel|mesh-list
6746488|NCT01994941|Ticagrelor|ticagrelor|mesh-list
6746489|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6746490|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6746491|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6746492|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6746493|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
6746494|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746495|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746496|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746497|NCT01994967|Bupivacaine|bupivacaine|mesh-list
6746498|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
6746499|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
6746500|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
6746501|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746502|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746503|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
6746504|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746505|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6746506|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6746507|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746508|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
6746509|NCT01995006|Dipyrone|dipyrone|mesh-list
6746510|NCT01995006|Naproxen|naproxen|mesh-list
6746511|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6746512|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6746513|NCT01995006|Analgesics|analgesics|mesh-ancestor
6746514|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
6746515|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746516|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746517|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6746518|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6746519|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
6746520|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6746521|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746522|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746523|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
6746524|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
6746525|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6746526|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6746527|NCT01995019|Prednisolone|prednisolone|mesh-list
6746528|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
6746529|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6746530|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
6746531|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6746532|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
6746533|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
6746534|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746535|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746536|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6746537|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
6746538|NCT01995019|Hormones|hormones|mesh-ancestor
6746539|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6746540|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6746541|NCT01995019|Protective Agents|protective agents|mesh-ancestor
6746542|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6746543|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746544|NCT01995032|Metformin|metformin|mesh-list
6746545|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6746546|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746547|NCT01995058|Prednisone|prednisone|mesh-list
6746548|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
6746549|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6746550|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
6746551|NCT01995058|Hormones|hormones|mesh-ancestor
6746552|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6746553|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746554|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6746555|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746556|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6746557|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746558|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746559|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
6746560|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6746561|NCT01995084|Imidazole|imidazole|mesh-list
6746562|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746563|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746564|NCT01995188|Bevacizumab|bevacizumab|mesh-list
6746565|NCT01995188|Carboplatin|carboplatin|mesh-list
6746566|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6746567|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746568|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6746569|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6746570|NCT01995188|Growth Substances|growth substances|mesh-ancestor
6746571|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746572|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
6746573|NCT01995214|Propofol|propofol|mesh-list
6746574|NCT01995214|Sevoflurane|sevoflurane|mesh-list
6746575|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6746576|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746577|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746578|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6746579|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
6746580|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
6746581|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6746582|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6746583|NCT01995292|Anesthetics|anesthetics|mesh-list
6746584|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
6746585|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746586|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746587|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
6746588|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746589|NCT01995331|Cyclosporine|cyclosporine|mesh-list
6746590|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
6746591|NCT01995331|Cyclosporins|cyclosporins|mesh-list
6746592|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6746593|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
6746594|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746595|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6746596|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6746597|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
6746598|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746599|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746600|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6746601|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746602|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
6746603|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746604|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
6746605|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6746606|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
6746607|NCT01995344|Fludarabine|fludarabine|mesh-list
6746608|NCT01995344|Interleukin-2|interleukin-2|mesh-list
6746609|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6746610|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
6746611|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746612|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6746613|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6746614|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
6746615|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746616|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746617|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6746618|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6746619|NCT01995344|Analgesics|analgesics|mesh-ancestor
6746620|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
6746621|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746622|NCT01995370|Aspirin|aspirin|mesh-list
6746623|NCT01995370|Cilostazol|cilostazol|mesh-list
6746624|NCT01995370|Clopidogrel|clopidogrel|mesh-list
6746625|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6746626|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6746627|NCT01995370|Analgesics|analgesics|mesh-ancestor
6746628|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
6746629|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746630|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746631|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6746632|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6746633|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6746634|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6746635|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746636|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6746637|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6746638|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746639|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
6746640|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6746641|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6746642|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6746643|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
6746644|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746645|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6746646|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
6746647|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6746648|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
6746649|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
6746650|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6746651|NCT01995370|Protective Agents|protective agents|mesh-ancestor
6746652|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6746653|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6746654|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6746655|NCT01995695|Vaccines|vaccines|mesh-list
6746656|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
6746657|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746658|NCT01995734|Pasireotide|pasireotide|mesh-list
6746659|NCT01995734|Hormones|hormones|mesh-ancestor
6746660|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6746661|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746662|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6746663|NCT01995799|Hematinics|hematinics|mesh-ancestor
6746664|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6746665|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6746666|NCT01995890|Nepafenac|nepafenac|mesh-list
6746667|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6746668|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6746669|NCT01995890|Analgesics|analgesics|mesh-ancestor
6746670|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
6746671|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746672|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746673|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6746674|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6746675|NCT01996085|Amlodipine|amlodipine|mesh-list
6746676|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6746677|NCT01996085|Telmisartan|telmisartan|mesh-list
6746678|NCT01996085|Lisinopril|lisinopril|mesh-list
6746679|NCT01996085|Nebivolol|nebivolol|mesh-list
6746680|NCT01996085|Indapamide|indapamide|mesh-list
6746681|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6746682|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6746683|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746684|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746685|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6746686|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746687|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
6746688|NCT01996085|Diuretics|diuretics|mesh-ancestor
6746689|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
6746690|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6746691|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6746692|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6746693|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6746694|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
6746695|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746696|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6746697|NCT01996085|Protective Agents|protective agents|mesh-ancestor
6746698|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6746699|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6746700|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6746701|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
6746702|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746703|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6746704|NCT01996150|Eusol|eusol|mesh-list
6746705|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
6746706|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746707|NCT01996189|Insulin|insulin|mesh-list
6746708|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6746709|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787237|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787238|NCT02218762|Fluticasone|fluticasone|mesh-list
6787239|NCT02218762|Xhance|xhance|mesh-list
6787240|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6787241|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6787242|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6787243|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6787244|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
6787245|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787246|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787247|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6787248|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
6787249|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
6787250|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6787251|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6787252|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6787253|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6787254|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
6787255|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787256|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787257|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
6787258|NCT02218762|Hormones|hormones|mesh-ancestor
6787259|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787260|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
6787261|NCT02218775|Aticaprant|aticaprant|mesh-list
6787262|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6787263|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787264|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
6787265|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787266|NCT02218814|Bupivacaine|bupivacaine|mesh-list
6787267|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
6787268|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
6787269|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787270|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787271|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
6787272|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787273|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6787274|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6787275|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6787276|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
6787277|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6787278|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
6787279|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787280|NCT02219100|Mifepristone|mifepristone|mesh-list
6787281|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6787282|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
6787283|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6787284|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787285|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6787286|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6787287|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6787288|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
6787289|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6787290|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6787291|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
6787292|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787293|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
6787294|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6787295|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6787296|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
6787297|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6787298|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6787299|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787300|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
6787301|NCT02219152|Coagulants|coagulants|mesh-ancestor
6787302|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
6787303|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6787304|NCT02219165|Antibodies|antibodies|mesh-list
6787305|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
6746710|NCT01996267|Paclitaxel|paclitaxel|mesh-list
6746711|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
6746712|NCT01996267|Carboplatin|carboplatin|mesh-list
6746713|NCT01996267|Fluorouracil|fluorouracil|mesh-list
6746714|NCT01996267|Trastuzumab|trastuzumab|mesh-list
6746715|NCT01996267|Pertuzumab|pertuzumab|mesh-list
6746716|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6746717|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746718|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
6746719|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
6746720|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
6746721|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746722|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6746723|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
6746724|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746725|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6746726|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6746727|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
6746728|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6746729|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
6746730|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6746731|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6746732|NCT01996293|Lamotrigine|lamotrigine|mesh-list
6746733|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
6746734|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6746735|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746736|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746737|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6746738|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746739|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6746740|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6746741|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746742|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6746743|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6746744|NCT01996306|Leucovorin|leucovorin|mesh-list
6746745|NCT01996306|Bevacizumab|bevacizumab|mesh-list
6746746|NCT01996306|Fluorouracil|fluorouracil|mesh-list
6746747|NCT01996306|Capecitabine|capecitabine|mesh-list
6746748|NCT01996306|Irinotecan|irinotecan|mesh-list
6746749|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6746750|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746751|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6746752|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6746753|NCT01996306|Growth Substances|growth substances|mesh-ancestor
6746754|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746755|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
6746756|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
6746757|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746758|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6746759|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6746760|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
6746761|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6746762|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6746763|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746764|NCT01996306|Antidotes|antidotes|mesh-ancestor
6746765|NCT01996306|Protective Agents|protective agents|mesh-ancestor
6746766|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
6746767|NCT01996306|Vitamins|vitamins|mesh-ancestor
6746768|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
6746769|NCT01996358|Rocuronium|rocuronium|mesh-list
6746770|NCT01996358|Succinylcholine|succinylcholine|mesh-list
6746771|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6746772|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6746773|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6746774|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746775|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746776|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6746777|NCT01996384|Lidocaine|lidocaine|mesh-list
6746778|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
6746779|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
6746780|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746781|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746782|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
6746783|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746784|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6746785|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6746786|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6746787|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746788|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746789|NCT01996423|Vitamin D|vitamin d|mesh-list
6746790|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
6746791|NCT01996423|Vitamins|vitamins|mesh-ancestor
6746792|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
6746793|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746794|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6746795|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6746796|NCT01996462|Dexetimide|dexetimide|mesh-list
6746797|NCT01996462|Citalopram|citalopram|mesh-list
6746798|NCT01996462|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6746799|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6746800|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746801|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746802|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746803|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
6746804|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746805|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6746806|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
6746807|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6746808|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6746809|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6746810|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
6746811|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
6746812|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746813|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6746814|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6746815|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
6746816|NCT01996475|Dexetimide|dexetimide|mesh-list
6746817|NCT01996475|Citalopram|citalopram|mesh-list
6746818|NCT01996475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6746819|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6746820|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746821|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746822|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746823|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
6746824|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746825|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6746826|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
6746827|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6746828|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6746829|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6746830|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
6746831|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
6746832|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746833|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6746834|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6746835|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
6746836|NCT01996488|Olanzapine|olanzapine|mesh-list
6746837|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
6746838|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
6746839|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746840|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746841|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6746842|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6746843|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6746844|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746845|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6746846|NCT01996488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6746847|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6746848|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746849|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746850|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746851|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
6746852|NCT01996501|Olanzapine|olanzapine|mesh-list
6746853|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
6746854|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
6746855|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746856|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746857|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6746858|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6746859|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6746860|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746861|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6746862|NCT01996501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6746863|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6746864|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746865|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746866|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746867|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
6746868|NCT01996579|Lactoferrin|lactoferrin|mesh-list
6746869|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746870|NCT01996618|Ranolazine|ranolazine|mesh-list
6746871|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6746872|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746873|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746874|NCT01996683|Deferiprone|deferiprone|mesh-list
6746875|NCT01996683|Deferoxamine|deferoxamine|mesh-list
6746876|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6746877|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
6746878|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
6746879|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746880|NCT01996683|Siderophores|siderophores|mesh-ancestor
6746881|NCT01996696|Metformin|metformin|mesh-list
6746882|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6746883|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746884|NCT01996735|Ticagrelor|ticagrelor|mesh-list
6746885|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6746886|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6746887|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6746888|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6746889|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
6746890|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746891|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746892|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746893|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
6746894|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6746895|NCT01996761|Protective Agents|protective agents|mesh-ancestor
6746896|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746897|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
6746898|NCT01996865|Rituximab|rituximab|mesh-list
6746899|NCT01996865|Lenalidomide|lenalidomide|mesh-list
6746900|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6746901|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746902|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
6746903|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746904|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6746905|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6746906|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6746907|NCT01996865|Growth Substances|growth substances|mesh-ancestor
6746908|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
6746909|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6746910|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
6746911|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6746912|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746913|NCT01997099|Diazepam|diazepam|mesh-list
6746914|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6746915|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
6746916|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
6746917|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
6746918|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746919|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746920|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6746921|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6746922|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6746923|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6746924|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6746925|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6746926|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6746927|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6746928|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6746929|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
6746930|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
6746931|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
6746932|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
6746933|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746934|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746935|NCT01997112|Acetaminophen|acetaminophen|mesh-list
6746936|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6746937|NCT01997112|Analgesics|analgesics|mesh-ancestor
6746938|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
6746939|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746940|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746941|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
6746942|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6746943|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6746944|NCT01997164|Aflibercept|aflibercept|mesh-list
6746945|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6746946|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6746947|NCT01997164|Growth Substances|growth substances|mesh-ancestor
6746948|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746949|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
6746950|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746951|NCT01997190|Valacyclovir|valacyclovir|mesh-list
6746952|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
6746953|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746954|NCT01997203|Vitamin D|vitamin d|mesh-list
6746955|NCT01997203|Interferons|interferons|mesh-list
6746956|NCT01997203|Ribavirin|ribavirin|mesh-list
6746957|NCT01997203|Vitamins|vitamins|mesh-ancestor
6746958|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
6746959|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746960|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6746961|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746962|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
6746963|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6746964|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
6746965|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746966|NCT01997255|Everolimus|everolimus|mesh-list
6746967|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6746968|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6746969|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
6746970|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746971|NCT01997294|Atorvastatin|atorvastatin|mesh-list
6746972|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6746973|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6746974|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
6746975|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746976|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6746977|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6746978|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6746979|NCT01997463|Albuterol|albuterol|mesh-list
6746980|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6746981|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
6746982|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6746983|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6746984|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6746985|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
6746986|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
6746987|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6746988|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6746989|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6746990|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6746991|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
6746992|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6746993|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746994|NCT01997580|Citalopram|citalopram|mesh-list
6746995|NCT01997580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6746996|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6746997|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6746998|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6746999|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747000|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
6747001|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747002|NCT01997580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6747003|NCT01997580|Antidepressive Agents|antidepressive agents|mesh-ancestor
6747004|NCT01997580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6747005|NCT01997593|Ropivacaine|ropivacaine|mesh-list
6747006|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
6747007|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
6747008|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747009|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747010|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
6747011|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747012|NCT01997632|Vaccines|vaccines|mesh-list
6747013|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
6747014|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747015|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
6747016|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6747017|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6747018|NCT01997658|Prednisolone|prednisolone|mesh-list
6747019|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
6747020|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6747021|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
6747022|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747023|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
6747024|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
6747025|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747026|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747027|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6747028|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
6747029|NCT01997658|Hormones|hormones|mesh-ancestor
6747030|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747031|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6747032|NCT01997658|Protective Agents|protective agents|mesh-ancestor
6747033|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6747034|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747035|NCT01997762|Resveratrol|resveratrol|mesh-list
6747036|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
6747037|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747038|NCT01997762|Protective Agents|protective agents|mesh-ancestor
6747039|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747040|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747041|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6747042|NCT01997775|Metformin|metformin|mesh-list
6747043|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6747044|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747045|NCT01997788|Morphine|morphine|mesh-list
6747046|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6747047|NCT01997788|Narcotics|narcotics|mesh-ancestor
6747048|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747049|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747050|NCT01997788|Analgesics|analgesics|mesh-ancestor
6747051|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
6747052|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747053|NCT01997801|Ketamine|ketamine|mesh-list
6747054|NCT01997801|Analgesics|analgesics|mesh-ancestor
6747055|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
6747056|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747057|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747058|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6747059|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6747060|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
6747061|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
6747062|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747063|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6747064|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6747065|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747066|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747067|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
6747068|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
6747069|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747070|NCT01997840|Dexamethasone|dexamethasone|mesh-list
6747071|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
6747072|NCT01997840|Pomalidomide|pomalidomide|mesh-list
6747073|NCT01997840|Ricolinostat|ricolinostat|mesh-list
6747074|NCT01997840|BB 1101|bb 1101|mesh-list
6747075|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747076|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
6747077|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
6747078|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747079|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747080|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6747081|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
6747082|NCT01997840|Hormones|hormones|mesh-ancestor
6747083|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747084|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6747085|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747086|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
6747087|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747088|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747089|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
6747090|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6747091|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6747092|NCT01997840|Growth Substances|growth substances|mesh-ancestor
6747093|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
6747094|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6747095|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6747096|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6747097|NCT01997944|Interferons|interferons|mesh-list
6747098|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
6747099|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
6747100|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6747101|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747102|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
6747103|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747104|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
6747105|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747106|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
6747107|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6747108|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6747109|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747110|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
6747111|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747112|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787306|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787307|NCT02219178|Dexamethasone|dexamethasone|mesh-list
6787308|NCT02219178|Lenalidomide|lenalidomide|mesh-list
6787309|NCT02219178|Bortezomib|bortezomib|mesh-list
6787310|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6787311|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
6787312|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
6787313|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787314|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787315|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787316|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
6787317|NCT02219178|Hormones|hormones|mesh-ancestor
6787318|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787319|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6787320|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787321|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
6787322|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6787323|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6787324|NCT02219178|Growth Substances|growth substances|mesh-ancestor
6787325|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
6787326|NCT02219191|Puerarin|puerarin|mesh-list
6787327|NCT02219191|Atorvastatin|atorvastatin|mesh-list
6787328|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6787329|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6787330|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
6787331|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787332|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6787333|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6787334|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787335|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
6787336|NCT02219217|Dolutegravir|dolutegravir|mesh-list
6787337|NCT02219217|Cobicistat|cobicistat|mesh-list
6787338|NCT02219217|Elvitegravir|elvitegravir|mesh-list
6787339|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6747113|NCT01998113|Insulin|insulin|mesh-list
6747114|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6747115|NCT01998113|Metformin|metformin|mesh-list
6747116|NCT01998113|Glyburide|glyburide|mesh-list
6747117|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6747118|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747119|NCT01998126|Nivolumab|nivolumab|mesh-list
6747120|NCT01998126|Ipilimumab|ipilimumab|mesh-list
6747121|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6747122|NCT01998126|Crizotinib|crizotinib|mesh-list
6747123|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6747124|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747125|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6747126|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747127|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6747128|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747129|NCT01998165|Remifentanil|remifentanil|mesh-list
6747130|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6747131|NCT01998165|Narcotics|narcotics|mesh-ancestor
6747132|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747133|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747134|NCT01998165|Analgesics|analgesics|mesh-ancestor
6747135|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
6747136|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747137|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
6747138|NCT01998217|Remifentanil|remifentanil|mesh-list
6747139|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6747140|NCT01998217|Narcotics|narcotics|mesh-ancestor
6747141|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747142|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747143|NCT01998217|Analgesics|analgesics|mesh-ancestor
6747144|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
6747145|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747146|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6747147|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6747148|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747149|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6747150|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6747151|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747152|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747153|NCT01998295|Lumefantrine|lumefantrine|mesh-list
6747154|NCT01998295|Artemether|artemether|mesh-list
6747155|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6747156|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
6747157|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6747158|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6747159|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747160|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
6747161|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6747162|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
6747163|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747164|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
6747165|NCT01998308|Protective Agents|protective agents|mesh-ancestor
6747166|NCT01998347|Paclitaxel|paclitaxel|mesh-list
6747167|NCT01998347|Fluorouracil|fluorouracil|mesh-list
6747168|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6747169|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747170|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
6747171|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
6747172|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
6747173|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747174|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
6747175|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6747176|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6747177|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
6747178|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747179|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6747180|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6747181|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747182|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
6747183|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
6747184|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747185|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6747186|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6747187|NCT01998503|Dexamethasone|dexamethasone|mesh-list
6747188|NCT01998503|Bortezomib|bortezomib|mesh-list
6747189|NCT01998503|Melphalan|melphalan|mesh-list
6747190|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747191|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
6747192|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
6747193|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747194|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747195|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6747196|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
6747197|NCT01998503|Hormones|hormones|mesh-ancestor
6747198|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747199|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6747200|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747201|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
6747202|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6747203|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
6747204|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747205|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6747206|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6747207|NCT01998529|Cisplatin|cisplatin|mesh-list
6747208|NCT01998529|Amifostine|amifostine|mesh-list
6747209|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747210|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6747211|NCT01998529|Protective Agents|protective agents|mesh-ancestor
6747212|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747213|NCT01998685|Fentanyl|fentanyl|mesh-list
6747214|NCT01998685|Midazolam|midazolam|mesh-list
6747215|NCT01998685|Remifentanil|remifentanil|mesh-list
6747216|NCT01998685|Propofol|propofol|mesh-list
6747217|NCT01998685|Sevoflurane|sevoflurane|mesh-list
6747218|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6747219|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747220|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747221|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6747222|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
6747223|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
6747224|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6747225|NCT01998685|Narcotics|narcotics|mesh-ancestor
6747226|NCT01998685|Analgesics|analgesics|mesh-ancestor
6747227|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
6747228|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747229|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6747230|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6747231|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6747232|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6747233|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
6747234|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
6747235|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747236|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747237|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6747238|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6747239|NCT01998698|Lidocaine|lidocaine|mesh-list
6747240|NCT01998698|Dipivefrin|dipivefrin|mesh-list
6747241|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
6747242|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6747243|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
6747244|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747245|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747246|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747247|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6747248|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
6747249|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
6747250|NCT01998698|Protective Agents|protective agents|mesh-ancestor
6747251|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
6747252|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
6747253|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747254|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
6747255|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747256|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6747257|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6747258|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6747259|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6747260|NCT01998763|Vitamin D|vitamin d|mesh-list
6747261|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
6747262|NCT01998763|Vitamins|vitamins|mesh-ancestor
6747263|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
6747264|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747265|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6747266|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6747267|NCT01998776|Misoprostol|misoprostol|mesh-list
6747268|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6747269|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
6747270|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6747271|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747272|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6747273|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6747274|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
6747275|NCT01998789|Everolimus|everolimus|mesh-list
6747276|NCT01998789|Tacrolimus|tacrolimus|mesh-list
6747277|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6747278|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
6747279|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747280|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6747281|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747282|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747283|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747284|NCT01999153|Ropivacaine|ropivacaine|mesh-list
6747285|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
6747286|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
6747287|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747288|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747289|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
6747290|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747291|NCT01999270|Bevacizumab|bevacizumab|mesh-list
6747292|NCT01999270|Irinotecan|irinotecan|mesh-list
6747293|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6747294|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747295|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6747296|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6747297|NCT01999270|Growth Substances|growth substances|mesh-ancestor
6747298|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747299|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
6747300|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6747301|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6747302|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747303|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747304|NCT01999309|Simvastatin|simvastatin|mesh-list
6747305|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6747306|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6747307|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
6747308|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747309|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6747310|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6747311|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747312|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
6747313|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6747314|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747315|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6747316|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
6747317|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6747318|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747319|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747320|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747321|NCT01999413|Cytarabine|cytarabine|mesh-list
6747322|NCT01999413|Daunorubicin|daunorubicin|mesh-list
6747323|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6747324|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
6747325|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747326|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747327|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
6747328|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747329|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6747330|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
6747331|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747332|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6747333|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6747334|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6747335|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747336|NCT01999647|Ropivacaine|ropivacaine|mesh-list
6747337|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
6747338|NCT01999647|Anesthetics|anesthetics|mesh-list
6747339|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747340|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747341|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
6747342|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747343|NCT01999673|Docetaxel|docetaxel|mesh-list
6747344|NCT01999673|Bavituximab|bavituximab|mesh-list
6747345|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6747346|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747347|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
6747348|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
6747349|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
6747350|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747351|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6747352|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
6747353|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747354|NCT01999686|Metformin|metformin|mesh-list
6747355|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6747356|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747357|NCT01999738|Folic Acid|folic acid|mesh-list
6747358|NCT01999738|Hematinics|hematinics|mesh-ancestor
6747359|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
6747360|NCT01999738|Vitamins|vitamins|mesh-ancestor
6747361|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
6747362|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787340|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6787341|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787342|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787343|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6787344|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6787345|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
6787346|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787347|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6787348|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6787349|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
6787350|NCT02219373|Gabapentin|gabapentin|mesh-list
6787351|NCT02219373|Analgesics|analgesics|mesh-ancestor
6787352|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
6787353|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787354|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787355|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
6787356|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6787357|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6787358|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787359|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6787360|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6787361|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6787362|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787363|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787364|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
6787365|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6787366|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6787367|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6787368|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6787369|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6787370|NCT02219412|Aspirin|aspirin|mesh-list
6787371|NCT02219412|Ticagrelor|ticagrelor|mesh-list
6787372|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6787373|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6787374|NCT02219412|Analgesics|analgesics|mesh-ancestor
6787375|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
6787376|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787377|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787378|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6787379|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6787380|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6787381|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6787382|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787383|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6787384|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6787385|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787386|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
6787387|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6787388|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6787389|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6787390|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
6787391|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787392|NCT02219490|Ribavirin|ribavirin|mesh-list
6787393|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
6787394|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787395|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
6787396|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787397|NCT02219581|Dexamethasone|dexamethasone|mesh-list
6787398|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
6787399|NCT02219581|BB 1101|bb 1101|mesh-list
6787400|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6787401|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
6787402|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
6787403|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787404|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787405|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787406|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
6747363|NCT01999829|Caffeine|caffeine|mesh-list
6747364|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747365|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6747366|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747367|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6747368|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747369|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6747370|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6747371|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
6747372|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747373|NCT01999842|Vaccines|vaccines|mesh-list
6747374|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
6747375|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747376|NCT01999907|Vitamin D|vitamin d|mesh-list
6747377|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
6747378|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
6747379|NCT01999907|Vitamins|vitamins|mesh-list
6747380|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
6747381|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747382|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6747383|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6747384|NCT01999933|Cisplatin|cisplatin|mesh-list
6747385|NCT01999933|Docetaxel|docetaxel|mesh-list
6747386|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747387|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
6747388|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
6747389|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
6747390|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747391|NCT02000089|Secretin|secretin|mesh-list
6747392|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6747393|NCT02000089|Hormones|hormones|mesh-ancestor
6747394|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747395|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747396|NCT02000102|Aflibercept|aflibercept|mesh-list
6747397|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6747398|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6747399|NCT02000102|Growth Substances|growth substances|mesh-ancestor
6747400|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747401|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
6747402|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747403|NCT02000193|Fulvestrant|fulvestrant|mesh-list
6747404|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6747405|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747406|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6747407|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6747408|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
6747409|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747410|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747411|NCT02000206|Ketamine|ketamine|mesh-list
6747412|NCT02000206|Alfentanil|alfentanil|mesh-list
6747413|NCT02000206|Propofol|propofol|mesh-list
6747414|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6747415|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747416|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747417|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6747418|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
6747419|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
6747420|NCT02000206|Analgesics|analgesics|mesh-ancestor
6747421|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
6747422|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747423|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6747424|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6747425|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6747426|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747427|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747428|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6747429|NCT02000206|Narcotics|narcotics|mesh-ancestor
6747430|NCT02000336|Prednisolone|prednisolone|mesh-list
6747431|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747432|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
6747433|NCT02000336|Hormones|hormones|mesh-ancestor
6747434|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747435|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747436|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6747437|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747438|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6747439|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6747440|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
6747441|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747442|NCT02000388|Ketorolac|ketorolac|mesh-list
6747443|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6747444|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6747445|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6747446|NCT02000388|Analgesics|analgesics|mesh-ancestor
6747447|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
6747448|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747449|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747450|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747451|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6747452|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6747453|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747454|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747455|NCT02000401|Ketorolac|ketorolac|mesh-list
6747456|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6747457|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6747458|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6747459|NCT02000401|Analgesics|analgesics|mesh-ancestor
6747460|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
6747461|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747462|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747463|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747464|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6747465|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6747466|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747467|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747468|NCT02000414|Daptomycin|daptomycin|mesh-list
6747469|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6747470|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747471|NCT02000596|Trastuzumab|trastuzumab|mesh-list
6747472|NCT02000596|Pertuzumab|pertuzumab|mesh-list
6747473|NCT02000596|Fulvestrant|fulvestrant|mesh-list
6747474|NCT02000596|Anastrozole|anastrozole|mesh-list
6747475|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6747476|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747477|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6747478|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6747479|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6747480|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
6747481|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747482|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747483|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6747484|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6747485|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747486|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747487|NCT02000674|Rocuronium|rocuronium|mesh-list
6747488|NCT02000674|Succinylcholine|succinylcholine|mesh-list
6747489|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6747490|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6747491|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6747492|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747493|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747494|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6747495|NCT02000700|Canagliflozin|canagliflozin|mesh-list
6747496|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6747497|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747498|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6747499|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747500|NCT02000726|Citalopram|citalopram|mesh-list
6747501|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
6747502|NCT02000726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6747503|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6747504|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6747505|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747506|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747507|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
6747508|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747509|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6747510|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6747511|NCT02000804|Darapladib|darapladib|mesh-list
6747512|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6747513|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747514|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747515|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6747516|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747517|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747518|NCT02000947|Durvalumab|durvalumab|mesh-list
6747519|NCT02000947|Tremelimumab|tremelimumab|mesh-list
6747520|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6747521|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6747522|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747523|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
6747524|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747525|NCT02001012|Chloroquine|chloroquine|mesh-list
6747526|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6747527|NCT02001012|Lumefantrine|lumefantrine|mesh-list
6747528|NCT02001012|Artemether|artemether|mesh-list
6747529|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6747530|NCT02001012|Amebicides|amebicides|mesh-ancestor
6747531|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6747532|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6747533|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747534|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
6747535|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6747536|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6747537|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6747538|NCT02001012|Analgesics|analgesics|mesh-ancestor
6747539|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
6747540|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747541|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747542|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747543|NCT02001012|Filaricides|filaricides|mesh-ancestor
6747544|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
6747545|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
6747546|NCT02001103|Memantine|memantine|mesh-list
6747547|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6747548|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6747549|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
6747550|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747551|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747552|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747553|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6747554|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6747555|NCT02001168|Docetaxel|docetaxel|mesh-list
6747556|NCT02001168|Pemetrexed|pemetrexed|mesh-list
6747557|NCT02001168|Cisplatin|cisplatin|mesh-list
6747558|NCT02001168|Endostatins|endostatins|mesh-list
6747559|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747560|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
6747561|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
6747562|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
6747563|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747564|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747565|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6747566|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6747567|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6747568|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6747569|NCT02001168|Growth Substances|growth substances|mesh-ancestor
6747570|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747571|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
6747572|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
6747573|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747574|NCT02001259|Lidocaine|lidocaine|mesh-list
6747575|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
6747576|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
6747577|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747578|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747579|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
6747580|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747581|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6747582|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6747583|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6747584|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6747585|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747586|NCT02001272|Paclitaxel|paclitaxel|mesh-list
6747587|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6747588|NCT02001272|Carboplatin|carboplatin|mesh-list
6747589|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6747590|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747591|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
6747592|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
6747593|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
6747594|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747595|NCT02001285|Remifentanil|remifentanil|mesh-list
6747596|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6747597|NCT02001285|Narcotics|narcotics|mesh-ancestor
6747598|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747599|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747600|NCT02001285|Analgesics|analgesics|mesh-ancestor
6747601|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
6747602|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747603|NCT02001298|Nitroprusside|nitroprusside|mesh-list
6747604|NCT02001298|Remifentanil|remifentanil|mesh-list
6747605|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6747606|NCT02001298|Narcotics|narcotics|mesh-ancestor
6747607|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747608|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747609|NCT02001298|Analgesics|analgesics|mesh-ancestor
6747610|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
6747611|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747612|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6747613|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
6747614|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6747615|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747616|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
6747617|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6747618|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6747619|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747620|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
6747621|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
6747622|NCT02001363|Liraglutide|liraglutide|mesh-list
6747623|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6747624|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747625|NCT02001363|Incretins|incretins|mesh-ancestor
6747626|NCT02001363|Hormones|hormones|mesh-ancestor
6747627|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747628|NCT02001428|Piperaquine|piperaquine|mesh-list
6747629|NCT02001428|Artenimol|artenimol|mesh-list
6747630|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
6747631|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6747632|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6747633|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787407|NCT02219581|Hormones|hormones|mesh-ancestor
6787408|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787409|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6787410|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787411|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
6787412|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787413|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787414|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
6787415|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
6787416|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6787417|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6787418|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787419|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787420|NCT02219646|Urological Agents|urological agents|mesh-ancestor
6787421|NCT02219659|Fentanyl|fentanyl|mesh-list
6787422|NCT02219659|Midazolam|midazolam|mesh-list
6787423|NCT02219659|Propofol|propofol|mesh-list
6787424|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6787425|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787426|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787427|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6787428|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
6787429|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
6787430|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6787431|NCT02219659|Narcotics|narcotics|mesh-ancestor
6787432|NCT02219659|Analgesics|analgesics|mesh-ancestor
6787433|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
6747634|NCT02001506|Docetaxel|docetaxel|mesh-list
6747635|NCT02001506|Epirubicin|epirubicin|mesh-list
6747636|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747637|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
6747638|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
6747639|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
6747640|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747641|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6747642|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6747643|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6747644|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747645|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
6747646|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747647|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6747648|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747649|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747650|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
6747651|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747652|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747653|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6747654|NCT02001584|Memantine|memantine|mesh-list
6747655|NCT02001584|Baclofen|baclofen|mesh-list
6747656|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6747657|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6747658|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
6747659|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747660|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747661|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747662|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6747663|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6747664|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6747665|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6747666|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747667|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6747668|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
6747669|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
6747670|NCT02001740|Lidocaine|lidocaine|mesh-list
6747671|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
6747672|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
6747673|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747674|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747675|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
6747676|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747677|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6747678|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6747679|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6747680|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6747681|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747682|NCT02001818|Interferons|interferons|mesh-list
6747683|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
6747684|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
6747685|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6747686|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
6747687|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747688|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
6747689|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747690|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
6747691|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747692|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6747693|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747694|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747695|NCT02001857|Hemostatics|hemostatics|mesh-list
6747696|NCT02001857|Coagulants|coagulants|mesh-ancestor
6747697|NCT02001883|Policosanol|policosanol|mesh-list
6747698|NCT02001883|Atorvastatin|atorvastatin|mesh-list
6747699|NCT02001883|Simvastatin|simvastatin|mesh-list
6747700|NCT02001883|Red yeast rice|red yeast rice|mesh-list
6747701|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6747702|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6747703|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
6747704|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747705|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6747706|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6747707|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747708|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6747709|NCT02001896|Gemcitabine|gemcitabine|mesh-list
6747710|NCT02001896|Carboplatin|carboplatin|mesh-list
6747711|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6747712|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747713|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6747714|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
6747715|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747716|NCT02001896|Antiviral Agents|antiviral agents|mesh-ancestor
6747717|NCT02001896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747718|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747719|NCT02001896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6747720|NCT02001896|Immunologic Factors|immunologic factors|mesh-ancestor
6747721|NCT02001896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747722|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6747723|NCT02001909|Neomycin|neomycin|mesh-list
6747724|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6747725|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747726|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6747727|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747728|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747729|NCT02001935|Theophylline|theophylline|mesh-list
6747730|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6747731|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
6747732|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747733|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747734|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6747735|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
6747736|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6747737|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747738|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747739|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
6747740|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6747741|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6747742|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
6747743|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747744|NCT02001948|Morphine|morphine|mesh-list
6747745|NCT02001948|Bupivacaine|bupivacaine|mesh-list
6747746|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
6747747|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
6747748|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747749|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747750|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
6747751|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747752|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6747753|NCT02001948|Narcotics|narcotics|mesh-ancestor
6747754|NCT02001948|Analgesics|analgesics|mesh-ancestor
6747755|NCT02001974|Paclitaxel|paclitaxel|mesh-list
6747756|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6747757|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747758|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
6747759|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
6747760|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
6747761|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747762|NCT02002000|Vitamin D|vitamin d|mesh-list
6747763|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
6747764|NCT02002000|Vitamins|vitamins|mesh-ancestor
6747765|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
6747766|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747767|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6747768|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6747769|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
6747770|NCT02002039|Hematinics|hematinics|mesh-ancestor
6747771|NCT02002065|Vaccines|vaccines|mesh-list
6747772|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
6747773|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747774|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6747775|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
6747776|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6747777|NCT02002078|Prednisolone|prednisolone|mesh-list
6747778|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
6747779|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6747780|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
6747781|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747782|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
6747783|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
6747784|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747785|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747786|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6747787|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
6747788|NCT02002078|Hormones|hormones|mesh-ancestor
6747789|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747790|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6747791|NCT02002078|Protective Agents|protective agents|mesh-ancestor
6747792|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6747793|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747794|NCT02002156|Vaccines|vaccines|mesh-list
6747795|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6747796|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
6747797|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
6747798|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747799|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6747800|NCT02002195|Leucovorin|leucovorin|mesh-list
6747801|NCT02002195|Fluorouracil|fluorouracil|mesh-list
6747802|NCT02002195|Capecitabine|capecitabine|mesh-list
6747803|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
6747804|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
6747805|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747806|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6747807|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747808|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6747809|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
6747810|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747811|NCT02002195|Antidotes|antidotes|mesh-ancestor
6747812|NCT02002195|Protective Agents|protective agents|mesh-ancestor
6747813|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
6747814|NCT02002195|Vitamins|vitamins|mesh-ancestor
6747815|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
6747816|NCT02002247|Selenium|selenium|mesh-list
6747817|NCT02002247|Selenious Acid|selenious acid|mesh-list
6747818|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
6747819|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
6747820|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747821|NCT02002247|Protective Agents|protective agents|mesh-ancestor
6747822|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747823|NCT02002247|Trace Elements|trace elements|mesh-ancestor
6747824|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
6747825|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
6747826|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6747827|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
6747828|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
6747829|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
6747830|NCT02002260|Estradiol|estradiol|mesh-list
6747831|NCT02002260|Estrogens|estrogens|mesh-ancestor
6747832|NCT02002260|Hormones|hormones|mesh-ancestor
6747833|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747834|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747835|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6747836|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6747837|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6747838|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6747839|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6747840|NCT02002286|Triptolide|triptolide|mesh-list
6747841|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6747842|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747843|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6747844|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
6747845|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6747846|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6747847|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
6747848|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6747849|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
6747850|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747851|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747852|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
6747853|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
6747854|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
6747855|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747856|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6747857|NCT02002325|Plasminogen|plasminogen|mesh-list
6747858|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6747859|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6747860|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747861|NCT02002377|Aflibercept|aflibercept|mesh-list
6747862|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6747863|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6747864|NCT02002377|Growth Substances|growth substances|mesh-ancestor
6747865|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747866|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
6747867|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747868|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6747869|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6747870|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747871|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6747872|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
6747873|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747874|NCT02002403|Danazol|danazol|mesh-list
6747875|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6747876|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
6747877|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747878|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747879|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
6747880|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
6747881|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6747882|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747883|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
6747884|NCT02002598|Dexamethasone|dexamethasone|mesh-list
6747885|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
6747886|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6747887|NCT02002598|BB 1101|bb 1101|mesh-list
6747888|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747889|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
6747890|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
6747891|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747892|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747893|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6747894|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
6747895|NCT02002598|Hormones|hormones|mesh-ancestor
6747896|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747897|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6747898|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747899|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
6747900|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6747901|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747902|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6747903|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
6747904|NCT02002611|Warfarin|warfarin|mesh-list
6747905|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
6747906|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
6747907|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6747908|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6747909|NCT02002663|Prednisolone|prednisolone|mesh-list
6747910|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
6747911|NCT02002663|Morphine|morphine|mesh-list
6747912|NCT02002663|Ropivacaine|ropivacaine|mesh-list
6747913|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6747914|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
6747915|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6747916|NCT02002663|Narcotics|narcotics|mesh-ancestor
6747917|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747918|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747919|NCT02002663|Analgesics|analgesics|mesh-ancestor
6747920|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
6747921|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747922|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
6747923|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
6747924|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747925|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
6747926|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
6747927|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6747928|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
6747929|NCT02002663|Hormones|hormones|mesh-ancestor
6747930|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747931|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6747932|NCT02002663|Protective Agents|protective agents|mesh-ancestor
6747933|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6747934|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6747935|NCT02002715|Budesonide|budesonide|mesh-list
6747936|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6747937|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6747938|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
6747939|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747940|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747941|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6747942|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
6747943|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
6747944|NCT02002715|Hormones|hormones|mesh-ancestor
6747945|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6747946|NCT02002741|Acetaminophen|acetaminophen|mesh-list
6747947|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6747948|NCT02002741|Analgesics|analgesics|mesh-ancestor
6747949|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
6747950|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747951|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747952|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
6747953|NCT02002754|Bambuterol|bambuterol|mesh-list
6747954|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6747955|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
6747956|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747957|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747958|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6747959|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
6747960|NCT02002806|Ethanol|ethanol|mesh-list
6747961|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6747962|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6747963|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6747964|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747965|NCT02002819|Levetiracetam|levetiracetam|mesh-list
6747966|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
6747967|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
6747968|NCT02002858|Nicotine|nicotine|mesh-list
6747969|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6747970|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
6747971|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747972|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747973|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6747974|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6747975|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
6747976|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747977|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747978|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
6747979|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6747980|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6747981|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747982|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
6747983|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747984|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747985|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
6747986|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6747987|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6747988|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6747989|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6747990|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6747991|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
6747992|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6747993|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6747994|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6747995|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6747996|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
6747997|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6747998|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6747999|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748000|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
6748001|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748002|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787434|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787435|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6787436|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6787437|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6787438|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6787439|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
6787440|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
6787441|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787442|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787443|NCT02219672|Ritonavir|ritonavir|mesh-list
6787444|NCT02219672|Lopinavir|lopinavir|mesh-list
6787445|NCT02219672|Tenofovir|tenofovir|mesh-list
6787446|NCT02219672|Lamivudine|lamivudine|mesh-list
6748003|NCT02003144|Eculizumab|eculizumab|mesh-list
6748004|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6748005|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6748006|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
6748007|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748008|NCT02003209|Carboplatin|carboplatin|mesh-list
6748009|NCT02003209|Docetaxel|docetaxel|mesh-list
6748010|NCT02003209|Trastuzumab|trastuzumab|mesh-list
6748011|NCT02003209|Goserelin|goserelin|mesh-list
6748012|NCT02003209|Pertuzumab|pertuzumab|mesh-list
6748013|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6748014|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6748015|NCT02003209|Antibodies|antibodies|mesh-list
6748016|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
6748017|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6748018|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
6748019|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
6748020|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748021|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748022|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
6748023|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
6748024|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
6748025|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748026|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6748027|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6748028|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748029|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6748030|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
6748031|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6748032|NCT02003313|Vaccines|vaccines|mesh-list
6748033|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
6748034|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748035|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6748036|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6748037|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748038|NCT02003495|Vaccines|vaccines|mesh-list
6748039|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
6748040|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748041|NCT02003664|Baclofen|baclofen|mesh-list
6748042|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6748043|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748044|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6748045|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748046|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6748047|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
6748048|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
6748049|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748050|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748051|NCT02003677|Insulin|insulin|mesh-list
6748052|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6748053|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
6748054|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
6748055|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6748056|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6748057|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748058|NCT02003742|Tamsulosin|tamsulosin|mesh-list
6748059|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6748060|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6748061|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6748062|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
6748063|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748064|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748065|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748066|NCT02003742|Urological Agents|urological agents|mesh-ancestor
6748067|NCT02003768|Propofol|propofol|mesh-list
6748068|NCT02003768|Desflurane|desflurane|mesh-list
6748069|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6748070|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748071|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748072|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6748073|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
6748074|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
6242780|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
6748075|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6748076|NCT02003885|Desflurane|desflurane|mesh-list
6748077|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6748078|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
6748079|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
6748080|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748081|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748082|NCT02004067|Cyclosporine|cyclosporine|mesh-list
6748083|NCT02004067|Castor Oil|castor oil|mesh-list
6748084|NCT02004067|Cyclosporins|cyclosporins|mesh-list
6748085|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748086|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748087|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6748088|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
6748089|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748090|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
6748091|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748092|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
6748093|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6748094|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6748095|NCT02004067|Cathartics|cathartics|mesh-ancestor
6748096|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6748097|NCT02004171|Nicotine|nicotine|mesh-list
6748098|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6748099|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
6748100|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748101|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748102|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6748103|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6748104|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
6748105|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748106|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748107|NCT02004184|Pemetrexed|pemetrexed|mesh-list
6748108|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748109|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748110|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748111|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6748112|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6748113|NCT02004197|Amoxicillin|amoxicillin|mesh-list
6748114|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
6748115|NCT02004197|Bismuth|bismuth|mesh-list
6748116|NCT02004197|Ranitidine|ranitidine|mesh-list
6748117|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6748118|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748119|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6748120|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748121|NCT02004197|Antacids|antacids|mesh-ancestor
6748122|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6748123|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6748124|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6748125|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
6748126|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
6748127|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748128|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748129|NCT02004301|Diclofenac|diclofenac|mesh-list
6748130|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6748131|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6748132|NCT02004301|Analgesics|analgesics|mesh-ancestor
6748133|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
6748134|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748135|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748136|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6748137|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6748138|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6748139|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748140|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748141|NCT02004314|Chloroquine|chloroquine|mesh-list
6748142|NCT02004314|Amebicides|amebicides|mesh-ancestor
6748143|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6748144|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6748145|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748146|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
6748147|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6748148|NCT02004418|Choline|choline|mesh-list
6748149|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
6748150|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6748151|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
6748152|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748153|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6748154|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6748155|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
6748156|NCT02004509|Anticoagulants|anticoagulants|mesh-list
6748157|NCT02004574|Betamethasone|betamethasone|mesh-list
6748158|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
6748159|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6748160|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
6748161|NCT02004574|Calcipotriene|calcipotriene|mesh-list
6748162|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6748163|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6748164|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
6748165|NCT02004574|Hormones|hormones|mesh-ancestor
6748166|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6748167|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748168|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6748169|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
6748170|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
6748171|NCT02004652|Prucalopride|prucalopride|mesh-list
6748172|NCT02004652|Laxatives|laxatives|mesh-ancestor
6748173|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6748174|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6748175|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6748176|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
6748177|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748178|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748179|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748180|NCT02004769|Docetaxel|docetaxel|mesh-list
6748181|NCT02004769|Capecitabine|capecitabine|mesh-list
6748182|NCT02004769|Trastuzumab|trastuzumab|mesh-list
6748183|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748184|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
6748185|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
6748186|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
6748187|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748188|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6748189|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
6748190|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6787447|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
6787448|NCT02219672|Triptolide|triptolide|mesh-list
6787449|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6787450|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6787451|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
6787452|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787453|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787454|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6787455|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6787456|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
6787457|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787458|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6787459|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6787460|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6787461|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6787462|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6787463|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6787464|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6787465|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787466|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6787467|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
6787468|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6787469|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6787470|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
6787471|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6787472|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
6787473|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787474|NCT02219698|Acetaminophen|acetaminophen|mesh-list
6787475|NCT02219698|Ibuprofen|ibuprofen|mesh-list
6787476|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6787477|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6787478|NCT02219698|Analgesics|analgesics|mesh-ancestor
6787479|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
6787480|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787481|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787482|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6787483|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6787484|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6787485|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787486|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787487|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
6787488|NCT02219737|Rituximab|rituximab|mesh-list
6787489|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6787490|NCT02219737|Carboplatin|carboplatin|mesh-list
6787491|NCT02219737|Etoposide|etoposide|mesh-list
6787492|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
6787493|NCT02219737|Ifosfamide|ifosfamide|mesh-list
6787494|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
6787495|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
6748191|NCT02004782|Prednisolone|prednisolone|mesh-list
6748192|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6748193|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
6748194|NCT02004782|Hormones|hormones|mesh-ancestor
6748195|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6748196|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748197|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6748198|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748199|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
6748200|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
6748201|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
6748202|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748203|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748204|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
6748205|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748206|NCT02004860|Ciclopirox|ciclopirox|mesh-list
6748207|NCT02004860|Tacrolimus|tacrolimus|mesh-list
6748208|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6748209|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
6748210|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748211|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6748212|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748213|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748214|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
6748215|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748216|NCT02004899|Fentanyl|fentanyl|mesh-list
6748217|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6748218|NCT02004899|Narcotics|narcotics|mesh-ancestor
6748219|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748220|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748221|NCT02004899|Analgesics|analgesics|mesh-ancestor
6748222|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
6748223|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748224|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6748225|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6748226|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
6748227|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
6748228|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6748229|NCT02005068|Cephalosporins|cephalosporins|mesh-list
6748230|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6748231|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748232|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6748233|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6748234|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6748235|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6748236|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748237|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748238|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748239|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6748240|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
6748241|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6748242|NCT02005120|Bevacizumab|bevacizumab|mesh-list
6748243|NCT02005120|Endostatins|endostatins|mesh-list
6748244|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6748245|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748246|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6748247|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6748248|NCT02005120|Growth Substances|growth substances|mesh-ancestor
6748249|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748250|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
6748251|NCT02005289|Lenalidomide|lenalidomide|mesh-list
6748252|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
6748253|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748254|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6748255|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6748256|NCT02005289|Growth Substances|growth substances|mesh-ancestor
6748257|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
6748258|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748259|NCT02005302|Vitamin D|vitamin d|mesh-list
6748260|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
6748261|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
6748262|NCT02005302|Vitamins|vitamins|mesh-list
6748263|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
6748264|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748265|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6748266|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6748267|NCT02005315|Gemcitabine|gemcitabine|mesh-list
6748268|NCT02005315|Paclitaxel|paclitaxel|mesh-list
6748269|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6748270|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748271|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
6748272|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
6748273|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
6748274|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748275|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6748276|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
6748277|NCT02005315|Antiviral Agents|antiviral agents|mesh-ancestor
6748278|NCT02005315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748279|NCT02005315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748280|NCT02005315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6748281|NCT02005315|Immunologic Factors|immunologic factors|mesh-ancestor
6748282|NCT02005315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748283|NCT02005419|Metformin|metformin|mesh-list
6748284|NCT02005419|Gemcitabine|gemcitabine|mesh-list
6748285|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6748286|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
6748287|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748288|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748289|NCT02005419|Antiviral Agents|antiviral agents|mesh-ancestor
6748290|NCT02005419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748291|NCT02005419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748292|NCT02005419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6748293|NCT02005419|Immunologic Factors|immunologic factors|mesh-ancestor
6748294|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748295|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6748296|NCT02005523|RNS60|rns60|mesh-list
6748297|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6748298|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6748299|NCT02005523|Analgesics|analgesics|mesh-ancestor
6748300|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
6748301|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748302|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748303|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6748304|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6748305|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6748306|NCT02005575|Dexamethasone|dexamethasone|mesh-list
6748307|NCT02005575|Bupivacaine|bupivacaine|mesh-list
6748308|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6748309|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
6748310|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
6748311|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748312|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748313|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6748314|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
6748315|NCT02005575|Hormones|hormones|mesh-ancestor
6748316|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6748317|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6748318|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748319|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
6748320|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
6748321|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748322|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
6748323|NCT02005588|Iron|iron|mesh-list
6748324|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
6748325|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
6748326|NCT02005588|Trace Elements|trace elements|mesh-ancestor
6748327|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
6748328|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748329|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
6748330|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
6748331|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748332|NCT02005653|Doxycycline|doxycycline|mesh-list
6748333|NCT02005653|Albendazole|albendazole|mesh-list
6748334|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
6748335|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6748336|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748337|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
6748338|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6748339|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6748340|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
6748341|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
6787496|NCT02219737|Antibodies|antibodies|mesh-list
6748342|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6748343|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
6748344|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
6748345|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
6748346|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748347|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748348|NCT02005653|Filaricides|filaricides|mesh-ancestor
6748349|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
6748350|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6748351|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748352|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
6748353|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6748354|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748355|NCT02005718|Vitamins|vitamins|mesh-ancestor
6748356|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
6748357|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6748358|NCT02005757|Mizoribine|mizoribine|mesh-list
6748359|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6748360|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6748361|NCT02005757|Analgesics|analgesics|mesh-ancestor
6748362|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
6748363|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748364|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748365|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6748366|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6748367|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6748368|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748369|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6748370|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748371|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
6748372|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6748373|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6748374|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748375|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748376|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6748377|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
6748378|NCT02005770|Propofol|propofol|mesh-list
6748379|NCT02005770|Sevoflurane|sevoflurane|mesh-list
6748380|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6748381|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748382|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748383|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6748384|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
6748385|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
6748386|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6748387|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6748388|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
6748389|NCT02005783|Docetaxel|docetaxel|mesh-list
6748390|NCT02005783|Epirubicin|epirubicin|mesh-list
6748391|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6748392|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
6748393|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748394|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6748395|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6748396|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
6748397|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748398|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748399|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6748400|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
6748401|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
6748402|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
6748403|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6748404|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6748405|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6748406|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748407|NCT02005822|Valganciclovir|valganciclovir|mesh-list
6748408|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
6748409|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748410|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6748411|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
6748412|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
6748413|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6748414|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6748415|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748416|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748417|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6748418|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748419|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6748420|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748421|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748422|NCT02006173|Lidocaine|lidocaine|mesh-list
6748423|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
6748424|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
6748425|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748426|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748427|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
6748428|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748429|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6748430|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6748431|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6748432|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6748433|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748434|NCT02006225|Plerixafor|plerixafor|mesh-list
6748435|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6748436|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6748437|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
6748438|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748439|NCT02006277|Crizotinib|crizotinib|mesh-list
6748440|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6748441|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748442|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6748443|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748444|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748445|NCT02006355|Ropivacaine|ropivacaine|mesh-list
6748446|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
6748447|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
6748448|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748449|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748450|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
6748451|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748452|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6748453|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6748454|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6748455|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
6748456|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748457|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748458|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
6748459|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748460|NCT02006498|Silymarin|silymarin|mesh-list
6748461|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
6748462|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748463|NCT02006498|Protective Agents|protective agents|mesh-ancestor
6748464|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787497|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
6787498|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6787499|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
6787500|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787501|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787502|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6787503|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6787504|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6787505|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6787506|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787507|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787508|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6787509|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
6787510|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
6787511|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
6787512|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
6787513|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
6787514|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
6787515|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
6787516|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6787517|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787518|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
6787519|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6787520|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6787521|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6787522|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787523|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
6787524|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
6787525|NCT02219789|Fulvestrant|fulvestrant|mesh-list
6787526|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6787527|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787528|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6787529|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6787530|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
6748465|NCT02006589|Candesartan|candesartan|mesh-list
6748466|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
6748467|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6748468|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6748469|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6748470|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748471|NCT02006602|Candesartan|candesartan|mesh-list
6748472|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
6748473|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6748474|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6748475|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6748476|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748477|NCT02006745|Ribavirin|ribavirin|mesh-list
6748478|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
6748479|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748480|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
6748481|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748482|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6748483|NCT02006849|Hormones|hormones|mesh-ancestor
6748484|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6748485|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748486|NCT02006914|Chromium|chromium|mesh-list
6748487|NCT02006914|Picolinic acid|picolinic acid|mesh-list
6748488|NCT02006914|Trace Elements|trace elements|mesh-ancestor
6748489|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
6748490|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748491|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6748492|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
6748493|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
6748494|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748495|NCT02006966|Lidocaine|lidocaine|mesh-list
6748496|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
6748497|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
6748498|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748499|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748500|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
6748501|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748502|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6748503|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6748504|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6748505|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6748506|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748507|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
6748508|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748509|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6748510|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6748511|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
6748512|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748513|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
6748514|NCT02007122|Cephalosporins|cephalosporins|mesh-list
6748515|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6748516|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748517|NCT02007148|Docetaxel|docetaxel|mesh-list
6748518|NCT02007148|Capecitabine|capecitabine|mesh-list
6748519|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748520|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
6748521|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
6748522|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
6748523|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748524|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6748525|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
6748526|NCT02007161|Diclofenac|diclofenac|mesh-list
6748527|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6748528|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6748529|NCT02007161|Analgesics|analgesics|mesh-ancestor
6748530|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
6748531|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748532|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748533|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6748534|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6748535|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6748536|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748537|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748538|NCT02007174|Bevacizumab|bevacizumab|mesh-list
6748539|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6748540|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748541|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6748542|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6748543|NCT02007174|Growth Substances|growth substances|mesh-ancestor
6748544|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748545|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
6748546|NCT02007330|Lidocaine|lidocaine|mesh-list
6748547|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
6748548|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
6748549|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748550|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748551|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
6748552|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748553|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6748554|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6748555|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6748556|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6748557|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748558|NCT02007408|Lidocaine|lidocaine|mesh-list
6748559|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
6748560|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
6748561|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748562|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748563|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
6748564|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748565|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6748566|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6748567|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6748568|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6748569|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748570|NCT02007447|Oxytocin|oxytocin|mesh-list
6748571|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
6748572|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6748573|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748574|NCT02007603|Amoxicillin|amoxicillin|mesh-list
6748575|NCT02007603|Ampicillin|ampicillin|mesh-list
6748576|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
6748577|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
6748578|NCT02007603|Sulbactam|sulbactam|mesh-list
6748579|NCT02007603|Sultamicillin|sultamicillin|mesh-list
6748580|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6748581|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748582|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748583|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748584|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6748585|NCT02007629|Riociguat|riociguat|mesh-list
6748586|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
6748587|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748588|NCT02007655|Apixaban|apixaban|mesh-list
6748589|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6748590|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
6748591|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6748592|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
6748593|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748594|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748595|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
6748596|NCT02007746|Liver Extracts|liver extracts|mesh-list
6748597|NCT02007746|Hematinics|hematinics|mesh-ancestor
6748598|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
6748599|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6748600|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748601|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748602|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6748603|NCT02007798|Analgesics|analgesics|mesh-ancestor
6748604|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
6748605|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748606|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6748607|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6748608|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6748609|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
6748610|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748611|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748612|NCT02007837|Aspirin|aspirin|mesh-list
6748613|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6748614|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6748615|NCT02007837|Analgesics|analgesics|mesh-ancestor
6748616|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
6748617|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748618|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748619|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6748620|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6748621|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6748622|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6748623|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748624|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6748625|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6748626|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748627|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
6748628|NCT02007850|Ropivacaine|ropivacaine|mesh-list
6748629|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
6748630|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
6748631|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748632|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748633|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
6748634|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748635|NCT02007915|Pamidronate|pamidronate|mesh-list
6748636|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6748637|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748638|NCT02007928|Olanzapine|olanzapine|mesh-list
6748639|NCT02007928|Risperidone|risperidone|mesh-list
6748640|NCT02007928|Aripiprazole|aripiprazole|mesh-list
6748641|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6748642|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
6748643|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748644|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748645|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748646|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6748647|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6748648|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748649|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6748650|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6748651|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
6748652|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
6748653|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
6748654|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748655|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6748656|NCT02007928|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6748657|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6748658|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6748659|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
6748660|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
6748661|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6748662|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6748663|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6748664|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6748665|NCT02008006|Cytarabine|cytarabine|mesh-list
6748666|NCT02008006|Etoposide|etoposide|mesh-list
6748667|NCT02008006|Melphalan|melphalan|mesh-list
6748668|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6748669|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6748670|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748671|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6748672|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6748673|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748674|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748675|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6748676|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
6748677|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
6748678|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748679|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6748680|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
6748681|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748682|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6748683|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
6748684|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6748685|NCT02008019|Everolimus|everolimus|mesh-list
6748686|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748687|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6748688|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
6748689|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748690|NCT02008123|Primidone|primidone|mesh-list
6748691|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
6748692|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
6748693|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
6748694|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748695|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748696|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748697|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
6748698|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6748699|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6748700|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748701|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
6748702|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748703|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748704|NCT02008162|Bromides|bromides|mesh-list
6748705|NCT02008162|Albuterol|albuterol|mesh-list
6748706|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
6748707|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
6748708|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
6748709|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748710|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748711|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6748712|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
6748713|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
6748714|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6748715|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
6748716|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748717|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748718|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
6748719|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
6748720|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6748721|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6748722|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6748723|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6748724|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
6748725|NCT02008201|Vitamin D|vitamin d|mesh-list
6748726|NCT02008201|Vitamins|vitamins|mesh-ancestor
6748727|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
6748728|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748729|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6748730|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
6748731|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6748732|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748733|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748734|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6748735|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6748736|NCT02008214|Protective Agents|protective agents|mesh-ancestor
6748737|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748738|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
6748739|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6748740|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
6787531|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787532|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787533|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6787534|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6787535|NCT02219867|Ketamine|ketamine|mesh-list
6787536|NCT02219867|Analgesics|analgesics|mesh-ancestor
6787537|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
6787538|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787539|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787540|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6787541|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6787542|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
6787543|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
6787544|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787545|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6787546|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6787547|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787548|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787549|NCT02219893|Immunotoxins|immunotoxins|mesh-list
6787550|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
6787551|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787552|NCT02219906|Resveratrol|resveratrol|mesh-list
6787553|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
6787554|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787555|NCT02219906|Protective Agents|protective agents|mesh-ancestor
6787556|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787557|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787558|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6787559|NCT02219984|Anticoagulants|anticoagulants|mesh-list
6787560|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
6787561|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6787562|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
6787563|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787564|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787565|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6787566|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
6787567|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6787568|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
6787569|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748741|NCT02008292|Physostigmine|physostigmine|mesh-list
6748742|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6748743|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748744|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748745|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
6748746|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748747|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748748|NCT02008292|Miotics|miotics|mesh-ancestor
6748749|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
6748750|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748751|NCT02008383|Panitumumab|panitumumab|mesh-list
6748752|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6748753|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748754|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
6748755|NCT02008422|Tegafur|tegafur|mesh-list
6748756|NCT02008422|Endostar protein|endostar protein|mesh-list
6748757|NCT02008422|Endostatins|endostatins|mesh-list
6748758|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748759|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6748760|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
6748761|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748762|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6748763|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6748764|NCT02008422|Growth Substances|growth substances|mesh-ancestor
6748765|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748766|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
6748767|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
6748768|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6748769|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6748770|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748771|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
6748772|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748773|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748774|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
6748775|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6748776|NCT02008578|Antibodies|antibodies|mesh-list
6748777|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
6748778|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748779|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
6748780|NCT02008721|Protective Agents|protective agents|mesh-ancestor
6748781|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748782|NCT02008734|Palbociclib|palbociclib|mesh-list
6748783|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748784|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6748785|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748786|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748787|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
6748788|NCT02008747|Analgesics|analgesics|mesh-ancestor
6748789|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
6748790|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748791|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748792|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
6748793|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748794|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6748795|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
6748796|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6748797|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6748798|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748799|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6748800|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
6748801|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6748802|NCT02008786|Ramipril|ramipril|mesh-list
6748803|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6748804|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6748805|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6748806|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
6748807|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748808|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6748809|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6748810|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748811|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6748812|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
6748813|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6748814|NCT02008968|Allopurinol|allopurinol|mesh-list
6748815|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
6748816|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748817|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748818|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
6748819|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6748820|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6748821|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
6748822|NCT02008968|Protective Agents|protective agents|mesh-ancestor
6748823|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748824|NCT02008981|Aspirin|aspirin|mesh-list
6748825|NCT02008981|Turmeric extract|turmeric extract|mesh-list
6748826|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6748827|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6748828|NCT02008981|Analgesics|analgesics|mesh-ancestor
6748829|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
6748830|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748831|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748832|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6748833|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6748834|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6748835|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6748836|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748837|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6748838|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6748839|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748840|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
6748841|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
6748842|NCT02008981|Protective Agents|protective agents|mesh-ancestor
6748843|NCT02009007|Phenylephrine|phenylephrine|mesh-list
6748844|NCT02009007|Dopamine|dopamine|mesh-list
6748845|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
6748846|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6748847|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
6748848|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
6748849|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748850|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748851|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
6748852|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6748853|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
6748854|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
6748855|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6748856|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6748857|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6748858|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
6748859|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748860|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748861|NCT02009007|Protective Agents|protective agents|mesh-ancestor
6748862|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
6748863|NCT02009098|Cefuroxime|cefuroxime|mesh-list
6748864|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
6748865|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6748866|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748867|NCT02009189|Taurolidine|taurolidine|mesh-list
6748868|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748869|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6748870|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748871|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
6748872|NCT02009202|Cathartics|cathartics|mesh-ancestor
6748873|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6748874|NCT02009215|Piperaquine|piperaquine|mesh-list
6748875|NCT02009215|Artenimol|artenimol|mesh-list
6748876|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
6748877|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6748878|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6748879|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748880|NCT02009280|Anesthetics|anesthetics|mesh-list
6748881|NCT02009280|Propofol|propofol|mesh-list
6748882|NCT02009280|Sevoflurane|sevoflurane|mesh-list
6748883|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748884|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748885|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6748886|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6748887|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
6748888|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6748889|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6748890|NCT02009306|Fentanyl|fentanyl|mesh-list
6748891|NCT02009306|Midazolam|midazolam|mesh-list
6748892|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6748893|NCT02009306|Narcotics|narcotics|mesh-ancestor
6748894|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6748895|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748896|NCT02009306|Analgesics|analgesics|mesh-ancestor
6748897|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
6748898|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748899|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6748900|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6748901|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
6748902|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
6748903|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6748904|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6748905|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6748906|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6748907|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
6748908|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
6748909|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748910|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748911|NCT02009410|Pancrelipase|pancrelipase|mesh-list
6748912|NCT02009410|Pancreatin|pancreatin|mesh-list
6748913|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6748914|NCT02009436|Azacitidine|azacitidine|mesh-list
6748915|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6748916|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
6748917|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748918|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748919|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748920|NCT02009449|Leucovorin|leucovorin|mesh-list
6748921|NCT02009449|Gemcitabine|gemcitabine|mesh-list
6748922|NCT02009449|Paclitaxel|paclitaxel|mesh-list
6748923|NCT02009449|Docetaxel|docetaxel|mesh-list
6748924|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6748925|NCT02009449|Carboplatin|carboplatin|mesh-list
6748926|NCT02009449|Fluorouracil|fluorouracil|mesh-list
6748927|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
6748928|NCT02009449|Capecitabine|capecitabine|mesh-list
6748929|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
6748930|NCT02009449|Nivolumab|nivolumab|mesh-list
6748931|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
6748932|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6748933|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748934|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
6748935|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
6748936|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
6748937|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748938|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6748939|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
6748940|NCT02009449|Antiviral Agents|antiviral agents|mesh-ancestor
6748941|NCT02009449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748942|NCT02009449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748943|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6748944|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
6748945|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748946|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6748947|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6748948|NCT02009449|Antidotes|antidotes|mesh-ancestor
6748949|NCT02009449|Protective Agents|protective agents|mesh-ancestor
6748950|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
6748951|NCT02009449|Vitamins|vitamins|mesh-ancestor
6748952|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
6748953|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
6748954|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
6748955|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6748956|NCT02009462|Protective Agents|protective agents|mesh-ancestor
6748957|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748958|NCT02009488|Canagliflozin|canagliflozin|mesh-list
6748959|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6748960|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748961|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6748962|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748963|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
6748964|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
6748965|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6748966|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
6748967|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6748968|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6748969|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6748970|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6748971|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748972|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
6748973|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6748974|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6748975|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6748976|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6748977|NCT02009579|Nintedanib|nintedanib|mesh-list
6748978|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748979|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6748980|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748981|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748982|NCT02009592|Rifaximin|rifaximin|mesh-list
6748983|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6748984|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748985|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6748986|NCT02009618|Rifaximin|rifaximin|mesh-list
6748987|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6748988|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6748989|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6748990|NCT02009631|Veliparib|veliparib|mesh-list
6748991|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6748992|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6748993|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6748994|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6748995|NCT02009709|Riboflavin|riboflavin|mesh-list
6748996|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6748997|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6748998|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
6748999|NCT02009709|Vitamins|vitamins|mesh-ancestor
6749000|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
6749001|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749002|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6749003|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
6749004|NCT02009748|Vitamin D|vitamin d|mesh-list
6749005|NCT02009748|Vitamins|vitamins|mesh-ancestor
6749006|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
6749007|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749008|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6749009|NCT02009787|Vitamin D|vitamin d|mesh-list
6749010|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
6749011|NCT02009787|Vitamins|vitamins|mesh-ancestor
6749012|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
6749013|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749014|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6749015|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6749016|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6749017|NCT02009943|Hematinics|hematinics|mesh-ancestor
6787570|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787571|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6787572|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
6787573|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
6787574|NCT02220023|Protective Agents|protective agents|mesh-ancestor
6787575|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
6787576|NCT02220036|Antacids|antacids|mesh-ancestor
6787577|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242781|NCT02655653|Coagulants|coagulants|mesh-ancestor
6787578|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787579|NCT02220049|Bortezomib|bortezomib|mesh-list
6749018|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
6749019|NCT02010164|Ubiquinone|ubiquinone|mesh-list
6749020|NCT02010164|Vitamins|vitamins|mesh-ancestor
6749021|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
6749022|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749023|NCT02010372|Vaccines|vaccines|mesh-list
6749024|NCT02010372|Immunologic Factors|immunologic factors|mesh-ancestor
6749025|NCT02010372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749026|NCT02010385|Octreotide|octreotide|mesh-list
6749027|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6749028|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6749029|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749030|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6749031|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6749032|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6749033|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
6749034|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749035|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749036|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
6749037|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6749038|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6749039|NCT02010723|Polidocanol|polidocanol|mesh-list
6749040|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6749041|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6749042|NCT02010762|Vitamin D|vitamin d|mesh-list
6749043|NCT02010762|Vitamins|vitamins|mesh-ancestor
6749044|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
6749045|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749046|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6749047|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
6749048|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6749049|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6749050|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6749051|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6749052|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749053|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
6749054|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749055|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749056|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6749057|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749058|NCT02010827|Glucagon|glucagon|mesh-list
6749059|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6749060|NCT02010827|Hormones|hormones|mesh-ancestor
6749061|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6749062|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749063|NCT02010905|Losartan|losartan|mesh-list
6749064|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6749065|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6749066|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6749067|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6749068|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749069|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
6749070|NCT02010944|Mirabegron|mirabegron|mesh-list
6749071|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6749072|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6749073|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
6749074|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749075|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749076|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749077|NCT02010944|Urological Agents|urological agents|mesh-ancestor
6749078|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6749079|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6749080|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6749081|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
6749082|NCT02010957|Etomidate|etomidate|mesh-list
6749083|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6749084|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749085|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749086|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6749087|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
6749088|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
6749089|NCT02010970|Itraconazole|itraconazole|mesh-list
6749090|NCT02010970|Diltiazem|diltiazem|mesh-list
6749091|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
6749092|NCT02010970|Midazolam|midazolam|mesh-list
6749093|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6749094|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749095|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6749096|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6749097|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749098|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6749099|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6749100|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6749101|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6749102|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
6749103|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
6749104|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
6749105|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
6749106|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749107|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749108|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
6749109|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749110|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6749111|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6749112|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749113|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6749114|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
6749115|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6749116|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6749117|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6749118|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6749119|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
6749120|NCT02011126|Imetelstat|imetelstat|mesh-list
6749121|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
6749122|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749123|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749124|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6749125|NCT02011191|Biotin|biotin|mesh-list
6749126|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
6749127|NCT02011191|Vitamins|vitamins|mesh-ancestor
6749128|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
6749129|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749130|NCT02011321|Clevidipine|clevidipine|mesh-list
6749131|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6749132|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6749133|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749134|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6749135|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749136|NCT02011347|Ketamine|ketamine|mesh-list
6749137|NCT02011347|Analgesics|analgesics|mesh-ancestor
6749138|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
6749139|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749140|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749141|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6749142|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6749143|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
6749144|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
6749145|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749146|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6749147|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6749148|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749149|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787580|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787581|NCT02220088|Leucovorin|leucovorin|mesh-list
6787582|NCT02220088|Fluorouracil|fluorouracil|mesh-list
6787583|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
6787584|NCT02220088|Sorafenib|sorafenib|mesh-list
6787585|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
6787586|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787587|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6787588|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787589|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6787590|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
6787591|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787592|NCT02220088|Antidotes|antidotes|mesh-ancestor
6787593|NCT02220088|Protective Agents|protective agents|mesh-ancestor
6787594|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
6787595|NCT02220088|Vitamins|vitamins|mesh-ancestor
6787596|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
6787597|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6242782|NCT02655679|Ether|ether|mesh-list
6749150|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
6749151|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6749152|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749153|NCT02011620|Isosorbide|isosorbide|mesh-list
6749154|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6749155|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6749156|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6749157|NCT02011620|Diuretics|diuretics|mesh-ancestor
6749158|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
6749159|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749160|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
6749161|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6749162|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749163|NCT02011633|Metformin|metformin|mesh-list
6749164|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6749165|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6749166|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749167|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6749168|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6749169|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
6749170|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749171|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6749172|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6749173|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749174|NCT02011659|Ramosetron|ramosetron|mesh-list
6749175|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
6749176|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
6749177|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749178|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749179|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6749180|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6749181|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
6749182|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749183|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749184|NCT02011737|Naftopidil|naftopidil|mesh-list
6749185|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6749186|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6749187|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
6749188|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749189|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749190|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749191|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6749192|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6749193|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6749194|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6749195|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6749196|NCT02011750|Valproic Acid|valproic acid|mesh-list
6749197|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
6749198|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749199|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749200|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
6749201|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749202|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749203|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
6749204|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6749205|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749206|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6749207|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
6749208|NCT02011828|Vitamin D|vitamin d|mesh-list
6749209|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6749210|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749211|NCT02011828|Vitamins|vitamins|mesh-ancestor
6749212|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
6749213|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6749214|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
6749215|NCT02011841|Rifaximin|rifaximin|mesh-list
6749216|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6749217|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749218|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6749219|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6749220|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749221|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749222|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749223|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6787598|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749224|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6749225|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6749226|NCT02011880|Corylifolin|corylifolin|mesh-list
6749227|NCT02011880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6749228|NCT02011880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749229|NCT02011880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749230|NCT02011880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6749231|NCT02011880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6749232|NCT02011880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749233|NCT02011906|Vitamins|vitamins|mesh-list
6749234|NCT02011906|Vitamin E|vitamin e|mesh-list
6749235|NCT02011906|Tocopherols|tocopherols|mesh-list
6749236|NCT02011906|Tocotrienols|tocotrienols|mesh-list
6749237|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
6749238|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
6749239|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749240|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
6749241|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749242|NCT02011906|Protective Agents|protective agents|mesh-ancestor
6749243|NCT02011958|Amphotericin B|amphotericin b|mesh-list
6749244|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6749245|NCT02011958|Miltefosine|miltefosine|mesh-list
6749246|NCT02011958|Amebicides|amebicides|mesh-ancestor
6749247|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6749248|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6749249|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749250|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6749251|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
6749252|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749253|NCT02011971|Vinpocetine|vinpocetine|mesh-list
6749254|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6749255|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749256|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749257|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
6749258|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6749259|NCT02011971|Protective Agents|protective agents|mesh-ancestor
6749260|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749261|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
6749262|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6749263|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6749264|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
6749265|NCT02012049|Risperidone|risperidone|mesh-list
6749266|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6749267|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
6749268|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749269|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749270|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749271|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6749272|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6749273|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749274|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6749275|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6749276|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
6749277|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
6749278|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749279|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6749280|NCT02012075|Metoprolol|metoprolol|mesh-list
6749281|NCT02012075|Carvedilol|carvedilol|mesh-list
6749282|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6749283|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6749284|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
6749285|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
6749286|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749287|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749288|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6749289|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6749290|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6749291|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
6749292|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749293|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749294|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
6749295|NCT02012075|Protective Agents|protective agents|mesh-ancestor
6749296|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6749297|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6749298|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6749299|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
6749300|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6749301|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6749302|NCT02012088|Prednisone|prednisone|mesh-list
6749303|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
6749304|NCT02012088|Rituximab|rituximab|mesh-list
6749305|NCT02012088|Doxorubicin|doxorubicin|mesh-list
6749306|NCT02012088|Vincristine|vincristine|mesh-list
6749307|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6749308|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
6749309|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749310|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6749311|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6749312|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
6749313|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749314|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749315|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6749316|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6749317|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6749318|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6749319|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6749320|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749321|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6749322|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
6749323|NCT02012088|Hormones|hormones|mesh-ancestor
6749324|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6749325|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6749326|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6749327|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
6749328|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6749329|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
6749330|NCT02012114|Cysteamine|cysteamine|mesh-list
6749331|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6749332|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749333|NCT02012140|Ticagrelor|ticagrelor|mesh-list
6749334|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6749335|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6749336|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6749337|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6749338|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
6749339|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749340|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749341|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749342|NCT02012166|Insulin|insulin|mesh-list
6749343|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6749344|NCT02012166|Octreotide|octreotide|mesh-list
6749345|NCT02012166|Glucagon|glucagon|mesh-list
6749346|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6749347|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749348|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6749349|NCT02012166|Hormones|hormones|mesh-ancestor
6749350|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6749351|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6749352|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749353|NCT02012244|Fentanyl|fentanyl|mesh-list
6749354|NCT02012244|Anesthetics|anesthetics|mesh-list
6749355|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
6749356|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6749357|NCT02012244|Narcotics|narcotics|mesh-ancestor
6749358|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749359|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749360|NCT02012244|Analgesics|analgesics|mesh-ancestor
6749361|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
6749362|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749363|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6749364|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6749365|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
6749366|NCT02012296|Mifepristone|mifepristone|mesh-list
6749367|NCT02012296|Androgens|androgens|mesh-list
6749368|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6749369|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
6749370|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6749371|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749372|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6749373|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6749374|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6749375|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
6749376|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6749377|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6749378|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
6749379|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6749380|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
6749381|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6749382|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6749383|NCT02012296|Hormones|hormones|mesh-ancestor
6749384|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6749385|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
6749386|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749387|NCT02012322|Ubiquinone|ubiquinone|mesh-list
6749388|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
6749389|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
6749390|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749391|NCT02012322|Vitamins|vitamins|mesh-ancestor
6749392|NCT02012335|Ketamine|ketamine|mesh-list
6749393|NCT02012335|Analgesics|analgesics|mesh-ancestor
6749394|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
6749395|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749396|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749397|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6749398|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6749399|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
6749400|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
6787599|NCT02220114|Vigabatrin|vigabatrin|mesh-list
6749401|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749402|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6749403|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6749404|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749405|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749406|NCT02012387|Omalizumab|omalizumab|mesh-list
6749407|NCT02012387|Vaccines|vaccines|mesh-list
6749408|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6749409|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
6749410|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749411|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6749412|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6749413|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
6749414|NCT02012465|Insulin|insulin|mesh-list
6749415|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
6749416|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6749417|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749418|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6749419|NCT02012517|Cefazolin|cefazolin|mesh-list
6749420|NCT02012517|Cephalexin|cephalexin|mesh-list
6749421|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6749422|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749423|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
6749424|NCT02012556|Tesamorelin|tesamorelin|mesh-list
6749425|NCT02012556|Growth Substances|growth substances|mesh-ancestor
6749426|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749427|NCT02012569|Hemostatics|hemostatics|mesh-list
6749428|NCT02012569|Coagulants|coagulants|mesh-ancestor
6749429|NCT02012595|Donepezil|donepezil|mesh-list
6749430|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6749431|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749432|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749433|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
6749434|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749435|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749436|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
6749437|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
6749438|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749439|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
6749440|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749441|NCT02012777|Propranolol|propranolol|mesh-list
6749442|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6749443|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6749444|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
6749445|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749446|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749447|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749448|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6749449|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6749450|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
6749451|NCT02012920|Seviteronel|seviteronel|mesh-list
6749452|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749453|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6749454|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749455|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749456|NCT02012933|Amifampridine|amifampridine|mesh-list
6749457|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6749458|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749459|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749460|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6749461|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6749462|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749463|NCT02012946|Simendan|simendan|mesh-list
6749464|NCT02012946|Dobutamine|dobutamine|mesh-list
6749465|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6749466|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
6749467|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6749468|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6749469|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749470|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749471|NCT02012946|Protective Agents|protective agents|mesh-ancestor
6749472|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749473|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
6749474|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
6749475|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749476|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6749477|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6749478|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6749479|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
6749480|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749481|NCT02012998|Vaccines|vaccines|mesh-list
6749482|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
6749483|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749484|NCT02013089|Everolimus|everolimus|mesh-list
6749485|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6749486|NCT02013089|Sorafenib|sorafenib|mesh-list
6749487|NCT02013089|Sunitinib|sunitinib|mesh-list
6749488|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
6749489|NCT02013089|Gefitinib|gefitinib|mesh-list
6749490|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749491|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6749492|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
6749493|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749494|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6749495|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749496|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749497|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6749498|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6749499|NCT02013089|Growth Substances|growth substances|mesh-ancestor
6749500|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
6749501|NCT02013102|Decitabine|decitabine|mesh-list
6749502|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6749503|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
6749504|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749505|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749506|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749507|NCT02013115|Budesonide|budesonide|mesh-list
6749508|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6749509|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6749510|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
6749511|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749512|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749513|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6749514|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
6749515|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
6749516|NCT02013115|Hormones|hormones|mesh-ancestor
6749517|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787600|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
6787601|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787602|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787603|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
6787604|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787605|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749518|NCT02013154|Paclitaxel|paclitaxel|mesh-list
6749519|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
6749520|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6749521|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749522|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
6749523|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
6749524|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
6749525|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749526|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6749527|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6749528|NCT02013219|Atezolizumab|atezolizumab|mesh-list
6749529|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749530|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6749531|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749532|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749533|NCT02013232|Aripiprazole|aripiprazole|mesh-list
6749534|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
6749535|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6749536|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6749537|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6749538|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749539|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749540|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
6749541|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
6749542|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749543|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749544|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6749545|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6749546|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
6749547|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6749548|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6749549|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6749550|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6749551|NCT02013258|Oxytocin|oxytocin|mesh-list
6749552|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
6749553|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6749554|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749555|NCT02013271|Paclitaxel|paclitaxel|mesh-list
6749556|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6749557|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749558|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
6749559|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
6749560|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
6749561|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749562|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
6749563|NCT02013336|Irinotecan|irinotecan|mesh-list
6749564|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6749565|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
6749566|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749567|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6749568|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6749569|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
6749570|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749571|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749572|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6749573|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6749574|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6749575|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749576|NCT02013362|Folic Acid|folic acid|mesh-list
6749577|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
6749578|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
6749579|NCT02013362|Vitamins|vitamins|mesh-ancestor
6749580|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
6749581|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749582|NCT02013362|Hematinics|hematinics|mesh-ancestor
6749583|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
6749584|NCT02013427|Naproxen|naproxen|mesh-list
6749585|NCT02013427|Omeprazole|omeprazole|mesh-list
6749586|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6749587|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6749588|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6749589|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749590|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749591|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6749592|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6749593|NCT02013427|Analgesics|analgesics|mesh-ancestor
6749594|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
6749595|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749596|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749597|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6749598|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6749599|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
6749600|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6749601|NCT02013453|Paclitaxel|paclitaxel|mesh-list
6749602|NCT02013453|Carboplatin|carboplatin|mesh-list
6749603|NCT02013453|Fluorouracil|fluorouracil|mesh-list
6749604|NCT02013453|Pemetrexed|pemetrexed|mesh-list
6749605|NCT02013453|Omeprazole|omeprazole|mesh-list
6749606|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6749607|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749608|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
6749609|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
6749610|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
6749611|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749612|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
6749613|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6749614|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6749615|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
6749616|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749617|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749618|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6749619|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6749620|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6749621|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6749622|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6749623|NCT02013492|Propranolol|propranolol|mesh-list
6749624|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6749625|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6749626|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
6749627|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749628|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749629|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749630|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6749631|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6749632|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
6749633|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
6749634|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6749635|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749636|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749637|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6749638|NCT02013570|Analgesics|analgesics|mesh-ancestor
6749639|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
6749640|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749641|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6749642|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6749643|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6749644|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
6749645|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749646|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749647|NCT02013648|Cytarabine|cytarabine|mesh-list
6749648|NCT02013648|Daunorubicin|daunorubicin|mesh-list
6749649|NCT02013648|Dasatinib|dasatinib|mesh-list
6749650|NCT02013648|Idarubicin|idarubicin|mesh-list
6749651|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6749652|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
6749653|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749654|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749655|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
6749656|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749657|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6749658|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
6749659|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749660|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6749661|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6749662|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6749663|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749664|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6749665|NCT02013700|Remestemcel-l|remestemcel-l|mesh-list
6749666|NCT02013700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6749667|NCT02013700|Antiviral Agents|antiviral agents|mesh-ancestor
6749668|NCT02013700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749669|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
6749670|NCT02013856|Procyanidin|procyanidin|mesh-list
6749671|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
6749672|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749673|NCT02013856|Protective Agents|protective agents|mesh-ancestor
6749674|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749675|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6749676|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6749677|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749678|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
6749679|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6749680|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749681|NCT02013960|Misoprostol|misoprostol|mesh-list
6749682|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6749683|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
6749684|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6749685|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749686|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6749687|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6749688|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
6749689|NCT02013986|Midazolam|midazolam|mesh-list
6749690|NCT02013986|Propofol|propofol|mesh-list
6749691|NCT02013986|Etomidate|etomidate|mesh-list
6749692|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6787606|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
6749693|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749694|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749695|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6749696|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
6749697|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
6749698|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6749699|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6749700|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6749701|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6749702|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
6749703|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
6749704|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749705|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749706|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6749707|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6749708|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6749709|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6749710|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749711|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
6749712|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749713|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749714|NCT02014103|Tacrolimus|tacrolimus|mesh-list
6749715|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6749716|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
6749717|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749718|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6749719|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749720|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749721|NCT02014337|Mifepristone|mifepristone|mesh-list
6749722|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6749723|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
6749724|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6749725|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749726|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6749727|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6749728|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6749729|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
6749730|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6749731|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6749732|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
6749733|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6749734|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
6749735|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6749736|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6749737|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
6749738|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6749739|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
6749740|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749741|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
6749742|NCT02014428|Protective Agents|protective agents|mesh-ancestor
6749743|NCT02014454|Propranolol|propranolol|mesh-list
6749744|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6749745|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6749746|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6749747|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6749748|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
6749749|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749750|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749751|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749752|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6749753|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6749754|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
6749755|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
6749756|NCT02014506|Fludarabine|fludarabine|mesh-list
6749757|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6749758|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6749759|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
6749760|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749761|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6749762|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6749763|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
6749764|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749765|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749766|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6749767|NCT02014532|Montelukast|montelukast|mesh-list
6749768|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
6749769|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6749770|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
6749771|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
6749772|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6749773|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749774|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6749775|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6749776|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749777|NCT02014545|Lucanthone|lucanthone|mesh-list
6749778|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
6749779|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6749780|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
6749781|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6749782|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749783|NCT02014558|Voriconazole|voriconazole|mesh-list
6749784|NCT02014558|Cephalexin|cephalexin|mesh-list
6749785|NCT02014558|Midazolam|midazolam|mesh-list
6749786|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6749787|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6749788|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749789|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749790|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6749791|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6749792|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6749793|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6749794|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
6749795|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
6749796|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
6749797|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
6749798|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749799|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749800|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
6749801|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749802|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6749803|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6749804|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749805|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6749806|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
6749807|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6749808|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6749809|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6749810|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
6749811|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
6749812|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6749813|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749814|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749815|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
6749816|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6749817|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749818|NCT02014714|Fentanyl|fentanyl|mesh-list
6749819|NCT02014714|Morphine|morphine|mesh-list
6749820|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6749821|NCT02014714|Narcotics|narcotics|mesh-ancestor
6749822|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749823|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749824|NCT02014714|Analgesics|analgesics|mesh-ancestor
6749825|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
6749826|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749827|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6749828|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6749829|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
6749830|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
6749831|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6749832|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6749833|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
6749834|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749835|NCT02014727|Antacids|antacids|mesh-ancestor
6749836|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749837|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6749838|NCT02014753|Cobalt|cobalt|mesh-list
6749839|NCT02014753|Chromium|chromium|mesh-list
6749840|NCT02014753|Everolimus|everolimus|mesh-list
6749841|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749842|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6749843|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
6749844|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749845|NCT02014753|Trace Elements|trace elements|mesh-ancestor
6749846|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
6749847|NCT02014831|Cetuximab|cetuximab|mesh-list
6749848|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6749849|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749850|NCT02014922|Vitamin E|vitamin e|mesh-list
6749851|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
6749852|NCT02014922|Tocopherols|tocopherols|mesh-list
6749853|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6749854|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6749855|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
6749856|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6749857|NCT02014922|Laxatives|laxatives|mesh-ancestor
6749858|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6749859|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
6749860|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749861|NCT02014922|Protective Agents|protective agents|mesh-ancestor
6749862|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749863|NCT02014922|Vitamins|vitamins|mesh-ancestor
6749864|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
6787607|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6787608|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
6787609|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787610|NCT02220218|Metformin|metformin|mesh-list
6787611|NCT02220218|Canagliflozin|canagliflozin|mesh-list
6787612|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6787613|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787614|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6787615|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787616|NCT02220296|Insulin|insulin|mesh-list
6787617|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6787618|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
6787619|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6787620|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787621|NCT02220335|Digoxin|digoxin|mesh-list
6787622|NCT02220335|Diuretics|diuretics|mesh-list
6787623|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6787624|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6787625|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6787626|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6787627|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787628|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787629|NCT02220335|Protective Agents|protective agents|mesh-ancestor
6787630|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787631|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
6787632|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
6787633|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
6787634|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787635|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6787636|NCT02220348|Linaclotide|linaclotide|mesh-list
6787637|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6787638|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
6787639|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787640|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787641|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
6787642|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6787643|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787644|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787645|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6787646|NCT02220361|Analgesics|analgesics|mesh-ancestor
6787647|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
6787648|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787649|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6787650|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6787651|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6787652|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
6787653|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787654|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787655|NCT02220400|Ketamine|ketamine|mesh-list
6787656|NCT02220400|Analgesics|analgesics|mesh-ancestor
6787657|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
6787658|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749865|NCT02015117|Trametinib|trametinib|mesh-list
6749866|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749867|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6749868|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749869|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749870|NCT02015156|Trastuzumab|trastuzumab|mesh-list
6749871|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6749872|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749873|NCT02015169|Lapatinib|lapatinib|mesh-list
6749874|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749875|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6749876|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749877|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749878|NCT02015182|Bupivacaine|bupivacaine|mesh-list
6749879|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
6749880|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
6749881|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6749882|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749883|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
6749884|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6749885|NCT02015260|Citric Acid|citric acid|mesh-list
6749886|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
6749887|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6749888|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
6749889|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
6749890|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749891|NCT02015299|Linagliptin|linagliptin|mesh-list
6749892|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6749893|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6749894|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749895|NCT02015299|Incretins|incretins|mesh-ancestor
6749896|NCT02015299|Hormones|hormones|mesh-ancestor
6749897|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6749898|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
6749899|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749900|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749901|NCT02015312|Silicon|silicon|mesh-list
6749902|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6749903|NCT02015312|Mannitol|mannitol|mesh-list
6749904|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6749905|NCT02015312|Diuretics|diuretics|mesh-ancestor
6749906|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
6749907|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749908|NCT02015312|Trace Elements|trace elements|mesh-ancestor
6749909|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
6749910|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
6749911|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749912|NCT02015312|Protective Agents|protective agents|mesh-ancestor
6749913|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6749914|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6749915|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749916|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6749917|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
6749918|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6749919|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
6749920|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749921|NCT02015403|Expectorants|expectorants|mesh-ancestor
6749922|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
6749923|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6749924|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
6749925|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749926|NCT02015403|Protective Agents|protective agents|mesh-ancestor
6749927|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749928|NCT02015403|Antidotes|antidotes|mesh-ancestor
6749929|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
6749930|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
6749931|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749932|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
6749933|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
6749934|NCT02015507|Ivacaftor|ivacaftor|mesh-list
6749935|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6749936|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749937|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6749938|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6749939|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749940|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749941|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749942|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6749943|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6749944|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6749945|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6749946|NCT02015559|Protective Agents|protective agents|mesh-list
6749947|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749948|NCT02015598|Carbocysteine|carbocysteine|mesh-list
6749949|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6749950|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6749951|NCT02015598|Expectorants|expectorants|mesh-ancestor
6749952|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
6749953|NCT02015611|Vitamin D|vitamin d|mesh-list
6749954|NCT02015611|Vitamins|vitamins|mesh-ancestor
6749955|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
6749956|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749957|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6749958|NCT02015650|Fluorouracil|fluorouracil|mesh-list
6749959|NCT02015650|Cetuximab|cetuximab|mesh-list
6749960|NCT02015650|Mitomycins|mitomycins|mesh-list
6749961|NCT02015650|Mitomycin|mitomycin|mesh-list
6749962|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
6749963|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749964|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6749965|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749966|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6749967|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
6749968|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749969|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6749970|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6749971|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
6749972|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6749973|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749974|NCT02015728|Etoposide|etoposide|mesh-list
6749975|NCT02015728|Everolimus|everolimus|mesh-list
6749976|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6749977|NCT02015728|Temozolomide|temozolomide|mesh-list
6749978|NCT02015728|Sorafenib|sorafenib|mesh-list
6749979|NCT02015728|Dasatinib|dasatinib|mesh-list
6749980|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6749981|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749982|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6749983|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6749984|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6749985|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6749986|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6749987|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
6749988|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749989|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6749990|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6749991|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
6749992|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6749993|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6749994|NCT02015923|Panitumumab|panitumumab|mesh-list
6749995|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6749996|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6749997|NCT02015949|Methylphenidate|methylphenidate|mesh-list
6749998|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6749999|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750000|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6750001|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6750002|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750003|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750004|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
6750005|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750006|NCT02015988|Simvastatin|simvastatin|mesh-list
6750007|NCT02015988|Fenofibrate|fenofibrate|mesh-list
6750008|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6750009|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6750010|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
6750011|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750012|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6750013|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6750014|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750015|NCT02016001|Fluorides|fluorides|mesh-list
6750016|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
6750017|NCT02016001|Protective Agents|protective agents|mesh-ancestor
6750018|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750019|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
6750020|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6750021|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750022|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6750023|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6750024|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750025|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750026|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750027|NCT02016196|Rifaximin|rifaximin|mesh-list
6750028|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6750029|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750030|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6750031|NCT02016209|Paclitaxel|paclitaxel|mesh-list
6750032|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6750033|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6750034|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750035|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
6750036|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
6750037|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
6750038|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750039|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
6750040|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6750041|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6750042|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750043|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750044|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6750045|NCT02016261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6750046|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6750047|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750048|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750049|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750050|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
6750051|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6750052|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
6750053|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6750054|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6750055|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750056|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6750057|NCT02016274|Paclitaxel|paclitaxel|mesh-list
6750058|NCT02016274|Cisplatin|cisplatin|mesh-list
6750059|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6750060|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750061|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
6750062|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
6750063|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
6750064|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750065|NCT02016287|Paclitaxel|paclitaxel|mesh-list
6750066|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6750067|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750068|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
6750069|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
6750070|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
6750071|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750072|NCT02016365|Doxycycline|doxycycline|mesh-list
6750073|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6750074|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6750075|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750076|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
6750077|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6750078|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6750079|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6750080|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6750081|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
6750082|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6750083|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750084|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750085|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6750086|NCT02016391|Analgesics|analgesics|mesh-ancestor
6750087|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
6750088|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750089|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6750090|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6750091|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6750092|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
6750093|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750094|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750095|NCT02016417|Gemcitabine|gemcitabine|mesh-list
6750096|NCT02016417|Cisplatin|cisplatin|mesh-list
6750097|NCT02016417|Docetaxel|docetaxel|mesh-list
6750098|NCT02016417|Fluorouracil|fluorouracil|mesh-list
6750099|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750100|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6750101|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
6750102|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750103|NCT02016417|Antiviral Agents|antiviral agents|mesh-ancestor
6750104|NCT02016417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750105|NCT02016417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750106|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6750107|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
6750108|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750109|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
6750110|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
6750111|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
6750112|NCT02016443|Tizanidine|tizanidine|mesh-list
6750113|NCT02016443|Analgesics|analgesics|mesh-ancestor
6750114|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
6750115|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750116|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750117|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
6750118|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6750119|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6750120|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
6750121|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
6750122|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6750123|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6750124|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6750125|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
6750126|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750127|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750128|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
6750129|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
6750130|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750131|NCT02016495|Protective Agents|protective agents|mesh-ancestor
6750132|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750133|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
6750134|NCT02016495|Vitamins|vitamins|mesh-ancestor
6750135|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
6750136|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6750137|NCT02016547|Abciximab|abciximab|mesh-list
6750138|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6750139|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6750140|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750141|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
6750142|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6750143|NCT02016664|Ketamine|ketamine|mesh-list
6750144|NCT02016664|Analgesics|analgesics|mesh-ancestor
6750145|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
6750146|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750147|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750148|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6750149|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6750150|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
6750151|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
6750152|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750153|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6750154|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6750155|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750156|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750157|NCT02016703|Erythritol|erythritol|mesh-list
6750158|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
6750159|NCT02016729|Trametinib|trametinib|mesh-list
6750160|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750161|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6750162|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750163|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787659|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787660|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6787661|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6787662|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
6787663|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
6787664|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787665|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6787666|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6787667|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787668|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787669|NCT02220426|Xenon|xenon|mesh-list
6787670|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6787671|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
6787672|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
6787673|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787674|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787675|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
6787676|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6787677|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787678|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787679|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6787680|NCT02220530|Fentanyl|fentanyl|mesh-list
6787681|NCT02220530|Midazolam|midazolam|mesh-list
6787682|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6787683|NCT02220530|Narcotics|narcotics|mesh-ancestor
6787684|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787685|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787686|NCT02220530|Analgesics|analgesics|mesh-ancestor
6750164|NCT02016807|Sucralfate|sucralfate|mesh-list
6750165|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6750166|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6750167|NCT02016820|Omeprazole|omeprazole|mesh-list
6750168|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6750169|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6750170|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6750171|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750172|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750173|NCT02016846|Liraglutide|liraglutide|mesh-list
6750174|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6750175|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750176|NCT02016846|Incretins|incretins|mesh-ancestor
6750177|NCT02016846|Hormones|hormones|mesh-ancestor
6750178|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6750179|NCT02016976|Midazolam|midazolam|mesh-list
6750180|NCT02016976|Meperidine|meperidine|mesh-list
6750181|NCT02016976|Analgesics|analgesics|mesh-list
6750182|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
6750183|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750184|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750185|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6750186|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6750187|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750188|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6750189|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6750190|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6750191|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6750192|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
6750193|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
6750194|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
6750195|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
6750196|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750197|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750198|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6750199|NCT02016976|Narcotics|narcotics|mesh-ancestor
6750200|NCT02017119|Lactulose|lactulose|mesh-list
6750201|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6750202|NCT02017197|Warfarin|warfarin|mesh-list
6750203|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
6750204|NCT02017314|Morphine|morphine|mesh-list
6750205|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6750206|NCT02017314|Narcotics|narcotics|mesh-ancestor
6750207|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750208|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750209|NCT02017314|Analgesics|analgesics|mesh-ancestor
6750210|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
6750211|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750212|NCT02017340|Nilvadipine|nilvadipine|mesh-list
6750213|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6750214|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6750215|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750216|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750217|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6750218|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750219|NCT02017392|Lidocaine|lidocaine|mesh-list
6750220|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
6750221|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
6750222|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750223|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750224|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
6750225|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750226|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6750227|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6750228|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6750229|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750230|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750231|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
6750232|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6750233|NCT02017405|Antibodies|antibodies|mesh-list
6750234|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
6750235|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750236|NCT02017457|Azacitidine|azacitidine|mesh-list
6750237|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6750238|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
6750239|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750240|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750241|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750242|NCT02017561|Metformin|metformin|mesh-list
6750243|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6750244|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750245|NCT02017600|Fluorouracil|fluorouracil|mesh-list
6750246|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750247|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
6750248|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750249|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6750250|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6750251|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
6750252|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750253|NCT02017613|Tenalisib|tenalisib|mesh-list
6750254|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
6750255|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750256|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750257|NCT02017639|Simvastatin|simvastatin|mesh-list
6750258|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6750259|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6750260|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
6750261|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750262|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6750263|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6750264|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750265|NCT02017704|Leucovorin|leucovorin|mesh-list
6750266|NCT02017704|Capecitabine|capecitabine|mesh-list
6750267|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
6750268|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6750269|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
6750270|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750271|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750272|NCT02017704|Antidotes|antidotes|mesh-ancestor
6750273|NCT02017704|Protective Agents|protective agents|mesh-ancestor
6750274|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750275|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
6750276|NCT02017704|Vitamins|vitamins|mesh-ancestor
6750277|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
6750278|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
6750279|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6750280|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750281|NCT02018055|Aspirin|aspirin|mesh-list
6750282|NCT02018055|Clopidogrel|clopidogrel|mesh-list
6750283|NCT02018055|Ticagrelor|ticagrelor|mesh-list
6750284|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6750285|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6750286|NCT02018055|Analgesics|analgesics|mesh-ancestor
6750287|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
6750288|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750289|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750290|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6750291|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6750292|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6750293|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6750294|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750295|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6750296|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6750297|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750298|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
6750299|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6750300|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6750301|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6750302|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
6750303|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750304|NCT02018081|Levofloxacin|levofloxacin|mesh-list
6750305|NCT02018081|Ofloxacin|ofloxacin|mesh-list
6750306|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6750307|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750308|NCT02018081|Renal Agents|renal agents|mesh-ancestor
6750309|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6750310|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6750311|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6750312|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750313|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750314|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750315|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6750316|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6750317|NCT02018094|Iodine|iodine|mesh-list
6750318|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
6750319|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
6750320|NCT02018094|Metronidazole|metronidazole|mesh-list
6750321|NCT02018094|Clindamycin|clindamycin|mesh-list
6750322|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6750323|NCT02018094|Teicoplanin|teicoplanin|mesh-list
6750324|NCT02018094|Povidone|povidone|mesh-list
6750325|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6750326|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750327|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
6750328|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6750329|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6750330|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6750331|NCT02018094|Trace Elements|trace elements|mesh-ancestor
6750332|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
6750333|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750334|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6750335|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750336|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750337|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
6750338|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
6750339|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6750340|NCT02018133|Vitamin D|vitamin d|mesh-list
6750341|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
6750342|NCT02018133|Vitamins|vitamins|mesh-ancestor
6750343|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
6750344|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750345|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6750346|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6750347|NCT02018159|Menotropins|menotropins|mesh-list
6750348|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6750349|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
6750350|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6750351|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750352|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
6750353|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
6750354|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
6750355|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750356|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750357|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
6750358|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750359|NCT02018263|Cocaine|cocaine|mesh-list
6750360|NCT02018263|Nicotine|nicotine|mesh-list
6750361|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6750362|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
6750363|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750364|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750365|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6750366|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6750367|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
6750368|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750369|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750370|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
6750371|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
6750372|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750373|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
6750374|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6750375|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6750376|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6750377|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750378|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
6750379|NCT02018276|Lidocaine|lidocaine|mesh-list
6750380|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
6750381|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
6750382|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750383|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750384|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
6750385|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750386|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6750387|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6750388|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6750389|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750390|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750391|NCT02018289|Triclosan|triclosan|mesh-list
6750392|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6750393|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750394|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6750395|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6750396|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
6750397|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750398|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6750399|NCT02018328|Curcumin|curcumin|mesh-list
6750400|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6750401|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6750402|NCT02018328|Analgesics|analgesics|mesh-ancestor
6750403|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
6750404|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750405|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750406|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6750407|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6750408|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750409|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750410|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750411|NCT02018367|Proflavine|proflavine|mesh-list
6750412|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6750413|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787687|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
6787688|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787689|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6787690|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6787691|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
6787692|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
6787693|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6787694|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6787695|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6787696|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6787697|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
6787698|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
6787699|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787700|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787701|NCT02220608|Bortezomib|bortezomib|mesh-list
6787702|NCT02220608|Lenograstim|lenograstim|mesh-list
6787703|NCT02220608|Sargramostim|sargramostim|mesh-list
6787704|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6787705|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
6787706|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787707|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787708|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
6787709|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6787710|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
6787711|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787712|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
6787713|NCT02220621|Protective Agents|protective agents|mesh-ancestor
6787714|NCT02220634|Regadenoson|regadenoson|mesh-list
6787715|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6787716|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6787717|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
6787718|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
6787719|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787720|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787721|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787722|NCT02220647|Metformin|metformin|mesh-list
6787723|NCT02220647|Linagliptin|linagliptin|mesh-list
6787724|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6787725|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787726|NCT02220647|Incretins|incretins|mesh-ancestor
6787727|NCT02220647|Hormones|hormones|mesh-ancestor
6787728|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787729|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6787730|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
6787731|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787732|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787733|NCT02220660|Olodaterol|olodaterol|mesh-list
6787734|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6787735|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
6787736|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787737|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787738|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6787739|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
6787740|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
6787741|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
6787742|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787743|NCT02220673|Protective Agents|protective agents|mesh-ancestor
6787744|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787745|NCT02220751|Doxycycline|doxycycline|mesh-list
6750414|NCT02018419|Vaccines|vaccines|mesh-list
6750415|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
6750416|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750417|NCT02018523|Lenalidomide|lenalidomide|mesh-list
6750418|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
6750419|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750420|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6750421|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6750422|NCT02018523|Growth Substances|growth substances|mesh-ancestor
6750423|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
6750424|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750425|NCT02018536|Simeprevir|simeprevir|mesh-list
6750426|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
6750427|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750428|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
6750429|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750430|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750431|NCT02018588|Tryptophan|tryptophan|mesh-list
6750432|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6750433|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
6750434|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6750435|NCT02018601|Acetaminophen|acetaminophen|mesh-list
6750436|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6750437|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6750438|NCT02018601|Analgesics|analgesics|mesh-ancestor
6750439|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
6750440|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750441|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750442|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
6750443|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6750444|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6750445|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6750446|NCT02018731|Metformin|metformin|mesh-list
6750447|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6750448|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750449|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
6750450|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
6750451|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6750452|NCT02018757|Estrogens|estrogens|mesh-ancestor
6750453|NCT02018757|Hormones|hormones|mesh-ancestor
6750454|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6750455|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750456|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6750457|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750458|NCT02018783|Listerine|listerine|mesh-list
6750459|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
6750460|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
6750461|NCT02018783|Protective Agents|protective agents|mesh-ancestor
6750462|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750463|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6750464|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750465|NCT02018796|Misoprostol|misoprostol|mesh-list
6750466|NCT02018796|Mifepristone|mifepristone|mesh-list
6750467|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6750468|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
6750469|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6750470|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750471|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6750472|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6750473|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
6750474|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6750475|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6750476|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6750477|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6750478|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
6750479|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6750480|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6750481|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
6750482|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6750483|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
6750484|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6750485|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6750486|NCT02018861|Rituximab|rituximab|mesh-list
6750487|NCT02018861|Carboplatin|carboplatin|mesh-list
6750488|NCT02018861|Etoposide|etoposide|mesh-list
6750489|NCT02018861|Ifosfamide|ifosfamide|mesh-list
6750490|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6750491|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750492|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
6750493|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750494|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6750495|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6750496|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6750497|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6750498|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750499|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750500|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6750501|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
6750502|NCT02018874|Gemcitabine|gemcitabine|mesh-list
6750503|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6750504|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
6750505|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750506|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750507|NCT02018874|Antiviral Agents|antiviral agents|mesh-ancestor
6750508|NCT02018874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750509|NCT02018874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750510|NCT02018874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6750511|NCT02018874|Immunologic Factors|immunologic factors|mesh-ancestor
6750512|NCT02018874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750513|NCT02018965|Vitamins|vitamins|mesh-list
6750514|NCT02018965|Niacin|niacin|mesh-list
6750515|NCT02018965|Niacinamide|niacinamide|mesh-list
6750516|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
6750517|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
6750518|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
6750519|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750520|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6750521|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
6750522|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750523|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6750524|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
6750525|NCT02018991|Everolimus|everolimus|mesh-list
6750526|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750527|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6750528|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
6750529|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750530|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
6750531|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6750532|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6750533|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6750534|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750535|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750536|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
6750537|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750538|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750539|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6750540|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750541|NCT02019056|Pyridoxine|pyridoxine|mesh-list
6750542|NCT02019056|Metadoxine|metadoxine|mesh-list
6750543|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6750544|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
6750545|NCT02019056|Vitamins|vitamins|mesh-ancestor
6750546|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
6750547|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750548|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
6750549|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6750550|NCT02019160|Fluorides|fluorides|mesh-list
6750551|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
6750552|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
6750553|NCT02019160|Protective Agents|protective agents|mesh-ancestor
6750554|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750555|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6750556|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750557|NCT02019186|Vitamins|vitamins|mesh-list
6750558|NCT02019186|Ascorbic Acid|ascorbic acid|mesh-list
6750559|NCT02019186|Vitamin E|vitamin e|mesh-list
6750560|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
6750561|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750562|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
6750563|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750564|NCT02019186|Protective Agents|protective agents|mesh-ancestor
6750565|NCT02019290|Midazolam|midazolam|mesh-list
6750566|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6750567|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6750568|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750569|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750570|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6750571|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6750572|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6750573|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6750574|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
6750575|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
6750576|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
6750577|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
6750578|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750579|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750580|NCT02019329|Risperidone|risperidone|mesh-list
6750581|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6750582|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
6750583|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750584|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750585|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750586|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6750587|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6750588|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750589|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6750590|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6750591|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
6750592|NCT02019355|Fluorouracil|fluorouracil|mesh-list
6750593|NCT02019355|Calcipotriene|calcipotriene|mesh-list
6750594|NCT02019355|Petrolatum|petrolatum|mesh-list
6750595|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
6750596|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750597|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6750598|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750599|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6750600|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
6750601|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750602|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
6750603|NCT02019355|Emollients|emollients|mesh-ancestor
6750604|NCT02019381|Vitamin D|vitamin d|mesh-list
6750605|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
6750606|NCT02019381|Vitamins|vitamins|mesh-list
6750607|NCT02019381|Calcium|calcium|mesh-list
6750608|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
6750609|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750610|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6750611|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6750612|NCT02019446|Terbinafine|terbinafine|mesh-list
6750613|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
6750614|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750615|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750616|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750617|NCT02019459|Nicotine|nicotine|mesh-list
6750618|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6750619|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
6750620|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750621|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750622|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6750623|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6750624|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
6750625|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750626|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750627|NCT02019485|Tapentadol|tapentadol|mesh-list
6750628|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6750629|NCT02019485|Narcotics|narcotics|mesh-ancestor
6750630|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750631|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750632|NCT02019485|Analgesics|analgesics|mesh-ancestor
6750633|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
6750634|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750635|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6750636|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6750637|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750638|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750639|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
6750640|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750641|NCT02019524|Folic Acid|folic acid|mesh-list
6750642|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
6750643|NCT02019524|Molgramostim|molgramostim|mesh-list
6750644|NCT02019524|Vaccines|vaccines|mesh-list
6750645|NCT02019524|Sargramostim|sargramostim|mesh-list
6750646|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
6750647|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750648|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750649|NCT02019524|Hematinics|hematinics|mesh-ancestor
6750650|NCT02019524|Vitamins|vitamins|mesh-ancestor
6750651|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
6750652|NCT02019784|Rifaximin|rifaximin|mesh-list
6750653|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6750654|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750655|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6750656|NCT02019797|Desflurane|desflurane|mesh-list
6750657|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6750658|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
6750659|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
6750660|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750661|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750662|NCT02019810|Dobutamine|dobutamine|mesh-list
6750663|NCT02019810|Norepinephrine|norepinephrine|mesh-list
6750664|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6750665|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6750666|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
6750667|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750668|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750669|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750670|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
6750671|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
6750672|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750673|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6750674|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6750675|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6750676|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6750677|NCT02019810|Protective Agents|protective agents|mesh-ancestor
6750678|NCT02019836|Vitamin D|vitamin d|mesh-list
6750679|NCT02019836|Vitamins|vitamins|mesh-ancestor
6750680|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
6750681|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750682|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6750683|NCT02019875|Clarithromycin|clarithromycin|mesh-list
6750684|NCT02019875|Rifampin|rifampin|mesh-list
6750685|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6750686|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750687|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6750688|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750689|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750690|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6750691|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6750692|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6750693|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
6750694|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
6750695|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6750696|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6750697|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6750698|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6750699|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6750700|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6750701|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6750702|NCT02020005|Nicotine|nicotine|mesh-list
6750703|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6750704|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
6750705|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750706|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750707|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6750708|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6750709|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
6750710|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750711|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750712|NCT02020070|Ipilimumab|ipilimumab|mesh-list
6750713|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6750714|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750715|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6750716|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750717|NCT02020122|Pregabalin|pregabalin|mesh-list
6750718|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6750719|NCT02020122|Analgesics|analgesics|mesh-ancestor
6750720|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
6750721|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750722|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750723|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
6750724|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6750725|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750726|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750727|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6750728|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6750729|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6750730|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750731|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6750732|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6750733|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6750734|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750735|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
6750736|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
6787746|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6787747|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787748|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
6787749|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6787750|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6787751|NCT02220777|Omeprazole|omeprazole|mesh-list
6787752|NCT02220777|ASP8477|asp8477|mesh-list
6787753|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6787754|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787755|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6787756|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787757|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787758|NCT02220803|Acetazolamide|acetazolamide|mesh-list
6787759|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
6787760|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6787761|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787762|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787763|NCT02220803|Diuretics|diuretics|mesh-ancestor
6787764|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
6787765|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787766|NCT02220829|Silodosin|silodosin|mesh-list
6787767|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6787768|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6787769|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6787770|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
6787771|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787772|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787773|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787774|NCT02220829|Urological Agents|urological agents|mesh-ancestor
6787775|NCT02220842|Atezolizumab|atezolizumab|mesh-list
6787776|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
6787777|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787778|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6787779|NCT02220868|Ribavirin|ribavirin|mesh-list
6787780|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
6787781|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6787782|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
6787783|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787784|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
6787785|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787786|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6787787|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6787788|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6787789|NCT02221063|Thiamine|thiamine|mesh-list
6787790|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
6787791|NCT02221063|Vitamins|vitamins|mesh-ancestor
6787792|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
6787793|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787794|NCT02221102|Aspirin|aspirin|mesh-list
6787795|NCT02221102|Edoxaban|edoxaban|mesh-list
6787796|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6787797|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6787798|NCT02221102|Analgesics|analgesics|mesh-ancestor
6787799|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
6787800|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787801|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787802|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6787803|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6787804|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6787805|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6787806|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787807|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6787808|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6787809|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787810|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
6787811|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6787812|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
6787813|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6787814|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
6787815|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
6787816|NCT02221154|Folic Acid|folic acid|mesh-list
6750737|NCT02020161|Methotrexate|methotrexate|mesh-list
6750738|NCT02020161|Idarubicin|idarubicin|mesh-list
6750739|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6750740|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
6750741|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6750742|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750743|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6750744|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
6750745|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750746|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750747|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
6750748|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750749|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6750750|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6750751|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
6750752|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6750753|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6750754|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6750755|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6750756|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6750757|NCT02020200|Methylphenidate|methylphenidate|mesh-list
6750758|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6750759|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750760|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6750761|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6750762|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750763|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750764|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
6750765|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750766|NCT02020213|Posaconazole|posaconazole|mesh-list
6750767|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
6750768|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750769|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6750770|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6750771|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6750772|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6750773|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6750774|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750775|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750776|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6750777|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
6750778|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6750779|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750780|NCT02020330|Lumefantrine|lumefantrine|mesh-list
6750781|NCT02020330|Artemether|artemether|mesh-list
6750782|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6750783|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
6750784|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6750785|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6750786|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750787|NCT02020499|Lanreotide|lanreotide|mesh-list
6750788|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750789|NCT02020551|Lidocaine|lidocaine|mesh-list
6750790|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
6750791|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
6750792|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750793|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750794|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
6750795|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750796|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6750797|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6750798|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6750799|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750800|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750801|NCT02020603|Epinephrine|epinephrine|mesh-list
6750802|NCT02020603|Racepinephrine|racepinephrine|mesh-list
6750803|NCT02020603|Hemostatics|hemostatics|mesh-list
6750804|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
6750805|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6750806|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6750807|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
6750808|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750809|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750810|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750811|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6750812|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6750813|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
6750814|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750815|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6750816|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
6750817|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
6750818|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
6750819|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6750820|NCT02020603|Coagulants|coagulants|mesh-ancestor
6750821|NCT02020629|Lixisenatide|lixisenatide|mesh-list
6750822|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6750823|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750824|NCT02020681|Fluorides|fluorides|mesh-list
6750825|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
6750826|NCT02020681|Protective Agents|protective agents|mesh-ancestor
6750827|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750828|NCT02020694|Vitamin D|vitamin d|mesh-list
6750829|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
6750830|NCT02020694|Vitamins|vitamins|mesh-list
6750831|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
6750832|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750833|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6750834|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6750835|NCT02020720|Fluorides|fluorides|mesh-list
6750836|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
6750837|NCT02020720|Protective Agents|protective agents|mesh-ancestor
6750838|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750839|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
6750840|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6750841|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6750842|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6750843|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750844|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750845|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
6750846|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750847|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750848|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6750849|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750850|NCT02021006|Amoxicillin|amoxicillin|mesh-list
6750851|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
6750852|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
6750853|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6750854|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
6750855|NCT02021006|Cefixime|cefixime|mesh-list
6750856|NCT02021006|Trimethoprim|trimethoprim|mesh-list
6750857|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
6750858|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6750859|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750860|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6750861|NCT02021006|Renal Agents|renal agents|mesh-ancestor
6750862|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
6750863|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6750864|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6750865|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6750866|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750867|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750868|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6750869|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6750870|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6750871|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6750872|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6750873|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6750874|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
6750875|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6750876|NCT02021097|Estradiol|estradiol|mesh-list
6750877|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6750878|NCT02021097|Estrogens|estrogens|mesh-ancestor
6750879|NCT02021097|Hormones|hormones|mesh-ancestor
6750880|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6750881|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750882|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6750883|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
6750884|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6750885|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6750886|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6750887|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6750888|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6750889|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
6750890|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6750891|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6750892|NCT02021123|Anidulafungin|anidulafungin|mesh-list
6750893|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
6750894|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750895|NCT02021201|Risperidone|risperidone|mesh-list
6750896|NCT02021201|Sertindole|sertindole|mesh-list
6750897|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6750898|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
6750899|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750900|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750901|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750902|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6750903|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6750904|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750905|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6750906|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6750907|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
6750908|NCT02021214|Methylphenidate|methylphenidate|mesh-list
6750909|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6750910|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750911|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6750912|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6750913|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6750914|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750915|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
6750916|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750917|NCT02021240|Dexamethasone|dexamethasone|mesh-list
6750918|NCT02021240|Ketamine|ketamine|mesh-list
6750919|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6750920|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
6750921|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
6750922|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750923|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750924|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6750925|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
6750926|NCT02021240|Hormones|hormones|mesh-ancestor
6750927|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6750928|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6750929|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750930|NCT02021240|Analgesics|analgesics|mesh-ancestor
6750931|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
6750932|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6750933|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6750934|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
6750935|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
6750936|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6750937|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6750938|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6750939|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750940|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750941|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
6750942|NCT02021409|Hematinics|hematinics|mesh-ancestor
6750943|NCT02021422|Fluorouracil|fluorouracil|mesh-list
6750944|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
6750945|NCT02021422|Irinotecan|irinotecan|mesh-list
6750946|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6750947|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
6750948|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750949|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6750950|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750951|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6750952|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
6750953|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750954|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6750955|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6750956|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750957|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6750958|NCT02021474|Phenol|phenol|mesh-list
6750959|NCT02021474|Histamine|histamine|mesh-list
6750960|NCT02021474|Histamine phosphate|histamine phosphate|mesh-list
6750961|NCT02021474|Histamine Agonists|histamine agonists|mesh-ancestor
6750962|NCT02021474|Histamine Agents|histamine agents|mesh-ancestor
6750963|NCT02021474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750964|NCT02021474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750965|NCT02021474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750966|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6750967|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6750968|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
6750969|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6750970|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6750971|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6750972|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750973|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
6750974|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6750975|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750976|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6750977|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
6750978|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6750979|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750980|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750981|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
6750982|NCT02021825|Analgesics|analgesics|mesh-ancestor
6750983|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
6750984|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6750985|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6750986|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6750987|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6750988|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6750989|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6750990|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6750991|NCT02021851|Dexamethasone|dexamethasone|mesh-list
6750992|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
6750993|NCT02021851|Ondansetron|ondansetron|mesh-list
6750994|NCT02021851|Aprepitant|aprepitant|mesh-list
6750995|NCT02021851|BB 1101|bb 1101|mesh-list
6750996|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6750997|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
6750998|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
6750999|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751000|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751001|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6751002|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
6751003|NCT02021851|Hormones|hormones|mesh-ancestor
6751004|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751005|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6751006|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751007|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
6751008|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751009|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751010|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
6751011|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
6751012|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6751013|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
6751014|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751015|NCT02021851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6751016|NCT02021851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6751017|NCT02021851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751018|NCT02021851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6751019|NCT02021851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6751020|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6787817|NCT02221154|Hematinics|hematinics|mesh-ancestor
6787818|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
6787819|NCT02221154|Vitamins|vitamins|mesh-ancestor
6787820|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
6787821|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787822|NCT02221180|Metformin|metformin|mesh-list
6787823|NCT02221180|Canagliflozin|canagliflozin|mesh-list
6787824|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6787825|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787826|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6787827|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787828|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
6787829|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6787830|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787831|NCT02221375|Ciclesonide|ciclesonide|mesh-list
6787832|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
6787833|NCT02221375|Hormones|hormones|mesh-ancestor
6787834|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787835|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787836|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6787837|NCT02221401|Metformin|metformin|mesh-list
6787838|NCT02221401|Linagliptin|linagliptin|mesh-list
6787839|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6787840|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787841|NCT02221401|Incretins|incretins|mesh-ancestor
6787842|NCT02221401|Hormones|hormones|mesh-ancestor
6787843|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787844|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6751021|NCT02021864|Vitamin D|vitamin d|mesh-list
6751022|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
6751023|NCT02021864|Vitamins|vitamins|mesh-ancestor
6751024|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
6751025|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751026|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6751027|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6751028|NCT02022059|Lidocaine|lidocaine|mesh-list
6751029|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
6751030|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
6751031|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751032|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751033|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
6751034|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751035|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6751036|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6751037|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6751038|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6751039|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751040|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6751041|NCT02022163|Vaccines|vaccines|mesh-list
6751042|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
6751043|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751044|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6751045|NCT02022163|Antacids|antacids|mesh-ancestor
6751046|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751047|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6751048|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6751049|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6751050|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
6751051|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6751052|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
6751053|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6751054|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751055|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6751056|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6751057|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751058|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6751059|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
6751060|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6751061|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
6751062|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6751063|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751064|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6751065|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6751066|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751067|NCT02022254|Metformin|metformin|mesh-list
6751068|NCT02022254|Warfarin|warfarin|mesh-list
6751069|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6751070|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751071|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
6751072|NCT02022280|Lansoprazole|lansoprazole|mesh-list
6751073|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
6751074|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6751075|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6751076|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6751077|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751078|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751079|NCT02022293|Atorvastatin|atorvastatin|mesh-list
6751080|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6751081|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6751082|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
6751083|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751084|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6751085|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6751086|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751087|NCT02022358|Leucovorin|leucovorin|mesh-list
6751088|NCT02022358|Folic Acid|folic acid|mesh-list
6751089|NCT02022358|Methotrexate|methotrexate|mesh-list
6751090|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
6751091|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6751092|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
6751093|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6751094|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751095|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751096|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
6751097|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751098|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751099|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
6751100|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751101|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6751102|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751103|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
6751104|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6751105|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6751106|NCT02022358|Antidotes|antidotes|mesh-ancestor
6751107|NCT02022358|Protective Agents|protective agents|mesh-ancestor
6751108|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
6751109|NCT02022358|Vitamins|vitamins|mesh-ancestor
6751110|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
6751111|NCT02022358|Hematinics|hematinics|mesh-ancestor
6751112|NCT02022475|Vitamin D|vitamin d|mesh-list
6751113|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
6751114|NCT02022475|Vitamins|vitamins|mesh-ancestor
6751115|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
6751116|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751117|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6751118|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6751119|NCT02022488|Midazolam|midazolam|mesh-list
6751120|NCT02022488|Ketamine|ketamine|mesh-list
6751121|NCT02022488|Alfentanil|alfentanil|mesh-list
6751122|NCT02022488|Analgesics|analgesics|mesh-ancestor
6751123|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
6751124|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751125|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751126|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6751127|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6751128|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
6751129|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
6751130|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751131|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6751132|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6751133|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751134|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751135|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6751136|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6751137|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6751138|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6751139|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6751140|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
6751141|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
6751142|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6751143|NCT02022488|Narcotics|narcotics|mesh-ancestor
6751144|NCT02022527|Aspirin|aspirin|mesh-list
6751145|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
6751146|NCT02022527|Salicylates|salicylates|mesh-list
6751147|NCT02022527|Warfarin|warfarin|mesh-list
6751148|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6751149|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6751150|NCT02022527|Analgesics|analgesics|mesh-ancestor
6751151|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
6751152|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751153|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751154|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6751155|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6751156|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6751157|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6751158|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751159|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6751160|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6751161|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751162|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
6751163|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
6751164|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751165|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
6751166|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
6751167|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
6751168|NCT02022540|Ranibizumab|ranibizumab|mesh-list
6751169|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6751170|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6751171|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6751172|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6751173|NCT02022540|Growth Substances|growth substances|mesh-ancestor
6751174|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751175|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
6751176|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751177|NCT02022592|Midazolam|midazolam|mesh-list
6751178|NCT02022592|Lormetazepam|lormetazepam|mesh-list
6751179|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6751180|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6751181|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751182|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751183|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6751184|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6751185|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6751186|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6751187|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
6751188|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
6751189|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
6751190|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
6751191|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751192|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751193|NCT02022644|Irinotecan|irinotecan|mesh-list
6751194|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6751195|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6751196|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751197|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751198|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751199|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
6751200|NCT02022709|Sertraline|sertraline|mesh-list
6751201|NCT02022709|Fluoxetine|fluoxetine|mesh-list
6751202|NCT02022709|Paroxetine|paroxetine|mesh-list
6751203|NCT02022709|Citalopram|citalopram|mesh-list
6751204|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
6751205|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6751206|NCT02022709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6751207|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6751208|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6751209|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751210|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751211|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
6751212|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751213|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6751214|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6751215|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6751216|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751217|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6751218|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6751219|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751220|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6751221|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6751222|NCT02022722|Triamcinolone|triamcinolone|mesh-list
6751223|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6751224|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6751225|NCT02022722|Bupivacaine|bupivacaine|mesh-list
6751226|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6751227|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
6751228|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
6751229|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751230|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751231|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
6751232|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751233|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6751234|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
6751235|NCT02022722|Hormones|hormones|mesh-ancestor
6751236|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751237|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751238|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
6751239|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751240|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751241|NCT02022761|Laninamivir|laninamivir|mesh-list
6751242|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
6751243|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751244|NCT02022852|Capecitabine|capecitabine|mesh-list
6751245|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751246|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
6751247|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751248|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751249|NCT02022917|Bevacizumab|bevacizumab|mesh-list
6751250|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6751251|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751252|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6751253|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6751254|NCT02022917|Growth Substances|growth substances|mesh-ancestor
6751255|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751256|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
6751257|NCT02022930|Triamcinolone|triamcinolone|mesh-list
6751258|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6751259|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6751260|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6751261|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6751262|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
6751263|NCT02022930|Hormones|hormones|mesh-ancestor
6751264|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751265|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751266|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751267|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
6751268|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751269|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751270|NCT02023021|Gemcitabine|gemcitabine|mesh-list
6751271|NCT02023021|Paclitaxel|paclitaxel|mesh-list
6751272|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6751273|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751274|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
6751275|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
6751276|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
6751277|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751278|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751279|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
6751280|NCT02023021|Antiviral Agents|antiviral agents|mesh-ancestor
6751281|NCT02023021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751282|NCT02023021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751283|NCT02023021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751284|NCT02023021|Immunologic Factors|immunologic factors|mesh-ancestor
6751285|NCT02023021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751286|NCT02023047|Nifedipine|nifedipine|mesh-list
6751287|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6751288|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6751289|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751290|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6751291|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751292|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
6751293|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
6751294|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6751295|NCT02023086|Tropicamide|tropicamide|mesh-list
6751296|NCT02023086|Mydriatics|mydriatics|mesh-list
6751297|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
6751298|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751299|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751300|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6751301|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6751302|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
6751303|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751304|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751305|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
6751306|NCT02023164|Promethazine|promethazine|mesh-list
6751307|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6751308|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6751309|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751310|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751311|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
6751312|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
6751313|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
6751314|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751315|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
6751316|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
6751317|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6751318|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6751319|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
6751320|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
6751321|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751322|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751323|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6751324|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
6751325|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
6751326|NCT02023359|Everolimus|everolimus|mesh-list
6751327|NCT02023359|Exemestane|exemestane|mesh-list
6751328|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751329|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751330|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
6751331|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751332|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6751333|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6751334|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751335|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751336|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6751337|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
6751338|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751339|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
6751340|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
6751341|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6751342|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
6751343|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751344|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751345|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6751346|NCT02023450|Ritonavir|ritonavir|mesh-list
6751347|NCT02023450|Saquinavir|saquinavir|mesh-list
6751348|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6751349|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6751350|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
6751351|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751352|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751353|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6751354|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6751355|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
6751356|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751357|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6751358|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6751359|NCT02023463|Leuprolide|leuprolide|mesh-list
6751360|NCT02023463|Goserelin|goserelin|mesh-list
6751361|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6751362|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
6751363|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6751364|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751365|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6751366|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787845|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
6787846|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787847|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787848|NCT02221414|Metformin|metformin|mesh-list
6751367|NCT02023554|Azithromycin|azithromycin|mesh-list
6751368|NCT02023554|Theophylline|theophylline|mesh-list
6751369|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6751370|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751371|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6751372|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
6751373|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751374|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751375|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6751376|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
6751377|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6751378|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751379|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751380|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
6751381|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6751382|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6751383|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
6751384|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751385|NCT02023567|Serotonin|serotonin|mesh-list
6751386|NCT02023567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
6751387|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6751388|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
6751389|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751390|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751391|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751392|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6751393|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6751394|NCT02023593|Leucovorin|leucovorin|mesh-list
6751395|NCT02023593|Fluorouracil|fluorouracil|mesh-list
6751396|NCT02023593|Irinotecan|irinotecan|mesh-list
6751397|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
6751398|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751399|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751400|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751401|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751402|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
6751403|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751404|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6751405|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6751406|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751407|NCT02023593|Antidotes|antidotes|mesh-ancestor
6751408|NCT02023593|Protective Agents|protective agents|mesh-ancestor
6751409|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
6751410|NCT02023593|Vitamins|vitamins|mesh-ancestor
6751411|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
6751412|NCT02023684|Lidocaine|lidocaine|mesh-list
6751413|NCT02023684|Ropivacaine|ropivacaine|mesh-list
6751414|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
6751415|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
6751416|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751417|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751418|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
6751419|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751420|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6751421|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6751422|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6751423|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6751424|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751425|NCT02023710|Paclitaxel|paclitaxel|mesh-list
6751426|NCT02023710|Bevacizumab|bevacizumab|mesh-list
6751427|NCT02023710|Carboplatin|carboplatin|mesh-list
6751428|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6751429|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751430|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
6751431|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
6751432|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
6751433|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751434|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6751435|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6751436|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6751437|NCT02023710|Growth Substances|growth substances|mesh-ancestor
6751438|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751439|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
6751440|NCT02023840|Metronidazole|metronidazole|mesh-list
6751441|NCT02023840|Erythritol|erythritol|mesh-list
6751442|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751443|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6751444|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6751445|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6751446|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
6751447|NCT02023853|Metronidazole|metronidazole|mesh-list
6751448|NCT02023853|Erythritol|erythritol|mesh-list
6751449|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751450|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6751451|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6751452|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6751453|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
6751454|NCT02023892|Atorvastatin|atorvastatin|mesh-list
6751455|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6751456|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6751457|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
6751458|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751459|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6751460|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6751461|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751462|NCT02023931|Sulforaphane|sulforaphane|mesh-list
6751463|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6751464|NCT02023931|Protective Agents|protective agents|mesh-ancestor
6751465|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751466|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751467|NCT02024009|Gemcitabine|gemcitabine|mesh-list
6751468|NCT02024009|Nelfinavir|nelfinavir|mesh-list
6751469|NCT02024009|Paclitaxel|paclitaxel|mesh-list
6751470|NCT02024009|Capecitabine|capecitabine|mesh-list
6751471|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6751472|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751473|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
6751474|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
6751475|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
6751476|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751477|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751478|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
6751479|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
6751480|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751481|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751482|NCT02024009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751483|NCT02024009|Immunologic Factors|immunologic factors|mesh-ancestor
6751484|NCT02024009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751485|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6751486|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6751487|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
6751488|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6751489|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6751490|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
6751491|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
6751492|NCT02024022|Cathartics|cathartics|mesh-ancestor
6751493|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6751494|NCT02024152|Cetirizine|cetirizine|mesh-list
6751495|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6751496|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6751497|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6751498|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
6751499|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
6751500|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751501|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751502|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751503|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
6751504|NCT02024217|Tegafur|tegafur|mesh-list
6751505|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751506|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751507|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
6751508|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751509|NCT02024230|Warfarin|warfarin|mesh-list
6751510|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
6751511|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
6751512|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6751513|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
6751514|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6751515|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
6751516|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751517|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751518|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
6751519|NCT02024256|Analgesics|analgesics|mesh-ancestor
6751520|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
6751521|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751522|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751523|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
6751524|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751525|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6751526|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
6751527|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6751528|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6751529|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751530|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6751531|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
6751532|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6751533|NCT02024295|Choline|choline|mesh-list
6751534|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
6751535|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
6751536|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6751537|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
6751538|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751539|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6751540|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6751541|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
6751542|NCT02024308|Cytarabine|cytarabine|mesh-list
6751543|NCT02024308|Fludarabine|fludarabine|mesh-list
6751544|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751545|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751546|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
6751547|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751548|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751549|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
6751550|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751551|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
6751552|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751553|NCT02024334|Leflunomide|leflunomide|mesh-list
6751554|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751555|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751556|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751557|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
6751558|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751559|NCT02024373|Atorvastatin|atorvastatin|mesh-list
6751560|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6751561|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6751562|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
6751563|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751564|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6751565|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6751566|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751567|NCT02024425|Antioxidants|antioxidants|mesh-list
6751568|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751569|NCT02024425|Protective Agents|protective agents|mesh-ancestor
6751570|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751571|NCT02024555|Azithromycin|azithromycin|mesh-list
6751572|NCT02024555|Levofloxacin|levofloxacin|mesh-list
6751573|NCT02024555|Ofloxacin|ofloxacin|mesh-list
6751574|NCT02024555|Rifampin|rifampin|mesh-list
6751575|NCT02024555|Ethambutol|ethambutol|mesh-list
6751576|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6751577|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751578|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6751579|NCT02024555|Renal Agents|renal agents|mesh-ancestor
6751580|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6751581|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6751582|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751583|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751584|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751585|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6751586|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6751587|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6751588|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
6751589|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
6751590|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6751591|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6751592|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6751593|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6751594|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6751595|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6751596|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6751597|NCT02024568|Pregabalin|pregabalin|mesh-list
6751598|NCT02024568|Analgesics|analgesics|mesh-ancestor
6751599|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
6751600|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751601|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751602|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
6751603|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6751604|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6751605|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751606|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6751607|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6751608|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6751609|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751610|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6751611|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
6751612|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6751613|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
6751614|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
6751615|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751616|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751617|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6751618|NCT02024594|Analgesics|analgesics|mesh-ancestor
6751619|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
6751620|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751621|NCT02024633|Gemcitabine|gemcitabine|mesh-list
6751622|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751623|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
6751624|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751625|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751626|NCT02024633|Antiviral Agents|antiviral agents|mesh-ancestor
6751627|NCT02024633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751628|NCT02024633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751629|NCT02024633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751630|NCT02024633|Immunologic Factors|immunologic factors|mesh-ancestor
6751631|NCT02024633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751632|NCT02024659|Budesonide|budesonide|mesh-list
6751633|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6751634|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6751635|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
6751636|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751637|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751638|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6751639|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
6751640|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
6751641|NCT02024659|Hormones|hormones|mesh-ancestor
6751642|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751643|NCT02024841|Docetaxel|docetaxel|mesh-list
6751644|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751645|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
6751646|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
6751647|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
6751648|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751649|NCT02024906|Caseins|caseins|mesh-list
6751650|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
6751651|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
6751652|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751653|NCT02024919|Diltiazem|diltiazem|mesh-list
6751654|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6751655|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6751656|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6751657|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751658|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6751659|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751660|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
6751661|NCT02024945|Propiverine|propiverine|mesh-list
6751662|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
6751663|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
6787849|NCT02221414|Linagliptin|linagliptin|mesh-list
6751664|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751665|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751666|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6751667|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6751668|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
6751669|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751670|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751671|NCT02024945|Urological Agents|urological agents|mesh-ancestor
6751672|NCT02024984|Clomiphene|clomiphene|mesh-list
6751673|NCT02024984|Enclomiphene|enclomiphene|mesh-list
6751674|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
6751675|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6751676|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
6751677|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751678|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751679|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6751680|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
6751681|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6751682|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6751683|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6751684|NCT02025010|Prednisone|prednisone|mesh-list
6751685|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
6751686|NCT02025010|Glucocorticoids|glucocorticoids|mesh-list
6751687|NCT02025010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6751688|NCT02025010|Hormones|hormones|mesh-ancestor
6751689|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751690|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751691|NCT02025010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6751692|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751693|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6751694|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751695|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751696|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
6751697|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6751698|NCT02025023|Triamcinolone|triamcinolone|mesh-list
6751699|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6751700|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6751701|NCT02025023|Fluorouracil|fluorouracil|mesh-list
6751702|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6751703|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
6751704|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751705|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751706|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751707|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751708|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
6751709|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751710|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6751711|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
6751712|NCT02025023|Hormones|hormones|mesh-ancestor
6751713|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751714|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751715|NCT02025036|Capecitabine|capecitabine|mesh-list
6751716|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
6751717|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751718|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
6751719|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751720|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751721|NCT02025140|Anesthetics|anesthetics|mesh-list
6751722|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751723|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751724|NCT02025166|Acetaminophen|acetaminophen|mesh-list
6751725|NCT02025166|Lornoxicam|lornoxicam|mesh-list
6751726|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6751727|NCT02025166|Analgesics|analgesics|mesh-ancestor
6751728|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
6751729|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751730|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751731|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
6751732|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6751733|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6751734|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6787850|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6787851|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787852|NCT02221414|Incretins|incretins|mesh-ancestor
6751735|NCT02025192|Capecitabine|capecitabine|mesh-list
6751736|NCT02025192|Trastuzumab|trastuzumab|mesh-list
6751737|NCT02025192|Tucatinib|tucatinib|mesh-list
6751738|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751739|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
6751740|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751741|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751742|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6751743|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6751744|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751745|NCT02025218|Gefitinib|gefitinib|mesh-list
6751746|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751747|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6751748|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751749|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751750|NCT02025348|Metoprolol|metoprolol|mesh-list
6751751|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6751752|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6751753|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
6751754|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
6751755|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751756|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751757|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6751758|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6751759|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6751760|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
6751761|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751762|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751763|NCT02025361|Lidocaine|lidocaine|mesh-list
6751764|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
6751765|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
6751766|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751767|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751768|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
6751769|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751770|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6751771|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6751772|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6751773|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6751774|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751775|NCT02025374|Bupivacaine|bupivacaine|mesh-list
6751776|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
6751777|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
6751778|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
6751779|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751780|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751781|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
6751782|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751783|NCT02025465|Metoprolol|metoprolol|mesh-list
6751784|NCT02025465|Diltiazem|diltiazem|mesh-list
6751785|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6751786|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6751787|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
6751788|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
6751789|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751790|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751791|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6751792|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6751793|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6751794|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
6751795|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751796|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751797|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6751798|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6751799|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6751800|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
6751801|NCT02025491|Amphotericin B|amphotericin b|mesh-list
6751802|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6751803|NCT02025491|Amebicides|amebicides|mesh-ancestor
6751804|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6751805|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6751806|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751807|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6751808|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
6751809|NCT02025608|Pramipexole|pramipexole|mesh-list
6751810|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
6751811|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751812|NCT02025608|Protective Agents|protective agents|mesh-ancestor
6751813|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751814|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6751815|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6751816|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
6751817|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
6751818|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751819|NCT02025712|Everolimus|everolimus|mesh-list
6751820|NCT02025712|Exemestane|exemestane|mesh-list
6751821|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751822|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751823|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
6751824|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751825|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6751826|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6751827|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751828|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751829|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6751830|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
6751831|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751832|NCT02025803|Capecitabine|capecitabine|mesh-list
6751833|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6751834|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
6751835|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751836|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751837|NCT02025855|Methadone|methadone|mesh-list
6751838|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6751839|NCT02025855|Narcotics|narcotics|mesh-ancestor
6751840|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6751841|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751842|NCT02025855|Analgesics|analgesics|mesh-ancestor
6751843|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
6751844|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751845|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
6751846|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
6751847|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
6751848|NCT02025868|Darunavir|darunavir|mesh-list
6751849|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6751850|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6751851|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
6751852|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751853|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6751854|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6751855|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751856|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751857|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6751858|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6751859|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
6751860|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
6751861|NCT02025881|Thiotepa|thiotepa|mesh-list
6751862|NCT02025881|Carboplatin|carboplatin|mesh-list
6751863|NCT02025881|Etoposide|etoposide|mesh-list
6751864|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751865|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
6751866|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751867|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6751868|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6751869|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
6751870|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751871|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751872|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6751873|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6751874|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6751875|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6751876|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751877|NCT02025998|Ibudilast|ibudilast|mesh-list
6751878|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6751879|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
6751880|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751881|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751882|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6751883|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
6751884|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6751885|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751886|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751887|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6751888|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
6751889|NCT02026050|Dexamethasone|dexamethasone|mesh-list
6751890|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
6751891|NCT02026050|BB 1101|bb 1101|mesh-list
6751892|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6751893|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
6751894|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
6751895|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751896|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751897|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6751898|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
6751899|NCT02026050|Hormones|hormones|mesh-ancestor
6751900|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751901|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6751902|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751903|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
6751904|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751905|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751906|NCT02026219|Clopidogrel|clopidogrel|mesh-list
6751907|NCT02026219|Ticagrelor|ticagrelor|mesh-list
6751908|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6751909|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6751910|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6751911|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6751912|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
6751913|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751914|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751915|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751916|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
6751917|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
6751918|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6751919|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6751920|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6751921|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751922|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751923|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6751924|NCT02026310|Metformin|metformin|mesh-list
6751925|NCT02026310|Glimepiride|glimepiride|mesh-list
6751926|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6751927|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751928|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6751929|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6751930|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
6751931|NCT02026479|Dexamethasone|dexamethasone|mesh-list
6751932|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
6751933|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
6751934|NCT02026479|BB 1101|bb 1101|mesh-list
6751935|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6751936|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
6751937|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
6751938|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751939|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751940|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6751941|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
6751942|NCT02026479|Hormones|hormones|mesh-ancestor
6751943|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6751944|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6751945|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751946|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
6751947|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751948|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751949|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
6751950|NCT02026492|Miotics|miotics|mesh-ancestor
6751951|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
6751952|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751953|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751954|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6751955|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6751956|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
6751957|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6751958|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6751959|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
6751960|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751961|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751962|NCT02026505|Bortezomib|bortezomib|mesh-list
6751963|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6751964|NCT02026518|Vitamin D|vitamin d|mesh-list
6751965|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
6751966|NCT02026518|Vitamins|vitamins|mesh-ancestor
6751967|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
6751968|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751969|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6751970|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6751971|NCT02026583|Simvastatin|simvastatin|mesh-list
6751972|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6751973|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6751974|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
6751975|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751976|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6751977|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6751978|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6751979|NCT02026765|Heparin|heparin|mesh-list
6751980|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
6751981|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6751982|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6751983|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751984|NCT02026778|Betahistine|betahistine|mesh-list
6751985|NCT02026778|Ondansetron|ondansetron|mesh-list
6751986|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
6751987|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
6751988|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6751989|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6751990|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6751991|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
6751992|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
6751993|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6751994|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
6751995|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6751996|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6751997|NCT02026778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6751998|NCT02026778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6751999|NCT02026778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6752000|NCT02026778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6752001|NCT02026778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6752002|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
6752003|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
6752004|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
6752005|NCT02026817|Metformin|metformin|mesh-list
6752006|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6752007|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6752008|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752009|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6752010|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6752011|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
6752012|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752013|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6752014|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6752015|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787853|NCT02221414|Hormones|hormones|mesh-ancestor
6787854|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787855|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6787856|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
6787857|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787858|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787859|NCT02221453|Triamcinolone|triamcinolone|mesh-list
6787860|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6787861|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6787862|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6787863|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6787864|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
6787865|NCT02221453|Hormones|hormones|mesh-ancestor
6787866|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787867|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787868|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6787869|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
6787870|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787871|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787872|NCT02221479|Plerixafor|plerixafor|mesh-list
6787873|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6787874|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6787875|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
6787876|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787877|NCT02221492|Plerixafor|plerixafor|mesh-list
6787878|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6787879|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6787880|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
6787881|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787882|NCT02221531|Carbetocin|carbetocin|mesh-list
6787883|NCT02221531|Oxytocin|oxytocin|mesh-list
6787884|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
6752016|NCT02026856|Selenious Acid|selenious acid|mesh-list
6752017|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
6752018|NCT02026856|Trace Elements|trace elements|mesh-ancestor
6752019|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
6752020|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752021|NCT02026869|Metformin|metformin|mesh-list
6752022|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6752023|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752024|NCT02026921|Carboplatin|carboplatin|mesh-list
6752025|NCT02026921|Docetaxel|docetaxel|mesh-list
6752026|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752027|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
6752028|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
6752029|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
6752030|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752031|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
6752032|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
6752033|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752034|NCT02026973|Fulvestrant|fulvestrant|mesh-list
6752035|NCT02026973|Anastrozole|anastrozole|mesh-list
6752036|NCT02026973|Somatostatin|somatostatin|mesh-list
6752037|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6752038|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752039|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6752040|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6752041|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
6752042|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752043|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752044|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6752045|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6752046|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752047|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752048|NCT02026973|Hormones|hormones|mesh-ancestor
6752049|NCT02027064|Interferons|interferons|mesh-list
6752050|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
6752051|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752052|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
6752053|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752054|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
6752055|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752056|NCT02027103|Metformin|metformin|mesh-list
6752057|NCT02027103|Pioglitazone|pioglitazone|mesh-list
6752058|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6752059|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752060|NCT02027220|Dexamethasone|dexamethasone|mesh-list
6752061|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
6752062|NCT02027220|Bortezomib|bortezomib|mesh-list
6752063|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752064|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
6752065|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752066|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6752067|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6752068|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
6752069|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752070|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752071|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6752072|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6752073|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
6752074|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
6752075|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752076|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752077|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
6752078|NCT02027220|Hormones|hormones|mesh-ancestor
6752079|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752080|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6752081|NCT02027298|Abatacept|abatacept|mesh-list
6752082|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6752083|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752084|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752085|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752086|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
6752087|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752088|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6752089|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
6752090|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
6752091|NCT02027324|Povidone|povidone|mesh-list
6752092|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6752093|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752094|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
6752095|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
6752096|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
6752097|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
6752098|NCT02027337|Drospirenone|drospirenone|mesh-list
6752099|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6752100|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6752101|NCT02027337|Cyproterone|cyproterone|mesh-list
6752102|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
6752103|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6752104|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6752105|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6752106|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
6752107|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6752108|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752109|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6752110|NCT02027337|Estrogens|estrogens|mesh-ancestor
6752111|NCT02027337|Hormones|hormones|mesh-ancestor
6752112|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752113|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6752114|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
6752115|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6752116|NCT02027337|Diuretics|diuretics|mesh-ancestor
6752117|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
6752118|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
6752119|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752120|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6752121|NCT02027363|Capecitabine|capecitabine|mesh-list
6752122|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6752123|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
6752124|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752125|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752126|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
6752127|NCT02027454|Cabotegravir|cabotegravir|mesh-list
6752128|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6752129|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752130|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6752131|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6752132|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752133|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752134|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752135|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6752136|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6752137|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6752138|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6752139|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
6752140|NCT02027493|Interferons|interferons|mesh-list
6752141|NCT02027493|Ribavirin|ribavirin|mesh-list
6752142|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
6752143|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
6752144|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6752145|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752146|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
6752147|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752148|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
6752149|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752150|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
6752151|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752152|NCT02027532|Vancomycin|vancomycin|mesh-list
6752153|NCT02027532|Cefazolin|cefazolin|mesh-list
6752154|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6752155|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752156|NCT02027675|Micronutrients|micronutrients|mesh-list
6752157|NCT02027675|Trace Elements|trace elements|mesh-list
6752158|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752159|NCT02027753|Metformin|metformin|mesh-list
6752160|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
6752161|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6752162|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6752163|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752164|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
6752165|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752166|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752167|NCT02027792|Diclofenac|diclofenac|mesh-list
6752168|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6752169|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6752170|NCT02027792|Analgesics|analgesics|mesh-ancestor
6752171|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
6752172|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752173|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752174|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6752175|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6752176|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6752177|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752178|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752179|NCT02027870|Sirolimus|sirolimus|mesh-list
6752180|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6752181|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752182|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6752183|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752184|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
6752185|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752186|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
6752187|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752188|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
6752189|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
6752190|NCT02027922|Protective Agents|protective agents|mesh-ancestor
6752191|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752192|NCT02027961|Durvalumab|durvalumab|mesh-list
6752193|NCT02027961|Trametinib|trametinib|mesh-list
6752194|NCT02027961|Dabrafenib|dabrafenib|mesh-list
6752195|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6752196|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752197|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6752198|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752199|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752200|NCT02027987|Valproic Acid|valproic acid|mesh-list
6752201|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
6752202|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752203|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752204|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
6752205|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752206|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752207|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
6752208|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6752209|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6752210|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6752211|NCT02028026|Citalopram|citalopram|mesh-list
6752212|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6752213|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6752214|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6752215|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6752216|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752217|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752218|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
6752219|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752220|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6752221|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
6752222|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6752223|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6752224|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6752225|NCT02028078|Insulin|insulin|mesh-list
6752226|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6752227|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6752228|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752229|NCT02028234|Omeprazole|omeprazole|mesh-list
6752230|NCT02028234|Pantoprazole|pantoprazole|mesh-list
6752231|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6752232|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752233|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6752234|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752235|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752236|NCT02028260|Modafinil|modafinil|mesh-list
6752237|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6752238|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752239|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6752240|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6752241|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6787885|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6752242|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752243|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6752244|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6752245|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
6752246|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6752247|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6752248|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6752249|NCT02028364|Everolimus|everolimus|mesh-list
6752250|NCT02028364|Exemestane|exemestane|mesh-list
6752251|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752252|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752253|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
6752254|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752255|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6752256|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6752257|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752258|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752259|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6752260|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
6752261|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752262|NCT02028403|BMS-936559|bms-936559|mesh-list
6752263|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6752264|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6752265|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752266|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
6752267|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787886|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787887|NCT02221570|Baclofen|baclofen|mesh-list
6787888|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6787889|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787890|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6787891|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6787892|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6787893|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
6787894|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
6787895|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787896|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787897|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
6787898|NCT02221583|Tacrolimus|tacrolimus|mesh-list
6787899|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6787900|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
6787901|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787902|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6787903|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787904|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787905|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6787906|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787907|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6787908|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
6787909|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6787910|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787911|NCT02221596|Vitamin D|vitamin d|mesh-list
6787912|NCT02221596|Vitamins|vitamins|mesh-ancestor
6787913|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
6787914|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787915|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6787916|NCT02221622|Pregnanolone|pregnanolone|mesh-list
6787917|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6787918|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
6787919|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787920|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787921|NCT02221635|Risperidone|risperidone|mesh-list
6787922|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6787923|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
6787924|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787925|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787926|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787927|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6787928|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6787929|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787930|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6787931|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6787932|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
6752268|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
6752269|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
6752270|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752271|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752272|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
6752273|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
6752274|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6752275|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6752276|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752277|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752278|NCT02028429|Urological Agents|urological agents|mesh-ancestor
6752279|NCT02028494|Capecitabine|capecitabine|mesh-list
6752280|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6752281|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
6752282|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752283|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752284|NCT02028507|Capecitabine|capecitabine|mesh-list
6752285|NCT02028507|Fulvestrant|fulvestrant|mesh-list
6752286|NCT02028507|Palbociclib|palbociclib|mesh-list
6752287|NCT02028507|Exemestane|exemestane|mesh-list
6752288|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6752289|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
6752290|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752291|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752292|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6752293|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6752294|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6752295|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
6752296|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752297|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752298|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6752299|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752300|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6752301|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6752302|NCT02028533|Oxytocin|oxytocin|mesh-list
6752303|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
6752304|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6752305|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752306|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
6752307|NCT02028598|Clomipramine|clomipramine|mesh-list
6752308|NCT02028598|Citric Acid|citric acid|mesh-list
6752309|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
6752310|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
6752311|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6752312|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
6752313|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
6752314|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752315|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
6752316|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6752317|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6752318|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752319|NCT02028598|Urological Agents|urological agents|mesh-ancestor
6752320|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6752321|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
6752322|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6752323|NCT02028598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6752324|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6752325|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6752326|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752327|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
6752328|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752329|NCT02028663|Esomeprazole|esomeprazole|mesh-list
6752330|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6752331|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752332|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6752333|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752334|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752335|NCT02028689|Metformin|metformin|mesh-list
6752336|NCT02028689|Lesinurad|lesinurad|mesh-list
6752337|NCT02028689|Furosemide|furosemide|mesh-list
6752338|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6752339|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752340|NCT02028689|Diuretics|diuretics|mesh-ancestor
6752341|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
6752342|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6787933|NCT02221752|Folic Acid|folic acid|mesh-list
6752343|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6752344|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752345|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
6752346|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6752347|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
6752348|NCT02028689|Renal Agents|renal agents|mesh-ancestor
6752349|NCT02028806|Leucovorin|leucovorin|mesh-list
6752350|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
6752351|NCT02028806|Irinotecan|irinotecan|mesh-list
6752352|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752353|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6752354|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6752355|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752356|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752357|NCT02028806|Antidotes|antidotes|mesh-ancestor
6752358|NCT02028806|Protective Agents|protective agents|mesh-ancestor
6752359|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752360|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
6752361|NCT02028806|Vitamins|vitamins|mesh-ancestor
6752362|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
6752363|NCT02028819|Dolutegravir|dolutegravir|mesh-list
6752364|NCT02028819|Ibalizumab|ibalizumab|mesh-list
6752365|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6752366|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6752367|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752368|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752369|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6752370|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6752371|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
6752372|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752373|NCT02028910|Ondansetron|ondansetron|mesh-list
6752374|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
6752375|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
6752376|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752377|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752378|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752379|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
6752380|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
6752381|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6752382|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
6752383|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752384|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752385|NCT02028910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6752386|NCT02028910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6752387|NCT02028910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6752388|NCT02028910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6752389|NCT02028910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6752390|NCT02028923|Morphine|morphine|mesh-list
6752391|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6752392|NCT02028923|Narcotics|narcotics|mesh-ancestor
6752393|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6752394|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752395|NCT02028923|Analgesics|analgesics|mesh-ancestor
6752396|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
6752397|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752398|NCT02028949|Idarubicin|idarubicin|mesh-list
6752399|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6752400|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752401|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6752402|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6752403|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752404|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752405|NCT02029001|Everolimus|everolimus|mesh-list
6752406|NCT02029001|Sorafenib|sorafenib|mesh-list
6752407|NCT02029001|Durvalumab|durvalumab|mesh-list
6752408|NCT02029001|Olaparib|olaparib|mesh-list
6752409|NCT02029001|Lapatinib|lapatinib|mesh-list
6752410|NCT02029001|Tremelimumab|tremelimumab|mesh-list
6752411|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752412|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752413|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
6752414|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752415|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6752416|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752417|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752418|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6752419|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6752420|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
6752421|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6752422|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
6752423|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752424|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
6752425|NCT02029105|Protective Agents|protective agents|mesh-ancestor
6752426|NCT02029118|Aspirin|aspirin|mesh-list
6752427|NCT02029118|Metoprolol|metoprolol|mesh-list
6752428|NCT02029118|Ramipril|ramipril|mesh-list
6752429|NCT02029118|Atorvastatin|atorvastatin|mesh-list
6752430|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6752431|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6752432|NCT02029118|Analgesics|analgesics|mesh-ancestor
6752433|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
6752434|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752435|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752436|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6752437|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6752438|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6752439|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6752440|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752441|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6752442|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6752443|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752444|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
6752445|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6752446|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6752447|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
6752448|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6752449|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6752450|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6752451|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6752452|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
6752453|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
6752454|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6752455|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6752456|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6752457|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
6752458|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752459|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6752460|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
6752461|NCT02029313|Montelukast|montelukast|mesh-list
6752462|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6752463|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
6752464|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6752465|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
6752466|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752467|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752468|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6752469|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6752470|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752471|NCT02029378|Eculizumab|eculizumab|mesh-list
6752472|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6752473|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752474|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
6752475|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752476|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6752477|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6752478|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6752479|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752480|NCT02029482|Ponesimod|ponesimod|mesh-list
6752481|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6752482|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752483|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752484|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
6752485|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752486|NCT02029534|Atorvastatin|atorvastatin|mesh-list
6752487|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6752488|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6752489|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
6752490|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752491|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6752492|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6752493|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752494|NCT02029573|Temozolomide|temozolomide|mesh-list
6752495|NCT02029573|Atorvastatin|atorvastatin|mesh-list
6752496|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6752497|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6752498|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
6752499|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752500|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6752501|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6752502|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752503|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6752504|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
6752505|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752506|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
6752507|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752508|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6752509|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6752510|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752511|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752512|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
6752513|NCT02029599|Acetaminophen|acetaminophen|mesh-list
6752514|NCT02029599|Methotrexate|methotrexate|mesh-list
6752515|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6752516|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
6752517|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6752518|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752519|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6752520|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
6752521|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752522|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752523|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
6752524|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752525|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6752526|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752527|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
6752528|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6752529|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6752530|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6752531|NCT02029599|Analgesics|analgesics|mesh-ancestor
6752532|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
6752533|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752534|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
6752535|NCT02029612|Nicotine|nicotine|mesh-list
6752536|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6752537|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
6752538|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752539|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752540|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6752541|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6752542|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
6752543|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752544|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752545|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6752546|NCT02029625|Ezetimibe|ezetimibe|mesh-list
6752547|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6752548|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6752549|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
6752550|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752551|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6752552|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6752553|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752554|NCT02029794|Acetic Acid|acetic acid|mesh-list
6752555|NCT02029794|Retinol acetate|retinol acetate|mesh-list
6752556|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6752557|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752558|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6752559|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
6752560|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752561|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6752562|NCT02029794|Protective Agents|protective agents|mesh-ancestor
6752563|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752564|NCT02029898|Remifentanil|remifentanil|mesh-list
6752565|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6752566|NCT02029898|Narcotics|narcotics|mesh-ancestor
6787934|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
6752567|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6752568|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752569|NCT02029898|Analgesics|analgesics|mesh-ancestor
6752570|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
6752571|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752572|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
6752573|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6752574|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752575|NCT02029937|Proflavine|proflavine|mesh-list
6752576|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6752577|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752578|NCT02029950|Cytarabine|cytarabine|mesh-list
6752579|NCT02029950|Etoposide|etoposide|mesh-list
6752580|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
6752581|NCT02029950|Daunorubicin|daunorubicin|mesh-list
6752582|NCT02029950|Idarubicin|idarubicin|mesh-list
6752583|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
6752584|NCT02029950|Pomalidomide|pomalidomide|mesh-list
6752585|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6752586|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752587|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6752588|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6752589|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752590|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752591|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6752592|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
6752593|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
6752594|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752595|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752596|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
6752597|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752598|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6752599|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6752600|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6752601|NCT02029950|Growth Substances|growth substances|mesh-ancestor
6752602|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
6752603|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
6752604|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
6752605|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
6752606|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
6752607|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
6752608|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6752609|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6752610|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
6752611|NCT02030028|Hormones|hormones|mesh-ancestor
6752612|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752613|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752614|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752615|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752616|NCT02030054|Atorvastatin|atorvastatin|mesh-list
6752617|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6752618|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6752619|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6752620|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
6752621|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752622|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6752623|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6752624|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787935|NCT02221752|Hematinics|hematinics|mesh-ancestor
6787936|NCT02221752|Vitamins|vitamins|mesh-ancestor
6787937|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
6787938|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787939|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
6787940|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787941|NCT02221765|Hormones|hormones|mesh-ancestor
6787942|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787943|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787944|NCT02221830|Oxytocin|oxytocin|mesh-list
6787945|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
6787946|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6787947|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787948|NCT02221960|Durvalumab|durvalumab|mesh-list
6787949|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6787950|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787951|NCT02221999|Paclitaxel|paclitaxel|mesh-list
6787952|NCT02221999|Letrozole|letrozole|mesh-list
6787953|NCT02221999|Hormones|hormones|mesh-list
6752625|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
6752626|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6752627|NCT02030314|Diuretics|diuretics|mesh-ancestor
6752628|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
6752629|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752630|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6752631|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6752632|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752633|NCT02030483|Dexamethasone|dexamethasone|mesh-list
6752634|NCT02030483|Lenalidomide|lenalidomide|mesh-list
6752635|NCT02030483|Palbociclib|palbociclib|mesh-list
6752636|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6752637|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
6752638|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
6752639|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752640|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752641|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752642|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
6752643|NCT02030483|Hormones|hormones|mesh-ancestor
6752644|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752645|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6752646|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752647|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
6752648|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6752649|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6752650|NCT02030483|Growth Substances|growth substances|mesh-ancestor
6752651|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
6752652|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6752653|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752654|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752655|NCT02030561|Trastuzumab|trastuzumab|mesh-list
6752656|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6752657|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752658|NCT02030639|ON 01910|on 01910|mesh-list
6752659|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752660|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6752661|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752662|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752663|NCT02030678|Irinotecan|irinotecan|mesh-list
6752664|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6752665|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6752666|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752667|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752668|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752669|NCT02030717|Clonidine|clonidine|mesh-list
6752670|NCT02030717|Anesthetics|anesthetics|mesh-list
6752671|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6752672|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752673|NCT02030717|Analgesics|analgesics|mesh-ancestor
6752674|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
6752675|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752676|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6752677|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
6752678|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
6752679|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6752680|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6752681|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6752682|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
6752683|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752684|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752685|NCT02030912|Amoxicillin|amoxicillin|mesh-list
6752686|NCT02030912|Minocycline|minocycline|mesh-list
6752687|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6752688|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752689|NCT02030964|Eflornithine|eflornithine|mesh-list
6752690|NCT02030964|Celecoxib|celecoxib|mesh-list
6752691|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
6752692|NCT02030964|Topotecan|topotecan|mesh-list
6752693|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752694|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
6752695|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752696|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6752697|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6752698|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
6752699|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752700|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752701|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6752702|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6752703|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6752704|NCT02030964|Analgesics|analgesics|mesh-ancestor
6752705|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
6752706|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752707|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6752708|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6752709|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6752710|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752711|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6752712|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6752713|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6752714|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6752715|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6752716|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752717|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
6752718|NCT02030977|Resveratrol|resveratrol|mesh-list
6752719|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
6752720|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752721|NCT02030977|Protective Agents|protective agents|mesh-ancestor
6752722|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752723|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752724|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6752725|NCT02030990|Fluorometholone|fluorometholone|mesh-list
6752726|NCT02030990|Mitomycins|mitomycins|mesh-list
6752727|NCT02030990|Mitomycin|mitomycin|mesh-list
6752728|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6752729|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752730|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
6752731|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752732|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6752733|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752734|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6752735|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
6752736|NCT02030990|Hormones|hormones|mesh-ancestor
6752737|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752738|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752739|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6752740|NCT02031016|Fentanyl|fentanyl|mesh-list
6752741|NCT02031016|Remifentanil|remifentanil|mesh-list
6752742|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6752743|NCT02031016|Narcotics|narcotics|mesh-ancestor
6752744|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6752745|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752746|NCT02031016|Analgesics|analgesics|mesh-ancestor
6752747|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
6752748|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752749|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6752750|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6752751|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
6752752|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
6752753|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6752754|NCT02031081|Prucalopride|prucalopride|mesh-list
6752755|NCT02031081|Laxatives|laxatives|mesh-ancestor
6752756|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752757|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6752758|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6752759|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
6752760|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752761|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752762|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752763|NCT02031211|Etanercept|etanercept|mesh-list
6752764|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6752765|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6752766|NCT02031211|Analgesics|analgesics|mesh-ancestor
6752767|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
6752768|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752769|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752770|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6752771|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6752772|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752773|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752774|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
6752775|NCT02031289|Folic Acid|folic acid|mesh-list
6752776|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
6752777|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
6752778|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
6752779|NCT02031289|Vitamins|vitamins|mesh-ancestor
6752780|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
6752781|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752782|NCT02031289|Hematinics|hematinics|mesh-ancestor
6752783|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
6752784|NCT02031367|Triamcinolone|triamcinolone|mesh-list
6752785|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6752786|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6752787|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6752788|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6752789|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
6752790|NCT02031367|Hormones|hormones|mesh-ancestor
6752791|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752792|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752793|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6752794|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
6752795|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752796|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752797|NCT02031419|Rituximab|rituximab|mesh-list
6752798|NCT02031419|Spebrutinib|spebrutinib|mesh-list
6752799|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6752800|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752801|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
6752802|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752803|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6752804|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6752805|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752806|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752807|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
6752808|NCT02031510|Bupivacaine|bupivacaine|mesh-list
6752809|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
6752810|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
6752811|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6752812|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752813|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
6752814|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752815|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6752816|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6752817|NCT02031510|Analgesics|analgesics|mesh-ancestor
6752818|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6752819|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6752820|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6752821|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
6752822|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752823|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752824|NCT02031523|Analgesics|analgesics|mesh-list
6752825|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
6752826|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752827|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752828|NCT02031601|Carboplatin|carboplatin|mesh-list
6752829|NCT02031601|Docetaxel|docetaxel|mesh-list
6752830|NCT02031601|Pemetrexed|pemetrexed|mesh-list
6752831|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6752832|NCT02031601|Gefitinib|gefitinib|mesh-list
6752833|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752834|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
6752835|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
6752836|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
6752837|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752838|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752839|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6752840|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6752841|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6752842|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
6752843|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
6752844|NCT02031692|Calcium|calcium|mesh-list
6752845|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6752846|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752847|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6752848|NCT02031692|Vitamins|vitamins|mesh-ancestor
6752849|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
6752850|NCT02031692|Antacids|antacids|mesh-ancestor
6752851|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752852|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752853|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6752854|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
6752855|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752856|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6752857|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752858|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6752859|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6752860|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787954|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6787955|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787956|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
6787957|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
6787958|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
6787959|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787960|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6787961|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787962|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6787963|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6787964|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787965|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6787966|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
6787967|NCT02222142|Anesthetics|anesthetics|mesh-list
6787968|NCT02222142|Isoflurane|isoflurane|mesh-list
6787969|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6787970|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787971|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6787972|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
6787973|NCT02222168|BI 409306|bi 409306|mesh-list
6787974|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6787975|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787976|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787977|NCT02222220|Metoclopramide|metoclopramide|mesh-list
6787978|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
6787979|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
6787980|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752861|NCT02031861|Nifedipine|nifedipine|mesh-list
6752862|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6752863|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6752864|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752865|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6752866|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752867|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
6752868|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
6752869|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6752870|NCT02031939|Capecitabine|capecitabine|mesh-list
6752871|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
6752872|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6752873|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
6752874|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752875|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752876|NCT02031965|Dexamethasone|dexamethasone|mesh-list
6752877|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6752878|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
6752879|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
6752880|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752881|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752882|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752883|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
6752884|NCT02031965|Hormones|hormones|mesh-ancestor
6752885|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752886|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6752887|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752888|NCT02031991|Bevacizumab|bevacizumab|mesh-list
6752889|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6752890|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752891|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6752892|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6752893|NCT02031991|Growth Substances|growth substances|mesh-ancestor
6752894|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752895|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
6752896|NCT02032043|Ivermectin|ivermectin|mesh-list
6752897|NCT02032043|Albendazole|albendazole|mesh-list
6752898|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6752899|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752900|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
6752901|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
6752902|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6752903|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6752904|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
6752905|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
6752906|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
6752907|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752908|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752909|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
6752910|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6752911|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
6752912|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6752913|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
6752914|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752915|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
6752916|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6752917|NCT02032134|Protective Agents|protective agents|mesh-ancestor
6752918|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752919|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6752920|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
6752921|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752922|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
6752923|NCT02032186|Cathartics|cathartics|mesh-ancestor
6752924|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752925|NCT02032290|Clopidogrel|clopidogrel|mesh-list
6752926|NCT02032290|Ticagrelor|ticagrelor|mesh-list
6752927|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6752928|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6752929|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6752930|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6752931|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
6752932|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752933|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752934|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752935|NCT02032303|Ticagrelor|ticagrelor|mesh-list
6752936|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6752937|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6752938|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6752939|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6752940|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6752941|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
6752942|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6752943|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6752944|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752945|NCT02032355|Anesthetics|anesthetics|mesh-list
6752946|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6752947|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752948|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
6752949|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6752950|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
6752951|NCT02032394|Povidone|povidone|mesh-list
6752952|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6752953|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752954|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
6752955|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
6752956|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
6752957|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
6752958|NCT02032654|Floxacillin|floxacillin|mesh-list
6752959|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6752960|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6752961|NCT02032784|Octreotide|octreotide|mesh-list
6752962|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6752963|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6752964|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752965|NCT02032797|Progesterone|progesterone|mesh-list
6752966|NCT02032797|Progestins|progestins|mesh-ancestor
6752967|NCT02032797|Hormones|hormones|mesh-ancestor
6752968|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6752969|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752970|NCT02032836|Iloprost|iloprost|mesh-list
6752971|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6752972|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
6752973|NCT02032927|Acetaminophen|acetaminophen|mesh-list
6752974|NCT02032927|Oxycodone|oxycodone|mesh-list
6752975|NCT02032927|Codeine|codeine|mesh-list
6752976|NCT02032927|Naloxone|naloxone|mesh-list
6752977|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6752978|NCT02032927|Analgesics|analgesics|mesh-ancestor
6752979|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
6752980|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6752981|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752982|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
6752983|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6752984|NCT02032927|Narcotics|narcotics|mesh-ancestor
6752985|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6752986|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6752987|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
6752988|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
6752989|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
6752990|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6752991|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6752992|NCT02033018|Aflibercept|aflibercept|mesh-list
6752993|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6752994|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6752995|NCT02033018|Growth Substances|growth substances|mesh-ancestor
6752996|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6752997|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
6752998|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6752999|NCT02033031|Bevacizumab|bevacizumab|mesh-list
6753000|NCT02033031|Ranibizumab|ranibizumab|mesh-list
6753001|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6753002|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753003|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6753004|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6753005|NCT02033031|Growth Substances|growth substances|mesh-ancestor
6753006|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753007|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
6753008|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
6753009|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753010|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753011|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
6753012|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6753013|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753014|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
6753015|NCT02033239|Insulin|insulin|mesh-list
6753016|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6753017|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
6753018|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
6753019|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6753020|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6753021|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753022|NCT02033356|Lidocaine|lidocaine|mesh-list
6753023|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
6753024|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
6753025|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753026|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753027|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
6753028|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753029|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6753030|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6753031|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6753032|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6753033|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753034|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6753035|NCT02033408|Amoxicillin|amoxicillin|mesh-list
6753036|NCT02033408|Metronidazole|metronidazole|mesh-list
6753037|NCT02033408|Vancomycin|vancomycin|mesh-list
6753038|NCT02033408|Doxycycline|doxycycline|mesh-list
6753039|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
6753040|NCT02033408|Gentamicins|gentamicins|mesh-list
6753041|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753042|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6753043|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6753044|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
6753045|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6753046|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6753047|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753048|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753049|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753050|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6753051|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6753052|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6753053|NCT02033434|Ketamine|ketamine|mesh-list
6753054|NCT02033434|Analgesics|analgesics|mesh-ancestor
6753055|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
6753056|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753057|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753058|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6753059|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6753060|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
6753061|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
6753062|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753063|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6753064|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6753065|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753066|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787981|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787982|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6787983|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6787984|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6787985|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
6787986|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6787987|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787988|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
6787989|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6787990|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6787991|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6787992|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6787993|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6787994|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6787995|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6787996|NCT02222350|Firuglipel|firuglipel|mesh-list
6787997|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6787998|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6787999|NCT02222376|Pirfenidone|pirfenidone|mesh-list
6788000|NCT02222376|Analgesics|analgesics|mesh-ancestor
6753067|NCT02033512|Hormones|hormones|mesh-list
6753068|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753069|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753070|NCT02033538|Paclitaxel|paclitaxel|mesh-list
6753071|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6753072|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6753073|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753074|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753075|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753076|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753077|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753078|NCT02033551|Paclitaxel|paclitaxel|mesh-list
6753079|NCT02033551|Carboplatin|carboplatin|mesh-list
6753080|NCT02033551|Veliparib|veliparib|mesh-list
6753081|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6753082|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753083|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753084|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753085|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753086|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753087|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6753088|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753089|NCT02033603|Ropivacaine|ropivacaine|mesh-list
6753090|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
6753091|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
6753092|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753093|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753094|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
6753095|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753096|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6753097|NCT02033707|Scopolamine|scopolamine|mesh-list
6753098|NCT02033707|Hallucinogens|hallucinogens|mesh-list
6753099|NCT02033707|Nicotine|nicotine|mesh-list
6753100|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6753101|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
6753102|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753103|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753104|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6753105|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6753106|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
6753107|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753108|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753109|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6753110|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
6753111|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6753112|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
6753113|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6753114|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6753115|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6753116|NCT02033733|Cisatracurium|cisatracurium|mesh-list
6753117|NCT02033733|Atracurium|atracurium|mesh-list
6753118|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
6753119|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6753120|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753121|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753122|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6753123|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6753124|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6753125|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
6753126|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753127|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753128|NCT02033798|Tamsulosin|tamsulosin|mesh-list
6753129|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6753130|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6753131|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6753132|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
6753133|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753134|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753135|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753136|NCT02033798|Urological Agents|urological agents|mesh-ancestor
6753137|NCT02033941|Phenol|phenol|mesh-list
6753138|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6753139|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753140|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
6753141|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6753142|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6753143|NCT02033967|Milrinone|milrinone|mesh-list
6753144|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
6753145|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6753146|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6753147|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6753148|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6753149|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753150|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753151|NCT02033967|Protective Agents|protective agents|mesh-ancestor
6753152|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753153|NCT02034071|Diazoxide|diazoxide|mesh-list
6753154|NCT02034071|Choline|choline|mesh-list
6753155|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
6753156|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6753157|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
6753158|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753159|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6753160|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6753161|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
6753162|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6753163|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
6753164|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6753165|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753166|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6753167|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753168|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753169|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6753170|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6753171|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753172|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6753173|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6753174|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6753175|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753176|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
6753177|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753178|NCT02034253|Risperidone|risperidone|mesh-list
6753179|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6753180|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
6753181|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753182|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753183|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753184|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6753185|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6753186|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753187|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6753188|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6753189|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
6753190|NCT02034292|Aspirin|aspirin|mesh-list
6753191|NCT02034292|Clopidogrel|clopidogrel|mesh-list
6753192|NCT02034292|APD791|apd791|mesh-list
6753193|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6753194|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6753195|NCT02034292|Analgesics|analgesics|mesh-ancestor
6753196|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
6753197|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753198|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753199|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6753200|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6753201|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6753202|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6753203|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753204|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6753205|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6753206|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753207|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
6753208|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6753209|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6753210|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6753211|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
6753212|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753213|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6753214|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6753215|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
6753216|NCT02034331|Acetylcholine|acetylcholine|mesh-list
6753217|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753218|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
6753219|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6753220|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
6753221|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753222|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753223|NCT02034500|Vaccines|vaccines|mesh-list
6753224|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
6753225|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753226|NCT02034604|Tamsulosin|tamsulosin|mesh-list
6753227|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6753228|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6753229|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6753230|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
6753231|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753232|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753233|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753234|NCT02034604|Urological Agents|urological agents|mesh-ancestor
6753235|NCT02034630|Busulfan|busulfan|mesh-list
6753236|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
6753237|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753238|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6753239|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
6753240|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753241|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6753242|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753243|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6753244|NCT02034838|Ritonavir|ritonavir|mesh-list
6753245|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6753246|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6753247|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6753248|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
6753249|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753250|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753251|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6753252|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6753253|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
6753254|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753255|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6753256|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6753257|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
6753258|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6753259|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
6753260|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753261|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
6753262|NCT02034890|Protective Agents|protective agents|mesh-ancestor
6753263|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
6753264|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6753265|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753266|NCT02034981|Crizotinib|crizotinib|mesh-list
6753267|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753268|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6753269|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753270|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753271|NCT02035020|Interferons|interferons|mesh-list
6753272|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
6753273|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753274|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
6753275|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753276|NCT02035072|Gemcitabine|gemcitabine|mesh-list
6753277|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
6753278|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6753279|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
6753280|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753281|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753282|NCT02035072|Antiviral Agents|antiviral agents|mesh-ancestor
6753283|NCT02035072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753284|NCT02035072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753285|NCT02035072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6753286|NCT02035072|Immunologic Factors|immunologic factors|mesh-ancestor
6753287|NCT02035072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788001|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
6788002|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788003|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753288|NCT02035215|Atorvastatin|atorvastatin|mesh-list
6753289|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6753290|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6753291|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
6753292|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753293|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6753294|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6753295|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753296|NCT02035371|Insulin|insulin|mesh-list
6753297|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6753298|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
6753299|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
6753300|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6753301|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6753302|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753303|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
6753304|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6753305|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6753306|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6753307|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6753308|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753309|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
6753310|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753311|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753312|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6753313|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753314|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6753315|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6753316|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753317|NCT02035488|Tobramycin|tobramycin|mesh-list
6753318|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6753319|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753320|NCT02035527|Docetaxel|docetaxel|mesh-list
6753321|NCT02035527|Sorafenib|sorafenib|mesh-list
6753322|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753323|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753324|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753325|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753326|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753327|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6753328|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753329|NCT02035709|Hydromorphone|hydromorphone|mesh-list
6753330|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6753331|NCT02035709|Narcotics|narcotics|mesh-ancestor
6753332|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753333|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753334|NCT02035709|Analgesics|analgesics|mesh-ancestor
6753335|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
6753336|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753337|NCT02035787|Metformin|metformin|mesh-list
6753338|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6753339|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753340|NCT02035800|Adalimumab|adalimumab|mesh-list
6753341|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6753342|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6753343|NCT02035891|Colchicine|colchicine|mesh-list
6753344|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
6753345|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6753346|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753347|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753348|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753349|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753350|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753351|NCT02035904|Morphine|morphine|mesh-list
6753352|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
6753353|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6753354|NCT02035904|Narcotics|narcotics|mesh-ancestor
6753355|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753356|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753357|NCT02035904|Analgesics|analgesics|mesh-ancestor
6753358|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
6753359|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753360|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
6753361|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
6753362|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
6753363|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6753364|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753365|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753366|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6753367|NCT02035930|Analgesics|analgesics|mesh-ancestor
6753368|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
6753369|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753370|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6753371|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6753372|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6753373|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
6753374|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753375|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753376|NCT02035943|Insulin|insulin|mesh-list
6753377|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6753378|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6753379|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753380|NCT02035956|Vaccines|vaccines|mesh-list
6753381|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
6753382|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753383|NCT02035982|Rivastigmine|rivastigmine|mesh-list
6753384|NCT02035982|Donepezil|donepezil|mesh-list
6753385|NCT02035982|Galantamine|galantamine|mesh-list
6753386|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
6753387|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753388|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753389|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
6753390|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753391|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753392|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
6753393|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6753394|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
6753395|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753396|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6753397|NCT02035982|Protective Agents|protective agents|mesh-ancestor
6753398|NCT02036008|Liver Extracts|liver extracts|mesh-list
6753399|NCT02036008|Hematinics|hematinics|mesh-ancestor
6753400|NCT02036060|Prednisone|prednisone|mesh-list
6753401|NCT02036060|Docetaxel|docetaxel|mesh-list
6753402|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753403|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753404|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753405|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753406|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753407|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6753408|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
6753409|NCT02036060|Hormones|hormones|mesh-ancestor
6753410|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753411|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753412|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6753413|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
6753414|NCT02036073|Hematinics|hematinics|mesh-ancestor
6753415|NCT02036086|Vemurafenib|vemurafenib|mesh-list
6753416|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753417|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6753418|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753419|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753420|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
6753421|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6753422|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6753423|NCT02036125|Prednisolone|prednisolone|mesh-list
6753424|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
6753425|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6753426|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
6753427|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6753428|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
6753429|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
6753430|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753431|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753432|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6753433|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
6753434|NCT02036125|Hormones|hormones|mesh-ancestor
6753435|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753436|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6753437|NCT02036125|Protective Agents|protective agents|mesh-ancestor
6753438|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6753439|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753440|NCT02036151|Fluorides|fluorides|mesh-list
6753441|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
6753442|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
6753443|NCT02036151|Protective Agents|protective agents|mesh-ancestor
6753444|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753445|NCT02036164|Paclitaxel|paclitaxel|mesh-list
6753446|NCT02036164|Cisplatin|cisplatin|mesh-list
6753447|NCT02036164|Carboplatin|carboplatin|mesh-list
6753448|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6753449|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753450|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753451|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753452|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753453|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753454|NCT02036229|Ivermectin|ivermectin|mesh-list
6753455|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6753456|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753457|NCT02036242|Sufentanil|sufentanil|mesh-list
6753458|NCT02036242|Ropivacaine|ropivacaine|mesh-list
6753459|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
6753460|NCT02036242|Anesthetics|anesthetics|mesh-list
6753461|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753462|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753463|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
6753464|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753465|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6753466|NCT02036242|Narcotics|narcotics|mesh-ancestor
6753467|NCT02036242|Analgesics|analgesics|mesh-ancestor
6753468|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6753469|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6753470|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
6753471|NCT02036255|Taurolidine|taurolidine|mesh-list
6753472|NCT02036255|Heparin|heparin|mesh-list
6753473|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
6753474|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6753475|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6753476|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753477|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753478|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6753479|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753480|NCT02036281|Substance P|substance p|mesh-list
6753481|NCT02036281|Neurokinin A|neurokinin a|mesh-list
6753482|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753483|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753484|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753485|NCT02036359|Docetaxel|docetaxel|mesh-list
6753486|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6753487|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753488|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753489|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753490|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753491|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753492|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6753493|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753494|NCT02036372|Insulin|insulin|mesh-list
6753495|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6753496|NCT02036372|Liraglutide|liraglutide|mesh-list
6753497|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6753498|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753499|NCT02036372|Incretins|incretins|mesh-ancestor
6753500|NCT02036372|Hormones|hormones|mesh-ancestor
6753501|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753502|NCT02036437|Misoprostol|misoprostol|mesh-list
6753503|NCT02036437|Dinoprostone|dinoprostone|mesh-list
6753504|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6753505|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
6753506|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6753507|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753508|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6753509|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6753510|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
6753511|NCT02036463|Prednisone|prednisone|mesh-list
6753512|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6753513|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
6753514|NCT02036463|Hormones|hormones|mesh-ancestor
6753515|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753516|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753517|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6753518|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753519|NCT02036489|Prednisone|prednisone|mesh-list
6753520|NCT02036489|Vincristine|vincristine|mesh-list
6753521|NCT02036489|Daunorubicin|daunorubicin|mesh-list
6753522|NCT02036489|Asparaginase|asparaginase|mesh-list
6753523|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
6753524|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6753525|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
6753526|NCT02036489|Hormones|hormones|mesh-ancestor
6753527|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753528|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753529|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6753530|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753531|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6753532|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753533|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753534|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753535|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753536|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6753537|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6753538|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6753539|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753540|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
6753541|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6753542|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6753543|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
6753544|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6753545|NCT02036528|Doxycycline|doxycycline|mesh-list
6753546|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
6753547|NCT02036528|Gentamicins|gentamicins|mesh-list
6753548|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6753549|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753550|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
6753551|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6753552|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6753553|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6753554|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6753555|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753556|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753557|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753558|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6753559|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6753560|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6753561|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
6753562|NCT02036554|Everolimus|everolimus|mesh-list
6753563|NCT02036554|Tacrolimus|tacrolimus|mesh-list
6753564|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6753565|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
6753566|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753567|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6753568|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753569|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753570|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753571|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6753572|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6753573|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
6753574|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6753575|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788004|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6788005|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6788006|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6788007|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788008|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788009|NCT02222428|Olodaterol|olodaterol|mesh-list
6788010|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6788011|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
6788012|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788013|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788014|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6788015|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
6788016|NCT02222441|Pioglitazone|pioglitazone|mesh-list
6788017|NCT02222441|Palbociclib|palbociclib|mesh-list
6788018|NCT02222441|Modafinil|modafinil|mesh-list
6788019|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6788020|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788021|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788022|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6788023|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788024|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788025|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6788026|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6788027|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6788028|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6788029|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6788030|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6788031|NCT02222480|Diuretics|diuretics|mesh-ancestor
6788032|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
6788033|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788034|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6788035|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6788036|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788037|NCT02222519|Bromides|bromides|mesh-list
6788038|NCT02222519|Rocuronium|rocuronium|mesh-list
6788039|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
6788040|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6788041|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6753576|NCT02036697|Fentanyl|fentanyl|mesh-list
6753577|NCT02036697|Morphine|morphine|mesh-list
6753578|NCT02036697|Bupivacaine|bupivacaine|mesh-list
6753579|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
6753580|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
6753581|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753582|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753583|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
6753584|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753585|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6753586|NCT02036697|Narcotics|narcotics|mesh-ancestor
6753587|NCT02036697|Analgesics|analgesics|mesh-ancestor
6753588|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6753589|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6753590|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
6753591|NCT02036723|Bevacizumab|bevacizumab|mesh-list
6753592|NCT02036723|Ranibizumab|ranibizumab|mesh-list
6753593|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6753594|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753595|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6753596|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6753597|NCT02036723|Growth Substances|growth substances|mesh-ancestor
6753598|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753599|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
6753600|NCT02036736|Propofol|propofol|mesh-list
6753601|NCT02036736|Anesthetics|anesthetics|mesh-list
6753602|NCT02036736|Desflurane|desflurane|mesh-list
6753603|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6753604|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753605|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753606|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6753607|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
6753608|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6753609|NCT02036827|Bromides|bromides|mesh-list
6753610|NCT02036827|Rocuronium|rocuronium|mesh-list
6753611|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
6753612|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6753613|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6753614|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6753615|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753616|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753617|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6753618|NCT02036879|Norethindrone|norethindrone|mesh-list
6753619|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
6753620|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6753621|NCT02036879|Estradiol|estradiol|mesh-list
6753622|NCT02036879|Estrogens|estrogens|mesh-ancestor
6753623|NCT02036879|Hormones|hormones|mesh-ancestor
6753624|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753625|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753626|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6753627|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
6753628|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6753629|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6753630|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6753631|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6753632|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6753633|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6753634|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6753635|NCT02036983|Anesthetics|anesthetics|mesh-list
6753636|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
6753637|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753638|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753639|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
6753640|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753641|NCT02037009|Anesthetics|anesthetics|mesh-list
6753642|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753643|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753644|NCT02037035|Ketamine|ketamine|mesh-list
6753645|NCT02037035|Analgesics|analgesics|mesh-ancestor
6753646|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
6753647|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753648|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753649|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6753650|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6753651|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
6753652|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
6753653|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753654|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6753655|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6753656|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753657|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753658|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
6753659|NCT02037126|Promethazine|promethazine|mesh-list
6753660|NCT02037126|Psilocybin|psilocybin|mesh-list
6753661|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6753662|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6753663|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753664|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753665|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
6753666|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
6753667|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
6753668|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753669|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
6753670|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
6753671|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6753672|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6753673|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
6753674|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
6753675|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753676|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753677|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6753678|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
6753679|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
6753680|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
6753681|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6753682|NCT02037191|Methotrexate|methotrexate|mesh-list
6753683|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6753684|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
6753685|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6753686|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753687|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6753688|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
6753689|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753690|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753691|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
6753692|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753693|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6753694|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6753695|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
6753696|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6753697|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6753698|NCT02037399|Dexamethasone|dexamethasone|mesh-list
6753699|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6753700|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
6753701|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
6753702|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753703|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753704|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6753705|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
6753706|NCT02037399|Hormones|hormones|mesh-ancestor
6753707|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753708|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6753709|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753710|NCT02037412|Clopidogrel|clopidogrel|mesh-list
6753711|NCT02037412|Ticagrelor|ticagrelor|mesh-list
6753712|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6753713|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6753714|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6753715|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6753716|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
6753717|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753718|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753719|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753720|NCT02037464|Capsaicin|capsaicin|mesh-list
6753721|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
6753722|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
6753723|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
6753724|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753725|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753726|NCT02037503|Ketamine|ketamine|mesh-list
6753727|NCT02037503|Analgesics|analgesics|mesh-ancestor
6753728|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
6753729|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753730|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753731|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6753732|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6753733|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
6753734|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
6753735|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753736|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6753737|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6753738|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753739|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753740|NCT02037516|Neostigmine|neostigmine|mesh-list
6753741|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6753742|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753743|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753744|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
6753745|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753746|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753747|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6753748|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
6753749|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753750|NCT02037633|Fentanyl|fentanyl|mesh-list
6753751|NCT02037633|Ropivacaine|ropivacaine|mesh-list
6753752|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
6753753|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
6753754|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753755|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753756|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
6753757|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753758|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6753759|NCT02037633|Narcotics|narcotics|mesh-ancestor
6753760|NCT02037633|Analgesics|analgesics|mesh-ancestor
6753761|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6753762|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6753763|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
6753764|NCT02037672|Metformin|metformin|mesh-list
6753765|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6753766|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753767|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
6753768|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
6753769|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
6753770|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753771|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753772|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
6753773|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753774|NCT02037724|Iron|iron|mesh-list
6753775|NCT02037724|Trace Elements|trace elements|mesh-ancestor
6753776|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
6753777|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753778|NCT02037737|Abatacept|abatacept|mesh-list
6753779|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6753780|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753781|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753782|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6753783|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
6753784|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753785|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6753786|NCT02037802|Fentanyl|fentanyl|mesh-list
6753787|NCT02037802|Meperidine|meperidine|mesh-list
6753788|NCT02037802|Bupivacaine|bupivacaine|mesh-list
6753789|NCT02037802|Propofol|propofol|mesh-list
6753790|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
6753791|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
6753792|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753793|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753794|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
6753795|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753796|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6753797|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6753798|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
6753799|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6753800|NCT02037802|Narcotics|narcotics|mesh-ancestor
6753801|NCT02037802|Analgesics|analgesics|mesh-ancestor
6753802|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6753803|NCT02037815|Mannitol|mannitol|mesh-list
6753804|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6753805|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6753806|NCT02037815|Diuretics|diuretics|mesh-ancestor
6753807|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
6753808|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753809|NCT02037919|Etonogestrel|etonogestrel|mesh-list
6753810|NCT02037919|Desogestrel|desogestrel|mesh-list
6753811|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6753812|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
6753813|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6753814|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753815|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6753816|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6753817|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6753818|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6753819|NCT02037919|Progestins|progestins|mesh-ancestor
6753820|NCT02037919|Hormones|hormones|mesh-ancestor
6753821|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753822|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
6753823|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6753824|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753825|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
6753826|NCT02037997|Docetaxel|docetaxel|mesh-list
6753827|NCT02037997|Pemetrexed|pemetrexed|mesh-list
6753828|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6753829|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753830|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753831|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753832|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753833|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753834|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753835|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6753836|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6753837|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6753838|NCT02038062|Sevoflurane|sevoflurane|mesh-list
6753839|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6753840|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6753841|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
6753842|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
6753843|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753844|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753845|NCT02038257|Petrolatum|petrolatum|mesh-list
6753846|NCT02038257|Emollients|emollients|mesh-ancestor
6753847|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
6753848|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6753849|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6753850|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
6753851|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
6753852|NCT02038335|Etonogestrel|etonogestrel|mesh-list
6753853|NCT02038335|Norethindrone|norethindrone|mesh-list
6753854|NCT02038335|Estradiol|estradiol|mesh-list
6753855|NCT02038335|Estrogens|estrogens|mesh-ancestor
6753856|NCT02038335|Hormones|hormones|mesh-ancestor
6753857|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753858|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753859|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6753860|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
6753861|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6753862|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6753863|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6753864|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6753865|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6753866|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6753867|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6753868|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788042|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6788043|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788044|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788045|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
6788046|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6788047|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788048|NCT02222636|Fentanyl|fentanyl|mesh-list
6788049|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
6788050|NCT02222636|Anesthetics|anesthetics|mesh-list
6788051|NCT02222636|Sevoflurane|sevoflurane|mesh-list
6788052|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788053|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788054|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6788055|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6788056|NCT02222636|Analgesics|analgesics|mesh-ancestor
6788057|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
6788058|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788059|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6788060|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6788061|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6788062|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
6788063|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788064|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788065|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6788066|NCT02222636|Narcotics|narcotics|mesh-ancestor
6788067|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6788068|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6788069|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
6788070|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6788071|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6788072|NCT02222649|Vitamin D|vitamin d|mesh-list
6788073|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
6788074|NCT02222649|Vitamins|vitamins|mesh-ancestor
6788075|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
6788076|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788077|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6788078|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6788079|NCT02222727|Donepezil|donepezil|mesh-list
6753869|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6753870|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
6753871|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6753872|NCT02038452|Prednisolone|prednisolone|mesh-list
6753873|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
6753874|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6753875|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
6753876|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6753877|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
6753878|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
6753879|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753880|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753881|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6753882|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
6753883|NCT02038452|Hormones|hormones|mesh-ancestor
6753884|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753885|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6753886|NCT02038452|Protective Agents|protective agents|mesh-ancestor
6753887|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6753888|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753889|NCT02038491|Anesthetics|anesthetics|mesh-list
6753890|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6753891|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753892|NCT02038621|Paclitaxel|paclitaxel|mesh-list
6753893|NCT02038621|Capecitabine|capecitabine|mesh-list
6753894|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
6753895|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6753896|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753897|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753898|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753899|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753900|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753901|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6753902|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
6753903|NCT02038634|Betamethasone|betamethasone|mesh-list
6753904|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6753905|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
6753906|NCT02038634|Hormones|hormones|mesh-ancestor
6753907|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6753908|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753909|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6753910|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
6753911|NCT02038699|TIC10 compound|tic10 compound|mesh-list
6753912|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753913|NCT02038777|Cytarabine|cytarabine|mesh-list
6753914|NCT02038777|Azacitidine|azacitidine|mesh-list
6753915|NCT02038777|Daunorubicin|daunorubicin|mesh-list
6753916|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6753917|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
6753918|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753919|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753920|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
6753921|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753922|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6753923|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
6753924|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753925|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753926|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6753927|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6753928|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6753929|NCT02038816|Azacitidine|azacitidine|mesh-list
6753930|NCT02038816|Deferasirox|deferasirox|mesh-list
6753931|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6753932|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
6753933|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753934|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753935|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753936|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6753937|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
6753938|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
6753939|NCT02038842|Vaccines|vaccines|mesh-list
6753940|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
6753941|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753942|NCT02038868|Tamsulosin|tamsulosin|mesh-list
6753943|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6753944|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6753945|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6753946|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
6753947|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753948|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753949|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753950|NCT02038868|Urological Agents|urological agents|mesh-ancestor
6753951|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
6753952|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6753953|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
6753954|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753955|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753956|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6753957|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
6753958|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
6753959|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6753960|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
6753961|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753962|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753963|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
6753964|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6753965|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
6753966|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6753967|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753968|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6753969|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
6753970|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
6753971|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6753972|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
6753973|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6753974|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753975|NCT02039063|Quetmolimab|quetmolimab|mesh-list
6753976|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6753977|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6753978|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
6753979|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6753980|NCT02039323|Tenofovir|tenofovir|mesh-list
6753981|NCT02039323|Maraviroc|maraviroc|mesh-list
6753982|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
6753983|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6753984|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6753985|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6753986|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6753987|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753988|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6753989|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6753990|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6753991|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6753992|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6753993|NCT02039336|Docetaxel|docetaxel|mesh-list
6753994|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6753995|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
6753996|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
6753997|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
6753998|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6753999|NCT02039362|Tenofovir|tenofovir|mesh-list
6754000|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
6754001|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754002|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6754003|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6754004|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754005|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754006|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6754007|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6754008|NCT02039453|Fentanyl|fentanyl|mesh-list
6754009|NCT02039453|Meperidine|meperidine|mesh-list
6754010|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6754011|NCT02039453|Narcotics|narcotics|mesh-ancestor
6754012|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754013|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754014|NCT02039453|Analgesics|analgesics|mesh-ancestor
6754015|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
6754016|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754017|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6754018|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6754019|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
6754020|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
6754021|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
6754022|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
6754023|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6754024|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754025|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754026|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
6754027|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6754028|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754029|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754030|NCT02039492|Spironolactone|spironolactone|mesh-list
6754031|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6754032|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
6754033|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754034|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754035|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6754036|NCT02039492|Diuretics|diuretics|mesh-ancestor
6754037|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
6754038|NCT02039518|Gemcitabine|gemcitabine|mesh-list
6754039|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6754040|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
6754041|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754042|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754043|NCT02039518|Antiviral Agents|antiviral agents|mesh-ancestor
6754044|NCT02039518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754045|NCT02039518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242783|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6242784|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
6242785|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
6242786|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6242787|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242788|NCT02656069|Glucagon|glucagon|mesh-list
6242789|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6242790|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6242791|NCT02656069|Hormones|hormones|mesh-ancestor
6242792|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6242793|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242794|NCT02656069|Incretins|incretins|mesh-ancestor
6242795|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
6754046|NCT02039518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6754047|NCT02039518|Immunologic Factors|immunologic factors|mesh-ancestor
6754048|NCT02039518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754049|NCT02039531|Mitogens|mitogens|mesh-list
6754050|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
6754051|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
6754052|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754053|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6754054|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
6754055|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754056|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
6754057|NCT02039531|Protective Agents|protective agents|mesh-ancestor
6754058|NCT02039661|Lidocaine|lidocaine|mesh-list
6754059|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
6754060|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
6754061|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754062|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754063|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
6754064|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754065|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6754066|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6754067|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6754068|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6754069|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754070|NCT02039700|Lesinurad|lesinurad|mesh-list
6754071|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
6754072|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6754073|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
6754074|NCT02039700|Renal Agents|renal agents|mesh-ancestor
6754075|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6754076|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6754077|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6754078|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6754079|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6754080|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
6754081|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754082|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754083|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754084|NCT02039791|Paclitaxel|paclitaxel|mesh-list
6754085|NCT02039791|Carboplatin|carboplatin|mesh-list
6754086|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
6754087|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6754088|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754089|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
6754090|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
6754091|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
6754092|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754093|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6754094|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6754095|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
6754096|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6754097|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
6754098|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754099|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
6754100|NCT02039804|Protective Agents|protective agents|mesh-ancestor
6754101|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6754102|NCT02039869|Omeprazole|omeprazole|mesh-list
6754103|NCT02039869|Sucralfate|sucralfate|mesh-list
6754104|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6754105|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6754106|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6754107|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754108|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754109|NCT02039960|Bupropion|bupropion|mesh-list
6754110|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6754111|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
6754112|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6754113|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6754114|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6754115|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6754116|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754117|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
6754118|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754119|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754120|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6754121|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6754122|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754123|NCT02039999|Citric Acid|citric acid|mesh-list
6754124|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
6754125|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6754126|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
6754127|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6754128|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
6754129|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
6754130|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754131|NCT02040064|Gefitinib|gefitinib|mesh-list
6754132|NCT02040064|Tremelimumab|tremelimumab|mesh-list
6754133|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754134|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6754135|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754136|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788080|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6788081|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788082|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788083|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
6788084|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788085|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788086|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
6788087|NCT02222740|Hydrocodone|hydrocodone|mesh-list
6788088|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6788089|NCT02222740|Narcotics|narcotics|mesh-ancestor
6788090|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788091|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788092|NCT02222740|Analgesics|analgesics|mesh-ancestor
6788093|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
6788094|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788095|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
6788096|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
6788097|NCT02222987|Clopidogrel|clopidogrel|mesh-list
6788098|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6788099|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6788100|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6788101|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6788102|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
6788103|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788104|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788105|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788106|NCT02223026|Metformin|metformin|mesh-list
6788107|NCT02223026|Linagliptin|linagliptin|mesh-list
6788108|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6788109|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788110|NCT02223026|Incretins|incretins|mesh-ancestor
6788111|NCT02223026|Hormones|hormones|mesh-ancestor
6788112|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788113|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6788114|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
6788115|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788116|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788117|NCT02223052|Azacitidine|azacitidine|mesh-list
6788118|NCT02223052|Cc-486|cc-486|mesh-list
6788119|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6788120|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
6788121|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788122|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788123|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788124|NCT02223299|Tryptophan|tryptophan|mesh-list
6788125|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6788126|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
6788127|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6788128|NCT02223377|Morphine|morphine|mesh-list
6788129|NCT02223377|Hydromorphone|hydromorphone|mesh-list
6788130|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6788131|NCT02223377|Narcotics|narcotics|mesh-ancestor
6788132|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788133|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788134|NCT02223377|Analgesics|analgesics|mesh-ancestor
6788135|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
6788136|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754137|NCT02040142|Mitomycins|mitomycins|mesh-list
6754138|NCT02040142|Mitomycin|mitomycin|mesh-list
6754139|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6754140|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754141|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
6754142|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754143|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6754144|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754145|NCT02040220|Aflibercept|aflibercept|mesh-list
6754146|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6754147|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6754148|NCT02040220|Growth Substances|growth substances|mesh-ancestor
6754149|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754150|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
6754151|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754152|NCT02040246|Metformin|metformin|mesh-list
6754153|NCT02040246|Repaglinide|repaglinide|mesh-list
6754154|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754155|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754156|NCT02040285|Metoclopramide|metoclopramide|mesh-list
6754157|NCT02040285|Bisacodyl|bisacodyl|mesh-list
6754158|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
6754159|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
6754160|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754161|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754162|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6754163|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6754164|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6754165|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
6754166|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754167|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754168|NCT02040285|Cathartics|cathartics|mesh-ancestor
6754169|NCT02040285|Laxatives|laxatives|mesh-ancestor
6754170|NCT02040311|Topiramate|topiramate|mesh-list
6754171|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
6754172|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754173|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754174|NCT02040350|Pralidoxime|pralidoxime|mesh-list
6754175|NCT02040350|Antidotes|antidotes|mesh-ancestor
6754176|NCT02040350|Protective Agents|protective agents|mesh-ancestor
6754177|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754178|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
6754179|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
6754180|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754181|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
6754182|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754183|NCT02040376|Metformin|metformin|mesh-list
6754184|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754185|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754186|NCT02040402|Vaccines|vaccines|mesh-list
6754187|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
6754188|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754189|NCT02040415|Eperisone|eperisone|mesh-list
6754190|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
6754191|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6754192|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6754193|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754194|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6754195|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754196|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6754197|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6754198|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754199|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
6754200|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
6754201|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
6754202|NCT02040441|Spironolactone|spironolactone|mesh-list
6754203|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6754204|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
6754205|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754206|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754207|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6754208|NCT02040441|Diuretics|diuretics|mesh-ancestor
6754209|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
6754210|NCT02040454|Paclitaxel|paclitaxel|mesh-list
6754211|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6754212|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754213|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
6754214|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
6754215|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
6754216|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754217|NCT02040571|Insulin|insulin|mesh-list
6754218|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754219|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754220|NCT02040597|Beclomethasone|beclomethasone|mesh-list
6754221|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
6754222|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
6754223|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6754224|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
6754225|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754226|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754227|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6754228|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
6754229|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6754230|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6754231|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6754232|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
6754233|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754234|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754235|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6754236|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6754237|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6754238|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
6754239|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6754240|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
6754241|NCT02040597|Hormones|hormones|mesh-ancestor
6754242|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754243|NCT02040636|Vaccines|vaccines|mesh-list
6754244|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
6754245|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754246|NCT02040649|Midazolam|midazolam|mesh-list
6754247|NCT02040649|Propofol|propofol|mesh-list
6754248|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6754249|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754250|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754251|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6754252|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
6754253|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
6754254|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6754255|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6754256|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6754257|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6754258|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
6754259|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
6754260|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754261|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754262|NCT02040662|Morphine|morphine|mesh-list
6754263|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6754264|NCT02040662|Narcotics|narcotics|mesh-ancestor
6754265|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754266|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754267|NCT02040662|Analgesics|analgesics|mesh-ancestor
6754268|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
6754269|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754270|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
6754271|NCT02040818|Tigecycline|tigecycline|mesh-list
6754272|NCT02040818|Heparin|heparin|mesh-list
6754273|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6754274|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
6754275|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6754276|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6754277|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754278|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
6754279|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754280|NCT02040818|Expectorants|expectorants|mesh-ancestor
6754281|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
6754282|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6754283|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
6754284|NCT02040818|Protective Agents|protective agents|mesh-ancestor
6754285|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754286|NCT02040818|Antidotes|antidotes|mesh-ancestor
6754287|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6754288|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6754289|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754290|NCT02040831|Vaccines|vaccines|mesh-list
6754291|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
6754292|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754293|NCT02040883|Olanzapine|olanzapine|mesh-list
6754294|NCT02040883|Risperidone|risperidone|mesh-list
6754295|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6754296|NCT02040883|Aripiprazole|aripiprazole|mesh-list
6754297|NCT02040883|Ziprasidone|ziprasidone|mesh-list
6754298|NCT02040883|Tandospirone|tandospirone|mesh-list
6754299|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6754300|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
6754301|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754302|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754303|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754304|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6754305|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6754306|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754307|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6754308|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6754309|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
6754310|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
6754311|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
6754312|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754313|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6754314|NCT02040883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6754315|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6754316|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6754317|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
6754318|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
6754319|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6754320|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6754321|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6754322|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6754323|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6754324|NCT02040909|Propofol|propofol|mesh-list
6754325|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6754326|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754327|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754328|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6754329|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
6754330|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
6754331|NCT02040935|Trastuzumab|trastuzumab|mesh-list
6754332|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6754333|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754334|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
6754335|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6754336|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754337|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6754338|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6754339|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754340|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754341|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754342|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6754343|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6754344|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6754345|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
6754346|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754347|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6754348|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6754349|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754350|NCT02041143|Caseins|caseins|mesh-list
6754351|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
6754352|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
6754353|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754354|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6754355|NCT02041234|Liraglutide|liraglutide|mesh-list
6754356|NCT02041234|Empagliflozin|empagliflozin|mesh-list
6754357|NCT02041234|Linagliptin|linagliptin|mesh-list
6754358|NCT02041234|Canagliflozin|canagliflozin|mesh-list
6754359|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6754360|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6754361|NCT02041234|Orlistat|orlistat|mesh-list
6754362|NCT02041234|Incretins|incretins|mesh-list
6754363|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754364|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754365|NCT02041234|Hormones|hormones|mesh-ancestor
6754366|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754367|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
6754368|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754369|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754370|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6754371|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6754372|NCT02041273|Palbociclib|palbociclib|mesh-list
6754373|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754374|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6754375|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754376|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754377|NCT02041338|Paclitaxel|paclitaxel|mesh-list
6754378|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6754379|NCT02041338|Carboplatin|carboplatin|mesh-list
6754380|NCT02041338|Epirubicin|epirubicin|mesh-list
6754381|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6754382|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754383|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
6754384|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
6754385|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
6754386|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754387|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6754388|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6754389|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6754390|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754391|NCT02041351|Docetaxel|docetaxel|mesh-list
6754392|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754393|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
6754394|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
6754395|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
6754396|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754397|NCT02041455|Amitriptyline|amitriptyline|mesh-list
6754398|NCT02041455|Melatonin|melatonin|mesh-list
6754399|NCT02041455|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6754400|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
6754401|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754402|NCT02041455|Protective Agents|protective agents|mesh-ancestor
6754403|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754404|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754405|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6754406|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
6754407|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6754408|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6754409|NCT02041455|Analgesics|analgesics|mesh-ancestor
6754410|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
6754411|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754412|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6754413|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6754414|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6754415|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
6754416|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754417|NCT02041455|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6754418|NCT02041455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6754419|NCT02041481|Leucovorin|leucovorin|mesh-list
6754420|NCT02041481|Fluorouracil|fluorouracil|mesh-list
6754421|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
6754422|NCT02041481|Calcium|calcium|mesh-list
6754423|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
6754424|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6754425|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754426|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
6754427|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754428|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6754429|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754430|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6754431|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
6754432|NCT02041481|Antidotes|antidotes|mesh-ancestor
6754433|NCT02041481|Protective Agents|protective agents|mesh-ancestor
6754434|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
6754435|NCT02041481|Vitamins|vitamins|mesh-ancestor
6754436|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
6754437|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6754438|NCT02041546|Poractant alfa|poractant alfa|mesh-list
6754439|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
6754440|NCT02041650|Ticagrelor|ticagrelor|mesh-list
6754441|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6754442|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6754443|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6754444|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6754445|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
6754446|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754447|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754448|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754449|NCT02041767|Ertapenem|ertapenem|mesh-list
6754450|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6754451|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788137|NCT02223416|Teriparatide|teriparatide|mesh-list
6788138|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6788139|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788140|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6788141|NCT02223533|Morphine|morphine|mesh-list
6788142|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6788143|NCT02223533|Narcotics|narcotics|mesh-ancestor
6788144|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788145|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788146|NCT02223533|Analgesics|analgesics|mesh-ancestor
6788147|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
6788148|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788149|NCT02223598|Dexamethasone|dexamethasone|mesh-list
6788150|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6788151|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
6788152|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
6788153|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788154|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788155|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6788156|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
6788157|NCT02223598|Hormones|hormones|mesh-ancestor
6788158|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788159|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6788160|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788161|NCT02223611|Cisplatin|cisplatin|mesh-list
6788162|NCT02223611|Vinorelbine|vinorelbine|mesh-list
6788163|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788164|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6788165|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
6788166|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
6788167|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
6788168|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788169|NCT02223819|Crizotinib|crizotinib|mesh-list
6788170|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788171|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6788172|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788173|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788174|NCT02223832|Ponesimod|ponesimod|mesh-list
6788175|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6788176|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788177|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6788178|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
6788179|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788180|NCT02223884|Carboplatin|carboplatin|mesh-list
6788181|NCT02223884|Docetaxel|docetaxel|mesh-list
6788182|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788183|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
6788184|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
6788185|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
6788186|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788187|NCT02223949|Alprostadil|alprostadil|mesh-list
6788188|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6788189|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
6788190|NCT02223949|Urological Agents|urological agents|mesh-ancestor
6788191|NCT02224014|Brotizolam|brotizolam|mesh-list
6788192|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6788193|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788194|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788195|NCT02224040|Azithromycin|azithromycin|mesh-list
6788196|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
6788197|NCT02224040|Cefixime|cefixime|mesh-list
6788198|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6788199|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788200|NCT02224066|Aspirin|aspirin|mesh-list
6788201|NCT02224066|Clopidogrel|clopidogrel|mesh-list
6788202|NCT02224066|Ticagrelor|ticagrelor|mesh-list
6788203|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6788204|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6788205|NCT02224066|Analgesics|analgesics|mesh-ancestor
6788206|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
6788207|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788208|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788209|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6788210|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788211|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6754452|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
6754453|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6754454|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754455|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6754456|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
6754457|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754458|NCT02042170|Hormones|hormones|mesh-list
6754459|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754460|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754461|NCT02042196|Cetrorelix|cetrorelix|mesh-list
6754462|NCT02042196|Estradiol|estradiol|mesh-list
6754463|NCT02042196|Estrogens|estrogens|mesh-ancestor
6754464|NCT02042196|Hormones|hormones|mesh-ancestor
6754465|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754466|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754467|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6754468|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6754469|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
6754470|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
6754471|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
6754472|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754473|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
6754474|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754475|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754476|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6754477|NCT02042287|Metronidazole|metronidazole|mesh-list
6754478|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754479|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6754480|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6754481|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6754482|NCT02042326|Sirolimus|sirolimus|mesh-list
6754483|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6754484|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754485|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6754486|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754487|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
6754488|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6754489|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
6754490|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754491|NCT02042391|Cytarabine|cytarabine|mesh-list
6754492|NCT02042391|Prednisone|prednisone|mesh-list
6754493|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
6754494|NCT02042391|Rituximab|rituximab|mesh-list
6754495|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
6754496|NCT02042391|Doxorubicin|doxorubicin|mesh-list
6754497|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6754498|NCT02042391|Vincristine|vincristine|mesh-list
6754499|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6754500|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
6754501|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754502|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6754503|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6754504|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
6754505|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754506|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754507|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6754508|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6754509|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6754510|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
6754511|NCT02042391|Hormones|hormones|mesh-ancestor
6754512|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754513|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6754514|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6754515|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
6754516|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
6754517|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754518|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6754519|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6754520|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6754521|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754522|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6754523|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
6754524|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
6754525|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
6754526|NCT02042482|Ubiquinone|ubiquinone|mesh-list
6754527|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
6754528|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
6754529|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754530|NCT02042482|Vitamins|vitamins|mesh-ancestor
6754531|NCT02042495|Metformin|metformin|mesh-list
6754532|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754533|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754534|NCT02042573|Sertraline|sertraline|mesh-list
6754535|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
6754536|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6754537|NCT02042573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6754538|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6754539|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6754540|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754541|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754542|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
6754543|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754544|NCT02042599|Sevoflurane|sevoflurane|mesh-list
6754545|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6754546|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6754547|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
6754548|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
6754549|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754550|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754551|NCT02042612|Sevoflurane|sevoflurane|mesh-list
6754552|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6754553|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6754554|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
6754555|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
6754556|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754557|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754558|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6754559|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6754560|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754561|NCT02042664|Metformin|metformin|mesh-list
6754562|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754563|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754564|NCT02042690|Dexamethasone|dexamethasone|mesh-list
6754565|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
6754566|NCT02042690|Methotrexate|methotrexate|mesh-list
6754567|NCT02042690|Epirubicin|epirubicin|mesh-list
6754568|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
6754569|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6754570|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
6754571|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754572|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6754573|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6754574|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
6754575|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754576|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754577|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6754578|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6754579|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
6754580|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
6754581|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754582|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6754583|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
6754584|NCT02042690|Hormones|hormones|mesh-ancestor
6754585|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754586|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6754587|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754588|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6754589|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
6754590|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6754591|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6754592|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
6754593|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
6754594|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6754595|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6754596|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6754597|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6754598|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6754599|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
6754600|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
6754601|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754602|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
6754603|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754604|NCT02042742|Protective Agents|protective agents|mesh-ancestor
6754605|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754606|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6754607|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6754608|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
6754609|NCT02042989|Vorinostat|vorinostat|mesh-list
6754610|NCT02042989|Ixazomib|ixazomib|mesh-list
6754611|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754612|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6754613|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754614|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754615|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
6754616|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6754617|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6754618|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754619|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6754620|NCT02043054|Liraglutide|liraglutide|mesh-list
6754621|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754622|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754623|NCT02043054|Incretins|incretins|mesh-ancestor
6754624|NCT02043054|Hormones|hormones|mesh-ancestor
6754625|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754626|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6754627|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
6754628|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754629|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754630|NCT02043171|Vitamin D|vitamin d|mesh-list
6754631|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
6754632|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
6754633|NCT02043171|Vitamins|vitamins|mesh-list
6754634|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
6754635|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754636|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6754637|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6754638|NCT02043223|Vitamins|vitamins|mesh-list
6754639|NCT02043223|Vitamin A|vitamin a|mesh-list
6754640|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
6754641|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
6754642|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754643|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
6754644|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754645|NCT02043223|Protective Agents|protective agents|mesh-ancestor
6754646|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6754647|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754648|NCT02043288|Gemcitabine|gemcitabine|mesh-list
6754649|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6754650|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
6754651|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754652|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754653|NCT02043288|Antiviral Agents|antiviral agents|mesh-ancestor
6754654|NCT02043288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754655|NCT02043288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754656|NCT02043288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6754657|NCT02043288|Immunologic Factors|immunologic factors|mesh-ancestor
6754658|NCT02043288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754659|NCT02043314|Isoniazid|isoniazid|mesh-list
6754660|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
6754661|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6754662|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754663|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6754664|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6754665|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
6754666|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754667|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6754668|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
6754669|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
6788212|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6788213|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788214|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6788215|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6788216|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788217|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
6788218|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6788219|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6788220|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6788221|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
6788222|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788223|NCT02224105|Prednisolone|prednisolone|mesh-list
6788224|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6788225|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
6788226|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6788227|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
6788228|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6788229|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
6788230|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6788231|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
6788232|NCT02224105|Hormones|hormones|mesh-ancestor
6788233|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788234|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788235|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6788236|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788237|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
6788238|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
6788239|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788240|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6788241|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6788242|NCT02224105|Protective Agents|protective agents|mesh-ancestor
6788243|NCT02224131|Aspirin|aspirin|mesh-list
6788244|NCT02224131|Clopidogrel|clopidogrel|mesh-list
6788245|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6788246|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6788247|NCT02224131|Analgesics|analgesics|mesh-ancestor
6788248|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
6788249|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788250|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788251|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6788252|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788253|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6788254|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6754670|NCT02043457|Hormones|hormones|mesh-list
6754671|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754672|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754673|NCT02043587|Leucovorin|leucovorin|mesh-list
6754674|NCT02043587|Cytarabine|cytarabine|mesh-list
6754675|NCT02043587|Prednisone|prednisone|mesh-list
6754676|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
6754677|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6754678|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6754679|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6754680|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
6754681|NCT02043587|Rituximab|rituximab|mesh-list
6754682|NCT02043587|Methotrexate|methotrexate|mesh-list
6754683|NCT02043587|Etoposide|etoposide|mesh-list
6754684|NCT02043587|Vincristine|vincristine|mesh-list
6754685|NCT02043587|Daunorubicin|daunorubicin|mesh-list
6754686|NCT02043587|Asparaginase|asparaginase|mesh-list
6754687|NCT02043587|Dasatinib|dasatinib|mesh-list
6754688|NCT02043587|Pegaspargase|pegaspargase|mesh-list
6754689|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6754690|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
6754691|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754692|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6754693|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6754694|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
6754695|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754696|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754697|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6754698|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6754699|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6754700|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
6754701|NCT02043587|Hormones|hormones|mesh-ancestor
6754702|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754703|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6754704|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6754705|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
6754706|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6754707|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6754708|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
6754709|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
6754710|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754711|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6754712|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6754713|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6754714|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6754715|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6754716|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
6754717|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754718|NCT02043587|Antidotes|antidotes|mesh-ancestor
6754719|NCT02043587|Protective Agents|protective agents|mesh-ancestor
6754720|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
6754721|NCT02043587|Vitamins|vitamins|mesh-ancestor
6754722|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
6754723|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
6754724|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
6754725|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
6754726|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6754727|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6754728|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
6754729|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6754730|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754731|NCT02043717|Vitamin D|vitamin d|mesh-list
6754732|NCT02043717|Vitamins|vitamins|mesh-ancestor
6754733|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
6754734|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754735|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6754736|NCT02043730|Gemcitabine|gemcitabine|mesh-list
6754737|NCT02043730|Paclitaxel|paclitaxel|mesh-list
6754738|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6754739|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754740|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
6754741|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
6754742|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
6754743|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754744|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6754745|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
6754746|NCT02043730|Antiviral Agents|antiviral agents|mesh-ancestor
6754747|NCT02043730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754748|NCT02043730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754749|NCT02043730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6754750|NCT02043730|Immunologic Factors|immunologic factors|mesh-ancestor
6754751|NCT02043730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754752|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
6754753|NCT02043756|Analgesics|analgesics|mesh-ancestor
6754754|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
6754755|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754756|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754757|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754758|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6754759|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6754760|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754761|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754762|NCT02043821|Capecitabine|capecitabine|mesh-list
6754763|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6754764|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
6754765|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754766|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754767|NCT02043886|Acarbose|acarbose|mesh-list
6754768|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6754769|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754770|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754771|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754772|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754773|NCT02043912|Haloperidol|haloperidol|mesh-list
6754774|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
6754775|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
6754776|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
6754777|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754778|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754779|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6754780|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6754781|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6754782|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754783|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6754784|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6754785|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
6754786|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754787|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754788|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6754789|NCT02043977|Propofol|propofol|mesh-list
6754790|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6754791|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754792|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754793|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6754794|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
6754795|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
6754796|NCT02044120|Irinotecan|irinotecan|mesh-list
6754797|NCT02044120|Temozolomide|temozolomide|mesh-list
6754798|NCT02044120|Niraparib|niraparib|mesh-list
6754799|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6754800|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6754801|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754802|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754803|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754804|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6754805|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
6754806|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6754807|NCT02044133|Vitamin D|vitamin d|mesh-list
6754808|NCT02044133|Vitamins|vitamins|mesh-ancestor
6754809|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
6754810|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754811|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6754812|NCT02044146|Clopidogrel|clopidogrel|mesh-list
6754813|NCT02044146|Ticagrelor|ticagrelor|mesh-list
6754814|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6754815|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6754816|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6754817|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6754818|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6754819|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
6754820|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754821|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754822|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754823|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
6754824|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6754825|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754826|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754827|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6754828|NCT02044224|Analgesics|analgesics|mesh-ancestor
6754829|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
6754830|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754831|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6754832|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6754833|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6754834|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
6754835|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754836|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754837|NCT02044250|Aspirin|aspirin|mesh-list
6754838|NCT02044250|Clopidogrel|clopidogrel|mesh-list
6754839|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6754840|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6754841|NCT02044250|Analgesics|analgesics|mesh-ancestor
6754842|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
6754843|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754844|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754845|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6754846|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6754847|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6754848|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6754849|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754850|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6754851|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6754852|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754853|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
6754854|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6754855|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6754856|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6754857|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
6754858|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6754859|NCT02044354|Docetaxel|docetaxel|mesh-list
6754860|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754861|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
6754862|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
6754863|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
6754864|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754865|NCT02044497|Oxycodone|oxycodone|mesh-list
6754866|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6754867|NCT02044497|Narcotics|narcotics|mesh-ancestor
6754868|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6754869|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754870|NCT02044497|Analgesics|analgesics|mesh-ancestor
6754871|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
6754872|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754873|NCT02044549|Oxytocin|oxytocin|mesh-list
6754874|NCT02044549|Carbetocin|carbetocin|mesh-list
6754875|NCT02044549|Methylergonovine|methylergonovine|mesh-list
6754876|NCT02044549|Syntometrine|syntometrine|mesh-list
6754877|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
6754878|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6754879|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754880|NCT02044601|Paclitaxel|paclitaxel|mesh-list
6754881|NCT02044601|Carboplatin|carboplatin|mesh-list
6754882|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6754883|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6754884|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754885|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
6754886|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
6754887|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
6754888|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754889|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6754890|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754891|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6754892|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6754893|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
6754894|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754895|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6754896|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754897|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754898|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754899|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
6754900|NCT02044653|Hematinics|hematinics|mesh-ancestor
6754901|NCT02044809|Cannabidiol|cannabidiol|mesh-list
6754902|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
6754903|NCT02044952|Mesalamine|mesalamine|mesh-list
6754904|NCT02044952|Triptolide|triptolide|mesh-list
6754905|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6754906|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6754907|NCT02044952|Analgesics|analgesics|mesh-ancestor
6754908|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
6754909|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754910|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754911|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6754912|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6754913|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754914|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6754915|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6754916|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
6754917|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6754918|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6754919|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
6754920|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6754921|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
6754922|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754923|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6754924|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6754925|NCT02044965|Trimethoprim|trimethoprim|mesh-list
6754926|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
6754927|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6754928|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6754929|NCT02044965|Renal Agents|renal agents|mesh-ancestor
6754930|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
6754931|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6754932|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6754933|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6754934|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754935|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754936|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6754937|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6754938|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6754939|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
6754940|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6754941|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754942|NCT02045017|Dexamethasone|dexamethasone|mesh-list
6754943|NCT02045017|Pomalidomide|pomalidomide|mesh-list
6754944|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6754945|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
6754946|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
6754947|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6754948|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754949|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6754950|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
6754951|NCT02045017|Hormones|hormones|mesh-ancestor
6754952|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6754953|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6754954|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754955|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
6754956|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6754957|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6754958|NCT02045017|Growth Substances|growth substances|mesh-ancestor
6754959|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
6754960|NCT02045030|Aflibercept|aflibercept|mesh-list
6754961|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6754962|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6754963|NCT02045030|Growth Substances|growth substances|mesh-ancestor
6754964|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754965|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
6754966|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754967|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
6754968|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6754969|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
6754970|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754971|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6754972|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6754973|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6754974|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754975|NCT02045069|Ivermectin|ivermectin|mesh-list
6754976|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6754977|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788255|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788256|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6788257|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6788258|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788259|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
6788260|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6788261|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6788262|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6788263|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
6788264|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788265|NCT02224144|Vitamin D|vitamin d|mesh-list
6788266|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
6788267|NCT02224144|Calcitriol|calcitriol|mesh-list
6788268|NCT02224144|Vitamins|vitamins|mesh-ancestor
6788269|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
6788270|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788271|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6788272|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6788273|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6788274|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6788275|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788276|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6788277|NCT02224170|Dexamethasone|dexamethasone|mesh-list
6788278|NCT02224170|Lidocaine|lidocaine|mesh-list
6788279|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6788280|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
6788281|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
6788282|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788283|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788284|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6754978|NCT02045290|Metformin|metformin|mesh-list
6754979|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6754980|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754981|NCT02045368|Methotrexate|methotrexate|mesh-list
6754982|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6754983|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
6754984|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6754985|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6754986|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6754987|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
6754988|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6754989|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6754990|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
6754991|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6754992|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6754993|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6754994|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
6754995|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6754996|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6754997|NCT02045589|Gemcitabine|gemcitabine|mesh-list
6754998|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6754999|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6755000|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
6755001|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755002|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755003|NCT02045589|Antiviral Agents|antiviral agents|mesh-ancestor
6755004|NCT02045589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755005|NCT02045589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755006|NCT02045589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755007|NCT02045589|Immunologic Factors|immunologic factors|mesh-ancestor
6755008|NCT02045589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755009|NCT02045602|Gemcitabine|gemcitabine|mesh-list
6755010|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6755011|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6755012|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
6755013|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755014|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755015|NCT02045602|Antiviral Agents|antiviral agents|mesh-ancestor
6755016|NCT02045602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755017|NCT02045602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755018|NCT02045602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755019|NCT02045602|Immunologic Factors|immunologic factors|mesh-ancestor
6755020|NCT02045602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755021|NCT02045667|Mexiletine|mexiletine|mesh-list
6755022|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6755023|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6755024|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6755025|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6755026|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755027|NCT02045693|Buprenorphine|buprenorphine|mesh-list
6755028|NCT02045693|Methadone|methadone|mesh-list
6755029|NCT02045693|Naloxone|naloxone|mesh-list
6755030|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6755031|NCT02045693|Narcotics|narcotics|mesh-ancestor
6755032|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755033|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755034|NCT02045693|Analgesics|analgesics|mesh-ancestor
6755035|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
6755036|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755037|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6755038|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
6755039|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
6755040|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
6755041|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
6755042|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
6755043|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755044|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755045|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
6755046|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755047|NCT02045849|Itraconazole|itraconazole|mesh-list
6755048|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
6755049|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755050|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6755051|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6755052|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755053|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755054|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6755055|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
6755056|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755057|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755058|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6755059|NCT02045914|Calcium|calcium|mesh-list
6755060|NCT02045914|Ionophores|ionophores|mesh-list
6755061|NCT02045914|Ionomycin|ionomycin|mesh-list
6755062|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
6755063|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6755064|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755065|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6755066|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755067|NCT02045940|GSK2881078|gsk2881078|mesh-list
6755068|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
6755069|NCT02045940|Hormones|hormones|mesh-ancestor
6755070|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755071|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755072|NCT02045953|Albuterol|albuterol|mesh-list
6755073|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6755074|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
6755075|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755076|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755077|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6755078|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
6755079|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
6755080|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6755081|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6755082|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6755083|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6755084|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
6755085|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755086|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755087|NCT02045992|Caffeine|caffeine|mesh-list
6755088|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6755089|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755090|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6755091|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755092|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755093|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6755094|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6755095|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
6755096|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755097|NCT02046044|Digoxin|digoxin|mesh-list
6755098|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6755099|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6755100|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755101|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755102|NCT02046044|Protective Agents|protective agents|mesh-ancestor
6755103|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755104|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
6755105|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6755106|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755107|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
6755108|NCT02046187|Temozolomide|temozolomide|mesh-list
6755109|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6755110|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
6755111|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755112|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755113|NCT02046304|Gemcitabine|gemcitabine|mesh-list
6755114|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6755115|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
6755116|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755117|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755118|NCT02046304|Antiviral Agents|antiviral agents|mesh-ancestor
6755119|NCT02046304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755120|NCT02046304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755121|NCT02046304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755122|NCT02046304|Immunologic Factors|immunologic factors|mesh-ancestor
6755123|NCT02046304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755124|NCT02046421|Gemcitabine|gemcitabine|mesh-list
6755125|NCT02046421|Carboplatin|carboplatin|mesh-list
6755126|NCT02046421|Mifepristone|mifepristone|mesh-list
6755127|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755128|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6755129|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
6755130|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755131|NCT02046421|Antiviral Agents|antiviral agents|mesh-ancestor
6755132|NCT02046421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755133|NCT02046421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755134|NCT02046421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755135|NCT02046421|Immunologic Factors|immunologic factors|mesh-ancestor
6755136|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755137|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6755138|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
6755139|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6755140|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6755141|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6755142|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6755143|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
6755144|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6755145|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6755146|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
6755147|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755148|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
6755149|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6755150|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6755151|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
6755152|NCT02046434|Glycerol|glycerol|mesh-list
6755153|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6755154|NCT02046434|Protective Agents|protective agents|mesh-ancestor
6755155|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755156|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755157|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
6755158|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6755159|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6755160|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6755161|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6755162|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
6755163|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755164|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755165|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755166|NCT02046460|Aspirin|aspirin|mesh-list
6755167|NCT02046460|Vitamin K|vitamin k|mesh-list
6755168|NCT02046460|Warfarin|warfarin|mesh-list
6755169|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
6755170|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
6755171|NCT02046460|Vitamins|vitamins|mesh-ancestor
6755172|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
6755173|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755174|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
6755175|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6755176|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6755177|NCT02046460|Analgesics|analgesics|mesh-ancestor
6755178|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
6755179|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755180|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755181|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755182|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6755183|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6755184|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755185|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6755186|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6755187|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755188|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
6755189|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6755190|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
6755191|NCT02046460|Coagulants|coagulants|mesh-ancestor
6755192|NCT02046486|Ticagrelor|ticagrelor|mesh-list
6755193|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6755194|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6755195|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6755196|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6755197|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
6755198|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755199|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755200|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755201|NCT02046499|Oxytocin|oxytocin|mesh-list
6755202|NCT02046499|Ergonovine|ergonovine|mesh-list
6755203|NCT02046499|Syntometrine|syntometrine|mesh-list
6755204|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
6755205|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6755206|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755207|NCT02046538|Leucovorin|leucovorin|mesh-list
6755208|NCT02046538|Fluorouracil|fluorouracil|mesh-list
6755209|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
6755210|NCT02046538|Irinotecan|irinotecan|mesh-list
6755211|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
6755212|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755213|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6755214|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755215|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755216|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
6755217|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755218|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6755219|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6755220|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755221|NCT02046538|Antidotes|antidotes|mesh-ancestor
6755222|NCT02046538|Protective Agents|protective agents|mesh-ancestor
6755223|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
6755224|NCT02046538|Vitamins|vitamins|mesh-ancestor
6755225|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
6755226|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6755227|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6755228|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6755229|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6755230|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755231|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
6755232|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755233|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755234|NCT02046577|Vitamin D|vitamin d|mesh-list
6755235|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
6755236|NCT02046577|Vitamins|vitamins|mesh-ancestor
6755237|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
6755238|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755239|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6755240|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6755241|NCT02046590|Propofol|propofol|mesh-list
6755242|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
6755243|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755244|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755245|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6755246|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6755247|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
6755248|NCT02046629|Teriflunomide|teriflunomide|mesh-list
6755249|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
6755250|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6755251|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6755252|NCT02046629|Analgesics|analgesics|mesh-ancestor
6755253|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
6755254|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755255|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755256|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755257|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755258|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755259|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
6755260|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6755261|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6755262|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
6755263|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755264|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6755265|NCT02046668|Spironolactone|spironolactone|mesh-list
6755266|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6755267|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
6755268|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755269|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755270|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6755271|NCT02046668|Diuretics|diuretics|mesh-ancestor
6755272|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
6755273|NCT02046694|Allopurinol|allopurinol|mesh-list
6755274|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
6755275|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755276|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755277|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
6755278|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755279|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6755280|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
6755281|NCT02046694|Protective Agents|protective agents|mesh-ancestor
6755282|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755283|NCT02046720|Propofol|propofol|mesh-list
6755284|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6755285|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755286|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755287|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6755288|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
6755289|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
6755290|NCT02046733|Nivolumab|nivolumab|mesh-list
6755291|NCT02046733|Ipilimumab|ipilimumab|mesh-list
6755292|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6755293|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755294|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6755295|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755296|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6755297|NCT02046850|Rifampin|rifampin|mesh-list
6755298|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6755299|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
6755300|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6755301|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755302|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
6755303|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6755304|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755305|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755306|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6755307|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6755308|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6755309|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6755310|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6755311|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6755312|NCT02046915|Dexamethasone|dexamethasone|mesh-list
6755313|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
6755314|NCT02046915|Pomalidomide|pomalidomide|mesh-list
6755315|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755316|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
6755317|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755318|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755319|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6755320|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
6755321|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755322|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755323|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6755324|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755325|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
6755326|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
6755327|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755328|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6755329|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
6755330|NCT02046915|Hormones|hormones|mesh-ancestor
6755331|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755332|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6755333|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6755334|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6755335|NCT02046915|Growth Substances|growth substances|mesh-ancestor
6755336|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
6788285|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
6788286|NCT02224170|Hormones|hormones|mesh-ancestor
6788287|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788288|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6788289|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788290|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
6788291|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
6788292|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788293|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
6788294|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6788295|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6788296|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6788297|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6788298|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788299|NCT02224391|Nicotine|nicotine|mesh-list
6788300|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6788301|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
6788302|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788303|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788304|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6788305|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6788306|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
6788307|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788308|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788309|NCT02224443|Fentanyl|fentanyl|mesh-list
6788310|NCT02224443|Midazolam|midazolam|mesh-list
6788311|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
6788312|NCT02224443|Remifentanil|remifentanil|mesh-list
6788313|NCT02224443|Propofol|propofol|mesh-list
6788314|NCT02224443|Etomidate|etomidate|mesh-list
6788315|NCT02224443|Sevoflurane|sevoflurane|mesh-list
6788316|NCT02224443|Atracurium|atracurium|mesh-list
6788317|NCT02224443|Cisatracurium|cisatracurium|mesh-list
6788318|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6788319|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788320|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788321|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6788322|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
6788323|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
6788324|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6788325|NCT02224443|Analgesics|analgesics|mesh-ancestor
6788326|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
6788327|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788328|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6788329|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6788330|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6788331|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
6788332|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788333|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788334|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6788335|NCT02224443|Narcotics|narcotics|mesh-ancestor
6788336|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6788337|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6788338|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6788339|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6788340|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
6788341|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
6788342|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6788343|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6788344|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6788345|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6755337|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
6755338|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6755339|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
6755340|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6755341|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
6755342|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755343|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755344|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
6755345|NCT02047019|Candesartan|candesartan|mesh-list
6755346|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
6755347|NCT02047019|Nifedipine|nifedipine|mesh-list
6755348|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6755349|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6755350|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6755351|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755352|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6755353|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6755354|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6755355|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755356|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
6755357|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
6755358|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6755359|NCT02047136|Histamine|histamine|mesh-list
6755360|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
6755361|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
6755362|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755363|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755364|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755365|NCT02047149|Zileuton|zileuton|mesh-list
6755366|NCT02047149|Dasatinib|dasatinib|mesh-list
6755367|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
6755368|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755369|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6755370|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755371|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755372|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6755373|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6755374|NCT02047149|Analgesics|analgesics|mesh-ancestor
6755375|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
6755376|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755377|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755378|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755379|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755380|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6755381|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6755382|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
6755383|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755384|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
6755385|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6755386|NCT02047162|Bismuth|bismuth|mesh-list
6755387|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
6755388|NCT02047162|Antacids|antacids|mesh-ancestor
6755389|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755390|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6755391|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
6755392|NCT02047175|Niacin|niacin|mesh-list
6755393|NCT02047175|Amlodipine|amlodipine|mesh-list
6755394|NCT02047175|Telmisartan|telmisartan|mesh-list
6755395|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6755396|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6755397|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6755398|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6755399|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755400|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6755401|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755402|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
6755403|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6755404|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6755405|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
6755406|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6755407|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6755408|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755409|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6755410|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6755411|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
6755412|NCT02047175|Vitamins|vitamins|mesh-ancestor
6755413|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
6755414|NCT02047201|Docetaxel|docetaxel|mesh-list
6755415|NCT02047201|Fluorouracil|fluorouracil|mesh-list
6755416|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755417|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
6755418|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
6755419|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
6755420|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755421|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
6755422|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6755423|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755424|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
6755425|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755426|NCT02047292|Tacrine|tacrine|mesh-list
6755427|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6755428|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755429|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755430|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
6755431|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755432|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755433|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6755434|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
6755435|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755436|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
6755437|NCT02047422|Metolazone|metolazone|mesh-list
6755438|NCT02047422|Furosemide|furosemide|mesh-list
6755439|NCT02047422|Spironolactone|spironolactone|mesh-list
6755440|NCT02047422|Diuretics|diuretics|mesh-ancestor
6755441|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
6755442|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755443|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6755444|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6755445|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755446|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6755447|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
6755448|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755449|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6755450|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6755451|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6755452|NCT02047474|Leucovorin|leucovorin|mesh-list
6755453|NCT02047474|Fluorouracil|fluorouracil|mesh-list
6755454|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
6755455|NCT02047474|Irinotecan|irinotecan|mesh-list
6755456|NCT02047474|Calcium|calcium|mesh-list
6755457|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
6755458|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6755459|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755460|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
6755461|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755462|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6755463|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755464|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755465|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
6755466|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6755467|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6755468|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755469|NCT02047474|Antidotes|antidotes|mesh-ancestor
6755470|NCT02047474|Protective Agents|protective agents|mesh-ancestor
6755471|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
6755472|NCT02047474|Vitamins|vitamins|mesh-ancestor
6755473|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
6755474|NCT02047539|Aspirin|aspirin|mesh-list
6755475|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6755476|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6755477|NCT02047539|Analgesics|analgesics|mesh-ancestor
6755478|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
6755479|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755480|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755481|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755482|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755483|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6755484|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6755485|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755486|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6755487|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6755488|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755489|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
6755490|NCT02047552|Iron|iron|mesh-list
6755491|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6755492|NCT02047552|Oxandrolone|oxandrolone|mesh-list
6755493|NCT02047552|Trace Elements|trace elements|mesh-ancestor
6755494|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
6755495|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755496|NCT02047552|Hematinics|hematinics|mesh-ancestor
6755497|NCT02047552|Androgens|androgens|mesh-ancestor
6755498|NCT02047552|Hormones|hormones|mesh-ancestor
6755499|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755500|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
6755501|NCT02047565|Edoxaban|edoxaban|mesh-list
6755502|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6755503|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
6755504|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6755505|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
6755506|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755507|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755508|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
6755509|NCT02047578|Busulfan|busulfan|mesh-list
6755510|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
6755511|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755512|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755513|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
6755514|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755515|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6755516|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755517|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6755518|NCT02047630|Latanoprost|latanoprost|mesh-list
6755519|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6755520|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6755521|NCT02047773|Meropenem|meropenem|mesh-list
6755522|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6755523|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755524|NCT02047799|Calcitriol|calcitriol|mesh-list
6755525|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6755526|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755527|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
6755528|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6755529|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755530|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6755531|NCT02047799|Vitamins|vitamins|mesh-ancestor
6755532|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
6755533|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6755534|NCT02047838|Hormones|hormones|mesh-list
6755535|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6755536|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755537|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755538|NCT02048007|Azithromycin|azithromycin|mesh-list
6755539|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6755540|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755541|NCT02048020|Paclitaxel|paclitaxel|mesh-list
6755542|NCT02048020|Carboplatin|carboplatin|mesh-list
6755543|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6755544|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755545|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
6755546|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
6755547|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
6755548|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755549|NCT02048085|Clopidogrel|clopidogrel|mesh-list
6755550|NCT02048085|Ticagrelor|ticagrelor|mesh-list
6755551|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6755552|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6755553|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6755554|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6755555|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
6755556|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755557|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755558|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755559|NCT02048098|Misoprostol|misoprostol|mesh-list
6755560|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6755561|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
6755562|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6755563|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755564|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6755565|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6755566|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
6755567|NCT02048150|Antibodies|antibodies|mesh-list
6755568|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6755569|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
6755570|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755571|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
6755572|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6755573|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755574|NCT02048215|Ephedrine|ephedrine|mesh-list
6755575|NCT02048215|Caffeine|caffeine|mesh-list
6755576|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6755577|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755578|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6755579|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755580|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755581|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6755582|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6755583|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
6755584|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755585|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
6755586|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
6755587|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755588|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6755589|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
6755590|NCT02048228|Clopidogrel|clopidogrel|mesh-list
6755591|NCT02048228|Ticagrelor|ticagrelor|mesh-list
6755592|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6755593|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6755594|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6755595|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6755596|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
6755597|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755598|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755599|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755600|NCT02048293|Remifentanil|remifentanil|mesh-list
6755601|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6755602|NCT02048293|Narcotics|narcotics|mesh-ancestor
6755603|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755604|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755605|NCT02048293|Analgesics|analgesics|mesh-ancestor
6755606|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
6755607|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755608|NCT02048319|Ethanol|ethanol|mesh-list
6755609|NCT02048319|Pasireotide|pasireotide|mesh-list
6755610|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6755611|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755612|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755613|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755614|NCT02048319|Hormones|hormones|mesh-ancestor
6755615|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755616|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6755617|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
6755618|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6755619|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6755620|NCT02048358|Prednisolone|prednisolone|mesh-list
6755621|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
6755622|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6755623|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
6755624|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755625|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
6755626|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
6755627|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755628|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755629|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6755630|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
6755631|NCT02048358|Hormones|hormones|mesh-ancestor
6755632|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755633|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6755634|NCT02048358|Protective Agents|protective agents|mesh-ancestor
6755635|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6755636|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755637|NCT02048384|Metformin|metformin|mesh-list
6755638|NCT02048384|Sirolimus|sirolimus|mesh-list
6755639|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6755640|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755641|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6755642|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755643|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6755644|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755645|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
6755646|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755647|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
6755648|NCT02048423|Ketamine|ketamine|mesh-list
6755649|NCT02048423|Analgesics|analgesics|mesh-ancestor
6755650|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
6755651|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755652|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755653|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6755654|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6755655|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
6755656|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
6755657|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755658|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6755659|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6755660|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755661|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755662|NCT02048475|Desflurane|desflurane|mesh-list
6755663|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6755664|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
6755665|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
6755666|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755667|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755668|NCT02048488|Belizatinib|belizatinib|mesh-list
6755669|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6755670|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755671|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755672|NCT02048540|Bevacizumab|bevacizumab|mesh-list
6755673|NCT02048540|Docetaxel|docetaxel|mesh-list
6755674|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
6755675|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6755676|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755677|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6755678|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6755679|NCT02048540|Growth Substances|growth substances|mesh-ancestor
6755680|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755681|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
6755682|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
6755683|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
6755684|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
6755685|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788346|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6788347|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6788348|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6788349|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
6788350|NCT02224456|Tenofovir|tenofovir|mesh-list
6788351|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
6788352|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788353|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6788354|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6788355|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788356|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788357|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6788358|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6788359|NCT02224534|Clopidogrel|clopidogrel|mesh-list
6788360|NCT02224534|Ticagrelor|ticagrelor|mesh-list
6788361|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6788362|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6788363|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6788364|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6788365|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
6788366|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788367|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788368|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788369|NCT02224768|Ipilimumab|ipilimumab|mesh-list
6788370|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6788371|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788372|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6788373|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788374|NCT02224937|Melatonin|melatonin|mesh-list
6788375|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
6788376|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788377|NCT02224937|Protective Agents|protective agents|mesh-ancestor
6788378|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788379|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788380|NCT02224950|Emollients|emollients|mesh-list
6788381|NCT02224950|Chitosan|chitosan|mesh-list
6788382|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6788383|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6788384|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
6788385|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788386|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6788387|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
6788388|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
6788389|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
6788390|NCT02224950|Coagulants|coagulants|mesh-ancestor
6788391|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
6788392|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
6788393|NCT02225054|Ropivacaine|ropivacaine|mesh-list
6788394|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6788395|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788396|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788397|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6788398|NCT02225054|Analgesics|analgesics|mesh-ancestor
6788399|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
6755686|NCT02048644|Beclomethasone|beclomethasone|mesh-list
6755687|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
6755688|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6755689|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
6755690|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755691|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755692|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6755693|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
6755694|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6755695|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6755696|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6755697|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
6755698|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755699|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755700|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755701|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
6755702|NCT02048644|Hormones|hormones|mesh-ancestor
6755703|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755704|NCT02048683|Sevoflurane|sevoflurane|mesh-list
6755705|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6755706|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6755707|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
6755708|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
6755709|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755710|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755711|NCT02048761|Metformin|metformin|mesh-list
6755712|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6755713|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755714|NCT02048800|Treosulfan|treosulfan|mesh-list
6755715|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6755716|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
6755717|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755718|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755719|NCT02048852|Menthol|menthol|mesh-list
6755720|NCT02048852|Nicotine|nicotine|mesh-list
6755721|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6755722|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
6755723|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755724|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755725|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6755726|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6755727|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
6755728|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755729|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755730|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
6755731|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
6755732|NCT02048865|Apixaban|apixaban|mesh-list
6755733|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6755734|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
6755735|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6755736|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
6755737|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755738|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755739|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
6755740|NCT02048917|Bupropion|bupropion|mesh-list
6755741|NCT02048917|Varenicline|varenicline|mesh-list
6755742|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6755743|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
6755744|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6755745|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6755746|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6755747|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6755748|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755749|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
6755750|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755751|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755752|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6755753|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6755754|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755755|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6755756|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6755757|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
6755758|NCT02048930|Budesonide|budesonide|mesh-list
6755759|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755760|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6755761|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
6755762|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755763|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755764|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6755765|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
6755766|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
6755767|NCT02048930|Hormones|hormones|mesh-ancestor
6755768|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755769|NCT02048943|Gemcitabine|gemcitabine|mesh-list
6755770|NCT02048943|Paclitaxel|paclitaxel|mesh-list
6755771|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6755772|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6755773|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755774|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
6755775|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
6755776|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
6755777|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755778|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6755779|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
6755780|NCT02048943|Antiviral Agents|antiviral agents|mesh-ancestor
6755781|NCT02048943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755782|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755783|NCT02048943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755784|NCT02048943|Immunologic Factors|immunologic factors|mesh-ancestor
6755785|NCT02048943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755786|NCT02048969|Flumazenil|flumazenil|mesh-list
6755787|NCT02048969|Antidotes|antidotes|mesh-ancestor
6755788|NCT02048969|Protective Agents|protective agents|mesh-ancestor
6755789|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755790|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
6755791|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
6755792|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755793|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755794|NCT02049034|Lixisenatide|lixisenatide|mesh-list
6755795|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6755796|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755797|NCT02049047|Everolimus|everolimus|mesh-list
6755798|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755799|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755800|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
6755801|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755802|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
6755803|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6755804|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6755805|NCT02049073|Prednisolone|prednisolone|mesh-list
6755806|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
6755807|NCT02049073|Zonisamide|zonisamide|mesh-list
6755808|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6755809|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
6755810|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755811|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
6755812|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
6755813|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755814|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755815|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6755816|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
6755817|NCT02049073|Hormones|hormones|mesh-ancestor
6755818|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755819|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6755820|NCT02049073|Protective Agents|protective agents|mesh-ancestor
6755821|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6755822|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755823|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
6755824|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6755825|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6755826|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755827|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6755828|NCT02049138|Upadacitinib|upadacitinib|mesh-list
6755829|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6755830|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6755831|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755832|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755833|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755834|NCT02049190|Onapristone|onapristone|mesh-list
6755835|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755836|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6755837|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
6755838|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6755839|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755840|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
6755841|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755842|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
6755843|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
6755844|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755845|NCT02049229|Everolimus|everolimus|mesh-list
6755846|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755847|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755848|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
6755849|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755850|NCT02049255|Bupivacaine|bupivacaine|mesh-list
6755851|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
6755852|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
6755853|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
6755854|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755855|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755856|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
6755857|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755858|NCT02049268|Ethanol|ethanol|mesh-list
6755859|NCT02049268|Nicotine|nicotine|mesh-list
6755860|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6755861|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
6755862|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755863|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755864|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6755865|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6755866|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
6755867|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755868|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755869|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6755870|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755871|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755872|NCT02049294|Omalizumab|omalizumab|mesh-list
6755873|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6755874|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6755875|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
6755876|NCT02049320|Remifentanil|remifentanil|mesh-list
6755877|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6755878|NCT02049320|Narcotics|narcotics|mesh-ancestor
6755879|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755880|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755881|NCT02049320|Analgesics|analgesics|mesh-ancestor
6755882|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
6755883|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755884|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
6755885|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
6755886|NCT02049346|Hematinics|hematinics|mesh-ancestor
6755887|NCT02049411|Ketamine|ketamine|mesh-list
6755888|NCT02049411|Analgesics|analgesics|mesh-ancestor
6755889|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
6755890|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755891|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755892|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6755893|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6755894|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
6755895|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
6755896|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755897|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6755898|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6755899|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6755900|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755901|NCT02049515|Ofatumumab|ofatumumab|mesh-list
6755902|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755903|NCT02049541|Rituximab|rituximab|mesh-list
6755904|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6755905|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755906|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
6755907|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755908|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755909|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
6755910|NCT02049580|Thiotepa|thiotepa|mesh-list
6755911|NCT02049580|Fludarabine|fludarabine|mesh-list
6755912|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755913|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
6755914|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755915|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755916|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6755917|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
6755918|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755919|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755920|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6755921|NCT02049593|Irinotecan|irinotecan|mesh-list
6755922|NCT02049593|Temozolomide|temozolomide|mesh-list
6755923|NCT02049593|Talazoparib|talazoparib|mesh-list
6755924|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
6755925|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6755926|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6755927|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755928|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755929|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755930|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6755931|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
6755932|NCT02049606|Nabumetone|nabumetone|mesh-list
6755933|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6755934|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6755935|NCT02049606|Analgesics|analgesics|mesh-ancestor
6755936|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
6755937|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755938|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755939|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755940|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755941|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6755942|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6755943|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755944|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755945|NCT02049671|Hormones|hormones|mesh-list
6755946|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6755947|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755948|NCT02049736|Telbivudine|telbivudine|mesh-list
6755949|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
6755950|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755951|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6755952|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755953|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755954|NCT02049762|Aspirin|aspirin|mesh-list
6755955|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6755956|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6755957|NCT02049762|Analgesics|analgesics|mesh-ancestor
6755958|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
6755959|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755960|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755961|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6755962|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6755963|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6755964|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6755965|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755966|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6755967|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6755968|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755969|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
6755970|NCT02049801|Cytarabine|cytarabine|mesh-list
6755971|NCT02049801|Idarubicin|idarubicin|mesh-list
6755972|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6755973|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
6755974|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6755975|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6755976|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
6755977|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6755978|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6755979|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
6755980|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755981|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6755982|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6755983|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6755984|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6755985|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
6755986|NCT02049970|Bupivacaine|bupivacaine|mesh-list
6755987|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
6755988|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
6755989|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6755990|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6755991|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
6755992|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6755993|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6755994|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6755995|NCT02049970|Analgesics|analgesics|mesh-ancestor
6755996|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6755997|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6755998|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6755999|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
6756000|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756001|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756002|NCT02050009|Metformin|metformin|mesh-list
6756003|NCT02050009|Paclitaxel|paclitaxel|mesh-list
6756004|NCT02050009|Carboplatin|carboplatin|mesh-list
6756005|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6756006|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756007|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
6756008|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
6756009|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
6756010|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756011|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6756012|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756013|NCT02050074|Metformin|metformin|mesh-list
6756014|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
6756015|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6756016|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756017|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6756018|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6756019|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
6756020|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756021|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6756022|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
6756023|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6756024|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
6756025|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
6756026|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756027|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756028|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6756029|NCT02050152|Analgesics|analgesics|mesh-ancestor
6756030|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
6756031|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756032|NCT02050178|Gemcitabine|gemcitabine|mesh-list
6756033|NCT02050178|Paclitaxel|paclitaxel|mesh-list
6756034|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6756035|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756036|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
6756037|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
6756038|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
6756039|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756040|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6756041|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
6756042|NCT02050178|Antiviral Agents|antiviral agents|mesh-ancestor
6756043|NCT02050178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756044|NCT02050178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756045|NCT02050178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6756046|NCT02050178|Immunologic Factors|immunologic factors|mesh-ancestor
6756047|NCT02050178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788400|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788401|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6788402|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6788403|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6788404|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
6788405|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788406|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788407|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
6788408|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
6788409|NCT02225067|Calcium|calcium|mesh-list
6788410|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6788411|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788412|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
6788413|NCT02225093|Caffeine|caffeine|mesh-list
6788414|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6788415|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788416|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6788417|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788418|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788419|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6788420|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6788421|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
6788422|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788423|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
6788424|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
6788425|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6788426|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6788427|NCT02225210|Fentanyl|fentanyl|mesh-list
6788428|NCT02225210|Midazolam|midazolam|mesh-list
6788429|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
6788430|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6788431|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788432|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788433|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6788434|NCT02225210|Analgesics|analgesics|mesh-ancestor
6788435|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
6756048|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
6756049|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
6756050|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6756051|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6756052|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756053|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756054|NCT02050360|Urological Agents|urological agents|mesh-ancestor
6756055|NCT02050529|Hydralazine|hydralazine|mesh-list
6756056|NCT02050529|Labetalol|labetalol|mesh-list
6756057|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6756058|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
6756059|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6756060|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6756061|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6756062|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756063|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756064|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756065|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
6756066|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
6756067|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756068|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6756069|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6756070|NCT02050594|Ipilimumab|ipilimumab|mesh-list
6756071|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6756072|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756073|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6756074|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756075|NCT02050672|Inositol|inositol|mesh-list
6756076|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
6756077|NCT02050672|Vitamins|vitamins|mesh-ancestor
6756078|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
6756079|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756080|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
6756081|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6756082|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756083|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
6756084|NCT02050802|Macitentan|macitentan|mesh-list
6756085|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6756086|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756087|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6756088|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6756089|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756090|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756091|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756092|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6756093|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6756094|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6756095|NCT02050893|Midazolam|midazolam|mesh-list
6756096|NCT02050893|Propofol|propofol|mesh-list
6756097|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6756098|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756099|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756100|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6756101|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
6756102|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
6756103|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6756104|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6756105|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6756106|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6756107|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
6756108|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
6756109|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756110|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756111|NCT02050958|Ibuprofen|ibuprofen|mesh-list
6756112|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6756113|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6756114|NCT02050958|Analgesics|analgesics|mesh-ancestor
6756115|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
6756116|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756117|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756118|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6756119|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6756120|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6756121|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756122|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756123|NCT02051023|Fluorometholone|fluorometholone|mesh-list
6756124|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
6756125|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6756126|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6756127|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6756128|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
6756129|NCT02051023|Hormones|hormones|mesh-ancestor
6756130|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6756131|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756132|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6756133|NCT02051153|Modafinil|modafinil|mesh-list
6756134|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6756135|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756136|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6756137|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6756138|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6756139|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756140|NCT02051231|Oxytocin|oxytocin|mesh-list
6756141|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
6756142|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6756143|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756144|NCT02051387|Cannabidiol|cannabidiol|mesh-list
6756145|NCT02051387|Olanzapine|olanzapine|mesh-list
6756146|NCT02051387|Risperidone|risperidone|mesh-list
6756147|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6756148|NCT02051387|Amisulpride|amisulpride|mesh-list
6756149|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6756150|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
6756151|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756152|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756153|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756154|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6756155|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6756156|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756157|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6756158|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6756159|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
6756160|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
6756161|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
6756162|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756163|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6756164|NCT02051387|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6756165|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6756166|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6756167|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
6756168|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
6756169|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6756170|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6756171|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6756172|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6756173|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6756174|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756175|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756176|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756177|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6756178|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
6756179|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6756180|NCT02051530|Tryptophan|tryptophan|mesh-list
6756181|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6756182|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
6756183|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6756184|NCT02051569|Tryptophan|tryptophan|mesh-list
6756185|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6756186|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
6756187|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6756188|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6756189|NCT02051738|Mebendazole|mebendazole|mesh-list
6756190|NCT02051738|Piperazine|piperazine|mesh-list
6756191|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
6756192|NCT02051738|DMP 777|dmp 777|mesh-list
6756193|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
6756194|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
6756195|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6756196|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756197|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
6756198|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
6756199|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
6756200|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756201|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756202|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756203|NCT02051751|Paclitaxel|paclitaxel|mesh-list
6756204|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6756205|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756206|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
6756207|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
6756208|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
6756209|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788436|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788437|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6788438|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6788439|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6788440|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
6788441|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788442|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788443|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6788444|NCT02225210|Narcotics|narcotics|mesh-ancestor
6788445|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6788446|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6788447|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
6788448|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
6788449|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6788450|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6788451|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6788452|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
6788453|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
6756210|NCT02051842|Metadoxine|metadoxine|mesh-list
6756211|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6756212|NCT02051868|Paclitaxel|paclitaxel|mesh-list
6756213|NCT02051868|Carboplatin|carboplatin|mesh-list
6756214|NCT02051868|Fluorouracil|fluorouracil|mesh-list
6756215|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6756216|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756217|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
6756218|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
6756219|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
6756220|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756221|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
6756222|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6756223|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6756224|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
6756225|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756226|NCT02051894|Dobutamine|dobutamine|mesh-list
6756227|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6756228|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
6756229|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
6756230|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756231|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756232|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6756233|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6756234|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6756235|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
6756236|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756237|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756238|NCT02051894|Protective Agents|protective agents|mesh-ancestor
6756239|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
6756240|NCT02051946|Diuretics|diuretics|mesh-ancestor
6756241|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
6756242|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756243|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756244|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756245|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
6756246|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
6756247|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6756248|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6756249|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6756250|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6756251|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756252|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
6756253|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756254|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756255|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6756256|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756257|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6756258|NCT02052128|Onapristone|onapristone|mesh-list
6756259|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756260|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6756261|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
6756262|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6756263|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756264|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
6756265|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6756266|NCT02052154|Vaccines|vaccines|mesh-list
6756267|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
6756268|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756269|NCT02052167|Methotrexate|methotrexate|mesh-list
6756270|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6756271|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
6756272|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6756273|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756274|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6756275|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
6756276|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756277|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756278|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
6756279|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756280|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6756281|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6756282|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
6756283|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788454|NCT02225275|Lenalidomide|lenalidomide|mesh-list
6756284|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6756285|NCT02052180|Bupivacaine|bupivacaine|mesh-list
6756286|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
6756287|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
6756288|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756289|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756290|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
6756291|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756292|NCT02052193|Vemurafenib|vemurafenib|mesh-list
6756293|NCT02052193|Dabrafenib|dabrafenib|mesh-list
6756294|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756295|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6756296|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756297|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756298|NCT02052258|Oxytocin|oxytocin|mesh-list
6756299|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
6756300|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6756301|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756302|NCT02052323|Artesunate|artesunate|mesh-list
6756303|NCT02052323|Mefloquine|mefloquine|mesh-list
6756304|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
6756305|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6756306|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6756307|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756308|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756309|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
6756310|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
6756311|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6756312|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
6756313|NCT02052336|Clarithromycin|clarithromycin|mesh-list
6756314|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6756315|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756316|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6756317|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756318|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756319|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6756320|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6756321|NCT02052388|Daptomycin|daptomycin|mesh-list
6756322|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6756323|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756324|NCT02052492|Vitamin D|vitamin d|mesh-list
6756325|NCT02052492|Vitamins|vitamins|mesh-ancestor
6756326|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
6756327|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756328|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6756329|NCT02052609|Brodalumab|brodalumab|mesh-list
6756330|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
6756331|NCT02052687|Imiquimod|imiquimod|mesh-list
6756332|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6756333|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
6756334|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756335|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756336|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
6756337|NCT02052713|Tamsulosin|tamsulosin|mesh-list
6756338|NCT02052713|Dutasteride|dutasteride|mesh-list
6756339|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6756340|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6756341|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6756342|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
6756343|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756344|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756345|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756346|NCT02052713|Urological Agents|urological agents|mesh-ancestor
6756347|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6756348|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6756349|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756350|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
6756351|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6756352|NCT02052726|Vaccines|vaccines|mesh-list
6756353|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
6756354|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756355|NCT02052908|Naproxen|naproxen|mesh-list
6756356|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6756357|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6756358|NCT02052908|Analgesics|analgesics|mesh-ancestor
6756359|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
6756360|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756361|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756362|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6756363|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6756364|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
6756365|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6756366|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756367|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756368|NCT02052934|Vaccines|vaccines|mesh-list
6756369|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
6756370|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756371|NCT02052973|Propolis|propolis|mesh-list
6756372|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756373|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
6756374|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6756375|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756376|NCT02053142|Acyclovir|acyclovir|mesh-list
6756377|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
6756378|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756379|NCT02053298|Timolol|timolol|mesh-list
6756380|NCT02053298|Dorzolamide|dorzolamide|mesh-list
6756381|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6756382|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6756383|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
6756384|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756385|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756386|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756387|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6756388|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6756389|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6756390|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756391|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
6756392|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6756393|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6756394|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756395|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
6756396|NCT02053363|Coagulants|coagulants|mesh-ancestor
6756397|NCT02053402|Vitamin D|vitamin d|mesh-list
6756398|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
6756399|NCT02053402|Vitamins|vitamins|mesh-ancestor
6756400|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
6756401|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756402|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6756403|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6788455|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
6788456|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
6788457|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788458|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6788459|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6788460|NCT02225275|Growth Substances|growth substances|mesh-ancestor
6788461|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
6788462|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788463|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6788464|NCT02225418|Ropivacaine|ropivacaine|mesh-list
6788465|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
6788466|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
6788467|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788468|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788469|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
6788470|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788471|NCT02225470|Vinorelbine|vinorelbine|mesh-list
6788472|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6788473|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788474|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
6788475|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
6788476|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
6788477|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788478|NCT02225548|Tadalafil|tadalafil|mesh-list
6788479|NCT02225548|Selegiline|selegiline|mesh-list
6788480|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
6788481|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6788482|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6788483|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788484|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788485|NCT02225548|Urological Agents|urological agents|mesh-ancestor
6788486|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
6788487|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6756404|NCT02053519|Vitamin D|vitamin d|mesh-list
6756405|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
6756406|NCT02053519|Vitamins|vitamins|mesh-ancestor
6756407|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
6756408|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756409|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6756410|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6756411|NCT02053558|Lidocaine|lidocaine|mesh-list
6756412|NCT02053558|Ropivacaine|ropivacaine|mesh-list
6756413|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
6756414|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
6756415|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756416|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756417|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
6756418|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756419|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6756420|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6756421|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6756422|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6756423|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756424|NCT02053597|Paclitaxel|paclitaxel|mesh-list
6756425|NCT02053597|Doxorubicin|doxorubicin|mesh-list
6756426|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6756427|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756428|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
6756429|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
6756430|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
6756431|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756432|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6756433|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6756434|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6756435|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756436|NCT02053675|Vasopressins|vasopressins|mesh-list
6756437|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
6756438|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
6756439|NCT02053675|Coagulants|coagulants|mesh-ancestor
6756440|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6756441|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6756442|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
6756443|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756444|NCT02053727|Abatacept|abatacept|mesh-list
6756445|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6756446|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756447|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756448|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6756449|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
6756450|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756451|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6756452|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
6756453|NCT02053766|Propofol|propofol|mesh-list
6756454|NCT02053766|Sevoflurane|sevoflurane|mesh-list
6756455|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6756456|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756457|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756458|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6756459|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
6756460|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
6756461|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6756462|NCT02053766|Analgesics|analgesics|mesh-ancestor
6756463|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
6756464|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756465|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6756466|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6756467|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6756468|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
6756469|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756470|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756471|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6756472|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6756473|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6756474|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
6756475|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6756476|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
6756477|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6756478|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756479|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6756480|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6756481|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756482|NCT02053818|Sufentanil|sufentanil|mesh-list
6756483|NCT02053818|Remifentanil|remifentanil|mesh-list
6756484|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6756485|NCT02053818|Narcotics|narcotics|mesh-ancestor
6756486|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756487|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756488|NCT02053818|Analgesics|analgesics|mesh-ancestor
6756489|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
6756490|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756491|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6756492|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6756493|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
6756494|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
6756495|NCT02053857|Amoxicillin|amoxicillin|mesh-list
6756496|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6756497|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756498|NCT02053909|Aspirin|aspirin|mesh-list
6756499|NCT02053909|Ticagrelor|ticagrelor|mesh-list
6756500|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6756501|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6756502|NCT02053909|Analgesics|analgesics|mesh-ancestor
6756503|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
6756504|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756505|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756506|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6756507|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6756508|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6756509|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6756510|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756511|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6756512|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6756513|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756514|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
6756515|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6756516|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6756517|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6756518|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
6756519|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756520|NCT02053922|Misoprostol|misoprostol|mesh-list
6756521|NCT02053922|Oxytocin|oxytocin|mesh-list
6756522|NCT02053922|Carbetocin|carbetocin|mesh-list
6756523|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6756524|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
6756525|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6756526|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756527|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6756528|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6756529|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
6756530|NCT02053935|Dopamine|dopamine|mesh-list
6756531|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6756532|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
6756533|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
6756534|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756535|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756536|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
6756537|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756538|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756539|NCT02053935|Protective Agents|protective agents|mesh-ancestor
6756540|NCT02053974|Spironolactone|spironolactone|mesh-list
6756541|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6756542|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
6756543|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6756544|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756545|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6756546|NCT02053974|Diuretics|diuretics|mesh-ancestor
6756547|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
6756548|NCT02054000|Tirofiban|tirofiban|mesh-list
6756549|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6756550|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6756551|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756552|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6756553|NCT02054052|Bevacizumab|bevacizumab|mesh-list
6756554|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6756555|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756556|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6756557|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6756558|NCT02054052|Growth Substances|growth substances|mesh-ancestor
6756559|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756560|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
6756561|NCT02054078|Bevacizumab|bevacizumab|mesh-list
6756562|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6756563|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756564|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6756565|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6756566|NCT02054078|Growth Substances|growth substances|mesh-ancestor
6756567|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756568|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
6756569|NCT02054143|Sevoflurane|sevoflurane|mesh-list
6756570|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6756571|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6756572|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
6756573|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
6756574|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756575|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756576|NCT02054182|Vitamin D|vitamin d|mesh-list
6756577|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
6756578|NCT02054182|Vitamins|vitamins|mesh-ancestor
6756579|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
6756580|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756581|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6756582|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6756583|NCT02054299|Thiamine|thiamine|mesh-list
6756584|NCT02054299|Proguanil|proguanil|mesh-list
6756585|NCT02054299|Sumatriptan|sumatriptan|mesh-list
6756586|NCT02054299|Amitriptyline|amitriptyline|mesh-list
6756587|NCT02054299|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6756588|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6756589|NCT02054299|Fenoterol|fenoterol|mesh-list
6756590|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6756591|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6756592|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6756593|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
6756594|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756595|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756596|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756597|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6756598|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
6756599|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6756600|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6756601|NCT02054299|Analgesics|analgesics|mesh-ancestor
6756602|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
6756603|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756604|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6756605|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6756606|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6756607|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
6756608|NCT02054299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6756609|NCT02054299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6756610|NCT02054299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756611|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6756612|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
6756613|NCT02054299|Vitamins|vitamins|mesh-ancestor
6756614|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
6756615|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
6756616|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6756617|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6756618|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756619|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
6756620|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6756621|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
6756622|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6756623|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
6756624|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
6756625|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
6756626|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6756627|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6756628|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6756629|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6756630|NCT02054429|Insulin|insulin|mesh-list
6756631|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6756632|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6756633|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756634|NCT02054442|Methotrexate|methotrexate|mesh-list
6756635|NCT02054442|Cetuximab|cetuximab|mesh-list
6756636|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6756637|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
6756638|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6756639|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756640|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6756641|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
6756642|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756643|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756644|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
6756645|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756646|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6756647|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6756648|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
6756649|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6756650|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6756651|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6756652|NCT02054468|Remifentanil|remifentanil|mesh-list
6756653|NCT02054468|Propofol|propofol|mesh-list
6756654|NCT02054468|Rocuronium|rocuronium|mesh-list
6756655|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6756656|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756657|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756658|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6756659|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
6756660|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
6756661|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6756662|NCT02054468|Narcotics|narcotics|mesh-ancestor
6756663|NCT02054468|Analgesics|analgesics|mesh-ancestor
6756664|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
6756665|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756666|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6756667|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6756668|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6756669|NCT02054637|Lanreotide|lanreotide|mesh-list
6756670|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756671|NCT02054663|Clopidogrel|clopidogrel|mesh-list
6756672|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6756673|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6756674|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6756675|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6756676|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
6756677|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756678|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756679|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756680|NCT02054676|Ibuprofen|ibuprofen|mesh-list
6756681|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6756682|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6756683|NCT02054676|Analgesics|analgesics|mesh-ancestor
6756684|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
6756685|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756686|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756687|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6756688|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6756689|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6756690|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756691|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756692|NCT02054793|Itraconazole|itraconazole|mesh-list
6756693|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
6756694|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756695|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6756696|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6756697|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756698|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756699|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6756700|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
6756701|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6756702|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756703|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6756704|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
6756705|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6756706|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756707|NCT02054884|Paclitaxel|paclitaxel|mesh-list
6756708|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6756709|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6756710|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756711|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
6756712|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
6756713|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
6756714|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756715|NCT02054936|Warfarin|warfarin|mesh-list
6756716|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
6756717|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
6756718|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6756719|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
6756720|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6756721|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
6756722|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756723|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756724|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
6756725|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6756726|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
6756727|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756728|NCT02054949|Expectorants|expectorants|mesh-ancestor
6756729|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
6756730|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6756731|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
6756732|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756733|NCT02054949|Protective Agents|protective agents|mesh-ancestor
6756734|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756735|NCT02054949|Antidotes|antidotes|mesh-ancestor
6756736|NCT02054975|Vitamin D|vitamin d|mesh-list
6756737|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
6756738|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
6756739|NCT02054975|Vitamins|vitamins|mesh-list
6756740|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
6756741|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756742|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6756743|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6756744|NCT02054988|Caffeine|caffeine|mesh-list
6756745|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6756746|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756747|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6756748|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756749|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756750|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6756751|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6756752|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
6756753|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756754|NCT02055014|Liraglutide|liraglutide|mesh-list
6756755|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6756756|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756757|NCT02055014|Incretins|incretins|mesh-ancestor
6756758|NCT02055014|Hormones|hormones|mesh-ancestor
6756759|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788488|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6788489|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6788490|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6788491|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6788492|NCT02225548|Protective Agents|protective agents|mesh-ancestor
6788493|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788494|NCT02225652|Paclitaxel|paclitaxel|mesh-list
6788495|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
6788496|NCT02225652|Fluorouracil|fluorouracil|mesh-list
6788497|NCT02225652|Epirubicin|epirubicin|mesh-list
6788498|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6788499|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788500|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
6788501|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
6788502|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
6788503|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788504|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6788505|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
6788506|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788507|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788508|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6788509|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
6788510|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6788511|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
6788512|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6788513|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6788514|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6788515|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6788516|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788517|NCT02225756|Cyclosporine|cyclosporine|mesh-list
6788518|NCT02225756|Cyclosporins|cyclosporins|mesh-list
6788519|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788520|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756760|NCT02055079|Sirolimus|sirolimus|mesh-list
6756761|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6756762|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756763|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6756764|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756765|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
6756766|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6756767|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
6756768|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756769|NCT02055131|Aspirin|aspirin|mesh-list
6756770|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6756771|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6756772|NCT02055131|Analgesics|analgesics|mesh-ancestor
6756773|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
6756774|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756775|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756776|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6756777|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6756778|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6756779|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6756780|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756781|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6756782|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6756783|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756784|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
6756785|NCT02055170|Finasteride|finasteride|mesh-list
6756786|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6756787|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6756788|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756789|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756790|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
6756791|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6756792|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756793|NCT02055170|Urological Agents|urological agents|mesh-ancestor
6756794|NCT02055183|Antitoxins|antitoxins|mesh-list
6756795|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
6756796|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
6756797|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756798|NCT02055196|Irinotecan|irinotecan|mesh-list
6756799|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6756800|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6756801|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756802|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756803|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756804|NCT02055274|Rotigotine|rotigotine|mesh-list
6756805|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
6756806|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
6756807|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756808|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756809|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756810|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
6756811|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6756812|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6756813|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6756814|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756815|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756816|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756817|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
6756818|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6756819|NCT02055378|Atropine|atropine|mesh-list
6756820|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6756821|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6756822|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6756823|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
6756824|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756825|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756826|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6756827|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
6756828|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
6756829|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
6756830|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6756831|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6756832|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
6756833|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756834|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756835|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
6756836|NCT02055456|Nandrolone|nandrolone|mesh-list
6756837|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
6756838|NCT02055456|Androgens|androgens|mesh-ancestor
6756839|NCT02055456|Hormones|hormones|mesh-ancestor
6756840|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6756841|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756842|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
6756843|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6756844|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
6756845|NCT02055482|Hematinics|hematinics|mesh-ancestor
6756846|NCT02055586|Alovudine|alovudine|mesh-list
6756847|NCT02055586|Fluorides|fluorides|mesh-list
6756848|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
6756849|NCT02055586|Protective Agents|protective agents|mesh-ancestor
6756850|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756851|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
6756852|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756853|NCT02055664|Ropivacaine|ropivacaine|mesh-list
6756854|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
6756855|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
6756856|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6756857|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756858|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
6756859|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756860|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
6756861|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6756862|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756863|NCT02055703|Itraconazole|itraconazole|mesh-list
6756864|NCT02055703|Rifampin|rifampin|mesh-list
6756865|NCT02055703|Digoxin|digoxin|mesh-list
6756866|NCT02055703|Donepezil|donepezil|mesh-list
6756867|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6756868|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756869|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756870|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
6756871|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756872|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756873|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
6756874|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
6756875|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756876|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6756877|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6756878|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6756879|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
6756880|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6756881|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6756882|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6756883|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
6756884|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6756885|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
6756886|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6756887|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6756888|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6756889|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6756890|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6756891|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6756892|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6756893|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6756894|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6756895|NCT02055703|Protective Agents|protective agents|mesh-ancestor
6756896|NCT02055716|Sulforaphane|sulforaphane|mesh-list
6756897|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6756898|NCT02055716|Protective Agents|protective agents|mesh-ancestor
6756899|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756900|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756901|NCT02055911|Ranibizumab|ranibizumab|mesh-list
6756902|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6756903|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6756904|NCT02055911|Growth Substances|growth substances|mesh-ancestor
6756905|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756906|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
6756907|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756908|NCT02056041|Liver Extracts|liver extracts|mesh-list
6756909|NCT02056041|Hematinics|hematinics|mesh-ancestor
6756910|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
6756911|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6756912|NCT02056184|Adalimumab|adalimumab|mesh-list
6756913|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6756914|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6756915|NCT02056210|Plerixafor|plerixafor|mesh-list
6756916|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6756917|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6756918|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
6756919|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6756920|NCT02056223|Acetaminophen|acetaminophen|mesh-list
6756921|NCT02056223|Ibuprofen|ibuprofen|mesh-list
6756922|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6756923|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6756924|NCT02056223|Analgesics|analgesics|mesh-ancestor
6756925|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
6756926|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756927|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756928|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6756929|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6756930|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6756931|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6756932|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756933|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
6756934|NCT02056249|Norepinephrine|norepinephrine|mesh-list
6756935|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6756936|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6756937|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
6756938|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756939|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756940|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756941|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
6756942|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
6756943|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756944|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6756945|NCT02056353|Insulin|insulin|mesh-list
6756946|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6756947|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756948|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
6756949|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
6756950|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756951|NCT02056366|Protective Agents|protective agents|mesh-ancestor
6756952|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756953|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
6756954|NCT02056366|Vitamins|vitamins|mesh-ancestor
6756955|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
6756956|NCT02056379|Dexamethasone|dexamethasone|mesh-list
6756957|NCT02056379|Budesonide|budesonide|mesh-list
6756958|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6756959|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
6756960|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
6756961|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6756962|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756963|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6756964|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
6756965|NCT02056379|Hormones|hormones|mesh-ancestor
6756966|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6756967|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6756968|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756969|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6756970|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6756971|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
6756972|NCT02056405|Mosapride|mosapride|mesh-list
6756973|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6756974|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6756975|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
6756976|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6756977|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756978|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756979|NCT02056418|Prednisone|prednisone|mesh-list
6756980|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
6756981|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6756982|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
6756983|NCT02056418|Hormones|hormones|mesh-ancestor
6756984|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6756985|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756986|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6756987|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756988|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
6756989|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6756990|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6756991|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6756992|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
6756993|NCT02056444|Coagulants|coagulants|mesh-ancestor
6756994|NCT02056587|Everolimus|everolimus|mesh-list
6756995|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6756996|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6756997|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
6756998|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6756999|NCT02056600|Metformin|metformin|mesh-list
6757000|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6757001|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757002|NCT02056665|Minocycline|minocycline|mesh-list
6757003|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6757004|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757005|NCT02056678|Acetaminophen|acetaminophen|mesh-list
6757006|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6757007|NCT02056678|Analgesics|analgesics|mesh-ancestor
6757008|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
6757009|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757010|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757011|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
6757012|NCT02056717|Dexamethasone|dexamethasone|mesh-list
6757013|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757014|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
6757015|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
6757016|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757017|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757018|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757019|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
6757020|NCT02056717|Hormones|hormones|mesh-ancestor
6757021|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6757022|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6757023|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757024|NCT02056730|Calcium|calcium|mesh-list
6757025|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6757026|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757027|NCT02056743|Fexofenadine|fexofenadine|mesh-list
6757028|NCT02056743|Losartan|losartan|mesh-list
6757029|NCT02056743|Midazolam|midazolam|mesh-list
6757030|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
6757031|NCT02056743|Caffeine|caffeine|mesh-list
6757032|NCT02056743|Omeprazole|omeprazole|mesh-list
6757033|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6757034|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6757035|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757036|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757037|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6757038|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6757039|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6757040|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6757041|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
6757042|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
6757043|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
6757044|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
6757045|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757046|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757047|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6757048|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6757049|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6757050|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6757051|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6757052|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757053|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6757054|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757055|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6757056|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6757057|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6757058|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6757059|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
6757060|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
6757061|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
6757062|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6757063|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6757064|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6757065|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6757066|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6757067|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
6757068|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
6788521|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6788522|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
6788523|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788524|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
6788525|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788526|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
6788527|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788528|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6788529|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6788530|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6788531|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6788532|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788533|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
6788534|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6788535|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
6788536|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6788537|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
6788538|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788539|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788540|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6788541|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
6788542|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788543|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788544|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6788545|NCT02225834|Atorvastatin|atorvastatin|mesh-list
6788546|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6788547|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6788548|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
6788549|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788550|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6788551|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6788552|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788553|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
6788554|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
6788555|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788556|NCT02225886|Protective Agents|protective agents|mesh-ancestor
6788557|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788558|NCT02225886|Vitamins|vitamins|mesh-ancestor
6788559|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
6788560|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6788561|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6788562|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788563|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6788564|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
6788565|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788566|NCT02226068|Cyclosporine|cyclosporine|mesh-list
6788567|NCT02226068|Cyclosporins|cyclosporins|mesh-list
6788568|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788569|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788570|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6788571|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
6788572|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788573|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
6757069|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
6757070|NCT02056847|Pitavastatin|pitavastatin|mesh-list
6757071|NCT02056847|Calcium|calcium|mesh-list
6757072|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6757073|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757074|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6757075|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6757076|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6757077|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6757078|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
6757079|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757080|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757081|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6757082|NCT02056899|Gabapentin|gabapentin|mesh-list
6757083|NCT02056899|Analgesics|analgesics|mesh-ancestor
6757084|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
6757085|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757086|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757087|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
6757088|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6757089|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6757090|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757091|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6757092|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6757093|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6757094|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757095|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757096|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
6757097|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6757098|NCT02056938|Basiliximab|basiliximab|mesh-list
6757099|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
6757100|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757101|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6757102|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
6757103|NCT02057003|Grazoprevir|grazoprevir|mesh-list
6757104|NCT02057003|Ledipasvir|ledipasvir|mesh-list
6757105|NCT02057003|Velpatasvir|velpatasvir|mesh-list
6757106|NCT02057003|Simeprevir|simeprevir|mesh-list
6757107|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
6757108|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757109|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
6757110|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757111|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757112|NCT02057094|Caseins|caseins|mesh-list
6757113|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
6757114|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
6757115|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757116|NCT02057107|Docetaxel|docetaxel|mesh-list
6757117|NCT02057107|Cetuximab|cetuximab|mesh-list
6757118|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757119|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
6757120|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
6757121|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
6757122|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757123|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6757124|NCT02057263|Alendronate|alendronate|mesh-list
6757125|NCT02057263|Diphosphonates|diphosphonates|mesh-list
6757126|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6757127|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757128|NCT02057289|Micafungin|micafungin|mesh-list
6757129|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
6757130|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757131|NCT02057328|Telmisartan|telmisartan|mesh-list
6757132|NCT02057328|Nebivolol|nebivolol|mesh-list
6757133|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6757134|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6757135|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6757136|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757137|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
6757138|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6757139|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6757140|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6757141|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
6757142|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757143|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757144|NCT02057367|Bupivacaine|bupivacaine|mesh-list
6757145|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
6757146|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
6757147|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757148|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757149|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
6757150|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757151|NCT02057484|Tacrolimus|tacrolimus|mesh-list
6757152|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6757153|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
6757154|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757155|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6757156|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757157|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757158|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
6757159|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
6757160|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
6757161|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757162|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757163|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
6757164|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757165|NCT02057679|Amoxicillin|amoxicillin|mesh-list
6757166|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6757167|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757168|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
6757169|NCT02057770|Busulfan|busulfan|mesh-list
6757170|NCT02057770|Fludarabine|fludarabine|mesh-list
6757171|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
6757172|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6757173|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
6757174|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757175|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757176|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6757177|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
6757178|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757179|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757180|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6757181|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6757182|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
6757183|NCT02057796|Efavirenz|efavirenz|mesh-list
6757184|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6757185|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6757186|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6757187|NCT02057796|Rifampin|rifampin|mesh-list
6757188|NCT02057796|Isoniazid|isoniazid|mesh-list
6757189|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
6757190|NCT02057796|Ethambutol|ethambutol|mesh-list
6757191|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6757192|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6757193|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757194|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757195|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
6757196|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757197|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6757198|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6757199|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6757200|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6757201|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6757202|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6757203|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6757204|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6757205|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6757206|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
6757207|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6757208|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
6757209|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6757210|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6757211|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6757212|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6757213|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6757214|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
6757215|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6757216|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6757217|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
6757218|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757219|NCT02057926|Tetracycline|tetracycline|mesh-list
6757220|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6757221|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757222|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6757223|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757224|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757225|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
6757226|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6757227|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6757228|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757229|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
6757230|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
6757231|NCT02058173|Chloroquine|chloroquine|mesh-list
6757232|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6757233|NCT02058173|Amebicides|amebicides|mesh-ancestor
6757234|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6757235|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6757236|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757237|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
6757238|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757239|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6757240|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6757241|NCT02058173|Analgesics|analgesics|mesh-ancestor
6757242|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
6757243|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757244|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757245|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757246|NCT02058173|Filaricides|filaricides|mesh-ancestor
6757247|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
6757248|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
6757249|NCT02058186|Vitamin D|vitamin d|mesh-list
6757250|NCT02058186|Vitamins|vitamins|mesh-ancestor
6757251|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
6757252|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757253|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6757254|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
6757255|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6757256|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
6757257|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6757258|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
6757259|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757260|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757261|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
6757262|NCT02058212|Vitamin E|vitamin e|mesh-list
6757263|NCT02058212|Selenium|selenium|mesh-list
6757264|NCT02058212|Vitamins|vitamins|mesh-ancestor
6757265|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
6757266|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757267|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
6757268|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757269|NCT02058212|Protective Agents|protective agents|mesh-ancestor
6757270|NCT02058212|Trace Elements|trace elements|mesh-ancestor
6757271|NCT02058277|Aprepitant|aprepitant|mesh-list
6757272|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
6757273|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
6757274|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757275|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757276|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757277|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6757278|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757279|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757280|NCT02058303|Bupivacaine|bupivacaine|mesh-list
6757281|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
6757282|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
6757283|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757284|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757285|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
6757286|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757287|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6757288|NCT02058420|Tocotrienols|tocotrienols|mesh-list
6757289|NCT02058420|Vitamin E|vitamin e|mesh-list
6757290|NCT02058420|Tocopherols|tocopherols|mesh-list
6757291|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
6757292|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757293|NCT02058420|Protective Agents|protective agents|mesh-ancestor
6757294|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757295|NCT02058420|Vitamins|vitamins|mesh-ancestor
6757296|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
6757297|NCT02058433|Paclitaxel|paclitaxel|mesh-list
6757298|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6757299|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6757300|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757301|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
6757302|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
6757303|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
6757304|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757305|NCT02058446|Amlodipine|amlodipine|mesh-list
6757306|NCT02058446|Valsartan|valsartan|mesh-list
6757307|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6757308|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6757309|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6757310|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6757311|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757312|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6757313|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757314|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
6757315|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6757316|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6757317|NCT02058485|Midazolam|midazolam|mesh-list
6757318|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
6757319|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6757320|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757321|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757322|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6757323|NCT02058485|Analgesics|analgesics|mesh-ancestor
6757324|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
6757325|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757326|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6757327|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6757328|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6757329|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
6757330|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757331|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757332|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6757333|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6757334|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6757335|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6757336|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6757337|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
6757338|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
6757339|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
6757340|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
6757341|NCT02058576|Tamsulosin|tamsulosin|mesh-list
6757342|NCT02058576|Dutasteride|dutasteride|mesh-list
6757343|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6757344|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6757345|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6757346|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
6757347|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757348|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757349|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757350|NCT02058576|Urological Agents|urological agents|mesh-ancestor
6757351|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6757352|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6757353|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757354|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
6757355|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788574|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788575|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
6788576|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788577|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6788578|NCT02226276|Copper|copper|mesh-list
6788579|NCT02226276|Trastuzumab|trastuzumab|mesh-list
6788580|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6788581|NCT02226276|Maytansine|maytansine|mesh-list
6788582|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6788583|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
6788584|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6788585|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788586|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788587|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6757356|NCT02058641|Darapladib|darapladib|mesh-list
6757357|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
6757358|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757359|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757360|NCT02058667|Paclitaxel|paclitaxel|mesh-list
6757361|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6757362|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757363|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
6757364|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
6757365|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
6757366|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757367|NCT02058693|Amphetamine|amphetamine|mesh-list
6757368|NCT02058693|Adderall|adderall|mesh-list
6757369|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6757370|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757371|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
6757372|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
6757373|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757374|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
6757375|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757376|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757377|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
6757378|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6757379|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6757380|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6757381|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6757382|NCT02058706|Leuprolide|leuprolide|mesh-list
6757383|NCT02058706|Goserelin|goserelin|mesh-list
6757384|NCT02058706|Bicalutamide|bicalutamide|mesh-list
6757385|NCT02058706|Androgens|androgens|mesh-list
6757386|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6757387|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
6757388|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6757389|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757390|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6757391|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757392|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
6757393|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
6757394|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6757395|NCT02058706|Hormones|hormones|mesh-ancestor
6757396|NCT02058823|Amlodipine|amlodipine|mesh-list
6757397|NCT02058823|Valsartan|valsartan|mesh-list
6757398|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6757399|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6757400|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6757401|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757402|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6757403|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757404|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
6757405|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6757406|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6757407|NCT02058875|Cyclosporine|cyclosporine|mesh-list
6757408|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
6757409|NCT02058875|Prednisone|prednisone|mesh-list
6757410|NCT02058875|Cyclosporins|cyclosporins|mesh-list
6757411|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757412|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
6757413|NCT02058875|Hormones|hormones|mesh-ancestor
6757414|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6757415|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757416|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6757417|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757418|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757419|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757420|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6757421|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
6757422|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
6757423|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757424|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
6757425|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757426|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6757427|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6757428|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6757429|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
6788588|NCT02226276|Trace Elements|trace elements|mesh-ancestor
6757430|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6757431|NCT02058901|Sunitinib|sunitinib|mesh-list
6757432|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757433|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6757434|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6757435|NCT02058901|Growth Substances|growth substances|mesh-ancestor
6757436|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757437|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
6757438|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6757439|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757440|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757441|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6757442|NCT02058979|Cefazolin|cefazolin|mesh-list
6757443|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757444|NCT02059018|Diclofenac|diclofenac|mesh-list
6788589|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
6757445|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
6757446|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
6757447|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6757448|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6757449|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6757450|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6757451|NCT02059018|Analgesics|analgesics|mesh-ancestor
6757452|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
6757453|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757454|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757455|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757456|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757457|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757458|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757459|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
6757460|NCT02059031|Cabotegravir|cabotegravir|mesh-list
6757461|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6757462|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6757463|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757464|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757465|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6757466|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6757467|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
6757468|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757469|NCT02059330|Palbociclib|palbociclib|mesh-list
6757470|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757471|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6757472|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757473|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757474|NCT02059460|Terlipressin|terlipressin|mesh-list
6757475|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6757476|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6757477|NCT02059564|Liraglutide|liraglutide|mesh-list
6757478|NCT02059564|Exenatide|exenatide|mesh-list
6757479|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6757480|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757481|NCT02059564|Incretins|incretins|mesh-ancestor
6757482|NCT02059564|Hormones|hormones|mesh-ancestor
6757483|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6757484|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6757485|NCT02059590|Isavuconazole|isavuconazole|mesh-list
6757486|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
6757487|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757488|NCT02059616|Amlodipine|amlodipine|mesh-list
6757489|NCT02059616|Candesartan|candesartan|mesh-list
6757490|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
6757491|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6757492|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6757493|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6757494|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757495|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6757496|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757497|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
6757498|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6757499|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6757500|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
6757501|NCT02059655|Bimatoprost|bimatoprost|mesh-list
6757502|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6757503|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6757504|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6757505|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6757506|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757507|NCT02059694|Lidocaine|lidocaine|mesh-list
6757508|NCT02059694|Epinephrine|epinephrine|mesh-list
6757509|NCT02059694|Racepinephrine|racepinephrine|mesh-list
6757510|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
6757511|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
6757512|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
6757513|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757514|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757515|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
6757516|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757517|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6757518|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6757519|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6757520|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6757521|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757522|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6757523|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6757524|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
6757525|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757526|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6757527|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6757528|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
6757529|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6757530|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
6757531|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
6757532|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
6757533|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6757534|NCT02059759|Aldesleukin|aldesleukin|mesh-list
6757535|NCT02059759|Interleukin-2|interleukin-2|mesh-list
6757536|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757537|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6757538|NCT02059759|Analgesics|analgesics|mesh-ancestor
6757539|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
6757540|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757541|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757542|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6757543|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6757544|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
6757545|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757546|NCT02059772|Ranibizumab|ranibizumab|mesh-list
6757547|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6757548|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6757549|NCT02059772|Growth Substances|growth substances|mesh-ancestor
6757550|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757551|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
6757552|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757553|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
6757554|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6757555|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
6757556|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757557|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757558|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6757559|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
6757560|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757561|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757562|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6757563|NCT02059876|Paclitaxel|paclitaxel|mesh-list
6757564|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6757565|NCT02059876|Carboplatin|carboplatin|mesh-list
6757566|NCT02059876|Trastuzumab|trastuzumab|mesh-list
6757567|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6757568|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757569|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
6757570|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
6757571|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
6757572|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757573|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6757574|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
6757575|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6757576|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6757577|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757578|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
6757579|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
6757580|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757581|NCT02059915|Oxycodone|oxycodone|mesh-list
6757582|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6757583|NCT02059915|Narcotics|narcotics|mesh-ancestor
6757584|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757585|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757586|NCT02059915|Analgesics|analgesics|mesh-ancestor
6757587|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
6757588|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757589|NCT02059967|Paclitaxel|paclitaxel|mesh-list
6757590|NCT02059967|Carboplatin|carboplatin|mesh-list
6757591|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6757592|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757593|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
6757594|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
6757595|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
6757596|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757597|NCT02060006|Meloxicam|meloxicam|mesh-list
6757598|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
6757599|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6757600|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6757601|NCT02060006|Analgesics|analgesics|mesh-ancestor
6757602|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
6757603|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757604|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757605|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757606|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757607|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6757608|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757609|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757610|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
6757611|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6757612|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6757613|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6757614|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
6757615|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757616|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6757617|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6757618|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757619|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6757620|NCT02060032|Atorvastatin|atorvastatin|mesh-list
6757621|NCT02060032|Simvastatin|simvastatin|mesh-list
6757622|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6757623|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6757624|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
6757625|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757626|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6757627|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6757628|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757629|NCT02060149|Minocycline|minocycline|mesh-list
6757630|NCT02060149|Sulbactam|sulbactam|mesh-list
6757631|NCT02060149|Cefoperazone|cefoperazone|mesh-list
6757632|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6757633|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6757634|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757635|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6757636|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757637|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757638|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
6757639|NCT02060201|Saxagliptin|saxagliptin|mesh-list
6757640|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6757641|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757642|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6757643|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757644|NCT02060201|Incretins|incretins|mesh-ancestor
6757645|NCT02060201|Hormones|hormones|mesh-ancestor
6757646|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6757647|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6757648|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
6757649|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757650|NCT02060253|Paclitaxel|paclitaxel|mesh-list
6757651|NCT02060253|Trastuzumab|trastuzumab|mesh-list
6757652|NCT02060253|Pertuzumab|pertuzumab|mesh-list
6757653|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6757654|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757655|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
6757656|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
6757657|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
6757658|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757659|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6757660|NCT02060279|Carotenoids|carotenoids|mesh-list
6757661|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
6757662|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757663|NCT02060279|Protective Agents|protective agents|mesh-ancestor
6757664|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757665|NCT02060305|Bevacizumab|bevacizumab|mesh-list
6757666|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6757667|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757668|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6757669|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6757670|NCT02060305|Growth Substances|growth substances|mesh-ancestor
6757671|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757672|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
6757673|NCT02060318|Infliximab|infliximab|mesh-list
6757674|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
6757675|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757676|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788590|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788591|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6788592|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
6788593|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
6788594|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
6788595|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
6788596|NCT02226289|Bevacizumab|bevacizumab|mesh-list
6788597|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6788598|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788599|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6788600|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6788601|NCT02226289|Growth Substances|growth substances|mesh-ancestor
6788602|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788603|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
6788604|NCT02226328|Fentanyl|fentanyl|mesh-list
6788605|NCT02226328|Midazolam|midazolam|mesh-list
6788606|NCT02226328|Propofol|propofol|mesh-list
6788607|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6788608|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788609|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788610|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6788611|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
6788612|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
6788613|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6788614|NCT02226328|Narcotics|narcotics|mesh-ancestor
6788615|NCT02226328|Analgesics|analgesics|mesh-ancestor
6788616|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
6788617|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788618|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6788619|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6788620|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6788621|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6788622|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
6788623|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
6788624|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788625|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788626|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
6788627|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6788628|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6788629|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788630|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6788631|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
6788632|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6788633|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788634|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788635|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788636|NCT02226341|Hormones|hormones|mesh-ancestor
6788637|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788638|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788639|NCT02226367|Prazosin|prazosin|mesh-list
6788640|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6788641|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6788642|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6788643|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6788644|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
6788645|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788646|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788647|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788648|NCT02226484|Quercetin|quercetin|mesh-list
6788649|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
6788650|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788651|NCT02226484|Protective Agents|protective agents|mesh-ancestor
6788652|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788653|NCT02226510|Metformin|metformin|mesh-list
6788654|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6788655|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788656|NCT02226588|Misoprostol|misoprostol|mesh-list
6757677|NCT02060396|Aspirin|aspirin|mesh-list
6757678|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6757679|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6757680|NCT02060396|Analgesics|analgesics|mesh-ancestor
6757681|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
6757682|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757683|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757684|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757685|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757686|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6757687|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6757688|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757689|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6757690|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6757691|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757692|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
6757693|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
6757694|NCT02060487|Citric Acid|citric acid|mesh-list
6757695|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
6757696|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
6757697|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6757698|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
6757699|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
6757700|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757701|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
6757702|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6757703|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6757704|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757705|NCT02060487|Urological Agents|urological agents|mesh-ancestor
6757706|NCT02060552|Diacetylrhein|diacetylrhein|mesh-list
6757707|NCT02060552|Colchicine|colchicine|mesh-list
6757708|NCT02060552|Febuxostat|febuxostat|mesh-list
6757709|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
6757710|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757711|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
6757712|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
6757713|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
6757714|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757715|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757716|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757717|NCT02060591|Bupivacaine|bupivacaine|mesh-list
6757718|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
6757719|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
6757720|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757721|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757722|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
6757723|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757724|NCT02060604|Ketorolac|ketorolac|mesh-list
6757725|NCT02060604|Ranibizumab|ranibizumab|mesh-list
6757726|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6757727|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6757728|NCT02060604|Growth Substances|growth substances|mesh-ancestor
6757729|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757730|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
6757731|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757732|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6757733|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6757734|NCT02060604|Analgesics|analgesics|mesh-ancestor
6757735|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
6757736|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757737|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757738|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757739|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6757740|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757741|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757742|NCT02060656|Gemcitabine|gemcitabine|mesh-list
6757743|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
6757744|NCT02060656|Rituximab|rituximab|mesh-list
6757745|NCT02060656|Lenalidomide|lenalidomide|mesh-list
6757746|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757747|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6757748|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
6757749|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757750|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757751|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6757752|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
6757753|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757754|NCT02060656|Antiviral Agents|antiviral agents|mesh-ancestor
6757755|NCT02060656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757756|NCT02060656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757757|NCT02060656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6757758|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6757759|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6757760|NCT02060656|Growth Substances|growth substances|mesh-ancestor
6757761|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
6757762|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757763|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
6757764|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
6757765|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757766|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757767|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
6757768|NCT02060656|Hormones|hormones|mesh-ancestor
6757769|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6757770|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6757771|NCT02060656|Protective Agents|protective agents|mesh-ancestor
6757772|NCT02060669|Capecitabine|capecitabine|mesh-list
6757773|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6757774|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
6757775|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757776|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757777|NCT02060734|Lidocaine|lidocaine|mesh-list
6757778|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
6757779|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
6757780|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757781|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757782|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
6757783|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757784|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6757785|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6757786|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6757787|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6757788|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757789|NCT02060786|Clopidogrel|clopidogrel|mesh-list
6757790|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6757791|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6757792|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6757793|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6757794|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
6757795|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757796|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757797|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757798|NCT02060851|Iron|iron|mesh-list
6757799|NCT02060851|Trace Elements|trace elements|mesh-ancestor
6757800|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
6757801|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757802|NCT02060916|PAZ320|paz320|mesh-list
6757803|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6757804|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757805|NCT02060929|Esketamine|esketamine|mesh-list
6757806|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
6757807|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6757808|NCT02060955|Bevacizumab|bevacizumab|mesh-list
6757809|NCT02060955|Irinotecan|irinotecan|mesh-list
6757810|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6757811|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757812|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6757813|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6757814|NCT02060955|Growth Substances|growth substances|mesh-ancestor
6757815|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757816|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
6757817|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6757818|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6757819|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757820|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757821|NCT02061007|Misonidazole|misonidazole|mesh-list
6757822|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757823|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6757824|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6757825|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757826|NCT02061124|Sevelamer|sevelamer|mesh-list
6757827|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
6757828|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
6757829|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757830|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6757831|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6757832|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757833|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6757834|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
6757835|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757836|NCT02061267|Niacin|niacin|mesh-list
6757837|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
6757838|NCT02061267|Vitamins|vitamins|mesh-ancestor
6757839|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
6757840|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757841|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
6757842|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6757843|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
6757844|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757845|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6757846|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
6757847|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
6757848|NCT02061293|Promethazine|promethazine|mesh-list
6757849|NCT02061293|Psilocybin|psilocybin|mesh-list
6757850|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6757851|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6757852|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757853|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757854|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
6757855|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
6757856|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
6757857|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757858|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
6757859|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
6757860|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757861|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6757862|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
6757863|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
6757864|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757865|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757866|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6757867|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
6757868|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
6757869|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
6757870|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6757871|NCT02061449|Romidepsin|romidepsin|mesh-list
6757872|NCT02061449|Poly ICLC|poly iclc|mesh-list
6757873|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
6757874|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
6757875|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757876|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6757877|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757878|NCT02061475|Lidocaine|lidocaine|mesh-list
6757879|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
6757880|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
6757881|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757882|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757883|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
6757884|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757885|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6757886|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6757887|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6757888|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6757889|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757890|NCT02061631|Dexamethasone|dexamethasone|mesh-list
6757891|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
6757892|NCT02061631|Docetaxel|docetaxel|mesh-list
6757893|NCT02061631|BB 1101|bb 1101|mesh-list
6757894|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757895|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757896|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
6757897|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
6757898|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757899|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757900|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757901|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
6757902|NCT02061631|Hormones|hormones|mesh-ancestor
6757903|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6757904|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6757905|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
6757906|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757907|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757908|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
6757909|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
6757910|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
6757911|NCT02061644|Anesthetics|anesthetics|mesh-list
6757912|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6757913|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757914|NCT02061657|Misoprostol|misoprostol|mesh-list
6757915|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6757916|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
6757917|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6757918|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757919|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6757920|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757921|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
6757922|NCT02061761|Nivolumab|nivolumab|mesh-list
6757923|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6757924|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757925|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6757926|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757927|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
6757928|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6757929|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
6757930|NCT02061800|Melphalan|melphalan|mesh-list
6757931|NCT02061800|Busulfan|busulfan|mesh-list
6757932|NCT02061800|Thiotepa|thiotepa|mesh-list
6757933|NCT02061800|Fludarabine|fludarabine|mesh-list
6757934|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
6757935|NCT02061800|Tacrolimus|tacrolimus|mesh-list
6757936|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6757937|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
6757938|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757939|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6757940|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6757941|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
6757942|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757943|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757944|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6757945|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6757946|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757947|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6757948|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
6757949|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
6757950|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757951|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757952|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
6757953|NCT02061800|Hormones|hormones|mesh-ancestor
6757954|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6757955|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6757956|NCT02061800|Protective Agents|protective agents|mesh-ancestor
6757957|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6757958|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6757959|NCT02061878|Bexarotene|bexarotene|mesh-list
6757960|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6757961|NCT02061917|Lobeline|lobeline|mesh-list
6757962|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6757963|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
6757964|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6757965|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757966|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6757967|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6757968|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
6757969|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6757970|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757971|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
6788657|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6788658|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
6788659|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6788660|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788661|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6788662|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6788663|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
6788664|NCT02226601|Aprepitant|aprepitant|mesh-list
6788665|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
6788666|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
6788667|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788668|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788669|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6788670|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6788671|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788672|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788673|NCT02226757|Paclitaxel|paclitaxel|mesh-list
6788674|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6788675|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788676|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
6788677|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
6788678|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
6788679|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788680|NCT02226783|Omeprazole|omeprazole|mesh-list
6788681|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6788682|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757972|NCT02062034|Vitamins|vitamins|mesh-list
6757973|NCT02062034|Vitamin E|vitamin e|mesh-list
6757974|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
6757975|NCT02062034|Ubiquinone|ubiquinone|mesh-list
6757976|NCT02062034|Antioxidants|antioxidants|mesh-list
6757977|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
6757978|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757979|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757980|NCT02062034|Protective Agents|protective agents|mesh-ancestor
6757981|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
6757982|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6757983|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757984|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
6757985|NCT02062112|Laxatives|laxatives|mesh-list
6757986|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6757987|NCT02062190|Resveratrol|resveratrol|mesh-list
6757988|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
6757989|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6757990|NCT02062190|Protective Agents|protective agents|mesh-ancestor
6757991|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6757992|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6757993|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6757994|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
6757995|NCT02062203|Glycine|glycine|mesh-list
6757996|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6757997|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6757998|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6757999|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6758000|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758001|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758002|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758003|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758004|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
6758005|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758006|NCT02062255|Aspirin|aspirin|mesh-list
6758007|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6758008|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6758009|NCT02062255|Analgesics|analgesics|mesh-ancestor
6758010|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
6758011|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758012|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758013|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6758014|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6758015|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6758016|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6758017|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758018|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6758019|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6758020|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758021|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
6758022|NCT02062281|Vaccines|vaccines|mesh-list
6758023|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6758024|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
6758025|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758026|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
6758027|NCT02062333|Esmolol|esmolol|mesh-list
6758028|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6758029|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758030|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758031|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6758032|NCT02062333|Analgesics|analgesics|mesh-ancestor
6758033|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
6758034|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758035|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6758036|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6758037|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6758038|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
6758039|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758040|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758041|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6758042|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6758043|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6758044|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
6758045|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6758046|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6758047|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758048|NCT02062489|Tamoxifen|tamoxifen|mesh-list
6758049|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6758050|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
6758051|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6758052|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758053|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6758054|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758055|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6758056|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6758057|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6758058|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
6758059|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758060|NCT02062892|Sirolimus|sirolimus|mesh-list
6758061|NCT02062892|Everolimus|everolimus|mesh-list
6758062|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758063|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6758064|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
6758065|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758066|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6758067|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758068|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6758069|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
6758070|NCT02062944|Sirolimus|sirolimus|mesh-list
6758071|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
6758072|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6758073|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758074|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6758075|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758076|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
6758077|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
6758078|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758079|NCT02062983|Trastuzumab|trastuzumab|mesh-list
6758080|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6758081|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758082|NCT02062996|Phenylephrine|phenylephrine|mesh-list
6758083|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
6758084|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6758085|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6758086|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
6758087|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758088|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758089|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758090|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
6758091|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
6758092|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758093|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
6758094|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6758095|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
6758096|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6758097|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
6758098|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6758099|NCT02062996|Protective Agents|protective agents|mesh-ancestor
6758100|NCT02063022|Dactinomycin|dactinomycin|mesh-list
6758101|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
6758102|NCT02063022|Melphalan|melphalan|mesh-list
6758103|NCT02063022|Busulfan|busulfan|mesh-list
6758104|NCT02063022|Ifosfamide|ifosfamide|mesh-list
6758105|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
6758106|NCT02063022|Doxorubicin|doxorubicin|mesh-list
6758107|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6758108|NCT02063022|Etoposide|etoposide|mesh-list
6758109|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
6758110|NCT02063022|Vincristine|vincristine|mesh-list
6758111|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6758112|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
6758113|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758114|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6758115|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6758116|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
6758117|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758118|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758119|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6758120|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6758121|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6758122|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6758123|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758124|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6758125|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
6758126|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
6758127|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
6758128|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6758129|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758130|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6758131|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6758132|NCT02063100|Losartan|losartan|mesh-list
6758133|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6758134|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6758135|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6758136|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6758137|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758138|NCT02063139|Fluticasone|fluticasone|mesh-list
6758139|NCT02063139|Beclomethasone|beclomethasone|mesh-list
6758140|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6758141|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6758142|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
6758143|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758144|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758145|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6758146|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
6758147|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
6758148|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6758149|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
6758150|NCT02063139|Hormones|hormones|mesh-ancestor
6758151|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6758152|NCT02063269|Rivastigmine|rivastigmine|mesh-list
6758153|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6758154|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758155|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758156|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
6758157|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758158|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758159|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6758160|NCT02063269|Protective Agents|protective agents|mesh-ancestor
6758161|NCT02063334|Vitamin D|vitamin d|mesh-list
6758162|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
6758163|NCT02063334|Vitamins|vitamins|mesh-ancestor
6758164|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
6758165|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758166|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6758167|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6758168|NCT02063360|Ritonavir|ritonavir|mesh-list
6758169|NCT02063360|Darunavir|darunavir|mesh-list
6758170|NCT02063360|Fostemsavir|fostemsavir|mesh-list
6758171|NCT02063360|Etravirine|etravirine|mesh-list
6758172|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6758173|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6758174|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
6758175|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758176|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758177|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6758178|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6758179|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
6758180|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758181|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6758182|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6758183|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6758184|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6758185|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6758186|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6758187|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
6758188|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6758189|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
6758190|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758191|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
6758192|NCT02063373|Protective Agents|protective agents|mesh-ancestor
6758193|NCT02063425|Fluoxetine|fluoxetine|mesh-list
6758194|NCT02063425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6758195|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6758196|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6758197|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758198|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758199|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
6758200|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758201|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6758202|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
6758203|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6758204|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6758205|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6758206|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758207|NCT02063529|Leucovorin|leucovorin|mesh-list
6758208|NCT02063529|Fluorouracil|fluorouracil|mesh-list
6758209|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
6758210|NCT02063529|Irinotecan|irinotecan|mesh-list
6758211|NCT02063529|Cetuximab|cetuximab|mesh-list
6758212|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
6758213|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
6758214|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758215|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6758216|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758217|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6758218|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
6758219|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758220|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6758221|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6758222|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758223|NCT02063529|Antidotes|antidotes|mesh-ancestor
6758224|NCT02063529|Protective Agents|protective agents|mesh-ancestor
6758225|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
6758226|NCT02063529|Vitamins|vitamins|mesh-ancestor
6758227|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
6758228|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6758229|NCT02063568|Oxytocin|oxytocin|mesh-list
6758230|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
6758231|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6758232|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758233|NCT02063620|Ketamine|ketamine|mesh-list
6758234|NCT02063620|Analgesics|analgesics|mesh-ancestor
6758235|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
6758236|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758237|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758238|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6758239|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6758240|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
6758241|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
6758242|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758243|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6758244|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6758245|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758246|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788683|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6788684|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788685|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758247|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
6758248|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6758249|NCT02063789|Antibodies|antibodies|mesh-list
6758250|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
6758251|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758252|NCT02063802|Metformin|metformin|mesh-list
6758253|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6758254|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758255|NCT02063841|Bismuth|bismuth|mesh-list
6758256|NCT02063841|Antacids|antacids|mesh-ancestor
6758257|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758258|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6758259|NCT02063945|Risperidone|risperidone|mesh-list
6758260|NCT02063945|Methylphenidate|methylphenidate|mesh-list
6758261|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6758262|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
6758263|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758264|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758265|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758266|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6758267|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6758268|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758269|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6758270|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6758271|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
6758272|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6758273|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6758274|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6758275|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6758276|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
6758277|NCT02064010|Acamprosate|acamprosate|mesh-list
6758278|NCT02064010|Calcium|calcium|mesh-list
6758279|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6758280|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758281|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6758282|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6758283|NCT02064023|Insulin|insulin|mesh-list
6758284|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6758285|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6758286|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758287|NCT02064036|Leuprolide|leuprolide|mesh-list
6758288|NCT02064036|Goserelin|goserelin|mesh-list
6758289|NCT02064036|Bicalutamide|bicalutamide|mesh-list
6758290|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6758291|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
6758292|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6758293|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758294|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6758295|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758296|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
6758297|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
6758298|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6758299|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
6758300|NCT02064049|Velpatasvir|velpatasvir|mesh-list
6758301|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
6758302|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758303|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
6758304|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
6758305|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
6758306|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758307|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758308|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
6758309|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758310|NCT02064140|Rocuronium|rocuronium|mesh-list
6758311|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6758312|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6758313|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6758314|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758315|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758316|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
6758317|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6758318|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
6758319|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
6758320|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6758321|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758322|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6788686|NCT02226913|Lidocaine|lidocaine|mesh-list
6758323|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6758324|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758325|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758326|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758327|NCT02064374|Metformin|metformin|mesh-list
6758328|NCT02064374|Dolutegravir|dolutegravir|mesh-list
6758329|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6758330|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758331|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6758332|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6758333|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758334|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758335|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6758336|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6758337|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
6758338|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758339|NCT02064465|Lamotrigine|lamotrigine|mesh-list
6758340|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
6758341|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6758342|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6758343|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758344|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6758345|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758346|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6758347|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6758348|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758349|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6758350|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6758351|NCT02064491|Paclitaxel|paclitaxel|mesh-list
6758352|NCT02064491|Docetaxel|docetaxel|mesh-list
6758353|NCT02064491|Cisplatin|cisplatin|mesh-list
6758354|NCT02064491|Carboplatin|carboplatin|mesh-list
6758355|NCT02064491|Pemetrexed|pemetrexed|mesh-list
6758356|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6758357|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6758358|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758359|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
6758360|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
6758361|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
6758362|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758363|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758364|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6758365|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6758366|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6758367|NCT02064504|Fluticasone|fluticasone|mesh-list
6758368|NCT02064504|Xhance|xhance|mesh-list
6758369|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6758370|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6758371|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
6758372|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758373|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758374|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6758375|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
6758376|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
6758377|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6758378|NCT02064517|Calcium|calcium|mesh-list
6758379|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6758380|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758381|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
6758382|NCT02064530|Bupivacaine|bupivacaine|mesh-list
6758383|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
6758384|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
6758385|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758386|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758387|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
6758388|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758389|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6758390|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6758391|NCT02064530|Analgesics|analgesics|mesh-ancestor
6758392|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6758393|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6758394|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6758395|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
6758396|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758397|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758398|NCT02064556|Amlodipine|amlodipine|mesh-list
6758399|NCT02064556|Candesartan|candesartan|mesh-list
6758400|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6758401|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6758402|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6758403|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758404|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6758405|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758406|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
6758407|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6758408|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6758409|NCT02064621|Amlodipine|amlodipine|mesh-list
6758410|NCT02064621|Candesartan|candesartan|mesh-list
6758411|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
6758412|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6758413|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6758414|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6758415|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758416|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6758417|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758418|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
6758419|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6758420|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6758421|NCT02064673|Curcumin|curcumin|mesh-list
6758422|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6758423|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6758424|NCT02064673|Analgesics|analgesics|mesh-ancestor
6758425|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
6758426|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758427|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758428|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6758429|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6758430|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758431|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758432|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758433|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
6758434|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
6758435|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
6758436|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758437|NCT02064777|Tacrolimus|tacrolimus|mesh-list
6758438|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6758439|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
6758440|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758441|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6758442|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758443|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758444|NCT02064829|Paclitaxel|paclitaxel|mesh-list
6758445|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6758446|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6758447|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758448|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
6758449|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
6758450|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
6758451|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758452|NCT02064842|Ritonavir|ritonavir|mesh-list
6758453|NCT02064842|Simeprevir|simeprevir|mesh-list
6758454|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6758455|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6758456|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
6758457|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758458|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758459|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6758460|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6758461|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
6758462|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758463|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6758464|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6758465|NCT02064881|Metformin|metformin|mesh-list
6758466|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6758467|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758468|NCT02064946|Vitamin D|vitamin d|mesh-list
6758469|NCT02064946|Vitamins|vitamins|mesh-ancestor
6758470|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
6758471|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758472|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6758473|NCT02065063|Palbociclib|palbociclib|mesh-list
6758474|NCT02065063|Trametinib|trametinib|mesh-list
6758475|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758476|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6758477|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758478|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758479|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
6758480|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
6758481|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
6758482|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758483|NCT02065128|Capsaicin|capsaicin|mesh-list
6758484|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
6758485|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
6758486|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
6758487|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758488|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758489|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
6758490|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6758491|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
6758492|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758493|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6758494|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6758495|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
6758496|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758497|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758498|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6758499|NCT02065219|Bupivacaine|bupivacaine|mesh-list
6758500|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
6758501|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
6758502|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758503|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758504|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
6758505|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758506|NCT02065349|ASP8477|asp8477|mesh-list
6758507|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758508|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758509|NCT02065388|Warfarin|warfarin|mesh-list
6758510|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
6758511|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
6758512|NCT02065401|Antacids|antacids|mesh-ancestor
6758513|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758514|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6758515|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
6758516|NCT02065414|Listerine|listerine|mesh-list
6758517|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6758518|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758519|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
6788687|NCT02226913|Epinephrine|epinephrine|mesh-list
6788688|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
6788689|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
6788690|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788691|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788692|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
6788693|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788694|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6788695|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6788696|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6788697|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6788698|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788699|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6788700|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6788701|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
6788702|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788703|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6788704|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6788705|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
6788706|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6788707|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
6788708|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
6788709|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
6788710|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6788711|NCT02226926|Aspirin|aspirin|mesh-list
6788712|NCT02226926|Dipyridamole|dipyridamole|mesh-list
6788713|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
6758520|NCT02065466|Paclitaxel|paclitaxel|mesh-list
6758521|NCT02065466|Bevacizumab|bevacizumab|mesh-list
6758522|NCT02065466|Temozolomide|temozolomide|mesh-list
6758523|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6758524|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758525|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
6758526|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
6758527|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
6758528|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758529|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6758530|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6758531|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6758532|NCT02065466|Growth Substances|growth substances|mesh-ancestor
6758533|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758534|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
6758535|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6758536|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
6758537|NCT02065492|Amlodipine|amlodipine|mesh-list
6758538|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
6758539|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6758540|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758541|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6758542|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6758543|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758544|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
6758545|NCT02065596|Vidarabine|vidarabine|mesh-list
6758546|NCT02065596|Fludarabine|fludarabine|mesh-list
6758547|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
6758548|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758549|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6758550|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
6758551|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758552|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6758553|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
6758554|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758555|NCT02065596|Antiviral Agents|antiviral agents|mesh-ancestor
6758556|NCT02065596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758557|NCT02065609|Trastuzumab|trastuzumab|mesh-list
6758558|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6758559|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758560|NCT02065739|Itraconazole|itraconazole|mesh-list
6758561|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
6758562|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
6758563|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758564|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6758565|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6758566|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758567|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758568|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6758569|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
6758570|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6758571|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758572|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6758573|NCT02065752|Metformin|metformin|mesh-list
6758574|NCT02065752|Canagliflozin|canagliflozin|mesh-list
6758575|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6758576|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758577|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6758578|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758579|NCT02065804|Bupivacaine|bupivacaine|mesh-list
6758580|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
6758581|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
6758582|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758583|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758584|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
6758585|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758586|NCT02065843|Midazolam|midazolam|mesh-list
6758587|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6758588|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6758589|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758590|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758591|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6758592|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6758593|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6758594|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6758595|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
6758596|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
6758597|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
6758598|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
6758599|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758600|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758601|NCT02065947|Lidocaine|lidocaine|mesh-list
6758602|NCT02065947|Epinephrine|epinephrine|mesh-list
6758603|NCT02065947|Racepinephrine|racepinephrine|mesh-list
6758604|NCT02065947|Fentanyl|fentanyl|mesh-list
6758605|NCT02065947|Midazolam|midazolam|mesh-list
6758606|NCT02065947|Ketamine|ketamine|mesh-list
6758607|NCT02065947|Bupivacaine|bupivacaine|mesh-list
6758608|NCT02065947|Propofol|propofol|mesh-list
6758609|NCT02065947|Sevoflurane|sevoflurane|mesh-list
6758610|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
6758611|NCT02065947|Atracurium|atracurium|mesh-list
6758612|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
6758613|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
6758614|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758615|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758616|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
6758617|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758618|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6758619|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6758620|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6758621|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6758622|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758623|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6758624|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6758625|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
6758626|NCT02065947|Analgesics|analgesics|mesh-ancestor
6758627|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6758628|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6758629|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6758630|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758631|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6758632|NCT02065947|Narcotics|narcotics|mesh-ancestor
6758633|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6758634|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6758635|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6758636|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6758637|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
6758638|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
6758639|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6758640|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6758641|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6758642|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6758643|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
6758644|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6758645|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6758646|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
6758647|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6758648|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
6758649|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
6758650|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
6758651|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6758652|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6758653|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6758654|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6758655|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6758656|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6758657|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
6758658|NCT02065986|Tenofovir|tenofovir|mesh-list
6758659|NCT02065986|Emtricitabine|emtricitabine|mesh-list
6758660|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6758661|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
6758662|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758663|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6758664|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6758665|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758666|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758667|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6758668|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6758669|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6758670|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758671|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6758672|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758673|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758674|NCT02066077|Propofol|propofol|mesh-list
6758675|NCT02066077|Etomidate|etomidate|mesh-list
6758676|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6758677|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758678|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758679|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6758680|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
6758681|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
6758682|NCT02066103|Paclitaxel|paclitaxel|mesh-list
6758683|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6758684|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758685|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
6758686|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
6758687|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
6758688|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758689|NCT02066207|Atorvastatin|atorvastatin|mesh-list
6758690|NCT02066207|Fenofibrate|fenofibrate|mesh-list
6758691|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6758692|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6758693|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
6758694|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758695|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6758696|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6758697|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758698|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
6758699|NCT02066220|Lomustine|lomustine|mesh-list
6758700|NCT02066220|Cisplatin|cisplatin|mesh-list
6758701|NCT02066220|Carboplatin|carboplatin|mesh-list
6758702|NCT02066220|Vincristine|vincristine|mesh-list
6758703|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6758704|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
6758705|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758706|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6758707|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6758708|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
6758709|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758710|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758711|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6758712|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6758713|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
6758714|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
6758715|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
6758716|NCT02066350|Pancrelipase|pancrelipase|mesh-list
6758717|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6758718|NCT02066454|Apixaban|apixaban|mesh-list
6758719|NCT02066454|Anticoagulants|anticoagulants|mesh-list
6758720|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6758721|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
6758722|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6758723|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
6758724|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758725|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758726|NCT02066532|Trastuzumab|trastuzumab|mesh-list
6758727|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6758728|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758729|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
6758730|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
6758731|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758732|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
6758733|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758734|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758735|NCT02066571|Droxidopa|droxidopa|mesh-list
6758736|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6758737|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6758738|NCT02066610|Selenium|selenium|mesh-list
6758739|NCT02066610|Selenious Acid|selenious acid|mesh-list
6758740|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
6758741|NCT02066610|Selenic Acid|selenic acid|mesh-list
6758742|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
6758743|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758744|NCT02066610|Protective Agents|protective agents|mesh-ancestor
6758745|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758746|NCT02066610|Trace Elements|trace elements|mesh-ancestor
6758747|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
6758748|NCT02066623|Everolimus|everolimus|mesh-list
6758749|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758750|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6758751|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
6758752|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758753|NCT02066649|Carvedilol|carvedilol|mesh-list
6758754|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6758755|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6758756|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
6758757|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758758|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758759|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758760|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6758761|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
6758762|NCT02066649|Protective Agents|protective agents|mesh-ancestor
6758763|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6758764|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6758765|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6758766|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
6758767|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6758768|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6758769|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
6758770|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
6758771|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6758772|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
6758773|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6758774|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
6758775|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758776|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758777|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
6758778|NCT02066675|Trabectedin|trabectedin|mesh-list
6758779|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6758780|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
6758781|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758782|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758783|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
6758784|NCT02066688|Vitamin D|vitamin d|mesh-list
6758785|NCT02066688|Folic Acid|folic acid|mesh-list
6758786|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
6758787|NCT02066688|Calcium|calcium|mesh-list
6758788|NCT02066688|Vitamins|vitamins|mesh-ancestor
6758789|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
6758790|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758791|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6758792|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6758793|NCT02066688|Hematinics|hematinics|mesh-ancestor
6758794|NCT02066818|Lidocaine|lidocaine|mesh-list
6758795|NCT02066818|Tetracaine|tetracaine|mesh-list
6758796|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
6758797|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
6758798|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758799|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758800|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
6758801|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758802|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6758803|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6758804|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6758805|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6758806|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758807|NCT02066844|Betamethasone|betamethasone|mesh-list
6758808|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
6758809|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6758810|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
6758811|NCT02066844|Lidocaine|lidocaine|mesh-list
6758812|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6758813|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
6758814|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
6758815|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758816|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758817|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
6758818|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758819|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6758820|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6758821|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6758822|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6758823|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758824|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6758825|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
6758826|NCT02066844|Hormones|hormones|mesh-ancestor
6758827|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6758828|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6758829|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
6758830|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
6758831|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758832|NCT02067013|Ranibizumab|ranibizumab|mesh-list
6758833|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6758834|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6758835|NCT02067013|Growth Substances|growth substances|mesh-ancestor
6758836|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758837|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
6758838|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758839|NCT02067065|Propofol|propofol|mesh-list
6758840|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6758841|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758842|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758843|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6758844|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
6758845|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
6758846|NCT02067078|Dexamethasone|dexamethasone|mesh-list
6758847|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
6758848|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6758849|NCT02067078|Clonidine|clonidine|mesh-list
6758850|NCT02067078|Epinephrine|epinephrine|mesh-list
6758851|NCT02067078|Racepinephrine|racepinephrine|mesh-list
6758852|NCT02067078|Ropivacaine|ropivacaine|mesh-list
6758853|NCT02067078|Bupivacaine|bupivacaine|mesh-list
6758854|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
6758855|NCT02067078|BB 1101|bb 1101|mesh-list
6758856|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6758857|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
6758858|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
6758859|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758860|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758861|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6758862|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
6758863|NCT02067078|Hormones|hormones|mesh-ancestor
6758864|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6758865|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6758866|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758867|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
6758868|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758869|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758870|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
6758871|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
6758872|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758873|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
6758874|NCT02067078|Analgesics|analgesics|mesh-ancestor
6758875|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6758876|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
6758877|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6758878|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6758879|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6758880|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
6758881|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6758882|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6758883|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6758884|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6758885|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6758886|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6758887|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6758888|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6758889|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
6758890|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
6758891|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
6758892|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6758893|NCT02067143|Cytarabine|cytarabine|mesh-list
6758894|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6758895|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
6758896|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758897|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758898|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
6758899|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758900|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6758901|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
6758902|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758903|NCT02067182|Dabigatran|dabigatran|mesh-list
6758904|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
6758905|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6758906|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
6758907|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758908|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758909|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
6788714|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6788715|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6788716|NCT02226926|Analgesics|analgesics|mesh-ancestor
6788717|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
6788718|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788719|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788720|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6788721|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788722|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6788723|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6788724|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758910|NCT02067338|Morphine|morphine|mesh-list
6758911|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
6758912|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6758913|NCT02067338|Narcotics|narcotics|mesh-ancestor
6758914|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758915|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758916|NCT02067338|Analgesics|analgesics|mesh-ancestor
6758917|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
6758918|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758919|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
6758920|NCT02067338|Coagulants|coagulants|mesh-ancestor
6758921|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
6758922|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6758923|NCT02067377|Antibodies|antibodies|mesh-list
6758924|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
6758925|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758926|NCT02067416|Paclitaxel|paclitaxel|mesh-list
6758927|NCT02067416|Docetaxel|docetaxel|mesh-list
6758928|NCT02067416|Epirubicin|epirubicin|mesh-list
6758929|NCT02067416|Taxane|taxane|mesh-list
6758930|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6758931|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758932|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
6758933|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
6758934|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
6758935|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758936|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6758937|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6758938|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6758939|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758940|NCT02067442|Acetaminophen|acetaminophen|mesh-list
6758941|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6758942|NCT02067442|Analgesics|analgesics|mesh-ancestor
6758943|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
6758944|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758945|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758946|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
6758947|NCT02067520|Hydromorphone|hydromorphone|mesh-list
6758948|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6758949|NCT02067520|Narcotics|narcotics|mesh-ancestor
6758950|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758951|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758952|NCT02067520|Analgesics|analgesics|mesh-ancestor
6758953|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
6758954|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6758955|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6758956|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6758957|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758958|NCT02067767|Lamivudine|lamivudine|mesh-list
6758959|NCT02067767|Abacavir|abacavir|mesh-list
6758960|NCT02067767|Dolutegravir|dolutegravir|mesh-list
6758961|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6758962|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6758963|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758964|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758965|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
6758966|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758967|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6758968|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6758969|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6758970|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6758971|NCT02067780|Levofloxacin|levofloxacin|mesh-list
6758972|NCT02067780|Ofloxacin|ofloxacin|mesh-list
6758973|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6758974|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6758975|NCT02067780|Renal Agents|renal agents|mesh-ancestor
6758976|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6758977|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6758978|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6758979|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6758980|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758981|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758982|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6758983|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6758984|NCT02067910|Abatacept|abatacept|mesh-list
6758985|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6758986|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6758987|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6758988|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6758989|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
6758990|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758991|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6758992|NCT02067936|Remifentanil|remifentanil|mesh-list
6758993|NCT02067936|Propofol|propofol|mesh-list
6758994|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6758995|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6758996|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6758997|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6758998|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
6758999|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
6759000|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6759001|NCT02067936|Narcotics|narcotics|mesh-ancestor
6759002|NCT02067936|Analgesics|analgesics|mesh-ancestor
6759003|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
6759004|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759005|NCT02067949|Simvastatin|simvastatin|mesh-list
6759006|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6759007|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6759008|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
6759009|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759010|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6759011|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6759012|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759013|NCT02068079|Vemurafenib|vemurafenib|mesh-list
6759014|NCT02068079|Trientine|trientine|mesh-list
6759015|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759016|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6759017|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759018|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759019|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
6759020|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
6759021|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
6759022|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759023|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
6759024|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759025|NCT02068092|Protective Agents|protective agents|mesh-ancestor
6759026|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759027|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6759028|NCT02068131|Capecitabine|capecitabine|mesh-list
6759029|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6759030|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
6759031|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759032|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759033|NCT02068170|Azithromycin|azithromycin|mesh-list
6759034|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
6759035|NCT02068170|Clarithromycin|clarithromycin|mesh-list
6759036|NCT02068170|Levofloxacin|levofloxacin|mesh-list
6759037|NCT02068170|Erythromycin|erythromycin|mesh-list
6759038|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
6759039|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6759040|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
6759041|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6759042|NCT02068170|Itraconazole|itraconazole|mesh-list
6759043|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6759044|NCT02068170|Fluconazole|fluconazole|mesh-list
6759045|NCT02068170|Ketoconazole|ketoconazole|mesh-list
6759046|NCT02068170|Voriconazole|voriconazole|mesh-list
6759047|NCT02068170|Sunitinib|sunitinib|mesh-list
6759048|NCT02068170|Methadone|methadone|mesh-list
6759049|NCT02068170|Haloperidol|haloperidol|mesh-list
6759050|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
6759051|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6759052|NCT02068170|Tacrolimus|tacrolimus|mesh-list
6759053|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6759054|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
6759055|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759056|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6759057|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759058|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759059|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6759060|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759061|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759062|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6759063|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6759064|NCT02068170|Growth Substances|growth substances|mesh-ancestor
6759065|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
6759066|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6759067|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6759068|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6759069|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6759070|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
6759071|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6759072|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6759073|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6759074|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6759075|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6759076|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6759077|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6759078|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
6759079|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6759080|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6759081|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
6759082|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6759083|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6759084|NCT02068170|Renal Agents|renal agents|mesh-ancestor
6759085|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6759086|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6759087|NCT02068170|Narcotics|narcotics|mesh-ancestor
6759088|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759089|NCT02068170|Analgesics|analgesics|mesh-ancestor
6759090|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
6759091|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759092|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
6759093|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
6759094|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6759095|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6759096|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
6759097|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
6759098|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6759099|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6759100|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6759101|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6759102|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6759103|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
6759104|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759105|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6759106|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
6759107|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6759108|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6759109|NCT02068196|Ipilimumab|ipilimumab|mesh-list
6759110|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6759111|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759112|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6759113|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759114|NCT02068209|Tramadol|tramadol|mesh-list
6759115|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6759116|NCT02068209|Narcotics|narcotics|mesh-ancestor
6759117|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759118|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759119|NCT02068209|Analgesics|analgesics|mesh-ancestor
6759120|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
6759121|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759122|NCT02068235|Ponesimod|ponesimod|mesh-list
6759123|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6759124|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759125|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6759126|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
6759127|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759128|NCT02068287|Esmolol|esmolol|mesh-list
6759129|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6759130|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6759131|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6759132|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
6759133|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759134|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759135|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759136|NCT02068339|Oltipraz|oltipraz|mesh-list
6759137|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
6759138|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759139|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
6759140|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6759141|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
6759142|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6759143|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6759144|NCT02068339|Protective Agents|protective agents|mesh-ancestor
6759145|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759146|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759147|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6759148|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6759149|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759150|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759151|NCT02068404|Nifedipine|nifedipine|mesh-list
6759152|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6759153|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6759154|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759155|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6759156|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759157|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
6759158|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
6759159|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6759160|NCT02068430|Riboflavin|riboflavin|mesh-list
6759161|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
6759162|NCT02068430|Vitamins|vitamins|mesh-ancestor
6759163|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
6759164|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759165|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6759166|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
6759167|NCT02068482|Rifaximin|rifaximin|mesh-list
6759168|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6759169|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759170|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6759171|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6759172|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
6759173|NCT02068560|Coagulants|coagulants|mesh-ancestor
6759174|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6759175|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
6759176|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759177|NCT02068586|Sunitinib|sunitinib|mesh-list
6759178|NCT02068586|Valproic Acid|valproic acid|mesh-list
6759179|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759180|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6759181|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6759182|NCT02068586|Growth Substances|growth substances|mesh-ancestor
6759183|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759184|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
6759185|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6759186|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759187|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759188|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
6759189|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
6759190|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759191|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
6759192|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6759193|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759194|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6759195|NCT02068625|Rasagiline|rasagiline|mesh-list
6759196|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6759197|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759198|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759199|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6759200|NCT02068625|Protective Agents|protective agents|mesh-ancestor
6759201|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759202|NCT02068690|BI 425809|bi 425809|mesh-list
6759203|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
6759204|NCT02068859|Diclofenac|diclofenac|mesh-list
6759205|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6759206|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6759207|NCT02068859|Analgesics|analgesics|mesh-ancestor
6759208|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
6759209|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759210|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759211|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6759212|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6759213|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6759214|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759215|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788725|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6788726|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6788727|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788728|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
6788729|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6788730|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
6788731|NCT02226978|Ritonavir|ritonavir|mesh-list
6788732|NCT02226978|Tipranavir|tipranavir|mesh-list
6788733|NCT02226978|Valacyclovir|valacyclovir|mesh-list
6788734|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6788735|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6788736|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
6788737|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788738|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788739|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6788740|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6788741|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
6788742|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788743|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6788744|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6788745|NCT02226991|Ritonavir|ritonavir|mesh-list
6788746|NCT02226991|Tipranavir|tipranavir|mesh-list
6788747|NCT02226991|Efavirenz|efavirenz|mesh-list
6788748|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6788749|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6788750|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
6788751|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788752|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788753|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6788754|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6788755|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
6788756|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788757|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6788758|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6788759|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6788760|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6788761|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6788762|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6759216|NCT02068937|Furosemide|furosemide|mesh-list
6759217|NCT02068937|Diuretics|diuretics|mesh-ancestor
6759218|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
6759219|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759220|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6759221|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6759222|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759223|NCT02069080|Plerixafor|plerixafor|mesh-list
6759224|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6759225|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6759226|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
6759227|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759228|NCT02069132|Warfarin|warfarin|mesh-list
6759229|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
6759230|NCT02069145|Sorafenib|sorafenib|mesh-list
6759231|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
6759232|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759233|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6759234|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759235|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759236|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
6759237|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759238|NCT02069158|Paclitaxel|paclitaxel|mesh-list
6759239|NCT02069158|Carboplatin|carboplatin|mesh-list
6759240|NCT02069158|Gedatolisib|gedatolisib|mesh-list
6759241|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6759242|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759243|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
6759244|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
6759245|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
6759246|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759247|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6759248|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759249|NCT02069197|Orlistat|orlistat|mesh-list
6759250|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759251|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759252|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6759253|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6759254|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
6759255|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6759256|NCT02069301|Fluoxetine|fluoxetine|mesh-list
6759257|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
6759258|NCT02069301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6759259|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6759260|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6759261|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759262|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759263|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
6759264|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759265|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6759266|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6759267|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6759268|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6759269|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759270|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
6759271|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6759272|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759273|NCT02069366|Dronabinol|dronabinol|mesh-list
6759274|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
6759275|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759276|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6759277|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6759278|NCT02069366|Analgesics|analgesics|mesh-ancestor
6759279|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
6759280|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759281|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6759282|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6759283|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759284|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759285|NCT02069366|Hormones|hormones|mesh-ancestor
6759286|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6759287|NCT02069418|Alovudine|alovudine|mesh-list
6759288|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6759289|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6759290|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759291|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
6759292|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759293|NCT02069431|Oxytocin|oxytocin|mesh-list
6759294|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
6759295|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6759296|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759297|NCT02069522|Carotenoids|carotenoids|mesh-list
6759298|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
6759299|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759300|NCT02069522|Protective Agents|protective agents|mesh-ancestor
6759301|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759302|NCT02069665|Ribavirin|ribavirin|mesh-list
6759303|NCT02069665|Ibuprofen|ibuprofen|mesh-list
6759304|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
6759305|NCT02069665|Albuterol|albuterol|mesh-list
6759306|NCT02069665|Guaifenesin|guaifenesin|mesh-list
6759307|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6759308|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
6759309|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759310|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
6759311|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759312|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6759313|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6759314|NCT02069665|Analgesics|analgesics|mesh-ancestor
6759315|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
6759316|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759317|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759318|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6759319|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6759320|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6759321|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759322|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6759323|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
6759324|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6759325|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
6759326|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
6759327|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6759328|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6759329|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6759330|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6759331|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
6759332|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759333|NCT02069665|Expectorants|expectorants|mesh-ancestor
6759334|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6759335|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
6759336|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6759337|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
6759338|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
6759339|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6759340|NCT02069808|Leuprolide|leuprolide|mesh-list
6759341|NCT02069808|Menotropins|menotropins|mesh-list
6759342|NCT02069808|Ganirelix|ganirelix|mesh-list
6759343|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6759344|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
6759345|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6759346|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759347|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6759348|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759349|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
6759350|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6759351|NCT02069886|Deferasirox|deferasirox|mesh-list
6759352|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6759353|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
6759354|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
6759355|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759356|NCT02069977|Aripiprazole|aripiprazole|mesh-list
6759357|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
6759358|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6759359|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6759360|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6759361|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759362|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759363|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
6759364|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
6759365|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759366|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759367|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6759368|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6759369|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
6759370|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6759371|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6759372|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6759373|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6759374|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
6759375|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6759376|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759377|NCT02069990|Vitamins|vitamins|mesh-ancestor
6759378|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
6759379|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6759380|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
6759381|NCT02070003|Narcotics|narcotics|mesh-ancestor
6759382|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759383|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759384|NCT02070003|Analgesics|analgesics|mesh-ancestor
6759385|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
6759386|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759387|NCT02070120|Mitomycins|mitomycins|mesh-list
6759388|NCT02070120|Mitomycin|mitomycin|mesh-list
6759389|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6759390|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759391|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
6759392|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759393|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6759394|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759395|NCT02070133|Simvastatin|simvastatin|mesh-list
6759396|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6759397|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6759398|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
6759399|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759400|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6759401|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6759402|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759403|NCT02070159|Clopidogrel|clopidogrel|mesh-list
6759404|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6759405|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6759406|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6759407|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6759408|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6759409|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
6759410|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759411|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759412|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759413|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6759414|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6759415|NCT02070198|Hormones|hormones|mesh-ancestor
6759416|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6759417|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759418|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
6759419|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6759420|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
6759421|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6759422|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6759423|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6759424|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759425|NCT02070289|PF-06372865|pf-06372865|mesh-list
6759426|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
6759427|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
6759428|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759429|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759430|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759431|NCT02070406|Aldesleukin|aldesleukin|mesh-list
6759432|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
6759433|NCT02070406|Fludarabine|fludarabine|mesh-list
6759434|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
6759435|NCT02070406|Interleukin-2|interleukin-2|mesh-list
6759436|NCT02070406|Vaccines|vaccines|mesh-list
6759437|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6759438|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6759439|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
6759440|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759441|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6759442|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6759443|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
6759444|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759445|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759446|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6759447|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6759448|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
6759449|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6759450|NCT02070406|Analgesics|analgesics|mesh-ancestor
6759451|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
6759452|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759453|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6759454|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6759455|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
6759456|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759457|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6788763|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6788764|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6788765|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6788766|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6788767|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6788768|NCT02227056|Methylphenidate|methylphenidate|mesh-list
6788769|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6788770|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788771|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6788772|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6788773|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6788774|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788775|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
6788776|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788777|NCT02227082|Olaparib|olaparib|mesh-list
6788778|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6788779|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788780|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788781|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788782|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
6788783|NCT02227173|Digoxin|digoxin|mesh-list
6788784|NCT02227173|Montelukast|montelukast|mesh-list
6788785|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6788786|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
6788787|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6788788|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
6788789|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788790|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788791|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6788792|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6788793|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788794|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6788795|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6788796|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788797|NCT02227173|Protective Agents|protective agents|mesh-ancestor
6788798|NCT02227173|Analgesics|analgesics|mesh-ancestor
6788799|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
6788800|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788801|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6788802|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6788803|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6788804|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788805|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6788806|NCT02227186|Vaccines|vaccines|mesh-list
6788807|NCT02227186|Immunologic Factors|immunologic factors|mesh-ancestor
6788808|NCT02227186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788809|NCT02227212|Insulin|insulin|mesh-list
6788810|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
6788811|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6788812|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788813|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
6788814|NCT02227264|Cinacalcet|cinacalcet|mesh-list
6788815|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6788816|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759458|NCT02070458|Cytarabine|cytarabine|mesh-list
6759459|NCT02070458|Etoposide|etoposide|mesh-list
6759460|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
6759461|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
6759462|NCT02070458|Ixazomib|ixazomib|mesh-list
6759463|NCT02070458|Glycine|glycine|mesh-list
6759464|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
6759465|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6759466|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759467|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6759468|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6759469|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759470|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759471|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6759472|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
6759473|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
6759474|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759475|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6759476|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
6759477|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759478|NCT02070458|Analgesics|analgesics|mesh-ancestor
6759479|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
6759480|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759481|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
6759482|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
6759483|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759484|NCT02070510|Lisinopril|lisinopril|mesh-list
6759485|NCT02070510|Warfarin|warfarin|mesh-list
6759486|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
6759487|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6759488|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
6759489|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759490|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759491|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6759492|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6759493|NCT02070510|Protective Agents|protective agents|mesh-ancestor
6759494|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759495|NCT02070653|Ticagrelor|ticagrelor|mesh-list
6759496|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6759497|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6759498|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6759499|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6759500|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
6759501|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759502|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759503|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759504|NCT02070679|Vitamin E|vitamin e|mesh-list
6759505|NCT02070679|Tocopherols|tocopherols|mesh-list
6759506|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
6759507|NCT02070679|Vitamins|vitamins|mesh-ancestor
6759508|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
6759509|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759510|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
6759511|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759512|NCT02070679|Protective Agents|protective agents|mesh-ancestor
6759513|NCT02070718|Pentazocine|pentazocine|mesh-list
6759514|NCT02070718|Naloxone|naloxone|mesh-list
6759515|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6759516|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759517|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
6759518|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759519|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6759520|NCT02070718|Narcotics|narcotics|mesh-ancestor
6759521|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759522|NCT02070718|Analgesics|analgesics|mesh-ancestor
6759523|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6759524|NCT02070796|Rotigotine|rotigotine|mesh-list
6759525|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
6759526|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
6759527|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759528|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759529|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759530|NCT02071004|Aspirin|aspirin|mesh-list
6759531|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6759532|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6759533|NCT02071004|Analgesics|analgesics|mesh-ancestor
6759534|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
6759535|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759536|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759537|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6759538|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6759539|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6759540|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6759541|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759542|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6759543|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6759544|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759545|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
6759546|NCT02071043|Capecitabine|capecitabine|mesh-list
6759547|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
6759548|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6759549|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
6759550|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759551|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759552|NCT02071069|Fluorouracil|fluorouracil|mesh-list
6759553|NCT02071069|Irinotecan|irinotecan|mesh-list
6759554|NCT02071069|Cetuximab|cetuximab|mesh-list
6759555|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
6759556|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759557|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6759558|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759559|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6759560|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
6759561|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759562|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6759563|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6759564|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759565|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6759566|NCT02071160|Melatonin|melatonin|mesh-list
6759567|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
6759568|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759569|NCT02071160|Protective Agents|protective agents|mesh-ancestor
6759570|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759571|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759572|NCT02071212|Ticagrelor|ticagrelor|mesh-list
6759573|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6759574|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6759575|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6759576|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6759577|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
6759578|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759579|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759580|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759581|NCT02071303|Celecoxib|celecoxib|mesh-list
6759582|NCT02071303|Tramadol|tramadol|mesh-list
6759583|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6759584|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6759585|NCT02071303|Analgesics|analgesics|mesh-ancestor
6759586|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
6759587|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759588|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759589|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6759590|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6759591|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6759592|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6759593|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759594|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759595|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6759596|NCT02071303|Narcotics|narcotics|mesh-ancestor
6759597|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759598|NCT02071316|Esomeprazole|esomeprazole|mesh-list
6759599|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
6759600|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6759601|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6759602|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759603|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
6759604|NCT02071316|Coagulants|coagulants|mesh-ancestor
6759605|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6759606|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6759607|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6759608|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759609|NCT02071342|Everolimus|everolimus|mesh-list
6759610|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759611|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6759612|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
6759613|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759614|NCT02071355|Simeprevir|simeprevir|mesh-list
6759615|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
6759616|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759617|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
6759618|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759619|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759620|NCT02071368|Metformin|metformin|mesh-list
6759621|NCT02071368|Canagliflozin|canagliflozin|mesh-list
6759622|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6759623|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759624|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6759625|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759626|NCT02071394|Xenon|xenon|mesh-list
6759627|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6759628|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
6759629|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
6759630|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759631|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759632|NCT02071407|Midazolam|midazolam|mesh-list
6759633|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6759634|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6759635|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759636|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759637|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6759638|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6759639|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6759640|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6759641|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
6759642|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
6759643|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
6759644|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
6759645|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759646|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759647|NCT02071433|Iodine|iodine|mesh-list
6759648|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6759649|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759650|NCT02071433|Trace Elements|trace elements|mesh-ancestor
6759651|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
6759652|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759653|NCT02071459|Droxidopa|droxidopa|mesh-list
6759654|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6759655|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6759656|NCT02071537|Gemcitabine|gemcitabine|mesh-list
6759657|NCT02071537|Chloroquine|chloroquine|mesh-list
6759658|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6759659|NCT02071537|Carboplatin|carboplatin|mesh-list
6759660|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759661|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6759662|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
6759663|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759664|NCT02071537|Antiviral Agents|antiviral agents|mesh-ancestor
6759665|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759666|NCT02071537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759667|NCT02071537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6759668|NCT02071537|Immunologic Factors|immunologic factors|mesh-ancestor
6759669|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759670|NCT02071537|Amebicides|amebicides|mesh-ancestor
6759671|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6759672|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6759673|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
6759674|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6759675|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6759676|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6759677|NCT02071537|Analgesics|analgesics|mesh-ancestor
6759678|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
6759679|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759680|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6759681|NCT02071537|Filaricides|filaricides|mesh-ancestor
6759682|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
6759683|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
6759684|NCT02071589|Nifedipine|nifedipine|mesh-list
6759685|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6759686|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6759687|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759688|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6759689|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759690|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
6759691|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
6759692|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6759693|NCT02071615|Methylphenidate|methylphenidate|mesh-list
6759694|NCT02071615|Caffeine|caffeine|mesh-list
6759695|NCT02071615|Modafinil|modafinil|mesh-list
6759696|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6759697|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759698|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6759699|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6759700|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6759701|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759702|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
6759703|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759704|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6759705|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759706|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6759707|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6759708|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
6759709|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6759710|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6759711|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6759712|NCT02071641|Sunitinib|sunitinib|mesh-list
6759713|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759714|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6759715|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6759716|NCT02071641|Growth Substances|growth substances|mesh-ancestor
6759717|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759718|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
6759719|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6759720|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759721|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759722|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6759723|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759724|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759725|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759726|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6759727|NCT02071862|Paclitaxel|paclitaxel|mesh-list
6759728|NCT02071862|Docetaxel|docetaxel|mesh-list
6759729|NCT02071862|Everolimus|everolimus|mesh-list
6759730|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6759731|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759732|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
6759733|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
6759734|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
6759735|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759736|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6759737|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
6759738|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759739|NCT02071888|Dexamethasone|dexamethasone|mesh-list
6759740|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
6759741|NCT02071888|Pomalidomide|pomalidomide|mesh-list
6759742|NCT02071888|BB 1101|bb 1101|mesh-list
6759743|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6759744|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
6759745|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
6759746|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759747|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759748|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6759749|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
6759750|NCT02071888|Hormones|hormones|mesh-ancestor
6759751|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6759752|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6759753|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759754|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
6759755|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759756|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759757|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
6759758|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6759759|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6759760|NCT02071888|Growth Substances|growth substances|mesh-ancestor
6759761|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
6759762|NCT02071927|Azacitidine|azacitidine|mesh-list
6759763|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6759764|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
6759765|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759766|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759767|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759768|NCT02071966|Clopidogrel|clopidogrel|mesh-list
6759769|NCT02071966|Ticagrelor|ticagrelor|mesh-list
6759770|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6759771|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6759772|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6759773|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6759774|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
6759775|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759776|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759777|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759778|NCT02072031|Sunitinib|sunitinib|mesh-list
6759779|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759780|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6759781|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6759782|NCT02072031|Growth Substances|growth substances|mesh-ancestor
6759783|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759784|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
6759785|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6759786|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759787|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759788|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
6759789|NCT02072083|Ketamine|ketamine|mesh-list
6759790|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6759791|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759792|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759793|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6759794|NCT02072083|Analgesics|analgesics|mesh-ancestor
6759795|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
6759796|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759797|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6759798|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6759799|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6759800|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
6759801|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759802|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759803|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6759804|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6759805|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
6759806|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
6759807|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6759808|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6788817|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6788818|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
6788819|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788820|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6788821|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
6788822|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
6788823|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788824|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788825|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6788826|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6788827|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6788828|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6788829|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788830|NCT02227550|Vitamin K|vitamin k|mesh-list
6788831|NCT02227550|Warfarin|warfarin|mesh-list
6788832|NCT02227550|Apixaban|apixaban|mesh-list
6788833|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
6788834|NCT02227550|Fluindione|fluindione|mesh-list
6788835|NCT02227550|Vitamins|vitamins|mesh-ancestor
6788836|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
6788837|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788838|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
6788839|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6788840|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
6788841|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6788842|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
6788843|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759809|NCT02072135|Bupivacaine|bupivacaine|mesh-list
6759810|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
6759811|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
6759812|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759813|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759814|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
6759815|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759816|NCT02072148|Cisplatin|cisplatin|mesh-list
6759817|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759818|NCT02072213|Tamsulosin|tamsulosin|mesh-list
6759819|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6759820|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6759821|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6759822|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
6759823|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759824|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759825|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759826|NCT02072213|Urological Agents|urological agents|mesh-ancestor
6759827|NCT02072278|Vortioxetine|vortioxetine|mesh-list
6759828|NCT02072278|Citalopram|citalopram|mesh-list
6759829|NCT02072278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6759830|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6759831|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6759832|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759833|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6759834|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
6759835|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759836|NCT02072278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6759837|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
6759838|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6759839|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6759840|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6759841|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759842|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6759843|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6759844|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6759845|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6759846|NCT02072291|Nifedipine|nifedipine|mesh-list
6759847|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6759848|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6759849|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759850|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6759851|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759852|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
6759853|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
6759854|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6759855|NCT02072317|Raltitrexed|raltitrexed|mesh-list
6759856|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6759857|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
6759858|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759859|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759860|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6759861|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759862|NCT02072330|Amlodipine|amlodipine|mesh-list
6759863|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6759864|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6759865|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6759866|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6759867|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6759868|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759869|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6759870|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759871|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
6759872|NCT02072330|Diuretics|diuretics|mesh-ancestor
6759873|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
6759874|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6759875|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6759876|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6759877|NCT02072382|Metformin|metformin|mesh-list
6759878|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6759879|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759880|NCT02072408|Aflibercept|aflibercept|mesh-list
6759881|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6759882|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6759883|NCT02072408|Growth Substances|growth substances|mesh-ancestor
6759884|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759885|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
6759886|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759887|NCT02072486|Sorafenib|sorafenib|mesh-list
6759888|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759889|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6759890|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759891|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759892|NCT02072512|Fulvestrant|fulvestrant|mesh-list
6759893|NCT02072512|Anastrozole|anastrozole|mesh-list
6759894|NCT02072512|Goserelin|goserelin|mesh-list
6759895|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6759896|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759897|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6759898|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6759899|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
6759900|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6759901|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759902|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6759903|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6759904|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759905|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759906|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6759907|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
6759908|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759909|NCT02072720|Bevacizumab|bevacizumab|mesh-list
6759910|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6759911|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759912|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6759913|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6759914|NCT02072720|Growth Substances|growth substances|mesh-ancestor
6759915|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759916|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
6759917|NCT02072746|Zinc|zinc|mesh-list
6759918|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
6759919|NCT02072746|Trace Elements|trace elements|mesh-ancestor
6759920|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
6759921|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759922|NCT02072746|Astringents|astringents|mesh-ancestor
6759923|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
6759924|NCT02072785|Vincristine|vincristine|mesh-list
6759925|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6759926|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759927|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
6759928|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
6759929|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
6759930|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759931|NCT02072798|Cefuroxime|cefuroxime|mesh-list
6759932|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
6759933|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6759934|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759935|NCT02072811|Cytarabine|cytarabine|mesh-list
6759936|NCT02072811|Daunorubicin|daunorubicin|mesh-list
6759937|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
6759938|NCT02072811|Cladribine|cladribine|mesh-list
6759939|NCT02072811|Sargramostim|sargramostim|mesh-list
6759940|NCT02072811|Lenograstim|lenograstim|mesh-list
6759941|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6759942|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
6759943|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759944|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759945|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
6759946|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759947|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6759948|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
6759949|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759950|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6759951|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6759952|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6759953|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759954|NCT02072811|Analgesics|analgesics|mesh-ancestor
6759955|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
6759956|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759957|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6759958|NCT02072967|Rituximab|rituximab|mesh-list
6759959|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6759960|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6759961|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759962|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
6759963|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759964|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6759965|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6759966|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
6759967|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759968|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
6759969|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6759970|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6759971|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6759972|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6759973|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6759974|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759975|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6759976|NCT02073149|Iron|iron|mesh-list
6759977|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
6759978|NCT02073149|Trace Elements|trace elements|mesh-ancestor
6759979|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
6759980|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759981|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6759982|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
6759983|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
6759984|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759985|NCT02073227|Metformin|metformin|mesh-list
6759986|NCT02073227|Canagliflozin|canagliflozin|mesh-list
6759987|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6759988|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759989|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6759990|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6759991|NCT02073357|Anesthetics|anesthetics|mesh-list
6759992|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6759993|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759994|NCT02073474|Nabiximols|nabiximols|mesh-list
6759995|NCT02073474|Analgesics|analgesics|mesh-ancestor
6759996|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
6759997|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6759998|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6759999|NCT02073526|Adalimumab|adalimumab|mesh-list
6760000|NCT02073526|Infliximab|infliximab|mesh-list
6760001|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
6760002|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760003|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6760004|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
6760005|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6760006|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6760007|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
6760008|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760009|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
6760010|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6760011|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
6760012|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760013|NCT02073552|Protective Agents|protective agents|mesh-ancestor
6760014|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760015|NCT02073552|Vitamins|vitamins|mesh-ancestor
6760016|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
6760017|NCT02073552|Laxatives|laxatives|mesh-ancestor
6760018|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6760019|NCT02073669|Interferons|interferons|mesh-list
6760020|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
6760021|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760022|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
6760023|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760024|NCT02073734|Dexamethasone|dexamethasone|mesh-list
6760025|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760026|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
6760027|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
6760028|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760029|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760030|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6760031|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
6760032|NCT02073734|Hormones|hormones|mesh-ancestor
6760033|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760034|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6760035|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788844|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788845|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6788846|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6788847|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
6788848|NCT02227550|Coagulants|coagulants|mesh-ancestor
6788849|NCT02227745|Dorzolamide|dorzolamide|mesh-list
6788850|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
6788851|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6788852|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
6788853|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788854|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
6788855|NCT02227745|Protective Agents|protective agents|mesh-ancestor
6788856|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6788857|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6788858|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788859|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788860|NCT02227797|Voriconazole|voriconazole|mesh-list
6788861|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
6788862|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788863|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6788864|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6788865|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760036|NCT02073773|Levodopa|levodopa|mesh-list
6760037|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6760038|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6760039|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
6760040|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760041|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760042|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760043|NCT02073838|Ribavirin|ribavirin|mesh-list
6760044|NCT02073838|Decitabine|decitabine|mesh-list
6760045|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
6760046|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760047|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
6760048|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760049|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6760050|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760051|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760052|NCT02073916|Paclitaxel|paclitaxel|mesh-list
6760053|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6760054|NCT02073916|Trastuzumab|trastuzumab|mesh-list
6760055|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6760056|NCT02073916|Lapatinib|lapatinib|mesh-list
6760057|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6760058|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760059|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
6760060|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
6760061|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
6760062|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760063|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6760064|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6760065|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760066|NCT02073994|Ivosidenib|ivosidenib|mesh-list
6760067|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760068|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760069|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760070|NCT02074137|Prednisone|prednisone|mesh-list
6760071|NCT02074137|Prednisolone|prednisolone|mesh-list
6760072|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760073|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
6760074|NCT02074137|Hormones|hormones|mesh-ancestor
6760075|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760076|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760077|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6760078|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760079|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6760080|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6760081|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6760082|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760083|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760084|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6760085|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6760086|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760087|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
6760088|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760089|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6760090|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6760091|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6760092|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760093|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760094|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6760095|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6760096|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760097|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
6760098|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760099|NCT02074189|Gemcitabine|gemcitabine|mesh-list
6760100|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760101|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6760102|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
6760103|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760104|NCT02074189|Antiviral Agents|antiviral agents|mesh-ancestor
6760105|NCT02074189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760106|NCT02074189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760107|NCT02074189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6760108|NCT02074189|Immunologic Factors|immunologic factors|mesh-ancestor
6760109|NCT02074189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760110|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6760111|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6760112|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760113|NCT02074228|Methylphenidate|methylphenidate|mesh-list
6760114|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6760115|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760116|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6760117|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6760118|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6760119|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760120|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
6760121|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760122|NCT02074267|Gabapentin|gabapentin|mesh-list
6760123|NCT02074267|Analgesics|analgesics|mesh-ancestor
6760124|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
6760125|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760126|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760127|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
6760128|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6760129|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6760130|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760131|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6760132|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6760133|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6760134|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760135|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760136|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
6760137|NCT02074280|Rifaximin|rifaximin|mesh-list
6760138|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6760139|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760140|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6760141|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6760142|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6760143|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6760144|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760145|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760146|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6760147|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6760148|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760149|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
6760150|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760151|NCT02074319|Methotrexate|methotrexate|mesh-list
6760152|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6760153|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
6760154|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6760155|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760156|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6760157|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
6760158|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760159|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760160|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
6760161|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760162|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6760163|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6760164|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
6760165|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6760166|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6760167|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
6760168|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6760169|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6760170|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760171|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
6760172|NCT02074436|Coagulants|coagulants|mesh-ancestor
6760173|NCT02074605|Interferons|interferons|mesh-list
6760174|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
6760175|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760176|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
6760177|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760178|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
6760179|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760180|NCT02074631|Vitamin D|vitamin d|mesh-list
6760181|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
6760182|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
6760183|NCT02074631|Pamidronate|pamidronate|mesh-list
6760184|NCT02074631|Calcium|calcium|mesh-list
6760185|NCT02074631|Vitamins|vitamins|mesh-ancestor
6760186|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
6760187|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760188|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6760189|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6760190|NCT02074800|Siltuximab|siltuximab|mesh-list
6760191|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6760192|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760193|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
6760194|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760195|NCT02074839|Ivosidenib|ivosidenib|mesh-list
6760196|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760197|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760198|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760199|NCT02074878|Sunitinib|sunitinib|mesh-list
6760200|NCT02074878|Crizotinib|crizotinib|mesh-list
6760201|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760202|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6760203|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6760204|NCT02074878|Growth Substances|growth substances|mesh-ancestor
6760205|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760206|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
6760207|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6760208|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760209|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760210|NCT02074891|Tenofovir|tenofovir|mesh-list
6760211|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
6760212|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760213|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6760214|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6760215|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760216|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760217|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6760218|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6760219|NCT02075034|ON 01910|on 01910|mesh-list
6760220|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760221|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6760222|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760223|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760224|NCT02075086|Bevacizumab|bevacizumab|mesh-list
6760225|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6760226|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760227|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6760228|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6760229|NCT02075086|Growth Substances|growth substances|mesh-ancestor
6760230|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760231|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
6760232|NCT02075112|Genistein|genistein|mesh-list
6760233|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760234|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6760235|NCT02075112|Protective Agents|protective agents|mesh-ancestor
6760236|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760237|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6760238|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760239|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760240|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
6760241|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6760242|NCT02075112|Estrogens|estrogens|mesh-ancestor
6760243|NCT02075112|Hormones|hormones|mesh-ancestor
6760244|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760245|NCT02075177|Ketoconazole|ketoconazole|mesh-list
6760246|NCT02075177|Fenretinide|fenretinide|mesh-list
6760247|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
6760248|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760249|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6760250|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6760251|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760252|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760253|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6760254|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
6760255|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760256|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760257|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6760258|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760259|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6760260|NCT02075177|Protective Agents|protective agents|mesh-ancestor
6760261|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
6760262|NCT02075242|Tacrolimus|tacrolimus|mesh-list
6760263|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6760264|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
6760265|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760266|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6760267|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760268|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760269|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6760270|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760271|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6760272|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
6760273|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6760274|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760275|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6760276|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6760277|NCT02075294|Entecavir|entecavir|mesh-list
6760278|NCT02075294|Adefovir|adefovir|mesh-list
6760279|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
6760280|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
6760281|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760282|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6760283|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6760284|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760285|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760286|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6788866|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788867|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6788868|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
6788869|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788870|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788871|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6788872|NCT02227823|Bromides|bromides|mesh-list
6788873|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6788874|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
6788875|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6788876|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788877|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788878|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
6788879|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788880|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788881|NCT02227901|Temozolomide|temozolomide|mesh-list
6788882|NCT02227901|Tipifarnib|tipifarnib|mesh-list
6788883|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6788884|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
6788885|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788886|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788887|NCT02227914|Sorafenib|sorafenib|mesh-list
6788888|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788889|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6788890|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788891|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788892|NCT02227927|Domperidone|domperidone|mesh-list
6788893|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
6788894|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
6788895|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788896|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788897|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6788898|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6788899|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
6788900|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788901|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788902|NCT02227940|Gemcitabine|gemcitabine|mesh-list
6788903|NCT02227940|Paclitaxel|paclitaxel|mesh-list
6788904|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6788905|NCT02227940|Cisplatin|cisplatin|mesh-list
6788906|NCT02227940|Ceritinib|ceritinib|mesh-list
6788907|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6788908|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788909|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
6788910|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
6788911|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
6760287|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6760288|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6760289|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6760290|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760291|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760292|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6760293|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6760294|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6760295|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
6760296|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760297|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760298|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6760299|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6760300|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
6760301|NCT02075619|Amlodipine|amlodipine|mesh-list
6760302|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6760303|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6760304|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6760305|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6760306|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760307|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6760308|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760309|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
6760310|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6760311|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6760312|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
6760313|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6760314|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6760315|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760316|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6760317|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6760318|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
6760319|NCT02075749|Triamcinolone|triamcinolone|mesh-list
6760320|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6760321|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6760322|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6760323|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760324|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
6760325|NCT02075749|Hormones|hormones|mesh-ancestor
6760326|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760327|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760328|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6760329|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
6760330|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760331|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760332|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
6760333|NCT02075970|Hematinics|hematinics|mesh-ancestor
6760334|NCT02076191|Decitabine|decitabine|mesh-list
6760335|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6760336|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
6760337|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760338|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760339|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760340|NCT02076217|Copper|copper|mesh-list
6760341|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6760342|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
6760343|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
6760344|NCT02076217|Etonogestrel|etonogestrel|mesh-list
6760345|NCT02076217|Desogestrel|desogestrel|mesh-list
6760346|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6760347|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760348|NCT02076217|Trace Elements|trace elements|mesh-ancestor
6760349|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
6760350|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6760351|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6760352|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6760353|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6760354|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6760355|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6760356|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6760357|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760358|NCT02076217|Progestins|progestins|mesh-ancestor
6760359|NCT02076217|Hormones|hormones|mesh-ancestor
6760360|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760361|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
6760362|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6760363|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
6760364|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760365|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760366|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
6760367|NCT02076373|Hematinics|hematinics|mesh-ancestor
6760368|NCT02076386|Dolutegravir|dolutegravir|mesh-list
6760369|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6760370|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6760371|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760372|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760373|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6760374|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6760375|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
6760376|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760377|NCT02076451|DS-8273a|ds-8273a|mesh-list
6760378|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6760379|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760380|NCT02076477|Docetaxel|docetaxel|mesh-list
6760381|NCT02076477|Pemetrexed|pemetrexed|mesh-list
6760382|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760383|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
6760384|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
6760385|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
6760386|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760387|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760388|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6760389|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6760390|NCT02076529|Ramosetron|ramosetron|mesh-list
6760391|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
6760392|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
6760393|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760394|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760395|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6760396|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6760397|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
6760398|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760399|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760400|NCT02076594|Docetaxel|docetaxel|mesh-list
6760401|NCT02076594|Capecitabine|capecitabine|mesh-list
6760402|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
6760403|NCT02076594|Epirubicin|epirubicin|mesh-list
6760404|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760405|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
6760406|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
6760407|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
6760408|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760409|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6760410|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
6760411|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6760412|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6760413|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6760414|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760415|NCT02076620|Doxorubicin|doxorubicin|mesh-list
6760416|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6760417|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760418|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6760419|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6760420|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760421|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760422|NCT02076646|Interleukin-2|interleukin-2|mesh-list
6760423|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760424|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6760425|NCT02076646|Analgesics|analgesics|mesh-ancestor
6760426|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
6760427|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760428|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760429|NCT02076659|Methotrexate|methotrexate|mesh-list
6760430|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6760431|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
6760432|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6760433|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760434|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6760435|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
6760436|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760437|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760438|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
6760439|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760440|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6760441|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6760442|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
6760443|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6760444|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6760445|NCT02076685|Isoniazid|isoniazid|mesh-list
6760446|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
6760447|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6760448|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760449|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6760450|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6760451|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
6760452|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760453|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6760454|NCT02076750|Vitamin D|vitamin d|mesh-list
6760455|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
6760456|NCT02076750|Vitamins|vitamins|mesh-ancestor
6760457|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
6760458|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760459|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6760460|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6760461|NCT02076815|Anagrelide|anagrelide|mesh-list
6760462|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6760463|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6760464|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760465|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6760466|NCT02076828|Zinc|zinc|mesh-list
6760467|NCT02076828|Glycine|glycine|mesh-list
6760468|NCT02076828|Trace Elements|trace elements|mesh-ancestor
6760469|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
6760470|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760471|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
6760472|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760473|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760474|NCT02076841|Interferons|interferons|mesh-list
6760475|NCT02076841|Interferon-beta|interferon-beta|mesh-list
6760476|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
6760477|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760478|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
6760479|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760480|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
6760481|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760482|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6760483|NCT02076893|Ibuprofen|ibuprofen|mesh-list
6760484|NCT02076893|Gabapentin|gabapentin|mesh-list
6760485|NCT02076893|Tramadol|tramadol|mesh-list
6760486|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6760487|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6760488|NCT02076893|Analgesics|analgesics|mesh-ancestor
6760489|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
6760490|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760491|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760492|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760493|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6760494|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6760495|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760496|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760497|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
6760498|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6760499|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6760500|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760501|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6760502|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6760503|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6760504|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760505|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
6760506|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6760507|NCT02076893|Narcotics|narcotics|mesh-ancestor
6760508|NCT02076945|Lidocaine|lidocaine|mesh-list
6760509|NCT02076945|Bupivacaine|bupivacaine|mesh-list
6760510|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
6760511|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
6760512|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760513|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760514|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
6760515|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760516|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6760517|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6760518|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6760519|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6760520|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760521|NCT02077010|Milrinone|milrinone|mesh-list
6760522|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6760523|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6760524|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
6760525|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6760526|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6760527|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760528|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760529|NCT02077010|Protective Agents|protective agents|mesh-ancestor
6760530|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788912|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788913|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6788914|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
6788915|NCT02227940|Antiviral Agents|antiviral agents|mesh-ancestor
6788916|NCT02227940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6788917|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6788918|NCT02227940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6788919|NCT02227940|Immunologic Factors|immunologic factors|mesh-ancestor
6788920|NCT02227940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788921|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6788922|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6788923|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
6788924|NCT02227992|Coagulants|coagulants|mesh-ancestor
6788925|NCT02228005|Sertraline|sertraline|mesh-list
6788926|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
6788927|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6788928|NCT02228005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6788929|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6788930|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6788931|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788932|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788933|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
6788934|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788935|NCT02228031|Oxytocin|oxytocin|mesh-list
6788936|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
6788937|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6788938|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788939|NCT02228083|Lidocaine|lidocaine|mesh-list
6788940|NCT02228083|Epinephrine|epinephrine|mesh-list
6788941|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
6788942|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
6788943|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788944|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788945|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
6788946|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788947|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6788948|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6788949|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6788950|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6788951|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788952|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6788953|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6788954|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
6788955|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788956|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6788957|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6788958|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
6788959|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6788960|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
6788961|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
6788962|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
6788963|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6788964|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6788965|NCT02228122|Laxatives|laxatives|mesh-ancestor
6788966|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6788967|NCT02228135|Dexamethasone|dexamethasone|mesh-list
6788968|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760531|NCT02077231|Vitamins|vitamins|mesh-list
6760532|NCT02077231|Vitamin A|vitamin a|mesh-list
6760533|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
6760534|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
6760535|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760536|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
6760537|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760538|NCT02077231|Protective Agents|protective agents|mesh-ancestor
6760539|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6760540|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760541|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6760542|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6760543|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6760544|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
6760545|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760546|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6760547|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6760548|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760549|NCT02077309|Linagliptin|linagliptin|mesh-list
6760550|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6760551|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760552|NCT02077309|Incretins|incretins|mesh-ancestor
6760553|NCT02077309|Hormones|hormones|mesh-ancestor
6760554|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760555|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6760556|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
6760557|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760558|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760559|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
6760560|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
6760561|NCT02077322|Coagulants|coagulants|mesh-ancestor
6760562|NCT02077348|Hormones|hormones|mesh-list
6760563|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760564|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760565|NCT02077400|Cefazolin|cefazolin|mesh-list
6760566|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6760567|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760568|NCT02077478|Remifentanil|remifentanil|mesh-list
6760569|NCT02077478|Propofol|propofol|mesh-list
6760570|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6760571|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760572|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760573|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6760574|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
6760575|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
6760576|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6760577|NCT02077478|Narcotics|narcotics|mesh-ancestor
6760578|NCT02077478|Analgesics|analgesics|mesh-ancestor
6760579|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
6760580|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760581|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
6760582|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
6760583|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6760584|NCT02077556|Prednisolone|prednisolone|mesh-list
6760585|NCT02077556|Everolimus|everolimus|mesh-list
6760586|NCT02077556|Tacrolimus|tacrolimus|mesh-list
6760587|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6760588|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
6760589|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760590|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6760591|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760592|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760593|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760594|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6760595|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6760596|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
6760597|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6760598|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760599|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760600|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
6760601|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
6760602|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760603|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6760604|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
6760605|NCT02077556|Hormones|hormones|mesh-ancestor
6760606|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760607|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6760608|NCT02077556|Protective Agents|protective agents|mesh-ancestor
6760609|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6760610|NCT02077634|Prednisone|prednisone|mesh-list
6760611|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
6760612|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760613|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
6760614|NCT02077634|Hormones|hormones|mesh-ancestor
6760615|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760616|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760617|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6760618|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760619|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6760620|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760621|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760622|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
6760623|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6760624|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
6760625|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6760626|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760627|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760628|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6760629|NCT02077712|Analgesics|analgesics|mesh-ancestor
6760630|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
6760631|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760632|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6760633|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6760634|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6760635|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
6760636|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760637|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760638|NCT02077751|Biotin|biotin|mesh-list
6760639|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
6760640|NCT02077751|Vitamins|vitamins|mesh-ancestor
6760641|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
6760642|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760643|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6760644|NCT02077777|Mesalamine|mesalamine|mesh-list
6760645|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6760646|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6760647|NCT02077777|Analgesics|analgesics|mesh-ancestor
6760648|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
6760649|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760650|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760651|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760652|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6760653|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
6760654|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6760655|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760656|NCT02077803|Metformin|metformin|mesh-list
6760657|NCT02077803|Canagliflozin|canagliflozin|mesh-list
6760658|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6760659|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760660|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6760661|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760662|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
6760663|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6760664|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760665|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
6760666|NCT02077933|Everolimus|everolimus|mesh-list
6760667|NCT02077933|Exemestane|exemestane|mesh-list
6760668|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760669|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6760670|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
6760671|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760672|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6760673|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6760674|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760675|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760676|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6760677|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
6760678|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760679|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6760680|NCT02077946|Liraglutide|liraglutide|mesh-list
6760681|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6760682|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760683|NCT02077946|Incretins|incretins|mesh-ancestor
6760684|NCT02077946|Hormones|hormones|mesh-ancestor
6760685|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760686|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6760687|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
6760688|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760689|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760690|NCT02077959|Lenalidomide|lenalidomide|mesh-list
6760691|NCT02077959|Pidilizumab|pidilizumab|mesh-list
6760692|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
6760693|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760694|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6760695|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6760696|NCT02077959|Growth Substances|growth substances|mesh-ancestor
6760697|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
6760698|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760699|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6760700|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
6760701|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760702|NCT02078063|Mepivacaine|mepivacaine|mesh-list
6760703|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
6760704|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
6760705|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760706|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760707|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
6760708|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760709|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
6760710|NCT02078089|Morphine|morphine|mesh-list
6760711|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6760712|NCT02078089|Narcotics|narcotics|mesh-ancestor
6760713|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760714|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760715|NCT02078089|Analgesics|analgesics|mesh-ancestor
6760716|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
6760717|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760718|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
6760719|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6760720|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6760721|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6760722|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760723|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6760724|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6760725|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
6760726|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
6760727|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760728|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
6760729|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760730|NCT02078167|Policosanol|policosanol|mesh-list
6760731|NCT02078167|Red yeast rice|red yeast rice|mesh-list
6760732|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6760733|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6760734|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6760735|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
6760736|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760737|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760738|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6760739|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6760740|NCT02078232|Pancrelipase|pancrelipase|mesh-list
6760741|NCT02078232|Pancreatin|pancreatin|mesh-list
6760742|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6760743|NCT02078323|Linaclotide|linaclotide|mesh-list
6760744|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6760745|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
6760746|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760747|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6760748|NCT02078336|Atropine|atropine|mesh-list
6760749|NCT02078336|Midazolam|midazolam|mesh-list
6760750|NCT02078336|Droperidol|droperidol|mesh-list
6760751|NCT02078336|Lorazepam|lorazepam|mesh-list
6760752|NCT02078336|Biperiden|biperiden|mesh-list
6760753|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6760754|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6760755|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760756|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760757|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6760758|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6760759|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6760760|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6760761|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
6760762|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
6760763|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
6760764|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
6760765|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760766|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760767|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6760768|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6760769|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
6760770|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760771|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6760772|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
6760773|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
6760774|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
6760775|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6760776|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6760777|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
6760778|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
6760779|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
6760780|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6760781|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6760782|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6760783|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6760784|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6760785|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6760786|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
6760787|NCT02078388|Doxorubicin|doxorubicin|mesh-list
6760788|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6760789|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760790|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6760791|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6760792|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760793|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760794|NCT02078440|Bromocriptine|bromocriptine|mesh-list
6760795|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6760796|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6760797|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
6760798|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760799|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760800|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
6760801|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
6760802|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760803|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760804|NCT02078583|Fentanyl|fentanyl|mesh-list
6760805|NCT02078583|Remifentanil|remifentanil|mesh-list
6760806|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6760807|NCT02078583|Narcotics|narcotics|mesh-ancestor
6760808|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760809|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760810|NCT02078583|Analgesics|analgesics|mesh-ancestor
6760811|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
6760812|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760813|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6760814|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6760815|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
6760816|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
6788969|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
6788970|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
6788971|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6788972|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788973|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6788974|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
6788975|NCT02228135|Hormones|hormones|mesh-ancestor
6788976|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6788977|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6788978|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6788979|NCT02228239|Mirtazapine|mirtazapine|mesh-list
6788980|NCT02228239|Esketamine|esketamine|mesh-list
6788981|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
6788982|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6788983|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6788984|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
6788985|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
6788986|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6788987|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6788988|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6788989|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6788990|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6788991|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6788992|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6788993|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6788994|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6788995|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
6788996|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6788997|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6788998|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
6788999|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6789000|NCT02228252|Caseins|caseins|mesh-list
6760817|NCT02078596|Valproic Acid|valproic acid|mesh-list
6760818|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
6760819|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760820|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760821|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
6760822|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760823|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760824|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
6760825|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6760826|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760827|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6760828|NCT02078609|Midostaurin|midostaurin|mesh-list
6760829|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760830|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6760831|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760832|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760833|NCT02078648|Poly I-C|poly i-c|mesh-list
6760834|NCT02078648|Bevacizumab|bevacizumab|mesh-list
6760835|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6760836|NCT02078648|Poly ICLC|poly iclc|mesh-list
6760837|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6760838|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760839|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6760840|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6760841|NCT02078648|Growth Substances|growth substances|mesh-ancestor
6760842|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760843|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
6760844|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
6760845|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
6760846|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
6760847|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760848|NCT02078648|Laxatives|laxatives|mesh-ancestor
6760849|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6760850|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6760851|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6760852|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6760853|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760854|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760855|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6760856|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6760857|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760858|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
6760859|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760860|NCT02078869|Progesterone|progesterone|mesh-list
6760861|NCT02078869|Progestins|progestins|mesh-ancestor
6760862|NCT02078869|Hormones|hormones|mesh-ancestor
6760863|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760864|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760865|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
6760866|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6760867|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6760868|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6760869|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6760870|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760871|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
6760872|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6760873|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760874|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6760875|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760876|NCT02078973|Tolvaptan|tolvaptan|mesh-list
6760877|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6760878|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760879|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
6760880|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760881|NCT02079064|Propofol|propofol|mesh-list
6760882|NCT02079064|Desflurane|desflurane|mesh-list
6760883|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6760884|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6760885|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760886|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6760887|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
6760888|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
6760889|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6760890|NCT02079181|Fluorides|fluorides|mesh-list
6760891|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
6760892|NCT02079181|Protective Agents|protective agents|mesh-ancestor
6760893|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760894|NCT02079194|Aspirin|aspirin|mesh-list
6760895|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6760896|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6760897|NCT02079194|Analgesics|analgesics|mesh-ancestor
6760898|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
6760899|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760900|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760901|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760902|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6760903|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6760904|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6760905|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760906|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6760907|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6760908|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760909|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
6760910|NCT02079220|Capecitabine|capecitabine|mesh-list
6760911|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
6760912|NCT02079220|Aflibercept|aflibercept|mesh-list
6760913|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6760914|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
6760915|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760916|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6760917|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6760918|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6760919|NCT02079220|Growth Substances|growth substances|mesh-ancestor
6760920|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760921|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
6760922|NCT02079298|Fluconazole|fluconazole|mesh-list
6760923|NCT02079298|Ibuprofen|ibuprofen|mesh-list
6760924|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6760925|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6760926|NCT02079298|Analgesics|analgesics|mesh-ancestor
6760927|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
6760928|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760929|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760930|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760931|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6760932|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6760933|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760934|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760935|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
6760936|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6760937|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6760938|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6760939|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6760940|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
6760941|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6760942|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6760943|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6760944|NCT02079337|Rocuronium|rocuronium|mesh-list
6760945|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6760946|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6760947|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6760948|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760949|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760950|NCT02079350|Polygeline|polygeline|mesh-list
6760951|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
6760952|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
6760953|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
6760954|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6760955|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
6760956|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760957|NCT02079506|Candesartan|candesartan|mesh-list
6760958|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6760959|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6760960|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6760961|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
6760962|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760963|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6760964|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6760965|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760966|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6760967|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6760968|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6760969|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6760970|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
6760971|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760972|NCT02079558|Oxytocin|oxytocin|mesh-list
6760973|NCT02079558|Carbetocin|carbetocin|mesh-list
6760974|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
6760975|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6760976|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760977|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6760978|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
6760979|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760980|NCT02079727|Celecoxib|celecoxib|mesh-list
6760981|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6760982|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6760983|NCT02079727|Analgesics|analgesics|mesh-ancestor
6760984|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
6760985|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6760986|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760987|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6760988|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6760989|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6760990|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6760991|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6760992|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6760993|NCT02079961|Micronutrients|micronutrients|mesh-list
6760994|NCT02079961|Trace Elements|trace elements|mesh-list
6760995|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6760996|NCT02079974|Pravastatin|pravastatin|mesh-list
6760997|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6760998|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6760999|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
6761000|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761001|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6761002|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6761003|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761004|NCT02080026|Chloroquine|chloroquine|mesh-list
6761005|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6761006|NCT02080026|Atovaquone|atovaquone|mesh-list
6761007|NCT02080026|Proguanil|proguanil|mesh-list
6761008|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6761009|NCT02080026|Vaccines|vaccines|mesh-list
6761010|NCT02080026|Amebicides|amebicides|mesh-ancestor
6761011|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6761012|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6761013|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761014|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
6761015|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6761016|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6761017|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6761018|NCT02080026|Analgesics|analgesics|mesh-ancestor
6761019|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
6761020|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761021|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761022|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6761023|NCT02080026|Filaricides|filaricides|mesh-ancestor
6761024|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
6761025|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
6761026|NCT02080026|Immunologic Factors|immunologic factors|mesh-ancestor
6761027|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761028|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761029|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
6761030|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6761031|NCT02080078|Theophylline|theophylline|mesh-list
6761032|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761033|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6761034|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761035|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761036|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6761037|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
6761038|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761039|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761040|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6761041|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
6761042|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6761043|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
6761044|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6761045|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6761046|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
6761047|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761048|NCT02080104|Oxytocin|oxytocin|mesh-list
6761049|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
6761050|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6761051|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761052|NCT02080169|Fentanyl|fentanyl|mesh-list
6761053|NCT02080169|Midazolam|midazolam|mesh-list
6761054|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
6761055|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6761056|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761057|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761058|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6761059|NCT02080169|Analgesics|analgesics|mesh-ancestor
6761060|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
6761061|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761062|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6761063|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6761064|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6761065|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
6761066|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761067|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761068|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6761069|NCT02080169|Narcotics|narcotics|mesh-ancestor
6761070|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6761071|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6761072|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
6761073|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
6761074|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6761075|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6761076|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6761077|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
6761078|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
6761079|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
6761080|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6761081|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
6761082|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761083|NCT02080182|Expectorants|expectorants|mesh-ancestor
6761084|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
6761085|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6761086|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
6761087|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761088|NCT02080182|Protective Agents|protective agents|mesh-ancestor
6761089|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761090|NCT02080182|Antidotes|antidotes|mesh-ancestor
6761091|NCT02080234|Gemcitabine|gemcitabine|mesh-list
6761092|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
6761093|NCT02080234|Asparaginase|asparaginase|mesh-list
6761094|NCT02080234|Pegaspargase|pegaspargase|mesh-list
6761095|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6761096|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
6761097|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761098|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761099|NCT02080234|Antiviral Agents|antiviral agents|mesh-ancestor
6761100|NCT02080234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761101|NCT02080234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761102|NCT02080234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6761103|NCT02080234|Immunologic Factors|immunologic factors|mesh-ancestor
6761104|NCT02080234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789001|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
6789002|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
6761105|NCT02080377|Glyburide|glyburide|mesh-list
6761106|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6761107|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761108|NCT02080416|Nelfinavir|nelfinavir|mesh-list
6761109|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6761110|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6761111|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
6761112|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761113|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761114|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6761115|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6761116|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
6761117|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761118|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
6761119|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6761120|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6761121|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761122|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
6761123|NCT02080494|Coagulants|coagulants|mesh-ancestor
6761124|NCT02080624|Sirolimus|sirolimus|mesh-list
6761125|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6761126|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761127|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6761128|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761129|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
6761130|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6761131|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
6761132|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761133|NCT02080715|Tolcapone|tolcapone|mesh-list
6761134|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6761135|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6761136|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6761137|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761138|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761139|NCT02080728|Ropivacaine|ropivacaine|mesh-list
6761140|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
6761141|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
6761142|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761143|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761144|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
6761145|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761146|NCT02080845|Theobromine|theobromine|mesh-list
6761147|NCT02080845|Caffeine|caffeine|mesh-list
6761148|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6761149|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761150|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6761151|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761152|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761153|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6761154|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6761155|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
6761156|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761157|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6761158|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
6761159|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761160|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6761161|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
6761162|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
6761163|NCT02080858|Apixaban|apixaban|mesh-list
6761164|NCT02080858|Ticagrelor|ticagrelor|mesh-list
6761165|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6761166|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6761167|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6761168|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6761169|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
6761170|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761171|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761172|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761173|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6761174|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
6761175|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6761176|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
6761177|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761178|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
6761179|NCT02081027|Riluzole|riluzole|mesh-list
6761180|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
6761181|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6761182|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6761183|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761184|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761185|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761186|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6761187|NCT02081027|Protective Agents|protective agents|mesh-ancestor
6761188|NCT02081144|Nicotine|nicotine|mesh-list
6761189|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6761190|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
6761191|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761192|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761193|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6761194|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6761195|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
6761196|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761197|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761198|NCT02081287|Inositol|inositol|mesh-list
6761199|NCT02081287|Lamotrigine|lamotrigine|mesh-list
6761200|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
6761201|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6761202|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6761203|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761204|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6761205|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761206|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6761207|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6761208|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761209|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6761210|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6761211|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
6761212|NCT02081287|Vitamins|vitamins|mesh-ancestor
6761213|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
6761214|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
6761215|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6761216|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
6761217|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761218|NCT02081339|Ranibizumab|ranibizumab|mesh-list
6761219|NCT02081339|Aflibercept|aflibercept|mesh-list
6761220|NCT02081339|Verteporfin|verteporfin|mesh-list
6761221|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6761222|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6761223|NCT02081339|Growth Substances|growth substances|mesh-ancestor
6761224|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761225|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
6761226|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761227|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6761228|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
6761229|NCT02081391|Tapentadol|tapentadol|mesh-list
6761230|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6761231|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6761232|NCT02081391|Narcotics|narcotics|mesh-ancestor
6761233|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761234|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761235|NCT02081391|Analgesics|analgesics|mesh-ancestor
6761236|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
6761237|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761238|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6761239|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6761240|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6761241|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761242|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
6761243|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761244|NCT02081404|Esomeprazole|esomeprazole|mesh-list
6761245|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6761246|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6761247|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6761248|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761249|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761250|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6761251|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6761252|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761253|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6761254|NCT02081495|Doxorubicin|doxorubicin|mesh-list
6761255|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6761256|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761257|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6761258|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6761259|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761260|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761261|NCT02081560|Colistin|colistin|mesh-list
6761262|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6761263|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761264|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
6761265|NCT02081755|Everolimus|everolimus|mesh-list
6761266|NCT02081755|Azathioprine|azathioprine|mesh-list
6761267|NCT02081755|Tacrolimus|tacrolimus|mesh-list
6761268|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6761269|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
6761270|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761271|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6761272|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761273|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761274|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761275|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6761276|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6761277|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
6761278|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6761279|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761280|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
6761281|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6761282|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6761283|NCT02081885|Chitosan|chitosan|mesh-list
6761284|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6761285|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6761286|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
6761287|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761288|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6761289|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
6761290|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
6761291|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
6761292|NCT02081885|Coagulants|coagulants|mesh-ancestor
6761293|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
6761294|NCT02082054|Atropine|atropine|mesh-list
6761295|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
6761296|NCT02082054|Ephedrine|ephedrine|mesh-list
6761297|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6761298|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6761299|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6761300|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
6761301|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761302|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761303|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6761304|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
6761305|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
6761306|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
6761307|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6761308|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6761309|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
6761310|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761311|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761312|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
6761313|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6761314|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6761315|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
6761316|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
6761317|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
6761318|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
6761319|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6761320|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
6761321|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
6761322|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6761323|NCT02082067|Ketorolac|ketorolac|mesh-list
6761324|NCT02082067|Morphine|morphine|mesh-list
6761325|NCT02082067|Anesthetics|anesthetics|mesh-list
6761326|NCT02082067|Ropivacaine|ropivacaine|mesh-list
6761327|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
6761328|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
6761329|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761330|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761331|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6761332|NCT02082067|Narcotics|narcotics|mesh-ancestor
6761333|NCT02082067|Analgesics|analgesics|mesh-ancestor
6761334|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
6761335|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761336|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6761337|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6761338|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6761339|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6761340|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6761341|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761342|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789003|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789004|NCT02228369|Osimertinib|osimertinib|mesh-list
6789005|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789006|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6789007|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789008|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789009|NCT02228473|Atropine|atropine|mesh-list
6789010|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
6789011|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6789012|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6789013|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6789014|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
6789015|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789016|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789017|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6789018|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
6789019|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
6789020|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
6789021|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6789022|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6789023|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
6789024|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789025|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789026|NCT02228512|Prednisone|prednisone|mesh-list
6789027|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
6789028|NCT02228512|Rituximab|rituximab|mesh-list
6789029|NCT02228512|Doxorubicin|doxorubicin|mesh-list
6789030|NCT02228512|Etoposide|etoposide|mesh-list
6789031|NCT02228512|Vincristine|vincristine|mesh-list
6789032|NCT02228512|Pomalidomide|pomalidomide|mesh-list
6789033|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6789034|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
6789035|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789036|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6789037|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6789038|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
6789039|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789040|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789041|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6789042|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6789043|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6789044|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6789045|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6789046|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789047|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6789048|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
6789049|NCT02228512|Hormones|hormones|mesh-ancestor
6789050|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6789051|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6789052|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6789053|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
6789054|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
6789055|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
6789056|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6789057|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6789058|NCT02228512|Growth Substances|growth substances|mesh-ancestor
6789059|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
6761343|NCT02082236|Sufentanil|sufentanil|mesh-list
6761344|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6761345|NCT02082236|Narcotics|narcotics|mesh-ancestor
6761346|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761347|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761348|NCT02082236|Analgesics|analgesics|mesh-ancestor
6761349|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
6761350|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761351|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6761352|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6761353|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
6761354|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
6761355|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
6761356|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
6761357|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761358|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761359|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761360|NCT02082405|Dexamethasone|dexamethasone|mesh-list
6761361|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
6761362|NCT02082405|Bortezomib|bortezomib|mesh-list
6761363|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6761364|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
6761365|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761366|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6761367|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6761368|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
6761369|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761370|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761371|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6761372|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6761373|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
6761374|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
6761375|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761376|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6761377|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
6761378|NCT02082405|Hormones|hormones|mesh-ancestor
6761379|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6761380|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6761381|NCT02082418|Caseins|caseins|mesh-list
6761382|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
6761383|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
6761384|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761385|NCT02082496|Liraglutide|liraglutide|mesh-list
6761386|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6761387|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761388|NCT02082496|Incretins|incretins|mesh-ancestor
6761389|NCT02082496|Hormones|hormones|mesh-ancestor
6761390|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6761391|NCT02082613|Polidocanol|polidocanol|mesh-list
6761392|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6761393|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6761394|NCT02082652|Etonogestrel|etonogestrel|mesh-list
6761395|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6761396|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
6761397|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6761398|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761399|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6761400|NCT02082665|Dabrafenib|dabrafenib|mesh-list
6761401|NCT02082665|Midazolam|midazolam|mesh-list
6761402|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6761403|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6761404|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6761405|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761406|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761407|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6761408|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6761409|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6761410|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6761411|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
6761412|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
6761413|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
6761414|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
6761415|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761416|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761417|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6761418|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6761419|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
6761420|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6761421|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6761422|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761423|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761424|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6761425|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
6761426|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
6761427|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6761428|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761429|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761430|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6761431|NCT02083055|Analgesics|analgesics|mesh-ancestor
6761432|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
6761433|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761434|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6761435|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6761436|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6761437|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
6761438|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761439|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761440|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
6761441|NCT02083068|Vaccines|vaccines|mesh-list
6761442|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
6761443|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761444|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
6761445|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6761446|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761447|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
6761448|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6761449|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761450|NCT02083276|Renal Agents|renal agents|mesh-ancestor
6761451|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6761452|NCT02083315|Morphine|morphine|mesh-list
6761453|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6761454|NCT02083315|Narcotics|narcotics|mesh-ancestor
6761455|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761456|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761457|NCT02083315|Analgesics|analgesics|mesh-ancestor
6761458|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
6761459|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761460|NCT02083328|Mannitol|mannitol|mesh-list
6761461|NCT02083328|Caffeine|caffeine|mesh-list
6761462|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6761463|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761464|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6761465|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761466|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761467|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6761468|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6761469|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
6761470|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761471|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6761472|NCT02083328|Diuretics|diuretics|mesh-ancestor
6761473|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
6761474|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
6761475|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6761476|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761477|NCT02083510|Colchicine|colchicine|mesh-list
6761478|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
6761479|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6761480|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
6761481|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
6761482|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
6761483|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761484|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761485|NCT02083536|Docetaxel|docetaxel|mesh-list
6761486|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761487|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
6761488|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
6761489|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
6761490|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761491|NCT02083575|Vitamins|vitamins|mesh-list
6761492|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
6761493|NCT02083575|Deferiprone|deferiprone|mesh-list
6761494|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
6761495|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761496|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
6761497|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761498|NCT02083575|Protective Agents|protective agents|mesh-ancestor
6761499|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6761500|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
6761501|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
6761502|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
6761503|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6761504|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6761505|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6761506|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
6761507|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761508|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6761509|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6761510|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761511|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6761512|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761513|NCT02083640|Palbociclib|palbociclib|mesh-list
6761514|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761515|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6761516|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761517|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761518|NCT02083692|Metformin|metformin|mesh-list
6761519|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6761520|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789060|NCT02228616|Lactulose|lactulose|mesh-list
6789061|NCT02228616|Prucalopride|prucalopride|mesh-list
6789062|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789063|NCT02228616|Laxatives|laxatives|mesh-ancestor
6789064|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
6789065|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6789066|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
6789067|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789068|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789069|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789070|NCT02228772|Cytarabine|cytarabine|mesh-list
6789071|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
6789072|NCT02228772|Doxorubicin|doxorubicin|mesh-list
6789073|NCT02228772|Methotrexate|methotrexate|mesh-list
6789074|NCT02228772|Vincristine|vincristine|mesh-list
6789075|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
6789076|NCT02228772|Ixazomib|ixazomib|mesh-list
6789077|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6789078|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
6789079|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789080|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6789081|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6789082|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
6789083|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789084|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789085|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6789086|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6789087|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6789088|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6789089|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789090|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6789091|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
6789092|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6789093|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6789094|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
6789095|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
6789096|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6789097|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6789098|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
6789099|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789100|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6789101|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
6789102|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
6789103|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
6789104|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
6789105|NCT02228850|Alprostadil|alprostadil|mesh-list
6789106|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6789107|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
6789108|NCT02228850|Urological Agents|urological agents|mesh-ancestor
6789109|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6761521|NCT02083874|Cannabidiol|cannabidiol|mesh-list
6761522|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
6761523|NCT02083991|Prednisolone|prednisolone|mesh-list
6761524|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
6761525|NCT02083991|Basiliximab|basiliximab|mesh-list
6761526|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6761527|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
6761528|NCT02083991|Hormones|hormones|mesh-ancestor
6761529|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6761530|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761531|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6761532|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761533|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
6761534|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6761535|NCT02084043|Amikacin|amikacin|mesh-list
6761536|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6761537|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761538|NCT02084225|Lidocaine|lidocaine|mesh-list
6761539|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
6761540|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
6761541|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761542|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761543|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
6761544|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761545|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6761546|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6761547|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6761548|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6761549|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761550|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6761551|NCT02084303|Hematinics|hematinics|mesh-ancestor
6761552|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6761553|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6761554|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6761555|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
6761556|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6761557|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6761558|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761559|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
6761560|NCT02084342|Coagulants|coagulants|mesh-ancestor
6761561|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6761562|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
6761563|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761564|NCT02084355|Fentanyl|fentanyl|mesh-list
6761565|NCT02084355|Oxycodone|oxycodone|mesh-list
6761566|NCT02084355|Hydromorphone|hydromorphone|mesh-list
6761567|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6761568|NCT02084355|Narcotics|narcotics|mesh-ancestor
6761569|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761570|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761571|NCT02084355|Analgesics|analgesics|mesh-ancestor
6761572|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
6761573|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761574|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6761575|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6761576|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
6761577|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
6761578|NCT02084368|Bupivacaine|bupivacaine|mesh-list
6761579|NCT02084368|Ropivacaine|ropivacaine|mesh-list
6761580|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
6761581|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
6761582|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761583|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761584|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
6761585|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761586|NCT02084420|Pantoprazole|pantoprazole|mesh-list
6761587|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6761588|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6761589|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6761590|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761591|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761592|NCT02084433|Anesthetics|anesthetics|mesh-list
6761593|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761594|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761595|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
6761596|NCT02084446|Prednisone|prednisone|mesh-list
6761597|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
6761598|NCT02084446|Everolimus|everolimus|mesh-list
6761599|NCT02084446|Tacrolimus|tacrolimus|mesh-list
6761600|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
6761601|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6761602|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6761603|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
6761604|NCT02084446|Hormones|hormones|mesh-ancestor
6761605|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6761606|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761607|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6761608|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761609|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6761610|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
6761611|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6761612|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789110|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6761613|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761614|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6761615|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6761616|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
6761617|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6761618|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761619|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
6761620|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
6761621|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761622|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6761623|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6761624|NCT02084446|Protective Agents|protective agents|mesh-ancestor
6761625|NCT02084472|Petrolatum|petrolatum|mesh-list
6761626|NCT02084472|Mineral Oil|mineral oil|mesh-list
6761627|NCT02084472|Glycerol|glycerol|mesh-list
6761628|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6761629|NCT02084472|Protective Agents|protective agents|mesh-ancestor
6761630|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761631|NCT02084472|Emollients|emollients|mesh-ancestor
6761632|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
6761633|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
6761634|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6761635|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6761636|NCT02084563|Cytarabine|cytarabine|mesh-list
6761637|NCT02084563|Decitabine|decitabine|mesh-list
6761638|NCT02084563|Daunorubicin|daunorubicin|mesh-list
6761639|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6761640|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
6761641|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761642|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761643|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
6761644|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761645|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6761646|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
6761647|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761648|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6761649|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6761650|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6761651|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761652|NCT02084576|Ketorolac|ketorolac|mesh-list
6761653|NCT02084576|Nepafenac|nepafenac|mesh-list
6761654|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6761655|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6761656|NCT02084576|Analgesics|analgesics|mesh-ancestor
6761657|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
6761658|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761659|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761660|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6761661|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6761662|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6761663|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761664|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761665|NCT02084589|Fentanyl|fentanyl|mesh-list
6761666|NCT02084589|Ropivacaine|ropivacaine|mesh-list
6761667|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
6761668|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
6761669|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761670|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761671|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
6761672|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761673|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6761674|NCT02084589|Narcotics|narcotics|mesh-ancestor
6761675|NCT02084589|Analgesics|analgesics|mesh-ancestor
6761676|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6761677|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6761678|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
6761679|NCT02084602|Artesunate|artesunate|mesh-list
6761680|NCT02084602|Mefloquine|mefloquine|mesh-list
6761681|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
6761682|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6761683|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6761684|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761685|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761686|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
6761687|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
6761688|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6761689|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
6761690|NCT02084615|Aspirin|aspirin|mesh-list
6761691|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6761692|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6761693|NCT02084615|Analgesics|analgesics|mesh-ancestor
6761694|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
6761695|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761696|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761697|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6761698|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6761699|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6761700|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6761701|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761702|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6761703|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6761704|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761705|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
6761706|NCT02084654|Exenatide|exenatide|mesh-list
6761707|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6761708|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761709|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6761710|NCT02084654|Incretins|incretins|mesh-ancestor
6761711|NCT02084654|Hormones|hormones|mesh-ancestor
6761712|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6761713|NCT02084719|Antibodies|antibodies|mesh-list
6761714|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
6761715|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761716|NCT02084732|Sorafenib|sorafenib|mesh-list
6761717|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761718|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6761719|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761720|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761721|NCT02084784|Methylene Blue|methylene blue|mesh-list
6761722|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761723|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761724|NCT02084875|Tofacitinib|tofacitinib|mesh-list
6761725|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6761726|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761727|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761728|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
6761729|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6761730|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761731|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6761732|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6761733|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761734|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761735|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761736|NCT02085005|Capecitabine|capecitabine|mesh-list
6761737|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
6761738|NCT02085005|Aflibercept|aflibercept|mesh-list
6761739|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6761740|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
6761741|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761742|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761743|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6761744|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6761745|NCT02085005|Growth Substances|growth substances|mesh-ancestor
6761746|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761747|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
6761748|NCT02085018|Omeprazole|omeprazole|mesh-list
6761749|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6761750|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6761751|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6761752|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761753|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761754|NCT02085109|Theobromine|theobromine|mesh-list
6761755|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6761756|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
6761757|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761758|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761759|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6761760|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
6761761|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
6761762|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
6761763|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
6761764|NCT02085239|Lidocaine|lidocaine|mesh-list
6761765|NCT02085239|Ropivacaine|ropivacaine|mesh-list
6761766|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
6761767|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
6761768|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761769|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761770|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
6761771|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761772|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6761773|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6761774|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6761775|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6761776|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761777|NCT02085265|Telmisartan|telmisartan|mesh-list
6761778|NCT02085265|Perindopril|perindopril|mesh-list
6761779|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6761780|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6761781|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6761782|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761783|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6761784|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
6761785|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761786|NCT02085291|Norepinephrine|norepinephrine|mesh-list
6761787|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6761788|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6761789|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
6761790|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761791|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761792|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761793|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
6761794|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
6761795|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761796|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6761797|NCT02085304|Temozolomide|temozolomide|mesh-list
6761798|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6761799|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
6761800|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761801|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761802|NCT02085317|Nitroprusside|nitroprusside|mesh-list
6761803|NCT02085317|Acetylcholine|acetylcholine|mesh-list
6761804|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6761805|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
6761806|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6761807|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761808|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6761809|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
6761810|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761811|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789111|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6789112|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789113|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789114|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6789115|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789116|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789117|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
6789118|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789119|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
6789120|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
6789121|NCT02228902|Trace Elements|trace elements|mesh-ancestor
6789122|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
6789123|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789124|NCT02228902|Hematinics|hematinics|mesh-ancestor
6789125|NCT02228928|Capsaicin|capsaicin|mesh-list
6789126|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
6789127|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
6789128|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
6789129|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789130|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789131|NCT02229045|Paclitaxel|paclitaxel|mesh-list
6789132|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6789133|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6789134|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789135|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
6789136|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
6789137|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
6761812|NCT02085408|Cytarabine|cytarabine|mesh-list
6761813|NCT02085408|Decitabine|decitabine|mesh-list
6761814|NCT02085408|Clofarabine|clofarabine|mesh-list
6761815|NCT02085408|Azacitidine|azacitidine|mesh-list
6761816|NCT02085408|Daunorubicin|daunorubicin|mesh-list
6761817|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6761818|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
6761819|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761820|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761821|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
6761822|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761823|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6761824|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
6761825|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761826|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6761827|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6761828|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6761829|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761830|NCT02085538|Palbociclib|palbociclib|mesh-list
6761831|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761832|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6761833|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761834|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761835|NCT02085577|Acetaminophen|acetaminophen|mesh-list
6761836|NCT02085577|Sufentanil|sufentanil|mesh-list
6761837|NCT02085577|Morphine|morphine|mesh-list
6761838|NCT02085577|Dsuvia|dsuvia|mesh-list
6761839|NCT02085577|Ketamine|ketamine|mesh-list
6761840|NCT02085577|Ondansetron|ondansetron|mesh-list
6761841|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6761842|NCT02085577|Narcotics|narcotics|mesh-ancestor
6761843|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761844|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761845|NCT02085577|Analgesics|analgesics|mesh-ancestor
6761846|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
6761847|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761848|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6761849|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6761850|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
6761851|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
6761852|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6761853|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6761854|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761855|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761856|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6761857|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
6761858|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
6761859|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
6761860|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6761861|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
6761862|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
6761863|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6761864|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
6761865|NCT02085577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6761866|NCT02085577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6761867|NCT02085577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6761868|NCT02085577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6761869|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6761870|NCT02085590|Vaccines|vaccines|mesh-list
6761871|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
6761872|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
6761873|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761874|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6761875|NCT02085603|Saracatinib|saracatinib|mesh-list
6761876|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761877|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761878|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761879|NCT02085655|Gemcitabine|gemcitabine|mesh-list
6761880|NCT02085655|Thalidomide|thalidomide|mesh-list
6761881|NCT02085655|Dexamethasone|dexamethasone|mesh-list
6761882|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
6761883|NCT02085655|Methotrexate|methotrexate|mesh-list
6761884|NCT02085655|Pegaspargase|pegaspargase|mesh-list
6761885|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6761886|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
6761887|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
6761888|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761889|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761890|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6761891|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
6761892|NCT02085655|Hormones|hormones|mesh-ancestor
6761893|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6761894|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6761895|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6761896|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6761897|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
6761898|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761899|NCT02085655|Antiviral Agents|antiviral agents|mesh-ancestor
6761900|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761901|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761902|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6761903|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
6761904|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6761905|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
6761906|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6761907|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
6761908|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6761909|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6761910|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6761911|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
6761912|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6761913|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6761914|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6761915|NCT02085655|Growth Substances|growth substances|mesh-ancestor
6761916|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
6761917|NCT02085824|Enoxaparin|enoxaparin|mesh-list
6761918|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
6761919|NCT02085824|Dabigatran|dabigatran|mesh-list
6761920|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6761921|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
6761922|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6761923|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
6761924|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761925|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761926|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
6761927|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6761928|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6761929|NCT02085902|Ropivacaine|ropivacaine|mesh-list
6761930|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
6761931|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
6761932|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761933|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761934|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
6761935|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761936|NCT02085967|Itraconazole|itraconazole|mesh-list
6761937|NCT02085967|Rifampin|rifampin|mesh-list
6761938|NCT02085967|Midazolam|midazolam|mesh-list
6761939|NCT02085967|Bupropion|bupropion|mesh-list
6761940|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6761941|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6761942|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6761943|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761944|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6761945|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6761946|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6761947|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6761948|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
6761949|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
6761950|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
6761951|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
6761952|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6761953|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6761954|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6761955|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
6761956|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6761957|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6761958|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6761959|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
6761960|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6761961|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6761962|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6761963|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
6761964|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6761965|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6761966|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6761967|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
6761968|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6761969|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6761970|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6761971|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
6761972|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6761973|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
6761974|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6761975|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6761976|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6761977|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6761978|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6761979|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6761980|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6761981|NCT02086019|Aspirin|aspirin|mesh-list
6761982|NCT02086019|Ramipril|ramipril|mesh-list
6761983|NCT02086019|Bisoprolol|bisoprolol|mesh-list
6761984|NCT02086019|Heparin|heparin|mesh-list
6761985|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6761986|NCT02086019|Tinzaparin|tinzaparin|mesh-list
6761987|NCT02086019|Dalteparin|dalteparin|mesh-list
6761988|NCT02086019|Clopidogrel|clopidogrel|mesh-list
6761989|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6761990|NCT02086019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6761991|NCT02086019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6761992|NCT02086019|Analgesics|analgesics|mesh-ancestor
6761993|NCT02086019|Sensory System Agents|sensory system agents|mesh-ancestor
6761994|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6761995|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6761996|NCT02086019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6761997|NCT02086019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6761998|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6761999|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6762000|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762001|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6762002|NCT02086019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6762003|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762004|NCT02086019|Antipyretics|antipyretics|mesh-ancestor
6762005|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6762006|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6762007|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6762008|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
6762009|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762010|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
6762011|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
6762012|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6762013|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6762014|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6762015|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
6762016|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
6762017|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
6762018|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6762019|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6762020|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6762021|NCT02086032|Estradiol|estradiol|mesh-list
6762022|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6762023|NCT02086032|Estrogens|estrogens|mesh-list
6762024|NCT02086032|Progesterone|progesterone|mesh-list
6762025|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
6762026|NCT02086032|Hormones|hormones|mesh-ancestor
6762027|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762028|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762029|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6762030|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
6762031|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6762032|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6762033|NCT02086032|Progestins|progestins|mesh-ancestor
6762034|NCT02086097|Ibuprofen|ibuprofen|mesh-list
6762035|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6762036|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6762037|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6762038|NCT02086097|Analgesics|analgesics|mesh-ancestor
6762039|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
6762040|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762041|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762042|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6762043|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6762044|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6762045|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762046|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762047|NCT02086188|Mirabegron|mirabegron|mesh-list
6762048|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6762049|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6762050|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6762051|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
6762052|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762053|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762054|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762055|NCT02086188|Urological Agents|urological agents|mesh-ancestor
6762056|NCT02086227|Glucagon|glucagon|mesh-list
6762057|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6762058|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762059|NCT02086227|Hormones|hormones|mesh-ancestor
6762060|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762061|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762062|NCT02086227|Incretins|incretins|mesh-ancestor
6762063|NCT02086253|BQ 788|bq 788|mesh-list
6762064|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6762065|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6762066|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762067|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6762068|NCT02086279|Hormones|hormones|mesh-list
6762069|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762070|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762071|NCT02086292|Lidocaine|lidocaine|mesh-list
6762072|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
6762073|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
6762074|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762075|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762076|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
6762077|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762078|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6762079|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6762080|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6762081|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6762082|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762083|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
6762084|NCT02086409|Vitamin D|vitamin d|mesh-list
6762085|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
6762086|NCT02086409|Vitamins|vitamins|mesh-list
6762087|NCT02086409|Calcium|calcium|mesh-list
6762088|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
6762089|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762090|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6762091|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6762092|NCT02086474|Bupivacaine|bupivacaine|mesh-list
6762093|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
6762094|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
6762095|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
6762096|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762097|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762098|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
6762099|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762100|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6762101|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
6762102|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
6762103|NCT02086474|Protective Agents|protective agents|mesh-ancestor
6762104|NCT02086526|Metformin|metformin|mesh-list
6762105|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6762106|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762107|NCT02086656|Bevacizumab|bevacizumab|mesh-list
6762108|NCT02086656|Capecitabine|capecitabine|mesh-list
6762109|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
6762110|NCT02086656|Irinotecan|irinotecan|mesh-list
6762111|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6762112|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762113|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6762114|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6762115|NCT02086656|Growth Substances|growth substances|mesh-ancestor
6762116|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762117|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
6762118|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6762119|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
6762120|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762121|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6762122|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6762123|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762124|NCT02086747|Acetaminophen|acetaminophen|mesh-list
6762125|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6762126|NCT02086747|Analgesics|analgesics|mesh-ancestor
6762127|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
6762128|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762129|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762130|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
6762131|NCT02086825|Rifaximin|rifaximin|mesh-list
6762132|NCT02086825|Lactulose|lactulose|mesh-list
6762133|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6762134|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762135|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762136|NCT02086838|Dextrans|dextrans|mesh-list
6762137|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
6762138|NCT02086838|Hematinics|hematinics|mesh-list
6762139|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
6762140|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
6762141|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
6762142|NCT02086903|Clopidogrel|clopidogrel|mesh-list
6762143|NCT02086903|Ticagrelor|ticagrelor|mesh-list
6762144|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6762145|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6762146|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6762147|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6762148|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
6762149|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762150|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762151|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762152|NCT02086929|Trazodone|trazodone|mesh-list
6762153|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6762154|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6762155|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6762156|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6762157|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762158|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762159|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762160|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6762161|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
6762162|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6762163|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6762164|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6762165|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762166|NCT02086929|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6762167|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
6762168|NCT02086942|Dexamethasone|dexamethasone|mesh-list
6762169|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
6762170|NCT02086942|Bortezomib|bortezomib|mesh-list
6762171|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6762172|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
6762173|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762174|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6762175|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6762176|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
6762177|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762178|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762179|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6762180|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6762181|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
6762182|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
6762183|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762184|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762185|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
6762186|NCT02086942|Hormones|hormones|mesh-ancestor
6762187|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762188|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6762189|NCT02086994|Misoprostol|misoprostol|mesh-list
6762190|NCT02086994|Carbetocin|carbetocin|mesh-list
6762191|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6762192|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
6762193|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6762194|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762195|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6762196|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762197|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
6762198|NCT02087007|Cilostazol|cilostazol|mesh-list
6762199|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6762200|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
6762201|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762202|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762203|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6762204|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
6762205|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6762206|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6762207|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762208|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6762209|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
6762210|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6762211|NCT02087007|Protective Agents|protective agents|mesh-ancestor
6762212|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6762213|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6762214|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762215|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6762216|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762217|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
6762218|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6762219|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6762220|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
6762221|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762222|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762223|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762224|NCT02087098|Urological Agents|urological agents|mesh-ancestor
6762225|NCT02087111|Interferons|interferons|mesh-list
6762226|NCT02087111|Ribavirin|ribavirin|mesh-list
6762227|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
6762228|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
6762229|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6762230|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762231|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
6762232|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762233|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
6762234|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762235|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
6762236|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762237|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
6762238|NCT02087202|Ketamine|ketamine|mesh-list
6762239|NCT02087202|Analgesics|analgesics|mesh-ancestor
6762240|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
6762241|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762242|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762243|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6762244|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6762245|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
6762246|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
6762247|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762248|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6762249|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6762250|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762251|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762252|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6762253|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
6762254|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6762255|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6762256|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6762257|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
6762258|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6762259|NCT02087215|Boron|boron|mesh-list
6762260|NCT02087215|Trace Elements|trace elements|mesh-ancestor
6762261|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
6762262|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762263|NCT02087332|Torsemide|torsemide|mesh-list
6762264|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6762265|NCT02087332|Diuretics|diuretics|mesh-ancestor
6762266|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
6762267|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762268|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6762269|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6762270|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762271|NCT02087384|Vaccines|vaccines|mesh-list
6762272|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
6762273|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762274|NCT02087462|Vitamins|vitamins|mesh-list
6762275|NCT02087462|Thiamine|thiamine|mesh-list
6762276|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
6762277|NCT02087462|Diclofenac|diclofenac|mesh-list
6762278|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
6762279|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762280|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6762281|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6762282|NCT02087462|Analgesics|analgesics|mesh-ancestor
6762283|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
6762284|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762285|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6762286|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6762287|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6762288|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762289|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762290|NCT02087475|Fluorouracil|fluorouracil|mesh-list
6762291|NCT02087475|Irinotecan|irinotecan|mesh-list
6762292|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
6762293|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762294|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6762295|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762296|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6762297|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
6762298|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762299|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6762300|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6762301|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762302|NCT02087488|Eszopiclone|eszopiclone|mesh-list
6762303|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6762304|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762305|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762306|NCT02087527|Dexamethasone|dexamethasone|mesh-list
6762307|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6762308|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
6762309|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
6762310|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762311|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762312|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762313|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
6762314|NCT02087527|Hormones|hormones|mesh-ancestor
6762315|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762316|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6762317|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762318|NCT02087540|Telmisartan|telmisartan|mesh-list
6762319|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6762320|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6762321|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6762322|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
6762323|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762324|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6762325|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6762326|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762327|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6762328|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6762329|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6762330|NCT02087566|Linezolid|linezolid|mesh-list
6762331|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6762332|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762333|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6762334|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762335|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762336|NCT02087579|Olanzapine|olanzapine|mesh-list
6762337|NCT02087579|Risperidone|risperidone|mesh-list
6762338|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6762339|NCT02087579|Aripiprazole|aripiprazole|mesh-list
6762340|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6762341|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6762342|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
6762343|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762344|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762345|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762346|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6762347|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6762348|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762349|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6762350|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6762351|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
6762352|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
6762353|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
6762354|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762355|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762356|NCT02087579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6762357|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6762358|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6762359|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
6762360|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
6762361|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6762362|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6762363|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6762364|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6762365|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6762366|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
6762367|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6762368|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6762369|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6762370|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762371|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762372|NCT02087683|Vitamin D|vitamin d|mesh-list
6762373|NCT02087683|Vitamins|vitamins|mesh-ancestor
6762374|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
6762375|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762376|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6762377|NCT02087722|Melatonin|melatonin|mesh-list
6762378|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
6762379|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762380|NCT02087722|Protective Agents|protective agents|mesh-ancestor
6762381|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762382|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762383|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
6762384|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6762385|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6762386|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
6762387|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
6762388|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6762389|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
6762390|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
6762391|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762392|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762393|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762394|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
6762395|NCT02087813|Hormones|hormones|mesh-ancestor
6762396|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762397|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6762398|NCT02087813|Protective Agents|protective agents|mesh-ancestor
6762399|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6762400|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762401|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6762402|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6762403|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762404|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762405|NCT02087826|Metformin|metformin|mesh-list
6762406|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6762407|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762408|NCT02088008|Valsartan|valsartan|mesh-list
6762409|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6762410|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6762411|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6762412|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762413|NCT02088060|Cannabidiol|cannabidiol|mesh-list
6762414|NCT02088060|Olanzapine|olanzapine|mesh-list
6762415|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
6762416|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
6762417|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762418|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762419|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762420|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6762421|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6762422|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762423|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6762424|NCT02088060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6762425|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6762426|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6762427|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762428|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762429|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
6762430|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
6762431|NCT02088112|Durvalumab|durvalumab|mesh-list
6762432|NCT02088112|Gefitinib|gefitinib|mesh-list
6762433|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6762434|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762435|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6762436|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762437|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762438|NCT02088398|Ricolinostat|ricolinostat|mesh-list
6762439|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762440|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6762441|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762442|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762443|NCT02088411|Diclofenac|diclofenac|mesh-list
6762444|NCT02088411|Wobenzym|wobenzym|mesh-list
6762445|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6762446|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6762447|NCT02088411|Analgesics|analgesics|mesh-ancestor
6762448|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
6762449|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762450|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762451|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6762452|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6762453|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6762454|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762455|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762456|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6762457|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
6762458|NCT02088424|Insulin|insulin|mesh-list
6762459|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6762460|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762461|NCT02088450|Nitrendipine|nitrendipine|mesh-list
6762462|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6762463|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6762464|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6762465|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762466|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6762467|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762468|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
6762469|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
6762470|NCT02088502|Theophylline|theophylline|mesh-list
6762471|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6762472|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
6762473|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762474|NCT02088502|Expectorants|expectorants|mesh-ancestor
6762475|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
6762476|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6762477|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
6762478|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762479|NCT02088502|Protective Agents|protective agents|mesh-ancestor
6762480|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762481|NCT02088502|Antidotes|antidotes|mesh-ancestor
6762482|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6762483|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
6762484|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762485|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6762486|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6762487|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762488|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
6762489|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6762490|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6762491|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
6762492|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762493|NCT02088515|Docetaxel|docetaxel|mesh-list
6762494|NCT02088515|Nedaplatin|nedaplatin|mesh-list
6762495|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762496|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
6762497|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
6762498|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
6762499|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762500|NCT02088528|Mitomycins|mitomycins|mesh-list
6762501|NCT02088528|Mitomycin|mitomycin|mesh-list
6762502|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6762503|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762504|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
6762505|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762506|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6762507|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762508|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
6762509|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6762510|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762511|NCT02088671|Propofol|propofol|mesh-list
6762512|NCT02088671|Desflurane|desflurane|mesh-list
6762513|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6762514|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762515|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762516|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6762517|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
6762518|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
6762519|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6789138|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789139|NCT02229058|Paclitaxel|paclitaxel|mesh-list
6789140|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6789141|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6789142|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789143|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
6789144|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
6789145|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
6789146|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789147|NCT02229084|Paclitaxel|paclitaxel|mesh-list
6789148|NCT02229084|Docetaxel|docetaxel|mesh-list
6789149|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
6789150|NCT02229084|Doxorubicin|doxorubicin|mesh-list
6789151|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
6789152|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6789153|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789154|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
6789155|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
6789156|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
6789157|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789158|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6762520|NCT02088684|Fulvestrant|fulvestrant|mesh-list
6762521|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6762522|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762523|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6762524|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6762525|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
6762526|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762527|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762528|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
6762529|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
6762530|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
6762531|NCT02088866|Lidocaine|lidocaine|mesh-list
6762532|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
6762533|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
6762534|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762535|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762536|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
6762537|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762538|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6762539|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6762540|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6762541|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6762542|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762543|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
6762544|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6762545|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
6762546|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762547|NCT02088918|Metformin|metformin|mesh-list
6762548|NCT02088918|Nateglinide|nateglinide|mesh-list
6762549|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6762550|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762551|NCT02088944|Infliximab|infliximab|mesh-list
6762552|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
6762553|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762554|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6762555|NCT02088970|Riboflavin|riboflavin|mesh-list
6762556|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6762557|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762558|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
6762559|NCT02088970|Vitamins|vitamins|mesh-ancestor
6762560|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
6762561|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762562|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6762563|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
6762564|NCT02088983|Choline|choline|mesh-list
6762565|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
6762566|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
6762567|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6762568|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
6762569|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762570|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762571|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6762572|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
6762573|NCT02089048|Auranofin|auranofin|mesh-list
6762574|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6762575|NCT02089061|Atorvastatin|atorvastatin|mesh-list
6762576|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6762577|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6762578|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6762579|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
6762580|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762581|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6762582|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6762583|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762584|NCT02089126|Glimepiride|glimepiride|mesh-list
6762585|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6762586|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6762587|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762588|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6762589|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
6762590|NCT02089178|Remifentanil|remifentanil|mesh-list
6762591|NCT02089178|Anesthetics|anesthetics|mesh-list
6762592|NCT02089178|Propofol|propofol|mesh-list
6762593|NCT02089178|Sevoflurane|sevoflurane|mesh-list
6762594|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762595|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762596|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6762597|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6762598|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
6762599|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6762600|NCT02089178|Narcotics|narcotics|mesh-ancestor
6762601|NCT02089178|Analgesics|analgesics|mesh-ancestor
6762602|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
6762603|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762604|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6762605|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6762606|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
6762607|NCT02089204|Fluorides|fluorides|mesh-list
6762608|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
6762609|NCT02089204|Protective Agents|protective agents|mesh-ancestor
6762610|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762611|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
6762612|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762613|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
6762614|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762615|NCT02089256|Liraglutide|liraglutide|mesh-list
6762616|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6762617|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762618|NCT02089256|Incretins|incretins|mesh-ancestor
6762619|NCT02089256|Hormones|hormones|mesh-ancestor
6762620|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762621|NCT02089295|Oxycodone|oxycodone|mesh-list
6762622|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6762623|NCT02089295|Narcotics|narcotics|mesh-ancestor
6762624|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762625|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762626|NCT02089295|Analgesics|analgesics|mesh-ancestor
6762627|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
6762628|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762629|NCT02089308|Nicotine|nicotine|mesh-list
6762630|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6762631|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
6762632|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762633|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762634|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6762635|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6762636|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
6762637|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762638|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762639|NCT02089386|Tamoxifen|tamoxifen|mesh-list
6762640|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6762641|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
6762642|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762643|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762644|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6762645|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762646|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6762647|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6762648|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6762649|NCT02089399|Olmesartan|olmesartan|mesh-list
6762650|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6762651|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6762652|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6762653|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
6762654|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762655|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6762656|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6762657|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762658|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6762659|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6762660|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6762661|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6762662|NCT02089438|Saxagliptin|saxagliptin|mesh-list
6762663|NCT02089438|Vildagliptin|vildagliptin|mesh-list
6762664|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6762665|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762666|NCT02089438|Incretins|incretins|mesh-ancestor
6762667|NCT02089438|Hormones|hormones|mesh-ancestor
6762668|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762669|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6762670|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
6762671|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762672|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762673|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
6762674|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6762675|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762676|NCT02089503|Ranibizumab|ranibizumab|mesh-list
6762677|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6762678|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6762679|NCT02089503|Growth Substances|growth substances|mesh-ancestor
6762680|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762681|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
6762682|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762683|NCT02089529|Ibuprofen|ibuprofen|mesh-list
6762684|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6762685|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6762686|NCT02089529|Analgesics|analgesics|mesh-ancestor
6762687|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
6762688|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762689|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762690|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6762691|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6762692|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6762693|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762694|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762695|NCT02089542|Methylene Blue|methylene blue|mesh-list
6762696|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762697|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762698|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6762699|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6762700|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762701|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6762702|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762703|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762704|NCT02089633|BCT-100|bct-100|mesh-list
6762705|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762706|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
6762707|NCT02089685|Ipilimumab|ipilimumab|mesh-list
6762708|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6762709|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762710|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6762711|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762712|NCT02089763|BCT-100|bct-100|mesh-list
6762713|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762714|NCT02089841|Lumefantrine|lumefantrine|mesh-list
6762715|NCT02089841|Artemether|artemether|mesh-list
6762716|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6762717|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
6762718|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6762719|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6762720|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762721|NCT02089854|Toremifene|toremifene|mesh-list
6762722|NCT02089854|Anastrozole|anastrozole|mesh-list
6762723|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6762724|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762725|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6762726|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6762727|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762728|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762729|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6762730|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
6762731|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762732|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762733|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6762734|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6762735|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6762736|NCT02089867|Ezetimibe|ezetimibe|mesh-list
6762737|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6762738|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6762739|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
6762740|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762741|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6762742|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
6762743|NCT02089932|Bupivacaine|bupivacaine|mesh-list
6762744|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
6762745|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
6762746|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762747|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762748|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
6762749|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762750|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6762751|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6762752|NCT02089932|Analgesics|analgesics|mesh-ancestor
6762753|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6762754|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6762755|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6762756|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
6762757|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762758|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762759|NCT02090036|Lumefantrine|lumefantrine|mesh-list
6762760|NCT02090036|Artemether|artemether|mesh-list
6762761|NCT02090036|Primaquine|primaquine|mesh-list
6762762|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6762763|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
6762764|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6762765|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6762766|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762767|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6762768|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6762769|NCT02090153|Leucovorin|leucovorin|mesh-list
6762770|NCT02090153|Tegafur|tegafur|mesh-list
6762771|NCT02090153|Antidotes|antidotes|mesh-ancestor
6762772|NCT02090153|Protective Agents|protective agents|mesh-ancestor
6762773|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762774|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
6762775|NCT02090153|Vitamins|vitamins|mesh-ancestor
6762776|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
6762777|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6762778|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
6762779|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762780|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789159|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
6789160|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789161|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6789162|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6789163|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
6789164|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6789165|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6789166|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6789167|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6789168|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789169|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6789170|NCT02229123|Levetiracetam|levetiracetam|mesh-list
6789171|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
6789172|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
6789173|NCT02229175|Bevacizumab|bevacizumab|mesh-list
6789174|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6789175|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789176|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6789177|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6789178|NCT02229175|Growth Substances|growth substances|mesh-ancestor
6789179|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789180|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
6789181|NCT02229201|Propofol|propofol|mesh-list
6789182|NCT02229201|Sevoflurane|sevoflurane|mesh-list
6789183|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6789184|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6789185|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789186|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6789187|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
6789188|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
6789189|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6789190|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6789191|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
6789192|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6789193|NCT02229240|Incretins|incretins|mesh-ancestor
6789194|NCT02229240|Hormones|hormones|mesh-ancestor
6789195|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6789196|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789197|NCT02229266|Cytarabine|cytarabine|mesh-list
6789198|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6789199|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
6789200|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789201|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789202|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
6789203|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789204|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6789205|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
6789206|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789207|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
6789208|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6762781|NCT02090244|Teriparatide|teriparatide|mesh-list
6762782|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6762783|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762784|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6762785|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
6762786|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762787|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
6762788|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762789|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762790|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6762791|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
6762792|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6762793|NCT02090322|Bevacizumab|bevacizumab|mesh-list
6762794|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6762795|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762796|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6762797|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6762798|NCT02090322|Growth Substances|growth substances|mesh-ancestor
6762799|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762800|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
6762801|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6762802|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
6762803|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6762804|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
6762805|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762806|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
6762807|NCT02090400|Calcium|calcium|mesh-list
6762808|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6762809|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762810|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6762811|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6762812|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
6762813|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762814|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6762815|NCT02090439|Silodosin|silodosin|mesh-list
6762816|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6762817|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6762818|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6762819|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
6762820|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762821|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762822|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762823|NCT02090439|Urological Agents|urological agents|mesh-ancestor
6762824|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
6762825|NCT02090504|Oxazepam|oxazepam|mesh-list
6762826|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6762827|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6762828|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
6762829|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
6762830|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762831|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762832|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6762833|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6762834|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6762835|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6762836|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
6762837|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
6762838|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762839|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762840|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
6762841|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
6762842|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6762843|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
6762844|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6762845|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
6762846|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762847|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762848|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
6762849|NCT02090673|Exenatide|exenatide|mesh-list
6762850|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6762851|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762852|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6762853|NCT02090673|Incretins|incretins|mesh-ancestor
6762854|NCT02090673|Hormones|hormones|mesh-ancestor
6789209|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6762855|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762856|NCT02090738|Amoxicillin|amoxicillin|mesh-list
6762857|NCT02090738|Clarithromycin|clarithromycin|mesh-list
6762858|NCT02090738|Acetazolamide|acetazolamide|mesh-list
6762859|NCT02090738|Esomeprazole|esomeprazole|mesh-list
6762860|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6762861|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762862|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6762863|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762864|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6762865|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762866|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762867|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6762868|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6762869|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6762870|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
6762871|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6762872|NCT02090738|Diuretics|diuretics|mesh-ancestor
6762873|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
6762874|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762875|NCT02090790|Dexamethasone|dexamethasone|mesh-list
6762876|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
6762877|NCT02090790|BB 1101|bb 1101|mesh-list
6762878|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6762879|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
6762880|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
6762881|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762882|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762883|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6762884|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
6762885|NCT02090790|Hormones|hormones|mesh-ancestor
6762886|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6762887|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6762888|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762889|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
6762890|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762891|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762892|NCT02090829|Oxytocin|oxytocin|mesh-list
6762893|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
6762894|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6762895|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762896|NCT02090920|Nifedipine|nifedipine|mesh-list
6762897|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6762898|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6762899|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762900|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6762901|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762902|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
6762903|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
6762904|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6762905|NCT02090933|Celecoxib|celecoxib|mesh-list
6762906|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6762907|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6762908|NCT02090933|Analgesics|analgesics|mesh-ancestor
6762909|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
6762910|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762911|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762912|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6762913|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6762914|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6762915|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6762916|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762917|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762918|NCT02091063|Ricolinostat|ricolinostat|mesh-list
6762919|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762920|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6762921|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762922|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762923|NCT02091180|Mannitol|mannitol|mesh-list
6762924|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6762925|NCT02091180|Diuretics|diuretics|mesh-ancestor
6762926|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
6762927|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762928|NCT02091219|Vitamin D|vitamin d|mesh-list
6762929|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
6762930|NCT02091219|Calcifediol|calcifediol|mesh-list
6762931|NCT02091219|Vitamins|vitamins|mesh-ancestor
6762932|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
6762933|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762934|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6762935|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6762936|NCT02091297|Acetaminophen|acetaminophen|mesh-list
6762937|NCT02091297|Morphine|morphine|mesh-list
6762938|NCT02091297|Ropivacaine|ropivacaine|mesh-list
6762939|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6762940|NCT02091297|Narcotics|narcotics|mesh-ancestor
6762941|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762942|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762943|NCT02091297|Analgesics|analgesics|mesh-ancestor
6762944|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
6762945|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762946|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
6762947|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
6762948|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6762949|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
6762950|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
6762951|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6762952|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6762953|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6762954|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6762955|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6762956|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762957|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6762958|NCT02091336|Metformin|metformin|mesh-list
6762959|NCT02091336|Glyburide|glyburide|mesh-list
6762960|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6762961|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762962|NCT02091388|Risperidone|risperidone|mesh-list
6762963|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6762964|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
6762965|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6762966|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762967|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762968|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6762969|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6762970|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762971|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6762972|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6762973|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
6762974|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
6762975|NCT02091401|Analgesics|analgesics|mesh-ancestor
6762976|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
6762977|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6762978|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762979|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
6762980|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6762981|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6762982|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
6762983|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6762984|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6762985|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6762986|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6762987|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
6762988|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6762989|NCT02091492|Teriparatide|teriparatide|mesh-list
6762990|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6762991|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762992|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6762993|NCT02091505|Ranibizumab|ranibizumab|mesh-list
6762994|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6762995|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6762996|NCT02091505|Growth Substances|growth substances|mesh-ancestor
6762997|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6762998|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
6762999|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763000|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
6763001|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6763002|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
6763003|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763004|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
6763005|NCT02091674|Protective Agents|protective agents|mesh-ancestor
6763006|NCT02091817|Oxytocin|oxytocin|mesh-list
6763007|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
6763008|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6763009|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763010|NCT02091830|Acetaminophen|acetaminophen|mesh-list
6763011|NCT02091830|Cortisone|cortisone|mesh-list
6763012|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6763013|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6763014|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763015|NCT02091830|Analgesics|analgesics|mesh-ancestor
6763016|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
6763017|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763018|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763019|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
6763020|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763021|NCT02091908|Lactitol|lactitol|mesh-list
6763022|NCT02091908|Vaccines|vaccines|mesh-list
6763023|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
6763024|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763025|NCT02091908|Cathartics|cathartics|mesh-ancestor
6763026|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6763027|NCT02091973|Everolimus|everolimus|mesh-list
6763028|NCT02091973|Tacrolimus|tacrolimus|mesh-list
6763029|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6763030|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
6763031|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763032|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6763033|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763034|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763035|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763036|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6763037|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
6763038|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6763039|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763040|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763041|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763042|NCT02092012|Analgesics|analgesics|mesh-ancestor
6763043|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
6763044|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763045|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6763046|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6763047|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6763048|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
6763049|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763050|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763051|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6763052|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763053|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763054|NCT02092038|Temozolomide|temozolomide|mesh-list
6763055|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6763056|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
6763057|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763058|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789210|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789211|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
6789212|NCT02229292|Coagulants|coagulants|mesh-ancestor
6789213|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
6789214|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6789215|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789216|NCT02229578|Lidocaine|lidocaine|mesh-list
6789217|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
6789218|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
6789219|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6789220|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789221|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
6789222|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789223|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6789224|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6789225|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6789226|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789227|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789228|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
6789229|NCT02229617|Testosterone|testosterone|mesh-list
6789230|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
6789231|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
6763059|NCT02092142|Vaccines|vaccines|mesh-list
6763060|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
6763061|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763062|NCT02092363|Paclitaxel|paclitaxel|mesh-list
6763063|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6763064|NCT02092363|Carboplatin|carboplatin|mesh-list
6763065|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
6763066|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6763067|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763068|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
6763069|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
6763070|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
6763071|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763072|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
6763073|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763074|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
6763075|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6763076|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763077|NCT02092376|Vitamins|vitamins|mesh-ancestor
6763078|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
6763079|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6763080|NCT02092428|Adenosine|adenosine|mesh-list
6763081|NCT02092428|Regadenoson|regadenoson|mesh-list
6763082|NCT02092428|Analgesics|analgesics|mesh-ancestor
6763083|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
6763084|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763085|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763086|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6763087|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
6763088|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6763089|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
6763090|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
6763091|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763092|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763093|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
6763094|NCT02092506|Amoxicillin|amoxicillin|mesh-list
6763095|NCT02092506|Metronidazole|metronidazole|mesh-list
6763096|NCT02092506|Clarithromycin|clarithromycin|mesh-list
6763097|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6763098|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6763099|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763100|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6763101|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6763102|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6763103|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763104|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763105|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6763106|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6763107|NCT02092532|Aflibercept|aflibercept|mesh-list
6763108|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6763109|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6763110|NCT02092532|Growth Substances|growth substances|mesh-ancestor
6763111|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763112|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
6763113|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763114|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
6763115|NCT02092558|Cephalosporins|cephalosporins|mesh-list
6763116|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6763117|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763118|NCT02092558|Renal Agents|renal agents|mesh-ancestor
6763119|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6763120|NCT02092597|Exenatide|exenatide|mesh-list
6763121|NCT02092597|Linagliptin|linagliptin|mesh-list
6763122|NCT02092597|Gliclazide|gliclazide|mesh-list
6763123|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6763124|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763125|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6763126|NCT02092597|Incretins|incretins|mesh-ancestor
6763127|NCT02092597|Hormones|hormones|mesh-ancestor
6763128|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6763129|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6763130|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
6763131|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763132|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763133|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
6763134|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6763135|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763136|NCT02092701|Vitamins|vitamins|mesh-ancestor
6763137|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
6763138|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6763139|NCT02092766|Artesunate|artesunate|mesh-list
6763140|NCT02092766|Quinine|quinine|mesh-list
6763141|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
6763142|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6763143|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6763144|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763145|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763146|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
6763147|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
6763148|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6763149|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
6763150|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6763151|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763152|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6763153|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763154|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763155|NCT02092766|Analgesics|analgesics|mesh-ancestor
6763156|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
6763157|NCT02092818|Riociguat|riociguat|mesh-list
6763158|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
6763159|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763160|NCT02092896|Liraglutide|liraglutide|mesh-list
6763161|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6763162|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763163|NCT02092896|Incretins|incretins|mesh-ancestor
6763164|NCT02092896|Hormones|hormones|mesh-ancestor
6763165|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6763166|NCT02092974|Citalopram|citalopram|mesh-list
6763167|NCT02092974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6763168|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6763169|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6763170|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763171|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763172|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
6763173|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763174|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6763175|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
6763176|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6763177|NCT02093000|Bevacizumab|bevacizumab|mesh-list
6763178|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6763179|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763180|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6763181|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6763182|NCT02093000|Growth Substances|growth substances|mesh-ancestor
6763183|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763184|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
6763185|NCT02093091|Vitremer|vitremer|mesh-list
6763186|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
6763187|NCT02093091|Protective Agents|protective agents|mesh-ancestor
6763188|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763189|NCT02093143|Remifentanil|remifentanil|mesh-list
6763190|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6763191|NCT02093143|Narcotics|narcotics|mesh-ancestor
6763192|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763193|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763194|NCT02093143|Analgesics|analgesics|mesh-ancestor
6763195|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
6763196|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763197|NCT02093195|Bosentan|bosentan|mesh-list
6763198|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6763199|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6763200|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
6763201|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6763202|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6763203|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763204|NCT02093299|Clopidogrel|clopidogrel|mesh-list
6763205|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6763206|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6763207|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6763208|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6763209|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
6763210|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763211|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763212|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763213|NCT02093403|Decitabine|decitabine|mesh-list
6763214|NCT02093403|Azacitidine|azacitidine|mesh-list
6763215|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6763216|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
6763217|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763218|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763219|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763220|NCT02093533|Eculizumab|eculizumab|mesh-list
6763221|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6763222|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6763223|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
6763224|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763225|NCT02093585|Tenofovir|tenofovir|mesh-list
6763226|NCT02093585|Abacavir|abacavir|mesh-list
6763227|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
6763228|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763229|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6763230|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6763231|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763232|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763233|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6763234|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6763235|NCT02093598|Sirolimus|sirolimus|mesh-list
6763236|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6763237|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763238|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6763239|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763240|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
6763241|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6763242|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
6763243|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763244|NCT02093728|Itraconazole|itraconazole|mesh-list
6763245|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6763246|NCT02093728|Fluconazole|fluconazole|mesh-list
6763247|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
6763248|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763249|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6763250|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6763251|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763252|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763253|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6763254|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
6763255|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6763256|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763257|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6763258|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6763259|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6763260|NCT02093741|Factor VIII|factor viii|mesh-list
6763261|NCT02093741|Coagulants|coagulants|mesh-ancestor
6763262|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6763263|NCT02093845|Everolimus|everolimus|mesh-list
6763264|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763265|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6763266|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
6763267|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763268|NCT02093910|Dexamethasone|dexamethasone|mesh-list
6763269|NCT02093910|Bortezomib|bortezomib|mesh-list
6763270|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763271|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
6763272|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
6763273|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763274|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763275|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6763276|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
6763277|NCT02093910|Hormones|hormones|mesh-ancestor
6763278|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6763279|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6763280|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789232|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6789233|NCT02229617|Androgens|androgens|mesh-ancestor
6789234|NCT02229617|Hormones|hormones|mesh-ancestor
6789235|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6789236|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789237|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6789238|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789239|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
6789240|NCT02229656|Olaparib|olaparib|mesh-list
6789241|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6789242|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789243|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789244|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789245|NCT02229721|Oxytocin|oxytocin|mesh-list
6789246|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
6789247|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6789248|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789249|NCT02229734|Androgens|androgens|mesh-list
6789250|NCT02229734|Hormones|hormones|mesh-ancestor
6789251|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6789252|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789253|NCT02229747|Diclofenac|diclofenac|mesh-list
6789254|NCT02229747|Meloxicam|meloxicam|mesh-list
6789255|NCT02229747|Nimesulide|nimesulide|mesh-list
6789256|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6789257|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6789258|NCT02229747|Analgesics|analgesics|mesh-ancestor
6789259|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
6789260|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789261|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789262|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6789263|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6789264|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6789265|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789266|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789267|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6789268|NCT02229760|Ritonavir|ritonavir|mesh-list
6789269|NCT02229760|Tipranavir|tipranavir|mesh-list
6789270|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6789271|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6789272|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
6789273|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789274|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789275|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6789276|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6789277|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
6789278|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789279|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6789280|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6789281|NCT02229773|Pravastatin|pravastatin|mesh-list
6789282|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6789283|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6789284|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
6763281|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6763282|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6763283|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763284|NCT02094053|Donepezil|donepezil|mesh-list
6763285|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6763286|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763287|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763288|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
6763289|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763290|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763291|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
6763292|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
6763293|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6763294|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6763295|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763296|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
6763297|NCT02094066|Coagulants|coagulants|mesh-ancestor
6763298|NCT02094157|Heparin|heparin|mesh-list
6763299|NCT02094157|Calcium heparin|calcium heparin|mesh-list
6763300|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6763301|NCT02094157|Tinzaparin|tinzaparin|mesh-list
6763302|NCT02094157|Dalteparin|dalteparin|mesh-list
6763303|NCT02094157|Warfarin|warfarin|mesh-list
6763304|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
6763305|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6763306|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6763307|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763308|NCT02094196|Ethanol|ethanol|mesh-list
6763309|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6763310|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763311|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763312|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763313|NCT02094222|Glycerol|glycerol|mesh-list
6763314|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6763315|NCT02094222|Protective Agents|protective agents|mesh-ancestor
6763316|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763317|NCT02094274|Fluticasone|fluticasone|mesh-list
6763318|NCT02094274|Xhance|xhance|mesh-list
6763319|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6763320|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763321|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6763322|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
6763323|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763324|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763325|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6763326|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
6763327|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
6763328|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6763329|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6763330|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6763331|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6763332|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
6763333|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763334|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763335|NCT02094287|Dimethindene|dimethindene|mesh-list
6763336|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
6763337|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
6763338|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6763339|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
6763340|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
6763341|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763342|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763343|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763344|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6763345|NCT02094313|Atorvastatin|atorvastatin|mesh-list
6763346|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
6763347|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6763348|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
6763349|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763350|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6763351|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6763352|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763353|NCT02094339|Analgesics|analgesics|mesh-list
6763354|NCT02094339|Ropivacaine|ropivacaine|mesh-list
6763355|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
6763356|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
6763357|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763358|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763359|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
6763360|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763361|NCT02094378|Esketamine|esketamine|mesh-list
6763362|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
6763363|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6763364|NCT02094391|Ipilimumab|ipilimumab|mesh-list
6763365|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6763366|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763367|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6763368|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763369|NCT02094469|Cilostazol|cilostazol|mesh-list
6763370|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6763371|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
6763372|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763373|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763374|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6763375|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
6763376|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6763377|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6763378|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763379|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6763380|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
6763381|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6763382|NCT02094469|Protective Agents|protective agents|mesh-ancestor
6763383|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6763384|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6763385|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763386|NCT02094599|Dronabinol|dronabinol|mesh-list
6763387|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
6763388|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763389|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6763390|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763391|NCT02094599|Analgesics|analgesics|mesh-ancestor
6763392|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
6763393|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763394|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6763395|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6763396|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763397|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763398|NCT02094599|Hormones|hormones|mesh-ancestor
6763399|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6763400|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
6763401|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6763402|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
6763403|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763404|NCT02094625|Expectorants|expectorants|mesh-ancestor
6763405|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
6763406|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6763407|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
6763408|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763409|NCT02094625|Protective Agents|protective agents|mesh-ancestor
6763410|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763411|NCT02094625|Antidotes|antidotes|mesh-ancestor
6763412|NCT02094651|Valproic Acid|valproic acid|mesh-list
6763413|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
6763414|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763415|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763416|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
6763417|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763418|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763419|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
6763420|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6763421|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763422|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6763423|NCT02094703|Levofloxacin|levofloxacin|mesh-list
6763424|NCT02094703|Ofloxacin|ofloxacin|mesh-list
6763425|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
6763426|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6763427|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763428|NCT02094703|Renal Agents|renal agents|mesh-ancestor
6763429|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6763430|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6763431|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6763432|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763433|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763434|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763435|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6763436|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6763437|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6763438|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6763439|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
6763440|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763441|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763442|NCT02094703|Urological Agents|urological agents|mesh-ancestor
6763443|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
6763444|NCT02094794|Etoposide|etoposide|mesh-list
6763445|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
6763446|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6763447|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
6763448|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763449|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763450|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6763451|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
6763452|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763453|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763454|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6763455|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6763456|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6763457|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6763458|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763459|NCT02094807|Acetaminophen|acetaminophen|mesh-list
6763460|NCT02094807|Diclofenac|diclofenac|mesh-list
6763461|NCT02094807|Oxycodone|oxycodone|mesh-list
6763462|NCT02094807|Tramadol|tramadol|mesh-list
6763463|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763464|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763465|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763466|NCT02094807|Analgesics|analgesics|mesh-ancestor
6763467|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
6763468|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763469|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
6763470|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6763471|NCT02094807|Narcotics|narcotics|mesh-ancestor
6763472|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6763473|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763474|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763475|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6763476|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763477|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763478|NCT02094833|Vaccines|vaccines|mesh-list
6763479|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
6763480|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763481|NCT02094924|Candesartan|candesartan|mesh-list
6763482|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
6763483|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6763484|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6763485|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6763486|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763487|NCT02094963|Clopidogrel|clopidogrel|mesh-list
6763488|NCT02094963|Ticagrelor|ticagrelor|mesh-list
6763489|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6763490|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6763491|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6763492|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6763493|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
6763494|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763495|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763496|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763497|NCT02095054|Cetuximab|cetuximab|mesh-list
6763498|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6763499|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763500|NCT02095119|Gemcitabine|gemcitabine|mesh-list
6763501|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
6763502|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763503|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6763504|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
6763505|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763506|NCT02095119|Antiviral Agents|antiviral agents|mesh-ancestor
6763507|NCT02095119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763508|NCT02095119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763509|NCT02095119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6763510|NCT02095119|Immunologic Factors|immunologic factors|mesh-ancestor
6763511|NCT02095119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763512|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6763513|NCT02095132|Irinotecan|irinotecan|mesh-list
6763514|NCT02095132|Camptothecin|camptothecin|mesh-list
6763515|NCT02095132|Adavosertib|adavosertib|mesh-list
6763516|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6763517|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6763518|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763519|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763520|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763521|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6763522|NCT02095184|Letrozole|letrozole|mesh-list
6763523|NCT02095184|Anastrozole|anastrozole|mesh-list
6763524|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763525|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6763526|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6763527|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763528|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763529|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6763530|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
6763531|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6763532|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763533|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6763534|NCT02095314|Vaccines|vaccines|mesh-list
6763535|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
6763536|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763537|NCT02095366|Sufentanil|sufentanil|mesh-list
6763538|NCT02095366|Morphine|morphine|mesh-list
6763539|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6763540|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6763541|NCT02095366|Narcotics|narcotics|mesh-ancestor
6763542|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763543|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763544|NCT02095366|Analgesics|analgesics|mesh-ancestor
6763545|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
6763546|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763547|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6763548|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6763549|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
6763550|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
6763551|NCT02095405|Caffeine|caffeine|mesh-list
6763552|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6763553|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763554|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6763555|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763556|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763557|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6763558|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6763559|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
6763560|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763561|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
6763562|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6763563|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763564|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6763565|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
6763566|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6763567|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763568|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763569|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763570|NCT02095509|Enoxaparin|enoxaparin|mesh-list
6763571|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
6763572|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6763573|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6763574|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763575|NCT02095522|Colchicine|colchicine|mesh-list
6763576|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
6763577|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763578|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
6763579|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
6763580|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
6763581|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763582|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763583|NCT02095548|Lorecivivint|lorecivivint|mesh-list
6763584|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763585|NCT02095574|Venetoclax|venetoclax|mesh-list
6763586|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763587|NCT02095665|Acetaminophen|acetaminophen|mesh-list
6763588|NCT02095665|Tamsulosin|tamsulosin|mesh-list
6763589|NCT02095665|Mirabegron|mirabegron|mesh-list
6763590|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763591|NCT02095665|Analgesics|analgesics|mesh-ancestor
6763592|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
6763593|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763594|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763595|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
6763596|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6763597|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6763598|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6763599|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
6763600|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763601|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763602|NCT02095665|Urological Agents|urological agents|mesh-ancestor
6763603|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6763604|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6763605|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6763606|NCT02095704|Acetaminophen|acetaminophen|mesh-list
6763607|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763608|NCT02095704|Analgesics|analgesics|mesh-ancestor
6763609|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
6763610|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763611|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763612|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
6789285|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789286|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6789287|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6789288|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789289|NCT02229786|Acetaminophen|acetaminophen|mesh-list
6789290|NCT02229786|Scopolamine|scopolamine|mesh-list
6789291|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6789292|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6789293|NCT02229786|Analgesics|analgesics|mesh-ancestor
6789294|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
6789295|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789296|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789297|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
6789298|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
6789299|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
6789300|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6789301|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6789302|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
6789303|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789304|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789305|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6789306|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
6789307|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789308|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
6789309|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6789310|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6789311|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6789312|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789313|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6789314|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6789315|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6789316|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789317|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6789318|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6789319|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6789320|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789321|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789322|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789323|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789324|NCT02229825|Analgesics|analgesics|mesh-ancestor
6789325|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
6789326|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789327|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
6789328|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6789329|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
6789330|NCT02229877|Omeprazole|omeprazole|mesh-list
6789331|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6789332|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789333|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6789334|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789335|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789336|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6789337|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6789338|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6789339|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789340|NCT02229942|Rituximab|rituximab|mesh-list
6789341|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6789342|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789343|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
6789344|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789345|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6789346|NCT02229955|Cyclosporine|cyclosporine|mesh-list
6763613|NCT02095717|Curcumin|curcumin|mesh-list
6763614|NCT02095717|Docetaxel|docetaxel|mesh-list
6763615|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763616|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
6763617|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
6763618|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
6763619|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763620|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6763621|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763622|NCT02095717|Analgesics|analgesics|mesh-ancestor
6763623|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
6763624|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763625|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763626|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763627|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763628|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763629|NCT02095730|Vitamins|vitamins|mesh-list
6763630|NCT02095730|Riboflavin|riboflavin|mesh-list
6763631|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
6763632|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
6763633|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763634|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6763635|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
6763636|NCT02095782|Paclitaxel|paclitaxel|mesh-list
6763637|NCT02095782|Carboplatin|carboplatin|mesh-list
6763638|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6763639|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6763640|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763641|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
6763642|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
6763643|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
6763644|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763645|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6763646|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763647|NCT02095834|Dexamethasone|dexamethasone|mesh-list
6763648|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
6763649|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6763650|NCT02095834|Ichthammol|ichthammol|mesh-list
6763651|NCT02095834|BB 1101|bb 1101|mesh-list
6763652|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763653|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
6763654|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
6763655|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763656|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763657|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6763658|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
6763659|NCT02095834|Hormones|hormones|mesh-ancestor
6763660|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6763661|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6763662|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763663|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6763664|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
6763665|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763666|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
6763667|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763668|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
6763669|NCT02095847|Proflavine|proflavine|mesh-list
6763670|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6763671|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763672|NCT02095886|BMS-955176|bms-955176|mesh-list
6763673|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6763674|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6763675|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
6763676|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763677|NCT02095899|Rufinamide|rufinamide|mesh-list
6763678|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
6763679|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6763680|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6763681|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6763682|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763683|NCT02095938|Amisulpride|amisulpride|mesh-list
6763684|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6763685|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6763686|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763687|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763688|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6763689|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6763690|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
6763691|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763692|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763693|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6763694|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
6763695|NCT02095990|Hydroquinone|hydroquinone|mesh-list
6763696|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
6763697|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763698|NCT02095990|Protective Agents|protective agents|mesh-ancestor
6763699|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763700|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6763701|NCT02096055|Idarubicin|idarubicin|mesh-list
6763702|NCT02096055|Cladribine|cladribine|mesh-list
6763703|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
6763704|NCT02096055|Guadecitabine|guadecitabine|mesh-list
6763705|NCT02096055|Azacitidine|azacitidine|mesh-list
6763706|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6763707|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763708|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6763709|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6763710|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763711|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763712|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6763713|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
6763714|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763715|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6763716|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
6763717|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
6763718|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6763719|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763720|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763721|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763722|NCT02096068|Analgesics|analgesics|mesh-ancestor
6763723|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
6763724|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763725|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6763726|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6763727|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6763728|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
6763729|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763730|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763731|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
6763732|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6763733|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763734|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
6763735|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
6763736|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6763737|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763738|NCT02096133|Vitamins|vitamins|mesh-ancestor
6763739|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
6763740|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6763741|NCT02096159|Trimethoprim|trimethoprim|mesh-list
6763742|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6763743|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
6763744|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6763745|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763746|NCT02096159|Renal Agents|renal agents|mesh-ancestor
6763747|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
6763748|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6763749|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6763750|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6763751|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763752|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763753|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6763754|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6763755|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6763756|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6763757|NCT02096224|Sevoflurane|sevoflurane|mesh-list
6763758|NCT02096224|Desflurane|desflurane|mesh-list
6763759|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6763760|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6763761|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
6763762|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
6763763|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763764|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763765|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
6763766|NCT02096250|Edetic Acid|edetic acid|mesh-list
6763767|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
6763768|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
6763769|NCT02096250|Trace Elements|trace elements|mesh-ancestor
6763770|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
6763771|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763772|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6763773|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
6763774|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
6763775|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763776|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
6763777|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6763778|NCT02096250|Hematinics|hematinics|mesh-ancestor
6763779|NCT02096289|Thioridazine|thioridazine|mesh-list
6763780|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6763781|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6763782|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763783|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763784|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6763785|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6763786|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
6763787|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763788|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763789|NCT02096315|Murepavadin|murepavadin|mesh-list
6763790|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6763791|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763792|NCT02096328|Murepavadin|murepavadin|mesh-list
6763793|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6763794|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763795|NCT02096354|Irinotecan|irinotecan|mesh-list
6763796|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763797|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6763798|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6763799|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763800|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763801|NCT02096380|Cisplatin|cisplatin|mesh-list
6763802|NCT02096380|Docetaxel|docetaxel|mesh-list
6763803|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763804|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
6763805|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
6763806|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
6763807|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763808|NCT02096419|Clopidogrel|clopidogrel|mesh-list
6763809|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6763810|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6763811|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6763812|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6763813|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
6763814|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763815|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763816|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763817|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
6763818|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6763819|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6763820|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6763821|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763822|NCT02096536|Vancomycin|vancomycin|mesh-list
6763823|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6763824|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763825|NCT02096601|Levodopa|levodopa|mesh-list
6763826|NCT02096601|Carbidopa|carbidopa|mesh-list
6763827|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6763828|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6763829|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
6763830|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763831|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763832|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763833|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6763834|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763835|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
6763836|NCT02096614|Fludarabine|fludarabine|mesh-list
6763837|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6763838|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
6763839|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763840|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763841|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6763842|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
6763843|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763844|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763845|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6763846|NCT02096913|Ibuprofen|ibuprofen|mesh-list
6763847|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6763848|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763849|NCT02096913|Analgesics|analgesics|mesh-ancestor
6763850|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
6763851|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763852|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763853|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763854|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763855|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6763856|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763857|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763858|NCT02096926|Ibuprofen|ibuprofen|mesh-list
6763859|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6763860|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6763861|NCT02096926|Analgesics|analgesics|mesh-ancestor
6763862|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
6763863|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763864|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763865|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763866|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763867|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6763868|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763869|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763870|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
6763871|NCT02096965|Tolvaptan|tolvaptan|mesh-list
6763872|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6763873|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763874|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
6763875|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763876|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6763877|NCT02097004|Entecavir|entecavir|mesh-list
6763878|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
6763879|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763880|NCT02097017|Lidocaine|lidocaine|mesh-list
6763881|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
6763882|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
6763883|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6763884|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763885|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
6763886|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6763887|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6763888|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6763889|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6763890|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6763891|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763892|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
6763893|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6763894|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6763895|NCT02097069|Folic Acid|folic acid|mesh-list
6763896|NCT02097069|Inositol|inositol|mesh-list
6763897|NCT02097069|Hematinics|hematinics|mesh-ancestor
6763898|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
6763899|NCT02097069|Vitamins|vitamins|mesh-ancestor
6763900|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
6763901|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763902|NCT02097082|Paclitaxel|paclitaxel|mesh-list
6763903|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6763904|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763905|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
6763906|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
6763907|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
6763908|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763909|NCT02097147|Paroxetine|paroxetine|mesh-list
6763910|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
6763911|NCT02097147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6763912|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6763913|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6763914|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763915|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763916|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
6763917|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763918|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6763919|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
6763920|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6763921|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6763922|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6763923|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763924|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6763925|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6763926|NCT02097160|Vitamin D|vitamin d|mesh-list
6763927|NCT02097160|Vitamins|vitamins|mesh-ancestor
6763928|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
6763929|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763930|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6763931|NCT02097173|Methotrexate|methotrexate|mesh-list
6763932|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6763933|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
6763934|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6763935|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763936|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6763937|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
6763938|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763939|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763940|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
6763941|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763942|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6763943|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6763944|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
6763945|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763946|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6763947|NCT02097225|Trametinib|trametinib|mesh-list
6763948|NCT02097225|Dabrafenib|dabrafenib|mesh-list
6763949|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763950|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6763951|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763952|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763953|NCT02097264|Adalimumab|adalimumab|mesh-list
6763954|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6763955|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6763956|NCT02097316|Insulin|insulin|mesh-list
6763957|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6763958|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763959|NCT02097329|Palbociclib|palbociclib|mesh-list
6763960|NCT02097329|Rabeprazole|rabeprazole|mesh-list
6763961|NCT02097329|Famotidine|famotidine|mesh-list
6763962|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
6763963|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
6763964|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6763965|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
6763966|NCT02097329|Antacids|antacids|mesh-list
6763967|NCT02097329|TEMPO|tempo|mesh-list
6763968|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6763969|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6763970|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763971|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763972|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6763973|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6763974|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6763975|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
6763976|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
6763977|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6763978|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763979|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
6763980|NCT02097329|Protective Agents|protective agents|mesh-ancestor
6763981|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6763982|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
6763983|NCT02097342|Linagliptin|linagliptin|mesh-list
6763984|NCT02097342|Voglibose|voglibose|mesh-list
6763985|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6763986|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6763987|NCT02097342|Incretins|incretins|mesh-ancestor
6763988|NCT02097342|Hormones|hormones|mesh-ancestor
6763989|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6763990|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6763991|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
6763992|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6763993|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6763994|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6763995|NCT02097381|Ritonavir|ritonavir|mesh-list
6763996|NCT02097381|Lopinavir|lopinavir|mesh-list
6763997|NCT02097381|Darunavir|darunavir|mesh-list
6763998|NCT02097381|Tenofovir|tenofovir|mesh-list
6763999|NCT02097381|Emtricitabine|emtricitabine|mesh-list
6764000|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6789347|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6764001|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6764002|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
6764003|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764004|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764005|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6764006|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6764007|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
6764008|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764009|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6764010|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6764011|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6764012|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6764013|NCT02097394|Pancreatin|pancreatin|mesh-list
6764014|NCT02097394|Pancrelipase|pancrelipase|mesh-list
6764015|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6764016|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
6764017|NCT02097407|Propofol|propofol|mesh-list
6764018|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6764019|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6764020|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764021|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6764022|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
6764023|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
6764024|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6764025|NCT02097407|Analgesics|analgesics|mesh-ancestor
6764026|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
6764027|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764028|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6764029|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6764030|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6764031|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
6764032|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764033|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764034|NCT02097459|Tamoxifen|tamoxifen|mesh-list
6764035|NCT02097459|Toremifene|toremifene|mesh-list
6764036|NCT02097459|Anastrozole|anastrozole|mesh-list
6764037|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6764038|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
6764039|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6764040|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764041|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6764042|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764043|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6764044|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6764045|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6764046|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6764047|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6764048|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764049|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764050|NCT02097511|Metoprolol|metoprolol|mesh-list
6764051|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
6764052|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6764053|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6764054|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
6764055|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
6764056|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764057|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764058|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6764059|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6764060|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6764061|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
6764062|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764063|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764064|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6764065|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6764066|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6764067|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6764068|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
6789348|NCT02229955|Cyclosporins|cyclosporins|mesh-list
6789349|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789350|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789351|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6789352|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
6764069|NCT02097589|Atorvastatin|atorvastatin|mesh-list
6764070|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6764071|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
6764072|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764073|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6764074|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6764075|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
6764076|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764077|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6764078|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6764079|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764080|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
6764081|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6764082|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6764083|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764084|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
6764085|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
6764086|NCT02097810|Entrectinib|entrectinib|mesh-list
6764087|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6764088|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764089|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764090|NCT02097953|Rifampin|rifampin|mesh-list
6764091|NCT02097953|Daptomycin|daptomycin|mesh-list
6764092|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6764093|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
6764094|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6764095|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764096|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
6764097|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6764098|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764099|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764100|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6764101|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6764102|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6764103|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6764104|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6764105|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6764106|NCT02097966|Ribavirin|ribavirin|mesh-list
6764107|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
6764108|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
6764109|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764110|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
6764111|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764112|NCT02098148|Xenon|xenon|mesh-list
6764113|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6764114|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
6764115|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
6764116|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6764117|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764118|NCT02098317|Vitamin D|vitamin d|mesh-list
6764119|NCT02098317|Vitamins|vitamins|mesh-ancestor
6764120|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
6764121|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764122|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6764123|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
6764124|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6764125|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6764126|NCT02098330|Prednisolone|prednisolone|mesh-list
6764127|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
6764128|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6764129|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
6764130|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6764131|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
6764132|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
6764133|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764134|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764135|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6764136|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
6764137|NCT02098330|Hormones|hormones|mesh-ancestor
6764138|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6764139|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6764140|NCT02098330|Protective Agents|protective agents|mesh-ancestor
6764141|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6764142|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764143|NCT02098343|Carboplatin|carboplatin|mesh-list
6764144|NCT02098343|Doxorubicin|doxorubicin|mesh-list
6764145|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6764146|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764147|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6764148|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6764149|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6764150|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764151|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764152|NCT02098421|Oxytocin|oxytocin|mesh-list
6764153|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
6764154|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6764155|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764156|NCT02098460|Cilostazol|cilostazol|mesh-list
6764157|NCT02098460|Atorvastatin|atorvastatin|mesh-list
6764158|NCT02098460|Probucol|probucol|mesh-list
6764159|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6764160|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6764161|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
6764162|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764163|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6764164|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6764165|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764166|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6764167|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
6764168|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764169|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764170|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6764171|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
6764172|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6764173|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6764174|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6764175|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
6764176|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6764177|NCT02098460|Protective Agents|protective agents|mesh-ancestor
6764178|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6764179|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6764180|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
6764181|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
6764182|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
6764183|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6764184|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764185|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6764186|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6764187|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764188|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764189|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764190|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
6764191|NCT02098499|Promethazine|promethazine|mesh-list
6764192|NCT02098499|Haloperidol|haloperidol|mesh-list
6764193|NCT02098499|Metoclopramide|metoclopramide|mesh-list
6764194|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
6764195|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6764196|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6764197|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6764198|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764199|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
6764200|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
6764201|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
6764202|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764203|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
6764204|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
6764205|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6764206|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6764207|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
6764208|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
6764209|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764210|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764211|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6764212|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
6764213|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
6764214|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6764215|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6764216|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6764217|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6764218|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
6764219|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6764220|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6764221|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6764222|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6764223|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764224|NCT02098590|Chloroquine|chloroquine|mesh-list
6764225|NCT02098590|Atovaquone|atovaquone|mesh-list
6764226|NCT02098590|Proguanil|proguanil|mesh-list
6764227|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
6764228|NCT02098590|Vaccines|vaccines|mesh-list
6764229|NCT02098590|Amebicides|amebicides|mesh-ancestor
6764230|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6764231|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6764232|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764233|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
6764234|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6764235|NCT02098590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764236|NCT02098590|Immunologic Factors|immunologic factors|mesh-ancestor
6764237|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764238|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764239|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
6764240|NCT02098616|Asunaprevir|asunaprevir|mesh-list
6764241|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
6764242|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764243|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764244|NCT02098629|Milrinone|milrinone|mesh-list
6764245|NCT02098629|Esmolol|esmolol|mesh-list
6764246|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6764247|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6764248|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6764249|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
6764250|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764251|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764252|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764253|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6764254|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6764255|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
6764256|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6764257|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6764258|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764259|NCT02098629|Protective Agents|protective agents|mesh-ancestor
6764260|NCT02098785|Caffeine|caffeine|mesh-list
6764261|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
6764262|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764263|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6764264|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764265|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6764266|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764267|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6764268|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6764269|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
6764270|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764271|NCT02098824|Methylphenidate|methylphenidate|mesh-list
6764272|NCT02098824|Galantamine|galantamine|mesh-list
6764273|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6764274|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764275|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6764276|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6764277|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6764278|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764279|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
6764280|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764281|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6764282|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764283|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
6764284|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6764285|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
6764286|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764287|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
6764288|NCT02098837|Dolutegravir|dolutegravir|mesh-list
6764289|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6764290|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6764291|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764292|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764293|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6764294|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6764295|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
6764296|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764297|NCT02098889|Scopolamine|scopolamine|mesh-list
6764298|NCT02098889|Bromides|bromides|mesh-list
6764299|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6764300|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
6764301|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6764302|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
6764303|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
6764304|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764305|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764306|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6764307|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
6764308|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6764309|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
6764310|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764311|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764312|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6764313|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
6764314|NCT02098915|Metoclopramide|metoclopramide|mesh-list
6764315|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
6764316|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
6764317|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764318|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764319|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6764320|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6764321|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6764322|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
6764323|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764324|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764325|NCT02098954|Gemcitabine|gemcitabine|mesh-list
6764326|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6764327|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6764328|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
6764329|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764330|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764331|NCT02098954|Antiviral Agents|antiviral agents|mesh-ancestor
6764332|NCT02098954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764333|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764334|NCT02098954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6764335|NCT02098954|Immunologic Factors|immunologic factors|mesh-ancestor
6764336|NCT02098954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764337|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6764338|NCT02098980|Vitamin D|vitamin d|mesh-list
6764339|NCT02098980|Vitamins|vitamins|mesh-ancestor
6764340|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
6764341|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764342|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6764343|NCT02099123|Atorvastatin|atorvastatin|mesh-list
6764344|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6764345|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6764346|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
6764347|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764348|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6764349|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6764350|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764351|NCT02099136|Celecoxib|celecoxib|mesh-list
6764352|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6764353|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6764354|NCT02099136|Analgesics|analgesics|mesh-ancestor
6764355|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
6764356|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764357|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764358|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6764359|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6764360|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6764361|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6764362|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764363|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789353|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789354|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
6789355|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789356|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
6789357|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6789358|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6789359|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6789360|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
6789361|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6789362|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6789363|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789364|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
6789365|NCT02229968|Coagulants|coagulants|mesh-ancestor
6789366|NCT02230033|Itraconazole|itraconazole|mesh-list
6789367|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
6789368|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
6789369|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789370|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6789371|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6789372|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789373|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789374|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6789375|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
6789376|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6789377|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789378|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6789379|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6789380|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
6789381|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6789382|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6789383|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
6789384|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789385|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6789386|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789387|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789388|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
6789389|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6789390|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764364|NCT02099175|Leucovorin|leucovorin|mesh-list
6764365|NCT02099175|Docetaxel|docetaxel|mesh-list
6764366|NCT02099175|Fluorouracil|fluorouracil|mesh-list
6764367|NCT02099175|Etoposide|etoposide|mesh-list
6764368|NCT02099175|Doxorubicin|doxorubicin|mesh-list
6764369|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6764370|NCT02099175|Ifosfamide|ifosfamide|mesh-list
6764371|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764372|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
6764373|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
6764374|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
6764375|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764376|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
6764377|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6764378|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6764379|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
6764380|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764381|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6764382|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6764383|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6764384|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764385|NCT02099175|Antidotes|antidotes|mesh-ancestor
6764386|NCT02099175|Protective Agents|protective agents|mesh-ancestor
6764387|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
6764388|NCT02099175|Vitamins|vitamins|mesh-ancestor
6764389|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
6764390|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6764391|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6764392|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
6764393|NCT02099188|Leucovorin|leucovorin|mesh-list
6764394|NCT02099188|Docetaxel|docetaxel|mesh-list
6764395|NCT02099188|Fluorouracil|fluorouracil|mesh-list
6764396|NCT02099188|Etoposide|etoposide|mesh-list
6764397|NCT02099188|Doxorubicin|doxorubicin|mesh-list
6764398|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6764399|NCT02099188|Ifosfamide|ifosfamide|mesh-list
6764400|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764401|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
6764402|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
6764403|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
6764404|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764405|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
6764406|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6764407|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6764408|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
6764409|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764410|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6764411|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6764412|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6764413|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764414|NCT02099188|Antidotes|antidotes|mesh-ancestor
6764415|NCT02099188|Protective Agents|protective agents|mesh-ancestor
6764416|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
6764417|NCT02099188|Vitamins|vitamins|mesh-ancestor
6764418|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
6764419|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6764420|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6764421|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
6764422|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6764423|NCT02099240|Amoxicillin|amoxicillin|mesh-list
6764424|NCT02099240|Azithromycin|azithromycin|mesh-list
6764425|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
6764426|NCT02099240|Vancomycin|vancomycin|mesh-list
6764427|NCT02099240|Clarithromycin|clarithromycin|mesh-list
6764428|NCT02099240|Doxycycline|doxycycline|mesh-list
6764429|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
6764430|NCT02099240|Levofloxacin|levofloxacin|mesh-list
6764431|NCT02099240|Ofloxacin|ofloxacin|mesh-list
6764432|NCT02099240|Minocycline|minocycline|mesh-list
6764433|NCT02099240|Rifampin|rifampin|mesh-list
6764434|NCT02099240|Clindamycin|clindamycin|mesh-list
6764435|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
6764436|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
6764437|NCT02099240|Gentamicins|gentamicins|mesh-list
6764438|NCT02099240|Isoniazid|isoniazid|mesh-list
6764439|NCT02099240|Meropenem|meropenem|mesh-list
6764440|NCT02099240|Tazobactam|tazobactam|mesh-list
6764441|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
6764442|NCT02099240|Cycloserine|cycloserine|mesh-list
6764443|NCT02099240|Linezolid|linezolid|mesh-list
6764444|NCT02099240|Piperacillin|piperacillin|mesh-list
6764445|NCT02099240|Metronidazole|metronidazole|mesh-list
6764446|NCT02099240|Imipenem|imipenem|mesh-list
6764447|NCT02099240|Penicillins|penicillins|mesh-list
6764448|NCT02099240|Erythromycin|erythromycin|mesh-list
6764449|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
6764450|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6764451|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
6764452|NCT02099240|Amikacin|amikacin|mesh-list
6764453|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
6764454|NCT02099240|Ceftazidime|ceftazidime|mesh-list
6764455|NCT02099240|Colistin|colistin|mesh-list
6764456|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6764457|NCT02099240|Ampicillin|ampicillin|mesh-list
6764458|NCT02099240|Rifabutin|rifabutin|mesh-list
6764459|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
6764460|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
6764461|NCT02099240|Mupirocin|mupirocin|mesh-list
6764462|NCT02099240|Rifapentine|rifapentine|mesh-list
6764463|NCT02099240|Cefepime|cefepime|mesh-list
6764464|NCT02099240|Fosfomycin|fosfomycin|mesh-list
6764465|NCT02099240|Cefuroxime|cefuroxime|mesh-list
6764466|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
6764467|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6764468|NCT02099240|Paromomycin|paromomycin|mesh-list
6764469|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
6764470|NCT02099240|Polymyxins|polymyxins|mesh-list
6764471|NCT02099240|Aztreonam|aztreonam|mesh-list
6764472|NCT02099240|Neomycin|neomycin|mesh-list
6764473|NCT02099240|Bacitracin|bacitracin|mesh-list
6764474|NCT02099240|Sulbactam|sulbactam|mesh-list
6764475|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
6764476|NCT02099240|Cefotaxime|cefotaxime|mesh-list
6764477|NCT02099240|Cefoxitin|cefoxitin|mesh-list
6764478|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
6764479|NCT02099240|Cefixime|cefixime|mesh-list
6764480|NCT02099240|Polymyxin B|polymyxin b|mesh-list
6764481|NCT02099240|Cefdinir|cefdinir|mesh-list
6764482|NCT02099240|Penicillin G|penicillin g|mesh-list
6764483|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
6764484|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
6764485|NCT02099240|Cloxacillin|cloxacillin|mesh-list
6764486|NCT02099240|Norfloxacin|norfloxacin|mesh-list
6764487|NCT02099240|Cefprozil|cefprozil|mesh-list
6764488|NCT02099240|Cephalosporins|cephalosporins|mesh-list
6764489|NCT02099240|Oxacillin|oxacillin|mesh-list
6764490|NCT02099240|Streptomycin|streptomycin|mesh-list
6764491|NCT02099240|Nafcillin|nafcillin|mesh-list
6764492|NCT02099240|Ticarcillin|ticarcillin|mesh-list
6764493|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
6764494|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
6764495|NCT02099240|Penicillin V|penicillin v|mesh-list
6764496|NCT02099240|Sultamicillin|sultamicillin|mesh-list
6764497|NCT02099240|Kanamycin|kanamycin|mesh-list
6764498|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
6764499|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
6764500|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
6764501|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
6764502|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
6764503|NCT02099240|Cefoperazone|cefoperazone|mesh-list
6764504|NCT02099240|Lincomycin|lincomycin|mesh-list
6764505|NCT02099240|Ethionamide|ethionamide|mesh-list
6764506|NCT02099240|Cefotetan|cefotetan|mesh-list
6764507|NCT02099240|Demeclocycline|demeclocycline|mesh-list
6764508|NCT02099240|Dirithromycin|dirithromycin|mesh-list
6764509|NCT02099240|Ceftibuten|ceftibuten|mesh-list
6764510|NCT02099240|Cefaclor|cefaclor|mesh-list
6764511|NCT02099240|Mafenide|mafenide|mesh-list
6764512|NCT02099240|Capreomycin|capreomycin|mesh-list
6764513|NCT02099240|Netilmicin|netilmicin|mesh-list
6764514|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
6764515|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
6764516|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
6764517|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
6764518|NCT02099240|Tobramycin|tobramycin|mesh-list
6764519|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
6764520|NCT02099240|Virginiamycin|virginiamycin|mesh-list
6764521|NCT02099240|Enoxacin|enoxacin|mesh-list
6764522|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6764523|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
6764524|NCT02099240|Methicillin|methicillin|mesh-list
6764525|NCT02099240|Bacampicillin|bacampicillin|mesh-list
6764526|NCT02099240|Carbenicillin|carbenicillin|mesh-list
6764527|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
6764528|NCT02099240|Mezlocillin|mezlocillin|mesh-list
6764529|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
6764530|NCT02099240|Cefamandole|cefamandole|mesh-list
6764531|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
6764532|NCT02099240|Cefonicid|cefonicid|mesh-list
6764533|NCT02099240|Cefmetazole|cefmetazole|mesh-list
6764534|NCT02099240|Loracarbef|loracarbef|mesh-list
6764535|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
6764536|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
6764537|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
6764538|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
6764539|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
6764540|NCT02099240|Methacycline|methacycline|mesh-list
6764541|NCT02099240|Tetracycline|tetracycline|mesh-list
6764542|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
6764543|NCT02099240|Dalfopristin|dalfopristin|mesh-list
6764544|NCT02099240|Novobiocin|novobiocin|mesh-list
6764545|NCT02099240|Spectinomycin|spectinomycin|mesh-list
6764546|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6764547|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
6764548|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
6764549|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6764550|NCT02099240|Methenamine|methenamine|mesh-list
6764551|NCT02099240|Sulperazone|sulperazone|mesh-list
6764552|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
6764553|NCT02099240|Cinoxacin|cinoxacin|mesh-list
6764554|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
6764555|NCT02099240|Trimethoprim|trimethoprim|mesh-list
6764556|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
6764557|NCT02099240|Procaine|procaine|mesh-list
6764558|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6764559|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6764560|NCT02099240|Cilastatin|cilastatin|mesh-list
6764561|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764562|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
6764563|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6764564|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6764565|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764566|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764567|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764568|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6764569|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
6764570|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6764571|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764572|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6764573|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6764574|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6764575|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6764576|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6764577|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6764578|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
6764579|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6764580|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6764581|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6764582|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6764583|NCT02099240|Renal Agents|renal agents|mesh-ancestor
6764584|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
6764585|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6764586|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6764587|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6764588|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6764589|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6764590|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6764591|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6764592|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6764593|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6764594|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
6764595|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6764596|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6764597|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6764598|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6764599|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6764600|NCT02099240|Analgesics|analgesics|mesh-ancestor
6764601|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
6764602|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764603|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6764604|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6764605|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
6764606|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6764607|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6764608|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6764609|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
6764610|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
6764611|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
6764612|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6764613|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6764614|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6764615|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6764616|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6764617|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
6764618|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
6764619|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6764620|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6764621|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764622|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6764623|NCT02099253|Analgesics|analgesics|mesh-ancestor
6764624|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
6764625|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764626|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6764627|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6764628|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6764629|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
6764630|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764631|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764632|NCT02099292|Rituximab|rituximab|mesh-list
6764633|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6764634|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764635|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
6764636|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764637|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6764638|NCT02099331|Melatonin|melatonin|mesh-list
6764639|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
6764640|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764641|NCT02099331|Protective Agents|protective agents|mesh-ancestor
6764642|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764643|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6764644|NCT02099357|Vitamin D|vitamin d|mesh-list
6764645|NCT02099357|Vitamins|vitamins|mesh-ancestor
6764646|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
6764647|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764648|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6764649|NCT02099396|Gemcitabine|gemcitabine|mesh-list
6764650|NCT02099396|Docetaxel|docetaxel|mesh-list
6764651|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6764652|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
6764653|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764654|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764655|NCT02099396|Antiviral Agents|antiviral agents|mesh-ancestor
6764656|NCT02099396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764657|NCT02099396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764658|NCT02099396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6764659|NCT02099396|Immunologic Factors|immunologic factors|mesh-ancestor
6764660|NCT02099396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764661|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
6764662|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
6764663|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
6764664|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
6764665|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6764666|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6764667|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
6764668|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764669|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6764670|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6764671|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764672|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764673|NCT02099604|Vitamin D|vitamin d|mesh-list
6764674|NCT02099604|Interferons|interferons|mesh-list
6764675|NCT02099604|Ribavirin|ribavirin|mesh-list
6764676|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
6764677|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
6764678|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6764679|NCT02099604|Vitamins|vitamins|mesh-ancestor
6764680|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
6764681|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764682|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6764683|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764684|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
6764685|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764686|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
6764687|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764688|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
6764689|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
6764690|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6764691|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6764692|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
6764693|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764694|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764695|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764696|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
6764697|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
6764698|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764699|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
6764700|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6764701|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
6764702|NCT02099695|Oxybutynin|oxybutynin|mesh-list
6764703|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
6764704|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
6764705|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764706|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764707|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6764708|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6764709|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
6764710|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764711|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764712|NCT02099695|Urological Agents|urological agents|mesh-ancestor
6764713|NCT02099825|Cycloserine|cycloserine|mesh-list
6764714|NCT02099825|Mifepristone|mifepristone|mesh-list
6764715|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
6764716|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
6764717|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6764718|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764719|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6764720|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6764721|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6764722|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
6764723|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6764724|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6764725|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
6764726|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6764727|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
6764728|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6764729|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
6764730|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6764731|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764732|NCT02099825|Renal Agents|renal agents|mesh-ancestor
6764733|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6764734|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
6764735|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6764736|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
6764737|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764738|NCT02099877|Fentanyl|fentanyl|mesh-list
6764739|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6764740|NCT02099877|Narcotics|narcotics|mesh-ancestor
6764741|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6764742|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764743|NCT02099877|Analgesics|analgesics|mesh-ancestor
6764744|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
6764745|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764746|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6764747|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6764748|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
6764749|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
6764750|NCT02099890|Curcumin|curcumin|mesh-list
6764751|NCT02099890|Antioxidants|antioxidants|mesh-list
6764752|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6764753|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6764754|NCT02099890|Analgesics|analgesics|mesh-ancestor
6764755|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
6764756|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764757|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764758|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6764759|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6764760|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764761|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764762|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764763|NCT02099890|Protective Agents|protective agents|mesh-ancestor
6764764|NCT02099916|Menotropins|menotropins|mesh-list
6764765|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764766|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6764767|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
6764768|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6764769|NCT02099955|Vitamin D|vitamin d|mesh-list
6764770|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
6764771|NCT02099955|Vitamins|vitamins|mesh-ancestor
6764772|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
6764773|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764774|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6764775|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6764776|NCT02099981|Pimagedine|pimagedine|mesh-list
6764777|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764778|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764779|NCT02100046|Ethosuximide|ethosuximide|mesh-list
6764780|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
6764781|NCT02100176|Dopamine|dopamine|mesh-list
6764782|NCT02100176|Rotigotine|rotigotine|mesh-list
6764783|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
6764784|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
6764785|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764786|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764787|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764788|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6764789|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
6764790|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
6764791|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764792|NCT02100176|Protective Agents|protective agents|mesh-ancestor
6764793|NCT02100202|Turmeric extract|turmeric extract|mesh-list
6764794|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
6764795|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764796|NCT02100202|Protective Agents|protective agents|mesh-ancestor
6764797|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764798|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
6764799|NCT02100267|Miotics|miotics|mesh-ancestor
6764800|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
6764801|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764802|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764803|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6764804|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6764805|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
6764806|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6764807|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6764808|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
6764809|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764810|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764811|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
6764812|NCT02100293|Analgesics|analgesics|mesh-ancestor
6764813|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
6764814|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764815|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764816|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
6764817|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6764818|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6764819|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
6764820|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6764821|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6764822|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764823|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6764824|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
6764825|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6764826|NCT02100423|Vitamin D|vitamin d|mesh-list
6764827|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
6764828|NCT02100423|Curcumin|curcumin|mesh-list
6764829|NCT02100423|Vitamins|vitamins|mesh-ancestor
6764830|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
6764831|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764832|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6764833|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6764834|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6764835|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6764836|NCT02100423|Analgesics|analgesics|mesh-ancestor
6764837|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
6764838|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764839|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6764840|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6764841|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764842|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764843|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764844|NCT02100462|Aspirin|aspirin|mesh-list
6764845|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6764846|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
6764847|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6764848|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6764849|NCT02100462|Analgesics|analgesics|mesh-ancestor
6764850|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
6764851|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764852|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764853|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6764854|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6764855|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6764856|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6764857|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764858|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6764859|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6764860|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764861|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
6764862|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6764863|NCT02100462|Diuretics|diuretics|mesh-ancestor
6764864|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
6764865|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6764866|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6764867|NCT02100488|Insulin|insulin|mesh-list
6764868|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6764869|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6764870|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764871|NCT02100553|Itraconazole|itraconazole|mesh-list
6764872|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6764873|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
6764874|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764875|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6764876|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6764877|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764878|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764879|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6764880|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
6764881|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6764882|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764883|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6764884|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
6764885|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
6764886|NCT02100605|Ephedrine|ephedrine|mesh-list
6764887|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6764888|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
6764889|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6764890|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764891|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
6764892|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
6764893|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764894|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
6764895|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764896|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764897|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6764898|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6764899|NCT02100761|Voriconazole|voriconazole|mesh-list
6764900|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
6764901|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764902|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6764903|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6764904|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764905|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764906|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6764907|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
6764908|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6764909|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764910|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6764911|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6764912|NCT02100787|Laxatives|laxatives|mesh-ancestor
6764913|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6764914|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
6764915|NCT02100852|Chlorambucil|chlorambucil|mesh-list
6764916|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6764917|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6764918|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6764919|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
6764920|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764921|NCT02100917|Trastuzumab|trastuzumab|mesh-list
6764922|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6764923|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789391|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6789392|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
6789393|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6789394|NCT02230163|Antibodies|antibodies|mesh-list
6789395|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
6789396|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789397|NCT02230176|Sunitinib|sunitinib|mesh-list
6789398|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6789399|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789400|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6789401|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6789402|NCT02230176|Growth Substances|growth substances|mesh-ancestor
6789403|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789404|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
6789405|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6789406|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789407|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789408|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6764924|NCT02101047|Phenylephrine|phenylephrine|mesh-list
6764925|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
6764926|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6764927|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
6764928|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
6764929|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6764930|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764931|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
6764932|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6764933|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
6764934|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
6764935|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6764936|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6764937|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6764938|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
6764939|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764940|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764941|NCT02101047|Protective Agents|protective agents|mesh-ancestor
6764942|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6764943|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6764944|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6764945|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
6764946|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764947|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6764948|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6764949|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764950|NCT02101138|Pramipexole|pramipexole|mesh-list
6764951|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
6764952|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764953|NCT02101138|Protective Agents|protective agents|mesh-ancestor
6764954|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764955|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6764956|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6764957|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
6764958|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
6764959|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764960|NCT02101151|Vitamin D|vitamin d|mesh-list
6764961|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
6764962|NCT02101151|Vitamins|vitamins|mesh-ancestor
6764963|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
6764964|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764965|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6764966|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6764967|NCT02101164|Denosumab|denosumab|mesh-list
6764968|NCT02101164|Pamidronate|pamidronate|mesh-list
6764969|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6764970|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764971|NCT02101203|Buspirone|buspirone|mesh-list
6764972|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6764973|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6764974|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6764975|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764976|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6764977|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6764978|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
6764979|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6764980|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764981|NCT02101216|Abacavir|abacavir|mesh-list
6764982|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
6764983|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6764984|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6764985|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6764986|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6764987|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
6764988|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6764989|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6764990|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6764991|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
6764992|NCT02101229|Insulin|insulin|mesh-list
6764993|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6764994|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6764995|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6764996|NCT02101255|Fluorides|fluorides|mesh-list
6764997|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
6764998|NCT02101255|Protective Agents|protective agents|mesh-ancestor
6764999|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765000|NCT02101476|Acetaminophen|acetaminophen|mesh-list
6765001|NCT02101476|Oxycodone|oxycodone|mesh-list
6765002|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6765003|NCT02101476|Analgesics|analgesics|mesh-ancestor
6765004|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
6765005|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765006|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765007|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
6765008|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6765009|NCT02101476|Narcotics|narcotics|mesh-ancestor
6765010|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765011|NCT02101567|Oxytocin|oxytocin|mesh-list
6765012|NCT02101567|Carbetocin|carbetocin|mesh-list
6765013|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
6765014|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6765015|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765016|NCT02101606|Tenecteplase|tenecteplase|mesh-list
6765017|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6765018|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6765019|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765020|NCT02101632|Petrolatum|petrolatum|mesh-list
6765021|NCT02101632|Emollients|emollients|mesh-ancestor
6765022|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
6765023|NCT02101710|Isosorbide|isosorbide|mesh-list
6765024|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6765025|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6765026|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6765027|NCT02101710|Diuretics|diuretics|mesh-ancestor
6765028|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
6765029|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765030|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
6765031|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6765032|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765033|NCT02101840|Oxycodone|oxycodone|mesh-list
6765034|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6765035|NCT02101840|Narcotics|narcotics|mesh-ancestor
6765036|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765037|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765038|NCT02101840|Analgesics|analgesics|mesh-ancestor
6765039|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
6765040|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765041|NCT02101892|Amitriptyline|amitriptyline|mesh-list
6765042|NCT02101892|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6765043|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6765044|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
6765045|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6765046|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6765047|NCT02101892|Analgesics|analgesics|mesh-ancestor
6765048|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
6765049|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765050|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765051|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6765052|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6765053|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6765054|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765055|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
6765056|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765057|NCT02101892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6765058|NCT02101892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6765059|NCT02101892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765060|NCT02101905|Lapatinib|lapatinib|mesh-list
6765061|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765062|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6765063|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765064|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765065|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6765066|NCT02101931|Levulinic acid|levulinic acid|mesh-list
6765067|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6765068|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
6765069|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765070|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765071|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6765072|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6765073|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6765074|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
6765075|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765076|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765077|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6765078|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6765079|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
6765080|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765081|NCT02102139|Propofol|propofol|mesh-list
6765082|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6765083|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765084|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765085|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6765086|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
6765087|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
6765088|NCT02102152|Tobramycin|tobramycin|mesh-list
6765089|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6765090|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765091|NCT02102243|Insulin|insulin|mesh-list
6765092|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6765093|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6765094|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765095|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
6765096|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
6765097|NCT02102295|Fluorides|fluorides|mesh-list
6765098|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
6765099|NCT02102295|Protective Agents|protective agents|mesh-ancestor
6765100|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765101|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
6765102|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765103|NCT02102295|Vitamins|vitamins|mesh-ancestor
6765104|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
6765105|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765106|NCT02102321|Albendazole|albendazole|mesh-list
6765107|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
6765108|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6765109|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765110|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
6765111|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6765112|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6765113|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
6765114|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
6765115|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
6765116|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765117|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765118|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6765119|NCT02102373|Laxatives|laxatives|mesh-ancestor
6765120|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6765121|NCT02102438|Paclitaxel|paclitaxel|mesh-list
6765122|NCT02102438|Carboplatin|carboplatin|mesh-list
6765123|NCT02102438|Trastuzumab|trastuzumab|mesh-list
6765124|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6765125|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765126|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
6765127|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
6765128|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
6765129|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765130|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6765131|NCT02102477|Androgens|androgens|mesh-list
6765132|NCT02102477|Hormones|hormones|mesh-ancestor
6765133|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765134|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765135|NCT02102516|Ketorolac|ketorolac|mesh-list
6765136|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6765137|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6765138|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6765139|NCT02102516|Analgesics|analgesics|mesh-ancestor
6765140|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
6765141|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765142|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765143|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6765144|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6765145|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6765146|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765147|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765148|NCT02102555|Acetaminophen|acetaminophen|mesh-list
6765149|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6765150|NCT02102555|Analgesics|analgesics|mesh-ancestor
6765151|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
6765152|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765153|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765154|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
6765155|NCT02102594|Bortezomib|bortezomib|mesh-list
6765156|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765157|NCT02102620|Lidocaine|lidocaine|mesh-list
6765158|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
6765159|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
6765160|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765161|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765162|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
6765163|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765164|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6765165|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6765166|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6765167|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6765168|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765169|NCT02102633|Dabigatran|dabigatran|mesh-list
6765170|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
6765171|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6765172|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
6765173|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765174|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765175|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
6765176|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6765177|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
6765178|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6765179|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
6765180|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6765181|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765182|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6765183|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6765184|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789409|NCT02230228|Vitamin A|vitamin a|mesh-list
6789410|NCT02230228|Retinol acetate|retinol acetate|mesh-list
6789411|NCT02230228|Vitamins|vitamins|mesh-ancestor
6789412|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
6789413|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789414|NCT02230228|Protective Agents|protective agents|mesh-ancestor
6789415|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6789416|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789417|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6789418|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
6789419|NCT02230319|Paclitaxel|paclitaxel|mesh-list
6789420|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6789421|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789422|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
6789423|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
6789424|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
6789425|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789426|NCT02230358|Anesthetics|anesthetics|mesh-list
6789427|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6789428|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765185|NCT02102672|Trimetazidine|trimetazidine|mesh-list
6765186|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
6765187|NCT02102698|Ecopipam|ecopipam|mesh-list
6765188|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6765189|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6765190|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765191|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765192|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6765193|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6765194|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
6765195|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765196|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765197|NCT02102711|Vitamin A|vitamin a|mesh-list
6765198|NCT02102711|Vitamins|vitamins|mesh-ancestor
6765199|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
6765200|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765201|NCT02102776|Mitomycins|mitomycins|mesh-list
6765202|NCT02102776|Mitomycin|mitomycin|mesh-list
6765203|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6765204|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765205|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
6765206|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765207|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6765208|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765209|NCT02102789|Leucovorin|leucovorin|mesh-list
6765210|NCT02102789|Dexamethasone|dexamethasone|mesh-list
6765211|NCT02102789|Fluorouracil|fluorouracil|mesh-list
6765212|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
6765213|NCT02102789|Floxuridine|floxuridine|mesh-list
6765214|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6765215|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
6765216|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
6765217|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765218|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765219|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6765220|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
6765221|NCT02102789|Hormones|hormones|mesh-ancestor
6765222|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765223|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6765224|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765225|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765226|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
6765227|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6765228|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6765229|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
6765230|NCT02102789|Antidotes|antidotes|mesh-ancestor
6765231|NCT02102789|Protective Agents|protective agents|mesh-ancestor
6765232|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
6765233|NCT02102789|Vitamins|vitamins|mesh-ancestor
6765234|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
6765235|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6765236|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
6765237|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765238|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6765239|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
6765240|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765241|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765242|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6765243|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6765244|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6765245|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
6765246|NCT02102815|Dexamethasone|dexamethasone|mesh-list
6765247|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6765248|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
6765249|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
6765250|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765251|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765252|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6765253|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
6765254|NCT02102815|Hormones|hormones|mesh-ancestor
6765255|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765256|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6765257|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765258|NCT02102828|Aspirin|aspirin|mesh-list
6765259|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6765260|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6765261|NCT02102828|Analgesics|analgesics|mesh-ancestor
6765262|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
6765263|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765264|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765265|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6765266|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6765267|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6765268|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6765269|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765270|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6765271|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6765272|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765273|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
6765274|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
6765275|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6765276|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
6765277|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765278|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6765279|NCT02102971|Liver Extracts|liver extracts|mesh-list
6765280|NCT02102971|Hematinics|hematinics|mesh-ancestor
6765281|NCT02103023|Imiquimod|imiquimod|mesh-list
6765282|NCT02103023|Vaccines|vaccines|mesh-list
6765283|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
6765284|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765285|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6765286|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765287|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
6765288|NCT02103049|Ezetimibe|ezetimibe|mesh-list
6765289|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6765290|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6765291|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
6765292|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765293|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6765294|NCT02103166|Scopolamine|scopolamine|mesh-list
6765295|NCT02103166|Bromides|bromides|mesh-list
6765296|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
6765297|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6765298|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
6765299|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
6765300|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765301|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765302|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6765303|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
6765304|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6765305|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
6765306|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765307|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765308|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6765309|NCT02103192|Antioxidants|antioxidants|mesh-list
6765310|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765311|NCT02103192|Protective Agents|protective agents|mesh-ancestor
6765312|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765313|NCT02103205|Iron|iron|mesh-list
6765314|NCT02103205|Lactoferrin|lactoferrin|mesh-list
6765315|NCT02103205|Trace Elements|trace elements|mesh-ancestor
6765316|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
6765317|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765318|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765319|NCT02103244|Carboplatin|carboplatin|mesh-list
6765320|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765321|NCT02103335|Dexamethasone|dexamethasone|mesh-list
6765322|NCT02103335|Pomalidomide|pomalidomide|mesh-list
6765323|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6765324|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
6765325|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
6765326|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765327|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765328|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6765329|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
6765330|NCT02103335|Hormones|hormones|mesh-ancestor
6765331|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765332|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6765333|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765334|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
6765335|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6765336|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6765337|NCT02103335|Growth Substances|growth substances|mesh-ancestor
6765338|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
6765339|NCT02103361|Ustekinumab|ustekinumab|mesh-list
6765340|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
6765341|NCT02103374|Terbutaline|terbutaline|mesh-list
6765342|NCT02103374|Ipratropium|ipratropium|mesh-list
6765343|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6765344|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
6765345|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765346|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765347|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6765348|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
6765349|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6765350|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
6765351|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765352|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765353|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
6765354|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
6765355|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6765356|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6765357|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6765358|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6765359|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
6765360|NCT02103465|Rotigotine|rotigotine|mesh-list
6765361|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
6765362|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
6765363|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765364|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765365|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765366|NCT02103556|Mineral Oil|mineral oil|mesh-list
6765367|NCT02103556|Emollients|emollients|mesh-ancestor
6765368|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
6765369|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6765370|NCT02103569|Norethindrone|norethindrone|mesh-list
6765371|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
6765372|NCT02103569|Estradiol|estradiol|mesh-list
6765373|NCT02103569|Asunaprevir|asunaprevir|mesh-list
6765374|NCT02103569|Estrogens|estrogens|mesh-ancestor
6765375|NCT02103569|Hormones|hormones|mesh-ancestor
6765376|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765377|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765378|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6765379|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
6765380|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6765381|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6765382|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6765383|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6765384|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6765385|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
6765386|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765387|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765388|NCT02103647|Pregabalin|pregabalin|mesh-list
6765389|NCT02103647|Analgesics|analgesics|mesh-ancestor
6765390|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
6765391|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765392|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765393|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
6765394|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6765395|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6765396|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765397|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6765398|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6765399|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6765400|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765401|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6765402|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6765403|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
6765404|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
6765405|NCT02103660|Progestins|progestins|mesh-list
6765406|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6765407|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765408|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6765409|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6765410|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6765411|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6765412|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6765413|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6765414|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6765415|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765416|NCT02103660|Hormones|hormones|mesh-ancestor
6765417|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765418|NCT02103686|Pregabalin|pregabalin|mesh-list
6765419|NCT02103686|Analgesics|analgesics|mesh-ancestor
6765420|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
6765421|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765422|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765423|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
6765424|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6765425|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6765426|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765427|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6765428|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6765429|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6765430|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765431|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6765432|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
6765433|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6765434|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6765435|NCT02103725|Analgesics|analgesics|mesh-ancestor
6765436|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
6765437|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765438|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765439|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6765440|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6765441|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
6765442|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6765443|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
6765444|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6765445|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765446|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765447|NCT02103738|Ranibizumab|ranibizumab|mesh-list
6765448|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6765449|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6765450|NCT02103738|Growth Substances|growth substances|mesh-ancestor
6765451|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765452|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
6765453|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765454|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6765455|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
6765456|NCT02103764|Desogestrel|desogestrel|mesh-list
6765457|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6765458|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6765459|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6765460|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
6765461|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6765462|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765463|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6765464|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6765465|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6765466|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6765467|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765468|NCT02103764|Progestins|progestins|mesh-ancestor
6765469|NCT02103764|Hormones|hormones|mesh-ancestor
6765470|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765471|NCT02103777|Caffeine|caffeine|mesh-list
6765472|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
6765473|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765474|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6765475|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765476|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6765477|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765478|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6765479|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6765480|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
6765481|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765482|NCT02103881|Ketamine|ketamine|mesh-list
6765483|NCT02103881|Haloperidol|haloperidol|mesh-list
6765484|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
6765485|NCT02103881|Analgesics|analgesics|mesh-ancestor
6765486|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
6765487|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765488|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765489|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6765490|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6765491|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
6765492|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
6765493|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765494|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6765495|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6765496|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765497|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765498|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
6765499|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
6765500|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6765501|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6765502|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6765503|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6765504|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6765505|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
6765506|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6765507|NCT02103998|Iodine|iodine|mesh-list
6765508|NCT02103998|Hormones|hormones|mesh-list
6765509|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765510|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765511|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6765512|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765513|NCT02103998|Trace Elements|trace elements|mesh-ancestor
6765514|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
6765515|NCT02104011|Propranolol|propranolol|mesh-list
6765516|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6765517|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6765518|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
6765519|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765520|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765521|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765522|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6765523|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6765524|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
6765525|NCT02104128|Bupropion|bupropion|mesh-list
6765526|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6765527|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
6765528|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6765529|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6765530|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6765531|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6765532|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765533|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
6765534|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765535|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765536|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6765537|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6765538|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765539|NCT02104193|Simvastatin|simvastatin|mesh-list
6765540|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6765541|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6765542|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
6765543|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765544|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6765545|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6765546|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789429|NCT02230371|Granisetron|granisetron|mesh-list
6789430|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
6789431|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
6789432|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789433|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789434|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789435|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6789436|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
6789437|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789438|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789439|NCT02230553|Lapatinib|lapatinib|mesh-list
6789440|NCT02230553|Trametinib|trametinib|mesh-list
6789441|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789442|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6789443|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789444|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789445|NCT02230618|Insulin|insulin|mesh-list
6789446|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
6789447|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6789448|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789449|NCT02230735|Epinephrine|epinephrine|mesh-list
6789450|NCT02230735|Racepinephrine|racepinephrine|mesh-list
6789451|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
6789452|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6789453|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6789454|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
6789455|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789456|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789457|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789458|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6789459|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6789460|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
6789461|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789462|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6789463|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
6789464|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
6789465|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
6789466|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6789467|NCT02230800|Tocovid|tocovid|mesh-list
6789468|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
6789469|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6789470|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789471|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789472|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6789473|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6789474|NCT02230800|Protective Agents|protective agents|mesh-ancestor
6789475|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789476|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
6789477|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6789478|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
6789479|NCT02230800|Vitamins|vitamins|mesh-ancestor
6765547|NCT02104284|Mannitol|mannitol|mesh-list
6765548|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
6765549|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6765550|NCT02104284|Diuretics|diuretics|mesh-ancestor
6765551|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
6765552|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765553|NCT02104284|Miotics|miotics|mesh-ancestor
6765554|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
6765555|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765556|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6765557|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
6765558|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
6765559|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6765560|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6765561|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
6765562|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765563|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765564|NCT02104297|Remifentanil|remifentanil|mesh-list
6765565|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6765566|NCT02104297|Narcotics|narcotics|mesh-ancestor
6765567|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765568|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765569|NCT02104297|Analgesics|analgesics|mesh-ancestor
6765570|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
6765571|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765572|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6765573|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765574|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
6765575|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765576|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765577|NCT02104323|Endostatins|endostatins|mesh-list
6765578|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765579|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6765580|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6765581|NCT02104323|Growth Substances|growth substances|mesh-ancestor
6765582|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765583|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
6765584|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
6765585|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6765586|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
6765587|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6765588|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765589|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6765590|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6765591|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6765592|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
6765593|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6765594|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6765595|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765596|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6765597|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6765598|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765599|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765600|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765601|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6765602|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
6765603|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6765604|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765605|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6765606|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6765607|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6765608|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
6765609|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
6765610|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6765611|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6765612|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6765613|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765614|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6765615|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6765616|NCT02104674|Montelukast|montelukast|mesh-list
6765617|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6765618|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
6765619|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6765620|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
6765621|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765622|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765623|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6765624|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6765625|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765626|NCT02104700|Tenofovir|tenofovir|mesh-list
6765627|NCT02104700|Emtricitabine|emtricitabine|mesh-list
6765628|NCT02104700|Rilpivirine|rilpivirine|mesh-list
6765629|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
6765630|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765631|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6765632|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6765633|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765634|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765635|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6765636|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6765637|NCT02104778|Dexamethasone|dexamethasone|mesh-list
6765638|NCT02104778|Epinephrine|epinephrine|mesh-list
6765639|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6765640|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
6765641|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
6765642|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765643|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765644|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6765645|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
6765646|NCT02104778|Hormones|hormones|mesh-ancestor
6765647|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765648|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6765649|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765650|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6765651|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6765652|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
6765653|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765654|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765655|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6765656|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6765657|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6765658|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
6765659|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
6765660|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
6765661|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6765662|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6765663|NCT02104843|Asunaprevir|asunaprevir|mesh-list
6765664|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6765665|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6765666|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
6765667|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765668|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6765669|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6765670|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765671|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
6765672|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
6765673|NCT02104986|Cisplatin|cisplatin|mesh-list
6765674|NCT02104986|Ifosfamide|ifosfamide|mesh-list
6765675|NCT02104986|Bleomycin|bleomycin|mesh-list
6765676|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765677|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6765678|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
6765679|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765680|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6765681|NCT02105077|Anesthetics|anesthetics|mesh-list
6765682|NCT02105077|Xenon|xenon|mesh-list
6765683|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765684|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765685|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6765686|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
6765687|NCT02105090|Anesthetics|anesthetics|mesh-list
6765688|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
6765689|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765690|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765691|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765692|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
6765693|NCT02105103|Insulin|insulin|mesh-list
6765694|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6765695|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765696|NCT02105155|Tacrolimus|tacrolimus|mesh-list
6765697|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6765698|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
6765699|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765700|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6765701|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765702|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765703|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
6765704|NCT02105311|Travoprost|travoprost|mesh-list
6765705|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6765706|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6765707|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765708|NCT02105350|Gemcitabine|gemcitabine|mesh-list
6765709|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
6765710|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6765711|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
6765712|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765713|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765714|NCT02105350|Antiviral Agents|antiviral agents|mesh-ancestor
6765715|NCT02105350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765716|NCT02105350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765717|NCT02105350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6765718|NCT02105350|Immunologic Factors|immunologic factors|mesh-ancestor
6765719|NCT02105350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765720|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
6765721|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
6765722|NCT02105610|Sevoflurane|sevoflurane|mesh-list
6765723|NCT02105610|Desflurane|desflurane|mesh-list
6765724|NCT02105610|Isoflurane|isoflurane|mesh-list
6765725|NCT02105610|Anesthetics|anesthetics|mesh-list
6765726|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
6765727|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6765728|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6765729|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
6765730|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765731|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765732|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6765733|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6765734|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6765735|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
6765736|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765737|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6765738|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6765739|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765740|NCT02105675|Docetaxel|docetaxel|mesh-list
6765741|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765742|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
6765743|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
6765744|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
6765745|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765746|NCT02105714|Formaldehyde|formaldehyde|mesh-list
6765747|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
6765748|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765749|NCT02105766|Sirolimus|sirolimus|mesh-list
6765750|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
6765751|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
6765752|NCT02105766|Pentostatin|pentostatin|mesh-list
6765753|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6765754|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
6765755|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765756|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6765757|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6765758|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
6765759|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765760|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765761|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6765762|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6765763|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765764|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6765765|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
6765766|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6765767|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
6765768|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765769|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6765770|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6765771|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765772|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6765773|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765774|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
6765775|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765776|NCT02105870|Abciximab|abciximab|mesh-list
6765777|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
6765778|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6789480|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
6789481|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
6789482|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6789483|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6789484|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6789485|NCT02230930|Apomorphine|apomorphine|mesh-list
6765779|NCT02106104|Glimepiride|glimepiride|mesh-list
6765780|NCT02106104|Linagliptin|linagliptin|mesh-list
6765781|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6765782|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6765783|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765784|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6765785|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
6765786|NCT02106104|Incretins|incretins|mesh-ancestor
6765787|NCT02106104|Hormones|hormones|mesh-ancestor
6765788|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765789|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6765790|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
6765791|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765792|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765793|NCT02106130|Rebamipide|rebamipide|mesh-list
6765794|NCT02106130|Mosapride|mosapride|mesh-list
6765795|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765796|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6765797|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6765798|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
6765799|NCT02106130|Protective Agents|protective agents|mesh-ancestor
6765800|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765801|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765802|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6765803|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
6765804|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765805|NCT02106182|Silodosin|silodosin|mesh-list
6765806|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6765807|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6765808|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6765809|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
6765810|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765811|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765812|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765813|NCT02106182|Urological Agents|urological agents|mesh-ancestor
6765814|NCT02106286|Bisoprolol|bisoprolol|mesh-list
6765815|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6765816|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
6765817|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
6765818|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765819|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765820|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6765821|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6765822|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6765823|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
6765824|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765825|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765826|NCT02106364|Insulin|insulin|mesh-list
6765827|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6765828|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
6765829|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6765830|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765831|NCT02106468|Prednisone|prednisone|mesh-list
6765832|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6765833|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
6765834|NCT02106468|Hormones|hormones|mesh-ancestor
6765835|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765836|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765837|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6765838|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765839|NCT02106481|Ropivacaine|ropivacaine|mesh-list
6765840|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
6765841|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
6765842|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765843|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765844|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
6765845|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765846|NCT02106507|Everolimus|everolimus|mesh-list
6765847|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765848|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6765849|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
6765850|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765851|NCT02106520|Bevacizumab|bevacizumab|mesh-list
6765852|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6765853|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765854|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6765855|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6765856|NCT02106520|Growth Substances|growth substances|mesh-ancestor
6765857|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765858|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
6765859|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6765860|NCT02106559|Trioxsalen|trioxsalen|mesh-list
6765861|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765862|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
6765863|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6765864|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
6765865|NCT02106572|Mitomycins|mitomycins|mesh-list
6765866|NCT02106572|Mitomycin|mitomycin|mesh-list
6765867|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6765868|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765869|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
6765870|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765871|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6765872|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765873|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6765874|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6765875|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
6765876|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765877|NCT02106637|Varenicline|varenicline|mesh-list
6765878|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6765879|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6765880|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
6765881|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6765882|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765883|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765884|NCT02106650|Leucovorin|leucovorin|mesh-list
6765885|NCT02106650|Folic Acid|folic acid|mesh-list
6765886|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
6765887|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
6765888|NCT02106650|Vitamins|vitamins|mesh-ancestor
6765889|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
6765890|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765891|NCT02106650|Antidotes|antidotes|mesh-ancestor
6765892|NCT02106650|Protective Agents|protective agents|mesh-ancestor
6765893|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
6765894|NCT02106650|Hematinics|hematinics|mesh-ancestor
6765895|NCT02106767|Rifampin|rifampin|mesh-list
6765896|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6765897|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6765898|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6765899|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
6765900|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765901|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6765902|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6765903|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765904|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6765905|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
6765906|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6765907|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6765908|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
6765909|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6765910|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6765911|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6765912|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6765913|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6765914|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6765915|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6765916|NCT02106793|Mitomycins|mitomycins|mesh-list
6765917|NCT02106793|Mitomycin|mitomycin|mesh-list
6765918|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6765919|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765920|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
6765921|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765922|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6765923|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765924|NCT02106806|Zinc|zinc|mesh-list
6765925|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
6765926|NCT02106806|Trace Elements|trace elements|mesh-ancestor
6765927|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
6765928|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765929|NCT02106806|Astringents|astringents|mesh-ancestor
6765930|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
6765931|NCT02106845|Digoxin|digoxin|mesh-list
6765932|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6765933|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6765934|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6765935|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
6765936|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765937|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6765938|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6765939|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765940|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6765941|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6765942|NCT02106845|Protective Agents|protective agents|mesh-ancestor
6765943|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765944|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
6765945|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
6765946|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6765947|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6765948|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765949|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765950|NCT02106871|Urological Agents|urological agents|mesh-ancestor
6765951|NCT02106988|Dexamethasone|dexamethasone|mesh-list
6765952|NCT02106988|Carboplatin|carboplatin|mesh-list
6765953|NCT02106988|Etoposide|etoposide|mesh-list
6765954|NCT02106988|Ifosfamide|ifosfamide|mesh-list
6765955|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
6765956|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6765957|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
6765958|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
6765959|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6765960|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765961|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6765962|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
6765963|NCT02106988|Hormones|hormones|mesh-ancestor
6765964|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6765965|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6765966|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6765967|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6765968|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6765969|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6765970|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6765971|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765972|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6765973|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
6765974|NCT02107079|Melatonin|melatonin|mesh-list
6765975|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
6765976|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6765977|NCT02107079|Protective Agents|protective agents|mesh-ancestor
6765978|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765979|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765980|NCT02107118|Complement Factor H|complement factor h|mesh-list
6765981|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6765982|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6765983|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
6765984|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765985|NCT02107144|Trimetazidine|trimetazidine|mesh-list
6765986|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
6765987|NCT02107170|Remifentanil|remifentanil|mesh-list
6765988|NCT02107170|Propofol|propofol|mesh-list
6765989|NCT02107170|Sevoflurane|sevoflurane|mesh-list
6765990|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6765991|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6765992|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6765993|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6765994|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
6765995|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
6765996|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6765997|NCT02107170|Narcotics|narcotics|mesh-ancestor
6765998|NCT02107170|Analgesics|analgesics|mesh-ancestor
6765999|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
6766000|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766001|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6766002|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6766003|NCT02107235|ON 01910|on 01910|mesh-list
6766004|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766005|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6766006|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766007|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766008|NCT02107365|Interferons|interferons|mesh-list
6766009|NCT02107365|Ribavirin|ribavirin|mesh-list
6766010|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
6766011|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
6766012|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6766013|NCT02107365|Asunaprevir|asunaprevir|mesh-list
6766014|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766015|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
6766016|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766017|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
6766018|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766019|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
6766020|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766021|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
6766022|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766023|NCT02107378|Paclitaxel|paclitaxel|mesh-list
6766024|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6766025|NCT02107378|Doxorubicin|doxorubicin|mesh-list
6766026|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6766027|NCT02107378|Topotecan|topotecan|mesh-list
6766028|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6766029|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766030|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
6766031|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
6766032|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
6766033|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766034|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6766035|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6766036|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6766037|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766038|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6766039|NCT02107391|Leuprolide|leuprolide|mesh-list
6766040|NCT02107391|Goserelin|goserelin|mesh-list
6766041|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6766042|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
6766043|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6766044|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766045|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6766046|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766047|NCT02107690|Lidocaine|lidocaine|mesh-list
6766048|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
6766049|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
6766050|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766051|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766052|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
6766053|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766054|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6766055|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6766056|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6766057|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6766058|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766059|NCT02107716|Lidocaine|lidocaine|mesh-list
6766060|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
6766061|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
6766062|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766063|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766064|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
6766065|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766066|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6766067|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6766068|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6766069|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6766070|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766071|NCT02107729|Lidocaine|lidocaine|mesh-list
6766072|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
6766073|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
6766074|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766075|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766076|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
6766077|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766078|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6766079|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6766080|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6766081|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6766082|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766083|NCT02107742|Lidocaine|lidocaine|mesh-list
6766084|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
6766085|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
6766086|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766087|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766088|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
6766089|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766090|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6766091|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6766092|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6766093|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6766094|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766095|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6766096|NCT02107755|Ipilimumab|ipilimumab|mesh-list
6766097|NCT02107755|Antibodies|antibodies|mesh-list
6766098|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
6766099|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6766100|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
6766101|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766102|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766103|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6766104|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789486|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6789487|NCT02230930|Emetics|emetics|mesh-ancestor
6789488|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789489|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
6789490|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789491|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789492|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
6789493|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
6789494|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789495|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789496|NCT02230982|Nintedanib|nintedanib|mesh-list
6789497|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789498|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6789499|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789500|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789501|NCT02231021|Pioglitazone|pioglitazone|mesh-list
6789502|NCT02231021|Alogliptin|alogliptin|mesh-list
6789503|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6789504|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789505|NCT02231021|Incretins|incretins|mesh-ancestor
6789506|NCT02231021|Hormones|hormones|mesh-ancestor
6766105|NCT02107807|Lactitol|lactitol|mesh-list
6766106|NCT02107807|Vaccines|vaccines|mesh-list
6766107|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
6766108|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766109|NCT02107807|Cathartics|cathartics|mesh-ancestor
6766110|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766111|NCT02107924|Vancomycin|vancomycin|mesh-list
6766112|NCT02107924|Tobramycin|tobramycin|mesh-list
6766113|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6766114|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766115|NCT02107937|Paclitaxel|paclitaxel|mesh-list
6766116|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6766117|NCT02107937|Carboplatin|carboplatin|mesh-list
6766118|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6766119|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766120|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
6766121|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
6766122|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
6766123|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766124|NCT02107950|Gemcitabine|gemcitabine|mesh-list
6766125|NCT02107950|Carboplatin|carboplatin|mesh-list
6766126|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766127|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6766128|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
6766129|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766130|NCT02107950|Antiviral Agents|antiviral agents|mesh-ancestor
6766131|NCT02107950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766132|NCT02107950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766133|NCT02107950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766134|NCT02107950|Immunologic Factors|immunologic factors|mesh-ancestor
6766135|NCT02107950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766136|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
6766137|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766138|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
6766139|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766140|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766141|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6766142|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
6766143|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766144|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766145|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6766146|NCT02108002|Vorinostat|vorinostat|mesh-list
6766147|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766148|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6766149|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766150|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766151|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
6766152|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6766153|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6766154|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6766155|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6766156|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766157|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
6766158|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766159|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766160|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6766161|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766162|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6766163|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766164|NCT02108301|Cyclosporine|cyclosporine|mesh-list
6766165|NCT02108301|Tacrolimus|tacrolimus|mesh-list
6766166|NCT02108301|Cyclosporins|cyclosporins|mesh-list
6766167|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766168|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
6766169|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766170|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6766171|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766172|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766173|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
6766174|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766175|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
6766176|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766177|NCT02108353|Melatonin|melatonin|mesh-list
6766178|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
6766179|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766180|NCT02108353|Protective Agents|protective agents|mesh-ancestor
6766181|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766182|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766183|NCT02108366|Oseltamivir|oseltamivir|mesh-list
6766184|NCT02108366|Celecoxib|celecoxib|mesh-list
6766185|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6766186|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766187|NCT02108366|Analgesics|analgesics|mesh-ancestor
6766188|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
6766189|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766190|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766191|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766192|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766193|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6766194|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6766195|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766196|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766197|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
6766198|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766199|NCT02108483|Dapsone|dapsone|mesh-list
6766200|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766201|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
6766202|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6766203|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6766204|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6766205|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766206|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766207|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
6766208|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6766209|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
6766210|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6766211|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6766212|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766213|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6766214|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6766215|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
6766216|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6766217|NCT02108548|Naproxen|naproxen|mesh-list
6766218|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6766219|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766220|NCT02108548|Analgesics|analgesics|mesh-ancestor
6766221|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
6766222|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766223|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766224|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766225|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766226|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
6766227|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6766228|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766229|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766230|NCT02108626|Nicotine|nicotine|mesh-list
6766231|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6766232|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
6766233|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766234|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766235|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6766236|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6766237|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
6766238|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766239|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766240|NCT02108639|Asunaprevir|asunaprevir|mesh-list
6766241|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
6766242|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766243|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766244|NCT02108743|Albuterol|albuterol|mesh-list
6766245|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6766246|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
6766247|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766248|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766249|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6766250|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
6766251|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
6766252|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6766253|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6766254|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6766255|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6766256|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
6766257|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766258|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766259|NCT02108756|Pantoprazole|pantoprazole|mesh-list
6766260|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6766261|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766262|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6766263|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766264|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766265|NCT02108795|Remifentanil|remifentanil|mesh-list
6766266|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6766267|NCT02108795|Narcotics|narcotics|mesh-ancestor
6766268|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766269|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766270|NCT02108795|Analgesics|analgesics|mesh-ancestor
6766271|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
6766272|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766273|NCT02108808|Clopidogrel|clopidogrel|mesh-list
6766274|NCT02108808|Ticagrelor|ticagrelor|mesh-list
6766275|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6766276|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6766277|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6766278|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6766279|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6766280|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
6766281|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766282|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766283|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766284|NCT02108847|Ropivacaine|ropivacaine|mesh-list
6766285|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
6766286|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
6766287|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766288|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766289|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
6766290|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766291|NCT02108860|Abatacept|abatacept|mesh-list
6766292|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6766293|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766294|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766295|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766296|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
6766297|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766298|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766299|NCT02108886|Montelukast|montelukast|mesh-list
6766300|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6766301|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
6766302|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6766303|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
6766304|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766305|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766306|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6766307|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6766308|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766309|NCT02108990|Acetaminophen|acetaminophen|mesh-list
6766310|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766311|NCT02108990|Analgesics|analgesics|mesh-ancestor
6766312|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
6766313|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766314|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766315|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
6766316|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
6766317|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766318|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
6766319|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6766320|NCT02109289|Etanercept|etanercept|mesh-list
6766321|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6766322|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766323|NCT02109289|Analgesics|analgesics|mesh-ancestor
6766324|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
6766325|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766326|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766327|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766328|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766329|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766330|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766331|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
6766332|NCT02109315|Ascorbic Acid|ascorbic acid|mesh-list
6766333|NCT02109315|Liraglutide|liraglutide|mesh-list
6766334|NCT02109315|Vitamins|vitamins|mesh-ancestor
6766335|NCT02109315|Micronutrients|micronutrients|mesh-ancestor
6766336|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766337|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6766338|NCT02109315|Incretins|incretins|mesh-ancestor
6766339|NCT02109315|Hormones|hormones|mesh-ancestor
6766340|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766341|NCT02109315|Antioxidants|antioxidants|mesh-ancestor
6766342|NCT02109315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766343|NCT02109315|Protective Agents|protective agents|mesh-ancestor
6766344|NCT02109328|Paclitaxel|paclitaxel|mesh-list
6766345|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6766346|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766347|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
6766348|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
6766349|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
6766350|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766351|NCT02109341|Paclitaxel|paclitaxel|mesh-list
6766352|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6766353|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6766354|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766355|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
6766356|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
6766357|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
6766358|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766359|NCT02109354|Vaccines|vaccines|mesh-list
6766360|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
6766361|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766362|NCT02109510|Lidocaine|lidocaine|mesh-list
6766363|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
6766364|NCT02109510|Ketamine|ketamine|mesh-list
6766365|NCT02109510|Anesthetics|anesthetics|mesh-list
6766366|NCT02109510|Propofol|propofol|mesh-list
6766367|NCT02109510|Sevoflurane|sevoflurane|mesh-list
6766368|NCT02109510|Rocuronium|rocuronium|mesh-list
6766369|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
6766370|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766371|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766372|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
6766373|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766374|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6766375|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6766376|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6766377|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6766378|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766379|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6766380|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6766381|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
6766382|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766383|NCT02109510|Analgesics|analgesics|mesh-ancestor
6766384|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6766385|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6766386|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6766387|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
6766388|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766389|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6766390|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6766391|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6766392|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6766393|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6766394|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6766395|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6766396|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6789507|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6789508|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6789509|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
6789510|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789511|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789512|NCT02231125|Losartan|losartan|mesh-list
6789513|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6789514|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6789515|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6789516|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6789517|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789518|NCT02231203|Tocopherols|tocopherols|mesh-list
6789519|NCT02231203|Antioxidants|antioxidants|mesh-list
6789520|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789521|NCT02231203|Protective Agents|protective agents|mesh-ancestor
6766397|NCT02109614|Niacin|niacin|mesh-list
6766398|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6766399|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
6766400|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766401|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6766402|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
6766403|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
6766404|NCT02109614|Vitamins|vitamins|mesh-ancestor
6766405|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
6766406|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766407|NCT02109627|Cytarabine|cytarabine|mesh-list
6766408|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6766409|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
6766410|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766411|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766412|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
6766413|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766414|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766415|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
6766416|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766417|NCT02109666|Abatacept|abatacept|mesh-list
6766418|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6766419|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766420|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766421|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766422|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
6766423|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766424|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766425|NCT02109679|Metformin|metformin|mesh-list
6766426|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6766427|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766428|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
6766429|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6766430|NCT02109718|Petrolatum|petrolatum|mesh-list
6766431|NCT02109718|Emollients|emollients|mesh-ancestor
6766432|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
6766433|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6766434|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766435|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6766436|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6766437|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
6766438|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6766439|NCT02109783|Caffeine|caffeine|mesh-list
6766440|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6766441|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766442|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6766443|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766444|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766445|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6766446|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6766447|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
6766448|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766449|NCT02109861|Dexamethasone|dexamethasone|mesh-list
6766450|NCT02109861|Bortezomib|bortezomib|mesh-list
6766451|NCT02109861|Melphalan|melphalan|mesh-list
6766452|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766453|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
6766454|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
6766455|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766456|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766457|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766458|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
6766459|NCT02109861|Hormones|hormones|mesh-ancestor
6766460|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766461|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6766462|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766463|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6766464|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
6766465|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766466|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6766467|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766468|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
6766469|NCT02109900|Progesterone|progesterone|mesh-list
6766470|NCT02109900|Progestins|progestins|mesh-ancestor
6766471|NCT02109900|Hormones|hormones|mesh-ancestor
6766472|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766473|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766474|NCT02109913|Everolimus|everolimus|mesh-list
6766475|NCT02109913|Exemestane|exemestane|mesh-list
6766476|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766477|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766478|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
6766479|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766480|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6766481|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6766482|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766483|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766484|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6766485|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
6766486|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766487|NCT02109965|Midazolam|midazolam|mesh-list
6766488|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
6766489|NCT02109965|Propofol|propofol|mesh-list
6766490|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6766491|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766492|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766493|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6766494|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
6766495|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
6766496|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766497|NCT02109965|Analgesics|analgesics|mesh-ancestor
6766498|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
6766499|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766500|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6766501|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6766502|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6766503|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
6766504|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766505|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766506|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6766507|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6766508|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6766509|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6766510|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
6766511|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
6766512|NCT02110082|Cetuximab|cetuximab|mesh-list
6766513|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6766514|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766515|NCT02110134|Hydroquinone|hydroquinone|mesh-list
6766516|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
6766517|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766518|NCT02110134|Protective Agents|protective agents|mesh-ancestor
6766519|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766520|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6766521|NCT02110303|Ticagrelor|ticagrelor|mesh-list
6766522|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6766523|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6766524|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6766525|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6766526|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
6766527|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766528|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766529|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766530|NCT02110316|Voriconazole|voriconazole|mesh-list
6766531|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
6766532|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766533|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6766534|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6766535|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766536|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766537|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6766538|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
6766539|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766540|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766541|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6766542|NCT02110355|Trametinib|trametinib|mesh-list
6766543|NCT02110355|Dabrafenib|dabrafenib|mesh-list
6766544|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766545|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6766546|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766547|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766548|NCT02110394|Rituximab|rituximab|mesh-list
6766549|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6766550|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6766551|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766552|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
6766553|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766554|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766555|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6766556|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
6766557|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766558|NCT02110459|Murepavadin|murepavadin|mesh-list
6766559|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6766560|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766561|NCT02110524|Paclitaxel|paclitaxel|mesh-list
6766562|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6766563|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766564|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
6766565|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
6766566|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
6766567|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766568|NCT02110537|Flecainide|flecainide|mesh-list
6766569|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6766570|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6766571|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6766572|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6766573|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766574|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
6766575|NCT02110654|Montelukast|montelukast|mesh-list
6766576|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6766577|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
6766578|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6766579|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
6766580|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766581|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766582|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6766583|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6766584|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766585|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766586|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
6766587|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6766588|NCT02110719|Acetaminophen|acetaminophen|mesh-list
6766589|NCT02110719|Dexamethasone|dexamethasone|mesh-list
6766590|NCT02110719|Ibuprofen|ibuprofen|mesh-list
6766591|NCT02110719|Celecoxib|celecoxib|mesh-list
6766592|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6766593|NCT02110719|Oxycodone|oxycodone|mesh-list
6766594|NCT02110719|Gabapentin|gabapentin|mesh-list
6766595|NCT02110719|Hydromorphone|hydromorphone|mesh-list
6766596|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766597|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
6766598|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
6766599|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766600|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766601|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766602|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
6766603|NCT02110719|Hormones|hormones|mesh-ancestor
6766604|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766605|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6766606|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766607|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766608|NCT02110719|Analgesics|analgesics|mesh-ancestor
6766609|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
6766610|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
6766611|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6766612|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766613|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6766614|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766615|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766616|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6766617|NCT02110719|Narcotics|narcotics|mesh-ancestor
6766618|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766619|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
6766620|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6766621|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6766622|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6766623|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6766624|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6766625|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766626|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
6766627|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6766628|NCT02110745|Propofol|propofol|mesh-list
6766629|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6766630|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766631|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766632|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6766633|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
6766634|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
6766635|NCT02110784|Piperaquine|piperaquine|mesh-list
6766636|NCT02110784|Artenimol|artenimol|mesh-list
6766637|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
6766638|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6766639|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6766640|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766641|NCT02110810|Indomethacin|indomethacin|mesh-list
6766642|NCT02110810|Glycerol|glycerol|mesh-list
6766643|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6766644|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766645|NCT02110810|Analgesics|analgesics|mesh-ancestor
6766646|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
6766647|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766648|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766649|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766650|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766651|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
6766652|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
6766653|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6766654|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6766655|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766656|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766657|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6766658|NCT02110810|Protective Agents|protective agents|mesh-ancestor
6766659|NCT02110953|Irinotecan|irinotecan|mesh-list
6766660|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6766661|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6766662|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766663|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766664|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766665|NCT02110966|Tramadol|tramadol|mesh-list
6766666|NCT02110966|Mepivacaine|mepivacaine|mesh-list
6766667|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6766668|NCT02110966|Narcotics|narcotics|mesh-ancestor
6766669|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766670|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766671|NCT02110966|Analgesics|analgesics|mesh-ancestor
6766672|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
6766673|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766674|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
6766675|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
6766676|NCT02110992|Docetaxel|docetaxel|mesh-list
6766677|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766678|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
6766679|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
6766680|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
6766681|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766682|NCT02111044|Octreotide|octreotide|mesh-list
6766683|NCT02111044|Somatostatin|somatostatin|mesh-list
6766684|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766685|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6766686|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766687|NCT02111044|Hormones|hormones|mesh-ancestor
6766688|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766689|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766690|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
6766691|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6766692|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6766693|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
6766694|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
6766695|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766696|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766697|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
6766698|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6766699|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
6766700|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
6766701|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6766702|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
6766703|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766704|NCT02111265|Sufentanil|sufentanil|mesh-list
6766705|NCT02111265|Remifentanil|remifentanil|mesh-list
6766706|NCT02111265|Cisatracurium|cisatracurium|mesh-list
6766707|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6766708|NCT02111265|Narcotics|narcotics|mesh-ancestor
6766709|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766710|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766711|NCT02111265|Analgesics|analgesics|mesh-ancestor
6766712|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
6766713|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766714|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6766715|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6766716|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
6766717|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
6766718|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6766719|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6766720|NCT02111317|Verapamil|verapamil|mesh-list
6766721|NCT02111317|Peficitinib|peficitinib|mesh-list
6766722|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6766723|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6766724|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6766725|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766726|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6766727|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766728|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
6766729|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766730|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766731|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
6789522|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789523|NCT02231203|Vitamins|vitamins|mesh-ancestor
6789524|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
6789525|NCT02231255|Pramipexole|pramipexole|mesh-list
6789526|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
6789527|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789528|NCT02231255|Protective Agents|protective agents|mesh-ancestor
6789529|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789530|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6789531|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6789532|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
6789533|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
6789534|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789535|NCT02231281|Ritonavir|ritonavir|mesh-list
6789536|NCT02231281|Lopinavir|lopinavir|mesh-list
6789537|NCT02231281|Tenofovir|tenofovir|mesh-list
6789538|NCT02231281|Lamivudine|lamivudine|mesh-list
6789539|NCT02231281|Zidovudine|zidovudine|mesh-list
6789540|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6789541|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6789542|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
6789543|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789544|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789545|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6789546|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6789547|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
6789548|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789549|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6789550|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6789551|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6789552|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6789553|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
6789554|NCT02231294|Pramipexole|pramipexole|mesh-list
6789555|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
6789556|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789557|NCT02231294|Protective Agents|protective agents|mesh-ancestor
6789558|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789559|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6789560|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6789561|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
6789562|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
6789563|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789564|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6789565|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6789566|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
6789567|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789568|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789569|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6789570|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
6789571|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
6766732|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
6766733|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6766734|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766735|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766736|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766737|NCT02111421|Analgesics|analgesics|mesh-ancestor
6766738|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
6766739|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766740|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6766741|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6766742|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6766743|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
6766744|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766745|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766746|NCT02111434|Testosterone|testosterone|mesh-list
6766747|NCT02111434|Androgens|androgens|mesh-ancestor
6766748|NCT02111434|Hormones|hormones|mesh-ancestor
6766749|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766750|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766751|NCT02111473|Testosterone|testosterone|mesh-list
6766752|NCT02111473|Androgens|androgens|mesh-ancestor
6766753|NCT02111473|Hormones|hormones|mesh-ancestor
6766754|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766755|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766756|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
6766757|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6766758|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6766759|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
6766760|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766761|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766762|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766763|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
6766764|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6766765|NCT02111590|Antibodies|antibodies|mesh-list
6766766|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
6766767|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766768|NCT02111629|Fluconazole|fluconazole|mesh-list
6766769|NCT02111629|Secnidazole|secnidazole|mesh-list
6766770|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
6766771|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766772|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6766773|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6766774|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766775|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766776|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6766777|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
6766778|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766779|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766780|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6766781|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6766782|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6766783|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6766784|NCT02111707|Indomethacin|indomethacin|mesh-list
6766785|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6766786|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766787|NCT02111707|Analgesics|analgesics|mesh-ancestor
6766788|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
6766789|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766790|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766791|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766792|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766793|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
6766794|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
6766795|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6766796|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6766797|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766798|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766799|NCT02111850|Aldesleukin|aldesleukin|mesh-list
6766800|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
6766801|NCT02111850|Fludarabine|fludarabine|mesh-list
6766802|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766803|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
6766804|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766805|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766806|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6766807|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
6766808|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766809|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766810|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6766811|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6766812|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6766813|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
6766814|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766815|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6766816|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6766817|NCT02111941|Vaccines|vaccines|mesh-list
6766818|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
6766819|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766820|NCT02112006|Bupivacaine|bupivacaine|mesh-list
6766821|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
6766822|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
6766823|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766824|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766825|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
6766826|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766827|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
6766828|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766829|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6766830|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
6766831|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6766832|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766833|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
6766834|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766835|NCT02112097|Etanercept|etanercept|mesh-list
6766836|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6766837|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766838|NCT02112097|Analgesics|analgesics|mesh-ancestor
6766839|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
6766840|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766841|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766842|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766843|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6766844|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766845|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6766846|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
6766847|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
6766848|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6766849|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6766850|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766851|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
6766852|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
6766853|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766854|NCT02112175|Lenalidomide|lenalidomide|mesh-list
6766855|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
6766856|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766857|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6766858|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6766859|NCT02112175|Growth Substances|growth substances|mesh-ancestor
6766860|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
6766861|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766862|NCT02112214|Bismuth|bismuth|mesh-list
6766863|NCT02112214|Antacids|antacids|mesh-ancestor
6766864|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766865|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766866|NCT02112292|Dronabinol|dronabinol|mesh-list
6766867|NCT02112292|Cannabidiol|cannabidiol|mesh-list
6766868|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
6766869|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
6766870|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766871|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6766872|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6766873|NCT02112292|Analgesics|analgesics|mesh-ancestor
6766874|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
6766875|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766876|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6766877|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6766878|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766879|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766880|NCT02112292|Hormones|hormones|mesh-ancestor
6766881|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766882|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
6766883|NCT02112305|Analgesics|analgesics|mesh-ancestor
6766884|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
6766885|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766886|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766887|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
6766888|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766889|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6766890|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
6766891|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6766892|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6766893|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766894|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6766895|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
6766896|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6766897|NCT02112422|Dexamethasone|dexamethasone|mesh-list
6766898|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
6766899|NCT02112422|BB 1101|bb 1101|mesh-list
6766900|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766901|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
6766902|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
6766903|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766904|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766905|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766906|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
6766907|NCT02112422|Hormones|hormones|mesh-ancestor
6766908|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766909|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6766910|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766911|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
6766912|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6766913|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766914|NCT02112487|Macitentan|macitentan|mesh-list
6766915|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6766916|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6766917|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766918|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6766919|NCT02112552|Paclitaxel|paclitaxel|mesh-list
6766920|NCT02112552|Carboplatin|carboplatin|mesh-list
6766921|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6766922|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766923|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
6766924|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
6766925|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
6766926|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766927|NCT02112578|Meclizine|meclizine|mesh-list
6766928|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
6766929|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
6766930|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
6766931|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766932|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766933|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766934|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6766935|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
6766936|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
6766937|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6766938|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766939|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6766940|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6766941|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6766942|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766943|NCT02112630|Interferons|interferons|mesh-list
6766944|NCT02112630|Ribavirin|ribavirin|mesh-list
6766945|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
6766946|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
6766947|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6766948|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
6766949|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
6766950|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766951|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
6766952|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766953|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
6766954|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766955|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
6766956|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766957|NCT02112643|Selenium|selenium|mesh-list
6766958|NCT02112643|Selenic Acid|selenic acid|mesh-list
6766959|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
6766960|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6766961|NCT02112643|Protective Agents|protective agents|mesh-ancestor
6766962|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766963|NCT02112643|Trace Elements|trace elements|mesh-ancestor
6766964|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
6766965|NCT02112695|Diprenorphine|diprenorphine|mesh-list
6766966|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6766967|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766968|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
6766969|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766970|NCT02112721|Vitamin D|vitamin d|mesh-list
6766971|NCT02112721|Vitamins|vitamins|mesh-ancestor
6766972|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
6766973|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766974|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6766975|NCT02112734|Vitamin D|vitamin d|mesh-list
6766976|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
6766977|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
6766978|NCT02112734|Vitamins|vitamins|mesh-list
6766979|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
6766980|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766981|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6766982|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6766983|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6766984|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
6766985|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6766986|NCT02112864|Dexamethasone|dexamethasone|mesh-list
6766987|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6766988|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
6766989|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
6766990|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6766991|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6766992|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6766993|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
6766994|NCT02112864|Hormones|hormones|mesh-ancestor
6766995|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6766996|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6766997|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6766998|NCT02112903|Vortioxetine|vortioxetine|mesh-list
6766999|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
6767000|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6767001|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6767002|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6767003|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767004|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767005|NCT02112903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6767006|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6767007|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6767008|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767009|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767010|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
6767011|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6767012|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6767013|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6767014|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6767015|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
6767016|NCT02112916|Leucovorin|leucovorin|mesh-list
6767017|NCT02112916|Folic Acid|folic acid|mesh-list
6767018|NCT02112916|Cytarabine|cytarabine|mesh-list
6767019|NCT02112916|Dexamethasone|dexamethasone|mesh-list
6767020|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
6767021|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
6767022|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6767023|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6767024|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6767025|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
6767026|NCT02112916|Ifosfamide|ifosfamide|mesh-list
6767027|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
6767028|NCT02112916|Doxorubicin|doxorubicin|mesh-list
6767029|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6767030|NCT02112916|Methotrexate|methotrexate|mesh-list
6767031|NCT02112916|Etoposide|etoposide|mesh-list
6767032|NCT02112916|Vincristine|vincristine|mesh-list
6767033|NCT02112916|Bortezomib|bortezomib|mesh-list
6767034|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
6767035|NCT02112916|Daunorubicin|daunorubicin|mesh-list
6767036|NCT02112916|Asparaginase|asparaginase|mesh-list
6767037|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
6767038|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
6767039|NCT02112916|Pegaspargase|pegaspargase|mesh-list
6767040|NCT02112916|Thioguanine|thioguanine|mesh-list
6767041|NCT02112916|BB 1101|bb 1101|mesh-list
6767042|NCT02112916|Calcium|calcium|mesh-list
6767043|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
6767044|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
6767045|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767046|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
6767047|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767048|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6767049|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6767050|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
6767051|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767052|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767053|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6767054|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767055|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
6767056|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
6767057|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767058|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6767059|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
6767060|NCT02112916|Hormones|hormones|mesh-ancestor
6767061|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767062|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6767063|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
6767064|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767065|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6767066|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6767067|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6767068|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6767069|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6767070|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6767071|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
6767072|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6767073|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6767074|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
6767075|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
6767076|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6767077|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6767078|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6767079|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
6767080|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767081|NCT02112916|Antidotes|antidotes|mesh-ancestor
6767082|NCT02112916|Protective Agents|protective agents|mesh-ancestor
6767083|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
6767084|NCT02112916|Vitamins|vitamins|mesh-ancestor
6767085|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
6767086|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
6767087|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
6767088|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
6767089|NCT02112916|Hematinics|hematinics|mesh-ancestor
6767090|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
6789572|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6789573|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789574|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789575|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6789576|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6789577|NCT02231333|Protective Agents|protective agents|mesh-ancestor
6789578|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789579|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
6789580|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6789581|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
6789582|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6789583|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6789584|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
6789585|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789586|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789587|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6789588|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
6789589|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6789590|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6789591|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
6789592|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789593|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789594|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6789595|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
6789596|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6789597|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6789598|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
6789599|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767091|NCT02112929|Xenon|xenon|mesh-list
6767092|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6767093|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
6767094|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
6767095|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767096|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767097|NCT02112981|Sirolimus|sirolimus|mesh-list
6767098|NCT02112981|Everolimus|everolimus|mesh-list
6767099|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767100|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767101|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
6767102|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767103|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6767104|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767105|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6767106|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
6767107|NCT02113072|Beclomethasone|beclomethasone|mesh-list
6767108|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767109|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
6767110|NCT02113072|Hormones|hormones|mesh-ancestor
6767111|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767112|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767113|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6767114|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
6767115|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
6767116|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
6767117|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
6767118|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767119|NCT02113150|Ketamine|ketamine|mesh-list
6767120|NCT02113150|Remifentanil|remifentanil|mesh-list
6767121|NCT02113150|Analgesics|analgesics|mesh-ancestor
6767122|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
6767123|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767124|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767125|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6767126|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6767127|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
6767128|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
6767129|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767130|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6767131|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6767132|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767133|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767134|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6767135|NCT02113150|Narcotics|narcotics|mesh-ancestor
6767136|NCT02113163|Metformin|metformin|mesh-list
6767137|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6767138|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6767139|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767140|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6767141|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6767142|NCT02113176|Minocycline|minocycline|mesh-list
6767143|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6767144|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767145|NCT02113202|Bevacizumab|bevacizumab|mesh-list
6767146|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6767147|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767148|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6767149|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6767150|NCT02113202|Growth Substances|growth substances|mesh-ancestor
6767151|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767152|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
6767153|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
6767154|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767155|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
6767156|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6767157|NCT02113319|Dasatinib|dasatinib|mesh-list
6767158|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767159|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6767160|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767161|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767162|NCT02113332|Liraglutide|liraglutide|mesh-list
6767163|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6767164|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767165|NCT02113332|Incretins|incretins|mesh-ancestor
6767166|NCT02113332|Hormones|hormones|mesh-ancestor
6789600|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767167|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767168|NCT02113397|Tobramycin|tobramycin|mesh-list
6767169|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6767170|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767171|NCT02113540|Atorvastatin|atorvastatin|mesh-list
6767172|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6767173|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6767174|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
6767175|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767176|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6767177|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6767178|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767179|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6767180|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
6767181|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6767182|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
6767183|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6767184|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767185|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6767186|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6767187|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767188|NCT02113566|Acetaminophen|acetaminophen|mesh-list
6767189|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6767190|NCT02113566|Analgesics|analgesics|mesh-ancestor
6767191|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
6767192|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767193|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767194|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
6767195|NCT02113631|Interferons|interferons|mesh-list
6767196|NCT02113631|Ribavirin|ribavirin|mesh-list
6767197|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
6767198|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
6767199|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6767200|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767201|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
6767202|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767203|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
6767204|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767205|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
6767206|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767207|NCT02113657|Ipilimumab|ipilimumab|mesh-list
6767208|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6767209|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767210|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6767211|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767212|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6767213|NCT02113735|Hormones|hormones|mesh-ancestor
6767214|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767215|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767216|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
6767217|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6767218|NCT02113800|Everolimus|everolimus|mesh-list
6767219|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767220|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767221|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
6767222|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767223|NCT02113813|Naquotinib|naquotinib|mesh-list
6767224|NCT02113813|Midazolam|midazolam|mesh-list
6767225|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6767226|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6767227|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767228|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767229|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6767230|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6767231|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6767232|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6767233|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
6767234|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
6767235|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
6767236|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
6767237|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767238|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767239|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767240|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6767241|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767242|NCT02113891|Eculizumab|eculizumab|mesh-list
6767243|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6767244|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767245|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
6767246|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767247|NCT02113904|Adalimumab|adalimumab|mesh-list
6767248|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767249|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6767250|NCT02113943|Citalopram|citalopram|mesh-list
6767251|NCT02113943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6767252|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6767253|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6767254|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767255|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767256|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
6767257|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767258|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6767259|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
6767260|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6767261|NCT02114021|Betamethasone|betamethasone|mesh-list
6767262|NCT02114021|Lidocaine|lidocaine|mesh-list
6767263|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
6767264|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
6767265|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767266|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767267|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
6767268|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767269|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6767270|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6767271|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6767272|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6767273|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767274|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767275|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
6767276|NCT02114021|Hormones|hormones|mesh-ancestor
6767277|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767278|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6767279|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
6767280|NCT02114073|Cyclosporine|cyclosporine|mesh-list
6767281|NCT02114073|Betamethasone|betamethasone|mesh-list
6767282|NCT02114073|Cyclosporins|cyclosporins|mesh-list
6767283|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767284|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767285|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767286|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
6767287|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767288|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
6767289|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767290|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
6767291|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6767292|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6767293|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767294|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
6767295|NCT02114073|Hormones|hormones|mesh-ancestor
6767296|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767297|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6767298|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
6767299|NCT02114099|Atorvastatin|atorvastatin|mesh-list
6767300|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6767301|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6767302|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
6767303|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767304|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6767305|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6767306|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767307|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
6767308|NCT02114229|Carboplatin|carboplatin|mesh-list
6767309|NCT02114229|Methotrexate|methotrexate|mesh-list
6767310|NCT02114229|Etoposide|etoposide|mesh-list
6767311|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
6767312|NCT02114229|Vincristine|vincristine|mesh-list
6767313|NCT02114229|Topotecan|topotecan|mesh-list
6767314|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767315|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
6767316|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767317|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6767318|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6767319|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
6767320|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767321|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767322|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6767323|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6767324|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
6767325|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6767326|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6767327|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
6767328|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
6767329|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767330|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6767331|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6767332|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6767333|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6767334|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6767335|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
6767336|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
6767337|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
6767338|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6767339|NCT02114333|Vaccines|vaccines|mesh-list
6767340|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
6767341|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767342|NCT02114346|Atorvastatin|atorvastatin|mesh-list
6767343|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6767344|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6767345|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
6767346|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767347|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6767348|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6767349|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767350|NCT02114359|Cisplatin|cisplatin|mesh-list
6767351|NCT02114359|Fluorouracil|fluorouracil|mesh-list
6767352|NCT02114359|Capecitabine|capecitabine|mesh-list
6767353|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
6767354|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767355|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
6767356|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767357|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6767358|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767359|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
6767360|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767361|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
6767362|NCT02114463|Analgesics|analgesics|mesh-list
6767363|NCT02114463|Ropivacaine|ropivacaine|mesh-list
6767364|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
6767365|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
6767366|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767367|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767368|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
6767369|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767370|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6767371|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6767372|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767373|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6767374|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6767375|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767376|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767377|NCT02114476|Progestins|progestins|mesh-list
6767378|NCT02114476|Hormones|hormones|mesh-ancestor
6767379|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767380|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767381|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
6767382|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6767383|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767384|NCT02114502|Pyridoxine|pyridoxine|mesh-list
6767385|NCT02114502|Gemcitabine|gemcitabine|mesh-list
6767386|NCT02114502|Dexamethasone|dexamethasone|mesh-list
6767387|NCT02114502|Melphalan|melphalan|mesh-list
6767388|NCT02114502|Busulfan|busulfan|mesh-list
6767389|NCT02114502|Vorinostat|vorinostat|mesh-list
6767390|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767391|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
6767392|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
6767393|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767394|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767395|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6767396|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
6767397|NCT02114502|Hormones|hormones|mesh-ancestor
6767398|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767399|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6767400|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767401|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6767402|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
6767403|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767404|NCT02114502|Antiviral Agents|antiviral agents|mesh-ancestor
6767405|NCT02114502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767406|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767407|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767408|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
6767409|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6767410|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
6767411|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6767412|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6767413|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
6767414|NCT02114502|Vitamins|vitamins|mesh-ancestor
6767415|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
6767416|NCT02114528|Amiodarone|amiodarone|mesh-list
6767417|NCT02114528|Sotalol|sotalol|mesh-list
6767418|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
6767419|NCT02114528|Mexiletine|mexiletine|mesh-list
6767420|NCT02114528|Procainamide|procainamide|mesh-list
6767421|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
6767422|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6767423|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6767424|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767425|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6767426|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6767427|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6767428|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767429|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6767430|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6767431|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6767432|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6767433|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6767434|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
6767435|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767436|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767437|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
6767438|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
6767439|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767440|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6789601|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6789602|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
6789603|NCT02231385|Acetic Acid|acetic acid|mesh-list
6789604|NCT02231385|Retinol acetate|retinol acetate|mesh-list
6789605|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6789606|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789607|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6789608|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
6789609|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789610|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6789611|NCT02231385|Protective Agents|protective agents|mesh-ancestor
6789612|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789613|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6789614|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6789615|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
6789616|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789617|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789618|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6789619|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
6789620|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6789621|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6789622|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
6789623|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789624|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789625|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6789626|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
6789627|NCT02231606|Methamphetamine|methamphetamine|mesh-list
6789628|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6789629|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789630|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
6789631|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
6789632|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789633|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
6789634|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789635|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789636|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
6789637|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6789638|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6789639|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789640|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6789641|NCT02231632|Vaccines|vaccines|mesh-list
6789642|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
6789643|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789644|NCT02231658|Liraglutide|liraglutide|mesh-list
6789645|NCT02231658|Lixisenatide|lixisenatide|mesh-list
6789646|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6789647|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789648|NCT02231658|Incretins|incretins|mesh-ancestor
6789649|NCT02231658|Hormones|hormones|mesh-ancestor
6789650|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6789651|NCT02231723|Leucovorin|leucovorin|mesh-list
6789652|NCT02231723|Gemcitabine|gemcitabine|mesh-list
6789653|NCT02231723|Paclitaxel|paclitaxel|mesh-list
6789654|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6789655|NCT02231723|Fluorouracil|fluorouracil|mesh-list
6789656|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
6789657|NCT02231723|Irinotecan|irinotecan|mesh-list
6789658|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6789659|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789660|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
6767441|NCT02114645|Leuprolide|leuprolide|mesh-list
6767442|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6767443|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6767444|NCT02114645|Estradiol|estradiol|mesh-list
6767445|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6767446|NCT02114645|Progesterone|progesterone|mesh-list
6767447|NCT02114645|Estrogens|estrogens|mesh-ancestor
6767448|NCT02114645|Hormones|hormones|mesh-ancestor
6767449|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767450|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767451|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6767452|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
6767453|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6767454|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6767455|NCT02114645|Progestins|progestins|mesh-ancestor
6767456|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6767457|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
6767458|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6767459|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767460|NCT02114658|Sorafenib|sorafenib|mesh-list
6767461|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767462|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6767463|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767464|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767465|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
6767466|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6767467|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767468|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6767469|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6767470|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767471|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767472|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767473|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6767474|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6767475|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6767476|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6767477|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6767478|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
6767479|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767480|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6767481|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6767482|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767483|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
6767484|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767485|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
6767486|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6767487|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6767488|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6767489|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767490|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
6767491|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767492|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767493|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6767494|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767495|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
6767496|NCT02114775|Hormones|hormones|mesh-list
6767497|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767498|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767499|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
6767500|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6767501|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6767502|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767503|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767504|NCT02114775|Urological Agents|urological agents|mesh-ancestor
6767505|NCT02115035|Vemurafenib|vemurafenib|mesh-list
6767506|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767507|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6767508|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767509|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767510|NCT02115087|Morphine|morphine|mesh-list
6767511|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6767512|NCT02115087|Narcotics|narcotics|mesh-ancestor
6767513|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767514|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767515|NCT02115087|Analgesics|analgesics|mesh-ancestor
6767516|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
6767517|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767518|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
6767519|NCT02115152|Fluorouracil|fluorouracil|mesh-list
6767520|NCT02115152|Capecitabine|capecitabine|mesh-list
6767521|NCT02115152|Epirubicin|epirubicin|mesh-list
6767522|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767523|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
6767524|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767525|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6767526|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6767527|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
6767528|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767529|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767530|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6767531|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
6767532|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6767533|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6767534|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6767535|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6767536|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767537|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
6767538|NCT02115204|Docetaxel|docetaxel|mesh-list
6767539|NCT02115204|Fluorouracil|fluorouracil|mesh-list
6767540|NCT02115204|Methotrexate|methotrexate|mesh-list
6767541|NCT02115204|Epirubicin|epirubicin|mesh-list
6767542|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767543|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
6767544|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767545|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6767546|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6767547|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
6767548|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767549|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767550|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6767551|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
6767552|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
6767553|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
6767554|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
6767555|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6767556|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6767557|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
6767558|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6767559|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
6767560|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767561|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6767562|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6767563|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6767564|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6767565|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6767566|NCT02115243|Ipilimumab|ipilimumab|mesh-list
6767567|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6767568|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767569|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6767570|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767571|NCT02115295|Cytarabine|cytarabine|mesh-list
6767572|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
6767573|NCT02115295|Venetoclax|venetoclax|mesh-list
6767574|NCT02115295|Idarubicin|idarubicin|mesh-list
6767575|NCT02115295|Cladribine|cladribine|mesh-list
6767576|NCT02115295|Midostaurin|midostaurin|mesh-list
6767577|NCT02115295|Staurosporine|staurosporine|mesh-list
6767578|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6767579|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
6767580|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767581|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767582|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
6767583|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767584|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767585|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
6767586|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767587|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6767588|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6767589|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6767590|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767591|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6767592|NCT02115360|Calcitonin|calcitonin|mesh-list
6767593|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
6767594|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
6767595|NCT02115360|Fentanyl|fentanyl|mesh-list
6767596|NCT02115360|Katacalcin|katacalcin|mesh-list
6767597|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6767598|NCT02115360|Narcotics|narcotics|mesh-ancestor
6767599|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767600|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767601|NCT02115360|Analgesics|analgesics|mesh-ancestor
6767602|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
6767603|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767604|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6767605|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6767606|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
6767607|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
6767608|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6767609|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6767610|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
6767611|NCT02115464|Metformin|metformin|mesh-list
6767612|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6767613|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767614|NCT02115490|Diphosphonates|diphosphonates|mesh-list
6767615|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6767616|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767617|NCT02115529|Nabilone|nabilone|mesh-list
6767618|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
6767619|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
6767620|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767621|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767622|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6767623|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6767624|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6767625|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767626|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6767627|NCT02115594|Fulvestrant|fulvestrant|mesh-list
6767628|NCT02115594|Entinostat|entinostat|mesh-list
6767629|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6767630|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767631|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6767632|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6767633|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
6767634|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767635|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767636|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6767637|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767638|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767639|NCT02115659|Triptolide|triptolide|mesh-list
6767640|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
6767641|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767642|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6767643|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
6767644|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6767645|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767646|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
6767647|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6767648|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
6767649|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767650|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767651|NCT02115724|Vitamins|vitamins|mesh-list
6767652|NCT02115724|Vitamin E|vitamin e|mesh-list
6767653|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
6767654|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
6767655|NCT02115724|Antioxidants|antioxidants|mesh-list
6767656|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
6767657|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767658|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767659|NCT02115724|Protective Agents|protective agents|mesh-ancestor
6767660|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
6767661|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
6767662|NCT02115763|Caffeine|caffeine|mesh-list
6767663|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6767664|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767665|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6767666|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767667|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767668|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6767669|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6767670|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
6767671|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767672|NCT02115776|Amoxicillin|amoxicillin|mesh-list
6767673|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
6767674|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
6767675|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
6767676|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6767677|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767678|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6767679|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
6767680|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6767681|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767682|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767683|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
6767684|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
6767685|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6767686|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767687|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6767688|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6767689|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
6767690|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6767691|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
6767692|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6767693|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
6767694|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6767695|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
6767696|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767697|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767698|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
6767699|NCT02116231|Cisplatin|cisplatin|mesh-list
6767700|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789661|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
6789662|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
6789663|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789664|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6789665|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
6789666|NCT02231723|Antiviral Agents|antiviral agents|mesh-ancestor
6789667|NCT02231723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789668|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789669|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6789670|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
6789671|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789672|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6789673|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6789674|NCT02231723|Antidotes|antidotes|mesh-ancestor
6789675|NCT02231723|Protective Agents|protective agents|mesh-ancestor
6789676|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
6789677|NCT02231723|Vitamins|vitamins|mesh-ancestor
6789678|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
6789679|NCT02231762|Temozolomide|temozolomide|mesh-list
6789680|NCT02231762|Lanreotide|lanreotide|mesh-list
6789681|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6789682|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
6789683|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789684|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789685|NCT02231775|Trametinib|trametinib|mesh-list
6789686|NCT02231775|Dabrafenib|dabrafenib|mesh-list
6789687|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789688|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6789689|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789690|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789691|NCT02231788|Amlodipine|amlodipine|mesh-list
6789692|NCT02231788|Telmisartan|telmisartan|mesh-list
6789693|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6789694|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6789695|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789696|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789697|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6789698|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789699|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
6789700|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6789701|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6767701|NCT02116257|Propacetamol|propacetamol|mesh-list
6767702|NCT02116257|Analgesics|analgesics|mesh-ancestor
6767703|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
6767704|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767705|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767706|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6767707|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6767708|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767709|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6767710|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
6767711|NCT02116348|Mitogens|mitogens|mesh-list
6767712|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
6767713|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767714|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6767715|NCT02116348|Protective Agents|protective agents|mesh-ancestor
6767716|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767717|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
6767718|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
6767719|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
6767720|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6767721|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767722|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767723|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
6767724|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6767725|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767726|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767727|NCT02116465|Levodopa|levodopa|mesh-list
6767728|NCT02116465|Carbidopa|carbidopa|mesh-list
6767729|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6767730|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6767731|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6767732|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
6767733|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767734|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767735|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767736|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6767737|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767738|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6767739|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
6767740|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
6767741|NCT02116556|Rifaximin|rifaximin|mesh-list
6767742|NCT02116556|Prednisone|prednisone|mesh-list
6767743|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767744|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
6767745|NCT02116556|Hormones|hormones|mesh-ancestor
6767746|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6767747|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767748|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6767749|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767750|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6767751|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767752|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6767753|NCT02116569|Daratumumab|daratumumab|mesh-list
6767754|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767755|NCT02116712|Saracatinib|saracatinib|mesh-list
6767756|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767757|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767758|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767759|NCT02116790|Naproxen|naproxen|mesh-list
6767760|NCT02116790|Levodopa|levodopa|mesh-list
6767761|NCT02116790|Carbidopa|carbidopa|mesh-list
6767762|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6767763|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6767764|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6767765|NCT02116790|Analgesics|analgesics|mesh-ancestor
6767766|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
6767767|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767768|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767769|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6767770|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6767771|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
6767772|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6767773|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767774|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767775|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6767776|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6767777|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
6767778|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767779|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6767780|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6767781|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
6767782|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
6767783|NCT02116842|Fentanyl|fentanyl|mesh-list
6767784|NCT02116842|Bupivacaine|bupivacaine|mesh-list
6767785|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
6767786|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
6767787|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767788|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767789|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
6767790|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767791|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6767792|NCT02116842|Narcotics|narcotics|mesh-ancestor
6767793|NCT02116842|Analgesics|analgesics|mesh-ancestor
6767794|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6767795|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6767796|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
6767797|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
6767798|NCT02116868|Nicardipine|nicardipine|mesh-list
6767799|NCT02116868|Urapidil|urapidil|mesh-list
6767800|NCT02116868|Remifentanil|remifentanil|mesh-list
6767801|NCT02116868|Esmolol|esmolol|mesh-list
6767802|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6767803|NCT02116868|Narcotics|narcotics|mesh-ancestor
6767804|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767805|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767806|NCT02116868|Analgesics|analgesics|mesh-ancestor
6767807|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
6767808|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767809|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6767810|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6767811|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6767812|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
6767813|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767814|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767815|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6767816|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6767817|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6767818|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
6767819|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6767820|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
6767821|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6767822|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6767823|NCT02116959|Carboplatin|carboplatin|mesh-list
6767824|NCT02116959|Etoposide|etoposide|mesh-list
6767825|NCT02116959|Vincristine|vincristine|mesh-list
6767826|NCT02116959|Melphalan|melphalan|mesh-list
6767827|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767828|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6767829|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6767830|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6767831|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767832|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767833|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
6767834|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
6767835|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
6767836|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6767837|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
6767838|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6767839|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767840|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
6767841|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767842|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
6767843|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6767844|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6767845|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767846|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
6767847|NCT02117128|Coagulants|coagulants|mesh-ancestor
6767848|NCT02117141|Hydrocodone|hydrocodone|mesh-list
6767849|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6767850|NCT02117141|Narcotics|narcotics|mesh-ancestor
6767851|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767852|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767853|NCT02117141|Analgesics|analgesics|mesh-ancestor
6767854|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
6767855|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767856|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
6767857|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
6767858|NCT02117167|Pemetrexed|pemetrexed|mesh-list
6767859|NCT02117167|Durvalumab|durvalumab|mesh-list
6767860|NCT02117167|Olaparib|olaparib|mesh-list
6767861|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767862|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767863|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767864|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6767865|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6767866|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6767867|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6767868|NCT02117219|Azacitidine|azacitidine|mesh-list
6767869|NCT02117219|Durvalumab|durvalumab|mesh-list
6767870|NCT02117219|Tremelimumab|tremelimumab|mesh-list
6767871|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6767872|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
6767873|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767874|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767875|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767876|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6767877|NCT02117362|Ipilimumab|ipilimumab|mesh-list
6767878|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6767879|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767880|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6767881|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767882|NCT02117401|Midazolam|midazolam|mesh-list
6767883|NCT02117401|Ketamine|ketamine|mesh-list
6767884|NCT02117401|Remifentanil|remifentanil|mesh-list
6767885|NCT02117401|Propofol|propofol|mesh-list
6767886|NCT02117401|Mivacurium|mivacurium|mesh-list
6767887|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6767888|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767889|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767890|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6767891|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
6767892|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
6767893|NCT02117401|Analgesics|analgesics|mesh-ancestor
6767894|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
6767895|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767896|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6767897|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6767898|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6767899|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767900|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767901|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6767902|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6767903|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6767904|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6767905|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
6767906|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
6767907|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6767908|NCT02117401|Narcotics|narcotics|mesh-ancestor
6767909|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6767910|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6767911|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6767912|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6767913|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6767914|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6767915|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
6767916|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767917|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6767918|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6767919|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767920|NCT02117466|Cetuximab|cetuximab|mesh-list
6767921|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6767922|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767923|NCT02117583|Oxycodone|oxycodone|mesh-list
6767924|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6767925|NCT02117583|Narcotics|narcotics|mesh-ancestor
6767926|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767927|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767928|NCT02117583|Analgesics|analgesics|mesh-ancestor
6767929|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
6767930|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767931|NCT02117596|Sirolimus|sirolimus|mesh-list
6767932|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6767933|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767934|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6767935|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6767936|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
6767937|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6767938|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
6767939|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767940|NCT02117622|Insulin|insulin|mesh-list
6767941|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6767942|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767943|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
6767944|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6767945|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
6767946|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767947|NCT02117700|Expectorants|expectorants|mesh-ancestor
6767948|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
6767949|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6767950|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
6767951|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767952|NCT02117700|Protective Agents|protective agents|mesh-ancestor
6767953|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767954|NCT02117700|Antidotes|antidotes|mesh-ancestor
6767955|NCT02117726|Midazolam|midazolam|mesh-list
6767956|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
6767957|NCT02117726|Propofol|propofol|mesh-list
6767958|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6767959|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6767960|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6767961|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6767962|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
6767963|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
6767964|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6767965|NCT02117726|Analgesics|analgesics|mesh-ancestor
6767966|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
6767967|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6767968|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6767969|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6767970|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6767971|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
6767972|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6767973|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767974|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6767975|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6767976|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6767977|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6767978|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
6767979|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
6767980|NCT02117739|Dapsone|dapsone|mesh-list
6767981|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767982|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
6767983|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6767984|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6767985|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6767986|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767987|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767988|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
6767989|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6767990|NCT02117752|Dapsone|dapsone|mesh-list
6767991|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6767992|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
6767993|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6767994|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6767995|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6767996|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6767997|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6767998|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
6767999|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6768000|NCT02117765|Ustekinumab|ustekinumab|mesh-list
6768001|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
6768002|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
6768003|NCT02117830|Enclomiphene|enclomiphene|mesh-list
6768004|NCT02117830|Clomiphene|clomiphene|mesh-list
6768005|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
6768006|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6768007|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768008|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6768009|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6768010|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768011|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768012|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768013|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6768014|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768015|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6768016|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
6768017|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6768018|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6768019|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
6768020|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6768021|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6768022|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
6768023|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768024|NCT02117869|Furocoumarins|furocoumarins|mesh-list
6768025|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
6768026|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6789702|NCT02231879|Plerixafor|plerixafor|mesh-list
6789703|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6789704|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6789705|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
6789706|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789707|NCT02231905|Pramipexole|pramipexole|mesh-list
6789708|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
6789709|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789710|NCT02231905|Protective Agents|protective agents|mesh-ancestor
6789711|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789712|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6789713|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6789714|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
6789715|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
6789716|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789717|NCT02231931|Metformin|metformin|mesh-list
6789718|NCT02231931|Digoxin|digoxin|mesh-list
6789719|NCT02231931|Furosemide|furosemide|mesh-list
6789720|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6789721|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6789722|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789723|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6789724|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6789725|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
6789726|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768027|NCT02117986|Colistin|colistin|mesh-list
6768028|NCT02117986|Polymyxins|polymyxins|mesh-list
6768029|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6768030|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768031|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6768032|NCT02118051|Progesterone|progesterone|mesh-list
6768033|NCT02118051|Ganirelix|ganirelix|mesh-list
6768034|NCT02118051|Progestins|progestins|mesh-ancestor
6768035|NCT02118051|Hormones|hormones|mesh-ancestor
6768036|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6768037|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768038|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
6768039|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6768040|NCT02118064|Irinotecan|irinotecan|mesh-list
6768041|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6768042|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6768043|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768044|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768045|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768046|NCT02118090|Chloroquine|chloroquine|mesh-list
6768047|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
6768048|NCT02118090|Amebicides|amebicides|mesh-ancestor
6768049|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6768050|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6768051|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768052|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
6768053|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6768054|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6768055|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6768056|NCT02118090|Analgesics|analgesics|mesh-ancestor
6768057|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
6768058|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768059|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768060|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6768061|NCT02118090|Filaricides|filaricides|mesh-ancestor
6768062|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
6768063|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
6768064|NCT02118142|Betaine|betaine|mesh-list
6768065|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6768066|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
6768067|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6768068|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
6768069|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768070|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6768071|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
6768072|NCT02118285|Fludarabine|fludarabine|mesh-list
6768073|NCT02118285|Interleukin-2|interleukin-2|mesh-list
6768074|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6768075|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
6768076|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768077|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6768078|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6768079|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
6768080|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768081|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768082|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6768083|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6768084|NCT02118285|Analgesics|analgesics|mesh-ancestor
6768085|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
6768086|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768087|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
6768088|NCT02118311|Fludarabine|fludarabine|mesh-list
6768089|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6768090|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
6768091|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768092|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6768093|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6768094|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
6768095|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768096|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768097|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6768098|NCT02118376|Exenatide|exenatide|mesh-list
6768099|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6768100|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768101|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6768102|NCT02118376|Incretins|incretins|mesh-ancestor
6768103|NCT02118376|Hormones|hormones|mesh-ancestor
6768104|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6768105|NCT02118467|Phenylephrine|phenylephrine|mesh-list
6768106|NCT02118467|Vasopressins|vasopressins|mesh-list
6768107|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
6768108|NCT02118467|Epinephrine|epinephrine|mesh-list
6768109|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
6768110|NCT02118467|Norepinephrine|norepinephrine|mesh-list
6768111|NCT02118467|Synephrine|synephrine|mesh-list
6768112|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6768113|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6768114|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
6768115|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768116|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768117|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768118|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6768119|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6768120|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
6768121|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768122|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6768123|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
6768124|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
6768125|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
6768126|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6768127|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6768128|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
6768129|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6768130|NCT02118467|Protective Agents|protective agents|mesh-ancestor
6768131|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
6768132|NCT02118467|Coagulants|coagulants|mesh-ancestor
6768133|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6768134|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
6768135|NCT02118532|Paclitaxel|paclitaxel|mesh-list
6768136|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6768137|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768138|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
6768139|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
6768140|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
6768141|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768142|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
6768143|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768144|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6768145|NCT02118675|Protective Agents|protective agents|mesh-ancestor
6768146|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768147|NCT02118688|Risperidone|risperidone|mesh-list
6768148|NCT02118688|Trazodone|trazodone|mesh-list
6768149|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6768150|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
6768151|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768152|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768153|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768154|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6768155|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6768156|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768157|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6768158|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6768159|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
6768160|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6768161|NCT02118688|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6768162|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6768163|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6768164|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6768165|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
6768166|NCT02118727|Memantine|memantine|mesh-list
6768167|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6768168|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6768169|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
6768170|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768171|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768172|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768173|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6768174|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6768175|NCT02118753|Eplerenone|eplerenone|mesh-list
6768176|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6768177|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
6768178|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6768179|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768180|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6768181|NCT02118753|Diuretics|diuretics|mesh-ancestor
6768182|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
6768183|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6768184|NCT02118844|Rocuronium|rocuronium|mesh-list
6768185|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6768186|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6768187|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6768188|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768189|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768190|NCT02118870|Aspirin|aspirin|mesh-list
6768191|NCT02118870|Clopidogrel|clopidogrel|mesh-list
6768192|NCT02118870|Ticagrelor|ticagrelor|mesh-list
6768193|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6768194|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6768195|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6768196|NCT02118870|Analgesics|analgesics|mesh-ancestor
6768197|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
6768198|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768199|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768200|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6768201|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6768202|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6768203|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6768204|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768205|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6768206|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6768207|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768208|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
6768209|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6768210|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6768211|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6768212|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
6768213|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768214|NCT02118909|Itraconazole|itraconazole|mesh-list
6768215|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
6768216|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
6768217|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768218|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6768219|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6768220|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768221|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768222|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6768223|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
6768224|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6768225|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768226|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6768227|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6768228|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6768229|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6768230|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768231|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6768232|NCT02118987|Omalizumab|omalizumab|mesh-list
6768233|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6768234|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6768235|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
6768236|NCT02119000|Bisacodyl|bisacodyl|mesh-list
6768237|NCT02119000|Cathartics|cathartics|mesh-ancestor
6768238|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6768239|NCT02119000|Laxatives|laxatives|mesh-ancestor
6768240|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6768241|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6768242|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
6768243|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6768244|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768245|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6768246|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6768247|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768248|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768249|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768250|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
6768251|NCT02119117|Vitamins|vitamins|mesh-ancestor
6768252|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
6768253|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768254|NCT02119143|Vitamins|vitamins|mesh-list
6768255|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
6768256|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768257|NCT02119234|Beclomethasone|beclomethasone|mesh-list
6768258|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
6768259|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
6768260|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6768261|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
6768262|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768263|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768264|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6768265|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
6768266|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6768267|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6768268|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6768269|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
6768270|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768271|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768272|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6768273|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6768274|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6768275|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
6768276|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6768277|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
6768278|NCT02119234|Hormones|hormones|mesh-ancestor
6768279|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6768280|NCT02119273|Prednisone|prednisone|mesh-list
6768281|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6768282|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
6768283|NCT02119273|Hormones|hormones|mesh-ancestor
6768284|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6768285|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768286|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6768287|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768288|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6768289|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6768290|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
6768291|NCT02119416|Caffeine|caffeine|mesh-list
6768292|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6768293|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768294|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6768295|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768296|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768297|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6768298|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6768299|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
6768300|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768301|NCT02119520|Atorvastatin|atorvastatin|mesh-list
6768302|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6768303|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6768304|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
6768305|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768306|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6768307|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6768308|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789727|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6789728|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6789729|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789730|NCT02231931|Diuretics|diuretics|mesh-ancestor
6789731|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
6789732|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6789733|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789734|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6789735|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6789736|NCT02231931|Protective Agents|protective agents|mesh-ancestor
6789737|NCT02231957|Vaccines|vaccines|mesh-list
6789738|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
6789739|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789740|NCT02232035|Diazepam|diazepam|mesh-list
6789741|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6789742|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
6789743|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
6789744|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
6789745|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789746|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789747|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789748|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6789749|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6789750|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6789751|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6789752|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6789753|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6789754|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6789755|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6789756|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
6789757|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
6789758|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
6789759|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
6789760|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789761|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789762|NCT02232139|Midazolam|midazolam|mesh-list
6789763|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6789764|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6789765|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6789766|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789767|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6789768|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6789769|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6789770|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6789771|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
6789772|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
6789773|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
6789774|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
6789775|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789776|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789777|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
6789778|NCT02232152|Fluorouracil|fluorouracil|mesh-list
6789779|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
6789780|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789781|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6789782|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789783|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6789784|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
6789785|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789786|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
6789787|NCT02232152|Protective Agents|protective agents|mesh-ancestor
6789788|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
6789789|NCT02232152|Vitamins|vitamins|mesh-ancestor
6789790|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
6789791|NCT02232269|Felodipine|felodipine|mesh-list
6789792|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6789793|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6789794|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6789795|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789796|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768309|NCT02119806|Fentanyl|fentanyl|mesh-list
6768310|NCT02119806|Midazolam|midazolam|mesh-list
6768311|NCT02119806|Propofol|propofol|mesh-list
6768312|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6768313|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768314|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768315|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6768316|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
6768317|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
6768318|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6768319|NCT02119806|Narcotics|narcotics|mesh-ancestor
6768320|NCT02119806|Analgesics|analgesics|mesh-ancestor
6768321|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
6768322|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768323|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6768324|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6768325|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6768326|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6768327|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
6768328|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
6768329|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768330|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768331|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6768332|NCT02119884|Octreotide|octreotide|mesh-list
6768333|NCT02119884|Terlipressin|terlipressin|mesh-list
6768334|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6768335|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6768336|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768337|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6768338|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6768339|NCT02120066|Plasminogen|plasminogen|mesh-list
6768340|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6768341|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6768342|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6768343|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768344|NCT02120092|Clopidogrel|clopidogrel|mesh-list
6768345|NCT02120092|Ticagrelor|ticagrelor|mesh-list
6768346|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6768347|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6768348|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6768349|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6768350|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
6768351|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768352|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768353|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768354|NCT02120118|Docetaxel|docetaxel|mesh-list
6768355|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768356|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
6768357|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
6768358|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
6768359|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768360|NCT02120196|Rifaximin|rifaximin|mesh-list
6768361|NCT02120196|Norfloxacin|norfloxacin|mesh-list
6768362|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6768363|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768364|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6768365|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6768366|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6768367|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768368|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768369|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768370|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6768371|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6768372|NCT02120274|Vitamin D|vitamin d|mesh-list
6768373|NCT02120274|Vitamins|vitamins|mesh-list
6768374|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
6768375|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
6768376|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
6768377|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768378|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6768379|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
6768380|NCT02120274|Hematinics|hematinics|mesh-ancestor
6768381|NCT02120339|Carvedilol|carvedilol|mesh-list
6768382|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6768383|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6768384|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
6768385|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768386|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768387|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768388|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6768389|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
6768390|NCT02120339|Protective Agents|protective agents|mesh-ancestor
6768391|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6768392|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6768393|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6768394|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
6768395|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6768396|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6768397|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
6768398|NCT02120404|Esmolol|esmolol|mesh-list
6768399|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6768400|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6768401|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6768402|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
6768403|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768404|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768405|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768406|NCT02120469|Everolimus|everolimus|mesh-list
6768407|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768408|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6768409|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
6768410|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768411|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
6768412|NCT02120547|Liver Extracts|liver extracts|mesh-list
6768413|NCT02120547|Hematinics|hematinics|mesh-ancestor
6768414|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6768415|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768416|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6768417|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6768418|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
6768419|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768420|NCT02120599|Folic Acid|folic acid|mesh-list
6768421|NCT02120599|Hematinics|hematinics|mesh-ancestor
6768422|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
6768423|NCT02120599|Vitamins|vitamins|mesh-ancestor
6768424|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
6768425|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768426|NCT02120612|Naloxone|naloxone|mesh-list
6768427|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6768428|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768429|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
6768430|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768431|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
6768432|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
6768433|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6768434|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768435|NCT02120651|Hemostatics|hemostatics|mesh-list
6768436|NCT02120651|Coagulants|coagulants|mesh-ancestor
6768437|NCT02120677|Itraconazole|itraconazole|mesh-list
6768438|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
6768439|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768440|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6768441|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6768442|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768443|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768444|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6768445|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
6768446|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6768447|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768448|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6768449|NCT02120703|Pregabalin|pregabalin|mesh-list
6768450|NCT02120703|Gabapentin|gabapentin|mesh-list
6768451|NCT02120703|Analgesics|analgesics|mesh-ancestor
6768452|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
6768453|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768454|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768455|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
6768456|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6768457|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6768458|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768459|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6768460|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6768461|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6768462|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768463|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6768464|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6768465|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6768466|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768467|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
6768468|NCT02120807|Pemetrexed|pemetrexed|mesh-list
6768469|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
6768470|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768471|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768472|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768473|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6768474|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6768475|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6768476|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
6768477|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768478|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6768479|NCT02120859|Paclitaxel|paclitaxel|mesh-list
6768480|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6768481|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768482|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
6768483|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
6768484|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
6768485|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768486|NCT02120872|Simvastatin|simvastatin|mesh-list
6768487|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6768488|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6768489|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
6768490|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768491|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6768492|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6768493|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768494|NCT02120911|Trastuzumab|trastuzumab|mesh-list
6768495|NCT02120911|Pertuzumab|pertuzumab|mesh-list
6768496|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6768497|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768498|NCT02121119|Lidocaine|lidocaine|mesh-list
6768499|NCT02121119|Bupivacaine|bupivacaine|mesh-list
6768500|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
6768501|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
6768502|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768503|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768504|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
6768505|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768506|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6768507|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6768508|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6768509|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6768510|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768511|NCT02121197|Dexamethasone|dexamethasone|mesh-list
6768512|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6768513|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
6768514|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
6768515|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768516|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768517|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6768518|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
6768519|NCT02121197|Hormones|hormones|mesh-ancestor
6768520|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6768521|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6768522|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768523|NCT02121288|Clopidogrel|clopidogrel|mesh-list
6768524|NCT02121288|Ticagrelor|ticagrelor|mesh-list
6768525|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6768526|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6768527|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6768528|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6768529|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
6768530|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768531|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768532|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768533|NCT02121353|Ranibizumab|ranibizumab|mesh-list
6768534|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6768535|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6768536|NCT02121353|Growth Substances|growth substances|mesh-ancestor
6768537|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768538|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
6768539|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768540|NCT02121366|Ethanol|ethanol|mesh-list
6768541|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6768542|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768543|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768544|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789797|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6789798|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789799|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
6789800|NCT02232308|Lisinopril|lisinopril|mesh-list
6789801|NCT02232308|Nizatidine|nizatidine|mesh-list
6789802|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6789803|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
6789804|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789805|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789806|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6789807|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6789808|NCT02232308|Protective Agents|protective agents|mesh-ancestor
6789809|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789810|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6789811|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789812|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6789813|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
6789814|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
6789815|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789816|NCT02232347|Sufentanil|sufentanil|mesh-list
6789817|NCT02232347|Ketamine|ketamine|mesh-list
6789818|NCT02232347|Analgesics|analgesics|mesh-ancestor
6789819|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
6789820|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789821|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789822|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6789823|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6789824|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
6789825|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
6789826|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6789827|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6789828|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6789829|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789830|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789831|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6789832|NCT02232347|Narcotics|narcotics|mesh-ancestor
6789833|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6789834|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6789835|NCT02232360|Fenofibrate|fenofibrate|mesh-list
6789836|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6789837|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6789838|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
6789839|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789840|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6789841|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6789842|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789843|NCT02232386|Rituximab|rituximab|mesh-list
6789844|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6789845|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789846|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
6789847|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789848|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6789849|NCT02232399|Simendan|simendan|mesh-list
6789850|NCT02232399|Milrinone|milrinone|mesh-list
6789851|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6789852|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
6789853|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6768545|NCT02121405|Capecitabine|capecitabine|mesh-list
6768546|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
6768547|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6768548|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
6768549|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768550|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768551|NCT02121444|Interferons|interferons|mesh-list
6768552|NCT02121444|Interferon-beta|interferon-beta|mesh-list
6768553|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
6768554|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768555|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
6768556|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768557|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
6768558|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768559|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6768560|NCT02121457|Selenium|selenium|mesh-list
6768561|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
6768562|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768563|NCT02121457|Protective Agents|protective agents|mesh-ancestor
6768564|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768565|NCT02121457|Trace Elements|trace elements|mesh-ancestor
6768566|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
6768567|NCT02121613|Tamsulosin|tamsulosin|mesh-list
6768568|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
6768569|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6768570|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6768571|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6768572|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
6768573|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768574|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768575|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768576|NCT02121613|Urological Agents|urological agents|mesh-ancestor
6768577|NCT02121782|Vaccines|vaccines|mesh-list
6768578|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
6768579|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768580|NCT02121951|Lidocaine|lidocaine|mesh-list
6768581|NCT02121951|Fentanyl|fentanyl|mesh-list
6768582|NCT02121951|Midazolam|midazolam|mesh-list
6768583|NCT02121951|Anesthetics|anesthetics|mesh-list
6768584|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
6768585|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
6768586|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6768587|NCT02121951|Narcotics|narcotics|mesh-ancestor
6768588|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768589|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768590|NCT02121951|Analgesics|analgesics|mesh-ancestor
6768591|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
6768592|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768593|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6768594|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6768595|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
6768596|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6768597|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6768598|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6768599|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6768600|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
6768601|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
6768602|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768603|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768604|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6768605|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6768606|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6768607|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6768608|NCT02121990|Paclitaxel|paclitaxel|mesh-list
6768609|NCT02121990|Bevacizumab|bevacizumab|mesh-list
6768610|NCT02121990|Olaparib|olaparib|mesh-list
6768611|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6768612|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768613|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
6768614|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
6768615|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
6768616|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768617|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6768618|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6768619|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6768620|NCT02121990|Growth Substances|growth substances|mesh-ancestor
6768621|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768622|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
6768623|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6768624|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768625|NCT02122003|Sorafenib|sorafenib|mesh-list
6768626|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768627|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6768628|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768629|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768630|NCT02122055|Fentanyl|fentanyl|mesh-list
6768631|NCT02122055|Midazolam|midazolam|mesh-list
6768632|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
6768633|NCT02122055|Propofol|propofol|mesh-list
6768634|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6768635|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768636|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768637|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6768638|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
6768639|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
6768640|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6768641|NCT02122055|Analgesics|analgesics|mesh-ancestor
6768642|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
6768643|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768644|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6768645|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6768646|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6768647|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
6768648|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768649|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768650|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6768651|NCT02122055|Narcotics|narcotics|mesh-ancestor
6768652|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6768653|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6768654|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6768655|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6768656|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
6768657|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
6768658|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
6768659|NCT02122081|Methotrexate|methotrexate|mesh-list
6768660|NCT02122081|Tacrolimus|tacrolimus|mesh-list
6768661|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
6768662|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6768663|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
6768664|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6768665|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
6768666|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768667|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6768668|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6768669|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
6768670|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768671|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768672|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6768673|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6768674|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
6768675|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6768676|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6768677|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
6768678|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
6768679|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768680|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6768681|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6768682|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6768683|NCT02122172|Afatinib|afatinib|mesh-list
6768684|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768685|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6768686|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768687|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768688|NCT02122185|Metformin|metformin|mesh-list
6768689|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6768690|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768691|NCT02122211|Betaine|betaine|mesh-list
6768692|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6768693|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
6768694|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6768695|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
6768696|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768697|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6768698|NCT02122393|Sertraline|sertraline|mesh-list
6768699|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
6768700|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6768701|NCT02122393|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6768702|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6768703|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6768704|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768705|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768706|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
6768707|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768708|NCT02122484|Colchicine|colchicine|mesh-list
6768709|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
6768710|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6768711|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
6768712|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
6768713|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
6768714|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768715|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768716|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
6768717|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6768718|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768719|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768720|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6768721|NCT02122510|Analgesics|analgesics|mesh-ancestor
6768722|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
6768723|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768724|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6768725|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6768726|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6768727|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
6768728|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768729|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768730|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6768731|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6768732|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6768733|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6768734|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768735|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768736|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6768737|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6768738|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768739|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
6768740|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768741|NCT02122562|Ketamine|ketamine|mesh-list
6768742|NCT02122562|Analgesics|analgesics|mesh-ancestor
6768743|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
6768744|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768745|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768746|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6768747|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6768748|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
6768749|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
6768750|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768751|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6768752|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6768753|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768754|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768755|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
6768756|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6768757|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
6768758|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768759|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
6768760|NCT02122601|Protective Agents|protective agents|mesh-ancestor
6768761|NCT02122627|Vitamin D|vitamin d|mesh-list
6768762|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
6768763|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
6768764|NCT02122627|Vitamins|vitamins|mesh-list
6768765|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
6768766|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768767|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6768768|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6768769|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
6768770|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6768771|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6768772|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768773|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
6768774|NCT02122679|Coagulants|coagulants|mesh-ancestor
6768775|NCT02122692|Itraconazole|itraconazole|mesh-list
6768776|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6768777|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
6768778|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768779|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6768780|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6768781|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768782|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768783|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6768784|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
6768785|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6768786|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768787|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6768788|NCT02122705|Remifentanil|remifentanil|mesh-list
6768789|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6768790|NCT02122705|Narcotics|narcotics|mesh-ancestor
6768791|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768792|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768793|NCT02122705|Analgesics|analgesics|mesh-ancestor
6768794|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
6768795|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768796|NCT02122731|Amiloride|amiloride|mesh-list
6768797|NCT02122731|Diuretics|diuretics|mesh-ancestor
6768798|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
6768799|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768800|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6768801|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6768802|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6768803|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768804|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6768805|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6768806|NCT02122809|Chiauranib|chiauranib|mesh-list
6768807|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768808|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6768809|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768810|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768811|NCT02122939|Citalopram|citalopram|mesh-list
6768812|NCT02122939|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6768813|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6768814|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6768815|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768816|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768817|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
6768818|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768819|NCT02122939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6768820|NCT02122939|Antidepressive Agents|antidepressive agents|mesh-ancestor
6768821|NCT02122939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6768822|NCT02123004|Clopidogrel|clopidogrel|mesh-list
6768823|NCT02123004|Ticagrelor|ticagrelor|mesh-list
6768824|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6768825|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6768826|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6768827|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6768828|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
6768829|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768830|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768831|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789854|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6789855|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789856|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789857|NCT02232399|Protective Agents|protective agents|mesh-ancestor
6789858|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789859|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6789860|NCT02232516|Lenalidomide|lenalidomide|mesh-list
6789861|NCT02232516|Romidepsin|romidepsin|mesh-list
6789862|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
6789863|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789864|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6768832|NCT02123056|Metoprolol|metoprolol|mesh-list
6768833|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6768834|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6768835|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
6768836|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
6768837|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768838|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768839|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6768840|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6768841|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6768842|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
6768843|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768844|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768845|NCT02123069|Nitroprusside|nitroprusside|mesh-list
6768846|NCT02123069|Phenylephrine|phenylephrine|mesh-list
6768847|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
6768848|NCT02123069|Norepinephrine|norepinephrine|mesh-list
6768849|NCT02123069|Acetylcholine|acetylcholine|mesh-list
6768850|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6768851|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
6768852|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
6768853|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768854|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768855|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
6768856|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6768857|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
6768858|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
6768859|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6768860|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6768861|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6768862|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
6768863|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768864|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768865|NCT02123069|Protective Agents|protective agents|mesh-ancestor
6768866|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6768867|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
6768868|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6768869|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6768870|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
6768871|NCT02123108|Basiliximab|basiliximab|mesh-list
6768872|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6768873|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
6768874|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768875|NCT02123121|Resveratrol|resveratrol|mesh-list
6768876|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
6768877|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768878|NCT02123121|Protective Agents|protective agents|mesh-ancestor
6768879|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768880|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768881|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6768882|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
6768883|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6768884|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768885|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
6768886|NCT02123355|Remifentanil|remifentanil|mesh-list
6768887|NCT02123355|Sevoflurane|sevoflurane|mesh-list
6768888|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
6768889|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
6768890|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768891|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768892|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6768893|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6768894|NCT02123355|Analgesics|analgesics|mesh-ancestor
6768895|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
6768896|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768897|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6768898|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6768899|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6768900|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
6768901|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768902|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768903|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6768904|NCT02123355|Narcotics|narcotics|mesh-ancestor
6768905|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6768906|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6768907|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
6768908|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6768909|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6768910|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6768911|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6768912|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6768913|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
6768914|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
6768915|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6768916|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
6768917|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768918|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
6768919|NCT02123368|Protective Agents|protective agents|mesh-ancestor
6768920|NCT02123381|Cetuximab|cetuximab|mesh-list
6768921|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6768922|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6768923|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6768924|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
6768925|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768926|NCT02123498|Omeprazole|omeprazole|mesh-list
6768927|NCT02123498|Pantoprazole|pantoprazole|mesh-list
6768928|NCT02123498|Ranitidine|ranitidine|mesh-list
6768929|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6768930|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6768931|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6768932|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6768933|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768934|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768935|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6768936|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
6768937|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
6768938|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768939|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768940|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
6768941|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6768942|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
6768943|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6768944|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
6768945|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6768946|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768947|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
6768948|NCT02123563|Listerine|listerine|mesh-list
6768949|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6768950|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768951|NCT02123589|Fentanyl|fentanyl|mesh-list
6768952|NCT02123589|Midazolam|midazolam|mesh-list
6768953|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6768954|NCT02123589|Narcotics|narcotics|mesh-ancestor
6768955|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6768956|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768957|NCT02123589|Analgesics|analgesics|mesh-ancestor
6768958|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
6768959|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6768960|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6768961|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6768962|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
6768963|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
6768964|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6768965|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6768966|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6768967|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6768968|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
6768969|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
6768970|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6768971|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6768972|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
6768973|NCT02123615|Antibodies|antibodies|mesh-list
6768974|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
6768975|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6768976|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6768977|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
6768978|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
6768979|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6768980|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6768981|NCT02123628|Doxycycline|doxycycline|mesh-list
6768982|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
6768983|NCT02123628|Levofloxacin|levofloxacin|mesh-list
6768984|NCT02123628|Rifampin|rifampin|mesh-list
6768985|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
6768986|NCT02123628|Linezolid|linezolid|mesh-list
6768987|NCT02123628|Cefepime|cefepime|mesh-list
6768988|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6768989|NCT02123628|Cefotaxime|cefotaxime|mesh-list
6768990|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
6768991|NCT02123628|Trimethoprim|trimethoprim|mesh-list
6768992|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
6768993|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6768994|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6768995|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
6768996|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
6768997|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6768998|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6768999|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6769000|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6769001|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769002|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769003|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769004|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6769005|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6769006|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6769007|NCT02123628|Renal Agents|renal agents|mesh-ancestor
6769008|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
6769009|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6769010|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6769011|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6769012|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6769013|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6769014|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6769015|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6769016|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6769017|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6769018|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6769019|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6769020|NCT02123654|Asunaprevir|asunaprevir|mesh-list
6769021|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
6769022|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769023|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769024|NCT02123979|Rotigotine|rotigotine|mesh-list
6769025|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
6769026|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
6769027|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769028|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769029|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769030|NCT02124005|Bupivacaine|bupivacaine|mesh-list
6769031|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
6769032|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
6769033|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769034|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769035|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
6769036|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769037|NCT02124070|Hormones|hormones|mesh-list
6769038|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6769039|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769040|NCT02124148|Leucovorin|leucovorin|mesh-list
6769041|NCT02124148|Fluorouracil|fluorouracil|mesh-list
6769042|NCT02124148|Pemetrexed|pemetrexed|mesh-list
6769043|NCT02124148|Cetuximab|cetuximab|mesh-list
6769044|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769045|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
6769046|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769047|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6769048|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769049|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
6769050|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769051|NCT02124148|Antidotes|antidotes|mesh-ancestor
6769052|NCT02124148|Protective Agents|protective agents|mesh-ancestor
6769053|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
6769054|NCT02124148|Vitamins|vitamins|mesh-ancestor
6769055|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
6769056|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769057|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6769058|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6769059|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6769060|NCT02124174|Azacitidine|azacitidine|mesh-list
6769061|NCT02124174|Valproic Acid|valproic acid|mesh-list
6769062|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6769063|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
6769064|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769065|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769066|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769067|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
6769068|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
6769069|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769070|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769071|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
6769072|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6769073|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769074|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6769075|NCT02124187|Nicotine|nicotine|mesh-list
6769076|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6769077|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
6769078|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769079|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769080|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6769081|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6769082|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
6769083|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769084|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769085|NCT02124200|Nicotine|nicotine|mesh-list
6769086|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6769087|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
6769088|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769089|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769090|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6769091|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6769092|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
6769093|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769094|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769095|NCT02124226|Methotrexate|methotrexate|mesh-list
6769096|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6769097|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
6769098|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6769099|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769100|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6769101|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
6769102|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769103|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769104|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
6769105|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769106|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6769107|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769108|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
6769109|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6769110|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6769111|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
6769112|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
6769113|NCT02124317|Paclitaxel|paclitaxel|mesh-list
6769114|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6769115|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6769116|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769117|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
6769118|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
6769119|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
6769120|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769121|NCT02124330|Bentonite|bentonite|mesh-list
6769122|NCT02124330|Antidotes|antidotes|mesh-ancestor
6769123|NCT02124330|Protective Agents|protective agents|mesh-ancestor
6769124|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769125|NCT02124369|Gemcitabine|gemcitabine|mesh-list
6769126|NCT02124369|Paclitaxel|paclitaxel|mesh-list
6769127|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6769128|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6769129|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769130|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
6769131|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
6769132|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
6769133|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769134|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6769135|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
6769136|NCT02124369|Antiviral Agents|antiviral agents|mesh-ancestor
6769137|NCT02124369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769138|NCT02124369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769139|NCT02124369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769140|NCT02124369|Immunologic Factors|immunologic factors|mesh-ancestor
6769141|NCT02124369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769142|NCT02124421|Paclitaxel|paclitaxel|mesh-list
6769143|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6769144|NCT02124421|Carboplatin|carboplatin|mesh-list
6769145|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6769146|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769147|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
6769148|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
6769149|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
6769150|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769151|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
6769152|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6769153|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
6769154|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769155|NCT02124525|Expectorants|expectorants|mesh-ancestor
6769156|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
6769157|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6769158|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
6769159|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769160|NCT02124525|Protective Agents|protective agents|mesh-ancestor
6769161|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769162|NCT02124525|Antidotes|antidotes|mesh-ancestor
6769163|NCT02124642|Folic Acid|folic acid|mesh-list
6769164|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
6769165|NCT02124642|Hematinics|hematinics|mesh-ancestor
6769166|NCT02124642|Vitamins|vitamins|mesh-ancestor
6769167|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
6769168|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769169|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
6769170|NCT02124655|Listerine|listerine|mesh-list
6769171|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6769172|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769173|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
6769174|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
6769175|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
6769176|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6769177|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6769178|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769179|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769180|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769181|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6769182|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6769183|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6769184|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
6789865|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6789866|NCT02232516|Growth Substances|growth substances|mesh-ancestor
6789867|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
6789868|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789869|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6789870|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6789871|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6789872|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6789873|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789874|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789875|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789876|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789877|NCT02232542|Analgesics|analgesics|mesh-ancestor
6789878|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
6789879|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789880|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
6789881|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6789882|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
6789883|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6789884|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6789885|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6789886|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789887|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789888|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789889|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789890|NCT02232555|Analgesics|analgesics|mesh-ancestor
6789891|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
6789892|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789893|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
6789894|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6789895|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
6789896|NCT02232581|Alovudine|alovudine|mesh-list
6789897|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
6789898|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
6789899|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789900|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
6789901|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789902|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6789903|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6789904|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6789905|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6789906|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6789907|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
6789908|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789909|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789910|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6789911|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
6789912|NCT02232607|Lacidipine|lacidipine|mesh-list
6789913|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6789914|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6789915|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789916|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789917|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6789918|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789919|NCT02232672|Choline|choline|mesh-list
6789920|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
6789921|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6789922|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
6769185|NCT02124850|Nivolumab|nivolumab|mesh-list
6769186|NCT02124850|Cetuximab|cetuximab|mesh-list
6769187|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6769188|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769189|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6769190|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769191|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
6769192|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6769193|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
6769194|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769195|NCT02124941|Expectorants|expectorants|mesh-ancestor
6769196|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
6769197|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6769198|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
6769199|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769200|NCT02124941|Protective Agents|protective agents|mesh-ancestor
6769201|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769202|NCT02124941|Antidotes|antidotes|mesh-ancestor
6769203|NCT02124954|Digoxin|digoxin|mesh-list
6769204|NCT02124954|Midazolam|midazolam|mesh-list
6769205|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6769206|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6769207|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769208|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769209|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6769210|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6769211|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6769212|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6769213|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
6769214|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
6769215|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
6769216|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
6769217|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769218|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769219|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6769220|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6769221|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769222|NCT02124954|Protective Agents|protective agents|mesh-ancestor
6769223|NCT02125084|Everolimus|everolimus|mesh-list
6769224|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769225|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769226|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
6769227|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769228|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
6769229|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
6769230|NCT02125188|Coagulants|coagulants|mesh-ancestor
6769231|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6769232|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
6769233|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769234|NCT02125201|Fentanyl|fentanyl|mesh-list
6769235|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6769236|NCT02125201|Narcotics|narcotics|mesh-ancestor
6769237|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769238|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769239|NCT02125201|Analgesics|analgesics|mesh-ancestor
6769240|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
6769241|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769242|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6769243|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6769244|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
6769245|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
6769246|NCT02125227|Metformin|metformin|mesh-list
6769247|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6769248|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6769249|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769250|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6769251|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6769252|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
6769253|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769254|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6769255|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6769256|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769257|NCT02125305|Metformin|metformin|mesh-list
6769258|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6769259|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769260|NCT02125318|Anagrelide|anagrelide|mesh-list
6769261|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6769262|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6769263|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769264|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6769265|NCT02125344|Paclitaxel|paclitaxel|mesh-list
6769266|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
6769267|NCT02125344|Carboplatin|carboplatin|mesh-list
6769268|NCT02125344|Doxorubicin|doxorubicin|mesh-list
6769269|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6769270|NCT02125344|Trastuzumab|trastuzumab|mesh-list
6769271|NCT02125344|Epirubicin|epirubicin|mesh-list
6769272|NCT02125344|Pertuzumab|pertuzumab|mesh-list
6769273|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6769274|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769275|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
6769276|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
6769277|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
6769278|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769279|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769280|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
6769281|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769282|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6769283|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6769284|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
6769285|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6769286|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6769287|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6769288|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6769289|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769290|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6769291|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
6769292|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769293|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6769294|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769295|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769296|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
6769297|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6769298|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769299|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6769300|NCT02125409|Aspirin|aspirin|mesh-list
6769301|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6769302|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6769303|NCT02125409|Analgesics|analgesics|mesh-ancestor
6769304|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
6769305|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769306|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769307|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6769308|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6769309|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6769310|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6769311|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769312|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6769313|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6769314|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769315|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
6769316|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
6769317|NCT02125500|Ledipasvir|ledipasvir|mesh-list
6769318|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
6769319|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769320|NCT02125513|Paclitaxel|paclitaxel|mesh-list
6769321|NCT02125513|Carboplatin|carboplatin|mesh-list
6769322|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6769323|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769324|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
6769325|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
6769326|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
6769327|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769328|NCT02125565|Lidocaine|lidocaine|mesh-list
6769329|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
6769330|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
6769331|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769332|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769333|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
6769334|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769335|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6769336|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6769337|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6769338|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6769339|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769340|NCT02125578|Interferons|interferons|mesh-list
6769341|NCT02125578|Interferon-beta|interferon-beta|mesh-list
6769342|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
6769343|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769344|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
6769345|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769346|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
6769347|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769348|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6769349|NCT02125617|Prednisolone|prednisolone|mesh-list
6769350|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6769351|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
6769352|NCT02125617|Hormones|hormones|mesh-ancestor
6769353|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6769354|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769355|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6769356|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769357|NCT02125630|Hormones|hormones|mesh-list
6769358|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6769359|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769360|NCT02125643|Caffeine|caffeine|mesh-list
6769361|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6769362|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769363|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6769364|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769365|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769366|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6769367|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6769368|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
6769369|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769370|NCT02125682|Atorvastatin|atorvastatin|mesh-list
6769371|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6769372|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6769373|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
6769374|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769375|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6769376|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6769377|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769378|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6769379|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6769380|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769381|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
6769382|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6769383|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769384|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6769385|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6769386|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769387|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769388|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769389|NCT02125864|Aflibercept|aflibercept|mesh-list
6769390|NCT02125864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6769391|NCT02125864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6769392|NCT02125864|Growth Substances|growth substances|mesh-ancestor
6769393|NCT02125864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769394|NCT02125864|Growth Inhibitors|growth inhibitors|mesh-ancestor
6769395|NCT02125864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769396|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
6769397|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6769398|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6769399|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769400|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
6769401|NCT02125890|Coagulants|coagulants|mesh-ancestor
6769402|NCT02125903|Ropivacaine|ropivacaine|mesh-list
6769403|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
6769404|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
6769405|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769406|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769407|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
6769408|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769409|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
6769410|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6769411|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6769412|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
6769413|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769414|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769415|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769416|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
6769417|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
6769418|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769419|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
6769420|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6769421|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
6769422|NCT02126020|Infliximab|infliximab|mesh-list
6769423|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
6769424|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6769425|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6769426|NCT02126137|Ezetimibe|ezetimibe|mesh-list
6769427|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6769428|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6769429|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
6769430|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769431|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6769432|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
6769433|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6769434|NCT02126267|Azithromycin|azithromycin|mesh-list
6769435|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6769436|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769437|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
6769438|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
6769439|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6769440|NCT02126293|Zinc|zinc|mesh-list
6769441|NCT02126293|Trace Elements|trace elements|mesh-ancestor
6769442|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
6769443|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769444|NCT02126332|Acetaminophen|acetaminophen|mesh-list
6769445|NCT02126332|Sufentanil|sufentanil|mesh-list
6769446|NCT02126332|Nefopam|nefopam|mesh-list
6769447|NCT02126332|Tramadol|tramadol|mesh-list
6769448|NCT02126332|Ropivacaine|ropivacaine|mesh-list
6769449|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
6769450|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
6769451|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769452|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769453|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
6769454|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769455|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6769456|NCT02126332|Analgesics|analgesics|mesh-ancestor
6769457|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
6769458|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6769459|NCT02126332|Narcotics|narcotics|mesh-ancestor
6769460|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6769461|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6769462|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
6789923|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789924|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789925|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6789926|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
6789927|NCT02232685|Choline|choline|mesh-list
6789928|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
6789929|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6789930|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
6789931|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789932|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789933|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6789934|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
6789935|NCT02232724|Choline|choline|mesh-list
6789936|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
6789937|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6789938|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
6789939|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789940|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789941|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6789942|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
6789943|NCT02232737|Nicotine|nicotine|mesh-list
6789944|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6789945|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
6789946|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6789947|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789948|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6789949|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6789950|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
6789951|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789952|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789953|NCT02232763|Losartan|losartan|mesh-list
6789954|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6789955|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6789956|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6789957|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6789958|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789959|NCT02232776|Losartan|losartan|mesh-list
6789960|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6789961|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6789962|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6789963|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6789964|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789965|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
6789966|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
6789967|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789968|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6789969|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
6789970|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6789971|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789972|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6789973|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6789974|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6789975|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
6789976|NCT02232932|Capecitabine|capecitabine|mesh-list
6789977|NCT02232932|Liver Extracts|liver extracts|mesh-list
6789978|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6789979|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
6789980|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789981|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6789982|NCT02232932|Hematinics|hematinics|mesh-ancestor
6789983|NCT02232945|Oseltamivir|oseltamivir|mesh-list
6789984|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
6789985|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6789986|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769463|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6769464|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6769465|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6769466|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
6769467|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769468|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6769469|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6769470|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769471|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6769472|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
6769473|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769474|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6769475|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6769476|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
6769477|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769478|NCT02126462|Antacids|antacids|mesh-ancestor
6769479|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769480|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6769481|NCT02126527|Sirolimus|sirolimus|mesh-list
6769482|NCT02126527|Auranofin|auranofin|mesh-list
6769483|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6769484|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769485|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6769486|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769487|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
6769488|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769489|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
6769490|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769491|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6769492|NCT02126579|Poly ICLC|poly iclc|mesh-list
6769493|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
6769494|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
6769495|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769496|NCT02126644|Glycolic acid|glycolic acid|mesh-list
6769497|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
6769498|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
6769499|NCT02126657|Glycolic acid|glycolic acid|mesh-list
6769500|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
6769501|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
6769502|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
6769503|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
6769504|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6769505|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6769506|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769507|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769508|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769509|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6769510|NCT02126761|Vaccines|vaccines|mesh-list
6769511|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
6769512|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769513|NCT02126917|Ethanol|ethanol|mesh-list
6769514|NCT02126917|Hydrocodone|hydrocodone|mesh-list
6769515|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6769516|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769517|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769518|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769519|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6769520|NCT02126917|Narcotics|narcotics|mesh-ancestor
6769521|NCT02126917|Analgesics|analgesics|mesh-ancestor
6769522|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
6769523|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769524|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
6769525|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
6769526|NCT02126943|Macitentan|macitentan|mesh-list
6769527|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
6769528|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
6769529|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769530|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
6769531|NCT02126956|Ponesimod|ponesimod|mesh-list
6769532|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6769533|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769534|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769535|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
6769536|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769537|NCT02126995|Metadoxine|metadoxine|mesh-list
6769538|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6769539|NCT02127034|Digoxin|digoxin|mesh-list
6769540|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
6769541|NCT02127034|Mirabegron|mirabegron|mesh-list
6769542|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6769543|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6769544|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769545|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769546|NCT02127034|Protective Agents|protective agents|mesh-ancestor
6769547|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769548|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6769549|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6769550|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
6769551|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769552|NCT02127034|Urological Agents|urological agents|mesh-ancestor
6769553|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6769554|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6769555|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6769556|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
6769557|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6769558|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6769559|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769560|NCT02127047|Incretins|incretins|mesh-ancestor
6769561|NCT02127047|Hormones|hormones|mesh-ancestor
6769562|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6769563|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6769564|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
6769565|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769566|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769567|NCT02127060|Ascorbic Acid|ascorbic acid|mesh-list
6769568|NCT02127060|Vitamins|vitamins|mesh-ancestor
6769569|NCT02127060|Micronutrients|micronutrients|mesh-ancestor
6769570|NCT02127060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769571|NCT02127060|Antioxidants|antioxidants|mesh-ancestor
6769572|NCT02127060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769573|NCT02127060|Protective Agents|protective agents|mesh-ancestor
6769574|NCT02127073|Oxytocin|oxytocin|mesh-list
6769575|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
6769576|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6769577|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769578|NCT02127086|Analgesics|analgesics|mesh-list
6769579|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
6769580|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769581|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769582|NCT02127138|Sirolimus|sirolimus|mesh-list
6769583|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6769584|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769585|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6769586|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769587|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
6769588|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769589|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
6769590|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769591|NCT02127151|Talazoparib|talazoparib|mesh-list
6769592|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6769593|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769594|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769595|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769596|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
6769597|NCT02127164|Eusol|eusol|mesh-list
6769598|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
6769599|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769600|NCT02127190|CXA-10|cxa-10|mesh-list
6769601|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6769602|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6769603|NCT02127320|Ezetimibe|ezetimibe|mesh-list
6769604|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6769605|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6769606|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
6769607|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769608|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6769609|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6769610|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769611|NCT02127437|Lanreotide|lanreotide|mesh-list
6769612|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769613|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6769614|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6769615|NCT02127489|Bupivacaine|bupivacaine|mesh-list
6769616|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
6769617|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
6769618|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769619|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769620|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
6769621|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769622|NCT02127541|Exenatide|exenatide|mesh-list
6769623|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6769624|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769625|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6769626|NCT02127541|Incretins|incretins|mesh-ancestor
6769627|NCT02127541|Hormones|hormones|mesh-ancestor
6769628|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6769629|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
6769630|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6769631|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6769632|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6769633|NCT02127593|Norgestimate|norgestimate|mesh-list
6769634|NCT02127593|Norgestrel|norgestrel|mesh-list
6769635|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6769636|NCT02127593|Estradiol|estradiol|mesh-list
6769637|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6769638|NCT02127593|Estrogens|estrogens|mesh-ancestor
6769639|NCT02127593|Hormones|hormones|mesh-ancestor
6769640|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6769641|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769642|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6769643|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
6769644|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6769645|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6769646|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6769647|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6769648|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6769649|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6769650|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769651|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6769652|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6769653|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769654|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769655|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769656|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6769657|NCT02127684|Ranibizumab|ranibizumab|mesh-list
6769658|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6769659|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6769660|NCT02127684|Growth Substances|growth substances|mesh-ancestor
6769661|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769662|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
6769663|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769664|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
6769665|NCT02127697|Albuterol|albuterol|mesh-list
6769666|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6769667|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
6769668|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769669|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769670|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6769671|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
6769672|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
6769673|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6769674|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6769675|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6769676|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6769677|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
6769678|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769679|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769680|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6769681|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6769682|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6769683|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
6769684|NCT02127736|Amitriptyline|amitriptyline|mesh-list
6769685|NCT02127736|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6769686|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6769687|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
6769688|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6769689|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6769690|NCT02127736|Analgesics|analgesics|mesh-ancestor
6769691|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
6769692|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769693|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769694|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6769695|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6769696|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6769697|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769698|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
6769699|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769700|NCT02127736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6769701|NCT02127736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6769702|NCT02127736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769703|NCT02127749|Metronidazole|metronidazole|mesh-list
6769704|NCT02127749|Vancomycin|vancomycin|mesh-list
6769705|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
6769706|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769707|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6769708|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6769709|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6769710|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6769711|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6769712|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769713|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769714|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769715|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6769716|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6769717|NCT02127775|Lesinurad|lesinurad|mesh-list
6769718|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
6769719|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6769720|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
6769721|NCT02127775|Renal Agents|renal agents|mesh-ancestor
6769722|NCT02127788|Micafungin|micafungin|mesh-list
6769723|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
6769724|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769725|NCT02127840|Epinephrine|epinephrine|mesh-list
6769726|NCT02127840|Racepinephrine|racepinephrine|mesh-list
6769727|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
6769728|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6769729|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6769730|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
6769731|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769732|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769733|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769734|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6769735|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6769736|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
6769737|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769738|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6769739|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
6769740|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
6769741|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
6769742|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6789987|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789988|NCT02232971|Glucagon|glucagon|mesh-list
6789989|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6789990|NCT02232971|Hormones|hormones|mesh-ancestor
6789991|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6789992|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6789993|NCT02233023|Dopamine|dopamine|mesh-list
6789994|NCT02233023|Pramipexole|pramipexole|mesh-list
6789995|NCT02233023|Bromocriptine|bromocriptine|mesh-list
6789996|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
6789997|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
6789998|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6789999|NCT02233023|Protective Agents|protective agents|mesh-ancestor
6790000|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790001|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6790002|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6790003|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
6790004|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790005|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6790006|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
6790007|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
6790008|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790009|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
6790010|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790011|NCT02233049|Everolimus|everolimus|mesh-list
6790012|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6790013|NCT02233049|Dasatinib|dasatinib|mesh-list
6790014|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790015|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6790016|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
6790017|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790018|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6790019|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790020|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790021|NCT02233075|Interferons|interferons|mesh-list
6790022|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
6790023|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
6790024|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6790025|NCT02233075|REP 2139|rep 2139|mesh-list
6790026|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790027|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
6769743|NCT02127853|Gabapentin|gabapentin|mesh-list
6769744|NCT02127853|Analgesics|analgesics|mesh-ancestor
6769745|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
6769746|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769747|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769748|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
6769749|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6769750|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6769751|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769752|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6769753|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6769754|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6769755|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769756|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769757|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
6769758|NCT02127866|Beclomethasone|beclomethasone|mesh-list
6769759|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
6769760|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
6769761|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6769762|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
6769763|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769764|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769765|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6769766|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
6769767|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6769768|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6769769|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6769770|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
6769771|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769772|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769773|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6769774|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6769775|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6769776|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
6769777|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6769778|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
6769779|NCT02127866|Hormones|hormones|mesh-ancestor
6769780|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6769781|NCT02127918|Clobazam|clobazam|mesh-list
6769782|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
6769783|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6769784|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6769785|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769786|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769787|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6769788|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6769789|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
6769790|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
6769791|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769792|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769793|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6769794|NCT02127996|Incretins|incretins|mesh-ancestor
6769795|NCT02127996|Hormones|hormones|mesh-ancestor
6769796|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6769797|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769798|NCT02128022|Glyburide|glyburide|mesh-list
6769799|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6769800|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769801|NCT02128061|Rituximab|rituximab|mesh-list
6769802|NCT02128061|Lenalidomide|lenalidomide|mesh-list
6769803|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6769804|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769805|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
6769806|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769807|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6769808|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6769809|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6769810|NCT02128061|Growth Substances|growth substances|mesh-ancestor
6769811|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
6769812|NCT02128100|Leucovorin|leucovorin|mesh-list
6769813|NCT02128100|Fluorouracil|fluorouracil|mesh-list
6769814|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
6769815|NCT02128100|Irinotecan|irinotecan|mesh-list
6769816|NCT02128100|Folfirinox|folfirinox|mesh-list
6769817|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
6769818|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769819|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6769820|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769821|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769822|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
6769823|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769824|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6769825|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6769826|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769827|NCT02128100|Antidotes|antidotes|mesh-ancestor
6769828|NCT02128100|Protective Agents|protective agents|mesh-ancestor
6769829|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
6769830|NCT02128100|Vitamins|vitamins|mesh-ancestor
6769831|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
6769832|NCT02128126|Vaccines|vaccines|mesh-list
6769833|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
6769834|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769835|NCT02128178|Enoxaparin|enoxaparin|mesh-list
6769836|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
6769837|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
6769838|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6769839|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6769840|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769841|NCT02128191|Ibuprofen|ibuprofen|mesh-list
6769842|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6769843|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6769844|NCT02128191|Analgesics|analgesics|mesh-ancestor
6769845|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
6769846|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769847|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769848|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6769849|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6769850|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6769851|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769852|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769853|NCT02128204|Lidocaine|lidocaine|mesh-list
6769854|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
6769855|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
6769856|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769857|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769858|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
6769859|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769860|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6769861|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6769862|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6769863|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6769864|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769865|NCT02128243|Leucovorin|leucovorin|mesh-list
6769866|NCT02128243|Cisplatin|cisplatin|mesh-list
6769867|NCT02128243|Docetaxel|docetaxel|mesh-list
6769868|NCT02128243|Fluorouracil|fluorouracil|mesh-list
6769869|NCT02128243|Capecitabine|capecitabine|mesh-list
6769870|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
6769871|NCT02128243|Epirubicin|epirubicin|mesh-list
6769872|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
6769873|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769874|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
6769875|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
6769876|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
6769877|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769878|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
6769879|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6769880|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769881|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
6769882|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769883|NCT02128243|Antidotes|antidotes|mesh-ancestor
6769884|NCT02128243|Protective Agents|protective agents|mesh-ancestor
6769885|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
6769886|NCT02128243|Vitamins|vitamins|mesh-ancestor
6769887|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
6769888|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6769889|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6769890|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6769891|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769892|NCT02128282|Gemcitabine|gemcitabine|mesh-list
6769893|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769894|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6769895|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
6769896|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769897|NCT02128282|Antiviral Agents|antiviral agents|mesh-ancestor
6769898|NCT02128282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769899|NCT02128282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769900|NCT02128282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769901|NCT02128282|Immunologic Factors|immunologic factors|mesh-ancestor
6769902|NCT02128282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769903|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
6769904|NCT02128308|Levofloxacin|levofloxacin|mesh-list
6769905|NCT02128308|Ofloxacin|ofloxacin|mesh-list
6769906|NCT02128308|Cycloserine|cycloserine|mesh-list
6769907|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
6769908|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
6769909|NCT02128308|Streptomycin|streptomycin|mesh-list
6769910|NCT02128308|Kanamycin|kanamycin|mesh-list
6769911|NCT02128308|Prothionamide|prothionamide|mesh-list
6769912|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6769913|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6769914|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769915|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6769916|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6769917|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769918|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769919|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769920|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6769921|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
6769922|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6769923|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769924|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6769925|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6769926|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6769927|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6769928|NCT02128308|Renal Agents|renal agents|mesh-ancestor
6769929|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6769930|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6769931|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6769932|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
6769933|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
6769934|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6769935|NCT02128321|Repaglinide|repaglinide|mesh-list
6769936|NCT02128321|Isavuconazole|isavuconazole|mesh-list
6769937|NCT02128321|Caffeine|caffeine|mesh-list
6769938|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6769939|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769940|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6769941|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769942|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769943|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6769944|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6769945|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
6769946|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6769947|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6769948|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
6769949|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6769950|NCT02128334|Leuprolide|leuprolide|mesh-list
6769951|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6769952|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
6769953|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6769954|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769955|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6769956|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769957|NCT02128360|Letrozole|letrozole|mesh-list
6769958|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769959|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6769960|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6769961|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769962|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769963|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6769964|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
6769965|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6769966|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769967|NCT02128425|Leucovorin|leucovorin|mesh-list
6769968|NCT02128425|Fluorouracil|fluorouracil|mesh-list
6769969|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
6769970|NCT02128425|Irinotecan|irinotecan|mesh-list
6769971|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
6769972|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
6769973|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6769974|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6769975|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6769976|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6769977|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
6769978|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769979|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6769980|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6769981|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6769982|NCT02128425|Antidotes|antidotes|mesh-ancestor
6769983|NCT02128425|Protective Agents|protective agents|mesh-ancestor
6769984|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
6769985|NCT02128425|Vitamins|vitamins|mesh-ancestor
6769986|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
6769987|NCT02128451|Fentanyl|fentanyl|mesh-list
6769988|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6769989|NCT02128451|Narcotics|narcotics|mesh-ancestor
6769990|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6769991|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6769992|NCT02128451|Analgesics|analgesics|mesh-ancestor
6769993|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
6769994|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6769995|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6769996|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6769997|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
6769998|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
6769999|NCT02128633|Listerine|listerine|mesh-list
6770000|NCT02128633|Fluorides|fluorides|mesh-list
6770001|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
6770002|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
6770003|NCT02128633|Protective Agents|protective agents|mesh-ancestor
6770004|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770005|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6770006|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770007|NCT02128646|Ketorolac|ketorolac|mesh-list
6770008|NCT02128646|Bupivacaine|bupivacaine|mesh-list
6770009|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
6770010|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
6770011|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770012|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770013|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
6770014|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770015|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6770016|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6770017|NCT02128646|Analgesics|analgesics|mesh-ancestor
6770018|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6770019|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770020|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6770021|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770022|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770023|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
6770024|NCT02128685|Progestins|progestins|mesh-ancestor
6770025|NCT02128685|Hormones|hormones|mesh-ancestor
6770026|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770027|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770028|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
6770029|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6770030|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
6770031|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6770032|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
6770033|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770034|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770035|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
6770036|NCT02128893|Isavuconazole|isavuconazole|mesh-list
6770037|NCT02128893|Esomeprazole|esomeprazole|mesh-list
6770038|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6770039|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6770040|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6770041|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770042|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770043|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
6770044|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770045|NCT02128906|Docetaxel|docetaxel|mesh-list
6770046|NCT02128906|Cetuximab|cetuximab|mesh-list
6770047|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770048|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
6770049|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
6770050|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
6770051|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770052|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6770053|NCT02128945|Fludarabine|fludarabine|mesh-list
6770054|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770055|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
6770056|NCT02128971|Trace Elements|trace elements|mesh-ancestor
6770057|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
6770058|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770059|NCT02128984|Antioxidants|antioxidants|mesh-list
6770060|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770061|NCT02128984|Protective Agents|protective agents|mesh-ancestor
6770062|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770063|NCT02129088|Esketamine|esketamine|mesh-list
6770064|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
6770065|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6770066|NCT02129101|Azacitidine|azacitidine|mesh-list
6770067|NCT02129101|Decitabine|decitabine|mesh-list
6770068|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6770069|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
6770070|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770071|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770072|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770073|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6770074|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6770075|NCT02129114|Estradiol|estradiol|mesh-list
6770076|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6770077|NCT02129114|Estrogens|estrogens|mesh-ancestor
6770078|NCT02129114|Hormones|hormones|mesh-ancestor
6770079|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770080|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770081|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6770082|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
6770083|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6770084|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6770085|NCT02129127|Paclitaxel|paclitaxel|mesh-list
6770086|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6770087|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770088|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
6770089|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
6770090|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
6770091|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770092|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
6770093|NCT02129166|Dasatinib|dasatinib|mesh-list
6770094|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770095|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6770096|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770097|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770098|NCT02129179|Glucagon|glucagon|mesh-list
6770099|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6770100|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6770101|NCT02129179|Hormones|hormones|mesh-ancestor
6770102|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770103|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770104|NCT02129179|Incretins|incretins|mesh-ancestor
6770105|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
6770106|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6770107|NCT02129231|Simvastatin|simvastatin|mesh-list
6770108|NCT02129231|Ezetimibe|ezetimibe|mesh-list
6770109|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
6770110|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6770111|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6770112|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
6770113|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770114|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6770115|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6770116|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770117|NCT02129231|Antacids|antacids|mesh-ancestor
6770118|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6770119|NCT02129257|Leucovorin|leucovorin|mesh-list
6770120|NCT02129257|Folic Acid|folic acid|mesh-list
6770121|NCT02129257|Fluorouracil|fluorouracil|mesh-list
6770122|NCT02129257|Irinotecan|irinotecan|mesh-list
6770123|NCT02129257|Aflibercept|aflibercept|mesh-list
6770124|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
6770125|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
6770126|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770127|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6770128|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770129|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770130|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
6770131|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770132|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6770133|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6770134|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770135|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6770136|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6770137|NCT02129257|Growth Substances|growth substances|mesh-ancestor
6770138|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
6770139|NCT02129257|Antidotes|antidotes|mesh-ancestor
6770140|NCT02129257|Protective Agents|protective agents|mesh-ancestor
6770141|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
6770142|NCT02129257|Vitamins|vitamins|mesh-ancestor
6770143|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
6770144|NCT02129257|Hematinics|hematinics|mesh-ancestor
6770145|NCT02129270|Lidocaine|lidocaine|mesh-list
6770146|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
6770147|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
6770148|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770149|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770150|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
6770151|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770152|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6770153|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6770154|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6770155|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6770156|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770157|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
6770158|NCT02129322|Sorafenib|sorafenib|mesh-list
6770159|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770160|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6770161|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770162|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770163|NCT02129400|Anesthetics|anesthetics|mesh-list
6770164|NCT02129400|Xenon|xenon|mesh-list
6770165|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770166|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770167|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6770168|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
6790028|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790029|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
6790030|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790031|NCT02233179|Calpastatin|calpastatin|mesh-list
6790032|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
6790033|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
6790034|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790035|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790036|NCT02233205|Gemcitabine|gemcitabine|mesh-list
6790037|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6790038|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
6790039|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790040|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790041|NCT02233205|Antiviral Agents|antiviral agents|mesh-ancestor
6790042|NCT02233205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790043|NCT02233205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790044|NCT02233205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6790045|NCT02233205|Immunologic Factors|immunologic factors|mesh-ancestor
6790046|NCT02233205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790047|NCT02233218|Amlodipine|amlodipine|mesh-list
6790048|NCT02233218|Telmisartan|telmisartan|mesh-list
6790049|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6790050|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6790051|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6790052|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6790053|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790054|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6790055|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790056|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
6790057|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6790058|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6790059|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
6790060|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6790061|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6790062|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790063|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6790064|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6790065|NCT02233231|Varenicline|varenicline|mesh-list
6790066|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6790067|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6790068|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
6790069|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790070|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790071|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790072|NCT02233244|Midazolam|midazolam|mesh-list
6790073|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6790074|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6790075|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790076|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790077|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6790078|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6790079|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6790080|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6790081|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
6790082|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
6790083|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
6790084|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
6790085|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790086|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790087|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
6790088|NCT02233322|Hematinics|hematinics|mesh-ancestor
6790089|NCT02233387|Imidazole|imidazole|mesh-list
6790090|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770169|NCT02129582|Methotrexate|methotrexate|mesh-list
6770170|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
6770171|NCT02129582|Fludarabine|fludarabine|mesh-list
6770172|NCT02129582|Busulfan|busulfan|mesh-list
6770173|NCT02129582|Tacrolimus|tacrolimus|mesh-list
6770174|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
6770175|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6770176|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
6770177|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6770178|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
6770179|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6770180|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770181|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6770182|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
6770183|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770184|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770185|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
6770186|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770187|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6770188|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770189|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
6770190|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770191|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6770192|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6770193|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
6770194|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6770195|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6770196|NCT02129595|Resveratrol|resveratrol|mesh-list
6770197|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
6770198|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770199|NCT02129595|Protective Agents|protective agents|mesh-ancestor
6770200|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770201|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770202|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6770203|NCT02129621|Spironolactone|spironolactone|mesh-list
6770204|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6770205|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
6770206|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770207|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770208|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6770209|NCT02129621|Diuretics|diuretics|mesh-ancestor
6770210|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
6770211|NCT02129634|Paclitaxel|paclitaxel|mesh-list
6770212|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6770213|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770214|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
6770215|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
6770216|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
6770217|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770218|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6770219|NCT02129673|Latanoprost|latanoprost|mesh-list
6770220|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6770221|NCT02129699|Denosumab|denosumab|mesh-list
6770222|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6770223|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770224|NCT02129764|Prednisone|prednisone|mesh-list
6770225|NCT02129764|Allopurinol|allopurinol|mesh-list
6770226|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6770227|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
6770228|NCT02129764|Hormones|hormones|mesh-ancestor
6770229|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770230|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770231|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6770232|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770233|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
6770234|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770235|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770236|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
6770237|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770238|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6770239|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
6770240|NCT02129764|Protective Agents|protective agents|mesh-ancestor
6770241|NCT02129829|Tenofovir|tenofovir|mesh-list
6770242|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
6770243|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770244|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6770245|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6770246|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770247|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770248|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6770249|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6770250|NCT02129933|Bevacizumab|bevacizumab|mesh-list
6770251|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6770252|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770253|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6770254|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6770255|NCT02129933|Growth Substances|growth substances|mesh-ancestor
6770256|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770257|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
6770258|NCT02129985|Metformin|metformin|mesh-list
6770259|NCT02129985|Exenatide|exenatide|mesh-list
6770260|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6770261|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770262|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6770263|NCT02129985|Incretins|incretins|mesh-ancestor
6770264|NCT02129985|Hormones|hormones|mesh-ancestor
6770265|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770266|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6770267|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6770268|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770269|NCT02130167|Atropine|atropine|mesh-list
6770270|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6770271|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6770272|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6770273|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
6770274|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770275|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770276|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6770277|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
6770278|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
6770279|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
6770280|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6770281|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6770282|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
6770283|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6770284|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770285|NCT02130323|Imiquimod|imiquimod|mesh-list
6770286|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6770287|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
6770288|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770289|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770290|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
6770291|NCT02130414|Cyclosporine|cyclosporine|mesh-list
6770292|NCT02130414|Cyclosporins|cyclosporins|mesh-list
6770293|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770294|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770295|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770296|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
6770297|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770298|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
6770299|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770300|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
6770301|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770302|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6770303|NCT02130440|Resveratrol|resveratrol|mesh-list
6770304|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
6770305|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770306|NCT02130440|Protective Agents|protective agents|mesh-ancestor
6770307|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770308|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770309|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6770310|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
6770311|NCT02130466|Trametinib|trametinib|mesh-list
6770312|NCT02130466|Dabrafenib|dabrafenib|mesh-list
6770313|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6770314|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770315|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6770316|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770317|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770318|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6770319|NCT02130661|Itraconazole|itraconazole|mesh-list
6770320|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
6770321|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770322|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6770323|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6770324|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770325|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770326|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6770327|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
6770328|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770329|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770330|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6770331|NCT02130700|Seviteronel|seviteronel|mesh-list
6770332|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770333|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6770334|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770335|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770336|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
6770337|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6770338|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770339|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6770340|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770341|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770342|NCT02130739|Fentanyl|fentanyl|mesh-list
6770343|NCT02130739|Propofol|propofol|mesh-list
6770344|NCT02130739|Ropivacaine|ropivacaine|mesh-list
6770345|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
6770346|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770347|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770348|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6770349|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6770350|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
6770351|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
6770352|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
6770353|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770354|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6770355|NCT02130739|Narcotics|narcotics|mesh-ancestor
6770356|NCT02130739|Analgesics|analgesics|mesh-ancestor
6770357|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6770358|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
6770359|NCT02130804|Salicylates|salicylates|mesh-list
6770360|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6770361|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6770362|NCT02130804|Analgesics|analgesics|mesh-ancestor
6770363|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
6770364|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770365|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770366|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6770367|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770368|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6770369|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770370|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770371|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
6770372|NCT02130817|Dexamethasone|dexamethasone|mesh-list
6770373|NCT02130817|Prednisone|prednisone|mesh-list
6770374|NCT02130817|Abatacept|abatacept|mesh-list
6770375|NCT02130817|Tacrolimus|tacrolimus|mesh-list
6770376|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
6770377|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6770378|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
6770379|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6770380|NCT02130817|Antibodies|antibodies|mesh-list
6770381|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
6770382|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
6770383|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6770384|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6770385|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
6770386|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
6770387|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770388|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770389|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6770390|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
6770391|NCT02130817|Hormones|hormones|mesh-ancestor
6770392|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770393|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6770394|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770395|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770396|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770397|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770398|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
6770399|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6770400|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6770401|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6770402|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
6770403|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6770404|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770405|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6770406|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770407|NCT02130830|Lidocaine|lidocaine|mesh-list
6770408|NCT02130830|Prilocaine|prilocaine|mesh-list
6770409|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
6770410|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
6770411|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770412|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770413|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
6770414|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770415|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6770416|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6770417|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6770418|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6770419|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770420|NCT02130869|Cytarabine|cytarabine|mesh-list
6770421|NCT02130869|Aldesleukin|aldesleukin|mesh-list
6770422|NCT02130869|Carboplatin|carboplatin|mesh-list
6770423|NCT02130869|Etoposide|etoposide|mesh-list
6770424|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
6770425|NCT02130869|Melphalan|melphalan|mesh-list
6770426|NCT02130869|Busulfan|busulfan|mesh-list
6770427|NCT02130869|Interleukin-2|interleukin-2|mesh-list
6770428|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6770429|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
6770430|NCT02130869|Sargramostim|sargramostim|mesh-list
6770431|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770432|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6770433|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6770434|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6770435|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770436|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770437|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
6770438|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770439|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6770440|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
6770441|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
6770442|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770443|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770444|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6770445|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
6770446|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6770447|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6770448|NCT02130869|Analgesics|analgesics|mesh-ancestor
6770449|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
6770450|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770451|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6770452|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6770453|NCT02130973|Denosumab|denosumab|mesh-list
6770454|NCT02130973|Teriparatide|teriparatide|mesh-list
6770455|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6770456|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770457|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6770458|NCT02131012|Celecoxib|celecoxib|mesh-list
6770459|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6770460|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6770461|NCT02131012|Analgesics|analgesics|mesh-ancestor
6770462|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
6770463|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770464|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770465|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6770466|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770467|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6770468|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6770469|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770470|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790091|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790092|NCT02233400|Acetaminophen|acetaminophen|mesh-list
6790093|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6790094|NCT02233400|Analgesics|analgesics|mesh-ancestor
6790095|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
6790096|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790097|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790098|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
6770471|NCT02131220|Tirofiban|tirofiban|mesh-list
6770472|NCT02131220|Saruplase|saruplase|mesh-list
6770473|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6770474|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6770475|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770476|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6770477|NCT02131246|Insulin|insulin|mesh-list
6770478|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6770479|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
6770480|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
6770481|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6770482|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6770483|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770484|NCT02131298|Itraconazole|itraconazole|mesh-list
6770485|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
6770486|NCT02131298|Palbociclib|palbociclib|mesh-list
6770487|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770488|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6770489|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770490|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770491|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
6770492|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770493|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6770494|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6770495|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6770496|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
6770497|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770498|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770499|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6770500|NCT02131350|Ranibizumab|ranibizumab|mesh-list
6770501|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6770502|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6770503|NCT02131350|Growth Substances|growth substances|mesh-ancestor
6770504|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770505|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
6770506|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770507|NCT02131480|Doxorubicin|doxorubicin|mesh-list
6770508|NCT02131480|Trabectedin|trabectedin|mesh-list
6770509|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6770510|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770511|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6770512|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6770513|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770514|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770515|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6770516|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
6770517|NCT02131493|Gemcitabine|gemcitabine|mesh-list
6770518|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6770519|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
6770520|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770521|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770522|NCT02131493|Antiviral Agents|antiviral agents|mesh-ancestor
6770523|NCT02131493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770524|NCT02131493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770525|NCT02131493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770526|NCT02131493|Immunologic Factors|immunologic factors|mesh-ancestor
6770527|NCT02131493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770528|NCT02131506|Lapatinib|lapatinib|mesh-list
6770529|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6770530|NCT02131506|Doxorubicin|doxorubicin|mesh-list
6770531|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770532|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6770533|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770534|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770535|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6770536|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6770537|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6770538|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6770539|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
6770540|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6770541|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6770542|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6770543|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770544|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770545|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
6770546|NCT02131688|Analgesics|analgesics|mesh-ancestor
6770547|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
6770548|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770549|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770550|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770551|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6770552|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6770553|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770554|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770555|NCT02131753|Cladribine|cladribine|mesh-list
6770556|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770557|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770558|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
6770559|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770560|NCT02131818|Amoxicillin|amoxicillin|mesh-list
6770561|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6770562|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770563|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
6770564|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6770565|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770566|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
6770567|NCT02131948|Insulin|insulin|mesh-list
6770568|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
6770569|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6770570|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770571|NCT02132000|Tamoxifen|tamoxifen|mesh-list
6770572|NCT02132000|Toremifene|toremifene|mesh-list
6770573|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6770574|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
6770575|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770576|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770577|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6770578|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770579|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6770580|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6770581|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6770582|NCT02132026|Denosumab|denosumab|mesh-list
6770583|NCT02132026|Alendronate|alendronate|mesh-list
6770584|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6770585|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770586|NCT02132091|Vitamins|vitamins|mesh-list
6770587|NCT02132091|Ascorbic Acid|ascorbic acid|mesh-list
6770588|NCT02132091|Vitamin E|vitamin e|mesh-list
6770589|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
6770590|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770591|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
6770592|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770593|NCT02132091|Protective Agents|protective agents|mesh-ancestor
6770594|NCT02132104|Hormones|hormones|mesh-list
6770595|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770596|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770597|NCT02132234|Adalimumab|adalimumab|mesh-list
6770598|NCT02132234|Etanercept|etanercept|mesh-list
6770599|NCT02132234|Infliximab|infliximab|mesh-list
6770600|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
6770601|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6770602|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770603|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6770604|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6770605|NCT02132234|Analgesics|analgesics|mesh-ancestor
6770606|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
6770607|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770608|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770609|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6770610|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770611|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
6770612|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
6770613|NCT02132260|Naftifine|naftifine|mesh-list
6770614|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
6770615|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770616|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6770617|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
6770618|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6770619|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6770620|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6770621|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770622|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770623|NCT02132390|Toremifene|toremifene|mesh-list
6770624|NCT02132390|Goserelin|goserelin|mesh-list
6770625|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6770626|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770627|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6770628|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6770629|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
6770630|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770631|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770632|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6770633|NCT02132403|Gemcitabine|gemcitabine|mesh-list
6770634|NCT02132403|Milk fat globule|milk fat globule|mesh-list
6770635|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6770636|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
6770637|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770638|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770639|NCT02132403|Antiviral Agents|antiviral agents|mesh-ancestor
6770640|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770641|NCT02132403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770642|NCT02132403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770643|NCT02132403|Immunologic Factors|immunologic factors|mesh-ancestor
6770644|NCT02132403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770645|NCT02132416|Acetaminophen|acetaminophen|mesh-list
6770646|NCT02132416|Ibuprofen|ibuprofen|mesh-list
6770647|NCT02132416|Diclofenac|diclofenac|mesh-list
6770648|NCT02132416|Morphine|morphine|mesh-list
6770649|NCT02132416|Oxycodone|oxycodone|mesh-list
6770650|NCT02132416|Tramadol|tramadol|mesh-list
6770651|NCT02132416|Anesthetics|anesthetics|mesh-list
6770652|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770653|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770654|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6770655|NCT02132416|Narcotics|narcotics|mesh-ancestor
6770656|NCT02132416|Analgesics|analgesics|mesh-ancestor
6770657|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
6770658|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770659|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6770660|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6770661|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6770662|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770663|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6770664|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770665|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770666|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
6770667|NCT02132442|Vitamin D|vitamin d|mesh-list
6770668|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
6770669|NCT02132442|Vitamins|vitamins|mesh-ancestor
6770670|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
6770671|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770672|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6770673|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6770674|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
6770675|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6770676|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770677|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
6770678|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6770679|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6770680|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
6770681|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770682|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6770683|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
6770684|NCT02132689|Heparin|heparin|mesh-list
6770685|NCT02132689|Calcium heparin|calcium heparin|mesh-list
6770686|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6770687|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770688|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
6770689|NCT02132897|Carbamazepine|carbamazepine|mesh-list
6770690|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
6770691|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
6770692|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6770693|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770694|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770695|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6770696|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6770697|NCT02132897|Analgesics|analgesics|mesh-ancestor
6770698|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
6770699|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770700|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6770701|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6770702|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770703|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6770704|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6790099|NCT02233439|Galactogogues|galactogogues|mesh-list
6790100|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790101|NCT02233452|Ketamine|ketamine|mesh-list
6790102|NCT02233452|Methadone|methadone|mesh-list
6790103|NCT02233452|Analgesics|analgesics|mesh-ancestor
6790104|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
6790105|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790106|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790107|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6790108|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6790109|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
6790110|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
6790111|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790112|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6790113|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6790114|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790115|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790116|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6790117|NCT02233452|Narcotics|narcotics|mesh-ancestor
6790118|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
6790119|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790120|NCT02233504|Deferasirox|deferasirox|mesh-list
6790121|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6790122|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
6790123|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
6790124|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790125|NCT02233556|Memantine|memantine|mesh-list
6790126|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6790127|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6790128|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
6790129|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790130|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790131|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790132|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6790133|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6790134|NCT02233582|Ibuprofen|ibuprofen|mesh-list
6790135|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6790136|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6790137|NCT02233582|Analgesics|analgesics|mesh-ancestor
6790138|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
6790139|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790140|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790141|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6790142|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6790143|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6790144|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790145|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790146|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6790147|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6790148|NCT02233621|Estradiol|estradiol|mesh-list
6790149|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6790150|NCT02233621|Estrogens|estrogens|mesh-ancestor
6790151|NCT02233621|Hormones|hormones|mesh-ancestor
6790152|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790153|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790154|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6790155|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
6790156|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6790157|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6770705|NCT02133014|Fluorouracil|fluorouracil|mesh-list
6770706|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
6770707|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770708|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6770709|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770710|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770711|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
6770712|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770713|NCT02133053|Beclomethasone|beclomethasone|mesh-list
6770714|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6770715|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
6770716|NCT02133053|Hormones|hormones|mesh-ancestor
6770717|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770718|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770719|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6770720|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
6770721|NCT02133079|Vaccines|vaccines|mesh-list
6770722|NCT02133079|Immunologic Factors|immunologic factors|mesh-ancestor
6770723|NCT02133079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770724|NCT02133105|Simendan|simendan|mesh-list
6770725|NCT02133105|Dobutamine|dobutamine|mesh-list
6770726|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6770727|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
6770728|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6770729|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6770730|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770731|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770732|NCT02133105|Protective Agents|protective agents|mesh-ancestor
6770733|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770734|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
6770735|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
6770736|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770737|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6770738|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6770739|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6770740|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
6770741|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6770742|NCT02133118|Pioglitazone|pioglitazone|mesh-list
6770743|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6770744|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770745|NCT02133287|Sirolimus|sirolimus|mesh-list
6770746|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
6770747|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6770748|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770749|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6770750|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770751|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
6770752|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770753|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
6770754|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770755|NCT02133326|Acetaminophen|acetaminophen|mesh-list
6770756|NCT02133326|Ibuprofen|ibuprofen|mesh-list
6770757|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6770758|NCT02133326|Analgesics|analgesics|mesh-ancestor
6770759|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
6770760|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770761|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770762|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
6770763|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6770764|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6770765|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770766|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6770767|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770768|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770769|NCT02133378|Hemostatics|hemostatics|mesh-list
6770770|NCT02133378|Coagulants|coagulants|mesh-ancestor
6770771|NCT02133404|Cinacalcet|cinacalcet|mesh-list
6770772|NCT02133404|ASP7991|asp7991|mesh-list
6770773|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6770774|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770775|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6770776|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
6770777|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770778|NCT02133469|Vaccines|vaccines|mesh-list
6770779|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6770780|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
6770781|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770782|NCT02133612|Paclitaxel|paclitaxel|mesh-list
6770783|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6770784|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6770785|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770786|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
6770787|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
6770788|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
6770789|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770790|NCT02133625|Pioglitazone|pioglitazone|mesh-list
6770791|NCT02133625|Carboplatin|carboplatin|mesh-list
6770792|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770793|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6770794|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770795|NCT02133638|Propofol|propofol|mesh-list
6770796|NCT02133638|Sevoflurane|sevoflurane|mesh-list
6770797|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6770798|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770799|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770800|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6770801|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
6770802|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
6770803|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6770804|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6770805|NCT02133677|Temozolomide|temozolomide|mesh-list
6770806|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6770807|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
6770808|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770809|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770810|NCT02133755|Bromocriptine|bromocriptine|mesh-list
6770811|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6770812|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6770813|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
6770814|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770815|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770816|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
6770817|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
6770818|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6770819|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770820|NCT02133820|Analgesics|analgesics|mesh-list
6770821|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
6770822|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770823|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770824|NCT02133885|Minocycline|minocycline|mesh-list
6770825|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6770826|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770827|NCT02133911|Ranolazine|ranolazine|mesh-list
6770828|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6770829|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6770830|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770831|NCT02133924|Prednisone|prednisone|mesh-list
6770832|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
6770833|NCT02133924|Natalizumab|natalizumab|mesh-list
6770834|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6770835|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
6770836|NCT02133924|Hormones|hormones|mesh-ancestor
6770837|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6770838|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770839|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6770840|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770841|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
6770842|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
6770843|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770844|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6770845|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6770846|NCT02133924|Protective Agents|protective agents|mesh-ancestor
6770847|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
6770848|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6770849|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
6770850|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770851|NCT02133989|Ticlopidine|ticlopidine|mesh-list
6770852|NCT02133989|Clopidogrel|clopidogrel|mesh-list
6770853|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6770854|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6770855|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6770856|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6770857|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
6770858|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6770859|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770860|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770861|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6770862|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6770863|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6770864|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6770865|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770866|NCT02134002|Disulfiram|disulfiram|mesh-list
6770867|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6770868|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6770869|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6770870|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770871|NCT02134067|Paclitaxel|paclitaxel|mesh-list
6770872|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6770873|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770874|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
6770875|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
6770876|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
6770877|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770878|NCT02134093|Midazolam|midazolam|mesh-list
6770879|NCT02134093|Sufentanil|sufentanil|mesh-list
6770880|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
6770881|NCT02134093|Remifentanil|remifentanil|mesh-list
6770882|NCT02134093|Anesthetics|anesthetics|mesh-list
6770883|NCT02134093|Propofol|propofol|mesh-list
6770884|NCT02134093|Etomidate|etomidate|mesh-list
6770885|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
6770886|NCT02134093|Rocuronium|rocuronium|mesh-list
6770887|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770888|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770889|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6770890|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6770891|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
6770892|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6770893|NCT02134093|Analgesics|analgesics|mesh-ancestor
6770894|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
6770895|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770896|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6770897|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6770898|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6770899|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
6770900|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6770901|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770902|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6770903|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6770904|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6770905|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6770906|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
6770907|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
6770908|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6770909|NCT02134093|Narcotics|narcotics|mesh-ancestor
6770910|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6770911|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6770912|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6770913|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6770914|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6770915|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
6770916|NCT02134106|Polymyxins|polymyxins|mesh-list
6770917|NCT02134106|Doripenem|doripenem|mesh-list
6770918|NCT02134106|Polymyxin B|polymyxin b|mesh-list
6770919|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6770920|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770921|NCT02134249|Cabergoline|cabergoline|mesh-list
6770922|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6770923|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6770924|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
6770925|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
6770926|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6770927|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770928|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770929|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
6770930|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6770931|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770932|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
6770933|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770934|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770935|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6770936|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
6770937|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770938|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770939|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6770940|NCT02134288|Everolimus|everolimus|mesh-list
6770941|NCT02134288|Abatacept|abatacept|mesh-list
6770942|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6770943|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6770944|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
6770945|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770946|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6770947|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770948|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6770949|NCT02134327|Midazolam|midazolam|mesh-list
6770950|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
6770951|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6770952|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770953|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770954|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6770955|NCT02134327|Analgesics|analgesics|mesh-ancestor
6770956|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
6770957|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770958|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6770959|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6770960|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6770961|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
6770962|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6770963|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770964|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6770965|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6770966|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6770967|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6770968|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6770969|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
6770970|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
6770971|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
6770972|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
6770973|NCT02134366|Lorazepam|lorazepam|mesh-list
6770974|NCT02134366|Clonazepam|clonazepam|mesh-list
6770975|NCT02134366|Clobazam|clobazam|mesh-list
6770976|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
6770977|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
6770978|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
6770979|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6770980|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6770981|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6770982|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6770983|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6770984|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6770985|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6770986|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6770987|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
6770988|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
6770989|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6770990|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6770991|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6770992|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
6770993|NCT02134379|Clotrimazole|clotrimazole|mesh-list
6770994|NCT02134379|Miconazole|miconazole|mesh-list
6770995|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6770996|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6770997|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
6770998|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6770999|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6771000|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771001|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771002|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6771003|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
6771004|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6771005|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771006|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6771007|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6771008|NCT02134405|Esomeprazole|esomeprazole|mesh-list
6771009|NCT02134405|Rebamipide|rebamipide|mesh-list
6771010|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6771011|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771012|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6771013|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771014|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771015|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
6771016|NCT02134405|Protective Agents|protective agents|mesh-ancestor
6771017|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771018|NCT02134457|Ranibizumab|ranibizumab|mesh-list
6771019|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6771020|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6771021|NCT02134457|Growth Substances|growth substances|mesh-ancestor
6771022|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771023|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
6771024|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771025|NCT02134470|Testosterone|testosterone|mesh-list
6771026|NCT02134470|Androgens|androgens|mesh-ancestor
6771027|NCT02134470|Hormones|hormones|mesh-ancestor
6771028|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6771029|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771030|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
6771031|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6771032|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771033|NCT02134626|Simvastatin|simvastatin|mesh-list
6771034|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6771035|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6771036|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
6771037|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771038|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6771039|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6771040|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771041|NCT02134639|Edotreotide|edotreotide|mesh-list
6771042|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6771043|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790158|NCT02233777|Pregabalin|pregabalin|mesh-list
6790159|NCT02233777|Analgesics|analgesics|mesh-ancestor
6790160|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
6790161|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790162|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790163|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
6790164|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6790165|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6790166|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790167|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6790168|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6790169|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6790170|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790171|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6790172|NCT02233790|Clopidogrel|clopidogrel|mesh-list
6790173|NCT02233790|Ticagrelor|ticagrelor|mesh-list
6790174|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6790175|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6790176|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6790177|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6790178|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
6790179|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790180|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790181|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790182|NCT02233816|Vaccines|vaccines|mesh-list
6790183|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
6790184|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790185|NCT02233881|Ipratropium|ipratropium|mesh-list
6790186|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790187|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
6790188|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790189|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790190|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6790191|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790192|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6790193|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
6790194|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771044|NCT02134717|Maraviroc|maraviroc|mesh-list
6771045|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6771046|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6771047|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771048|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6771049|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6771050|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
6771051|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771052|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6771053|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6771054|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771055|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6771056|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771057|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771058|NCT02134899|Everolimus|everolimus|mesh-list
6771059|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
6771060|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771061|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6771062|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
6771063|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771064|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771065|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771066|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6771067|NCT02134938|Cathartics|cathartics|mesh-ancestor
6771068|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771069|NCT02134964|Dapansutrile|dapansutrile|mesh-list
6771070|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6771071|NCT02134990|Docetaxel|docetaxel|mesh-list
6771072|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771073|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
6771074|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
6771075|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
6771076|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771077|NCT02135029|Atorvastatin|atorvastatin|mesh-list
6771078|NCT02135029|Bococizumab|bococizumab|mesh-list
6771079|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6771080|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6771081|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
6771082|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771083|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6771084|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6771085|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771086|NCT02135055|Midazolam|midazolam|mesh-list
6771087|NCT02135055|Morphine|morphine|mesh-list
6771088|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6771089|NCT02135055|Narcotics|narcotics|mesh-ancestor
6771090|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771091|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771092|NCT02135055|Analgesics|analgesics|mesh-ancestor
6771093|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
6771094|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771095|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6771096|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6771097|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6771098|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6771099|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6771100|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6771101|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
6771102|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
6771103|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
6771104|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
6771105|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771106|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771107|NCT02135120|Morphine|morphine|mesh-list
6771108|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771109|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771110|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6771111|NCT02135120|Narcotics|narcotics|mesh-ancestor
6771112|NCT02135120|Analgesics|analgesics|mesh-ancestor
6771113|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
6771114|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771115|NCT02135133|Ofatumumab|ofatumumab|mesh-list
6771116|NCT02135133|Idelalisib|idelalisib|mesh-list
6771117|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771118|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771119|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771120|NCT02135224|Fentanyl|fentanyl|mesh-list
6771121|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6771122|NCT02135224|Narcotics|narcotics|mesh-ancestor
6771123|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771124|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771125|NCT02135224|Analgesics|analgesics|mesh-ancestor
6771126|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
6771127|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771128|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6771129|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6771130|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
6771131|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
6771132|NCT02135263|Enalapril|enalapril|mesh-list
6771133|NCT02135263|Methylphenidate|methylphenidate|mesh-list
6771134|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6771135|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771136|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6771137|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6771138|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6771139|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771140|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
6771141|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771142|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6771143|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
6771144|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771145|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6771146|NCT02135315|Antihypertensive Agents|antihypertensive agents|mesh-list
6771147|NCT02135315|Labetalol|labetalol|mesh-list
6771148|NCT02135315|Nicardipine|nicardipine|mesh-list
6771149|NCT02135315|Isosorbide|isosorbide|mesh-list
6771150|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6771151|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6771152|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6771153|NCT02135315|Diuretics|diuretics|mesh-ancestor
6771154|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
6771155|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771156|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
6771157|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6771158|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771159|NCT02135315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6771160|NCT02135315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6771161|NCT02135315|Adrenergic Agents|adrenergic agents|mesh-ancestor
6771162|NCT02135315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771163|NCT02135315|Sympathomimetics|sympathomimetics|mesh-ancestor
6771164|NCT02135315|Autonomic Agents|autonomic agents|mesh-ancestor
6771165|NCT02135315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771166|NCT02135315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6771167|NCT02135315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6771168|NCT02135315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6771169|NCT02135315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6771170|NCT02135315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6771171|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
6771172|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6771173|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6771174|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
6771175|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6771176|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6771177|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771178|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
6771179|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771180|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771181|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6771182|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771183|NCT02135354|Azithromycin|azithromycin|mesh-list
6771184|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6771185|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771186|NCT02135393|Folic Acid|folic acid|mesh-list
6771187|NCT02135393|Hematinics|hematinics|mesh-ancestor
6771188|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
6771189|NCT02135393|Vitamins|vitamins|mesh-ancestor
6771190|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
6771191|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771192|NCT02135419|Fluorouracil|fluorouracil|mesh-list
6771193|NCT02135419|Imiquimod|imiquimod|mesh-list
6771194|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
6771195|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771196|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6771197|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771198|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6771199|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
6771200|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771201|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6771202|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
6771203|NCT02135510|Palonosetron|palonosetron|mesh-list
6771204|NCT02135510|Metoclopramide|metoclopramide|mesh-list
6771205|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
6771206|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
6771207|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771208|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771209|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771210|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6771211|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6771212|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
6771213|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771214|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771215|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6771216|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6771217|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
6771218|NCT02135588|Plasminogen|plasminogen|mesh-list
6771219|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6771220|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6771221|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6771222|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771223|NCT02135627|Epinephrine|epinephrine|mesh-list
6771224|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6771225|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6771226|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
6771227|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771228|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771229|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771230|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6771231|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6771232|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
6771233|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771234|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6771235|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
6771236|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
6771237|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
6771238|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6771239|NCT02135640|Denosumab|denosumab|mesh-list
6771240|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6771241|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771242|NCT02135770|Heparin|heparin|mesh-list
6771243|NCT02135770|Calcium heparin|calcium heparin|mesh-list
6771244|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
6771245|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6771246|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6771247|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771248|NCT02135822|Gemcitabine|gemcitabine|mesh-list
6771249|NCT02135822|Paclitaxel|paclitaxel|mesh-list
6771250|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6771251|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6771252|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771253|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
6771254|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
6771255|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
6771256|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771257|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6771258|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
6771259|NCT02135822|Antiviral Agents|antiviral agents|mesh-ancestor
6771260|NCT02135822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771261|NCT02135822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771262|NCT02135822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6771263|NCT02135822|Immunologic Factors|immunologic factors|mesh-ancestor
6771264|NCT02135822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771265|NCT02135874|Cytarabine|cytarabine|mesh-list
6771266|NCT02135874|Dexamethasone|dexamethasone|mesh-list
6771267|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
6771268|NCT02135874|Rituximab|rituximab|mesh-list
6771269|NCT02135874|Vincristine|vincristine|mesh-list
6771270|NCT02135874|Sorafenib|sorafenib|mesh-list
6771271|NCT02135874|Idarubicin|idarubicin|mesh-list
6771272|NCT02135874|Clofarabine|clofarabine|mesh-list
6771273|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6771274|NCT02135874|Antibodies|antibodies|mesh-list
6771275|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
6771276|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6771277|NCT02135874|BB 1101|bb 1101|mesh-list
6771278|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
6771279|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771280|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6771281|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
6771282|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
6771283|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771284|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771285|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
6771286|NCT02135874|Hormones|hormones|mesh-ancestor
6771287|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6771288|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6771289|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771290|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
6771291|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771292|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771293|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6771294|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6771295|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
6771296|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
6771297|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771298|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6771299|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6771300|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
6771301|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
6771302|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
6771303|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6771304|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6771305|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6771306|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6771307|NCT02135887|Leucovorin|leucovorin|mesh-list
6771308|NCT02135887|Folic Acid|folic acid|mesh-list
6771309|NCT02135887|Fluorouracil|fluorouracil|mesh-list
6771310|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
6771311|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
6771312|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
6771313|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771314|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6771315|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771316|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6771317|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
6771318|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771319|NCT02135887|Antidotes|antidotes|mesh-ancestor
6771320|NCT02135887|Protective Agents|protective agents|mesh-ancestor
6771321|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
6771322|NCT02135887|Vitamins|vitamins|mesh-ancestor
6771323|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
6771324|NCT02135887|Hematinics|hematinics|mesh-ancestor
6771325|NCT02135913|Vitamin D|vitamin d|mesh-list
6771326|NCT02135913|Vitamins|vitamins|mesh-ancestor
6771327|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
6771328|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771329|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6771330|NCT02135965|Caffeine|caffeine|mesh-list
6771331|NCT02135965|Albuterol|albuterol|mesh-list
6771332|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6771333|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771334|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6771335|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771336|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771337|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6771338|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6771339|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
6771340|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771341|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6771342|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
6771343|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771344|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6771345|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
6771346|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
6771347|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6771348|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6771349|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6771350|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6771351|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
6771352|NCT02136030|Amphotericin B|amphotericin b|mesh-list
6771353|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6771354|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
6771355|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
6771356|NCT02136030|Amebicides|amebicides|mesh-ancestor
6771357|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6771358|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6771359|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771360|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6771361|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
6771362|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6771363|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771364|NCT02136147|Guanfacine|guanfacine|mesh-list
6771365|NCT02136147|Methylphenidate|methylphenidate|mesh-list
6771366|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6771367|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6771368|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6771369|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771370|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6771371|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6771372|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6771373|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771374|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
6771375|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771376|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6771377|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
6771378|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6771379|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6771380|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6771381|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6771382|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6790195|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790196|NCT02233894|Ipratropium|ipratropium|mesh-list
6790197|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790198|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
6790199|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790200|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790201|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6790202|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790203|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6790204|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
6790205|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790206|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790207|NCT02233907|Oxitropium|oxitropium|mesh-list
6790208|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
6790209|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
6790210|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790211|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790212|NCT02233920|Oxitropium|oxitropium|mesh-list
6790213|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
6790214|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
6790215|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790216|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790217|NCT02233972|Midazolam|midazolam|mesh-list
6790218|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6790219|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6790220|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790221|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790222|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6790223|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6790224|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6790225|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6790226|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
6790227|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
6790228|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
6790229|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
6790230|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790231|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790232|NCT02234037|Decitabine|decitabine|mesh-list
6790233|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6790234|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
6790235|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790236|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790237|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790238|NCT02234050|Trabectedin|trabectedin|mesh-list
6790239|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6790240|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
6790241|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790242|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790243|NCT02234193|Lidocaine|lidocaine|mesh-list
6790244|NCT02234193|Epinephrine|epinephrine|mesh-list
6790245|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
6790246|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
6790247|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790248|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771383|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
6771384|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
6771385|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6771386|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6771387|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771388|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771389|NCT02136329|Urological Agents|urological agents|mesh-ancestor
6771390|NCT02136511|Rituximab|rituximab|mesh-list
6771391|NCT02136511|Idelalisib|idelalisib|mesh-list
6771392|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6771393|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771394|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
6771395|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771396|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6771397|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771398|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771399|NCT02136589|Diclofenac|diclofenac|mesh-list
6771400|NCT02136589|Travoprost|travoprost|mesh-list
6771401|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6771402|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6771403|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6771404|NCT02136589|Analgesics|analgesics|mesh-ancestor
6771405|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
6771406|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771407|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771408|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6771409|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6771410|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6771411|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771412|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771413|NCT02136641|Fentanyl|fentanyl|mesh-list
6771414|NCT02136641|Midazolam|midazolam|mesh-list
6771415|NCT02136641|Ketamine|ketamine|mesh-list
6771416|NCT02136641|Analgesics|analgesics|mesh-ancestor
6771417|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
6771418|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771419|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771420|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6771421|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6771422|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
6771423|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
6771424|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771425|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6771426|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6771427|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771428|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771429|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6771430|NCT02136641|Narcotics|narcotics|mesh-ancestor
6771431|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6771432|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6771433|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6771434|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6771435|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6771436|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
6771437|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
6771438|NCT02136693|Psyllium|psyllium|mesh-list
6771439|NCT02136693|Cathartics|cathartics|mesh-ancestor
6771440|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771441|NCT02136771|Vitamin D|vitamin d|mesh-list
6771442|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
6771443|NCT02136771|Vitamins|vitamins|mesh-ancestor
6771444|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
6771445|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771446|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6771447|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6771448|NCT02136784|Morphine|morphine|mesh-list
6771449|NCT02136784|Oxycodone|oxycodone|mesh-list
6771450|NCT02136784|Buprenorphine|buprenorphine|mesh-list
6771451|NCT02136784|Hydromorphone|hydromorphone|mesh-list
6771452|NCT02136784|Hydrocodone|hydrocodone|mesh-list
6771453|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6771454|NCT02136784|Narcotics|narcotics|mesh-ancestor
6771455|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771456|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771457|NCT02136784|Analgesics|analgesics|mesh-ancestor
6771458|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
6771459|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771460|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6771461|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
6771462|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
6771463|NCT02136823|Isradipine|isradipine|mesh-list
6771464|NCT02136823|Riluzole|riluzole|mesh-list
6771465|NCT02136823|Memantine|memantine|mesh-list
6771466|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6771467|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6771468|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
6771469|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771470|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771471|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771472|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6771473|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6771474|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
6771475|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6771476|NCT02136823|Protective Agents|protective agents|mesh-ancestor
6771477|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6771478|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6771479|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6771480|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6771481|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
6771482|NCT02136875|Fluticasone|fluticasone|mesh-list
6771483|NCT02136875|Xhance|xhance|mesh-list
6771484|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6771485|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6771486|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6771487|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
6771488|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771489|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771490|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6771491|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
6771492|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
6771493|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6771494|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6771495|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6771496|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6771497|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
6771498|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771499|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771500|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
6771501|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6771502|NCT02136888|Ponesimod|ponesimod|mesh-list
6771503|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6771504|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771505|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6771506|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6771507|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771508|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771509|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771510|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6771511|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
6771512|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6771513|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771514|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6771515|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6771516|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6771517|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6771518|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6771519|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
6771520|NCT02136979|Propofol|propofol|mesh-list
6771521|NCT02136979|Sevoflurane|sevoflurane|mesh-list
6771522|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6771523|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771524|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771525|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6771526|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
6771527|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
6771528|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6771529|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6771530|NCT02136992|Pirfenidone|pirfenidone|mesh-list
6771531|NCT02136992|Analgesics|analgesics|mesh-ancestor
6771532|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
6771533|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771534|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771535|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6771536|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6771537|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6771538|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6771539|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771540|NCT02137083|Docetaxel|docetaxel|mesh-list
6771541|NCT02137083|Fulvestrant|fulvestrant|mesh-list
6771542|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771543|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
6771544|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
6771545|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
6771546|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771547|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6771548|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6771549|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6771550|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
6771551|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6771552|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771553|NCT02137109|Natalizumab|natalizumab|mesh-list
6771554|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
6771555|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771556|NCT02137161|Tobramycin|tobramycin|mesh-list
6771557|NCT02137161|Dexamethasone|dexamethasone|mesh-list
6771558|NCT02137161|Bromfenac|bromfenac|mesh-list
6771559|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6771560|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6771561|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
6771562|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
6771563|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771564|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771565|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771566|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
6771567|NCT02137161|Hormones|hormones|mesh-ancestor
6771568|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6771569|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6771570|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771571|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6771572|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6771573|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771574|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6771575|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6771576|NCT02137161|Analgesics|analgesics|mesh-ancestor
6771577|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
6771578|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6771579|NCT02137213|Naloxone|naloxone|mesh-list
6771580|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6771581|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771582|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
6771583|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771584|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
6771585|NCT02137239|Prednisone|prednisone|mesh-list
6771586|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
6771587|NCT02137239|Everolimus|everolimus|mesh-list
6771588|NCT02137239|Abatacept|abatacept|mesh-list
6771589|NCT02137239|Tacrolimus|tacrolimus|mesh-list
6771590|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
6771591|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6771592|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
6771593|NCT02137239|Hormones|hormones|mesh-ancestor
6771594|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6771595|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771596|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6771597|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771598|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6771599|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
6771600|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6771601|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771602|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771603|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6771604|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6771605|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
6771606|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6771607|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771608|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
6771609|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
6771610|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771611|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771612|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6771613|NCT02137239|Protective Agents|protective agents|mesh-ancestor
6771614|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6771615|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6771616|NCT02137265|Clomiphene|clomiphene|mesh-list
6771617|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6771618|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
6771619|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6771620|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771621|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6771622|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
6771623|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6771624|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6771625|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6771626|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
6771627|NCT02137278|Levodopa|levodopa|mesh-list
6771628|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
6771629|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
6771630|NCT02137278|Diuretics|diuretics|mesh-list
6771631|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6771632|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
6771633|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771634|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
6771635|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771636|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771637|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6771638|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6771639|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6771640|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771641|NCT02137356|Capecitabine|capecitabine|mesh-list
6771642|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6771643|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
6771644|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771645|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771646|NCT02137395|Dexamethasone|dexamethasone|mesh-list
6771647|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6771648|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
6771649|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
6771650|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771651|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771652|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771653|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
6771654|NCT02137395|Hormones|hormones|mesh-ancestor
6771655|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6771656|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6771657|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771658|NCT02137421|Resveratrol|resveratrol|mesh-list
6771659|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
6771660|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771661|NCT02137421|Protective Agents|protective agents|mesh-ancestor
6771662|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771663|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771664|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6771665|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
6771666|NCT02137434|Calcium|calcium|mesh-list
6771667|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6771668|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771669|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6771670|NCT02137525|Fentanyl|fentanyl|mesh-list
6771671|NCT02137525|Morphine|morphine|mesh-list
6771672|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6771673|NCT02137525|Narcotics|narcotics|mesh-ancestor
6771674|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771675|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771676|NCT02137525|Analgesics|analgesics|mesh-ancestor
6771677|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
6771678|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771679|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6771680|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6771681|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
6771682|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
6771683|NCT02137616|Olanzapine|olanzapine|mesh-list
6771684|NCT02137616|Risperidone|risperidone|mesh-list
6771685|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6771686|NCT02137616|Aripiprazole|aripiprazole|mesh-list
6771687|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6771688|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
6771689|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771690|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771691|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771692|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6771693|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6771694|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771695|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6771696|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6771697|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
6771698|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
6771699|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
6771700|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771701|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771702|NCT02137616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6771703|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6771704|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6771705|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
6771706|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
6771707|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6771708|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6771709|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6771710|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6771711|NCT02137629|Azacitidine|azacitidine|mesh-list
6771712|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6771713|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
6771714|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771715|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771716|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771717|NCT02137668|Vancomycin|vancomycin|mesh-list
6771718|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6771719|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771720|NCT02137681|Rituximab|rituximab|mesh-list
6771721|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6771722|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771723|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
6771724|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771725|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6771726|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6771727|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6771728|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771729|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6771730|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
6771731|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771732|NCT02137733|Carvedilol|carvedilol|mesh-list
6771733|NCT02137733|Bisoprolol|bisoprolol|mesh-list
6771734|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6771735|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6771736|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
6771737|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771738|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771739|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771740|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6771741|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
6771742|NCT02137733|Protective Agents|protective agents|mesh-ancestor
6771743|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6771744|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6771745|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6771746|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
6771747|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6771748|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6771749|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
6771750|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
6771751|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771752|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6771753|NCT02137759|Temozolomide|temozolomide|mesh-list
6771754|NCT02137759|Belinostat|belinostat|mesh-list
6771755|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6771756|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
6771757|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771758|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771759|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6771760|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771761|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
6771762|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6771763|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771764|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771765|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6771766|NCT02137863|Analgesics|analgesics|mesh-ancestor
6771767|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
6771768|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771769|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6771770|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6771771|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6771772|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
6771773|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771774|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790249|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
6790250|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790251|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6790252|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6790253|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6790254|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6790255|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790256|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6790257|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6790258|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
6790259|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790260|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6790261|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790262|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
6790263|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6771775|NCT02137928|Carboplatin|carboplatin|mesh-list
6771776|NCT02137928|Etoposide|etoposide|mesh-list
6771777|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
6771778|NCT02137928|Vincristine|vincristine|mesh-list
6771779|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771780|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6771781|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6771782|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6771783|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771784|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771785|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
6771786|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
6771787|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
6771788|NCT02137954|Lidocaine|lidocaine|mesh-list
6771789|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
6771790|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
6771791|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771792|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771793|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
6771794|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771795|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6771796|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6771797|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6771798|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6771799|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771800|NCT02137993|Olanzapine|olanzapine|mesh-list
6771801|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
6771802|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
6771803|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771804|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771805|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6771806|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6771807|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6771808|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771809|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6771810|NCT02137993|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6771811|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6771812|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6771813|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771814|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771815|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
6771816|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6771817|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
6771818|NCT02138019|Coagulants|coagulants|mesh-ancestor
6771819|NCT02138045|Liraglutide|liraglutide|mesh-list
6771820|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6771821|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771822|NCT02138045|Incretins|incretins|mesh-ancestor
6771823|NCT02138045|Hormones|hormones|mesh-ancestor
6771824|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6771825|NCT02138058|Topiramate|topiramate|mesh-list
6771826|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
6771827|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6771828|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771829|NCT02138084|Ritonavir|ritonavir|mesh-list
6771830|NCT02138084|Fostemsavir|fostemsavir|mesh-list
6771831|NCT02138084|Rifabutin|rifabutin|mesh-list
6771832|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6771833|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6771834|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
6771835|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771836|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771837|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6771838|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6771839|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
6771840|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771841|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6771842|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6771843|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6771844|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6771845|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
6771846|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6771847|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6771848|NCT02138292|Trametinib|trametinib|mesh-list
6771849|NCT02138292|Digoxin|digoxin|mesh-list
6771850|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771851|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6771852|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771853|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771854|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6771855|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6771856|NCT02138292|Protective Agents|protective agents|mesh-ancestor
6771857|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771858|NCT02138357|Buprenorphine|buprenorphine|mesh-list
6771859|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6771860|NCT02138357|Narcotics|narcotics|mesh-ancestor
6771861|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771862|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771863|NCT02138357|Analgesics|analgesics|mesh-ancestor
6771864|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
6771865|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771866|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6771867|NCT02138383|Gemcitabine|gemcitabine|mesh-list
6771868|NCT02138383|Paclitaxel|paclitaxel|mesh-list
6771869|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6771870|NCT02138383|Androgens|androgens|mesh-list
6771871|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6771872|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771873|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
6771874|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
6771875|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
6771876|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771877|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6771878|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
6771879|NCT02138383|Antiviral Agents|antiviral agents|mesh-ancestor
6771880|NCT02138383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771881|NCT02138383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771882|NCT02138383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6771883|NCT02138383|Immunologic Factors|immunologic factors|mesh-ancestor
6771884|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771885|NCT02138383|Hormones|hormones|mesh-ancestor
6771886|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6771887|NCT02138396|Fentanyl|fentanyl|mesh-list
6771888|NCT02138396|Naltrexone|naltrexone|mesh-list
6771889|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6771890|NCT02138396|Narcotics|narcotics|mesh-ancestor
6771891|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771892|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771893|NCT02138396|Analgesics|analgesics|mesh-ancestor
6771894|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
6771895|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771896|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6771897|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6771898|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
6771899|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
6771900|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6771901|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6771902|NCT02138409|Fentanyl|fentanyl|mesh-list
6771903|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6771904|NCT02138409|Narcotics|narcotics|mesh-ancestor
6771905|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6771906|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771907|NCT02138409|Analgesics|analgesics|mesh-ancestor
6771908|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
6771909|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771910|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6771911|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6771912|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
6771913|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
6771914|NCT02138500|PF-06372865|pf-06372865|mesh-list
6771915|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
6771916|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
6771917|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771918|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771919|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771920|NCT02138539|Hydroquinone|hydroquinone|mesh-list
6771921|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
6771922|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771923|NCT02138539|Protective Agents|protective agents|mesh-ancestor
6771924|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771925|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6771926|NCT02138552|Octenidine|octenidine|mesh-list
6771927|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771928|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6771929|NCT02138617|Leucovorin|leucovorin|mesh-list
6771930|NCT02138617|Bevacizumab|bevacizumab|mesh-list
6771931|NCT02138617|Fluorouracil|fluorouracil|mesh-list
6771932|NCT02138617|Irinotecan|irinotecan|mesh-list
6771933|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
6771934|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6771935|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6771936|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6771937|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6771938|NCT02138617|Growth Substances|growth substances|mesh-ancestor
6771939|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771940|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
6771941|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
6771942|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771943|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6771944|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6771945|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
6771946|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6771947|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6771948|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771949|NCT02138617|Antidotes|antidotes|mesh-ancestor
6771950|NCT02138617|Protective Agents|protective agents|mesh-ancestor
6771951|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
6771952|NCT02138617|Vitamins|vitamins|mesh-ancestor
6771953|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
6771954|NCT02138630|Capsaicin|capsaicin|mesh-list
6771955|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
6771956|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
6771957|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
6771958|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771959|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771960|NCT02138708|Adenosine|adenosine|mesh-list
6771961|NCT02138708|Acetylcholine|acetylcholine|mesh-list
6771962|NCT02138708|Analgesics|analgesics|mesh-ancestor
6771963|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
6771964|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6771965|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771966|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6771967|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
6771968|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6771969|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
6771970|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
6771971|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771972|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771973|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6771974|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
6771975|NCT02138773|Tamsulosin|tamsulosin|mesh-list
6771976|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6771977|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6771978|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6771979|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
6771980|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6771981|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771982|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6771983|NCT02138773|Urological Agents|urological agents|mesh-ancestor
6771984|NCT02138799|Rifampin|rifampin|mesh-list
6771985|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6771986|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
6771987|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6771988|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6771989|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
6771990|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6771991|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6771992|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6771993|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6771994|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6771995|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6771996|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6771997|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6771998|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6771999|NCT02138812|Paclitaxel|paclitaxel|mesh-list
6772000|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6772001|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772002|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
6772003|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
6772004|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
6772005|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772006|NCT02138929|Everolimus|everolimus|mesh-list
6772007|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772008|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6772009|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
6772010|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772011|NCT02138955|Curcumin|curcumin|mesh-list
6772012|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6772013|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6772014|NCT02138955|Analgesics|analgesics|mesh-ancestor
6772015|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
6772016|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772017|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772018|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6772019|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6772020|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772021|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772022|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772023|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6772024|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
6772025|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772026|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6772027|NCT02139098|Amitriptyline|amitriptyline|mesh-list
6772028|NCT02139098|Zolpidem|zolpidem|mesh-list
6772029|NCT02139098|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6772030|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6772031|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6772032|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772033|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772034|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6772035|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
6772036|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
6772037|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772038|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772039|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6772040|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
6772041|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6772042|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6772043|NCT02139098|Analgesics|analgesics|mesh-ancestor
6772044|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
6772045|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772046|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6772047|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6772048|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6772049|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
6772050|NCT02139098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6772051|NCT02139098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6772052|NCT02139241|Ramosetron|ramosetron|mesh-list
6772053|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
6772054|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
6772055|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772056|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772057|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6772058|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6772059|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
6772060|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772061|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772062|NCT02139267|Vaccines|vaccines|mesh-list
6772063|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
6772064|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772065|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
6772066|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6772067|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6772068|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772069|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
6772070|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772071|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772072|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6772073|NCT02139579|Bevacizumab|bevacizumab|mesh-list
6772074|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6772075|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772076|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6772077|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6772078|NCT02139579|Growth Substances|growth substances|mesh-ancestor
6772079|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772080|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
6790264|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790265|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
6790266|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
6790267|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6790268|NCT02234349|Pancrelipase|pancrelipase|mesh-list
6790269|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6790270|NCT02234440|Metformin|metformin|mesh-list
6790271|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6790272|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790273|NCT02234466|Dexamethasone|dexamethasone|mesh-list
6790274|NCT02234466|Ondansetron|ondansetron|mesh-list
6790275|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6790276|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
6790277|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
6790278|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790279|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790280|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6790281|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
6790282|NCT02234466|Hormones|hormones|mesh-ancestor
6790283|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790284|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6790285|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790286|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
6790287|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
6790288|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6790289|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
6790290|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790291|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790292|NCT02234466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6790293|NCT02234466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6790294|NCT02234466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790295|NCT02234466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6790296|NCT02234466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6790297|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6790298|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6790299|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6790300|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
6790301|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790302|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6790303|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6790304|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790305|NCT02234544|Vitamin D|vitamin d|mesh-list
6790306|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
6790307|NCT02234544|Ezetimibe|ezetimibe|mesh-list
6790308|NCT02234544|Vitamins|vitamins|mesh-ancestor
6790309|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
6772081|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6772082|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
6772083|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6772084|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
6772085|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
6772086|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
6772087|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772088|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
6772089|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6772090|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6772091|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6772092|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6772093|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772094|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6772095|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772096|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6772097|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6772098|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772099|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6772100|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6772101|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
6772102|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772103|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
6772104|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6772105|NCT02139761|Analgesics|analgesics|mesh-ancestor
6772106|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
6772107|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772108|NCT02139852|Capsaicin|capsaicin|mesh-list
6772109|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
6772110|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
6772111|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
6772112|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772113|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772114|NCT02139904|Vinorelbine|vinorelbine|mesh-list
6772115|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6772116|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772117|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
6772118|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
6772119|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
6772120|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772121|NCT02139930|Nicotine|nicotine|mesh-list
6772122|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6772123|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
6772124|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772125|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772126|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6772127|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6772128|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
6772129|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772130|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772131|NCT02140047|Vaccines|vaccines|mesh-list
6772132|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
6772133|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772134|NCT02140073|Domperidone|domperidone|mesh-list
6772135|NCT02140073|Omeprazole|omeprazole|mesh-list
6772136|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6772137|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6772138|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6772139|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772140|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772141|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
6772142|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
6772143|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772144|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772145|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6772146|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
6772147|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772148|NCT02140151|Ranibizumab|ranibizumab|mesh-list
6772149|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6772150|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6772151|NCT02140151|Growth Substances|growth substances|mesh-ancestor
6772152|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772153|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
6772154|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772155|NCT02140242|Daunorubicin|daunorubicin|mesh-list
6772156|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6772157|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772158|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6772159|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6772160|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772161|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772162|NCT02140255|Ritonavir|ritonavir|mesh-list
6772163|NCT02140255|Lopinavir|lopinavir|mesh-list
6772164|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
6772165|NCT02140255|Nevirapine|nevirapine|mesh-list
6772166|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6772167|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6772168|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6772169|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
6772170|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772171|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772172|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6772173|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6772174|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
6772175|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772176|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6772177|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6772178|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6772179|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6772180|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6772181|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6772182|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6772183|NCT02140268|Midazolam|midazolam|mesh-list
6772184|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6772185|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6772186|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772187|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772188|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6772189|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6772190|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6772191|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6772192|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
6772193|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
6772194|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
6772195|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
6772196|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772197|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772198|NCT02140281|Cefadroxil|cefadroxil|mesh-list
6772199|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6772200|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772201|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6772202|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772203|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6772204|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772205|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772206|NCT02140437|Fulvestrant|fulvestrant|mesh-list
6772207|NCT02140437|Anastrozole|anastrozole|mesh-list
6772208|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6772209|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772210|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6772211|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6772212|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
6772213|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6772214|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772215|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6772216|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6772217|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772218|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772219|NCT02140450|Timolol|timolol|mesh-list
6772220|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6772221|NCT02140450|Mannitol|mannitol|mesh-list
6772222|NCT02140450|Acetazolamide|acetazolamide|mesh-list
6772223|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6772224|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6772225|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
6772226|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772227|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772228|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772229|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6772230|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6772231|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6772232|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6772233|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6772234|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6772235|NCT02140450|Diuretics|diuretics|mesh-ancestor
6772236|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
6772237|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
6772238|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6772239|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772240|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6772241|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6772242|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6772243|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
6772244|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772245|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6772246|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6772247|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772248|NCT02140515|Hormones|hormones|mesh-list
6772249|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6772250|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6772251|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772252|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
6772253|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
6772254|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
6772255|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6772256|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6772257|NCT02140632|Prednisolone|prednisolone|mesh-list
6772258|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
6772259|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6772260|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
6772261|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6772262|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
6772263|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
6772264|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772265|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772266|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6772267|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
6772268|NCT02140632|Hormones|hormones|mesh-ancestor
6772269|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6772270|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6772271|NCT02140632|Protective Agents|protective agents|mesh-ancestor
6772272|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6772273|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772274|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
6772275|NCT02140736|Hematinics|hematinics|mesh-ancestor
6772276|NCT02140801|Clopidogrel|clopidogrel|mesh-list
6772277|NCT02140801|Ticagrelor|ticagrelor|mesh-list
6772278|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6772279|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6772280|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6772281|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6772282|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
6772283|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772284|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772285|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772286|NCT02140814|Niacinamide|niacinamide|mesh-list
6772287|NCT02140814|Niacin|niacin|mesh-list
6772288|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
6772289|NCT02140814|Vitamins|vitamins|mesh-ancestor
6772290|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
6772291|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772292|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
6772293|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6772294|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
6772295|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772296|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6772297|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
6772298|NCT02140840|Trametinib|trametinib|mesh-list
6772299|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772300|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6772301|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772302|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772303|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
6772304|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6772305|NCT02140983|Liraglutide|liraglutide|mesh-list
6772306|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6772307|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772308|NCT02140983|Incretins|incretins|mesh-ancestor
6772309|NCT02140983|Hormones|hormones|mesh-ancestor
6772310|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6772311|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6772312|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
6772313|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772314|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
6772315|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
6772316|NCT02141035|Vitamins|vitamins|mesh-ancestor
6772317|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
6772318|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772319|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
6772320|NCT02141087|Pirfenidone|pirfenidone|mesh-list
6772321|NCT02141087|Analgesics|analgesics|mesh-ancestor
6772322|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
6772323|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772324|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772325|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6772326|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6772327|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6772328|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6772329|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772330|NCT02141100|Thioguanine|thioguanine|mesh-list
6772331|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6772332|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
6772333|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772334|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772335|NCT02141113|Guanfacine|guanfacine|mesh-list
6772336|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6772337|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6772338|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6772339|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6772340|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
6772341|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772342|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772343|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772344|NCT02141139|Ibuprofen|ibuprofen|mesh-list
6772345|NCT02141139|Ketorolac|ketorolac|mesh-list
6772346|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6772347|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6772348|NCT02141139|Analgesics|analgesics|mesh-ancestor
6772349|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
6772350|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772351|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772352|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6772353|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6772354|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6772355|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772356|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772357|NCT02141178|Bupivacaine|bupivacaine|mesh-list
6772358|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
6772359|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
6772360|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772361|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772362|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
6772363|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790310|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790311|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6790312|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6790313|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6790314|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6790315|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
6790316|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790317|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6790318|NCT02234739|Voriconazole|voriconazole|mesh-list
6790319|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
6790320|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790321|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6790322|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6790323|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790324|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790325|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6790326|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
6790327|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790328|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790329|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6790330|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
6790331|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6790332|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
6790333|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6790334|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
6790335|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790336|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790337|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
6790338|NCT02234869|Interferons|interferons|mesh-list
6790339|NCT02234869|Interferon-beta|interferon-beta|mesh-list
6790340|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
6790341|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
6790342|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790343|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
6790344|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790345|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
6790346|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790347|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6790348|NCT02234882|Fostemsavir|fostemsavir|mesh-list
6790349|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6790350|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6790351|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6790352|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
6790353|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790354|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6790355|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6790356|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790357|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6790358|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6790359|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
6790360|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790361|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6790362|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6790363|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
6790364|NCT02234921|Imiquimod|imiquimod|mesh-list
6790365|NCT02234921|Vaccines|vaccines|mesh-list
6790366|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
6790367|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790368|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6790369|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6790370|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6790371|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
6772364|NCT02141321|Alprostadil|alprostadil|mesh-list
6772365|NCT02141321|Misoprostol|misoprostol|mesh-list
6772366|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6772367|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
6772368|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6772369|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772370|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6772371|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6772372|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
6772373|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6772374|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
6772375|NCT02141321|Urological Agents|urological agents|mesh-ancestor
6772376|NCT02141347|Durvalumab|durvalumab|mesh-list
6772377|NCT02141347|Tremelimumab|tremelimumab|mesh-list
6772378|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6772379|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772380|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
6772381|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6772382|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772383|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772384|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6772385|NCT02141412|Analgesics|analgesics|mesh-ancestor
6772386|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
6772387|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772388|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6772389|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6772390|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6772391|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
6772392|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772393|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772394|NCT02141425|Peficitinib|peficitinib|mesh-list
6772395|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772396|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772397|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6772398|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
6772399|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772400|NCT02141477|Decitabine|decitabine|mesh-list
6772401|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
6772402|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6772403|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
6772404|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772405|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772406|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772407|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6772408|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6772409|NCT02141542|Tremelimumab|tremelimumab|mesh-list
6772410|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772411|NCT02141698|Esomeprazole|esomeprazole|mesh-list
6772412|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6772413|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6772414|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6772415|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772416|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772417|NCT02141737|Lidocaine|lidocaine|mesh-list
6772418|NCT02141737|Fentanyl|fentanyl|mesh-list
6772419|NCT02141737|Midazolam|midazolam|mesh-list
6772420|NCT02141737|Etomidate|etomidate|mesh-list
6772421|NCT02141737|Rocuronium|rocuronium|mesh-list
6772422|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
6772423|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
6772424|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772425|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772426|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
6772427|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772428|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6772429|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6772430|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6772431|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6772432|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772433|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6772434|NCT02141737|Narcotics|narcotics|mesh-ancestor
6772435|NCT02141737|Analgesics|analgesics|mesh-ancestor
6772436|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6772437|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6772438|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
6772439|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6772440|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6772441|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6772442|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6772443|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
6772444|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
6772445|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772446|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6772447|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6772448|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6772449|NCT02141958|Fenretinide|fenretinide|mesh-list
6772450|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772451|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6772452|NCT02141958|Protective Agents|protective agents|mesh-ancestor
6772453|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772454|NCT02142010|Paclitaxel|paclitaxel|mesh-list
6772455|NCT02142010|Cisplatin|cisplatin|mesh-list
6772456|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6772457|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772458|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
6772459|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
6772460|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
6772461|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772462|NCT02142036|Trastuzumab|trastuzumab|mesh-list
6772463|NCT02142036|Cetuximab|cetuximab|mesh-list
6772464|NCT02142036|Panitumumab|panitumumab|mesh-list
6772465|NCT02142036|Everolimus|everolimus|mesh-list
6772466|NCT02142036|Sunitinib|sunitinib|mesh-list
6772467|NCT02142036|Dasatinib|dasatinib|mesh-list
6772468|NCT02142036|Lapatinib|lapatinib|mesh-list
6772469|NCT02142036|Gefitinib|gefitinib|mesh-list
6772470|NCT02142036|Afatinib|afatinib|mesh-list
6772471|NCT02142036|Vemurafenib|vemurafenib|mesh-list
6772472|NCT02142036|Dabrafenib|dabrafenib|mesh-list
6772473|NCT02142036|Crizotinib|crizotinib|mesh-list
6772474|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6772475|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772476|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6772477|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
6772478|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772479|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6772480|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772481|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772482|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6772483|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6772484|NCT02142036|Growth Substances|growth substances|mesh-ancestor
6772485|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
6772486|NCT02142075|Daptomycin|daptomycin|mesh-list
6772487|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6772488|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772489|NCT02142140|Methylphenidate|methylphenidate|mesh-list
6772490|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6772491|NCT02142140|Adderall|adderall|mesh-list
6772492|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
6772493|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
6772494|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6772495|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772496|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6772497|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6772498|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6772499|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772500|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
6772501|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772502|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6772503|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
6772504|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
6772505|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6772506|NCT02142192|Natalizumab|natalizumab|mesh-list
6772507|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
6772508|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772509|NCT02142205|Natalizumab|natalizumab|mesh-list
6772510|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
6772511|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772512|NCT02142218|Nivolumab|nivolumab|mesh-list
6772513|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6772514|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772515|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6772516|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772517|NCT02142296|Aflibercept|aflibercept|mesh-list
6772518|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6772519|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6772520|NCT02142296|Growth Substances|growth substances|mesh-ancestor
6772521|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772522|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
6772523|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772524|NCT02142309|Pioglitazone|pioglitazone|mesh-list
6772525|NCT02142309|Glimepiride|glimepiride|mesh-list
6772526|NCT02142309|Vildagliptin|vildagliptin|mesh-list
6772527|NCT02142309|Canagliflozin|canagliflozin|mesh-list
6772528|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6772529|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772530|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6772531|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6772532|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
6772533|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6772534|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
6772535|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772536|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772537|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6772538|NCT02142335|Rituximab|rituximab|mesh-list
6772539|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6772540|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772541|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
6772542|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772543|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6772544|NCT02142530|Belinostat|belinostat|mesh-list
6772545|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772546|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6772547|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772548|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772549|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
6772550|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
6772551|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
6772552|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6772553|NCT02142543|Protective Agents|protective agents|mesh-ancestor
6772554|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772555|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6772556|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
6772557|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6772558|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6772559|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6772560|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772561|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772562|NCT02142569|Tocotrienols|tocotrienols|mesh-list
6772563|NCT02142569|Vitamin E|vitamin e|mesh-list
6772564|NCT02142569|Tocopherols|tocopherols|mesh-list
6772565|NCT02142569|Red yeast rice|red yeast rice|mesh-list
6772566|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
6772567|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772568|NCT02142569|Protective Agents|protective agents|mesh-ancestor
6772569|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772570|NCT02142569|Vitamins|vitamins|mesh-ancestor
6772571|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
6772572|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6772573|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6772574|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6772575|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
6772576|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772577|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6772578|NCT02142595|Midazolam|midazolam|mesh-list
6772579|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
6772580|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6772581|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772582|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772583|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6772584|NCT02142595|Analgesics|analgesics|mesh-ancestor
6772585|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
6772586|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772587|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6772588|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6772589|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6772590|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
6772591|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772592|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772593|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6772594|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6772595|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6772596|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6772597|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6772598|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
6772599|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
6772600|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
6772601|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
6772602|NCT02142634|Budesonide|budesonide|mesh-list
6772603|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6772604|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6772605|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
6772606|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772607|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772608|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6772609|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
6772610|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
6772611|NCT02142634|Hormones|hormones|mesh-ancestor
6772612|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6772613|NCT02142751|Meropenem|meropenem|mesh-list
6772614|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
6772615|NCT02142751|Fosfomycin|fosfomycin|mesh-list
6772616|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6772617|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6772618|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772619|NCT02142777|Equol|equol|mesh-list
6772620|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
6772621|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6772622|NCT02142777|Estrogens|estrogens|mesh-ancestor
6772623|NCT02142777|Hormones|hormones|mesh-ancestor
6772624|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6772625|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772626|NCT02142790|Paclitaxel|paclitaxel|mesh-list
6772627|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6772628|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772629|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
6772630|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
6772631|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
6772632|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772633|NCT02142829|Bupivacaine|bupivacaine|mesh-list
6772634|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
6772635|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
6772636|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772637|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772638|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
6772639|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772640|NCT02142868|Letrozole|letrozole|mesh-list
6772641|NCT02142868|Palbociclib|palbociclib|mesh-list
6772642|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772643|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6772644|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6772645|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772646|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772647|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6772648|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
6772649|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6772650|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772651|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6772652|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
6772653|NCT02142920|Gedatolisib|gedatolisib|mesh-list
6772654|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6772655|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772656|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790372|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790373|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790374|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6790375|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6790376|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
6790377|NCT02235012|Ketamine|ketamine|mesh-list
6790378|NCT02235012|Analgesics|analgesics|mesh-ancestor
6790379|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
6790380|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790381|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790382|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6790383|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6790384|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
6790385|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
6790386|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790387|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6790388|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6790389|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790390|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790391|NCT02235194|Chromium|chromium|mesh-list
6790392|NCT02235194|Picolinic acid|picolinic acid|mesh-list
6790393|NCT02235194|Trace Elements|trace elements|mesh-ancestor
6790394|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
6790395|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790396|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6790397|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
6790398|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
6790399|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772657|NCT02143050|Metformin|metformin|mesh-list
6772658|NCT02143050|Trametinib|trametinib|mesh-list
6772659|NCT02143050|Dabrafenib|dabrafenib|mesh-list
6772660|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6772661|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772662|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772663|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6772664|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772665|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772666|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
6772667|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6772668|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6772669|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772670|NCT02143219|Leucovorin|leucovorin|mesh-list
6772671|NCT02143219|Folic Acid|folic acid|mesh-list
6772672|NCT02143219|Irinotecan|irinotecan|mesh-list
6772673|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
6772674|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
6772675|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6772676|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6772677|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772678|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772679|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772680|NCT02143219|Antidotes|antidotes|mesh-ancestor
6772681|NCT02143219|Protective Agents|protective agents|mesh-ancestor
6772682|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772683|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
6772684|NCT02143219|Vitamins|vitamins|mesh-ancestor
6772685|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
6772686|NCT02143219|Hematinics|hematinics|mesh-ancestor
6772687|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6772688|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6772689|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772690|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6772691|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772692|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772693|NCT02143362|Remifentanil|remifentanil|mesh-list
6772694|NCT02143362|Anesthetics|anesthetics|mesh-list
6772695|NCT02143362|Propofol|propofol|mesh-list
6772696|NCT02143362|Cisatracurium|cisatracurium|mesh-list
6772697|NCT02143362|Atracurium|atracurium|mesh-list
6772698|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772699|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772700|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6772701|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6772702|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
6772703|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6772704|NCT02143362|Narcotics|narcotics|mesh-ancestor
6772705|NCT02143362|Analgesics|analgesics|mesh-ancestor
6772706|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
6772707|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772708|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6772709|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6772710|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6772711|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6772712|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6772713|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
6772714|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772715|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772716|NCT02143414|Prednisone|prednisone|mesh-list
6772717|NCT02143414|Cortisone|cortisone|mesh-list
6772718|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6772719|NCT02143414|Methotrexate|methotrexate|mesh-list
6772720|NCT02143414|Vincristine|vincristine|mesh-list
6772721|NCT02143414|Dasatinib|dasatinib|mesh-list
6772722|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
6772723|NCT02143414|Blinatumomab|blinatumomab|mesh-list
6772724|NCT02143414|Antibodies|antibodies|mesh-list
6772725|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
6772726|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6772727|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
6772728|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
6772729|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
6772730|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772731|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772732|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6772733|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
6772734|NCT02143414|Hormones|hormones|mesh-ancestor
6772735|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6772736|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6772737|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6772738|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
6772739|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6772740|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6772741|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
6772742|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772743|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
6772744|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772745|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6772746|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6772747|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6772748|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6772749|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6772750|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
6772751|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
6772752|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
6772753|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6772754|NCT02143440|Insulin|insulin|mesh-list
6772755|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6772756|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772757|NCT02143479|Tacrolimus|tacrolimus|mesh-list
6772758|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6772759|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
6772760|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772761|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6772762|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772763|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772764|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6772765|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
6772766|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6772767|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
6772768|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772769|NCT02143518|Antacids|antacids|mesh-ancestor
6772770|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772771|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6772772|NCT02143531|Haloperidol|haloperidol|mesh-list
6772773|NCT02143531|Ondansetron|ondansetron|mesh-list
6772774|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
6772775|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
6772776|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
6772777|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772778|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772779|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6772780|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
6772781|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
6772782|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6772783|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
6772784|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772785|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772786|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6772787|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6772788|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772789|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6772790|NCT02143531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6772791|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6772792|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
6772793|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6772794|NCT02143570|Darifenacin|darifenacin|mesh-list
6772795|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6772796|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6772797|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
6772798|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772799|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772800|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772801|NCT02143570|Urological Agents|urological agents|mesh-ancestor
6772802|NCT02143622|Cetuximab|cetuximab|mesh-list
6772803|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6772804|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772805|NCT02143687|Sevoflurane|sevoflurane|mesh-list
6772806|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6772807|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6772808|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
6772809|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
6772810|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772811|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772812|NCT02143726|Everolimus|everolimus|mesh-list
6772813|NCT02143726|Sorafenib|sorafenib|mesh-list
6772814|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772815|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6772816|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
6772817|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772818|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6772819|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772820|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772821|NCT02143765|Acarbose|acarbose|mesh-list
6772822|NCT02143765|Mitiglinide|mitiglinide|mesh-list
6772823|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6772824|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772825|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772826|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6772827|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772828|NCT02143804|Molgramostim|molgramostim|mesh-list
6772829|NCT02143804|Sargramostim|sargramostim|mesh-list
6772830|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
6772831|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772832|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772833|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
6772834|NCT02143830|Busulfan|busulfan|mesh-list
6772835|NCT02143830|Fludarabine|fludarabine|mesh-list
6772836|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
6772837|NCT02143830|Lenograstim|lenograstim|mesh-list
6772838|NCT02143830|Sargramostim|sargramostim|mesh-list
6772839|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6772840|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
6772841|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772842|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6772843|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6772844|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
6772845|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772846|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772847|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6772848|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6772849|NCT02143934|Chloroquine|chloroquine|mesh-list
6772850|NCT02143934|Lumefantrine|lumefantrine|mesh-list
6772851|NCT02143934|Artemether|artemether|mesh-list
6772852|NCT02143934|Primaquine|primaquine|mesh-list
6772853|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6772854|NCT02143934|Amebicides|amebicides|mesh-ancestor
6772855|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6772856|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6772857|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772858|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
6772859|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6772860|NCT02144025|Cyclosporine|cyclosporine|mesh-list
6772861|NCT02144025|Cyclosporins|cyclosporins|mesh-list
6772862|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772863|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772864|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6772865|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
6772866|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772867|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
6772868|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772869|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
6772870|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6772871|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6772872|NCT02144064|Heparin|heparin|mesh-list
6772873|NCT02144064|Calcium heparin|calcium heparin|mesh-list
6772874|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
6772875|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6772876|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6772877|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772878|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
6772879|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6772880|NCT02144194|Docetaxel|docetaxel|mesh-list
6772881|NCT02144194|Vinorelbine|vinorelbine|mesh-list
6772882|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772883|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
6772884|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
6772885|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
6772886|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772887|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6772888|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
6772889|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6772890|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6772891|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6772892|NCT02144246|Norgestimate|norgestimate|mesh-list
6772893|NCT02144246|Norgestrel|norgestrel|mesh-list
6772894|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6772895|NCT02144246|Estradiol|estradiol|mesh-list
6772896|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6772897|NCT02144246|Estrogens|estrogens|mesh-ancestor
6772898|NCT02144246|Hormones|hormones|mesh-ancestor
6772899|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6772900|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772901|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6772902|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
6772903|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6772904|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6772905|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6772906|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6772907|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6772908|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6772909|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772910|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6772911|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6772912|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772913|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772914|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772915|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6772916|NCT02144376|Psyllium|psyllium|mesh-list
6772917|NCT02144376|Cathartics|cathartics|mesh-ancestor
6772918|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6772919|NCT02144389|Praziquantel|praziquantel|mesh-list
6772920|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
6772921|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6772922|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772923|NCT02144415|Amphetamine|amphetamine|mesh-list
6772924|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6772925|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
6772926|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6772927|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772928|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
6772929|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
6772930|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772931|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
6772932|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772933|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772934|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
6772935|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6772936|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6772937|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6772938|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6772939|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
6772940|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6772941|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790400|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
6790401|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6790402|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790403|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
6790404|NCT02235246|Analgesics|analgesics|mesh-ancestor
6790405|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
6790406|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790407|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790408|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
6790409|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790410|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6790411|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
6790412|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6790413|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6790414|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790415|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6790416|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
6790417|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6790418|NCT02235324|Leucovorin|leucovorin|mesh-list
6790419|NCT02235324|Fluorouracil|fluorouracil|mesh-list
6790420|NCT02235324|Aflibercept|aflibercept|mesh-list
6790421|NCT02235324|Calcium|calcium|mesh-list
6790422|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
6790423|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
6790424|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6790425|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790426|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
6790427|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790428|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6790429|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790430|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6790431|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
6790432|NCT02235324|Antidotes|antidotes|mesh-ancestor
6790433|NCT02235324|Protective Agents|protective agents|mesh-ancestor
6790434|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
6790435|NCT02235324|Vitamins|vitamins|mesh-ancestor
6790436|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
6790437|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6790438|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6790439|NCT02235324|Growth Substances|growth substances|mesh-ancestor
6790440|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
6790441|NCT02235337|Riboflavin|riboflavin|mesh-list
6790442|NCT02235337|Vitamins|vitamins|mesh-ancestor
6790443|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
6790444|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790445|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
6790446|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6790447|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
6790448|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6790449|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6790450|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6790451|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790452|NCT02235402|Lacidipine|lacidipine|mesh-list
6790453|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
6790454|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6790455|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6790456|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6790457|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790458|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6790459|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790460|NCT02235402|Diuretics|diuretics|mesh-ancestor
6790461|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
6790462|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6790463|NCT02235415|Lacidipine|lacidipine|mesh-list
6790464|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6772942|NCT02144623|Valproic Acid|valproic acid|mesh-list
6772943|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
6772944|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6772945|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772946|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
6772947|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6772948|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772949|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
6772950|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6772951|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772952|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6772953|NCT02144662|Ranibizumab|ranibizumab|mesh-list
6772954|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6772955|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6772956|NCT02144662|Growth Substances|growth substances|mesh-ancestor
6772957|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772958|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
6772959|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772960|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
6772961|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
6772962|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6772963|NCT02144753|Psyllium|psyllium|mesh-list
6772964|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
6772965|NCT02144753|Cathartics|cathartics|mesh-ancestor
6772966|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6772967|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
6772968|NCT02144766|Ropivacaine|ropivacaine|mesh-list
6772969|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
6772970|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
6772971|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6772972|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772973|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
6772974|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772975|NCT02144792|Verapamil|verapamil|mesh-list
6772976|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6772977|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6772978|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6772979|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6772980|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6772981|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772982|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
6772983|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6772984|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
6772985|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6772986|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
6772987|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6772988|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6772989|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6772990|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6772991|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6772992|NCT02144831|Aspirin|aspirin|mesh-list
6772993|NCT02144831|Clopidogrel|clopidogrel|mesh-list
6772994|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6772995|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6772996|NCT02144831|Analgesics|analgesics|mesh-ancestor
6772997|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
6772998|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6772999|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773000|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6773001|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6773002|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6773003|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6773004|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773005|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6773006|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6773007|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773008|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
6773009|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6773010|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6773011|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6773012|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
6773013|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773014|NCT02144922|Pitavastatin|pitavastatin|mesh-list
6773015|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6773016|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6773017|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6773018|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
6773019|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773020|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773021|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6773022|NCT02145065|Paclitaxel|paclitaxel|mesh-list
6773023|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6773024|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773025|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
6773026|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
6773027|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
6773028|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773029|NCT02145091|Psilocybin|psilocybin|mesh-list
6773030|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
6773031|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
6773032|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773033|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6773034|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6773035|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
6773036|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773037|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773038|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6773039|NCT02145104|Valsartan|valsartan|mesh-list
6773040|NCT02145104|Cilnidipine|cilnidipine|mesh-list
6773041|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6773042|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6773043|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6773044|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773045|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6773046|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773047|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6773048|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773049|NCT02145143|Vemurafenib|vemurafenib|mesh-list
6773050|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773051|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6773052|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773053|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773054|NCT02145195|Vitamin D|vitamin d|mesh-list
6773055|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
6773056|NCT02145195|Vitamins|vitamins|mesh-ancestor
6773057|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
6773058|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773059|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6773060|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6773061|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
6773062|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6773063|NCT02145338|Trimethoprim|trimethoprim|mesh-list
6773064|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
6773065|NCT02145338|Cephalexin|cephalexin|mesh-list
6773066|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6773067|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773068|NCT02145338|Renal Agents|renal agents|mesh-ancestor
6773069|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
6773070|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6773071|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6773072|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6773073|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773074|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773075|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6773076|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6773077|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6773078|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6773079|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
6773080|NCT02145520|Analgesics|analgesics|mesh-ancestor
6773081|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
6773082|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773083|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773084|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
6773085|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773086|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6773087|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
6773088|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6773089|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773090|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773091|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6773092|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
6773093|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6773094|NCT02145546|Amiodarone|amiodarone|mesh-list
6773095|NCT02145546|Sotalol|sotalol|mesh-list
6773096|NCT02145546|Propafenone|propafenone|mesh-list
6773097|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6773098|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
6773099|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6773100|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773101|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773102|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6773103|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6773104|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6773105|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773106|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6773107|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6773108|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6773109|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6773110|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6773111|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
6773112|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773113|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773114|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
6773115|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
6773116|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773117|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6773118|NCT02145559|Metformin|metformin|mesh-list
6773119|NCT02145559|Sirolimus|sirolimus|mesh-list
6773120|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6773121|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773122|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6773123|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773124|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6773125|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773126|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
6773127|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6773128|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
6773129|NCT02145585|Anesthetics|anesthetics|mesh-list
6773130|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773131|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773132|NCT02145598|Lenalidomide|lenalidomide|mesh-list
6773133|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
6773134|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773135|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6773136|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6773137|NCT02145598|Growth Substances|growth substances|mesh-ancestor
6773138|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
6773139|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773140|NCT02145611|Vildagliptin|vildagliptin|mesh-list
6773141|NCT02145611|Glyburide|glyburide|mesh-list
6773142|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6773143|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773144|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6773145|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
6773146|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773147|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773148|NCT02145624|Vaccines|vaccines|mesh-list
6773149|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
6773150|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773151|NCT02145637|Afatinib|afatinib|mesh-list
6773152|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773153|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6773154|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773155|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773156|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
6773157|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6773158|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6773159|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6773160|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773161|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773162|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
6773163|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773164|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773165|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6773166|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773167|NCT02145715|Thalidomide|thalidomide|mesh-list
6773168|NCT02145715|Dexamethasone|dexamethasone|mesh-list
6773169|NCT02145715|Bortezomib|bortezomib|mesh-list
6773170|NCT02145715|Panobinostat|panobinostat|mesh-list
6773171|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6773172|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
6773173|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
6773174|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773175|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773176|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6773177|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
6773178|NCT02145715|Hormones|hormones|mesh-ancestor
6773179|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773180|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6773181|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773182|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6773183|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
6773184|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
6773185|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6773186|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773187|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6773188|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6773189|NCT02145715|Growth Substances|growth substances|mesh-ancestor
6773190|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
6773191|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6773192|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773193|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773194|NCT02145767|Progesterone|progesterone|mesh-list
6773195|NCT02145767|Progestins|progestins|mesh-ancestor
6773196|NCT02145767|Hormones|hormones|mesh-ancestor
6790465|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6773197|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773198|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773199|NCT02145832|Fluconazole|fluconazole|mesh-list
6773200|NCT02145832|Micafungin|micafungin|mesh-list
6773201|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
6773202|NCT02145832|Clotrimazole|clotrimazole|mesh-list
6773203|NCT02145832|Miconazole|miconazole|mesh-list
6773204|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773205|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6773206|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6773207|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773208|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773209|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6773210|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
6773211|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773212|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773213|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6773214|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6773215|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6773216|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6773217|NCT02145884|Timolol|timolol|mesh-list
6773218|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6773219|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6773220|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
6773221|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773222|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773223|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773224|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6773225|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6773226|NCT02145910|Vemurafenib|vemurafenib|mesh-list
6773227|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773228|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6773229|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773230|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773231|NCT02145949|Tryptophan|tryptophan|mesh-list
6773232|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6773233|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
6773234|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6773235|NCT02145975|Fentanyl|fentanyl|mesh-list
6773236|NCT02145975|Morphine|morphine|mesh-list
6773237|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
6773238|NCT02145975|Narcotics|narcotics|mesh-ancestor
6773239|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773240|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773241|NCT02145975|Analgesics|analgesics|mesh-ancestor
6773242|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
6773243|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773244|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6773245|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6773246|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
6773247|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
6773248|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6773249|NCT02146118|Silybin|silybin|mesh-list
6773250|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773251|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6773252|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773253|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773254|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6773255|NCT02146118|Protective Agents|protective agents|mesh-ancestor
6773256|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773257|NCT02146209|Metronidazole|metronidazole|mesh-list
6773258|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773259|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6773260|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6773261|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6773262|NCT02146222|Docetaxel|docetaxel|mesh-list
6773263|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773264|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
6773265|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
6773266|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
6773267|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790466|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6790467|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773268|NCT02146261|Quetmolimab|quetmolimab|mesh-list
6773269|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6773270|NCT02146300|Xylometazoline|xylometazoline|mesh-list
6773271|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
6773272|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6773273|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
6773274|NCT02146391|Enclomiphene|enclomiphene|mesh-list
6773275|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6773276|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
6773277|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773278|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773279|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6773280|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
6773281|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6773282|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6773283|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6773284|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
6773285|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6773286|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6773287|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773288|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
6773289|NCT02146456|Coagulants|coagulants|mesh-ancestor
6773290|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
6773291|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6773292|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773293|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773294|NCT02146547|Aripiprazole|aripiprazole|mesh-list
6773295|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6773296|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
6773297|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6773298|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6773299|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6773300|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773301|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773302|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
6773303|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
6773304|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773305|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773306|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6773307|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6773308|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
6773309|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6773310|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6773311|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6773312|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6773313|NCT02146638|Fentanyl|fentanyl|mesh-list
6773314|NCT02146638|Morphine|morphine|mesh-list
6773315|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6773316|NCT02146638|Narcotics|narcotics|mesh-ancestor
6773317|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773318|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773319|NCT02146638|Analgesics|analgesics|mesh-ancestor
6773320|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
6773321|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773322|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6773323|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6773324|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
6773325|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
6773326|NCT02146651|Insulin|insulin|mesh-list
6773327|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6773328|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
6773329|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6773330|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773331|NCT02146703|Gemcitabine|gemcitabine|mesh-list
6773332|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6773333|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
6773334|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773335|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773336|NCT02146703|Antiviral Agents|antiviral agents|mesh-ancestor
6773337|NCT02146703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773338|NCT02146703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773339|NCT02146703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6773340|NCT02146703|Immunologic Factors|immunologic factors|mesh-ancestor
6773341|NCT02146703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773342|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
6773343|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773344|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6773345|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773346|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773347|NCT02146911|Bupropion|bupropion|mesh-list
6773348|NCT02146911|Varenicline|varenicline|mesh-list
6773349|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6773350|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
6773351|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6773352|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6773353|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6773354|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773355|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773356|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
6773357|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773358|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773359|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6773360|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6773361|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773362|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6773363|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6773364|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
6773365|NCT02146937|Bicalutamide|bicalutamide|mesh-list
6773366|NCT02146937|Finasteride|finasteride|mesh-list
6773367|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
6773368|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
6773369|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773370|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773371|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773372|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6773373|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6773374|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773375|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773376|NCT02146937|Urological Agents|urological agents|mesh-ancestor
6773377|NCT02146976|Propofol|propofol|mesh-list
6773378|NCT02146976|Sevoflurane|sevoflurane|mesh-list
6773379|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6773380|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773381|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773382|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6773383|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
6773384|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
6773385|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6773386|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6773387|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6773388|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
6773389|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
6773390|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
6773391|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
6773392|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773393|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6773394|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
6773395|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
6773396|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773397|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773398|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6773399|NCT02147015|Hormones|hormones|mesh-ancestor
6773400|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773401|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6773402|NCT02147015|Protective Agents|protective agents|mesh-ancestor
6773403|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773404|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773405|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6773406|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
6773407|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
6773408|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773409|NCT02147041|Protective Agents|protective agents|mesh-ancestor
6773410|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773411|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
6773412|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6773413|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773414|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6773415|NCT02147054|Rocuronium|rocuronium|mesh-list
6773416|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6773417|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6773418|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6773419|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773420|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773421|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6773422|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773423|NCT02147262|Doxycycline|doxycycline|mesh-list
6773424|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6773425|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773426|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
6773427|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6773428|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6773429|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6773430|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6773431|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6773432|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773433|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773434|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6773435|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6773436|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6773437|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6773438|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
6773439|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773440|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773441|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6773442|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6773443|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
6773444|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6773445|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6773446|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
6773447|NCT02147535|Methylphenidate|methylphenidate|mesh-list
6773448|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6773449|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773450|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6773451|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6773452|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773453|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773454|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
6773455|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773456|NCT02147548|Lorazepam|lorazepam|mesh-list
6773457|NCT02147548|Etifoxine|etifoxine|mesh-list
6773458|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
6773459|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
6773460|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
6773461|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773462|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773463|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6773464|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6773465|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773466|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6773467|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6773468|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6773469|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
6773470|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
6773471|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773472|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773473|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
6773474|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6773475|NCT02147678|Remifentanil|remifentanil|mesh-list
6773476|NCT02147678|Propofol|propofol|mesh-list
6773477|NCT02147678|Etomidate|etomidate|mesh-list
6773478|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
6773479|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773480|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773481|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6773482|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6773483|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
6773484|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6773485|NCT02147678|Narcotics|narcotics|mesh-ancestor
6773486|NCT02147678|Analgesics|analgesics|mesh-ancestor
6773487|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
6773488|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773489|NCT02147730|Anesthetics|anesthetics|mesh-list
6773490|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773491|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773492|NCT02147808|Midazolam|midazolam|mesh-list
6773493|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6773494|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6773495|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773496|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773497|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6773498|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6773499|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6773500|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6773501|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
6773502|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
6773503|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
6773504|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
6773505|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773506|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773507|NCT02147873|Azacitidine|azacitidine|mesh-list
6773508|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6773509|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
6773510|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773511|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773512|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790468|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6790469|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790470|NCT02235428|Bromides|bromides|mesh-list
6790471|NCT02235428|Albuterol|albuterol|mesh-list
6790472|NCT02235428|Ipratropium|ipratropium|mesh-list
6790473|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
6790474|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790475|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
6790476|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790477|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790478|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6790479|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790480|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
6790481|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6790482|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6790483|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6790484|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6790485|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
6790486|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790487|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790488|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6790489|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
6790490|NCT02235480|Tazarotene|tazarotene|mesh-list
6790491|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
6790492|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
6790493|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6790494|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6790495|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6790496|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790497|NCT02235532|Fluorides|fluorides|mesh-list
6790498|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
6790499|NCT02235532|Protective Agents|protective agents|mesh-ancestor
6790500|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790501|NCT02235558|Verapamil|verapamil|mesh-list
6790502|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6790503|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6790504|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6790505|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790506|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6790507|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790508|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
6790509|NCT02235584|Dexamethasone|dexamethasone|mesh-list
6790510|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6790511|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
6790512|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
6790513|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790514|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790515|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6790516|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
6790517|NCT02235584|Hormones|hormones|mesh-ancestor
6790518|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790519|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6790520|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790521|NCT02235662|Tenofovir|tenofovir|mesh-list
6790522|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
6773513|NCT02147925|Metformin|metformin|mesh-list
6773514|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
6773515|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6773516|NCT02147925|Liraglutide|liraglutide|mesh-list
6773517|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6773518|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773519|NCT02147925|Incretins|incretins|mesh-ancestor
6773520|NCT02147925|Hormones|hormones|mesh-ancestor
6773521|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773522|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6773523|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
6773524|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773525|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773526|NCT02147938|Tacrolimus|tacrolimus|mesh-list
6773527|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6773528|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
6773529|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773530|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6773531|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773532|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773533|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
6773534|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6773535|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773536|NCT02147964|Ketoconazole|ketoconazole|mesh-list
6773537|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
6773538|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6773539|NCT02147964|Testosterone|testosterone|mesh-list
6773540|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
6773541|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
6773542|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6773543|NCT02147964|Dutasteride|dutasteride|mesh-list
6773544|NCT02147964|Acyline|acyline|mesh-list
6773545|NCT02147964|Androgens|androgens|mesh-ancestor
6773546|NCT02147964|Hormones|hormones|mesh-ancestor
6773547|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773548|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773549|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6773550|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773551|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
6773552|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
6773553|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773554|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6773555|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6773556|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773557|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773558|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6773559|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
6773560|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6773561|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6773562|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6773563|NCT02148016|Levofloxacin|levofloxacin|mesh-list
6773564|NCT02148016|Ofloxacin|ofloxacin|mesh-list
6773565|NCT02148016|Betamethasone|betamethasone|mesh-list
6773566|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6773567|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773568|NCT02148016|Renal Agents|renal agents|mesh-ancestor
6773569|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6773570|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6773571|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6773572|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773573|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773574|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773575|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6773576|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6773577|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6773578|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
6773579|NCT02148016|Hormones|hormones|mesh-ancestor
6773580|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773581|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773582|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6773583|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
6773584|NCT02148094|Tenofovir|tenofovir|mesh-list
6773585|NCT02148094|Emtricitabine|emtricitabine|mesh-list
6773586|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6773587|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
6773588|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773589|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6773590|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6773591|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773592|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773593|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6773594|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6773595|NCT02148120|Beclomethasone|beclomethasone|mesh-list
6773596|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
6773597|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6773598|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
6773599|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773600|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773601|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6773602|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
6773603|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6773604|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6773605|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6773606|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
6773607|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773608|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773609|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6773610|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
6773611|NCT02148120|Hormones|hormones|mesh-ancestor
6773612|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773613|NCT02148328|Vaccines|vaccines|mesh-list
6773614|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
6773615|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773616|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
6773617|NCT02148367|Hematinics|hematinics|mesh-ancestor
6773618|NCT02148380|Carboplatin|carboplatin|mesh-list
6773619|NCT02148380|Pemetrexed|pemetrexed|mesh-list
6773620|NCT02148380|Gefitinib|gefitinib|mesh-list
6773621|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773622|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773623|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773624|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6773625|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6773626|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6773627|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
6773628|NCT02148393|Estradiol|estradiol|mesh-list
6773629|NCT02148393|Progesterone|progesterone|mesh-list
6773630|NCT02148393|Estrogens|estrogens|mesh-ancestor
6773631|NCT02148393|Hormones|hormones|mesh-ancestor
6773632|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773633|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773634|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6773635|NCT02148393|Progestins|progestins|mesh-ancestor
6773636|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
6773637|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6773638|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773639|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773640|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6773641|NCT02148432|Analgesics|analgesics|mesh-ancestor
6773642|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
6773643|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773644|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6773645|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6773646|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6773647|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
6773648|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773649|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773650|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
6773651|NCT02148549|Irinotecan|irinotecan|mesh-list
6790523|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
6773652|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773653|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6773654|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6773655|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773656|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773657|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6773658|NCT02148601|Vancomycin|vancomycin|mesh-list
6773659|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773660|NCT02148640|Infliximab|infliximab|mesh-list
6773661|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
6773662|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6773663|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6773664|NCT02148783|Methylphenidate|methylphenidate|mesh-list
6773665|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6773666|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773667|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6773668|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6773669|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773670|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773671|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
6773672|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773673|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
6773674|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6773675|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
6773676|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773677|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
6773678|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6773679|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773680|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773681|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6773682|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773683|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6773684|NCT02148861|Insulin|insulin|mesh-list
6773685|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6773686|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6773687|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773688|NCT02148913|Melphalan|melphalan|mesh-list
6773689|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6773690|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6773691|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
6773692|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773693|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773694|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6773695|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6773696|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
6773697|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773698|NCT02148978|Saxagliptin|saxagliptin|mesh-list
6773699|NCT02148978|Incretins|incretins|mesh-ancestor
6773700|NCT02148978|Hormones|hormones|mesh-ancestor
6773701|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773702|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773703|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6773704|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
6773705|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773706|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773707|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6773708|NCT02149095|Treprostinil|treprostinil|mesh-list
6773709|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6773710|NCT02149212|Aminaftone|aminaftone|mesh-list
6773711|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
6773712|NCT02149212|Coagulants|coagulants|mesh-ancestor
6773713|NCT02149225|Poly I-C|poly i-c|mesh-list
6773714|NCT02149225|Molgramostim|molgramostim|mesh-list
6773715|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6773716|NCT02149225|Vaccines|vaccines|mesh-list
6773717|NCT02149225|Sargramostim|sargramostim|mesh-list
6773718|NCT02149225|Poly ICLC|poly iclc|mesh-list
6773719|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
6773720|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773721|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773722|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
6773723|NCT02149225|Laxatives|laxatives|mesh-ancestor
6773724|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6773725|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
6773726|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773727|NCT02149277|Lenograstim|lenograstim|mesh-list
6773728|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6773729|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
6773730|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773731|NCT02149329|Meropenem|meropenem|mesh-list
6773732|NCT02149329|Imipenem|imipenem|mesh-list
6773733|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
6773734|NCT02149329|Cilastatin|cilastatin|mesh-list
6773735|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6773736|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773737|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
6773738|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773739|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773740|NCT02149407|Glycerol|glycerol|mesh-list
6773741|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6773742|NCT02149407|Protective Agents|protective agents|mesh-ancestor
6773743|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773744|NCT02149433|Prednisone|prednisone|mesh-list
6773745|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6773746|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
6773747|NCT02149433|Hormones|hormones|mesh-ancestor
6773748|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773749|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773750|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6773751|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773752|NCT02149459|Metformin|metformin|mesh-list
6773753|NCT02149459|Biguanides|biguanides|mesh-list
6773754|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6773755|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790524|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790525|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6790526|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6790527|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790528|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790529|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6790530|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6790531|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6790532|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
6790533|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6790534|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790535|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6790536|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6790537|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6790538|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
6790539|NCT02235805|Cathartics|cathartics|mesh-ancestor
6790540|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6790541|NCT02235857|Dextrans|dextrans|mesh-list
6790542|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
6790543|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
6790544|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
6790545|NCT02235909|Losartan|losartan|mesh-list
6790546|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6790547|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6790548|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6790549|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6790550|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6790551|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790552|NCT02235948|Folic Acid|folic acid|mesh-list
6790553|NCT02235948|Hematinics|hematinics|mesh-ancestor
6790554|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
6790555|NCT02235948|Vitamins|vitamins|mesh-ancestor
6790556|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
6790557|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790558|NCT02235961|Liraglutide|liraglutide|mesh-list
6790559|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6790560|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790561|NCT02235961|Incretins|incretins|mesh-ancestor
6790562|NCT02235961|Hormones|hormones|mesh-ancestor
6790563|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790564|NCT02236013|Cytarabine|cytarabine|mesh-list
6790565|NCT02236013|Daunorubicin|daunorubicin|mesh-list
6790566|NCT02236013|Idarubicin|idarubicin|mesh-list
6790567|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6790568|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
6790569|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790570|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790571|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
6773756|NCT02149628|Propofol|propofol|mesh-list
6773757|NCT02149628|Desflurane|desflurane|mesh-list
6773758|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6773759|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773760|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773761|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6773762|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
6773763|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
6773764|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6773765|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
6773766|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6773767|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
6773768|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773769|NCT02149758|Etoricoxib|etoricoxib|mesh-list
6773770|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6773771|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6773772|NCT02149758|Analgesics|analgesics|mesh-ancestor
6773773|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
6773774|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773775|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773776|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6773777|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6773778|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6773779|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6773780|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773781|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773782|NCT02149823|Oxytocin|oxytocin|mesh-list
6773783|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
6773784|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6773785|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773786|NCT02149888|Tenofovir|tenofovir|mesh-list
6773787|NCT02149888|Emtricitabine|emtricitabine|mesh-list
6773788|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
6773789|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773790|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6773791|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6773792|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773793|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773794|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6773795|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6773796|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
6773797|NCT02149901|Ephedrine|ephedrine|mesh-list
6773798|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6773799|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
6773800|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773801|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773802|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6773803|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
6773804|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
6773805|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6773806|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6773807|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
6773808|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
6773809|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773810|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773811|NCT02149914|Rabeprazole|rabeprazole|mesh-list
6773812|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6773813|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6773814|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6773815|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773816|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773817|NCT02149927|Sevoflurane|sevoflurane|mesh-list
6773818|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6773819|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6773820|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
6773821|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
6773822|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773823|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773824|NCT02149953|Glycine|glycine|mesh-list
6773825|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
6773826|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773827|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773828|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773829|NCT02149992|Inositol|inositol|mesh-list
6773830|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
6773831|NCT02149992|Vitamins|vitamins|mesh-ancestor
6773832|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
6773833|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773834|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
6773835|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6773836|NCT02150031|Lidocaine|lidocaine|mesh-list
6773837|NCT02150031|Epinephrine|epinephrine|mesh-list
6773838|NCT02150031|Racepinephrine|racepinephrine|mesh-list
6773839|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
6773840|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
6773841|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
6773842|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773843|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773844|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
6773845|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773846|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6773847|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6773848|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6773849|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773850|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773851|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6773852|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773853|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
6773854|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
6773855|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6773856|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6773857|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
6773858|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773859|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6773860|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6773861|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
6773862|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6773863|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
6773864|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
6773865|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
6773866|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6773867|NCT02150122|Vitamin D|vitamin d|mesh-list
6773868|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
6773869|NCT02150122|Vitamins|vitamins|mesh-ancestor
6773870|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
6773871|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773872|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6773873|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6773874|NCT02150161|Lidocaine|lidocaine|mesh-list
6773875|NCT02150161|Fentanyl|fentanyl|mesh-list
6773876|NCT02150161|Ketamine|ketamine|mesh-list
6773877|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
6773878|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
6773879|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773880|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773881|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
6773882|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6773883|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6773884|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6773885|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6773886|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6773887|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773888|NCT02150161|Analgesics|analgesics|mesh-ancestor
6773889|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6773890|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6773891|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
6773892|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6773893|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6773894|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6773895|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6773896|NCT02150161|Narcotics|narcotics|mesh-ancestor
6773897|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6773898|NCT02150291|Folic Acid|folic acid|mesh-list
6773899|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
6773900|NCT02150291|Hematinics|hematinics|mesh-ancestor
6773901|NCT02150291|Vitamins|vitamins|mesh-ancestor
6773902|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
6773903|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773904|NCT02150317|Sorafenib|sorafenib|mesh-list
6773905|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
6773906|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773907|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6773908|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773909|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773910|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6773911|NCT02150317|Estrogens|estrogens|mesh-ancestor
6773912|NCT02150317|Hormones|hormones|mesh-ancestor
6773913|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773914|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773915|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6773916|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
6773917|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6773918|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
6773919|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773920|NCT02150447|Lansoprazole|lansoprazole|mesh-list
6773921|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6773922|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6773923|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6773924|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773925|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773926|NCT02150473|Adalimumab|adalimumab|mesh-list
6773927|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6773928|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6773929|NCT02150616|Sevoflurane|sevoflurane|mesh-list
6773930|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6773931|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6773932|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
6773933|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
6773934|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6773935|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773936|NCT02150707|Liraglutide|liraglutide|mesh-list
6773937|NCT02150707|Exenatide|exenatide|mesh-list
6773938|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6773939|NCT02150707|Glucagon|glucagon|mesh-list
6773940|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6773941|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6773942|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773943|NCT02150707|Incretins|incretins|mesh-ancestor
6773944|NCT02150707|Hormones|hormones|mesh-ancestor
6773945|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6773946|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6773947|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6773948|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
6773949|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773950|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773951|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
6773952|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6773953|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6773954|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6773955|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773956|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
6773957|NCT02150720|Coagulants|coagulants|mesh-ancestor
6773958|NCT02150785|Streptokinase|streptokinase|mesh-list
6773959|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6773960|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6773961|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773962|NCT02150928|Asparaginase|asparaginase|mesh-list
6773963|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773964|NCT02150993|Ritonavir|ritonavir|mesh-list
6773965|NCT02150993|Lopinavir|lopinavir|mesh-list
6773966|NCT02150993|Tenofovir|tenofovir|mesh-list
6773967|NCT02150993|Lamivudine|lamivudine|mesh-list
6773968|NCT02150993|Zidovudine|zidovudine|mesh-list
6773969|NCT02150993|Emtricitabine|emtricitabine|mesh-list
6773970|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
6773971|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
6773972|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6773973|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6773974|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
6773975|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773976|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773977|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6773978|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6773979|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
6773980|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773981|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6773982|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6773983|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6773984|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6773985|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
6773986|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6773987|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6790572|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790573|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6790574|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
6790575|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790576|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6790577|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6790578|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6790579|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790580|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
6790581|NCT02236026|ST 1435|st 1435|mesh-list
6790582|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6790583|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790584|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6790585|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6790586|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790587|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790588|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790589|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6790590|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
6790591|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6790592|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790593|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6790594|NCT02236052|Vaccines|vaccines|mesh-list
6790595|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
6790596|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790597|NCT02236065|Lenograstim|lenograstim|mesh-list
6790598|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6790599|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
6790600|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790601|NCT02236078|Isoniazid|isoniazid|mesh-list
6790602|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
6790603|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6790604|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790605|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6790606|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6790607|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
6790608|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790609|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6790610|NCT02236169|Bromides|bromides|mesh-list
6790611|NCT02236169|Norflurane|norflurane|mesh-list
6790612|NCT02236169|Ipratropium|ipratropium|mesh-list
6790613|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
6790614|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790615|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
6790616|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790617|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790618|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6790619|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790620|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6790621|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
6790622|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790623|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790624|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
6790625|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790626|NCT02236182|Bromides|bromides|mesh-list
6790627|NCT02236182|Ipratropium|ipratropium|mesh-list
6773988|NCT02151084|Gemcitabine|gemcitabine|mesh-list
6773989|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6773990|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6773991|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
6773992|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6773993|NCT02151084|Antiviral Agents|antiviral agents|mesh-ancestor
6773994|NCT02151084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6773995|NCT02151084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6773996|NCT02151084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6773997|NCT02151084|Immunologic Factors|immunologic factors|mesh-ancestor
6773998|NCT02151084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6773999|NCT02151201|Vaccines|vaccines|mesh-list
6774000|NCT02151201|Immunologic Factors|immunologic factors|mesh-ancestor
6774001|NCT02151201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774002|NCT02151240|Acyclovir|acyclovir|mesh-list
6774003|NCT02151240|Foscarnet|foscarnet|mesh-list
6774004|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
6774005|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
6774006|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774007|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6774008|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6774009|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774010|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774011|NCT02151279|Chitosan|chitosan|mesh-list
6774012|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6774013|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6774014|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
6774015|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774016|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6774017|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
6774018|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
6774019|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
6774020|NCT02151279|Coagulants|coagulants|mesh-ancestor
6774021|NCT02151305|Remifentanil|remifentanil|mesh-list
6774022|NCT02151305|Propofol|propofol|mesh-list
6774023|NCT02151305|Sevoflurane|sevoflurane|mesh-list
6774024|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6774025|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774026|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774027|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6774028|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
6774029|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
6774030|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6774031|NCT02151305|Narcotics|narcotics|mesh-ancestor
6774032|NCT02151305|Analgesics|analgesics|mesh-ancestor
6774033|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
6774034|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774035|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6774036|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6774037|NCT02151344|Vaccines|vaccines|mesh-list
6774038|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
6774039|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774040|NCT02151604|Xenon|xenon|mesh-list
6774041|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6774042|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
6774043|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
6774044|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774045|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774046|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
6774047|NCT02151630|Salicylates|salicylates|mesh-list
6774048|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774049|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
6774050|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
6774051|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
6774052|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6774053|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6774054|NCT02151630|Analgesics|analgesics|mesh-ancestor
6774055|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
6774056|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774057|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774058|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774059|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6774060|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6774061|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774062|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774063|NCT02151695|Aflibercept|aflibercept|mesh-list
6774064|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6774065|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6774066|NCT02151695|Growth Substances|growth substances|mesh-ancestor
6774067|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774068|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
6774069|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774070|NCT02151721|Gefitinib|gefitinib|mesh-list
6774071|NCT02151721|Vorinostat|vorinostat|mesh-list
6774072|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774073|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6774074|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774075|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774076|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6774077|NCT02151812|Paclitaxel|paclitaxel|mesh-list
6774078|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6774079|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6774080|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774081|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
6774082|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
6774083|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
6774084|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774085|NCT02151916|Fluorides|fluorides|mesh-list
6774086|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
6774087|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
6774088|NCT02151916|Protective Agents|protective agents|mesh-ancestor
6774089|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774090|NCT02151929|Everolimus|everolimus|mesh-list
6774091|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774092|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774093|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
6774094|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774095|NCT02151968|Anesthetics|anesthetics|mesh-list
6774096|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
6774097|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774098|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774099|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
6774100|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774101|NCT02152059|Nintedanib|nintedanib|mesh-list
6774102|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774103|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6774104|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774105|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774106|NCT02152176|Morphine|morphine|mesh-list
6774107|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6774108|NCT02152176|Narcotics|narcotics|mesh-ancestor
6774109|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774110|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774111|NCT02152176|Analgesics|analgesics|mesh-ancestor
6774112|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
6774113|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774114|NCT02152228|Teriparatide|teriparatide|mesh-list
6774115|NCT02152228|Hormones|hormones|mesh-list
6774116|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
6774117|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6774118|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774119|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6774120|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6774121|NCT02152306|Amlodipine|amlodipine|mesh-list
6774122|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6774123|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6774124|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6774125|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774126|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6774127|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774128|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
6774129|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
6774130|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6774131|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6774132|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774133|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6774134|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6774135|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774136|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774137|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774138|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6774139|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
6774140|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6774141|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774142|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6774143|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6774144|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6774145|NCT02152358|Acyclovir|acyclovir|mesh-list
6774146|NCT02152358|Ganciclovir|ganciclovir|mesh-list
6774147|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6774148|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
6774149|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774150|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6774151|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774152|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774153|NCT02152410|Morphine|morphine|mesh-list
6774154|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6774155|NCT02152410|Narcotics|narcotics|mesh-ancestor
6774156|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774157|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774158|NCT02152410|Analgesics|analgesics|mesh-ancestor
6774159|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
6774160|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774161|NCT02152423|Enoxaparin|enoxaparin|mesh-list
6774162|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
6774163|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6774164|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6774165|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774166|NCT02152475|Curcumin|curcumin|mesh-list
6774167|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6774168|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6774169|NCT02152475|Analgesics|analgesics|mesh-ancestor
6774170|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
6774171|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774172|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774173|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774174|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6774175|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774176|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774177|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774178|NCT02152514|Sufentanil|sufentanil|mesh-list
6774179|NCT02152514|Morphine|morphine|mesh-list
6774180|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6774181|NCT02152514|Narcotics|narcotics|mesh-ancestor
6774182|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774183|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774184|NCT02152514|Analgesics|analgesics|mesh-ancestor
6774185|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
6774186|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774187|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6774188|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6774189|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
6774190|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
6774191|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
6774192|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6774193|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774194|NCT02152579|Isosorbide|isosorbide|mesh-list
6774195|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6774196|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6774197|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6774198|NCT02152579|Diuretics|diuretics|mesh-ancestor
6774199|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
6774200|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774201|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
6774202|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6774203|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774204|NCT02152709|Vaccines|vaccines|mesh-list
6774205|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
6774206|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774207|NCT02152787|Propofol|propofol|mesh-list
6774208|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6774209|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774210|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774211|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6774212|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
6774213|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
6774214|NCT02152800|Valacyclovir|valacyclovir|mesh-list
6774215|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
6774216|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774217|NCT02152865|Lupeol|lupeol|mesh-list
6774218|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774219|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
6774220|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6774221|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6774222|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774223|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
6774224|NCT02152917|Coagulants|coagulants|mesh-ancestor
6774225|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6774226|NCT02152943|Trastuzumab|trastuzumab|mesh-list
6774227|NCT02152943|Everolimus|everolimus|mesh-list
6774228|NCT02152943|Letrozole|letrozole|mesh-list
6774229|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
6774230|NCT02152943|Antibodies|antibodies|mesh-list
6774231|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
6774232|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6774233|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
6774234|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774235|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774236|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774237|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6774238|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6774239|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790628|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
6774240|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774241|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6774242|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
6774243|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6774244|NCT02152969|Amlodipine|amlodipine|mesh-list
6774245|NCT02152969|Telmisartan|telmisartan|mesh-list
6774246|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
6774247|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6774248|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6774249|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6774250|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774251|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6774252|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774253|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
6774254|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6774255|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6774256|NCT02152969|Diuretics|diuretics|mesh-ancestor
6774257|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
6774258|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6774259|NCT02153060|Dexamethasone|dexamethasone|mesh-list
6774260|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
6774261|NCT02153060|BB 1101|bb 1101|mesh-list
6774262|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774263|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
6774264|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
6774265|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774266|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774267|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6774268|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
6774269|NCT02153060|Hormones|hormones|mesh-ancestor
6774270|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6774271|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6774272|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774273|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
6774274|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774275|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774276|NCT02153125|Eplerenone|eplerenone|mesh-list
6774277|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6774278|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
6774279|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6774280|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774281|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6774282|NCT02153125|Diuretics|diuretics|mesh-ancestor
6774283|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
6774284|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6774285|NCT02153177|Acetaminophen|acetaminophen|mesh-list
6774286|NCT02153177|Ibuprofen|ibuprofen|mesh-list
6774287|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
6774288|NCT02153177|Hydrocodone|hydrocodone|mesh-list
6774289|NCT02153177|Oxycodone|oxycodone|mesh-list
6774290|NCT02153177|Omeprazole|omeprazole|mesh-list
6774291|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6774292|NCT02153177|Analgesics|analgesics|mesh-ancestor
6774293|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
6774294|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774295|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774296|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
6774297|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6774298|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774299|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6774300|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6774301|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774302|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774303|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6774304|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6774305|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6774306|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6774307|NCT02153177|Narcotics|narcotics|mesh-ancestor
6774308|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774309|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
6774310|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
6774311|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6774312|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774313|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
6774314|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6774315|NCT02153281|Phenelzine|phenelzine|mesh-list
6774316|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
6774317|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6774318|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
6774319|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774320|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774321|NCT02153424|Apixaban|apixaban|mesh-list
6774322|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6774323|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
6774324|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6774325|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
6774326|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774327|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774328|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
6774329|NCT02153437|Sotalol|sotalol|mesh-list
6774330|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6774331|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6774332|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
6774333|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774334|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774335|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774336|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6774337|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
6774338|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
6774339|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774340|NCT02153450|Metformin|metformin|mesh-list
6774341|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6774342|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774343|NCT02153541|Antipyrine|antipyrine|mesh-list
6774344|NCT02153541|Benzocaine|benzocaine|mesh-list
6774345|NCT02153541|Mineral Oil|mineral oil|mesh-list
6774346|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
6774347|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
6774348|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774349|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774350|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
6774351|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774352|NCT02153541|Emollients|emollients|mesh-ancestor
6774353|NCT02153541|Dermatologic Agents|dermatologic agents|mesh-ancestor
6774354|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6774355|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6774356|NCT02153541|Analgesics|analgesics|mesh-ancestor
6774357|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774358|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6774359|NCT02153567|Citalopram|citalopram|mesh-list
6774360|NCT02153567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6774361|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6774362|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6774363|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774364|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774365|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
6774366|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774367|NCT02153567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6774368|NCT02153567|Antidepressive Agents|antidepressive agents|mesh-ancestor
6774369|NCT02153567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6774370|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
6774371|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6774372|NCT02153580|Fludarabine|fludarabine|mesh-list
6774373|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
6774374|NCT02153580|Etoposide|etoposide|mesh-list
6774375|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
6774376|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
6774377|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774378|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
6774379|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774380|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6774381|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6774382|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
6774383|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774384|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774385|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6774386|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6774387|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
6774388|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6774389|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6774390|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6774391|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774392|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
6774393|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
6774394|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
6774395|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
6774396|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
6774397|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
6774398|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6774399|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6774400|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6774401|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774402|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
6774403|NCT02153593|Coagulants|coagulants|mesh-ancestor
6774404|NCT02153606|Glycerol|glycerol|mesh-list
6774405|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6774406|NCT02153606|Protective Agents|protective agents|mesh-ancestor
6774407|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774408|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
6774409|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6774410|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774411|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
6774412|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
6774413|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6774414|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6774415|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6774416|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774417|NCT02153866|Vaccines|vaccines|mesh-list
6774418|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
6774419|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774420|NCT02153879|Niacin|niacin|mesh-list
6774421|NCT02153879|Fenofibrate|fenofibrate|mesh-list
6774422|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6774423|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
6774424|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774425|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6774426|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
6774427|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
6774428|NCT02153879|Vitamins|vitamins|mesh-ancestor
6774429|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
6774430|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774431|NCT02153944|Propranolol|propranolol|mesh-list
6774432|NCT02153944|Methylphenidate|methylphenidate|mesh-list
6774433|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6774434|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774435|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6774436|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6774437|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6774438|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774439|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
6774440|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774441|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6774442|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6774443|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
6774444|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6774445|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6774446|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
6774447|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
6774448|NCT02154074|Isoflurane|isoflurane|mesh-list
6774449|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
6774450|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774451|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774452|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6774453|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6774454|NCT02154074|Analgesics|analgesics|mesh-ancestor
6774455|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
6774456|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774457|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6774458|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6774459|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6774460|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
6774461|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774462|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774463|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6774464|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
6774465|NCT02154217|Timolol|timolol|mesh-list
6774466|NCT02154217|Bimatoprost|bimatoprost|mesh-list
6774467|NCT02154217|Latanoprost|latanoprost|mesh-list
6774468|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6774469|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6774470|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
6774471|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774472|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774473|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774474|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6774475|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6774476|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6774477|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6774478|NCT02154230|Calcium|calcium|mesh-list
6774479|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6774480|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774481|NCT02154269|Lenograstim|lenograstim|mesh-list
6774482|NCT02154269|Sargramostim|sargramostim|mesh-list
6774483|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6774484|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
6774485|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774486|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
6774487|NCT02154334|Phenylephrine|phenylephrine|mesh-list
6774488|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
6774489|NCT02154334|Esketamine|esketamine|mesh-list
6774490|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774491|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
6774492|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6774493|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
6774494|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6774495|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6774496|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6774497|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
6774498|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774499|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774500|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774501|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
6774502|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
6774503|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774504|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
6774505|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6774506|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
6774507|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6774508|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
6774509|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6774510|NCT02154334|Protective Agents|protective agents|mesh-ancestor
6774511|NCT02154360|Aprepitant|aprepitant|mesh-list
6774512|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
6774513|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
6774514|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774515|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774516|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6774517|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6774518|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774519|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774520|NCT02154438|Ketamine|ketamine|mesh-list
6774521|NCT02154438|Analgesics|analgesics|mesh-ancestor
6774522|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
6774523|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774524|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774525|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6774526|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6774527|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
6774528|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
6774529|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774530|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6774531|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6774532|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774533|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774534|NCT02154464|Acetaminophen|acetaminophen|mesh-list
6774535|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6774536|NCT02154464|Analgesics|analgesics|mesh-ancestor
6774537|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
6774538|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774539|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774540|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
6774541|NCT02154503|Minoxidil|minoxidil|mesh-list
6774542|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6774543|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
6774544|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
6774545|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6774546|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6774547|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774548|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
6774549|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
6774550|NCT02154646|Gemcitabine|gemcitabine|mesh-list
6774551|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6774552|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
6774553|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774554|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774555|NCT02154646|Antiviral Agents|antiviral agents|mesh-ancestor
6774556|NCT02154646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774557|NCT02154646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774558|NCT02154646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774559|NCT02154646|Immunologic Factors|immunologic factors|mesh-ancestor
6774560|NCT02154646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790629|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790630|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
6790631|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790632|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790633|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6790634|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790635|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6790636|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
6790637|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790638|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790639|NCT02236260|Lidocaine|lidocaine|mesh-list
6774561|NCT02154737|Gemcitabine|gemcitabine|mesh-list
6774562|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6774563|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6774564|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
6774565|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774566|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774567|NCT02154737|Antiviral Agents|antiviral agents|mesh-ancestor
6774568|NCT02154737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774569|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774570|NCT02154737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774571|NCT02154737|Immunologic Factors|immunologic factors|mesh-ancestor
6774572|NCT02154737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774573|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6774574|NCT02154776|Letrozole|letrozole|mesh-list
6774575|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774576|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6774577|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6774578|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774579|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774580|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6774581|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
6774582|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6774583|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774584|NCT02154789|Polidocanol|polidocanol|mesh-list
6774585|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
6774586|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6774587|NCT02154854|Tacrolimus|tacrolimus|mesh-list
6774588|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774589|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
6774590|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774591|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6774592|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774593|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774594|NCT02154932|Misoprostol|misoprostol|mesh-list
6774595|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6774596|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
6774597|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6774598|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774599|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6774600|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6774601|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
6774602|NCT02155023|Insulin|insulin|mesh-list
6774603|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6774604|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6774605|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774606|NCT02155049|Bimatoprost|bimatoprost|mesh-list
6774607|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6774608|NCT02155088|Gemcitabine|gemcitabine|mesh-list
6774609|NCT02155088|Paclitaxel|paclitaxel|mesh-list
6774610|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6774611|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774612|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
6774613|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
6774614|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
6774615|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774616|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6774617|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
6774618|NCT02155088|Antiviral Agents|antiviral agents|mesh-ancestor
6774619|NCT02155088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774620|NCT02155088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774621|NCT02155088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774622|NCT02155088|Immunologic Factors|immunologic factors|mesh-ancestor
6774623|NCT02155088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774624|NCT02155166|Ibuprofen|ibuprofen|mesh-list
6774625|NCT02155166|Lidocaine|lidocaine|mesh-list
6774626|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
6774627|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
6774628|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774629|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774630|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
6774631|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774632|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6774633|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6774634|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6774635|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6774636|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774637|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6774638|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6774639|NCT02155166|Analgesics|analgesics|mesh-ancestor
6774640|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774641|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6774642|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6774643|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774644|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
6774645|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6774646|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774647|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6774648|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6774649|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774650|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774651|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774652|NCT02155374|Insulin|insulin|mesh-list
6774653|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6774654|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
6774655|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
6774656|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6774657|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774658|NCT02155439|Triamcinolone|triamcinolone|mesh-list
6774659|NCT02155439|Fluorouracil|fluorouracil|mesh-list
6774660|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
6774661|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774662|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6774663|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774664|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774665|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
6774666|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774667|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774668|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
6774669|NCT02155439|Hormones|hormones|mesh-ancestor
6774670|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6774671|NCT02155504|Itraconazole|itraconazole|mesh-list
6774672|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
6774673|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774674|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6774675|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6774676|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774677|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774678|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6774679|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
6774680|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6774681|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774682|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6774683|NCT02155517|Propofol|propofol|mesh-list
6774684|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6774685|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774686|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774687|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6774688|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
6774689|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
6774690|NCT02155530|Atorvastatin|atorvastatin|mesh-list
6774691|NCT02155530|Pravastatin|pravastatin|mesh-list
6774692|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6774693|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6774694|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
6774695|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774696|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6774697|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6774698|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774699|NCT02155634|Lenalidomide|lenalidomide|mesh-list
6774700|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
6774701|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774702|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6774703|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6774704|NCT02155634|Growth Substances|growth substances|mesh-ancestor
6774705|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
6774706|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774707|NCT02155777|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
6774708|NCT02155777|Norinyl|norinyl|mesh-list
6774709|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6774710|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6774711|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6774712|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
6774713|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6774714|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774715|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6774716|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6774717|NCT02155777|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
6774718|NCT02155777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6774719|NCT02155803|Hormones|hormones|mesh-list
6774720|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6774721|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6774722|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
6774723|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6774724|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774725|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774726|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774727|NCT02156336|Ranolazine|ranolazine|mesh-list
6774728|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6774729|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6774730|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790640|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
6790641|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
6790642|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790643|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790644|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
6790645|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790646|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6790647|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6790648|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6790649|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6790650|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790651|NCT02236403|Metronidazole|metronidazole|mesh-list
6790652|NCT02236403|Ivermectin|ivermectin|mesh-list
6790653|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790654|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6790655|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6790656|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6790657|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6790658|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6790659|NCT02236715|Ipratropium|ipratropium|mesh-list
6790660|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790661|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
6790662|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790663|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790664|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6790665|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790666|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6790667|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
6790668|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790669|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790670|NCT02236728|Pramipexole|pramipexole|mesh-list
6790671|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
6790672|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790673|NCT02236728|Protective Agents|protective agents|mesh-ancestor
6790674|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790675|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6790676|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6790677|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
6790678|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
6790679|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790680|NCT02236741|Pramipexole|pramipexole|mesh-list
6790681|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
6790682|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790683|NCT02236741|Protective Agents|protective agents|mesh-ancestor
6790684|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790685|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6790686|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6790687|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
6790688|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
6790689|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790690|NCT02236793|Becaplermin|becaplermin|mesh-list
6774731|NCT02156375|Ustekinumab|ustekinumab|mesh-list
6774732|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
6774733|NCT02156570|Ribavirin|ribavirin|mesh-list
6774734|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
6774735|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
6774736|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774737|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
6774738|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774739|NCT02156596|Ketoprofen|ketoprofen|mesh-list
6774740|NCT02156596|Morphine|morphine|mesh-list
6774741|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6774742|NCT02156596|Narcotics|narcotics|mesh-ancestor
6774743|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774744|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774745|NCT02156596|Analgesics|analgesics|mesh-ancestor
6774746|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
6774747|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774748|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6774749|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6774750|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6774751|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6774752|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6774753|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774754|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774755|NCT02156661|Oxytocin|oxytocin|mesh-list
6774756|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
6774757|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6774758|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774759|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
6774760|NCT02156726|Fludarabine|fludarabine|mesh-list
6774761|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774762|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
6774763|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774764|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6774765|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6774766|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
6774767|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774768|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774769|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6774770|NCT02156739|Edetic Acid|edetic acid|mesh-list
6774771|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
6774772|NCT02156739|Antidotes|antidotes|mesh-ancestor
6774773|NCT02156739|Protective Agents|protective agents|mesh-ancestor
6774774|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774775|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
6774776|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
6774777|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774778|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6774779|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
6774780|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6774781|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
6774782|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
6774783|NCT02156843|Vitamins|vitamins|mesh-ancestor
6774784|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
6774785|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774786|NCT02156960|Denosumab|denosumab|mesh-list
6774787|NCT02156960|Teriparatide|teriparatide|mesh-list
6774788|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6774789|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774790|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6774791|NCT02156999|Vitamin D|vitamin d|mesh-list
6774792|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
6774793|NCT02156999|Vitamins|vitamins|mesh-ancestor
6774794|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
6774795|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774796|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6774797|NCT02157012|Tofacitinib|tofacitinib|mesh-list
6774798|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6774799|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774800|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774801|NCT02157077|Aflibercept|aflibercept|mesh-list
6774802|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6774803|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6774804|NCT02157077|Growth Substances|growth substances|mesh-ancestor
6774805|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774806|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
6774807|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774808|NCT02157181|Rituximab|rituximab|mesh-list
6774809|NCT02157181|Cladribine|cladribine|mesh-list
6774810|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6774811|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774812|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
6774813|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774814|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6774815|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774816|NCT02157207|Vitamins|vitamins|mesh-list
6774817|NCT02157207|Vitamin E|vitamin e|mesh-list
6774818|NCT02157207|Antioxidants|antioxidants|mesh-list
6774819|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
6774820|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774821|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774822|NCT02157207|Protective Agents|protective agents|mesh-ancestor
6774823|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
6774824|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6774825|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
6774826|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6774827|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
6774828|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774829|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774830|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
6774831|NCT02157311|Tenofovir|tenofovir|mesh-list
6774832|NCT02157311|Lamivudine|lamivudine|mesh-list
6774833|NCT02157311|Emtricitabine|emtricitabine|mesh-list
6774834|NCT02157311|Efavirenz|efavirenz|mesh-list
6774835|NCT02157311|Lopinavir|lopinavir|mesh-list
6774836|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6774837|NCT02157311|Darunavir|darunavir|mesh-list
6774838|NCT02157311|Abacavir|abacavir|mesh-list
6774839|NCT02157311|Rilpivirine|rilpivirine|mesh-list
6774840|NCT02157311|Etravirine|etravirine|mesh-list
6774841|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
6774842|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774843|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6774844|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6774845|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774846|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774847|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6774848|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6774849|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6774850|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6774851|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6774852|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6774853|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6774854|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6774855|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6774856|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6774857|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
6774858|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6774859|NCT02157337|Atorvastatin|atorvastatin|mesh-list
6774860|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6774861|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6774862|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
6774863|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774864|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6774865|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6774866|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774867|NCT02157415|Polihexanide|polihexanide|mesh-list
6774868|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
6774869|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774870|NCT02157428|Flumazenil|flumazenil|mesh-list
6774871|NCT02157428|Antidotes|antidotes|mesh-ancestor
6774872|NCT02157428|Protective Agents|protective agents|mesh-ancestor
6774873|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774874|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
6774875|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
6774876|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774877|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774878|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
6774879|NCT02157467|BMS-955176|bms-955176|mesh-list
6774880|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6774881|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6774882|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774883|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6774884|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6774885|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774886|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774887|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774888|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6774889|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
6774890|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6774891|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774892|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6774893|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6790691|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
6774894|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6774895|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6774896|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6774897|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
6774898|NCT02157558|Fexofenadine|fexofenadine|mesh-list
6774899|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6774900|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6774901|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6774902|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
6774903|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
6774904|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774905|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774906|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774907|NCT02157571|Levofloxacin|levofloxacin|mesh-list
6774908|NCT02157571|Ofloxacin|ofloxacin|mesh-list
6774909|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
6774910|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
6774911|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6774912|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774913|NCT02157571|Renal Agents|renal agents|mesh-ancestor
6774914|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6774915|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6774916|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6774917|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774918|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774919|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774920|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6774921|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6774922|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6774923|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
6774924|NCT02157649|Codeine|codeine|mesh-list
6774925|NCT02157649|Guaifenesin|guaifenesin|mesh-list
6774926|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
6774927|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6774928|NCT02157649|Narcotics|narcotics|mesh-ancestor
6774929|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774930|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774931|NCT02157649|Analgesics|analgesics|mesh-ancestor
6774932|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
6774933|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774934|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
6774935|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
6774936|NCT02157649|Expectorants|expectorants|mesh-ancestor
6774937|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6774938|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6774939|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
6774940|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774941|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774942|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
6774943|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6774944|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
6774945|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
6774946|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
6774947|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6774948|NCT02157792|Gemcitabine|gemcitabine|mesh-list
6774949|NCT02157792|Carboplatin|carboplatin|mesh-list
6774950|NCT02157792|Irinotecan|irinotecan|mesh-list
6774951|NCT02157792|Etoposide|etoposide|mesh-list
6774952|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6774953|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6774954|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
6774955|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774956|NCT02157792|Antiviral Agents|antiviral agents|mesh-ancestor
6774957|NCT02157792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6774958|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6774959|NCT02157792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6774960|NCT02157792|Immunologic Factors|immunologic factors|mesh-ancestor
6774961|NCT02157792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774962|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6774963|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6774964|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6774965|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6774966|NCT02157818|Midazolam|midazolam|mesh-list
6774967|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
6774968|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6774969|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6774970|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774971|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6774972|NCT02157818|Analgesics|analgesics|mesh-ancestor
6774973|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
6774974|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6774975|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6774976|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6774977|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6774978|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
6774979|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6774980|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6774981|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6774982|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6774983|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6774984|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6774985|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6774986|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
6774987|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
6774988|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
6774989|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
6790692|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
6790693|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6790694|NCT02236793|Growth Substances|growth substances|mesh-ancestor
6790695|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774990|NCT02157974|Exenatide|exenatide|mesh-list
6774991|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6774992|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6774993|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6774994|NCT02157974|Incretins|incretins|mesh-ancestor
6774995|NCT02157974|Hormones|hormones|mesh-ancestor
6774996|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6774997|NCT02158013|Diltiazem|diltiazem|mesh-list
6774998|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6774999|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6775000|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6775001|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775002|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6775003|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775004|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
6775005|NCT02158052|Tacrolimus|tacrolimus|mesh-list
6775006|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6775007|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6775008|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
6775009|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775010|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6775011|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775012|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775013|NCT02158078|Insulin|insulin|mesh-list
6775014|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6775015|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775016|NCT02158117|Naloxone|naloxone|mesh-list
6775017|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6775018|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775019|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
6775020|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775021|NCT02158143|Vitamin D|vitamin d|mesh-list
6775022|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
6775023|NCT02158143|Vitamins|vitamins|mesh-ancestor
6775024|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
6775025|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775026|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6775027|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6775028|NCT02158182|Rifaximin|rifaximin|mesh-list
6775029|NCT02158182|Lactulose|lactulose|mesh-list
6775030|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
6775031|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6775032|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775033|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6775034|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
6775035|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6775036|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775037|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775038|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775039|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
6775040|NCT02158221|Growth Substances|growth substances|mesh-ancestor
6775041|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775042|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
6775043|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775044|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775045|NCT02158234|Cisplatin|cisplatin|mesh-list
6775046|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
6775047|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775048|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775049|NCT02158286|Acetaminophen|acetaminophen|mesh-list
6775050|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6775051|NCT02158286|Analgesics|analgesics|mesh-ancestor
6775052|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
6775053|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775054|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775055|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
6775056|NCT02158481|Carotenoids|carotenoids|mesh-list
6775057|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
6775058|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775059|NCT02158481|Protective Agents|protective agents|mesh-ancestor
6775060|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775061|NCT02158585|Lamotrigine|lamotrigine|mesh-list
6775062|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
6775063|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6775064|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6775065|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775066|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6775067|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775068|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6775069|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6775070|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6775071|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6775072|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6775073|NCT02158598|Vitamin D|vitamin d|mesh-list
6775074|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
6775075|NCT02158598|Vitamins|vitamins|mesh-list
6775076|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
6775077|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775078|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6775079|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6775080|NCT02158624|Ranibizumab|ranibizumab|mesh-list
6775081|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6775082|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6775083|NCT02158624|Growth Substances|growth substances|mesh-ancestor
6775084|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775085|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
6775086|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775087|NCT02158689|Letrozole|letrozole|mesh-list
6775088|NCT02158689|Menotropins|menotropins|mesh-list
6775089|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775090|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6775091|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6775092|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775093|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775094|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6775095|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
6775096|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775097|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775098|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6775099|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
6775100|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775101|NCT02158702|Dexamethasone|dexamethasone|mesh-list
6775102|NCT02158702|Pomalidomide|pomalidomide|mesh-list
6775103|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775104|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
6775105|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
6775106|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775107|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775108|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6775109|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
6775110|NCT02158702|Hormones|hormones|mesh-ancestor
6775111|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775112|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6775113|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775114|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
6775115|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6775116|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6775117|NCT02158702|Growth Substances|growth substances|mesh-ancestor
6775118|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
6775119|NCT02158845|Leuprolide|leuprolide|mesh-list
6775120|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
6775121|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6775122|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
6775123|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775124|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775125|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6775126|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775127|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6775128|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
6775129|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6775130|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6775131|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6775132|NCT02158910|Donepezil|donepezil|mesh-list
6775133|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6775134|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775135|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775136|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
6775137|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775138|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775139|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
6775140|NCT02159027|Maraviroc|maraviroc|mesh-list
6775141|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6775142|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6775143|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775144|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6775145|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6775146|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
6775147|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775148|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
6775149|NCT02159066|Infigratinib|infigratinib|mesh-list
6775150|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775151|NCT02159131|Cabotegravir|cabotegravir|mesh-list
6775152|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
6775153|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6775154|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
6775155|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775156|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775157|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6775158|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6775159|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6775160|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6775161|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6775162|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775163|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775164|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6775165|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6775166|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
6775167|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775168|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
6775169|NCT02159196|Albuterol|albuterol|mesh-list
6775170|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6775171|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
6775172|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775173|NCT02159196|Expectorants|expectorants|mesh-ancestor
6775174|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
6775175|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6775176|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
6775177|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775178|NCT02159196|Protective Agents|protective agents|mesh-ancestor
6775179|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775180|NCT02159196|Antidotes|antidotes|mesh-ancestor
6775181|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6775182|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
6775183|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775184|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6775185|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
6775186|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775187|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6775188|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6775189|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6775190|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
6775191|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775192|NCT02159248|Gemcitabine|gemcitabine|mesh-list
6775193|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
6775194|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6775195|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
6775196|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775197|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775198|NCT02159248|Antiviral Agents|antiviral agents|mesh-ancestor
6775199|NCT02159248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775200|NCT02159248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775201|NCT02159248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6775202|NCT02159248|Immunologic Factors|immunologic factors|mesh-ancestor
6775203|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775204|NCT02159248|Analgesics|analgesics|mesh-ancestor
6775205|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
6775206|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775207|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6775208|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6775209|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775210|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6775211|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6775212|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6775213|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6775214|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
6775215|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
6775216|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775217|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6775218|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
6775219|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775220|NCT02159287|Heparin|heparin|mesh-list
6775221|NCT02159287|Calcium heparin|calcium heparin|mesh-list
6775222|NCT02159287|Enoxaparin|enoxaparin|mesh-list
6775223|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
6775224|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
6775225|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6775226|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6775227|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775228|NCT02159313|Riociguat|riociguat|mesh-list
6775229|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
6775230|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775231|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6775232|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6775233|NCT02159326|Riociguat|riociguat|mesh-list
6775234|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
6775235|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775236|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6775237|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
6775238|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775239|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775240|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6775241|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6775242|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6775243|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6775244|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6775245|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6775246|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6775247|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6775248|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6775249|NCT02159573|Natalizumab|natalizumab|mesh-list
6775250|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
6775251|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775252|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
6775253|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6775254|NCT02159599|Ritonavir|ritonavir|mesh-list
6775255|NCT02159599|Darunavir|darunavir|mesh-list
6775256|NCT02159599|Tenofovir|tenofovir|mesh-list
6775257|NCT02159599|Lamivudine|lamivudine|mesh-list
6775258|NCT02159599|Emtricitabine|emtricitabine|mesh-list
6775259|NCT02159599|Abacavir|abacavir|mesh-list
6775260|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6775261|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6775262|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
6775263|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775264|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775265|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6775266|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6775267|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
6775268|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775269|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6775270|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6775271|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6775272|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6775273|NCT02159651|Tacrolimus|tacrolimus|mesh-list
6775274|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6775275|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
6775276|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775277|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6775278|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775279|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790696|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
6790697|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
6790698|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790699|NCT02236936|Cetuximab|cetuximab|mesh-list
6790700|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775280|NCT02159690|Prednisone|prednisone|mesh-list
6775281|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
6775282|NCT02159690|Dutasteride|dutasteride|mesh-list
6775283|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775284|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
6775285|NCT02159690|Hormones|hormones|mesh-ancestor
6775286|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775287|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775288|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6775289|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775290|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6775291|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775292|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775293|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
6775294|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6775295|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6775296|NCT02159820|Paclitaxel|paclitaxel|mesh-list
6775297|NCT02159820|Carboplatin|carboplatin|mesh-list
6775298|NCT02159820|Decitabine|decitabine|mesh-list
6775299|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6775300|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775301|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
6775302|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
6775303|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
6775304|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775305|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6775306|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
6775307|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775308|NCT02159911|Misoprostol|misoprostol|mesh-list
6775309|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6775310|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
6775311|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775312|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775313|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6775314|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6775315|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
6775316|NCT02160015|Rituximab|rituximab|mesh-list
6775317|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6775318|NCT02160015|Lenalidomide|lenalidomide|mesh-list
6775319|NCT02160015|Antibodies|antibodies|mesh-list
6775320|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
6775321|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6775322|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
6775323|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775324|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775325|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6775326|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6775327|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6775328|NCT02160015|Growth Substances|growth substances|mesh-ancestor
6775329|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
6775330|NCT02160028|Anesthetics|anesthetics|mesh-list
6775331|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6775332|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775333|NCT02160054|Tacrolimus|tacrolimus|mesh-list
6775334|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6775335|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
6775336|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775337|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6775338|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775339|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775340|NCT02160080|Interferons|interferons|mesh-list
6775341|NCT02160080|Ribavirin|ribavirin|mesh-list
6775342|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
6775343|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775344|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
6775345|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775346|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
6775347|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775348|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
6775349|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775350|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
6775351|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6775352|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6775353|NCT02160132|Prednisolone|prednisolone|mesh-list
6775354|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
6775355|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6775356|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
6775357|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775358|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
6775359|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
6775360|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775361|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775362|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6775363|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
6775364|NCT02160132|Hormones|hormones|mesh-ancestor
6775365|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775366|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6775367|NCT02160132|Protective Agents|protective agents|mesh-ancestor
6775368|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6775369|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775370|NCT02160158|Fesoterodine|fesoterodine|mesh-list
6775371|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6775372|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6775373|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
6775374|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775375|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775376|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775377|NCT02160158|Urological Agents|urological agents|mesh-ancestor
6775378|NCT02160184|Pancrelipase|pancrelipase|mesh-list
6775379|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6775380|NCT02160223|Neostigmine|neostigmine|mesh-list
6775381|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6775382|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775383|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775384|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
6775385|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775386|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775387|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6775388|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
6775389|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775390|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6775391|NCT02160236|Tenoxicam|tenoxicam|mesh-list
6775392|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6775393|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6775394|NCT02160236|Analgesics|analgesics|mesh-ancestor
6775395|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
6775396|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775397|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775398|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775399|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6775400|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6775401|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775402|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775403|NCT02160275|Insulin|insulin|mesh-list
6775404|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6775405|NCT02160275|Pancrelipase|pancrelipase|mesh-list
6775406|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6775407|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775408|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6775409|NCT02160301|Acetaminophen|acetaminophen|mesh-list
6775410|NCT02160301|Dexamethasone|dexamethasone|mesh-list
6775411|NCT02160301|Celecoxib|celecoxib|mesh-list
6775412|NCT02160301|Oxycodone|oxycodone|mesh-list
6775413|NCT02160301|Gabapentin|gabapentin|mesh-list
6775414|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775415|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
6775416|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
6775417|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775418|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775419|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6775420|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
6775421|NCT02160301|Hormones|hormones|mesh-ancestor
6775422|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775423|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6775424|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775425|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6775426|NCT02160301|Analgesics|analgesics|mesh-ancestor
6775427|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
6775428|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
6775429|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6775430|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6775431|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6775432|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6775433|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775434|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775435|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6775436|NCT02160301|Narcotics|narcotics|mesh-ancestor
6775437|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6775438|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
6775439|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6775440|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6775441|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6775442|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6775443|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6775444|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775445|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
6775446|NCT02160353|Prednisolone|prednisolone|mesh-list
6775447|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
6775448|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775449|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
6775450|NCT02160353|Hormones|hormones|mesh-ancestor
6775451|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775452|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775453|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6775454|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775455|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6775456|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775457|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775458|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
6775459|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6775460|NCT02160548|Atropine|atropine|mesh-list
6775461|NCT02160548|Albuterol|albuterol|mesh-list
6775462|NCT02160548|Pralidoxime|pralidoxime|mesh-list
6775463|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6775464|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
6775465|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775466|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775467|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6775468|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
6775469|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
6775470|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775471|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6775472|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6775473|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6775474|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
6775475|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775476|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775477|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6775478|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6775479|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
6775480|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
6775481|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6775482|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6775483|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
6775484|NCT02160548|Antidotes|antidotes|mesh-ancestor
6775485|NCT02160548|Protective Agents|protective agents|mesh-ancestor
6775486|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
6775487|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
6775488|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
6775489|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6775490|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6775491|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775492|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
6775493|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
6775494|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
6775495|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6775496|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6775497|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775498|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
6775499|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
6775500|NCT02160704|Enclomiphene|enclomiphene|mesh-list
6775501|NCT02160704|Clomiphene|clomiphene|mesh-list
6775502|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
6775503|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6775504|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
6775505|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775506|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775507|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6775508|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
6775509|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775510|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6775511|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6775512|NCT02160743|Metformin|metformin|mesh-list
6775513|NCT02160743|Atorvastatin|atorvastatin|mesh-list
6775514|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6775515|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775516|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6775517|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6775518|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
6775519|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775520|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6775521|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6775522|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775523|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
6775524|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6775525|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775526|NCT02161055|Insulin|insulin|mesh-list
6775527|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6775528|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6775529|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775530|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
6775531|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6775532|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6775533|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6775534|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6775535|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775536|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
6775537|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775538|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775539|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6775540|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775541|NCT02161237|Tacrolimus|tacrolimus|mesh-list
6775542|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6775543|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
6775544|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775545|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6775546|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775547|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775548|NCT02161354|Buprenorphine|buprenorphine|mesh-list
6775549|NCT02161354|Naloxone|naloxone|mesh-list
6775550|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6775551|NCT02161354|Narcotics|narcotics|mesh-ancestor
6775552|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6775553|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775554|NCT02161354|Analgesics|analgesics|mesh-ancestor
6775555|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
6775556|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775557|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6775558|NCT02161367|Simethicone|simethicone|mesh-list
6775559|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
6775560|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775561|NCT02161367|Emollients|emollients|mesh-ancestor
6775562|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
6790701|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6790702|NCT02236962|Pioglitazone|pioglitazone|mesh-list
6790703|NCT02236962|Ephedrine|ephedrine|mesh-list
6790704|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6790705|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790706|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6790707|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
6775563|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6775564|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6775565|NCT02161614|Estradiol|estradiol|mesh-list
6775566|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6775567|NCT02161614|Estrogens|estrogens|mesh-ancestor
6775568|NCT02161614|Hormones|hormones|mesh-ancestor
6775569|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775570|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775571|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6775572|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
6775573|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775574|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6775575|NCT02161653|Pyridoxine|pyridoxine|mesh-list
6775576|NCT02161653|Prednisone|prednisone|mesh-list
6775577|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
6775578|NCT02161653|Metadoxine|metadoxine|mesh-list
6775579|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775580|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
6775581|NCT02161653|Hormones|hormones|mesh-ancestor
6775582|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775583|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775584|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6775585|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775586|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6775587|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775588|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775589|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6775590|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6775591|NCT02161653|Protective Agents|protective agents|mesh-ancestor
6775592|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
6775593|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6775594|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
6775595|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6775596|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
6775597|NCT02161653|Vitamins|vitamins|mesh-ancestor
6775598|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
6775599|NCT02161679|Carboplatin|carboplatin|mesh-list
6775600|NCT02161679|Camptothecin|camptothecin|mesh-list
6775601|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
6775602|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775603|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6775604|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6775605|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6775606|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775607|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775608|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
6775609|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775610|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
6775611|NCT02161692|Carboplatin|carboplatin|mesh-list
6775612|NCT02161692|Etoposide|etoposide|mesh-list
6775613|NCT02161692|Bleomycin|bleomycin|mesh-list
6775614|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6775615|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
6775616|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775617|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6775618|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6775619|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
6775620|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775621|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775622|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6775623|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6775624|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6775625|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6775626|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775627|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6775628|NCT02161770|Osimertinib|osimertinib|mesh-list
6775629|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775630|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6775631|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775632|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775633|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
6775634|NCT02161783|Fludarabine|fludarabine|mesh-list
6775635|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6775636|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
6775637|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775638|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6775639|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6775640|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
6775641|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775642|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775643|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6775644|NCT02161822|Simvastatin|simvastatin|mesh-list
6775645|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6775646|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6775647|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
6775648|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775649|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6775650|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6775651|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775652|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
6775653|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
6775654|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775655|NCT02161952|Pirfenidone|pirfenidone|mesh-list
6775656|NCT02161952|Analgesics|analgesics|mesh-ancestor
6775657|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
6775658|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775659|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775660|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6775661|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6775662|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775663|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6775664|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775665|NCT02161965|Warfarin|warfarin|mesh-list
6775666|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
6775667|NCT02161965|Fluindione|fluindione|mesh-list
6775668|NCT02161965|Phenindione|phenindione|mesh-list
6775669|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
6775670|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6775671|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
6775672|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6775673|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
6775674|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775675|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775676|NCT02161991|Aprepitant|aprepitant|mesh-list
6775677|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
6775678|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
6775679|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775680|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775681|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6775682|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6775683|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775684|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775685|NCT02162121|Ketorolac|ketorolac|mesh-list
6775686|NCT02162121|Buprenorphine|buprenorphine|mesh-list
6775687|NCT02162121|Anesthetics|anesthetics|mesh-list
6775688|NCT02162121|Ropivacaine|ropivacaine|mesh-list
6775689|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
6775690|NCT02162121|Mepivacaine|mepivacaine|mesh-list
6775691|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
6775692|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6775693|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775694|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
6775695|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775696|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6775697|NCT02162121|Narcotics|narcotics|mesh-ancestor
6775698|NCT02162121|Analgesics|analgesics|mesh-ancestor
6775699|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6775700|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6775701|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6775702|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775703|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6775704|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6775705|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775706|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775707|NCT02162134|Cefuroxime|cefuroxime|mesh-list
6775708|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
6775709|NCT02162134|Ketorolac|ketorolac|mesh-list
6775710|NCT02162134|Midazolam|midazolam|mesh-list
6775711|NCT02162134|Propofol|propofol|mesh-list
6775712|NCT02162134|Sevoflurane|sevoflurane|mesh-list
6775713|NCT02162134|Atracurium|atracurium|mesh-list
6775714|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6775715|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6775716|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775717|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6775718|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
6775719|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
6775720|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6775721|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6775722|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6775723|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6775724|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
6775725|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
6775726|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775727|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775728|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6775729|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6775730|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6775731|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6775732|NCT02162134|Analgesics|analgesics|mesh-ancestor
6775733|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
6775734|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775735|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775736|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6775737|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6775738|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775739|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6775740|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775741|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6775742|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6775743|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6775744|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6775745|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6775746|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
6775747|NCT02162251|Donepezil|donepezil|mesh-list
6775748|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6775749|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775750|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775751|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
6775752|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775753|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775754|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
6775755|NCT02162264|Donepezil|donepezil|mesh-list
6775756|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6775757|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775758|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775759|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
6775760|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775761|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775762|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
6775763|NCT02162303|Colchicine|colchicine|mesh-list
6775764|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
6775765|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6775766|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
6775767|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
6775768|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
6775769|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775770|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775771|NCT02162381|Methylphenidate|methylphenidate|mesh-list
6775772|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6775773|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775774|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6775775|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6775776|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6775777|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775778|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
6775779|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775780|NCT02162407|Insulin|insulin|mesh-list
6775781|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6775782|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
6775783|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6775784|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775785|NCT02162485|Fluticasone|fluticasone|mesh-list
6775786|NCT02162485|Xhance|xhance|mesh-list
6775787|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6775788|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6775789|NCT02162485|Charcoal|charcoal|mesh-list
6775790|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775791|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6775792|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
6775793|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775794|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775795|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6775796|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
6775797|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
6775798|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6775799|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6775800|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6775801|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6775802|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
6775803|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775804|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775805|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
6775806|NCT02162485|Hormones|hormones|mesh-ancestor
6775807|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775808|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
6775809|NCT02162485|Antidotes|antidotes|mesh-ancestor
6775810|NCT02162485|Protective Agents|protective agents|mesh-ancestor
6775811|NCT02162537|Bevacizumab|bevacizumab|mesh-list
6775812|NCT02162537|Pemetrexed|pemetrexed|mesh-list
6775813|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6775814|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775815|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6775816|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6775817|NCT02162537|Growth Substances|growth substances|mesh-ancestor
6775818|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775819|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
6775820|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775821|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775822|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6775823|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6775824|NCT02162550|Exenatide|exenatide|mesh-list
6775825|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6775826|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775827|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6775828|NCT02162550|Incretins|incretins|mesh-ancestor
6775829|NCT02162550|Hormones|hormones|mesh-ancestor
6775830|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775831|NCT02162563|Leucovorin|leucovorin|mesh-list
6775832|NCT02162563|Bevacizumab|bevacizumab|mesh-list
6775833|NCT02162563|Panitumumab|panitumumab|mesh-list
6775834|NCT02162563|Fluorouracil|fluorouracil|mesh-list
6775835|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
6775836|NCT02162563|Irinotecan|irinotecan|mesh-list
6775837|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
6775838|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6775839|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775840|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6775841|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6775842|NCT02162563|Growth Substances|growth substances|mesh-ancestor
6775843|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775844|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
6775845|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
6775846|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775847|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6775848|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6775849|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
6775850|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6775851|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6775852|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775853|NCT02162563|Antidotes|antidotes|mesh-ancestor
6775854|NCT02162563|Protective Agents|protective agents|mesh-ancestor
6775855|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
6775856|NCT02162563|Vitamins|vitamins|mesh-ancestor
6775857|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
6775858|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
6775859|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6775860|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
6775861|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775862|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
6775863|NCT02162693|Protective Agents|protective agents|mesh-ancestor
6775864|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6775865|NCT02162784|Budesonide|budesonide|mesh-list
6775866|NCT02162784|Albuterol|albuterol|mesh-list
6775867|NCT02162784|Procaterol|procaterol|mesh-list
6775868|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775869|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6775870|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
6775871|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775872|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775873|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6775874|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
6775875|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
6775876|NCT02162784|Hormones|hormones|mesh-ancestor
6775877|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775878|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
6775879|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775880|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6775881|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6775882|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6775883|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
6775884|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775885|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775886|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
6775887|NCT02162797|Zinc|zinc|mesh-list
6775888|NCT02162797|Trace Elements|trace elements|mesh-ancestor
6775889|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
6775890|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775891|NCT02162810|Prednisolone|prednisolone|mesh-list
6775892|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6775893|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
6775894|NCT02162810|Hormones|hormones|mesh-ancestor
6775895|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775896|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775897|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6775898|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775899|NCT02162849|Nicotine|nicotine|mesh-list
6775900|NCT02162849|Varenicline|varenicline|mesh-list
6775901|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6775902|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
6775903|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6775904|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775905|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6775906|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6775907|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
6775908|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6775909|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775910|NCT02162875|Praziquantel|praziquantel|mesh-list
6775911|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
6775912|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6775913|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775914|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6775915|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6775916|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
6775917|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775918|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775919|NCT02162966|Colistin|colistin|mesh-list
6775920|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6775921|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775922|NCT02163070|Vitamins|vitamins|mesh-list
6775923|NCT02163070|Vitamin E|vitamin e|mesh-list
6775924|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
6775925|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775926|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
6775927|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775928|NCT02163070|Protective Agents|protective agents|mesh-ancestor
6775929|NCT02163161|Abrocitinib|abrocitinib|mesh-list
6775930|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6775931|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775932|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775933|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
6775934|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6775935|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775936|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775937|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6775938|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6775939|NCT02163174|Protective Agents|protective agents|mesh-ancestor
6775940|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775941|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
6775942|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6775943|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
6790708|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
6790709|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790710|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6790711|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
6790712|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790713|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790714|NCT02237027|Tenofovir|tenofovir|mesh-list
6790715|NCT02237027|Emtricitabine|emtricitabine|mesh-list
6790716|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6790717|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
6790718|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790719|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6790720|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6790721|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790722|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790723|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6790724|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6790725|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6790726|NCT02237053|Octreotide|octreotide|mesh-list
6790727|NCT02237053|Glucagon|glucagon|mesh-list
6790728|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790729|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6790730|NCT02237053|Hormones|hormones|mesh-ancestor
6790731|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790732|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6790733|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790734|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
6790735|NCT02237079|Estrogens|estrogens|mesh-list
6790736|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6790737|NCT02237079|Hormones|hormones|mesh-ancestor
6790738|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790739|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790740|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6790741|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6790742|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
6790743|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6790744|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
6790745|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
6790746|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
6790747|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6790748|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790749|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6790750|NCT02237209|Vaccines|vaccines|mesh-list
6790751|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
6790752|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790753|NCT02237261|Prednisone|prednisone|mesh-list
6790754|NCT02237261|Bortezomib|bortezomib|mesh-list
6790755|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6790756|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6790757|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
6790758|NCT02237261|Hormones|hormones|mesh-ancestor
6790759|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790760|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790761|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6790762|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790763|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6790764|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
6790765|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790766|NCT02237326|Acetic Acid|acetic acid|mesh-list
6790767|NCT02237326|Retinol acetate|retinol acetate|mesh-list
6790768|NCT02237326|Lugol's solution|lugol's solution|mesh-list
6790769|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6790770|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790771|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6790772|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
6790773|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790774|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6790775|NCT02237326|Protective Agents|protective agents|mesh-ancestor
6790776|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790777|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
6775944|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
6775945|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6775946|NCT02163213|Antibodies|antibodies|mesh-list
6775947|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
6775948|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775949|NCT02163291|Paclitaxel|paclitaxel|mesh-list
6775950|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6775951|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775952|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
6775953|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
6775954|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
6775955|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775956|NCT02163330|Acetazolamide|acetazolamide|mesh-list
6775957|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
6775958|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6775959|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775960|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775961|NCT02163330|Diuretics|diuretics|mesh-ancestor
6775962|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
6775963|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775964|NCT02163356|Ketoconazole|ketoconazole|mesh-list
6775965|NCT02163356|Vincristine|vincristine|mesh-list
6775966|NCT02163356|Fenretinide|fenretinide|mesh-list
6775967|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6775968|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6775969|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
6775970|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
6775971|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
6775972|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6775973|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
6775974|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6775975|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6775976|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6775977|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6775978|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6775979|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
6775980|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6775981|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775982|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6775983|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6775984|NCT02163356|Protective Agents|protective agents|mesh-ancestor
6775985|NCT02163616|Misoprostol|misoprostol|mesh-list
6775986|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6775987|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
6775988|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6775989|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775990|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6775991|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6775992|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
6775993|NCT02163655|Furosemide|furosemide|mesh-list
6775994|NCT02163655|Diuretics|diuretics|mesh-ancestor
6775995|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
6775996|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6775997|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6775998|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6775999|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776000|NCT02163707|Psilocybin|psilocybin|mesh-list
6776001|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
6776002|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776003|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6776004|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6776005|NCT02163720|Doxorubicin|doxorubicin|mesh-list
6776006|NCT02163720|Trabectedin|trabectedin|mesh-list
6776007|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6776008|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776009|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6776010|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6776011|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776012|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776013|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6776014|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
6776015|NCT02163954|Clopidogrel|clopidogrel|mesh-list
6776016|NCT02163954|Ticagrelor|ticagrelor|mesh-list
6776017|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6790778|NCT02237326|Coagulants|coagulants|mesh-ancestor
6776018|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6776019|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6776020|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6776021|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
6776022|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776023|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776024|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776025|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
6776026|NCT02163980|Ropivacaine|ropivacaine|mesh-list
6776027|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6776028|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776029|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776030|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6776031|NCT02163980|Analgesics|analgesics|mesh-ancestor
6776032|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
6776033|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776034|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6776035|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6776036|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6776037|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
6776038|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776039|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776040|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
6776041|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
6776042|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6776043|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6776044|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6776045|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776046|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
6776047|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776048|NCT02164032|Insulin|insulin|mesh-list
6776049|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6776050|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6776051|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776052|NCT02164045|Fostemsavir|fostemsavir|mesh-list
6776053|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6776054|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6776055|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
6776056|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776057|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6776058|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6776059|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776060|NCT02164097|Heparin|heparin|mesh-list
6776061|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
6776062|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6776063|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6776064|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776065|NCT02164110|Vaccines|vaccines|mesh-list
6776066|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
6776067|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776068|NCT02164214|Etanercept|etanercept|mesh-list
6776069|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6776070|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6776071|NCT02164214|Analgesics|analgesics|mesh-ancestor
6776072|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
6776073|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776074|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776075|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6776076|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6776077|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6776078|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6776079|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
6776080|NCT02164253|Deferiprone|deferiprone|mesh-list
6776081|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6776082|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
6776083|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
6776084|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776085|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
6776086|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6776087|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776088|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
6776089|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6776090|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776091|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776092|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6776093|NCT02164448|Analgesics|analgesics|mesh-ancestor
6776094|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
6776095|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776096|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6776097|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6776098|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6776099|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
6776100|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776101|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776102|NCT02164552|Vitamin D|vitamin d|mesh-list
6776103|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
6776104|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
6776105|NCT02164552|Vitamins|vitamins|mesh-list
6776106|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
6776107|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776108|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6776109|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6776110|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
6776111|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6776112|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6776113|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776114|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
6776115|NCT02164565|Coagulants|coagulants|mesh-ancestor
6776116|NCT02164578|Aspirin|aspirin|mesh-list
6776117|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
6776118|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6776119|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6776120|NCT02164578|Analgesics|analgesics|mesh-ancestor
6776121|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
6776122|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776123|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776124|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6776125|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6776126|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6776127|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6776128|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776129|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6776130|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6776131|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776132|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
6776133|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6776134|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
6776135|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6776136|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
6776137|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
6776138|NCT02164604|Ranibizumab|ranibizumab|mesh-list
6776139|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6776140|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6776141|NCT02164604|Growth Substances|growth substances|mesh-ancestor
6776142|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776143|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
6776144|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776145|NCT02164734|Remifentanil|remifentanil|mesh-list
6776146|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6776147|NCT02164734|Narcotics|narcotics|mesh-ancestor
6776148|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776149|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776150|NCT02164734|Analgesics|analgesics|mesh-ancestor
6776151|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
6776152|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776153|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
6776154|NCT02164773|Analgesics|analgesics|mesh-ancestor
6776155|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
6776156|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776157|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776158|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
6776159|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776160|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6776161|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
6776162|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6776163|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6776164|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776165|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6776166|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
6776167|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6776168|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
6776169|NCT02164812|Efavirenz|efavirenz|mesh-list
6776170|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6776171|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776172|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6776173|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6776174|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776175|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776176|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776177|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6776178|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6776179|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
6776180|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6776181|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6776182|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6776183|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6776184|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6776185|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6776186|NCT02164825|Morphine|morphine|mesh-list
6776187|NCT02164825|Ropivacaine|ropivacaine|mesh-list
6776188|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6776189|NCT02164825|Narcotics|narcotics|mesh-ancestor
6776190|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776191|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776192|NCT02164825|Analgesics|analgesics|mesh-ancestor
6776193|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
6776194|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776195|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
6776196|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
6776197|NCT02164838|Axitinib|axitinib|mesh-list
6776198|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776199|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6776200|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776201|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776202|NCT02164890|Micafungin|micafungin|mesh-list
6776203|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
6776204|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790779|NCT02237339|Allopurinol|allopurinol|mesh-list
6790780|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
6790781|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790782|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790783|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
6790784|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6790785|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6790786|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
6790787|NCT02237339|Protective Agents|protective agents|mesh-ancestor
6790788|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790789|NCT02237365|Aspirin|aspirin|mesh-list
6790790|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6790791|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6790792|NCT02237365|Analgesics|analgesics|mesh-ancestor
6790793|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
6790794|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790795|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790796|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6790797|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6790798|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6790799|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6790800|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790801|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6790802|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6790803|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790804|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
6790805|NCT02237443|Bromides|bromides|mesh-list
6790806|NCT02237443|Rocuronium|rocuronium|mesh-list
6790807|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
6790808|NCT02237443|Succinylcholine|succinylcholine|mesh-list
6790809|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
6790810|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6790811|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6790812|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6790813|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790814|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790815|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6790816|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6790817|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6790818|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
6790819|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790820|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790821|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
6790822|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6790823|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790824|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790825|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6790826|NCT02237495|Analgesics|analgesics|mesh-ancestor
6790827|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
6790828|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790829|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6790830|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6790831|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6776205|NCT02164955|Pomalidomide|pomalidomide|mesh-list
6776206|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
6776207|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776208|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6776209|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6776210|NCT02164955|Growth Substances|growth substances|mesh-ancestor
6776211|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
6776212|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776213|NCT02165007|Sirolimus|sirolimus|mesh-list
6776214|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6776215|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776216|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6776217|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776218|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
6776219|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6776220|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
6776221|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776222|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
6776223|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6776224|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
6776225|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776226|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
6776227|NCT02165020|Protective Agents|protective agents|mesh-ancestor
6776228|NCT02165033|Budesonide|budesonide|mesh-list
6776229|NCT02165033|Procaterol|procaterol|mesh-list
6776230|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6776231|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6776232|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
6776233|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776234|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776235|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6776236|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
6776237|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
6776238|NCT02165033|Hormones|hormones|mesh-ancestor
6776239|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6776240|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
6776241|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6776242|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6776243|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6776244|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
6776245|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776246|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776247|NCT02165046|Budesonide|budesonide|mesh-list
6776248|NCT02165046|Procaterol|procaterol|mesh-list
6776249|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6776250|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6776251|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
6776252|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776253|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776254|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6776255|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
6776256|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
6776257|NCT02165046|Hormones|hormones|mesh-ancestor
6776258|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6776259|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
6776260|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6776261|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6776262|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6776263|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
6776264|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776265|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776266|NCT02165098|Cariprazine|cariprazine|mesh-list
6776267|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6776268|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6776269|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776270|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776271|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6776272|NCT02165189|Ribavirin|ribavirin|mesh-list
6776273|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
6776274|NCT02165189|Simeprevir|simeprevir|mesh-list
6776275|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
6776276|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776277|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
6776278|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776279|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
6776280|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776281|NCT02165215|Etrolizumab|etrolizumab|mesh-list
6776282|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6776283|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
6776284|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776285|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
6776286|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
6776287|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6776288|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776289|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6776290|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6776291|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776292|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776293|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776294|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6776295|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
6776296|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6776297|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776298|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6776299|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6776300|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6776301|NCT02165449|Ketamine|ketamine|mesh-list
6776302|NCT02165449|Analgesics|analgesics|mesh-ancestor
6776303|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
6776304|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776305|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776306|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6776307|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6776308|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
6776309|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
6776310|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776311|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6776312|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6776313|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776314|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776315|NCT02165475|Loperamide|loperamide|mesh-list
6776316|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
6776317|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6776318|NCT02165566|Insulin|insulin|mesh-list
6776319|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6776320|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
6776321|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6776322|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776323|NCT02165644|Nimodipine|nimodipine|mesh-list
6776324|NCT02165644|Acetazolamide|acetazolamide|mesh-list
6776325|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
6776326|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6776327|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776328|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776329|NCT02165644|Diuretics|diuretics|mesh-ancestor
6776330|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
6776331|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776332|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6776333|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6776334|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6776335|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6776336|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
6776337|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
6776338|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776339|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776340|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
6776341|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6776342|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776343|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
6776344|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6776345|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
6776346|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776347|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
6776348|NCT02165917|Protective Agents|protective agents|mesh-ancestor
6776349|NCT02165930|Naltrexone|naltrexone|mesh-list
6776350|NCT02165930|Oxycodone|oxycodone|mesh-list
6776351|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6776352|NCT02165930|Narcotics|narcotics|mesh-ancestor
6776353|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776354|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776355|NCT02165930|Analgesics|analgesics|mesh-ancestor
6776356|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
6776357|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776358|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6776359|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6776360|NCT02166229|Valproic Acid|valproic acid|mesh-list
6776361|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
6776362|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776363|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776364|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
6776365|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776366|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776367|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
6776368|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6776369|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776370|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6776371|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6776372|NCT02166359|Icodextrin|icodextrin|mesh-list
6776373|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
6776374|NCT02166450|Nystatin|nystatin|mesh-list
6776375|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6776376|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776377|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
6776378|NCT02166450|Ionophores|ionophores|mesh-ancestor
6776379|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6776380|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790832|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
6790833|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790834|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790835|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
6790836|NCT02237534|Calcium|calcium|mesh-list
6790837|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6790838|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790839|NCT02237534|Antacids|antacids|mesh-ancestor
6790840|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790841|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6790842|NCT02237560|Camphor|camphor|mesh-list
6790843|NCT02237560|Salicylates|salicylates|mesh-list
6790844|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
6790845|NCT02237560|Menthol|menthol|mesh-list
6790846|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6790847|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790848|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
6790849|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
6790850|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6790851|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6790852|NCT02237560|Analgesics|analgesics|mesh-ancestor
6790853|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
6790854|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790855|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790856|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6790857|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6790858|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6790859|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790860|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790861|NCT02237651|Anesthetics|anesthetics|mesh-list
6790862|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790863|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790864|NCT02237690|Doxorubicin|doxorubicin|mesh-list
6790865|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6790866|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6790867|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790868|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6790869|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6790870|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790871|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790872|NCT02237729|Adalimumab|adalimumab|mesh-list
6790873|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6790874|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6790875|NCT02237755|Citric Acid|citric acid|mesh-list
6790876|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
6790877|NCT02237755|Clomiphene|clomiphene|mesh-list
6790878|NCT02237755|Enclomiphene|enclomiphene|mesh-list
6790879|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
6790880|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
6790881|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6790882|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
6790883|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
6790884|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776381|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
6776382|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6776383|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
6776384|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776385|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
6776386|NCT02166554|Protective Agents|protective agents|mesh-ancestor
6776387|NCT02166593|Atorvastatin|atorvastatin|mesh-list
6776388|NCT02166593|Pravastatin|pravastatin|mesh-list
6776389|NCT02166593|Fenofibrate|fenofibrate|mesh-list
6776390|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6776391|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6776392|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
6776393|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776394|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6790885|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6790886|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
6790887|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790888|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790889|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6790890|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
6790891|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6790892|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6790893|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6790894|NCT02237768|Dirithromycin|dirithromycin|mesh-list
6790895|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6790896|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790897|NCT02237807|Dirithromycin|dirithromycin|mesh-list
6790898|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6790899|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790900|NCT02237820|Dexamethasone|dexamethasone|mesh-list
6790901|NCT02237820|Prednisone|prednisone|mesh-list
6790902|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6790903|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
6790904|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
6790905|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790906|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790907|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6790908|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
6790909|NCT02237820|Hormones|hormones|mesh-ancestor
6790910|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6790911|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6790912|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790913|NCT02237859|Vancomycin|vancomycin|mesh-list
6790914|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6790915|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6790916|NCT02237924|Endostar protein|endostar protein|mesh-list
6790917|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6790918|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6790919|NCT02237924|Growth Substances|growth substances|mesh-ancestor
6790920|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790921|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
6790922|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6790923|NCT02237937|Amitriptyline|amitriptyline|mesh-list
6790924|NCT02237937|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
6790925|NCT02237937|Citalopram|citalopram|mesh-list
6790926|NCT02237937|Paroxetine|paroxetine|mesh-list
6790927|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6790928|NCT02237937|Sertraline|sertraline|mesh-list
6790929|NCT02237937|Nortriptyline|nortriptyline|mesh-list
6790930|NCT02237937|Trimipramine|trimipramine|mesh-list
6790931|NCT02237937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6790932|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6790933|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6790934|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790935|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790936|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
6790937|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790938|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6790939|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
6790940|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6790941|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790942|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6790943|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6776395|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6776396|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776397|NCT02166632|Bupivacaine|bupivacaine|mesh-list
6776398|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
6776399|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
6776400|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776401|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776402|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
6776403|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776404|NCT02166671|Vaccines|vaccines|mesh-list
6776405|NCT02166671|Immunologic Factors|immunologic factors|mesh-ancestor
6776406|NCT02166671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776407|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6776408|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6776409|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6776410|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
6776411|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776412|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6776413|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6776414|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776415|NCT02166853|Midazolam|midazolam|mesh-list
6776416|NCT02166853|Sevoflurane|sevoflurane|mesh-list
6776417|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6776418|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6776419|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776420|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776421|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6776422|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6776423|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6776424|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6776425|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
6776426|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
6776427|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
6776428|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
6776429|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776430|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776431|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6776432|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6776433|NCT02166905|Poly I-C|poly i-c|mesh-list
6776434|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6776435|NCT02166905|Poly ICLC|poly iclc|mesh-list
6776436|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
6776437|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
6776438|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776439|NCT02166905|Laxatives|laxatives|mesh-ancestor
6776440|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6776441|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
6776442|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776443|NCT02166944|Tamoxifen|tamoxifen|mesh-list
6776444|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6776445|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
6776446|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6776447|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776448|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6776449|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776450|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6776451|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6776452|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6776453|NCT02167061|Metformin|metformin|mesh-list
6776454|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6776455|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776456|NCT02167165|Digoxin|digoxin|mesh-list
6776457|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6776458|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6776459|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776460|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776461|NCT02167165|Protective Agents|protective agents|mesh-ancestor
6776462|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776463|NCT02167178|Polygeline|polygeline|mesh-list
6776464|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
6776465|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
6776466|NCT02167321|Leucovorin|leucovorin|mesh-list
6776467|NCT02167321|Fluorouracil|fluorouracil|mesh-list
6776468|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
6776469|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
6776470|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776471|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6776472|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776473|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6776474|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
6776475|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776476|NCT02167321|Antidotes|antidotes|mesh-ancestor
6776477|NCT02167321|Protective Agents|protective agents|mesh-ancestor
6776478|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
6776479|NCT02167321|Vitamins|vitamins|mesh-ancestor
6776480|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
6776481|NCT02167425|Methadone|methadone|mesh-list
6776482|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6776483|NCT02167425|Narcotics|narcotics|mesh-ancestor
6776484|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776485|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776486|NCT02167425|Analgesics|analgesics|mesh-ancestor
6776487|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
6776488|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776489|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
6776490|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
6776491|NCT02167464|Coal Tar|coal tar|mesh-list
6776492|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6776493|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
6776494|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
6776495|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
6776496|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6776497|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776498|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6776499|NCT02167464|Diuretics|diuretics|mesh-ancestor
6776500|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
6776501|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
6776502|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
6776503|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
6776504|NCT02167620|Metformin|metformin|mesh-list
6776505|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6776506|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776507|NCT02167633|Pantoprazole|pantoprazole|mesh-list
6776508|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6776509|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
6776510|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6776511|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6776512|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776513|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776514|NCT02167633|Hormones|hormones|mesh-ancestor
6776515|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6776516|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776517|NCT02167685|Brincidofovir|brincidofovir|mesh-list
6776518|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
6776519|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776520|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
6776521|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6776522|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6776523|NCT02167698|Prednisolone|prednisolone|mesh-list
6776524|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
6776525|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6776526|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
6776527|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6776528|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
6776529|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
6776530|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776531|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776532|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6776533|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
6776534|NCT02167698|Hormones|hormones|mesh-ancestor
6776535|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6776536|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6776537|NCT02167698|Protective Agents|protective agents|mesh-ancestor
6776538|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6776539|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776540|NCT02167763|Copper|copper|mesh-list
6776541|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
6776542|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6776543|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776544|NCT02167763|Trace Elements|trace elements|mesh-ancestor
6776545|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
6776546|NCT02167854|Trastuzumab|trastuzumab|mesh-list
6776547|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6776548|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776549|NCT02167945|Ribavirin|ribavirin|mesh-list
6776550|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
6776551|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776552|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
6776553|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776554|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
6776555|NCT02167958|Fludarabine|fludarabine|mesh-list
6776556|NCT02167958|Tacrolimus|tacrolimus|mesh-list
6776557|NCT02167958|Sargramostim|sargramostim|mesh-list
6776558|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6776559|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
6776560|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776561|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6776562|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6776563|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
6776564|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776565|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776566|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6776567|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6776568|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776569|NCT02168010|Neurotropin|neurotropin|mesh-list
6776570|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6776571|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
6776572|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776573|NCT02168010|Analgesics|analgesics|mesh-ancestor
6776574|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
6776575|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776576|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
6790944|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6790945|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6790946|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6790947|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6790948|NCT02237937|Analgesics|analgesics|mesh-ancestor
6790949|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
6790950|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6790951|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
6790952|NCT02237937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6790953|NCT02237937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6790954|NCT02237937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6790955|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6790956|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790957|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
6790958|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790959|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790960|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6790961|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790962|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6790963|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6790964|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6790965|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
6790966|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790967|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790968|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
6790969|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
6790970|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790971|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
6790972|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790973|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6790974|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6790975|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790976|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6790977|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6790978|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6790979|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
6790980|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790981|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790982|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
6790983|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6790984|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
6790985|NCT02238132|Ipratropium|ipratropium|mesh-list
6790986|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790987|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
6790988|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6790989|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776577|NCT02168075|Mannitol|mannitol|mesh-list
6776578|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6776579|NCT02168075|Diuretics|diuretics|mesh-ancestor
6776580|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
6776581|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776582|NCT02168127|Methylphenidate|methylphenidate|mesh-list
6776583|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6776584|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776585|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6776586|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6776587|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6776588|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776589|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
6776590|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776591|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
6776592|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6776593|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6776594|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
6776595|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776596|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776597|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
6776598|NCT02168140|Protective Agents|protective agents|mesh-ancestor
6776599|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776600|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
6776601|NCT02168140|Vitamins|vitamins|mesh-ancestor
6776602|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
6776603|NCT02168205|Pomalidomide|pomalidomide|mesh-list
6776604|NCT02168205|Caffeine|caffeine|mesh-list
6776605|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6776606|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776607|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6776608|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776609|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776610|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6776611|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6776612|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
6776613|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776614|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
6776615|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6776616|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6776617|NCT02168205|Growth Substances|growth substances|mesh-ancestor
6776618|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
6776619|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776620|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
6776621|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6776622|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
6776623|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776624|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
6776625|NCT02168426|Protective Agents|protective agents|mesh-ancestor
6776626|NCT02168543|Alendronate|alendronate|mesh-list
6776627|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6776628|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776629|NCT02168569|Artesunate|artesunate|mesh-list
6776630|NCT02168569|Lumefantrine|lumefantrine|mesh-list
6776631|NCT02168569|Artemether|artemether|mesh-list
6776632|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6776633|NCT02168569|Amodiaquine|amodiaquine|mesh-list
6776634|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
6776635|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6776636|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6776637|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776638|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776639|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
6776640|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
6776641|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
6776642|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
6776643|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
6776644|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6776645|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6776646|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776647|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
6776648|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776649|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776650|NCT02168751|Propofol|propofol|mesh-list
6776651|NCT02168751|Sevoflurane|sevoflurane|mesh-list
6776652|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6776653|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776654|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776655|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6776656|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
6776657|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
6776658|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6776659|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6776660|NCT02168829|Aspirin|aspirin|mesh-list
6776661|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
6776662|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6776663|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6776664|NCT02168829|Analgesics|analgesics|mesh-ancestor
6776665|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
6776666|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776667|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776668|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6776669|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6776670|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6776671|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6776672|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776673|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6776674|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6776675|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776676|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
6776677|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6776678|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
6776679|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6776680|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
6776681|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
6776682|NCT02168881|Misoprostol|misoprostol|mesh-list
6776683|NCT02168881|Dinoprostone|dinoprostone|mesh-list
6776684|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6776685|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
6776686|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6776687|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776688|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6776689|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6776690|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
6776691|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
6776692|NCT02168907|Rituximab|rituximab|mesh-list
6776693|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6776694|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6776695|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776696|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
6776697|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776698|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6776699|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6776700|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
6776701|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776702|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
6776703|NCT02168907|Protective Agents|protective agents|mesh-ancestor
6776704|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
6776705|NCT02168907|Vitamins|vitamins|mesh-ancestor
6776706|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
6776707|NCT02168959|Bupivacaine|bupivacaine|mesh-list
6776708|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
6776709|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
6776710|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776711|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776712|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
6776713|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776714|NCT02169063|Listerine|listerine|mesh-list
6776715|NCT02169063|Fluorides|fluorides|mesh-list
6776716|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
6776717|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
6776718|NCT02169063|Protective Agents|protective agents|mesh-ancestor
6776719|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776720|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6776721|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776722|NCT02169089|Spironolactone|spironolactone|mesh-list
6776723|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6776724|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
6776725|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6776726|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776727|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6776728|NCT02169089|Diuretics|diuretics|mesh-ancestor
6776729|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
6776730|NCT02169154|Diclofenac|diclofenac|mesh-list
6776731|NCT02169154|Menthol|menthol|mesh-list
6776732|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6776733|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6776734|NCT02169154|Analgesics|analgesics|mesh-ancestor
6776735|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
6776736|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776737|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776738|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6776739|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6776740|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6776741|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776742|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776743|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
6776744|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
6776745|NCT02169167|Octenidine|octenidine|mesh-list
6776746|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776747|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6776748|NCT02169544|Abatacept|abatacept|mesh-list
6776749|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6776750|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776751|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776752|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6776753|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
6776754|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776755|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6776756|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
6776757|NCT02169570|Vitamin D|vitamin d|mesh-list
6776758|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
6776759|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
6776760|NCT02169570|Vitamins|vitamins|mesh-list
6776761|NCT02169570|Calcium|calcium|mesh-list
6776762|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
6776763|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776764|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6776765|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6776766|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6776767|NCT02169596|Ticagrelor|ticagrelor|mesh-list
6776768|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6776769|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6776770|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6776771|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6776772|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
6776773|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776774|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776775|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776776|NCT02169609|Interleukin-2|interleukin-2|mesh-list
6776777|NCT02169609|Dinutuximab|dinutuximab|mesh-list
6776778|NCT02169609|Isotretinoin|isotretinoin|mesh-list
6776779|NCT02169609|Sargramostim|sargramostim|mesh-list
6776780|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776781|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6776782|NCT02169609|Analgesics|analgesics|mesh-ancestor
6776783|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
6776784|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776785|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776786|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
6776787|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
6776788|NCT02169648|Ranibizumab|ranibizumab|mesh-list
6776789|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6776790|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6776791|NCT02169648|Growth Substances|growth substances|mesh-ancestor
6776792|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776793|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
6776794|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776795|NCT02169713|Tamsulosin|tamsulosin|mesh-list
6776796|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
6776797|NCT02169713|Mirabegron|mirabegron|mesh-list
6776798|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6776799|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6776800|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6776801|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
6776802|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776803|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776804|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776805|NCT02169713|Urological Agents|urological agents|mesh-ancestor
6776806|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6776807|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6776808|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
6776809|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6776810|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6776811|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6776812|NCT02169752|Ambrisentan|ambrisentan|mesh-list
6776813|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6790990|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6790991|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
6790992|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6790993|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
6790994|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6790995|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6790996|NCT02238145|Ipratropium|ipratropium|mesh-list
6790997|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6790998|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
6790999|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791000|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791001|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791002|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
6776814|NCT02169804|Enclomiphene|enclomiphene|mesh-list
6776815|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6776816|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
6776817|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6776818|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776819|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6776820|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
6776821|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6776822|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6776823|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6776824|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
6776825|NCT02169843|Sevoflurane|sevoflurane|mesh-list
6776826|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6776827|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776828|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776829|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6776830|NCT02169843|Analgesics|analgesics|mesh-ancestor
6776831|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
6776832|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776833|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6776834|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6776835|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6776836|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
6776837|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776838|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776839|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6776840|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6776841|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
6776842|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
6776843|NCT02169856|Cefuroxime|cefuroxime|mesh-list
6776844|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
6776845|NCT02169856|Ketorolac|ketorolac|mesh-list
6776846|NCT02169856|Midazolam|midazolam|mesh-list
6776847|NCT02169856|Propofol|propofol|mesh-list
6776848|NCT02169856|Sevoflurane|sevoflurane|mesh-list
6776849|NCT02169856|Atracurium|atracurium|mesh-list
6776850|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6776851|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776852|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776853|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6776854|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
6776855|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
6776856|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6776857|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6776858|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6776859|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6776860|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
6776861|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
6776862|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6776863|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776864|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6776865|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6776866|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6776867|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6776868|NCT02169856|Analgesics|analgesics|mesh-ancestor
6776869|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
6776870|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776871|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6776872|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6776873|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6776874|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776875|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6776876|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776877|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6776878|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6776879|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6776880|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
6776881|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6776882|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
6776883|NCT02169882|Rifampin|rifampin|mesh-list
6776884|NCT02169882|Dexamethasone|dexamethasone|mesh-list
6776885|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6776886|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
6776887|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
6776888|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776889|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776890|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6776891|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
6776892|NCT02169882|Hormones|hormones|mesh-ancestor
6776893|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6776894|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6776895|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776896|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6776897|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
6776898|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6776899|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776900|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
6776901|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6776902|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776903|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776904|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6776905|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6776906|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6776907|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6776908|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6776909|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6776910|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
6776911|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776912|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776913|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6776914|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6776915|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6776916|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
6776917|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6776918|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776919|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6776920|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6776921|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6776922|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6776923|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6776924|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6776925|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6776926|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6776927|NCT02170090|Gemcitabine|gemcitabine|mesh-list
6776928|NCT02170090|Capecitabine|capecitabine|mesh-list
6776929|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6776930|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6776931|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
6776932|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776933|NCT02170090|Antiviral Agents|antiviral agents|mesh-ancestor
6776934|NCT02170090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6776935|NCT02170090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776936|NCT02170090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6776937|NCT02170090|Immunologic Factors|immunologic factors|mesh-ancestor
6776938|NCT02170090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776939|NCT02170116|Dabigatran|dabigatran|mesh-list
6776940|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
6776941|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6776942|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
6776943|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776944|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776945|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
6776946|NCT02170246|Telmisartan|telmisartan|mesh-list
6776947|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6776948|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6776949|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6776950|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776951|NCT02170324|Exenatide|exenatide|mesh-list
6776952|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6776953|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776954|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6776955|NCT02170324|Incretins|incretins|mesh-ancestor
6776956|NCT02170324|Hormones|hormones|mesh-ancestor
6776957|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6776958|NCT02170402|Factor VIII|factor viii|mesh-list
6776959|NCT02170402|Coagulants|coagulants|mesh-ancestor
6776960|NCT02170415|Pregabalin|pregabalin|mesh-list
6776961|NCT02170415|Anesthetics|anesthetics|mesh-list
6776962|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
6776963|NCT02170415|Analgesics|analgesics|mesh-ancestor
6776964|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
6776965|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6776966|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6776967|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
6776968|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6776969|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6776970|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776971|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6776972|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6776973|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6776974|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6776975|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6776976|NCT02170571|Dabigatran|dabigatran|mesh-list
6776977|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
6776978|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6776979|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
6776980|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776981|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776982|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
6776983|NCT02170584|Dabigatran|dabigatran|mesh-list
6776984|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
6776985|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6776986|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
6776987|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776988|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776989|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
6776990|NCT02170597|Dabigatran|dabigatran|mesh-list
6776991|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
6776992|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6776993|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
6776994|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6776995|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6776996|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
6776997|NCT02170610|Pantoprazole|pantoprazole|mesh-list
6776998|NCT02170610|Dabigatran|dabigatran|mesh-list
6776999|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6777000|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6777001|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6777002|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777003|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777004|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
6777005|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777006|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777007|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
6777008|NCT02170623|Pantoprazole|pantoprazole|mesh-list
6777009|NCT02170623|Dabigatran|dabigatran|mesh-list
6777010|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6777011|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6777012|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6777013|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777014|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777015|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
6777016|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777017|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777018|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
6777019|NCT02170636|Pantoprazole|pantoprazole|mesh-list
6777020|NCT02170636|Dabigatran|dabigatran|mesh-list
6777021|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6777022|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6777023|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6777024|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777025|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777026|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
6777027|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777028|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777029|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
6777030|NCT02170675|Ketoconazole|ketoconazole|mesh-list
6777031|NCT02170675|Dabigatran|dabigatran|mesh-list
6777032|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
6777033|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777034|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777035|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777036|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777037|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
6777038|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
6777039|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6777040|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6777041|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6777042|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6777043|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
6777044|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6777045|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777046|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6777047|NCT02170701|Dabigatran|dabigatran|mesh-list
6777048|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
6777049|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777050|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777051|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777052|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777053|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
6777054|NCT02170740|Pantoprazole|pantoprazole|mesh-list
6777055|NCT02170740|Dabigatran|dabigatran|mesh-list
6777056|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6777057|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6777058|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6777059|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777060|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777061|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
6777062|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777063|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777064|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
6777065|NCT02170766|Pantoprazole|pantoprazole|mesh-list
6777066|NCT02170766|Dabigatran|dabigatran|mesh-list
6777067|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6777068|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6777069|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6777070|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777071|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777072|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
6777073|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777074|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777075|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
6777076|NCT02170792|Ranitidine|ranitidine|mesh-list
6777077|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6777078|NCT02170792|Dabigatran|dabigatran|mesh-list
6777079|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6777080|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6777081|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6777082|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
6777083|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
6777084|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777085|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777086|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777087|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
6777088|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777089|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777090|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777091|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
6777092|NCT02170805|Pantoprazole|pantoprazole|mesh-list
6777093|NCT02170805|Dabigatran|dabigatran|mesh-list
6777094|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6777095|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6777096|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6777097|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777098|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777099|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
6777100|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777101|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777102|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
6777103|NCT02170831|Dabigatran|dabigatran|mesh-list
6777104|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
6777105|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777106|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777107|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777108|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777109|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
6777110|NCT02170844|Dabigatran|dabigatran|mesh-list
6777111|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
6777112|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777113|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777114|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777115|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777116|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
6777117|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
6777118|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6777119|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
6777120|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777121|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
6777122|NCT02170857|Protective Agents|protective agents|mesh-ancestor
6777123|NCT02170896|Pantoprazole|pantoprazole|mesh-list
6777124|NCT02170896|Dabigatran|dabigatran|mesh-list
6777125|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6777126|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6777127|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6777128|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777129|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777130|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
6777131|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777132|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777133|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
6777134|NCT02170909|Dabigatran|dabigatran|mesh-list
6777135|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
6777136|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777137|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777138|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777139|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777140|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
6777141|NCT02170922|Dabigatran|dabigatran|mesh-list
6777142|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
6777143|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777144|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777145|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777146|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777147|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
6777148|NCT02170935|Dabigatran|dabigatran|mesh-list
6777149|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
6777150|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777151|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777152|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777153|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777154|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
6777155|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
6777156|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6777157|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6777158|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777159|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6777160|NCT02170948|Analgesics|analgesics|mesh-ancestor
6777161|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
6777162|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777163|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6777164|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6777165|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6777166|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
6777167|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777168|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777169|NCT02170974|Dabigatran|dabigatran|mesh-list
6777170|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
6777171|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777172|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777173|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777174|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777175|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
6777176|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
6777177|NCT02170987|Dabigatran|dabigatran|mesh-list
6777178|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6777179|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6777180|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6777181|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6777182|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777183|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777184|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777185|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
6777186|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777187|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777188|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
6777189|NCT02171000|Dabigatran|dabigatran|mesh-list
6777190|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
6777191|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777192|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777193|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777194|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777195|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
6777196|NCT02171013|Dabigatran|dabigatran|mesh-list
6777197|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
6777198|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777199|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777200|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777201|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777202|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
6777203|NCT02171026|Amiodarone|amiodarone|mesh-list
6777204|NCT02171026|Dabigatran|dabigatran|mesh-list
6777205|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
6777206|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777207|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777208|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777209|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777210|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
6777211|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6777212|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
6777213|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6777214|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6777215|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6777216|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6777217|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6777218|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6777219|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6777220|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6777221|NCT02171039|Dabigatran|dabigatran|mesh-list
6777222|NCT02171039|Atorvastatin|atorvastatin|mesh-list
6777223|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6777224|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6777225|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
6777226|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777227|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6777228|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6777229|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777230|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
6777231|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777232|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777233|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
6777234|NCT02171052|Digoxin|digoxin|mesh-list
6777235|NCT02171052|Dabigatran|dabigatran|mesh-list
6777236|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
6777237|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777238|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777239|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777240|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777241|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
6777242|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6777243|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6777244|NCT02171052|Protective Agents|protective agents|mesh-ancestor
6777245|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777246|NCT02171156|Nintedanib|nintedanib|mesh-list
6777247|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777248|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777249|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777250|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777251|NCT02171182|Capsaicin|capsaicin|mesh-list
6777252|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
6777253|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
6777254|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
6777255|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777256|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777257|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6777258|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
6777259|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6777260|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
6777261|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777262|NCT02171221|DFP-11207|dfp-11207|mesh-list
6777263|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6777264|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
6777265|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777266|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777267|NCT02171299|Ropivacaine|ropivacaine|mesh-list
6777268|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
6777269|NCT02171299|Anesthetics|anesthetics|mesh-list
6777270|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6777271|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777272|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
6777273|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777274|NCT02171325|Irinotecan|irinotecan|mesh-list
6777275|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6777276|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6777277|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777278|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777279|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777280|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6777281|NCT02171338|Azithromycin|azithromycin|mesh-list
6777282|NCT02171338|Clarithromycin|clarithromycin|mesh-list
6777283|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
6777284|NCT02171338|Tazobactam|tazobactam|mesh-list
6777285|NCT02171338|Piperacillin|piperacillin|mesh-list
6777286|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6777287|NCT02171338|Penicillin G|penicillin g|mesh-list
6777288|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6777289|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6777290|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777291|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777292|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6777293|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6777294|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6777295|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6777296|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777297|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6777298|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6777299|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
6777300|NCT02171390|Testosterone|testosterone|mesh-list
6777301|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
6777302|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
6777303|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6777304|NCT02171390|Androgens|androgens|mesh-ancestor
6777305|NCT02171390|Hormones|hormones|mesh-ancestor
6777306|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6777307|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777308|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6777309|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777310|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
6777311|NCT02171416|Rilonacept|rilonacept|mesh-list
6777312|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6777313|NCT02171442|Dabigatran|dabigatran|mesh-list
6777314|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
6777315|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777316|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777317|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777318|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777319|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
6777320|NCT02171455|Dabigatran|dabigatran|mesh-list
6777321|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
6777322|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777323|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777324|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777325|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777326|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
6777327|NCT02171468|Dabigatran|dabigatran|mesh-list
6777328|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
6777329|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777330|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777331|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777332|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777333|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
6791003|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791004|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791005|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791006|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791007|NCT02238158|Ipratropium|ipratropium|mesh-list
6791008|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791009|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
6791010|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791011|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791012|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791013|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791014|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791015|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791016|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791017|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791018|NCT02238171|Ipratropium|ipratropium|mesh-list
6791019|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791020|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
6791021|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791022|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791023|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791024|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791025|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791026|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791027|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791028|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791029|NCT02238184|Ipratropium|ipratropium|mesh-list
6791030|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791031|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
6791032|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791033|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791034|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791035|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791036|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791037|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791038|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791039|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791040|NCT02238197|Ipratropium|ipratropium|mesh-list
6791041|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791042|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
6791043|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791044|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791045|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791046|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791047|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791048|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791049|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791050|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791051|NCT02238210|Ipratropium|ipratropium|mesh-list
6791052|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777334|NCT02171481|Dabigatran|dabigatran|mesh-list
6777335|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
6777336|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777337|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777338|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777339|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777340|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
6777341|NCT02171494|Warfarin|warfarin|mesh-list
6777342|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
6777343|NCT02171507|Diclofenac|diclofenac|mesh-list
6777344|NCT02171507|Dabigatran|dabigatran|mesh-list
6777345|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6777346|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6777347|NCT02171507|Analgesics|analgesics|mesh-ancestor
6777348|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
6777349|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777350|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777351|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6777352|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6777353|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6777354|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777355|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777356|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
6777357|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777358|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777359|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
6777360|NCT02171520|Dabigatran|dabigatran|mesh-list
6777361|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
6777362|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777363|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777364|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777365|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777366|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
6777367|NCT02171533|Verapamil|verapamil|mesh-list
6777368|NCT02171533|Dabigatran|dabigatran|mesh-list
6777369|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
6777370|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777371|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777372|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777373|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777374|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
6777375|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6777376|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6777377|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6777378|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6777379|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777380|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
6777381|NCT02171546|Fexofenadine|fexofenadine|mesh-list
6777382|NCT02171546|Quinidine|quinidine|mesh-list
6777383|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
6777384|NCT02171546|Dabigatran|dabigatran|mesh-list
6777385|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
6777386|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777387|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777388|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777389|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777390|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
6777391|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6777392|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6777393|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6777394|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
6777395|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
6777396|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777397|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777398|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6777399|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6777400|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
6777401|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6777402|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
6777403|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6777404|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6777405|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6777406|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6777407|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777408|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777409|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6777410|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6777411|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6777412|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6777413|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6777414|NCT02171559|Enoxaparin|enoxaparin|mesh-list
6777415|NCT02171559|Dabigatran|dabigatran|mesh-list
6777416|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
6777417|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6777418|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6777419|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777420|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
6777421|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777422|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777423|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777424|NCT02171572|Dabigatran|dabigatran|mesh-list
6777425|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
6777426|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777427|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777428|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777429|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777430|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
6777431|NCT02171585|Clarithromycin|clarithromycin|mesh-list
6777432|NCT02171585|Dabigatran|dabigatran|mesh-list
6777433|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6777434|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6777435|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6777436|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777437|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777438|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6777439|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6777440|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
6777441|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777442|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777443|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
6777444|NCT02171598|Dabigatran|dabigatran|mesh-list
6777445|NCT02171598|Clopidogrel|clopidogrel|mesh-list
6777446|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6777447|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6777448|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6777449|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6777450|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
6777451|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777452|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777453|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777454|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
6777455|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777456|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777457|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777458|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
6777459|NCT02171624|Quinidine|quinidine|mesh-list
6777460|NCT02171624|Dabigatran|dabigatran|mesh-list
6777461|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
6777462|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6777463|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777464|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777465|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777466|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
6777467|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6777468|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6777469|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
6777470|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777471|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777472|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6777473|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
6777474|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6777475|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6777476|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6777477|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6777478|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777479|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777480|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6777481|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6777482|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6777483|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6777484|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6777485|NCT02171637|Afatinib|afatinib|mesh-list
6777486|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777487|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777488|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777489|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777490|NCT02171650|Afatinib|afatinib|mesh-list
6777491|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777492|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777493|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777494|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777495|NCT02171663|Afatinib|afatinib|mesh-list
6777496|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777497|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777498|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777499|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777500|NCT02171676|Docetaxel|docetaxel|mesh-list
6777501|NCT02171676|Afatinib|afatinib|mesh-list
6777502|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777503|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
6777504|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
6777505|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
6777506|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777507|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777508|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777509|NCT02171689|Afatinib|afatinib|mesh-list
6777510|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777511|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777512|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777513|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777514|NCT02171702|Afatinib|afatinib|mesh-list
6777515|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777516|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777517|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777518|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777519|NCT02171715|Afatinib|afatinib|mesh-list
6777520|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777521|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777522|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777523|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777524|NCT02171728|Afatinib|afatinib|mesh-list
6777525|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777526|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777527|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777528|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777529|NCT02171741|Docetaxel|docetaxel|mesh-list
6777530|NCT02171741|Afatinib|afatinib|mesh-list
6777531|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777532|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
6777533|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
6777534|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
6777535|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777536|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777537|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777538|NCT02171754|Ritonavir|ritonavir|mesh-list
6777539|NCT02171754|Afatinib|afatinib|mesh-list
6777540|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6777541|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6777542|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777543|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777544|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777545|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6777546|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6777547|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
6777548|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6777549|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6777550|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6777551|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777552|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777553|NCT02171767|Afatinib|afatinib|mesh-list
6777554|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777555|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6777556|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777557|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777558|NCT02171780|Olodaterol|olodaterol|mesh-list
6777559|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777560|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
6777561|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777562|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777563|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777564|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777565|NCT02171793|Olodaterol|olodaterol|mesh-list
6777566|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777567|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
6777568|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777569|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777570|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777571|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777572|NCT02171806|Olodaterol|olodaterol|mesh-list
6777573|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777574|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
6777575|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777576|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777577|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777578|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777579|NCT02171832|Olodaterol|olodaterol|mesh-list
6777580|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777581|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
6777582|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777583|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777584|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777585|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777586|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
6777587|NCT02171910|Doxapram|doxapram|mesh-list
6777588|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6777589|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777590|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777591|NCT02171975|Anesthetics|anesthetics|mesh-list
6777592|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6777593|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777594|NCT02171988|Propranolol|propranolol|mesh-list
6777595|NCT02171988|Bisoprolol|bisoprolol|mesh-list
6777596|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6777597|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6777598|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6777599|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
6777600|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791053|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
6791054|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791055|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791056|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791057|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791058|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6791059|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
6791060|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791061|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791062|NCT02238223|Epinastine|epinastine|mesh-list
6791063|NCT02238223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6791064|NCT02238223|Histamine Antagonists|histamine antagonists|mesh-ancestor
6791065|NCT02238223|Histamine Agents|histamine agents|mesh-ancestor
6791066|NCT02238223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791067|NCT02238223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791068|NCT02238223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791069|NCT02238236|Epinastine|epinastine|mesh-list
6791070|NCT02238236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6791071|NCT02238236|Histamine Antagonists|histamine antagonists|mesh-ancestor
6791072|NCT02238236|Histamine Agents|histamine agents|mesh-ancestor
6791073|NCT02238236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791074|NCT02238236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791075|NCT02238236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791076|NCT02238249|Epinastine|epinastine|mesh-list
6791077|NCT02238249|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6791078|NCT02238249|Histamine Antagonists|histamine antagonists|mesh-ancestor
6791079|NCT02238249|Histamine Agents|histamine agents|mesh-ancestor
6791080|NCT02238249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791081|NCT02238249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791082|NCT02238249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791083|NCT02238262|Telmisartan|telmisartan|mesh-list
6791084|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6791085|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6777601|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777602|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777603|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6777604|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6777605|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
6777606|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
6777607|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
6777608|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777609|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6777610|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6777611|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777612|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777613|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6777614|NCT02172001|Hematinics|hematinics|mesh-ancestor
6777615|NCT02172014|Fentanyl|fentanyl|mesh-list
6777616|NCT02172014|Midazolam|midazolam|mesh-list
6777617|NCT02172014|Citric Acid|citric acid|mesh-list
6777618|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
6777619|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6777620|NCT02172014|Narcotics|narcotics|mesh-ancestor
6777621|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6777622|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777623|NCT02172014|Analgesics|analgesics|mesh-ancestor
6777624|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
6777625|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777626|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6777627|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6777628|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
6777629|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
6777630|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6777631|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6777632|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6777633|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6777634|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
6777635|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
6777636|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777637|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777638|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
6777639|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6777640|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
6777641|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
6777642|NCT02172105|Olodaterol|olodaterol|mesh-list
6777643|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777644|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
6777645|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777646|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777647|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777648|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777649|NCT02172131|Olodaterol|olodaterol|mesh-list
6777650|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777651|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
6777652|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777653|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777654|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777655|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777656|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
6777657|NCT02172144|Olodaterol|olodaterol|mesh-list
6777658|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6777659|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6777660|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6777661|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6777662|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777663|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777664|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6777665|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777666|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777667|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
6777668|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777669|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777670|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777671|NCT02172157|Olodaterol|olodaterol|mesh-list
6777672|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777673|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
6777674|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777675|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777676|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777677|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777678|NCT02172170|Empagliflozin|empagliflozin|mesh-list
6777679|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6777680|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777681|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6777682|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777683|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6777684|NCT02172196|Empagliflozin|empagliflozin|mesh-list
6777685|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6777686|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777687|NCT02172196|Incretins|incretins|mesh-ancestor
6777688|NCT02172196|Hormones|hormones|mesh-ancestor
6777689|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6777690|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6777691|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777692|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777693|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777694|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6777695|NCT02172209|Empagliflozin|empagliflozin|mesh-list
6777696|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6777697|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777698|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6777699|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777700|NCT02172222|Linagliptin|linagliptin|mesh-list
6777701|NCT02172222|Empagliflozin|empagliflozin|mesh-list
6777702|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6777703|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777704|NCT02172222|Incretins|incretins|mesh-ancestor
6777705|NCT02172222|Hormones|hormones|mesh-ancestor
6777706|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6777707|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6777708|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
6777709|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777710|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777711|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6777712|NCT02172235|Pioglitazone|pioglitazone|mesh-list
6777713|NCT02172235|Empagliflozin|empagliflozin|mesh-list
6777714|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6777715|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777716|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6777717|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777718|NCT02172248|Metformin|metformin|mesh-list
6777719|NCT02172248|Empagliflozin|empagliflozin|mesh-list
6777720|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6777721|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777722|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6777723|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777724|NCT02172261|Glimepiride|glimepiride|mesh-list
6777725|NCT02172261|Empagliflozin|empagliflozin|mesh-list
6777726|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6777727|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6777728|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777729|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6777730|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
6777731|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6777732|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777733|NCT02172274|Empagliflozin|empagliflozin|mesh-list
6777734|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6777735|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777736|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6777737|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777738|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
6777739|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6777740|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777741|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
6777742|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777743|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777744|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777745|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777746|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
6777747|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777748|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777749|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777750|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777751|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6777752|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6777753|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6777754|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
6777755|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
6777756|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777757|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
6777758|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777759|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777760|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777761|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777762|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
6777763|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777764|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777765|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777766|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777767|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
6777768|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777769|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
6777770|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777771|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777772|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777773|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777774|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
6777775|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777776|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777777|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777778|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777779|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
6777780|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777781|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
6777782|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777783|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777784|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777785|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777786|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
6777787|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777788|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777789|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777790|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777791|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
6777792|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777793|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
6777794|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777795|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777796|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777797|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777798|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
6777799|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777800|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777801|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777802|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777803|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
6777804|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777805|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
6777806|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777807|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777808|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777809|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777810|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
6777811|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777812|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777813|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777814|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777815|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
6777816|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777817|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
6777818|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777819|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777820|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777821|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777822|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
6777823|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777824|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777825|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777826|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777827|NCT02172404|Ipratropium|ipratropium|mesh-list
6777828|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777829|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
6777830|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777831|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777832|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777833|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777834|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777835|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777836|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777837|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777838|NCT02172417|Ranitidine|ranitidine|mesh-list
6777839|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6777840|NCT02172417|Cimetidine|cimetidine|mesh-list
6777841|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
6777842|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777843|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
6777844|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777845|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777846|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777847|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777848|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
6777849|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777850|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777851|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777852|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777853|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6777854|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6777855|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6777856|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
6777857|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
6777858|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6777859|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6777860|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6777861|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
6777862|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777863|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
6777864|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777865|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777866|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777867|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777868|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
6777869|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777870|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777871|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777872|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777873|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
6777874|NCT02172443|Ipratropium|ipratropium|mesh-list
6777875|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777876|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
6777877|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777878|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777879|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777880|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777881|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
6777882|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777883|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777884|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777885|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777886|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
6777887|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777888|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
6777889|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777890|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777891|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777892|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777893|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
6777894|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777895|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777896|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777897|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777898|NCT02172469|Bromides|bromides|mesh-list
6777899|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
6777900|NCT02172469|Ipratropium|ipratropium|mesh-list
6777901|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777902|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
6777903|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777904|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777905|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777906|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777907|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
6777908|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777909|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777910|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777911|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777912|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
6777913|NCT02172482|Bromides|bromides|mesh-list
6777914|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
6777915|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777916|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
6777917|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777918|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777919|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777920|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777921|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
6777922|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777923|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777924|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777925|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777926|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
6777927|NCT02172495|Bromides|bromides|mesh-list
6777928|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
6777929|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777930|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
6777931|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777932|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777933|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777934|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777935|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
6777936|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777937|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777938|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777939|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777940|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
6777941|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
6777942|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777943|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
6777944|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777945|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777946|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777947|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777948|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
6777949|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777950|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777951|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777952|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777953|NCT02172521|Bromides|bromides|mesh-list
6777954|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
6777955|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777956|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
6777957|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777958|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777959|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777960|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777961|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
6777962|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777963|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777964|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777965|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777966|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
6777967|NCT02172534|Bromides|bromides|mesh-list
6777968|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
6777969|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777970|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
6777971|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777972|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777973|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777974|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777975|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
6777976|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777977|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777978|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777979|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777980|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
6777981|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
6777982|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777983|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
6777984|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777985|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777986|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777987|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
6777988|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
6777989|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6777990|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
6777991|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6777992|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6777993|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
6777994|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6777995|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
6777996|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6777997|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6777998|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6777999|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778000|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
6778001|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6778002|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778003|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778004|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778005|NCT02172573|Pramipexole|pramipexole|mesh-list
6778006|NCT02172573|Bromocriptine|bromocriptine|mesh-list
6778007|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
6778008|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778009|NCT02172573|Protective Agents|protective agents|mesh-ancestor
6778010|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778011|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6778012|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6778013|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
6778014|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
6778015|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778016|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
6778017|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778018|NCT02172586|Losartan|losartan|mesh-list
6778019|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6778020|NCT02172586|Telmisartan|telmisartan|mesh-list
6778021|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6778022|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6778023|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6778024|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6778025|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778026|NCT02172586|Diuretics|diuretics|mesh-ancestor
6778027|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
6778028|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778029|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6778030|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6778031|NCT02172651|Vitamin D|vitamin d|mesh-list
6778032|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
6778033|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
6778034|NCT02172651|Vitamins|vitamins|mesh-list
6778035|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
6778036|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778037|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6778038|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6778039|NCT02172729|Lidocaine|lidocaine|mesh-list
6778040|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
6778041|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
6778042|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6778043|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778044|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
6778045|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778046|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6778047|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6778048|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6778049|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6778050|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778051|NCT02172768|Micafungin|micafungin|mesh-list
6778052|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
6778053|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778054|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
6778055|NCT02172781|Ipratropium|ipratropium|mesh-list
6778056|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6778057|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
6778058|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778059|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778060|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778061|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778062|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
6778063|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6778064|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778065|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778066|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778067|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
6778068|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6778069|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6778070|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
6778071|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778072|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778073|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778074|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778075|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
6778076|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6778077|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778078|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778079|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778080|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6778081|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6778082|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6778083|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
6778084|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
6778085|NCT02172807|Oxitropium|oxitropium|mesh-list
6778086|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6778087|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
6778088|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778089|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778090|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778091|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778092|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
6778093|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6778094|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778095|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778096|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778097|NCT02172846|Paclitaxel|paclitaxel|mesh-list
6778098|NCT02172846|Carboplatin|carboplatin|mesh-list
6778099|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6778100|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778101|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
6778102|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
6778103|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
6778104|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778105|NCT02172872|Decitabine|decitabine|mesh-list
6778106|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6778107|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
6778108|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778109|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778110|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791086|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6791087|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791088|NCT02238275|Telmisartan|telmisartan|mesh-list
6791089|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6791090|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6791091|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6791092|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791093|NCT02238288|Acetaminophen|acetaminophen|mesh-list
6791094|NCT02238288|Lidocaine|lidocaine|mesh-list
6791095|NCT02238288|Epinephrine|epinephrine|mesh-list
6791096|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
6791097|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
6791098|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
6791099|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791100|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791101|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
6791102|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791103|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6791104|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6791105|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6791106|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791107|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791108|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6791109|NCT02238288|Analgesics|analgesics|mesh-ancestor
6791110|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
6791111|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6791112|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6791113|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
6791114|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791115|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6791116|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791117|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
6791118|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791119|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791120|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
6778111|NCT02172976|Gemcitabine|gemcitabine|mesh-list
6778112|NCT02172976|Fluorouracil|fluorouracil|mesh-list
6778113|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
6778114|NCT02172976|Irinotecan|irinotecan|mesh-list
6778115|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6778116|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
6778117|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778118|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778119|NCT02172976|Antiviral Agents|antiviral agents|mesh-ancestor
6778120|NCT02172976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778121|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778122|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6778123|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
6778124|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778125|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6778126|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6778127|NCT02173093|Aldesleukin|aldesleukin|mesh-list
6778128|NCT02173093|Interleukin-2|interleukin-2|mesh-list
6778129|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778130|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6778131|NCT02173093|Analgesics|analgesics|mesh-ancestor
6778132|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
6778133|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778134|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778135|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6778136|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6778137|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
6778138|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778139|NCT02173106|Cyclosporine|cyclosporine|mesh-list
6778140|NCT02173106|Cyclosporins|cyclosporins|mesh-list
6778141|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778142|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778143|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6778144|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
6778145|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778146|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
6778147|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778148|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
6778149|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6778150|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6778151|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
6778152|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
6778153|NCT02173132|Vitamins|vitamins|mesh-ancestor
6778154|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
6778155|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778156|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
6778157|NCT02173145|Azithromycin|azithromycin|mesh-list
6778158|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6778159|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778160|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
6778161|NCT02173262|Sargramostim|sargramostim|mesh-list
6778162|NCT02173262|Lenograstim|lenograstim|mesh-list
6778163|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
6778164|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778165|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6778166|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6778167|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778168|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6778169|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6778170|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778171|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778172|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778173|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6778174|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6778175|NCT02173288|Furosemide|furosemide|mesh-list
6778176|NCT02173288|Spironolactone|spironolactone|mesh-list
6778177|NCT02173288|Tolvaptan|tolvaptan|mesh-list
6778178|NCT02173288|Midodrine|midodrine|mesh-list
6778179|NCT02173288|Diuretics|diuretics|mesh-ancestor
6778180|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
6778181|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778182|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6778183|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6778184|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778185|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6778186|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
6778187|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778188|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6778189|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6778190|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
6778191|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
6778192|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778193|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6778194|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6778195|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6778196|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6778197|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
6778198|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778199|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6778200|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6778201|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6778202|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778203|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778204|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6778205|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6778206|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778207|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778208|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778209|NCT02173418|Ropivacaine|ropivacaine|mesh-list
6778210|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
6778211|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
6778212|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6778213|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778214|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
6778215|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778216|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6778217|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6778218|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778219|NCT02173457|Incretins|incretins|mesh-ancestor
6778220|NCT02173457|Hormones|hormones|mesh-ancestor
6778221|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778222|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6778223|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
6778224|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778225|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778226|NCT02173639|Metformin|metformin|mesh-list
6778227|NCT02173639|Linagliptin|linagliptin|mesh-list
6778228|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6778229|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778230|NCT02173639|Incretins|incretins|mesh-ancestor
6778231|NCT02173639|Hormones|hormones|mesh-ancestor
6778232|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778233|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6778234|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
6778235|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778236|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778237|NCT02173652|Linagliptin|linagliptin|mesh-list
6778238|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6778239|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778240|NCT02173652|Incretins|incretins|mesh-ancestor
6778241|NCT02173652|Hormones|hormones|mesh-ancestor
6778242|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778243|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6778244|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
6778245|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778246|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778247|NCT02173665|Linagliptin|linagliptin|mesh-list
6778248|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6778249|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778250|NCT02173665|Incretins|incretins|mesh-ancestor
6778251|NCT02173665|Hormones|hormones|mesh-ancestor
6778252|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778253|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6778254|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
6778255|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778256|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778257|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
6778258|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6778259|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6778260|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
6778261|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778262|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778263|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778264|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778265|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
6778266|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6778267|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778268|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778269|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778270|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6778271|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6778272|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6778273|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
6778274|NCT02173717|Rifampin|rifampin|mesh-list
6778275|NCT02173717|Dabigatran|dabigatran|mesh-list
6778276|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
6778277|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6778278|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
6778279|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778280|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778281|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
6778282|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6778283|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
6778284|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6778285|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778286|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
6778287|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6778288|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6778289|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6778290|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6778291|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6778292|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6778293|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6778294|NCT02173730|Pantoprazole|pantoprazole|mesh-list
6778295|NCT02173730|Dabigatran|dabigatran|mesh-list
6778296|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6778297|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6778298|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6778299|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778300|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778301|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
6778302|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6778303|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
6778304|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
6778305|NCT02173756|Morphine|morphine|mesh-list
6778306|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6778307|NCT02173756|Narcotics|narcotics|mesh-ancestor
6778308|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6778309|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778310|NCT02173756|Analgesics|analgesics|mesh-ancestor
6778311|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
6778312|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778313|NCT02173782|Fenoterol|fenoterol|mesh-list
6778314|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6778315|NCT02173782|Ipratropium|ipratropium|mesh-list
6778316|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6778317|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
6778318|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778319|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778320|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778321|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778322|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
6778323|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
6778324|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6778325|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6778326|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6778327|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6778328|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
6778329|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778330|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778331|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6778332|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778333|NCT02173795|Fenoterol|fenoterol|mesh-list
6778334|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6778335|NCT02173795|Ipratropium|ipratropium|mesh-list
6778336|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6778337|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
6778338|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778339|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778340|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778341|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778342|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
6778343|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
6778344|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6778345|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6778346|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6778347|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6778348|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
6778349|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778350|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778351|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6778352|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778353|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
6778354|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
6778355|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6778356|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
6778357|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6778358|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778359|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6778360|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6778361|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6778362|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6778363|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6778364|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6778365|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6778366|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778367|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778368|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778369|NCT02173873|Aflibercept|aflibercept|mesh-list
6778370|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6778371|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6778372|NCT02173873|Growth Substances|growth substances|mesh-ancestor
6778373|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778374|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
6778375|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778376|NCT02173886|Bupropion|bupropion|mesh-list
6778377|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6778378|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
6778379|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6778380|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6778381|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6778382|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6778383|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778384|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
6778385|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778386|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778387|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6778388|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6778389|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778390|NCT02173912|Amlodipine|amlodipine|mesh-list
6778391|NCT02173912|Candesartan|candesartan|mesh-list
6778392|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
6778393|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6778394|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6778395|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6778396|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778397|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6778398|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778399|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
6778400|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6778401|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6778402|NCT02173951|Deferiprone|deferiprone|mesh-list
6778403|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6778404|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
6778405|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
6778406|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778407|NCT02173964|Pinaverium|pinaverium|mesh-list
6778408|NCT02173964|Bromides|bromides|mesh-list
6778409|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
6778410|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6778411|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6778412|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778413|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6778414|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778415|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
6778416|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
6778417|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778418|NCT02173990|Aflibercept|aflibercept|mesh-list
6778419|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6778420|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6778421|NCT02173990|Growth Substances|growth substances|mesh-ancestor
6778422|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778423|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
6778424|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778425|NCT02174068|Acetaminophen|acetaminophen|mesh-list
6778426|NCT02174068|Nefopam|nefopam|mesh-list
6778427|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6778428|NCT02174068|Analgesics|analgesics|mesh-ancestor
6778429|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
6778430|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778431|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778432|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
6778433|NCT02174094|Clobazam|clobazam|mesh-list
6778434|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
6778435|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6778436|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6778437|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6778438|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778439|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6778440|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6778441|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
6778442|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
6778443|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778444|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778445|NCT02174120|Propofol|propofol|mesh-list
6778446|NCT02174120|Etomidate|etomidate|mesh-list
6778447|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6778448|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6778449|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778450|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6778451|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
6778452|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
6778453|NCT02174172|Interferons|interferons|mesh-list
6778454|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
6778455|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
6778456|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6778457|NCT02174172|Bevacizumab|bevacizumab|mesh-list
6778458|NCT02174172|Ipilimumab|ipilimumab|mesh-list
6778459|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
6778460|NCT02174172|Atezolizumab|atezolizumab|mesh-list
6778461|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6778462|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778463|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6778464|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6778465|NCT02174172|Growth Substances|growth substances|mesh-ancestor
6778466|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778467|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
6778468|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
6778469|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778470|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6778471|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778472|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
6778473|NCT02174211|Ranibizumab|ranibizumab|mesh-list
6778474|NCT02174211|Aflibercept|aflibercept|mesh-list
6778475|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6778476|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6778477|NCT02174211|Growth Substances|growth substances|mesh-ancestor
6778478|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778479|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
6778480|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778481|NCT02174250|Rifampin|rifampin|mesh-list
6778482|NCT02174250|Istradefylline|istradefylline|mesh-list
6778483|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6778484|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
6778485|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6778486|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778487|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
6778488|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6778489|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778490|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778491|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6778492|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6778493|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6778494|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6778495|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6778496|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6778497|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
6778498|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6778499|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6778500|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
6778501|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778502|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778503|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
6778504|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
6778505|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
6778506|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778507|NCT02174328|Aspirin|aspirin|mesh-list
6778508|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6778509|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6778510|NCT02174328|Analgesics|analgesics|mesh-ancestor
6778511|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
6778512|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778513|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778514|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6778515|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6778516|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6778517|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6778518|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778519|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6778520|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6778521|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778522|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
6791121|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
6791122|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6791123|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6791124|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6791125|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
6791126|NCT02238288|Coagulants|coagulants|mesh-ancestor
6791127|NCT02238314|Ritonavir|ritonavir|mesh-list
6791128|NCT02238314|Tipranavir|tipranavir|mesh-list
6791129|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
6791130|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6791131|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6791132|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
6791133|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791134|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791135|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6791136|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6791137|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
6791138|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791139|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6791140|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6791141|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6791142|NCT02238340|Ketoprofen|ketoprofen|mesh-list
6791143|NCT02238340|Morphine|morphine|mesh-list
6791144|NCT02238340|Oxycodone|oxycodone|mesh-list
6791145|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6791146|NCT02238340|Narcotics|narcotics|mesh-ancestor
6791147|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6791148|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791149|NCT02238340|Analgesics|analgesics|mesh-ancestor
6791150|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
6791151|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791152|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6791153|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6791154|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6778523|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
6778524|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778525|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6778526|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778527|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778528|NCT02174549|Tirapazamine|tirapazamine|mesh-list
6778529|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778530|NCT02174575|Sevoflurane|sevoflurane|mesh-list
6778531|NCT02174575|Desflurane|desflurane|mesh-list
6778532|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6778533|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6778534|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
6778535|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
6778536|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6778537|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778538|NCT02174588|Midazolam|midazolam|mesh-list
6778539|NCT02174588|Propofol|propofol|mesh-list
6778540|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6778541|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6778542|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778543|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6778544|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
6778545|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
6778546|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6778547|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6778548|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6778549|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6778550|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
6778551|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
6778552|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778553|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778554|NCT02174666|Vitamin D|vitamin d|mesh-list
6778555|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
6778556|NCT02174666|Vitamins|vitamins|mesh-list
6778557|NCT02174666|Genistein|genistein|mesh-list
6778558|NCT02174666|Biochanin A|biochanin a|mesh-list
6778559|NCT02174666|Daidzein|daidzein|mesh-list
6778560|NCT02174666|Formononetin|formononetin|mesh-list
6778561|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
6778562|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778563|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6778564|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6778565|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6778566|NCT02174666|Protective Agents|protective agents|mesh-ancestor
6778567|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778568|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6778569|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778570|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778571|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
6778572|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6778573|NCT02174666|Estrogens|estrogens|mesh-ancestor
6778574|NCT02174666|Hormones|hormones|mesh-ancestor
6778575|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778576|NCT02174718|Vitamin D|vitamin d|mesh-list
6778577|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
6778578|NCT02174718|Vitamins|vitamins|mesh-ancestor
6778579|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
6778580|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778581|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6778582|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6778583|NCT02174757|Doxycycline|doxycycline|mesh-list
6778584|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6778585|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778586|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
6778587|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6778588|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6778589|NCT02174887|Gemcitabine|gemcitabine|mesh-list
6778590|NCT02174887|Paclitaxel|paclitaxel|mesh-list
6778591|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6778592|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778593|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
6778594|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
6778595|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
6778596|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778597|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6778598|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
6778599|NCT02174887|Antiviral Agents|antiviral agents|mesh-ancestor
6778600|NCT02174887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778601|NCT02174887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778602|NCT02174887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6778603|NCT02174887|Immunologic Factors|immunologic factors|mesh-ancestor
6778604|NCT02174887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778605|NCT02174900|Lumefantrine|lumefantrine|mesh-list
6778606|NCT02174900|Artemether|artemether|mesh-list
6778607|NCT02174900|Primaquine|primaquine|mesh-list
6778608|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
6778609|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
6778610|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6778611|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6778612|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778613|NCT02174939|Cilostazol|cilostazol|mesh-list
6778614|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6778615|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
6778616|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778617|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778618|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778619|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778620|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6778621|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6778622|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778623|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6778624|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
6778625|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6778626|NCT02174939|Protective Agents|protective agents|mesh-ancestor
6778627|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6778628|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6778629|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778630|NCT02175017|Nivolumab|nivolumab|mesh-list
6778631|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6778632|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778633|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6778634|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778635|NCT02175030|Copper|copper|mesh-list
6778636|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
6778637|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6778638|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
6778639|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6778640|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778641|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6778642|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6778643|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6778644|NCT02175030|Trace Elements|trace elements|mesh-ancestor
6778645|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
6778646|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6778647|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6778648|NCT02175069|Ropivacaine|ropivacaine|mesh-list
6778649|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
6778650|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
6778651|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6778652|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778653|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
6778654|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778655|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
6778656|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6778657|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
6778658|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778659|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778660|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778661|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778662|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
6778663|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6778664|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778665|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778666|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778667|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6778668|NCT02175355|Telmisartan|telmisartan|mesh-list
6778669|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6778670|NCT02175355|Diuretics|diuretics|mesh-ancestor
6778671|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
6778672|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778673|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6778674|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791155|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6778675|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778676|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6778677|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6778678|NCT02175381|Gemcitabine|gemcitabine|mesh-list
6778679|NCT02175381|Carboplatin|carboplatin|mesh-list
6778680|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778681|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6778682|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
6778683|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778684|NCT02175381|Antiviral Agents|antiviral agents|mesh-ancestor
6778685|NCT02175381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778686|NCT02175381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778687|NCT02175381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6778688|NCT02175381|Immunologic Factors|immunologic factors|mesh-ancestor
6778689|NCT02175381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778690|NCT02175394|Linagliptin|linagliptin|mesh-list
6778691|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6778692|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6778693|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6778694|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778695|NCT02175394|Incretins|incretins|mesh-ancestor
6778696|NCT02175394|Hormones|hormones|mesh-ancestor
6778697|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778698|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6778699|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
6778700|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778701|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778702|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6778703|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
6778704|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6778705|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6778706|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6778707|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6778708|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6778709|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6778710|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6778711|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6778712|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6778713|NCT02175407|Itraconazole|itraconazole|mesh-list
6778714|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
6778715|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778716|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6778717|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6778718|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778719|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778720|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6778721|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
6778722|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778723|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778724|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6778725|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
6778726|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
6778727|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778728|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6778729|NCT02175446|Bevacizumab|bevacizumab|mesh-list
6778730|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6778731|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778732|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6778733|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6778734|NCT02175446|Growth Substances|growth substances|mesh-ancestor
6778735|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778736|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
6778737|NCT02175485|Fexofenadine|fexofenadine|mesh-list
6778738|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6778739|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6778740|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6778741|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
6778742|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
6778743|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778744|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778745|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778746|NCT02175589|Colchicine|colchicine|mesh-list
6778747|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
6778748|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6778749|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
6778750|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
6778751|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
6778752|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778753|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778754|NCT02175602|Citalopram|citalopram|mesh-list
6778755|NCT02175602|Sertraline|sertraline|mesh-list
6778756|NCT02175602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6778757|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6778758|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6778759|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778760|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778761|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
6778762|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778763|NCT02175602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6778764|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
6778765|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6778766|NCT02175680|Leronlimab|leronlimab|mesh-list
6778767|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
6778768|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
6778769|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778770|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6778771|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6778772|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
6778773|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778774|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
6778775|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6778776|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778777|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6778778|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778779|NCT02175888|Iron|iron|mesh-list
6778780|NCT02175888|Trace Elements|trace elements|mesh-ancestor
6778781|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
6778782|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778783|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6778784|NCT02175901|Amoxicillin|amoxicillin|mesh-list
6778785|NCT02175901|Metronidazole|metronidazole|mesh-list
6778786|NCT02175901|Clarithromycin|clarithromycin|mesh-list
6778787|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6778788|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
6778789|NCT02175901|Lansoprazole|lansoprazole|mesh-list
6778790|NCT02175901|Bismuth|bismuth|mesh-list
6778791|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6778792|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778793|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778794|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
6778795|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6778796|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6778797|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6778798|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778799|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6778800|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6778801|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6778802|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6778803|NCT02175901|Antacids|antacids|mesh-ancestor
6778804|NCT02175901|Diuretics|diuretics|mesh-ancestor
6778805|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
6778806|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778807|NCT02175901|Expectorants|expectorants|mesh-ancestor
6778808|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778809|NCT02175914|Erythromycin|erythromycin|mesh-list
6778810|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
6778811|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
6778812|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
6778813|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6778814|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778815|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6778816|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6778817|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778818|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778819|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6778820|NCT02175927|Amoxicillin|amoxicillin|mesh-list
6778821|NCT02175927|Metronidazole|metronidazole|mesh-list
6778822|NCT02175927|Tetracycline|tetracycline|mesh-list
6778823|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6778824|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
6778825|NCT02175927|Lansoprazole|lansoprazole|mesh-list
6778826|NCT02175927|Bismuth|bismuth|mesh-list
6778827|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6778828|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778829|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778830|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
6778831|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6778832|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6778833|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6778834|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6778835|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778836|NCT02175927|Antacids|antacids|mesh-ancestor
6778837|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6778838|NCT02175927|Diuretics|diuretics|mesh-ancestor
6778839|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
6778840|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778841|NCT02175927|Expectorants|expectorants|mesh-ancestor
6778842|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778843|NCT02176044|Nitroprusside|nitroprusside|mesh-list
6778844|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6778845|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
6778846|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6778847|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778848|NCT02176057|Azithromycin|azithromycin|mesh-list
6778849|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6778850|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791156|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6791157|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791158|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791159|NCT02238353|Fluticasone|fluticasone|mesh-list
6791160|NCT02238353|Azelastine|azelastine|mesh-list
6791161|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6791162|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6791163|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
6791164|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791165|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791166|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6791167|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
6791168|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
6791169|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6791170|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
6791171|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791172|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791173|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6791174|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6791175|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
6791176|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
6791177|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778851|NCT02176122|Meropenem|meropenem|mesh-list
6778852|NCT02176122|Tazobactam|tazobactam|mesh-list
6778853|NCT02176122|Piperacillin|piperacillin|mesh-list
6778854|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6778855|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6778856|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6778857|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6778858|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6778859|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778860|NCT02176135|Auranofin|auranofin|mesh-list
6778861|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6778862|NCT02176161|Metformin|metformin|mesh-list
6778863|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6778864|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778865|NCT02176187|Fenoterol|fenoterol|mesh-list
6778866|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6778867|NCT02176187|Ipratropium|ipratropium|mesh-list
6778868|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6778869|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
6778870|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778871|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778872|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778873|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778874|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
6778875|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
6778876|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6778877|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6778878|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6778879|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6778880|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
6778881|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778882|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778883|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6778884|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778885|NCT02176200|Fenoterol|fenoterol|mesh-list
6778886|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
6778887|NCT02176200|Ipratropium|ipratropium|mesh-list
6778888|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6778889|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
6778890|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778891|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778892|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778893|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778894|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
6778895|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
6778896|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6778897|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6778898|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6778899|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6778900|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
6778901|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6778902|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778903|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6778904|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
6778905|NCT02176213|Dexamethasone|dexamethasone|mesh-list
6778906|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
6778907|NCT02176213|Pomalidomide|pomalidomide|mesh-list
6778908|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6778909|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
6778910|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778911|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6791178|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
6791179|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
6791180|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6791181|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
6791182|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6791183|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791184|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6791185|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6791186|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791187|NCT02238392|Adenosine|adenosine|mesh-list
6791188|NCT02238392|Analgesics|analgesics|mesh-ancestor
6791189|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
6791190|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791191|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778912|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6778913|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
6778914|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778915|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778916|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6778917|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6778918|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
6778919|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
6778920|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778921|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6778922|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
6778923|NCT02176213|Hormones|hormones|mesh-ancestor
6778924|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778925|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6778926|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6778927|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6778928|NCT02176213|Growth Substances|growth substances|mesh-ancestor
6778929|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
6778930|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6778931|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
6778932|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6778933|NCT02176304|Prednisolone|prednisolone|mesh-list
6778934|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
6778935|NCT02176304|Lidocaine|lidocaine|mesh-list
6778936|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6778937|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
6778938|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
6778939|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
6778940|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6778941|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778942|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
6778943|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778944|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6778945|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6778946|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6778947|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6778948|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778949|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6778950|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
6778951|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
6778952|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6778953|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
6778954|NCT02176304|Hormones|hormones|mesh-ancestor
6778955|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6778956|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6778957|NCT02176304|Protective Agents|protective agents|mesh-ancestor
6778958|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6778959|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778960|NCT02176369|Vinorelbine|vinorelbine|mesh-list
6778961|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6778962|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778963|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
6778964|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
6778965|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
6778966|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778967|NCT02176460|Colchicine|colchicine|mesh-list
6778968|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
6778969|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6778970|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
6778971|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
6778972|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
6778973|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778974|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6778975|NCT02176499|Telmisartan|telmisartan|mesh-list
6778976|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6778977|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6778978|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6778979|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778980|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6778981|NCT02176512|Telmisartan|telmisartan|mesh-list
6778982|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6778983|NCT02176512|Diuretics|diuretics|mesh-ancestor
6778984|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
6778985|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778986|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6778987|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6778988|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6778989|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6778990|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6778991|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
6778992|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
6778993|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6778994|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6778995|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6778996|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
6778997|NCT02176681|Vildagliptin|vildagliptin|mesh-list
6778998|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6778999|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779000|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6779001|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
6779002|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779003|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779004|NCT02176720|Fluorides|fluorides|mesh-list
6779005|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
6779006|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
6779007|NCT02176720|Protective Agents|protective agents|mesh-ancestor
6779008|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779009|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
6779010|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779011|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779012|NCT02176733|Cyclosporine|cyclosporine|mesh-list
6779013|NCT02176733|Cyclosporins|cyclosporins|mesh-list
6779014|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779015|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779016|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6779017|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
6779018|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779019|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
6779020|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779021|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
6779022|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779023|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6779024|NCT02176759|Citric Acid|citric acid|mesh-list
6779025|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
6779026|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
6779027|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6779028|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
6779029|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
6779030|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779031|NCT02176850|Telmisartan|telmisartan|mesh-list
6779032|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779033|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6779034|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6779035|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779036|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6779037|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
6779038|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779039|NCT02177071|Methotrexate|methotrexate|mesh-list
6779040|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
6779041|NCT02177071|Azathioprine|azathioprine|mesh-list
6779042|NCT02177071|Infliximab|infliximab|mesh-list
6779043|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6779044|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
6779045|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6779046|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779047|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6779048|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
6779049|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779050|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779051|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
6779052|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779053|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6779054|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6779055|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
6779056|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779057|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6779058|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6779059|NCT02177175|Carvedilol|carvedilol|mesh-list
6779060|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6779061|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6779062|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
6779063|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779064|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779065|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779066|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779067|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
6779068|NCT02177175|Protective Agents|protective agents|mesh-ancestor
6779069|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6779070|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779071|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6779072|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
6779073|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6779074|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6779075|NCT02177253|Bromides|bromides|mesh-list
6779076|NCT02177253|Albuterol|albuterol|mesh-list
6779077|NCT02177253|Ipratropium|ipratropium|mesh-list
6779078|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
6779079|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6779080|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
6779081|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779082|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779083|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6779084|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
6779085|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
6779086|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6779087|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6779088|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6779089|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6779090|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
6779091|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779092|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779093|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6779094|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
6779095|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6779096|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
6779097|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6779098|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
6779099|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779100|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779101|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6779102|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
6779103|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
6779104|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6779105|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
6779106|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779107|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779108|NCT02177318|Bromides|bromides|mesh-list
6779109|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
6779110|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6779111|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
6779112|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779113|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779114|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6779115|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
6779116|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
6779117|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6779118|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
6779119|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779120|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779121|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
6779122|NCT02177331|Lacidipine|lacidipine|mesh-list
6779123|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779124|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6779125|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779126|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779127|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6779128|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779129|NCT02177344|Bromides|bromides|mesh-list
6779130|NCT02177344|Ipratropium|ipratropium|mesh-list
6779131|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
6779132|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6779133|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
6779134|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779135|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779136|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6779137|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
6779138|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6779139|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
6779140|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779141|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779142|NCT02177357|Pramipexole|pramipexole|mesh-list
6779143|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
6779144|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779145|NCT02177357|Protective Agents|protective agents|mesh-ancestor
6779146|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779147|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6779148|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6779149|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
6779150|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
6779151|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779152|NCT02177370|Fenoterol|fenoterol|mesh-list
6779153|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6779154|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
6779155|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779156|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779157|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6779158|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
6779159|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
6779160|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
6779161|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6779162|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6779163|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6779164|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6779165|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
6779166|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779167|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779168|NCT02177396|Valsartan|valsartan|mesh-list
6779169|NCT02177396|Telmisartan|telmisartan|mesh-list
6779170|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779171|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6779172|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6779173|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779174|NCT02177409|Amlodipine|amlodipine|mesh-list
6779175|NCT02177409|Telmisartan|telmisartan|mesh-list
6779176|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779177|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6779178|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779179|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779180|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6779181|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779182|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
6779183|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6779184|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6779185|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6779186|NCT02177422|Telmisartan|telmisartan|mesh-list
6779187|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779188|NCT02177422|Diuretics|diuretics|mesh-ancestor
6779189|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
6779190|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779191|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6779192|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779193|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779194|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6779195|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6779196|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6779197|NCT02177435|Telmisartan|telmisartan|mesh-list
6779198|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6779199|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779200|NCT02177435|Diuretics|diuretics|mesh-ancestor
6779201|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
6779202|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779203|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6779204|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6791192|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6779205|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779206|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6779207|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6779208|NCT02177448|Enalapril|enalapril|mesh-list
6779209|NCT02177448|Enalaprilat|enalaprilat|mesh-list
6779210|NCT02177448|Telmisartan|telmisartan|mesh-list
6779211|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6779212|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
6779213|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779214|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779215|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779216|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6779217|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6779218|NCT02177461|Telmisartan|telmisartan|mesh-list
6779219|NCT02177461|Clonidine|clonidine|mesh-list
6779220|NCT02177461|Enalapril|enalapril|mesh-list
6779221|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779222|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6779223|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6779224|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779225|NCT02177461|Analgesics|analgesics|mesh-ancestor
6779226|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
6779227|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779228|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779229|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
6779230|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
6779231|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6779232|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6779233|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6779234|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
6779235|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779236|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6779237|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
6779238|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779239|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6779240|NCT02177487|Telmisartan|telmisartan|mesh-list
6779241|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6779242|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779243|NCT02177487|Diuretics|diuretics|mesh-ancestor
6779244|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
6779245|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779246|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6779247|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779248|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779249|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6779250|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6779251|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6779252|NCT02177500|Telmisartan|telmisartan|mesh-list
6779253|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
6779254|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779255|NCT02177500|Diuretics|diuretics|mesh-ancestor
6779256|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
6779257|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779258|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6779259|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779260|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779261|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6779262|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6779263|NCT02177539|Phenylephrine|phenylephrine|mesh-list
6779264|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
6779265|NCT02177539|Tropicamide|tropicamide|mesh-list
6779266|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
6779267|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6779268|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
6779269|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
6779270|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779271|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779272|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
6779273|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6779274|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
6779275|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
6779276|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6779277|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6779278|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6779279|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
6779280|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779281|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779282|NCT02177539|Protective Agents|protective agents|mesh-ancestor
6779283|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6779284|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6779285|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
6779286|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
6779287|NCT02177552|Carboplatin|carboplatin|mesh-list
6779288|NCT02177552|Docetaxel|docetaxel|mesh-list
6779289|NCT02177552|Capecitabine|capecitabine|mesh-list
6779290|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
6779291|NCT02177552|Epirubicin|epirubicin|mesh-list
6779292|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779293|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
6779294|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
6779295|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
6779296|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779297|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6779298|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
6779299|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6779300|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6779301|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6779302|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779303|NCT02177578|Temozolomide|temozolomide|mesh-list
6779304|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6779305|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
6779306|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779307|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779308|NCT02177643|Diacetylrhein|diacetylrhein|mesh-list
6779309|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6791193|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
6791194|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6791195|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
6791196|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
6791197|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6791198|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791199|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
6791200|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6791201|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791202|NCT02238418|Vitamins|vitamins|mesh-ancestor
6791203|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
6791204|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6791205|NCT02238431|Leuprolide|leuprolide|mesh-list
6791206|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6791207|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
6791208|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6791209|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791210|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6791211|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791212|NCT02238444|Aspirin|aspirin|mesh-list
6791213|NCT02238444|Heparin|heparin|mesh-list
6791214|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
6791215|NCT02238444|Tinzaparin|tinzaparin|mesh-list
6791216|NCT02238444|Dalteparin|dalteparin|mesh-list
6791217|NCT02238444|Dipyridamole|dipyridamole|mesh-list
6791218|NCT02238444|Warfarin|warfarin|mesh-list
6791219|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6791220|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6791221|NCT02238444|Analgesics|analgesics|mesh-ancestor
6791222|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
6791223|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6791224|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791225|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6791226|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6791227|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6791228|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6791229|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791230|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6791231|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6791232|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791233|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
6791234|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
6791235|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6779310|NCT02177734|Vaccines|vaccines|mesh-list
6779311|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
6779312|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779313|NCT02177760|Sirolimus|sirolimus|mesh-list
6779314|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6779315|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779316|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6779317|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779318|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
6779319|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6779320|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
6779321|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779322|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
6779323|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779324|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6779325|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779326|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779327|NCT02177851|Iron|iron|mesh-list
6779328|NCT02177851|Trace Elements|trace elements|mesh-ancestor
6779329|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
6779330|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779331|NCT02177955|Midazolam|midazolam|mesh-list
6779332|NCT02177955|Diazepam|diazepam|mesh-list
6779333|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6779334|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6779335|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6779336|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779337|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6779338|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6779339|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6779340|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6779341|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
6779342|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
6779343|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
6779344|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
6779345|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779346|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779347|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
6779348|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
6779349|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
6779350|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779351|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6779352|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6779353|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6779354|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
6779355|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6779356|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779357|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6779358|NCT02178124|Donepezil|donepezil|mesh-list
6779359|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6779360|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779361|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779362|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
6779363|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779364|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779365|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
6779366|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
6779367|NCT02178137|Astringents|astringents|mesh-ancestor
6779368|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779369|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
6779370|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
6779371|NCT02178150|Antacids|antacids|mesh-ancestor
6779372|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779373|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6779374|NCT02178254|Fosfomycin|fosfomycin|mesh-list
6779375|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6779376|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779377|NCT02178293|Ketoprofen|ketoprofen|mesh-list
6779378|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
6779379|NCT02178293|Benzydamine|benzydamine|mesh-list
6779380|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6779381|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6779382|NCT02178293|Analgesics|analgesics|mesh-ancestor
6779383|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
6779384|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779385|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779386|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6779387|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779388|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6779389|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779390|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779391|NCT02178306|Telmisartan|telmisartan|mesh-list
6779392|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779393|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6779394|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6779395|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779396|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6779397|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779398|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6779399|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779400|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779401|NCT02178410|Vitamin D|vitamin d|mesh-list
6779402|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
6779403|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
6779404|NCT02178410|Vitamins|vitamins|mesh-list
6779405|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
6779406|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779407|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6779408|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6779409|NCT02178449|Dexamethasone|dexamethasone|mesh-list
6779410|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
6779411|NCT02178449|Ropivacaine|ropivacaine|mesh-list
6779412|NCT02178449|BB 1101|bb 1101|mesh-list
6779413|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6779414|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
6779415|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
6779416|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779417|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779418|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6779419|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
6779420|NCT02178449|Hormones|hormones|mesh-ancestor
6779421|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6779422|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6779423|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779424|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
6779425|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
6779426|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6779427|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
6779428|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
6779429|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779430|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779431|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
6779432|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6779433|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779434|NCT02178488|Vitamins|vitamins|mesh-ancestor
6779435|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
6779436|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6779437|NCT02178566|Treprostinil|treprostinil|mesh-list
6779438|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779439|NCT02178644|Capecitabine|capecitabine|mesh-list
6779440|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6779441|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
6779442|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779443|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779444|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
6779445|NCT02178683|Tacrolimus|tacrolimus|mesh-list
6779446|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6779447|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
6779448|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779449|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6779450|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779451|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779452|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6779453|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779454|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6779455|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
6779456|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6779457|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779458|NCT02178761|Chromium|chromium|mesh-list
6779459|NCT02178761|Everolimus|everolimus|mesh-list
6779460|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779461|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6779462|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
6779463|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779464|NCT02178761|Trace Elements|trace elements|mesh-ancestor
6779465|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
6779466|NCT02178813|Minocycline|minocycline|mesh-list
6779467|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6779468|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779469|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6779470|NCT02179008|Latanoprost|latanoprost|mesh-list
6779471|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6779472|NCT02179034|Menthol|menthol|mesh-list
6779473|NCT02179034|Nicotine|nicotine|mesh-list
6779474|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6779475|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
6779476|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779477|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779478|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6779479|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6779480|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
6779481|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779482|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779483|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
6779484|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
6779485|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
6779486|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6779487|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6779488|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779489|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779490|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
6779491|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779492|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779493|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6779494|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779495|NCT02179255|Hormones|hormones|mesh-list
6779496|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
6779497|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6779498|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779499|NCT02179268|Sertraline|sertraline|mesh-list
6779500|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6779501|NCT02179268|Citalopram|citalopram|mesh-list
6779502|NCT02179268|Reboxetine|reboxetine|mesh-list
6779503|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
6779504|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6779505|NCT02179268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6779506|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6779507|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6779508|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779509|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779510|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
6779511|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779512|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6779513|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6779514|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6779515|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
6779516|NCT02179294|Meperidine|meperidine|mesh-list
6779517|NCT02179294|Remifentanil|remifentanil|mesh-list
6779518|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6779519|NCT02179294|Narcotics|narcotics|mesh-ancestor
6779520|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6779521|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779522|NCT02179294|Analgesics|analgesics|mesh-ancestor
6779523|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
6779524|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779525|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6791236|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
6791237|NCT02238457|Losartan|losartan|mesh-list
6791238|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6791239|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6791240|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6791241|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6791242|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791243|NCT02238470|Warfarin|warfarin|mesh-list
6791244|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
6791245|NCT02238470|Dabigatran|dabigatran|mesh-list
6791246|NCT02238470|Apixaban|apixaban|mesh-list
6791247|NCT02238470|Anticoagulants|anticoagulants|mesh-list
6791248|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6779526|NCT02179528|Etoposide|etoposide|mesh-list
6779527|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6779528|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779529|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6779530|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6779531|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779532|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779533|NCT02179567|Bevacizumab|bevacizumab|mesh-list
6779534|NCT02179567|Docetaxel|docetaxel|mesh-list
6779535|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6779536|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6779537|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6779538|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6779539|NCT02179567|Growth Substances|growth substances|mesh-ancestor
6779540|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779541|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
6779542|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
6779543|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
6779544|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
6779545|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779546|NCT02179645|Celecoxib|celecoxib|mesh-list
6779547|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6779548|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6779549|NCT02179645|Analgesics|analgesics|mesh-ancestor
6779550|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
6779551|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779552|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779553|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6779554|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779555|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6779556|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6779557|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779558|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779559|NCT02179658|Vancomycin|vancomycin|mesh-list
6779560|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
6779561|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6779562|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779563|NCT02179775|Propranolol|propranolol|mesh-list
6779564|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6779565|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6779566|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
6779567|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779568|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779569|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779570|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6779571|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6779572|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
6779573|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
6779574|NCT02179814|Promethazine|promethazine|mesh-list
6779575|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6779576|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6779577|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6779578|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779579|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
6779580|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
6779581|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
6779582|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779583|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
6779584|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
6779585|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6779586|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6779587|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
6779588|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
6779589|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779590|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779591|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6779592|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
6779593|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
6779594|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6779595|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779596|NCT02179931|Flupenthixol|flupenthixol|mesh-list
6779597|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
6779598|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6779599|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6779600|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6779601|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779602|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6779603|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6779604|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
6779605|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779606|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779607|NCT02179970|Plerixafor|plerixafor|mesh-list
6779608|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6779609|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6779610|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
6779611|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6779612|NCT02179996|Vaccines|vaccines|mesh-list
6779613|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
6779614|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779615|NCT02180048|Caffeine|caffeine|mesh-list
6779616|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6779617|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779618|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6779619|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779620|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779621|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6779622|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6779623|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
6779624|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6779625|NCT02180087|Ketoprofen|ketoprofen|mesh-list
6779626|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6779627|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6779628|NCT02180087|Analgesics|analgesics|mesh-ancestor
6779629|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
6779630|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6779631|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6779632|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6779633|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6779634|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6779635|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6779636|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779637|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6779638|NCT02180204|Tenecteplase|tenecteplase|mesh-list
6779639|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6779640|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6779641|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6779642|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
6779643|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6779644|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6791249|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
6791278|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
6791279|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6791280|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6791281|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791282|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
6791283|NCT02238639|Coagulants|coagulants|mesh-ancestor
6791250|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6791251|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
6791252|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791253|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791254|NCT02238496|Sirolimus|sirolimus|mesh-list
6791255|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6791256|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6791257|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6791258|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791259|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
6791260|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6791261|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
6791262|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6791263|NCT02238509|Trastuzumab|trastuzumab|mesh-list
6791264|NCT02238509|Lapatinib|lapatinib|mesh-list
6791265|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6791266|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6791267|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6791268|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6791269|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6791270|NCT02238535|Iloprost|iloprost|mesh-list
6791271|NCT02238535|Warfarin|warfarin|mesh-list
6791272|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
6791273|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6791274|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
6791275|NCT02238548|Vaccines|vaccines|mesh-list
6791276|NCT02238548|Immunologic Factors|immunologic factors|mesh-ancestor
6791277|NCT02238548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5962812|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5962813|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
5962814|NCT04607733|Mirikizumab|mirikizumab|mesh-list
5962815|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5962816|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5962817|NCT04607733|Analgesics|analgesics|mesh-ancestor
5962818|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
5962819|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6242796|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6242797|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6242798|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242799|NCT02656173|Tamsulosin|tamsulosin|mesh-list
6242800|NCT02656173|Mirabegron|mirabegron|mesh-list
6242801|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6242802|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6242803|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6242804|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
6242805|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6242806|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6242807|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6242808|NCT02656173|Urological Agents|urological agents|mesh-ancestor
6242809|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6242810|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6242811|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6242812|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
6242813|NCT02656329|Lugol's solution|lugol's solution|mesh-list
6242814|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6242815|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6242816|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722346|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5722347|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5722348|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5722349|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722350|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5722351|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5722352|NCT03199924|Analgesics|analgesics|mesh-ancestor
5722353|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722354|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5722355|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722356|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
5722357|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5722358|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5722359|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
5722360|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5722361|NCT03199664|Tacrolimus|tacrolimus|mesh-list
5722362|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5722363|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
5722364|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722365|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5722366|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722367|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722368|NCT03199690|Rifampin|rifampin|mesh-list
5722369|NCT03199690|Dolutegravir|dolutegravir|mesh-list
5722370|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5722371|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
5722372|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5722373|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722374|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
5722375|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5722376|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722377|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722378|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5722379|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5722380|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5722381|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5722382|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5722383|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5722384|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5722385|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5722386|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5722387|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5722388|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
5722389|NCT03199950|Haloperidol|haloperidol|mesh-list
5722390|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
5722391|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
5722392|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
5722393|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722394|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722395|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5722396|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5722397|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5722398|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722399|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5722400|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5722401|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
5722402|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722403|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722404|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5722405|NCT03199677|Apatinib|apatinib|mesh-list
5722406|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722407|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5722408|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722409|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722410|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5722411|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
5722412|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5722413|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
5722414|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5722415|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722416|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5722417|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5722418|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722419|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
5722420|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5722421|NCT03199820|Dinoprostone|dinoprostone|mesh-list
5722422|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
5722423|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5722424|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722425|NCT03199339|Midazolam|midazolam|mesh-list
5722426|NCT03199339|Bupropion|bupropion|mesh-list
5722427|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5722428|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5722429|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722430|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722431|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5722432|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5722433|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5722434|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5722435|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
5722436|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
5722437|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
5722438|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
5722439|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722440|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722441|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5722442|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
5722443|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5722444|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5722445|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5722446|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
5722447|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5722448|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5722449|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722450|NCT03199261|Exenatide|exenatide|mesh-list
5722451|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5722452|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722453|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5722454|NCT03199261|Incretins|incretins|mesh-ancestor
5722455|NCT03199261|Hormones|hormones|mesh-ancestor
5722456|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722457|NCT03199300|Trastuzumab|trastuzumab|mesh-list
5722458|NCT03199300|Bleomycin|bleomycin|mesh-list
5722459|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722460|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5722461|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5722462|NCT03199482|Dexamethasone|dexamethasone|mesh-list
5722463|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722464|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
5722465|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
5722466|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722467|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722468|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5722469|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
5722470|NCT03199482|Hormones|hormones|mesh-ancestor
5722471|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722472|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5722473|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722474|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5722475|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
5722476|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722477|NCT03199430|Protective Agents|protective agents|mesh-ancestor
5722478|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722479|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5722480|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5722481|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722482|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5722483|NCT03199547|Azithromycin|azithromycin|mesh-list
5722484|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5722485|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722486|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
5722487|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5722488|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5722489|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5722490|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5722491|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722492|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
5722493|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722494|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722495|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5722496|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722497|NCT03199521|Thrombin|thrombin|mesh-list
5722498|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
5722499|NCT03199521|Coagulants|coagulants|mesh-ancestor
5971412|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971413|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971414|NCT04528563|Analgesics|analgesics|mesh-ancestor
5971415|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
5971416|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971417|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5971418|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5971419|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971420|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5971421|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5971422|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971423|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971424|NCT04528277|Isoniazid|isoniazid|mesh-list
5971425|NCT04528277|Rifapentine|rifapentine|mesh-list
5971426|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
5971427|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5971428|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971429|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5971430|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5971431|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
5971432|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971433|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5971434|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5971435|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
5971436|NCT04528290|Ozanimod|ozanimod|mesh-list
5971437|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5971438|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722500|NCT03199170|Morphine|morphine|mesh-list
5722501|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5722502|NCT03199170|Narcotics|narcotics|mesh-ancestor
5722503|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722504|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722505|NCT03199170|Analgesics|analgesics|mesh-ancestor
5722506|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
5722507|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722508|NCT03199157|Fentanyl|fentanyl|mesh-list
5722509|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5722510|NCT03199157|Narcotics|narcotics|mesh-ancestor
5722511|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722512|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722513|NCT03199157|Analgesics|analgesics|mesh-ancestor
5722514|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
5722515|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722516|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5722517|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5722518|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
5722519|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
5722520|NCT03199105|Tetracaine|tetracaine|mesh-list
5722521|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
5722522|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
5722523|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722524|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722525|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
5722526|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722527|NCT03198637|Cisatracurium|cisatracurium|mesh-list
5722528|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5722529|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5722530|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722531|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722532|NCT03198741|Aspirin|aspirin|mesh-list
5722533|NCT03198741|Clopidogrel|clopidogrel|mesh-list
5722534|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5722535|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5722536|NCT03198741|Analgesics|analgesics|mesh-ancestor
5722537|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
5722538|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722539|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722540|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722541|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722542|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5722543|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5722544|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722545|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5722546|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5722547|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722548|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
5722549|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5722550|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5722551|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5722552|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
5722553|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722554|NCT03198819|Cefotaxime|cefotaxime|mesh-list
5722555|NCT03198819|Cefoxitin|cefoxitin|mesh-list
5722556|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5722557|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722558|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
5722559|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5722560|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5722561|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5722562|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5722563|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722564|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
5722565|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722566|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722567|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5722568|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722569|NCT03198676|Poly I-C|poly i-c|mesh-list
5722570|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
5722571|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722572|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
5722573|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
5722574|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722575|NCT03198585|Empagliflozin|empagliflozin|mesh-list
5722576|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5722577|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722578|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5722579|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722580|NCT03198403|Epinephrine|epinephrine|mesh-list
5722581|NCT03198403|Bupivacaine|bupivacaine|mesh-list
5722582|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
5722583|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
5722584|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722585|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722586|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
5722587|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722588|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5722589|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5722590|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
5722591|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722592|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722593|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5722594|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5971439|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5971440|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
5971441|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971442|NCT04528173|Ketorolac|ketorolac|mesh-list
5971443|NCT04528173|Fentanyl|fentanyl|mesh-list
5971444|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
5971445|NCT04528173|Morphine|morphine|mesh-list
5971446|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5722595|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
5722596|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5722597|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
5722598|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
5722599|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
5722600|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5722601|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5722602|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5722603|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722604|NCT03198949|Everolimus|everolimus|mesh-list
5722605|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722606|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5722607|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
5722608|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722609|NCT03198208|Fentanyl|fentanyl|mesh-list
5722610|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5722611|NCT03198208|Narcotics|narcotics|mesh-ancestor
5722612|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722613|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722614|NCT03198208|Analgesics|analgesics|mesh-ancestor
5722615|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
5722616|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722617|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5722618|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5722619|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
5722620|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
5722621|NCT03198338|Bupivacaine|bupivacaine|mesh-list
5722622|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
5722623|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
5722624|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722625|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722626|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
5722627|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722628|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
5722629|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5722630|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
5722631|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722632|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722633|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5722634|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
5722635|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722636|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722637|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5722638|NCT03198130|Cemiplimab|cemiplimab|mesh-list
5722639|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5722640|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722641|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
5722642|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5722643|NCT03197961|Tenofovir|tenofovir|mesh-list
5722644|NCT03197961|Emtricitabine|emtricitabine|mesh-list
5722645|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5722646|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
5722647|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
5722648|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722649|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5722650|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5971447|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971448|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971449|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5971450|NCT04528173|Analgesics|analgesics|mesh-ancestor
5971451|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
5971452|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971453|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5971454|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5971455|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5971456|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
5971457|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971458|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971459|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5971460|NCT04528173|Narcotics|narcotics|mesh-ancestor
5971461|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5722651|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722652|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722653|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5722654|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5722655|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5722656|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5722657|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5722658|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
5722659|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5722660|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722661|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5722662|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5722663|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5722664|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5722665|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722666|NCT03197779|Aspirin|aspirin|mesh-list
5722667|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5722668|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5722669|NCT03197779|Analgesics|analgesics|mesh-ancestor
5722670|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
5722671|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722672|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722673|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722674|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722675|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5722676|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5722677|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722678|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5722679|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5722680|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722681|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
5722682|NCT03197818|Budesonide|budesonide|mesh-list
5722683|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
5722684|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722685|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5722686|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
5722687|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722688|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722689|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5722690|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
5722691|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
5722692|NCT03197818|Hormones|hormones|mesh-ancestor
5722693|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722694|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5722695|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5722696|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5722697|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
5722698|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722699|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722700|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
5722701|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5722702|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722703|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
5722704|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5722705|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722706|NCT03197623|Alendronate|alendronate|mesh-list
5722707|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5722708|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722709|NCT03197571|Leucovorin|leucovorin|mesh-list
5722710|NCT03197571|Paclitaxel|paclitaxel|mesh-list
5722711|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
5722712|NCT03197571|Bevacizumab|bevacizumab|mesh-list
5722713|NCT03197571|Fluorouracil|fluorouracil|mesh-list
5722714|NCT03197571|Capecitabine|capecitabine|mesh-list
5722715|NCT03197571|Fulvestrant|fulvestrant|mesh-list
5722716|NCT03197571|Avelumab|avelumab|mesh-list
5722717|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5971462|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5722718|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722719|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
5722720|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
5722721|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
5722722|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722723|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5722724|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
5722725|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722726|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722727|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5722728|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
5722729|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5722730|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5722731|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5722732|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5722733|NCT03197571|Growth Substances|growth substances|mesh-ancestor
5722734|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
5722735|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
5722736|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5722737|NCT03197571|Antidotes|antidotes|mesh-ancestor
5722738|NCT03197571|Protective Agents|protective agents|mesh-ancestor
5722739|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
5722740|NCT03197571|Vitamins|vitamins|mesh-ancestor
5722741|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
5722742|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5722743|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5722744|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5722745|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
5722746|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722747|NCT03198013|Prednisolone|prednisolone|mesh-list
5722748|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722749|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
5722750|NCT03198013|Hormones|hormones|mesh-ancestor
5722751|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722752|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722753|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5722754|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722755|NCT03197584|Leucovorin|leucovorin|mesh-list
5722756|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
5971463|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
5971464|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
5971465|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5971466|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971467|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5971468|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5971469|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971470|NCT04528329|Dexamethasone|dexamethasone|mesh-list
5971471|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
5971472|NCT04528329|BB 1101|bb 1101|mesh-list
5971473|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971474|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
5971475|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
5971476|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722757|NCT03197584|Bevacizumab|bevacizumab|mesh-list
5722758|NCT03197584|Fluorouracil|fluorouracil|mesh-list
5722759|NCT03197584|Capecitabine|capecitabine|mesh-list
5722760|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
5722761|NCT03197584|Fulvestrant|fulvestrant|mesh-list
5722762|NCT03197584|Avelumab|avelumab|mesh-list
5722763|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722764|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722765|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5722766|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
5722767|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722768|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722769|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5722770|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
5722771|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5722772|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5722773|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5722774|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5722775|NCT03197584|Growth Substances|growth substances|mesh-ancestor
5722776|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
5722777|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
5722778|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5722779|NCT03197584|Antidotes|antidotes|mesh-ancestor
5722780|NCT03197584|Protective Agents|protective agents|mesh-ancestor
5722781|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
5722782|NCT03197584|Vitamins|vitamins|mesh-ancestor
5722783|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
5722784|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5722785|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5722786|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5722787|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
5722788|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722789|NCT03197493|Levodopa|levodopa|mesh-list
5722790|NCT03197493|Carbidopa|carbidopa|mesh-list
5722791|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5722792|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5722793|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5722794|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
5722795|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722796|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722797|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722798|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5722799|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722800|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5722801|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
5722802|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
5722803|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
5722804|NCT03197506|Temozolomide|temozolomide|mesh-list
5722805|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5722806|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722807|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5722808|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
5722809|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722810|NCT03197480|Aflibercept|aflibercept|mesh-list
5722811|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5722812|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5722813|NCT03197480|Growth Substances|growth substances|mesh-ancestor
5722814|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722815|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
5722816|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722817|NCT03197402|Caseins|caseins|mesh-list
5722818|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
5722819|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
5722820|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722821|NCT03197298|Clopidogrel|clopidogrel|mesh-list
5722822|NCT03197298|Ticagrelor|ticagrelor|mesh-list
5722823|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5722824|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5722825|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5722826|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5971477|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971478|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971479|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
5971480|NCT04528329|Hormones|hormones|mesh-ancestor
5971481|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971482|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5971483|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971484|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
5971485|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971486|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971487|NCT04528095|Clozapine|clozapine|mesh-list
5971488|NCT04528095|Amisulpride|amisulpride|mesh-list
5971489|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5971490|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
5971491|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971492|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971493|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971494|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5971495|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5971496|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971497|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5971498|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
5971499|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
5971500|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5971501|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
5971502|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5971503|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
5971504|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
5971505|NCT04528056|Ambrisentan|ambrisentan|mesh-list
5722827|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
5722828|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722829|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722830|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722831|NCT03197207|Camphor|camphor|mesh-list
5722832|NCT03197207|Salicylates|salicylates|mesh-list
5722833|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
5722834|NCT03197207|Menthol|menthol|mesh-list
5722835|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5722836|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722837|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
5722838|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
5722839|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5722840|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5722841|NCT03197207|Analgesics|analgesics|mesh-ancestor
5722842|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
5722843|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722844|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722845|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971506|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971507|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5971508|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5971509|NCT04528056|Analgesics|analgesics|mesh-ancestor
5971510|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
5971511|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971512|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971513|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971514|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5971515|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971516|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5971517|NCT04528004|Niacinamide|niacinamide|mesh-list
5971518|NCT04528004|Niacin|niacin|mesh-list
5971519|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
5971520|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
5971521|NCT04528004|Vitamins|vitamins|mesh-ancestor
5971522|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
5971523|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971524|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5971525|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
5971526|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971527|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5971528|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
5971529|NCT04527757|Anesthetics|anesthetics|mesh-list
5971530|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971531|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971532|NCT04527562|Colchicine|colchicine|mesh-list
5971533|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
5971534|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5971535|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
5971536|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
5971537|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
5971538|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971539|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971540|NCT04527679|Lenvatinib|lenvatinib|mesh-list
5971541|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971542|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5971543|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971544|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971545|NCT04527900|Paclitaxel|paclitaxel|mesh-list
5971546|NCT04527900|Carboplatin|carboplatin|mesh-list
5971547|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5971548|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971549|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
5971550|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
5971551|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
5971552|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971553|NCT04527432|Antibodies|antibodies|mesh-list
5971554|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
5971555|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971556|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
5722846|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5722847|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5722848|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722849|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722850|NCT03197740|Donepezil|donepezil|mesh-list
5722851|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5722852|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722853|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722854|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
5722855|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5722856|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722857|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
5722858|NCT03197233|Vitamin D|vitamin d|mesh-list
5722859|NCT03197233|Vitamins|vitamins|mesh-list
5722860|NCT03197233|Vitamin A|vitamin a|mesh-list
5722861|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
5722862|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
5722863|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722864|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
5722865|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722866|NCT03197233|Protective Agents|protective agents|mesh-ancestor
5722867|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5722868|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722869|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5722870|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
5722871|NCT03197077|Desogestrel|desogestrel|mesh-list
5722872|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
5722873|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
5722874|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5722875|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5722876|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722877|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5722878|NCT03197077|Hormones|hormones|mesh-ancestor
5722879|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722880|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5722881|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5722882|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5722883|NCT03197077|Progestins|progestins|mesh-ancestor
5722884|NCT03196869|Cisplatin|cisplatin|mesh-list
5722885|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722886|NCT03196921|Amphotericin B|amphotericin b|mesh-list
5722887|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5722888|NCT03196921|Amebicides|amebicides|mesh-ancestor
5722889|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5722890|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5722891|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722892|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5722893|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
5722894|NCT03196986|Bevacizumab|bevacizumab|mesh-list
5722895|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5722896|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722897|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5722898|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5722899|NCT03196986|Growth Substances|growth substances|mesh-ancestor
5722900|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722901|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
5722902|NCT03196934|Cannabidiol|cannabidiol|mesh-list
5722903|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
5722904|NCT03197012|Octreotide|octreotide|mesh-list
5971557|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5971558|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971559|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
5971560|NCT04527666|Anticoagulants|anticoagulants|mesh-list
5971561|NCT04527211|Ivermectin|ivermectin|mesh-list
5971562|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5971563|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971564|NCT05140811|Azacitidine|azacitidine|mesh-list
5971565|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5971566|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
5971567|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971568|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971569|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971570|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5971571|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5971572|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971573|NCT05140655|Fulvestrant|fulvestrant|mesh-list
5971574|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5971575|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971576|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5722905|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5722906|NCT03197012|Edotreotide|edotreotide|mesh-list
5722907|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
5722908|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
5722909|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722910|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5722911|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5722912|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5722913|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971577|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5971578|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
5971579|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971580|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244291|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6244292|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244293|NCT02692391|Indomethacin|indomethacin|mesh-list
6244294|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6244295|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6244296|NCT02692391|Analgesics|analgesics|mesh-ancestor
6244297|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
6244298|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244299|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244300|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244301|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244302|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
6244303|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
6244304|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6244305|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6244306|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722914|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
5722915|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5722916|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
5722917|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722918|NCT03197103|Expectorants|expectorants|mesh-ancestor
5722919|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
5722920|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5722921|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
5722922|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722923|NCT03197103|Protective Agents|protective agents|mesh-ancestor
5722924|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722925|NCT03197103|Antidotes|antidotes|mesh-ancestor
5722926|NCT03196817|Betamethasone|betamethasone|mesh-list
5722927|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
5722928|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5722929|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
5722930|NCT03196817|Lidocaine|lidocaine|mesh-list
5722931|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5722932|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
5722933|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
5722934|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5722935|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722936|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
5722937|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722938|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5722939|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5722940|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5722941|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5722942|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722943|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5722944|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
5722945|NCT03196817|Hormones|hormones|mesh-ancestor
5722946|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5722947|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5722948|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
5722949|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
5722950|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5722951|NCT03196882|Iron|iron|mesh-list
5722952|NCT03196882|Trace Elements|trace elements|mesh-ancestor
5722953|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
5722954|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722955|NCT03196843|Raltitrexed|raltitrexed|mesh-list
5722956|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5722957|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
5722958|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722959|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5722960|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5722961|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5722962|NCT03196648|Fluorides|fluorides|mesh-list
5722963|NCT03196648|Antioxidants|antioxidants|mesh-list
5722964|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
5722965|NCT03196648|Protective Agents|protective agents|mesh-ancestor
5722966|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971581|NCT05140525|Macitentan|macitentan|mesh-list
5971582|NCT05140525|Riociguat|riociguat|mesh-list
5722967|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244307|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722970|NCT03196466|Topiramate|topiramate|mesh-list
5722971|NCT03196466|Pregabalin|pregabalin|mesh-list
5722972|NCT03196466|Lamotrigine|lamotrigine|mesh-list
5722973|NCT03196466|Zonisamide|zonisamide|mesh-list
5722974|NCT03196466|Lacosamide|lacosamide|mesh-list
5722975|NCT03196466|Carbamazepine|carbamazepine|mesh-list
5722976|NCT03196466|Phenytoin|phenytoin|mesh-list
5722977|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
5722978|NCT03196466|Rufinamide|rufinamide|mesh-list
5971583|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5971584|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5971585|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971586|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5971587|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
5971588|NCT05140512|Goserelin|goserelin|mesh-list
5971589|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5971590|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971591|NCT05140499|Bupivacaine|bupivacaine|mesh-list
5971592|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
5971593|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
5971594|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971595|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971596|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
5971597|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971598|NCT05140278|Artesunate|artesunate|mesh-list
5971599|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
5971600|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5971601|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5971602|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971603|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971604|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
5971605|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
5971606|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5971607|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
5971608|NCT05140096|Fluconazole|fluconazole|mesh-list
5971609|NCT05140096|Isavuconazole|isavuconazole|mesh-list
5971610|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
5971611|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
5971612|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971613|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5971614|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5971615|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971616|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971617|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5722979|NCT03196466|Cannabidiol|cannabidiol|mesh-list
5722980|NCT03196466|Levetiracetam|levetiracetam|mesh-list
5722981|NCT03196466|Valproic Acid|valproic acid|mesh-list
5722982|NCT03196466|Brivaracetam|brivaracetam|mesh-list
5722983|NCT03196466|Phenobarbital|phenobarbital|mesh-list
5722984|NCT03196466|Clobazam|clobazam|mesh-list
5722985|NCT03196466|Ethosuximide|ethosuximide|mesh-list
5722986|NCT03196466|Tiagabine|tiagabine|mesh-list
5722987|NCT03196466|Stiripentol|stiripentol|mesh-list
5722988|NCT03196466|Primidone|primidone|mesh-list
5722989|NCT03196466|Felbamate|felbamate|mesh-list
5722990|NCT03196466|Analgesics|analgesics|mesh-ancestor
5722991|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
5722992|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5722993|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5722994|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
5722995|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5722996|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5722997|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5722998|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5722999|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5723000|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5723001|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723002|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5723003|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5723004|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
5723005|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5723006|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5723007|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723008|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
5723009|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723010|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
5723011|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5723012|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5723013|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5723014|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5723015|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5723016|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5723017|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5723018|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5723019|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
5723020|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5723021|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5723022|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
5723023|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
5723024|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5723025|NCT03196401|Durvalumab|durvalumab|mesh-list
5723026|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5723027|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723028|NCT03196479|Ketamine|ketamine|mesh-list
5723029|NCT03196479|Propofol|propofol|mesh-list
5723030|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5723031|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723032|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723033|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5723034|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
5723035|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
5723036|NCT03196479|Analgesics|analgesics|mesh-ancestor
5723037|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
5723038|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723039|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5971618|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
5723040|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5971619|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971620|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971621|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5971622|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5971623|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971624|NCT05139966|Fluorides|fluorides|mesh-list
5971625|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
5971626|NCT05139966|Protective Agents|protective agents|mesh-ancestor
5971627|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971628|NCT05139667|Tacrolimus|tacrolimus|mesh-list
5971629|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5971630|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
5971631|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971632|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5723041|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5723042|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723043|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723044|NCT03196531|Loratadine|loratadine|mesh-list
5723045|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
5723046|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
5723047|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5723048|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5723049|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5723050|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
5723051|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
5723052|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723053|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723054|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723055|NCT03196362|Metformin|metformin|mesh-list
5723056|NCT03196362|Pioglitazone|pioglitazone|mesh-list
5723057|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5723058|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723059|NCT03196154|Insulin|insulin|mesh-list
5723060|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5723061|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723062|NCT03195634|Carvedilol|carvedilol|mesh-list
5723063|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5723064|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5723065|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
5723066|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723067|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723068|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723069|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5723070|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
5723071|NCT03195634|Protective Agents|protective agents|mesh-ancestor
5723072|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5723073|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5723074|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5723075|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
5723076|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5723077|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5971633|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971634|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971635|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
5971636|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
5971637|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971638|NCT05139472|Empagliflozin|empagliflozin|mesh-list
5971639|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5971640|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971641|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5971642|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971643|NCT05139420|Topiramate|topiramate|mesh-list
5971644|NCT05139420|Phentermine|phentermine|mesh-list
5971645|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
5971646|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5723078|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
5723079|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5723080|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5723081|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723082|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
5723083|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
5723084|NCT03195569|Paclitaxel|paclitaxel|mesh-list
5723085|NCT03195569|Bevacizumab|bevacizumab|mesh-list
5971647|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971648|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5971649|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
5971650|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5971651|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
5971652|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
5971653|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971654|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
5971655|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971656|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971657|NCT05139238|Labetalol|labetalol|mesh-list
5971658|NCT05139238|Nifedipine|nifedipine|mesh-list
5971659|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5971660|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5971661|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971662|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5971663|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971664|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
5971665|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
5971666|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5971667|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5971668|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5971669|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
5971670|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971671|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5971672|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
5971673|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
5971674|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971675|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5971676|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5971677|NCT05139095|Apatinib|apatinib|mesh-list
5971678|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971679|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5971680|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971681|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971682|NCT05139030|Bupivacaine|bupivacaine|mesh-list
5971683|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
5971684|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
5971685|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971686|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971687|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
5971688|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971689|NCT05138978|Listerine|listerine|mesh-list
5971690|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
5971691|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
5971692|NCT05138978|Protective Agents|protective agents|mesh-ancestor
5971693|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971694|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5971695|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971696|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5971697|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5971698|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5723086|NCT03195569|Carboplatin|carboplatin|mesh-list
5723087|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5723088|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723089|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
5723090|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
5723091|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
5723092|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723093|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5723094|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5723095|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5723096|NCT03195569|Growth Substances|growth substances|mesh-ancestor
5723097|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723098|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
5723099|NCT03195946|Midazolam|midazolam|mesh-list
5723100|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5723101|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5723102|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723103|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723104|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5723105|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5723106|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5723107|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5723108|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
5723109|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
5723110|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
5723111|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
5723112|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723113|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723114|NCT03195673|Terazosin|terazosin|mesh-list
5723115|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5723116|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5723117|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5723118|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
5723119|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723120|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723121|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723122|NCT03195673|Urological Agents|urological agents|mesh-ancestor
5723123|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
5723124|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5723125|NCT03195543|Thrombin|thrombin|mesh-list
5723126|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
5723127|NCT03195543|Coagulants|coagulants|mesh-ancestor
5723128|NCT03195530|Propofol|propofol|mesh-list
5723129|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5723130|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971699|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5971700|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5971701|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971702|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971703|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5971704|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5971705|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971706|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
5971707|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5971708|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
5971709|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5971710|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971711|NCT05138822|Renal Agents|renal agents|mesh-ancestor
5971712|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5971713|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5971714|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5971715|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971716|NCT05138549|Beta Carotene|beta carotene|mesh-list
5971717|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971718|NCT05138549|Provitamins|provitamins|mesh-ancestor
5971719|NCT05138549|Vitamins|vitamins|mesh-ancestor
5971720|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
5971721|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
5971722|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
5971723|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5971724|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971725|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
5723131|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723132|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5723133|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
5723134|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
5723135|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
5723136|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
5723137|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5723138|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5723139|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
5723140|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723141|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5723142|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5723143|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971726|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
5723144|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723145|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5723146|NCT03195491|Nivolumab|nivolumab|mesh-list
5723147|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5723148|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723149|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5723150|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723151|NCT03195413|Lidocaine|lidocaine|mesh-list
5723152|NCT03195413|Epinephrine|epinephrine|mesh-list
5723153|NCT03195413|Racepinephrine|racepinephrine|mesh-list
5723154|NCT03195413|Bupivacaine|bupivacaine|mesh-list
5723155|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
5723156|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
5723157|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
5723158|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723159|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723160|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
5723161|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723162|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5723163|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5723164|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5723165|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5723166|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723167|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5723168|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5723169|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
5723170|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723171|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5723172|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5723173|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
5723174|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5723175|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
5723176|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
5723177|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
5723178|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5723179|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
5723180|NCT03195374|Narcotics|narcotics|mesh-ancestor
5723181|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723182|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723183|NCT03195374|Analgesics|analgesics|mesh-ancestor
5723184|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
5723185|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723186|NCT03195205|Antibodies|antibodies|mesh-list
5723187|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
5723188|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723189|NCT03195257|Glucagon|glucagon|mesh-list
5723190|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
5723191|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
5723192|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5723193|NCT03195257|Hormones|hormones|mesh-ancestor
5723194|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5723195|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723196|NCT03195257|Incretins|incretins|mesh-ancestor
5723197|NCT03195049|Bilirubin|bilirubin|mesh-list
5723198|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
5723199|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723200|NCT03195049|Protective Agents|protective agents|mesh-ancestor
5723201|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723202|NCT03195153|Allopurinol|allopurinol|mesh-list
5723203|NCT03195153|Atorvastatin|atorvastatin|mesh-list
5723204|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5723205|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5723206|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
5723207|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723208|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5723209|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5723210|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723211|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
5723212|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723213|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5723214|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
5723215|NCT03195153|Protective Agents|protective agents|mesh-ancestor
5723216|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723217|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5723218|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5723219|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723220|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
5723221|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5723222|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723223|NCT03195309|Fentanyl|fentanyl|mesh-list
5723224|NCT03195309|Ropivacaine|ropivacaine|mesh-list
5971727|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5971728|NCT05126121|Amoxicillin|amoxicillin|mesh-list
5971729|NCT05126121|Clarithromycin|clarithromycin|mesh-list
5971730|NCT05126121|Levofloxacin|levofloxacin|mesh-list
5971731|NCT05126121|Ofloxacin|ofloxacin|mesh-list
5971732|NCT05126121|Tetracycline|tetracycline|mesh-list
5971733|NCT05126121|Tinidazole|tinidazole|mesh-list
5971734|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5971735|NCT05126121|Furazolidone|furazolidone|mesh-list
5971736|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971737|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
5971738|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5971739|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971740|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971741|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5971742|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5971743|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5971744|NCT05126121|Renal Agents|renal agents|mesh-ancestor
5971745|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5971746|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5971747|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971748|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5971749|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
5971750|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
5723225|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
5723226|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
5723227|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723228|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723229|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
5723230|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723231|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5723232|NCT03195309|Narcotics|narcotics|mesh-ancestor
5723233|NCT03195309|Analgesics|analgesics|mesh-ancestor
5723234|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5723235|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5723236|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
5723237|NCT03195023|Amlodipine|amlodipine|mesh-list
5723238|NCT03195023|Lisinopril|lisinopril|mesh-list
5723239|NCT03195023|Lercanidipine|lercanidipine|mesh-list
5723240|NCT03195023|Furosemide|furosemide|mesh-list
5723241|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5723242|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5723243|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5723244|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5723245|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5723246|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723247|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5723248|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723249|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
5723250|NCT03195023|Diuretics|diuretics|mesh-ancestor
5723251|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
5723252|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5723253|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
5723254|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5723255|NCT03195023|Protective Agents|protective agents|mesh-ancestor
5723256|NCT03194932|Cytarabine|cytarabine|mesh-list
5723257|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
5723258|NCT03194932|Methotrexate|methotrexate|mesh-list
5723259|NCT03194932|Azacitidine|azacitidine|mesh-list
5723260|NCT03194932|Venetoclax|venetoclax|mesh-list
5723261|NCT03194932|Idarubicin|idarubicin|mesh-list
5723262|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5723263|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
5723264|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5723265|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723266|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5723267|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
5723268|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723269|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723270|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
5723271|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723272|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5723273|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5723274|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
5723275|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723276|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5723277|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
5723278|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723279|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5723280|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5723281|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5723282|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5723283|NCT03194906|Memantine|memantine|mesh-list
5723284|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5723285|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5723286|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
5723287|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723288|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971751|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5971752|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5971753|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5971754|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
5971755|NCT05108688|Sumatriptan|sumatriptan|mesh-list
5971756|NCT05108688|Mirtazapine|mirtazapine|mesh-list
5971757|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5971758|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5971759|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5971760|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
5971761|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723289|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723290|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5723291|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5723292|NCT03194815|Rituximab|rituximab|mesh-list
5723293|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
5971762|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723294|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5723295|NCT03194815|Antibodies|antibodies|mesh-list
5723296|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
5723297|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5723298|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5723299|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723300|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
5723301|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723302|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723303|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
5723304|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
5723305|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
5723306|NCT03194620|Procyanidin|procyanidin|mesh-list
5723307|NCT03194620|Theaflavin|theaflavin|mesh-list
5723308|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
6244308|NCT02692755|Letrozole|letrozole|mesh-list
5723309|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723310|NCT03194620|Protective Agents|protective agents|mesh-ancestor
5723311|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723312|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5723313|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5723314|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723315|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5723316|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723317|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
5723318|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723319|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
5723320|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5723321|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5723322|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
5723323|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
5723324|NCT03194867|Cemiplimab|cemiplimab|mesh-list
5723325|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5723326|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723327|NCT03194685|FF-10101|ff-10101|mesh-list
5723328|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5723329|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723330|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971763|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971764|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
5971765|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5971766|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5971767|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
5971768|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
5971769|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5971770|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5971771|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971772|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5971773|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5971774|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5971775|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
5971776|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5723331|NCT03194724|Vitamin A|vitamin a|mesh-list
5723332|NCT03194724|Vitamins|vitamins|mesh-ancestor
5723333|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
5723334|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723335|NCT03194633|Nifedipine|nifedipine|mesh-list
5723336|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5723337|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5723338|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723339|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5723340|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723341|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
5723342|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
5723343|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5723344|NCT03194659|Choline|choline|mesh-list
5723345|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
5723346|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5723347|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
5723348|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723349|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5723350|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5723351|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
5971777|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5971778|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
5971779|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
5971780|NCT05080790|Interleukin-2|interleukin-2|mesh-list
5971781|NCT05080790|Dinutuximab|dinutuximab|mesh-list
5971782|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971783|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5971784|NCT05080790|Analgesics|analgesics|mesh-ancestor
5723352|NCT03194594|Dexamethasone|dexamethasone|mesh-list
5723353|NCT03194594|Ketamine|ketamine|mesh-list
5723354|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5723355|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
5723356|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
5723357|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723358|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723359|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5723360|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
5723361|NCT03194594|Hormones|hormones|mesh-ancestor
5723362|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5723363|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5723364|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723365|NCT03194594|Analgesics|analgesics|mesh-ancestor
5723366|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
5723367|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5723368|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5723369|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
5723370|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
5723371|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723372|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5723373|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5723374|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723375|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723376|NCT03194555|Acetaminophen|acetaminophen|mesh-list
5723377|NCT03194555|Naltrexone|naltrexone|mesh-list
5723378|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5723379|NCT03194555|Analgesics|analgesics|mesh-ancestor
5723380|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
5723381|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723382|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723383|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
5723384|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5723385|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5971785|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
5971786|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971787|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971788|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5971789|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
5971790|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
5971791|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971792|NCT04918017|Esomeprazole|esomeprazole|mesh-list
5971793|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5971794|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5971795|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971796|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971797|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723386|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
5723387|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
5723388|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723389|NCT03194139|Protective Agents|protective agents|mesh-ancestor
5723390|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723391|NCT03194204|Doxycycline|doxycycline|mesh-list
5723392|NCT03194204|Uric Acid|uric acid|mesh-list
5723393|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
5723394|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5723395|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723396|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
5723397|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5723398|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5723399|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
5723400|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723401|NCT03194204|Protective Agents|protective agents|mesh-ancestor
5723402|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723403|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
5723404|NCT03194126|Misoprostol|misoprostol|mesh-list
5723405|NCT03194126|Mifepristone|mifepristone|mesh-list
5723406|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5723407|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
5723408|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5723409|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723410|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5723411|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5723412|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
5723413|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5723414|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5723415|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5723416|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5723417|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
5971798|NCT04590248|Adavosertib|adavosertib|mesh-list
5971799|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971800|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971801|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
5971802|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5971803|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
5971804|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971805|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
5971806|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
5971807|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5971808|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971809|NCT04502693|Vaccines|vaccines|mesh-list
5971810|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
5971811|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971812|NCT04459871|Thrombin|thrombin|mesh-list
5971813|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
5971814|NCT04459871|Coagulants|coagulants|mesh-ancestor
5971815|NCT04455139|Melphalan|melphalan|mesh-list
5971816|NCT04455139|Topotecan|topotecan|mesh-list
5971817|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5971818|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
5971819|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971820|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971821|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5971822|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5971823|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
5971824|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971825|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5971826|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5971827|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723418|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5723419|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5971828|NCT04447183|Iodine|iodine|mesh-list
5723420|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
5723421|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5723422|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
5723423|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5723424|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5723425|NCT03194061|Cisplatin|cisplatin|mesh-list
5723426|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723427|NCT03194074|Propofol|propofol|mesh-list
5723428|NCT03194074|Desflurane|desflurane|mesh-list
5723429|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5723430|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723431|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723432|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5723433|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
5723434|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
5723435|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5723436|NCT03193749|Amiodarone|amiodarone|mesh-list
5723437|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5723438|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
5723439|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5723440|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5723441|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723442|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5723443|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5723444|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5723445|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723446|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5723447|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5723448|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5723449|NCT03193684|Dapagliflozin|dapagliflozin|mesh-list
5723450|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5723451|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723452|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5723453|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723454|NCT03193944|Vitamin D|vitamin d|mesh-list
5723455|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
5723456|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
5723457|NCT03193944|Vitamins|vitamins|mesh-list
5723458|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
5723459|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723460|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5723461|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5723462|NCT03193957|Etanercept|etanercept|mesh-list
5723463|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5723464|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5723465|NCT03193957|Analgesics|analgesics|mesh-ancestor
5723466|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
5723467|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723468|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723469|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5723470|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723471|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5723472|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5723473|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
5723474|NCT03193814|Apatinib|apatinib|mesh-list
5723475|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971829|NCT04447183|Hormones|hormones|mesh-list
5971830|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971831|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971832|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5971833|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971834|NCT04447183|Trace Elements|trace elements|mesh-ancestor
5971835|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
5971836|NCT04417088|Carboplatin|carboplatin|mesh-list
5971837|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971838|NCT04380545|Interferons|interferons|mesh-list
5971839|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
5971840|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
5971841|NCT04380545|Fluorouracil|fluorouracil|mesh-list
5971842|NCT04380545|Nivolumab|nivolumab|mesh-list
5971843|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
5971844|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971845|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5971846|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971847|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5971848|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
5723476|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5723477|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723478|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723479|NCT03193788|Folic Acid|folic acid|mesh-list
5723480|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
5723481|NCT03193788|Hydroxocobalamin|hydroxocobalamin|mesh-list
5723482|NCT03193788|Dexamethasone|dexamethasone|mesh-list
5723483|NCT03193788|Pemetrexed|pemetrexed|mesh-list
5723484|NCT03193788|Vitamins|vitamins|mesh-ancestor
5723485|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
5723486|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723487|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5723488|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
5723489|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
5723490|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723491|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5723492|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
5723493|NCT03193788|Hormones|hormones|mesh-ancestor
5723494|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5723495|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5723496|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723497|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723498|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723499|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5723500|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5723501|NCT03193788|Hematinics|hematinics|mesh-ancestor
5723502|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
5723503|NCT03193853|Paclitaxel|paclitaxel|mesh-list
5723504|NCT03193853|Serabelisib|serabelisib|mesh-list
5723505|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5723506|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723507|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
5723508|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
5723509|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
5723510|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723511|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723512|NCT03193866|Interferons|interferons|mesh-list
5723513|NCT03193866|Interferon-beta|interferon-beta|mesh-list
5723514|NCT03193866|Rituximab|rituximab|mesh-list
5723515|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
5723516|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
5723517|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
5723518|NCT03193866|Natalizumab|natalizumab|mesh-list
5723519|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
5971849|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723520|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
6244309|NCT02692755|Fulvestrant|fulvestrant|mesh-list
5723521|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5723522|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723523|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
5723524|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723525|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723526|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
5723527|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723528|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
5723529|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723530|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5723531|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
5723532|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5723533|NCT03193723|Anesthetics|anesthetics|mesh-list
5723534|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723535|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723536|NCT03193710|Remifentanil|remifentanil|mesh-list
5723537|NCT03193710|Propofol|propofol|mesh-list
5723538|NCT03193710|Sevoflurane|sevoflurane|mesh-list
5723539|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5723540|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723541|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723542|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5723543|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
5971850|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5971851|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5971852|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
5971853|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971854|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
5971855|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5971856|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
5971857|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5971858|NCT04312594|Expectorants|expectorants|mesh-ancestor
5971859|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
5971860|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5971861|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
5971862|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971863|NCT04312594|Protective Agents|protective agents|mesh-ancestor
5971864|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723544|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
5723545|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5723546|NCT03193710|Narcotics|narcotics|mesh-ancestor
5723547|NCT03193710|Analgesics|analgesics|mesh-ancestor
5723548|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
5723549|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723550|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5723551|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5723552|NCT03193918|Paclitaxel|paclitaxel|mesh-list
5723553|NCT03193918|Ramucirumab|ramucirumab|mesh-list
5723554|NCT03193918|Crenolanib|crenolanib|mesh-list
5723555|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5723556|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723557|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
5723558|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
5723559|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
5723560|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723561|NCT03194009|Metformin|metformin|mesh-list
5723562|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5723563|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723564|NCT03193372|Azelaic acid|azelaic acid|mesh-list
5723565|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723566|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
5723567|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
5971865|NCT04312594|Antidotes|antidotes|mesh-ancestor
5971866|NCT04291508|Acetaminophen|acetaminophen|mesh-list
5971867|NCT04291508|Ascorbic Acid|ascorbic acid|mesh-list
5971868|NCT04291508|Vitamins|vitamins|mesh-ancestor
5971869|NCT04291508|Micronutrients|micronutrients|mesh-ancestor
5971870|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971871|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5971872|NCT04291508|Analgesics|analgesics|mesh-ancestor
5971873|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
5971874|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971875|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
5971876|NCT04291508|Antioxidants|antioxidants|mesh-ancestor
5971877|NCT04291508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971878|NCT04291508|Protective Agents|protective agents|mesh-ancestor
5971879|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
5971880|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971881|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5971882|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971883|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971884|NCT04265755|Erenumab|erenumab|mesh-list
5971885|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5971886|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971887|NCT04265755|Analgesics|analgesics|mesh-ancestor
5971888|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
5971889|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971890|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971891|NCT04246541|Acetaminophen|acetaminophen|mesh-list
5971892|NCT04246541|Ketorolac|ketorolac|mesh-list
5971893|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
5971894|NCT04246541|Oxycodone|oxycodone|mesh-list
5971895|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5971896|NCT04246541|Analgesics|analgesics|mesh-ancestor
5971897|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
5971898|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971899|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971900|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
5971901|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5971902|NCT04246541|Narcotics|narcotics|mesh-ancestor
5971903|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5971904|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5971905|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971906|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5971907|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5971908|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971909|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971910|NCT04238416|Lactulose|lactulose|mesh-list
5971911|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5723568|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5723569|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
5723570|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5723571|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
5723572|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723573|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723574|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
5723575|NCT03193424|Docetaxel|docetaxel|mesh-list
5723576|NCT03193424|Apatinib|apatinib|mesh-list
5723577|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723578|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
5723579|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
5723580|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
5723581|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723582|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5723583|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723584|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
5723585|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5723586|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5723587|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5723588|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5723589|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723590|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
5723591|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723592|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723593|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5971912|NCT04201496|Empagliflozin|empagliflozin|mesh-list
5971913|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5723594|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723595|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
5723596|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5723597|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5723598|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5723599|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5723600|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723601|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
5723602|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723603|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723604|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5723605|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723606|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5723607|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
5723608|NCT03193307|BI 409306|bi 409306|mesh-list
5723609|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5971914|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971915|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5971916|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971917|NCT04129216|Tamoxifen|tamoxifen|mesh-list
5971918|NCT04129216|Letrozole|letrozole|mesh-list
5971919|NCT04129216|Exemestane|exemestane|mesh-list
5971920|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971921|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971922|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5971923|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5971924|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971925|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5971926|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
5971927|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971928|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971929|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5971930|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5971931|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5971932|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5971933|NCT04106414|Nivolumab|nivolumab|mesh-list
5971934|NCT04106414|Linrodostat|linrodostat|mesh-list
5971935|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5971936|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971937|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5971938|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971939|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971940|NCT04102618|Trastuzumab|trastuzumab|mesh-list
5971941|NCT04102618|Letrozole|letrozole|mesh-list
5971942|NCT04102618|Atezolizumab|atezolizumab|mesh-list
5971943|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5971944|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971945|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5971946|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5971947|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971948|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971949|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5971950|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
5971951|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971952|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244310|NCT02692755|Palbociclib|palbociclib|mesh-list
6244311|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244312|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6244313|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6244314|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244315|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244316|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6244317|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
6244318|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6244319|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244320|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6244321|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5723610|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723611|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723612|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5723613|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
5723614|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5723615|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723616|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5723617|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5723618|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5723619|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5723620|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5723621|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5723622|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5723623|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5723624|NCT03193463|Topotecan|topotecan|mesh-list
5723625|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5723626|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5723627|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723628|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723629|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723630|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
5723631|NCT03193281|Dasatinib|dasatinib|mesh-list
5723632|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971953|NCT04052880|Dexamethasone|dexamethasone|mesh-list
5971954|NCT04052880|Lenalidomide|lenalidomide|mesh-list
5971955|NCT04052880|Bortezomib|bortezomib|mesh-list
5971956|NCT04052880|Daratumumab|daratumumab|mesh-list
5971957|NCT04052880|Ixazomib|ixazomib|mesh-list
5971958|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5971959|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
5971960|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
5971961|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5971962|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971963|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5971964|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
5971965|NCT04052880|Hormones|hormones|mesh-ancestor
5971966|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5971967|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5971968|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971969|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
5971970|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5723633|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5723634|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723635|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723636|NCT03193606|Fluorides|fluorides|mesh-list
5723637|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
5723638|NCT03193606|Protective Agents|protective agents|mesh-ancestor
5723639|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723640|NCT03193203|Etanercept|etanercept|mesh-list
5723641|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5723642|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5723643|NCT03193203|Analgesics|analgesics|mesh-ancestor
5723644|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
5723645|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723646|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723647|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5723648|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723649|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5723650|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5723651|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
5723652|NCT03192878|Infliximab|infliximab|mesh-list
5723653|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
5723654|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5723655|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723656|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
5723657|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5723658|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723659|NCT03193073|Mitogens|mitogens|mesh-list
5723660|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
5723661|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723662|NCT03192943|Nivolumab|nivolumab|mesh-list
5723663|NCT03192943|Linrodostat|linrodostat|mesh-list
5723664|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5723665|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723666|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5971971|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5971972|NCT04052880|Growth Substances|growth substances|mesh-ancestor
5971973|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
5971974|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
5971975|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971976|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971977|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5971978|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5971979|NCT04002297|Rituximab|rituximab|mesh-list
5971980|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5971981|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
5971982|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5971983|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971984|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
5971985|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5971986|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5971987|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5971988|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
5971989|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971990|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5971991|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5971992|NCT03993379|Ipilimumab|ipilimumab|mesh-list
5971993|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5971994|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5971995|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5971996|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5971997|NCT03955198|Durvalumab|durvalumab|mesh-list
5971998|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5971999|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972000|NCT03921866|Palbociclib|palbociclib|mesh-list
5972001|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972002|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5972003|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972004|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972005|NCT03772158|Cetirizine|cetirizine|mesh-list
5972006|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5972007|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5972008|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5972009|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
5972010|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
5972011|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723667|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723668|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723669|NCT03193112|S 20098|s 20098|mesh-list
5723670|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5723671|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5723672|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723673|NCT03192969|Abatacept|abatacept|mesh-list
5723674|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
5723675|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5723676|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723677|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723678|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5723679|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
5723680|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723681|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723682|NCT03192969|Hormones|hormones|mesh-ancestor
5723683|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5723684|NCT03192566|Acetaminophen|acetaminophen|mesh-list
5723685|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5723686|NCT03192566|Analgesics|analgesics|mesh-ancestor
5723687|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
5723688|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723689|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723690|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
5972012|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972013|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972014|NCT03724890|Avelumab|avelumab|mesh-list
5972015|NCT03724890|Peposertib|peposertib|mesh-list
5972016|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972017|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972018|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5972019|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972020|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972021|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
5972022|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5972023|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
5972024|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972025|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
5972026|NCT03723590|Protective Agents|protective agents|mesh-ancestor
5972027|NCT03697512|Rituximab|rituximab|mesh-list
5972028|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972029|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972030|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
5972031|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972032|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972038|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
5972039|NCT03613727|Vitamins|vitamins|mesh-ancestor
5972040|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
5972041|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972042|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
5972043|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972044|NCT03613727|Protective Agents|protective agents|mesh-ancestor
5972045|NCT03558854|Aspirin|aspirin|mesh-list
5972046|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5972047|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5972048|NCT03558854|Analgesics|analgesics|mesh-ancestor
5972049|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
5972050|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972051|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972052|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5972053|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972054|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5972055|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5972056|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972057|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5972058|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5972059|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972060|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
5972061|NCT03495960|Rituximab|rituximab|mesh-list
5972062|NCT03495960|Methotrexate|methotrexate|mesh-list
5972063|NCT03495960|Lenalidomide|lenalidomide|mesh-list
5972064|NCT03495960|Temozolomide|temozolomide|mesh-list
5972065|NCT03495960|Procarbazine|procarbazine|mesh-list
5972066|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972067|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972068|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
5972069|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972070|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972071|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5972072|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
5972073|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5972074|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972075|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
6244322|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5723691|NCT03192618|Leucovorin|leucovorin|mesh-list
5723692|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
5723693|NCT03192618|Calcium|calcium|mesh-list
5723694|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
5723695|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5723696|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723697|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723698|NCT03192618|Antidotes|antidotes|mesh-ancestor
5723699|NCT03192618|Protective Agents|protective agents|mesh-ancestor
5723700|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
5723701|NCT03192618|Vitamins|vitamins|mesh-ancestor
5723702|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
5972076|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972077|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
5972078|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972079|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5972080|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5972081|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5972082|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5972083|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5972084|NCT03495960|Growth Substances|growth substances|mesh-ancestor
5972085|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
5972086|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5972087|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
5972088|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
5972089|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972090|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972091|NCT03444753|Nivolumab|nivolumab|mesh-list
5972092|NCT03444753|Ipilimumab|ipilimumab|mesh-list
5972093|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972094|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972095|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5972096|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972097|NCT03430895|Durvalumab|durvalumab|mesh-list
5972098|NCT03430895|Tremelimumab|tremelimumab|mesh-list
5972099|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972100|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972101|NCT03409458|Avelumab|avelumab|mesh-list
5972102|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972103|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972104|NCT03402841|Olaparib|olaparib|mesh-list
5972105|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5972106|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972107|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972108|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972109|NCT03388138|Ketotifen|ketotifen|mesh-list
5972110|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
5972111|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
5972112|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5972113|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
5972114|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
5723703|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5723704|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5723705|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5723706|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
5723707|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723708|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5723709|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5723710|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723711|NCT03192657|Basiliximab|basiliximab|mesh-list
5723712|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
5723713|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5723714|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
5723715|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723716|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723717|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723718|NCT03192644|Leucovorin|leucovorin|mesh-list
5972115|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972116|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972117|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972118|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5972119|NCT03366272|Gemcitabine|gemcitabine|mesh-list
5972120|NCT03366272|Rituximab|rituximab|mesh-list
5972121|NCT03366272|Nivolumab|nivolumab|mesh-list
5972122|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
5972123|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972124|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972125|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
5972126|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972127|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972128|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972129|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
5972130|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972131|NCT03366272|Antiviral Agents|antiviral agents|mesh-ancestor
5972132|NCT03366272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972133|NCT03366272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972134|NCT03366272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5972135|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5972136|NCT03243058|Aldesleukin|aldesleukin|mesh-list
5972137|NCT03243058|Interleukin-2|interleukin-2|mesh-list
5972138|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972139|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5972140|NCT03243058|Analgesics|analgesics|mesh-ancestor
5972141|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
5972142|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972143|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972144|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5972145|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5972146|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
5972147|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972148|NCT03230838|Meropenem|meropenem|mesh-list
5972149|NCT03230838|Tazobactam|tazobactam|mesh-list
5972150|NCT03230838|Ceftolozane|ceftolozane|mesh-list
5723719|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
5723720|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
5972151|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
5723721|NCT03192644|Epirubicin|epirubicin|mesh-list
5723722|NCT03192644|Calcium|calcium|mesh-list
5723723|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
5723724|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972152|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5972153|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972154|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5972155|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972156|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972157|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5972158|NCT03230838|Renal Agents|renal agents|mesh-ancestor
5972159|NCT03143985|Pomalidomide|pomalidomide|mesh-list
5972160|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
5972161|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972162|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5972163|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5972164|NCT03143985|Growth Substances|growth substances|mesh-ancestor
5972165|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
5972166|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972167|NCT03113955|Epirubicin|epirubicin|mesh-list
5972168|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5972169|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972170|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5972171|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5972172|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972173|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972174|NCT03034096|Propofol|propofol|mesh-list
5972175|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5972176|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972177|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972178|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5972179|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
5972180|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
5972181|NCT03029234|Dexamethasone|dexamethasone|mesh-list
5972182|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5972183|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
5972184|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
5972185|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972186|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972187|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5972188|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
5972189|NCT03029234|Hormones|hormones|mesh-ancestor
5972190|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5972191|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5972192|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972193|NCT03016338|Niraparib|niraparib|mesh-list
5972194|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5972195|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972196|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972197|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972198|NCT02995694|Estradiol|estradiol|mesh-list
5972199|NCT02995694|Estrogens|estrogens|mesh-ancestor
5972200|NCT02995694|Hormones|hormones|mesh-ancestor
5972201|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5972202|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972203|NCT02983045|Paclitaxel|paclitaxel|mesh-list
5972204|NCT02983045|Cisplatin|cisplatin|mesh-list
5972205|NCT02983045|Carboplatin|carboplatin|mesh-list
5723725|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5723726|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723727|NCT03192644|Antidotes|antidotes|mesh-ancestor
5723728|NCT03192644|Protective Agents|protective agents|mesh-ancestor
5723729|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
5723730|NCT03192644|Vitamins|vitamins|mesh-ancestor
5723731|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
5723732|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5723733|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5723734|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5723735|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723736|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723737|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5723738|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
5723739|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5723740|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
5723741|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5723742|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723743|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5723744|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5723745|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723746|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
5723747|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
5723748|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5723749|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5723750|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723751|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723752|NCT03192709|Urological Agents|urological agents|mesh-ancestor
5723753|NCT03192449|Albendazole|albendazole|mesh-list
5723754|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
5723755|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5723756|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723757|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
5723758|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5723759|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5723760|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
5723761|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
5723762|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
5723763|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723764|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723765|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
5723766|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723767|NCT03192215|Aspirin|aspirin|mesh-list
5723768|NCT03192215|Apixaban|apixaban|mesh-list
5723769|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5723770|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5723771|NCT03192215|Analgesics|analgesics|mesh-ancestor
5723772|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
5723773|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723774|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723775|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5723776|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723777|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5723778|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5723779|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723780|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5723781|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5723782|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723783|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
5723784|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5723785|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
5723786|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5723787|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
5723788|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
5723789|NCT03192371|Vaccines|vaccines|mesh-list
5723790|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
5723791|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723792|NCT03192111|Entinostat|entinostat|mesh-list
5723793|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723794|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5723795|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723796|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723797|NCT03192293|Metformin|metformin|mesh-list
5723798|NCT03192293|Fulvestrant|fulvestrant|mesh-list
5972206|NCT02983045|Nivolumab|nivolumab|mesh-list
5972207|NCT02983045|Pemetrexed|pemetrexed|mesh-list
5972208|NCT02983045|Ipilimumab|ipilimumab|mesh-list
5972209|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5972210|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972211|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
5972212|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
5972213|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
5972214|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972215|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972216|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5723799|NCT03192293|Simvastatin|simvastatin|mesh-list
5723800|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5723801|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723802|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5723803|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5723804|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
5723805|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723806|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5723807|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5723808|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723809|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5723810|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723811|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5723812|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5723813|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
5723814|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5723815|NCT03192332|Plasminogen|plasminogen|mesh-list
5723816|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5723817|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5723818|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5723819|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723820|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
5723821|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5723822|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723823|NCT03192059|Aspirin|aspirin|mesh-list
5723824|NCT03192059|Vitamin D|vitamin d|mesh-list
5723825|NCT03192059|Curcumin|curcumin|mesh-list
5723826|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
5723827|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
5723828|NCT03192059|Lansoprazole|lansoprazole|mesh-list
5723829|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
5723830|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5723831|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
5723832|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723833|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723834|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5723835|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
5972217|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972218|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5972219|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5972220|NCT02937818|Carboplatin|carboplatin|mesh-list
5972221|NCT02937818|Durvalumab|durvalumab|mesh-list
5972222|NCT02937818|Olaparib|olaparib|mesh-list
5972223|NCT02937818|Tremelimumab|tremelimumab|mesh-list
5972224|NCT02937818|Adavosertib|adavosertib|mesh-list
5972225|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972226|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972227|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5972228|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972229|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972230|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
5972231|NCT02926833|Fludarabine|fludarabine|mesh-list
5972232|NCT02926833|Atezolizumab|atezolizumab|mesh-list
5972233|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5972234|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
5972235|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972236|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972237|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5972238|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
5972239|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972240|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972241|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6244323|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6244324|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6244325|NCT02694328|Olanzapine|olanzapine|mesh-list
6244326|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
6244327|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
6244328|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244329|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244330|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6244331|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6244332|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6244333|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244334|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5723836|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723837|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723838|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5723839|NCT03192059|Vitamins|vitamins|mesh-ancestor
5723840|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
5723841|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5723842|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5723843|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5723844|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5723845|NCT03192059|Analgesics|analgesics|mesh-ancestor
5723846|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
5723847|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723848|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5723849|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5723850|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5723851|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5723852|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5723853|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723854|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
5723855|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5723856|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5723857|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5723858|NCT03192033|Hemostatics|hemostatics|mesh-list
5723859|NCT03192033|Coagulants|coagulants|mesh-ancestor
6244335|NCT02694328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6244336|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6244337|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6244338|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244339|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244340|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
6244341|NCT02694523|Adalimumab|adalimumab|mesh-list
6244342|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6244343|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244344|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244345|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
6244346|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244347|NCT02694536|Gemcitabine|gemcitabine|mesh-list
6244348|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6244349|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6244350|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
6244351|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244352|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244353|NCT02694536|Antiviral Agents|antiviral agents|mesh-ancestor
5972242|NCT02720445|Nicotine|nicotine|mesh-list
5972243|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5972244|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
5972245|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972246|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972247|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5972248|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5972249|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
5972250|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972251|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972252|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
5972253|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5972254|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
5972255|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972256|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
5972257|NCT02698865|Protective Agents|protective agents|mesh-ancestor
5972258|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
5972259|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5972260|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972261|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5972262|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972263|NCT02611037|Gemcitabine|gemcitabine|mesh-list
5972264|NCT02611037|Methotrexate|methotrexate|mesh-list
5972265|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972266|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972267|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
5972268|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972269|NCT02611037|Antiviral Agents|antiviral agents|mesh-ancestor
5972270|NCT02611037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972271|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972272|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5972273|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
5972274|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972275|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5972276|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
5972277|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5972278|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
5972279|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5972280|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972281|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5972282|NCT02599714|Fulvestrant|fulvestrant|mesh-list
5972283|NCT02599714|Palbociclib|palbociclib|mesh-list
5972284|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5972285|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723884|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
5723885|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
5723886|NCT03191981|Lenalidomide|lenalidomide|mesh-list
5723887|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5723888|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
5723889|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723890|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723891|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5723892|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
5723893|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723894|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723895|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5723896|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5723897|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5723898|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5723899|NCT03191981|Growth Substances|growth substances|mesh-ancestor
5723900|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
5723901|NCT03191903|Triamcinolone|triamcinolone|mesh-list
5723902|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5723903|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5723904|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5723905|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5723906|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
5723907|NCT03191903|Hormones|hormones|mesh-ancestor
5723908|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5723909|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723910|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5723911|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
5723912|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723913|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723914|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
5723915|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723916|NCT03191721|Triclosan|triclosan|mesh-list
5723917|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
5723918|NCT03191721|Fluorides|fluorides|mesh-list
5723919|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
5723920|NCT03191721|Protective Agents|protective agents|mesh-ancestor
5723921|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723922|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5723923|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5723924|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5972286|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5723925|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
5723926|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972287|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5972288|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
5972289|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5723927|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5723928|NCT03191539|Apremilast|apremilast|mesh-list
5723929|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5723930|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5723931|NCT03191539|Analgesics|analgesics|mesh-ancestor
5723932|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
5723933|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723934|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723935|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5723936|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723937|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5723938|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5723939|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723940|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723941|NCT03191461|Adenosine|adenosine|mesh-list
5723942|NCT03191461|Analgesics|analgesics|mesh-ancestor
5723943|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
5723944|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723945|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723946|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5723947|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
5723948|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5723949|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
5723950|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
5723951|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723952|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723953|NCT03191383|Vaccines|vaccines|mesh-list
5723954|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
5723955|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723956|NCT03191370|Anesthetics|anesthetics|mesh-list
5723957|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
5723958|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972290|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723959|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723960|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
5723961|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5723962|NCT03191240|Vasopressins|vasopressins|mesh-list
5723963|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
5723964|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
5723965|NCT03191240|Coagulants|coagulants|mesh-ancestor
5972291|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5972292|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972293|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972294|NCT02535325|Cisplatin|cisplatin|mesh-list
5972295|NCT02535325|Pemetrexed|pemetrexed|mesh-list
5972296|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972297|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972298|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972299|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5972300|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5972301|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
5972302|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972303|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972304|NCT02454933|Durvalumab|durvalumab|mesh-list
5972305|NCT02454933|Osimertinib|osimertinib|mesh-list
5972306|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972307|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972308|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5972309|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972310|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972311|NCT02282020|Olaparib|olaparib|mesh-list
5972312|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5972313|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972314|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972315|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972316|NCT02257567|Rituximab|rituximab|mesh-list
5972317|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
5972318|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5972319|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5972320|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
5972321|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972322|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972323|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
5723966|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5723967|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5723968|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
5723969|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723970|NCT03191162|Benzonidazole|benzonidazole|mesh-list
5723971|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5723972|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
5723973|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723974|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5723975|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5723976|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5723977|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723978|NCT03191305|Warfarin|warfarin|mesh-list
5723979|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
5972324|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972325|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972326|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5972327|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
5972328|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972329|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
5972330|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972331|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
5972332|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972333|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972334|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5972335|NCT02129647|Axitinib|axitinib|mesh-list
5972336|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972337|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5972338|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972339|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972340|NCT01959139|Leucovorin|leucovorin|mesh-list
5972341|NCT01959139|Fluorouracil|fluorouracil|mesh-list
5972342|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
5972343|NCT01959139|Irinotecan|irinotecan|mesh-list
5972344|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
5972345|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972346|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
5972347|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972348|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972349|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972350|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5972351|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
5972352|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5972353|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5972354|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972355|NCT01959139|Antidotes|antidotes|mesh-ancestor
5972356|NCT01959139|Protective Agents|protective agents|mesh-ancestor
5972357|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
5972358|NCT01959139|Vitamins|vitamins|mesh-ancestor
5972359|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
5972360|NCT01874353|Olaparib|olaparib|mesh-list
5972361|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5972362|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5723980|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
5723981|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
5723982|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5723983|NCT03190798|Canagliflozin|canagliflozin|mesh-list
5723984|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5723985|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723986|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5723987|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723988|NCT03190681|Methylphenidate|methylphenidate|mesh-list
5723989|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5723990|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5723991|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5972363|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972364|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972365|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
5972366|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5972367|NCT01870193|Glycine|glycine|mesh-list
5972368|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
5972369|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972370|NCT01870193|Expectorants|expectorants|mesh-ancestor
5972371|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
5972372|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5972373|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
5972374|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972375|NCT01870193|Protective Agents|protective agents|mesh-ancestor
5972376|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972377|NCT01870193|Antidotes|antidotes|mesh-ancestor
5972378|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
5972379|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972380|NCT01805284|Linezolid|linezolid|mesh-list
5972381|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5972382|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972383|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5972384|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972385|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972386|NCT01695941|Rituximab|rituximab|mesh-list
5972387|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5972388|NCT01695941|Bortezomib|bortezomib|mesh-list
5972389|NCT01695941|Antibodies|antibodies|mesh-list
5972390|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
5972391|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5972392|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
5972393|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972394|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972395|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5723992|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5723993|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5723994|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5723995|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
5723996|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5723997|NCT03190733|Fludarabine|fludarabine|mesh-list
5723998|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5723999|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
5724000|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
5724001|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724002|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
5724003|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5724004|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724005|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5724006|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724007|NCT03190603|Celecoxib|celecoxib|mesh-list
5724008|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5724009|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5724010|NCT03190603|Analgesics|analgesics|mesh-ancestor
5724011|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
5724012|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724013|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724014|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724015|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724016|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5724017|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5724018|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724019|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724020|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
5724021|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5724022|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5724023|NCT03190642|Prednisolone|prednisolone|mesh-list
5724024|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
5724025|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5724026|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
5724027|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5724028|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
5724029|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
5724030|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724031|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724032|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5724033|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
5972396|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5724034|NCT03190642|Hormones|hormones|mesh-ancestor
5724035|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5724036|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5724037|NCT03190642|Protective Agents|protective agents|mesh-ancestor
5724038|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5724039|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724040|NCT03190616|Apatinib|apatinib|mesh-list
5724041|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724042|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5724043|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724044|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724045|NCT03190668|Cefazolin|cefazolin|mesh-list
5724046|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
5724047|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5724048|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724049|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5724050|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
5724051|NCT03190447|Laxatives|laxatives|mesh-ancestor
5724052|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5724053|NCT03190304|Enalapril|enalapril|mesh-list
5724054|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5724055|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5724056|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
5724057|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724058|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5724059|NCT03189953|Exenatide|exenatide|mesh-list
5724060|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5724061|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724062|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5724063|NCT03189953|Incretins|incretins|mesh-ancestor
5724064|NCT03189953|Hormones|hormones|mesh-ancestor
5724065|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5724066|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
5724067|NCT03190265|Nivolumab|nivolumab|mesh-list
5724068|NCT03190265|Ipilimumab|ipilimumab|mesh-list
5724069|NCT03190265|Pancrelipase|pancrelipase|mesh-list
5724070|NCT03190265|Vaccines|vaccines|mesh-list
5724071|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
5724072|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724073|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5724074|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724075|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5724076|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
5724077|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724078|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724079|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5724080|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5724081|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5724082|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5724083|NCT03190239|Pemetrexed|pemetrexed|mesh-list
5724084|NCT03190239|Apatinib|apatinib|mesh-list
5724085|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724086|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724087|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724088|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5724089|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5724090|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5724091|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5724092|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724093|NCT03189836|Rituximab|rituximab|mesh-list
5724094|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5724095|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5724096|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
5724097|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724098|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5724099|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
5724100|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724101|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
5724102|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
5724103|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
5724104|NCT03189901|Simendan|simendan|mesh-list
5724105|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5724106|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
5724107|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5724108|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5724109|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724110|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724111|NCT03189901|Protective Agents|protective agents|mesh-ancestor
5724112|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724113|NCT03189641|Cilostazol|cilostazol|mesh-list
5724114|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5724115|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
5724116|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5724117|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5724118|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5724119|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
5724120|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5972397|NCT01638533|Romidepsin|romidepsin|mesh-list
5972398|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972399|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5972400|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972401|NCT01522976|Lenalidomide|lenalidomide|mesh-list
5972402|NCT01522976|Azacitidine|azacitidine|mesh-list
5972403|NCT01522976|Vorinostat|vorinostat|mesh-list
5972404|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
5972405|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972406|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5972407|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5972408|NCT01522976|Growth Substances|growth substances|mesh-ancestor
5972409|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
5972410|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972411|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972412|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
5972413|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972414|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972415|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5972416|NCT01366144|Paclitaxel|paclitaxel|mesh-list
5972417|NCT01366144|Carboplatin|carboplatin|mesh-list
5972418|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5972419|NCT01366144|Veliparib|veliparib|mesh-list
5972420|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5972421|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972422|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
5972423|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
5972424|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
5972425|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724121|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5724122|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5724123|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5724124|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
5724125|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5724126|NCT03189641|Protective Agents|protective agents|mesh-ancestor
5724127|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5724128|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5724129|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5724130|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
5724131|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
5724132|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5724133|NCT03189732|Metformin|metformin|mesh-list
5724134|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5724135|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972426|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5972427|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972428|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
5972429|NCT01286272|Bortezomib|bortezomib|mesh-list
5972430|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5972431|NCT01286272|Ofatumumab|ofatumumab|mesh-list
5972432|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5972433|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5972434|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972435|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5972436|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
5972437|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972438|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5972439|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
5972440|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
5972441|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972442|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
5972443|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972444|NCT01145495|Rituximab|rituximab|mesh-list
5972445|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5972446|NCT01145495|Lenalidomide|lenalidomide|mesh-list
5972447|NCT01145495|Antibodies|antibodies|mesh-list
5972448|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
5972449|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5972450|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
5972451|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972452|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972453|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972454|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5972455|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5972456|NCT01145495|Growth Substances|growth substances|mesh-ancestor
5972457|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
5972458|NCT01139970|Temozolomide|temozolomide|mesh-list
5972459|NCT01139970|Veliparib|veliparib|mesh-list
5972460|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5972461|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
5972462|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972463|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972464|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5972465|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972466|NCT01134601|Capecitabine|capecitabine|mesh-list
5972467|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972468|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
5972469|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972470|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972471|NCT00731731|Temozolomide|temozolomide|mesh-list
5972472|NCT00731731|Vorinostat|vorinostat|mesh-list
5972473|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5972474|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
5972475|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972476|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972477|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5972478|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972479|NCT00588991|Carboplatin|carboplatin|mesh-list
5972480|NCT00588991|Topotecan|topotecan|mesh-list
5972481|NCT00588991|Veliparib|veliparib|mesh-list
5972482|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972483|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5972484|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5972485|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972486|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972487|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5972488|NCT00336063|Azacitidine|azacitidine|mesh-list
5972489|NCT00336063|Vorinostat|vorinostat|mesh-list
5972490|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972491|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
5972492|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972493|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972494|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972495|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5972496|NCT00268385|Temozolomide|temozolomide|mesh-list
5972497|NCT00268385|Vorinostat|vorinostat|mesh-list
5972498|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5972499|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
5972500|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972501|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972502|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5972503|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972504|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5972505|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5972506|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
5972507|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972508|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972509|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972510|NCT00095784|Decitabine|decitabine|mesh-list
5972511|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972512|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
5972513|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972514|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972515|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972516|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
5972517|NCT00070499|Dasatinib|dasatinib|mesh-list
5972518|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972519|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5972520|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972521|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244354|NCT02694536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244355|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244356|NCT02694536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6244357|NCT02694536|Immunologic Factors|immunologic factors|mesh-ancestor
6244358|NCT02694536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244359|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6244360|NCT02694601|Caffeine|caffeine|mesh-list
6244361|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6244362|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244363|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6244364|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244365|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244366|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6244367|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6244368|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
6244369|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244370|NCT02694718|Capecitabine|capecitabine|mesh-list
6244371|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
6244372|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6244373|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
6244374|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244375|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244376|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
6244377|NCT02694978|Hematinics|hematinics|mesh-ancestor
6244378|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
6244379|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6244380|NCT02695290|Afatinib|afatinib|mesh-list
6244381|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244382|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6244383|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972522|NCT04515134|Ubiquinone|ubiquinone|mesh-list
5972523|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
5972524|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
5972525|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972526|NCT04515134|Vitamins|vitamins|mesh-ancestor
5972527|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5972528|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5972529|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244384|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244385|NCT02695446|Minocycline|minocycline|mesh-list
6244386|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6244387|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244388|NCT02695537|Cannabidiol|cannabidiol|mesh-list
6244389|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
6244390|NCT02695628|Misonidazole|misonidazole|mesh-list
6244391|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244392|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6244393|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6244394|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244395|NCT02695719|Lubiprostone|lubiprostone|mesh-list
6244396|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6244397|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6244398|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244399|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6244400|NCT02696434|Naltrexone|naltrexone|mesh-list
6244401|NCT02696434|Buprenorphine|buprenorphine|mesh-list
6244402|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6244403|NCT02696434|Narcotics|narcotics|mesh-ancestor
6244404|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244405|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244406|NCT02696434|Analgesics|analgesics|mesh-ancestor
6244407|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
6244408|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244409|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6244410|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6244411|NCT02696785|Adalimumab|adalimumab|mesh-list
6244412|NCT02696785|Ixekizumab|ixekizumab|mesh-list
6244413|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244414|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244415|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6244416|NCT02696798|Ixekizumab|ixekizumab|mesh-list
6244417|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
6244418|NCT02696850|Budesonide|budesonide|mesh-list
6244419|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244420|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6244421|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
6244422|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244423|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244424|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6244425|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
6244426|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
6244427|NCT02696850|Hormones|hormones|mesh-ancestor
6244428|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6244429|NCT02697071|Ketamine|ketamine|mesh-list
6244430|NCT02697071|Analgesics|analgesics|mesh-ancestor
6244431|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
6244432|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244433|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244434|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6244435|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6244436|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
6244437|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
5972530|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
5972531|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
5972532|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5972533|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5972534|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972535|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972536|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972537|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972538|NCT04489433|Trametinib|trametinib|mesh-list
5972539|NCT04489433|Dabrafenib|dabrafenib|mesh-list
5972540|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972541|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5972542|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972543|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972544|NCT04488237|Vitamin D|vitamin d|mesh-list
5972545|NCT04488237|Vitamins|vitamins|mesh-ancestor
5972546|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
5972547|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972548|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5972549|NCT04484363|Azacitidine|azacitidine|mesh-list
5972550|NCT04484363|Pevonedistat|pevonedistat|mesh-list
5972551|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972552|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
5972553|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972554|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972555|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972556|NCT04482361|Antibodies|antibodies|mesh-list
5972557|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
5972558|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244438|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244439|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6244440|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6244441|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244442|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244443|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
6244444|NCT02697188|Testosterone|testosterone|mesh-list
6244445|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
6244446|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
6244447|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6244448|NCT02697188|Androgens|androgens|mesh-ancestor
6244449|NCT02697188|Hormones|hormones|mesh-ancestor
6244450|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6244451|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244452|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6244453|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244454|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
6244455|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
6244456|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6244457|NCT02697292|Antibodies|antibodies|mesh-list
6244458|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
6244459|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6244460|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
6244461|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244462|NCT02697617|Pioglitazone|pioglitazone|mesh-list
6244463|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6244464|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244465|NCT02697773|Tanezumab|tanezumab|mesh-list
6244466|NCT02697773|Analgesics|analgesics|mesh-ancestor
6244467|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
6244468|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244469|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244470|NCT02697916|Aspirin|aspirin|mesh-list
6244471|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6244472|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6244473|NCT02697916|Analgesics|analgesics|mesh-ancestor
5972559|NCT04477382|Tretinoin|tretinoin|mesh-list
5972560|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972561|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
5972562|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
6244474|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
6244475|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972563|NCT04455776|Propofol|propofol|mesh-list
5972564|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5972565|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972566|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972567|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5972568|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
5972569|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
5972570|NCT04446793|Bevacizumab|bevacizumab|mesh-list
5972571|NCT04446793|Onvansertib|onvansertib|mesh-list
5972572|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972573|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972574|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5972575|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5972576|NCT04446793|Growth Substances|growth substances|mesh-ancestor
5972577|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972578|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
5972579|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5972580|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972581|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972582|NCT04445415|Antibodies|antibodies|mesh-list
5972583|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
5972584|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244476|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244477|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244478|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244479|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6244480|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6244481|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244482|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6244483|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6244484|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244485|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
6244486|NCT02698215|Naltrexone|naltrexone|mesh-list
6244487|NCT02698215|Varenicline|varenicline|mesh-list
5972585|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
5972586|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
5972587|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972588|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
6244488|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6244489|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6244490|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244491|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
6244492|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244493|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6244494|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6244495|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
6244496|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244497|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244498|NCT02698410|Temozolomide|temozolomide|mesh-list
6244499|NCT02698410|Lanreotide|lanreotide|mesh-list
6244500|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6244501|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
6244502|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244503|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244504|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
6244505|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
6244506|NCT02698475|Ustekinumab|ustekinumab|mesh-list
6244507|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
6244508|NCT02698566|Ranibizumab|ranibizumab|mesh-list
6244509|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6244510|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6244511|NCT02698566|Growth Substances|growth substances|mesh-ancestor
6244512|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244513|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
6244514|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244515|NCT02698735|Gentamicins|gentamicins|mesh-list
6244516|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6244517|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244518|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6244519|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244520|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244521|NCT02699099|Vitamin A|vitamin a|mesh-list
6244522|NCT02699099|Vaccines|vaccines|mesh-list
6244523|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
6244524|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972589|NCT04407572|Vitamin D|vitamin d|mesh-list
5972590|NCT04407572|Vitamins|vitamins|mesh-list
5972591|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
5972592|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
5972593|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
5972594|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972595|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5972596|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
5972597|NCT04407572|Hematinics|hematinics|mesh-ancestor
6244525|NCT02699099|Vitamins|vitamins|mesh-ancestor
6244526|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
6244527|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6244528|NCT02699125|Guanfacine|guanfacine|mesh-list
6244529|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6244530|NCT02699125|Diuretics|diuretics|mesh-ancestor
6244531|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
6244532|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244533|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6244534|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6244535|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244536|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6244537|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6244538|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6244539|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
6244540|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244541|NCT02699450|Ranibizumab|ranibizumab|mesh-list
6244542|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6244543|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6244544|NCT02699450|Growth Substances|growth substances|mesh-ancestor
6244545|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244546|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
6244547|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244548|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6244549|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6244550|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6244551|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244552|NCT02699892|Rituximab|rituximab|mesh-list
6244553|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244554|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244555|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
6244556|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244557|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244558|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
6244559|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6244560|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244561|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6244562|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244563|NCT02700412|Cannabidiol|cannabidiol|mesh-list
6244564|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
6244565|NCT02700815|Diclofenac|diclofenac|mesh-list
6244566|NCT02700815|Capsaicin|capsaicin|mesh-list
6244567|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6244568|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6244569|NCT02700815|Analgesics|analgesics|mesh-ancestor
6244570|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
6244571|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244572|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244573|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244574|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244575|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6244576|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244577|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244578|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
6244579|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
6244580|NCT02701062|Warfarin|warfarin|mesh-list
6244581|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
6244582|NCT02701062|Dabigatran|dabigatran|mesh-list
6244583|NCT02701062|Apixaban|apixaban|mesh-list
6244584|NCT02701062|Anticoagulants|anticoagulants|mesh-list
6244585|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6244586|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
6244587|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5972598|NCT04405284|Disinfectants|disinfectants|mesh-list
5972599|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972600|NCT04397302|Valsartan|valsartan|mesh-list
5972601|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5972602|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5972603|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5972604|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972605|NCT04396587|Sufentanil|sufentanil|mesh-list
5972606|NCT04396587|Oxycodone|oxycodone|mesh-list
5972607|NCT04396587|Hydromorphone|hydromorphone|mesh-list
5972608|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5972609|NCT04396587|Narcotics|narcotics|mesh-ancestor
5972610|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972611|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972612|NCT04396587|Analgesics|analgesics|mesh-ancestor
5972613|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
5972614|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972615|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5972616|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5972617|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
5972618|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
5972619|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5972620|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5972621|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
5972622|NCT04389294|Antibodies|antibodies|mesh-list
5972623|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
5972624|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244588|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
6244589|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244590|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244591|NCT02701257|Glucagon|glucagon|mesh-list
6244592|NCT02701257|Pancrelipase|pancrelipase|mesh-list
6244593|NCT02701257|Pancreatin|pancreatin|mesh-list
6244594|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6244595|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6244596|NCT02701257|Hormones|hormones|mesh-ancestor
6244597|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6244598|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244599|NCT02701257|Incretins|incretins|mesh-ancestor
5972625|NCT04381091|Idebenone|idebenone|mesh-list
5972626|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
5972627|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972628|NCT04381091|Protective Agents|protective agents|mesh-ancestor
5972629|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972630|NCT04377295|Ranibizumab|ranibizumab|mesh-list
5972631|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5972632|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5972633|NCT04377295|Growth Substances|growth substances|mesh-ancestor
5972634|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972635|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
5972636|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972637|NCT04374123|Antibodies|antibodies|mesh-list
5972638|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
5972639|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
5972640|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244600|NCT02701296|Epinephrine|epinephrine|mesh-list
6244601|NCT02701296|Ropivacaine|ropivacaine|mesh-list
6244602|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
6244603|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
6244604|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244605|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244606|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
6244607|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244608|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6244609|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6244610|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
6244611|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244612|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244613|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6244614|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6244615|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
6244616|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6244617|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
6244618|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
6244619|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
6244620|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6244621|NCT02701400|Durvalumab|durvalumab|mesh-list
6244622|NCT02701400|Ipilimumab|ipilimumab|mesh-list
6244623|NCT02701400|Tremelimumab|tremelimumab|mesh-list
6244624|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244625|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244626|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6244627|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244628|NCT02701582|Phenylephrine|phenylephrine|mesh-list
6244629|NCT02701582|Epinephrine|epinephrine|mesh-list
6244630|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
6244631|NCT02701582|Synephrine|synephrine|mesh-list
6244632|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6244633|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6244634|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
6244635|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244636|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244637|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244638|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6244639|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5972641|NCT04367688|Tenofovir|tenofovir|mesh-list
5972642|NCT04367688|Emtricitabine|emtricitabine|mesh-list
5972643|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
5972644|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972645|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5972646|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5972647|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972648|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972649|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5972650|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5972651|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
5972652|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5972653|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
5972654|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972655|NCT04365725|Remdesivir|remdesivir|mesh-list
5972656|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
5972657|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972658|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
5972659|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972660|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
5972661|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5972662|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
5972663|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972664|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972665|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5972666|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
5972667|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5972668|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
5972669|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972670|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972671|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5972672|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
5972673|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
5972674|NCT04358588|Protective Agents|protective agents|mesh-ancestor
5972675|NCT04356950|Thrombin|thrombin|mesh-list
5972676|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
5972677|NCT04356950|Coagulants|coagulants|mesh-ancestor
6244640|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
6244641|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244642|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6244643|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
6244644|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
6244645|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
6244646|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6244647|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6244648|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
6244649|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6244650|NCT02701582|Protective Agents|protective agents|mesh-ancestor
6244651|NCT02701764|Pregabalin|pregabalin|mesh-list
6244652|NCT02701764|Analgesics|analgesics|mesh-ancestor
6244653|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
6244654|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244655|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244656|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
6244657|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6244658|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6244659|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244660|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6244661|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6244662|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6244663|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244664|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6244665|NCT02702011|Empagliflozin|empagliflozin|mesh-list
6244666|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6244667|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244668|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6244669|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244670|NCT02702388|Lenvatinib|lenvatinib|mesh-list
6244671|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244672|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6244673|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244674|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244675|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
6244676|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244677|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972678|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
5972679|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5972680|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5972681|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5972682|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972683|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
5972684|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972685|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972686|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
5972687|NCT04350021|Capecitabine|capecitabine|mesh-list
5972688|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5972689|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
5972690|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972691|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972692|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5972693|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
5972694|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972695|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972696|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5972697|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972698|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
5972699|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5972700|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
5972701|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244678|NCT02703259|Acetaminophen|acetaminophen|mesh-list
6244679|NCT02703259|Celecoxib|celecoxib|mesh-list
6244680|NCT02703259|Gabapentin|gabapentin|mesh-list
6244681|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6244682|NCT02703259|Analgesics|analgesics|mesh-ancestor
6244683|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
6244684|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244685|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244686|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
6244687|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6244688|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244689|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244690|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6244691|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6244692|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244693|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244694|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
6244695|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6244696|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6244697|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244698|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6244699|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6244700|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6244701|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244702|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
6244703|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
6244704|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6244705|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244706|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
6244707|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6244708|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244709|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
6244710|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6244711|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244712|NCT02703636|Rivastigmine|rivastigmine|mesh-list
6244713|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6244714|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244715|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244716|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
6244717|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244718|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244719|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5972702|NCT04334837|Copper|copper|mesh-list
5972703|NCT04334837|Trace Elements|trace elements|mesh-ancestor
5972704|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
5972705|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972706|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
5972707|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5972708|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972709|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972710|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972711|NCT04321733|Amoxicillin|amoxicillin|mesh-list
5972712|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
5972713|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
5972714|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
5972715|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5972716|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972717|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5972718|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972719|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244720|NCT02703636|Protective Agents|protective agents|mesh-ancestor
6244721|NCT02703779|Plerixafor|plerixafor|mesh-list
6244722|NCT02703779|Bortezomib|bortezomib|mesh-list
6244723|NCT02703779|Lenograstim|lenograstim|mesh-list
6244724|NCT02703779|Sargramostim|sargramostim|mesh-list
6244725|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6244726|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
6244727|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244728|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244729|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6244730|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6244731|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
6244732|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244733|NCT02703909|Rocuronium|rocuronium|mesh-list
6244734|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5972720|NCT04319341|Autoantibodies|autoantibodies|mesh-list
5972721|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
5972722|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972723|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
5972724|NCT04318405|Hematinics|hematinics|mesh-ancestor
5972725|NCT04314336|Coal Tar|coal tar|mesh-list
5972726|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
5972727|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
5972728|NCT04312555|Alprostadil|alprostadil|mesh-list
5972729|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5972730|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
5972731|NCT04312555|Urological Agents|urological agents|mesh-ancestor
5972732|NCT04310631|Ranibizumab|ranibizumab|mesh-list
5972733|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5972734|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5972735|NCT04310631|Growth Substances|growth substances|mesh-ancestor
5972736|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972737|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
5972738|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972739|NCT04302012|Mydriatics|mydriatics|mesh-list
5972740|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
5972741|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972742|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972743|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
5972744|NCT04296253|Mitogens|mitogens|mesh-list
5972745|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
5972746|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972752|NCT04288713|Eculizumab|eculizumab|mesh-list
5972753|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5972754|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5972755|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
5972756|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972757|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5972758|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
5972759|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972760|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
6244735|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6244736|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6244737|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244738|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244739|NCT02703948|Lidocaine|lidocaine|mesh-list
6244740|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
6244741|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
6244742|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244743|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244744|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
6244745|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244746|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6244747|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6244748|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6244749|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6244750|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244751|NCT02704104|Hemostatics|hemostatics|mesh-list
6244752|NCT02704104|Coagulants|coagulants|mesh-ancestor
6244753|NCT02704156|Gemcitabine|gemcitabine|mesh-list
6244754|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
6244755|NCT02704156|Trametinib|trametinib|mesh-list
6244756|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6244757|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
6244758|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244759|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244760|NCT02704156|Antiviral Agents|antiviral agents|mesh-ancestor
6244761|NCT02704156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244762|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244763|NCT02704156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6244764|NCT02704156|Immunologic Factors|immunologic factors|mesh-ancestor
6244765|NCT02704156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244766|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244767|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6244768|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6244769|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6244770|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6244771|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
6244772|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244773|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6244774|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6244775|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244776|NCT02705105|Nivolumab|nivolumab|mesh-list
6244777|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
6244778|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244779|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244780|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6244781|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244782|NCT02705352|Fluorouracil|fluorouracil|mesh-list
6244783|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
6244784|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244785|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6244786|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244787|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5972761|NCT04267601|Anagliptin|anagliptin|mesh-list
5972762|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5972763|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
5972764|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972765|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972766|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5972767|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972768|NCT04264884|Daratumumab|daratumumab|mesh-list
5972769|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972770|NCT04261231|Anesthetics|anesthetics|mesh-list
5972771|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972772|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244788|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
6244789|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244790|NCT02705716|Fluorides|fluorides|mesh-list
6244791|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
6244792|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
6244793|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
6244794|NCT02705716|Protective Agents|protective agents|mesh-ancestor
6244795|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244796|NCT02705807|Epoprostenol|epoprostenol|mesh-list
6244797|NCT02705807|Tezosentan|tezosentan|mesh-list
6244798|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6244799|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6244800|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
6244801|NCT02706249|Enoxaparin|enoxaparin|mesh-list
6244802|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
6244803|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6244804|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6244805|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244806|NCT02706483|Plecanatide|plecanatide|mesh-list
5972773|NCT04260139|Metronidazole|metronidazole|mesh-list
5972774|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972775|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5972776|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5972777|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5972778|NCT04256265|Risdiplam|risdiplam|mesh-list
5972779|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5972780|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972781|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972782|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5972783|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
5972784|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972785|NCT04240509|Tenofovir|tenofovir|mesh-list
5972786|NCT04240509|Emtricitabine|emtricitabine|mesh-list
5972787|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
5972788|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972789|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5972790|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5972791|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972792|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972793|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5972794|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5972795|NCT04238741|Anesthetics|anesthetics|mesh-list
5972796|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972797|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244807|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6244808|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
6244809|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244810|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6244811|NCT02706873|Methotrexate|methotrexate|mesh-list
6244812|NCT02706873|Upadacitinib|upadacitinib|mesh-list
6244813|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6244814|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
6244815|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6244816|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244817|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6244818|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
6244819|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244820|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244821|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
6244822|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244823|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6244824|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6244825|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
6244826|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244827|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6244828|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6244829|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6244830|NCT02706899|Azacitidine|azacitidine|mesh-list
5972798|NCT04233047|Fostemsavir|fostemsavir|mesh-list
5972799|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5972800|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5972801|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
5972802|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972803|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5972804|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5972805|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972806|NCT04230707|Melatonin|melatonin|mesh-list
5972807|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
5972808|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972809|NCT04230707|Protective Agents|protective agents|mesh-ancestor
5972810|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972811|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972812|NCT04221568|Fentanyl|fentanyl|mesh-list
5972813|NCT04221568|Bupivacaine|bupivacaine|mesh-list
5972814|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
5972815|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
5972816|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
5972817|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972818|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972819|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
5972820|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972821|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5972822|NCT04221568|Narcotics|narcotics|mesh-ancestor
5972823|NCT04221568|Analgesics|analgesics|mesh-ancestor
5972824|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5972825|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5972826|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
5972827|NCT04220203|Capecitabine|capecitabine|mesh-list
5972828|NCT04220203|Trastuzumab|trastuzumab|mesh-list
5972829|NCT04220203|Tucatinib|tucatinib|mesh-list
5972830|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5972831|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
5972832|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972833|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972834|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972835|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5972836|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244831|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6244832|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
6244833|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244834|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244835|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244836|NCT02706951|Methotrexate|methotrexate|mesh-list
6244837|NCT02706951|Upadacitinib|upadacitinib|mesh-list
6244838|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6244839|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
6244840|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6244841|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244842|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6244843|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
6244844|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244845|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972837|NCT04204928|Pralsetinib|pralsetinib|mesh-list
5972838|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972839|NCT04195009|Anesthetics|anesthetics|mesh-list
5972840|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972841|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244846|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
6244847|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244848|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6244849|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6244850|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
6244851|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244852|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6244853|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6244854|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6244855|NCT02707523|Azithromycin|azithromycin|mesh-list
6244856|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6244857|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244858|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
6244859|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6244860|NCT02707601|Ledipasvir|ledipasvir|mesh-list
6244861|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6244862|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
6244863|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244864|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6244865|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6244866|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
6244867|NCT02707640|Pirfenidone|pirfenidone|mesh-list
6244868|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6244869|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
6244870|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244871|NCT02707640|Expectorants|expectorants|mesh-ancestor
6244872|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
6244873|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6244874|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
6244875|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244876|NCT02707640|Protective Agents|protective agents|mesh-ancestor
5972842|NCT04187248|Asparaginase|asparaginase|mesh-list
5972843|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972844|NCT04179266|Ketamine|ketamine|mesh-list
5972845|NCT04179266|Analgesics|analgesics|mesh-ancestor
5972846|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
5972847|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972848|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972849|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5972850|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5972851|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
5972852|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
5972853|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972854|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5972855|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5972856|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972857|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972858|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5972859|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244877|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244878|NCT02707640|Antidotes|antidotes|mesh-ancestor
6244879|NCT02707640|Analgesics|analgesics|mesh-ancestor
6244880|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
6244881|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244882|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6244883|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6244884|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6244885|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6244886|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244887|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6244888|NCT02707757|Hematinics|hematinics|mesh-ancestor
6244889|NCT02707861|Ibalizumab|ibalizumab|mesh-list
6244890|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6244891|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
6244892|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244893|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6244894|NCT02707952|Ritonavir|ritonavir|mesh-list
6244895|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6244896|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6244897|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
6244898|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244899|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244900|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6244901|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6244902|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
6244903|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6244904|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6244905|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6244906|NCT02707965|Topiramate|topiramate|mesh-list
6244907|NCT02707965|Lamotrigine|lamotrigine|mesh-list
6244908|NCT02707965|Zonisamide|zonisamide|mesh-list
6244909|NCT02707965|Carbamazepine|carbamazepine|mesh-list
6244910|NCT02707965|Phenytoin|phenytoin|mesh-list
6244911|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
6244912|NCT02707965|Levetiracetam|levetiracetam|mesh-list
6244913|NCT02707965|Valproic Acid|valproic acid|mesh-list
6244914|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
6244915|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5972860|NCT04163224|Imidacloprid|imidacloprid|mesh-list
5972861|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
5972862|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972863|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972864|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972865|NCT04152941|Olaparib|olaparib|mesh-list
5972866|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5972867|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5972868|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972869|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244916|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244917|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
6244918|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6244919|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6244920|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244921|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6244922|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6244923|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6244924|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244925|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6244926|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6244927|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
6244928|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6244929|NCT02707965|Analgesics|analgesics|mesh-ancestor
6244930|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
6244931|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244932|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5972870|NCT04138641|Cangrelor|cangrelor|mesh-list
5972871|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5972872|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5972873|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5972874|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5972875|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
5972876|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972877|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972878|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972879|NCT04135092|Aldesleukin|aldesleukin|mesh-list
5972880|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
5972881|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
5972882|NCT04135092|Fludarabine|fludarabine|mesh-list
5972883|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5972884|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
5972885|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972886|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5972887|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5972888|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
5972889|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972890|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5972891|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5972892|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5972893|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5972894|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5972895|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
5972896|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972897|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
5972898|NCT04132882|Antidotes|antidotes|mesh-ancestor
5972899|NCT04132882|Protective Agents|protective agents|mesh-ancestor
5972900|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972901|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
5972902|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972903|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
5972904|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5972905|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972906|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
5972907|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
5972908|NCT04130776|Kallikreins|kallikreins|mesh-list
5972909|NCT04130776|Coagulants|coagulants|mesh-ancestor
5972910|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
5972911|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
5972912|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5972913|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972914|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
5972915|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5972916|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
5972917|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
5972918|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972919|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972920|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5972921|NCT04124562|Analgesics|analgesics|mesh-ancestor
5972922|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
5972923|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972924|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
5972925|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5972926|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
5972927|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972928|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
5972929|NCT04124133|Protective Agents|protective agents|mesh-ancestor
6244933|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6244934|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244935|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
6244936|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244937|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6244938|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6244939|NCT02708238|Simethicone|simethicone|mesh-list
6244940|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
6244941|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244942|NCT02708238|Emollients|emollients|mesh-ancestor
6244943|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
6244944|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
6244945|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6244946|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244947|NCT02708355|Esomeprazole|esomeprazole|mesh-list
6244948|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6244949|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6244950|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6244951|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6244952|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244953|NCT02708433|Lidocaine|lidocaine|mesh-list
6244954|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
6244955|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
6244956|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6244957|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244958|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
6244959|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244960|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6244961|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6244962|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6244963|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6244964|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244965|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
6244966|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6244967|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6244968|NCT02709005|Monolaurin|monolaurin|mesh-list
6244969|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
6244970|NCT02709005|Protective Agents|protective agents|mesh-ancestor
6244971|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244972|NCT02709018|Losartan|losartan|mesh-list
6244973|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6244974|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5972930|NCT04114500|Estradiol|estradiol|mesh-list
5972931|NCT04114500|Progesterone|progesterone|mesh-list
5972932|NCT04114500|Estrogens|estrogens|mesh-ancestor
5972933|NCT04114500|Hormones|hormones|mesh-ancestor
5972934|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5972935|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972936|NCT04114500|Progestins|progestins|mesh-ancestor
5972937|NCT04112277|Morphine|morphine|mesh-list
5972938|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5972939|NCT04112277|Narcotics|narcotics|mesh-ancestor
5972940|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972941|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972942|NCT04112277|Analgesics|analgesics|mesh-ancestor
5972943|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
5972944|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244975|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6244976|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6244977|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244978|NCT02709109|Ivacaftor|ivacaftor|mesh-list
6244979|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6244980|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6244981|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244982|NCT02709486|Tanezumab|tanezumab|mesh-list
6244983|NCT02709486|Analgesics|analgesics|mesh-ancestor
6244984|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
6244985|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244986|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6244987|NCT02709746|Vortioxetine|vortioxetine|mesh-list
6244988|NCT02709746|Fluoxetine|fluoxetine|mesh-list
6244989|NCT02709746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6244990|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6244991|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6244992|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6244993|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6244994|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
6244995|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972945|NCT04102319|Hepcidins|hepcidins|mesh-list
5972946|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5972947|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
5972948|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5972949|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
5972950|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
5972951|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972952|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972953|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5972954|NCT04095494|Analgesics|analgesics|mesh-ancestor
5972955|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
5972956|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6244996|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6244997|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
6244998|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6244999|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6245000|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6245001|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245002|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6245003|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6245004|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245005|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6245006|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6245007|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6245008|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6245009|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
6245010|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6245011|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245012|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
6245013|NCT02709889|Dexamethasone|dexamethasone|mesh-list
6245014|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6245015|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
6245016|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
6245017|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245018|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245019|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245020|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
6245021|NCT02709889|Hormones|hormones|mesh-ancestor
6245022|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6245023|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6245024|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245025|NCT02710045|Vaccines|vaccines|mesh-list
6245026|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
6245027|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972957|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5972958|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5972959|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972960|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
5972961|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5972962|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5972963|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972964|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972965|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5972966|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5972967|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5972968|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
5972969|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972970|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972971|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5972972|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5972973|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
6245028|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6245029|NCT02710071|Nebivolol|nebivolol|mesh-list
6245030|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6245031|NCT02710071|Diuretics|diuretics|mesh-ancestor
6245032|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
6245033|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245034|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6245035|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245036|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245037|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
6245038|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6245039|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6245040|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6245041|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
6245042|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245043|NCT02710214|Estrogens|estrogens|mesh-list
6245044|NCT02710214|Hormones|hormones|mesh-ancestor
6245045|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5972974|NCT04059991|Vaccines|vaccines|mesh-list
5972975|NCT04059991|Immunologic Factors|immunologic factors|mesh-ancestor
5972976|NCT04059991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972977|NCT04049084|Adenosine|adenosine|mesh-list
5972978|NCT04049084|Analgesics|analgesics|mesh-ancestor
5972979|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
5972980|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5972981|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972982|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5972983|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
5972984|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5972985|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
5972986|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
5972987|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5972988|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5972989|NCT04045171|Tacrolimus|tacrolimus|mesh-list
5972990|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5972991|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
5972992|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5972993|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5972994|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245046|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245047|NCT02710526|Buprenorphine|buprenorphine|mesh-list
6245048|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6245049|NCT02710526|Narcotics|narcotics|mesh-ancestor
6245050|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245051|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245052|NCT02710526|Analgesics|analgesics|mesh-ancestor
6245053|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
6245054|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245055|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6245056|NCT02710630|Dabigatran|dabigatran|mesh-list
6245057|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
6245058|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5972995|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245059|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
6245060|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245061|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245062|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
6245063|NCT02710669|Propafenone|propafenone|mesh-list
6245064|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6245065|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6245066|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6245067|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245068|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245069|NCT02710890|Lacosamide|lacosamide|mesh-list
6245070|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
6245071|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6245072|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6245073|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245074|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245075|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
6245076|NCT02710981|Clomiphene|clomiphene|mesh-list
6245077|NCT02710981|Enclomiphene|enclomiphene|mesh-list
6245078|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
6245079|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245080|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
6245081|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6245082|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6245083|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245084|NCT02710981|Urological Agents|urological agents|mesh-ancestor
6245085|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6245086|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
6245087|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6245088|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245089|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6245090|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
6245091|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6245092|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6245093|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6245094|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
6245095|NCT02711306|Cathartics|cathartics|mesh-ancestor
6245096|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245097|NCT02711553|Gemcitabine|gemcitabine|mesh-list
6245098|NCT02711553|Ramucirumab|ramucirumab|mesh-list
6245099|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245100|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6245101|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
6245102|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245103|NCT02711553|Antiviral Agents|antiviral agents|mesh-ancestor
5972996|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
5972997|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5972998|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5972999|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973000|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5973001|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
5973002|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5973003|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973004|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973005|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5973006|NCT03994419|Anesthetics|anesthetics|mesh-list
5973007|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973008|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973009|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
5973010|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973011|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973012|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
5973013|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5973014|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973048|NCT03947099|Ketamine|ketamine|mesh-list
5973049|NCT03947099|Analgesics|analgesics|mesh-ancestor
5973050|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
5973051|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973052|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973053|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5973054|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5973055|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
5973056|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
5973057|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973058|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5973059|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5973060|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5973061|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973124|NCT03851965|Plasminogen|plasminogen|mesh-list
5973125|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5973126|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5973127|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245104|NCT02711553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245105|NCT02711553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245106|NCT02711553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6245107|NCT02711553|Immunologic Factors|immunologic factors|mesh-ancestor
6245108|NCT02711553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245109|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6245110|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
6245111|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6245112|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245113|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245114|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
6245115|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245116|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245117|NCT02711995|Laxatives|laxatives|mesh-ancestor
6245118|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245119|NCT02712008|Aflibercept|aflibercept|mesh-list
6245120|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6245121|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6245122|NCT02712008|Growth Substances|growth substances|mesh-ancestor
6245123|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245124|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
6245125|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245126|NCT02712047|Fluticasone|fluticasone|mesh-list
6245127|NCT02712047|Xhance|xhance|mesh-list
6245128|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6245129|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6245130|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
6245131|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973015|NCT03979625|Heparin|heparin|mesh-list
5973016|NCT03979625|Antibodies|antibodies|mesh-list
5973017|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
5973018|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973019|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
5973020|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5973021|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5973022|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973023|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
5973024|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
5973025|NCT03974464|Coagulants|coagulants|mesh-ancestor
5973026|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5973027|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
5973028|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
5973029|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973030|NCT03970265|Meropenem|meropenem|mesh-list
5973031|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5973032|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973033|NCT03967483|Indomethacin|indomethacin|mesh-list
5973034|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5973035|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5973036|NCT03967483|Analgesics|analgesics|mesh-ancestor
5973037|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
5973038|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973039|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973040|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973041|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973042|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
5973043|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
5973044|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5973045|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5973046|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973047|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973062|NCT03930017|Vaccines|vaccines|mesh-list
5973063|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
5973064|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973128|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5973129|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245132|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245133|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6245134|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
6245135|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
6245136|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6245137|NCT02712788|Milrinone|milrinone|mesh-list
6245138|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6245139|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6245140|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
6245141|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6245142|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6245143|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245144|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245145|NCT02712788|Protective Agents|protective agents|mesh-ancestor
6245146|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245147|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
6245148|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6245149|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245150|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5973065|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5973066|NCT03920566|Dalteparin|dalteparin|mesh-list
5973067|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
5973068|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5973069|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5973070|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973071|NCT03914170|Cetuximab|cetuximab|mesh-list
5973072|NCT03914170|Folfirinox|folfirinox|mesh-list
5973073|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973074|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973075|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
5973076|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5973077|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
5973078|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973079|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973080|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5973081|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
5973082|NCT03907605|Hormones|hormones|mesh-list
5973083|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973084|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973085|NCT03903406|Dexamethasone|dexamethasone|mesh-list
5973086|NCT03903406|Lenalidomide|lenalidomide|mesh-list
5973087|NCT03903406|Ixazomib|ixazomib|mesh-list
5973088|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973089|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
5973090|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
5973091|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973092|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973093|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5973094|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
5973095|NCT03903406|Hormones|hormones|mesh-ancestor
5973096|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973097|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5973098|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973099|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
5973100|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5973101|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5973102|NCT03903406|Growth Substances|growth substances|mesh-ancestor
5973103|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
5973104|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
5973105|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973106|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973130|NCT03833323|Treprostinil|treprostinil|mesh-list
5973131|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5973132|NCT03829579|Esketamine|esketamine|mesh-list
5973133|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
5973134|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5973135|NCT03828162|Anticoagulants|anticoagulants|mesh-list
5973136|NCT03819413|Antibodies|antibodies|mesh-list
5973137|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
5973107|NCT03897192|Bevacizumab|bevacizumab|mesh-list
5973108|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973109|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973110|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5973111|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5973112|NCT03897192|Growth Substances|growth substances|mesh-ancestor
5973113|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973114|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
5973115|NCT03896815|INCB054329|incb054329|mesh-list
5973116|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973117|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
5973118|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973138|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
5973139|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973140|NCT03819452|Vitamin D|vitamin d|mesh-list
5973141|NCT03819452|Vitamins|vitamins|mesh-ancestor
5973142|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
5973143|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973144|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5973145|NCT03815422|Anesthetics|anesthetics|mesh-list
5973146|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973147|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245151|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6245152|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245153|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245154|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
6245155|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245156|NCT02713178|Bupivacaine|bupivacaine|mesh-list
6245157|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
6245158|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
6245159|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245160|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245161|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
6245162|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245163|NCT02713204|Aflibercept|aflibercept|mesh-list
6245164|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6245165|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6245166|NCT02713204|Growth Substances|growth substances|mesh-ancestor
6245167|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245168|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
6245169|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245170|NCT02713230|Bupivacaine|bupivacaine|mesh-list
6245171|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
6245172|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
6245173|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245174|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245175|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
6245176|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973119|NCT03881917|Cystatins|cystatins|mesh-list
5973120|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5973121|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
5973122|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973123|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973148|NCT03811366|Prednisone|prednisone|mesh-list
5973149|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973150|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
5973151|NCT03811366|Hormones|hormones|mesh-ancestor
5973152|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973153|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973154|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5973155|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973156|NCT03806543|Vancomycin|vancomycin|mesh-list
5973157|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5973158|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973159|NCT03804099|Aflibercept|aflibercept|mesh-list
5973160|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5973161|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5973162|NCT03804099|Growth Substances|growth substances|mesh-ancestor
5973163|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973164|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
5973165|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973166|NCT03797547|Aflibercept|aflibercept|mesh-list
5973167|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5973168|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5973169|NCT03797547|Growth Substances|growth substances|mesh-ancestor
5973170|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973171|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
5973172|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973173|NCT03793400|Bevacizumab|bevacizumab|mesh-list
5973174|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973175|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973176|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5973177|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5973178|NCT03793400|Growth Substances|growth substances|mesh-ancestor
5973179|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973180|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
6245177|NCT02713490|Bupivacaine|bupivacaine|mesh-list
6245178|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
6245179|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
6245180|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245181|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245182|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
6245183|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245184|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
6245185|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245186|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245187|NCT02713698|Propofol|propofol|mesh-list
6245188|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6245189|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245190|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245191|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6245192|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
6245193|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
6245194|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
6245195|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6245196|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245197|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245198|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
6245199|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245200|NCT02713867|Nivolumab|nivolumab|mesh-list
6245201|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245202|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245203|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5973181|NCT03792334|Anesthetics|anesthetics|mesh-list
5973182|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973183|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973184|NCT03789968|Tenofovir|tenofovir|mesh-list
5973185|NCT03789968|Emtricitabine|emtricitabine|mesh-list
5973186|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5973187|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
5973188|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973189|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5973190|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5973191|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973192|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973193|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5973194|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5973195|NCT03778424|Rufinamide|rufinamide|mesh-list
5973196|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
5973197|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5973198|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5973199|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5973200|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245204|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245205|NCT02714062|Topiramate|topiramate|mesh-list
6245206|NCT02714062|Phentermine|phentermine|mesh-list
6245207|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
6245208|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6245209|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245210|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6245211|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
6245212|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6245213|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
6245214|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
6245215|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245216|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
6245217|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245218|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245219|NCT02714283|Azithromycin|azithromycin|mesh-list
6245220|NCT02714283|Erythromycin|erythromycin|mesh-list
6245221|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6245222|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245223|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245224|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6245225|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245226|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245227|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6245228|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6245229|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6245230|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245231|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973201|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5973202|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5973203|NCT03767712|Antibodies|antibodies|mesh-list
5973204|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
5973205|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
5973206|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973207|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
5973208|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
5973209|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973210|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
5973211|NCT03760562|Hormones|hormones|mesh-ancestor
5973212|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973213|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973239|NCT05142319|Vaccines|vaccines|mesh-list
5973240|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
5973241|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973249|NCT05142189|Docetaxel|docetaxel|mesh-list
5973250|NCT05142189|Cemiplimab|cemiplimab|mesh-list
5973251|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973252|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
5973253|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
5973254|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
5973255|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973256|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973257|NCT05142085|Mineral Oil|mineral oil|mesh-list
5973258|NCT05142085|Emollients|emollients|mesh-ancestor
5973259|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
5973260|NCT05142072|Vitamin D|vitamin d|mesh-list
5973261|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
5973262|NCT05142072|Vitamins|vitamins|mesh-ancestor
5973263|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
5973264|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973265|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5973266|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5973267|NCT05141968|Vitamin D|vitamin d|mesh-list
5973268|NCT05141968|Vitamins|vitamins|mesh-ancestor
5973269|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
5973270|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973271|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5973272|NCT05141877|Anesthetics|anesthetics|mesh-list
5973273|NCT05141877|Propofol|propofol|mesh-list
5973274|NCT05141877|Sevoflurane|sevoflurane|mesh-list
5973275|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973276|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973277|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5973278|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5973279|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
5973214|NCT03751397|Cystatins|cystatins|mesh-list
5973215|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
5973216|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
5973217|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973218|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973219|NCT03748095|Tazobactam|tazobactam|mesh-list
5973220|NCT03748095|Piperacillin|piperacillin|mesh-list
5973221|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5973222|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973223|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5973224|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973225|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973226|NCT03744546|Tilavonemab|tilavonemab|mesh-list
5973227|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
5973228|NCT03738683|Tazobactam|tazobactam|mesh-list
5973229|NCT03738683|Piperacillin|piperacillin|mesh-list
5973230|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
5973231|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5973232|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973233|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5973234|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973235|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973236|NCT03738553|Trastuzumab|trastuzumab|mesh-list
5973237|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973238|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973280|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5973281|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5973282|NCT05141864|Lidocaine|lidocaine|mesh-list
5973283|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
5973284|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
5973285|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973286|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973287|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
5973288|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973289|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5973290|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5973291|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5973292|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5973293|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973294|NCT05141682|Azacitidine|azacitidine|mesh-list
5973295|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5973296|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
5973297|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973298|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973299|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245232|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245233|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245234|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6245235|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
6245236|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6245237|NCT02714504|Voriconazole|voriconazole|mesh-list
6245238|NCT02714504|Posaconazole|posaconazole|mesh-list
6245239|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
6245240|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245241|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6245242|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6245243|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245244|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245245|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6245246|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
6245247|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6245248|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245249|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6245250|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6245251|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6245252|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6245253|NCT02714569|Atorvastatin|atorvastatin|mesh-list
6245254|NCT02714569|Simvastatin|simvastatin|mesh-list
6245255|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6245256|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5973300|NCT05141474|Aldesleukin|aldesleukin|mesh-list
5973301|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
5973302|NCT05141474|Fludarabine|fludarabine|mesh-list
5973303|NCT05141474|Interleukin-2|interleukin-2|mesh-list
5973304|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5973305|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
5973306|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973307|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973308|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5973309|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
5973310|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973311|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973312|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5973313|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5973314|NCT05141474|Analgesics|analgesics|mesh-ancestor
5973315|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
5973316|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973317|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5973318|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5973319|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
5973320|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973321|NCT05141344|Melatonin|melatonin|mesh-list
5973322|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
5973323|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973324|NCT05141344|Protective Agents|protective agents|mesh-ancestor
5973325|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973326|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973327|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
5973328|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5973329|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5973330|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5973331|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5973332|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973333|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
5973334|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5973335|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973336|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5973337|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973338|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
5973339|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
5973340|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973341|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5973342|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5973343|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973344|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973345|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5973346|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5973347|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
5973348|NCT05140941|Velpatasvir|velpatasvir|mesh-list
5973349|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
5973350|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973351|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
5973352|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
5973353|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
5973354|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973355|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973356|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
5973357|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973358|NCT05114460|Naloxone|naloxone|mesh-list
5973359|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5973360|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973361|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
5973362|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973363|NCT05111314|Edetic Acid|edetic acid|mesh-list
5973364|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5973365|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
5973366|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
5973367|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973368|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
5973369|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5973370|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5973371|NCT05089175|Aspirin|aspirin|mesh-list
5973372|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5973373|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5973374|NCT05089175|Analgesics|analgesics|mesh-ancestor
5973375|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
5973376|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973377|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973378|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973379|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973380|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5973381|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5973382|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973383|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5973384|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5973385|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973386|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
5973387|NCT05075993|Paclitaxel|paclitaxel|mesh-list
5973388|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5973389|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
5973390|NCT05075993|Bevacizumab|bevacizumab|mesh-list
5973391|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5973392|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973393|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
5973394|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
5973395|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
5973396|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973397|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5973398|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
5973399|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973400|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973401|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5973402|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
5973403|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5973404|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973405|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5973406|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5973407|NCT05075993|Growth Substances|growth substances|mesh-ancestor
5973408|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
5973409|NCT05066997|Dexamethasone|dexamethasone|mesh-list
5973410|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
5973411|NCT05066997|BB 1101|bb 1101|mesh-list
5973412|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973413|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
5973414|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
5973415|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973416|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973417|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5973418|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
5973419|NCT05066997|Hormones|hormones|mesh-ancestor
5973420|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973421|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5973422|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973423|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
5973424|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973425|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973426|NCT05064449|Itraconazole|itraconazole|mesh-list
5973427|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
5973428|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
5973429|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973430|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5973431|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5973432|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973433|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973434|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5973435|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
5973436|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973437|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973438|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5973439|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5973440|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5973441|NCT05064449|Analgesics|analgesics|mesh-ancestor
5973442|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
5973443|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973444|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973445|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973446|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5973447|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5973448|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973449|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973450|NCT05053334|Omalizumab|omalizumab|mesh-list
5973451|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5973452|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5973453|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
5973454|NCT05046639|Lidocaine|lidocaine|mesh-list
5973455|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
5973456|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
5973457|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973458|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973459|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
5973460|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973461|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5973462|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5973463|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5973464|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5973465|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973466|NCT05045066|Vitamin D|vitamin d|mesh-list
5973467|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
5973468|NCT05045066|Vitamins|vitamins|mesh-ancestor
5973469|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
5973470|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973471|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5973472|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5973473|NCT05033639|Melatonin|melatonin|mesh-list
5973474|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
5973475|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973476|NCT05033639|Protective Agents|protective agents|mesh-ancestor
5973477|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973478|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973479|NCT04970355|Erenumab|erenumab|mesh-list
5973480|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
5973481|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973482|NCT04970355|Analgesics|analgesics|mesh-ancestor
5973483|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
5973484|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973485|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973486|NCT04963283|Nivolumab|nivolumab|mesh-list
5973487|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973488|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973489|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5973490|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973491|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
5973492|NCT04931615|Thrombin|thrombin|mesh-list
5973493|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
5973494|NCT04931615|Coagulants|coagulants|mesh-ancestor
6245257|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
6245258|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245259|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6245260|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6245261|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245262|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
6245263|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6245264|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245265|NCT02715700|Methadone|methadone|mesh-list
6245266|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6245267|NCT02715700|Narcotics|narcotics|mesh-ancestor
6245268|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245269|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245270|NCT02715700|Analgesics|analgesics|mesh-ancestor
6245271|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
6245272|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245273|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
6245274|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
6245275|NCT02715726|Atorvastatin|atorvastatin|mesh-list
6245276|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6245277|NCT02715726|Simvastatin|simvastatin|mesh-list
6245278|NCT02715726|Ezetimibe|ezetimibe|mesh-list
6245279|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6245280|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6245281|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6245282|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
6245283|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245284|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6245285|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6245286|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245287|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
6245288|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245289|NCT02715804|Gemcitabine|gemcitabine|mesh-list
6245290|NCT02715804|Paclitaxel|paclitaxel|mesh-list
6245291|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6245292|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245293|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
6245294|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
6245295|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
6245296|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245297|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5973495|NCT04912921|Palmidrol|palmidrol|mesh-list
5973496|NCT04912921|Analgesics|analgesics|mesh-ancestor
5973497|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
5973498|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973499|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973500|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5973501|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5973502|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973503|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973504|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
5973505|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973506|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5973507|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5973508|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5973509|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973510|NCT04912921|Hormones|hormones|mesh-ancestor
5973511|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973512|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
5973513|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5973514|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973515|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5973516|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973517|NCT04870138|Azithromycin|azithromycin|mesh-list
5973518|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
5973519|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
5973520|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5973521|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973522|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5973523|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5973524|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973525|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973526|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973527|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5973528|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5973529|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
5973530|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5973531|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973532|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5973533|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973534|NCT04789616|Maraviroc|maraviroc|mesh-list
5973535|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5973536|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5973537|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973538|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5973539|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5973540|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
5973541|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973542|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5973543|NCT04729296|Golimumab|golimumab|mesh-list
5973544|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
5973545|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973546|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5973547|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
5973548|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973549|NCT04686786|PF-06372865|pf-06372865|mesh-list
5973550|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
5973551|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
5973552|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5973553|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973554|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973555|NCT04649060|Dexamethasone|dexamethasone|mesh-list
5973556|NCT04649060|Melphalan|melphalan|mesh-list
5973557|NCT04649060|Daratumumab|daratumumab|mesh-list
5973558|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973559|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
5973560|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
5973561|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973562|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973563|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5973564|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
5973565|NCT04649060|Hormones|hormones|mesh-ancestor
5973566|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973567|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5973568|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973569|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5973570|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
5973571|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973572|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5973573|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5973574|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
5973575|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5973576|NCT04642352|Bupivacaine|bupivacaine|mesh-list
5973577|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
5973578|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
5973579|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973580|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973581|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
5973582|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973583|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973584|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
5973585|NCT04642352|Hormones|hormones|mesh-ancestor
5973586|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973587|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5973588|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
5973589|NCT04641273|Pregabalin|pregabalin|mesh-list
5973590|NCT04641273|Analgesics|analgesics|mesh-ancestor
5973591|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
5973592|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973593|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973594|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
5973595|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5973596|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5973597|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973598|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5973599|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5973600|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5973601|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973602|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5973603|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
5973604|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5973605|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5973606|NCT04628338|Interferons|interferons|mesh-list
5973607|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
5973608|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973609|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
5973610|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973611|NCT04566328|Dexamethasone|dexamethasone|mesh-list
5973612|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
5973613|NCT04566328|Lenalidomide|lenalidomide|mesh-list
5973614|NCT04566328|Bortezomib|bortezomib|mesh-list
5973615|NCT04566328|Daratumumab|daratumumab|mesh-list
5973616|NCT04566328|Ichthammol|ichthammol|mesh-list
5973617|NCT04566328|BB 1101|bb 1101|mesh-list
5973618|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5973619|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973620|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
5973621|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
5973622|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973623|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973624|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5973625|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
5973626|NCT04566328|Hormones|hormones|mesh-ancestor
5973627|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973628|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5973629|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973630|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
5973631|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973632|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973633|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
5973634|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5973635|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5973636|NCT04566328|Growth Substances|growth substances|mesh-ancestor
5973637|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
5973638|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
5973639|NCT04558190|Ubiquinone|ubiquinone|mesh-list
5973640|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
5973641|NCT04558190|Albuterol|albuterol|mesh-list
5973642|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5973643|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
5973644|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973645|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973646|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5973647|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
5973648|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
5973649|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5973650|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5973651|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5973652|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5973653|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
5973654|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5973655|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973656|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
5973657|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
5973658|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5973659|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
5973660|NCT04551365|Chitosan|chitosan|mesh-list
5973661|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5973662|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5973663|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
5973664|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973665|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5973666|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
5973667|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
5973668|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
5973669|NCT04551365|Coagulants|coagulants|mesh-ancestor
5973670|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
5973671|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5973672|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973673|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973674|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5973675|NCT04535089|Lidocaine|lidocaine|mesh-list
5973676|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
5973677|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
5973678|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
5973679|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973680|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973681|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
5973682|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973683|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5973684|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5973685|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5973686|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5973687|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973688|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5973689|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5973690|NCT04535089|Analgesics|analgesics|mesh-ancestor
5973691|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5973692|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5973693|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5973694|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
5973695|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5973696|NCT04476420|Betamethasone|betamethasone|mesh-list
5973697|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
5973698|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5973699|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
5973700|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5973701|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973702|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
5973703|NCT04476420|Hormones|hormones|mesh-ancestor
5973704|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973705|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973706|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5973707|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
5973708|NCT04462471|Vemurafenib|vemurafenib|mesh-list
5973709|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973710|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5973711|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973712|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973713|NCT04446117|Prednisone|prednisone|mesh-list
5973714|NCT04446117|Atezolizumab|atezolizumab|mesh-list
5973715|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
5973716|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973717|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
5973718|NCT04446117|Hormones|hormones|mesh-ancestor
5973719|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973720|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973721|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5973722|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973723|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5973724|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973725|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973726|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
5973727|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5973728|NCT04444869|Cisplatin|cisplatin|mesh-list
5973729|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973730|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
5973731|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5973732|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5973733|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
5973734|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973735|NCT04410653|Afatinib|afatinib|mesh-list
5973736|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973737|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5973738|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973739|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973740|NCT04392505|Durvalumab|durvalumab|mesh-list
5973741|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973742|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973743|NCT04374630|Paclitaxel|paclitaxel|mesh-list
5973744|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5973745|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973746|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
5973747|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
5973748|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
5973749|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245298|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
6245299|NCT02715804|Antiviral Agents|antiviral agents|mesh-ancestor
6245300|NCT02715804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245301|NCT02715804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245302|NCT02715804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6245303|NCT02715804|Immunologic Factors|immunologic factors|mesh-ancestor
5973750|NCT04340193|Nivolumab|nivolumab|mesh-list
5973751|NCT04340193|Ipilimumab|ipilimumab|mesh-list
5973752|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973753|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973754|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5973755|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973756|NCT04329325|Dexamethasone|dexamethasone|mesh-list
5973757|NCT04329325|Methotrexate|methotrexate|mesh-list
5973758|NCT04329325|Dasatinib|dasatinib|mesh-list
5973759|NCT04329325|Blinatumomab|blinatumomab|mesh-list
5973760|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973761|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
5973762|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
5973763|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973764|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973765|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5973766|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
5973767|NCT04329325|Hormones|hormones|mesh-ancestor
5973768|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973769|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5973770|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973771|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5973772|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
5973773|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5973774|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5973775|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
5973776|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973777|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
5973778|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973779|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5973780|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5973781|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
5973782|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973783|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5973784|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5973785|NCT04308694|Methadone|methadone|mesh-list
5973786|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5973787|NCT04308694|Narcotics|narcotics|mesh-ancestor
5973788|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973789|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973790|NCT04308694|Analgesics|analgesics|mesh-ancestor
5973791|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
5973792|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973793|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
5973794|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
5973795|NCT04290624|Listerine|listerine|mesh-list
5973796|NCT04290624|Fluorides|fluorides|mesh-list
5973797|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
5973798|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
5973799|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
5973800|NCT04290624|Protective Agents|protective agents|mesh-ancestor
5973801|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973802|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5973803|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973804|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5973805|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
5973806|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5973807|NCT04223765|Fludarabine|fludarabine|mesh-list
5973808|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5973809|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
5973810|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973811|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973812|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5973813|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
5973814|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973815|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973816|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5973831|NCT04216524|Cytarabine|cytarabine|mesh-list
5973832|NCT04216524|Dexamethasone|dexamethasone|mesh-list
5973833|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
5973834|NCT04216524|Prednisone|prednisone|mesh-list
5973835|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
5973836|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5973837|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5973838|NCT04216524|Prednisolone|prednisolone|mesh-list
5973839|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
5973840|NCT04216524|Cortisone|cortisone|mesh-list
5973841|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
5973842|NCT04216524|Rituximab|rituximab|mesh-list
5973843|NCT04216524|Doxorubicin|doxorubicin|mesh-list
5973844|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5973845|NCT04216524|Methotrexate|methotrexate|mesh-list
5973846|NCT04216524|Vincristine|vincristine|mesh-list
5973847|NCT04216524|Daunorubicin|daunorubicin|mesh-list
5973848|NCT04216524|Venetoclax|venetoclax|mesh-list
5973849|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
5973850|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5973851|NCT04216524|Antibodies|antibodies|mesh-list
5973852|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
5973853|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5973854|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5973855|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
5973856|NCT04216524|BB 1101|bb 1101|mesh-list
5973857|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5973858|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
5973859|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973860|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973861|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5973862|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
5973863|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973864|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973865|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5973866|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973867|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
5973868|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
5973869|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973870|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5973871|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
5973872|NCT04216524|Hormones|hormones|mesh-ancestor
6245304|NCT02715804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973873|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5973874|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5973875|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
5973876|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973877|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5973878|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5973879|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5973880|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5973881|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
5973882|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5973883|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5973884|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
5973885|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
5973886|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5973887|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5973888|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
5973889|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973890|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5973891|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
5973892|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
5973893|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
5973894|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5973895|NCT04216524|Protective Agents|protective agents|mesh-ancestor
5973896|NCT04187196|Propofol|propofol|mesh-list
5973897|NCT04187196|Methohexital|methohexital|mesh-list
5973898|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5973899|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973900|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973901|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5973902|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
5973903|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
5973904|NCT04175613|Apremilast|apremilast|mesh-list
5973905|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5973906|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5973907|NCT04175613|Analgesics|analgesics|mesh-ancestor
5973908|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
5973909|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973910|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973911|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973912|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973913|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
5973914|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5973915|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973916|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973917|NCT04174196|Lenalidomide|lenalidomide|mesh-list
5973918|NCT04174196|Cc-486|cc-486|mesh-list
5973919|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
5973920|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973921|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5973922|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5973923|NCT04174196|Growth Substances|growth substances|mesh-ancestor
5973924|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
5973925|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973926|NCT04171141|Bevacizumab|bevacizumab|mesh-list
5973927|NCT04171141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973928|NCT04171141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973929|NCT04171141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5973930|NCT04171141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5973931|NCT04171141|Growth Substances|growth substances|mesh-ancestor
5973932|NCT04171141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973933|NCT04171141|Growth Inhibitors|growth inhibitors|mesh-ancestor
5973934|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
5973935|NCT04109885|Promethazine|promethazine|mesh-list
5973936|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
5973937|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5973938|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5973939|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5973940|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973941|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
5973942|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
5973943|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
5973944|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973945|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
5973946|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
5973947|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5973948|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5973949|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
5973950|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
5973951|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5973952|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973953|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5973954|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
5973955|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
5973956|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5973957|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5973958|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5973959|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5973960|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
5973961|NCT04089553|Durvalumab|durvalumab|mesh-list
5973962|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5973963|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5973964|NCT04078737|Aspirin|aspirin|mesh-list
5973965|NCT04078737|Clopidogrel|clopidogrel|mesh-list
5973966|NCT04078737|Ticagrelor|ticagrelor|mesh-list
5973967|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5973968|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5973969|NCT04078737|Analgesics|analgesics|mesh-ancestor
5973970|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
5973971|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5973972|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5973973|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5973974|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5973975|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5973976|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5973977|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973978|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5973979|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5973980|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5973981|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
5973982|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5973983|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5973984|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5973985|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
5973986|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5973987|NCT04058197|Deferoxamine|deferoxamine|mesh-list
5973988|NCT04058197|Siderophores|siderophores|mesh-ancestor
5973989|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5973990|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
5973991|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
5973992|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5973993|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5973994|NCT03999411|Nicotine|nicotine|mesh-list
5973995|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
5973996|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5973997|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5973998|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
5973999|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974000|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974001|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5974002|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5974003|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
5974004|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5974005|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974006|NCT03958981|Castor Oil|castor oil|mesh-list
5974007|NCT03958981|Cathartics|cathartics|mesh-ancestor
5974008|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5974009|NCT03937635|Dexamethasone|dexamethasone|mesh-list
5974010|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
5974011|NCT03937635|Lenalidomide|lenalidomide|mesh-list
5974012|NCT03937635|Daratumumab|daratumumab|mesh-list
5974013|NCT03937635|Ichthammol|ichthammol|mesh-list
5974014|NCT03937635|BB 1101|bb 1101|mesh-list
5974015|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974016|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
5974017|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
5974018|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974019|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974020|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5974021|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
5974022|NCT03937635|Hormones|hormones|mesh-ancestor
5974023|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974024|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5974025|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974026|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
5974027|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5974028|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5974029|NCT03937635|Growth Substances|growth substances|mesh-ancestor
5974030|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
5974031|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
5974032|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974033|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974034|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
5974035|NCT03908437|Buprenorphine|buprenorphine|mesh-list
5974036|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
5974037|NCT03908437|Naloxone|naloxone|mesh-list
5974038|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5974039|NCT03908437|Narcotics|narcotics|mesh-ancestor
5974040|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5974041|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974042|NCT03908437|Analgesics|analgesics|mesh-ancestor
5974043|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
5974044|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974045|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5974046|NCT03892369|Ethanol|ethanol|mesh-list
5974047|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5974048|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974049|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5974050|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974051|NCT03878589|Oxytocin|oxytocin|mesh-list
5974052|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
5974053|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5974054|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974055|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
5974056|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974057|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974058|NCT03803605|Vorinostat|vorinostat|mesh-list
5974059|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974060|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5974061|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974062|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974063|NCT03774394|Clopidogrel|clopidogrel|mesh-list
5974064|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5974065|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5974066|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5974067|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5974068|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
5974069|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5974070|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974071|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974072|NCT03770728|Metformin|metformin|mesh-list
5974073|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
5974074|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5974075|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974076|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5974077|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
5974078|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974079|NCT03737110|Rilonacept|rilonacept|mesh-list
5974080|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974081|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
5974082|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5974083|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974084|NCT03687957|Temozolomide|temozolomide|mesh-list
5974085|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5974086|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
5974087|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974088|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974089|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
5974090|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974091|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974092|NCT03542669|Doxorubicin|doxorubicin|mesh-list
5974093|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5974094|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974095|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5974096|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5974097|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974098|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974099|NCT03524235|Rituximab|rituximab|mesh-list
5974100|NCT03524235|Fludarabine|fludarabine|mesh-list
5974101|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5974102|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974103|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974104|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
5974105|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974106|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5974107|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974108|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5974109|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
6245305|NCT02716194|Factor VIII|factor viii|mesh-list
6245306|NCT02716194|Coagulants|coagulants|mesh-ancestor
6245307|NCT02716779|Interferons|interferons|mesh-list
6245308|NCT02716779|Ribavirin|ribavirin|mesh-list
6245309|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245310|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
6245311|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245312|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
6245313|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245314|NCT02716805|Melphalan|melphalan|mesh-list
6245315|NCT02716805|Durvalumab|durvalumab|mesh-list
6245316|NCT02716805|Tremelimumab|tremelimumab|mesh-list
6245317|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6245318|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
6245319|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245320|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245321|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6245322|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6245323|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
6245324|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245325|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245326|NCT02716818|Dexamethasone|dexamethasone|mesh-list
6245327|NCT02716818|Prednisone|prednisone|mesh-list
6245328|NCT02716818|Prednisolone|prednisolone|mesh-list
6245329|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
6245330|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6245331|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6245332|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6245333|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
6245334|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6245335|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
5974110|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
5974111|NCT03514901|Nivolumab|nivolumab|mesh-list
5974112|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974113|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974114|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5974115|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974116|NCT03471624|Tenofovir|tenofovir|mesh-list
5974117|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
5974118|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974119|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5974120|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5974121|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974122|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974123|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5974124|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5974125|NCT03462966|Rifaximin|rifaximin|mesh-list
5974126|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5974127|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974128|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5974129|NCT03462251|Paclitaxel|paclitaxel|mesh-list
5974130|NCT03462251|Bevacizumab|bevacizumab|mesh-list
5974131|NCT03462251|Capecitabine|capecitabine|mesh-list
5974132|NCT03462251|Fulvestrant|fulvestrant|mesh-list
5974133|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5974134|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5974135|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974136|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
5974137|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
5974138|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
5974139|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974140|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974141|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5974142|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5974143|NCT03462251|Growth Substances|growth substances|mesh-ancestor
5974144|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974145|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
5974146|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5974147|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
5974148|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5974149|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5974150|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5974151|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
5974152|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974153|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5974154|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974155|NCT03369197|Anesthetics|anesthetics|mesh-list
5974156|NCT03369197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5974157|NCT03369197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974158|NCT03338647|Doxorubicin|doxorubicin|mesh-list
5974159|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5974160|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974161|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5974162|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5974163|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974164|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974165|NCT03332095|Tenofovir|tenofovir|mesh-list
5974166|NCT03332095|Lamivudine|lamivudine|mesh-list
5974167|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5974168|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
5974169|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974170|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5974171|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5974172|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974173|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974174|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5974175|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
5974176|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974177|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974178|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
5974179|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5974180|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5974181|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
5974182|NCT03220477|Guadecitabine|guadecitabine|mesh-list
5974183|NCT03220477|Mocetinostat|mocetinostat|mesh-list
5974184|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974185|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974186|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5974187|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974188|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974189|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
5974190|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974191|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974192|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5974193|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5974194|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
5974195|NCT03051516|Vaccines|vaccines|mesh-list
5974196|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
5974197|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974198|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5974199|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
6245336|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
5974200|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5974201|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
5974202|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974203|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974204|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974205|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5974206|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
5974207|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974208|NCT02894398|Letrozole|letrozole|mesh-list
5974209|NCT02894398|Fulvestrant|fulvestrant|mesh-list
5974210|NCT02894398|Palbociclib|palbociclib|mesh-list
5974211|NCT02894398|Anastrozole|anastrozole|mesh-list
5974212|NCT02894398|Exemestane|exemestane|mesh-list
5974213|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974214|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5974215|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5974216|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974217|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974218|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5974219|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
5974220|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974221|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974222|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5974223|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5974224|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5974225|NCT02852057|Timolol|timolol|mesh-list
5974226|NCT02852057|Dorzolamide|dorzolamide|mesh-list
5974227|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5974228|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5974229|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
5974230|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5974231|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974232|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974233|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5974234|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5974235|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974236|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5974237|NCT02734537|Cisplatin|cisplatin|mesh-list
5974238|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974239|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5974240|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5974241|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
5974242|NCT02710734|Doxorubicin|doxorubicin|mesh-list
5974243|NCT02710734|Methotrexate|methotrexate|mesh-list
5974244|NCT02710734|Mitomycins|mitomycins|mesh-list
5974245|NCT02710734|Mitomycin|mitomycin|mesh-list
5974246|NCT02710734|Vinblastine|vinblastine|mesh-list
5974247|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974248|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5974249|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5974250|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5974251|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974252|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974253|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5974254|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
5974255|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5974256|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974257|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5974258|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
5974259|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
5974260|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5974261|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5974262|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
5974263|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5974264|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5974265|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
5974266|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5974267|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
5974268|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
5974269|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
5974270|NCT02611024|Irinotecan|irinotecan|mesh-list
5974271|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5974272|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5974273|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974274|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974275|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974276|NCT02564796|Iron|iron|mesh-list
5974277|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
5974278|NCT02564796|Trace Elements|trace elements|mesh-ancestor
5974279|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
5974280|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974281|NCT02564796|Hematinics|hematinics|mesh-ancestor
5974282|NCT02562716|Gemcitabine|gemcitabine|mesh-list
5974283|NCT02562716|Paclitaxel|paclitaxel|mesh-list
5974284|NCT02562716|Camptothecin|camptothecin|mesh-list
5974285|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5974286|NCT02562716|Fluorouracil|fluorouracil|mesh-list
5974287|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
5974288|NCT02562716|Irinotecan|irinotecan|mesh-list
5974289|NCT02562716|Pancrelipase|pancrelipase|mesh-list
5974290|NCT02562716|Pancreatin|pancreatin|mesh-list
5974291|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5974292|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974293|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
5974294|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
5974295|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
5974296|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974297|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5974298|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
5974299|NCT02562716|Antiviral Agents|antiviral agents|mesh-ancestor
5974300|NCT02562716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974301|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974302|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5974303|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
5974304|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974305|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5974306|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5974307|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5974308|NCT02558010|Morphine|morphine|mesh-list
5974309|NCT02558010|Methadone|methadone|mesh-list
5974310|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5974311|NCT02558010|Narcotics|narcotics|mesh-ancestor
5974312|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5974313|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974314|NCT02558010|Analgesics|analgesics|mesh-ancestor
5974315|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
5974316|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974317|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
5974318|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
5974319|NCT02502006|Celecoxib|celecoxib|mesh-list
5974320|NCT02502006|Naproxen|naproxen|mesh-list
5974321|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5974322|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5974323|NCT02502006|Analgesics|analgesics|mesh-ancestor
5974324|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
5974325|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974326|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974327|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974328|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5974329|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5974330|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5974331|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974332|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974333|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
5974334|NCT02481245|Bezafibrate|bezafibrate|mesh-list
5974335|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5974336|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
5974337|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974338|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5974339|NCT02477384|Propranolol|propranolol|mesh-list
5974340|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5974341|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5974342|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
5974343|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5974344|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974345|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974346|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5974347|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5974348|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
5974349|NCT02442349|Osimertinib|osimertinib|mesh-list
5974350|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974351|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5974352|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974353|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974354|NCT02427724|Lidocaine|lidocaine|mesh-list
5974355|NCT02427724|Tetracaine|tetracaine|mesh-list
5974356|NCT02427724|Prilocaine|prilocaine|mesh-list
5974357|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
5974358|NCT02427724|Anesthetics|anesthetics|mesh-list
5974359|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5974360|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974361|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
5974362|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974363|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5974364|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5974365|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5974366|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5974367|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974368|NCT02393794|Nivolumab|nivolumab|mesh-list
5974369|NCT02393794|Romidepsin|romidepsin|mesh-list
5974370|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5974371|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974372|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974373|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5974374|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974375|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5974376|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974377|NCT02343042|Clarithromycin|clarithromycin|mesh-list
5974378|NCT02343042|Dexamethasone|dexamethasone|mesh-list
5974379|NCT02343042|Lenalidomide|lenalidomide|mesh-list
5974380|NCT02343042|Bortezomib|bortezomib|mesh-list
5974381|NCT02343042|Daratumumab|daratumumab|mesh-list
5974382|NCT02343042|Pomalidomide|pomalidomide|mesh-list
5974383|NCT02343042|Ixazomib|ixazomib|mesh-list
5974384|NCT02343042|Elotuzumab|elotuzumab|mesh-list
5974385|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974386|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
5974387|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
5974388|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974389|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974390|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5974391|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
5974392|NCT02343042|Hormones|hormones|mesh-ancestor
5974393|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974394|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5974395|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974396|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
5974397|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5974398|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5974399|NCT02343042|Growth Substances|growth substances|mesh-ancestor
5974400|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
5974401|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5974402|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974403|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5974404|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974405|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974406|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5974407|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5974408|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
5974409|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
5974410|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5974411|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974412|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974413|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
5974414|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974415|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974416|NCT02094261|Osimertinib|osimertinib|mesh-list
5974417|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974418|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5974419|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974420|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974421|NCT02047513|Gemcitabine|gemcitabine|mesh-list
5974422|NCT02047513|Paclitaxel|paclitaxel|mesh-list
5974423|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5974424|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5974425|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974426|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
5974427|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
5974428|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
5974429|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974430|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5974431|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
5974432|NCT02047513|Antiviral Agents|antiviral agents|mesh-ancestor
5974433|NCT02047513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974434|NCT02047513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974435|NCT02047513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5974436|NCT02047513|Immunologic Factors|immunologic factors|mesh-ancestor
5974437|NCT02047513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974438|NCT02043847|Melphalan|melphalan|mesh-list
5974439|NCT02043847|Lenograstim|lenograstim|mesh-list
5974440|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5974441|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
5974442|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974443|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5974444|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
5974445|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974446|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974447|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5974448|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5974449|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
5974450|NCT01976286|Salicylates|salicylates|mesh-list
5974451|NCT01976286|Glycolic acid|glycolic acid|mesh-list
5974452|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974453|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
5974454|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
5974455|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
6245337|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974456|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5974457|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5974458|NCT01976286|Analgesics|analgesics|mesh-ancestor
5974459|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
5974460|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974461|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974462|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974463|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5974464|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5974465|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974466|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974467|NCT01775644|Bevacizumab|bevacizumab|mesh-list
5974468|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974469|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974470|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5974471|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5974472|NCT01775644|Growth Substances|growth substances|mesh-ancestor
5974473|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974474|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
5974475|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
5974476|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5974477|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5974478|NCT01496976|Prednisolone|prednisolone|mesh-list
5974479|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
5974480|NCT01496976|Lenalidomide|lenalidomide|mesh-list
5974481|NCT01496976|Ofatumumab|ofatumumab|mesh-list
5974482|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5974483|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
5974484|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
5974485|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974486|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5974487|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5974488|NCT01496976|Growth Substances|growth substances|mesh-ancestor
5974489|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
5974490|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974491|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974492|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
5974493|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
5974494|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974495|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5974496|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
5974497|NCT01496976|Hormones|hormones|mesh-ancestor
5974498|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974499|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5974500|NCT01496976|Protective Agents|protective agents|mesh-ancestor
5974501|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5974502|NCT01472081|Nivolumab|nivolumab|mesh-list
5974503|NCT01472081|Ipilimumab|ipilimumab|mesh-list
5974504|NCT01472081|Sunitinib|sunitinib|mesh-list
5974505|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974506|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974507|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5974508|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974509|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5974510|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5974511|NCT01472081|Growth Substances|growth substances|mesh-ancestor
5974512|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974513|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
5974514|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5974515|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974516|NCT01367002|Paclitaxel|paclitaxel|mesh-list
5974517|NCT01367002|Carboplatin|carboplatin|mesh-list
5974518|NCT01367002|Trastuzumab|trastuzumab|mesh-list
5974519|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5974520|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974521|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
5974522|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
5974523|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
5974524|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974525|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245338|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245339|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245340|NCT02716818|Hormones|hormones|mesh-ancestor
6245341|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6245342|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6245343|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245344|NCT02717195|Olanzapine|olanzapine|mesh-list
6245345|NCT02717195|Risperidone|risperidone|mesh-list
6245346|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6245347|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
6245348|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245349|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245350|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245351|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6245352|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6245353|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245354|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6245355|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6245356|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
6245357|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
6245358|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
6245359|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974526|NCT01309672|Prednisone|prednisone|mesh-list
5974527|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
5974528|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974529|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
5974530|NCT01309672|Hormones|hormones|mesh-ancestor
5974531|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974532|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974533|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5974534|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974535|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5974536|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974537|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974538|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
5974539|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5974540|NCT01131169|Vidarabine|vidarabine|mesh-list
5974541|NCT01131169|Fludarabine|fludarabine|mesh-list
5974542|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
5974543|NCT01131169|Melphalan|melphalan|mesh-list
5974544|NCT01131169|Busulfan|busulfan|mesh-list
5974545|NCT01131169|Lenograstim|lenograstim|mesh-list
5974546|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974547|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5974548|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
5974549|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974550|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5974551|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
5974552|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974553|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
5974554|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974555|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5974556|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
5974557|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5974558|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5974559|NCT00882505|Vitamin D|vitamin d|mesh-list
5974560|NCT00882505|Vitamins|vitamins|mesh-ancestor
5974561|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
5974562|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974563|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5974564|NCT00871013|Thalidomide|thalidomide|mesh-list
5974565|NCT00871013|Dexamethasone|dexamethasone|mesh-list
5974566|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
5974567|NCT00871013|Melphalan|melphalan|mesh-list
5974568|NCT00871013|Doxorubicin|doxorubicin|mesh-list
5974569|NCT00871013|Etoposide|etoposide|mesh-list
5974570|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5974571|NCT00871013|Bortezomib|bortezomib|mesh-list
5974572|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5974573|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
5974574|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974575|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5974576|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5974577|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
5974578|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974579|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974580|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5974581|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974582|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
5974583|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
5974584|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974585|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5974586|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
5974587|NCT00871013|Hormones|hormones|mesh-ancestor
5974588|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974589|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5974590|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5974591|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5974592|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5974593|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974594|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5974595|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
5974596|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5974597|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974598|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5974599|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5974600|NCT00871013|Growth Substances|growth substances|mesh-ancestor
5974601|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
5974602|NCT00774345|Lenalidomide|lenalidomide|mesh-list
5974603|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
5974604|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974605|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5974606|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5974607|NCT00774345|Growth Substances|growth substances|mesh-ancestor
5974608|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
5974609|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974610|NCT00735657|Iodine|iodine|mesh-list
5974611|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5974612|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974613|NCT00735657|Trace Elements|trace elements|mesh-ancestor
5974614|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
5974615|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974616|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
5974617|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
5974618|NCT00258427|Busulfan|busulfan|mesh-list
5974619|NCT00258427|Fludarabine|fludarabine|mesh-list
5974620|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
5974621|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5974622|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5974623|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
5974624|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974625|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5974626|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5974627|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
5974628|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974629|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974630|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5974631|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5974632|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
5974633|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974634|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
5974635|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
5974636|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974637|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5974638|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
5974639|NCT00258427|Hormones|hormones|mesh-ancestor
5974640|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974641|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5974642|NCT00258427|Protective Agents|protective agents|mesh-ancestor
5974643|NCT00250341|Beclomethasone|beclomethasone|mesh-list
5974644|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
5974645|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974646|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
5974647|NCT00250341|Hormones|hormones|mesh-ancestor
5974648|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974649|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974650|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5974651|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
5974652|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5974653|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
5974654|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974655|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
5974656|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
5974657|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5974658|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5974659|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974660|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5974661|NCT03723538|Analgesics|analgesics|mesh-ancestor
5974662|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
5974663|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974664|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5974665|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5974666|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5974667|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
5974668|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5974669|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974670|NCT00000102|Nifedipine|nifedipine|mesh-list
5974671|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5974672|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5974673|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974674|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5974675|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974676|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
5974677|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
5974678|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5974679|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
5974680|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5974681|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5974682|NCT00000134|Ganciclovir|ganciclovir|mesh-list
5974683|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5974684|NCT00000134|Foscarnet|foscarnet|mesh-list
5974685|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
5974686|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974687|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5974688|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974689|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974690|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5974691|NCT00000136|Ganciclovir|ganciclovir|mesh-list
5974692|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5974693|NCT00000136|Foscarnet|foscarnet|mesh-list
5974694|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
5974695|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974696|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5974697|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974698|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974699|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5974700|NCT00000142|Cidofovir|cidofovir|mesh-list
5974701|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
5974702|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974703|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974704|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974705|NCT00000143|Ganciclovir|ganciclovir|mesh-list
5974706|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5974707|NCT00000143|Cidofovir|cidofovir|mesh-list
5974708|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
5974709|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974710|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5974711|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974712|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974713|NCT00000371|Cycloserine|cycloserine|mesh-list
5974714|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5974715|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974716|NCT00000371|Renal Agents|renal agents|mesh-ancestor
5974717|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5974718|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
5974719|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5974720|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
5974721|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974722|NCT00000378|Sertraline|sertraline|mesh-list
5974723|NCT00000378|Nortriptyline|nortriptyline|mesh-list
5974724|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
5974725|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5974726|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5974727|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5974728|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5974729|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974730|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5974731|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
5974732|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974733|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5974734|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5974735|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
5974736|NCT00000479|Aspirin|aspirin|mesh-list
5974737|NCT00000479|Vitamin E|vitamin e|mesh-list
5974738|NCT00000479|Vitamins|vitamins|mesh-ancestor
5974739|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
5974740|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974741|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5974742|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5974743|NCT00000479|Analgesics|analgesics|mesh-ancestor
5974744|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
5974745|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974746|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974747|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5974748|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5974749|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5974750|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974751|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5974752|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5974753|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974754|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
5974755|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
5974756|NCT00000479|Protective Agents|protective agents|mesh-ancestor
5974757|NCT00000575|Nedocromil|nedocromil|mesh-list
5974758|NCT00000575|Budesonide|budesonide|mesh-list
5974759|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974760|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5974761|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
5974762|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974763|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974764|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5974765|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
5974766|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
5974767|NCT00000575|Hormones|hormones|mesh-ancestor
5974768|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974769|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
5974770|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
5974771|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5974772|NCT00000620|Insulin|insulin|mesh-list
5974773|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5974774|NCT00000620|Metformin|metformin|mesh-list
5974775|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
5974776|NCT00000620|Pioglitazone|pioglitazone|mesh-list
5974777|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
5974778|NCT00000620|Glimepiride|glimepiride|mesh-list
5974779|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
5974780|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
5974781|NCT00000620|Acarbose|acarbose|mesh-list
5974782|NCT00000620|Repaglinide|repaglinide|mesh-list
5974783|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5974784|NCT00000620|Metoprolol|metoprolol|mesh-list
5974785|NCT00000620|Felodipine|felodipine|mesh-list
5974786|NCT00000620|Amlodipine|amlodipine|mesh-list
5974787|NCT00000620|Valsartan|valsartan|mesh-list
5974788|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5974789|NCT00000620|Carvedilol|carvedilol|mesh-list
5974790|NCT00000620|Candesartan|candesartan|mesh-list
5974791|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
5974792|NCT00000620|Lisinopril|lisinopril|mesh-list
5974793|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
5974794|NCT00000620|Diltiazem|diltiazem|mesh-list
5974795|NCT00000620|Benazepril|benazepril|mesh-list
5974796|NCT00000620|Hydralazine|hydralazine|mesh-list
5974797|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
5974798|NCT00000620|Reserpine|reserpine|mesh-list
5974799|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
5974800|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
5974801|NCT00000620|Triamterene|triamterene|mesh-list
5974802|NCT00000620|Furosemide|furosemide|mesh-list
5974803|NCT00000620|Simvastatin|simvastatin|mesh-list
5974804|NCT00000620|Fenofibrate|fenofibrate|mesh-list
5974805|NCT00000620|Terazosin|terazosin|mesh-list
5974806|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974807|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5974808|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5974809|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974810|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5974811|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
5974812|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5974813|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5974814|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
5974815|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5974816|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5974817|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974818|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5974819|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5974820|NCT00000620|Diuretics|diuretics|mesh-ancestor
5974821|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
5974822|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5974823|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5974824|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5974825|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
5974826|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
5974827|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
5974828|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974829|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5974830|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5974831|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5974832|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
5974833|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5974834|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
5974835|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
5974836|NCT00000620|Protective Agents|protective agents|mesh-ancestor
5974837|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5974838|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5974839|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5974840|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
5974841|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5974842|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5974843|NCT00000620|Urological Agents|urological agents|mesh-ancestor
5974844|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5974845|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5974846|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5974847|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5974848|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5974849|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5974850|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
5974851|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5974852|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5974853|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
5974854|NCT00001151|Calcitriol|calcitriol|mesh-list
5974855|NCT00001151|Vitamins|vitamins|mesh-ancestor
5974856|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
5974857|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974858|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5974859|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5974860|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5974861|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5974862|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974863|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5974864|NCT00001213|Cysteamine|cysteamine|mesh-list
5974865|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
5974866|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974867|NCT00001262|Copper|copper|mesh-list
5974868|NCT00001262|Trace Elements|trace elements|mesh-ancestor
5974869|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
5974870|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974871|NCT00001304|Vitamin D|vitamin d|mesh-list
5974872|NCT00001304|Calcitriol|calcitriol|mesh-list
5974873|NCT00001304|Calcium|calcium|mesh-list
5974874|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
5974875|NCT00001304|Hormones|hormones|mesh-list
5974876|NCT00001304|Vitamins|vitamins|mesh-ancestor
5974877|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
5974878|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974879|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5974880|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5974881|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5974882|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5974883|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5974884|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974885|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5974886|NCT00001566|Indinavir|indinavir|mesh-list
5974887|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5974888|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5974889|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
5974890|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974891|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974892|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5974893|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5974894|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
5974895|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974896|NCT00001575|Edetic Acid|edetic acid|mesh-list
5974897|NCT00001575|Calcium|calcium|mesh-list
5974898|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
5974899|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5974900|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974901|NCT00001575|Antidotes|antidotes|mesh-ancestor
5974902|NCT00001575|Protective Agents|protective agents|mesh-ancestor
5974903|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
5974904|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
5974905|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974906|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5974907|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
5974908|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5974909|NCT00001586|Vidarabine|vidarabine|mesh-list
5974910|NCT00001586|Rituximab|rituximab|mesh-list
5974911|NCT00001586|Fludarabine|fludarabine|mesh-list
5974912|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
5974913|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5974914|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974915|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
5974916|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974917|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5974918|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5974919|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
5974920|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974921|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5974922|NCT00001586|Antiviral Agents|antiviral agents|mesh-ancestor
5974923|NCT00001586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5974924|NCT00001596|Pirfenidone|pirfenidone|mesh-list
5974925|NCT00001596|Analgesics|analgesics|mesh-ancestor
5974926|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
5974927|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974928|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974929|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5974930|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5974931|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5974932|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5974933|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974934|NCT00001656|Olanzapine|olanzapine|mesh-list
5974935|NCT00001656|Clozapine|clozapine|mesh-list
5974936|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
5974937|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
5974938|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974939|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974940|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5974941|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5974942|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5974943|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5974944|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5974945|NCT00001656|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5974946|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5974947|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5974948|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974949|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5974950|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
5974951|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5974952|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
5974953|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
5974954|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
5974955|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5974956|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
5974957|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974958|NCT00001723|Orlistat|orlistat|mesh-list
5974959|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5974960|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974961|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5974962|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5974963|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
5974964|NCT00001832|Fludarabine|fludarabine|mesh-list
5974965|NCT00001832|Interleukin-2|interleukin-2|mesh-list
5974966|NCT00001832|Sargramostim|sargramostim|mesh-list
5974967|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5974968|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
5974969|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974970|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5974971|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5974972|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
5974973|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974974|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5974975|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5974976|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5974977|NCT00001832|Analgesics|analgesics|mesh-ancestor
5974978|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
5974979|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5974980|NCT00001849|Edetic Acid|edetic acid|mesh-list
5974981|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
5974982|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5974983|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974984|NCT00001849|Antidotes|antidotes|mesh-ancestor
5974985|NCT00001849|Protective Agents|protective agents|mesh-ancestor
5974986|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
5974987|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
5974988|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5974989|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
5974990|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5974991|NCT00001880|Cyclosporine|cyclosporine|mesh-list
5974992|NCT00001880|Methotrexate|methotrexate|mesh-list
5974993|NCT00001880|Cyclosporins|cyclosporins|mesh-list
5974994|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5974995|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
5974996|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5974997|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5974998|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5974999|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
5975000|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975001|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975002|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
5975003|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975004|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5975005|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975006|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
5975007|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975008|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5975009|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
5975010|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975011|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5975012|NCT00001941|Daclizumab|daclizumab|mesh-list
5975013|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975014|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
5975015|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975016|NCT00001959|Pirfenidone|pirfenidone|mesh-list
5975017|NCT00001959|Analgesics|analgesics|mesh-ancestor
5975018|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
5975019|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975020|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975021|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5975022|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5975023|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5975024|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975025|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975026|NCT00001962|Daclizumab|daclizumab|mesh-list
5975027|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975028|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
5975029|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975030|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
5975031|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975032|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975033|NCT00002525|Leucovorin|leucovorin|mesh-list
5975034|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
5975035|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
5975036|NCT00002525|Fluorouracil|fluorouracil|mesh-list
5975037|NCT00002525|Calcium|calcium|mesh-list
5975038|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
5975039|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5975040|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975041|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
5975042|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975043|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5975044|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975045|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975046|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
5975047|NCT00002525|Antidotes|antidotes|mesh-ancestor
5975048|NCT00002525|Protective Agents|protective agents|mesh-ancestor
5975049|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
5975050|NCT00002525|Vitamins|vitamins|mesh-ancestor
5975051|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
5975052|NCT00002558|Paclitaxel|paclitaxel|mesh-list
5975053|NCT00002558|Etoposide|etoposide|mesh-list
5975054|NCT00002558|Carboplatin|carboplatin|mesh-list
5975055|NCT00002558|Ifosfamide|ifosfamide|mesh-list
5975056|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5975057|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975058|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
5975059|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
5975060|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
5975061|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975062|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5975063|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5975064|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975065|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5975066|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
5975067|NCT00002597|Leuprolide|leuprolide|mesh-list
5975068|NCT00002597|Goserelin|goserelin|mesh-list
5975069|NCT00002597|Flutamide|flutamide|mesh-list
5975070|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5975071|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
5975072|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5975073|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975074|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5975075|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975076|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
5975077|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
5975078|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975079|NCT00002601|Doxorubicin|doxorubicin|mesh-list
5975080|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5975081|NCT00002601|Melphalan|melphalan|mesh-list
5975082|NCT00002601|Ifosfamide|ifosfamide|mesh-list
5975083|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975084|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5975085|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5975086|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5975087|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975088|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975089|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
5975090|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975091|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5975092|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
5975093|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5975094|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975095|NCT00002651|Goserelin|goserelin|mesh-list
5975096|NCT00002651|Bicalutamide|bicalutamide|mesh-list
5975097|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5975098|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975099|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
5975100|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
5975101|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975102|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975103|NCT00002766|Cytarabine|cytarabine|mesh-list
5975104|NCT00002766|Dactinomycin|dactinomycin|mesh-list
5975105|NCT00002766|Prednisone|prednisone|mesh-list
5975106|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
5975107|NCT00002766|Carmustine|carmustine|mesh-list
5975108|NCT00002766|Doxorubicin|doxorubicin|mesh-list
5975109|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5975110|NCT00002766|Methotrexate|methotrexate|mesh-list
5975111|NCT00002766|Etoposide|etoposide|mesh-list
5975112|NCT00002766|Vincristine|vincristine|mesh-list
5975113|NCT00002766|Daunorubicin|daunorubicin|mesh-list
5975114|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
5975115|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
5975116|NCT00002766|Pegaspargase|pegaspargase|mesh-list
5975117|NCT00002766|Sargramostim|sargramostim|mesh-list
5975118|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975119|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
5975120|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975121|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975122|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5975123|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
5975124|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975125|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975126|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5975127|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5975128|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5975129|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5975130|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975131|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5975132|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
5975133|NCT00002766|Hormones|hormones|mesh-ancestor
5975134|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975135|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5975136|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5975137|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
5975138|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5975139|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5975140|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
5975141|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
5975142|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5975143|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5975144|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5975145|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
5975146|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975147|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
5975148|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
5975149|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
5975150|NCT00002766|Analgesics|analgesics|mesh-ancestor
5975151|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
5975152|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975153|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5975154|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5975155|NCT00002842|Leucovorin|leucovorin|mesh-list
5975156|NCT00002842|Fluorouracil|fluorouracil|mesh-list
5975157|NCT00002842|Floxuridine|floxuridine|mesh-list
5975158|NCT00002842|Calcium|calcium|mesh-list
5975159|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
5975160|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5975161|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975162|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
5975163|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975164|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5975165|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975166|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975167|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
5975168|NCT00002842|Antidotes|antidotes|mesh-ancestor
5975169|NCT00002842|Protective Agents|protective agents|mesh-ancestor
5975170|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
5975171|NCT00002842|Vitamins|vitamins|mesh-ancestor
5975172|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
5975173|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
5975174|NCT00002850|Ofloxacin|ofloxacin|mesh-list
5975175|NCT00002850|Trimethoprim|trimethoprim|mesh-list
5975176|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
5975177|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5975178|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975179|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5975180|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5975181|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975182|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975183|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975184|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5975185|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5975186|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5975187|NCT00002850|Renal Agents|renal agents|mesh-ancestor
5975188|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
5975189|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5975190|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5975191|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5975192|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5975193|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5975194|NCT00002874|Bicalutamide|bicalutamide|mesh-list
5975195|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
5975196|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
5975197|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975198|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975199|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975200|NCT00002931|Paclitaxel|paclitaxel|mesh-list
5975201|NCT00002931|Etoposide|etoposide|mesh-list
5975202|NCT00002931|Carboplatin|carboplatin|mesh-list
5975203|NCT00002931|Ifosfamide|ifosfamide|mesh-list
5975204|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5975205|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975206|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
5975207|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
5975208|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
5975209|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975210|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5975211|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5975212|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975213|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5975214|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
5975215|NCT00003042|Tamoxifen|tamoxifen|mesh-list
5975216|NCT00003042|Paclitaxel|paclitaxel|mesh-list
5975217|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
5975218|NCT00003042|Doxorubicin|doxorubicin|mesh-list
5975219|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5975220|NCT00003042|Melphalan|melphalan|mesh-list
5975221|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5975222|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975223|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
5975224|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
5975225|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
5975226|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975227|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975228|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
5975229|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975230|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975231|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5975232|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
5975233|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5975234|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5975235|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5975236|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5975237|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975238|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5975239|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
5975240|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975241|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5975242|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5975243|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5975244|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5975245|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
5975246|NCT00003138|Lenograstim|lenograstim|mesh-list
5975247|NCT00003138|Sargramostim|sargramostim|mesh-list
5975248|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5975249|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
5975250|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975251|NCT00003138|Hematinics|hematinics|mesh-ancestor
5975252|NCT00003199|Tamoxifen|tamoxifen|mesh-list
5975253|NCT00003199|Aldesleukin|aldesleukin|mesh-list
5975254|NCT00003199|Melphalan|melphalan|mesh-list
5975255|NCT00003199|Busulfan|busulfan|mesh-list
5975256|NCT00003199|Thiotepa|thiotepa|mesh-list
5975257|NCT00003199|Interleukin-2|interleukin-2|mesh-list
5975258|NCT00003199|Sargramostim|sargramostim|mesh-list
5975259|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975260|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5975261|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
5975262|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975263|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5975264|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975265|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
5975266|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975267|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5975268|NCT00003199|Analgesics|analgesics|mesh-ancestor
5975269|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
5975270|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975271|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5975272|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
5975273|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975274|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5975275|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5975276|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5975277|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5975278|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5975279|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5975280|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
5975281|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975282|NCT00003222|Aldesleukin|aldesleukin|mesh-list
5975283|NCT00003222|Interleukin-2|interleukin-2|mesh-list
5975284|NCT00003222|Sargramostim|sargramostim|mesh-list
5975285|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
5975286|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975287|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5975288|NCT00003222|Analgesics|analgesics|mesh-ancestor
5975289|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
5975290|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975291|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975292|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
5975293|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5975294|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5975295|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
5975296|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975297|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5975298|NCT00003224|Vaccines|vaccines|mesh-list
5975299|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
5975300|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
5975301|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975302|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5975303|NCT00003270|Cyclosporine|cyclosporine|mesh-list
5975304|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
5975305|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
5975306|NCT00003270|Busulfan|busulfan|mesh-list
5975307|NCT00003270|Cyclosporins|cyclosporins|mesh-list
5975308|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5975309|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975310|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
5975311|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975312|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975313|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5975314|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
5975315|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975316|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975317|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5975318|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975319|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
5975320|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975321|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
5975322|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5975323|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5975324|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
5975325|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
5975326|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975327|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5975328|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
5975329|NCT00003270|Hormones|hormones|mesh-ancestor
5975330|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975331|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5975332|NCT00003270|Protective Agents|protective agents|mesh-ancestor
5975333|NCT05235100|Apatinib|apatinib|mesh-list
5975334|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975335|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5975336|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975337|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245360|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245361|NCT02717195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6245362|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6245363|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245364|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6245365|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
6245366|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245367|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
6245368|NCT02717754|Oseltamivir|oseltamivir|mesh-list
6245369|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
6245370|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245371|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245372|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245373|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6245374|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5975338|NCT05234840|Triamcinolone|triamcinolone|mesh-list
5975339|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5975340|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
5975341|NCT05234840|Hormones|hormones|mesh-ancestor
5975342|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975343|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975344|NCT05234697|Remifentanil|remifentanil|mesh-list
5975345|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5975346|NCT05234697|Narcotics|narcotics|mesh-ancestor
5975347|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5975348|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975349|NCT05234697|Analgesics|analgesics|mesh-ancestor
5975350|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
5975351|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975352|NCT05234684|Prednisone|prednisone|mesh-list
5975353|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
5975354|NCT05234684|Vincristine|vincristine|mesh-list
5975355|NCT05234684|Rituximab|rituximab|mesh-list
5975356|NCT05234684|Doxorubicin|doxorubicin|mesh-list
5975357|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975358|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
5975359|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975360|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975361|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5975362|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
5975363|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975364|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975365|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5975366|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5975367|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
5975368|NCT05234684|Hormones|hormones|mesh-ancestor
5975369|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975370|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5975371|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5975372|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
5975373|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
5975374|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
5975375|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975376|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5975377|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5975378|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5975379|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975380|NCT05234619|Ketorolac|ketorolac|mesh-list
5975381|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
5975382|NCT05234619|Lidocaine|lidocaine|mesh-list
5975383|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
5975384|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
5975385|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5975386|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975387|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
5975388|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975389|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5975390|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5975391|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5975392|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5975393|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975394|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5975395|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5975396|NCT05234619|Analgesics|analgesics|mesh-ancestor
5975397|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5975398|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975399|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5975400|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975401|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
5975402|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975403|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975404|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5975405|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5975406|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5975407|NCT05234307|Nivolumab|nivolumab|mesh-list
5975408|NCT05234307|Adenosine|adenosine|mesh-list
5975409|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
5975410|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975411|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975412|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5975413|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975414|NCT05234307|Analgesics|analgesics|mesh-ancestor
5975415|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
5975416|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975417|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975418|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5975419|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
5975420|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
5975421|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
5975422|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
5975423|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975424|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5975425|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5975426|NCT05234112|Acetic Acid|acetic acid|mesh-list
5975427|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5975428|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975429|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5975430|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5975431|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975432|NCT05233982|Olaparib|olaparib|mesh-list
5975433|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5975434|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975435|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975436|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975437|NCT05233735|Betamethasone|betamethasone|mesh-list
5975438|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5975439|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
5975440|NCT05233735|Hormones|hormones|mesh-ancestor
5975441|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975442|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975443|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5975444|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
5975445|NCT05233722|Sirolimus|sirolimus|mesh-list
5975446|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975447|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5975448|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975449|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5975450|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975451|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
5975452|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975453|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
5975454|NCT05233709|Fesoterodine|fesoterodine|mesh-list
5975455|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5975456|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5975457|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
5975458|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975459|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975460|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975461|NCT05233709|Urological Agents|urological agents|mesh-ancestor
5975472|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
5975473|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5975474|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5975475|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975476|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5975477|NCT05233605|Analgesics|analgesics|mesh-ancestor
5975478|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
5975479|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975480|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5975481|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5975482|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5975483|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
5975484|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975485|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975486|NCT05233579|Sulforaphane|sulforaphane|mesh-list
5975487|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5975488|NCT05233579|Protective Agents|protective agents|mesh-ancestor
5975489|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975490|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975491|NCT05233566|Ketamine|ketamine|mesh-list
5975492|NCT05233566|Analgesics|analgesics|mesh-ancestor
5975493|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
5975494|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975495|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975496|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5975497|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5975498|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
5975499|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
5975500|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5975501|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5975502|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5975503|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975504|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975505|NCT05233514|Metformin|metformin|mesh-list
5975506|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5975507|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245375|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6245376|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245377|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245378|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
5975508|NCT05233462|Bupivacaine|bupivacaine|mesh-list
5975509|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
5975510|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
5975511|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5975512|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975513|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
5975514|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975515|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
5975516|NCT05233358|Nivolumab|nivolumab|mesh-list
5975517|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
5975518|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975519|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975520|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975521|NCT05233332|Vemurafenib|vemurafenib|mesh-list
5975522|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975523|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5975524|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975525|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975526|NCT05233228|Nicotine|nicotine|mesh-list
5975527|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5975528|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
5975529|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975530|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975531|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5975532|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5975533|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
5975534|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975535|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975536|NCT05233202|Simendan|simendan|mesh-list
5975537|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5975538|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
5975539|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5975540|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5975541|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975542|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975543|NCT05233202|Protective Agents|protective agents|mesh-ancestor
5975544|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975545|NCT05233163|Empagliflozin|empagliflozin|mesh-list
5975546|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5975547|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975548|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5975549|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975550|NCT05233124|Aspirin|aspirin|mesh-list
5975551|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
5975552|NCT05233124|Clopidogrel|clopidogrel|mesh-list
5975553|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5975554|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5975555|NCT05233124|Analgesics|analgesics|mesh-ancestor
5975556|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
5975557|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975558|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975559|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5975560|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975561|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5975562|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5975563|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975564|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5975565|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5975566|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975567|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
5975568|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5975569|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5975570|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5975571|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
5975572|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975573|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5975574|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
5975575|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5975576|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
5975577|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
5975578|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
5975579|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5975580|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975581|NCT05232994|Metformin|metformin|mesh-list
5975582|NCT05232994|Esomeprazole|esomeprazole|mesh-list
5975583|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5975584|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975585|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5975586|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5975587|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5975588|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975589|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975590|NCT05232929|Risdiplam|risdiplam|mesh-list
5975591|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5975592|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975593|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975594|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
5975595|NCT05232851|Vaccines|vaccines|mesh-list
5975596|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
5975597|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975598|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975599|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975600|NCT05232734|Caffeine|caffeine|mesh-list
5975601|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
5975602|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975603|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5975604|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975605|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5975606|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975607|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5975608|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5975609|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
5975610|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975611|NCT05232630|Fenfluramine|fenfluramine|mesh-list
5975612|NCT05232630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5975613|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5975614|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5975615|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975616|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975617|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
5975618|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975619|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
5975620|NCT05232461|Celecoxib|celecoxib|mesh-list
5975621|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5975622|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5975623|NCT05232461|Analgesics|analgesics|mesh-ancestor
5975624|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
5975625|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975626|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975627|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5975628|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975629|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5975630|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5975631|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975632|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975633|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5975634|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975635|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5975636|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5975637|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975638|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5975639|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5975640|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
5975641|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975642|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975643|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5975644|NCT05232396|Antibodies|antibodies|mesh-list
5975645|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
5975646|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5975647|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
5975648|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975649|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975650|NCT05232370|Losartan|losartan|mesh-list
5975651|NCT05232370|Enalapril|enalapril|mesh-list
5975652|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5975653|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5975654|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5975655|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5975656|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5975657|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5975658|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975659|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
5975673|NCT05232344|Estradiol|estradiol|mesh-list
5975674|NCT05232344|Progesterone|progesterone|mesh-list
5975675|NCT05232344|Estrogens|estrogens|mesh-ancestor
5975676|NCT05232344|Hormones|hormones|mesh-ancestor
5975677|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975678|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975679|NCT05232344|Progestins|progestins|mesh-ancestor
5975680|NCT05232227|Primaquine|primaquine|mesh-list
5975681|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
5975682|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5975683|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5975684|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975685|NCT05232123|Cannabidiol|cannabidiol|mesh-list
5975686|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
6245379|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245380|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245381|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6245382|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245383|NCT02718326|Aflibercept|aflibercept|mesh-list
6245384|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6245385|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6245386|NCT02718326|Growth Substances|growth substances|mesh-ancestor
6245387|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245388|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
5975687|NCT05232084|Fentanyl|fentanyl|mesh-list
5975688|NCT05232084|Bupivacaine|bupivacaine|mesh-list
5975689|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
5975690|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
5975691|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5975692|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975693|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
5975694|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975695|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5975696|NCT05232084|Narcotics|narcotics|mesh-ancestor
5975697|NCT05232084|Analgesics|analgesics|mesh-ancestor
5975698|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5975699|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5975700|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
5975701|NCT05232071|Empagliflozin|empagliflozin|mesh-list
5975702|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5975703|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975704|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5975705|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975706|NCT05232032|Nociceptin|nociceptin|mesh-list
5975707|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
5975708|NCT05232006|Niraparib|niraparib|mesh-list
5975709|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5975710|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975711|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975712|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975739|NCT05231460|Narcotics|narcotics|mesh-list
5975740|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5975741|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975742|NCT05231460|Analgesics|analgesics|mesh-ancestor
5975743|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
5975744|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975745|NCT05231330|Fluorides|fluorides|mesh-list
5975746|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
5975747|NCT05231330|Protective Agents|protective agents|mesh-ancestor
5975748|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975749|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5975750|NCT05231148|Calcium|calcium|mesh-list
5975751|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5975752|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975753|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975754|NCT05231122|Bevacizumab|bevacizumab|mesh-list
5975755|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5975756|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
5975757|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
5975758|NCT05231122|Antibodies|antibodies|mesh-list
5975759|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
5975760|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5975761|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
5975762|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975763|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5975764|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5975765|NCT05231122|Growth Substances|growth substances|mesh-ancestor
5975766|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975767|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
5975768|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
5975769|NCT05230901|Dihydralazine|dihydralazine|mesh-list
5975770|NCT05230901|Spironolactone|spironolactone|mesh-list
5975771|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5975772|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
5975773|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975774|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975775|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5975776|NCT05230901|Diuretics|diuretics|mesh-ancestor
5975777|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
5975778|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5975779|NCT05230797|Zinc|zinc|mesh-list
5975780|NCT05230797|Propolis|propolis|mesh-list
5975781|NCT05230797|Eugenol|eugenol|mesh-list
5975782|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
5975783|NCT05230797|Trace Elements|trace elements|mesh-ancestor
5975784|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
5975785|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975786|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975787|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
5975788|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
5975789|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5975790|NCT05230797|Protective Agents|protective agents|mesh-ancestor
5975791|NCT05230758|Metformin|metformin|mesh-list
5975792|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5975793|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975794|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
5975795|NCT05230654|Aprepitant|aprepitant|mesh-list
5975796|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
5975797|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
5975798|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975799|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975800|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5975801|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
5975802|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975803|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245389|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245390|NCT02718417|Paclitaxel|paclitaxel|mesh-list
6245391|NCT02718417|Carboplatin|carboplatin|mesh-list
6245392|NCT02718417|Avelumab|avelumab|mesh-list
6245393|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6245394|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6245395|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245396|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
6245397|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
6245398|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
5975804|NCT05230472|Simvastatin|simvastatin|mesh-list
5975805|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5975806|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5975807|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
5975808|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975809|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5975810|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5975811|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975812|NCT05229003|Irinotecan|irinotecan|mesh-list
5975813|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5975814|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5975815|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975816|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975817|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975818|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
5975819|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975820|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
5975821|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
5975822|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
5975823|NCT05218499|Doxorubicin|doxorubicin|mesh-list
5975824|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5975825|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975826|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5975827|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5975828|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975829|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975830|NCT05217758|Mifepristone|mifepristone|mesh-list
5975831|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
5975832|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
5975833|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5975834|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975835|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5975836|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5975837|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5975838|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
5975839|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5975840|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5975841|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
5975842|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975843|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
5975844|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5975845|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
5975846|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
5975847|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975848|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975849|NCT05211895|Durvalumab|durvalumab|mesh-list
5975850|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975851|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975852|NCT05211570|Azacitidine|azacitidine|mesh-list
5975853|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5975854|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
5975855|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975856|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975857|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975858|NCT05211154|Diclofenac|diclofenac|mesh-list
5975859|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5975860|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5975861|NCT05211154|Analgesics|analgesics|mesh-ancestor
5975862|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
5975863|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975864|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975865|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5975866|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975867|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5975868|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975869|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975870|NCT05209555|Pilocarpine|pilocarpine|mesh-list
5975871|NCT05209555|Miotics|miotics|mesh-ancestor
5975872|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
5975873|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975874|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975875|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
5975876|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5975877|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
5975878|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975879|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975880|NCT05209490|Iodine|iodine|mesh-list
5975881|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5975882|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975883|NCT05209490|Trace Elements|trace elements|mesh-ancestor
5975884|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
5975885|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975886|NCT05209074|Ivosidenib|ivosidenib|mesh-list
5975887|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975888|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975889|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975890|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
5975891|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
5975892|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975893|NCT05208034|Methotrexate|methotrexate|mesh-list
5975894|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5975895|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
5975896|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5975897|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975898|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5975899|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
5975900|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975901|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975902|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
5975903|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975904|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5975905|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975906|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
5975907|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975908|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5975909|NCT05207137|Vaccines|vaccines|mesh-list
5975910|NCT05207137|Immunologic Factors|immunologic factors|mesh-ancestor
5975911|NCT05207137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975912|NCT05205473|Lidocaine|lidocaine|mesh-list
5975913|NCT05205473|Anesthetics|anesthetics|mesh-list
5975914|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
5975915|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5975916|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975917|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
5975918|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5975919|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5975920|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5975921|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5975922|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5975923|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975924|NCT05203276|Endostar protein|endostar protein|mesh-list
5975925|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5975926|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5975927|NCT05203276|Growth Substances|growth substances|mesh-ancestor
5975928|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975929|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
5975930|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975931|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
5975932|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975933|NCT05202158|Gentamicins|gentamicins|mesh-list
5975934|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5975935|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975936|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5975937|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975938|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975939|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
5975940|NCT05199493|Giapreza|giapreza|mesh-list
5975941|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
5975942|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5975943|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5975944|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
5975945|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975946|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975947|NCT05188170|Niclosamide|niclosamide|mesh-list
5975948|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
5975949|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5975950|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
5975951|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5975952|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5975953|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
5975954|NCT05184777|Estradiol|estradiol|mesh-list
5975955|NCT05184777|Progesterone|progesterone|mesh-list
5975956|NCT05184777|Estrogens|estrogens|mesh-ancestor
5975957|NCT05184777|Hormones|hormones|mesh-ancestor
5975958|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5975959|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245399|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245400|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245401|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
6245402|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245403|NCT02718898|Ixekizumab|ixekizumab|mesh-list
6245404|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
6245405|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
6245406|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6245407|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245408|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5975960|NCT05184777|Progestins|progestins|mesh-ancestor
5975961|NCT05183178|Ticagrelor|ticagrelor|mesh-list
5975962|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5975963|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5975964|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5975965|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5975966|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5975967|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
5975968|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5975969|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975970|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245409|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6245410|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245411|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245412|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245413|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6245414|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6245415|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6245416|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
6245417|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245418|NCT02720081|Albuterol|albuterol|mesh-list
6245419|NCT02720081|Montelukast|montelukast|mesh-list
6245420|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6245421|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
6245422|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6245423|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
6245424|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6245425|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245426|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6245427|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6245428|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245429|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6245430|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
6245431|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245432|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
6245433|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6245434|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6245435|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6245436|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6245437|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
6245438|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245439|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6245440|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6245441|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245442|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6245443|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
6245444|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975971|NCT05180357|Benralizumab|benralizumab|mesh-list
5975972|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5975973|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
5975974|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
5975975|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
5975976|NCT05176470|Fludarabine|fludarabine|mesh-list
5975977|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5975978|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
5975979|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5975980|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5975981|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5975982|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
5975983|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975984|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975985|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5975986|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975987|NCT05174455|Niraparib|niraparib|mesh-list
5975988|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5975989|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5975990|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5975991|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975992|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
5975993|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975994|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975995|NCT05170685|Nivolumab|nivolumab|mesh-list
5975996|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5975997|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5975998|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5975999|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976000|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
5976001|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976002|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976003|NCT05162014|Empagliflozin|empagliflozin|mesh-list
5976004|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
5976005|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5976006|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976007|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976008|NCT05159427|Glipizide|glipizide|mesh-list
5976009|NCT05159427|Rifaximin|rifaximin|mesh-list
5976010|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5976011|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976012|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5976013|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5976014|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976015|NCT05153174|Sulforaphane|sulforaphane|mesh-list
5976016|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5976017|NCT05153174|Protective Agents|protective agents|mesh-ancestor
5976018|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976019|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976020|NCT05152628|Tacrolimus|tacrolimus|mesh-list
5976021|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5976022|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
5976023|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976024|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5976025|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976026|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245445|NCT02720198|Milnacipran|milnacipran|mesh-list
5976027|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5976028|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5976029|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6245446|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5976030|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976031|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976032|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5976033|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5976034|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976035|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
5976036|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976037|NCT05151640|Nintedanib|nintedanib|mesh-list
5976038|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976039|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976040|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976041|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976042|NCT05151471|Edaravone|edaravone|mesh-list
5976043|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5976044|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
5976045|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976046|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5976047|NCT05151471|Protective Agents|protective agents|mesh-ancestor
5976048|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976049|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5976050|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
5976051|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976052|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
5976053|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5976054|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976055|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5976056|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976057|NCT05135650|Myeloma Proteins|myeloma proteins|mesh-list
5976058|NCT05135650|Paraproteins|paraproteins|mesh-list
5976059|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
5976060|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976066|NCT05124171|Vaccines|vaccines|mesh-list
5976067|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
5976068|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976069|NCT05120895|Pravastatin|pravastatin|mesh-list
6245447|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
5976070|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5976071|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5976072|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
5976073|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976074|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5976075|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5976076|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976077|NCT05116202|Nivolumab|nivolumab|mesh-list
5976078|NCT05116202|Ipilimumab|ipilimumab|mesh-list
5976079|NCT05116202|Atezolizumab|atezolizumab|mesh-list
5976080|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976081|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976082|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5976083|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976084|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
5976085|NCT05114590|Lixisenatide|lixisenatide|mesh-list
5976086|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5976087|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976088|NCT05111002|Doxycycline|doxycycline|mesh-list
5976089|NCT05111002|Lefamulin|lefamulin|mesh-list
5976090|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5976091|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976092|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
5976093|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5976094|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5976095|NCT05109728|Temozolomide|temozolomide|mesh-list
5976096|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
5976097|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5976098|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5976099|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
5976100|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976101|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976102|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
5976103|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
5976104|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5976105|NCT05107193|Afatinib|afatinib|mesh-list
5976106|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976107|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976108|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976109|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976110|NCT05105061|Ketamine|ketamine|mesh-list
5976111|NCT05105061|Analgesics|analgesics|mesh-ancestor
5976112|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
5976113|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976114|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976115|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5976116|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5976117|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
5976118|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
5976119|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976120|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5976121|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5976122|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976123|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245448|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
6245449|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5976124|NCT05098470|Metformin|metformin|mesh-list
5976125|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
5976126|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5976127|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976128|NCT05098041|Rifampin|rifampin|mesh-list
5976129|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5976130|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
5976131|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5976132|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976133|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
5976134|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5976135|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976136|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976137|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5976138|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5976139|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
5976140|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
5976141|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
5976142|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5976143|NCT05093296|Naltrexone|naltrexone|mesh-list
5976144|NCT05093296|Oxytocin|oxytocin|mesh-list
5976145|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
5976146|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5976147|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976148|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5976149|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5976150|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
5976151|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976152|NCT05091905|Ropivacaine|ropivacaine|mesh-list
5976153|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
5976154|NCT05091905|Anesthetics|anesthetics|mesh-list
5976155|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976156|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976157|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
5976158|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976159|NCT05087992|Bevacizumab|bevacizumab|mesh-list
5976160|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976161|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976162|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5976163|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5976164|NCT05087992|Growth Substances|growth substances|mesh-ancestor
5976165|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976166|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
5976167|NCT05076149|Ivacaftor|ivacaftor|mesh-list
5976168|NCT05076149|Elexacaftor|elexacaftor|mesh-list
5976169|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
5976170|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5976171|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976172|NCT05075876|Granisetron|granisetron|mesh-list
5976173|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
5976174|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
5976175|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976176|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976177|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5976178|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5976179|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
5976180|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976181|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976182|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
5976183|NCT05073237|Estrogens|estrogens|mesh-list
5976184|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
5976185|NCT05073237|Hormones|hormones|mesh-ancestor
6245450|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5976186|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5976187|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976188|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5976189|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5976190|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
5976191|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5976194|NCT05056883|Ivermectin|ivermectin|mesh-list
5976195|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5976196|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976197|NCT05055128|Lansoprazole|lansoprazole|mesh-list
5976198|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
5976199|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5976200|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5976201|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5976202|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976203|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976204|NCT05046314|Vincristine|vincristine|mesh-list
5976205|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5976206|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976207|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
5976208|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
5976209|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
5976210|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976211|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
5976212|NCT05045170|Propofol|propofol|mesh-list
5976213|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
5976214|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976215|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976216|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5976217|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5976218|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
5976219|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5976220|NCT05045170|Analgesics|analgesics|mesh-ancestor
5976221|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
5976222|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976223|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5976224|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5976225|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5976226|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
5976227|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976228|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976229|NCT05042934|Irinotecan|irinotecan|mesh-list
5976230|NCT05042934|Camptothecin|camptothecin|mesh-list
5976231|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5976232|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5976233|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245451|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5976234|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976235|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976236|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5976237|NCT05034627|Asparaginase|asparaginase|mesh-list
5976238|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976239|NCT05027204|Docetaxel|docetaxel|mesh-list
5976240|NCT05027204|Nivolumab|nivolumab|mesh-list
5976241|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976242|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
5976243|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
5976244|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
5976245|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976246|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976247|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5976248|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
5976249|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5976250|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976251|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976252|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5976253|NCT05025605|Analgesics|analgesics|mesh-ancestor
5976254|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
5976255|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976256|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5976257|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5976258|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5976259|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
5976260|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976261|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976262|NCT05023070|Cannabidiol|cannabidiol|mesh-list
5976263|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
5976264|NCT05022784|Nintedanib|nintedanib|mesh-list
5976265|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976266|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976267|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976268|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976269|NCT05018273|Atezolizumab|atezolizumab|mesh-list
5976270|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976271|NCT05014282|Nicotine|nicotine|mesh-list
5976272|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5976273|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
5976274|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976275|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976276|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5976277|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5976278|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
5976279|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976280|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976281|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
5976282|NCT05014230|Narcotics|narcotics|mesh-ancestor
5976283|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976284|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976285|NCT05014230|Analgesics|analgesics|mesh-ancestor
5976286|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
5976287|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976288|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5976289|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5976290|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5976291|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976292|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976293|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5976294|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5976295|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976296|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
5976297|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976298|NCT05006573|Benralizumab|benralizumab|mesh-list
5976299|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5976300|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
5976301|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
5976302|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5976303|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976304|NCT05005507|Tenofovir|tenofovir|mesh-list
5976305|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5976306|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
5976307|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976308|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5976309|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5976310|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976311|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976312|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5976313|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5976314|NCT05004987|Dexetimide|dexetimide|mesh-list
5976315|NCT05004987|Citalopram|citalopram|mesh-list
5976316|NCT05004987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5976317|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5976318|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5976319|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976320|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976321|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
5976322|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976323|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5976324|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
5976325|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5976326|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5976327|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5976328|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
5976329|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
5976330|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976331|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5976332|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5976333|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
5976334|NCT05004805|Methylene Blue|methylene blue|mesh-list
5976335|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976336|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976337|NCT05004259|Daratumumab|daratumumab|mesh-list
5976338|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976339|NCT05002127|Paclitaxel|paclitaxel|mesh-list
5976340|NCT05002127|Trastuzumab|trastuzumab|mesh-list
5976341|NCT05002127|Ramucirumab|ramucirumab|mesh-list
5976342|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5976343|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976344|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
5976345|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
5976346|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
5976347|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976348|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976349|NCT04999644|Nicotine|nicotine|mesh-list
5976350|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5976351|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
5976352|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976353|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976354|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5976355|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5976356|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
5976357|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976358|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976359|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
5976360|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
5976361|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976362|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
5976363|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
5976364|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976365|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976366|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6245452|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245453|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245454|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6245455|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6245456|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245457|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976367|NCT04979780|Heparin|heparin|mesh-list
5976368|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5976369|NCT04979780|Tinzaparin|tinzaparin|mesh-list
5976370|NCT04979780|Dalteparin|dalteparin|mesh-list
5976371|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
5976372|NCT04979780|Anticoagulants|anticoagulants|mesh-list
5976373|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5976374|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5976375|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976376|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5976377|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
5976378|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5976379|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
5976380|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976381|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5976382|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
5976383|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976384|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5976385|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
5976386|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976387|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976388|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5976389|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5976390|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5976391|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
5976392|NCT04965220|Trametinib|trametinib|mesh-list
5976393|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976394|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976395|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976396|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976397|NCT04965090|Lazertinib|lazertinib|mesh-list
5976398|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976399|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976400|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976401|NCT04958226|Midazolam|midazolam|mesh-list
5976402|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5976403|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5976404|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976405|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976406|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5976407|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5976408|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5976409|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5976410|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
5976411|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
5976412|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
5976413|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
5976414|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976415|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976416|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
5976417|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5976418|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976419|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5976420|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976421|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
5976422|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5976423|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976424|NCT04945655|Vaccines|vaccines|mesh-list
5976425|NCT04945655|Immunologic Factors|immunologic factors|mesh-ancestor
5976426|NCT04945655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976427|NCT04943900|Nivolumab|nivolumab|mesh-list
5976428|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976429|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976430|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5976431|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976432|NCT04937166|Azacitidine|azacitidine|mesh-list
5976433|NCT04937166|Venetoclax|venetoclax|mesh-list
5976434|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5976435|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
5976436|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976437|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976438|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976439|NCT04928950|Charcoal|charcoal|mesh-list
5976440|NCT04928950|Antidotes|antidotes|mesh-ancestor
5976441|NCT04928950|Protective Agents|protective agents|mesh-ancestor
5976442|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976443|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
5976444|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5976445|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5976446|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5976447|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
5976448|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976449|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976450|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976451|NCT04920539|Dronabinol|dronabinol|mesh-list
5976452|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
5976453|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976454|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5976455|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5976456|NCT04920539|Analgesics|analgesics|mesh-ancestor
5976457|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
5976458|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976459|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5976460|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5976461|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976462|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976463|NCT04920539|Hormones|hormones|mesh-ancestor
5976464|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5976465|NCT04919382|Temozolomide|temozolomide|mesh-list
5976466|NCT04919382|Atezolizumab|atezolizumab|mesh-list
5976467|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5976468|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5976469|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
5976470|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976471|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976472|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
5976473|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976474|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
5976475|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5976476|NCT04910269|Antibodies|antibodies|mesh-list
5976477|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
5976478|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976479|NCT04908202|BMS-986165|bms-986165|mesh-list
5976480|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
5976481|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976482|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976483|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976484|NCT04905407|Azacitidine|azacitidine|mesh-list
5976485|NCT04905407|Venetoclax|venetoclax|mesh-list
5976486|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5976487|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
5976488|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976489|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976490|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976491|NCT04901377|Dienogest|dienogest|mesh-list
5976492|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5976493|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5976494|NCT04901377|Estradiol|estradiol|mesh-list
5976495|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5976496|NCT04901377|Estrogens|estrogens|mesh-ancestor
5976497|NCT04901377|Hormones|hormones|mesh-ancestor
5976498|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5976499|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976500|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5976501|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
5976502|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5976503|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5976504|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5976505|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5976506|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5976507|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
5976508|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5976509|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976510|NCT04878432|Azacitidine|azacitidine|mesh-list
5976511|NCT04878432|Decitabine|decitabine|mesh-list
5976512|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5976513|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
5976514|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976515|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976516|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976517|NCT04876248|Lenalidomide|lenalidomide|mesh-list
5976518|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
5976519|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976520|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5976521|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5976522|NCT04876248|Growth Substances|growth substances|mesh-ancestor
5976523|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
5976524|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976525|NCT04864743|Factor VIII|factor viii|mesh-list
5976526|NCT04864743|Coagulants|coagulants|mesh-ancestor
5976527|NCT04862143|Fulvestrant|fulvestrant|mesh-list
5976528|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5976529|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976530|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5976531|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5976532|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
5976533|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5976534|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976535|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
5976536|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
5976537|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
5976538|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976539|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976540|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
5976541|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976542|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
5976543|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
5976544|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976545|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976546|NCT04857034|BMS-986165|bms-986165|mesh-list
5976547|NCT04857034|Dermatologic Agents|dermatologic agents|mesh-ancestor
5976548|NCT04857034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976549|NCT04857034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976550|NCT04857034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976551|NCT04852003|Morphine|morphine|mesh-list
5976552|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5976553|NCT04852003|Narcotics|narcotics|mesh-ancestor
5976554|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976555|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976556|NCT04852003|Analgesics|analgesics|mesh-ancestor
5976557|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
5976558|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976559|NCT04849364|Capecitabine|capecitabine|mesh-list
5976560|NCT04849364|Atezolizumab|atezolizumab|mesh-list
5976561|NCT04849364|Talazoparib|talazoparib|mesh-list
5976562|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5976563|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
5976564|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976565|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976566|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5976567|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976568|NCT04845035|Cytarabine|cytarabine|mesh-list
5976569|NCT04845035|Methotrexate|methotrexate|mesh-list
5976570|NCT04845035|Dasatinib|dasatinib|mesh-list
5976571|NCT04845035|Ponatinib|ponatinib|mesh-list
5976572|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5976573|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
5976574|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5976575|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976576|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5976577|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
5976578|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976579|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976580|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
5976581|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976582|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5976583|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5976584|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
5976585|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5976586|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5976587|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
5976588|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976589|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976590|NCT04844866|Gemcitabine|gemcitabine|mesh-list
5976591|NCT04844866|Rituximab|rituximab|mesh-list
5976592|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
5976593|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5976594|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5976595|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
5976596|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976597|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976598|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
5976599|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976600|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5976601|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5976602|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
5976603|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976604|NCT04844866|Antiviral Agents|antiviral agents|mesh-ancestor
5976605|NCT04844866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976606|NCT04844866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976607|NCT04844866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5976608|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5976609|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
6245458|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245459|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6245460|NCT02720198|Analgesics|analgesics|mesh-ancestor
6245461|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
6245462|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245463|NCT02720484|Nivolumab|nivolumab|mesh-list
6245464|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976610|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
5976611|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976612|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976613|NCT04810598|Venetoclax|venetoclax|mesh-list
5976614|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976615|NCT04800393|Propofol|propofol|mesh-list
5976616|NCT04800393|Sevoflurane|sevoflurane|mesh-list
5976617|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5976618|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976619|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976620|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5976621|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
5976622|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
5976623|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5976624|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5976625|NCT04796922|Rituximab|rituximab|mesh-list
5976626|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
5976627|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976628|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976629|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
5976630|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976631|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5976632|NCT04790903|Prednisone|prednisone|mesh-list
5976633|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
5976634|NCT04790903|Rituximab|rituximab|mesh-list
5976635|NCT04790903|Doxorubicin|doxorubicin|mesh-list
5976636|NCT04790903|Venetoclax|venetoclax|mesh-list
5976637|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5976638|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
5976639|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976640|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5976641|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5976642|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
5976643|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976644|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976645|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5976646|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976647|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5976648|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5976649|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5976650|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976651|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5976652|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
5976653|NCT04790903|Hormones|hormones|mesh-ancestor
5976654|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5976655|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5976656|NCT04790513|Evolocumab|evolocumab|mesh-list
5976657|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5976658|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5976659|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
5976660|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976661|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5976662|NCT04790370|Heparin|heparin|mesh-list
5976663|NCT04790370|Calcium heparin|calcium heparin|mesh-list
5976664|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
5976665|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5976666|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5976667|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976668|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
5976669|NCT04789408|Fludarabine|fludarabine|mesh-list
5976670|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5976671|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
5976672|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976673|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5976674|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5976675|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
5976676|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976677|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976678|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5976679|NCT04786210|Triamcinolone|triamcinolone|mesh-list
5976680|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5976681|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5976682|NCT04786210|Fluorouracil|fluorouracil|mesh-list
5976683|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5976684|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
5976685|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976686|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5976687|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976688|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5976689|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
5976690|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976691|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5976692|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
5976693|NCT04786210|Hormones|hormones|mesh-ancestor
5976694|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5976695|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976696|NCT04782778|Bupivacaine|bupivacaine|mesh-list
5976697|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
5976698|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
5976699|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976700|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976701|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
5976702|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976703|NCT04779320|Vedolizumab|vedolizumab|mesh-list
5976704|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5976705|NCT04763512|Caseins|caseins|mesh-list
5976706|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
5976707|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
5976708|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976709|NCT04761861|Vildagliptin|vildagliptin|mesh-list
5976710|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5976711|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976712|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5976713|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
5976714|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976715|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976716|NCT04761094|Insulin|insulin|mesh-list
5976717|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5976718|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976719|NCT04756271|Antibodies|antibodies|mesh-list
5976720|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
5976721|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
5976722|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976730|NCT04739813|Prednisone|prednisone|mesh-list
5976731|NCT04739813|Lenalidomide|lenalidomide|mesh-list
5976732|NCT04739813|Venetoclax|venetoclax|mesh-list
5976733|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
5976734|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5976735|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
5976736|NCT04739813|Hormones|hormones|mesh-ancestor
5976737|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5976738|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976739|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5976740|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976741|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
5976742|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5976743|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5976744|NCT04739813|Growth Substances|growth substances|mesh-ancestor
5976745|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
5976746|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976750|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
5976751|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976752|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976753|NCT04739150|Nintedanib|nintedanib|mesh-list
5976754|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976755|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976756|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976757|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976758|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5976759|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5976760|NCT04729023|Temazepam|temazepam|mesh-list
5976761|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5976762|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976763|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976764|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5976765|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5976766|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5976767|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
5976768|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
5976769|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976770|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976771|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
5976772|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5976773|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976774|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5976775|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976776|NCT04722575|Atezolizumab|atezolizumab|mesh-list
5976777|NCT04722575|Vemurafenib|vemurafenib|mesh-list
5976778|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976779|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976780|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976781|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976782|NCT04718350|Simendan|simendan|mesh-list
5976783|NCT04718350|Milrinone|milrinone|mesh-list
5976784|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5976785|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
5976786|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5976787|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5976788|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976789|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976790|NCT04718350|Protective Agents|protective agents|mesh-ancestor
5976791|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976792|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5976793|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
5976794|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5976795|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
5976796|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5976797|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976798|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5976799|NCT04714710|Diuretics|diuretics|mesh-ancestor
5976800|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
5976801|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
5976802|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
5976803|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976804|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5976805|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5976806|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
5976807|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976808|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976809|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5976810|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
5976811|NCT04700072|Lenvatinib|lenvatinib|mesh-list
5976812|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976813|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976814|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5976815|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976816|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976817|NCT04698434|Esketamine|esketamine|mesh-list
5976818|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
5976819|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5976820|NCT04696575|Lamivudine|lamivudine|mesh-list
5976821|NCT04696575|Carboplatin|carboplatin|mesh-list
5976822|NCT04696575|Etoposide|etoposide|mesh-list
5976823|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
5976824|NCT04696575|Atezolizumab|atezolizumab|mesh-list
5976825|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
5976826|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5976827|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976828|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5976829|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5976830|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5976831|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976832|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976833|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5976834|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5976835|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
5976836|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976837|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5976838|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5976839|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
5976840|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976841|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
5976842|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
5976843|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
5976844|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
5976845|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
5976846|NCT04681430|Gabexate|gabexate|mesh-list
5976847|NCT04681430|Camostat|camostat|mesh-list
5976848|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
5976849|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976850|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976851|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5976852|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5976853|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
6245465|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245466|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5976854|NCT04677816|Vitamin D|vitamin d|mesh-list
5976855|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
5976856|NCT04677816|Vitamins|vitamins|mesh-ancestor
5976857|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
5976858|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976859|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5976860|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5976861|NCT04675931|Artesunate|artesunate|mesh-list
5976862|NCT04675931|Lumefantrine|lumefantrine|mesh-list
5976863|NCT04675931|Artemether|artemether|mesh-list
5976864|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5976865|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
5976866|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5976867|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5976868|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976869|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976870|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
5976871|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
5976872|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5976873|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
5976874|NCT04674774|Lansoprazole|lansoprazole|mesh-list
5976875|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
5976876|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5976877|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5976878|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
5976879|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976880|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976881|NCT04672512|Prednisone|prednisone|mesh-list
5976882|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5976883|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
5976884|NCT04672512|Hormones|hormones|mesh-ancestor
5976885|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5976886|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976887|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5976888|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976889|NCT04666038|Rituximab|rituximab|mesh-list
5976890|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5976891|NCT04666038|Idelalisib|idelalisib|mesh-list
5976892|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976893|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976894|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
5976895|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976896|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5976897|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5976898|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
5976899|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976900|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976901|NCT04665570|Metformin|metformin|mesh-list
5976902|NCT04665570|Acarbose|acarbose|mesh-list
5976903|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5976904|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976905|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5976906|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976907|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976908|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
5976909|NCT04660539|Azathioprine|azathioprine|mesh-list
5976910|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5976911|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976912|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5976913|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
5976914|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5976915|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976916|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976917|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976918|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
5976919|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5976920|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5976921|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
5976922|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976923|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5976924|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
5976925|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5976926|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976927|NCT04651439|Lenograstim|lenograstim|mesh-list
5976928|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5976929|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
5976930|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976931|NCT04650217|Levodopa|levodopa|mesh-list
5976932|NCT04650217|Carbidopa|carbidopa|mesh-list
5976933|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5976934|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5976935|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5976936|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
5976937|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976938|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976939|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976940|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5976941|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5976942|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5976943|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
5976944|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
5976945|NCT04650074|Lidocaine|lidocaine|mesh-list
5976946|NCT04650074|Ketamine|ketamine|mesh-list
5976947|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
5976948|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
5976949|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5976950|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976951|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
5976952|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976953|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5976954|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5976955|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5976956|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5976957|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976958|NCT04650074|Analgesics|analgesics|mesh-ancestor
5976959|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5976960|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5976961|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
5976962|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5976963|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5976964|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5976965|NCT04641195|Vitamin D|vitamin d|mesh-list
5976966|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
5976967|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
5976968|NCT04641195|Vitamins|vitamins|mesh-list
5976969|NCT04641195|Zinc|zinc|mesh-list
5976970|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
5976971|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976972|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5976973|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5976974|NCT04641195|Trace Elements|trace elements|mesh-ancestor
5976975|NCT04640168|Remdesivir|remdesivir|mesh-list
5976976|NCT04640168|Dexamethasone|dexamethasone|mesh-list
5976977|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5976978|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
5976979|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
5976980|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5976981|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5976982|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5976983|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
5976984|NCT04640168|Hormones|hormones|mesh-ancestor
5976985|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5976986|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5976987|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5976988|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
5976989|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976990|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
5976991|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5976992|NCT04634799|Plasminogen|plasminogen|mesh-list
5976993|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
5976994|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
5976995|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5976996|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5976997|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5976998|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5976999|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
5977000|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977001|NCT04634539|Gemcitabine|gemcitabine|mesh-list
5977002|NCT04634539|Paclitaxel|paclitaxel|mesh-list
5977003|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5977004|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977005|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
5977006|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
5977007|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
5977008|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977009|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977010|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
5977011|NCT04634539|Antiviral Agents|antiviral agents|mesh-ancestor
5977012|NCT04634539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977013|NCT04634539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977014|NCT04634539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977015|NCT04634539|Immunologic Factors|immunologic factors|mesh-ancestor
5977016|NCT04634539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977017|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
5977018|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
5977019|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5977020|NCT04629248|Acetaminophen|acetaminophen|mesh-list
5977021|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
5977022|NCT04629248|Promethazine|promethazine|mesh-list
5977023|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
5977024|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
5977025|NCT04629248|Tacrolimus|tacrolimus|mesh-list
5977026|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977027|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
5977028|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977029|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5977030|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977031|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977032|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5977033|NCT04629248|Analgesics|analgesics|mesh-ancestor
5977034|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
5977035|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977036|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
5977037|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5977038|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
5977039|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
5977040|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5977041|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
5977042|NCT04629248|Hormones|hormones|mesh-ancestor
5977043|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977044|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5977045|NCT04629248|Protective Agents|protective agents|mesh-ancestor
5977046|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977047|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977048|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5977049|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5977050|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5977051|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
5977052|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
5977053|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5977054|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
5977055|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
5977056|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5977057|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5977058|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
5977059|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
5977060|NCT04618523|Artesunate|artesunate|mesh-list
5977061|NCT04618523|Lumefantrine|lumefantrine|mesh-list
5977062|NCT04618523|Artemether|artemether|mesh-list
5977063|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5977064|NCT04618523|Amodiaquine|amodiaquine|mesh-list
5977065|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
5977066|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5977067|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5977068|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977069|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977070|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
5977071|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
5977072|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
5977073|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
5977074|NCT04613518|BMS-986165|bms-986165|mesh-list
5977075|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
5977076|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977077|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977078|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977079|NCT04608266|Camostat|camostat|mesh-list
5977080|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
5977081|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977082|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977083|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5977084|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5977085|NCT04607460|Coal Tar|coal tar|mesh-list
5977086|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
5977087|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
5977088|NCT04607421|Leucovorin|leucovorin|mesh-list
5977089|NCT04607421|Bevacizumab|bevacizumab|mesh-list
5977090|NCT04607421|Cetuximab|cetuximab|mesh-list
5977091|NCT04607421|Fluorouracil|fluorouracil|mesh-list
5977092|NCT04607421|Capecitabine|capecitabine|mesh-list
5977093|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
5977094|NCT04607421|Irinotecan|irinotecan|mesh-list
5977095|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977096|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977097|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5977098|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5977099|NCT04607421|Growth Substances|growth substances|mesh-ancestor
5977100|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977101|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
5977102|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
5977103|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977104|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977105|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977106|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
5977107|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5977108|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5977109|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977110|NCT04607421|Antidotes|antidotes|mesh-ancestor
5977111|NCT04607421|Protective Agents|protective agents|mesh-ancestor
5977112|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
5977113|NCT04607421|Vitamins|vitamins|mesh-ancestor
5977114|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
5977115|NCT04603807|Crizotinib|crizotinib|mesh-list
5977116|NCT04603807|Entrectinib|entrectinib|mesh-list
5977117|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977118|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977119|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977120|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977121|NCT04599816|Simendan|simendan|mesh-list
5977122|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5977123|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
5977124|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5977125|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5977126|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977127|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977128|NCT04599816|Protective Agents|protective agents|mesh-ancestor
5977129|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977130|NCT04599777|Sorafenib|sorafenib|mesh-list
5977131|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977132|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977133|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977134|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977135|NCT04589845|Trastuzumab|trastuzumab|mesh-list
5977136|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
5977137|NCT04589845|Atezolizumab|atezolizumab|mesh-list
5977138|NCT04589845|Maytansine|maytansine|mesh-list
5977139|NCT04589845|Pralsetinib|pralsetinib|mesh-list
5977140|NCT04589845|Entrectinib|entrectinib|mesh-list
5977141|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977142|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977143|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5977144|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
5977145|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
5977146|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
5977147|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977148|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977149|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977150|NCT04582669|Triamcinolone|triamcinolone|mesh-list
5977151|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5977152|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5977153|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5977154|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5977155|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
5977156|NCT04582669|Hormones|hormones|mesh-ancestor
5977157|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977158|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977159|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977160|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
5977161|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977162|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977163|NCT04576455|Fulvestrant|fulvestrant|mesh-list
5977164|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5977165|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5977166|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977167|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5977168|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5977169|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
5977170|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977171|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977172|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5977173|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977174|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977175|NCT04567407|Ropivacaine|ropivacaine|mesh-list
5977176|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
5977177|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
5977178|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5977179|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977180|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
5977181|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977187|NCT04562285|Antibodies|antibodies|mesh-list
5977188|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
5977189|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977190|NCT04562246|Antibodies|antibodies|mesh-list
5977191|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
5977192|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977193|NCT04559581|Nintedanib|nintedanib|mesh-list
5977194|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977195|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977196|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977197|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977198|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5977199|NCT04556773|Paclitaxel|paclitaxel|mesh-list
5977200|NCT04556773|Capecitabine|capecitabine|mesh-list
5977201|NCT04556773|Trastuzumab|trastuzumab|mesh-list
5977202|NCT04556773|Durvalumab|durvalumab|mesh-list
5977203|NCT04556773|Fulvestrant|fulvestrant|mesh-list
5977204|NCT04556773|Anastrozole|anastrozole|mesh-list
5977205|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5977206|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977207|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
5977208|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
5977209|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
5977210|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977211|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977212|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
5977213|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977214|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5977215|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5977216|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5977217|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
5977218|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977219|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977220|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5977221|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5977222|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977223|NCT04551495|Letrozole|letrozole|mesh-list
5977224|NCT04551495|Goserelin|goserelin|mesh-list
5977225|NCT04551495|Entrectinib|entrectinib|mesh-list
5977226|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977227|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5977228|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5977229|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977230|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977231|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5977232|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
5977233|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977234|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977235|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5977236|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977237|NCT04551300|Sevelamer|sevelamer|mesh-list
5977238|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
5977239|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
5977240|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245467|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245468|NCT02720523|Upadacitinib|upadacitinib|mesh-list
6245469|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6245470|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6245471|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245472|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245473|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6245474|NCT02720536|Deferasirox|deferasirox|mesh-list
6245475|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6245476|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
6245477|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
6245478|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245479|NCT02721017|Fentanyl|fentanyl|mesh-list
6245480|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6245481|NCT02721017|Narcotics|narcotics|mesh-ancestor
6245482|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245483|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245484|NCT02721017|Analgesics|analgesics|mesh-ancestor
6245485|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
6245486|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245487|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6245488|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6245489|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
6245490|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
6245491|NCT02721641|Trastuzumab|trastuzumab|mesh-list
6245492|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245493|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245494|NCT02721875|Azacitidine|azacitidine|mesh-list
6245495|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6245496|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
6245497|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245498|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245499|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245500|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6245501|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
6245502|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245503|NCT02722044|Adalimumab|adalimumab|mesh-list
6245504|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6245505|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6245506|NCT02722239|Metformin|metformin|mesh-list
6245507|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
6245508|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6245509|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245510|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6245511|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245512|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
6245513|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6245514|NCT02722278|Testosterone|testosterone|mesh-list
6245515|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
6245516|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
6245517|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6245518|NCT02722278|Androgens|androgens|mesh-ancestor
6245519|NCT02722278|Hormones|hormones|mesh-ancestor
6245520|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6245521|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977241|NCT04550260|Cisplatin|cisplatin|mesh-list
5977242|NCT04550260|Fluorouracil|fluorouracil|mesh-list
5977243|NCT04550260|Capecitabine|capecitabine|mesh-list
5977244|NCT04550260|Durvalumab|durvalumab|mesh-list
5977245|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977246|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
5977247|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977248|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977249|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977250|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
5977251|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977252|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977253|NCT04546581|Remdesivir|remdesivir|mesh-list
5977254|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
5977255|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5977256|NCT04546581|Antibodies|antibodies|mesh-list
5977257|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
5977258|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977259|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
5977260|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977261|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
5977262|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977263|NCT04546425|Vaccines|vaccines|mesh-list
5977264|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5977265|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
5977266|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977267|NCT04544293|Molgramostim|molgramostim|mesh-list
5977268|NCT04544293|Sargramostim|sargramostim|mesh-list
5977269|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
5977270|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977271|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977272|NCT04541290|Tacrolimus|tacrolimus|mesh-list
5977273|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977274|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
5977275|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977276|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5977277|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977278|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977279|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
5977280|NCT04539808|Leucovorin|leucovorin|mesh-list
5977281|NCT04539808|Folic Acid|folic acid|mesh-list
5977282|NCT04539808|Fluorouracil|fluorouracil|mesh-list
5977283|NCT04539808|Capecitabine|capecitabine|mesh-list
5977284|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
5977285|NCT04539808|Irinotecan|irinotecan|mesh-list
5977286|NCT04539808|Camptothecin|camptothecin|mesh-list
5977287|NCT04539808|Losartan|losartan|mesh-list
5977288|NCT04539808|Calcium|calcium|mesh-list
5977289|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
5977290|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5977291|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977292|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5977293|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
5977294|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977295|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977296|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977297|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977298|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
5977299|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5977300|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5977301|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977302|NCT04539808|Antidotes|antidotes|mesh-ancestor
5977303|NCT04539808|Protective Agents|protective agents|mesh-ancestor
5977304|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
5977305|NCT04539808|Vitamins|vitamins|mesh-ancestor
5977306|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
5977307|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5977308|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5977309|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5977310|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5977311|NCT04539808|Hematinics|hematinics|mesh-ancestor
5977312|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5977313|NCT04535505|Erythromycin|erythromycin|mesh-list
5977314|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
5977315|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
5977316|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
5977317|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5977318|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977319|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5977320|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5977321|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977322|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977323|NCT04532528|Dabigatran|dabigatran|mesh-list
5977324|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
5977325|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5977326|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
5977327|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977328|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977329|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
5977330|NCT04531462|Empagliflozin|empagliflozin|mesh-list
5977331|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5977332|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977333|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5977334|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977335|NCT04527393|Morphine|morphine|mesh-list
5977336|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5977337|NCT04527393|Narcotics|narcotics|mesh-ancestor
5977338|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5977339|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977340|NCT04527393|Analgesics|analgesics|mesh-ancestor
5977341|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
5977342|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977343|NCT04525547|Nintedanib|nintedanib|mesh-list
5977344|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977345|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977346|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977347|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977348|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
5977349|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977350|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
5977351|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977352|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
5977353|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977354|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977355|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5977356|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977357|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
5977358|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977359|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977360|NCT04512066|Risperidone|risperidone|mesh-list
5977361|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5977362|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
5977363|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5977364|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977365|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977366|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5977367|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5977368|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5977369|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5977370|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5977371|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
5977372|NCT04504864|Aspirin|aspirin|mesh-list
5977373|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5977374|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5977375|NCT04504864|Analgesics|analgesics|mesh-ancestor
5977376|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
5977377|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977378|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977379|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5977380|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977381|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5977382|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5977383|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977384|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5977385|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5977386|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977387|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
5977388|NCT04504734|Bucillamine|bucillamine|mesh-list
5977389|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5977390|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5977391|NCT04504734|Analgesics|analgesics|mesh-ancestor
5977392|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
5977393|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977394|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977395|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5977396|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977397|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
5977398|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977399|NCT04504734|Protective Agents|protective agents|mesh-ancestor
5977400|NCT04497155|Norepinephrine|norepinephrine|mesh-list
5977401|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5977402|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5977403|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
5977404|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5977405|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977406|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977407|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
5977408|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
5977409|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977410|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5977411|NCT04496999|Midostaurin|midostaurin|mesh-list
5977412|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977413|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977414|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977415|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977416|NCT04493320|Levodopa|levodopa|mesh-list
5977417|NCT04493320|Carbidopa|carbidopa|mesh-list
5977418|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5977419|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5977420|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5977421|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
5977422|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5977423|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977424|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245522|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5977425|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5977426|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977427|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5977428|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
5977429|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
5977430|NCT04491968|Methadone|methadone|mesh-list
5977431|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5977432|NCT04491968|Narcotics|narcotics|mesh-ancestor
5977433|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5977434|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977435|NCT04491968|Analgesics|analgesics|mesh-ancestor
5977436|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
5977437|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977438|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
5977439|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
5977440|NCT04483505|Fulvestrant|fulvestrant|mesh-list
5977441|NCT04483505|Palbociclib|palbociclib|mesh-list
5977442|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5977443|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977444|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5977445|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5977446|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
5977447|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977448|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977449|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977450|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977451|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977452|NCT04468984|Navitoclax|navitoclax|mesh-list
5977453|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977454|NCT04461639|Factor VIII|factor viii|mesh-list
5977455|NCT04461639|Coagulants|coagulants|mesh-ancestor
5977456|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
5977457|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
5977458|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5977459|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977460|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977461|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5977462|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
5977463|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977464|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977465|NCT04443348|Paclitaxel|paclitaxel|mesh-list
5977466|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
5977467|NCT04443348|Carboplatin|carboplatin|mesh-list
5977468|NCT04443348|Doxorubicin|doxorubicin|mesh-list
5977469|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
5977470|NCT04443348|Capecitabine|capecitabine|mesh-list
5977471|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5977472|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977473|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
5977474|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
5977475|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
5977476|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977477|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977478|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
5977479|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977480|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977481|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5977482|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
5977483|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5977484|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5977485|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5977486|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5977487|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977488|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977489|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977490|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
5977491|NCT04437303|Anticoagulants|anticoagulants|mesh-list
5977492|NCT04428151|Paclitaxel|paclitaxel|mesh-list
5977493|NCT04428151|Docetaxel|docetaxel|mesh-list
5977494|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
5977495|NCT04428151|Capecitabine|capecitabine|mesh-list
5977496|NCT04428151|Cetuximab|cetuximab|mesh-list
5977497|NCT04428151|Lenvatinib|lenvatinib|mesh-list
5977498|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5977499|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977500|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
5977501|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
5977502|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
5977503|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977504|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977505|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977506|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
5977507|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977508|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977509|NCT04413786|Oxytocin|oxytocin|mesh-list
5977510|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
5977511|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5977512|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977513|NCT04408638|Gemcitabine|gemcitabine|mesh-list
5977514|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
5977515|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
5977516|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977517|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
5977518|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977519|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977520|NCT04408638|Antiviral Agents|antiviral agents|mesh-ancestor
5977521|NCT04408638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977522|NCT04408638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977523|NCT04408638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977524|NCT04408638|Immunologic Factors|immunologic factors|mesh-ancestor
5977525|NCT04408638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977526|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977527|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
5977528|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5977529|NCT04400383|Antibodies|antibodies|mesh-list
5977530|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
5977531|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5977532|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
5977533|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977534|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245523|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245524|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
6245525|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
6245526|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6245527|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245528|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245529|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
5977535|NCT04395508|Trastuzumab|trastuzumab|mesh-list
5977536|NCT04395508|Pertuzumab|pertuzumab|mesh-list
5977537|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977538|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977539|NCT04394624|Ramucirumab|ramucirumab|mesh-list
5977540|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977541|NCT04383743|Cisplatin|cisplatin|mesh-list
5977542|NCT04383743|Doxorubicin|doxorubicin|mesh-list
5977543|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5977544|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
5977545|NCT04383743|Methotrexate|methotrexate|mesh-list
5977546|NCT04383743|Daunorubicin|daunorubicin|mesh-list
5977547|NCT04383743|Vinblastine|vinblastine|mesh-list
5977548|NCT04383743|Lenograstim|lenograstim|mesh-list
5977549|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977550|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5977551|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5977552|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5977553|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977554|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977555|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977556|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5977557|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
5977558|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5977559|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977560|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977561|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
5977562|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
5977563|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5977564|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977565|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
5977566|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977567|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5977568|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5977569|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5977570|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
5977571|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
5977572|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
5977573|NCT04382326|Vaccines|vaccines|mesh-list
5977574|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5977575|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
5977576|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977577|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
5977578|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977579|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977580|NCT04380740|Abatacept|abatacept|mesh-list
5977581|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5977582|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977583|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977584|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977585|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
5977586|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977587|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977588|NCT04378959|Lidocaine|lidocaine|mesh-list
5977589|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
5977590|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
5977591|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5977592|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977593|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
5977594|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977595|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5977596|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
5977597|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5977598|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5977599|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977600|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
5977601|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977602|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977603|NCT04358393|Azacitidine|azacitidine|mesh-list
5977604|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977605|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
5977606|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977607|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977608|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977609|NCT04351555|Carboplatin|carboplatin|mesh-list
5977610|NCT04351555|Pemetrexed|pemetrexed|mesh-list
5977611|NCT04351555|Osimertinib|osimertinib|mesh-list
5977612|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977613|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977614|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977615|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5977616|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5977617|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977618|NCT04347486|Atropine|atropine|mesh-list
5977619|NCT04347486|Neostigmine|neostigmine|mesh-list
5977620|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5977621|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5977622|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5977623|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
5977624|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977625|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977626|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5977627|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
5977628|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
5977629|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
5977630|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5977631|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5977632|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
5977633|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5977634|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977635|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5977636|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977637|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
5977638|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
5977639|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
5977640|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5977641|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5977642|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977643|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977644|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977645|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977646|NCT04338698|Azithromycin|azithromycin|mesh-list
5977647|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
5977648|NCT04338698|Oseltamivir|oseltamivir|mesh-list
5977649|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5977650|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977651|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
5977652|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5977653|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5977654|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977655|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977656|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977657|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
5977658|NCT04331938|Anesthetics|anesthetics|mesh-list
5977659|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5977660|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977661|NCT04326738|Midazolam|midazolam|mesh-list
5977662|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5977663|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5977664|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5977665|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977666|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5977667|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5977668|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5977669|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5977670|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
5977671|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
5977672|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
5977673|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
5977674|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5977675|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977676|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
5977677|NCT04305054|Lenvatinib|lenvatinib|mesh-list
5977678|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977679|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977680|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977681|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977682|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977683|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
5977684|NCT04305041|Lenvatinib|lenvatinib|mesh-list
5977685|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977686|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977687|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977688|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977689|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977690|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
5977691|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977692|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977693|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
5977694|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
5977695|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
5977696|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977697|NCT04300920|Expectorants|expectorants|mesh-ancestor
5977698|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
5977699|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5977700|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
5977701|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977702|NCT04300920|Protective Agents|protective agents|mesh-ancestor
5977703|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977704|NCT04300920|Antidotes|antidotes|mesh-ancestor
5977705|NCT04288427|Finasteride|finasteride|mesh-list
5977706|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5977707|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5977708|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977709|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977710|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
5977711|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977712|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977713|NCT04288427|Urological Agents|urological agents|mesh-ancestor
5977714|NCT04282668|Tretinoin|tretinoin|mesh-list
5977715|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977716|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
5977717|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
5977718|NCT04274894|Testosterone|testosterone|mesh-list
5977719|NCT04274894|Androgens|androgens|mesh-ancestor
5977720|NCT04274894|Hormones|hormones|mesh-ancestor
5977721|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977722|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977723|NCT04263090|Nivolumab|nivolumab|mesh-list
5977724|NCT04263090|ON 01910|on 01910|mesh-list
5977725|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977726|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977727|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5977728|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977729|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977730|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977731|NCT04258852|Nicotine|nicotine|mesh-list
5977732|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5977733|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
5977734|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977735|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977736|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5977737|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5977738|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
5977739|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5977740|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977741|NCT04255381|Pancrelipase|pancrelipase|mesh-list
5977742|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5977743|NCT04246086|Lenalidomide|lenalidomide|mesh-list
5977744|NCT04246086|Obinutuzumab|obinutuzumab|mesh-list
5977745|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
5977746|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977747|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5977748|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5977749|NCT04246086|Growth Substances|growth substances|mesh-ancestor
5977750|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
5977751|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977752|NCT04246086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977753|NCT04236141|Rituximab|rituximab|mesh-list
5977754|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5977755|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977756|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977757|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
5977758|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977759|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977760|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5977761|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
5977762|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977763|NCT04229381|Coal Tar|coal tar|mesh-list
5977764|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
5977765|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
5977766|NCT04222972|Gemcitabine|gemcitabine|mesh-list
5977767|NCT04222972|Paclitaxel|paclitaxel|mesh-list
5977768|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5977769|NCT04222972|Carboplatin|carboplatin|mesh-list
5977770|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
5977771|NCT04222972|Pemetrexed|pemetrexed|mesh-list
5977772|NCT04222972|Pralsetinib|pralsetinib|mesh-list
5977773|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5977774|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977775|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
5977776|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
5977777|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
5977778|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977779|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977780|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
5977781|NCT04222972|Antiviral Agents|antiviral agents|mesh-ancestor
5977782|NCT04222972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977783|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977784|NCT04222972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977785|NCT04222972|Immunologic Factors|immunologic factors|mesh-ancestor
5977786|NCT04222972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977787|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977788|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5977789|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5977790|NCT04210037|Paclitaxel|paclitaxel|mesh-list
5977791|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5977792|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977793|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
5977794|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
5977795|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
5977796|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977797|NCT04206787|Afatinib|afatinib|mesh-list
5977798|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977799|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977800|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977801|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977802|NCT04203927|Empagliflozin|empagliflozin|mesh-list
5977803|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5977804|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977805|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5977806|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977807|NCT04200066|Tamoxifen|tamoxifen|mesh-list
5977808|NCT04200066|Temozolomide|temozolomide|mesh-list
5977809|NCT04200066|Maprotiline|maprotiline|mesh-list
5977810|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5977811|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
5977812|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977813|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977814|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5977815|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
5977816|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977817|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977818|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5977819|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5977820|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5977821|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5977822|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5977823|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
5977824|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5977825|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5977826|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5977827|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5977828|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
5977829|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5977830|NCT04186871|Abatacept|abatacept|mesh-list
5977831|NCT04186871|Branebrutinib|branebrutinib|mesh-list
5977832|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5977833|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977834|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977835|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977836|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
5977837|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977838|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977839|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977840|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977841|NCT04183712|Gemcitabine|gemcitabine|mesh-list
5977842|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
5977843|NCT04183712|Afatinib|afatinib|mesh-list
5977844|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5977845|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
5977846|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977847|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977848|NCT04183712|Antiviral Agents|antiviral agents|mesh-ancestor
5977849|NCT04183712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977850|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977851|NCT04183712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5977852|NCT04183712|Immunologic Factors|immunologic factors|mesh-ancestor
5977853|NCT04183712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977854|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977855|NCT04180813|Linagliptin|linagliptin|mesh-list
5977856|NCT04180813|Acarbose|acarbose|mesh-list
5977857|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5977858|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977859|NCT04180813|Incretins|incretins|mesh-ancestor
5977860|NCT04180813|Hormones|hormones|mesh-ancestor
5977861|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977862|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5977863|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
5977864|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977865|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977866|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
5977867|NCT04171167|Fluticasone|fluticasone|mesh-list
5977868|NCT04171167|Xhance|xhance|mesh-list
5977869|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5977870|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5977871|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
5977872|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977873|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977874|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5977875|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
5977876|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
5977877|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5977878|NCT04160546|Aspirin|aspirin|mesh-list
5977879|NCT04160546|Ponatinib|ponatinib|mesh-list
5977880|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5977881|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5977882|NCT04160546|Analgesics|analgesics|mesh-ancestor
5977883|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
5977884|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977885|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977886|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5977887|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977888|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5977889|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5977890|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977891|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5977892|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5977893|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977894|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
5977895|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977896|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977897|NCT04154956|Docetaxel|docetaxel|mesh-list
5977898|NCT04154956|Maytansine|maytansine|mesh-list
5977899|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977900|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
5977901|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
5977902|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
5977903|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977904|NCT04154956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6245530|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6245531|NCT02722564|Ethanol|ethanol|mesh-list
6245532|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6245533|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245534|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5977905|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
5977906|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977907|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977908|NCT04134000|Atezolizumab|atezolizumab|mesh-list
5977909|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977910|NCT04111458|Trametinib|trametinib|mesh-list
5977911|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977912|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977913|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977914|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977915|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
5977916|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5977917|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977918|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977919|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5977920|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5977921|NCT04094207|Protective Agents|protective agents|mesh-ancestor
5977922|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977923|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
5977924|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5977925|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
5977926|NCT04093024|Nintedanib|nintedanib|mesh-list
5977927|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977928|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977929|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977930|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977931|NCT04080947|Montelukast|montelukast|mesh-list
5977932|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5977933|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
5977934|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5977935|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
5977936|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5977937|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977938|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5977939|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5977940|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977941|NCT04079621|Primaquine|primaquine|mesh-list
5977942|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
5977943|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5977944|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5977945|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5977950|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
5977951|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
5977952|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977953|NCT04074330|Rituximab|rituximab|mesh-list
5977954|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977955|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977956|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
5977957|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977958|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5977959|NCT04069819|Cilostazol|cilostazol|mesh-list
5977960|NCT04069819|Citalopram|citalopram|mesh-list
5977961|NCT04069819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5977962|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5977963|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5977964|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977965|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5977966|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
5977967|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5977968|NCT04069819|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5977969|NCT04069819|Antidepressive Agents|antidepressive agents|mesh-ancestor
5977970|NCT04069819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5977971|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
5977972|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5977973|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5977974|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5977975|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
5977976|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5977977|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6245535|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245536|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
6245537|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6245538|NCT02722837|Velpatasvir|velpatasvir|mesh-list
6245539|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
6245540|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245541|NCT02722967|Aripiprazole|aripiprazole|mesh-list
6245542|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
6245543|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6245544|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6245545|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6245546|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245547|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245548|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
6245549|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
6245550|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245551|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245552|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6245553|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5977978|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5977979|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
5977980|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5977981|NCT04069819|Protective Agents|protective agents|mesh-ancestor
5977982|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
5977983|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5977984|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977985|NCT04039607|Nivolumab|nivolumab|mesh-list
5977986|NCT04039607|Ipilimumab|ipilimumab|mesh-list
5977987|NCT04039607|Sorafenib|sorafenib|mesh-list
5977988|NCT04039607|Lenvatinib|lenvatinib|mesh-list
5977989|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5977990|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5977991|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5977992|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5977993|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5977994|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5977995|NCT04029688|Cytarabine|cytarabine|mesh-list
5977996|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
5977997|NCT04029688|Fludarabine|fludarabine|mesh-list
5977998|NCT04029688|Topotecan|topotecan|mesh-list
5977999|NCT04029688|Venetoclax|venetoclax|mesh-list
5978000|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5978001|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
5978002|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978003|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5978004|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5978005|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
5978006|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978007|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978008|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5978009|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5978010|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
5978011|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
5978012|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978013|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5978014|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5978015|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978016|NCT04025359|Dronabinol|dronabinol|mesh-list
5978017|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
5978018|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978019|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5978020|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5978021|NCT04025359|Analgesics|analgesics|mesh-ancestor
5978022|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
5978023|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978024|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
5978025|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
5978026|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978027|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978028|NCT04025359|Hormones|hormones|mesh-ancestor
5978029|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978030|NCT04017468|Vancomycin|vancomycin|mesh-list
5978031|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5978032|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978033|NCT04015739|Bevacizumab|bevacizumab|mesh-list
5978034|NCT04015739|Durvalumab|durvalumab|mesh-list
5978035|NCT04015739|Olaparib|olaparib|mesh-list
5978036|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978037|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978038|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5978039|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5978040|NCT04015739|Growth Substances|growth substances|mesh-ancestor
5978041|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978042|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
5978043|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978044|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978045|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978046|NCT04015180|Aflibercept|aflibercept|mesh-list
5978047|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5978048|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5978049|NCT04015180|Growth Substances|growth substances|mesh-ancestor
5978050|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978051|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
5978052|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978053|NCT03976375|Docetaxel|docetaxel|mesh-list
5978054|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
5978055|NCT03976375|Lenvatinib|lenvatinib|mesh-list
5978056|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978057|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
5978058|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
5978059|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
5978060|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978061|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978062|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5978063|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978064|NCT03969901|Relebactam|relebactam|mesh-list
5978065|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
5978066|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978067|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978068|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5978069|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978070|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
5978071|NCT03952299|Oxybutynin|oxybutynin|mesh-list
5978072|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
5978073|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
5978074|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978075|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978076|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5978077|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5978078|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
5978079|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978080|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978081|NCT03952299|Urological Agents|urological agents|mesh-ancestor
5978082|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5978083|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978084|NCT03952299|Renal Agents|renal agents|mesh-ancestor
5978085|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
5978086|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978087|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978088|NCT03948464|Morphine|morphine|mesh-list
5978089|NCT03948464|Methadone|methadone|mesh-list
5978090|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5978091|NCT03948464|Narcotics|narcotics|mesh-ancestor
5978092|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5978093|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978094|NCT03948464|Analgesics|analgesics|mesh-ancestor
5978095|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
5978096|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978097|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
5978098|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
5978099|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5978100|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5978101|NCT03941730|Estradiol|estradiol|mesh-list
5978102|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5978103|NCT03941730|Estrogens|estrogens|mesh-ancestor
5978104|NCT03941730|Hormones|hormones|mesh-ancestor
5978105|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978106|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978107|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5978108|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
5978109|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5978110|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5978111|NCT03933384|Tenofovir|tenofovir|mesh-list
5978112|NCT03933384|Entecavir|entecavir|mesh-list
5978113|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
5978114|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978115|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5978116|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5978117|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978118|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978119|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5978120|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5978121|NCT03919071|Trametinib|trametinib|mesh-list
5978122|NCT03919071|Dabrafenib|dabrafenib|mesh-list
5978123|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5978124|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978125|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5978126|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978127|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978128|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5978129|NCT03919071|Protective Agents|protective agents|mesh-ancestor
5978130|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978131|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5978132|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
5978133|NCT03916003|Primaquine|primaquine|mesh-list
5978134|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
5978135|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5978136|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5978137|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978138|NCT03907969|AZD7648|azd7648|mesh-list
5978139|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5978140|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978141|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978142|NCT03901469|Talazoparib|talazoparib|mesh-list
5978143|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978144|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978145|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978146|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978147|NCT03899987|Aspirin|aspirin|mesh-list
5978148|NCT03899987|Interferons|interferons|mesh-list
5978149|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
5978150|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
5978151|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
5978152|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978153|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
5978154|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978155|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5978156|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5978157|NCT03899987|Analgesics|analgesics|mesh-ancestor
5978158|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
5978159|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978160|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978161|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978162|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5978163|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5978164|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5978165|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978166|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5978167|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5978168|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978169|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
5978170|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
5978171|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
5978172|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5978173|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5978174|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5978175|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978176|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
5978177|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978178|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245554|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
6245555|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6245556|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6245557|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6245558|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6245559|NCT02723006|Nivolumab|nivolumab|mesh-list
6245560|NCT02723006|Ipilimumab|ipilimumab|mesh-list
6245561|NCT02723006|Vedolizumab|vedolizumab|mesh-list
6245562|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245563|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245564|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6245565|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245566|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245567|NCT02723084|Ribavirin|ribavirin|mesh-list
6245568|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
6245569|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
6245570|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245571|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
6245572|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245573|NCT02723591|Tacrolimus|tacrolimus|mesh-list
6245574|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6245575|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
6245576|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245577|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6245578|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245579|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245580|NCT02723630|Lenvatinib|lenvatinib|mesh-list
6245581|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245582|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6245583|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245584|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245585|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
6245586|NCT02723786|Azathioprine|azathioprine|mesh-list
6245587|NCT02723786|Tacrolimus|tacrolimus|mesh-list
6245588|NCT02723786|Basiliximab|basiliximab|mesh-list
6245589|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6245590|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
6245591|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245592|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6245593|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245594|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245595|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6245596|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245597|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6245598|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
6245599|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6245600|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245601|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
6245602|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6245603|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6245604|NCT02724020|Everolimus|everolimus|mesh-list
6245605|NCT02724020|Serabelisib|serabelisib|mesh-list
6245606|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245607|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6245608|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
6245609|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245610|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245611|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245612|NCT02724033|Dexamethasone|dexamethasone|mesh-list
6245613|NCT02724033|Ondansetron|ondansetron|mesh-list
6245614|NCT02724033|Antiemetics|antiemetics|mesh-list
6245615|NCT02724033|Bupivacaine|bupivacaine|mesh-list
6245616|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6245617|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
6245618|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245619|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245620|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245621|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
6245622|NCT02724033|Hormones|hormones|mesh-ancestor
6245623|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6245624|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6245625|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245626|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245627|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
5978179|NCT03882047|Fluticasone|fluticasone|mesh-list
5978180|NCT03882047|Xhance|xhance|mesh-list
5978181|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
5978182|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978183|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5978184|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
5978185|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978186|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978187|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5978188|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
5978189|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
5978190|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5978191|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
5978192|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
5978193|NCT03879772|Beclomethasone|beclomethasone|mesh-list
5978194|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978195|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978196|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
5978197|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5978198|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
5978199|NCT03879772|Hormones|hormones|mesh-ancestor
5978200|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978201|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978202|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5978203|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
5978204|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
5978205|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5978206|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
5978207|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
5978208|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978209|NCT03873402|Nivolumab|nivolumab|mesh-list
5978210|NCT03873402|Ipilimumab|ipilimumab|mesh-list
5978211|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978212|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978213|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5978214|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978215|NCT03871465|Triamcinolone|triamcinolone|mesh-list
5978216|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5978217|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5978218|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5978219|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978220|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
5978221|NCT03871465|Hormones|hormones|mesh-ancestor
5978222|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978223|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978224|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5978225|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
5978226|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978227|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978228|NCT03866174|Niacin|niacin|mesh-list
5978229|NCT03866174|Psilocybin|psilocybin|mesh-list
5978230|NCT03866174|Vitamins|vitamins|mesh-ancestor
5978231|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
5978232|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978233|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
5978234|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5978235|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
5978236|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978237|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5978238|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
5978239|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
5978240|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5978241|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
5978242|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978243|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
5978244|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5978245|NCT03860233|Oxytocin|oxytocin|mesh-list
5978246|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
5978247|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5978248|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978249|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
5978250|NCT03855228|Loratadine|loratadine|mesh-list
5978251|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978252|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
5978253|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5978254|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
5978255|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5978256|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5978257|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
5978258|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
5978259|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978260|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978261|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978262|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
5978263|NCT03855189|Beclomethasone|beclomethasone|mesh-list
5978264|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978265|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
5978266|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5978267|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
5978268|NCT03855189|Hormones|hormones|mesh-ancestor
5978269|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978270|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978271|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5978272|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
5978273|NCT03845543|Paclitaxel|paclitaxel|mesh-list
5978274|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5978275|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978276|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
5978277|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
5978278|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
5978279|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978280|NCT03841617|Hormones|hormones|mesh-list
5978281|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978282|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978283|NCT03840200|Rucaparib|rucaparib|mesh-list
5978284|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978285|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978286|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978287|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978288|NCT03837899|Durvalumab|durvalumab|mesh-list
5978289|NCT03837899|Tremelimumab|tremelimumab|mesh-list
5978290|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5978291|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978292|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978293|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
5978294|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978295|NCT03830918|Temozolomide|temozolomide|mesh-list
5978296|NCT03830918|Atezolizumab|atezolizumab|mesh-list
5978297|NCT03830918|Niraparib|niraparib|mesh-list
5978298|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5978299|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5978300|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
5978301|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978302|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978303|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
5978304|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978305|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978306|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978307|NCT03828292|Dexamethasone|dexamethasone|mesh-list
5978308|NCT03828292|Bortezomib|bortezomib|mesh-list
5978309|NCT03828292|Pomalidomide|pomalidomide|mesh-list
5978310|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978311|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
5978312|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
5978313|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978314|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978315|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5978316|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
5978317|NCT03828292|Hormones|hormones|mesh-ancestor
5978318|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978319|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5978320|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978321|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
5978322|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5978323|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5978324|NCT03828292|Growth Substances|growth substances|mesh-ancestor
5978325|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
5978326|NCT03820726|Nintedanib|nintedanib|mesh-list
5978327|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978328|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5978329|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978330|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978331|NCT03785210|Vancomycin|vancomycin|mesh-list
5978332|NCT03785210|Nivolumab|nivolumab|mesh-list
5978333|NCT03785210|Tadalafil|tadalafil|mesh-list
5978334|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978335|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978336|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5978337|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978338|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5978339|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978340|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
5978341|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5978342|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5978343|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978344|NCT03785210|Urological Agents|urological agents|mesh-ancestor
5978345|NCT03769285|Niacinamide|niacinamide|mesh-list
5978346|NCT03769285|Niacin|niacin|mesh-list
5978347|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
5978348|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
5978349|NCT03769285|Vitamins|vitamins|mesh-ancestor
5978350|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
5978351|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978352|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5978353|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
5978354|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978355|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5978356|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
5978357|NCT03768492|Caffeine|caffeine|mesh-list
5978358|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5978359|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978360|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5978361|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978362|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978363|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5978364|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5978365|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
5978366|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978367|NCT03764631|Empagliflozin|empagliflozin|mesh-list
5978368|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5978369|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5978370|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978371|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5978372|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978373|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
5978374|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978375|NCT03761030|Levodopa|levodopa|mesh-list
5978376|NCT03761030|Carbidopa|carbidopa|mesh-list
5978377|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5978378|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5978379|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5978380|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
5978381|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978382|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978383|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978384|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5978385|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978386|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5978387|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
5978388|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
5978389|NCT03747120|Paclitaxel|paclitaxel|mesh-list
5978390|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
5978391|NCT03747120|Trastuzumab|trastuzumab|mesh-list
5978392|NCT03747120|Pertuzumab|pertuzumab|mesh-list
5978393|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5978394|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978395|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
5978396|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
5978397|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
5978398|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978399|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978400|NCT03745144|Cladribine|cladribine|mesh-list
5978401|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5978402|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
5978403|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978404|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5978405|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
6245628|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
5978406|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978407|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5978408|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
5978409|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5978410|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5978411|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5978412|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5978413|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5978414|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5978415|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
5978416|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
5978417|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
5978418|NCT03742895|Olaparib|olaparib|mesh-list
5978419|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978420|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978421|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978422|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978440|NCT03736720|Leucovorin|leucovorin|mesh-list
5978441|NCT03736720|Fluorouracil|fluorouracil|mesh-list
5978442|NCT03736720|Irinotecan|irinotecan|mesh-list
5978443|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
5978444|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978445|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5978446|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978447|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5978448|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
5978449|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978450|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5978451|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5978452|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978453|NCT03736720|Antidotes|antidotes|mesh-ancestor
5978454|NCT03736720|Protective Agents|protective agents|mesh-ancestor
5978455|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
5978456|NCT03736720|Vitamins|vitamins|mesh-ancestor
5978457|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
5978458|NCT03725202|Upadacitinib|upadacitinib|mesh-list
5978459|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
5978460|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5978461|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978462|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978463|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5978464|NCT03710824|Nintedanib|nintedanib|mesh-list
5978465|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978466|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5978467|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978468|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978469|NCT03703375|Gemcitabine|gemcitabine|mesh-list
5978470|NCT03703375|Azacitidine|azacitidine|mesh-list
5978471|NCT03703375|Romidepsin|romidepsin|mesh-list
5978472|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5978473|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
5978474|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978475|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978476|NCT03703375|Antiviral Agents|antiviral agents|mesh-ancestor
5978477|NCT03703375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978478|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978479|NCT03703375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5978480|NCT03703375|Immunologic Factors|immunologic factors|mesh-ancestor
5978481|NCT03703375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978482|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5978483|NCT03656081|Itraconazole|itraconazole|mesh-list
5978484|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
5978485|NCT03656081|Amphotericin B|amphotericin b|mesh-list
5978486|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
5978487|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978488|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5978489|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5978490|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978491|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978492|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5978493|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
5978494|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978495|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978496|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5978497|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5978498|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5978499|NCT03656081|Amebicides|amebicides|mesh-ancestor
5978500|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5978501|NCT03648892|Raclopride|raclopride|mesh-list
5978502|NCT03648892|Fallypride|fallypride|mesh-list
5978503|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5978504|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5978505|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5978506|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978507|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5978508|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5978509|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
5978510|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978511|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978512|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5978513|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
5978514|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5978515|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978516|NCT03645408|Exenatide|exenatide|mesh-list
5978517|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5978518|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978519|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5978520|NCT03645408|Incretins|incretins|mesh-ancestor
5978521|NCT03645408|Hormones|hormones|mesh-ancestor
5978522|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978523|NCT03639935|Nivolumab|nivolumab|mesh-list
5978524|NCT03639935|Rucaparib|rucaparib|mesh-list
5978525|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978526|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978527|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5978528|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978529|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978530|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978531|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
5978532|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5978533|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
5978534|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5978535|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
5978536|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978537|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978538|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
5978539|NCT03623828|Apomorphine|apomorphine|mesh-list
5978540|NCT03623828|Emetics|emetics|mesh-ancestor
5978541|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978542|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
5978543|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978544|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5978545|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
5978546|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
5978547|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978548|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978549|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
5978550|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
5978551|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978552|NCT03594110|Empagliflozin|empagliflozin|mesh-list
5978553|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5978554|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978555|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5978556|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978557|NCT03586609|Cytarabine|cytarabine|mesh-list
5978558|NCT03586609|Azacitidine|azacitidine|mesh-list
5978559|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
5978560|NCT03586609|Venetoclax|venetoclax|mesh-list
5978561|NCT03586609|Cladribine|cladribine|mesh-list
5978562|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5978563|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
5978564|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978565|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978566|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
5978567|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978568|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5978569|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
5978570|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978571|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245629|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245630|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
6245631|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
6245632|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
6245633|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6245634|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
6245635|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245636|NCT02724033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6245637|NCT02724033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6245638|NCT02724033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6245639|NCT02724033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6245640|NCT02724111|Rocuronium|rocuronium|mesh-list
6245641|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6245642|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6245643|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6245644|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245645|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245646|NCT02724423|Diazepam|diazepam|mesh-list
6245647|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6245648|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
6245649|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
6245650|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
6245651|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245652|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245653|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245654|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6245655|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245656|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6245657|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6245658|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6245659|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6245660|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6245661|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6245662|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
6245663|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
6245664|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
6245665|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
6245666|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245667|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245668|NCT02724592|Fluorides|fluorides|mesh-list
6245669|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
6245670|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
6245671|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
6245672|NCT02724592|Protective Agents|protective agents|mesh-ancestor
6245673|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245674|NCT02724878|Bevacizumab|bevacizumab|mesh-list
6245675|NCT02724878|Atezolizumab|atezolizumab|mesh-list
6245676|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245677|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245678|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6245679|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6245680|NCT02724878|Growth Substances|growth substances|mesh-ancestor
6245681|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245682|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
6245683|NCT02725008|Dexamethasone|dexamethasone|mesh-list
6245684|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6245685|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
6245686|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
6245687|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978572|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
5978573|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5978574|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
5978575|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
5978576|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
5978577|NCT03565913|Calcium|calcium|mesh-list
5978578|NCT03565913|Calcium acetate|calcium acetate|mesh-list
5978579|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5978580|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978581|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5978582|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
5978583|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
5978584|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978585|NCT03565913|Cathartics|cathartics|mesh-ancestor
5978586|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5978593|NCT03546686|Nivolumab|nivolumab|mesh-list
5978594|NCT03546686|Ipilimumab|ipilimumab|mesh-list
5978595|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978596|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978597|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5978598|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978599|NCT03528642|Temozolomide|temozolomide|mesh-list
5978600|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5978601|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
5978602|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978603|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978604|NCT03523156|Azithromycin|azithromycin|mesh-list
5978605|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5978606|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978607|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5978608|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5978609|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5978610|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978611|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978612|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5978613|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5978614|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978615|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
5978616|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978617|NCT03498521|Gemcitabine|gemcitabine|mesh-list
5978618|NCT03498521|Bevacizumab|bevacizumab|mesh-list
5978619|NCT03498521|Carboplatin|carboplatin|mesh-list
5978620|NCT03498521|Trastuzumab|trastuzumab|mesh-list
5978621|NCT03498521|Atezolizumab|atezolizumab|mesh-list
5978622|NCT03498521|Olaparib|olaparib|mesh-list
5978623|NCT03498521|Pertuzumab|pertuzumab|mesh-list
5978624|NCT03498521|Vemurafenib|vemurafenib|mesh-list
5978625|NCT03498521|Ivosidenib|ivosidenib|mesh-list
5978626|NCT03498521|Entrectinib|entrectinib|mesh-list
5978627|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978628|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978629|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978630|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5978631|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5978632|NCT03498521|Growth Substances|growth substances|mesh-ancestor
5978633|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978634|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
5978635|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5978636|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
5978637|NCT03498521|Antiviral Agents|antiviral agents|mesh-ancestor
5978638|NCT03498521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978639|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978640|NCT03498521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5978641|NCT03498521|Immunologic Factors|immunologic factors|mesh-ancestor
5978642|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5978643|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978644|NCT03497689|Treprostinil|treprostinil|mesh-list
5978645|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5978646|NCT03476317|Vancomycin|vancomycin|mesh-list
5978647|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
5978648|NCT03476317|Neomycin|neomycin|mesh-list
5978649|NCT03476317|Fluconazole|fluconazole|mesh-list
5978650|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
5978651|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5978652|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978653|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5978654|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5978655|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978656|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978657|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978658|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5978659|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5978660|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
5978661|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5978662|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5978663|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
5978664|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978665|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978666|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5978667|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5978668|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5978669|NCT03476317|Laxatives|laxatives|mesh-ancestor
5978670|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5978671|NCT03472274|Durvalumab|durvalumab|mesh-list
5978672|NCT03472274|Tremelimumab|tremelimumab|mesh-list
5978673|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978674|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978675|NCT03456076|Gemcitabine|gemcitabine|mesh-list
5978676|NCT03456076|Carboplatin|carboplatin|mesh-list
5978677|NCT03456076|Pemetrexed|pemetrexed|mesh-list
5978678|NCT03456076|Vinorelbine|vinorelbine|mesh-list
5978679|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978680|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5978681|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
5978682|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978683|NCT03456076|Antiviral Agents|antiviral agents|mesh-ancestor
5978684|NCT03456076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978685|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978686|NCT03456076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5978687|NCT03456076|Immunologic Factors|immunologic factors|mesh-ancestor
5978688|NCT03456076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978689|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5978690|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5978691|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5978692|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
5978693|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
5978694|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
5978695|NCT03442556|Carboplatin|carboplatin|mesh-list
5978696|NCT03442556|Docetaxel|docetaxel|mesh-list
5978697|NCT03442556|Rucaparib|rucaparib|mesh-list
5978698|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978699|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
5978700|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
5978701|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
5978702|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978703|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978704|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978705|NCT03436654|Prednisone|prednisone|mesh-list
5978706|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
5978707|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978708|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
5978709|NCT03436654|Hormones|hormones|mesh-ancestor
5978710|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978711|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978712|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5978713|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978714|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5978715|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978716|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978717|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
5978718|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5978719|NCT03434158|Olaparib|olaparib|mesh-list
5978720|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978721|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245688|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978722|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978723|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978724|NCT03425201|Niraparib|niraparib|mesh-list
5978725|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978726|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978727|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978728|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978729|NCT03416153|Paclitaxel|paclitaxel|mesh-list
5978730|NCT03416153|Carboplatin|carboplatin|mesh-list
5978731|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5978732|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978733|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
5978734|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
5978735|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
5978736|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978737|NCT03408340|Fentanyl|fentanyl|mesh-list
5978738|NCT03408340|Ketamine|ketamine|mesh-list
5978739|NCT03408340|Propofol|propofol|mesh-list
5978740|NCT03408340|Sevoflurane|sevoflurane|mesh-list
5978741|NCT03408340|Rocuronium|rocuronium|mesh-list
5978742|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
5978743|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5978744|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978745|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
5978746|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978747|NCT03408340|Analgesics|analgesics|mesh-ancestor
5978748|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5978749|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5978750|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
5978751|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5978752|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5978753|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978754|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978755|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5978756|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
5978757|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
5978758|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5978759|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5978760|NCT03408340|Narcotics|narcotics|mesh-ancestor
5978761|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5978762|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5978763|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5978764|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5978765|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
5978766|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978767|NCT03397004|Doxycycline|doxycycline|mesh-list
5978768|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5978769|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978770|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
5978771|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5978772|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5978773|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
5978774|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
5978775|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978776|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
5978777|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978778|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978779|NCT03363464|Empagliflozin|empagliflozin|mesh-list
5978780|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5978781|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5978782|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978783|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5978784|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978785|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
5978786|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978787|NCT03362190|Ranibizumab|ranibizumab|mesh-list
5978788|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5978789|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5978790|NCT03362190|Growth Substances|growth substances|mesh-ancestor
5978791|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978792|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
5978793|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978794|NCT03347929|Naproxen|naproxen|mesh-list
5978795|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5978796|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5978797|NCT03347929|Analgesics|analgesics|mesh-ancestor
5978798|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
5978799|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978800|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978801|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978802|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5978803|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
5978804|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5978805|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978806|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978807|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
5978808|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978809|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978810|NCT03346668|Gabapentin|gabapentin|mesh-list
5978811|NCT03346668|Analgesics|analgesics|mesh-ancestor
5978812|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
5978813|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978814|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978815|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
5978816|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5978817|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5978818|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5978819|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5978820|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5978821|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5978822|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978823|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978824|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
5978825|NCT03338790|Prednisone|prednisone|mesh-list
5978826|NCT03338790|Docetaxel|docetaxel|mesh-list
5978827|NCT03338790|Nivolumab|nivolumab|mesh-list
5978828|NCT03338790|Rucaparib|rucaparib|mesh-list
5978829|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978830|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
5978831|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
5978832|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
5978833|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978834|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978835|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
5978836|NCT03338790|Hormones|hormones|mesh-ancestor
5978837|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978838|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978839|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5978840|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978841|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5978842|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5978843|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978844|NCT03332797|Palbociclib|palbociclib|mesh-list
5978845|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978846|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5978847|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978848|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978849|NCT03309150|Paclitaxel|paclitaxel|mesh-list
5978850|NCT03309150|Carboplatin|carboplatin|mesh-list
5978851|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5978852|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978853|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
5978854|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
5978855|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
5978856|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978857|NCT03304717|Tenofovir|tenofovir|mesh-list
5978858|NCT03304717|Emtricitabine|emtricitabine|mesh-list
5978859|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
5978860|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978861|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5978862|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5978863|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978864|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978865|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5978866|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5978867|NCT03289299|Dexamethasone|dexamethasone|mesh-list
5978868|NCT03289299|Lenalidomide|lenalidomide|mesh-list
5978869|NCT03289299|Daratumumab|daratumumab|mesh-list
5978870|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5978871|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
5978872|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
5978873|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978874|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978875|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5978876|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
5978877|NCT03289299|Hormones|hormones|mesh-ancestor
5978878|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5978879|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5978880|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978881|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
5978882|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5978883|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5978884|NCT03289299|Growth Substances|growth substances|mesh-ancestor
5978885|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
5978886|NCT03277495|Nicotine|nicotine|mesh-list
5978887|NCT03277495|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5978888|NCT03277495|Autonomic Agents|autonomic agents|mesh-ancestor
5978889|NCT03277495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978890|NCT03277495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978891|NCT03277495|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5978892|NCT03277495|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5978893|NCT03277495|Cholinergic Agents|cholinergic agents|mesh-ancestor
5978894|NCT03277495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978895|NCT03277495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978896|NCT03272685|Nicotine|nicotine|mesh-list
5978897|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5978898|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
5978899|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978900|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978901|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5978902|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5978903|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
5978904|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978905|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978906|NCT03258593|Durvalumab|durvalumab|mesh-list
5978907|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978908|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978909|NCT03258567|Nivolumab|nivolumab|mesh-list
5978910|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978911|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978912|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5978913|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978914|NCT03253679|Adavosertib|adavosertib|mesh-list
5978915|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978916|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978917|NCT03252522|Micronutrients|micronutrients|mesh-list
5978918|NCT03252522|Trace Elements|trace elements|mesh-list
5978919|NCT03252522|Antioxidants|antioxidants|mesh-list
5978920|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978921|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978922|NCT03252522|Protective Agents|protective agents|mesh-ancestor
5978923|NCT03223155|Nivolumab|nivolumab|mesh-list
5978924|NCT03223155|Ipilimumab|ipilimumab|mesh-list
5978925|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978926|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978927|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5978928|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978929|NCT03217201|Methamphetamine|methamphetamine|mesh-list
5978930|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5978931|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978932|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
5978933|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
5978934|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978935|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
5978936|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978937|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978938|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
5978939|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5978940|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5978941|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5978942|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5978943|NCT03212274|Olaparib|olaparib|mesh-list
5978944|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5978945|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978946|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978947|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245689|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245690|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
6245691|NCT02725008|Hormones|hormones|mesh-ancestor
6245692|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6245693|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6245694|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245695|NCT02725268|Paclitaxel|paclitaxel|mesh-list
6245696|NCT02725268|Serabelisib|serabelisib|mesh-list
6245697|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6245698|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245699|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
6245700|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
6245701|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
6245702|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245703|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245704|NCT02725411|Celecoxib|celecoxib|mesh-list
6245705|NCT02725411|Tanezumab|tanezumab|mesh-list
6245706|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6245707|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6245708|NCT02725411|Analgesics|analgesics|mesh-ancestor
6245709|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
6245710|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245711|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245712|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6245713|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6245714|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6245715|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6245716|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245717|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245718|NCT02725710|Gabapentin|gabapentin|mesh-list
6245719|NCT02725710|Analgesics|analgesics|mesh-ancestor
6245720|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
6245721|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245722|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245723|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
6245724|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6245725|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6245726|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245727|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6245728|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6245729|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6245730|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245731|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245732|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
6245733|NCT02725866|Ritonavir|ritonavir|mesh-list
6245734|NCT02725866|Ribavirin|ribavirin|mesh-list
6245735|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6245736|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6245737|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
6245738|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245739|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245740|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6245741|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6245742|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
6245743|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245744|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6245745|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6245746|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
6245747|NCT02726022|Ribavirin|ribavirin|mesh-list
6245748|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6245749|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
6245750|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245751|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
6245752|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245753|NCT02726113|Vitamin D|vitamin d|mesh-list
6245754|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
6245755|NCT02726113|Vitamins|vitamins|mesh-ancestor
6245756|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
6245757|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245758|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6245759|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6245760|NCT02726178|Ibuprofen|ibuprofen|mesh-list
6245761|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5978948|NCT03182179|Ondansetron|ondansetron|mesh-list
5978949|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
5978950|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
5978951|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5978952|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978953|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5978954|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
5978955|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
5978956|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5978957|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
5978958|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5978959|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978960|NCT03182179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5978961|NCT03182179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5978962|NCT03182179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5978963|NCT03182179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5978964|NCT03182179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5978965|NCT03179761|Vaccines|vaccines|mesh-list
5978966|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
5978967|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978968|NCT03178552|Gemcitabine|gemcitabine|mesh-list
5978969|NCT03178552|Bevacizumab|bevacizumab|mesh-list
5978970|NCT03178552|Carboplatin|carboplatin|mesh-list
5978971|NCT03178552|Pemetrexed|pemetrexed|mesh-list
5978972|NCT03178552|Atezolizumab|atezolizumab|mesh-list
5978973|NCT03178552|Vemurafenib|vemurafenib|mesh-list
5978974|NCT03178552|Entrectinib|entrectinib|mesh-list
5978975|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5978976|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5978977|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5978978|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5978979|NCT03178552|Growth Substances|growth substances|mesh-ancestor
5978980|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5978981|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
5978982|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5978983|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
5978984|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5978985|NCT03178552|Antiviral Agents|antiviral agents|mesh-ancestor
5978986|NCT03178552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978987|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5978988|NCT03178552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5978989|NCT03178552|Immunologic Factors|immunologic factors|mesh-ancestor
5978990|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5978991|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5978992|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5978993|NCT03167242|Lumefantrine|lumefantrine|mesh-list
5978994|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
5978995|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
5978996|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5978997|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5978998|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5978999|NCT03164473|Rituximab|rituximab|mesh-list
5979000|NCT03164473|Azathioprine|azathioprine|mesh-list
5979001|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979002|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979003|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
5979004|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979005|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979006|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
5979007|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979008|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979009|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979010|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
5979011|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979012|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979013|NCT03153280|Capecitabine|capecitabine|mesh-list
5979014|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
5979015|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979016|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
5979017|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979018|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979019|NCT03147612|Cytarabine|cytarabine|mesh-list
5979020|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
5979021|NCT03147612|Rituximab|rituximab|mesh-list
5979022|NCT03147612|Methotrexate|methotrexate|mesh-list
5979023|NCT03147612|Vincristine|vincristine|mesh-list
5979024|NCT03147612|Blinatumomab|blinatumomab|mesh-list
5979025|NCT03147612|Ponatinib|ponatinib|mesh-list
5979026|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5979027|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
5979028|NCT03147612|Antibodies|antibodies|mesh-list
5979029|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
5979030|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5979031|NCT03147612|Lenograstim|lenograstim|mesh-list
5979032|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
5979033|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979034|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
5979035|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979036|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979037|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5979038|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
5979039|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979040|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979041|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5979042|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5979043|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
5979044|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5979045|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979046|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
5979047|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
5979048|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979049|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5979050|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5979051|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5979052|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
5979053|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5979054|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5979055|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
5979056|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
5979057|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
5979058|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979059|NCT03141684|Bevacizumab|bevacizumab|mesh-list
5979060|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5979061|NCT03141684|Atezolizumab|atezolizumab|mesh-list
5979062|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
5979063|NCT03141684|Antibodies|antibodies|mesh-list
5979064|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
5979065|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5979066|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
5979067|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979068|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5979069|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5979070|NCT03141684|Growth Substances|growth substances|mesh-ancestor
5979071|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979072|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
5979073|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
5979074|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
5979075|NCT03139370|Fludarabine|fludarabine|mesh-list
5979076|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979077|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
5979078|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979079|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979080|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5979081|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
5979082|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979083|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979084|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5979085|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
5979086|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5979087|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5979088|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979089|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
5979090|NCT03113253|Coagulants|coagulants|mesh-ancestor
5979091|NCT03111992|Spartalizumab|spartalizumab|mesh-list
5979092|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5979093|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979094|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979095|NCT03101046|Docetaxel|docetaxel|mesh-list
5979096|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979097|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
5979098|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
5979099|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
5979100|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979101|NCT03059173|Inositol|inositol|mesh-list
5979102|NCT03059173|Clomiphene|clomiphene|mesh-list
5979103|NCT03059173|Enclomiphene|enclomiphene|mesh-list
5979104|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
5979105|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5979106|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
5979107|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979108|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979109|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5979110|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
5979111|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5979112|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5979113|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5979114|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
5979115|NCT03059173|Vitamins|vitamins|mesh-ancestor
5979116|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
5979117|NCT03057106|Durvalumab|durvalumab|mesh-list
5979118|NCT03057106|Tremelimumab|tremelimumab|mesh-list
5979119|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979120|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979121|NCT03015129|Durvalumab|durvalumab|mesh-list
5979122|NCT03015129|Tremelimumab|tremelimumab|mesh-list
5979123|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979124|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979125|NCT03013491|Ipilimumab|ipilimumab|mesh-list
5979126|NCT03013491|Vemurafenib|vemurafenib|mesh-list
5979127|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979128|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979129|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5979130|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979131|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979132|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979133|NCT03008369|Lenvatinib|lenvatinib|mesh-list
5979134|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979135|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979136|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979137|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979138|NCT02963493|Dexamethasone|dexamethasone|mesh-list
5979139|NCT02963493|Melphalan|melphalan|mesh-list
5979140|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5979141|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
5979142|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
5979143|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979144|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979145|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5979146|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
5979147|NCT02963493|Hormones|hormones|mesh-ancestor
5979148|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979149|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5979150|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979151|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5979152|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
5979153|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979154|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5979155|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979156|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
5979157|NCT02947503|Metformin|metformin|mesh-list
5979158|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5979159|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979160|NCT02930902|Gemcitabine|gemcitabine|mesh-list
5979161|NCT02930902|Paclitaxel|paclitaxel|mesh-list
5979162|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5979163|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
5979164|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5979165|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979166|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
5979167|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
5979168|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
5979169|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979170|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979171|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
5979172|NCT02930902|Antiviral Agents|antiviral agents|mesh-ancestor
5979173|NCT02930902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5979174|NCT02930902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979175|NCT02930902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979176|NCT02930902|Immunologic Factors|immunologic factors|mesh-ancestor
5979177|NCT02930902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979178|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979179|NCT02921555|Prednisone|prednisone|mesh-list
5979180|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
5979181|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5979182|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5979183|NCT02921555|Prednisolone|prednisolone|mesh-list
5979184|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
5979185|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5979186|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
5979187|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5979188|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
5979189|NCT02921555|Hormones|hormones|mesh-ancestor
5979190|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979191|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979192|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5979193|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979194|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
5979195|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
5979196|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979197|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5979198|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5979199|NCT02921555|Protective Agents|protective agents|mesh-ancestor
5979200|NCT02899078|Nivolumab|nivolumab|mesh-list
5979201|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979202|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979203|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5979204|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979205|NCT02895373|Alprostadil|alprostadil|mesh-list
5979206|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5979207|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
5979208|NCT02895373|Urological Agents|urological agents|mesh-ancestor
5979209|NCT02893917|Olaparib|olaparib|mesh-list
5979210|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5979211|NCT02893917|Cediranib|cediranib|mesh-list
5979212|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979213|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979214|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979215|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979216|NCT02869789|Nivolumab|nivolumab|mesh-list
5979217|NCT02869789|Ipilimumab|ipilimumab|mesh-list
5979218|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979219|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979220|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5979221|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979222|NCT02864914|Empagliflozin|empagliflozin|mesh-list
5979223|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
5979224|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
5979225|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979226|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5979227|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979228|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
5979229|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979230|NCT02861573|Dexamethasone|dexamethasone|mesh-list
5979231|NCT02861573|Prednisone|prednisone|mesh-list
5979232|NCT02861573|Carboplatin|carboplatin|mesh-list
5979233|NCT02861573|Docetaxel|docetaxel|mesh-list
5979234|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
5979235|NCT02861573|Etoposide|etoposide|mesh-list
5979236|NCT02861573|Olaparib|olaparib|mesh-list
5979237|NCT02861573|Lenvatinib|lenvatinib|mesh-list
5979238|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
5979239|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5979240|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
5979241|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
5979242|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979243|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979244|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5979245|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
5979246|NCT02861573|Hormones|hormones|mesh-ancestor
5979247|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979248|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5979249|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979250|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
5979251|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
5979252|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
5979253|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979254|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979255|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5979256|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5979257|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5979258|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979259|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5979260|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979261|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5979262|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
5979263|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5979264|NCT02861417|Vidarabine|vidarabine|mesh-list
5979265|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
5979266|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
5979267|NCT02861417|Busulfan|busulfan|mesh-list
5979268|NCT02861417|Thiotepa|thiotepa|mesh-list
5979269|NCT02861417|Fludarabine|fludarabine|mesh-list
5979270|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
5979271|NCT02861417|Tacrolimus|tacrolimus|mesh-list
5979272|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979273|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
5979274|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979275|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979276|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5979277|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
5979278|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979279|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979280|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5979281|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979282|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
5979283|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
5979284|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5979285|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5979286|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979287|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5979288|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5979289|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
5979290|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5979291|NCT02849496|Atezolizumab|atezolizumab|mesh-list
5979292|NCT02849496|Olaparib|olaparib|mesh-list
5979293|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
5979294|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5979295|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979296|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979297|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979298|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
5979299|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979300|NCT02825160|Iloprost|iloprost|mesh-list
5979301|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5979302|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
5979303|NCT02814916|Dalbavancin|dalbavancin|mesh-list
5979304|NCT02814916|Teicoplanin|teicoplanin|mesh-list
5979305|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5979306|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5979307|NCT02799602|Docetaxel|docetaxel|mesh-list
5979308|NCT02799602|Androgens|androgens|mesh-list
5979309|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979310|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
5979311|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
5979312|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
5979313|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979314|NCT02799602|Hormones|hormones|mesh-ancestor
5979315|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979316|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979317|NCT02788591|Esomeprazole|esomeprazole|mesh-list
5979318|NCT02788591|Omeprazole|omeprazole|mesh-list
5979319|NCT02788591|Pantoprazole|pantoprazole|mesh-list
5979320|NCT02788591|Lansoprazole|lansoprazole|mesh-list
5979321|NCT02788591|Sucralfate|sucralfate|mesh-list
5979322|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5979323|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5979324|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5979325|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979326|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979327|NCT02772588|Leuprolide|leuprolide|mesh-list
5979328|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5979329|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
5979330|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5979331|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979332|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5979333|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979334|NCT02766478|Genistein|genistein|mesh-list
5979335|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5979336|NCT02766478|Protective Agents|protective agents|mesh-ancestor
5979337|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979338|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979339|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979340|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979341|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979342|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
5979343|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
5979344|NCT02766478|Estrogens|estrogens|mesh-ancestor
5979345|NCT02766478|Hormones|hormones|mesh-ancestor
5979346|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979347|NCT02759419|Riociguat|riociguat|mesh-list
5979348|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
5979349|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979350|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5979351|NCT02748057|Ezetimibe|ezetimibe|mesh-list
5979352|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5979353|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5979354|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
5979355|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979356|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5979357|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5979358|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979359|NCT02741570|Cisplatin|cisplatin|mesh-list
5979360|NCT02741570|Carboplatin|carboplatin|mesh-list
5979361|NCT02741570|Fluorouracil|fluorouracil|mesh-list
5979362|NCT02741570|Nivolumab|nivolumab|mesh-list
5979363|NCT02741570|Cetuximab|cetuximab|mesh-list
5979364|NCT02741570|Ipilimumab|ipilimumab|mesh-list
5979365|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979366|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
5979367|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979368|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979369|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979370|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
5979371|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979372|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979373|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5979374|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
5979375|NCT02741271|Prednisone|prednisone|mesh-list
5979376|NCT02741271|Prednisolone|prednisolone|mesh-list
5979377|NCT02741271|Albuterol|albuterol|mesh-list
5979378|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5979379|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
5979380|NCT02741271|Hormones|hormones|mesh-ancestor
5979381|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979382|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979383|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5979384|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979385|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
5979386|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979387|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5979388|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5979389|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
5979390|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
5979391|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5979392|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5979393|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5979394|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5979395|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
5979396|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979397|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979398|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
5979399|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5979400|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5979401|NCT02741245|Ezetimibe|ezetimibe|mesh-list
5979402|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5979403|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5979404|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
5979405|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979406|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5979407|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5979408|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979409|NCT02728050|Cytarabine|cytarabine|mesh-list
5979410|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
5979411|NCT02728050|Sorafenib|sorafenib|mesh-list
5979412|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
5979413|NCT02728050|Cladribine|cladribine|mesh-list
5979414|NCT02728050|Lenograstim|lenograstim|mesh-list
5979415|NCT02728050|Sargramostim|sargramostim|mesh-list
5979416|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5979417|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
5979418|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979419|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979420|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
5979421|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979422|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979423|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
5979424|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5979425|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979426|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979427|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979428|NCT02728050|Analgesics|analgesics|mesh-ancestor
5979429|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
5979430|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979431|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5979432|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5979433|NCT02727998|Midazolam|midazolam|mesh-list
5979434|NCT02727998|Ketamine|ketamine|mesh-list
5979435|NCT02727998|Analgesics|analgesics|mesh-ancestor
5979436|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
5979437|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979438|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979439|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5979440|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5979441|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
5979442|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
5979443|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5979444|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5979445|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5979446|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979447|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979448|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5979449|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5979450|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5979451|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5979452|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5979453|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
5979454|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
5979455|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
5979456|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979457|NCT02705963|Trametinib|trametinib|mesh-list
5979458|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5979459|NCT02705963|Norethindrone|norethindrone|mesh-list
5979460|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
5979461|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
5979462|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
5979463|NCT02705963|Estradiol|estradiol|mesh-list
5979464|NCT02705963|Estrogens|estrogens|mesh-ancestor
5979465|NCT02705963|Hormones|hormones|mesh-ancestor
5979466|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979467|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979468|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5979469|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5979470|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5979471|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979472|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979473|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979474|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979475|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5979476|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6245762|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6245763|NCT02726178|Analgesics|analgesics|mesh-ancestor
6245764|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
6245765|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245766|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245767|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5979477|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
5979478|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979479|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979480|NCT02675231|Trastuzumab|trastuzumab|mesh-list
5979481|NCT02675231|Fulvestrant|fulvestrant|mesh-list
5979482|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979483|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979484|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5979485|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5979486|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5979487|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
5979488|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979489|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979490|NCT02662257|Propofol|propofol|mesh-list
5979491|NCT02662257|Sevoflurane|sevoflurane|mesh-list
5979492|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5979493|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5979494|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979495|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5979496|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
5979497|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
5979498|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5979499|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
5979500|NCT02650401|Entrectinib|entrectinib|mesh-list
5979501|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979502|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979503|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979504|NCT02648477|Doxorubicin|doxorubicin|mesh-list
5979505|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5979506|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
5979507|NCT02648477|Letrozole|letrozole|mesh-list
5979508|NCT02648477|Anastrozole|anastrozole|mesh-list
5979509|NCT02648477|Exemestane|exemestane|mesh-list
5979510|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5979511|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979512|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5979513|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5979514|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979515|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979516|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979517|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5979518|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5979519|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5979520|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
5979521|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979522|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979523|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5979524|NCT02626507|Fulvestrant|fulvestrant|mesh-list
5979525|NCT02626507|Goserelin|goserelin|mesh-list
5979526|NCT02626507|Palbociclib|palbociclib|mesh-list
5979527|NCT02626507|Gedatolisib|gedatolisib|mesh-list
5979528|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5979529|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979530|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5979531|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5979532|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
5979533|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979534|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979535|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979536|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979537|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979538|NCT02607722|Nintedanib|nintedanib|mesh-list
5979539|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979540|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979541|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979542|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979543|NCT02605967|Spartalizumab|spartalizumab|mesh-list
5979544|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5979545|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979546|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979547|NCT02595892|Gemcitabine|gemcitabine|mesh-list
5979548|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979549|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
6245768|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979550|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979551|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979552|NCT02595892|Antiviral Agents|antiviral agents|mesh-ancestor
5979553|NCT02595892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5979554|NCT02595892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979555|NCT02595892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979556|NCT02595892|Immunologic Factors|immunologic factors|mesh-ancestor
5979557|NCT02595892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979558|NCT02584634|Avelumab|avelumab|mesh-list
5979559|NCT02584634|Crizotinib|crizotinib|mesh-list
5979560|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979561|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979562|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979563|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979564|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979565|NCT02581137|Metformin|metformin|mesh-list
5979566|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5979567|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979568|NCT02570503|Ketorolac|ketorolac|mesh-list
5979569|NCT02570503|Clonidine|clonidine|mesh-list
5979570|NCT02570503|Epinephrine|epinephrine|mesh-list
5979571|NCT02570503|Ropivacaine|ropivacaine|mesh-list
5979572|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
5979573|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
5979574|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5979575|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979576|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
5979577|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979578|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5979579|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5979580|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
5979581|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979582|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979583|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5979584|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5979585|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
5979586|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5979587|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
5979588|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
5979589|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
5979590|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5979591|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5979592|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5979593|NCT02570503|Analgesics|analgesics|mesh-ancestor
5979594|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5979595|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979596|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5979597|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979598|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5979599|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
5979600|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5979601|NCT02564068|Oxytocin|oxytocin|mesh-list
5979602|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
5979603|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5979604|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979605|NCT02562235|Riociguat|riociguat|mesh-list
5979606|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
5979607|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979608|NCT02553265|Carbidopa|carbidopa|mesh-list
5979609|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5979610|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5979611|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
5979612|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979613|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979614|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979615|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5979616|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979617|NCT02550288|Atorvastatin|atorvastatin|mesh-list
5979618|NCT02550288|Ezetimibe|ezetimibe|mesh-list
5979619|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5979620|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5979621|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
5979622|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979623|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5979624|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5979625|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979626|NCT02546661|Durvalumab|durvalumab|mesh-list
5979627|NCT02546661|Olaparib|olaparib|mesh-list
5979628|NCT02546661|Adavosertib|adavosertib|mesh-list
5979629|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979630|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979631|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5979632|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979633|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979634|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
5979635|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5979636|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5979637|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979638|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
5979639|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979640|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979641|NCT02499328|Durvalumab|durvalumab|mesh-list
5979642|NCT02499328|Tremelimumab|tremelimumab|mesh-list
5979643|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979644|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979645|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
5979646|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5979647|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5979648|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979649|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5979650|NCT02492269|Analgesics|analgesics|mesh-ancestor
5979651|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
5979652|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979653|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
5979654|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5979655|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5979656|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
5979657|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979658|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979659|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
5979660|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5979661|NCT02469753|Analgesics|analgesics|mesh-ancestor
5979662|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
5979663|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979664|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979665|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5979666|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979667|NCT02467153|Vitamin D|vitamin d|mesh-list
5979668|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
5979669|NCT02467153|Vitamins|vitamins|mesh-ancestor
5979670|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
5979671|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979672|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5979673|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5979674|NCT02464969|Apixaban|apixaban|mesh-list
5979675|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5979676|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
5979677|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5979678|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
5979679|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979680|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979681|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
5979682|NCT02460224|Spartalizumab|spartalizumab|mesh-list
5979683|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5979684|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979685|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979686|NCT02459457|Paclitaxel|paclitaxel|mesh-list
5979687|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5979688|NCT02459457|Carboplatin|carboplatin|mesh-list
5979689|NCT02459457|Fluorouracil|fluorouracil|mesh-list
5979690|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5979691|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979692|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
5979693|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
5979694|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
5979695|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979696|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
5979697|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979698|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979699|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
5979700|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979701|NCT02407236|Ustekinumab|ustekinumab|mesh-list
5979702|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
5979703|NCT02397083|Everolimus|everolimus|mesh-list
5979704|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
5979705|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979706|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979707|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
5979708|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979709|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5979710|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
5979711|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5979712|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5979713|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5979714|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5979715|NCT02386774|Benoxinate|benoxinate|mesh-list
5979716|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
5979717|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
5979718|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
5979719|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
5979720|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5979721|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979722|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
5979723|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979724|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
5979725|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5979726|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
5979727|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5979728|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979729|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5979730|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5979731|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5979732|NCT02320435|Trastuzumab|trastuzumab|mesh-list
5979733|NCT02320435|Pertuzumab|pertuzumab|mesh-list
5979734|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979735|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979736|NCT02320396|Desloratadine|desloratadine|mesh-list
5979737|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5979738|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
5979739|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979740|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979741|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979742|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5979743|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5979744|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
5979745|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
5979746|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
5979747|NCT02306161|Ifosfamide|ifosfamide|mesh-list
5979748|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
5979749|NCT02306161|Doxorubicin|doxorubicin|mesh-list
5979750|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5979751|NCT02306161|Etoposide|etoposide|mesh-list
5979752|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
5979753|NCT02306161|Vincristine|vincristine|mesh-list
5979754|NCT02306161|Daunorubicin|daunorubicin|mesh-list
5979755|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
5979756|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5979757|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979758|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
5979759|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979760|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979761|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5979762|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
5979763|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979764|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979765|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5979766|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5979767|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5979768|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5979769|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979770|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5979771|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
5979772|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
5979773|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
5979774|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
5979775|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
5979776|NCT02299505|Ceritinib|ceritinib|mesh-list
5979777|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979778|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979779|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979780|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979781|NCT02282345|Talazoparib|talazoparib|mesh-list
5979782|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5979783|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979784|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979785|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979786|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5979787|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5979788|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979789|NCT02250014|Sargramostim|sargramostim|mesh-list
5979790|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
5979791|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979792|NCT02235701|Ifosfamide|ifosfamide|mesh-list
5979793|NCT02235701|Doxorubicin|doxorubicin|mesh-list
5979794|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5979795|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
5979796|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979797|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979798|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5979799|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5979800|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5979801|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979802|NCT02235688|Gemcitabine|gemcitabine|mesh-list
5979803|NCT02235688|Doxorubicin|doxorubicin|mesh-list
5979804|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979805|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
5979806|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979807|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979808|NCT02235688|Antiviral Agents|antiviral agents|mesh-ancestor
5979809|NCT02235688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5979810|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979811|NCT02235688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979812|NCT02235688|Immunologic Factors|immunologic factors|mesh-ancestor
5979813|NCT02235688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979814|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5979815|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5979816|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5979817|NCT02185560|Sorafenib|sorafenib|mesh-list
5979818|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979819|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979820|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979821|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979822|NCT02152982|Temozolomide|temozolomide|mesh-list
5979823|NCT02152982|Veliparib|veliparib|mesh-list
5979824|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5979825|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
5979826|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979827|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979828|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5979829|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979830|NCT02115074|Celecoxib|celecoxib|mesh-list
5979831|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5979832|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5979833|NCT02115074|Analgesics|analgesics|mesh-ancestor
5979834|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
5979835|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979836|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979837|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5979838|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979839|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5979840|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5979841|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979842|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979843|NCT02070549|Trametinib|trametinib|mesh-list
5979844|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979845|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5979846|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979847|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979848|NCT02066636|Nivolumab|nivolumab|mesh-list
5979849|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979850|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979851|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5979852|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979853|NCT02053246|Nebivolol|nebivolol|mesh-list
5979854|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5979855|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
5979856|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
5979857|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5979858|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5979859|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
5979860|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979861|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979862|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979863|NCT02049905|Gemcitabine|gemcitabine|mesh-list
5979864|NCT02049905|Docetaxel|docetaxel|mesh-list
5979865|NCT02049905|Doxorubicin|doxorubicin|mesh-list
5979866|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5979867|NCT02049905|Ifosfamide|ifosfamide|mesh-list
5979868|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
5979869|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5979870|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
5979871|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979872|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979873|NCT02049905|Antiviral Agents|antiviral agents|mesh-ancestor
5979874|NCT02049905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5979875|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979876|NCT02049905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5979877|NCT02049905|Immunologic Factors|immunologic factors|mesh-ancestor
5979878|NCT02049905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979879|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
5979880|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
5979881|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
5979882|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5979883|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5979884|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5979885|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5979886|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
5979887|NCT02043678|Prednisone|prednisone|mesh-list
5979888|NCT02043678|Prednisolone|prednisolone|mesh-list
5979889|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
5979890|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5979891|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
5979892|NCT02043678|Hormones|hormones|mesh-ancestor
5979893|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979894|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979895|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5979896|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979897|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
5979898|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
5979899|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979900|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979901|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979902|NCT02005471|Rituximab|rituximab|mesh-list
5979903|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
5979904|NCT02005471|Venetoclax|venetoclax|mesh-list
5979905|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5979906|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5979907|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
5979908|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979909|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979910|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5979911|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
5979912|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979913|NCT01980940|Etoricoxib|etoricoxib|mesh-list
5979914|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
5979915|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5979916|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5979917|NCT01980940|Analgesics|analgesics|mesh-ancestor
5979918|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
5979919|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5979920|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979921|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5979922|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5979923|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5979924|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5979925|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979926|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979927|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
5979928|NCT01980940|Protective Agents|protective agents|mesh-ancestor
5979929|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5979930|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
5979931|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5979932|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
5979933|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979934|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5979935|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
5979936|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979937|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979938|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5979939|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5979940|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5979941|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
5979942|NCT01923298|Estradiol|estradiol|mesh-list
5979943|NCT01923298|Estrogens|estrogens|mesh-ancestor
5979944|NCT01923298|Hormones|hormones|mesh-ancestor
5979945|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5979946|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979947|NCT01918033|Desloratadine|desloratadine|mesh-list
5979948|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5979949|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
5979950|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979951|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979952|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979953|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5979954|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5979955|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
5979956|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
5979957|NCT01916980|Desloratadine|desloratadine|mesh-list
5979958|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5979959|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
5979960|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979961|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979962|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979963|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5979964|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5979965|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
5979966|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
5979967|NCT01916967|Desloratadine|desloratadine|mesh-list
5979968|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5979969|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
5979970|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5979971|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979972|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5979973|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5979974|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5979975|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
5979976|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
5979977|NCT01910402|Ritonavir|ritonavir|mesh-list
5979978|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5979979|NCT01910402|Tenofovir|tenofovir|mesh-list
5979980|NCT01910402|Lamivudine|lamivudine|mesh-list
5979981|NCT01910402|Emtricitabine|emtricitabine|mesh-list
5979982|NCT01910402|Abacavir|abacavir|mesh-list
5979983|NCT01910402|Dolutegravir|dolutegravir|mesh-list
5979984|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5979985|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5979986|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
5979987|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5979988|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5979989|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5979990|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5979991|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
5979992|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5979993|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5979994|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5979995|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5979996|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5979997|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5979998|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5979999|NCT01893320|Decitabine|decitabine|mesh-list
5980000|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5980001|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
5980002|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980003|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980004|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980005|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
5980006|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5980007|NCT01867606|Antibodies|antibodies|mesh-list
5980008|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
5980009|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980010|NCT01857063|Montelukast|montelukast|mesh-list
5980011|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5980012|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980013|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5980014|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
5980015|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980016|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980017|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5980018|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5980019|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980020|NCT01854268|Capsaicin|capsaicin|mesh-list
5980021|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
5980022|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980023|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
5980024|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980025|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245769|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6245770|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245771|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245772|NCT02726620|Lidocaine|lidocaine|mesh-list
6245773|NCT02726620|Atropine|atropine|mesh-list
6245774|NCT02726620|Terlipressin|terlipressin|mesh-list
6245775|NCT02726620|Phenylephrine|phenylephrine|mesh-list
6245776|NCT02726620|Dobutamine|dobutamine|mesh-list
6245777|NCT02726620|Dopamine|dopamine|mesh-list
6245778|NCT02726620|Milrinone|milrinone|mesh-list
6245779|NCT02726620|Isoproterenol|isoproterenol|mesh-list
6245780|NCT02726620|Vasopressins|vasopressins|mesh-list
6245781|NCT02726620|Arginine Vasopressin|arginine vasopressin|mesh-list
6245782|NCT02726620|Epinephrine|epinephrine|mesh-list
6245783|NCT02726620|Norepinephrine|norepinephrine|mesh-list
6245784|NCT02726620|Ephedrine|ephedrine|mesh-list
6245785|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
6245786|NCT02726620|Bupivacaine|bupivacaine|mesh-list
6245787|NCT02726620|Ropivacaine|ropivacaine|mesh-list
6245788|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
6245789|NCT02726620|Tetracaine|tetracaine|mesh-list
6245790|NCT02726620|Prilocaine|prilocaine|mesh-list
6245791|NCT02726620|Mepivacaine|mepivacaine|mesh-list
6245792|NCT02726620|Benzocaine|benzocaine|mesh-list
6245793|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
6245794|NCT02726620|Procaine|procaine|mesh-list
6245795|NCT02726620|Anesthetics|anesthetics|mesh-list
6245796|NCT02726620|Propofol|propofol|mesh-list
6245797|NCT02726620|Sevoflurane|sevoflurane|mesh-list
6245798|NCT02726620|Desflurane|desflurane|mesh-list
6245799|NCT02726620|Isoflurane|isoflurane|mesh-list
6245800|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6245801|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
6245802|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
6245803|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6245804|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245805|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
6245806|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245807|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6245808|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6245809|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6245810|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245811|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245812|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6245813|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6245814|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
6245815|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6245816|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6245817|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6245818|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6245819|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
6245820|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245821|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5980026|NCT01853826|Afatinib|afatinib|mesh-list
5980027|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980028|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5980029|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980030|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980031|NCT01852812|Montelukast|montelukast|mesh-list
5980032|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5980033|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980034|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5980035|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
5980036|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980037|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980038|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5980039|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5980040|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980041|NCT01844986|Olaparib|olaparib|mesh-list
5980042|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
5980043|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980044|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980045|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980046|NCT01828021|Margetuximab|margetuximab|mesh-list
5980047|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980048|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5980049|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5980050|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5980051|NCT01709318|Etonogestrel|etonogestrel|mesh-list
5980052|NCT01709318|Estradiol|estradiol|mesh-list
5980053|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5980054|NCT01709318|Estrogens|estrogens|mesh-ancestor
5980055|NCT01709318|Hormones|hormones|mesh-ancestor
5980056|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980057|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980058|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5980059|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
5980060|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5980061|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5980062|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5980063|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5980064|NCT01698918|Dexamethasone|dexamethasone|mesh-list
5980065|NCT01698918|Everolimus|everolimus|mesh-list
5980066|NCT01698918|Letrozole|letrozole|mesh-list
5980067|NCT01698918|Exemestane|exemestane|mesh-list
5980068|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980069|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
5980070|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
5980071|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980072|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980073|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5980074|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
5980075|NCT01698918|Hormones|hormones|mesh-ancestor
5980076|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980077|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5980078|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980079|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5980080|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
5980081|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5980082|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5980083|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980084|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980085|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5980086|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
5980087|NCT01673620|Loratadine|loratadine|mesh-list
5980088|NCT01673620|Montelukast|montelukast|mesh-list
5980089|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5980090|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980091|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5980092|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
5980093|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980094|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980095|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5980096|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5980097|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980098|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
5980099|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980100|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980101|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5980102|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5980103|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
5980104|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
5980105|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980106|NCT01617187|Olanzapine|olanzapine|mesh-list
5980107|NCT01617187|Asenapine|asenapine|mesh-list
5980108|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
5980109|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
5980110|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980111|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980112|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5980113|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5980114|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5980115|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5980116|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5980117|NCT01617187|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5980118|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5980119|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5980120|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980121|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980122|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
5980123|NCT01611883|Ezetimibe|ezetimibe|mesh-list
5980124|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980125|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980126|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
5980127|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980128|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980129|NCT01572675|Celecoxib|celecoxib|mesh-list
5980130|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5980131|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5980132|NCT01572675|Analgesics|analgesics|mesh-ancestor
5980133|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
5980134|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980135|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980136|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980137|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980138|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5980139|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5980140|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980141|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980142|NCT01554163|Celecoxib|celecoxib|mesh-list
5980143|NCT01554163|Etoricoxib|etoricoxib|mesh-list
5980144|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5980145|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5980146|NCT01554163|Analgesics|analgesics|mesh-ancestor
5980147|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
5980148|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980149|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980150|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980151|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980152|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5980153|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5980154|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980155|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980156|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
5980157|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980158|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980159|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980160|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5980161|NCT01490190|Etonogestrel|etonogestrel|mesh-list
5980162|NCT01490190|NuvaRing|nuvaring|mesh-list
5980163|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5980164|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5980165|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5980166|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
5980167|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5980168|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980169|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5980170|NCT01490190|Estrogens|estrogens|mesh-ancestor
5980171|NCT01490190|Hormones|hormones|mesh-ancestor
5980172|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980173|NCT01473108|Eplerenone|eplerenone|mesh-list
5980174|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5980175|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
5980176|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980177|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980178|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5980179|NCT01473108|Diuretics|diuretics|mesh-ancestor
5980180|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
5980181|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5980182|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
5980183|NCT01471340|Prednisone|prednisone|mesh-list
5980184|NCT01471340|Prednisolone|prednisolone|mesh-list
5980185|NCT01471340|Albuterol|albuterol|mesh-list
5980186|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
5980187|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
5980188|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980189|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
5980190|NCT01471340|Hormones|hormones|mesh-ancestor
5980191|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980192|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980193|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5980194|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980195|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
5980196|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980197|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5980198|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5980199|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980200|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5980201|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5980202|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5980203|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
5980204|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980205|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980206|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
5980207|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5980208|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980209|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980210|NCT01462370|Acetaminophen|acetaminophen|mesh-list
5980211|NCT01462370|Ibuprofen|ibuprofen|mesh-list
5980212|NCT01462370|Etoricoxib|etoricoxib|mesh-list
5980213|NCT01462370|Caffeine|caffeine|mesh-list
5980214|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5980215|NCT01462370|Analgesics|analgesics|mesh-ancestor
5980216|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
5980217|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980218|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980219|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
5980220|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5980221|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980222|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980223|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5980224|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980225|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980226|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5980227|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5980228|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5980229|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5980230|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
5980231|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980232|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5980233|NCT01381679|Ezetimibe|ezetimibe|mesh-list
5980234|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980235|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980236|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
5980237|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980238|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980239|NCT01379989|Carboplatin|carboplatin|mesh-list
5980240|NCT01379989|Doxorubicin|doxorubicin|mesh-list
5980241|NCT01379989|Trabectedin|trabectedin|mesh-list
5980242|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980243|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5980244|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5980245|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5980246|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980247|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980248|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5980249|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
5980250|NCT01370603|Atorvastatin|atorvastatin|mesh-list
5980251|NCT01370603|Ezetimibe|ezetimibe|mesh-list
5980252|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980253|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980254|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
5980255|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980256|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980257|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5980258|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980259|NCT01370590|Atorvastatin|atorvastatin|mesh-list
5980260|NCT01370590|Ezetimibe|ezetimibe|mesh-list
5980261|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980262|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980263|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
5980264|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980265|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980266|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5980267|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980268|NCT01349907|Asenapine|asenapine|mesh-list
5980269|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5980270|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5980271|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5980272|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980273|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5980274|NCT01345656|Spironolactone|spironolactone|mesh-list
5980275|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
5980276|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
5980277|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980278|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980279|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5980280|NCT01345656|Diuretics|diuretics|mesh-ancestor
5980281|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
5980282|NCT01277822|Losartan|losartan|mesh-list
5980283|NCT01277822|Amlodipine|amlodipine|mesh-list
5980284|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5980285|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5980286|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5980287|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980288|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5980289|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980290|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
5980291|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5980292|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5980293|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5980294|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
5980295|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5980296|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
5980297|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980298|NCT01261247|Panobinostat|panobinostat|mesh-list
5980299|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
5980300|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980301|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980302|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980303|NCT01208207|Naproxen|naproxen|mesh-list
5980304|NCT01208207|Etoricoxib|etoricoxib|mesh-list
5980305|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5980306|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5980307|NCT01208207|Analgesics|analgesics|mesh-ancestor
5980308|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
5980309|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980310|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980311|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980312|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980313|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
5980314|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5980315|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980316|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980317|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5980318|NCT01208181|Etoricoxib|etoricoxib|mesh-list
5980319|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5980320|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5980321|NCT01208181|Analgesics|analgesics|mesh-ancestor
5980322|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
5980323|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980324|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980325|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980326|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980327|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5980328|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5980329|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980330|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980331|NCT01206517|Asenapine|asenapine|mesh-list
5980332|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5980333|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5980334|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5980335|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980336|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5980337|NCT01190267|Asenapine|asenapine|mesh-list
5980338|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5980339|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5980340|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5980341|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980342|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5980343|NCT01190254|Asenapine|asenapine|mesh-list
5980344|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5980345|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5980346|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5980347|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980348|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5980349|NCT01154036|Atorvastatin|atorvastatin|mesh-list
5980350|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
5980351|NCT01154036|Ezetimibe|ezetimibe|mesh-list
5980352|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980353|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980354|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
5980355|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980356|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980357|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5980358|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980359|NCT01101464|Asenapine|asenapine|mesh-list
5980360|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5980361|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5980362|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5980363|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980364|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5980365|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
5980366|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980367|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980368|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980369|NCT01030341|Insulin|insulin|mesh-list
5980370|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5980371|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5980372|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980373|NCT01013649|Gemcitabine|gemcitabine|mesh-list
5980374|NCT01013649|Fluorouracil|fluorouracil|mesh-list
5980375|NCT01013649|Capecitabine|capecitabine|mesh-list
5980376|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5980377|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5980378|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
5980379|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980380|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980381|NCT01013649|Antiviral Agents|antiviral agents|mesh-ancestor
5980382|NCT01013649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5980383|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980384|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5980385|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
5980386|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980387|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5980388|NCT00979901|Loratadine|loratadine|mesh-list
5980389|NCT00979901|Montelukast|montelukast|mesh-list
5980390|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5980391|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980392|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5980393|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
5980394|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980395|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980396|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5980397|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5980398|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980399|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
5980400|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980401|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980402|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5980403|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5980404|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
5980405|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
5980406|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980407|NCT00977574|Sirolimus|sirolimus|mesh-list
5980408|NCT00977574|Paclitaxel|paclitaxel|mesh-list
5980409|NCT00977574|Epothilones|epothilones|mesh-list
5980410|NCT00977574|Epothilone B|epothilone b|mesh-list
5980411|NCT00977574|Bevacizumab|bevacizumab|mesh-list
5980412|NCT00977574|Carboplatin|carboplatin|mesh-list
5980413|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5980414|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5980415|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
5980416|NCT00977574|Antibodies|antibodies|mesh-list
5980417|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
5980418|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5980419|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
5980420|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5980421|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980422|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
5980423|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
5980424|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
5980425|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980426|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5980427|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5980428|NCT00977574|Growth Substances|growth substances|mesh-ancestor
5980429|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980430|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
5980431|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
5980432|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5980433|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5980434|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5980435|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
5980436|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5980437|NCT00963599|Loratadine|loratadine|mesh-list
5980438|NCT00963599|Montelukast|montelukast|mesh-list
5980439|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5980440|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980441|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5980442|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
5980443|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980444|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980445|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5980446|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5980447|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980448|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
5980449|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980450|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980451|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5980452|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5980453|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
5980454|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
5980455|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980456|NCT00953680|Losartan|losartan|mesh-list
5980457|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5980458|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5980459|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5980460|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5980461|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5980462|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980463|NCT00953680|Diuretics|diuretics|mesh-ancestor
5980464|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
5980465|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980466|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5980467|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5980468|NCT00945035|Etoricoxib|etoricoxib|mesh-list
5980469|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5980470|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5980471|NCT00945035|Analgesics|analgesics|mesh-ancestor
5980472|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
5980473|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980474|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980475|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980476|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980477|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5980478|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5980479|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980480|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980481|NCT00943852|Losartan|losartan|mesh-list
5980482|NCT00943852|Isosorbide|isosorbide|mesh-list
5980483|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
5980484|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
5980485|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5980486|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5980487|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5980488|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5980489|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980490|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
5980491|NCT00943852|Diuretics|diuretics|mesh-ancestor
5980492|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
5980493|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980494|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
5980495|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
5980496|NCT00909389|Simvastatin|simvastatin|mesh-list
5980497|NCT00909389|Ezetimibe|ezetimibe|mesh-list
5980498|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
5980499|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980500|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980501|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
5980502|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980503|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980504|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5980505|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980506|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5980507|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
5980508|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5980522|NCT00820027|Ibuprofen|ibuprofen|mesh-list
5980523|NCT00820027|Etoricoxib|etoricoxib|mesh-list
5980524|NCT00820027|Morphine|morphine|mesh-list
5980525|NCT00820027|Oxycodone|oxycodone|mesh-list
5980526|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5980527|NCT00820027|Narcotics|narcotics|mesh-ancestor
5980528|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5980529|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980530|NCT00820027|Analgesics|analgesics|mesh-ancestor
5980531|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
5980532|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980533|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5980534|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5980535|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980536|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980537|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5980538|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980539|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980540|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5980541|NCT00788710|Etoricoxib|etoricoxib|mesh-list
5980542|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5980543|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5980544|NCT00788710|Analgesics|analgesics|mesh-ancestor
5980545|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
5980546|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980547|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980548|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980549|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980550|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5980551|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5980552|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980553|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980554|NCT00785291|Paclitaxel|paclitaxel|mesh-list
5980555|NCT00785291|Epothilones|epothilones|mesh-list
5980556|NCT00785291|Epothilone B|epothilone b|mesh-list
5980557|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5980558|NCT00785291|Bevacizumab|bevacizumab|mesh-list
5980559|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5980560|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
5980561|NCT00785291|Antibodies|antibodies|mesh-list
5980562|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
5980563|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5980564|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
5980565|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5980566|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980567|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
5980568|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
5980569|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
5980570|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980571|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5980572|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5980573|NCT00785291|Growth Substances|growth substances|mesh-ancestor
5980574|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980575|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
5980576|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
5980577|NCT00783224|Fluticasone|fluticasone|mesh-list
5980578|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
5980579|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980580|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5980581|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
5980582|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980583|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980584|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5980585|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980586|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980587|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980588|NCT00780403|Cetirizine|cetirizine|mesh-list
5980589|NCT00780403|Desloratadine|desloratadine|mesh-list
5980590|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980591|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5980592|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5980593|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
5980594|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
5980595|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980596|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980597|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980598|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5980599|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
5980600|NCT00779116|Cetirizine|cetirizine|mesh-list
5980601|NCT00779116|Desloratadine|desloratadine|mesh-list
5980602|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980603|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5980604|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5980605|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
5980606|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
5980607|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980608|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980609|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980610|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5980611|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
5980612|NCT00764478|Asenapine|asenapine|mesh-list
5980613|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5980614|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5980615|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5980616|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980617|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5980618|NCT00761527|Desloratadine|desloratadine|mesh-list
5980619|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5980620|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
5980621|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980622|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980623|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980624|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5980625|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5980626|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
5980627|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
5980628|NCT00757627|Etoricoxib|etoricoxib|mesh-list
5980629|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5980630|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5980631|NCT00757627|Analgesics|analgesics|mesh-ancestor
5980632|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
5980633|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980634|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980635|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980636|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980637|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5980638|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5980639|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980640|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980641|NCT00756938|Losartan|losartan|mesh-list
5980642|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5980643|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5980644|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5980645|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5980646|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980647|NCT00746590|Tretazicar|tretazicar|mesh-list
5980648|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980649|NCT00730132|Ezetimibe|ezetimibe|mesh-list
5980650|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980651|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980652|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
5980653|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980654|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980655|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
5980656|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980657|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980658|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980659|NCT00723736|Desloratadine|desloratadine|mesh-list
5980660|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5980661|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
5980662|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980663|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980664|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980665|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5980666|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5980667|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
5980668|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
5980669|NCT00705081|Ezetimibe|ezetimibe|mesh-list
5980670|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980671|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980672|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
5980673|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980674|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980675|NCT00704769|Desloratadine|desloratadine|mesh-list
5980676|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5980677|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
5980678|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980679|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980680|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980681|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5980682|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5980683|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
5980684|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
5980685|NCT00704535|Ezetimibe|ezetimibe|mesh-list
5980686|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980687|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980688|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
5980689|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980690|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6245822|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6245823|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
6245824|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6245825|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
6245826|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
6245827|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
6245828|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5980691|NCT00694850|Riociguat|riociguat|mesh-list
5980692|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
5980693|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980694|NCT00694369|Acetaminophen|acetaminophen|mesh-list
5980695|NCT00694369|Ibuprofen|ibuprofen|mesh-list
5980696|NCT00694369|Etoricoxib|etoricoxib|mesh-list
5980697|NCT00694369|Codeine|codeine|mesh-list
5980698|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5980699|NCT00694369|Analgesics|analgesics|mesh-ancestor
5980700|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
5980701|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980702|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980703|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
5980704|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5980705|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980706|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980707|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5980708|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980709|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980710|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5980711|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
5980712|NCT00694369|Narcotics|narcotics|mesh-ancestor
5980713|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5980714|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
5980715|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980716|NCT00671528|Gentamicins|gentamicins|mesh-list
5980717|NCT00671528|Clotrimazole|clotrimazole|mesh-list
5980718|NCT00671528|Miconazole|miconazole|mesh-list
5980719|NCT00671528|Betamethasone|betamethasone|mesh-list
5980720|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
5980721|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
5980722|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
5980723|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
5980724|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980725|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
5980726|NCT00671528|Hormones|hormones|mesh-ancestor
5980727|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980728|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980729|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5980730|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980731|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5980732|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5980733|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5980734|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980735|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980736|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5980737|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
5980738|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5980739|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5980740|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5980741|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
5980742|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5980743|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5980744|NCT00667823|Macitentan|macitentan|mesh-list
5980745|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
5980746|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
5980747|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980748|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
5980749|NCT00652327|Atorvastatin|atorvastatin|mesh-list
5980750|NCT00652327|Simvastatin|simvastatin|mesh-list
5980751|NCT00652327|Ezetimibe|ezetimibe|mesh-list
5980752|NCT00652327|Pravastatin|pravastatin|mesh-list
5980753|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
5980754|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980755|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980756|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
5980757|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980758|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980759|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980760|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
5980761|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
5980762|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5980763|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
5980764|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980765|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980766|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5980767|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980768|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
5980769|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
5980770|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5980771|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
5980772|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980773|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980774|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980775|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980776|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980777|NCT00602641|Thalidomide|thalidomide|mesh-list
5980778|NCT00602641|Prednisone|prednisone|mesh-list
5980779|NCT00602641|Cortisone|cortisone|mesh-list
5980780|NCT00602641|Lenalidomide|lenalidomide|mesh-list
5980781|NCT00602641|Melphalan|melphalan|mesh-list
5980782|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
5980783|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5980784|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980785|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
5980786|NCT00602641|Hormones|hormones|mesh-ancestor
5980787|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980788|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980789|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5980790|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980791|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
5980792|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5980793|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5980794|NCT00602641|Growth Substances|growth substances|mesh-ancestor
5980795|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
5980796|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5980797|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
5980798|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980799|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5980800|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5980801|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
5980802|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5980803|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5980804|NCT00568178|Losartan|losartan|mesh-list
5980805|NCT00568178|Amlodipine|amlodipine|mesh-list
5980806|NCT00568178|Enalapril|enalapril|mesh-list
5980807|NCT00568178|Enalaprilat|enalaprilat|mesh-list
5980808|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5980809|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5980810|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5980811|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980812|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5980813|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980814|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
5980815|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5980816|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5980817|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5980818|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980819|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5980820|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
5980821|NCT00549848|Cytarabine|cytarabine|mesh-list
5980822|NCT00549848|Dexamethasone|dexamethasone|mesh-list
5980823|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
5980824|NCT00549848|Prednisone|prednisone|mesh-list
5980825|NCT00549848|Prednisolone|prednisolone|mesh-list
5980826|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
5980827|NCT00549848|Doxorubicin|doxorubicin|mesh-list
5980828|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5980829|NCT00549848|Methotrexate|methotrexate|mesh-list
5980830|NCT00549848|Etoposide|etoposide|mesh-list
5980831|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
5980832|NCT00549848|Vincristine|vincristine|mesh-list
5980833|NCT00549848|Daunorubicin|daunorubicin|mesh-list
5980834|NCT00549848|Asparaginase|asparaginase|mesh-list
5980835|NCT00549848|Dasatinib|dasatinib|mesh-list
5980836|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
5980837|NCT00549848|Clofarabine|clofarabine|mesh-list
5980838|NCT00549848|Pegaspargase|pegaspargase|mesh-list
5980839|NCT00549848|Thioguanine|thioguanine|mesh-list
5980840|NCT00549848|BB 1101|bb 1101|mesh-list
5980841|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5980842|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
5980843|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980844|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5980845|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5980846|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
5980847|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980848|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980849|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5980850|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980851|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
5980852|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
5980853|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980854|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5980855|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
5980856|NCT00549848|Hormones|hormones|mesh-ancestor
5980857|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980858|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5980859|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
5980860|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980861|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5980862|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5980863|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5980864|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5980865|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
5980866|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5980867|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5980868|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
5980869|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980870|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5980871|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5980872|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5980873|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
5980874|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5980875|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
5980876|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
5980877|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
5980878|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5980879|NCT00545844|Montelukast|montelukast|mesh-list
5980880|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5980881|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
5980882|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5980883|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
5980884|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980885|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980886|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5980887|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5980888|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980889|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
5980890|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
5980891|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
5980892|NCT00511355|Estradiol|estradiol|mesh-list
5980893|NCT00511355|Estrogens|estrogens|mesh-ancestor
5980894|NCT00511355|Hormones|hormones|mesh-ancestor
5980895|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980896|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980897|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5980898|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
5980899|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5980900|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5980901|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5980902|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5980903|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5980904|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
5980905|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
5980906|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980907|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980908|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980909|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
5980910|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980911|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980912|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980913|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
5980914|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980915|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980916|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980917|NCT00447603|Losartan|losartan|mesh-list
5980918|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
5980919|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5980920|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5980921|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5980922|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5980923|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980924|NCT00447603|Diuretics|diuretics|mesh-ancestor
5980925|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
5980926|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980927|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
5980928|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5980929|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
5980930|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980931|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980932|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980933|NCT00423488|Simvastatin|simvastatin|mesh-list
5980934|NCT00423488|Ezetimibe|ezetimibe|mesh-list
5980935|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980936|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980937|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
5980938|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980939|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980940|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5980941|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980942|NCT00413972|Simvastatin|simvastatin|mesh-list
5980943|NCT00413972|Ezetimibe|ezetimibe|mesh-list
5980944|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5980945|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5980946|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
5980947|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980948|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5980949|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5980950|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5980951|NCT00391170|Dexamethasone|dexamethasone|mesh-list
5980952|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5980953|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
5980954|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
5980955|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5980956|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980957|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5980958|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
5980959|NCT00391170|Hormones|hormones|mesh-ancestor
5980960|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980961|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5980962|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980963|NCT00359138|Cetirizine|cetirizine|mesh-list
5980964|NCT00359138|Loratadine|loratadine|mesh-list
5980965|NCT00359138|Levocetirizine|levocetirizine|mesh-list
5980966|NCT00359138|Desloratadine|desloratadine|mesh-list
5980967|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
5980968|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5980969|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
5980970|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
5980971|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5980972|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5980973|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980974|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5980975|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5980976|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
5980977|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
5980978|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
5980979|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
5980980|NCT00350701|Testosterone|testosterone|mesh-list
5980981|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
5980982|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
5980983|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5980984|NCT00350701|Androgens|androgens|mesh-ancestor
5980985|NCT00350701|Hormones|hormones|mesh-ancestor
5980986|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5980987|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980988|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5980989|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5980990|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
5980991|NCT00335816|Leucovorin|leucovorin|mesh-list
5980992|NCT00335816|Fluorouracil|fluorouracil|mesh-list
5980993|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
5980994|NCT00335816|Calcium|calcium|mesh-list
5980995|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
5980996|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5980997|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5980998|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
5980999|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981000|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981001|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981002|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981003|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
5981004|NCT00335816|Antidotes|antidotes|mesh-ancestor
5981005|NCT00335816|Protective Agents|protective agents|mesh-ancestor
5981006|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
5981007|NCT00335816|Vitamins|vitamins|mesh-ancestor
5981008|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
5981009|NCT00319449|Atorvastatin|atorvastatin|mesh-list
5981010|NCT00319449|Ezetimibe|ezetimibe|mesh-list
5981011|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5981012|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5981013|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
5981014|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981015|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5981016|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5981017|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981018|NCT00305344|Vaccines|vaccines|mesh-list
5981019|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
5981020|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981021|NCT00289887|Losartan|losartan|mesh-list
5981022|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5981023|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5981024|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5981025|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5981026|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981027|NCT00281320|Asenapine|asenapine|mesh-list
5981028|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5981029|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5981030|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5981031|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981032|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5981033|NCT00276016|Phenylephrine|phenylephrine|mesh-list
5981034|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
5981035|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
5981036|NCT00276016|Ephedrine|ephedrine|mesh-list
5981037|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5981038|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
5981039|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
5981040|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5981041|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981042|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
5981043|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5981044|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
5981045|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
5981046|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5981047|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5981048|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5981049|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
5981050|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5981051|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981052|NCT00276016|Protective Agents|protective agents|mesh-ancestor
5981053|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5981054|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5981055|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5981056|NCT00265343|Olanzapine|olanzapine|mesh-list
5981057|NCT00265343|Asenapine|asenapine|mesh-list
5981058|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
5981059|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
5981060|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5981061|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981062|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5981063|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5981064|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5981065|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5981066|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5981067|NCT00265343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5981068|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5981069|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245829|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5981070|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981071|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5981072|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
5981073|NCT00264147|Diclofenac|diclofenac|mesh-list
5981074|NCT00264147|Etoricoxib|etoricoxib|mesh-list
5981075|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5981076|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5981077|NCT00264147|Analgesics|analgesics|mesh-ancestor
5981078|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
5981079|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5981080|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981081|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5981082|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981083|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5981084|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981085|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981086|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5981087|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
5981088|NCT00217737|Leucovorin|leucovorin|mesh-list
5981089|NCT00217737|Folic Acid|folic acid|mesh-list
5981090|NCT00217737|Bevacizumab|bevacizumab|mesh-list
5981091|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5981092|NCT00217737|Fluorouracil|fluorouracil|mesh-list
5981093|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
5981094|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
5981095|NCT00217737|Antibodies|antibodies|mesh-list
5981096|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
5981097|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5981098|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
5981099|NCT00217737|Calcium|calcium|mesh-list
5981100|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
5981101|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981102|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5981103|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5981104|NCT00217737|Growth Substances|growth substances|mesh-ancestor
5981105|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981106|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
5981107|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
5981108|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5981109|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5981110|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
5981111|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981112|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981113|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981114|NCT00217737|Antidotes|antidotes|mesh-ancestor
5981115|NCT00217737|Protective Agents|protective agents|mesh-ancestor
5981116|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
5981117|NCT00217737|Vitamins|vitamins|mesh-ancestor
5981118|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
5981119|NCT00217737|Hematinics|hematinics|mesh-ancestor
5981120|NCT00202878|Simvastatin|simvastatin|mesh-list
5981121|NCT00202878|Ezetimibe|ezetimibe|mesh-list
5981122|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
5981123|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5981124|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5981125|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
5981126|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981127|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5981128|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5981129|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981130|NCT00174265|Olanzapine|olanzapine|mesh-list
5981131|NCT00174265|Asenapine|asenapine|mesh-list
5981132|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
5981133|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
5981134|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5981135|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981136|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5981137|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5981138|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5981139|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5981140|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5981141|NCT00174265|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5981142|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5981143|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5981144|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981145|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5981146|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
5981147|NCT00159783|Olanzapine|olanzapine|mesh-list
5981148|NCT00159783|Asenapine|asenapine|mesh-list
5981149|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
5981150|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
5981151|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5981152|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981153|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5981154|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5981155|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5981156|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5981157|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5981158|NCT00159783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5981159|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5981160|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5981161|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981162|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5981163|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
5981164|NCT00114101|Lenalidomide|lenalidomide|mesh-list
5981165|NCT00114101|Melphalan|melphalan|mesh-list
5981166|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
5981167|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5981168|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
5981169|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981170|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5981171|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5981172|NCT00114101|Growth Substances|growth substances|mesh-ancestor
5981173|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
5981174|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981175|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981176|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
5981177|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981178|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981179|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981180|NCT00092677|Simvastatin|simvastatin|mesh-list
5981181|NCT00092677|Ezetimibe|ezetimibe|mesh-list
5981182|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5981183|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5981184|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
5981185|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981186|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5981187|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5981188|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981189|NCT00090259|Losartan|losartan|mesh-list
5981190|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5981191|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5981192|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5981193|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5981194|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981195|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
5981196|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981197|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5981198|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981199|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981200|NCT00003298|Leucovorin|leucovorin|mesh-list
5981201|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
5981202|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
5981203|NCT00003298|Paclitaxel|paclitaxel|mesh-list
5981204|NCT00003298|Cisplatin|cisplatin|mesh-list
5981205|NCT00003298|Fluorouracil|fluorouracil|mesh-list
5981206|NCT00003298|Calcium|calcium|mesh-list
5981207|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
5981208|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981209|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981210|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981211|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981212|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981213|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981214|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5981215|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981216|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
5981217|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981218|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981219|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
5981220|NCT00003298|Antidotes|antidotes|mesh-ancestor
5981221|NCT00003298|Protective Agents|protective agents|mesh-ancestor
5981222|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
5981223|NCT00003298|Vitamins|vitamins|mesh-ancestor
5981224|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
5981225|NCT00003377|Paclitaxel|paclitaxel|mesh-list
5981226|NCT00003377|Cisplatin|cisplatin|mesh-list
5981227|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981228|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981229|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981230|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981231|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981232|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981233|NCT00003389|Prednisone|prednisone|mesh-list
5981234|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
5981235|NCT00003389|Dacarbazine|dacarbazine|mesh-list
5981236|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
5981237|NCT00003389|Doxorubicin|doxorubicin|mesh-list
5981238|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981239|NCT00003389|Etoposide|etoposide|mesh-list
5981240|NCT00003389|Vincristine|vincristine|mesh-list
5981241|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
5981242|NCT00003389|Bleomycin|bleomycin|mesh-list
5981243|NCT00003389|Vinblastine|vinblastine|mesh-list
5981244|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
5981245|NCT00003389|Imidazole|imidazole|mesh-list
5981246|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981247|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
5981248|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981249|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981250|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981251|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
5981252|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981253|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981254|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981255|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981256|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981257|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981258|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981259|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5981260|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
5981261|NCT00003389|Hormones|hormones|mesh-ancestor
5981262|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5981263|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981264|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981265|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981266|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981267|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981268|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
5981269|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
5981270|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
5981271|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981272|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
5981273|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981274|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981275|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5981276|NCT00003631|Cytarabine|cytarabine|mesh-list
5981277|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
5981278|NCT00003631|Melphalan|melphalan|mesh-list
5981279|NCT00003631|Ifosfamide|ifosfamide|mesh-list
5981280|NCT00003631|Carmustine|carmustine|mesh-list
5981281|NCT00003631|Carboplatin|carboplatin|mesh-list
5981282|NCT00003631|Etoposide|etoposide|mesh-list
5981283|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981284|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
5981285|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981286|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981287|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981288|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
5981289|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981290|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981291|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981292|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981293|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981294|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981295|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981296|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981297|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
5981298|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
5981299|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981300|NCT00003641|Interferons|interferons|mesh-list
5981301|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
5981302|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
5981303|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981304|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
5981305|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981306|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
5981307|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981308|NCT00003644|Paclitaxel|paclitaxel|mesh-list
5981309|NCT00003644|Carboplatin|carboplatin|mesh-list
5981310|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981311|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981312|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981313|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981314|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981315|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981316|NCT00003645|Leuprolide|leuprolide|mesh-list
5981317|NCT00003645|Goserelin|goserelin|mesh-list
5981318|NCT00003645|Flutamide|flutamide|mesh-list
5981319|NCT00003645|Bicalutamide|bicalutamide|mesh-list
5981320|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5981321|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
5981322|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5981323|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981324|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981325|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981326|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
5981327|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
5981328|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5981329|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
5981330|NCT00003659|Rituximab|rituximab|mesh-list
5981331|NCT00003659|Fludarabine|fludarabine|mesh-list
5981332|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
5981333|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981334|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
5981335|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981336|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981337|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981338|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
5981339|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981340|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981341|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981342|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5981343|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981344|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
5981345|NCT00003702|Dactinomycin|dactinomycin|mesh-list
5981346|NCT00003702|Cactinomycin|cactinomycin|mesh-list
5981347|NCT00003702|Methotrexate|methotrexate|mesh-list
5981348|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5981349|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
5981350|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5981351|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981352|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981353|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
5981354|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981355|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981356|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
5981357|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981358|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5981359|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981360|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
5981361|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981362|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5981363|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5981364|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981365|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981366|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5981367|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
5981368|NCT00003782|Docetaxel|docetaxel|mesh-list
5981369|NCT00003782|Doxorubicin|doxorubicin|mesh-list
5981370|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981371|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
5981372|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981373|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981374|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981375|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
5981376|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981377|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981378|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981379|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981380|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981381|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981382|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981383|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981384|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981385|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981386|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
5981387|NCT00003816|Melphalan|melphalan|mesh-list
5981388|NCT00003816|Busulfan|busulfan|mesh-list
5981389|NCT00003816|Thiotepa|thiotepa|mesh-list
5981390|NCT00003816|Carboplatin|carboplatin|mesh-list
5981391|NCT00003816|Fludarabine|fludarabine|mesh-list
5981392|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
5981393|NCT00003816|Etoposide|etoposide|mesh-list
5981394|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5981395|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981396|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
5981397|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981398|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981399|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981400|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
5981401|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981402|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981403|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981404|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981405|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
5981406|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981407|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981408|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981409|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981410|NCT00003820|Rituximab|rituximab|mesh-list
5981411|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5981412|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981413|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
5981414|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981415|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981416|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
5981417|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981418|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5981419|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5981420|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981421|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5981422|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981423|NCT00003875|Aldesleukin|aldesleukin|mesh-list
5981424|NCT00003875|Etoposide|etoposide|mesh-list
5981425|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
5981426|NCT00003875|Busulfan|busulfan|mesh-list
5981427|NCT00003875|Interleukin-2|interleukin-2|mesh-list
5981428|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981429|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981430|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981431|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981432|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981433|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981434|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
5981435|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981436|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
5981437|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981438|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981439|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981440|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5981441|NCT00003875|Analgesics|analgesics|mesh-ancestor
5981442|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
5981443|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5981444|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5981445|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5981446|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
5981447|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981448|NCT00003896|Paclitaxel|paclitaxel|mesh-list
5981449|NCT00003896|Doxorubicin|doxorubicin|mesh-list
5981450|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981451|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981452|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981453|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981454|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981455|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981456|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981457|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981458|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981459|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981460|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981461|NCT00003907|Cisplatin|cisplatin|mesh-list
5981462|NCT00003907|Doxorubicin|doxorubicin|mesh-list
5981463|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981464|NCT00003907|Mitomycins|mitomycins|mesh-list
5981465|NCT00003907|Mitomycin|mitomycin|mesh-list
5981466|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981467|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981468|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981469|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981470|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981471|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981472|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
5981473|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5981474|NCT00003910|Prednisone|prednisone|mesh-list
5981475|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
5981476|NCT00003910|Methotrexate|methotrexate|mesh-list
5981477|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981478|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
5981479|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981480|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981481|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981482|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
5981483|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981484|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981485|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981486|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5981487|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
5981488|NCT00003910|Hormones|hormones|mesh-ancestor
5981489|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5981490|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981491|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5981492|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
5981493|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5981494|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981495|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
5981496|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
5981497|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981498|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5981499|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5981500|NCT00004031|Prednisone|prednisone|mesh-list
5981501|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
5981502|NCT00004031|Carmustine|carmustine|mesh-list
5981503|NCT00004031|Rituximab|rituximab|mesh-list
5981504|NCT00004031|Doxorubicin|doxorubicin|mesh-list
5981505|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981506|NCT00004031|Etoposide|etoposide|mesh-list
5981507|NCT00004031|Vincristine|vincristine|mesh-list
5981508|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981509|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
5981510|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981511|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981512|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981513|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
5981514|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981515|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981516|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981517|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5981518|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981519|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981520|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981521|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981522|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5981523|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
5981524|NCT00004031|Hormones|hormones|mesh-ancestor
5981525|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5981526|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981527|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981528|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981529|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981530|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981531|NCT00004054|Paclitaxel|paclitaxel|mesh-list
5981532|NCT00004054|Etoposide|etoposide|mesh-list
5981533|NCT00004054|Bicalutamide|bicalutamide|mesh-list
5981534|NCT00004054|Flutamide|flutamide|mesh-list
5981535|NCT00004054|Estramustine|estramustine|mesh-list
5981536|NCT00004054|Warfarin|warfarin|mesh-list
5981537|NCT00004054|Hormones|hormones|mesh-list
5981538|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5981539|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981540|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981541|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981542|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981543|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981544|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981545|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981546|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981547|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981548|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5981549|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981550|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
5981551|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
5981552|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
5981553|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981554|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981555|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
5981556|NCT00004088|Pamidronate|pamidronate|mesh-list
5981557|NCT00004088|Interferons|interferons|mesh-list
5981558|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
5981559|NCT00004088|Thalidomide|thalidomide|mesh-list
5981560|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
5981561|NCT00004088|Melphalan|melphalan|mesh-list
5981562|NCT00004088|Busulfan|busulfan|mesh-list
5981563|NCT00004088|Lenograstim|lenograstim|mesh-list
5981564|NCT00004088|Sargramostim|sargramostim|mesh-list
5981565|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981566|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
5981567|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981568|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981569|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981570|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
5981571|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981572|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981573|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981574|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
5981575|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981576|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5981577|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
5981578|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5981579|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5981580|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5981581|NCT00004088|Growth Substances|growth substances|mesh-ancestor
5981582|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
5981583|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6245830|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
6245831|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6245832|NCT02726620|Protective Agents|protective agents|mesh-ancestor
6245833|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6245834|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
6245835|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6245836|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6245837|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
6245838|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
6245839|NCT02726620|Coagulants|coagulants|mesh-ancestor
6245840|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
6245841|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
6245842|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6245843|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
6245844|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6245845|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
6245846|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
6245847|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
6245848|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6245849|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245850|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6245851|NCT02726789|Interferons|interferons|mesh-list
6245852|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
5981584|NCT00004092|Paclitaxel|paclitaxel|mesh-list
5981585|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
5981586|NCT00004092|Carboplatin|carboplatin|mesh-list
5981587|NCT00004092|Doxorubicin|doxorubicin|mesh-list
5981588|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981589|NCT00004092|Thiotepa|thiotepa|mesh-list
5981590|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981591|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981592|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981593|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981594|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981595|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981596|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981597|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
5981598|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981599|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981600|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981601|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
5981602|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981603|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981604|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981605|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981606|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981607|NCT00004124|Prednisone|prednisone|mesh-list
5981608|NCT00004124|Goserelin|goserelin|mesh-list
5981609|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
5981610|NCT00004124|Bicalutamide|bicalutamide|mesh-list
5981611|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5981612|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
5981613|NCT00004124|Hormones|hormones|mesh-ancestor
5981614|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5981615|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981616|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981617|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981618|NCT00004124|Analgesics|analgesics|mesh-ancestor
5981619|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
5981620|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5981621|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981622|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981623|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981624|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981625|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
5981626|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
5981627|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
5981628|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5981629|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981630|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
5981631|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981632|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5981633|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5981634|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981635|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5981636|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981637|NCT00004228|Leucovorin|leucovorin|mesh-list
5981638|NCT00004228|Cytarabine|cytarabine|mesh-list
5981639|NCT00004228|Dexamethasone|dexamethasone|mesh-list
5981640|NCT00004228|Prednisone|prednisone|mesh-list
5981641|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
5981642|NCT00004228|Doxorubicin|doxorubicin|mesh-list
5981643|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981644|NCT00004228|Methotrexate|methotrexate|mesh-list
5981645|NCT00004228|Vincristine|vincristine|mesh-list
5981646|NCT00004228|Daunorubicin|daunorubicin|mesh-list
5981647|NCT00004228|Asparaginase|asparaginase|mesh-list
5981648|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
5981649|NCT00004228|Thioguanine|thioguanine|mesh-list
5981650|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
5981651|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981652|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
5981653|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981654|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981655|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981656|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
5981657|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981658|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981659|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981660|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5981661|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
5981662|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
5981663|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5981664|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5981665|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
5981666|NCT00004228|Hormones|hormones|mesh-ancestor
5981667|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5981668|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981669|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981670|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981671|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981672|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981673|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5981674|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
5981675|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5981676|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981677|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
5981678|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
5981679|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5981680|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5981681|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
5981682|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981683|NCT00004228|Antidotes|antidotes|mesh-ancestor
5981684|NCT00004228|Protective Agents|protective agents|mesh-ancestor
5981685|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
5981686|NCT00004228|Vitamins|vitamins|mesh-ancestor
5981687|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
5981688|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981689|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981690|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981691|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981692|NCT00004259|Carmustine|carmustine|mesh-list
5981693|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981694|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
5981695|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981696|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981697|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
5981698|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981699|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
5981700|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
5981701|NCT00004547|Paclitaxel|paclitaxel|mesh-list
5981702|NCT00004547|Cisplatin|cisplatin|mesh-list
5981703|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981704|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981705|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981706|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981707|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981708|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981709|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
5981710|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5981711|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5981712|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
5981713|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
5981714|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
5981715|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5981716|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981717|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981718|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
5981719|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
5981720|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981721|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
5981722|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981723|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981724|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981725|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
5981726|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981727|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981728|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981729|NCT00004635|Thalidomide|thalidomide|mesh-list
5981730|NCT00004635|Leuprolide|leuprolide|mesh-list
5981731|NCT00004635|Goserelin|goserelin|mesh-list
5981732|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981733|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
5981734|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981735|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
5981736|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5981737|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981738|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5981739|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5981740|NCT00004635|Growth Substances|growth substances|mesh-ancestor
5981741|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
5981742|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981743|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5981744|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
5981745|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5981746|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981747|NCT00004859|Thalidomide|thalidomide|mesh-list
5981748|NCT00004859|Paclitaxel|paclitaxel|mesh-list
5981749|NCT00004859|Carboplatin|carboplatin|mesh-list
5981750|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981751|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981752|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981753|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981754|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981755|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981756|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981757|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
5981758|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981759|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
5981760|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5981761|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981762|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5981763|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5981764|NCT00004859|Growth Substances|growth substances|mesh-ancestor
5981765|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
5981766|NCT00004888|Docetaxel|docetaxel|mesh-list
5981767|NCT00004888|Doxorubicin|doxorubicin|mesh-list
5981768|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981769|NCT00004888|Trastuzumab|trastuzumab|mesh-list
5981770|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981771|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981772|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981773|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981774|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981775|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981776|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981777|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981778|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981779|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5981780|NCT00004978|Aldesleukin|aldesleukin|mesh-list
5981781|NCT00004978|Interleukin-2|interleukin-2|mesh-list
5981782|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981783|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5981784|NCT00004978|Analgesics|analgesics|mesh-ancestor
5981785|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
5981786|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5981787|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981788|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5981789|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5981790|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
5981791|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981792|NCT00005044|Bicalutamide|bicalutamide|mesh-list
5981793|NCT00005044|Flutamide|flutamide|mesh-list
5981794|NCT00005044|Hormones|hormones|mesh-list
5981795|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
5981796|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5981797|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981798|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
5981799|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
5981800|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981801|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981802|NCT00005047|Doxorubicin|doxorubicin|mesh-list
5981803|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981804|NCT00005047|Methotrexate|methotrexate|mesh-list
5981805|NCT00005047|Vinblastine|vinblastine|mesh-list
5981806|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981807|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981808|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981809|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981810|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981811|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981812|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5981813|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
5981814|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5981815|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981816|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981817|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
5981818|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
5981819|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5981820|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981821|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
5981822|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981823|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5981824|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981825|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981826|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981827|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981828|NCT00005669|Metformin|metformin|mesh-list
5981829|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5981830|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981831|NCT00005803|Cytarabine|cytarabine|mesh-list
5981832|NCT00005803|Cyclosporine|cyclosporine|mesh-list
5981833|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
5981834|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
5981835|NCT00005803|Melphalan|melphalan|mesh-list
5981836|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
5981837|NCT00005803|Carmustine|carmustine|mesh-list
5981838|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
5981839|NCT00005803|Fludarabine|fludarabine|mesh-list
5981840|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
5981841|NCT00005803|Etoposide|etoposide|mesh-list
5981842|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
5981843|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
5981844|NCT00005803|Cyclosporins|cyclosporins|mesh-list
5981845|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981846|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
5981847|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981848|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981849|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981850|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
5981851|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981852|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981853|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981854|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981855|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
5981856|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981857|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981858|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981859|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981860|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
5981861|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981862|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
5981863|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
5981864|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5981865|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981866|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5981867|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
5981868|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5981869|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
5981870|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981871|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981872|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981873|NCT00005901|Pamidronate|pamidronate|mesh-list
5981874|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5981875|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981876|NCT00005906|Octreotide|octreotide|mesh-list
5981877|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5981878|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981879|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981880|NCT00005908|Tamoxifen|tamoxifen|mesh-list
5981881|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
5981882|NCT00005908|Docetaxel|docetaxel|mesh-list
5981883|NCT00005908|Doxorubicin|doxorubicin|mesh-list
5981884|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981885|NCT00005908|Capecitabine|capecitabine|mesh-list
5981886|NCT00005908|Anastrozole|anastrozole|mesh-list
5981887|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981888|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
5981889|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981890|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981891|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981892|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
5981893|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981894|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981895|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981896|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981897|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981898|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981899|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981900|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981901|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981902|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981903|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5981904|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
5981905|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5981906|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
5981907|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5981908|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5981909|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5981910|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5981911|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5981912|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5981913|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5981914|NCT00005937|Cyclosporine|cyclosporine|mesh-list
5981915|NCT00005937|Cyclosporins|cyclosporins|mesh-list
5981916|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5981917|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981918|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981919|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981920|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
5981921|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981922|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
5981923|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981924|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
5981925|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981926|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5981927|NCT00006011|Paclitaxel|paclitaxel|mesh-list
5981928|NCT00006011|Doxorubicin|doxorubicin|mesh-list
5981929|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981930|NCT00006011|Lenograstim|lenograstim|mesh-list
5981931|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981932|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981933|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981934|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981935|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981936|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981937|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981938|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981939|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981940|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981941|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5981942|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
5981943|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981944|NCT00006046|Antibodies|antibodies|mesh-list
5981945|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5981946|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
5981947|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981948|NCT00006099|Antibodies|antibodies|mesh-list
5981949|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5981950|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
5981951|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981952|NCT00006101|Eflornithine|eflornithine|mesh-list
5981953|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981954|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5981955|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5981956|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5981957|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981958|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5981959|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981960|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981961|NCT00006110|Paclitaxel|paclitaxel|mesh-list
5981962|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
5981963|NCT00006110|Doxorubicin|doxorubicin|mesh-list
5981964|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5981965|NCT00006110|Trastuzumab|trastuzumab|mesh-list
5981966|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5981967|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5981968|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
5981969|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
5981970|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
5981971|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981972|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5981973|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
5981974|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981975|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5981976|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5981977|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
5981978|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5981979|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5981980|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5981981|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5981982|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5981983|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5981984|NCT00006164|Ribavirin|ribavirin|mesh-list
5981985|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5981986|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
5981987|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
5981988|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5981989|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
5981990|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5981991|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
5981992|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5981993|NCT00006170|Bupropion|bupropion|mesh-list
5981994|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5981995|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
5981996|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5981997|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5981998|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5981999|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5982000|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982001|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
5982002|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5982003|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982004|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5982005|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5982006|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982007|NCT00006178|Sirolimus|sirolimus|mesh-list
5982008|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
5982009|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5982010|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982011|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982012|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982013|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
5982014|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982015|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
5982016|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982017|NCT00006184|Cyclosporine|cyclosporine|mesh-list
5982018|NCT00006184|Prednisone|prednisone|mesh-list
5982019|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
5982020|NCT00006184|Doxorubicin|doxorubicin|mesh-list
5982021|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5982022|NCT00006184|Methotrexate|methotrexate|mesh-list
5982023|NCT00006184|Fludarabine|fludarabine|mesh-list
5982024|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
5982025|NCT00006184|Etoposide|etoposide|mesh-list
5982026|NCT00006184|Vincristine|vincristine|mesh-list
5982027|NCT00006184|Bortezomib|bortezomib|mesh-list
5982028|NCT00006184|Molgramostim|molgramostim|mesh-list
5982029|NCT00006184|Cyclosporins|cyclosporins|mesh-list
5982030|NCT00006184|Lenograstim|lenograstim|mesh-list
5982031|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
5982032|NCT00006184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5982033|NCT00006184|Antibodies|antibodies|mesh-list
5982034|NCT00006184|Sargramostim|sargramostim|mesh-list
5982035|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
5982036|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982037|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
5982038|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982039|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982040|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982041|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
5982042|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982043|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982044|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982045|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982046|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982047|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982048|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982049|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5982050|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
5982051|NCT00006184|Hormones|hormones|mesh-ancestor
5982052|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5982053|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5982054|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5982055|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
5982056|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5982057|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982058|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
5982059|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
5982060|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5982061|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5982062|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982063|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5982064|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982065|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982066|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982067|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
5982068|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982069|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5982070|NCT00006227|Paclitaxel|paclitaxel|mesh-list
5982071|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982072|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982073|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982074|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982075|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982076|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982077|NCT00006237|Interferons|interferons|mesh-list
5982078|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
5982079|NCT00006237|Aldesleukin|aldesleukin|mesh-list
5982080|NCT00006237|Interleukin-2|interleukin-2|mesh-list
5982081|NCT00006237|Dacarbazine|dacarbazine|mesh-list
5982082|NCT00006237|Vinblastine|vinblastine|mesh-list
5982083|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982084|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
5982085|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982086|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
5982087|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982088|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5982089|NCT00006237|Analgesics|analgesics|mesh-ancestor
5982090|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
5982091|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5982092|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5982093|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5982094|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982095|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
5982096|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982097|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982098|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982099|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982100|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982101|NCT00006244|Interferons|interferons|mesh-list
5982102|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
5982103|NCT00006244|Aldesleukin|aldesleukin|mesh-list
5982104|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
5982105|NCT00006244|Melphalan|melphalan|mesh-list
5982106|NCT00006244|Interleukin-2|interleukin-2|mesh-list
5982107|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982108|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
5982109|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982110|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982111|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
5982112|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982113|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982114|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982115|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
5982116|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982117|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5982118|NCT00006244|Analgesics|analgesics|mesh-ancestor
5982119|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
5982120|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5982121|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5982122|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5982123|NCT00006289|Neurotropin|neurotropin|mesh-list
5982124|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5982125|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
5982126|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982127|NCT00006289|Analgesics|analgesics|mesh-ancestor
5982128|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
5982129|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5982130|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
5982131|NCT00006305|Biguanides|biguanides|mesh-list
5982132|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
5982133|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
5982134|NCT00006305|Calcium|calcium|mesh-list
5982135|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
5982136|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
5982137|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
5982138|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5982139|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982140|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5982141|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5982142|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
5982143|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5982144|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982145|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
5982146|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982147|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5982148|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
5982149|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982150|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5982151|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
5982152|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982153|NCT00006392|Vitamins|vitamins|mesh-list
5982154|NCT00006392|Vitamin E|vitamin e|mesh-list
5982155|NCT00006392|Tocopherols|tocopherols|mesh-list
5982156|NCT00006392|Tocotrienols|tocotrienols|mesh-list
5982157|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
5982158|NCT00006392|Selenium|selenium|mesh-list
5982159|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
5982160|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982161|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
5982162|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982163|NCT00006392|Protective Agents|protective agents|mesh-ancestor
5982164|NCT00006392|Trace Elements|trace elements|mesh-ancestor
5982165|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
5982166|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982167|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
5982168|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982169|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982170|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5982171|NCT00006489|Naltrexone|naltrexone|mesh-list
5982172|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5982173|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5982174|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982175|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
5982176|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5982177|NCT00006604|Ritonavir|ritonavir|mesh-list
5982178|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5982179|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5982180|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
5982181|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982182|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982183|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5982184|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5982185|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
5982186|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982187|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5982188|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5982189|NCT00006721|Prednisone|prednisone|mesh-list
5982190|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
5982191|NCT00006721|Rituximab|rituximab|mesh-list
5982192|NCT00006721|Doxorubicin|doxorubicin|mesh-list
5982193|NCT00006721|Vincristine|vincristine|mesh-list
5982194|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982195|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
5982196|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982197|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6245853|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
5982198|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982199|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
5982200|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982201|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982202|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982203|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5982204|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982205|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982206|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982207|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982208|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5982209|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
5982210|NCT00006721|Hormones|hormones|mesh-ancestor
5982211|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5982212|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5982213|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982214|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982215|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982216|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982217|NCT00006903|Fulvestrant|fulvestrant|mesh-list
5982218|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5982219|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982220|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5982221|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5982222|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
5982223|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5982224|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982225|NCT00007020|Cholic Acids|cholic acids|mesh-list
5982226|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5982227|NCT00007345|Romidepsin|romidepsin|mesh-list
5982228|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982229|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982230|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
5982231|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982232|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
5982233|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982234|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982235|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982236|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
5982237|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982238|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982239|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982240|NCT00008138|Paclitaxel|paclitaxel|mesh-list
5982241|NCT00008138|Carboplatin|carboplatin|mesh-list
5982242|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982243|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982244|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982245|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982246|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982247|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982248|NCT00008385|Selenium|selenium|mesh-list
5982249|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
5982250|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982251|NCT00008385|Protective Agents|protective agents|mesh-ancestor
5982252|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982253|NCT00008385|Trace Elements|trace elements|mesh-ancestor
5982254|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
5982255|NCT00009737|Leucovorin|leucovorin|mesh-list
5982256|NCT00009737|Fluorouracil|fluorouracil|mesh-list
5982257|NCT00009737|Capecitabine|capecitabine|mesh-list
5982258|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
5982259|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982260|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982261|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982262|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982263|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
5982264|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982265|NCT00009737|Antidotes|antidotes|mesh-ancestor
5982266|NCT00009737|Protective Agents|protective agents|mesh-ancestor
5982267|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
5982268|NCT00009737|Vitamins|vitamins|mesh-ancestor
5982269|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
5982270|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
5982271|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6245854|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5982272|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982273|NCT00010257|Paclitaxel|paclitaxel|mesh-list
5982274|NCT00010257|Carboplatin|carboplatin|mesh-list
5982275|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982276|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982277|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982278|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982279|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982280|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982281|NCT00010439|Alendronate|alendronate|mesh-list
5982282|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5982283|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982284|NCT00011986|Gemcitabine|gemcitabine|mesh-list
5982285|NCT00011986|Paclitaxel|paclitaxel|mesh-list
5982286|NCT00011986|Carboplatin|carboplatin|mesh-list
5982287|NCT00011986|Doxorubicin|doxorubicin|mesh-list
5982288|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5982289|NCT00011986|Topotecan|topotecan|mesh-list
5982290|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982291|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982292|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982293|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982294|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982295|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982296|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982297|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
5982298|NCT00011986|Antiviral Agents|antiviral agents|mesh-ancestor
5982299|NCT00011986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982300|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982301|NCT00011986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982302|NCT00011986|Immunologic Factors|immunologic factors|mesh-ancestor
5982303|NCT00011986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982304|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982305|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982306|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982307|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5982308|NCT00012012|Amifostine|amifostine|mesh-list
5982309|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5982310|NCT00012012|Protective Agents|protective agents|mesh-ancestor
5982311|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982312|NCT00012298|Rituximab|rituximab|mesh-list
5982313|NCT00012298|Oprelvekin|oprelvekin|mesh-list
5982314|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5982315|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5982316|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982317|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
5982318|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982319|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982320|NCT00013611|Aldesleukin|aldesleukin|mesh-list
5982321|NCT00013611|Interleukin-2|interleukin-2|mesh-list
5982322|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982323|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5982324|NCT00013611|Analgesics|analgesics|mesh-ancestor
5982325|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
5982326|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5982327|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982328|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5982329|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5982330|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
5982331|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982332|NCT00014222|Paclitaxel|paclitaxel|mesh-list
5982333|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
5982334|NCT00014222|Doxorubicin|doxorubicin|mesh-list
5982335|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5982336|NCT00014222|Fluorouracil|fluorouracil|mesh-list
5982337|NCT00014222|Epirubicin|epirubicin|mesh-list
5982338|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
5982339|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982340|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982341|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982342|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982343|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982344|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982345|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982346|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
5982347|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982348|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982349|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982350|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
5982351|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982352|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982353|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982354|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982355|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982356|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
5982357|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982358|NCT00014222|Hematinics|hematinics|mesh-ancestor
5982359|NCT00014495|Cytarabine|cytarabine|mesh-list
5982360|NCT00014495|Bismuth|bismuth|mesh-list
5982361|NCT00014495|Antibodies|antibodies|mesh-list
5982362|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5982363|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
5982364|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982365|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982366|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
5982367|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982368|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982369|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
5982370|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982371|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982372|NCT00014495|Antacids|antacids|mesh-ancestor
5982373|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5982374|NCT00014911|Sirolimus|sirolimus|mesh-list
5982375|NCT00014911|Pentamidine|pentamidine|mesh-list
5982376|NCT00014911|Trimethoprim|trimethoprim|mesh-list
5982377|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
5982378|NCT00014911|Ganciclovir|ganciclovir|mesh-list
5982379|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
5982380|NCT00014911|Tacrolimus|tacrolimus|mesh-list
5982381|NCT00014911|Daclizumab|daclizumab|mesh-list
5982382|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982383|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
5982384|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982385|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5982386|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982387|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982388|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5982389|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982390|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982391|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982392|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
5982393|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5982394|NCT00014911|Renal Agents|renal agents|mesh-ancestor
5982395|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
5982396|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5982397|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5982398|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5982399|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5982400|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5982401|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5982402|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
5982403|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5982404|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5982405|NCT00015457|Amlodipine|amlodipine|mesh-list
5982406|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
5982407|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5982408|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5982409|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982410|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
5982411|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5982412|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982413|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5982414|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5982415|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5982416|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
5982417|NCT00015847|Interferons|interferons|mesh-list
5982418|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
5982419|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
5982420|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982421|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
5982422|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982423|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
5982424|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982425|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5982426|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245855|NCT02726789|Entecavir|entecavir|mesh-list
5982427|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982428|NCT00016718|Emtricitabine|emtricitabine|mesh-list
5982429|NCT00016718|Efavirenz|efavirenz|mesh-list
5982430|NCT00016718|Didanosine|didanosine|mesh-list
5982431|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
5982432|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982433|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5982434|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5982435|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982436|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982437|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5982438|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5982439|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5982440|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5982441|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5982442|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5982443|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5982444|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5982445|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
5982446|NCT00016913|Paclitaxel|paclitaxel|mesh-list
5982447|NCT00016913|Carboplatin|carboplatin|mesh-list
5982448|NCT00016913|Leuprolide|leuprolide|mesh-list
5982449|NCT00016913|Goserelin|goserelin|mesh-list
5982450|NCT00016913|Estramustine|estramustine|mesh-list
5982451|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982452|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982453|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982454|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982455|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982456|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982457|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5982458|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
5982459|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5982460|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982461|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5982462|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982463|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
5982464|NCT00017563|Docetaxel|docetaxel|mesh-list
5982465|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
5982466|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982467|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982468|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982469|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982470|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982471|NCT00017563|Analgesics|analgesics|mesh-ancestor
5982472|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
5982473|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5982474|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982475|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982476|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982477|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982478|NCT00018031|Ribavirin|ribavirin|mesh-list
5982479|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5982480|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
5982481|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
5982482|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982483|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
5982484|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982485|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
5982486|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982487|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5982488|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5982489|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982490|NCT00019682|Aldesleukin|aldesleukin|mesh-list
5982491|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982492|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5982493|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5982494|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
5982495|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982496|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
5982497|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982498|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5982499|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982500|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982501|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
5982502|NCT00021255|Carboplatin|carboplatin|mesh-list
5982503|NCT00021255|Docetaxel|docetaxel|mesh-list
5982504|NCT00021255|Doxorubicin|doxorubicin|mesh-list
5982505|NCT00021255|Trastuzumab|trastuzumab|mesh-list
5982506|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982507|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
5982508|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982509|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982510|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982511|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
5982512|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982513|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982514|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982515|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982516|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982517|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982518|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982519|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982520|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982521|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982522|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5982523|NCT00021541|Tipifarnib|tipifarnib|mesh-list
5982524|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982525|NCT00022490|Cytarabine|cytarabine|mesh-list
5982526|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
5982527|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982528|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
5982529|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982530|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982531|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
5982532|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982533|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982534|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
5982535|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982536|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5982537|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982538|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
5982539|NCT00022516|Methotrexate|methotrexate|mesh-list
5982540|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982541|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
5982542|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982543|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982544|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982545|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
5982546|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982547|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982548|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982549|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5982550|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
5982551|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5982552|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982553|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
5982554|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
5982555|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982556|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5982557|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5982558|NCT00022633|Gemcitabine|gemcitabine|mesh-list
5982559|NCT00022633|Paclitaxel|paclitaxel|mesh-list
5982560|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982561|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982562|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982563|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982564|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982565|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982566|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982567|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
5982568|NCT00022633|Antiviral Agents|antiviral agents|mesh-ancestor
5982569|NCT00022633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982570|NCT00022633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982571|NCT00022633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982572|NCT00022633|Immunologic Factors|immunologic factors|mesh-ancestor
5982573|NCT00022633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982574|NCT00022659|Bevacizumab|bevacizumab|mesh-list
5982575|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5982576|NCT00022659|Antibodies|antibodies|mesh-list
5982577|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
5982578|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5982579|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982580|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5982581|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5982582|NCT00022659|Growth Substances|growth substances|mesh-ancestor
5982583|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982584|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
5982585|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
5982586|NCT00022672|Trastuzumab|trastuzumab|mesh-list
5982587|NCT00022672|Anastrozole|anastrozole|mesh-list
5982588|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5982589|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982590|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5982591|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5982592|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5982593|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982594|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982595|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5982596|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
5982597|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5982598|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982599|NCT00022698|Capecitabine|capecitabine|mesh-list
5982600|NCT00022698|Irinotecan|irinotecan|mesh-list
5982601|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982602|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
5982603|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982604|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982605|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5982606|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982607|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982608|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
5982609|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5982610|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5982611|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982612|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5982613|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5982614|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
5982615|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982616|NCT00023309|Lamivudine|lamivudine|mesh-list
5982617|NCT00023309|Adefovir|adefovir|mesh-list
5982618|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5982619|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5982620|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5982621|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982622|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982623|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
5982624|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982625|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5982626|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5982627|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5982628|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
5982629|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982630|NCT00023452|Isoniazid|isoniazid|mesh-list
5982631|NCT00023452|Rifapentine|rifapentine|mesh-list
5982632|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
5982633|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5982634|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982635|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5982636|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5982637|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
5982638|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982639|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5982640|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5982641|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
5982642|NCT00023673|Paclitaxel|paclitaxel|mesh-list
5982643|NCT00023673|Carboplatin|carboplatin|mesh-list
5982644|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982645|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982646|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982647|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982648|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982649|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982650|NCT00023712|Bortezomib|bortezomib|mesh-list
5982651|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982652|NCT00023764|Bortezomib|bortezomib|mesh-list
5982653|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982654|NCT00024102|Doxorubicin|doxorubicin|mesh-list
5982655|NCT00024102|Capecitabine|capecitabine|mesh-list
5982656|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982657|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982658|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982659|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982660|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982661|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982662|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982663|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
5982664|NCT00024167|Ketoconazole|ketoconazole|mesh-list
5982665|NCT00024167|Dexamethasone|dexamethasone|mesh-list
5982666|NCT00024167|Prednisone|prednisone|mesh-list
5982667|NCT00024167|Estramustine|estramustine|mesh-list
5982668|NCT00024167|Docetaxel|docetaxel|mesh-list
5982669|NCT00024167|Doxorubicin|doxorubicin|mesh-list
5982670|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5982671|NCT00024167|Vinblastine|vinblastine|mesh-list
5982672|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5982673|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
5982674|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
5982675|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5982676|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982677|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5982678|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
5982679|NCT00024167|Hormones|hormones|mesh-ancestor
5982680|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5982681|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5982682|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982683|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982684|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982685|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982686|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982687|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982688|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982689|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982690|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982691|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
5982692|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982693|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5982694|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5982695|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5982696|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
5982697|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5982698|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982699|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982700|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
5982701|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
5982702|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982703|NCT00025155|Epothilones|epothilones|mesh-list
5982704|NCT00025155|Epothilone B|epothilone b|mesh-list
5982705|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982706|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982707|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982708|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982709|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982710|NCT00025233|Bevacizumab|bevacizumab|mesh-list
5982711|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5982712|NCT00025233|Antibodies|antibodies|mesh-list
5982713|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
5982714|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5982715|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982716|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5982717|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5982718|NCT00025233|Growth Substances|growth substances|mesh-ancestor
5982719|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982720|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
5982721|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
5982722|NCT00025259|Cytarabine|cytarabine|mesh-list
5982723|NCT00025259|Dexamethasone|dexamethasone|mesh-list
5982724|NCT00025259|Prednisone|prednisone|mesh-list
5982725|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
5982726|NCT00025259|Cortisone|cortisone|mesh-list
5982727|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
5982728|NCT00025259|Cisplatin|cisplatin|mesh-list
5982729|NCT00025259|Doxorubicin|doxorubicin|mesh-list
5982730|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5982731|NCT00025259|Etoposide|etoposide|mesh-list
5982732|NCT00025259|Vincristine|vincristine|mesh-list
5982733|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
5982734|NCT00025259|Bleomycin|bleomycin|mesh-list
5982735|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
5982736|NCT00025259|Lenograstim|lenograstim|mesh-list
5982737|NCT00025259|BB 1101|bb 1101|mesh-list
5982738|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982739|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
5982740|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982741|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982742|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982743|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
5982744|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982745|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982746|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982747|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5982748|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
5982749|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
5982750|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5982751|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5982752|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
5982753|NCT00025259|Hormones|hormones|mesh-ancestor
5982754|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5982755|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5982756|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982757|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982758|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982759|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982760|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982761|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5982762|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982763|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
5982764|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
5982765|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982766|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982767|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982768|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982769|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
5982770|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
5982771|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
5982772|NCT00025506|Thalidomide|thalidomide|mesh-list
5982773|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982774|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
5982775|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982776|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
5982777|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5982778|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982779|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5982780|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5982781|NCT00025506|Growth Substances|growth substances|mesh-ancestor
5982782|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
5982783|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982784|NCT00025662|Interleukin-2|interleukin-2|mesh-list
5982785|NCT00025662|Immunotoxins|immunotoxins|mesh-list
5982786|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982787|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5982788|NCT00025662|Analgesics|analgesics|mesh-ancestor
5982789|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
5982790|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5982791|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982792|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
5982793|NCT00026208|Prednisone|prednisone|mesh-list
5982794|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
5982795|NCT00026208|Doxorubicin|doxorubicin|mesh-list
5982796|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5982797|NCT00026208|Etoposide|etoposide|mesh-list
5982798|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
5982799|NCT00026208|Vincristine|vincristine|mesh-list
5982800|NCT00026208|Bleomycin|bleomycin|mesh-list
5982801|NCT00026208|Vinblastine|vinblastine|mesh-list
5982802|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982803|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
5982804|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982805|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982806|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982807|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
5982808|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982809|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982810|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982811|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5982812|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982813|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982814|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982815|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5982816|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
5982817|NCT00026208|Hormones|hormones|mesh-ancestor
5982818|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5982819|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5982820|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982821|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982822|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982823|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982824|NCT00026221|Interferons|interferons|mesh-list
5982825|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
5982826|NCT00026221|Bevacizumab|bevacizumab|mesh-list
5982827|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5982828|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982829|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5982830|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5982831|NCT00026221|Growth Substances|growth substances|mesh-ancestor
5982832|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982833|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
5982834|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
5982835|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982836|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
5982837|NCT00026312|Vitamin A|vitamin a|mesh-list
5982838|NCT00026312|Aldesleukin|aldesleukin|mesh-list
5982839|NCT00026312|Interleukin-2|interleukin-2|mesh-list
5982840|NCT00026312|Tretinoin|tretinoin|mesh-list
5982841|NCT00026312|Dinutuximab|dinutuximab|mesh-list
5982842|NCT00026312|Isotretinoin|isotretinoin|mesh-list
5982843|NCT00026312|Sargramostim|sargramostim|mesh-list
5982844|NCT00026312|Vitamins|vitamins|mesh-ancestor
5982845|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
5982846|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982847|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982848|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5982849|NCT00026312|Analgesics|analgesics|mesh-ancestor
5982850|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
5982851|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5982852|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
5982853|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5982854|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5982855|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
5982856|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982857|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
5982858|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
5982859|NCT00026494|Temozolomide|temozolomide|mesh-list
5982860|NCT00026494|Vinorelbine|vinorelbine|mesh-list
5982861|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982862|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
5982863|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982864|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982865|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982866|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982867|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982868|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982869|NCT00027027|Pertuzumab|pertuzumab|mesh-list
5982870|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5982871|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982872|NCT00027378|Fluoxetine|fluoxetine|mesh-list
5982873|NCT00027378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5982874|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5982875|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5982876|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982877|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5982878|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
5982879|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982880|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5982881|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
5982882|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5982883|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5982884|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5982885|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982886|NCT00027560|Cyclosporine|cyclosporine|mesh-list
5982887|NCT00027560|Fludarabine|fludarabine|mesh-list
5982888|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
5982889|NCT00027560|Melphalan|melphalan|mesh-list
5982890|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
5982891|NCT00027560|Cyclosporins|cyclosporins|mesh-list
5982892|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982893|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5982894|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
5982895|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982896|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982897|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
5982898|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982899|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982900|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
5982901|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982902|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
5982903|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982904|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5982905|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982906|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
5982907|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982908|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5982909|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
5982910|NCT00027846|Carboplatin|carboplatin|mesh-list
5982911|NCT00027846|Etoposide|etoposide|mesh-list
5982912|NCT00027846|Vincristine|vincristine|mesh-list
5982913|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
5982914|NCT00027846|Lenograstim|lenograstim|mesh-list
5982915|NCT00027846|Sargramostim|sargramostim|mesh-list
5982916|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5982917|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
5982918|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982919|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982920|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982921|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
5982922|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982923|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982924|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5982925|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982926|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982927|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982928|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982929|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5982930|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982931|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982932|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982933|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
5982934|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
5982935|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
5982936|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982937|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5982938|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982939|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982940|NCT00028093|Ribavirin|ribavirin|mesh-list
5982941|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5982942|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
5982943|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
5982944|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982945|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
5982946|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5982947|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
5982948|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982949|NCT00028262|Cysteamine|cysteamine|mesh-list
5982950|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
5982951|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982952|NCT00028769|Paclitaxel|paclitaxel|mesh-list
5982953|NCT00028769|Etoposide|etoposide|mesh-list
5982954|NCT00028769|Leuprolide|leuprolide|mesh-list
5982955|NCT00028769|Goserelin|goserelin|mesh-list
5982956|NCT00028769|Bicalutamide|bicalutamide|mesh-list
5982957|NCT00028769|Flutamide|flutamide|mesh-list
5982958|NCT00028769|Estramustine|estramustine|mesh-list
5982959|NCT00028769|Nilutamide|nilutamide|mesh-list
5982960|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5982961|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982962|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
5982963|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
5982964|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
5982965|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5982966|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5982967|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5982968|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5982969|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5982970|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
5982971|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5982972|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982973|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5982974|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
5982975|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
5982976|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5982977|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5982978|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
5982979|NCT00029107|Rituximab|rituximab|mesh-list
5982980|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5982981|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5982982|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
5982983|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982984|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5982985|NCT00029536|Progesterone|progesterone|mesh-list
5982986|NCT00029536|Progestins|progestins|mesh-ancestor
5982987|NCT00029536|Hormones|hormones|mesh-ancestor
5982988|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5982989|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982990|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
5982991|NCT00030147|Estradiol|estradiol|mesh-list
5982992|NCT00030147|Estrogens|estrogens|mesh-ancestor
5982993|NCT00030147|Hormones|hormones|mesh-ancestor
5982994|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5982995|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5982996|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5982997|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
5982998|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5982999|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5983000|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5983001|NCT00030264|Methotrexate|methotrexate|mesh-list
5983002|NCT00030264|Vinblastine|vinblastine|mesh-list
5983003|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5983004|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
5983005|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5983006|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983007|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983008|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
5983009|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983010|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983011|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983012|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983013|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5983014|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983015|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
5983016|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983017|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5983018|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983019|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983020|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983021|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983022|NCT00030901|Selenium|selenium|mesh-list
5983023|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
5983024|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983025|NCT00030901|Protective Agents|protective agents|mesh-ancestor
5983026|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983027|NCT00030901|Trace Elements|trace elements|mesh-ancestor
5983028|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
5983029|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
5983030|NCT00030992|Promethazine|promethazine|mesh-list
5983031|NCT00030992|Ranitidine|ranitidine|mesh-list
5983032|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
5983033|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5983034|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5983035|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5983036|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983037|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
5983038|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
5983039|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
6245856|NCT02726789|REP 2139|rep 2139|mesh-list
5983040|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983041|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
5983042|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
5983043|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5983044|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5983045|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
5983046|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
5983047|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5983048|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983049|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5983050|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
5983051|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983052|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5983053|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
5983054|NCT00031447|Acyclovir|acyclovir|mesh-list
5983055|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
5983056|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983057|NCT00031460|Acyclovir|acyclovir|mesh-list
5983058|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
5983059|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983060|NCT00031486|Valacyclovir|valacyclovir|mesh-list
5983061|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
5983062|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983063|NCT00031551|Etanercept|etanercept|mesh-list
5983064|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5983065|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5983066|NCT00031551|Analgesics|analgesics|mesh-ancestor
5983067|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
5983068|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983069|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983070|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983071|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983072|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5983073|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983074|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
5983075|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
5983076|NCT00031590|Lomustine|lomustine|mesh-list
5983077|NCT00031590|Etoposide|etoposide|mesh-list
5983078|NCT00031590|Vincristine|vincristine|mesh-list
5983079|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983080|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
5983081|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983082|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983083|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5983084|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
5983085|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983086|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983087|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5983088|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983089|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5983090|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983091|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983092|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983093|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983094|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983095|NCT00031694|Paclitaxel|paclitaxel|mesh-list
5983096|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
5983097|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983098|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983099|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983100|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983101|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983102|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983103|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5983104|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
5983105|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983106|NCT00032487|Metformin|metformin|mesh-list
5983107|NCT00032487|Glimepiride|glimepiride|mesh-list
5983108|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
5983109|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5983110|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983111|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5983112|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983113|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
5983114|NCT00032591|Thrombin|thrombin|mesh-list
5983115|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
5983116|NCT00032591|Coagulants|coagulants|mesh-ancestor
5983117|NCT00033371|Eflornithine|eflornithine|mesh-list
5983118|NCT00033371|Celecoxib|celecoxib|mesh-list
5983119|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5983120|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5983121|NCT00033371|Analgesics|analgesics|mesh-ancestor
5983122|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
5983123|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983124|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983125|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983126|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983127|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5983128|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5983129|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983130|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983131|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983132|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5983133|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5983134|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5983135|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983136|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
5983137|NCT00033514|Trastuzumab|trastuzumab|mesh-list
5983138|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5983139|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5983140|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983141|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5983142|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983143|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983144|NCT00033540|Gemcitabine|gemcitabine|mesh-list
5983145|NCT00033540|Capecitabine|capecitabine|mesh-list
5983146|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983147|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
5983148|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983149|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983150|NCT00033540|Antiviral Agents|antiviral agents|mesh-ancestor
5983151|NCT00033540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983152|NCT00033540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983153|NCT00033540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983154|NCT00033540|Immunologic Factors|immunologic factors|mesh-ancestor
5983155|NCT00033540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983156|NCT00033657|Paclitaxel|paclitaxel|mesh-list
5983157|NCT00033657|Camptothecin|camptothecin|mesh-list
5983158|NCT00033657|Cisplatin|cisplatin|mesh-list
5983159|NCT00033657|Irinotecan|irinotecan|mesh-list
5983160|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983161|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983162|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983163|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983164|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983165|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983166|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5983167|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983168|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983169|NCT00033917|Indomethacin|indomethacin|mesh-list
5983170|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5983171|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5983172|NCT00033917|Analgesics|analgesics|mesh-ancestor
5983173|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
5983174|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983175|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983176|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983177|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983178|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
5983179|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
5983180|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5983181|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5983182|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983183|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983184|NCT00035555|Cyclosporine|cyclosporine|mesh-list
5983185|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
5983186|NCT00035555|Abatacept|abatacept|mesh-list
5983187|NCT00035555|Cyclosporins|cyclosporins|mesh-list
5983188|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983189|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983190|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983191|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
5983192|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983193|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
5983194|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983195|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983196|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983197|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5983198|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983199|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983200|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5983201|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
5983202|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5983203|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5983204|NCT00035815|Mitogens|mitogens|mesh-list
5983205|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983206|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983207|NCT00035932|Ritonavir|ritonavir|mesh-list
5983208|NCT00035932|Lopinavir|lopinavir|mesh-list
5983209|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5983210|NCT00035932|Saquinavir|saquinavir|mesh-list
5983211|NCT00035932|Tenofovir|tenofovir|mesh-list
5983212|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5983213|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5983214|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
5983215|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983216|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983217|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5983218|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5983219|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
5983220|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983221|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5983222|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5983223|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5983224|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5983225|NCT00036270|Tamoxifen|tamoxifen|mesh-list
5983226|NCT00036270|Exemestane|exemestane|mesh-list
5983227|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5983228|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
5983229|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983230|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983231|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5983232|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983233|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5983234|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5983235|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5983236|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5983237|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5983238|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983239|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983240|NCT00036569|Interferons|interferons|mesh-list
5983241|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
5983242|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983243|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
5983244|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983245|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
5983246|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983247|NCT00036738|Cyclosporine|cyclosporine|mesh-list
5983248|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
5983249|NCT00036738|Fludarabine|fludarabine|mesh-list
5983250|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
5983251|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
5983252|NCT00036738|Dasatinib|dasatinib|mesh-list
5983253|NCT00036738|Cyclosporins|cyclosporins|mesh-list
5983254|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983255|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983256|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
5983257|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983258|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983259|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
5983260|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983261|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983262|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
5983263|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983264|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983265|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983266|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5983267|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983268|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5983269|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
5983270|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5983271|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5983272|NCT00038103|Celecoxib|celecoxib|mesh-list
5983273|NCT00038103|Exemestane|exemestane|mesh-list
5983274|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5983275|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5983276|NCT00038103|Analgesics|analgesics|mesh-ancestor
5983277|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
5983278|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983279|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983280|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983281|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983282|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5983283|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5983284|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983285|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983286|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983287|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5983288|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5983289|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5983290|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
5983291|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983292|NCT00038467|Tamoxifen|tamoxifen|mesh-list
5983293|NCT00038467|Exemestane|exemestane|mesh-list
5983294|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5983295|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
5983296|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983297|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983298|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5983299|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983300|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5983301|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5983302|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5983303|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5983304|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5983305|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983306|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983307|NCT00038610|Cytarabine|cytarabine|mesh-list
5983308|NCT00038610|Dexamethasone|dexamethasone|mesh-list
5983309|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
5983310|NCT00038610|Doxorubicin|doxorubicin|mesh-list
5983311|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5983312|NCT00038610|Methotrexate|methotrexate|mesh-list
5983313|NCT00038610|Vincristine|vincristine|mesh-list
5983314|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
5983315|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983316|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
5983317|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983318|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983319|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5983320|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
5983321|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983322|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983323|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5983324|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983325|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
5983326|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
5983327|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983328|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5983329|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
5983330|NCT00038610|Hormones|hormones|mesh-ancestor
5983331|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983332|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5983333|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983334|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5983335|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983336|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983337|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5983338|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
5983339|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5983340|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983341|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
5983342|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983343|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5983344|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5983345|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
5983346|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983347|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983348|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983349|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983350|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983351|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5983352|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
5983353|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983354|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5983355|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983356|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983357|NCT00038857|Vidarabine|vidarabine|mesh-list
5983358|NCT00038857|Fludarabine|fludarabine|mesh-list
5983359|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
5983360|NCT00038857|Melphalan|melphalan|mesh-list
5983361|NCT00038857|Thiotepa|thiotepa|mesh-list
5983362|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
5983363|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5983364|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983365|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983366|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
5983367|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983368|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983369|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
5983370|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983371|NCT00038857|Antiviral Agents|antiviral agents|mesh-ancestor
5983372|NCT00038857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983373|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5983374|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
5983375|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5983376|NCT00038948|Cyclosporine|cyclosporine|mesh-list
5983377|NCT00038948|Sirolimus|sirolimus|mesh-list
5983378|NCT00038948|Tacrolimus|tacrolimus|mesh-list
5983379|NCT00038948|Cyclosporins|cyclosporins|mesh-list
5983380|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983381|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
5983382|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983383|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5983384|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983385|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983386|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
5983387|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983388|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983389|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983390|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5983391|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983392|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983393|NCT00039130|Leucovorin|leucovorin|mesh-list
5983394|NCT00039130|Cytarabine|cytarabine|mesh-list
5983395|NCT00039130|Dexamethasone|dexamethasone|mesh-list
5983396|NCT00039130|Prednisone|prednisone|mesh-list
5983397|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
5983398|NCT00039130|Ifosfamide|ifosfamide|mesh-list
5983399|NCT00039130|Rituximab|rituximab|mesh-list
5983400|NCT00039130|Doxorubicin|doxorubicin|mesh-list
5983401|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5983402|NCT00039130|Methotrexate|methotrexate|mesh-list
5983403|NCT00039130|Etoposide|etoposide|mesh-list
5983404|NCT00039130|Vincristine|vincristine|mesh-list
5983405|NCT00039130|Allopurinol|allopurinol|mesh-list
5983406|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
5983407|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983408|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
5983409|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983410|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983411|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5983412|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
5983413|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983414|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983415|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5983416|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983417|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
5983418|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
5983419|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983420|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5983421|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
5983422|NCT00039130|Hormones|hormones|mesh-ancestor
6245857|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983423|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983424|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5983425|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5983426|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983427|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5983428|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983429|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983430|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5983431|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
5983432|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5983433|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983434|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
5983435|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983436|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5983437|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5983438|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983439|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
5983440|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983441|NCT00039130|Antidotes|antidotes|mesh-ancestor
5983442|NCT00039130|Protective Agents|protective agents|mesh-ancestor
5983443|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
5983444|NCT00039130|Vitamins|vitamins|mesh-ancestor
5983445|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
5983446|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983447|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983448|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983449|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
5983450|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5983451|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
5983452|NCT00039195|Prednisone|prednisone|mesh-list
5983453|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
5983454|NCT00039195|Ifosfamide|ifosfamide|mesh-list
5983455|NCT00039195|Rituximab|rituximab|mesh-list
5983456|NCT00039195|Carboplatin|carboplatin|mesh-list
5983457|NCT00039195|Doxorubicin|doxorubicin|mesh-list
5983458|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5983459|NCT00039195|Etoposide|etoposide|mesh-list
5983460|NCT00039195|Vincristine|vincristine|mesh-list
5983461|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983462|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
5983463|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983464|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983465|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5983466|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
5983467|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983468|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983469|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5983470|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5983471|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983472|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5983473|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983474|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983475|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983476|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
5983477|NCT00039195|Hormones|hormones|mesh-ancestor
5983478|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983479|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5983480|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983481|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983482|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983483|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983484|NCT00039377|Leucovorin|leucovorin|mesh-list
5983485|NCT00039377|Cytarabine|cytarabine|mesh-list
5983486|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
5983487|NCT00039377|Methotrexate|methotrexate|mesh-list
5983488|NCT00039377|Etoposide|etoposide|mesh-list
5983489|NCT00039377|Vincristine|vincristine|mesh-list
5983490|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
5983491|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
5983492|NCT00039377|Tacrolimus|tacrolimus|mesh-list
5983493|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
5983494|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983495|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
5983496|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983497|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983498|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5983499|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
5983500|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983501|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983502|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5983503|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5983504|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
5983505|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5983506|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983507|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
5983508|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983509|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983510|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5983511|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5983512|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983513|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5983514|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983515|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
5983516|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983517|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5983518|NCT00039377|Antidotes|antidotes|mesh-ancestor
5983519|NCT00039377|Protective Agents|protective agents|mesh-ancestor
5983520|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
5983521|NCT00039377|Vitamins|vitamins|mesh-ancestor
5983522|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
5983523|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983524|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983525|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983526|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5983527|NCT00039871|Ribavirin|ribavirin|mesh-list
5983528|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5983529|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
5983530|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
5983531|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983532|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
5983533|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983534|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
5983535|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983536|NCT00040365|Amifostine|amifostine|mesh-list
5983537|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5983538|NCT00040365|Protective Agents|protective agents|mesh-ancestor
5983539|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983540|NCT00040664|Ritonavir|ritonavir|mesh-list
5983541|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
5983542|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5983543|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5983544|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
5983545|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983546|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983547|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5983548|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5983549|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
5983550|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983551|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5983552|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5983553|NCT00040846|Cyclosporine|cyclosporine|mesh-list
5983554|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
5983555|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5983556|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
5983557|NCT00040846|Fludarabine|fludarabine|mesh-list
5983558|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
5983559|NCT00040846|Antibodies|antibodies|mesh-list
5983560|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
5983561|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5983562|NCT00040846|Cyclosporins|cyclosporins|mesh-list
5983563|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
5983564|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983565|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983566|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983567|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
5983568|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983569|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983570|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983571|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
5983572|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983573|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983574|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983575|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5983576|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983577|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5983578|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
5983579|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5983580|NCT00040937|Thalidomide|thalidomide|mesh-list
5983581|NCT00040937|Dexamethasone|dexamethasone|mesh-list
5983582|NCT00040937|Prednisone|prednisone|mesh-list
5983583|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
5983584|NCT00040937|Melphalan|melphalan|mesh-list
5983585|NCT00040937|Sargramostim|sargramostim|mesh-list
5983586|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983587|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
5983588|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983589|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983590|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5983591|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
5983592|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983593|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983594|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5983595|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983596|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
5983597|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
5983598|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983599|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5983600|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
5983601|NCT00040937|Hormones|hormones|mesh-ancestor
5983602|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983603|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5983604|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
5983605|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5983606|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983607|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5983608|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5983609|NCT00040937|Growth Substances|growth substances|mesh-ancestor
5983610|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
5983611|NCT00041067|Docetaxel|docetaxel|mesh-list
5983612|NCT00041067|Trastuzumab|trastuzumab|mesh-list
5983613|NCT00041067|Vinorelbine|vinorelbine|mesh-list
5983614|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983615|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983616|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983617|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983618|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983619|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5983620|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983621|NCT00041080|Tamoxifen|tamoxifen|mesh-list
5983622|NCT00041080|Thalidomide|thalidomide|mesh-list
5983623|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5983624|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
5983625|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983626|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983627|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5983628|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983629|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5983630|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5983631|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5983632|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983633|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
5983634|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
5983635|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5983636|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983637|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5983638|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5983639|NCT00041080|Growth Substances|growth substances|mesh-ancestor
5983640|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
5983641|NCT00041119|Paclitaxel|paclitaxel|mesh-list
5983642|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
5983643|NCT00041119|Doxorubicin|doxorubicin|mesh-list
5983644|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5983645|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983646|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983647|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983648|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983649|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983650|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983651|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983652|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
5983653|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983654|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983655|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5983656|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
5983657|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5983658|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983659|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5983660|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983661|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983662|NCT00041132|Leucovorin|leucovorin|mesh-list
5983663|NCT00041132|Cytarabine|cytarabine|mesh-list
5983664|NCT00041132|Dexamethasone|dexamethasone|mesh-list
5983665|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
5983666|NCT00041132|Rituximab|rituximab|mesh-list
5983667|NCT00041132|Doxorubicin|doxorubicin|mesh-list
5983668|NCT00041132|Methotrexate|methotrexate|mesh-list
5983669|NCT00041132|Vincristine|vincristine|mesh-list
5983670|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
5983671|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983672|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
5983673|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983674|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983675|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5983676|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
5983677|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983678|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983679|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5983680|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983681|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
5983682|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
5983683|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983684|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5983685|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
5983686|NCT00041132|Hormones|hormones|mesh-ancestor
5983687|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983688|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5983689|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5983690|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983691|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5983692|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983693|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983694|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5983695|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
5983696|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5983697|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983698|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
5983699|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983700|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5983701|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5983702|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
5983703|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983704|NCT00041132|Antidotes|antidotes|mesh-ancestor
5983705|NCT00041132|Protective Agents|protective agents|mesh-ancestor
5983706|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
5983707|NCT00041132|Vitamins|vitamins|mesh-ancestor
5983708|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
5983709|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983710|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983711|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983712|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983713|NCT00041470|Paclitaxel|paclitaxel|mesh-list
5983714|NCT00041470|Vinorelbine|vinorelbine|mesh-list
5983715|NCT00041470|Trastuzumab|trastuzumab|mesh-list
5983716|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983717|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983718|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983719|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983720|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983721|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983722|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5983723|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
5983724|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5983725|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5983726|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983727|NCT00041938|Aspirin|aspirin|mesh-list
5983728|NCT00041938|Warfarin|warfarin|mesh-list
5983729|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5983730|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5983731|NCT00041938|Analgesics|analgesics|mesh-ancestor
5983732|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
5983733|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983734|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983735|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983736|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983737|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5983738|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5983739|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983740|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5983741|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5983742|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983743|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
5983744|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
5983745|NCT00042224|Clozapine|clozapine|mesh-list
5983746|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5983747|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
5983748|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5983749|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983750|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983751|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5983752|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5983753|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5983754|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5983755|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
5983756|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
5983757|NCT00042432|Cinacalcet|cinacalcet|mesh-list
5983758|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5983759|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983760|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5983761|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
5983762|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983763|NCT00042939|Docetaxel|docetaxel|mesh-list
5983764|NCT00042939|Irinotecan|irinotecan|mesh-list
5983765|NCT00042939|Cetuximab|cetuximab|mesh-list
5983766|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983767|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983768|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983769|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983770|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983771|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5983772|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983773|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983774|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5983775|NCT00042991|Gefitinib|gefitinib|mesh-list
5983776|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983777|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5983778|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983779|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983780|NCT00043186|Denosumab|denosumab|mesh-list
5983781|NCT00043186|Alendronate|alendronate|mesh-list
5983782|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5983783|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983784|NCT00043550|Sertraline|sertraline|mesh-list
5983785|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5983786|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
5983787|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5983788|NCT00043550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5983789|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5983790|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5983791|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983792|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5983793|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
5983794|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983795|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5983796|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5983797|NCT00043979|Cyclosporine|cyclosporine|mesh-list
5983798|NCT00043979|Sirolimus|sirolimus|mesh-list
5983799|NCT00043979|Prednisone|prednisone|mesh-list
5983800|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
5983801|NCT00043979|Melphalan|melphalan|mesh-list
5983802|NCT00043979|Doxorubicin|doxorubicin|mesh-list
5983803|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5983804|NCT00043979|Fludarabine|fludarabine|mesh-list
5983805|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
5983806|NCT00043979|Etoposide|etoposide|mesh-list
5983807|NCT00043979|Vincristine|vincristine|mesh-list
5983808|NCT00043979|Tacrolimus|tacrolimus|mesh-list
5983809|NCT00043979|Cyclosporins|cyclosporins|mesh-list
5983810|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5983811|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983812|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
5983813|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983814|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983815|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5983816|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
5983817|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983818|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983819|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5983820|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983821|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5983822|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983823|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983824|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5983825|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
5983826|NCT00043979|Hormones|hormones|mesh-ancestor
5983827|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5983828|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5983829|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983830|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
5983831|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983832|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5983833|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
5983834|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
5983835|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
5983836|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
5983837|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983838|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983839|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5983840|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5983841|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5983842|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5983843|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5983844|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5983845|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983846|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5983847|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5983848|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5983849|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5983850|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
5983851|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5983852|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983853|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5983854|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5983855|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
5983856|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5983857|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5983858|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
5983859|NCT00044044|Haloperidol|haloperidol|mesh-list
5983860|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
5983861|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5983862|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
5983863|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
5983864|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983865|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983866|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5983867|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5983868|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5983869|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5983870|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5983871|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5983872|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
5983873|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5983874|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983875|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5983876|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5983877|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5983878|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5983879|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
5983880|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5983881|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5983882|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
5983883|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5983884|NCT00044083|Tolcapone|tolcapone|mesh-list
5983885|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5983886|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5983887|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5983888|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983889|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983890|NCT00044213|Vitamins|vitamins|mesh-list
5983891|NCT00044213|Edetic Acid|edetic acid|mesh-list
5983892|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
5983893|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
5983894|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983895|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
5983896|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
5983897|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
5983898|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
5983899|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983900|NCT00044213|Antidotes|antidotes|mesh-ancestor
5983901|NCT00044213|Protective Agents|protective agents|mesh-ancestor
5983902|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5983903|NCT00044512|Sorafenib|sorafenib|mesh-list
5983904|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983905|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5983906|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983907|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983908|NCT00044655|Olanzapine|olanzapine|mesh-list
5983909|NCT00044655|Risperidone|risperidone|mesh-list
5983910|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5983911|NCT00044655|Aripiprazole|aripiprazole|mesh-list
5983912|NCT00044655|Ziprasidone|ziprasidone|mesh-list
5983913|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5983914|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
5983915|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5983916|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983917|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983918|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5983919|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5983920|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5983921|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5983922|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5983923|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
5983924|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
5983925|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
5983926|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5983927|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5983928|NCT00044655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5983929|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5983930|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5983931|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
5983932|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
5983933|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5983934|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5983935|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5983936|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5983937|NCT00045032|Trastuzumab|trastuzumab|mesh-list
5983938|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5983939|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983940|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5983941|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983942|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5983943|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983944|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983945|NCT00045162|Irinotecan|irinotecan|mesh-list
5983946|NCT00045162|Etoposide|etoposide|mesh-list
5983947|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983948|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5983949|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5983950|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983951|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983952|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5983953|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5983954|NCT00045305|Cyclosporine|cyclosporine|mesh-list
5983955|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
5983956|NCT00045305|Methotrexate|methotrexate|mesh-list
5983957|NCT00045305|Pentostatin|pentostatin|mesh-list
5983958|NCT00045305|Methoxsalen|methoxsalen|mesh-list
5983959|NCT00045305|Cyclosporins|cyclosporins|mesh-list
5983960|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5983961|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
5983962|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5983963|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983964|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983965|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
5983966|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983967|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983968|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
5983969|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983970|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5983971|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983972|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
5983973|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5983974|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5983975|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
5983976|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983977|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5983978|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5983979|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5983980|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
5983981|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5983982|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
5983983|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5983984|NCT00045435|Cyclosporine|cyclosporine|mesh-list
5983985|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
5983986|NCT00045435|Fludarabine|fludarabine|mesh-list
5983987|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
5983988|NCT00045435|Cyclosporins|cyclosporins|mesh-list
5983989|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5983990|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5983991|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
5983992|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5983993|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5983994|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
5983995|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5983996|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5983997|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
5983998|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5983999|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
5984000|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984001|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5984002|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984003|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5984004|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
5984005|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5984006|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5984007|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984008|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5984009|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984010|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984011|NCT00045630|Gemcitabine|gemcitabine|mesh-list
5984012|NCT00045630|Paclitaxel|paclitaxel|mesh-list
5984013|NCT00045630|Carboplatin|carboplatin|mesh-list
5984014|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984015|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984016|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984017|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984018|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984019|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984020|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984021|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
5984022|NCT00045630|Antiviral Agents|antiviral agents|mesh-ancestor
5984023|NCT00045630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984024|NCT00045630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984025|NCT00045630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984026|NCT00045630|Immunologic Factors|immunologic factors|mesh-ancestor
5984027|NCT00045630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245858|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
6245859|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245860|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
6245861|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245862|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
5984028|NCT00045708|Epothilones|epothilones|mesh-list
5984029|NCT00045708|Epothilone B|epothilone b|mesh-list
5984030|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
5984031|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984032|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984033|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984034|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984035|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984036|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
5984037|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984038|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5984039|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984040|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984041|NCT00045942|Itraconazole|itraconazole|mesh-list
5984042|NCT00045942|Midostaurin|midostaurin|mesh-list
5984043|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
5984044|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984045|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5984046|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5984047|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984048|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984049|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5984050|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
5984051|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984052|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984053|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5984054|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984055|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5984056|NCT00046228|Reteplase|reteplase|mesh-list
5984057|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5984058|NCT00046228|Abciximab|abciximab|mesh-list
5984059|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
5984060|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5984061|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5984062|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5984063|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984064|NCT00046475|Midodrine|midodrine|mesh-list
5984065|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
5984066|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
5984067|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5984068|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984069|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5984070|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5984071|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5984072|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5984073|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
5984074|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5984075|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984076|NCT00046566|Caseins|caseins|mesh-list
5984077|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
5984078|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
5984079|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984080|NCT00046839|Celecoxib|celecoxib|mesh-list
5984081|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
5984082|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5984083|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5984084|NCT00046839|Analgesics|analgesics|mesh-ancestor
5984085|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
5984086|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5984087|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984088|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5984089|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984090|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5984091|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984092|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984093|NCT00046930|Cytarabine|cytarabine|mesh-list
5984094|NCT00046930|Daunorubicin|daunorubicin|mesh-list
5984095|NCT00046930|Molgramostim|molgramostim|mesh-list
5984096|NCT00046930|Lenograstim|lenograstim|mesh-list
5984097|NCT00046930|Sargramostim|sargramostim|mesh-list
5984098|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5984099|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
5984100|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984101|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984102|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
5984103|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984104|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984105|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
5984106|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984107|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984108|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984109|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5984110|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5984111|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984112|NCT00047008|Cisplatin|cisplatin|mesh-list
5984113|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984114|NCT00047060|Cyclosporine|cyclosporine|mesh-list
5984115|NCT00047060|Fludarabine|fludarabine|mesh-list
5984116|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
5984117|NCT00047060|Cyclosporins|cyclosporins|mesh-list
5984118|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984119|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984120|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984121|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
5984122|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984123|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984124|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
5984125|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984126|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
5984127|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984128|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5984129|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5984130|NCT00047320|Carboplatin|carboplatin|mesh-list
5984131|NCT00047320|Etoposide|etoposide|mesh-list
5984132|NCT00047320|Ifosfamide|ifosfamide|mesh-list
5984133|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
5984134|NCT00047320|Thiotepa|thiotepa|mesh-list
5984135|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984136|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984137|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5984138|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5984139|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984140|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984141|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984142|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
5984143|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984144|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984145|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
5984146|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984147|NCT00047697|Donepezil|donepezil|mesh-list
5984148|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
5984149|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984150|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984151|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
5984152|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5984153|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984154|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
5984155|NCT00047879|Interferons|interferons|mesh-list
5984156|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
5984157|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
5984158|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5984159|NCT00047879|Thalidomide|thalidomide|mesh-list
5984160|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984161|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
5984162|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984163|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
5984164|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984165|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984166|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
5984167|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5984168|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5984169|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5984170|NCT00047879|Growth Substances|growth substances|mesh-ancestor
5984171|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
5984172|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
5984173|NCT00048035|Hematinics|hematinics|mesh-ancestor
5984174|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
5984175|NCT00048048|Hematinics|hematinics|mesh-ancestor
5984176|NCT00048061|Vitamin D|vitamin d|mesh-list
5984177|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
5984178|NCT00048061|Calcium|calcium|mesh-list
5984179|NCT00048061|Vitamins|vitamins|mesh-ancestor
5984180|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
5984181|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984182|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5984183|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5984184|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
5984185|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5984186|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984187|NCT00048165|Cyclosporine|cyclosporine|mesh-list
5984188|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
5984189|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
5984190|NCT00048165|Cyclosporins|cyclosporins|mesh-list
5984191|NCT00048165|Daclizumab|daclizumab|mesh-list
5984192|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984193|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984194|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984195|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
5984196|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984197|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
5984198|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984199|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
5984200|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984201|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5984202|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984203|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984204|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5984205|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
5984206|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5984207|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5984208|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
5984209|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
5984210|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5984211|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5984212|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
5984213|NCT00048165|Hormones|hormones|mesh-ancestor
5984214|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984215|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5984216|NCT00048165|Protective Agents|protective agents|mesh-ancestor
5984217|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
5984218|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5984219|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
5984220|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984221|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984222|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
5984223|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984224|NCT00048542|Adalimumab|adalimumab|mesh-list
5984225|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5984226|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984227|NCT00048568|Methotrexate|methotrexate|mesh-list
5984228|NCT00048568|Abatacept|abatacept|mesh-list
5984229|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5984230|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
5984231|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5984232|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984233|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984234|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
5984235|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984236|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984237|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
5984238|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984239|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5984240|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984241|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
5984242|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984243|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5984244|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5984245|NCT00048581|Abatacept|abatacept|mesh-list
5984246|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5984247|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984248|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984249|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984250|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
5984251|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984252|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984253|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5984254|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
5984255|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984256|NCT00048737|Vidarabine|vidarabine|mesh-list
5984257|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
5984258|NCT00048737|Rituximab|rituximab|mesh-list
5984259|NCT00048737|Fludarabine|fludarabine|mesh-list
5984260|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
5984261|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984262|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
5984263|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984264|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984265|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984266|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
5984267|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984268|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984269|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984270|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5984271|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984272|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
5984273|NCT00048737|Antiviral Agents|antiviral agents|mesh-ancestor
5984274|NCT00048737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984275|NCT00048815|Citalopram|citalopram|mesh-list
5984276|NCT00048815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5984277|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5984278|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5984279|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984280|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5984281|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
5984282|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984283|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5984284|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
5984285|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5984286|NCT00048893|Metronidazole|metronidazole|mesh-list
5984287|NCT00048893|Paclitaxel|paclitaxel|mesh-list
5984288|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
5984289|NCT00048893|Doxorubicin|doxorubicin|mesh-list
5984290|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5984291|NCT00048893|Fludarabine|fludarabine|mesh-list
5984292|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
5984293|NCT00048893|Vaccines|vaccines|mesh-list
5984294|NCT00048893|Sargramostim|sargramostim|mesh-list
5984295|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
5984296|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984297|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984298|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984299|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984300|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984301|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984302|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984303|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984304|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984305|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984306|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
5984307|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984308|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984309|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5984310|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5984311|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984312|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984313|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
5984314|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984315|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5984316|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5984317|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5984318|NCT00048932|Abatacept|abatacept|mesh-list
5984319|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5984320|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984321|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984322|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984323|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
5984324|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984325|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984326|NCT00049036|Prednisone|prednisone|mesh-list
5984327|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
5984328|NCT00049036|Rituximab|rituximab|mesh-list
5984329|NCT00049036|Doxorubicin|doxorubicin|mesh-list
5984330|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5984331|NCT00049036|Etoposide|etoposide|mesh-list
5984332|NCT00049036|Vincristine|vincristine|mesh-list
5984333|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
5984334|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984335|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
5984336|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984337|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984338|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984339|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
5984340|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984341|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984342|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984343|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5984344|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984345|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5984346|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5984347|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984348|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5984349|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
5984350|NCT00049036|Hormones|hormones|mesh-ancestor
5984351|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984352|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5984353|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984354|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984355|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984356|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984357|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
5984358|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984359|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5984360|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984361|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984362|NCT00049257|Paclitaxel|paclitaxel|mesh-list
5984363|NCT00049257|Carboplatin|carboplatin|mesh-list
5984364|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984365|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984366|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984367|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984368|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984369|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984370|NCT00049322|Bevacizumab|bevacizumab|mesh-list
5984371|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5984372|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984373|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5984374|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5984375|NCT00049322|Growth Substances|growth substances|mesh-ancestor
5984376|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984377|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
5984378|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
5984379|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
5984380|NCT00049504|Fludarabine|fludarabine|mesh-list
5984381|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
5984382|NCT00049504|Tacrolimus|tacrolimus|mesh-list
5984383|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984384|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
5984385|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984386|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984387|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984388|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
5984389|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984390|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984391|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984392|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984393|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
5984394|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5984395|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984396|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984397|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5984398|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
5984399|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5984400|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984401|NCT00049517|Cytarabine|cytarabine|mesh-list
5984402|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
5984403|NCT00049517|Busulfan|busulfan|mesh-list
5984404|NCT00049517|Daunorubicin|daunorubicin|mesh-list
5984405|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
5984406|NCT00049517|Sargramostim|sargramostim|mesh-list
5984407|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984408|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
5984409|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984410|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984411|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984412|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
5984413|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984414|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984415|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984416|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984417|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
5984418|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
5984419|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984420|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984421|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5984422|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5984423|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984424|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5984425|NCT00049530|Interferons|interferons|mesh-list
5984426|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
5984427|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
5984428|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5984429|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984430|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
5984431|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984432|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
5984433|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984434|NCT00049543|Gefitinib|gefitinib|mesh-list
5984435|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984436|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5984437|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984438|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984439|NCT00049673|Thalidomide|thalidomide|mesh-list
5984440|NCT00049673|Prednisone|prednisone|mesh-list
5984441|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5984442|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
5984443|NCT00049673|Hormones|hormones|mesh-ancestor
5984444|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984445|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984446|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5984447|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984448|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984449|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
5984450|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
5984451|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5984452|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984453|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5984454|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5984455|NCT00049673|Growth Substances|growth substances|mesh-ancestor
5984456|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
5984457|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5984458|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
5984459|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984460|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
5984461|NCT00050011|Letrozole|letrozole|mesh-list
5984462|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984463|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5984464|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5984465|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984466|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984467|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5984468|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
5984469|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984470|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984471|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5984472|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
5984473|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
5984474|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984475|NCT00050167|Paclitaxel|paclitaxel|mesh-list
5984476|NCT00050167|Docetaxel|docetaxel|mesh-list
5984477|NCT00050167|Capecitabine|capecitabine|mesh-list
5984478|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984479|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984480|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984481|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984482|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984483|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984484|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984485|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
5984486|NCT00050622|Methylphenidate|methylphenidate|mesh-list
5984487|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5984488|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984489|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5984490|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5984491|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5984492|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984493|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
5984494|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5984495|NCT00050778|Interferons|interferons|mesh-list
5984496|NCT00050778|Interferon-beta|interferon-beta|mesh-list
5984497|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
5984498|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
5984499|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984500|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
5984501|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984502|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5984503|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
5984504|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984505|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5984506|NCT00050960|Paclitaxel|paclitaxel|mesh-list
5984507|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5984508|NCT00050960|Carboplatin|carboplatin|mesh-list
5984509|NCT00050960|Bexarotene|bexarotene|mesh-list
5984510|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984511|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984512|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984513|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984514|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984515|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984516|NCT00050986|Temozolomide|temozolomide|mesh-list
5984517|NCT00050986|Tipifarnib|tipifarnib|mesh-list
5984518|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984519|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
5984520|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984521|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984522|NCT00051168|Travoprost|travoprost|mesh-list
5984523|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5984524|NCT00051311|Cyclosporine|cyclosporine|mesh-list
5984525|NCT00051311|Prednisone|prednisone|mesh-list
5984526|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
5984527|NCT00051311|Doxorubicin|doxorubicin|mesh-list
5984528|NCT00051311|Methotrexate|methotrexate|mesh-list
5984529|NCT00051311|Fludarabine|fludarabine|mesh-list
5984530|NCT00051311|Etoposide|etoposide|mesh-list
5984531|NCT00051311|Vincristine|vincristine|mesh-list
5984532|NCT00051311|Cyclosporins|cyclosporins|mesh-list
5984533|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984534|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
5984535|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984536|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984537|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984538|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
5984539|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984540|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984541|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984542|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984543|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5984544|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5984545|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984546|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5984547|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
5984548|NCT00051311|Hormones|hormones|mesh-ancestor
5984549|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984550|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5984551|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5984552|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
5984553|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5984554|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984555|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
5984556|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
5984557|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5984558|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5984559|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984560|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984561|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984562|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984563|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
5984564|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984565|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5984566|NCT00051558|Alendronate|alendronate|mesh-list
5984567|NCT00051558|Teriparatide|teriparatide|mesh-list
5984568|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5984569|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984570|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5984571|NCT00051636|Vitamin D|vitamin d|mesh-list
5984572|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
5984573|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
5984574|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
5984575|NCT00051636|Calcium|calcium|mesh-list
5984576|NCT00051636|Vitamins|vitamins|mesh-ancestor
5984577|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
5984578|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984579|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5984580|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5984581|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5984582|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5984583|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984584|NCT00052078|Sertraline|sertraline|mesh-list
5984585|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
5984586|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5984587|NCT00052078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5984588|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5984589|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5984590|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984591|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5984592|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
5984593|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984594|NCT00052429|Fluorouracil|fluorouracil|mesh-list
5984595|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984596|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
5984597|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984598|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984599|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984600|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
5984601|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984602|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
5984603|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984604|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5984605|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984606|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984607|NCT00052715|Poly ICLC|poly iclc|mesh-list
5984608|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
5984609|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
5984610|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984611|NCT00052910|Leucovorin|leucovorin|mesh-list
5984612|NCT00052910|Fluorouracil|fluorouracil|mesh-list
5984613|NCT00052910|Epirubicin|epirubicin|mesh-list
5984614|NCT00052910|Calcium|calcium|mesh-list
5984615|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
5984616|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984617|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5984618|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984619|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
5984620|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984621|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984622|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984623|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
5984624|NCT00052910|Antidotes|antidotes|mesh-ancestor
5984625|NCT00052910|Protective Agents|protective agents|mesh-ancestor
5984626|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
5984627|NCT00052910|Vitamins|vitamins|mesh-ancestor
5984628|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
5984629|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984630|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5984631|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5984632|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984633|NCT00053014|Cyclosporine|cyclosporine|mesh-list
5984634|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
5984635|NCT00053014|Fludarabine|fludarabine|mesh-list
5984636|NCT00053014|Cyclosporins|cyclosporins|mesh-list
5984637|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984638|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984639|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984640|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
5984641|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984642|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984643|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
5984644|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984645|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
5984646|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984647|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5984648|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984649|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5984650|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
5984651|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5984652|NCT00053352|Etoposide|etoposide|mesh-list
5984653|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
5984654|NCT00053352|Bleomycin|bleomycin|mesh-list
5984655|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984656|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984657|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5984658|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5984659|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984660|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984661|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984662|NCT00053365|Irofulven|irofulven|mesh-list
5984663|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984664|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
5984665|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984666|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984667|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
5984668|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
5984669|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5984670|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984671|NCT00053482|Vaccines|vaccines|mesh-list
5984672|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
5984673|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984674|NCT00053677|Naltrexone|naltrexone|mesh-list
5984675|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5984676|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5984677|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984678|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
5984679|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5984680|NCT00053703|Olanzapine|olanzapine|mesh-list
5984681|NCT00053703|Risperidone|risperidone|mesh-list
5984682|NCT00053703|Molindone|molindone|mesh-list
5984683|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5984684|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
5984685|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5984686|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984687|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984688|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5984689|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5984690|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5984691|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5984692|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5984693|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
5984694|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
5984695|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
5984696|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5984697|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5984698|NCT00053703|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5984699|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5984700|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5984701|NCT00053846|Buspirone|buspirone|mesh-list
5984702|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5984703|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5984704|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5984705|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984706|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5984707|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5984708|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
5984709|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5984710|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984711|NCT00053898|Tamoxifen|tamoxifen|mesh-list
5984712|NCT00053898|Anastrozole|anastrozole|mesh-list
5984713|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984714|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5984715|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
5984716|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984717|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984718|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5984719|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984720|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5984721|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5984722|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5984723|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5984724|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5984725|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984726|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
5984727|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
5984728|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
5984729|NCT00053989|Fludarabine|fludarabine|mesh-list
5984730|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
5984731|NCT00053989|Tacrolimus|tacrolimus|mesh-list
5984732|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5984733|NCT00053989|Sargramostim|sargramostim|mesh-list
5984734|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984735|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
5984736|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984737|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984738|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984739|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
5984740|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984741|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984742|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984743|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984744|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
5984745|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5984746|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984747|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984748|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5984749|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
5984750|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5984751|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984752|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5984753|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
5984754|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
5984755|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5984756|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5984757|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
5984758|NCT00053989|Hormones|hormones|mesh-ancestor
5984759|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984760|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5984761|NCT00053989|Protective Agents|protective agents|mesh-ancestor
5984762|NCT00054028|Suramin|suramin|mesh-list
5984763|NCT00054028|Paclitaxel|paclitaxel|mesh-list
5984764|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984765|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984766|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984767|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984768|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984769|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984770|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
5984771|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
5984772|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5984773|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984774|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5984775|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5984776|NCT00054132|Bevacizumab|bevacizumab|mesh-list
5984777|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5984778|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5984779|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
5984780|NCT00054132|Antibodies|antibodies|mesh-list
5984781|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
5984782|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5984783|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
5984784|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984785|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5984786|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5984787|NCT00054132|Growth Substances|growth substances|mesh-ancestor
5984788|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984789|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
5984790|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
5984791|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5984792|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984793|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984794|NCT00054275|Docetaxel|docetaxel|mesh-list
5984795|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5984796|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984797|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984798|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984799|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984800|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984801|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5984802|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984803|NCT00054327|Cytarabine|cytarabine|mesh-list
5984804|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
5984805|NCT00054327|Busulfan|busulfan|mesh-list
5984806|NCT00054327|Etoposide|etoposide|mesh-list
5984807|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
5984808|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984809|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
5984810|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984811|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984812|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984813|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
5984814|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984815|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984816|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984817|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984818|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5984819|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5984820|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984821|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984822|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
5984823|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
5984824|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984825|NCT00054353|Cyclosporine|cyclosporine|mesh-list
5984826|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
5984827|NCT00054353|Fludarabine|fludarabine|mesh-list
5984828|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
5984829|NCT00054353|Melphalan|melphalan|mesh-list
5984830|NCT00054353|Cyclosporins|cyclosporins|mesh-list
5984831|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984832|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984833|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
5984834|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984835|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984836|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
5984837|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984838|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984839|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
5984840|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984841|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
5984842|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984843|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5984844|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984845|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5984846|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
5984847|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5984848|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984849|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
5984850|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984851|NCT00054639|Rituximab|rituximab|mesh-list
5984852|NCT00054639|Oblimersen|oblimersen|mesh-list
5984853|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5984854|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984855|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
5984856|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984857|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984858|NCT00054665|Prednisone|prednisone|mesh-list
5984859|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
5984860|NCT00054665|Doxorubicin|doxorubicin|mesh-list
5984861|NCT00054665|Etoposide|etoposide|mesh-list
5984862|NCT00054665|Vincristine|vincristine|mesh-list
5984863|NCT00054665|Bortezomib|bortezomib|mesh-list
5984864|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984865|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
5984866|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984867|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984868|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5984869|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
5984870|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984871|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984872|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5984873|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5984874|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5984875|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5984876|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984877|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5984878|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
5984879|NCT00054665|Hormones|hormones|mesh-ancestor
5984880|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984881|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5984882|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984883|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984884|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984885|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984886|NCT00054691|Gefitinib|gefitinib|mesh-list
5984887|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984888|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5984889|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984890|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984891|NCT00054704|Riluzole|riluzole|mesh-list
5984892|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
5984893|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5984894|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5984895|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5984896|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984897|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984898|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5984899|NCT00054704|Protective Agents|protective agents|mesh-ancestor
5984900|NCT00054717|Ritonavir|ritonavir|mesh-list
5984901|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
5984902|NCT00054717|Tipranavir|tipranavir|mesh-list
5984903|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
5984904|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5984905|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984906|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984907|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5984908|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5984909|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
5984910|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984911|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5984912|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5984913|NCT00054756|Hormones|hormones|mesh-list
5984914|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
5984915|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984916|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984917|NCT00055237|Bevacizumab|bevacizumab|mesh-list
5984918|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5984919|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984920|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5984921|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5984922|NCT00055237|Growth Substances|growth substances|mesh-ancestor
5984923|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984924|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
5984925|NCT00055497|Adalimumab|adalimumab|mesh-list
5984926|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5984927|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5984928|NCT00055601|Gemcitabine|gemcitabine|mesh-list
5984929|NCT00055601|Paclitaxel|paclitaxel|mesh-list
5984930|NCT00055601|Fluorouracil|fluorouracil|mesh-list
5984931|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5984932|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984933|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
5984934|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
5984935|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
5984936|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984937|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5984938|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
5984939|NCT00055601|Antiviral Agents|antiviral agents|mesh-ancestor
5984940|NCT00055601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5984941|NCT00055601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984942|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5984943|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
5984944|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984945|NCT00055692|Bevacizumab|bevacizumab|mesh-list
5984946|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5984947|NCT00055692|Antibodies|antibodies|mesh-list
5984948|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
5984949|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5984950|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984951|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5984952|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5984953|NCT00055692|Growth Substances|growth substances|mesh-ancestor
5984954|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984955|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
5984956|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
5984957|NCT00056160|Dexamethasone|dexamethasone|mesh-list
5984958|NCT00056160|Lenalidomide|lenalidomide|mesh-list
5984959|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5984960|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
5984961|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
5984962|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5984963|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984964|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5984965|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
5984966|NCT00056160|Hormones|hormones|mesh-ancestor
5984967|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984968|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5984969|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5984970|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
5984971|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5984972|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5984973|NCT00056160|Growth Substances|growth substances|mesh-ancestor
5984974|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
5984975|NCT00056407|Dutasteride|dutasteride|mesh-list
5984976|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5984977|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5984978|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5984979|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984980|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
5984981|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5984982|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984983|NCT00056472|Olanzapine|olanzapine|mesh-list
5984984|NCT00056472|Sertraline|sertraline|mesh-list
5984985|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
5984986|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
5984987|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5984988|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5984989|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5984990|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5984991|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5984992|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5984993|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5984994|NCT00056472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5984995|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5984996|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5984997|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5984998|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5984999|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
5985000|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
5985001|NCT00056498|Risperidone|risperidone|mesh-list
5985002|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5985003|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
5985004|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5985005|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985006|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985007|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5985008|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5985009|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5985010|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5985011|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5985012|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
5985013|NCT00056550|Antithrombins|antithrombins|mesh-list
5985014|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
5985015|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5985016|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
5985017|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985018|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985019|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
5985020|NCT00056862|Ribavirin|ribavirin|mesh-list
5985021|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5985022|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
5985023|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
5985024|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985025|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
5985026|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985027|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
5985028|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985029|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
5985030|NCT00057330|Vaccines|vaccines|mesh-list
5985031|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
5985032|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
5985033|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985034|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5985035|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985036|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985037|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
5985038|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985039|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
5985040|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5985041|NCT00057330|Protective Agents|protective agents|mesh-ancestor
5985042|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
5985043|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6245863|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6245864|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245865|NCT02727322|Renal Agents|renal agents|mesh-ancestor
6245866|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6245867|NCT02727660|Budesonide|budesonide|mesh-list
6245868|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
6245869|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6245870|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6245871|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
6245872|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245873|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245874|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6245875|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
6245876|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
6245877|NCT02727660|Hormones|hormones|mesh-ancestor
6245878|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6245879|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6245880|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6245881|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6245882|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
6245883|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245884|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245885|NCT02728089|Tazobactam|tazobactam|mesh-list
6245886|NCT02728089|Ceftolozane|ceftolozane|mesh-list
6245887|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6245888|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245889|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6245890|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245891|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245892|NCT02728102|Lenalidomide|lenalidomide|mesh-list
6245893|NCT02728102|Melphalan|melphalan|mesh-list
6245894|NCT02728102|Molgramostim|molgramostim|mesh-list
6245895|NCT02728102|Vaccines|vaccines|mesh-list
6245896|NCT02728102|Sargramostim|sargramostim|mesh-list
6245897|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
6245898|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245899|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6245900|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6245901|NCT02728102|Growth Substances|growth substances|mesh-ancestor
6245902|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
6245903|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245904|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6245905|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
6245906|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245907|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6245908|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6245909|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
5985044|NCT00057681|Valproic Acid|valproic acid|mesh-list
5985045|NCT00057681|Risperidone|risperidone|mesh-list
5985046|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
5985047|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5985048|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
5985049|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5985050|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985051|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985052|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5985053|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5985054|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5985055|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5985056|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5985057|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
5985058|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
5985059|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985060|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
5985061|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
5985062|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
5985063|NCT00057785|Fluorouracil|fluorouracil|mesh-list
5985064|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985065|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
5985066|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985067|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5985068|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985069|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
5985070|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985071|NCT00057811|Leucovorin|leucovorin|mesh-list
5985072|NCT00057811|Cytarabine|cytarabine|mesh-list
5985073|NCT00057811|Prednisone|prednisone|mesh-list
5985074|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
5985075|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5985076|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5985077|NCT00057811|Prednisolone|prednisolone|mesh-list
5985078|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
5985079|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
5985080|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5985081|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5985082|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5985083|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
5985084|NCT00057811|Rituximab|rituximab|mesh-list
5985085|NCT00057811|Doxorubicin|doxorubicin|mesh-list
5985086|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5985087|NCT00057811|Methotrexate|methotrexate|mesh-list
5985088|NCT00057811|Etoposide|etoposide|mesh-list
5985089|NCT00057811|Vincristine|vincristine|mesh-list
5985090|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
5985091|NCT00057811|Rasburicase|rasburicase|mesh-list
5985092|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5985093|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
5985094|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
5985095|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985096|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
5985097|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985098|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985099|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5985100|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
5985101|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985102|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985103|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5985104|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5985105|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985106|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5985107|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985108|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985109|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5985110|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
5985111|NCT00057811|Hormones|hormones|mesh-ancestor
5985112|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985113|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5985114|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5985115|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
5985116|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5985117|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5985118|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
5985119|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
5985120|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5985121|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5985122|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985123|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
5985124|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985125|NCT00057811|Antidotes|antidotes|mesh-ancestor
5985126|NCT00057811|Protective Agents|protective agents|mesh-ancestor
5985127|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
5985128|NCT00057811|Vitamins|vitamins|mesh-ancestor
5985129|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
5985130|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985131|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985132|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985133|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
5985134|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
5985135|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985136|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5985137|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5985138|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
5985139|NCT00057837|Cisplatin|cisplatin|mesh-list
5985140|NCT00057837|Irinotecan|irinotecan|mesh-list
5985141|NCT00057837|Etoposide|etoposide|mesh-list
5985142|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
5985143|NCT00057837|Topotecan|topotecan|mesh-list
5985144|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
5985145|NCT00057837|Camptothecin|camptothecin|mesh-list
5985146|NCT00057837|Lenograstim|lenograstim|mesh-list
5985147|NCT00057837|Sargramostim|sargramostim|mesh-list
5985148|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985149|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5985150|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985151|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985152|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985153|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985154|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5985155|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5985156|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
5985157|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985158|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
5985159|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
5985160|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985161|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985162|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985163|NCT00057863|Paclitaxel|paclitaxel|mesh-list
5985164|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
5985165|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985166|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985167|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985168|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985169|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985170|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985171|NCT00057876|Gemcitabine|gemcitabine|mesh-list
5985172|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5985173|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
5985174|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985175|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985176|NCT00057876|Antiviral Agents|antiviral agents|mesh-ancestor
5985177|NCT00057876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985178|NCT00057876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985179|NCT00057876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985180|NCT00057876|Immunologic Factors|immunologic factors|mesh-ancestor
5985181|NCT00057876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985182|NCT00057941|Fulvestrant|fulvestrant|mesh-list
5985183|NCT00057941|Anastrozole|anastrozole|mesh-list
5985184|NCT00057941|Gefitinib|gefitinib|mesh-list
5985185|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5985186|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985187|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5985188|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5985189|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
5985190|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985191|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985192|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5985193|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985194|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985195|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5985196|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5985197|NCT00057954|Cyclosporine|cyclosporine|mesh-list
5985198|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
5985199|NCT00057954|Methotrexate|methotrexate|mesh-list
5985200|NCT00057954|Pentostatin|pentostatin|mesh-list
5985201|NCT00057954|Cyclosporins|cyclosporins|mesh-list
5985202|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5985203|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
5985204|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5985205|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985206|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5985207|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
5985208|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985209|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985210|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
5985211|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985212|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5985213|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985214|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
5985215|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985216|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5985217|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
5985218|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985219|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5985220|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985221|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5985222|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
5985223|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5985224|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
5985225|NCT00058019|Epothilones|epothilones|mesh-list
5985226|NCT00058019|Epothilone B|epothilone b|mesh-list
5985227|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985228|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985229|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985230|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985231|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985232|NCT00058123|Poly ICLC|poly iclc|mesh-list
5985233|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
5985234|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
5985235|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985236|NCT00058240|Alvocidib|alvocidib|mesh-list
5985237|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985238|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
5985239|NCT00058240|Growth Substances|growth substances|mesh-ancestor
5985240|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985241|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5985242|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985243|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985244|NCT00058370|Vincristine|vincristine|mesh-list
5985245|NCT00058370|Lomustine|lomustine|mesh-list
5985246|NCT00058370|Antibodies|antibodies|mesh-list
5985247|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5985248|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
5985249|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985250|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985251|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985252|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985253|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985254|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985255|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985256|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5985257|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
5985258|NCT00058422|Prednisone|prednisone|mesh-list
5985259|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
5985260|NCT00058422|Rituximab|rituximab|mesh-list
5985261|NCT00058422|Doxorubicin|doxorubicin|mesh-list
5985262|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5985263|NCT00058422|Vincristine|vincristine|mesh-list
5985264|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
5985265|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5985266|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985267|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
5985268|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985269|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985270|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5985271|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
5985272|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985273|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985274|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5985275|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5985276|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985277|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5985278|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985279|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985280|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5985281|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
5985282|NCT00058422|Hormones|hormones|mesh-ancestor
5985283|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985284|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5985285|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985286|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985287|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985288|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985289|NCT00058422|Hematinics|hematinics|mesh-ancestor
5985290|NCT00058539|Pertuzumab|pertuzumab|mesh-list
5985291|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5985292|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985293|NCT00058552|Pertuzumab|pertuzumab|mesh-list
5985294|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5985295|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985296|NCT00058825|Cyclosporine|cyclosporine|mesh-list
5985297|NCT00058825|Fludarabine|fludarabine|mesh-list
5985298|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
5985299|NCT00058825|Tacrolimus|tacrolimus|mesh-list
5985300|NCT00058825|Cyclosporins|cyclosporins|mesh-list
5985301|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985302|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985303|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985304|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
5985305|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985306|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5985307|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985308|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
5985309|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985310|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
5985311|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985312|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5985313|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
5985314|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
5985315|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5985316|NCT00059215|Clopidogrel|clopidogrel|mesh-list
5985317|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5985318|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5985319|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5985320|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5985321|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5985322|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
5985323|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5985324|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985325|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985326|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
5985327|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
5985328|NCT00059228|Estradiol|estradiol|mesh-list
5985329|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
5985330|NCT00059228|Estrogens|estrogens|mesh-ancestor
5985331|NCT00059228|Hormones|hormones|mesh-ancestor
5985332|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985333|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985334|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5985335|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
5985336|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5985337|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5985338|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
5985339|NCT00059332|Analgesics|analgesics|mesh-ancestor
5985340|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
5985341|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985342|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985343|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
5985344|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5985345|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5985346|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
5985347|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5985348|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5985349|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985350|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5985351|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
5985352|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5985353|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
5985354|NCT00059475|Interleukin-2|interleukin-2|mesh-list
5985355|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985356|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5985357|NCT00059475|Analgesics|analgesics|mesh-ancestor
5985358|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
5985359|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985360|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985361|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5985362|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
5985363|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985364|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
5985365|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985366|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
5985367|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5985368|NCT00059475|Protective Agents|protective agents|mesh-ancestor
5985369|NCT00059787|Paclitaxel|paclitaxel|mesh-list
5985370|NCT00059787|Carboplatin|carboplatin|mesh-list
5985371|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5985372|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985373|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985374|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985375|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985376|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985377|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985378|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5985379|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985380|NCT00059839|Prednisone|prednisone|mesh-list
5985381|NCT00059839|Doxorubicin|doxorubicin|mesh-list
5985382|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5985383|NCT00059839|Methotrexate|methotrexate|mesh-list
5985384|NCT00059839|Vincristine|vincristine|mesh-list
5985385|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
5985386|NCT00059839|Vinblastine|vinblastine|mesh-list
5985387|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985388|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985389|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5985390|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985391|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985392|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985393|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5985394|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
5985395|NCT00059839|Hormones|hormones|mesh-ancestor
5985396|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985397|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985398|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5985399|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5985400|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
5985401|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5985402|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5985403|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
5985404|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
5985405|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5985406|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985407|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
5985408|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985409|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5985410|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985411|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985412|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985413|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985414|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5985415|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5985416|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985417|NCT00060346|Prednisone|prednisone|mesh-list
5985418|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
5985419|NCT00060346|Rituximab|rituximab|mesh-list
5985420|NCT00060346|Doxorubicin|doxorubicin|mesh-list
5985421|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5985422|NCT00060346|Vincristine|vincristine|mesh-list
5985423|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985424|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
5985425|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985426|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985427|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5985428|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
5985429|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985430|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985431|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5985432|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5985433|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985434|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5985435|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985436|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985437|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5985438|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
5985439|NCT00060346|Hormones|hormones|mesh-ancestor
5985440|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985441|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5985442|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985443|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985444|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985445|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985446|NCT00060424|Cyclosporine|cyclosporine|mesh-list
5985447|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
5985448|NCT00060424|Fludarabine|fludarabine|mesh-list
5985449|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
5985450|NCT00060424|Cyclosporins|cyclosporins|mesh-list
5985451|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985452|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5985453|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
5985454|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985455|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985456|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
5985457|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985458|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985459|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
5985460|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985461|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
5985462|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985463|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5985464|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985465|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5985466|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
5985467|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5985468|NCT00060528|Metronidazole|metronidazole|mesh-list
5985469|NCT00060528|Molgramostim|molgramostim|mesh-list
5985470|NCT00060528|Sargramostim|sargramostim|mesh-list
5985471|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
5985472|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985473|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985474|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985475|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5985476|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5985477|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5985478|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
5985479|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5985480|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
5985481|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985482|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985483|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5985484|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
5985485|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5985486|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
5985487|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985488|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5985489|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5985490|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
5985491|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
5985492|NCT00060840|Protective Agents|protective agents|mesh-ancestor
5985493|NCT00060944|Dexamethasone|dexamethasone|mesh-list
5985494|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
5985495|NCT00060944|Trabectedin|trabectedin|mesh-list
5985496|NCT00060944|BB 1101|bb 1101|mesh-list
5985497|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5985498|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
5985499|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
5985500|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985501|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985502|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5985503|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
5985504|NCT00060944|Hormones|hormones|mesh-ancestor
5985505|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985506|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5985507|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985508|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
5985509|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985510|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985511|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5985512|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
5985513|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
5985514|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5985515|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985516|NCT00061373|Aspirin|aspirin|mesh-list
5985517|NCT00061373|Tinzaparin|tinzaparin|mesh-list
5985518|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
5985519|NCT00061373|Dalteparin|dalteparin|mesh-list
5985520|NCT00061373|Eptifibatide|eptifibatide|mesh-list
5985521|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5985522|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5985523|NCT00061373|Analgesics|analgesics|mesh-ancestor
5985524|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
5985525|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985526|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985527|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5985528|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985529|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5985530|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5985531|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985532|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5985533|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5985534|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985535|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
5985536|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
5985537|NCT00061633|Vancomycin|vancomycin|mesh-list
5985538|NCT00061633|Penicillins|penicillins|mesh-list
5985539|NCT00061633|Telavancin|telavancin|mesh-list
5985540|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5985541|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985542|NCT00061893|Celecoxib|celecoxib|mesh-list
5985543|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
5985544|NCT00061893|Ifosfamide|ifosfamide|mesh-list
5985545|NCT00061893|Doxorubicin|doxorubicin|mesh-list
5985546|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5985547|NCT00061893|Etoposide|etoposide|mesh-list
5985548|NCT00061893|Vincristine|vincristine|mesh-list
5985549|NCT00061893|Vinblastine|vinblastine|mesh-list
5985550|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985551|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
5985552|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985553|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985554|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5985555|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
5985556|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985557|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985558|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5985559|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985560|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5985561|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985562|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985563|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985564|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985565|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985566|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985567|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5985568|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5985569|NCT00061893|Analgesics|analgesics|mesh-ancestor
5985570|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
5985571|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985572|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5985573|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5985574|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5985575|NCT00061932|Irinotecan|irinotecan|mesh-list
5985576|NCT00061932|Bortezomib|bortezomib|mesh-list
5985577|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5985578|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985579|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985580|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985581|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985582|NCT00061945|Leucovorin|leucovorin|mesh-list
5985583|NCT00061945|Cytarabine|cytarabine|mesh-list
5985584|NCT00061945|Acyclovir|acyclovir|mesh-list
5985585|NCT00061945|Trimethoprim|trimethoprim|mesh-list
5985586|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
5985587|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5985588|NCT00061945|Dexamethasone|dexamethasone|mesh-list
5985589|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
5985590|NCT00061945|Methotrexate|methotrexate|mesh-list
5985591|NCT00061945|Vincristine|vincristine|mesh-list
5985592|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
5985593|NCT00061945|Daunorubicin|daunorubicin|mesh-list
5985594|NCT00061945|Asparaginase|asparaginase|mesh-list
5985595|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
5985596|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
5985597|NCT00061945|Allopurinol|allopurinol|mesh-list
5985598|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
5985599|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985600|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
5985601|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985602|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985603|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5985604|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
5985605|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985606|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985607|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5985608|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5985609|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
5985610|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
5985611|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985612|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5985613|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
5985614|NCT00061945|Hormones|hormones|mesh-ancestor
5985615|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985616|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5985617|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5985618|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
5985619|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5985620|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5985621|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
5985622|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
5985623|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985624|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5985625|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5985626|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
5985627|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985628|NCT00061945|Antidotes|antidotes|mesh-ancestor
5985629|NCT00061945|Protective Agents|protective agents|mesh-ancestor
5985630|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
5985631|NCT00061945|Vitamins|vitamins|mesh-ancestor
5985632|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
5985633|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985634|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985635|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985636|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985637|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5985638|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985639|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5985640|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985641|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5985642|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
5985643|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5985644|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
5985645|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5985646|NCT00061945|Renal Agents|renal agents|mesh-ancestor
5985647|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
5985648|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5985649|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5985650|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5985651|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5985652|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5985653|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5985654|NCT00062010|Interferons|interferons|mesh-list
5985655|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
5985656|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
5985657|NCT00062010|Paclitaxel|paclitaxel|mesh-list
5985658|NCT00062010|Tretinoin|tretinoin|mesh-list
5985659|NCT00062010|Isotretinoin|isotretinoin|mesh-list
5985660|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985661|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985662|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985663|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985664|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985665|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985666|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
5985667|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985668|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
5985669|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985670|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
5985671|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
5985672|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
5985673|NCT00062374|Alovudine|alovudine|mesh-list
5985674|NCT00062374|Cisplatin|cisplatin|mesh-list
5985675|NCT00062374|Irinotecan|irinotecan|mesh-list
5985676|NCT00062374|Camptothecin|camptothecin|mesh-list
5985677|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5985678|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985679|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5985680|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985681|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985682|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985683|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5985684|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985685|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
5985686|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
5985687|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985688|NCT00062439|Docetaxel|docetaxel|mesh-list
5985689|NCT00062439|Etoposide|etoposide|mesh-list
5985690|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985691|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985692|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985693|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985694|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985695|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985696|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5985697|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985698|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985699|NCT00062647|Vancomycin|vancomycin|mesh-list
5985700|NCT00062647|Cloxacillin|cloxacillin|mesh-list
5985701|NCT00062647|Oxacillin|oxacillin|mesh-list
5985702|NCT00062647|Telavancin|telavancin|mesh-list
5985703|NCT00062647|Nafcillin|nafcillin|mesh-list
5985704|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5985705|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985706|NCT00062738|Paroxetine|paroxetine|mesh-list
5985707|NCT00062738|Nortriptyline|nortriptyline|mesh-list
5985708|NCT00062738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5985709|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5985710|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5985711|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985712|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5985713|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
5985714|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985715|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5985716|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
5985717|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5985718|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5985719|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5985720|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985721|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5985722|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5985723|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
5985724|NCT00062764|Pioglitazone|pioglitazone|mesh-list
5985725|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5985726|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985727|NCT00063154|Pertuzumab|pertuzumab|mesh-list
5985728|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5985729|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985730|NCT00063232|Metformin|metformin|mesh-list
5985731|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5985732|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985733|NCT00063258|Paclitaxel|paclitaxel|mesh-list
5985734|NCT00063258|Carboplatin|carboplatin|mesh-list
5985735|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5985736|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985737|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985738|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985739|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985740|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985741|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985742|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5985743|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985744|NCT00063362|Lamotrigine|lamotrigine|mesh-list
5985745|NCT00063362|Valproic Acid|valproic acid|mesh-list
5985746|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
5985747|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
5985748|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5985749|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985750|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985751|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
5985752|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5985753|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5985754|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985755|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
5985756|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5985757|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5985758|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5985759|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5985760|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5985761|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
5985762|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5985763|NCT00063570|Gemcitabine|gemcitabine|mesh-list
5985764|NCT00063570|Pemetrexed|pemetrexed|mesh-list
5985765|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5985766|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
5985767|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985768|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985769|NCT00063570|Antiviral Agents|antiviral agents|mesh-ancestor
5985770|NCT00063570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985771|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985772|NCT00063570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985773|NCT00063570|Immunologic Factors|immunologic factors|mesh-ancestor
5985774|NCT00063570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985775|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5985776|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5985777|NCT00063622|Vitamin E|vitamin e|mesh-list
5985778|NCT00063622|Pioglitazone|pioglitazone|mesh-list
5985779|NCT00063622|Vitamins|vitamins|mesh-ancestor
5985780|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
5985781|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985782|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5985783|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
5985784|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985785|NCT00063622|Protective Agents|protective agents|mesh-ancestor
5985786|NCT00063635|Vitamin E|vitamin e|mesh-list
5985787|NCT00063635|Metformin|metformin|mesh-list
5985788|NCT00063635|Vitamins|vitamins|mesh-ancestor
5985789|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
5985790|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985791|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5985792|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
5985793|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985794|NCT00063635|Protective Agents|protective agents|mesh-ancestor
5985795|NCT00063934|Docetaxel|docetaxel|mesh-list
5985796|NCT00063934|Doxorubicin|doxorubicin|mesh-list
5985797|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5985798|NCT00063934|Oblimersen|oblimersen|mesh-list
5985799|NCT00063934|Lenograstim|lenograstim|mesh-list
5985800|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985801|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985802|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985803|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985804|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985805|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985806|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5985807|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985808|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985809|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5985810|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
5985811|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985812|NCT00063999|Paclitaxel|paclitaxel|mesh-list
5985813|NCT00063999|Cisplatin|cisplatin|mesh-list
5985814|NCT00063999|Carboplatin|carboplatin|mesh-list
5985815|NCT00063999|Doxorubicin|doxorubicin|mesh-list
5985816|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5985817|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5985818|NCT00063999|Lenograstim|lenograstim|mesh-list
5985819|NCT00063999|Sargramostim|sargramostim|mesh-list
5985820|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985821|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985822|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985823|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985824|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985825|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985826|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985827|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5985828|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985829|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985830|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5985831|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
5985832|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985833|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
5985834|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
5985835|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
5985836|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
5985837|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5985838|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
5985839|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5985840|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985841|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5985842|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
5985843|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
5985844|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5985845|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985846|NCT00064038|Dexamethasone|dexamethasone|mesh-list
5985847|NCT00064038|Lenalidomide|lenalidomide|mesh-list
5985848|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5985849|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
5985850|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
5985851|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985852|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985853|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5985854|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
5985855|NCT00064038|Hormones|hormones|mesh-ancestor
5985856|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985857|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5985858|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985859|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
5985860|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5985861|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5985862|NCT00064038|Growth Substances|growth substances|mesh-ancestor
5985863|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
5985864|NCT00064077|Gemcitabine|gemcitabine|mesh-list
5985865|NCT00064077|Paclitaxel|paclitaxel|mesh-list
5985866|NCT00064077|Vinorelbine|vinorelbine|mesh-list
5985867|NCT00064077|Cisplatin|cisplatin|mesh-list
5985868|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5985869|NCT00064077|Topotecan|topotecan|mesh-list
5985870|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5985871|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985872|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985873|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985874|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985875|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985876|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5985877|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
5985878|NCT00064077|Antiviral Agents|antiviral agents|mesh-ancestor
5985879|NCT00064077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985880|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985881|NCT00064077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985882|NCT00064077|Immunologic Factors|immunologic factors|mesh-ancestor
5985883|NCT00064077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985884|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5985885|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985886|NCT00064259|Fluorouracil|fluorouracil|mesh-list
5985887|NCT00064259|Oblimersen|oblimersen|mesh-list
5985888|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985889|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
5985890|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985891|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5985892|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985893|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
5985894|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985895|NCT00064337|Thalidomide|thalidomide|mesh-list
5985896|NCT00064337|Dexamethasone|dexamethasone|mesh-list
5985897|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
5985898|NCT00064337|Melphalan|melphalan|mesh-list
5985899|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985900|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
5985901|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985902|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985903|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5985904|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
5985905|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985906|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985907|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5985908|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5985909|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
5985910|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
5985911|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985912|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5985913|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
5985914|NCT00064337|Hormones|hormones|mesh-ancestor
5985915|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985916|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5985917|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
5985918|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5985919|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985920|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5985921|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5985922|NCT00064337|Growth Substances|growth substances|mesh-ancestor
5985923|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
5985924|NCT00064350|Sorafenib|sorafenib|mesh-list
5985925|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985926|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5985927|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985928|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985929|NCT00064701|Cyclosporine|cyclosporine|mesh-list
5985930|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
5985931|NCT00064701|Tacrolimus|tacrolimus|mesh-list
5985932|NCT00064701|Cyclosporins|cyclosporins|mesh-list
5985933|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985934|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
5985935|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985936|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5985937|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985938|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985939|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
5985940|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5985941|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
5985942|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5985943|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5985944|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985945|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5985946|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
5985947|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5985948|NCT00064792|Simvastatin|simvastatin|mesh-list
5985949|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5985950|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5985951|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
5985952|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985953|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5985954|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5985955|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985956|NCT00064844|Nicotine|nicotine|mesh-list
5985957|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5985958|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
5985959|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5985960|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985961|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5985962|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5985963|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
5985964|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5985965|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985966|NCT00064987|Hormones|hormones|mesh-list
5985967|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
5985968|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5985969|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985970|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
5985971|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5985972|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985973|NCT00065156|Lenalidomide|lenalidomide|mesh-list
5985974|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
5985975|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5985976|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5985977|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5985978|NCT00065156|Growth Substances|growth substances|mesh-ancestor
5985979|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
5985980|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985981|NCT00065182|Docetaxel|docetaxel|mesh-list
5985982|NCT00065182|Topotecan|topotecan|mesh-list
5985983|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5985984|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
5985985|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
5985986|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
5985987|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985988|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5985989|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5985990|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985991|NCT00065260|Cyclosporine|cyclosporine|mesh-list
5985992|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
5985993|NCT00065260|Cyclosporins|cyclosporins|mesh-list
5985994|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
5985995|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5985996|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5985997|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5985998|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5985999|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
5986000|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986001|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
5986002|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986003|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
5986004|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986005|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5986006|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986007|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986008|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
5986009|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986010|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986011|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5986012|NCT00065468|Interferons|interferons|mesh-list
5986013|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
5986014|NCT00065468|Sirolimus|sirolimus|mesh-list
5986015|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986016|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
5986017|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986018|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
5986019|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986020|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5986021|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5986022|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
5986023|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986024|NCT00065507|Entecavir|entecavir|mesh-list
5986025|NCT00065507|Adefovir|adefovir|mesh-list
5986026|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
5986027|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986028|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5986029|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5986030|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986031|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986032|NCT00065611|Dexamethasone|dexamethasone|mesh-list
5986033|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5986034|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
5986035|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
5986036|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5986037|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986038|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5986039|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
5986040|NCT00065611|Hormones|hormones|mesh-ancestor
5986041|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5986042|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5986043|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986044|NCT00065806|Atorvastatin|atorvastatin|mesh-list
5986045|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5986046|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5986047|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
5986048|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986049|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5986050|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5986051|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986052|NCT00066066|Amoxicillin|amoxicillin|mesh-list
5986053|NCT00066066|Metronidazole|metronidazole|mesh-list
5986054|NCT00066066|Doxycycline|doxycycline|mesh-list
5986055|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5986056|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986057|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5986058|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5986059|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
5986060|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
5986061|NCT00066170|Modafinil|modafinil|mesh-list
5986062|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5986063|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986064|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5986065|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5986066|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5986067|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986068|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5986069|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5986070|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
5986071|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
5986072|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5986073|NCT00066222|Etoposide|etoposide|mesh-list
5986074|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986075|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5986076|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5986077|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5986078|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986079|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986080|NCT00066365|Molgramostim|molgramostim|mesh-list
5986081|NCT00066365|Sargramostim|sargramostim|mesh-list
5986082|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
5986083|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986084|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986085|NCT00066469|Prednisone|prednisone|mesh-list
5986086|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
5986087|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5986088|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5986089|NCT00066469|Prednisolone|prednisolone|mesh-list
5986090|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
5986091|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
5986092|NCT00066469|Rituximab|rituximab|mesh-list
5986093|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5986094|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
5986095|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986096|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
5986097|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986098|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986099|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986100|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
5986101|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986102|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986103|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5986104|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986105|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5986106|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
5986107|NCT00066469|Hormones|hormones|mesh-ancestor
5986108|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5986109|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5986110|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
5986111|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
5986112|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5986113|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5986114|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5986115|NCT00066469|Protective Agents|protective agents|mesh-ancestor
5986116|NCT00066573|Anastrozole|anastrozole|mesh-list
5986117|NCT00066573|Exemestane|exemestane|mesh-list
5986118|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5986119|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986120|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5986121|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5986122|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986123|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986124|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5986125|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
5986126|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5986127|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986128|NCT00066677|Docetaxel|docetaxel|mesh-list
5986129|NCT00066677|Bevacizumab|bevacizumab|mesh-list
5986130|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986131|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
5986132|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
5986133|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
5986134|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986135|NCT00066677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986136|NCT00066677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5986137|NCT00066677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5986138|NCT00066677|Growth Substances|growth substances|mesh-ancestor
5986139|NCT00066677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986140|NCT00066677|Growth Inhibitors|growth inhibitors|mesh-ancestor
5986141|NCT00066690|Tamoxifen|tamoxifen|mesh-list
5986142|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5986143|NCT00066690|Exemestane|exemestane|mesh-list
5986144|NCT00066690|Tryptophan|tryptophan|mesh-list
5986145|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986146|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5986147|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986148|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5986149|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
5986150|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5986151|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986152|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5986153|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5986154|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5986155|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5986156|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5986157|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986158|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
5986159|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5986160|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
5986161|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5986162|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5986163|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5986164|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
5986165|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5986166|NCT00066703|Tamoxifen|tamoxifen|mesh-list
5986167|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5986168|NCT00066703|Exemestane|exemestane|mesh-list
5986169|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5986170|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
5986171|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5986172|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986173|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5986174|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986175|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5986176|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5986177|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5986178|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5986179|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5986180|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986181|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986182|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
5986183|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5986184|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
5986185|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5986186|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5986187|NCT00066742|Etoposide|etoposide|mesh-list
5986188|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
5986189|NCT00066742|Tirapazamine|tirapazamine|mesh-list
5986190|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986191|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5986192|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5986193|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5986194|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986195|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986196|NCT00066781|Gemcitabine|gemcitabine|mesh-list
5986197|NCT00066781|Irinotecan|irinotecan|mesh-list
5986198|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986199|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
5986200|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986201|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986202|NCT00066781|Antiviral Agents|antiviral agents|mesh-ancestor
5986203|NCT00066781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986204|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986205|NCT00066781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986206|NCT00066781|Immunologic Factors|immunologic factors|mesh-ancestor
5986207|NCT00066781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986208|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5986209|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5986210|NCT00066937|Benztropine|benztropine|mesh-list
5986211|NCT00066937|Nortriptyline|nortriptyline|mesh-list
5986212|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5986213|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
5986214|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5986215|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5986216|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5986217|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5986218|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986219|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
5986220|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5986221|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986222|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5986223|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5986224|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
5986225|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
5986226|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5986227|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5986228|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5986229|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
5986230|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5986231|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
5986232|NCT00066963|Fluorides|fluorides|mesh-list
5986233|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
5986234|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
5986235|NCT00066963|Protective Agents|protective agents|mesh-ancestor
5986236|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986237|NCT00067002|Vidarabine|vidarabine|mesh-list
5986238|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
5986239|NCT00067002|Melphalan|melphalan|mesh-list
5986240|NCT00067002|Thiotepa|thiotepa|mesh-list
5986241|NCT00067002|Rituximab|rituximab|mesh-list
5986242|NCT00067002|Fludarabine|fludarabine|mesh-list
5986243|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
5986244|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986245|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
5986246|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986247|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986248|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986249|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
5986250|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986251|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986252|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5986253|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986254|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986255|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
5986256|NCT00067002|Antiviral Agents|antiviral agents|mesh-ancestor
5986257|NCT00067002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986258|NCT00067028|Cytarabine|cytarabine|mesh-list
5986259|NCT00067028|Clofarabine|clofarabine|mesh-list
5986260|NCT00067028|Idarubicin|idarubicin|mesh-list
5986261|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986262|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
5986263|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986264|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986265|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
5986266|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986267|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986268|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
5986269|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986270|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5986271|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5986272|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5986273|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6245910|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6245911|NCT02728206|Velpatasvir|velpatasvir|mesh-list
6245912|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
6245913|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6245914|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
6245915|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245916|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245917|NCT02728895|Vedolizumab|vedolizumab|mesh-list
6245918|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6245919|NCT02729025|Evolocumab|evolocumab|mesh-list
6245920|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6245921|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6245922|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
6245923|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245924|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6245925|NCT02729051|Albuterol|albuterol|mesh-list
6245926|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6245927|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
6245928|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245929|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245930|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6245931|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
6245932|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
6245933|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6245934|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6245935|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6245936|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6245937|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
6245938|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6245939|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245940|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
6245941|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
6245942|NCT02729545|Cyproterone|cyproterone|mesh-list
6245943|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6245944|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6245945|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6245946|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
6245947|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6245948|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245949|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6245950|NCT02729545|Estrogens|estrogens|mesh-ancestor
6245951|NCT02729545|Hormones|hormones|mesh-ancestor
6245952|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6245953|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
6245954|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
6245955|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245956|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6245957|NCT02729896|Rituximab|rituximab|mesh-list
6245958|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
6245959|NCT02729896|Atezolizumab|atezolizumab|mesh-list
6245960|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245961|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245962|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
6245963|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245964|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6245965|NCT02729909|Lubiprostone|lubiprostone|mesh-list
6245966|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6245967|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245968|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245969|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
6245970|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245971|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245972|NCT02730195|Pioglitazone|pioglitazone|mesh-list
6245973|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5986274|NCT00067808|Decitabine|decitabine|mesh-list
5986275|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986276|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
5986277|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986278|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986279|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986280|NCT00067990|Losartan|losartan|mesh-list
5986281|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5986282|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5986283|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5986284|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5986285|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986286|NCT00068250|Rituximab|rituximab|mesh-list
5986287|NCT00068250|Methotrexate|methotrexate|mesh-list
5986288|NCT00068250|Temozolomide|temozolomide|mesh-list
5986289|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986290|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986291|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
5986292|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986293|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986294|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5986295|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
5986296|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5986297|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986298|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
5986299|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986300|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
5986301|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986302|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5986303|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986304|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5986305|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986306|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
5986307|NCT00068341|Carboplatin|carboplatin|mesh-list
5986308|NCT00068341|Docetaxel|docetaxel|mesh-list
5986309|NCT00068341|Trastuzumab|trastuzumab|mesh-list
5986310|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986311|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
5986312|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
5986313|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
5986314|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986315|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986316|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5986317|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986318|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5986319|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986320|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986321|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
5986322|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986323|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5986324|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986325|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986326|NCT00068393|Gemcitabine|gemcitabine|mesh-list
5986327|NCT00068393|Doxorubicin|doxorubicin|mesh-list
5986328|NCT00068393|Lenograstim|lenograstim|mesh-list
5986329|NCT00068393|Sargramostim|sargramostim|mesh-list
5986330|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986331|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
5986332|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986333|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986334|NCT00068393|Antiviral Agents|antiviral agents|mesh-ancestor
5986335|NCT00068393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986336|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986337|NCT00068393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986338|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
5986339|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986340|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5986341|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5986342|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5986343|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5986344|NCT00068406|Cisplatin|cisplatin|mesh-list
5986345|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986346|NCT00068419|Tamoxifen|tamoxifen|mesh-list
5986347|NCT00068419|Sulindac|sulindac|mesh-list
5986348|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986349|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5986350|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
5986351|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5986352|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986353|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5986354|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986355|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5986356|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5986357|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5986358|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5986359|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5986360|NCT00068419|Analgesics|analgesics|mesh-ancestor
5986361|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
5986362|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5986363|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5986364|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986365|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5986366|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986367|NCT00068445|Lamotrigine|lamotrigine|mesh-list
5986368|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
5986369|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5986370|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5986371|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986372|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5986373|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986374|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5986375|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5986376|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5986377|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5986378|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5986379|NCT00068575|Interferons|interferons|mesh-list
5986380|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
5986381|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
5986382|NCT00068575|Cisplatin|cisplatin|mesh-list
5986383|NCT00068575|Fluorouracil|fluorouracil|mesh-list
5986384|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986385|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
5986386|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986387|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986388|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986389|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
5986390|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986391|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
5986392|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986393|NCT00068588|Capecitabine|capecitabine|mesh-list
5986394|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986395|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
5986396|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986397|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986398|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
5986399|NCT00068601|Goserelin|goserelin|mesh-list
5986400|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986401|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
5986402|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986403|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986404|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986405|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
5986406|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986407|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986408|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5986409|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5986410|NCT00068692|Leucovorin|leucovorin|mesh-list
5986411|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
5986412|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
5986413|NCT00068692|Fluorouracil|fluorouracil|mesh-list
5986414|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
5986415|NCT00068692|Irinotecan|irinotecan|mesh-list
5986416|NCT00068692|Camptothecin|camptothecin|mesh-list
5986417|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
5986418|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986419|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
5986420|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986421|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986422|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986423|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986424|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
5986425|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5986426|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5986427|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986428|NCT00068692|Antidotes|antidotes|mesh-ancestor
5986429|NCT00068692|Protective Agents|protective agents|mesh-ancestor
5986430|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
5986431|NCT00068692|Vitamins|vitamins|mesh-ancestor
5986432|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
5986433|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5986434|NCT00068770|Celecoxib|celecoxib|mesh-list
5986435|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5986436|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5986437|NCT00068770|Analgesics|analgesics|mesh-ancestor
5986438|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
5986439|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5986440|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986441|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5986442|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986443|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5986444|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5986445|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986446|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986447|NCT00069095|Leucovorin|leucovorin|mesh-list
5986448|NCT00069095|Bevacizumab|bevacizumab|mesh-list
5986449|NCT00069095|Fluorouracil|fluorouracil|mesh-list
5986450|NCT00069095|Capecitabine|capecitabine|mesh-list
5986451|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
5986452|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986453|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986454|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5986455|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5986456|NCT00069095|Growth Substances|growth substances|mesh-ancestor
5986457|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986458|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
5986459|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
5986460|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986461|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986462|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986463|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
5986464|NCT00069095|Antidotes|antidotes|mesh-ancestor
5986465|NCT00069095|Protective Agents|protective agents|mesh-ancestor
5986466|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
5986467|NCT00069095|Vitamins|vitamins|mesh-ancestor
5986468|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
5986469|NCT00069108|Leucovorin|leucovorin|mesh-list
5986470|NCT00069108|Capecitabine|capecitabine|mesh-list
5986471|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
5986472|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986473|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
5986474|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986475|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986476|NCT00069108|Antidotes|antidotes|mesh-ancestor
5986477|NCT00069108|Protective Agents|protective agents|mesh-ancestor
5986478|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986479|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
5986480|NCT00069108|Vitamins|vitamins|mesh-ancestor
5986481|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
5986482|NCT00069121|Leucovorin|leucovorin|mesh-list
5986483|NCT00069121|Fluorouracil|fluorouracil|mesh-list
5986484|NCT00069121|Capecitabine|capecitabine|mesh-list
5986485|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
5986486|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
5986487|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986488|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986489|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986490|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986491|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
5986492|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986493|NCT00069121|Antidotes|antidotes|mesh-ancestor
5986494|NCT00069121|Protective Agents|protective agents|mesh-ancestor
5986495|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
5986496|NCT00069121|Vitamins|vitamins|mesh-ancestor
5986497|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
5986498|NCT00069160|Docetaxel|docetaxel|mesh-list
5986499|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
5986500|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986501|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
5986502|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
5986503|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
5986504|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986505|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5986506|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
5986507|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986508|NCT00069784|Insulin|insulin|mesh-list
5986509|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
5986510|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
5986511|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5986512|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986513|NCT00069823|Esomeprazole|esomeprazole|mesh-list
5986514|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
5986515|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
5986516|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5986517|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986518|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986519|NCT00069953|Paclitaxel|paclitaxel|mesh-list
5986520|NCT00069953|Fluorouracil|fluorouracil|mesh-list
5986521|NCT00069953|Lenograstim|lenograstim|mesh-list
5986522|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5986523|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986524|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
5986525|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
5986526|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
5986527|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986528|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
5986529|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986530|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986531|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
5986532|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986533|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5986534|NCT00070070|Sargramostim|sargramostim|mesh-list
5986535|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
5986536|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
5986537|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986538|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5986539|NCT00070109|Trabectedin|trabectedin|mesh-list
5986540|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986541|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
5986542|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986543|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986544|NCT00070135|Methotrexate|methotrexate|mesh-list
5986545|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
5986546|NCT00070135|Fludarabine|fludarabine|mesh-list
5986547|NCT00070135|Busulfan|busulfan|mesh-list
5986548|NCT00070135|Tacrolimus|tacrolimus|mesh-list
5986549|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5986550|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5986551|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
5986552|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5986553|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986554|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986555|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
5986556|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986557|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986558|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
5986559|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986560|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5986561|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986562|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
5986563|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986564|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5986565|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5986566|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
5986567|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986568|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5986569|NCT00070291|Cyclosporine|cyclosporine|mesh-list
5986570|NCT00070291|Cyclosporins|cyclosporins|mesh-list
5986571|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986572|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986573|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986574|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
5986575|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986576|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
5986577|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986578|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
5986579|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986580|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5986581|NCT00070317|Methylene Blue|methylene blue|mesh-list
5986582|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
5986583|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986584|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986585|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5986586|NCT00070941|Citalopram|citalopram|mesh-list
5986587|NCT00070941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5986588|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5986589|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5986590|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986591|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5986592|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
5986593|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986594|NCT00070941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5986595|NCT00070941|Antidepressive Agents|antidepressive agents|mesh-ancestor
5986596|NCT00070941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5986597|NCT00071006|Axitinib|axitinib|mesh-list
5986598|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986599|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5986600|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986601|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986602|NCT00071396|Rituximab|rituximab|mesh-list
5986603|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
5986604|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986605|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986606|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
5986607|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986608|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986609|NCT00071487|Belimumab|belimumab|mesh-list
5986610|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986611|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
5986612|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986613|NCT00071721|Valproic Acid|valproic acid|mesh-list
5986614|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
5986615|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986616|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986617|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
5986618|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5986619|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986620|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
5986621|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5986622|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5986623|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5986624|NCT00071760|Ritonavir|ritonavir|mesh-list
5986625|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
5986626|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5986627|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5986628|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
5986629|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986630|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986631|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5986632|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5986633|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
5986634|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986635|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5986636|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5986637|NCT00071799|Cytarabine|cytarabine|mesh-list
5986638|NCT00071799|Azacitidine|azacitidine|mesh-list
5986639|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986640|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
5986641|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986642|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986643|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
5986644|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986645|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986646|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
5986647|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986648|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986649|NCT00071812|Belimumab|belimumab|mesh-list
5986650|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986651|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
5986652|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986653|NCT00071890|Aldesleukin|aldesleukin|mesh-list
5986654|NCT00071890|Interleukin-2|interleukin-2|mesh-list
5986655|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986656|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5986657|NCT00071890|Analgesics|analgesics|mesh-ancestor
5986658|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
5986659|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5986660|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986661|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5986662|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5986663|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
5986664|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986665|NCT00071981|Molgramostim|molgramostim|mesh-list
5986666|NCT00071981|Vaccines|vaccines|mesh-list
5986667|NCT00071981|Sargramostim|sargramostim|mesh-list
5986668|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
5986669|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
5986670|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986671|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986672|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5986673|NCT00072176|Sirolimus|sirolimus|mesh-list
5986674|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5986675|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986676|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5986677|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986678|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
5986679|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986680|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
5986681|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986682|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
5986683|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986684|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5986685|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986686|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986687|NCT00072280|Dactinomycin|dactinomycin|mesh-list
5986688|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
5986689|NCT00072280|Ifosfamide|ifosfamide|mesh-list
5986690|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
5986691|NCT00072280|Etoposide|etoposide|mesh-list
5986692|NCT00072280|Vincristine|vincristine|mesh-list
5986693|NCT00072280|Lenograstim|lenograstim|mesh-list
5986694|NCT00072280|Sargramostim|sargramostim|mesh-list
5986695|NCT00072280|Mesna|mesna|mesh-list
5986696|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986697|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
5986698|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986699|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986700|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986701|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
5986702|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986703|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986704|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5986705|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5986706|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5986707|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5986708|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986709|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5986710|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
5986711|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
5986712|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
5986713|NCT00072280|Protective Agents|protective agents|mesh-ancestor
5986714|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5986715|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986716|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5986717|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5986718|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5986719|NCT00072384|Carboplatin|carboplatin|mesh-list
5986720|NCT00072384|Etoposide|etoposide|mesh-list
5986721|NCT00072384|Vincristine|vincristine|mesh-list
5986722|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
5986723|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986724|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5986725|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5986726|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5986727|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986728|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986729|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
5986730|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
5986731|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
5986732|NCT00072449|Rituximab|rituximab|mesh-list
5986733|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986734|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986735|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
5986736|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986737|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986738|NCT00072475|Vatalanib|vatalanib|mesh-list
5986739|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5986740|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986741|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986742|NCT00072514|Gemcitabine|gemcitabine|mesh-list
5986743|NCT00072514|Dexamethasone|dexamethasone|mesh-list
5986744|NCT00072514|Rituximab|rituximab|mesh-list
5986745|NCT00072514|Carboplatin|carboplatin|mesh-list
5986746|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5986747|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
5986748|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
5986749|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5986750|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986751|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5986752|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
5986753|NCT00072514|Hormones|hormones|mesh-ancestor
5986754|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5986755|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5986756|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986757|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986758|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
5986759|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986760|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986761|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
5986762|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986763|NCT00072514|Antiviral Agents|antiviral agents|mesh-ancestor
5986764|NCT00072514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986765|NCT00072514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986766|NCT00072514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986767|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
5986768|NCT00072566|Bevacizumab|bevacizumab|mesh-list
5986769|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5986770|NCT00072566|Antibodies|antibodies|mesh-list
5986771|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
5986772|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5986773|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
5986774|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
5986775|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986776|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
5986777|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986778|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986779|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986780|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
5986781|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986782|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986783|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5986784|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5986785|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5986786|NCT00072566|Growth Substances|growth substances|mesh-ancestor
5986787|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
5986788|NCT00073008|Lapatinib|lapatinib|mesh-list
5986789|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986790|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5986791|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986792|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986793|NCT00073021|Mesalamine|mesalamine|mesh-list
5986794|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5986795|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5986796|NCT00073021|Analgesics|analgesics|mesh-ancestor
5986797|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
5986798|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5986799|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986800|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5986801|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986802|NCT00073073|Vitamin D|vitamin d|mesh-list
5986803|NCT00073073|Exemestane|exemestane|mesh-list
5986804|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
5986805|NCT00073073|Calcium|calcium|mesh-list
5986806|NCT00073073|Vitamins|vitamins|mesh-ancestor
5986807|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
5986808|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986809|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5986810|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5986811|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986812|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5986813|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5986814|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986815|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986816|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5986817|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
5986818|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5986819|NCT00073073|Antacids|antacids|mesh-ancestor
5986820|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5986821|NCT00073307|Sorafenib|sorafenib|mesh-list
5986822|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986823|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5986824|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986825|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986826|NCT00073528|Letrozole|letrozole|mesh-list
5986827|NCT00073528|Lapatinib|lapatinib|mesh-list
5986828|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986829|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5986830|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5986831|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986832|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986833|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5986834|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
5986835|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5986836|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986837|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5986838|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
5986839|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986840|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986841|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5986842|NCT00073918|Iodine|iodine|mesh-list
5986843|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
5986844|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
5986845|NCT00073918|Etoposide|etoposide|mesh-list
5986846|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
5986847|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
5986848|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5986849|NCT00073918|Antibodies|antibodies|mesh-list
5986850|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
5986851|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5986852|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986853|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
5986854|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986855|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986856|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986857|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
5986858|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986859|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986860|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5986861|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5986862|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5986863|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5986864|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986865|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5986866|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986867|NCT00073918|Trace Elements|trace elements|mesh-ancestor
5986868|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
5986869|NCT00073957|Cytarabine|cytarabine|mesh-list
5986870|NCT00073957|Rituximab|rituximab|mesh-list
5986871|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986872|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986873|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
5986874|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986875|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986876|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986877|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
5986878|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986879|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
5986880|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986881|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986882|NCT00073983|Gemcitabine|gemcitabine|mesh-list
5986883|NCT00073983|Docetaxel|docetaxel|mesh-list
5986884|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986885|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
5986886|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986887|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986888|NCT00073983|Antiviral Agents|antiviral agents|mesh-ancestor
5986889|NCT00073983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986890|NCT00073983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986891|NCT00073983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986892|NCT00073983|Immunologic Factors|immunologic factors|mesh-ancestor
5986893|NCT00073983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986894|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
5986895|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
5986896|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
5986897|NCT00074035|Pentostatin|pentostatin|mesh-list
5986898|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986899|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
5986900|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986901|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986902|NCT00074165|Cytarabine|cytarabine|mesh-list
5986903|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
5986904|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
5986905|NCT00074165|Rituximab|rituximab|mesh-list
5986906|NCT00074165|Carboplatin|carboplatin|mesh-list
5986907|NCT00074165|Etoposide|etoposide|mesh-list
5986908|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
5986909|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986910|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
5986911|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986912|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986913|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986914|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
5986915|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986916|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986917|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5986918|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986919|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5986920|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5986921|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5986922|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986923|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986924|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
5986925|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
5986926|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986927|NCT00074165|Antidotes|antidotes|mesh-ancestor
5986928|NCT00074165|Protective Agents|protective agents|mesh-ancestor
5986929|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
5986930|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
5986931|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5986932|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
5986933|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
5986934|NCT00074269|Cyclosporine|cyclosporine|mesh-list
5986935|NCT00074269|Methotrexate|methotrexate|mesh-list
5986936|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
5986937|NCT00074269|Fludarabine|fludarabine|mesh-list
5986938|NCT00074269|Melphalan|melphalan|mesh-list
5986939|NCT00074269|Cyclosporins|cyclosporins|mesh-list
5986940|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5986941|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5986942|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
5986943|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5986944|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986945|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5986946|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
5986947|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986948|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986949|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
5986950|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986951|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5986952|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986953|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
5986954|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986955|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5986956|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
5986957|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5986958|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5986959|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986960|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
5986961|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5986962|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
5986963|NCT00074282|Rituximab|rituximab|mesh-list
5986964|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
5986965|NCT00074282|Pentostatin|pentostatin|mesh-list
5986966|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5986967|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
5986968|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986969|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5986970|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5986971|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
5986972|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986973|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986974|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5986975|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5986976|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
5986977|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986978|NCT00074308|Bevacizumab|bevacizumab|mesh-list
5986979|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5986980|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
5986981|NCT00074308|Antibodies|antibodies|mesh-list
5986982|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
5986983|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5986984|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5986985|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5986986|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5986987|NCT00074308|Growth Substances|growth substances|mesh-ancestor
5986988|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5986989|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
5986990|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
5986991|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5986992|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986993|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986994|NCT00074412|Nevirapine|nevirapine|mesh-list
5986995|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5986996|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5986997|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5986998|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5986999|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
5987000|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987001|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5987002|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5987003|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5987004|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5987005|NCT00074490|Prednisone|prednisone|mesh-list
5987006|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
5987007|NCT00074490|Rituximab|rituximab|mesh-list
5987008|NCT00074490|Doxorubicin|doxorubicin|mesh-list
5987009|NCT00074490|Fludarabine|fludarabine|mesh-list
5987010|NCT00074490|Etoposide|etoposide|mesh-list
5987011|NCT00074490|Vincristine|vincristine|mesh-list
5987012|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987013|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
5987014|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987015|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987016|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5987017|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
5987018|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987019|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987020|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5987021|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5987022|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5987023|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5987024|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5987025|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987026|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987027|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
5987028|NCT00074490|Hormones|hormones|mesh-ancestor
5987029|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5987030|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5987031|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5987032|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987033|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987034|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987035|NCT00074581|Ritonavir|ritonavir|mesh-list
5987036|NCT00074581|Lopinavir|lopinavir|mesh-list
5987037|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5987038|NCT00074581|Tenofovir|tenofovir|mesh-list
5987039|NCT00074581|Lamivudine|lamivudine|mesh-list
5987040|NCT00074581|Zidovudine|zidovudine|mesh-list
5987041|NCT00074581|Emtricitabine|emtricitabine|mesh-list
5987042|NCT00074581|Nevirapine|nevirapine|mesh-list
5987043|NCT00074581|Stavudine|stavudine|mesh-list
5987044|NCT00074581|Didanosine|didanosine|mesh-list
5987045|NCT00074581|Efavirenz|efavirenz|mesh-list
5987046|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5987047|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5987048|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
5987049|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987050|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987051|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5987052|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5987053|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
5987054|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987055|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5987056|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5987057|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5987058|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5987059|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
5987060|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5987061|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5987062|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5987063|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5987064|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5987065|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
5987066|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
5987067|NCT00074711|Calcium|calcium|mesh-list
5987068|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5987069|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987070|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5987071|NCT00074711|Antacids|antacids|mesh-ancestor
5987072|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987073|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5987074|NCT00074802|Paroxetine|paroxetine|mesh-list
5987075|NCT00074802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5987076|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5987077|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5987078|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987079|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5987080|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
5987081|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987082|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5987083|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
5987084|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5987085|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5987086|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5987087|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987088|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
5987089|NCT00074815|Citalopram|citalopram|mesh-list
5987090|NCT00074815|Fluoxetine|fluoxetine|mesh-list
5987091|NCT00074815|Paroxetine|paroxetine|mesh-list
5987092|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5987093|NCT00074815|Sertraline|sertraline|mesh-list
5987094|NCT00074815|Clomipramine|clomipramine|mesh-list
5987095|NCT00074815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
5987096|NCT00074815|Serotonin|serotonin|mesh-list
5987097|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5987098|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5987099|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987100|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5987101|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
5987102|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987103|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5987104|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
5987105|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5987106|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5987107|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5987108|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987109|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5987110|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5987111|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5987112|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5987113|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5987114|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5987115|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5987116|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
5987117|NCT00075023|Thalidomide|thalidomide|mesh-list
5987118|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987119|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
5987120|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987121|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
5987122|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5987123|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987124|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5987125|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5987126|NCT00075023|Growth Substances|growth substances|mesh-ancestor
5987127|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
5987128|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987129|NCT00075218|Sunitinib|sunitinib|mesh-list
5987130|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987131|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5987132|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5987133|NCT00075218|Growth Substances|growth substances|mesh-ancestor
5987134|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987135|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
5987136|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5987137|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987138|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987139|NCT00075270|Paclitaxel|paclitaxel|mesh-list
5987140|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5987141|NCT00075270|Lapatinib|lapatinib|mesh-list
5987142|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5987143|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987144|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987145|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987146|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987147|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987148|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5987149|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987150|NCT00075335|Plerixafor|plerixafor|mesh-list
5987151|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5987152|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5987153|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
5987154|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987155|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
5987156|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987157|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5987158|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987159|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987160|NCT00075478|Cyclosporine|cyclosporine|mesh-list
5987161|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
5987162|NCT00075478|Fludarabine|fludarabine|mesh-list
5987163|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
5987164|NCT00075478|Cyclosporins|cyclosporins|mesh-list
5987165|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987166|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5987167|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
5987168|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987169|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987170|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
5987171|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987172|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987173|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
5987174|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987175|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
5987176|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987177|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5987178|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5987179|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5987180|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
5987181|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5987182|NCT00075504|Gemcitabine|gemcitabine|mesh-list
5987183|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5987184|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
5987185|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987186|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987187|NCT00075504|Antiviral Agents|antiviral agents|mesh-ancestor
5987188|NCT00075504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987189|NCT00075504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987190|NCT00075504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987191|NCT00075504|Immunologic Factors|immunologic factors|mesh-ancestor
5987192|NCT00075504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987193|NCT00075582|Dactinomycin|dactinomycin|mesh-list
5987194|NCT00075582|Cactinomycin|cactinomycin|mesh-list
5987195|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
5987196|NCT00075582|Vincristine|vincristine|mesh-list
5987197|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987198|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
5987199|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987200|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987201|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5987202|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
5987203|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987204|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987205|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5987206|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5987207|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987208|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987209|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987210|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5987211|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987212|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5987213|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5987214|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987215|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5987216|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
5987217|NCT00075725|Leucovorin|leucovorin|mesh-list
5987218|NCT00075725|Folic Acid|folic acid|mesh-list
5987219|NCT00075725|Cytarabine|cytarabine|mesh-list
5987220|NCT00075725|Dexamethasone|dexamethasone|mesh-list
5987221|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
5987222|NCT00075725|Prednisone|prednisone|mesh-list
5987223|NCT00075725|Cortisone|cortisone|mesh-list
5987224|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
5987225|NCT00075725|Doxorubicin|doxorubicin|mesh-list
5987226|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5987227|NCT00075725|Methotrexate|methotrexate|mesh-list
5987228|NCT00075725|Vincristine|vincristine|mesh-list
5987229|NCT00075725|Daunorubicin|daunorubicin|mesh-list
5987230|NCT00075725|Asparaginase|asparaginase|mesh-list
5987231|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
5987232|NCT00075725|Pegaspargase|pegaspargase|mesh-list
5987233|NCT00075725|Thioguanine|thioguanine|mesh-list
5987234|NCT00075725|BB 1101|bb 1101|mesh-list
5987235|NCT00075725|Calcium|calcium|mesh-list
5987236|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
5987237|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
5987238|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987239|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
5987240|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987241|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987242|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5987243|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
5987244|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987245|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987246|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5987247|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987248|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
5987249|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
5987250|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987251|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5987252|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
5987253|NCT00075725|Hormones|hormones|mesh-ancestor
5987254|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5987255|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5987256|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
5987257|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987258|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5987259|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5987260|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5987261|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5987262|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5987263|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5987264|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
5987265|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5987266|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5987267|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
5987268|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
5987269|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5987270|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5987271|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
5987272|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987273|NCT00075725|Antidotes|antidotes|mesh-ancestor
5987274|NCT00075725|Protective Agents|protective agents|mesh-ancestor
5987275|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
5987276|NCT00075725|Vitamins|vitamins|mesh-ancestor
5987277|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
5987278|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5987279|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987280|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987281|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987282|NCT00075725|Hematinics|hematinics|mesh-ancestor
5987283|NCT00075764|Fulvestrant|fulvestrant|mesh-list
5987284|NCT00075764|Anastrozole|anastrozole|mesh-list
5987285|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5987286|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987287|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5987288|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5987289|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
5987290|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5987291|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987292|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5987293|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5987294|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987295|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987296|NCT00075803|Fluconazole|fluconazole|mesh-list
5987297|NCT00075803|Voriconazole|voriconazole|mesh-list
5987298|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
5987299|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987300|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5987301|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5987302|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987303|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987304|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5987305|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
5987306|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5987307|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987308|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5987309|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5987310|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5987311|NCT00075829|Thalidomide|thalidomide|mesh-list
5987312|NCT00075829|Dexamethasone|dexamethasone|mesh-list
5987313|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987314|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
5987315|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
5987316|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987317|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987318|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5987319|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
5987320|NCT00075829|Hormones|hormones|mesh-ancestor
5987321|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5987322|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5987323|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987324|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987325|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
5987326|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
5987327|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5987328|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987329|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5987330|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5987331|NCT00075829|Growth Substances|growth substances|mesh-ancestor
5987332|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
5987333|NCT00075881|Bortezomib|bortezomib|mesh-list
5987334|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987335|NCT00075946|Rituximab|rituximab|mesh-list
5987336|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5987337|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987338|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
5987339|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987340|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6245974|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987341|NCT00076011|Mitogens|mitogens|mesh-list
5987342|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
5987343|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987344|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987345|NCT00076011|Growth Substances|growth substances|mesh-ancestor
5987346|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987347|NCT00076024|Docetaxel|docetaxel|mesh-list
5987348|NCT00076024|Axitinib|axitinib|mesh-list
5987349|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987350|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987351|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987352|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987353|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987354|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5987355|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987356|NCT00076102|Pirfenidone|pirfenidone|mesh-list
5987357|NCT00076102|Analgesics|analgesics|mesh-ancestor
5987358|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
5987359|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987360|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987361|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5987362|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5987363|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987364|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987365|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987366|NCT00076336|Lamivudine|lamivudine|mesh-list
5987367|NCT00076336|Telbivudine|telbivudine|mesh-list
5987368|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5987369|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5987370|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987371|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987372|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
5987373|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987374|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5987375|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5987376|NCT00076570|Sirolimus|sirolimus|mesh-list
5987377|NCT00076570|Tacrolimus|tacrolimus|mesh-list
5987378|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987379|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
5987380|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987381|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5987382|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987383|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987384|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5987385|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987386|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5987387|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987388|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
5987389|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
5987390|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5987391|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
5987392|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
5987393|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
5987394|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
5987395|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5987396|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987397|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
5987398|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5987399|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987400|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
5987401|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987402|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
5987403|NCT00076752|Promethazine|promethazine|mesh-list
5987404|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
5987405|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
5987406|NCT00076752|Rituximab|rituximab|mesh-list
5987407|NCT00076752|Fludarabine|fludarabine|mesh-list
5987408|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
5987409|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987410|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
5987411|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987412|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987413|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5987414|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
5987415|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987416|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987417|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5987418|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5987419|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5987420|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
5987421|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987422|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
5987423|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
5987424|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987425|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5987426|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
5987427|NCT00076752|Hormones|hormones|mesh-ancestor
5987428|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5987429|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5987430|NCT00076752|Protective Agents|protective agents|mesh-ancestor
5987431|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5987432|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5987433|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5987434|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
5987435|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
5987436|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
5987437|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5987438|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
5987439|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
5987440|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5987441|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5987442|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
5987443|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
5987444|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5987445|NCT00077064|Captopril|captopril|mesh-list
5987446|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5987447|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
5987448|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987449|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987450|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5987451|NCT00077207|Carboplatin|carboplatin|mesh-list
5987452|NCT00077207|Vincristine|vincristine|mesh-list
5987453|NCT00077207|Temozolomide|temozolomide|mesh-list
5987454|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987455|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5987456|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987457|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987458|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987459|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987460|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5987461|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
5987462|NCT00077376|Carboplatin|carboplatin|mesh-list
5987463|NCT00077376|Trastuzumab|trastuzumab|mesh-list
5987464|NCT00077376|Epothilone B|epothilone b|mesh-list
5987465|NCT00077376|Epothilones|epothilones|mesh-list
5987466|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987467|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5987468|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987469|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987470|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987471|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987472|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
5987473|NCT00077610|Hematinics|hematinics|mesh-ancestor
5987474|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
5987475|NCT00077623|Hematinics|hematinics|mesh-ancestor
5987476|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5987477|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
5987478|NCT00077636|Ribavirin|ribavirin|mesh-list
5987479|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
5987480|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987481|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
5987482|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987483|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
5987484|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987485|NCT00077649|Ribavirin|ribavirin|mesh-list
5987486|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5987487|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
5987488|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
5987489|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
5987490|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
5987491|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987492|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
5987493|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987494|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
5987495|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987496|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987497|NCT00077675|Vancomycin|vancomycin|mesh-list
5987498|NCT00077675|Penicillins|penicillins|mesh-list
5987499|NCT00077675|Telavancin|telavancin|mesh-list
5987500|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5987501|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987502|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
5987503|NCT00077766|Hematinics|hematinics|mesh-ancestor
5987504|NCT00077857|Docetaxel|docetaxel|mesh-list
5987505|NCT00077857|Capecitabine|capecitabine|mesh-list
5987506|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987507|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987508|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987509|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987510|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987511|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5987512|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
5987513|NCT00077974|Sunitinib|sunitinib|mesh-list
5987514|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987515|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5987516|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5987517|NCT00077974|Growth Substances|growth substances|mesh-ancestor
5987518|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987519|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
5987520|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5987521|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987522|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987523|NCT00078286|Sertraline|sertraline|mesh-list
5987524|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
5987525|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5987526|NCT00078286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5987527|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5987528|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5987529|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987530|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5987531|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
5987532|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987533|NCT00078312|Modafinil|modafinil|mesh-list
5987534|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5987535|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987536|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5987537|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5987538|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5987539|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987540|NCT00078325|Modafinil|modafinil|mesh-list
5987541|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5987542|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987543|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5987544|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5987545|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5987546|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987547|NCT00078338|Interferons|interferons|mesh-list
5987548|NCT00078338|Interferon-beta|interferon-beta|mesh-list
5987549|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
5987550|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
5987551|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
5987552|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987553|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
5987554|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987555|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
5987556|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987557|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5987558|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987559|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987560|NCT00078377|Modafinil|modafinil|mesh-list
5987561|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5987562|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987563|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5987564|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5987565|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5987566|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987567|NCT00078403|Ribavirin|ribavirin|mesh-list
5987568|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5987569|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
5987570|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987571|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
5987572|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987573|NCT00078559|Acetaminophen|acetaminophen|mesh-list
5987574|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
5987575|NCT00078559|Promethazine|promethazine|mesh-list
5987576|NCT00078559|Sirolimus|sirolimus|mesh-list
5987577|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5987578|NCT00078559|Nystatin|nystatin|mesh-list
5987579|NCT00078559|Clotrimazole|clotrimazole|mesh-list
5987580|NCT00078559|Miconazole|miconazole|mesh-list
5987581|NCT00078559|Pentamidine|pentamidine|mesh-list
5987582|NCT00078559|Trimethoprim|trimethoprim|mesh-list
5987583|NCT00078559|Valganciclovir|valganciclovir|mesh-list
5987584|NCT00078559|Acyclovir|acyclovir|mesh-list
5987585|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
5987586|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
5987587|NCT00078559|Tacrolimus|tacrolimus|mesh-list
5987588|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987589|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
5987590|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987591|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5987592|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987593|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987594|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5987595|NCT00078559|Analgesics|analgesics|mesh-ancestor
5987596|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
5987597|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987598|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
5987599|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5987600|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987601|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5987602|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987603|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
5987604|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987605|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
5987606|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
5987607|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5987608|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
5987609|NCT00078559|Hormones|hormones|mesh-ancestor
5987610|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5987611|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5987612|NCT00078559|Protective Agents|protective agents|mesh-ancestor
5987613|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5987614|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5987615|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5987616|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5987617|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
5987618|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
5987619|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
5987620|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
5987621|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
5987622|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5987623|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5987624|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
5987625|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
5987626|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5987627|NCT00078559|Renal Agents|renal agents|mesh-ancestor
5987628|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
5987629|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5987630|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5987631|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5987632|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5987633|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5987634|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5987635|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
5987636|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5987637|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
5987638|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5987639|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
5987640|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5987641|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5987642|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
5987643|NCT00078559|Ionophores|ionophores|mesh-ancestor
5987644|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5987645|NCT00078715|Yohimbine|yohimbine|mesh-list
5987646|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
5987647|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
5987648|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987649|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987650|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5987651|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5987652|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5987653|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
5987654|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5987655|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987656|NCT00078715|Urological Agents|urological agents|mesh-ancestor
5987657|NCT00078754|Valproic Acid|valproic acid|mesh-list
5987658|NCT00078754|Fluoxetine|fluoxetine|mesh-list
5987659|NCT00078754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5987660|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5987661|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5987662|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987663|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5987664|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
5987665|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987666|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5987667|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
5987668|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5987669|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5987670|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5987671|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987672|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
5987673|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
5987674|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
5987675|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5987676|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5987677|NCT00078767|Sertraline|sertraline|mesh-list
5987678|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
5987679|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5987680|NCT00078767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5987681|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5987682|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5987683|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987684|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5987685|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
5987686|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987687|NCT00078819|Etanercept|etanercept|mesh-list
5987688|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5987689|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5987690|NCT00078819|Analgesics|analgesics|mesh-ancestor
5987691|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
5987692|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987693|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987694|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987695|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987696|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5987697|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987698|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
5987699|NCT00078897|Selenium|selenium|mesh-list
5987700|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
5987701|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987702|NCT00078897|Protective Agents|protective agents|mesh-ancestor
5987703|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987704|NCT00078897|Trace Elements|trace elements|mesh-ancestor
5987705|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
5987706|NCT00078949|Gemcitabine|gemcitabine|mesh-list
5987707|NCT00078949|Cytarabine|cytarabine|mesh-list
5987708|NCT00078949|Dexamethasone|dexamethasone|mesh-list
5987709|NCT00078949|Rituximab|rituximab|mesh-list
5987710|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987711|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987712|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
5987713|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
5987714|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987715|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987716|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5987717|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
5987718|NCT00078949|Hormones|hormones|mesh-ancestor
5987719|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5987720|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5987721|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5987722|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
5987723|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987724|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5987725|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
5987726|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987727|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
5987728|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987729|NCT00078949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987730|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987731|NCT00079001|Vitamin D|vitamin d|mesh-list
5987732|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
5987733|NCT00079001|Calcium|calcium|mesh-list
5987734|NCT00079001|Androgens|androgens|mesh-list
5987735|NCT00079001|Vitamins|vitamins|mesh-ancestor
5987736|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
5987737|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987738|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5987739|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5987740|NCT00079001|Hormones|hormones|mesh-ancestor
5987741|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5987742|NCT00079040|Bevacizumab|bevacizumab|mesh-list
5987743|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5987744|NCT00079040|Etoposide|etoposide|mesh-list
5987745|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
5987746|NCT00079040|Antibodies|antibodies|mesh-list
5987747|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
5987748|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5987749|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987750|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5987751|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5987752|NCT00079040|Growth Substances|growth substances|mesh-ancestor
5987753|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987754|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
5987755|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
5987756|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5987757|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5987758|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5987759|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987760|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987761|NCT00079183|Sirolimus|sirolimus|mesh-list
5987762|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5987763|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987764|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5987765|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987766|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
5987767|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987768|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
5987769|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987770|NCT00079274|Leucovorin|leucovorin|mesh-list
5987771|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5987772|NCT00079274|Cetuximab|cetuximab|mesh-list
5987773|NCT00079274|Fluorouracil|fluorouracil|mesh-list
5987774|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
5987775|NCT00079274|Irinotecan|irinotecan|mesh-list
5987776|NCT00079274|Antibodies|antibodies|mesh-list
5987777|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
5987778|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5987779|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
5987780|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
5987781|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987782|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987783|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
5987784|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987785|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5987786|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987787|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5987788|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5987789|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987790|NCT00079274|Antidotes|antidotes|mesh-ancestor
5987791|NCT00079274|Protective Agents|protective agents|mesh-ancestor
5987792|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
5987793|NCT00079274|Vitamins|vitamins|mesh-ancestor
5987794|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
5987795|NCT00079326|Trastuzumab|trastuzumab|mesh-list
5987796|NCT00079326|Epothilone B|epothilone b|mesh-list
5987797|NCT00079326|Epothilones|epothilones|mesh-list
5987798|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5987799|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987800|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987801|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987802|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987803|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987804|NCT00079339|Tipifarnib|tipifarnib|mesh-list
5987805|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987806|NCT00079417|Iodine|iodine|mesh-list
5987807|NCT00079417|Carboplatin|carboplatin|mesh-list
5987808|NCT00079417|Vincristine|vincristine|mesh-list
5987809|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987810|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5987811|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987812|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987813|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987814|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987815|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
5987816|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987817|NCT00079417|Trace Elements|trace elements|mesh-ancestor
5987818|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
5987819|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987820|NCT00079677|Modafinil|modafinil|mesh-list
5987821|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5987822|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987823|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5987824|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5987825|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5987826|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987827|NCT00079937|Fluticasone|fluticasone|mesh-list
5987828|NCT00079937|Omalizumab|omalizumab|mesh-list
5987829|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987830|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5987831|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
5987832|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987833|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987834|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5987835|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
5987836|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
5987837|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5987838|NCT00080119|Isoniazid|isoniazid|mesh-list
5987839|NCT00080119|Trimethoprim|trimethoprim|mesh-list
5987840|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
5987841|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
5987842|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5987843|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987844|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
5987845|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5987846|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
5987847|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987848|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5987849|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5987850|NCT00080119|Renal Agents|renal agents|mesh-ancestor
5987851|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
5987852|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5987853|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5987854|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5987855|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987856|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5987857|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
5987858|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5987859|NCT00080223|Pirfenidone|pirfenidone|mesh-list
5987860|NCT00080223|Analgesics|analgesics|mesh-ancestor
5987861|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
5987862|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987863|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987864|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5987865|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5987866|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987867|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987868|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987869|NCT00080288|Modafinil|modafinil|mesh-list
5987870|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5987871|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987872|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5987873|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5987874|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6245975|NCT02730208|Ivacaftor|ivacaftor|mesh-list
5987875|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987876|NCT00080301|Capecitabine|capecitabine|mesh-list
5987877|NCT00080301|Epothilones|epothilones|mesh-list
5987878|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5987879|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
5987880|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987881|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987882|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
5987883|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
5987884|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
5987885|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
5987886|NCT00080483|Testosterone|testosterone|mesh-list
5987887|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
5987888|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
5987889|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5987890|NCT00080483|Androgens|androgens|mesh-ancestor
5987891|NCT00080483|Hormones|hormones|mesh-ancestor
5987892|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5987893|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987894|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5987895|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987896|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
5987897|NCT00080899|Fenretinide|fenretinide|mesh-list
5987898|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987899|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
5987900|NCT00080899|Protective Agents|protective agents|mesh-ancestor
5987901|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987902|NCT00080938|Temozolomide|temozolomide|mesh-list
5987903|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5987904|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
5987905|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987906|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987907|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
5987908|NCT00081159|Doxorubicin|doxorubicin|mesh-list
5987909|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5987910|NCT00081159|Leuprolide|leuprolide|mesh-list
5987911|NCT00081159|Goserelin|goserelin|mesh-list
5987912|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5987913|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987914|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5987915|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5987916|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987917|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987918|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5987919|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987920|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
5987921|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
5987922|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5987923|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5987924|NCT00081263|Celecoxib|celecoxib|mesh-list
5987925|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
5987926|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5987927|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5987928|NCT00081263|Analgesics|analgesics|mesh-ancestor
5987929|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
5987930|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5987931|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987932|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5987933|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5987934|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5987935|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5987936|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987937|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987938|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
5987939|NCT00081289|Leucovorin|leucovorin|mesh-list
5987940|NCT00081289|Folic Acid|folic acid|mesh-list
5987941|NCT00081289|Fluorouracil|fluorouracil|mesh-list
5987942|NCT00081289|Capecitabine|capecitabine|mesh-list
5987943|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
5987944|NCT00081289|Irinotecan|irinotecan|mesh-list
5987945|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
5987946|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
5987947|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987948|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5987949|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987950|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5987951|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
5987952|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987953|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5987954|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5987955|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5987956|NCT00081289|Antidotes|antidotes|mesh-ancestor
5987957|NCT00081289|Protective Agents|protective agents|mesh-ancestor
5987958|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
5987959|NCT00081289|Vitamins|vitamins|mesh-ancestor
5987960|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
5987961|NCT00081289|Hematinics|hematinics|mesh-ancestor
5987962|NCT00081328|Metformin|metformin|mesh-list
5987963|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
5987964|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5987965|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987966|NCT00081458|Teduglutide|teduglutide|mesh-list
5987967|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5987968|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
5987969|NCT00081458|Protective Agents|protective agents|mesh-ancestor
5987970|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987971|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
5987972|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5987973|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987974|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
5987975|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5987976|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5987977|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5987978|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987979|NCT00081770|Ribavirin|ribavirin|mesh-list
5987980|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5987981|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
5987982|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5987983|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
5987984|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5987985|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
5987986|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5987987|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
5987988|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987989|NCT00081861|Bevacizumab|bevacizumab|mesh-list
5987990|NCT00081861|Rituximab|rituximab|mesh-list
5987991|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5987992|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5987993|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5987994|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5987995|NCT00081861|Growth Substances|growth substances|mesh-ancestor
5987996|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5987997|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
5987998|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
5987999|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988000|NCT00081939|Thalidomide|thalidomide|mesh-list
5988001|NCT00081939|Bortezomib|bortezomib|mesh-list
5988002|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988003|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988004|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
5988005|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988006|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
5988007|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5988008|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988009|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5988010|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5988011|NCT00081939|Growth Substances|growth substances|mesh-ancestor
5988012|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
5988013|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
5988014|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988015|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5988016|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988017|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988018|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
5988019|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5988020|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988021|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5988022|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5988023|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988024|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988025|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988026|NCT00082329|Plerixafor|plerixafor|mesh-list
5988027|NCT00082329|Lenograstim|lenograstim|mesh-list
5988028|NCT00082329|Sargramostim|sargramostim|mesh-list
5988029|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5988030|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
5988031|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988032|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5988033|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5988034|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
5988035|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988036|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
5988037|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
5988038|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5988039|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988040|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
5988041|NCT00082381|Exenatide|exenatide|mesh-list
5988042|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5988043|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988044|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5988045|NCT00082381|Incretins|incretins|mesh-ancestor
5988046|NCT00082381|Hormones|hormones|mesh-ancestor
5988047|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988048|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
5988049|NCT00082407|Exenatide|exenatide|mesh-list
5988050|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
5988051|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5988052|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988053|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5988054|NCT00082407|Incretins|incretins|mesh-ancestor
5988055|NCT00082407|Hormones|hormones|mesh-ancestor
5988056|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988057|NCT00082433|Capecitabine|capecitabine|mesh-list
5988058|NCT00082433|Epothilones|epothilones|mesh-list
5988059|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988060|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
5988061|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988062|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988063|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988064|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988065|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988066|NCT00082628|Hormones|hormones|mesh-list
5988067|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988068|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988069|NCT00082758|Interleukin-2|interleukin-2|mesh-list
5988070|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
5988071|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988072|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5988073|NCT00082758|Analgesics|analgesics|mesh-ancestor
5988074|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
5988075|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5988076|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988077|NCT00082810|Fulvestrant|fulvestrant|mesh-list
5988078|NCT00082810|Tipifarnib|tipifarnib|mesh-list
5988079|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5988080|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988081|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
5988082|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5988083|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
5988084|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988085|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988086|NCT00082888|Tipifarnib|tipifarnib|mesh-list
5988087|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988088|NCT00083122|Cisplatin|cisplatin|mesh-list
5988089|NCT00083122|Alvocidib|alvocidib|mesh-list
5988090|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988091|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
5988092|NCT00083122|Growth Substances|growth substances|mesh-ancestor
5988093|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988094|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5988095|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988096|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988097|NCT00083174|Exemestane|exemestane|mesh-list
5988098|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988099|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5988100|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5988101|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988102|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988103|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5988104|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
5988105|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988106|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988107|NCT00083226|Doxorubicin|doxorubicin|mesh-list
5988108|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5988109|NCT00083226|Bortezomib|bortezomib|mesh-list
5988110|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5988111|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988112|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5988113|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5988114|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988115|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988116|NCT00083382|Pamidronate|pamidronate|mesh-list
5988117|NCT00083382|Thalidomide|thalidomide|mesh-list
5988118|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988119|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
5988120|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988121|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
5988122|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5988123|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988124|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5988125|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5988126|NCT00083382|Growth Substances|growth substances|mesh-ancestor
5988127|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
5988128|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988129|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5988130|NCT00083551|Interferons|interferons|mesh-list
5988131|NCT00083551|Cytarabine|cytarabine|mesh-list
5988132|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
5988133|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
5988134|NCT00083551|Thalidomide|thalidomide|mesh-list
5988135|NCT00083551|Dexamethasone|dexamethasone|mesh-list
5988136|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
5988137|NCT00083551|Melphalan|melphalan|mesh-list
5988138|NCT00083551|Carmustine|carmustine|mesh-list
5988139|NCT00083551|Cisplatin|cisplatin|mesh-list
5988140|NCT00083551|Doxorubicin|doxorubicin|mesh-list
5988141|NCT00083551|Etoposide|etoposide|mesh-list
5988142|NCT00083551|Vincristine|vincristine|mesh-list
5988143|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988144|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
5988145|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988146|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988147|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5988148|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
5988149|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988150|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988151|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5988152|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5988153|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
5988154|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
5988155|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5988156|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5988157|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
5988158|NCT00083551|Hormones|hormones|mesh-ancestor
5988159|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988160|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5988161|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5988162|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5988163|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5988164|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988165|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5988166|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
5988167|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988168|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988169|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
5988170|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988171|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988172|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988173|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
5988174|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5988175|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5988176|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5988177|NCT00083551|Growth Substances|growth substances|mesh-ancestor
5988178|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
5988179|NCT00083616|Panitumumab|panitumumab|mesh-list
5988180|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5988181|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988182|NCT00083720|Cetuximab|cetuximab|mesh-list
5988183|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5988184|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988185|NCT00083889|Interferons|interferons|mesh-list
5988186|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
5988187|NCT00083889|Sunitinib|sunitinib|mesh-list
5988188|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988189|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
5988190|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988191|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
5988192|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988193|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5988194|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5988195|NCT00083889|Growth Substances|growth substances|mesh-ancestor
5988196|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
5988197|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5988198|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988199|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988200|NCT00084136|Tenofovir|tenofovir|mesh-list
5988201|NCT00084136|Lamivudine|lamivudine|mesh-list
5988202|NCT00084136|Zidovudine|zidovudine|mesh-list
5988203|NCT00084136|Emtricitabine|emtricitabine|mesh-list
5988204|NCT00084136|Efavirenz|efavirenz|mesh-list
5988205|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
5988206|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5988207|NCT00084136|Didanosine|didanosine|mesh-list
5988208|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
5988209|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
5988210|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988211|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5988212|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5988213|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988214|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988215|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5988216|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5988217|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
5988218|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5988219|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5988220|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5988221|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5988222|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5988223|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5988224|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5988225|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5988226|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
5988227|NCT00084149|Ritonavir|ritonavir|mesh-list
5988228|NCT00084149|Lopinavir|lopinavir|mesh-list
5988229|NCT00084149|Lamivudine|lamivudine|mesh-list
5988230|NCT00084149|Zidovudine|zidovudine|mesh-list
5988231|NCT00084149|Abacavir|abacavir|mesh-list
5988232|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5988233|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5988234|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
5988235|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988236|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988237|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5988238|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5988239|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
5988240|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988241|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5988242|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5988243|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5988244|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5988245|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
5988246|NCT00084266|Vancomycin|vancomycin|mesh-list
5988247|NCT00084266|Linezolid|linezolid|mesh-list
5988248|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5988249|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988250|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5988251|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988252|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988253|NCT00084318|Docetaxel|docetaxel|mesh-list
5988254|NCT00084318|Cetuximab|cetuximab|mesh-list
5988255|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988256|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988257|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988258|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988259|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988260|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6245976|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6245977|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6245978|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245979|NCT02730247|Paclitaxel|paclitaxel|mesh-list
6245980|NCT02730247|Ramucirumab|ramucirumab|mesh-list
6245981|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6245982|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6245983|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
6245984|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
6245985|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
6245986|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6245987|NCT02730351|Fluticasone|fluticasone|mesh-list
6245988|NCT02730351|Xhance|xhance|mesh-list
6245989|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6245990|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6245991|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
6245992|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6245993|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6245994|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6245995|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
6245996|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
6245997|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6245998|NCT02730377|Liraglutide|liraglutide|mesh-list
6245999|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
6246000|NCT02730377|Meglitinide|meglitinide|mesh-list
6246001|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6246002|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6246003|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
6246004|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6246005|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246006|NCT02730377|Incretins|incretins|mesh-ancestor
6246007|NCT02730377|Hormones|hormones|mesh-ancestor
6246008|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246009|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246010|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
6246011|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246012|NCT02730455|Natalizumab|natalizumab|mesh-list
6246013|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
6246014|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246015|NCT02730871|Timolol|timolol|mesh-list
6246016|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6246017|NCT02730871|Travoprost|travoprost|mesh-list
6246018|NCT02730871|Brinzolamide|brinzolamide|mesh-list
6246019|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6246020|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6246021|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
6246022|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246023|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246024|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246025|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6246026|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6246027|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6246028|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6246029|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6246030|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6246031|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246032|NCT02730884|ON 01910|on 01910|mesh-list
6246033|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246034|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6246035|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246036|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246037|NCT02730962|Vancomycin|vancomycin|mesh-list
6246038|NCT02730962|Clindamycin|clindamycin|mesh-list
6246039|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
6246040|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
6246041|NCT02730962|Neomycin|neomycin|mesh-list
6246042|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6246043|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246044|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6246045|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246046|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246047|NCT02731131|Ribavirin|ribavirin|mesh-list
5988261|NCT00084409|Iloprost|iloprost|mesh-list
5988262|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5988263|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
5988264|NCT00084617|Capecitabine|capecitabine|mesh-list
5988265|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
5988266|NCT00084617|Irinotecan|irinotecan|mesh-list
5988267|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988268|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
5988269|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988270|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988271|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5988272|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5988273|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988274|NCT00084682|Romidepsin|romidepsin|mesh-list
5988275|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5988276|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988277|NCT00084747|Bortezomib|bortezomib|mesh-list
5988278|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988279|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
5988280|NCT00084838|Leucovorin|leucovorin|mesh-list
5988281|NCT00084838|Cytarabine|cytarabine|mesh-list
5988282|NCT00084838|Dactinomycin|dactinomycin|mesh-list
5988283|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
5988284|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5988285|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5988286|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5988287|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
5988288|NCT00084838|Temozolomide|temozolomide|mesh-list
5988289|NCT00084838|Cisplatin|cisplatin|mesh-list
5988290|NCT00084838|Doxorubicin|doxorubicin|mesh-list
5988291|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5988292|NCT00084838|Methotrexate|methotrexate|mesh-list
5988293|NCT00084838|Etoposide|etoposide|mesh-list
5988294|NCT00084838|Vincristine|vincristine|mesh-list
5988295|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
5988296|NCT00084838|Razoxane|razoxane|mesh-list
5988297|NCT00084838|Lenograstim|lenograstim|mesh-list
5988298|NCT00084838|Calcium|calcium|mesh-list
5988299|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
5988300|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988301|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
5988302|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988303|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988304|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5988305|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
5988306|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988307|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988308|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5988309|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5988310|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5988311|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5988312|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988313|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5988314|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5988315|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5988316|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
5988317|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5988318|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988319|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
5988320|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
5988321|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5988322|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5988323|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5988324|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5988325|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
5988326|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988327|NCT00084838|Antidotes|antidotes|mesh-ancestor
5988328|NCT00084838|Protective Agents|protective agents|mesh-ancestor
5988329|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
5988330|NCT00084838|Vitamins|vitamins|mesh-ancestor
5988331|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
5988332|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988333|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988334|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988335|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5988336|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5988337|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5988338|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5988339|NCT00084864|Calcitriol|calcitriol|mesh-list
5988340|NCT00084864|Dexamethasone|dexamethasone|mesh-list
5988341|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5988342|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
5988343|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
5988344|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5988345|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988346|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5988347|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
5988348|NCT00084864|Hormones|hormones|mesh-ancestor
5988349|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988350|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5988351|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988352|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5988353|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
5988354|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5988355|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988356|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5988357|NCT00084864|Vitamins|vitamins|mesh-ancestor
5988358|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
5988359|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5988360|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
5988361|NCT00085098|Cisplatin|cisplatin|mesh-list
5988362|NCT00085098|Carboplatin|carboplatin|mesh-list
5988363|NCT00085098|Etoposide|etoposide|mesh-list
5988364|NCT00085098|Lenograstim|lenograstim|mesh-list
5988365|NCT00085098|Sargramostim|sargramostim|mesh-list
5988366|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988367|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
5988368|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988369|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988370|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5988371|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
5988372|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988373|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988374|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5988375|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5988376|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5988377|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5988378|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988379|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5988380|NCT00085254|Temozolomide|temozolomide|mesh-list
5988381|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5988382|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
5988383|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988384|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988385|NCT00085293|Decitabine|decitabine|mesh-list
5988386|NCT00085293|Azacitidine|azacitidine|mesh-list
5988387|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5988388|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988389|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
5988390|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988391|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988392|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988393|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5988394|NCT00085410|Bortezomib|bortezomib|mesh-list
5988395|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988396|NCT00085423|Aldesleukin|aldesleukin|mesh-list
5988397|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
5988398|NCT00085423|Fludarabine|fludarabine|mesh-list
5988399|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
5988400|NCT00085423|Interleukin-2|interleukin-2|mesh-list
5988401|NCT00085423|Molgramostim|molgramostim|mesh-list
5988402|NCT00085423|Sargramostim|sargramostim|mesh-list
5988403|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988404|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
5988405|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988406|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988407|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5988408|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
5988409|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988410|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988411|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5988412|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988413|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
5988414|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5988415|NCT00085423|Analgesics|analgesics|mesh-ancestor
5988416|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
5988417|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5988418|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5988419|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5988420|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
5988421|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988422|NCT00085436|Interferons|interferons|mesh-list
5988423|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
5988424|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
5988425|NCT00085436|Aldesleukin|aldesleukin|mesh-list
5988426|NCT00085436|Vaccines|vaccines|mesh-list
5988427|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
5988428|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988429|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988430|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
5988431|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988432|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5988433|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5988434|NCT00085540|Romidepsin|romidepsin|mesh-list
5988435|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5988436|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988437|NCT00085566|Everolimus|everolimus|mesh-list
5988438|NCT00085566|Gefitinib|gefitinib|mesh-list
5988439|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988440|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988441|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
5988442|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988443|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5988444|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988445|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988446|NCT00085644|Adalimumab|adalimumab|mesh-list
5988447|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5988448|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988449|NCT00085709|Cytarabine|cytarabine|mesh-list
5988450|NCT00085709|Daunorubicin|daunorubicin|mesh-list
5988451|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
5988452|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988453|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
5988454|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988455|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988456|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
5988457|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988458|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988459|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
5988460|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988461|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5988462|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5988463|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5988464|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988465|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5988466|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
5988467|NCT00085735|Lomustine|lomustine|mesh-list
5988468|NCT00085735|Cisplatin|cisplatin|mesh-list
5988469|NCT00085735|Vincristine|vincristine|mesh-list
5988470|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988471|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
5988472|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988473|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988474|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5988475|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
5988476|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988477|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988478|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5988479|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5988480|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988481|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988482|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988483|NCT00085839|Paclitaxel|paclitaxel|mesh-list
5988484|NCT00085839|Carboplatin|carboplatin|mesh-list
5988485|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5988486|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5988487|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988488|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988489|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988490|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988491|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988492|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5988493|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988494|NCT00085917|Interferons|interferons|mesh-list
5988495|NCT00085917|Ribavirin|ribavirin|mesh-list
5988496|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
5988497|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5988498|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988499|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
5988500|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988501|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
5988502|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988503|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
5988504|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988505|NCT00086138|Sertraline|sertraline|mesh-list
5988506|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
5988507|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5988508|NCT00086138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5988509|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5988510|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5988511|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988512|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988513|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
5988514|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988515|NCT00086190|Paroxetine|paroxetine|mesh-list
5988516|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
5988517|NCT00086190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5988518|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5988519|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5988520|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988521|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988522|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
5988523|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988524|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5988525|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
5988526|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5988527|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5988528|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5988529|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988530|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5988531|NCT00086281|Zolpidem|zolpidem|mesh-list
5988532|NCT00086281|Modafinil|modafinil|mesh-list
5988533|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5988534|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988535|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
5988536|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5988537|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5988538|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988539|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
5988540|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
5988541|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5988542|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
5988543|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
5988544|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
5988545|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988546|NCT00086307|Pramipexole|pramipexole|mesh-list
5988547|NCT00086307|Citalopram|citalopram|mesh-list
5988548|NCT00086307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5988549|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5988550|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5988551|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988552|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988553|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
5988554|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988555|NCT00086307|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5988556|NCT00086307|Antidepressive Agents|antidepressive agents|mesh-ancestor
5988557|NCT00086307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5988558|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5988559|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5988560|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
5988561|NCT00086307|Protective Agents|protective agents|mesh-ancestor
5988562|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
5988563|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
5988564|NCT00086346|Cyclosporine|cyclosporine|mesh-list
5988565|NCT00086346|Sirolimus|sirolimus|mesh-list
5988566|NCT00086346|Tacrolimus|tacrolimus|mesh-list
5988567|NCT00086346|Cyclosporins|cyclosporins|mesh-list
5988568|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988569|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
5988570|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988571|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5988572|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988573|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988574|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
5988575|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988576|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
5988577|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988578|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5988579|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5988580|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988581|NCT00086385|Bupropion|bupropion|mesh-list
5988582|NCT00086385|Nicotine|nicotine|mesh-list
5988583|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5988584|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
5988585|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5988586|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988587|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5988588|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5988589|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
5988590|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988591|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988592|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5988593|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
5988594|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5988595|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5988596|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5988597|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5988598|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
5988599|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5988600|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5988601|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988602|NCT00086411|Bupropion|bupropion|mesh-list
5988603|NCT00086411|Nicotine|nicotine|mesh-list
5988604|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5988605|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
5988606|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5988607|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988608|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5988609|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5988610|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
5988611|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988612|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988613|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5988614|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
5988615|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5988616|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
5988617|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5988618|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5988619|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
5988620|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5988621|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5988622|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988623|NCT00086502|Metformin|metformin|mesh-list
5988624|NCT00086502|Pioglitazone|pioglitazone|mesh-list
5988625|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5988626|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5988627|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988628|NCT00086502|Incretins|incretins|mesh-ancestor
5988629|NCT00086502|Hormones|hormones|mesh-ancestor
5988630|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988631|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5988632|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
5988633|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988634|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988635|NCT00086515|Metformin|metformin|mesh-list
5988636|NCT00086515|Pioglitazone|pioglitazone|mesh-list
5988637|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5988638|NCT00086515|Glipizide|glipizide|mesh-list
5988639|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5988640|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988641|NCT00086515|Incretins|incretins|mesh-ancestor
5988642|NCT00086515|Hormones|hormones|mesh-ancestor
6246048|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5988643|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988644|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5988645|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
5988646|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988647|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988648|NCT00086580|Vidarabine|vidarabine|mesh-list
5988649|NCT00086580|Fludarabine|fludarabine|mesh-list
5988650|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
5988651|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
5988652|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988653|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988654|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
5988655|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988656|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988657|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
5988658|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988659|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
5988660|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988661|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5988662|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
5988663|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988664|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5988665|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
5988666|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
5988667|NCT00086957|Docetaxel|docetaxel|mesh-list
5988668|NCT00086957|Trastuzumab|trastuzumab|mesh-list
5988669|NCT00086957|Gefitinib|gefitinib|mesh-list
5988670|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988671|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988672|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988673|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988674|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988675|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5988676|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5988677|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988678|NCT00086996|Fluorouracil|fluorouracil|mesh-list
5988679|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
5988680|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
5988681|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988682|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988683|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988684|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988685|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
5988686|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988687|NCT00087126|Topotecan|topotecan|mesh-list
5988688|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5988689|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5988690|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988691|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988692|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988693|NCT00087139|Epothilones|epothilones|mesh-list
5988694|NCT00087139|Epothilone B|epothilone b|mesh-list
5988695|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988696|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988697|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988698|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988699|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988700|NCT00087152|Capecitabine|capecitabine|mesh-list
5988701|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
5988702|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988703|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
5988704|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988705|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988706|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5988707|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988708|NCT00087490|Vancomycin|vancomycin|mesh-list
5988709|NCT00087490|Linezolid|linezolid|mesh-list
5988710|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5988711|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988712|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5988713|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988714|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988715|NCT00087516|Metformin|metformin|mesh-list
5988716|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5988717|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5988718|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988719|NCT00087516|Incretins|incretins|mesh-ancestor
5988720|NCT00087516|Hormones|hormones|mesh-ancestor
5988721|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988722|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5988723|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
5988724|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988725|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988726|NCT00087529|Rituximab|rituximab|mesh-list
5988727|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5988728|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988729|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
5988730|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988731|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988732|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
5988733|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
5988734|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
5988735|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5988736|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
5988737|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
5988738|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5988739|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988740|NCT00087568|Ribavirin|ribavirin|mesh-list
5988741|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5988742|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
5988743|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988744|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
5988745|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988746|NCT00087594|Ribavirin|ribavirin|mesh-list
5988747|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5988748|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
5988749|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988750|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
5988751|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988752|NCT00087607|Ribavirin|ribavirin|mesh-list
5988753|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5988754|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5988755|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
5988756|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988757|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
5988758|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988759|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5988760|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
5988761|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988762|NCT00087646|Ribavirin|ribavirin|mesh-list
5988763|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5988764|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
5988765|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
5988766|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988767|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
5988768|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988769|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
5988770|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988771|NCT00087672|Lenalidomide|lenalidomide|mesh-list
5988772|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
5988773|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988774|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5988775|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5988776|NCT00087672|Growth Substances|growth substances|mesh-ancestor
5988777|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
5988778|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988779|NCT00087685|Everolimus|everolimus|mesh-list
5988780|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988781|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988782|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
5988783|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988784|NCT00087698|Pemetrexed|pemetrexed|mesh-list
5988785|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988786|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988787|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988788|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5988789|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5988790|NCT00088153|Progesterone|progesterone|mesh-list
5988791|NCT00088153|Estrogens|estrogens|mesh-list
5988792|NCT00088153|Progestins|progestins|mesh-ancestor
5988793|NCT00088153|Hormones|hormones|mesh-ancestor
6246049|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
5988794|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988795|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988796|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
5988797|NCT00088166|Hormones|hormones|mesh-ancestor
5988798|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988799|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988800|NCT00088218|Cytarabine|cytarabine|mesh-list
5988801|NCT00088218|Clofarabine|clofarabine|mesh-list
5988802|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988803|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
5988804|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988805|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988806|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
5988807|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988808|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988809|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
5988810|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988811|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
5988812|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
5988813|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988814|NCT00088413|Molgramostim|molgramostim|mesh-list
5988815|NCT00088413|Sargramostim|sargramostim|mesh-list
5988816|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
5988817|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988818|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988819|NCT00088452|Lamotrigine|lamotrigine|mesh-list
5988820|NCT00088452|Valproic Acid|valproic acid|mesh-list
5988821|NCT00088452|Ethosuximide|ethosuximide|mesh-list
5988822|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
5988823|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5988824|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5988825|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988826|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5988827|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988828|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5988829|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5988830|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5988831|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5988832|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5988833|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988834|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
5988835|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988836|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
5988837|NCT00088465|Olanzapine|olanzapine|mesh-list
5988838|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
5988839|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
5988840|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5988841|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988842|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5988843|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5988844|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5988845|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5988846|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5988847|NCT00088465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5988848|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5988849|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5988850|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988851|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988852|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
5988853|NCT00088530|Gemcitabine|gemcitabine|mesh-list
5988854|NCT00088530|Prednisone|prednisone|mesh-list
5988855|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
5988856|NCT00088530|Rituximab|rituximab|mesh-list
5988857|NCT00088530|Etoposide|etoposide|mesh-list
5988858|NCT00088530|Vincristine|vincristine|mesh-list
5988859|NCT00088530|Vinorelbine|vinorelbine|mesh-list
5988860|NCT00088530|Pixantrone|pixantrone|mesh-list
5988861|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988862|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
5988863|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988864|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988865|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5988866|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
5988867|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988868|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988869|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5988870|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5988871|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988872|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
5988873|NCT00088530|Antiviral Agents|antiviral agents|mesh-ancestor
5988874|NCT00088530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5988875|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988876|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5988877|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
5988878|NCT00088530|Hormones|hormones|mesh-ancestor
5988879|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988880|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5988881|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5988882|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5988883|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5988884|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988885|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988886|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988887|NCT00088595|Pasireotide|pasireotide|mesh-list
5988888|NCT00088595|Hormones|hormones|mesh-ancestor
5988889|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988890|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988891|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5988892|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5988893|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5988894|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5988895|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988896|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5988897|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5988898|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5988899|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5988900|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
5988901|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988902|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988903|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5988904|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5988905|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
5988906|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5988907|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5988908|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
5988909|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
5988910|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5988911|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5988912|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5988913|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988914|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5988915|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
5988916|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5988917|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5988918|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
5988919|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988920|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988921|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5988922|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5988923|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
5988924|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5988925|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5988926|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
5988927|NCT00088699|Ketamine|ketamine|mesh-list
5988928|NCT00088699|Analgesics|analgesics|mesh-ancestor
5988929|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
5988930|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5988931|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988932|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
5988933|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
5988934|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
5988935|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
5988936|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5988937|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5988938|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5988939|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5988940|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988941|NCT00088881|Prednisone|prednisone|mesh-list
5988942|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
5988943|NCT00088881|Rituximab|rituximab|mesh-list
5988944|NCT00088881|Doxorubicin|doxorubicin|mesh-list
5988945|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5988946|NCT00088881|Vincristine|vincristine|mesh-list
5988947|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988948|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
5988949|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988950|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5988951|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5988952|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
5988953|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988954|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988955|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5988956|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5988957|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5988958|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5988959|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5988960|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988961|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5988962|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
5988963|NCT00088881|Hormones|hormones|mesh-ancestor
5988964|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5988965|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5988966|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5988967|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988968|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988969|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988970|NCT00088907|Docetaxel|docetaxel|mesh-list
5988971|NCT00088907|Gefitinib|gefitinib|mesh-list
5988972|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988973|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988974|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988975|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988976|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988977|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5988978|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5988979|NCT00088985|Trastuzumab|trastuzumab|mesh-list
5988980|NCT00088985|Vinorelbine|vinorelbine|mesh-list
5988981|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5988982|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988983|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5988984|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
5988985|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
5988986|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
5988987|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988988|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
5988989|NCT00089011|Fludarabine|fludarabine|mesh-list
5988990|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
5988991|NCT00089011|Tacrolimus|tacrolimus|mesh-list
5988992|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5988993|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5988994|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
5988995|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5988996|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5988997|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
5988998|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5988999|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5989000|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989001|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5989002|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5989003|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
5989004|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5989005|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989006|NCT00089024|Leucovorin|leucovorin|mesh-list
5989007|NCT00089024|Gemcitabine|gemcitabine|mesh-list
5989008|NCT00089024|Fluorouracil|fluorouracil|mesh-list
5989009|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
5989010|NCT00089024|Calcium|calcium|mesh-list
5989011|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
5989012|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989013|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
5989014|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989015|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989016|NCT00089024|Antiviral Agents|antiviral agents|mesh-ancestor
5989017|NCT00089024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989018|NCT00089024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989019|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989020|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
5989021|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989022|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5989023|NCT00089024|Antidotes|antidotes|mesh-ancestor
5989024|NCT00089024|Protective Agents|protective agents|mesh-ancestor
5989025|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
5989026|NCT00089024|Vitamins|vitamins|mesh-ancestor
5989027|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
5989028|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5989029|NCT00089076|Ipilimumab|ipilimumab|mesh-list
5989030|NCT00089076|Antibodies|antibodies|mesh-list
5989031|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
5989032|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5989033|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
5989034|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989035|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989036|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5989037|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989038|NCT00089102|Gemcitabine|gemcitabine|mesh-list
5989039|NCT00089102|Irinotecan|irinotecan|mesh-list
5989040|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989041|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
5989042|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989043|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989044|NCT00089102|Antiviral Agents|antiviral agents|mesh-ancestor
5989045|NCT00089102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989046|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989047|NCT00089102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989048|NCT00089102|Immunologic Factors|immunologic factors|mesh-ancestor
5989049|NCT00089102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989050|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5989051|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5989052|NCT00089284|Rituximab|rituximab|mesh-list
5989053|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
5989054|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989055|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989056|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
5989057|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989058|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989059|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
5989060|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
5989061|NCT00089297|Paclitaxel|paclitaxel|mesh-list
5989062|NCT00089297|Carboplatin|carboplatin|mesh-list
5989063|NCT00089297|Cetuximab|cetuximab|mesh-list
5989064|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5989065|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989066|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989067|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989068|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989069|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989070|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989071|NCT00089479|Capecitabine|capecitabine|mesh-list
5989072|NCT00089479|Docetaxel|docetaxel|mesh-list
5989073|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989074|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
5989075|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989076|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989077|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989078|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989079|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989080|NCT00089505|Ritonavir|ritonavir|mesh-list
5989081|NCT00089505|Lopinavir|lopinavir|mesh-list
5989082|NCT00089505|Tenofovir|tenofovir|mesh-list
5989083|NCT00089505|Emtricitabine|emtricitabine|mesh-list
5989084|NCT00089505|Nevirapine|nevirapine|mesh-list
5989085|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5989086|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5989087|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5989088|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
5989089|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989090|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989091|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5989092|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5989093|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
5989094|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989095|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5989096|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5989097|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5989098|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5989099|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5989100|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5989101|NCT00089544|Thalidomide|thalidomide|mesh-list
5989102|NCT00089544|Doxorubicin|doxorubicin|mesh-list
5989103|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5989104|NCT00089544|Ifosfamide|ifosfamide|mesh-list
5989105|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
5989106|NCT00089544|Dacarbazine|dacarbazine|mesh-list
5989107|NCT00089544|Imidazole|imidazole|mesh-list
5989108|NCT00089544|Lenograstim|lenograstim|mesh-list
5989109|NCT00089544|Sargramostim|sargramostim|mesh-list
5989110|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5989111|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989112|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5989113|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5989114|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989115|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989116|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5989117|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
5989118|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989119|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5989120|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
5989121|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989122|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
5989123|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5989124|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989125|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5989126|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5989127|NCT00089544|Growth Substances|growth substances|mesh-ancestor
5989128|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
5989129|NCT00089583|Ritonavir|ritonavir|mesh-list
5989130|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
5989131|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5989132|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5989133|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
5989134|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989135|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989136|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5989137|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5989138|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
5989139|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989140|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5989141|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5989142|NCT00089609|Thalidomide|thalidomide|mesh-list
5989143|NCT00089609|Prednisone|prednisone|mesh-list
5989144|NCT00089609|Bevacizumab|bevacizumab|mesh-list
5989145|NCT00089609|Docetaxel|docetaxel|mesh-list
5989146|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989147|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989148|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5989149|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5989150|NCT00089609|Growth Substances|growth substances|mesh-ancestor
5989151|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989152|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
5989153|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989154|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989155|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989156|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989157|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5989158|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
5989159|NCT00089609|Hormones|hormones|mesh-ancestor
5989160|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989161|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5989162|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989163|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
5989164|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
5989165|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5989166|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989167|NCT00089635|Panitumumab|panitumumab|mesh-list
5989168|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989169|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989170|NCT00089648|Sunitinib|sunitinib|mesh-list
5989171|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989172|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5989173|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5989174|NCT00089648|Growth Substances|growth substances|mesh-ancestor
5989175|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989176|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
5989177|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989178|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989179|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989180|NCT00089661|Denosumab|denosumab|mesh-list
5989181|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5989182|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989183|NCT00089674|Denosumab|denosumab|mesh-list
5989184|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5989185|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989186|NCT00089778|Aldesleukin|aldesleukin|mesh-list
5989187|NCT00089778|Interleukin-2|interleukin-2|mesh-list
5989188|NCT00089778|Mitogens|mitogens|mesh-list
5989189|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989190|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5989191|NCT00089778|Analgesics|analgesics|mesh-ancestor
5989192|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
5989193|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5989194|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989195|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989196|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989197|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5989198|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5989199|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
5989200|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989201|NCT00089791|Denosumab|denosumab|mesh-list
5989202|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5989203|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989204|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
5989205|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
5989206|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
5989207|NCT00089843|Testosterone|testosterone|mesh-list
5989208|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
5989209|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
5989210|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5989211|NCT00089843|Androgens|androgens|mesh-ancestor
5989212|NCT00089843|Hormones|hormones|mesh-ancestor
5989213|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989214|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989215|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5989216|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989217|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
5989218|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5989219|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5989220|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989221|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5989222|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5989223|NCT00089999|Lapatinib|lapatinib|mesh-list
5989224|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989225|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989226|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989227|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989228|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
5989229|NCT00090051|Rituximab|rituximab|mesh-list
5989230|NCT00090051|Fludarabine|fludarabine|mesh-list
5989231|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
5989232|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989233|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
5989234|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989235|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989236|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5989237|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
5989238|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989239|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989240|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5989241|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989242|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989243|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
5989244|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
5989245|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
5989246|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989247|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5989248|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
5989249|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5989250|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989251|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
5989252|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5989253|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5989254|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
5989255|NCT00090103|Tamsulosin|tamsulosin|mesh-list
5989256|NCT00090103|Dutasteride|dutasteride|mesh-list
5989257|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5989258|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5989259|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5989260|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
5989261|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5989262|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989263|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989264|NCT00090103|Urological Agents|urological agents|mesh-ancestor
5989265|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
5989266|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5989267|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989268|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
5989269|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246050|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246051|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
6246052|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246053|NCT02731313|Trastuzumab|trastuzumab|mesh-list
6246054|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246055|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246056|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
6246057|NCT02731469|Hematinics|hematinics|mesh-ancestor
6246058|NCT02731638|Voriconazole|voriconazole|mesh-list
6246059|NCT02731638|Natamycin|natamycin|mesh-list
6246060|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
6246061|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246062|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6246063|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6246064|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246065|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246066|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6246067|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
6246068|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246069|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246070|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6246071|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6246072|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6246073|NCT02731729|Nivolumab|nivolumab|mesh-list
6246074|NCT02731729|Ipilimumab|ipilimumab|mesh-list
6246075|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246076|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246077|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6246078|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246079|NCT02731820|Vitamin D|vitamin d|mesh-list
6246080|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
6246081|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
6246082|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
6246083|NCT02731820|Calcium|calcium|mesh-list
6246084|NCT02731820|Vitamins|vitamins|mesh-ancestor
6246085|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
6246086|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246087|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6246088|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6246089|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246090|NCT02731820|Antacids|antacids|mesh-ancestor
6246091|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6246092|NCT02731820|Diuretics|diuretics|mesh-ancestor
6246093|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
6246094|NCT02731820|Expectorants|expectorants|mesh-ancestor
6246095|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
6246096|NCT02731833|Fluorides|fluorides|mesh-list
6246097|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
6246098|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
5989270|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
5989271|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
5989272|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989273|NCT00090402|Protective Agents|protective agents|mesh-ancestor
5989274|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989275|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
5989276|NCT00090402|Vitamins|vitamins|mesh-ancestor
5989277|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
5989278|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
5989279|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989280|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989281|NCT00090545|Sorafenib|sorafenib|mesh-list
5989282|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989283|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989284|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989285|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989286|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
5989287|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
5989288|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
5989289|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
5989290|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5989291|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989292|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989293|NCT00090584|Urological Agents|urological agents|mesh-ancestor
5989294|NCT00090610|Carboplatin|carboplatin|mesh-list
5989295|NCT00090610|Docetaxel|docetaxel|mesh-list
5989296|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989297|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989298|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989299|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989300|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989301|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
5989302|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
5989303|NCT00090753|Hematinics|hematinics|mesh-ancestor
5989304|NCT00090766|Valganciclovir|valganciclovir|mesh-list
5989305|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
5989306|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989307|NCT00090779|Ritonavir|ritonavir|mesh-list
5989308|NCT00090779|Lopinavir|lopinavir|mesh-list
5989309|NCT00090779|Tenofovir|tenofovir|mesh-list
5989310|NCT00090779|Emtricitabine|emtricitabine|mesh-list
5989311|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5989312|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5989313|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5989314|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
5989315|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989316|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989317|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5989318|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5989319|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
5989320|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989321|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5989322|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5989323|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5989324|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5989325|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
5989326|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
5989327|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
5989328|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
5989329|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5989330|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989331|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
5989332|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5989333|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989334|NCT00090857|Letrozole|letrozole|mesh-list
5989335|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989336|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5989337|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5989338|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989339|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989340|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5989341|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
5989342|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989343|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989344|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
5989345|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989346|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989347|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989348|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989349|NCT00091026|Gemcitabine|gemcitabine|mesh-list
5989350|NCT00091026|Bevacizumab|bevacizumab|mesh-list
5989351|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5989352|NCT00091026|Cetuximab|cetuximab|mesh-list
5989353|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5989354|NCT00091026|Antibodies|antibodies|mesh-list
5989355|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
5989356|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5989357|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989358|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5989359|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5989360|NCT00091026|Growth Substances|growth substances|mesh-ancestor
5989361|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989362|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
5989363|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
5989364|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989365|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
5989366|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989367|NCT00091026|Antiviral Agents|antiviral agents|mesh-ancestor
5989368|NCT00091026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989369|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989370|NCT00091026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989371|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989372|NCT00091260|Dexamethasone|dexamethasone|mesh-list
5989373|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
5989374|NCT00091260|Lenalidomide|lenalidomide|mesh-list
5989375|NCT00091260|BB 1101|bb 1101|mesh-list
5989376|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5989377|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
5989378|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
5989379|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5989380|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989381|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5989382|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
5989383|NCT00091260|Hormones|hormones|mesh-ancestor
5989384|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989385|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5989386|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989387|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
5989388|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989389|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989390|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
5989391|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5989392|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5989393|NCT00091260|Growth Substances|growth substances|mesh-ancestor
5989394|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
5989395|NCT00091273|Sargramostim|sargramostim|mesh-list
5989396|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
5989397|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
5989398|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989399|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5989400|NCT00091442|Docetaxel|docetaxel|mesh-list
5989401|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5989402|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989403|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989404|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989405|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989406|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989407|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5989408|NCT00091507|Insulin|insulin|mesh-list
5989409|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5989410|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989411|NCT00091572|Temozolomide|temozolomide|mesh-list
5989412|NCT00091572|Dacarbazine|dacarbazine|mesh-list
5989413|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5989414|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
5989415|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989416|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989417|NCT00091793|Denosumab|denosumab|mesh-list
5989418|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5989419|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989420|NCT00091819|Vancomycin|vancomycin|mesh-list
5989421|NCT00091819|Telavancin|telavancin|mesh-list
5989422|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5989423|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989424|NCT00091832|Denosumab|denosumab|mesh-list
5989425|NCT00091832|Diphosphonates|diphosphonates|mesh-list
5989426|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5989427|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989428|NCT00091949|Pioglitazone|pioglitazone|mesh-list
5989429|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5989430|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989431|NCT00092417|Vaccines|vaccines|mesh-list
5989432|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
5989433|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989434|NCT00092534|Vaccines|vaccines|mesh-list
5989435|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
5989436|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989437|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
5989438|NCT00093015|Hematinics|hematinics|mesh-ancestor
5989439|NCT00093041|Zalutumumab|zalutumumab|mesh-list
5989440|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989441|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989442|NCT00093145|Paclitaxel|paclitaxel|mesh-list
5989443|NCT00093145|Carboplatin|carboplatin|mesh-list
5989444|NCT00093145|Trastuzumab|trastuzumab|mesh-list
5989445|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5989446|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5989447|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989448|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989449|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989450|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989451|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989452|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989453|NCT00093379|Capecitabine|capecitabine|mesh-list
5989454|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
5989455|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989456|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
5989457|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989458|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989459|NCT00093470|Tipifarnib|tipifarnib|mesh-list
5989460|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989461|NCT00093496|Gemcitabine|gemcitabine|mesh-list
5989462|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989463|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
5989464|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989465|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989466|NCT00093496|Antiviral Agents|antiviral agents|mesh-ancestor
5989467|NCT00093496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989468|NCT00093496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989469|NCT00093496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989470|NCT00093496|Immunologic Factors|immunologic factors|mesh-ancestor
5989471|NCT00093496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989472|NCT00093756|Paclitaxel|paclitaxel|mesh-list
5989473|NCT00093756|Carboplatin|carboplatin|mesh-list
5989474|NCT00093756|Bortezomib|bortezomib|mesh-list
5989475|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5989476|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989477|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989478|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989479|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989480|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989481|NCT00093782|Sirolimus|sirolimus|mesh-list
5989482|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5989483|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989484|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5989485|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989486|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
5989487|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989488|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
5989489|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989490|NCT00093795|Gemcitabine|gemcitabine|mesh-list
5989491|NCT00093795|Paclitaxel|paclitaxel|mesh-list
5989492|NCT00093795|Docetaxel|docetaxel|mesh-list
5989493|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
5989494|NCT00093795|Doxorubicin|doxorubicin|mesh-list
5989495|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5989496|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989497|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989498|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989499|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989500|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989501|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989502|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
5989503|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989504|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989505|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5989506|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
5989507|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5989508|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989509|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
5989510|NCT00093795|Antiviral Agents|antiviral agents|mesh-ancestor
5989511|NCT00093795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989512|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989513|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5989514|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5989515|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5989516|NCT00093808|Capecitabine|capecitabine|mesh-list
5989517|NCT00093808|Trastuzumab|trastuzumab|mesh-list
5989518|NCT00093808|Vinorelbine|vinorelbine|mesh-list
5989519|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989520|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
5989521|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989522|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989523|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989524|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5989525|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989526|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989527|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989528|NCT00094055|Axitinib|axitinib|mesh-list
5989529|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989530|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989531|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989532|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989533|NCT00094094|Axitinib|axitinib|mesh-list
5989534|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989535|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989536|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989537|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989538|NCT00094107|Axitinib|axitinib|mesh-list
5989539|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989540|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989541|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989542|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989543|NCT00094172|Atorvastatin|atorvastatin|mesh-list
5989544|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5989545|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5989546|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
5989547|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989548|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5989549|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5989550|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989551|NCT00094302|Spironolactone|spironolactone|mesh-list
5989552|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
5989553|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
5989554|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989555|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989556|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
5989557|NCT00094302|Diuretics|diuretics|mesh-ancestor
5989558|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
5989559|NCT00094328|Anastrozole|anastrozole|mesh-list
5989560|NCT00094328|Bicalutamide|bicalutamide|mesh-list
5989561|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5989562|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989563|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
5989564|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5989565|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989566|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989567|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5989568|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
5989569|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989570|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989571|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
5989572|NCT00094445|Curcumin|curcumin|mesh-list
5989573|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5989574|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5989575|NCT00094445|Analgesics|analgesics|mesh-ancestor
5989576|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
5989577|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5989578|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989579|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5989580|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989581|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989582|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989583|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989584|NCT00094458|Azathioprine|azathioprine|mesh-list
5989585|NCT00094458|Infliximab|infliximab|mesh-list
5989586|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
5989587|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5989588|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989589|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
5989590|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989591|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989592|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989593|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989594|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
5989595|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989596|NCT00094497|Doxorubicin|doxorubicin|mesh-list
5989597|NCT00094497|Etoposide|etoposide|mesh-list
5989598|NCT00094497|Mitotane|mitotane|mesh-list
5989599|NCT00094497|Streptozocin|streptozocin|mesh-list
5989600|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989601|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5989602|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5989603|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5989604|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989605|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989606|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5989607|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5989608|NCT00094653|Ipilimumab|ipilimumab|mesh-list
5989609|NCT00094653|Vaccines|vaccines|mesh-list
5989610|NCT00094653|Antibodies|antibodies|mesh-list
5989611|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5989612|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
5989613|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989614|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989615|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989616|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5989617|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989618|NCT00094757|Pioglitazone|pioglitazone|mesh-list
5989619|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5989620|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5989621|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989622|NCT00094757|Incretins|incretins|mesh-ancestor
5989623|NCT00094757|Hormones|hormones|mesh-ancestor
5989624|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989625|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5989626|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
5989627|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989628|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989629|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5989630|NCT00094770|Glipizide|glipizide|mesh-list
5989631|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5989632|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989633|NCT00094770|Incretins|incretins|mesh-ancestor
5989634|NCT00094770|Hormones|hormones|mesh-ancestor
5989635|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989636|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5989637|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
5989638|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989639|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989640|NCT00094835|Paclitaxel|paclitaxel|mesh-list
5989641|NCT00094835|Carboplatin|carboplatin|mesh-list
5989642|NCT00094835|Panitumumab|panitumumab|mesh-list
5989643|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
5989644|NCT00094835|Imetelstat|imetelstat|mesh-list
5989645|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5989646|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989647|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989648|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989649|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989650|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989651|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989652|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989653|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989654|NCT00094861|Paclitaxel|paclitaxel|mesh-list
5989655|NCT00094861|Carboplatin|carboplatin|mesh-list
5989656|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5989657|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989658|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989659|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989660|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989661|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989662|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
5989663|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
5989664|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
5989665|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5989666|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989667|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5989668|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
5989669|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5989670|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
5989671|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989672|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5989673|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
5989674|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
5989675|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
5989676|NCT00094887|Protective Agents|protective agents|mesh-ancestor
5989677|NCT00094900|Rilonacept|rilonacept|mesh-list
5989678|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5989679|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5989680|NCT00095056|Glipizide|glipizide|mesh-list
5989681|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5989682|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989683|NCT00095056|Incretins|incretins|mesh-ancestor
5989684|NCT00095056|Hormones|hormones|mesh-ancestor
5989685|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989686|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5989687|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
5989688|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989689|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989690|NCT00095121|Lamivudine|lamivudine|mesh-list
5989691|NCT00095121|Adefovir|adefovir|mesh-list
5989692|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5989693|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5989694|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5989695|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989696|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989697|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
5989698|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989699|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5989700|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5989701|NCT00095147|Methotrexate|methotrexate|mesh-list
5989702|NCT00095147|Abatacept|abatacept|mesh-list
5989703|NCT00095147|Infliximab|infliximab|mesh-list
5989704|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5989705|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
5989706|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5989707|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989708|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989709|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
5989710|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989711|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989712|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
5989713|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989714|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5989715|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989716|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
5989717|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989718|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5989719|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5989720|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5989721|NCT00095173|Abatacept|abatacept|mesh-list
5989722|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5989723|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989724|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989725|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989726|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
5989727|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989728|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989729|NCT00095199|Docetaxel|docetaxel|mesh-list
5989730|NCT00095199|Pemetrexed|pemetrexed|mesh-list
5989731|NCT00095199|Cetuximab|cetuximab|mesh-list
5989732|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989733|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989734|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989735|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989736|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989737|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989738|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5989739|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5989740|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989741|NCT00095212|Testosterone|testosterone|mesh-list
5989742|NCT00095212|Androgens|androgens|mesh-ancestor
5989743|NCT00095212|Hormones|hormones|mesh-ancestor
5989744|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989745|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989746|NCT00095238|Irbesartan|irbesartan|mesh-list
5989747|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5989748|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5989749|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5989750|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989751|NCT00095498|Denosumab|denosumab|mesh-list
5989752|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5989753|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989754|NCT00095563|Lapatinib|lapatinib|mesh-list
5989755|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989756|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989757|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989758|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989759|NCT00095836|Gefitinib|gefitinib|mesh-list
5989760|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989761|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989762|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989763|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989764|NCT00095875|Carboplatin|carboplatin|mesh-list
5989765|NCT00095875|Docetaxel|docetaxel|mesh-list
5989766|NCT00095875|Fluorouracil|fluorouracil|mesh-list
5989767|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989768|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989769|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989770|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989771|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989772|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
5989773|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989774|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989775|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
5989776|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989777|NCT00095940|Lapatinib|lapatinib|mesh-list
5989778|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989779|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989780|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989781|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989782|NCT00095979|Epothilones|epothilones|mesh-list
5989783|NCT00095979|Epothilone B|epothilone b|mesh-list
5989784|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989785|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989786|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989787|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989788|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989789|NCT00096018|Thalidomide|thalidomide|mesh-list
5989790|NCT00096018|Fludarabine|fludarabine|mesh-list
5989791|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
5989792|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989793|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989794|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
5989795|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989796|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989797|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
5989798|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989799|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
5989800|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5989801|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989802|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5989803|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5989804|NCT00096018|Growth Substances|growth substances|mesh-ancestor
5989805|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
5989806|NCT00096031|Cetuximab|cetuximab|mesh-list
5989807|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989808|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989809|NCT00096044|Rituximab|rituximab|mesh-list
5989810|NCT00096044|Lenalidomide|lenalidomide|mesh-list
5989811|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989812|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989813|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
5989814|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989815|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989816|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5989817|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5989818|NCT00096044|Growth Substances|growth substances|mesh-ancestor
5989819|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
5989820|NCT00096122|Cytarabine|cytarabine|mesh-list
5989821|NCT00096122|Idarubicin|idarubicin|mesh-list
5989822|NCT00096122|Tipifarnib|tipifarnib|mesh-list
5989823|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989824|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
5989825|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989826|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989827|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
5989828|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989829|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989830|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
5989831|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989832|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5989833|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5989834|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5989835|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989836|NCT00096135|Leucovorin|leucovorin|mesh-list
5989837|NCT00096135|Cytarabine|cytarabine|mesh-list
5989838|NCT00096135|Dexamethasone|dexamethasone|mesh-list
5989839|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
5989840|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5989841|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5989842|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5989843|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
5989844|NCT00096135|Methotrexate|methotrexate|mesh-list
5989845|NCT00096135|Etoposide|etoposide|mesh-list
5989846|NCT00096135|Vincristine|vincristine|mesh-list
5989847|NCT00096135|Daunorubicin|daunorubicin|mesh-list
5989848|NCT00096135|Asparaginase|asparaginase|mesh-list
5989849|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
5989850|NCT00096135|Pegaspargase|pegaspargase|mesh-list
5989851|NCT00096135|Lenograstim|lenograstim|mesh-list
5989852|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
5989853|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989854|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
5989855|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989856|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989857|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5989858|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
5989859|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989860|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989861|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5989862|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5989863|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
5989864|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
5989865|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5989866|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5989867|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
5989868|NCT00096135|Hormones|hormones|mesh-ancestor
5989869|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5989870|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5989871|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5989872|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
5989873|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5989874|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989875|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
5989876|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
5989877|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989878|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5989879|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5989880|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5989881|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5989882|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5989883|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5989884|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
5989885|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989886|NCT00096135|Antidotes|antidotes|mesh-ancestor
5989887|NCT00096135|Protective Agents|protective agents|mesh-ancestor
5989888|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
5989889|NCT00096135|Vitamins|vitamins|mesh-ancestor
5989890|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
5989891|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989892|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989893|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989894|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5989895|NCT00096161|Cyclosporine|cyclosporine|mesh-list
5989896|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
5989897|NCT00096161|Vidarabine|vidarabine|mesh-list
5989898|NCT00096161|Pentostatin|pentostatin|mesh-list
5989899|NCT00096161|Cyclosporins|cyclosporins|mesh-list
5989900|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989901|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989902|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989903|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
5989904|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989905|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
5989906|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5989907|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
5989908|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989909|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5989910|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5989911|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989912|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5989913|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
5989914|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5989915|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
5989916|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
5989917|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
5989918|NCT00096174|Cisplatin|cisplatin|mesh-list
5989919|NCT00096174|Cetuximab|cetuximab|mesh-list
5989920|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989921|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5989922|NCT00096226|Paclitaxel|paclitaxel|mesh-list
5989923|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5989924|NCT00096226|Carboplatin|carboplatin|mesh-list
5989925|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5989926|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989927|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
5989928|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
5989929|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
5989930|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989931|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5989932|NCT00096265|Temozolomide|temozolomide|mesh-list
5989933|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989934|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5989935|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5989936|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989937|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5989938|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
5989939|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
5989940|NCT00096278|Leucovorin|leucovorin|mesh-list
5989941|NCT00096278|Folic Acid|folic acid|mesh-list
5989942|NCT00096278|Bevacizumab|bevacizumab|mesh-list
5989943|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5989944|NCT00096278|Fluorouracil|fluorouracil|mesh-list
5989945|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
5989946|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
5989947|NCT00096278|Antibodies|antibodies|mesh-list
5989948|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
5989949|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5989950|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
5989951|NCT00096278|Calcium|calcium|mesh-list
5989952|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
5989953|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989954|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5989955|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5989956|NCT00096278|Growth Substances|growth substances|mesh-ancestor
5989957|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989958|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
5989959|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
5989960|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5989961|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5989962|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
5989963|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989964|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989965|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989966|NCT00096278|Antidotes|antidotes|mesh-ancestor
5989967|NCT00096278|Protective Agents|protective agents|mesh-ancestor
5989968|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
5989969|NCT00096278|Vitamins|vitamins|mesh-ancestor
5989970|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
5989971|NCT00096278|Hematinics|hematinics|mesh-ancestor
5989972|NCT00096356|Vitamins|vitamins|mesh-list
5989973|NCT00096356|Vitamin E|vitamin e|mesh-list
5989974|NCT00096356|Tocopherols|tocopherols|mesh-list
5989975|NCT00096356|Tocotrienols|tocotrienols|mesh-list
5989976|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
5989977|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
5989978|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989979|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
5989980|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989981|NCT00096356|Protective Agents|protective agents|mesh-ancestor
5989982|NCT00096382|Aldesleukin|aldesleukin|mesh-list
5989983|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
5989984|NCT00096382|Fludarabine|fludarabine|mesh-list
5989985|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
5989986|NCT00096382|Interleukin-2|interleukin-2|mesh-list
5989987|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5989988|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
5989989|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5989990|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5989991|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5989992|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
5989993|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5989994|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5989995|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5989996|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5989997|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
5989998|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5989999|NCT00096382|Analgesics|analgesics|mesh-ancestor
5990000|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
5990001|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5990002|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5990003|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5990004|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
5990005|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990006|NCT00096447|Lapatinib|lapatinib|mesh-list
5990007|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990008|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990009|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990010|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990011|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
5990012|NCT00096460|Carmustine|carmustine|mesh-list
5990013|NCT00096460|Rituximab|rituximab|mesh-list
5990014|NCT00096460|Methotrexate|methotrexate|mesh-list
5990015|NCT00096460|Fludarabine|fludarabine|mesh-list
5990016|NCT00096460|Etoposide|etoposide|mesh-list
5990017|NCT00096460|Tacrolimus|tacrolimus|mesh-list
5990018|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990019|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
5990020|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990021|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5990022|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5990023|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
5990024|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990025|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990026|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5990027|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990028|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5990029|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
5990030|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5990031|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990032|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
5990033|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
5990034|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990035|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5990036|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990037|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5990038|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5990039|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990040|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5990041|NCT00096486|Everolimus|everolimus|mesh-list
5990042|NCT00096486|Gefitinib|gefitinib|mesh-list
5990043|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990044|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990045|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
5990046|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990047|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990048|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990049|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990050|NCT00096538|Valganciclovir|valganciclovir|mesh-list
5990051|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
5990052|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990053|NCT00096785|Entecavir|entecavir|mesh-list
5990054|NCT00096785|Adefovir|adefovir|mesh-list
5990055|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
5990056|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990057|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5990058|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990059|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990060|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990061|NCT00096941|Pertuzumab|pertuzumab|mesh-list
5990062|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990063|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246099|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
6246100|NCT02731833|Protective Agents|protective agents|mesh-ancestor
6246101|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246102|NCT02732015|Dexamethasone|dexamethasone|mesh-list
6246103|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
6246104|NCT02732015|Doxorubicin|doxorubicin|mesh-list
6246105|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6246106|NCT02732015|Vincristine|vincristine|mesh-list
6246107|NCT02732015|Daunorubicin|daunorubicin|mesh-list
6246108|NCT02732015|Ifosfamide|ifosfamide|mesh-list
6246109|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
6246110|NCT02732015|Ondansetron|ondansetron|mesh-list
6246111|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
6246112|NCT02732015|Aprepitant|aprepitant|mesh-list
6246113|NCT02732015|BB 1101|bb 1101|mesh-list
6246114|NCT02732015|Rolapitant|rolapitant|mesh-list
6246115|NCT02732015|Mesna|mesna|mesh-list
6246116|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246117|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
6246118|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
6246119|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246120|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246121|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6246122|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
6246123|NCT02732015|Hormones|hormones|mesh-ancestor
6246124|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246125|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6246126|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246127|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
6246128|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246129|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246130|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6246131|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6246132|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6246133|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6246134|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
6246135|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
6246136|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
6246137|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6246138|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
6246139|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
6246140|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
6246141|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6246142|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
6246143|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246144|NCT02732015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6246145|NCT02732015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5990064|NCT00096954|Omalizumab|omalizumab|mesh-list
5990065|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
5990066|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5990067|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
5990068|NCT00096993|Gemcitabine|gemcitabine|mesh-list
5990069|NCT00096993|Pertuzumab|pertuzumab|mesh-list
5990070|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990071|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
5990072|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990073|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990074|NCT00096993|Antiviral Agents|antiviral agents|mesh-ancestor
5990075|NCT00096993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990076|NCT00096993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990077|NCT00096993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990078|NCT00096993|Immunologic Factors|immunologic factors|mesh-ancestor
5990079|NCT00096993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990080|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990081|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
5990082|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990083|NCT00097448|Prednisone|prednisone|mesh-list
5990084|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
5990085|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5990086|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5990087|NCT00097448|Prednisolone|prednisolone|mesh-list
5990088|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
5990089|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5990090|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
5990091|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5990092|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
5990093|NCT00097448|Hormones|hormones|mesh-ancestor
5990094|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5990095|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990096|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5990097|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990098|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
5990099|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
5990100|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5990101|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5990102|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5990103|NCT00097448|Protective Agents|protective agents|mesh-ancestor
5990104|NCT00097500|Metformin|metformin|mesh-list
5990105|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
5990106|NCT00097500|Exenatide|exenatide|mesh-list
5990107|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5990108|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990109|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5990110|NCT00097500|Incretins|incretins|mesh-ancestor
5990111|NCT00097500|Hormones|hormones|mesh-ancestor
5990112|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5990113|NCT00097591|Clopidogrel|clopidogrel|mesh-list
5990114|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
5990115|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
5990116|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
5990117|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
5990118|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5990119|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
5990120|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5990121|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990122|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990123|NCT00097669|Folic Acid|folic acid|mesh-list
5990124|NCT00097669|Hematinics|hematinics|mesh-ancestor
5990125|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
5990126|NCT00097669|Vitamins|vitamins|mesh-ancestor
5990127|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
5990128|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990129|NCT00097695|Icatibant|icatibant|mesh-list
5990130|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5990131|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5990132|NCT00097695|Analgesics|analgesics|mesh-ancestor
5990133|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
5990134|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5990135|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990136|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5990137|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5990138|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
5990139|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
5990140|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990141|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
5990142|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990143|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
5990144|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
5990145|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5990146|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5990147|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990148|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5990149|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
5990150|NCT00097773|Tobramycin|tobramycin|mesh-list
5990151|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5990152|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990153|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5990154|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990155|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990156|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990157|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990158|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
5990159|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5990160|NCT00097786|Nateglinide|nateglinide|mesh-list
5990161|NCT00097786|Valsartan|valsartan|mesh-list
5990162|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5990163|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5990164|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
5990165|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990166|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5990167|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990168|NCT00097981|Thalidomide|thalidomide|mesh-list
5990169|NCT00097981|Dexamethasone|dexamethasone|mesh-list
5990170|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5990171|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
5990172|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
5990173|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5990174|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990175|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5990176|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
5990177|NCT00097981|Hormones|hormones|mesh-ancestor
5990178|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5990179|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5990180|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990181|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990182|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
5990183|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
5990184|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5990185|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990186|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5990187|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5990188|NCT00097981|Growth Substances|growth substances|mesh-ancestor
5990189|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
5990190|NCT00098020|Isotretinoin|isotretinoin|mesh-list
5990191|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
5990192|NCT00098059|Famciclovir|famciclovir|mesh-list
5990193|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
5990194|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990195|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990196|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990197|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990198|NCT00098254|Sorafenib|sorafenib|mesh-list
5990199|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990200|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990201|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990202|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990203|NCT00098293|Lamivudine|lamivudine|mesh-list
5990204|NCT00098293|Zidovudine|zidovudine|mesh-list
5990205|NCT00098293|Efavirenz|efavirenz|mesh-list
5990206|NCT00098293|Maraviroc|maraviroc|mesh-list
5990207|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5990208|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990209|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990210|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990211|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
5990212|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990213|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5990214|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5990215|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
5990216|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5990217|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5990218|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5990219|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5990220|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5990221|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5990222|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5990223|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5990224|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5990225|NCT00098306|Maraviroc|maraviroc|mesh-list
5990226|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5990227|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5990228|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990229|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5990230|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5990231|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
5990232|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990233|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5990234|NCT00098371|Alvocidib|alvocidib|mesh-list
5990235|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990236|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
5990237|NCT00098371|Growth Substances|growth substances|mesh-ancestor
5990238|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990239|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990240|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990241|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990242|NCT00098475|Thalidomide|thalidomide|mesh-list
5990243|NCT00098475|Dexamethasone|dexamethasone|mesh-list
5990244|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
5990245|NCT00098475|Lenalidomide|lenalidomide|mesh-list
5990246|NCT00098475|Ichthammol|ichthammol|mesh-list
5990247|NCT00098475|BB 1101|bb 1101|mesh-list
5990248|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5990249|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
5990250|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
5990251|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5990252|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990253|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5990254|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
5990255|NCT00098475|Hormones|hormones|mesh-ancestor
5990256|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5990257|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5990258|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990259|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
5990260|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990261|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990262|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
5990263|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5990264|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5990265|NCT00098475|Growth Substances|growth substances|mesh-ancestor
5990266|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
5990267|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990268|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
5990269|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5990270|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990271|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
5990272|NCT00098670|Rituximab|rituximab|mesh-list
5990273|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5990274|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
5990275|NCT00098670|Fludarabine|fludarabine|mesh-list
5990276|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
5990277|NCT00098670|Antibodies|antibodies|mesh-list
5990278|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
5990279|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5990280|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
5990281|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990282|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990283|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5990284|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990285|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
5990286|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990287|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990288|NCT00098722|Maraviroc|maraviroc|mesh-list
5990289|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5990290|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5990291|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990292|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5990293|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5990294|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
5990295|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990296|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5990297|NCT00098748|Maraviroc|maraviroc|mesh-list
5990298|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
5990299|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
5990300|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990301|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5990302|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5990303|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
5990304|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990305|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
5990306|NCT00098774|Leucovorin|leucovorin|mesh-list
5990307|NCT00098774|Cytarabine|cytarabine|mesh-list
5990308|NCT00098774|Rituximab|rituximab|mesh-list
5990309|NCT00098774|Methotrexate|methotrexate|mesh-list
5990310|NCT00098774|Etoposide|etoposide|mesh-list
5990311|NCT00098774|Temozolomide|temozolomide|mesh-list
5990312|NCT00098774|Calcium|calcium|mesh-list
5990313|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
5990314|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990315|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990316|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
5990317|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990318|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5990319|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5990320|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5990321|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
5990322|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5990323|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990324|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
5990325|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990326|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
5990327|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990328|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5990329|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990330|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990331|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5990332|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5990333|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990334|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
5990335|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990336|NCT00098774|Antidotes|antidotes|mesh-ancestor
5990337|NCT00098774|Protective Agents|protective agents|mesh-ancestor
5990338|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
5990339|NCT00098774|Vitamins|vitamins|mesh-ancestor
5990340|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
5990341|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5990342|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
5990343|NCT00098787|Leucovorin|leucovorin|mesh-list
5990344|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
5990345|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
5990346|NCT00098787|Bevacizumab|bevacizumab|mesh-list
5990347|NCT00098787|Fluorouracil|fluorouracil|mesh-list
5990348|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
5990349|NCT00098787|Irinotecan|irinotecan|mesh-list
5990350|NCT00098787|Camptothecin|camptothecin|mesh-list
5990351|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
5990352|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990353|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990354|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5990355|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5990356|NCT00098787|Growth Substances|growth substances|mesh-ancestor
5990357|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990358|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
5990359|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
5990360|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990361|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990362|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990363|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
5990364|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5990365|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990366|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990367|NCT00098787|Antidotes|antidotes|mesh-ancestor
5990368|NCT00098787|Protective Agents|protective agents|mesh-ancestor
5990369|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
5990370|NCT00098787|Vitamins|vitamins|mesh-ancestor
5990371|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
5990372|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5990373|NCT00098813|Romidepsin|romidepsin|mesh-list
5990374|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5990375|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990376|NCT00098839|Leucovorin|leucovorin|mesh-list
5990377|NCT00098839|Cytarabine|cytarabine|mesh-list
5990378|NCT00098839|Prednisone|prednisone|mesh-list
5990379|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
5990380|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
5990381|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
5990382|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
5990383|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
5990384|NCT00098839|Doxorubicin|doxorubicin|mesh-list
5990385|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5990386|NCT00098839|Methotrexate|methotrexate|mesh-list
5990387|NCT00098839|Etoposide|etoposide|mesh-list
5990388|NCT00098839|Vincristine|vincristine|mesh-list
5990389|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
5990390|NCT00098839|Asparaginase|asparaginase|mesh-list
5990391|NCT00098839|Pegaspargase|pegaspargase|mesh-list
5990392|NCT00098839|Epratuzumab|epratuzumab|mesh-list
5990393|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
5990394|NCT00098839|Razoxane|razoxane|mesh-list
5990395|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
5990396|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990397|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
5990398|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990399|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5990400|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5990401|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
5990402|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990403|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990404|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5990405|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5990406|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5990407|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990408|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990409|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5990410|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
5990411|NCT00098839|Hormones|hormones|mesh-ancestor
5990412|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5990413|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5990414|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5990415|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
5990416|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5990417|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990418|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
5990419|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
5990420|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5990421|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990422|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5990423|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
5990424|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990425|NCT00098839|Antidotes|antidotes|mesh-ancestor
5990426|NCT00098839|Protective Agents|protective agents|mesh-ancestor
5990427|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
5990428|NCT00098839|Vitamins|vitamins|mesh-ancestor
5990429|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
5990430|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
5990431|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
5990432|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
5990433|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990434|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5990435|NCT00098865|Thalidomide|thalidomide|mesh-list
5990436|NCT00098865|Temozolomide|temozolomide|mesh-list
5990437|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5990438|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
5990439|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990440|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990441|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990442|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
5990443|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990444|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
5990445|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5990446|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990447|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5990448|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5990449|NCT00098865|Growth Substances|growth substances|mesh-ancestor
5990450|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
5990451|NCT00098956|Topotecan|topotecan|mesh-list
5990452|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
5990453|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5990454|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990455|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990456|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990457|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990458|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990459|NCT00099021|Pioglitazone|pioglitazone|mesh-list
5990460|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5990461|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990462|NCT00099047|Celecoxib|celecoxib|mesh-list
5990463|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5990464|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5990465|NCT00099047|Analgesics|analgesics|mesh-ancestor
5990466|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
5990467|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5990468|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990469|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5990470|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5990471|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5990472|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5990473|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990474|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990475|NCT00099268|Levodopa|levodopa|mesh-list
5990476|NCT00099268|Carbidopa|carbidopa|mesh-list
5990477|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
5990478|NCT00099268|Entacapone|entacapone|mesh-list
5990479|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
5990480|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
5990481|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
5990482|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5990483|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990484|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990485|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
5990486|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990487|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5990488|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
5990489|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
5990490|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
5990491|NCT00099359|Lamivudine|lamivudine|mesh-list
5990492|NCT00099359|Zidovudine|zidovudine|mesh-list
5990493|NCT00099359|Nevirapine|nevirapine|mesh-list
5990494|NCT00099359|Nelfinavir|nelfinavir|mesh-list
5990495|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5990496|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990497|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990498|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990499|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
5990500|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990501|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5990502|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5990503|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
5990504|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5990505|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5990506|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5990507|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5990508|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
5990509|NCT00099632|Ritonavir|ritonavir|mesh-list
5990510|NCT00099632|Lopinavir|lopinavir|mesh-list
5990511|NCT00099632|Tenofovir|tenofovir|mesh-list
5990512|NCT00099632|Lamivudine|lamivudine|mesh-list
5990513|NCT00099632|Zidovudine|zidovudine|mesh-list
5990514|NCT00099632|Emtricitabine|emtricitabine|mesh-list
5990515|NCT00099632|Nevirapine|nevirapine|mesh-list
5990516|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5990517|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
5990518|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5990519|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5990520|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
5990521|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990522|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990523|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5990524|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5990525|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
5990526|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990527|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5990528|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5990529|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5990530|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990531|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
5990532|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5990533|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5990534|NCT00099983|Risperidone|risperidone|mesh-list
5990535|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5990536|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
5990537|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5990538|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990539|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990540|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5990541|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5990542|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5990543|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5990544|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5990545|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
5990546|NCT00100048|Tenofovir|tenofovir|mesh-list
5990547|NCT00100048|Lamivudine|lamivudine|mesh-list
5990548|NCT00100048|Efavirenz|efavirenz|mesh-list
5990549|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
5990550|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
5990551|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990552|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5990553|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990554|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990555|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990556|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5990557|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5990558|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5990559|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5990560|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5990561|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5990562|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5990563|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5990564|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5990565|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5990566|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
5990567|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5990568|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5990569|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
5990570|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5990571|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990572|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990573|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
5990574|NCT00100178|Daclizumab|daclizumab|mesh-list
5990575|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5990576|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990577|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5990578|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
5990579|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5990580|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990581|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990582|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990583|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990584|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
5990585|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990586|NCT00100659|Interferons|interferons|mesh-list
5990587|NCT00100659|Ribavirin|ribavirin|mesh-list
5990588|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990589|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
5990590|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990591|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
5990592|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990593|NCT00100698|Hormones|hormones|mesh-list
5990594|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5990595|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990596|NCT00100789|Gemcitabine|gemcitabine|mesh-list
5990597|NCT00100789|Paclitaxel|paclitaxel|mesh-list
5990598|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5990599|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990600|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
5990601|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
5990602|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
5990603|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990604|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990605|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
5990606|NCT00100789|Antiviral Agents|antiviral agents|mesh-ancestor
5990607|NCT00100789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990608|NCT00100789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990609|NCT00100789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990610|NCT00100789|Immunologic Factors|immunologic factors|mesh-ancestor
5990611|NCT00100789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990612|NCT00100802|Temozolomide|temozolomide|mesh-list
5990613|NCT00100802|Lomustine|lomustine|mesh-list
5990614|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5990615|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
5990616|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990617|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990618|NCT00100815|Gemcitabine|gemcitabine|mesh-list
5990619|NCT00100815|Bevacizumab|bevacizumab|mesh-list
5990620|NCT00100815|Capecitabine|capecitabine|mesh-list
5990621|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990622|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990623|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5990624|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5990625|NCT00100815|Growth Substances|growth substances|mesh-ancestor
5990626|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990627|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
5990628|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990629|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
5990630|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990631|NCT00100815|Antiviral Agents|antiviral agents|mesh-ancestor
5990632|NCT00100815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990633|NCT00100815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990634|NCT00100815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990635|NCT00100815|Immunologic Factors|immunologic factors|mesh-ancestor
5990636|NCT00100841|Leucovorin|leucovorin|mesh-list
5990637|NCT00100841|Bevacizumab|bevacizumab|mesh-list
5990638|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5990639|NCT00100841|Cetuximab|cetuximab|mesh-list
5990640|NCT00100841|Fluorouracil|fluorouracil|mesh-list
5990641|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
5990642|NCT00100841|Antibodies|antibodies|mesh-list
5990643|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
5990644|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5990645|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
5990646|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990647|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5990648|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5990649|NCT00100841|Growth Substances|growth substances|mesh-ancestor
5990650|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990651|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
5990652|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
5990653|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
5990654|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990655|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990656|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990657|NCT00100841|Antidotes|antidotes|mesh-ancestor
5990658|NCT00100841|Protective Agents|protective agents|mesh-ancestor
5990659|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
5990660|NCT00100841|Vitamins|vitamins|mesh-ancestor
5990661|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
5990662|NCT00101010|Prednisone|prednisone|mesh-list
5990663|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
5990664|NCT00101010|Rituximab|rituximab|mesh-list
5990665|NCT00101010|Doxorubicin|doxorubicin|mesh-list
5990666|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5990667|NCT00101010|Vincristine|vincristine|mesh-list
5990668|NCT00101010|Lenograstim|lenograstim|mesh-list
5990669|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990670|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
5990671|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990672|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5990673|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5990674|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
5990675|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990676|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990677|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5990678|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990679|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5990680|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5990681|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990682|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990683|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5990684|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
5990685|NCT00101010|Hormones|hormones|mesh-ancestor
5990686|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5990687|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5990688|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5990689|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5990690|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
5990691|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
5990692|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
5990693|NCT00101036|Lapatinib|lapatinib|mesh-list
5990694|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990695|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990696|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990697|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990698|NCT00101101|Aldesleukin|aldesleukin|mesh-list
5990699|NCT00101101|Dexamethasone|dexamethasone|mesh-list
5990700|NCT00101101|Prednisone|prednisone|mesh-list
5990701|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
5990702|NCT00101101|Doxorubicin|doxorubicin|mesh-list
5990703|NCT00101101|Vincristine|vincristine|mesh-list
5990704|NCT00101101|Interleukin-2|interleukin-2|mesh-list
5990705|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990706|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
5990707|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990708|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5990709|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5990710|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
5990711|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990712|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990713|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5990714|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5990715|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
5990716|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
5990717|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5990718|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5990719|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
5990720|NCT00101101|Hormones|hormones|mesh-ancestor
5990721|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5990722|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5990723|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5990724|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5990725|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990726|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990727|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5990728|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
5990729|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
5990730|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
5990731|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5990732|NCT00101101|Analgesics|analgesics|mesh-ancestor
5990733|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
5990734|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5990735|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5990736|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
5990737|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990738|NCT00101166|Vaccines|vaccines|mesh-list
5990739|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
5990740|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990741|NCT00101192|Cetuximab|cetuximab|mesh-list
5990742|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990743|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990744|NCT00101283|Gemcitabine|gemcitabine|mesh-list
5990745|NCT00101283|Carboplatin|carboplatin|mesh-list
5990746|NCT00101283|Pemetrexed|pemetrexed|mesh-list
5990747|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990748|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990749|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
5990750|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990751|NCT00101283|Antiviral Agents|antiviral agents|mesh-ancestor
5990752|NCT00101283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990753|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990754|NCT00101283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990755|NCT00101283|Immunologic Factors|immunologic factors|mesh-ancestor
5990756|NCT00101283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990757|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5990758|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990759|NCT00101361|Oxandrolone|oxandrolone|mesh-list
5990760|NCT00101361|Androgens|androgens|mesh-ancestor
5990761|NCT00101361|Hormones|hormones|mesh-ancestor
5990762|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5990763|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990764|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
5990765|NCT00101400|Sorafenib|sorafenib|mesh-list
5990766|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990767|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990768|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990769|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990770|NCT00101413|Sorafenib|sorafenib|mesh-list
5990771|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990772|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990773|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990774|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990775|NCT00101452|Citalopram|citalopram|mesh-list
5990776|NCT00101452|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5990777|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5990778|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5990779|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990780|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5990781|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
5990782|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990783|NCT00101452|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5990784|NCT00101452|Antidepressive Agents|antidepressive agents|mesh-ancestor
5990785|NCT00101452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5990786|NCT00101582|Cisplatin|cisplatin|mesh-list
5990787|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990788|NCT00101647|Dasatinib|dasatinib|mesh-list
5990789|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990790|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990791|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990792|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990793|NCT00101660|Dasatinib|dasatinib|mesh-list
5990794|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990795|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990796|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990797|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990798|NCT00101686|Bevacizumab|bevacizumab|mesh-list
5990799|NCT00101686|Capecitabine|capecitabine|mesh-list
5990800|NCT00101686|Irinotecan|irinotecan|mesh-list
5990801|NCT00101686|Fluorouracil|fluorouracil|mesh-list
5990802|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990803|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990804|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5990805|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5990806|NCT00101686|Growth Substances|growth substances|mesh-ancestor
5990807|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990808|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
5990809|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990810|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
5990811|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990812|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5990813|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990814|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990815|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990816|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
5990817|NCT00101816|Dasatinib|dasatinib|mesh-list
5990818|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990819|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990820|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990821|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990822|NCT00101907|Gemcitabine|gemcitabine|mesh-list
5990823|NCT00101907|Panitumumab|panitumumab|mesh-list
5990824|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
5990825|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990826|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990827|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
5990828|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990829|NCT00101907|Antiviral Agents|antiviral agents|mesh-ancestor
5990830|NCT00101907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990831|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990832|NCT00101907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990833|NCT00101907|Immunologic Factors|immunologic factors|mesh-ancestor
5990834|NCT00101907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990835|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990836|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990837|NCT00102063|Aripiprazole|aripiprazole|mesh-list
5990838|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
5990839|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5990840|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5990841|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5990842|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5990843|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990844|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
5990845|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
5990846|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5990847|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990848|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5990849|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5990850|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
5990851|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5990852|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5990853|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5990854|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5990855|NCT00102440|Allopurinol|allopurinol|mesh-list
5990856|NCT00102440|Febuxostat|febuxostat|mesh-list
5990857|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
5990858|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990859|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990860|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
5990861|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5990862|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5990863|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
5990864|NCT00102440|Protective Agents|protective agents|mesh-ancestor
5990865|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990866|NCT00102518|Aripiprazole|aripiprazole|mesh-list
5990867|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
5990868|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5990869|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5990870|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5990871|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5990872|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990873|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
5990874|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
5990875|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5990876|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990877|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5990878|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5990879|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
5990880|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5990881|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5990882|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5990883|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5990884|NCT00102531|Cisplatin|cisplatin|mesh-list
5990885|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990886|NCT00102687|Azacitidine|azacitidine|mesh-list
5990887|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990888|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
5990889|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990890|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990891|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990892|NCT00102804|Pemetrexed|pemetrexed|mesh-list
5990893|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990894|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990895|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990896|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5990897|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990898|NCT00102960|Ritonavir|ritonavir|mesh-list
5990899|NCT00102960|Lopinavir|lopinavir|mesh-list
5990900|NCT00102960|Lamivudine|lamivudine|mesh-list
5990901|NCT00102960|Zidovudine|zidovudine|mesh-list
5990902|NCT00102960|Nevirapine|nevirapine|mesh-list
5990903|NCT00102960|Abacavir|abacavir|mesh-list
5990904|NCT00102960|Didanosine|didanosine|mesh-list
5990905|NCT00102960|Efavirenz|efavirenz|mesh-list
5990906|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5990907|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5990908|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
5990909|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990910|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990911|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5990912|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5990913|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
5990914|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5990915|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5990916|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5990917|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5990918|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990919|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
5990920|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5990921|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5990922|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5990923|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5990924|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5990925|NCT00103116|Vaccines|vaccines|mesh-list
5990926|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
5990927|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990928|NCT00103142|Sargramostim|sargramostim|mesh-list
5990929|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
5990930|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990931|NCT00103194|Lapatinib|lapatinib|mesh-list
5990932|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990933|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5990934|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990935|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990936|NCT00103207|Cetuximab|cetuximab|mesh-list
5990937|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5990938|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990939|NCT00103259|Irinotecan|irinotecan|mesh-list
5990940|NCT00103259|Bortezomib|bortezomib|mesh-list
5990941|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5990942|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990943|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990944|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990945|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990946|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
5990947|NCT00103285|Leucovorin|leucovorin|mesh-list
5990948|NCT00103285|Folic Acid|folic acid|mesh-list
5990949|NCT00103285|Cytarabine|cytarabine|mesh-list
5990950|NCT00103285|Dexamethasone|dexamethasone|mesh-list
5990951|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
5990952|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
5990953|NCT00103285|Doxorubicin|doxorubicin|mesh-list
5990954|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5990955|NCT00103285|Methotrexate|methotrexate|mesh-list
5990956|NCT00103285|Vincristine|vincristine|mesh-list
5990957|NCT00103285|Asparaginase|asparaginase|mesh-list
5990958|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
5990959|NCT00103285|Pegaspargase|pegaspargase|mesh-list
5990960|NCT00103285|Thioguanine|thioguanine|mesh-list
5990961|NCT00103285|BB 1101|bb 1101|mesh-list
5990962|NCT00103285|Calcium|calcium|mesh-list
5990963|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
5990964|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
5990965|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5990966|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
5990967|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5990968|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5990969|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5990970|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
5990971|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5990972|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5990973|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5990974|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5990975|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
5990976|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
5990977|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5990978|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5990979|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
5990980|NCT00103285|Hormones|hormones|mesh-ancestor
5990981|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5990982|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5990983|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
5990984|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5990985|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5990986|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5990987|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5990988|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5990989|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5990990|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5990991|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
5990992|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5990993|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5990994|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
5990995|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
5990996|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5990997|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5990998|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
5990999|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991000|NCT00103285|Antidotes|antidotes|mesh-ancestor
5991001|NCT00103285|Protective Agents|protective agents|mesh-ancestor
5991002|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
5991003|NCT00103285|Vitamins|vitamins|mesh-ancestor
5991004|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
5991005|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5991006|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
5991007|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
5991008|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
5991009|NCT00103285|Hematinics|hematinics|mesh-ancestor
5991010|NCT00103376|Bortezomib|bortezomib|mesh-list
5991011|NCT00103376|Androgens|androgens|mesh-list
5991012|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
5991013|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991014|NCT00103376|Hormones|hormones|mesh-ancestor
5991015|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991016|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991017|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
5991018|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
5991019|NCT00103402|Alfuzosin|alfuzosin|mesh-list
5991020|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5991021|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5991022|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5991023|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
5991024|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5991025|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991026|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991027|NCT00103402|Urological Agents|urological agents|mesh-ancestor
5991028|NCT00103506|Doxorubicin|doxorubicin|mesh-list
5991029|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5991030|NCT00103506|Bortezomib|bortezomib|mesh-list
5991031|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991032|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991033|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5991034|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5991035|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991036|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991037|NCT00103610|Plerixafor|plerixafor|mesh-list
5991038|NCT00103610|Sargramostim|sargramostim|mesh-list
5991039|NCT00103610|Lenograstim|lenograstim|mesh-list
5991040|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
5991041|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991042|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5991043|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5991044|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5991045|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
5991046|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991047|NCT00103662|Plerixafor|plerixafor|mesh-list
5991048|NCT00103662|Sargramostim|sargramostim|mesh-list
5991049|NCT00103662|Lenograstim|lenograstim|mesh-list
5991050|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
5991051|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991052|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5991053|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5991054|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5991055|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
5991056|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991057|NCT00103740|Vitamin D|vitamin d|mesh-list
5991058|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
5991059|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
5991060|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
5991061|NCT00103740|Calcium|calcium|mesh-list
5991062|NCT00103740|Vitamins|vitamins|mesh-ancestor
5991063|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
5991064|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991065|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5991066|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5991067|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5991068|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5991069|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991070|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
5991071|NCT00103844|Dasatinib|dasatinib|mesh-list
5991072|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991073|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5991074|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991075|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991076|NCT00103857|Metformin|metformin|mesh-list
5991077|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5991078|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5991079|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991080|NCT00103857|Incretins|incretins|mesh-ancestor
5991081|NCT00103857|Hormones|hormones|mesh-ancestor
5991082|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991083|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5991084|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
5991085|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991086|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991087|NCT00104052|Ribavirin|ribavirin|mesh-list
5991088|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
5991089|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
5991090|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
5991091|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991092|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
5991093|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991094|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
5991095|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991096|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
5991097|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5991098|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991099|NCT00104247|Verapamil|verapamil|mesh-list
5991100|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5991101|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5991102|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5991103|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991104|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5991105|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991106|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
5991107|NCT00104299|Prednisone|prednisone|mesh-list
5991108|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
5991109|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
5991110|NCT00104299|Rituximab|rituximab|mesh-list
5991111|NCT00104299|Azathioprine|azathioprine|mesh-list
5991112|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
5991113|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991114|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
5991115|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991116|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991117|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5991118|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
5991119|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991120|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991121|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5991122|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5991123|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5991124|NCT00104299|Hormones|hormones|mesh-ancestor
5991125|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991126|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991127|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
5991128|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
5991129|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5991130|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5991131|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5991132|NCT00104299|Protective Agents|protective agents|mesh-ancestor
5991133|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
5991134|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5991135|NCT00104416|Lamotrigine|lamotrigine|mesh-list
5991136|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
5991137|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5991138|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5991139|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991140|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5991141|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991142|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5991143|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5991144|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5991145|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5991146|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
5991147|NCT00104572|Vitamin D|vitamin d|mesh-list
5991148|NCT00104572|Anastrozole|anastrozole|mesh-list
5991149|NCT00104572|Calcium|calcium|mesh-list
5991150|NCT00104572|Testosterone|testosterone|mesh-list
5991151|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5991152|NCT00104572|Vitamins|vitamins|mesh-ancestor
5991153|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
5991154|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991155|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5991156|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5991157|NCT00104572|Androgens|androgens|mesh-ancestor
5991158|NCT00104572|Hormones|hormones|mesh-ancestor
5991159|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991160|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991161|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991162|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5991163|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991164|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991165|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5991166|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
6246146|NCT02732015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246147|NCT02732015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6246148|NCT02732015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6246149|NCT02732015|Protective Agents|protective agents|mesh-ancestor
6246150|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6246151|NCT02732119|Everolimus|everolimus|mesh-list
6246152|NCT02732119|Exemestane|exemestane|mesh-list
6246153|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246154|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6246155|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
6246156|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246157|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6246158|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6246159|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246160|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246161|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6246162|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
6246163|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246164|NCT02732587|Saracatinib|saracatinib|mesh-list
6246165|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246166|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246167|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246168|NCT02732639|Interferons|interferons|mesh-list
6246169|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246170|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
6246171|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246172|NCT02732899|Sirolimus|sirolimus|mesh-list
6246173|NCT02732899|Aflibercept|aflibercept|mesh-list
6246174|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6246175|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246176|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6246177|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246178|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
6246179|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6246180|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
6246181|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246182|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6246183|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6246184|NCT02732899|Growth Substances|growth substances|mesh-ancestor
6246185|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
6246186|NCT02732912|Zopiclone|zopiclone|mesh-list
5991167|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
5991168|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991169|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
5991170|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
5991171|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5991172|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991173|NCT00104637|Urological Agents|urological agents|mesh-ancestor
5991174|NCT00104650|Denosumab|denosumab|mesh-list
5991175|NCT00104650|Diphosphonates|diphosphonates|mesh-list
5991176|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5991177|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991178|NCT00104676|Paclitaxel|paclitaxel|mesh-list
5991179|NCT00104676|Etoposide|etoposide|mesh-list
5991180|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
5991181|NCT00104676|Ifosfamide|ifosfamide|mesh-list
5991182|NCT00104676|Bleomycin|bleomycin|mesh-list
5991183|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5991184|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991185|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
5991186|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
5991187|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
5991188|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991189|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5991190|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5991191|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991192|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5991193|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
5991194|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991195|NCT00104858|Cyclosporine|cyclosporine|mesh-list
5991196|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
5991197|NCT00104858|Rituximab|rituximab|mesh-list
5991198|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5991199|NCT00104858|Fludarabine|fludarabine|mesh-list
5991200|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
5991201|NCT00104858|Antibodies|antibodies|mesh-list
5991202|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
5991203|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5991204|NCT00104858|Cyclosporins|cyclosporins|mesh-list
5991205|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
5991206|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991207|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991208|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991209|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5991210|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
5991211|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991212|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991213|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991214|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
5991215|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991216|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
5991217|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5991218|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991219|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5991220|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
5991221|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991222|NCT00104871|Bortezomib|bortezomib|mesh-list
5991223|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991224|NCT00104884|Romidepsin|romidepsin|mesh-list
5991225|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991226|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991227|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
5991228|NCT00105001|Sirolimus|sirolimus|mesh-list
5991229|NCT00105001|Fludarabine|fludarabine|mesh-list
5991230|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
5991231|NCT00105001|Tacrolimus|tacrolimus|mesh-list
5991232|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991233|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5991234|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
5991235|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991236|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991237|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
5991238|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991239|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5991240|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991241|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991242|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5991243|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
5991244|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991245|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991246|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
5991247|NCT00105027|Triamcinolone|triamcinolone|mesh-list
5991248|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
5991249|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
5991250|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
5991251|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5991252|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
5991253|NCT00105027|Hormones|hormones|mesh-ancestor
5991254|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991255|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991256|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991257|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
5991258|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991259|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991260|NCT00105066|Metformin|metformin|mesh-list
5991261|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5991262|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991263|NCT00105079|Ritonavir|ritonavir|mesh-list
5991264|NCT00105079|Lopinavir|lopinavir|mesh-list
5991265|NCT00105079|Saquinavir|saquinavir|mesh-list
5991266|NCT00105079|Tenofovir|tenofovir|mesh-list
5991267|NCT00105079|Emtricitabine|emtricitabine|mesh-list
5991268|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5991269|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5991270|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5991271|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
5991272|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991273|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991274|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5991275|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5991276|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
5991277|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991278|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5991279|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5991280|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5991281|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5991282|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
5991283|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5991284|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5991285|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
5991286|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991287|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
5991288|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
5991289|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991290|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991291|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
5991292|NCT00105183|Antibodies|antibodies|mesh-list
5991293|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
5991294|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5991295|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5991296|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
5991297|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5991298|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
5991299|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991300|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991301|NCT00105196|Aripiprazole|aripiprazole|mesh-list
5991302|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
5991303|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5991304|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5991305|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5991306|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5991307|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991308|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
5991309|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
5991310|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5991311|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991312|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5991313|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5991314|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
5991315|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5991316|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5991317|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5991318|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5991319|NCT00105235|Cyclosporine|cyclosporine|mesh-list
5991320|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
5991321|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
5991322|NCT00105235|Tacrolimus|tacrolimus|mesh-list
5991323|NCT00105235|Cyclosporins|cyclosporins|mesh-list
5991324|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991325|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
5991326|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991327|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5991328|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991329|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991330|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
5991331|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991332|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
5991333|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991334|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991335|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991336|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5991337|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
5991338|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991339|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5991340|NCT00105443|Sorafenib|sorafenib|mesh-list
5991341|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991342|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5991343|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991344|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991345|NCT00105469|Tobramycin|tobramycin|mesh-list
5991346|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991347|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991348|NCT00105482|Naltrexone|naltrexone|mesh-list
5991349|NCT00105482|Nicotine|nicotine|mesh-list
5991350|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
5991351|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
5991352|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5991353|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991354|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
5991355|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
5991356|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
5991357|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5991358|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991359|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5991360|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5991361|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
5991362|NCT00105534|Azithromycin|azithromycin|mesh-list
5991363|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991364|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991365|NCT00105586|Citalopram|citalopram|mesh-list
5991366|NCT00105586|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5991367|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5991368|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5991369|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991370|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5991371|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
5991372|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991373|NCT00105586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5991374|NCT00105586|Antidepressive Agents|antidepressive agents|mesh-ancestor
5991375|NCT00105586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5991376|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5991377|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5991378|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5991379|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5991380|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991381|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5991382|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991383|NCT00105989|Analgesics|analgesics|mesh-ancestor
5991384|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
5991385|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5991386|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
5991387|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5991388|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
5991389|NCT00106002|Pemetrexed|pemetrexed|mesh-list
5991390|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991391|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991392|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991393|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5991394|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5991395|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
5991396|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5991397|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5991398|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991399|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5991400|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991401|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5991402|NCT00106106|Acamprosate|acamprosate|mesh-list
5991403|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5991404|NCT00106184|Rituximab|rituximab|mesh-list
5991405|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5991406|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991407|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
5991408|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991409|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991410|NCT00106353|Sirolimus|sirolimus|mesh-list
5991411|NCT00106353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991412|NCT00106353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991413|NCT00106353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991414|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991415|NCT00106353|Antifungal Agents|antifungal agents|mesh-ancestor
5991416|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991417|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
5991418|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991419|NCT00106392|Tacrolimus|tacrolimus|mesh-list
5991420|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991421|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
5991422|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991423|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5991424|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991425|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991426|NCT00106431|Romidepsin|romidepsin|mesh-list
5991427|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991428|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991429|NCT00106535|Methotrexate|methotrexate|mesh-list
5991430|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5991431|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
5991432|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5991433|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991434|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5991435|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
5991436|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991437|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991438|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
5991439|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991440|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5991441|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991442|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
5991443|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991444|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5991445|NCT00106639|Tacrolimus|tacrolimus|mesh-list
5991446|NCT00106639|Tofacitinib|tofacitinib|mesh-list
5991447|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991448|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
5991449|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991450|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5991451|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991452|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991453|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5991454|NCT00106704|Pioglitazone|pioglitazone|mesh-list
5991455|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
5991456|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5991457|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991458|NCT00106704|Incretins|incretins|mesh-ancestor
5991459|NCT00106704|Hormones|hormones|mesh-ancestor
5991460|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991461|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
5991462|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
5991463|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991464|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991465|NCT00107120|Citalopram|citalopram|mesh-list
5991466|NCT00107120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5991467|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5991468|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5991469|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991470|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5991471|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
5991472|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991473|NCT00107120|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5991474|NCT00107120|Antidepressive Agents|antidepressive agents|mesh-ancestor
5991475|NCT00107120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5991476|NCT00107198|Prednisone|prednisone|mesh-list
5991477|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
5991478|NCT00107198|Doxorubicin|doxorubicin|mesh-list
5991479|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5991480|NCT00107198|Vincristine|vincristine|mesh-list
5991481|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991482|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
5991483|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991484|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991485|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5991486|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
5991487|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991488|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991489|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5991490|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991491|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5991492|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5991493|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991494|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5991495|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
5991496|NCT00107198|Hormones|hormones|mesh-ancestor
5991497|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991498|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991499|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5991500|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
5991501|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
5991502|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
5991503|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
5991504|NCT00107276|Capecitabine|capecitabine|mesh-list
5991505|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991506|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
5991507|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991508|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991509|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5991510|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
5991511|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991512|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991513|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5991514|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5991515|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
5991516|NCT00107380|Prednisone|prednisone|mesh-list
5991517|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
5991518|NCT00107380|Rituximab|rituximab|mesh-list
5991519|NCT00107380|Doxorubicin|doxorubicin|mesh-list
5991520|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5991521|NCT00107380|Vincristine|vincristine|mesh-list
5991522|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
5991523|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991524|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
5991525|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991526|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991527|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5991528|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
5991529|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991530|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991531|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5991532|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5991533|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991534|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5991535|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5991536|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991537|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5991538|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
5991539|NCT00107380|Hormones|hormones|mesh-ancestor
5991540|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991541|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991542|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5991543|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
5991544|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
5991545|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
5991546|NCT00107536|Lapatinib|lapatinib|mesh-list
5991547|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991548|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5991549|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991550|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991551|NCT00107653|Ribavirin|ribavirin|mesh-list
5991552|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
5991553|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
5991554|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
5991555|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991556|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
5991557|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991558|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
5991559|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991560|NCT00107744|Caseins|caseins|mesh-list
5991561|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
5991562|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
5991563|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991564|NCT00107783|Nitisinone|nitisinone|mesh-list
5991565|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991566|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991567|NCT00107900|Edoxaban|edoxaban|mesh-list
5991568|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
5991569|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
5991570|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5991571|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
5991572|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991573|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991574|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
5991575|NCT00107952|Vancomycin|vancomycin|mesh-list
5991576|NCT00107952|Telavancin|telavancin|mesh-list
5991577|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991578|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991579|NCT00107978|Vancomycin|vancomycin|mesh-list
5991580|NCT00107978|Telavancin|telavancin|mesh-list
5991581|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991582|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991583|NCT00107991|Etanercept|etanercept|mesh-list
5991584|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5991585|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5991586|NCT00107991|Analgesics|analgesics|mesh-ancestor
5991587|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
5991588|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5991589|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991590|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5991591|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991592|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5991593|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991594|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
5991595|NCT00108069|Tamoxifen|tamoxifen|mesh-list
5991596|NCT00108069|Bortezomib|bortezomib|mesh-list
5991597|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991598|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5991599|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
5991600|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991601|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991602|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991603|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
5991604|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
5991605|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5991606|NCT00108082|Atenolol|atenolol|mesh-list
5991607|NCT00108082|Carvedilol|carvedilol|mesh-list
5991608|NCT00108082|Lisinopril|lisinopril|mesh-list
5991609|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
5991610|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
5991611|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
5991612|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5991613|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991614|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991615|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5991616|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
5991617|NCT00108082|Protective Agents|protective agents|mesh-ancestor
5991618|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
5991619|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5991620|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5991621|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
5991622|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
5991623|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
5991624|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5991625|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
5991626|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991627|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
5991628|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
5991629|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
5991630|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
5991631|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5991632|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
5991633|NCT00108160|Mupirocin|mupirocin|mesh-list
5991634|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991635|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991636|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5991637|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991638|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991639|NCT00108355|Octreotide|octreotide|mesh-list
5991640|NCT00108355|Midodrine|midodrine|mesh-list
5991641|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5991642|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991643|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991644|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
5991645|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
5991646|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5991647|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991648|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
5991649|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
5991650|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
5991651|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
5991652|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
5991653|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5991654|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991655|NCT00108485|Niacin|niacin|mesh-list
5991656|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5991657|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
5991658|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991659|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5991660|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
5991661|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
5991662|NCT00108485|Vitamins|vitamins|mesh-ancestor
5991663|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
5991664|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991665|NCT00108524|Orlistat|orlistat|mesh-list
5991666|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991667|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991668|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5991669|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5991670|NCT00108550|Gabapentin|gabapentin|mesh-list
5991671|NCT00108550|Analgesics|analgesics|mesh-ancestor
5991672|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
5991673|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5991674|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991675|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
5991676|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
5991677|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5991678|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5991679|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5991680|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5991681|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
5991682|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5991683|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991684|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
5991685|NCT00108732|Metronidazole|metronidazole|mesh-list
5991686|NCT00108732|Goserelin|goserelin|mesh-list
5991687|NCT00108732|Bicalutamide|bicalutamide|mesh-list
5991688|NCT00108732|Vaccines|vaccines|mesh-list
5991689|NCT00108732|Sargramostim|sargramostim|mesh-list
5991690|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
5991691|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991692|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991693|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991694|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
5991695|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
5991696|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991697|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991698|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991699|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5991700|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5991701|NCT00108745|Paclitaxel|paclitaxel|mesh-list
5991702|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5991703|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
5991704|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5991705|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991706|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
5991707|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
5991708|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
5991709|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991710|NCT00108953|Doxorubicin|doxorubicin|mesh-list
5991711|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
5991712|NCT00108953|Sorafenib|sorafenib|mesh-list
5991713|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991714|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991715|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5991716|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5991717|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991718|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991719|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5991720|NCT00109005|Lenalidomide|lenalidomide|mesh-list
5991721|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
5991722|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991723|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5991724|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5991725|NCT00109005|Growth Substances|growth substances|mesh-ancestor
5991726|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
5991727|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991728|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
5991729|NCT00109031|Etoposide|etoposide|mesh-list
5991730|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991731|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
5991732|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991733|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991734|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5991735|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
5991736|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991737|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991738|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5991739|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5991740|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5991741|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5991742|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991743|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
5991744|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
5991745|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991746|NCT00109473|Prednisone|prednisone|mesh-list
5991747|NCT00109473|Hormones|hormones|mesh-list
5991748|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5991749|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
5991750|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991751|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991752|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991753|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991754|NCT00109590|Ritonavir|ritonavir|mesh-list
5991755|NCT00109590|Lopinavir|lopinavir|mesh-list
5991756|NCT00109590|Zidovudine|zidovudine|mesh-list
5991757|NCT00109590|Nevirapine|nevirapine|mesh-list
5991758|NCT00109590|Didanosine|didanosine|mesh-list
5991759|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
5991760|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
5991761|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
5991762|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991763|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991764|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5991765|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5991766|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
5991767|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991768|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
5991769|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5991770|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
5991771|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5991772|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5991773|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5991774|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5991775|NCT00109733|Hormones|hormones|mesh-list
5991776|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991777|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991778|NCT00109772|Lenalidomide|lenalidomide|mesh-list
5991779|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
5991780|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991781|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5991782|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5991783|NCT00109772|Growth Substances|growth substances|mesh-ancestor
5991784|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
5991785|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991786|NCT00109837|Leucovorin|leucovorin|mesh-list
5991787|NCT00109837|Cytarabine|cytarabine|mesh-list
5991788|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
5991789|NCT00109837|Dexamethasone|dexamethasone|mesh-list
5991790|NCT00109837|Prednisone|prednisone|mesh-list
5991791|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
5991792|NCT00109837|Doxorubicin|doxorubicin|mesh-list
5991793|NCT00109837|Methotrexate|methotrexate|mesh-list
5991794|NCT00109837|Vincristine|vincristine|mesh-list
5991795|NCT00109837|Daunorubicin|daunorubicin|mesh-list
5991796|NCT00109837|Asparaginase|asparaginase|mesh-list
5991797|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
5991798|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
5991799|NCT00109837|Thioguanine|thioguanine|mesh-list
5991800|NCT00109837|Allopurinol|allopurinol|mesh-list
5991801|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991802|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
5991803|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991804|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991805|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5991806|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
5991807|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991808|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991809|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5991810|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5991811|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
5991812|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
5991813|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5991814|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5991815|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
5991816|NCT00109837|Hormones|hormones|mesh-ancestor
5991817|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991818|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991819|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991820|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5991821|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5991822|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991823|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
5991824|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
5991825|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
5991826|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5991827|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
5991828|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
5991829|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5991830|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5991831|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
5991832|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991833|NCT00109837|Antidotes|antidotes|mesh-ancestor
5991834|NCT00109837|Protective Agents|protective agents|mesh-ancestor
5991835|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
5991836|NCT00109837|Vitamins|vitamins|mesh-ancestor
5991837|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
5991838|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5991839|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
5991840|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
5991841|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
5991842|NCT00109837|Analgesics|analgesics|mesh-ancestor
5991843|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
5991844|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
5991845|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5991846|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
5991847|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
5991848|NCT00109837|Renal Agents|renal agents|mesh-ancestor
5991849|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991850|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
5991851|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
5991852|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
5991853|NCT00109850|Irinotecan|irinotecan|mesh-list
5991854|NCT00109850|Cetuximab|cetuximab|mesh-list
5991855|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991856|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5991857|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5991858|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991859|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991860|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5991861|NCT00109928|Gemcitabine|gemcitabine|mesh-list
5991862|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
5991863|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
5991864|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
5991865|NCT00109928|Prednisolone|prednisolone|mesh-list
5991866|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
5991867|NCT00109928|Etoposide|etoposide|mesh-list
5991868|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
5991869|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
5991870|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991871|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5991872|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
5991873|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991874|NCT00109928|Antiviral Agents|antiviral agents|mesh-ancestor
5991875|NCT00109928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991876|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991877|NCT00109928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991878|NCT00109928|Immunologic Factors|immunologic factors|mesh-ancestor
5991879|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991880|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5991881|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
5991882|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5991883|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5991884|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
5991885|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
5991886|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5991887|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5991888|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
5991889|NCT00109928|Hormones|hormones|mesh-ancestor
5991890|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991891|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
5991892|NCT00109928|Protective Agents|protective agents|mesh-ancestor
5991893|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991894|NCT00109967|Sirolimus|sirolimus|mesh-list
5991895|NCT00109967|Rituximab|rituximab|mesh-list
5991896|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5991897|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991898|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
5991899|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991900|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991901|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5991902|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991903|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5991904|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
5991905|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991906|NCT00110019|Paclitaxel|paclitaxel|mesh-list
5991907|NCT00110019|Carboplatin|carboplatin|mesh-list
5991908|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5991909|NCT00110019|Sorafenib|sorafenib|mesh-list
5991910|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5991911|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991912|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
5991913|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
5991914|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
5991915|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991916|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5991917|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991918|NCT00110084|Gemcitabine|gemcitabine|mesh-list
5991919|NCT00110084|Paclitaxel|paclitaxel|mesh-list
5991920|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5991921|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5991922|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991923|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
5991924|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
5991925|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
5991926|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991927|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5991928|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
5991929|NCT00110084|Antiviral Agents|antiviral agents|mesh-ancestor
5991930|NCT00110084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991931|NCT00110084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991932|NCT00110084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5991933|NCT00110084|Immunologic Factors|immunologic factors|mesh-ancestor
5991934|NCT00110084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991935|NCT00110149|Rituximab|rituximab|mesh-list
5991936|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5991937|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991938|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
5991939|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991940|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5991941|NCT00110214|Prednisone|prednisone|mesh-list
5991942|NCT00110214|Bevacizumab|bevacizumab|mesh-list
5991943|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
5991944|NCT00110214|Docetaxel|docetaxel|mesh-list
5991945|NCT00110214|Antibodies|antibodies|mesh-list
5991946|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
5991947|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
5991948|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991949|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5991950|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5991951|NCT00110214|Growth Substances|growth substances|mesh-ancestor
5991952|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5991953|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
5991954|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
5991955|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
5991956|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
5991957|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
5991958|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991959|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5991960|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
5991961|NCT00110214|Hormones|hormones|mesh-ancestor
5991962|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5991963|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5991964|NCT00110266|Deferasirox|deferasirox|mesh-list
5991965|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5991966|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
5991967|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
5991968|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991969|NCT00110305|Efavirenz|efavirenz|mesh-list
5991970|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
5991971|NCT00110305|Rilpivirine|rilpivirine|mesh-list
5991972|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5991973|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991974|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991975|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
5991976|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991977|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5991978|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5991979|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5991980|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5991981|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5991982|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5991983|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5991984|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5991985|NCT00110357|Irinotecan|irinotecan|mesh-list
5991986|NCT00110357|Cetuximab|cetuximab|mesh-list
5991987|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5991988|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5991989|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5991990|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5991991|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991992|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5991993|NCT00110396|Interferons|interferons|mesh-list
5991994|NCT00110396|Interferon-beta|interferon-beta|mesh-list
5991995|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
5991996|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5991997|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
5991998|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5991999|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
5992000|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992001|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5992002|NCT00110461|Aripiprazole|aripiprazole|mesh-list
5992003|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
5992004|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5992005|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5992006|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5992007|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5992008|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992009|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
5992010|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
5992011|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5992012|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992013|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
5992014|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
5992015|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
5992016|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
5992017|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
5992018|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
5992019|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
5992020|NCT00110513|Antithrombins|antithrombins|mesh-list
5992021|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
5992022|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
5992023|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
5992024|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992025|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992026|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
5992027|NCT00110617|Deferasirox|deferasirox|mesh-list
5992028|NCT00110617|Deferoxamine|deferoxamine|mesh-list
5992029|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5992030|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
5992031|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
5992032|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992033|NCT00110617|Siderophores|siderophores|mesh-ancestor
5992034|NCT00110812|Aldesleukin|aldesleukin|mesh-list
5992035|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992036|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5992037|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5992038|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
5992039|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992040|NCT00110890|Cinacalcet|cinacalcet|mesh-list
5992041|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5992042|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992043|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
5992044|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
5992045|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5992046|NCT00110994|Sorafenib|sorafenib|mesh-list
5992047|NCT00110994|Dacarbazine|dacarbazine|mesh-list
5992048|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992049|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992050|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992051|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992052|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5992053|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
5992054|NCT00111007|Paclitaxel|paclitaxel|mesh-list
5992055|NCT00111007|Carboplatin|carboplatin|mesh-list
5992056|NCT00111007|Sorafenib|sorafenib|mesh-list
5992057|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5992058|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992059|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
5992060|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
5992061|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
5992062|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992063|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992064|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992065|NCT00111241|Letrozole|letrozole|mesh-list
5992066|NCT00111241|Anastrozole|anastrozole|mesh-list
5992067|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
5992068|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992069|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
5992070|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992071|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992072|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
5992073|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
5992074|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5992075|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992076|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5992077|NCT00111657|Rasburicase|rasburicase|mesh-list
5992078|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
5992079|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6246187|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6246188|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246189|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246190|NCT02732938|Gemcitabine|gemcitabine|mesh-list
6246191|NCT02732938|Paclitaxel|paclitaxel|mesh-list
6246192|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6246193|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246194|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
6246195|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
6246196|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
6246197|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246198|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6246199|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
6246200|NCT02732938|Antiviral Agents|antiviral agents|mesh-ancestor
6246201|NCT02732938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246202|NCT02732938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246203|NCT02732938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6246204|NCT02732938|Immunologic Factors|immunologic factors|mesh-ancestor
6246205|NCT02732938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246206|NCT02733588|Glucagon|glucagon|mesh-list
6246207|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6246208|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6246209|NCT02733588|Hormones|hormones|mesh-ancestor
6246210|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246211|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246212|NCT02733588|Incretins|incretins|mesh-ancestor
6246213|NCT02733757|Clonidine|clonidine|mesh-list
6246214|NCT02733757|Analgesics|analgesics|mesh-ancestor
6246215|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
6246216|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246217|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246218|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6246219|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
6246220|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
6246221|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6246222|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6246223|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6246224|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
6246225|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246226|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246227|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
6246228|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
6246229|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246230|NCT02734147|Protective Agents|protective agents|mesh-ancestor
6246231|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246232|NCT02734147|Vitamins|vitamins|mesh-ancestor
6246233|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
6246234|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
6246235|NCT02734238|Testosterone|testosterone|mesh-list
6246236|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
6246237|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
6246238|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6246239|NCT02734238|Androgens|androgens|mesh-ancestor
6246240|NCT02734238|Hormones|hormones|mesh-ancestor
6246241|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246242|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246243|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6246244|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246245|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
6246246|NCT02734355|Amlodipine|amlodipine|mesh-list
6246247|NCT02734355|Telmisartan|telmisartan|mesh-list
6246248|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
6246249|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6246250|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6246251|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6246252|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246253|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6246254|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246255|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
6246256|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
5992080|NCT00111761|Leucovorin|leucovorin|mesh-list
5992081|NCT00111761|Fluorouracil|fluorouracil|mesh-list
5992082|NCT00111761|Irinotecan|irinotecan|mesh-list
5992083|NCT00111761|Panitumumab|panitumumab|mesh-list
5992084|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
5992085|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992086|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992087|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992088|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992089|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
5992090|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992091|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5992092|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5992093|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992094|NCT00111761|Antidotes|antidotes|mesh-ancestor
5992095|NCT00111761|Protective Agents|protective agents|mesh-ancestor
5992096|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
5992097|NCT00111761|Vitamins|vitamins|mesh-ancestor
5992098|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
5992099|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992100|NCT00111813|Bortezomib|bortezomib|mesh-list
5992101|NCT00111813|Vorinostat|vorinostat|mesh-list
5992102|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992103|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
5992104|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992105|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992106|NCT00111839|Pemetrexed|pemetrexed|mesh-list
5992107|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992108|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992109|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992110|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
5992111|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5992112|NCT00111917|Infliximab|infliximab|mesh-list
5992113|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
5992114|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5992115|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992116|NCT00112047|Tenofovir|tenofovir|mesh-list
5992117|NCT00112047|Lamivudine|lamivudine|mesh-list
5992118|NCT00112047|Zidovudine|zidovudine|mesh-list
5992119|NCT00112047|Emtricitabine|emtricitabine|mesh-list
5992120|NCT00112047|Efavirenz|efavirenz|mesh-list
5992121|NCT00112047|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5992122|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
5992123|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
5992124|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992125|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5992126|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5992127|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992128|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992129|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5992130|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5992131|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
5992132|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
5992133|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5992134|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
5992135|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
5992136|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5992137|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
5992138|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
5992139|NCT00112151|Testosterone|testosterone|mesh-list
5992140|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
5992141|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
5992142|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
5992143|NCT00112151|Androgens|androgens|mesh-ancestor
5992144|NCT00112151|Hormones|hormones|mesh-ancestor
5992145|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5992146|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992147|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5992148|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992149|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
5992150|NCT00112294|Paclitaxel|paclitaxel|mesh-list
5992151|NCT00112294|Docetaxel|docetaxel|mesh-list
5992152|NCT00112294|Carboplatin|carboplatin|mesh-list
5992153|NCT00112294|Cetuximab|cetuximab|mesh-list
5992154|NCT00112294|Taxane|taxane|mesh-list
5992155|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5992156|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992157|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
5992158|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
5992159|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
5992160|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992161|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992162|NCT00112385|Etanercept|etanercept|mesh-list
5992163|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5992164|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5992165|NCT00112385|Analgesics|analgesics|mesh-ancestor
5992166|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
5992167|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5992168|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992169|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5992170|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992171|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5992172|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992173|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
5992174|NCT00112437|Vitamin D|vitamin d|mesh-list
5992175|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
5992176|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
5992177|NCT00112437|Calcium|calcium|mesh-list
5992178|NCT00112437|Vitamins|vitamins|mesh-ancestor
5992179|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
5992180|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992181|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5992182|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
5992183|NCT00112437|Antacids|antacids|mesh-ancestor
5992184|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992185|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5992186|NCT00112463|Romidepsin|romidepsin|mesh-list
5992187|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5992188|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992189|NCT00112489|Paclitaxel|paclitaxel|mesh-list
5992190|NCT00112489|Carboplatin|carboplatin|mesh-list
5992191|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5992192|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992193|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
5992194|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
5992195|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
5992196|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992197|NCT00112502|Thalidomide|thalidomide|mesh-list
5992198|NCT00112502|Celecoxib|celecoxib|mesh-list
5992199|NCT00112502|Temozolomide|temozolomide|mesh-list
5992200|NCT00112502|Isotretinoin|isotretinoin|mesh-list
5992201|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5992202|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
5992203|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992204|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992205|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5992206|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5992207|NCT00112502|Analgesics|analgesics|mesh-ancestor
5992208|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
5992209|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5992210|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992211|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5992212|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992213|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
5992214|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5992215|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992216|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992217|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
5992218|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
5992219|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5992220|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992221|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5992222|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5992223|NCT00112502|Growth Substances|growth substances|mesh-ancestor
5992224|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
5992225|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
5992226|NCT00112580|Ipilimumab|ipilimumab|mesh-list
5992227|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992228|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992229|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5992230|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992231|NCT00112593|Cyclosporine|cyclosporine|mesh-list
5992232|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
5992233|NCT00112593|Fludarabine|fludarabine|mesh-list
5992234|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
5992235|NCT00112593|Cyclosporins|cyclosporins|mesh-list
5992236|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992237|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992238|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
5992239|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992240|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992241|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
5992242|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992243|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992244|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
5992245|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992246|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
5992247|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992248|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5992249|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5992250|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5992251|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
5992252|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5992253|NCT00112671|Sorafenib|sorafenib|mesh-list
5992254|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992255|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992256|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992257|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992258|NCT00112723|Alvocidib|alvocidib|mesh-list
5992259|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992260|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
5992261|NCT00112723|Growth Substances|growth substances|mesh-ancestor
5992262|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992263|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992264|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992265|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992266|NCT00112736|Sirolimus|sirolimus|mesh-list
5992267|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
5992268|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992269|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992270|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992271|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992272|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5992273|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992274|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5992275|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
5992276|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992277|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
5992278|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992279|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
5992280|NCT00112827|Melphalan|melphalan|mesh-list
5992281|NCT00112827|Lenalidomide|lenalidomide|mesh-list
5992282|NCT00112827|Lenograstim|lenograstim|mesh-list
5992283|NCT00112827|Sargramostim|sargramostim|mesh-list
5992284|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992285|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
5992286|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992287|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992288|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5992289|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
5992290|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992291|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992292|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5992293|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5992294|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5992295|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5992296|NCT00112827|Growth Substances|growth substances|mesh-ancestor
5992297|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
5992298|NCT00112905|Sorafenib|sorafenib|mesh-list
5992299|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992300|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992301|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992302|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992303|NCT00112918|Leucovorin|leucovorin|mesh-list
5992304|NCT00112918|Bevacizumab|bevacizumab|mesh-list
5992305|NCT00112918|Fluorouracil|fluorouracil|mesh-list
5992306|NCT00112918|Capecitabine|capecitabine|mesh-list
5992307|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
5992308|NCT00112918|Calcium|calcium|mesh-list
5992309|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
5992310|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992311|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992312|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5992313|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5992314|NCT00112918|Growth Substances|growth substances|mesh-ancestor
5992315|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992316|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
5992317|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
5992318|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
5992319|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992320|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992321|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992322|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
5992323|NCT00112918|Antidotes|antidotes|mesh-ancestor
5992324|NCT00112918|Protective Agents|protective agents|mesh-ancestor
5992325|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
5992326|NCT00112918|Vitamins|vitamins|mesh-ancestor
5992327|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
5992328|NCT00112957|Vaccines|vaccines|mesh-list
5992329|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
5992330|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992331|NCT00113087|Enalapril|enalapril|mesh-list
5992332|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
5992333|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
5992334|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992335|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992336|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
5992337|NCT00113217|Bevacizumab|bevacizumab|mesh-list
5992338|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992339|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992340|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5992341|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5992342|NCT00113217|Growth Substances|growth substances|mesh-ancestor
5992343|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992344|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
5992345|NCT00113230|Bevacizumab|bevacizumab|mesh-list
5992346|NCT00113230|Capecitabine|capecitabine|mesh-list
5992347|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992348|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992349|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5992350|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5992351|NCT00113230|Growth Substances|growth substances|mesh-ancestor
5992352|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992353|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
5992354|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992355|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
5992356|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992357|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
5992358|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
5992359|NCT00113269|Tacrolimus|tacrolimus|mesh-list
5992360|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
5992361|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
5992362|NCT00113269|Basiliximab|basiliximab|mesh-list
5992363|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992364|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
5992365|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992366|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5992367|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992368|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992369|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5992370|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992371|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
5992372|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
5992373|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5992374|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992375|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992376|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
5992377|NCT00113295|Paroxetine|paroxetine|mesh-list
5992378|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
5992379|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5992380|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
5992381|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
5992382|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
5992383|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992384|NCT00113295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5992385|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5992386|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5992387|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992388|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5992389|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
5992390|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5992391|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5992392|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5992393|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992394|NCT00113321|Decitabine|decitabine|mesh-list
5992395|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992396|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
5992397|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992398|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992399|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992400|NCT00113360|Everolimus|everolimus|mesh-list
5992401|NCT00113360|Octreotide|octreotide|mesh-list
5992402|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992403|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992404|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
5992405|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992406|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5992407|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5992408|NCT00113373|Lapatinib|lapatinib|mesh-list
5992409|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992410|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992411|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992412|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992413|NCT00113490|Palivizumab|palivizumab|mesh-list
5992414|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
5992415|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992416|NCT00113516|Paclitaxel|paclitaxel|mesh-list
5992417|NCT00113516|Carboplatin|carboplatin|mesh-list
5992418|NCT00113516|Sunitinib|sunitinib|mesh-list
5992419|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5992420|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992421|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
5992422|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
5992423|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
5992424|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992425|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5992426|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5992427|NCT00113516|Growth Substances|growth substances|mesh-ancestor
5992428|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992429|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
5992430|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992431|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992432|NCT00113529|Sunitinib|sunitinib|mesh-list
5992433|NCT00113529|Gefitinib|gefitinib|mesh-list
5992434|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992435|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5992436|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5992437|NCT00113529|Growth Substances|growth substances|mesh-ancestor
5992438|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992439|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
5992440|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992441|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992442|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992443|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
5992444|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
5992445|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
5992446|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992447|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
5992448|NCT00113568|Coagulants|coagulants|mesh-ancestor
5992449|NCT00113607|Dexamethasone|dexamethasone|mesh-list
5992450|NCT00113607|Trabectedin|trabectedin|mesh-list
5992451|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5992452|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
5992453|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
5992454|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5992455|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992456|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5992457|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
5992458|NCT00113607|Hormones|hormones|mesh-ancestor
5992459|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5992460|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5992461|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992462|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5992463|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
5992464|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992465|NCT00113763|Panitumumab|panitumumab|mesh-list
5992466|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992467|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992468|NCT00113841|Curcumin|curcumin|mesh-list
5992469|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5992470|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5992471|NCT00113841|Analgesics|analgesics|mesh-ancestor
5992472|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
5992473|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5992474|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992475|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5992476|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992477|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992478|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992479|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992480|NCT00114114|Goserelin|goserelin|mesh-list
5992481|NCT00114114|Testosterone|testosterone|mesh-list
5992482|NCT00114114|Androgens|androgens|mesh-ancestor
5992483|NCT00114114|Hormones|hormones|mesh-ancestor
5992484|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5992485|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992486|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
5992487|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992488|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
5992489|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
5992490|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5992491|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5992492|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992493|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5992494|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992495|NCT00114127|Analgesics|analgesics|mesh-ancestor
5992496|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
5992497|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5992498|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
5992499|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5992500|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
5992501|NCT00114140|Temozolomide|temozolomide|mesh-list
5992502|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5992503|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
5992504|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992505|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992506|NCT00114166|Topotecan|topotecan|mesh-list
5992507|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5992508|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5992509|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992510|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992511|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992512|NCT00114218|Gemcitabine|gemcitabine|mesh-list
5992513|NCT00114218|Docetaxel|docetaxel|mesh-list
5992514|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992515|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
5992516|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992517|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992518|NCT00114218|Antiviral Agents|antiviral agents|mesh-ancestor
5992519|NCT00114218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992520|NCT00114218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992521|NCT00114218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992522|NCT00114218|Immunologic Factors|immunologic factors|mesh-ancestor
5992523|NCT00114218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992524|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
5992525|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
5992526|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
5992527|NCT00114231|Capecitabine|capecitabine|mesh-list
5992528|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
5992529|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992530|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
5992531|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992532|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992533|NCT00114244|Gemcitabine|gemcitabine|mesh-list
5992534|NCT00114244|Sorafenib|sorafenib|mesh-list
5992535|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992536|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
5992537|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992538|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992539|NCT00114244|Antiviral Agents|antiviral agents|mesh-ancestor
5992540|NCT00114244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992541|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992542|NCT00114244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992543|NCT00114244|Immunologic Factors|immunologic factors|mesh-ancestor
5992544|NCT00114244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992545|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992546|NCT00114504|Simvastatin|simvastatin|mesh-list
5992547|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
5992548|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
5992549|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
5992550|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992551|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5992552|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
5992553|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992554|NCT00114517|Estradiol|estradiol|mesh-list
5992555|NCT00114517|Estrogens|estrogens|mesh-list
5992556|NCT00114517|Hormones|hormones|mesh-ancestor
5992557|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5992558|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992559|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
5992560|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992561|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
5992562|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992563|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992564|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
5992565|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
5992566|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992567|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992568|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
5992569|NCT00114738|Rituximab|rituximab|mesh-list
5992570|NCT00114738|Bortezomib|bortezomib|mesh-list
5992571|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992572|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992573|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
5992574|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992575|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992576|NCT00114777|Cyclosporine|cyclosporine|mesh-list
5992577|NCT00114777|Abatacept|abatacept|mesh-list
5992578|NCT00114777|Cyclosporins|cyclosporins|mesh-list
5992579|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992580|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992581|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992582|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
5992583|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992584|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
5992585|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992586|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
5992587|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992588|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
5992589|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
5992590|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992591|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
5992592|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
5992593|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992594|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992595|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992596|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992597|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5992598|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
5992599|NCT00114972|Paclitaxel|paclitaxel|mesh-list
5992600|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
5992601|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
5992602|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992603|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
5992604|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
5992605|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
5992606|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992607|NCT00115037|Naltrexone|naltrexone|mesh-list
5992608|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
5992609|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
5992610|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992611|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
5992612|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5992613|NCT00115063|Orlistat|orlistat|mesh-list
5992614|NCT00115063|Sibutramine|sibutramine|mesh-list
5992615|NCT00115063|Diethylpropion|diethylpropion|mesh-list
5992616|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992617|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992618|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
5992619|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
5992620|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
5992621|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5992622|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
5992623|NCT00115297|Montelukast|montelukast|mesh-list
5992624|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
5992625|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
5992626|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
5992627|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
5992628|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
5992629|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992630|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
5992631|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
5992632|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992633|NCT00115336|Ibuprofen|ibuprofen|mesh-list
5992634|NCT00115336|Ketorolac|ketorolac|mesh-list
5992635|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5992636|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5992637|NCT00115336|Analgesics|analgesics|mesh-ancestor
5992638|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
5992639|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5992640|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992641|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5992642|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992643|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
5992644|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992645|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992646|NCT00115349|Deferiprone|deferiprone|mesh-list
5992647|NCT00115349|Deferoxamine|deferoxamine|mesh-list
5992648|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5992649|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
5992650|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
5992651|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992652|NCT00115349|Siderophores|siderophores|mesh-ancestor
5992653|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
5992654|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992655|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992656|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992657|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992658|NCT00115765|Bevacizumab|bevacizumab|mesh-list
5992659|NCT00115765|Panitumumab|panitumumab|mesh-list
5992660|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
5992661|NCT00115765|Irinotecan|irinotecan|mesh-list
5992662|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992663|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992664|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
5992665|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
5992666|NCT00115765|Growth Substances|growth substances|mesh-ancestor
5992667|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992668|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
5992669|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
5992670|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
5992671|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992672|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992673|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
5992674|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
5992675|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
5992676|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
5992677|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
5992678|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992679|NCT00115804|Fluoxetine|fluoxetine|mesh-list
5992680|NCT00115804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5992681|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5992682|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5992683|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992684|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5992685|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
5992686|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992687|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
5992688|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
5992689|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5992690|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
5992691|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
5992692|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992693|NCT00116207|Niacinamide|niacinamide|mesh-list
5992694|NCT00116207|Allopurinol|allopurinol|mesh-list
5992695|NCT00116207|Antioxidants|antioxidants|mesh-list
5992696|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
5992697|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992698|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992699|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
5992700|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992701|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
5992702|NCT00116207|Protective Agents|protective agents|mesh-ancestor
5992703|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992704|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
5992705|NCT00116207|Vitamins|vitamins|mesh-ancestor
5992706|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
5992707|NCT00116272|Etanercept|etanercept|mesh-list
5992708|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
5992709|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
5992710|NCT00116272|Analgesics|analgesics|mesh-ancestor
5992711|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
5992712|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
5992713|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992714|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
5992715|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992716|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
5992717|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992718|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
5992719|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
5992720|NCT00116649|Imiquimod|imiquimod|mesh-list
5992721|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
5992722|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
5992723|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992724|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992725|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
5992726|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5992727|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5992728|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5992729|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5992730|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992731|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992732|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
5992733|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992734|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5992735|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5992736|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
5992737|NCT00116831|Glipizide|glipizide|mesh-list
5992738|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5992739|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992740|NCT00116844|Valacyclovir|valacyclovir|mesh-list
5992741|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
5992742|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992743|NCT00116857|Sertraline|sertraline|mesh-list
5992744|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
5992745|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
5992746|NCT00116857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
5992747|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
5992748|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
5992749|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992750|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5992751|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
5992752|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992753|NCT00117156|Rituximab|rituximab|mesh-list
5992754|NCT00117156|Fludarabine|fludarabine|mesh-list
5992755|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
5992756|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992757|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
5992758|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992759|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
5992760|NCT00117507|Deferasirox|deferasirox|mesh-list
5992761|NCT00117507|Chelating Agents|chelating agents|mesh-list
5992762|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
5992763|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
5992764|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992765|NCT00117572|Docetaxel|docetaxel|mesh-list
5992766|NCT00117572|Fluorouracil|fluorouracil|mesh-list
5992767|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
5992768|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992769|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
5992770|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
5992771|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
5992772|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992773|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
5992774|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
5992775|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992776|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
5992777|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992778|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
5992779|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992780|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5992781|NCT00117598|Sirolimus|sirolimus|mesh-list
5992782|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
5992783|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992784|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
5992785|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992786|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
5992787|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
5992788|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
5992789|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992790|NCT00117637|Interferons|interferons|mesh-list
5992791|NCT00117637|Sorafenib|sorafenib|mesh-list
5992792|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
5992793|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
5992794|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992795|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
5992796|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992797|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246257|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6246258|NCT02734862|Fluconazole|fluconazole|mesh-list
6246259|NCT02734862|Caspofungin|caspofungin|mesh-list
6246260|NCT02734862|Rezafungin|rezafungin|mesh-list
6246261|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
6246262|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246263|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6246264|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6246265|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246266|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246267|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6246268|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
6246269|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246270|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246271|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6246272|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6246273|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
6246274|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6246275|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
6246276|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246277|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246278|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6246279|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
6246280|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6246281|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
6246282|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246283|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246284|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6246285|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
6246286|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
6246287|NCT02734953|Protective Agents|protective agents|mesh-ancestor
6246288|NCT02735044|Insulin|insulin|mesh-list
6246289|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6246290|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
6246291|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
5992798|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
5992799|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
5992800|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
5992801|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
5992802|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992803|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992804|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
5992805|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
5992806|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
5992807|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
5992808|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
5992809|NCT00117715|Caffeine|caffeine|mesh-list
5992810|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
5992811|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
5992812|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
5992813|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
5992814|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
5992815|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
5992816|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
5992817|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
5992818|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
5992819|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
5992820|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
5992821|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
5992822|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6246292|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246293|NCT02735187|Vitamin D|vitamin d|mesh-list
6246294|NCT02735187|Vitamins|vitamins|mesh-ancestor
6246295|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
6246296|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246297|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6246298|NCT02735200|Vitamin D|vitamin d|mesh-list
6246299|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
6246300|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
6246301|NCT02735200|Vitamins|vitamins|mesh-list
6246302|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
6246303|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246304|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6246305|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6246306|NCT02735421|Adapalene|adapalene|mesh-list
6246307|NCT02735421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6246308|NCT02735421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6246309|NCT02735421|Analgesics|analgesics|mesh-ancestor
6246310|NCT02735421|Sensory System Agents|sensory system agents|mesh-ancestor
6246311|NCT02735421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246312|NCT02735421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246313|NCT02735421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246314|NCT02735421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6246315|NCT02735421|Dermatologic Agents|dermatologic agents|mesh-ancestor
6246316|NCT02735577|Disulfiram|disulfiram|mesh-list
6246317|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6246318|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6246319|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246320|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246321|NCT02736175|Dexamethasone|dexamethasone|mesh-list
6246322|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246323|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
6246324|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
6246325|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246326|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246327|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6246328|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
6246329|NCT02736175|Hormones|hormones|mesh-ancestor
6246330|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246331|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6246332|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246333|NCT02736409|Budesonide|budesonide|mesh-list
6246334|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246335|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6246336|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
6246337|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246338|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246339|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6246340|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
6246341|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
6246342|NCT02736409|Hormones|hormones|mesh-ancestor
6246343|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246344|NCT02736474|Naltrexone|naltrexone|mesh-list
6246345|NCT02736474|Bupropion|bupropion|mesh-list
6246346|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6246347|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6246348|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246349|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
6246350|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246351|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6246352|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
6246353|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6246354|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6246355|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6246356|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6246357|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246358|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
6246359|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246360|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6246361|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6246362|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246363|NCT02736578|Cetuximab|cetuximab|mesh-list
6246364|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246365|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246366|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6246367|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
6246368|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246369|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
6246370|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6246371|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6246372|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6246373|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6246374|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246375|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
6246376|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246377|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246378|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6246379|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246380|NCT02737072|Durvalumab|durvalumab|mesh-list
6246381|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246382|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246383|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
6246384|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246385|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6246386|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246387|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246388|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
6246389|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246390|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246391|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6246392|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
6246393|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6246394|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
6246395|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246396|NCT02737358|Expectorants|expectorants|mesh-ancestor
6246397|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
6246398|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6246399|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
6246400|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246401|NCT02737358|Protective Agents|protective agents|mesh-ancestor
6246402|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246403|NCT02737358|Antidotes|antidotes|mesh-ancestor
6246404|NCT02737501|Crizotinib|crizotinib|mesh-list
6246405|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246406|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6246407|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246408|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246409|NCT02737826|Buprenorphine|buprenorphine|mesh-list
6246410|NCT02737826|Gabapentin|gabapentin|mesh-list
6246411|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6246412|NCT02737826|Narcotics|narcotics|mesh-ancestor
6246413|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246414|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246415|NCT02737826|Analgesics|analgesics|mesh-ancestor
6246416|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
6246417|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246418|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6246419|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
6246420|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6246421|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6246422|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6246423|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6246424|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6246425|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246426|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246427|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
6246428|NCT02737891|Metoprolol|metoprolol|mesh-list
6246429|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6246430|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6246431|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
6246432|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
6246433|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246434|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246435|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6246436|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6246437|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6246438|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
6246439|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246440|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246441|NCT02737930|Fluoxetine|fluoxetine|mesh-list
6246442|NCT02737930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6246443|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6246444|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6246445|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246446|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246447|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
6246448|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246449|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6246450|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
6246451|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6246452|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6246453|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6246454|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246455|NCT02738008|Tenofovir|tenofovir|mesh-list
6246456|NCT02738008|Entecavir|entecavir|mesh-list
6246457|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
6246458|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6246459|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
6246460|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246461|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6246462|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6246463|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246464|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246465|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6246466|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6246467|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
6246468|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246469|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246470|NCT02738151|Insulin|insulin|mesh-list
6246471|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6246472|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
6246473|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6246474|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246475|NCT02738203|Lidocaine|lidocaine|mesh-list
6246476|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
6246477|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
6246478|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246479|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246480|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
6246481|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246482|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6246483|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6246484|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6246485|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6246486|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246487|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
6246488|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
6246489|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246490|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6246491|NCT02738580|Hormones|hormones|mesh-ancestor
6246492|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246493|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246494|NCT02738879|Metformin|metformin|mesh-list
6246495|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
6246496|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6246497|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6246498|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246499|NCT02738879|Incretins|incretins|mesh-ancestor
6246500|NCT02738879|Hormones|hormones|mesh-ancestor
6246501|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246502|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6246503|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
6246504|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246505|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246506|NCT02739360|Idelalisib|idelalisib|mesh-list
6246507|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246508|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246509|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246510|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
6246511|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
6246512|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6246513|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246514|NCT02739698|Paclitaxel|paclitaxel|mesh-list
6246515|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6246516|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246517|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
6246518|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
6246519|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
6246520|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246521|NCT02739828|Adalimumab|adalimumab|mesh-list
6246522|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246523|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6246524|NCT02739984|Evolocumab|evolocumab|mesh-list
6246525|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6246526|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6246527|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6246528|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
6246529|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246530|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6246531|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
6246532|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246533|NCT02739997|Metronidazole|metronidazole|mesh-list
6246534|NCT02739997|Tazobactam|tazobactam|mesh-list
6246535|NCT02739997|Ceftolozane|ceftolozane|mesh-list
6246536|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246537|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6246538|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6246539|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6246540|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6246541|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246542|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246543|NCT02740114|Oxycodone|oxycodone|mesh-list
6246544|NCT02740114|Bupivacaine|bupivacaine|mesh-list
6246545|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
6246546|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
6246547|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246548|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246549|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
6246550|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246551|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6246552|NCT02740114|Narcotics|narcotics|mesh-ancestor
6246553|NCT02740114|Analgesics|analgesics|mesh-ancestor
6246554|NCT02740543|Fluticasone|fluticasone|mesh-list
6246555|NCT02740543|Xhance|xhance|mesh-list
6246556|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246557|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6246558|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
6246559|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246560|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246561|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6246562|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
6246563|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
6246564|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6246565|NCT02740582|Tolcapone|tolcapone|mesh-list
6246566|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6246567|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6246568|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6246569|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246570|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246571|NCT02740660|Caffeine|caffeine|mesh-list
6246572|NCT02740660|Albuterol|albuterol|mesh-list
6246573|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6246574|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246575|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6246576|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246577|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246578|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6246579|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6246580|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
6246581|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246582|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6246583|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
6246584|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246585|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6246586|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
6246587|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
6246588|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6246589|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6246590|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6246591|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6246592|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
6246593|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
6246594|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246595|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246596|NCT02741076|Oxymorphone|oxymorphone|mesh-list
6246597|NCT02741076|Morphine|morphine|mesh-list
6246598|NCT02741076|Oxycodone|oxycodone|mesh-list
6246599|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
6246600|NCT02741076|Narcotics|narcotics|mesh-ancestor
6246601|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246602|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246603|NCT02741076|Analgesics|analgesics|mesh-ancestor
6246604|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
6246605|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246606|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6246607|NCT02741310|Sumatriptan|sumatriptan|mesh-list
6246608|NCT02741310|Erenumab|erenumab|mesh-list
6246609|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6246610|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6246611|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6246612|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
6246613|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246614|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246615|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246616|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6246617|NCT02741310|Analgesics|analgesics|mesh-ancestor
6246618|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
6246619|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246620|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6246621|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
6246622|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246623|NCT02741687|Insulin|insulin|mesh-list
6246624|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6246625|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
6246626|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6246627|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
6246628|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
6246629|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
6246630|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6246631|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246632|NCT02741687|Incretins|incretins|mesh-ancestor
6246633|NCT02741687|Hormones|hormones|mesh-ancestor
6246634|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246635|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6246636|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
6246637|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246638|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246639|NCT02741713|Lidocaine|lidocaine|mesh-list
6246640|NCT02741713|Clonidine|clonidine|mesh-list
6246641|NCT02741713|Epinephrine|epinephrine|mesh-list
6246642|NCT02741713|Racepinephrine|racepinephrine|mesh-list
6246643|NCT02741713|Bupivacaine|bupivacaine|mesh-list
6246644|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6246645|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
6246646|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
6246647|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
6246648|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246649|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246650|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
6246651|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246652|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6246653|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6246654|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6246655|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6246656|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246657|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6246658|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6246659|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
6246660|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246661|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6246662|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6246663|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
6246664|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6246665|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
6246666|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
6246667|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
6246668|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6246669|NCT02741713|Analgesics|analgesics|mesh-ancestor
6246670|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6246671|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
6246672|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6246673|NCT02742519|Ivacaftor|ivacaftor|mesh-list
6246674|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6246675|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6246676|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246677|NCT02742532|Oxytocin|oxytocin|mesh-list
6246678|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
6246679|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6246680|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246681|NCT02742649|Timolol|timolol|mesh-list
6246682|NCT02742649|Bimatoprost|bimatoprost|mesh-list
6246683|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6246684|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6246685|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
6246686|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246687|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246688|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246689|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6246690|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6246691|NCT02742987|Clopidogrel|clopidogrel|mesh-list
6246692|NCT02742987|Ticagrelor|ticagrelor|mesh-list
6246693|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6246694|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6246695|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6246696|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6246697|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
6246698|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246699|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246700|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246701|NCT02743078|Bevacizumab|bevacizumab|mesh-list
6246702|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246703|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246704|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6246705|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6246706|NCT02743078|Growth Substances|growth substances|mesh-ancestor
6246707|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246708|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
6246709|NCT02743221|Trifluridine|trifluridine|mesh-list
6246710|NCT02743221|Bevacizumab|bevacizumab|mesh-list
6246711|NCT02743221|Capecitabine|capecitabine|mesh-list
6246712|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246713|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246714|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6246715|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6246716|NCT02743221|Growth Substances|growth substances|mesh-ancestor
6246717|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246718|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
6246719|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6246720|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
6246721|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246722|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
6246723|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246724|NCT02743377|Rolipram|rolipram|mesh-list
6246725|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
6246726|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6246727|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6246728|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6246729|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246730|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246731|NCT02743494|Nivolumab|nivolumab|mesh-list
6246732|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246733|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246734|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6246735|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246736|NCT02743780|MGV354|mgv354|mesh-list
6246737|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
6246738|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246739|NCT02743949|Esomeprazole|esomeprazole|mesh-list
6246740|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6246741|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6246742|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6246743|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246744|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246745|NCT02744391|Levodopa|levodopa|mesh-list
6246746|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6246747|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6246748|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
6246749|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246750|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246751|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246752|NCT02744755|Adalimumab|adalimumab|mesh-list
6246753|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246754|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6246755|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6246756|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246757|NCT02744898|Paclitaxel|paclitaxel|mesh-list
6246758|NCT02744898|Carboplatin|carboplatin|mesh-list
6246759|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6246760|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6246761|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246762|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
6246763|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
6246764|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
6246765|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246766|NCT02745080|Adalimumab|adalimumab|mesh-list
6246767|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246768|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6246769|NCT02745353|Naloxegol|naloxegol|mesh-list
6246770|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6246771|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246772|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
6246773|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246774|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
6246775|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6246776|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6246777|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
6246778|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246779|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246780|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246781|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
6246782|NCT02745535|Velpatasvir|velpatasvir|mesh-list
6246783|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
6246784|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6246785|NCT02746575|Metoprolol|metoprolol|mesh-list
6246786|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6246787|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6246788|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
6246789|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
6246790|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246791|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246792|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6246793|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6246794|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6246795|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
6246796|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246797|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246798|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6246799|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246800|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
6246801|NCT02746991|Hormones|hormones|mesh-ancestor
6246802|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246803|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246804|NCT02747004|Tamoxifen|tamoxifen|mesh-list
6246805|NCT02747004|Loperamide|loperamide|mesh-list
6246806|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
6246807|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6246808|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
6246809|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246810|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246811|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6246812|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246813|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6246814|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6246815|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6246816|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6246817|NCT02747043|Rituximab|rituximab|mesh-list
6246818|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246819|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246820|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
6246821|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246822|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6246823|NCT02747186|Lidocaine|lidocaine|mesh-list
6246824|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
6246825|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
6246826|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246827|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246828|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
6246829|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246830|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6246831|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6246832|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6246833|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6246834|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246835|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
6246836|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6246837|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6246838|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246839|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
6246840|NCT02747615|Coagulants|coagulants|mesh-ancestor
6246841|NCT02747628|Melatonin|melatonin|mesh-list
6246842|NCT02747628|Nicotine|nicotine|mesh-list
6246843|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6246844|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
6246845|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246846|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246847|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6246848|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6246849|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
6246850|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246851|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246852|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
6246853|NCT02747628|Protective Agents|protective agents|mesh-ancestor
6246854|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246855|NCT02747875|Fentanyl|fentanyl|mesh-list
6246856|NCT02747875|Methadone|methadone|mesh-list
6246857|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6246858|NCT02747875|Narcotics|narcotics|mesh-ancestor
6246859|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246860|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246861|NCT02747875|Analgesics|analgesics|mesh-ancestor
6246862|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
6246863|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246864|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6246865|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6246866|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
6246867|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
6246868|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
6246869|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
6246870|NCT02748070|Fluticasone|fluticasone|mesh-list
6246871|NCT02748070|Prednisone|prednisone|mesh-list
6246872|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246873|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
6246874|NCT02748070|Hormones|hormones|mesh-ancestor
6246875|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246876|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246877|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6246878|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246879|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6246880|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
6246881|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246882|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6246883|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
6246884|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
6246885|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6246886|NCT02748213|Docetaxel|docetaxel|mesh-list
6246887|NCT02748213|Capecitabine|capecitabine|mesh-list
6246888|NCT02748213|Trastuzumab|trastuzumab|mesh-list
6246889|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246890|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
6246891|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
6246892|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
6246893|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246894|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6246895|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
6246896|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246897|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
6246898|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246899|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
6246900|NCT02748512|Hormones|hormones|mesh-ancestor
6246901|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246902|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246903|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
6246904|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
6246905|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6246906|NCT02748785|Methotrexate|methotrexate|mesh-list
6246907|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6246908|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
6246909|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6246910|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246911|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6246912|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
6246913|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246914|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246915|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
6246916|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246917|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6246918|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6246919|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
6246920|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6246921|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6246922|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6246923|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
6246924|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246925|NCT02748889|Carboplatin|carboplatin|mesh-list
6246926|NCT02748889|Etoposide|etoposide|mesh-list
6246927|NCT02748889|Atezolizumab|atezolizumab|mesh-list
6246928|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246929|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6246930|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6246931|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6246932|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246933|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246934|NCT02749370|Etanercept|etanercept|mesh-list
6246935|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6246936|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6246937|NCT02749370|Analgesics|analgesics|mesh-ancestor
6246938|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
6246939|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6246940|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246941|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246942|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6246943|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6246944|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6246945|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
6246946|NCT02749721|Vortioxetine|vortioxetine|mesh-list
6246947|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
6246948|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6246949|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6246950|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6246951|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246952|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246953|NCT02749721|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6246954|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6246955|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6246956|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246957|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246958|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
6246959|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6246960|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6246961|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6246962|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6246963|NCT02749799|Betamethasone|betamethasone|mesh-list
6246964|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
6246965|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6246966|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
6246967|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6246968|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6246969|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
6246970|NCT02749799|Hormones|hormones|mesh-ancestor
6246971|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6246972|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246973|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6246974|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
6246975|NCT02750306|Suvorexant|suvorexant|mesh-list
6246976|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6246977|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6246978|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6246979|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246980|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6246981|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6246982|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246983|NCT02750332|Nitisinone|nitisinone|mesh-list
6246984|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246985|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246986|NCT02750345|Nitisinone|nitisinone|mesh-list
6246987|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6246988|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6246989|NCT02750410|Dulaglutide|dulaglutide|mesh-list
6246990|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6246991|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6246992|NCT02750514|Nivolumab|nivolumab|mesh-list
6246993|NCT02750514|Ipilimumab|ipilimumab|mesh-list
6246994|NCT02750514|Dasatinib|dasatinib|mesh-list
6246995|NCT02750514|Linrodostat|linrodostat|mesh-list
6246996|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6246997|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6246998|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6246999|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247000|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6247001|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247002|NCT02750709|Nitisinone|nitisinone|mesh-list
6247003|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247004|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247005|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
6247006|NCT02750761|Tedizolid|tedizolid|mesh-list
6247007|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
6247008|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6247009|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247010|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6247011|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247012|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247013|NCT02750800|Adalimumab|adalimumab|mesh-list
6247014|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247015|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6247016|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
6247017|NCT02750930|Incretins|incretins|mesh-ancestor
6247018|NCT02750930|Hormones|hormones|mesh-ancestor
6247019|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247020|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247021|NCT02750943|Fluorides|fluorides|mesh-list
6247022|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
6247023|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
6247024|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
6247025|NCT02750943|Protective Agents|protective agents|mesh-ancestor
6247026|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247027|NCT02751320|Citric Acid|citric acid|mesh-list
6247028|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
6247029|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
6247030|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6247031|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
6247032|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
6247033|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247034|NCT02751359|Cannabidiol|cannabidiol|mesh-list
6247035|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
6247036|NCT02751385|Nintedanib|nintedanib|mesh-list
6247037|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
6247038|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
6247039|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247040|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6247041|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247042|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247043|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6247044|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
6247045|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6247046|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247047|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
6247048|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6247049|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6247050|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6247051|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6247052|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
6247053|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
6247054|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
6247055|NCT02751450|Fluorides|fluorides|mesh-list
6247056|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
6247057|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
6247058|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
6247059|NCT02751450|Protective Agents|protective agents|mesh-ancestor
6247060|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247061|NCT02751931|Mirabegron|mirabegron|mesh-list
6247062|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6247063|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6247064|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6247065|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
6247066|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247067|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247068|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247069|NCT02751931|Urological Agents|urological agents|mesh-ancestor
6247070|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
6247071|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6247072|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247073|NCT02752256|Plasminogen|plasminogen|mesh-list
6247074|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6247075|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6247076|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6247077|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247078|NCT02752633|Allopurinol|allopurinol|mesh-list
6247079|NCT02752633|Febuxostat|febuxostat|mesh-list
6247080|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
6247081|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247082|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247083|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
6247084|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6247085|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6247086|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
6247087|NCT02752633|Protective Agents|protective agents|mesh-ancestor
6247088|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247089|NCT02752906|Vaccines|vaccines|mesh-list
6247090|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
6247091|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247092|NCT02752958|Fluorides|fluorides|mesh-list
6247093|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
6247094|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
6247095|NCT02752958|Protective Agents|protective agents|mesh-ancestor
6247096|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247097|NCT02753075|Fluorides|fluorides|mesh-list
6247098|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
6247099|NCT02753075|Protective Agents|protective agents|mesh-ancestor
6247100|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247101|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
6247102|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6247103|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6247104|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247105|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
6247106|NCT02753816|Coagulants|coagulants|mesh-ancestor
6247107|NCT02753881|Doxorubicin|doxorubicin|mesh-list
6247108|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6247109|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6247110|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247111|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6247112|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6247113|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247114|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247115|NCT02753946|Tazobactam|tazobactam|mesh-list
6247116|NCT02753946|Piperacillin|piperacillin|mesh-list
6247117|NCT02753946|Fosfomycin|fosfomycin|mesh-list
6247118|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6247119|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6247120|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247121|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6247122|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247123|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247124|NCT02754518|Valsartan|valsartan|mesh-list
6247125|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6247126|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6247127|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6247128|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6247129|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247130|NCT02754570|Pilocarpine|pilocarpine|mesh-list
6247131|NCT02754570|Miotics|miotics|mesh-ancestor
6247132|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
6247133|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247134|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247135|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6247136|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6247137|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
6247138|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247139|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247140|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
6247141|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6247142|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
6247143|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
6247144|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247145|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247146|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6247147|NCT02755090|Analgesics|analgesics|mesh-ancestor
6247148|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
6247149|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247150|NCT02755116|Olanzapine|olanzapine|mesh-list
6247151|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
6247152|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
6247153|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247154|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247155|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6247156|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6247157|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6247158|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247159|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6247160|NCT02755116|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6247161|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6247162|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6247163|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247164|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247165|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
6247166|NCT02755818|Heparin|heparin|mesh-list
6247167|NCT02755818|Calcium heparin|calcium heparin|mesh-list
6247168|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
6247169|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6247170|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6247171|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247172|NCT02756013|Paclitaxel|paclitaxel|mesh-list
6247173|NCT02756013|Carboplatin|carboplatin|mesh-list
6247174|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6247175|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247176|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
6247177|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
6247178|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
6247179|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247180|NCT02756364|Fulvestrant|fulvestrant|mesh-list
6247181|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6247182|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247183|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6247184|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6247185|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
6247186|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247187|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247188|NCT02756572|Cytarabine|cytarabine|mesh-list
6247189|NCT02756572|Cyclosporine|cyclosporine|mesh-list
6247190|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
6247191|NCT02756572|Sirolimus|sirolimus|mesh-list
6247192|NCT02756572|Fludarabine|fludarabine|mesh-list
6247193|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
6247194|NCT02756572|Melphalan|melphalan|mesh-list
6247195|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
6247196|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
6247197|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
6247198|NCT02756572|Cladribine|cladribine|mesh-list
6247199|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
6247200|NCT02756572|Cyclosporins|cyclosporins|mesh-list
6247201|NCT02756572|Lenograstim|lenograstim|mesh-list
6247202|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247203|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6247204|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
6247205|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247206|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6247207|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
6247208|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247209|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6247210|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
6247211|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247212|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247213|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
6247214|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
6247215|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6247216|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6247217|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6247218|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6247219|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
6247220|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6247221|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6247222|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
6247223|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6247224|NCT02756572|Analgesics|analgesics|mesh-ancestor
6247225|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
6247226|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247227|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6247228|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6247229|NCT02756611|Venetoclax|venetoclax|mesh-list
6247230|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247231|NCT02756624|Cetirizine|cetirizine|mesh-list
6247232|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6247233|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
6247234|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6247235|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
6247236|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
6247237|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247238|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247239|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247240|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6247241|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6247242|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6247243|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247244|NCT02756832|Alogliptin|alogliptin|mesh-list
6247245|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6247246|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247247|NCT02756832|Incretins|incretins|mesh-ancestor
6247248|NCT02756832|Hormones|hormones|mesh-ancestor
6247249|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247250|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6247251|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
6247252|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247253|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247254|NCT02757105|Ondansetron|ondansetron|mesh-list
6247255|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
6247256|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
6247257|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247258|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247259|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6247260|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
6247261|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
6247262|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6247263|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
6247264|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247265|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247266|NCT02757105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6247267|NCT02757105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6247268|NCT02757105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247269|NCT02757105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6247270|NCT02757105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6247271|NCT02757352|Ixekizumab|ixekizumab|mesh-list
6247272|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
6247273|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
6247274|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6247275|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247276|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247277|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6247278|NCT02757625|Analgesics|analgesics|mesh-ancestor
6247279|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
6247280|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247281|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6247282|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6247283|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6247284|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
6247285|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247286|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247287|NCT02757768|Tamsulosin|tamsulosin|mesh-list
6247288|NCT02757768|Mirabegron|mirabegron|mesh-list
6247289|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6247290|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6247291|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6247292|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
6247293|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247294|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247295|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247296|NCT02757768|Urological Agents|urological agents|mesh-ancestor
6247297|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6247298|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6247299|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6247300|NCT02758171|Empagliflozin|empagliflozin|mesh-list
6247301|NCT02758171|Linagliptin|linagliptin|mesh-list
6247302|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6247303|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247304|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6247305|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247306|NCT02758171|Incretins|incretins|mesh-ancestor
6247307|NCT02758171|Hormones|hormones|mesh-ancestor
6247308|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247309|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6247310|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
6247311|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247312|NCT02759016|BI 836826|bi 836826|mesh-list
6247313|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6247314|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247315|NCT02759120|Doxycycline|doxycycline|mesh-list
6247316|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6247317|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
6247318|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
6247319|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
6247320|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6247321|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6247322|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6247323|NCT02759120|Renal Agents|renal agents|mesh-ancestor
6247324|NCT02759185|Dronabinol|dronabinol|mesh-list
6247325|NCT02759185|Cannabidiol|cannabidiol|mesh-list
6247326|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
6247327|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
6247328|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247329|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6247330|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6247331|NCT02759185|Analgesics|analgesics|mesh-ancestor
6247332|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
6247333|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247334|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6247335|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6247336|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247337|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247338|NCT02759185|Hormones|hormones|mesh-ancestor
6247339|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247340|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
6247341|NCT02759315|Ruzasvir|ruzasvir|mesh-list
6247342|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
6247343|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247344|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
6247345|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247346|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6247347|NCT02760069|Ondansetron|ondansetron|mesh-list
6247348|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
6247349|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
6247350|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247351|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247352|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6247353|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
6247354|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
6247355|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6247356|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
6247357|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247358|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247359|NCT02760069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6247360|NCT02760069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6247361|NCT02760069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247362|NCT02760069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6247363|NCT02760069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6247364|NCT02760407|Adalimumab|adalimumab|mesh-list
6247365|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247366|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6247367|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
6247368|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6247369|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6247370|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6247371|NCT02760862|Mannitol|mannitol|mesh-list
6247372|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247373|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6247374|NCT02760862|Diuretics|diuretics|mesh-ancestor
6247375|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
6247376|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247377|NCT02761252|Montelukast|montelukast|mesh-list
6247378|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6247379|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
6247380|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
6247381|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
6247382|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247383|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247384|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6247385|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6247386|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247387|NCT02761330|Ketamine|ketamine|mesh-list
6247388|NCT02761330|Analgesics|analgesics|mesh-ancestor
6247389|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
6247390|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247391|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247392|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6247393|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6247394|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
6247395|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
6247396|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247397|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6247398|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6247399|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247400|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247401|NCT02761629|Interferons|interferons|mesh-list
6247402|NCT02761629|Ribavirin|ribavirin|mesh-list
6247403|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
6247404|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
6247405|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6247406|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247407|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
6247408|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247409|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
6247410|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247411|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
6247412|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247413|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
6247414|NCT02761642|Hematinics|hematinics|mesh-ancestor
6247415|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
6247416|NCT02761915|Fludarabine|fludarabine|mesh-list
6247417|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6247418|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
6247419|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247420|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6247421|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6247422|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
6247423|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247424|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247425|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6247426|NCT02761980|Acetaminophen|acetaminophen|mesh-list
6247427|NCT02761980|Ibuprofen|ibuprofen|mesh-list
6247428|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6247429|NCT02761980|Analgesics|analgesics|mesh-ancestor
6247430|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
6247431|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247432|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247433|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
6247434|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6247435|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247436|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6247437|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6247438|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247439|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247440|NCT02762071|Bupivacaine|bupivacaine|mesh-list
6247441|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
6247442|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
6247443|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247444|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247445|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
6247446|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247447|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
6247448|NCT02762331|Vitamins|vitamins|mesh-ancestor
6247449|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
6247450|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247451|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
6247452|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247453|NCT02762331|Protective Agents|protective agents|mesh-ancestor
6247454|NCT02762370|Triamcinolone|triamcinolone|mesh-list
6247455|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6247456|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6247457|NCT02762370|FX006|fx006|mesh-list
6247458|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6247459|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247460|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
6247461|NCT02762370|Hormones|hormones|mesh-ancestor
6247462|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247463|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247464|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6247465|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
6247466|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247467|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247468|NCT02762513|Axitinib|axitinib|mesh-list
6247469|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247470|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6247471|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247472|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247473|NCT02762578|Insulin|insulin|mesh-list
6247474|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6247475|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
6247476|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
6247477|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6247478|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
6247479|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6247480|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247481|NCT02762799|Lenograstim|lenograstim|mesh-list
6247482|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6247483|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
6247484|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247485|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6247486|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
6247487|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247488|NCT02763566|Letrozole|letrozole|mesh-list
6247489|NCT02763566|Fulvestrant|fulvestrant|mesh-list
6247490|NCT02763566|Anastrozole|anastrozole|mesh-list
6247491|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247492|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6247493|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6247494|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247495|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247496|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6247497|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
6247498|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247499|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247500|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6247501|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6247502|NCT02763579|Carboplatin|carboplatin|mesh-list
6247503|NCT02763579|Etoposide|etoposide|mesh-list
6247504|NCT02763579|Atezolizumab|atezolizumab|mesh-list
6247505|NCT02763579|Antibodies|antibodies|mesh-list
6247506|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6247507|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
6247508|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247509|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247510|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6247511|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6247512|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6247513|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247514|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247515|NCT02764333|Durvalumab|durvalumab|mesh-list
6247516|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6247517|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247518|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6247519|NCT02764697|Hormones|hormones|mesh-ancestor
6247520|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247521|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247522|NCT02764762|Adalimumab|adalimumab|mesh-list
6247523|NCT02764762|Methotrexate|methotrexate|mesh-list
6247524|NCT02764762|Vedolizumab|vedolizumab|mesh-list
6247525|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6247526|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
6247527|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6247528|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247529|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6247530|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
6247531|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247532|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247533|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
6247534|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247535|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6247536|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6247537|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
6247538|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6247539|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6247540|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247541|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6247542|NCT02765100|Minocycline|minocycline|mesh-list
6247543|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6247544|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247545|NCT02765165|Lomustine|lomustine|mesh-list
6247546|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6247547|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
6247548|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247549|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247550|NCT02765256|Promethazine|promethazine|mesh-list
6247551|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
6247552|NCT02765256|Vancomycin|vancomycin|mesh-list
6247553|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
6247554|NCT02765256|Neomycin|neomycin|mesh-list
6247555|NCT02765256|Fluconazole|fluconazole|mesh-list
6247556|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6247557|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6247558|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247559|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6247560|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6247561|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247562|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247563|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247564|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6247565|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6247566|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
6247567|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6247568|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6247569|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
6247570|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247571|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247572|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6247573|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6247574|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
6247575|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
6247576|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6247577|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
6247578|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
6247579|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247580|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6247581|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6247582|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6247583|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247584|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
6247585|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
6247586|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
6247587|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247588|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
6247589|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
6247590|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6247591|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6247592|NCT02765256|Laxatives|laxatives|mesh-ancestor
6247593|NCT02765490|Simeprevir|simeprevir|mesh-list
6247594|NCT02765490|Odalasvir|odalasvir|mesh-list
6247595|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
6247596|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247597|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
6247598|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247599|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247600|NCT02766023|Metronidazole|metronidazole|mesh-list
6247601|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247602|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6247603|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6247604|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6247605|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6247606|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247607|NCT02766517|Capsaicin|capsaicin|mesh-list
6247608|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
6247609|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
6247610|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
6247611|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247612|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247613|NCT02766608|Budesonide|budesonide|mesh-list
6247614|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
6247615|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
6247616|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247617|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6247618|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
6247619|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247620|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247621|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6247622|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
6247623|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
6247624|NCT02766608|Hormones|hormones|mesh-ancestor
6247625|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247626|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6247627|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6247628|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6247629|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
6247630|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247631|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247632|NCT02766673|Albuterol|albuterol|mesh-list
6247633|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6247634|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
6247635|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247636|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247637|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6247638|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
6247639|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
6247640|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6247641|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6247642|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6247643|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6247644|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
6247645|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247646|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247647|NCT02766777|Lubiprostone|lubiprostone|mesh-list
6247648|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6247649|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6247650|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247651|NCT02767128|Citric Acid|citric acid|mesh-list
6247652|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
6247653|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
6247654|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6247655|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
6247656|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
6247657|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247658|NCT02767271|Luliconazole|luliconazole|mesh-list
6247659|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
6247660|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247661|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
6247662|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6247663|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6247664|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247665|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
6247666|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
6247667|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6247668|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247669|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
6247670|NCT02767492|Hormones|hormones|mesh-ancestor
6247671|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247672|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247673|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6247674|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
6247675|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
6247676|NCT02767765|Hematinics|hematinics|mesh-ancestor
6247677|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
6247678|NCT02767869|Antacids|antacids|mesh-ancestor
6247679|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247680|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6247681|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
6247682|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6247683|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247684|NCT02767947|Luliconazole|luliconazole|mesh-list
6247685|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
6247686|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247687|NCT02768194|Fluorides|fluorides|mesh-list
6247688|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
6247689|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
6247690|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
6247691|NCT02768194|Protective Agents|protective agents|mesh-ancestor
6247692|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247693|NCT02768298|Enalapril|enalapril|mesh-list
6247694|NCT02768298|Enalaprilat|enalaprilat|mesh-list
6247695|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6247696|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6247697|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
6247698|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247699|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247700|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6247701|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6247702|NCT02768558|Nivolumab|nivolumab|mesh-list
6247703|NCT02768558|Etoposide|etoposide|mesh-list
6247704|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247705|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6247706|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6247707|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247708|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6247709|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6247710|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6247711|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247712|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
6247713|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6247714|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247715|NCT02769065|Donepezil|donepezil|mesh-list
6247716|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6247717|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247718|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247719|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
6247720|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247721|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247722|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
6247723|NCT02769247|Naproxen|naproxen|mesh-list
6247724|NCT02769247|Lidocaine|lidocaine|mesh-list
6247725|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
6247726|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
6247727|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247728|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247729|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
6247730|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247731|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6247732|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6247733|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6247734|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6247735|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247736|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6247737|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6247738|NCT02769247|Analgesics|analgesics|mesh-ancestor
6247739|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247740|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6247741|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
6247742|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6247743|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247744|NCT02769481|Glimepiride|glimepiride|mesh-list
6247745|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
6247746|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6247747|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6247748|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247749|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6247750|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
6247751|NCT02769624|Treprostinil|treprostinil|mesh-list
6247752|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6247753|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6247754|NCT02769702|Hormones|hormones|mesh-ancestor
6247755|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247756|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247757|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6247758|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247759|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6247760|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247761|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247762|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6247763|NCT02770248|Brinzolamide|brinzolamide|mesh-list
6247764|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6247765|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6247766|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6247767|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6247768|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
6247769|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247770|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247771|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247772|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6247773|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247774|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
6247775|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
6247776|NCT02770365|Estradiol|estradiol|mesh-list
6247777|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
6247778|NCT02770365|Estrogens|estrogens|mesh-ancestor
6247779|NCT02770365|Hormones|hormones|mesh-ancestor
6247780|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247781|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247782|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6247783|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
6247784|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6247785|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6247786|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
6247787|NCT02770521|Treprostinil|treprostinil|mesh-list
6247788|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6247789|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247790|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6247791|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
6247792|NCT02770612|Narcotics|narcotics|mesh-ancestor
6247793|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247794|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247795|NCT02770612|Analgesics|analgesics|mesh-ancestor
6247796|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
6247797|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247798|NCT02770820|Aldesleukin|aldesleukin|mesh-list
6247799|NCT02770820|Interleukin-2|interleukin-2|mesh-list
6247800|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247801|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6247802|NCT02770820|Analgesics|analgesics|mesh-ancestor
6247803|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
6247804|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247805|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247806|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6247807|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6247808|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
6247809|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247810|NCT02771093|Alogliptin|alogliptin|mesh-list
6247811|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6247812|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247813|NCT02771093|Incretins|incretins|mesh-ancestor
6247814|NCT02771093|Hormones|hormones|mesh-ancestor
6247815|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247816|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6247817|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
6247818|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247819|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247820|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6247821|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6247822|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
6247823|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247824|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
6247825|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
6247826|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247827|NCT02772783|Insulin|insulin|mesh-list
6247828|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6247829|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6247830|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247831|NCT02772978|Tolcapone|tolcapone|mesh-list
6247832|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6247833|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6247834|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
6247835|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247836|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247837|NCT02773368|Insulin|insulin|mesh-list
6247838|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6247839|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
6247840|NCT02773368|Liraglutide|liraglutide|mesh-list
6247841|NCT02773368|Xultophy|xultophy|mesh-list
6247842|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6247843|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247844|NCT02773368|Incretins|incretins|mesh-ancestor
6247845|NCT02773368|Hormones|hormones|mesh-ancestor
6247846|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247847|NCT02773758|Fluorides|fluorides|mesh-list
6247848|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
6247849|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
6247850|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
6247851|NCT02773758|Protective Agents|protective agents|mesh-ancestor
6247852|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247853|NCT02774226|Vitamins|vitamins|mesh-list
6247854|NCT02774226|Vitamin E|vitamin e|mesh-list
6247855|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
6247856|NCT02774226|Antioxidants|antioxidants|mesh-list
6247857|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
6247858|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247859|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247860|NCT02774226|Protective Agents|protective agents|mesh-ancestor
6247861|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
6247862|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6247863|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247864|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6247865|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247866|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247867|NCT02774343|Pioglitazone|pioglitazone|mesh-list
6247868|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6247869|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247870|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6247871|NCT02774681|Trastuzumab|trastuzumab|mesh-list
6247872|NCT02774681|Palbociclib|palbociclib|mesh-list
6247873|NCT02774681|Antibodies|antibodies|mesh-list
6247874|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
6247875|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6247876|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
6247877|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247878|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247879|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6247880|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247881|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247882|NCT02775240|Maribavir|maribavir|mesh-list
6247883|NCT02775240|Digoxin|digoxin|mesh-list
6247884|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
6247885|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6247886|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6247887|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247888|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247889|NCT02775240|Protective Agents|protective agents|mesh-ancestor
6247890|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247891|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
6247892|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
6247893|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6247894|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6247895|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6247896|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
6247897|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247898|NCT02775617|Azithromycin|azithromycin|mesh-list
6247899|NCT02775617|Ivermectin|ivermectin|mesh-list
6247900|NCT02775617|Permethrin|permethrin|mesh-list
6247901|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6247902|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247903|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6247904|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247905|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247906|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
6247907|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
6247908|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6247909|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6247910|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247911|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247912|NCT02775903|Azacitidine|azacitidine|mesh-list
6247913|NCT02775903|Durvalumab|durvalumab|mesh-list
6247914|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6247915|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
6247916|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247917|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247918|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247919|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6247920|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6247921|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
6247922|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6247923|NCT02776683|Bevacizumab|bevacizumab|mesh-list
6247924|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6247925|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247926|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6247927|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6247928|NCT02776683|Growth Substances|growth substances|mesh-ancestor
6247929|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247930|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
6247931|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
6247932|NCT02777242|Testosterone|testosterone|mesh-list
6247933|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
6247934|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
6247935|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6247936|NCT02777242|Androgens|androgens|mesh-ancestor
6247937|NCT02777242|Hormones|hormones|mesh-ancestor
6247938|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247939|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247940|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6247941|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247942|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
6247943|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
6247944|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247945|NCT02777554|Thalidomide|thalidomide|mesh-list
6247946|NCT02777554|Apremilast|apremilast|mesh-list
6247947|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6247948|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6247949|NCT02777554|Analgesics|analgesics|mesh-ancestor
6247950|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
6247951|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247952|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247953|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247954|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6247955|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6247956|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6247957|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6247958|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6247959|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6247960|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
6247961|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
6247962|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6247963|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6247964|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6247965|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6247966|NCT02777554|Growth Substances|growth substances|mesh-ancestor
6247967|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
6247968|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6247969|NCT02777749|Bupivacaine|bupivacaine|mesh-list
6247970|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
6247971|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
6247972|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247973|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247974|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
6247975|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247976|NCT02777970|Acetaminophen|acetaminophen|mesh-list
6247977|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
6247978|NCT02777970|Tramadol|tramadol|mesh-list
6247979|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6247980|NCT02777970|Analgesics|analgesics|mesh-ancestor
6247981|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
6247982|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6247983|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247984|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
6247985|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6247986|NCT02777970|Narcotics|narcotics|mesh-ancestor
6247987|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6247988|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6247989|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6247990|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6247991|NCT02778100|Phenylephrine|phenylephrine|mesh-list
6247992|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
6247993|NCT02778100|Glucagon|glucagon|mesh-list
6247994|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6247995|NCT02778100|Hormones|hormones|mesh-ancestor
6247996|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6247997|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6247998|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6247999|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6248000|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
6248001|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248002|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248003|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
6248004|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
6248005|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248006|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
6248007|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6248008|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
6248009|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6248010|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
6248011|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6248012|NCT02778100|Protective Agents|protective agents|mesh-ancestor
6248013|NCT02778113|Glucagon|glucagon|mesh-list
6248014|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6248015|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6248016|NCT02778113|Hormones|hormones|mesh-ancestor
6248017|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248018|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248019|NCT02778113|Incretins|incretins|mesh-ancestor
6248020|NCT02778867|Fluticasone|fluticasone|mesh-list
6248021|NCT02778867|Xhance|xhance|mesh-list
6248022|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248023|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6248024|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
6248025|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248026|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248027|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6248028|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
6248029|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
6248030|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6248031|NCT02778880|Fentanyl|fentanyl|mesh-list
6248032|NCT02778880|Ketamine|ketamine|mesh-list
6248033|NCT02778880|Analgesics|analgesics|mesh-ancestor
6248034|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
6248035|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248036|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248037|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6248038|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6248039|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
6248040|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
6248041|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248042|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6248043|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6248044|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248045|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248046|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6248047|NCT02778880|Narcotics|narcotics|mesh-ancestor
6248048|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6248049|NCT02779166|Celecoxib|celecoxib|mesh-list
6248050|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6248051|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6248052|NCT02779166|Analgesics|analgesics|mesh-ancestor
6248053|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
6248054|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248055|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248056|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248057|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6248058|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6248059|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6248060|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248061|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248062|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6248063|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6248064|NCT02780167|Abrocitinib|abrocitinib|mesh-list
6248065|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6248066|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248067|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248068|NCT02780622|Oseltamivir|oseltamivir|mesh-list
6248069|NCT02780622|Warfarin|warfarin|mesh-list
6248070|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
6248071|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
6248072|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248073|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248074|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248075|NCT02780687|Afatinib|afatinib|mesh-list
6248076|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248077|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6248078|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248079|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248080|NCT02780700|Capecitabine|capecitabine|mesh-list
6248081|NCT02780700|Nintedanib|nintedanib|mesh-list
6248082|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6248083|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
6248084|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248085|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248086|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6248087|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248088|NCT02780869|Thrombin|thrombin|mesh-list
6248089|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
6248090|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
6248091|NCT02780869|Coagulants|coagulants|mesh-ancestor
6248092|NCT02781311|Finasteride|finasteride|mesh-list
6248093|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6248094|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6248095|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248096|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248097|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
6248098|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248099|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248100|NCT02781311|Urological Agents|urological agents|mesh-ancestor
6248101|NCT02781454|Mexiletine|mexiletine|mesh-list
6248102|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6248103|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6248104|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6248105|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6248106|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248107|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
6248108|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6248109|NCT02781558|Velpatasvir|velpatasvir|mesh-list
6248110|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
6248111|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248112|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
6248113|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6248114|NCT02781571|Velpatasvir|velpatasvir|mesh-list
6248115|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
6248116|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248117|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6248118|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248119|NCT02781649|Ribavirin|ribavirin|mesh-list
6248120|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
6248121|NCT02781649|Grazoprevir|grazoprevir|mesh-list
6248122|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
6248123|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
6248124|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248125|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
6248126|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248127|NCT02781818|Triamcinolone|triamcinolone|mesh-list
6248128|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6248129|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6248130|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6248131|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248132|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
6248133|NCT02781818|Hormones|hormones|mesh-ancestor
6248134|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248135|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248136|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6248137|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
6248138|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248139|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248140|NCT02782169|Pregabalin|pregabalin|mesh-list
6248141|NCT02782169|Analgesics|analgesics|mesh-ancestor
6248142|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
6248143|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248144|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248145|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
6248146|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6248147|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6248148|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248149|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6248150|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6248151|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6248152|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248153|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6248154|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
6248155|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6248156|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
6248157|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248158|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
6248159|NCT02782676|Protective Agents|protective agents|mesh-ancestor
6248160|NCT02783170|Vaccines|vaccines|mesh-list
6248161|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
6248162|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248163|NCT02783443|Anesthetics|anesthetics|mesh-list
6248164|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248165|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248166|NCT02783599|Doxorubicin|doxorubicin|mesh-list
6248167|NCT02783599|Olaratumab|olaratumab|mesh-list
6248168|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6248169|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248170|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6248171|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6248172|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248173|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248174|NCT02783729|Zolpidem|zolpidem|mesh-list
6248175|NCT02783729|Lemborexant|lemborexant|mesh-list
6248176|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6248177|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6248178|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248179|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248180|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6248181|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
6248182|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
6248183|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248184|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248185|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6248186|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6248187|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
6248188|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6248189|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
6248190|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248191|NCT02785159|Tazarotene|tazarotene|mesh-list
6248192|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
6248193|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
6248194|NCT02785172|Clobetasol|clobetasol|mesh-list
6248195|NCT02785172|Halobetasol|halobetasol|mesh-list
6248196|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6248197|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248198|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
6248199|NCT02785172|Hormones|hormones|mesh-ancestor
6248200|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248201|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248202|NCT02785185|Clobetasol|clobetasol|mesh-list
6248203|NCT02785185|Halobetasol|halobetasol|mesh-list
6248204|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6248205|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248206|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
6248207|NCT02785185|Hormones|hormones|mesh-ancestor
6248208|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248209|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248210|NCT02785406|Suvorexant|suvorexant|mesh-list
6248211|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6248212|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6248213|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248214|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248215|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6248216|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248217|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248218|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
6248219|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6248220|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248221|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6248222|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6248223|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248224|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248225|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248226|NCT02785900|Azacitidine|azacitidine|mesh-list
6248227|NCT02785900|Decitabine|decitabine|mesh-list
6248228|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6248229|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
6248230|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248231|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248232|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248233|NCT02785939|Docetaxel|docetaxel|mesh-list
6248234|NCT02785939|Palbociclib|palbociclib|mesh-list
6248235|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248236|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
6248237|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
6248238|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
6248239|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248240|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6248241|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248242|NCT02786498|Vitamin D|vitamin d|mesh-list
6248243|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
6248244|NCT02786498|Vitamins|vitamins|mesh-ancestor
6248245|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
6248246|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248247|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6248248|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6248249|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
6248250|NCT02786719|Doxorubicin|doxorubicin|mesh-list
6248251|NCT02786719|Etoposide|etoposide|mesh-list
6248252|NCT02786719|Vincristine|vincristine|mesh-list
6248253|NCT02786719|Topotecan|topotecan|mesh-list
6248254|NCT02786719|Sargramostim|sargramostim|mesh-list
6248255|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6248256|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
6248257|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248258|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6248259|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6248260|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
6248261|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248262|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248263|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6248264|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6248265|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6248266|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6248267|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248268|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6248269|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
6248270|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
6248271|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
6248272|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6248273|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6248274|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6248275|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
6248276|NCT02787057|Vancomycin|vancomycin|mesh-list
6248277|NCT02787057|Ceftazidime|ceftazidime|mesh-list
6248278|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6248279|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248280|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6248281|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6248282|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248283|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248284|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248285|NCT02787083|Mirabegron|mirabegron|mesh-list
6248286|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6248287|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6248288|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6248289|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
6248290|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248291|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248292|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248293|NCT02787083|Urological Agents|urological agents|mesh-ancestor
6248294|NCT02787304|Volixibat|volixibat|mesh-list
6248295|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6248296|NCT02787551|Metformin|metformin|mesh-list
6248297|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
6248298|NCT02787551|Pioglitazone|pioglitazone|mesh-list
6248299|NCT02787551|Liraglutide|liraglutide|mesh-list
6248300|NCT02787551|Exenatide|exenatide|mesh-list
6248301|NCT02787551|Dulaglutide|dulaglutide|mesh-list
6248302|NCT02787551|Lixisenatide|lixisenatide|mesh-list
6248303|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6248304|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6248305|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
6248306|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248307|NCT02787551|Incretins|incretins|mesh-ancestor
6248308|NCT02787551|Hormones|hormones|mesh-ancestor
6248309|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248310|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6248311|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248312|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6248313|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
6248314|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248315|NCT02788019|Ropivacaine|ropivacaine|mesh-list
6248316|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
6248317|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
6248318|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248319|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248320|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
6248321|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248322|NCT02788097|Progesterone|progesterone|mesh-list
6248323|NCT02788097|Progestins|progestins|mesh-ancestor
6248324|NCT02788097|Hormones|hormones|mesh-ancestor
6248325|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248326|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248327|NCT02788175|Vedolizumab|vedolizumab|mesh-list
6248328|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6248329|NCT02788279|Atezolizumab|atezolizumab|mesh-list
6248330|NCT02788279|Antibodies|antibodies|mesh-list
6248331|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
6248332|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248333|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248334|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6248335|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6248336|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6248337|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6248338|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248339|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
6248340|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248341|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248342|NCT02788474|Nintedanib|nintedanib|mesh-list
6248343|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248344|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6248345|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248346|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248347|NCT02788513|BI 425809|bi 425809|mesh-list
6248348|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
6248349|NCT02788656|Valsartan|valsartan|mesh-list
6248350|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
6248351|NCT02788656|Giapreza|giapreza|mesh-list
6248352|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
6248353|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
6248354|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
6248355|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
6248356|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
6248357|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6248358|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248359|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
6248360|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6248361|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6248362|NCT02789033|Isosorbide|isosorbide|mesh-list
6248363|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
6248364|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
6248365|NCT02789033|Chitosan|chitosan|mesh-list
6248366|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6248367|NCT02789033|Diuretics|diuretics|mesh-ancestor
6248368|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
6248369|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248370|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
6248371|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
6248372|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248373|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6248374|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6248375|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
6248376|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6248377|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
6248378|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
6248379|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
6248380|NCT02789033|Coagulants|coagulants|mesh-ancestor
6248381|NCT02789111|Alvimopan|alvimopan|mesh-list
6248382|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6248383|NCT02789410|Morphine|morphine|mesh-list
6248384|NCT02789410|Hydromorphone|hydromorphone|mesh-list
6248385|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6248386|NCT02789410|Narcotics|narcotics|mesh-ancestor
6248387|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248388|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248389|NCT02789410|Analgesics|analgesics|mesh-ancestor
6248390|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
6248391|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248392|NCT02790736|Propranolol|propranolol|mesh-list
6248393|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6248394|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6248395|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
6248396|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248397|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248398|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248399|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6248400|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6248401|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
6248402|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
6248403|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6248404|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6248405|NCT02790788|Prednisolone|prednisolone|mesh-list
6248406|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
6248407|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
6248408|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6248409|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6248410|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
6248411|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248412|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
6248413|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
6248414|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248415|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248416|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6248417|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
6248418|NCT02790788|Hormones|hormones|mesh-ancestor
6248419|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248420|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6248421|NCT02790788|Protective Agents|protective agents|mesh-ancestor
6248422|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6248423|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248424|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6248425|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
6248426|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248427|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
6248428|NCT02791308|Tacrolimus|tacrolimus|mesh-list
6248429|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6248430|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6248431|NCT02791308|Analgesics|analgesics|mesh-ancestor
6248432|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
6248433|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248434|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248435|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248436|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6248437|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
6248438|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6248439|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
6248440|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6248441|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248442|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248443|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6248444|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6248445|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6248446|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248447|NCT02791490|Metformin|metformin|mesh-list
6248448|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6248449|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6248450|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248451|NCT02791490|Incretins|incretins|mesh-ancestor
6248452|NCT02791490|Hormones|hormones|mesh-ancestor
6248453|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248454|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6248455|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
6248456|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248457|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248458|NCT02791763|Glycine|glycine|mesh-list
6248459|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
6248460|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248461|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248462|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248463|NCT02791906|Ascorbic Acid|ascorbic acid|mesh-list
6248464|NCT02791906|Vitamins|vitamins|mesh-ancestor
6248465|NCT02791906|Micronutrients|micronutrients|mesh-ancestor
6248466|NCT02791906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248467|NCT02791906|Antioxidants|antioxidants|mesh-ancestor
6248468|NCT02791906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248469|NCT02791906|Protective Agents|protective agents|mesh-ancestor
6248470|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
6248471|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6248472|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
6248473|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248474|NCT02791945|Expectorants|expectorants|mesh-ancestor
6248475|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
6248476|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6248477|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
6248478|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248479|NCT02791945|Protective Agents|protective agents|mesh-ancestor
6248480|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248481|NCT02791945|Antidotes|antidotes|mesh-ancestor
6248482|NCT02792062|Relugolix|relugolix|mesh-list
6248483|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
6248484|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
6248485|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248486|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248487|NCT02792192|Atezolizumab|atezolizumab|mesh-list
6248488|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248489|NCT02792218|Teriflunomide|teriflunomide|mesh-list
6248490|NCT02792218|Ofatumumab|ofatumumab|mesh-list
6248491|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6248492|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248493|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
6248494|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248495|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6248496|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6248497|NCT02792218|Analgesics|analgesics|mesh-ancestor
6248498|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
6248499|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248500|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248501|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6248502|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6248503|NCT02792231|Teriflunomide|teriflunomide|mesh-list
6248504|NCT02792231|Ofatumumab|ofatumumab|mesh-list
6248505|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6248506|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248507|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
6248508|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248509|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6248510|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6248511|NCT02792231|Analgesics|analgesics|mesh-ancestor
6248512|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
6248513|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248514|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248515|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6248516|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6248517|NCT02792517|Erenumab|erenumab|mesh-list
6248518|NCT02792517|Norgestimate|norgestimate|mesh-list
6248519|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
6248520|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
6248521|NCT02792517|Estradiol|estradiol|mesh-list
6248522|NCT02792517|Estrogens|estrogens|mesh-ancestor
6248523|NCT02792517|Hormones|hormones|mesh-ancestor
6248524|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248525|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248526|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6248527|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6248528|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6248529|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
6248530|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248531|NCT02792517|Analgesics|analgesics|mesh-ancestor
6248532|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
6248533|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248534|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6248535|NCT02792699|Rituximab|rituximab|mesh-list
6248536|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6248537|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248538|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
6248539|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248540|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6248541|NCT02792829|Lenvatinib|lenvatinib|mesh-list
6248542|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248543|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6248544|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248545|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248546|NCT02793128|Mitomycins|mitomycins|mesh-list
6248547|NCT02793128|Mitomycin|mitomycin|mesh-list
6248548|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6248549|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248550|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
6248551|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248552|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6248553|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248554|NCT02793154|Exenatide|exenatide|mesh-list
6248555|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
6248556|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6248557|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248558|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6248559|NCT02793154|Incretins|incretins|mesh-ancestor
6248560|NCT02793154|Hormones|hormones|mesh-ancestor
6248561|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248562|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
6248563|NCT02793622|Piperaquine|piperaquine|mesh-list
6248564|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
6248565|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
6248566|NCT02793622|Artenimol|artenimol|mesh-list
6248567|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
6248568|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6248569|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6248570|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248571|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6248572|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248573|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248574|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6248575|NCT02793622|Renal Agents|renal agents|mesh-ancestor
6248576|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6248577|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6248578|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
6248579|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6248580|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
6248581|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248582|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6248583|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6248584|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
6248585|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248586|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248587|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6248588|NCT02793947|Epinephrine|epinephrine|mesh-list
6248589|NCT02793947|Morphine|morphine|mesh-list
6248590|NCT02793947|Ropivacaine|ropivacaine|mesh-list
6248591|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6248592|NCT02793947|Narcotics|narcotics|mesh-ancestor
6248593|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248594|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248595|NCT02793947|Analgesics|analgesics|mesh-ancestor
6248596|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
6248597|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248598|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
6248599|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
6248600|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6248601|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6248602|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
6248603|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248604|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248605|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6248606|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6248607|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
6248608|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6248609|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
6248610|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
6248611|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
6248612|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6248613|NCT02794441|Dexamethasone|dexamethasone|mesh-list
6248614|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248615|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
6248616|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
6248617|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248618|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248619|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6248620|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
6248621|NCT02794441|Hormones|hormones|mesh-ancestor
6248622|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248623|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6248624|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248625|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
6248626|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248627|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248628|NCT02794974|Anesthetics|anesthetics|mesh-list
6248629|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248630|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248631|NCT02795117|Ivermectin|ivermectin|mesh-list
6248632|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6248633|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248634|NCT02796144|Metformin|metformin|mesh-list
6248635|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6248636|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248637|NCT02796352|Interleukin-2|interleukin-2|mesh-list
6248638|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248639|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6248640|NCT02796352|Analgesics|analgesics|mesh-ancestor
6248641|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
6248642|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248643|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248644|NCT02796560|Travoprost|travoprost|mesh-list
6248645|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6248646|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6248647|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
6248648|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6248649|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
6248650|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248651|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248652|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6248653|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
6248654|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6248655|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6248656|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6248657|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
6248658|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248659|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248660|NCT02796677|Bromides|bromides|mesh-list
6248661|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
6248662|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
6248663|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6248664|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
6248665|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248666|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248667|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6248668|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
6248669|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6248670|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6248671|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6248672|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
6248673|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248674|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248675|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
6248676|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6248677|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
6248678|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
6248679|NCT02796755|Riluzole|riluzole|mesh-list
6248680|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
6248681|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6248682|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6248683|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248684|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248685|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248686|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6248687|NCT02796755|Protective Agents|protective agents|mesh-ancestor
6248688|NCT02797080|Interferons|interferons|mesh-list
6248689|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
6248690|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248691|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
6248692|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248693|NCT02797522|Acetaminophen|acetaminophen|mesh-list
6248694|NCT02797522|Tenofovir|tenofovir|mesh-list
6248695|NCT02797522|Entecavir|entecavir|mesh-list
6248696|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
6248697|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
6248698|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
6248699|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248700|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6248701|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6248702|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248703|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248704|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6248705|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6248706|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6248707|NCT02797522|Analgesics|analgesics|mesh-ancestor
6248708|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
6248709|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248710|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248711|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
6248712|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
6248713|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248714|NCT02797808|Sertraline|sertraline|mesh-list
6248715|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
6248716|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6248717|NCT02797808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6248718|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6248719|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6248720|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248721|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248722|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
6248723|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248724|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6248725|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
6248726|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248727|NCT02798835|Dexamethasone|dexamethasone|mesh-list
6248728|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
6248729|NCT02798835|Fentanyl|fentanyl|mesh-list
6248730|NCT02798835|Bupivacaine|bupivacaine|mesh-list
6248731|NCT02798835|Ropivacaine|ropivacaine|mesh-list
6248732|NCT02798835|BB 1101|bb 1101|mesh-list
6248733|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248734|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
6248735|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
6248736|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248737|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248738|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6248739|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
6248740|NCT02798835|Hormones|hormones|mesh-ancestor
6248741|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248742|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6248743|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248744|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
6248745|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248746|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248747|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
6248748|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
6248749|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248750|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
6248751|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6248752|NCT02798835|Narcotics|narcotics|mesh-ancestor
6248753|NCT02798835|Analgesics|analgesics|mesh-ancestor
6248754|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6248755|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6248756|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
6248757|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6248758|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6248759|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
6248760|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
6248761|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6248762|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
6248763|NCT02799381|Levodopa|levodopa|mesh-list
6248764|NCT02799381|Carbidopa|carbidopa|mesh-list
6248765|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
6248766|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
6248767|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6248768|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
6248769|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248770|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248771|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248772|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6248773|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248774|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6248775|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
6248776|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
6248777|NCT02799784|Albuterol|albuterol|mesh-list
6248778|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6248779|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
6248780|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248781|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248782|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6248783|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
6248784|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
6248785|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6248786|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6248787|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6248788|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6248789|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
6248790|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248791|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248792|NCT02800148|Azelaic acid|azelaic acid|mesh-list
6248793|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248794|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
6248795|NCT02800642|Aflibercept|aflibercept|mesh-list
6248796|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6248797|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6248798|NCT02800642|Growth Substances|growth substances|mesh-ancestor
6248799|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248800|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
6248801|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248802|NCT02800928|Aticaprant|aticaprant|mesh-list
6248803|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6248804|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248805|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
6248806|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248807|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
6248808|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6248809|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248810|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6248811|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6248812|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248813|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248814|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248815|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6248816|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6248817|NCT02801617|Latanoprost|latanoprost|mesh-list
6248818|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6248819|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6248820|NCT02801669|Edoxaban|edoxaban|mesh-list
6248821|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6248822|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
6248823|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6248824|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
6248825|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248826|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248827|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
6248828|NCT02802111|Albuterol|albuterol|mesh-list
6248829|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6248830|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
6248831|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248832|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248833|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6248834|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
6248835|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
6248836|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6248837|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6248838|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6248839|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6248840|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
6248841|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248842|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248843|NCT02802241|Peppermint oil|peppermint oil|mesh-list
6248844|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
6248845|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
6248846|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248847|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248848|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6248849|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
6248850|NCT02802345|Nintedanib|nintedanib|mesh-list
6248851|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
6248852|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
6248853|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6248854|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6248855|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248856|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248857|NCT02802345|Urological Agents|urological agents|mesh-ancestor
6248858|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248859|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6248860|NCT02802449|Vitamin D|vitamin d|mesh-list
6248861|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
6248862|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
6248863|NCT02802449|Calcifediol|calcifediol|mesh-list
6248864|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6248865|NCT02802449|Vitamins|vitamins|mesh-list
6248866|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
6248867|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248868|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6248869|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6248870|NCT02802501|Piperaquine|piperaquine|mesh-list
6248871|NCT02802501|Primaquine|primaquine|mesh-list
6248872|NCT02802501|Artenimol|artenimol|mesh-list
6248873|NCT02802501|Tafenoquine|tafenoquine|mesh-list
6248874|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
6248875|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6248876|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6248877|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248878|NCT02802514|Exenatide|exenatide|mesh-list
6248879|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
6248880|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6248881|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6248882|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248883|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6248884|NCT02802514|Incretins|incretins|mesh-ancestor
6248885|NCT02802514|Hormones|hormones|mesh-ancestor
6248886|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248887|NCT02802735|Apremilast|apremilast|mesh-list
6248888|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6248889|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6248890|NCT02802735|Analgesics|analgesics|mesh-ancestor
6248891|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
6248892|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248893|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248894|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6248895|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6248896|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6248897|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6248898|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248899|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248900|NCT02802865|Letrozole|letrozole|mesh-list
6248901|NCT02802865|Clomiphene|clomiphene|mesh-list
6248902|NCT02802865|Enclomiphene|enclomiphene|mesh-list
6248903|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
6248904|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248905|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248906|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6248907|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6248908|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248909|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6248910|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
6248911|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6248912|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248913|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6248914|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
6248915|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6248916|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6248917|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6248918|NCT02803138|Ritonavir|ritonavir|mesh-list
6248919|NCT02803138|Ribavirin|ribavirin|mesh-list
6248920|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6248921|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6248922|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
6248923|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248924|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248925|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6248926|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6248927|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
6248928|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248929|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6248930|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6248931|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
6248932|NCT02803229|Amphetamine|amphetamine|mesh-list
6248933|NCT02803229|Adderall|adderall|mesh-list
6248934|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6248935|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248936|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
6248937|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
6248938|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6248939|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
6248940|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248941|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248942|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
6248943|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6248944|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6248945|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6248946|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6248947|NCT02803749|Buspirone|buspirone|mesh-list
6248948|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6248949|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6248950|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6248951|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248952|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6248953|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6248954|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
6248955|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6248956|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248957|NCT02804399|Rifampin|rifampin|mesh-list
6248958|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6248959|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
6248960|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6248961|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248962|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
6248963|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6248964|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248965|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248966|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6248967|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6248968|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6248969|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6248970|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6248971|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6248972|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
6248973|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6248974|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
6248975|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6248976|NCT02804594|Expectorants|expectorants|mesh-ancestor
6248977|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
6248978|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6248979|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
6248980|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248981|NCT02804594|Protective Agents|protective agents|mesh-ancestor
6248982|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6248983|NCT02804594|Antidotes|antidotes|mesh-ancestor
6248984|NCT02805179|Temozolomide|temozolomide|mesh-list
6248985|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6248986|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
6248987|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248988|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248989|NCT02805660|Durvalumab|durvalumab|mesh-list
6248990|NCT02805660|Mocetinostat|mocetinostat|mesh-list
6248991|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6248992|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6248993|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6248994|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6248995|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6248996|NCT02805907|Calcifediol|calcifediol|mesh-list
6248997|NCT02805907|Vitamins|vitamins|mesh-ancestor
6248998|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
6248999|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249000|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6249001|NCT02805972|Naloxone|naloxone|mesh-list
6249002|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6249003|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249004|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
6249005|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249006|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
6249007|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6249008|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6249009|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249010|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
6249011|NCT02806024|Coagulants|coagulants|mesh-ancestor
6249012|NCT02806232|Praziquantel|praziquantel|mesh-list
6249013|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
6249014|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6249015|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249016|NCT02806414|Ivermectin|ivermectin|mesh-list
6249017|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6249018|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249019|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6249020|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
6249021|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249022|NCT02806544|Tamoxifen|tamoxifen|mesh-list
6249023|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6249024|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
6249025|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249026|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249027|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6249028|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249029|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6249030|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6249031|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6249032|NCT02806869|Ibuprofen|ibuprofen|mesh-list
6249033|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6249034|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249035|NCT02806869|Analgesics|analgesics|mesh-ancestor
6249036|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
6249037|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249038|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249039|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249040|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249041|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6249042|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249043|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249044|NCT02806947|Sirolimus|sirolimus|mesh-list
6249045|NCT02806947|Prednisone|prednisone|mesh-list
6249046|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249047|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
6249048|NCT02806947|Hormones|hormones|mesh-ancestor
6249049|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249050|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249051|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6249052|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249053|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6249054|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249055|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6249056|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
6249057|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6249058|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
6249059|NCT02806973|Glucagon|glucagon|mesh-list
6249060|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6249061|NCT02806973|Hormones|hormones|mesh-ancestor
6249062|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249063|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249064|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
6249065|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
6249066|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6249067|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6249068|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
6249069|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249070|NCT02807623|Ibuprofen|ibuprofen|mesh-list
6249071|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6249072|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249073|NCT02807623|Analgesics|analgesics|mesh-ancestor
6249074|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
6249075|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249076|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249077|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249078|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249079|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6249080|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249081|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249082|NCT02807844|Spartalizumab|spartalizumab|mesh-list
6249083|NCT02807844|Sargramostim|sargramostim|mesh-list
6249084|NCT02807844|Immunologic Factors|immunologic factors|mesh-ancestor
6249085|NCT02807844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249086|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6249087|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249088|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249089|NCT02808052|Minocycline|minocycline|mesh-list
6249090|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6249091|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249092|NCT02808819|Benralizumab|benralizumab|mesh-list
6249093|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6249094|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
6249095|NCT02808975|Adalimumab|adalimumab|mesh-list
6249096|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249097|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249098|NCT02809053|Rituximab|rituximab|mesh-list
6249099|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6249100|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249101|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
6249102|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249103|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249104|NCT02810392|Insulin|insulin|mesh-list
6249105|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6249106|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6249107|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249108|NCT02810457|Paclitaxel|paclitaxel|mesh-list
6249109|NCT02810457|Bevacizumab|bevacizumab|mesh-list
6249110|NCT02810457|Carboplatin|carboplatin|mesh-list
6249111|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6249112|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249113|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
6249114|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
6249115|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
6249116|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249117|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6249118|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6249119|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6249120|NCT02810457|Growth Substances|growth substances|mesh-ancestor
6249121|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249122|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
6249123|NCT02810873|Copper|copper|mesh-list
6249124|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
6249125|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6249126|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6249127|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249128|NCT02810873|Trace Elements|trace elements|mesh-ancestor
6249129|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
6249130|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249131|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
6249132|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
6249133|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249134|NCT02810964|Sulforaphane|sulforaphane|mesh-list
6249135|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6249136|NCT02810964|Protective Agents|protective agents|mesh-ancestor
6249137|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249138|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249139|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
6249140|NCT02811861|Everolimus|everolimus|mesh-list
6249141|NCT02811861|Sunitinib|sunitinib|mesh-list
6249142|NCT02811861|Lenvatinib|lenvatinib|mesh-list
6249143|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6249144|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249145|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6249146|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
6249147|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249148|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6249149|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6249150|NCT02811861|Growth Substances|growth substances|mesh-ancestor
6249151|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
6249152|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6249153|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249154|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249155|NCT02812186|Rocuronium|rocuronium|mesh-list
6249156|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6249157|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6249158|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6249159|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249160|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249161|NCT02812238|Niacinamide|niacinamide|mesh-list
6249162|NCT02812238|Niacin|niacin|mesh-list
6249163|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
6249164|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
6249165|NCT02812238|Vitamins|vitamins|mesh-ancestor
6249166|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
6249167|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249168|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6249169|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
6249170|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249171|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6249172|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
6249173|NCT02812342|Tofacitinib|tofacitinib|mesh-list
6249174|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6249175|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249176|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249177|NCT02812771|Efinaconazole|efinaconazole|mesh-list
6249178|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
6249179|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249180|NCT02813070|Flutemetamol|flutemetamol|mesh-list
6249181|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6249182|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249183|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6249184|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6249185|NCT02813551|Torsemide|torsemide|mesh-list
6249186|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6249187|NCT02813551|Diuretics|diuretics|mesh-ancestor
6249188|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
6249189|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249190|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6249191|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6249192|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249193|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
6249194|NCT02813694|Lefamulin|lefamulin|mesh-list
6249195|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6249196|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249197|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6249198|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6249199|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249200|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249201|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249202|NCT02814175|Adalimumab|adalimumab|mesh-list
6249203|NCT02814175|Methotrexate|methotrexate|mesh-list
6249204|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6249205|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
6249206|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6249207|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249208|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6249209|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
6249210|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249211|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249212|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
6249213|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249214|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6249215|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6249216|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
6249217|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249218|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6249219|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249220|NCT02814279|Dipyrone|dipyrone|mesh-list
6249221|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
6249222|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6249223|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249224|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
6249225|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6249226|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249227|NCT02814279|Analgesics|analgesics|mesh-ancestor
6249228|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
6249229|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249230|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249231|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249232|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249233|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
6249234|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
6249235|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6249236|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
6249237|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6249238|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6249239|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249240|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6249241|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249242|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6249243|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249244|NCT02814643|Benralizumab|benralizumab|mesh-list
6249245|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6249246|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
6249247|NCT02815644|Empagliflozin|empagliflozin|mesh-list
6249248|NCT02815644|Linagliptin|linagliptin|mesh-list
6249249|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6249250|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249251|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6249252|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249253|NCT02815644|Incretins|incretins|mesh-ancestor
6249254|NCT02815644|Hormones|hormones|mesh-ancestor
6249255|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249256|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6249257|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
6249258|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249259|NCT02815709|Morphine|morphine|mesh-list
6249260|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6249261|NCT02815709|Narcotics|narcotics|mesh-ancestor
6249262|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249263|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249264|NCT02815709|Analgesics|analgesics|mesh-ancestor
6249265|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
6249266|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249267|NCT02816138|Nicotine|nicotine|mesh-list
6249268|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6249269|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
6249270|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249271|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249272|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6249273|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6249274|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
6249275|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6249276|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249277|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
6249278|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
6249279|NCT02817555|Hematinics|hematinics|mesh-ancestor
6249280|NCT02817763|Dipyrone|dipyrone|mesh-list
6249281|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6249282|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249283|NCT02817763|Analgesics|analgesics|mesh-ancestor
6249284|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
6249285|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249286|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249287|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249288|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249289|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
6249290|NCT02817828|Drospirenone|drospirenone|mesh-list
6249291|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6249292|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
6249293|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249294|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249295|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6249296|NCT02817828|Diuretics|diuretics|mesh-ancestor
6249297|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
6249298|NCT02817841|Drospirenone|drospirenone|mesh-list
6249299|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6249300|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
6249301|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249302|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249303|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6249304|NCT02817841|Diuretics|diuretics|mesh-ancestor
6249305|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
6249306|NCT02818036|Naltrexone|naltrexone|mesh-list
6249307|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6249308|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6249309|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249310|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
6249311|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249312|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
6249313|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6249314|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249315|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249316|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249317|NCT02818569|Analgesics|analgesics|mesh-ancestor
6249318|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
6249319|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249320|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6249321|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6249322|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6249323|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
6249324|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6249325|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249326|NCT02818777|Cannabidiol|cannabidiol|mesh-list
6249327|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
6249328|NCT02818998|Aflibercept|aflibercept|mesh-list
6249329|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6249330|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6249331|NCT02818998|Growth Substances|growth substances|mesh-ancestor
6249332|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249333|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
6249334|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249335|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
6249336|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6249337|NCT02819297|Laxatives|laxatives|mesh-list
6249338|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6249339|NCT02819310|Laxatives|laxatives|mesh-list
6249340|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6249341|NCT02819479|Bevacizumab|bevacizumab|mesh-list
6249342|NCT02819479|Mannitol|mannitol|mesh-list
6249343|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6249344|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249345|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6249346|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6249347|NCT02819479|Growth Substances|growth substances|mesh-ancestor
6249348|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249349|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
6249350|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
6249351|NCT02819479|Diuretics|diuretics|mesh-ancestor
6249352|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
6249353|NCT02819726|Rituximab|rituximab|mesh-list
6249354|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6249355|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249356|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
6249357|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249358|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249359|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
6249360|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6249361|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249362|NCT02820324|Morphine|morphine|mesh-list
6249363|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6249364|NCT02820324|Narcotics|narcotics|mesh-ancestor
6249365|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249366|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249367|NCT02820324|Analgesics|analgesics|mesh-ancestor
6249368|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
6249369|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249370|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6249371|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249372|NCT02821338|Lamotrigine|lamotrigine|mesh-list
6249373|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
6249374|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6249375|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6249376|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249377|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6249378|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249379|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6249380|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6249381|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249382|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6249383|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6249384|NCT02821416|Benralizumab|benralizumab|mesh-list
6249385|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6249386|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
6249387|NCT02821715|Flecainide|flecainide|mesh-list
6249388|NCT02821715|Modafinil|modafinil|mesh-list
6249389|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6249390|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249391|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
6249392|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6249393|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6249394|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249395|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6249396|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6249397|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6249398|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6249399|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
6249400|NCT02821819|Hormones|hormones|mesh-ancestor
6249401|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249402|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249403|NCT02821910|Metformin|metformin|mesh-list
6249404|NCT02821910|Empagliflozin|empagliflozin|mesh-list
6249405|NCT02821910|Linagliptin|linagliptin|mesh-list
6249406|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6249407|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249408|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6249409|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249410|NCT02821910|Incretins|incretins|mesh-ancestor
6249411|NCT02821910|Hormones|hormones|mesh-ancestor
6249412|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249413|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6249414|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
6249415|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249416|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
6249417|NCT02822222|Cathartics|cathartics|mesh-ancestor
6249418|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6249419|NCT02822794|Ribavirin|ribavirin|mesh-list
6249420|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
6249421|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6249422|NCT02822794|Velpatasvir|velpatasvir|mesh-list
6249423|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
6249424|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249425|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
6249426|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249427|NCT02822950|Ceftazidime|ceftazidime|mesh-list
6249428|NCT02822950|Avibactam|avibactam|mesh-list
6249429|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
6249430|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6249431|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249432|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6249433|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249434|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249435|NCT02823080|Cetrorelix|cetrorelix|mesh-list
6249436|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6249437|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
6249438|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6249439|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249440|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
6249441|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249442|NCT02823431|Lidocaine|lidocaine|mesh-list
6249443|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
6249444|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
6249445|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249446|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249447|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
6249448|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249449|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6249450|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6249451|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6249452|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6249453|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249454|NCT02823470|Ivacaftor|ivacaftor|mesh-list
6249455|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6249456|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6249457|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249458|NCT02824224|Tamoxifen|tamoxifen|mesh-list
6249459|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6249460|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
6249461|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249462|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249463|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6249464|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249465|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6249466|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6249467|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6249468|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6249469|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6249470|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
6249471|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6249472|NCT02825212|Ledipasvir|ledipasvir|mesh-list
6249473|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6249474|NCT02825212|Velpatasvir|velpatasvir|mesh-list
6249475|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
6249476|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249477|NCT02825251|Insulin|insulin|mesh-list
6249478|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6249479|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
6249480|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
6249481|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6249482|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6249483|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249484|NCT02825420|Trabectedin|trabectedin|mesh-list
6249485|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6249486|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
6249487|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249488|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249489|NCT02826603|Ustekinumab|ustekinumab|mesh-list
6249490|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
6249491|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
6249492|NCT02828358|Leucovorin|leucovorin|mesh-list
6249493|NCT02828358|Folic Acid|folic acid|mesh-list
6249494|NCT02828358|Cytarabine|cytarabine|mesh-list
6249495|NCT02828358|Dexamethasone|dexamethasone|mesh-list
6249496|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
6249497|NCT02828358|Prednisolone|prednisolone|mesh-list
6249498|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6249499|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
6249500|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6249501|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
6249502|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
6249503|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
6249504|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
6249505|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
6249506|NCT02828358|Cortisone|cortisone|mesh-list
6249507|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
6249508|NCT02828358|Methotrexate|methotrexate|mesh-list
6249509|NCT02828358|Vincristine|vincristine|mesh-list
6249510|NCT02828358|Azacitidine|azacitidine|mesh-list
6249511|NCT02828358|Daunorubicin|daunorubicin|mesh-list
6249512|NCT02828358|Asparaginase|asparaginase|mesh-list
6249513|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
6249514|NCT02828358|Pegaspargase|pegaspargase|mesh-list
6249515|NCT02828358|Thioguanine|thioguanine|mesh-list
6249516|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6249517|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
6249518|NCT02828358|BB 1101|bb 1101|mesh-list
6249519|NCT02828358|Calcium|calcium|mesh-list
6249520|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
6249521|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
6249522|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6249523|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
6249524|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249525|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249526|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6249527|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
6249528|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249529|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249530|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6249531|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249532|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
6249533|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
6249534|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249535|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6249536|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
6249537|NCT02828358|Hormones|hormones|mesh-ancestor
6249538|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249539|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6249540|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
6249541|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249542|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6249543|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6249544|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6249545|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
6249546|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6249547|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6249548|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
6249549|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
6249550|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6249551|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6249552|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
6249553|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249554|NCT02828358|Antidotes|antidotes|mesh-ancestor
6249555|NCT02828358|Protective Agents|protective agents|mesh-ancestor
6249556|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
6249557|NCT02828358|Vitamins|vitamins|mesh-ancestor
6249558|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
6249559|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6249560|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
6249561|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
6249562|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
6249563|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6249564|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6249565|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6249566|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6249567|NCT02828358|Hematinics|hematinics|mesh-ancestor
6249568|NCT02829034|Ranolazine|ranolazine|mesh-list
6249569|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6249570|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6249571|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249572|NCT02829775|Interferons|interferons|mesh-list
6249573|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
6249574|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
6249575|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6249576|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249577|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
6249578|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249579|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
6249580|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249586|NCT02829944|Ketorolac|ketorolac|mesh-list
6249587|NCT02829944|Ropivacaine|ropivacaine|mesh-list
6249588|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
6249589|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
6249590|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249591|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249592|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
6249593|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249594|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6249595|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249596|NCT02829944|Analgesics|analgesics|mesh-ancestor
6249597|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249598|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249599|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6249600|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249601|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249602|NCT02829983|Clarithromycin|clarithromycin|mesh-list
6249603|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6249604|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249605|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6249606|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249607|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249608|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6249609|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6249610|NCT02829996|Latanoprost|latanoprost|mesh-list
6249611|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6249612|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6249613|NCT02830776|Bimatoprost|bimatoprost|mesh-list
6249614|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6249615|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6249616|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6249617|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6249618|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6249619|NCT02831569|Loxoprofen|loxoprofen|mesh-list
6249620|NCT02831569|Methocarbamol|methocarbamol|mesh-list
6249621|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6249622|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249623|NCT02831569|Analgesics|analgesics|mesh-ancestor
6249624|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
6249625|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249626|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249627|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249628|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249629|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6249630|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6249631|NCT02831816|Ethanol|ethanol|mesh-list
6249632|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
6249633|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6249634|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6249635|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249636|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249637|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249638|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
6249639|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
6249640|NCT02831855|Methotrexate|methotrexate|mesh-list
6249641|NCT02831855|Tofacitinib|tofacitinib|mesh-list
6249642|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6249643|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
6249644|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6249645|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249646|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6249647|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
6249648|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249649|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249650|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
6249651|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249652|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6249653|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6249654|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
6249655|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249656|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6249657|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6249658|NCT02831998|Ethanol|ethanol|mesh-list
6249659|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
6249660|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6249661|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6249662|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249663|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249664|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249665|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
6249666|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
6249667|NCT02832037|BI 425809|bi 425809|mesh-list
6249668|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
6249669|NCT02832115|Lidocaine|lidocaine|mesh-list
6249670|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
6249671|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
6249672|NCT02832115|Anesthetics|anesthetics|mesh-list
6249673|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249674|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249675|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
6249676|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249677|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6249678|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6249679|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6249680|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6249681|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249682|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
6249683|NCT02832167|Nivolumab|nivolumab|mesh-list
6249684|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6249685|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249686|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6249687|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249688|NCT02832375|Fluorides|fluorides|mesh-list
6249689|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
6249690|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
6249691|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
6249692|NCT02832375|Protective Agents|protective agents|mesh-ancestor
6249693|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249694|NCT02833350|Folic Acid|folic acid|mesh-list
6249695|NCT02833350|Adalimumab|adalimumab|mesh-list
6249696|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249697|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249698|NCT02833350|Hematinics|hematinics|mesh-ancestor
6249699|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
6249700|NCT02833350|Vitamins|vitamins|mesh-ancestor
6249701|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
6249702|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249703|NCT02833415|Empagliflozin|empagliflozin|mesh-list
6249704|NCT02833415|Glycerol|glycerol|mesh-list
6249705|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6249706|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249707|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6249708|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249709|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6249710|NCT02833415|Protective Agents|protective agents|mesh-ancestor
6249711|NCT02833844|Evolocumab|evolocumab|mesh-list
6249712|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6249713|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6249714|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
6249715|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249716|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6249717|NCT02833948|Aspirin|aspirin|mesh-list
6249718|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
6249719|NCT02833948|Clopidogrel|clopidogrel|mesh-list
6249720|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6249721|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6249722|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6249723|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6249724|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
6249725|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6249726|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249727|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249728|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6249729|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
6249730|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6249731|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
6249732|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249733|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
6249734|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6249735|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249736|NCT02833948|Analgesics|analgesics|mesh-ancestor
6249737|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
6249738|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249739|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249740|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249741|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6249742|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6249743|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6249744|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
6249745|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6249746|NCT02834247|Nivolumab|nivolumab|mesh-list
6249747|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6249748|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249749|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6249750|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249751|NCT02834390|Cytarabine|cytarabine|mesh-list
6249752|NCT02834390|Daunorubicin|daunorubicin|mesh-list
6249753|NCT02834390|Idarubicin|idarubicin|mesh-list
6249754|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6249755|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
6249756|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249757|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249758|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
6249759|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249760|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6249761|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
6249762|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249763|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6249764|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6249765|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6249766|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249767|NCT02834624|Poractant alfa|poractant alfa|mesh-list
6249768|NCT02834624|Calfactant|calfactant|mesh-list
6249769|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
6249770|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
6249771|NCT02834663|Ranibizumab|ranibizumab|mesh-list
6249772|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6249773|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6249774|NCT02834663|Growth Substances|growth substances|mesh-ancestor
6249775|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249776|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
6249777|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249778|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
6249779|NCT02835339|Analgesics|analgesics|mesh-ancestor
6249780|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
6249781|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249782|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249783|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
6249784|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249785|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6249786|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
6249787|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6249788|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6249789|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249790|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6249791|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
6249792|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6249793|NCT02835846|Estrogens|estrogens|mesh-list
6249794|NCT02835846|Hormones|hormones|mesh-ancestor
6249795|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249796|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249797|NCT02836496|Prednisone|prednisone|mesh-list
6249798|NCT02836496|Prednisolone|prednisolone|mesh-list
6249799|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249800|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
6249801|NCT02836496|Hormones|hormones|mesh-ancestor
6249802|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249803|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249804|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6249805|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249806|NCT02836652|Aspirin|aspirin|mesh-list
6249807|NCT02836652|Warfarin|warfarin|mesh-list
6249808|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6249809|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249810|NCT02836652|Analgesics|analgesics|mesh-ancestor
6249811|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
6249812|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249813|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249814|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249815|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249816|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6249817|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6249818|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249819|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6249820|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6249821|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249822|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
6249823|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
6249824|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
6249825|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6249826|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249827|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
6249828|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
6249829|NCT02837237|Hormones|hormones|mesh-ancestor
6249830|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249831|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249832|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
6249833|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6249834|NCT02837237|Diuretics|diuretics|mesh-ancestor
6249835|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
6249836|NCT02837744|Hemostatics|hemostatics|mesh-list
6249837|NCT02837744|Coagulants|coagulants|mesh-ancestor
6249838|NCT02838134|Rocuronium|rocuronium|mesh-list
6249839|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6249840|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6249841|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6249842|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249843|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249844|NCT02838420|Crizotinib|crizotinib|mesh-list
6249845|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249846|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6249847|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249848|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249849|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
6249850|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249851|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249852|NCT02839200|Zolpidem|zolpidem|mesh-list
6249853|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6249854|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6249855|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6249856|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249857|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
6249858|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
6249859|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
6249860|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6249861|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249862|NCT02839681|Maytansine|maytansine|mesh-list
6249863|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6249864|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249865|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
6249866|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
6249867|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
6249868|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249869|NCT02839772|Glycerol|glycerol|mesh-list
6249870|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
6249871|NCT02839772|Protective Agents|protective agents|mesh-ancestor
6249872|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249873|NCT02839876|Acetaminophen|acetaminophen|mesh-list
6249874|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249875|NCT02839876|Analgesics|analgesics|mesh-ancestor
6249876|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
6249877|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249878|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249879|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
6249880|NCT02839889|Naloxegol|naloxegol|mesh-list
6249881|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6249882|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249883|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
6249884|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249885|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
6249886|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6249887|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6249888|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249889|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
6249890|NCT02840097|Coagulants|coagulants|mesh-ancestor
6249891|NCT02840461|Ivermectin|ivermectin|mesh-list
6249892|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6249893|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249894|NCT02841033|Daratumumab|daratumumab|mesh-list
6249895|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249896|NCT02841241|Esmolol|esmolol|mesh-list
6249897|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6249898|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6249899|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6249900|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
6249901|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6249902|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249903|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249904|NCT02842073|Naltrexone|naltrexone|mesh-list
6249905|NCT02842073|Bupropion|bupropion|mesh-list
6249906|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6249907|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6249908|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249909|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
6249910|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249911|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6249912|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
6249913|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6249914|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6249915|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6249916|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6249917|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249918|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
6249919|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6249920|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6249921|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6249922|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249923|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6249924|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
6249925|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6249926|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6249927|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249928|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249929|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
6249930|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6249931|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6249932|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6249933|NCT02842853|Vaccines|vaccines|mesh-list
6249934|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
6249935|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249936|NCT02842866|Vaccines|vaccines|mesh-list
6249937|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
6249938|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249939|NCT02844439|XL647|xl647|mesh-list
6249940|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249941|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6249942|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249943|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249944|NCT02844582|Prednisone|prednisone|mesh-list
6249945|NCT02844582|Cortisone|cortisone|mesh-list
6249946|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249947|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
6249948|NCT02844582|Hormones|hormones|mesh-ancestor
6249949|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6249950|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249951|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6249952|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6249953|NCT02845336|Celecoxib|celecoxib|mesh-list
6249954|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
6249955|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6249956|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6249957|NCT02845336|Analgesics|analgesics|mesh-ancestor
6249958|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
6249959|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249960|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249961|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6249962|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6249963|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6249964|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6249965|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249966|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249967|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6249968|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6249969|NCT02845375|Neostigmine|neostigmine|mesh-list
6249970|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6249971|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6249972|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249973|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
6249974|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6249975|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249976|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6249977|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
6249978|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249979|NCT02845752|Bromides|bromides|mesh-list
6249980|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
6249981|NCT02845752|Olodaterol|olodaterol|mesh-list
6249982|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6249983|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
6249984|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6249985|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6249986|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6249987|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
6249988|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
6249989|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6249990|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
6249991|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6249992|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6249993|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
6249994|NCT02846233|Metformin|metformin|mesh-list
6249995|NCT02846233|Empagliflozin|empagliflozin|mesh-list
6249996|NCT02846233|Dulaglutide|dulaglutide|mesh-list
6249997|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6249998|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
6249999|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6250000|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250001|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250002|NCT02846233|Incretins|incretins|mesh-ancestor
6250003|NCT02846233|Hormones|hormones|mesh-ancestor
6250004|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250005|NCT02846792|Nivolumab|nivolumab|mesh-list
6250006|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250007|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250008|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6250009|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250010|NCT02847260|Treprostinil|treprostinil|mesh-list
6250011|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6250012|NCT02847494|Dexamethasone|dexamethasone|mesh-list
6250013|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
6250014|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6250015|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6250016|NCT02847494|Prednisolone|prednisolone|mesh-list
6250017|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
6250018|NCT02847494|Metoclopramide|metoclopramide|mesh-list
6250019|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6250020|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
6250021|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6250022|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
6250023|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
6250024|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250025|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250026|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6250027|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
6250028|NCT02847494|Hormones|hormones|mesh-ancestor
6250029|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250030|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6250031|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250032|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6250033|NCT02847494|Protective Agents|protective agents|mesh-ancestor
6250034|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6250035|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6250036|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
6250037|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250038|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250039|NCT02848599|Morphine|morphine|mesh-list
6250040|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
6250041|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6250042|NCT02848599|Narcotics|narcotics|mesh-ancestor
6250043|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6250044|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250045|NCT02848599|Analgesics|analgesics|mesh-ancestor
6250046|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
6250047|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250048|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
6250049|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
6250050|NCT02848651|Atezolizumab|atezolizumab|mesh-list
6250051|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250052|NCT02848729|Acetaminophen|acetaminophen|mesh-list
6250053|NCT02848729|Morphine|morphine|mesh-list
6250054|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6250055|NCT02848729|Narcotics|narcotics|mesh-ancestor
6250056|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6250057|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250058|NCT02848729|Analgesics|analgesics|mesh-ancestor
6250059|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
6250060|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250061|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6250062|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
6250063|NCT02848833|Empagliflozin|empagliflozin|mesh-list
6250064|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6250065|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250066|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6250067|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250068|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6250069|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6250070|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250071|NCT02849080|Incretins|incretins|mesh-ancestor
6250072|NCT02849080|Hormones|hormones|mesh-ancestor
6250073|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250074|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6250075|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
6250076|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250077|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250078|NCT02849184|Suvorexant|suvorexant|mesh-list
6250079|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6250080|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6250081|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6250082|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250083|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6250084|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250085|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250086|NCT02849509|Vitamin K|vitamin k|mesh-list
6250087|NCT02849509|Dabigatran|dabigatran|mesh-list
6250088|NCT02849509|Vitamins|vitamins|mesh-ancestor
6250089|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
6250090|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250091|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
6250092|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6250093|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
6250094|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250095|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250096|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
6250097|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6250098|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6250099|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
6250100|NCT02849509|Coagulants|coagulants|mesh-ancestor
6250101|NCT02849678|Lidocaine|lidocaine|mesh-list
6250102|NCT02849678|Ropivacaine|ropivacaine|mesh-list
6250103|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
6250104|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
6250105|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6250106|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250107|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
6250108|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250109|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6250110|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6250111|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6250112|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6250113|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250114|NCT02849704|Pancrelipase|pancrelipase|mesh-list
6250115|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6250116|NCT02850276|Bromides|bromides|mesh-list
6250117|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
6250118|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
6250119|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6250120|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250121|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250122|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250123|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250124|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250125|NCT02850601|Dexamethasone|dexamethasone|mesh-list
6250126|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6250127|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
6250128|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
6250129|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250130|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250131|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6250132|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
6250133|NCT02850601|Hormones|hormones|mesh-ancestor
6250134|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250135|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6250136|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250137|NCT02850965|Adalimumab|adalimumab|mesh-list
6250138|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6250139|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6250140|NCT02851108|Primaquine|primaquine|mesh-list
6250141|NCT02851108|Phenothiazine|phenothiazine|mesh-list
6250142|NCT02851108|Methylene Blue|methylene blue|mesh-list
6250143|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
6250144|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6250145|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6250146|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250147|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250148|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250149|NCT02852005|Vaccines|vaccines|mesh-list
6250150|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
6250151|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250152|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
6250153|NCT02852265|Etonogestrel|etonogestrel|mesh-list
6250154|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6250155|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250156|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6250157|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6250158|NCT02852434|Lidocaine|lidocaine|mesh-list
6250159|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
6250160|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
6250161|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6250162|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250163|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
6250164|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250165|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6250166|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6250167|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6250168|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6250169|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250170|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
6250171|NCT02853123|Olodaterol|olodaterol|mesh-list
6250172|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6250173|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
6250174|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250175|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250176|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6250177|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
6250178|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
6250179|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6250180|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250181|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250182|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250183|NCT02853305|Gemcitabine|gemcitabine|mesh-list
6250184|NCT02853305|Carboplatin|carboplatin|mesh-list
6250185|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
6250186|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250187|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6250188|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
6250189|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250190|NCT02853305|Antiviral Agents|antiviral agents|mesh-ancestor
6250191|NCT02853305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250192|NCT02853305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250193|NCT02853305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250194|NCT02853305|Immunologic Factors|immunologic factors|mesh-ancestor
6250195|NCT02853305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250196|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250197|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
6250198|NCT02853318|Bevacizumab|bevacizumab|mesh-list
6250199|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
6250200|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6250201|NCT02853318|Antibodies|antibodies|mesh-list
6250202|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
6250203|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6250204|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
6250205|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
6250206|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250207|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
6250208|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250209|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6250210|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6250211|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
6250212|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250213|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250214|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6250215|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6250216|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6250217|NCT02853318|Growth Substances|growth substances|mesh-ancestor
6250218|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
6250219|NCT02854527|Metformin|metformin|mesh-list
6250220|NCT02854527|Digoxin|digoxin|mesh-list
6250221|NCT02854527|Furosemide|furosemide|mesh-list
6250222|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6250223|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6250224|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250225|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6250226|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6250227|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
6250228|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250229|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6250230|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6250231|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250232|NCT02854527|Diuretics|diuretics|mesh-ancestor
6250233|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
6250234|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6250235|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6250236|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6250237|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6250238|NCT02854527|Protective Agents|protective agents|mesh-ancestor
6250239|NCT02854631|Prednisolone|prednisolone|mesh-list
6250240|NCT02854631|Selonsertib|selonsertib|mesh-list
6250241|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6250242|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
6250243|NCT02854631|Hormones|hormones|mesh-ancestor
6250244|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250245|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250246|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6250247|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250248|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6250249|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250250|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250251|NCT02854800|Varenicline|varenicline|mesh-list
6250252|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6250253|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6250254|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250255|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250256|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250257|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250258|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
6250259|NCT02855086|Cetuximab|cetuximab|mesh-list
6250260|NCT02855086|Antibodies|antibodies|mesh-list
6250261|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
6250262|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6250263|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
6250264|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250265|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250266|NCT02855359|Prednisone|prednisone|mesh-list
6250267|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
6250268|NCT02855359|Rituximab|rituximab|mesh-list
6250269|NCT02855359|Doxorubicin|doxorubicin|mesh-list
6250270|NCT02855359|Vincristine|vincristine|mesh-list
6250271|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250272|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
6250273|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250274|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6250275|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6250276|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
6250277|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250278|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250279|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6250280|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250281|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6250282|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6250283|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6250284|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250285|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6250286|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
6250287|NCT02855359|Hormones|hormones|mesh-ancestor
6250288|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250289|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6250290|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6250291|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
6250292|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
6250293|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
6250294|NCT02856555|Firsocostat|firsocostat|mesh-list
6250295|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250296|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250297|NCT02856802|Sumatriptan|sumatriptan|mesh-list
6250298|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6250299|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6250300|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6250301|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
6250302|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250303|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250304|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250305|NCT02856880|Zinc|zinc|mesh-list
6250306|NCT02856880|Trace Elements|trace elements|mesh-ancestor
6250307|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
6250308|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250309|NCT02858076|Aflibercept|aflibercept|mesh-list
6250310|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
6250311|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6250312|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6250313|NCT02858076|Growth Substances|growth substances|mesh-ancestor
6250314|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250315|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
6250316|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250317|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
6250318|NCT02858180|Ledipasvir|ledipasvir|mesh-list
6250319|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
6250320|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250321|NCT02858401|Vesatolimod|vesatolimod|mesh-list
6250322|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
6250323|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250324|NCT02858713|Betamethasone|betamethasone|mesh-list
6250325|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
6250326|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
6250327|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
6250328|NCT02858713|Calcipotriene|calcipotriene|mesh-list
6250329|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
6250330|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6250331|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
6250332|NCT02858713|Hormones|hormones|mesh-ancestor
6250333|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250334|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250335|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6250336|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
6250337|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
6250338|NCT02859142|Nicotine|nicotine|mesh-list
6250339|NCT02859142|Varenicline|varenicline|mesh-list
6250340|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6250341|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
6250342|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250343|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250344|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6250345|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6250346|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250347|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250348|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250349|NCT02859246|Guaifenesin|guaifenesin|mesh-list
6250350|NCT02859246|Expectorants|expectorants|mesh-ancestor
6250351|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
6250352|NCT02859324|Nivolumab|nivolumab|mesh-list
6250353|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250354|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250355|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6250356|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250357|NCT02859441|Ranibizumab|ranibizumab|mesh-list
6250358|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6250359|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6250360|NCT02859441|Growth Substances|growth substances|mesh-ancestor
6250361|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250362|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
6250363|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250364|NCT02859454|Avelumab|avelumab|mesh-list
6250365|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250366|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250367|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
6250368|NCT02860507|Neostigmine|neostigmine|mesh-list
6250369|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6250370|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250371|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250372|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250373|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250374|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250375|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6250376|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
6250377|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250378|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6250379|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6250380|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6250381|NCT02860546|Nivolumab|nivolumab|mesh-list
6250382|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250383|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250384|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6250385|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250386|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6250387|NCT02860845|Clindamycin|clindamycin|mesh-list
6250388|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
6250389|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
6250390|NCT02860845|Clotrimazole|clotrimazole|mesh-list
6250391|NCT02860845|Miconazole|miconazole|mesh-list
6250392|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
6250393|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250394|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6250395|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250396|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250397|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6250398|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6250399|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6250400|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6250401|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
6250402|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250403|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250404|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6250405|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6250406|NCT02861131|Neostigmine|neostigmine|mesh-list
6250407|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6250408|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250409|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250410|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250411|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250412|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250413|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6250414|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
6250415|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250416|NCT02861586|Vaccines|vaccines|mesh-list
6250417|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
6250418|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250419|NCT02861664|Fluorides|fluorides|mesh-list
6250420|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
6250421|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
6250422|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
6250423|NCT02861664|Protective Agents|protective agents|mesh-ancestor
6250424|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250425|NCT02862106|Vaccines|vaccines|mesh-list
6250426|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
6250427|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250428|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
6250429|NCT02862535|Nivolumab|nivolumab|mesh-list
6250430|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250431|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250432|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6250433|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250434|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
6250435|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250436|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
6250437|NCT02862574|Methotrexate|methotrexate|mesh-list
6250438|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6250439|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
6250440|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6250441|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250442|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6250443|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
6250444|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250445|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250446|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
6250447|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250448|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6250449|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250450|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
6250451|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6250452|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6250453|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6250454|NCT02862600|Perhexiline|perhexiline|mesh-list
6250455|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6250456|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6250457|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250458|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6250459|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250460|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
6250461|NCT02862730|Pancrelipase|pancrelipase|mesh-list
6250462|NCT02862730|Pancreatin|pancreatin|mesh-list
6250463|NCT02862730|Hormones|hormones|mesh-list
6250464|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250465|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250466|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6250467|NCT02862912|Fentanyl|fentanyl|mesh-list
6250468|NCT02862912|Bupivacaine|bupivacaine|mesh-list
6250469|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
6250470|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
6250471|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
6250472|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6250473|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250474|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
6250475|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250476|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6250477|NCT02862912|Narcotics|narcotics|mesh-ancestor
6250478|NCT02862912|Analgesics|analgesics|mesh-ancestor
6250479|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6250480|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6250481|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
6250482|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
6250483|NCT02863263|Povidone|povidone|mesh-list
6250484|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
6250485|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
6250486|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6250487|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250488|NCT02863328|Empagliflozin|empagliflozin|mesh-list
6250489|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6250490|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250491|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6250492|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250493|NCT02863354|Aflibercept|aflibercept|mesh-list
6250494|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6250495|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6250496|NCT02863354|Growth Substances|growth substances|mesh-ancestor
6250497|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250498|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
6250499|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250500|NCT02863419|Liraglutide|liraglutide|mesh-list
6250501|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6250502|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250503|NCT02863419|Incretins|incretins|mesh-ancestor
6250504|NCT02863419|Hormones|hormones|mesh-ancestor
6250505|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250506|NCT02863575|Ibuprofen|ibuprofen|mesh-list
6250507|NCT02863575|Caffeine|caffeine|mesh-list
6250508|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6250509|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6250510|NCT02863575|Analgesics|analgesics|mesh-ancestor
6250511|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
6250512|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250513|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250514|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6250515|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6250516|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6250517|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250518|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250519|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6250520|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6250521|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6250522|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6250523|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
6250524|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250525|NCT02864316|Nivolumab|nivolumab|mesh-list
6250526|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250527|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250528|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6250529|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250530|NCT02864368|Temozolomide|temozolomide|mesh-list
6250531|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6250532|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
6250533|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250534|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250535|NCT02864381|Nivolumab|nivolumab|mesh-list
6250536|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250537|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250538|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6250539|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250540|NCT02864394|Docetaxel|docetaxel|mesh-list
6250541|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
6250542|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250543|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
6250544|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
6250545|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
6250546|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250547|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250548|NCT02864706|Cyclosporine|cyclosporine|mesh-list
6250549|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
6250550|NCT02864706|Everolimus|everolimus|mesh-list
6250551|NCT02864706|Cyclosporins|cyclosporins|mesh-list
6250552|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250553|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250554|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250555|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
6250556|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250557|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
6250558|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250559|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
6250560|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6250561|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6250562|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250563|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6250564|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6250565|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
6250566|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6250567|NCT02865187|Vitamin D|vitamin d|mesh-list
6250568|NCT02865187|Vitamins|vitamins|mesh-ancestor
6250569|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
6250570|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250571|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6250572|NCT02865499|Acarbose|acarbose|mesh-list
6250573|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
6250574|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250575|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250576|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6250577|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250578|NCT02865590|Cimetidine|cimetidine|mesh-list
6250579|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6250580|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6250581|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6250582|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
6250583|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
6250584|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250585|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250586|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250587|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6250588|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6250589|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250590|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6250591|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6250592|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250593|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
6250594|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250595|NCT02865811|Doxorubicin|doxorubicin|mesh-list
6250596|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6250597|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
6250598|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6250599|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250600|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6250601|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6250602|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250603|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250604|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250605|NCT02866175|Vitamin K|vitamin k|mesh-list
6250606|NCT02866175|Edoxaban|edoxaban|mesh-list
6250607|NCT02866175|Clopidogrel|clopidogrel|mesh-list
6250608|NCT02866175|Ticagrelor|ticagrelor|mesh-list
6250609|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
6250610|NCT02866175|Vitamins|vitamins|mesh-ancestor
6250611|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
6250612|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250613|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6250614|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6250615|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6250616|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6250617|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
6250618|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250619|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250620|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6250621|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6250622|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
6250623|NCT02866175|Coagulants|coagulants|mesh-ancestor
6250624|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6250625|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
6250626|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6250627|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
6250628|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250629|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
6250630|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
6250631|NCT02866643|Etonogestrel|etonogestrel|mesh-list
6250632|NCT02866643|Desogestrel|desogestrel|mesh-list
6250633|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6250634|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250635|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6250636|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6250637|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6250638|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6250639|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6250640|NCT02866643|Progestins|progestins|mesh-ancestor
6250641|NCT02866643|Hormones|hormones|mesh-ancestor
6250642|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250643|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
6250644|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6250645|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6250646|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250647|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
6250648|NCT02867163|Coagulants|coagulants|mesh-ancestor
6250649|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
6250650|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6250651|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250652|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
6250653|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6250654|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
6250655|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250656|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
6250657|NCT02867605|Protective Agents|protective agents|mesh-ancestor
6250658|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6250659|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6250660|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
6250661|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6250662|NCT02868242|Ledipasvir|ledipasvir|mesh-list
6250663|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
6250664|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250665|NCT02869438|Benralizumab|benralizumab|mesh-list
6250666|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6250667|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
6250668|NCT02869451|Bupropion|bupropion|mesh-list
6250669|NCT02869451|Nicotine|nicotine|mesh-list
6250670|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6250671|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
6250672|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250673|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250674|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6250675|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6250676|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250677|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250678|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250679|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6250680|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
6250681|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6250682|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6250683|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6250684|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6250685|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
6250686|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6250687|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6250688|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250689|NCT02869893|Secretin|secretin|mesh-list
6250690|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6250691|NCT02869893|Hormones|hormones|mesh-ancestor
6250692|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250693|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250694|NCT02870283|Carbamazepine|carbamazepine|mesh-list
6250695|NCT02870283|Valproic Acid|valproic acid|mesh-list
6250696|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6250697|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250698|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250699|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
6250700|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6250701|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6250702|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250703|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
6250704|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
6250705|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250706|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6250707|NCT02870283|Analgesics|analgesics|mesh-ancestor
6250708|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
6250709|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250710|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6250711|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6250712|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6250713|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6250714|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6250715|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6250716|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6250717|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
6250718|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250719|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250720|NCT02870920|Durvalumab|durvalumab|mesh-list
6250721|NCT02870920|Tremelimumab|tremelimumab|mesh-list
6250722|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250723|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250724|NCT02870972|Berotralstat|berotralstat|mesh-list
6250725|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250726|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250727|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
6250728|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6250729|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
6250730|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250731|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250732|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6250733|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
6250734|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6250735|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
6250736|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250737|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250738|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
6250739|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
6250740|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
6250741|NCT02871011|Protective Agents|protective agents|mesh-ancestor
6250742|NCT02871492|Acyclovir|acyclovir|mesh-list
6250743|NCT02871492|Pritelivir|pritelivir|mesh-list
6250744|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
6250745|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250746|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250747|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250748|NCT02871635|Adalimumab|adalimumab|mesh-list
6250749|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6250750|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6250751|NCT02872012|Lidocaine|lidocaine|mesh-list
6250752|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
6250753|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
6250754|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6250755|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250756|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
6250757|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250758|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6250759|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6250760|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6250761|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6250762|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250763|NCT02872311|Vaccines|vaccines|mesh-list
6250764|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
6250765|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250766|NCT02872857|Galantamine|galantamine|mesh-list
6250767|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6250768|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250769|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250770|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250771|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250772|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250773|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6250774|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
6250775|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250776|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
6250777|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
6250778|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6250779|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6250780|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6250781|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250782|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250783|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250784|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250785|NCT02873338|Cytarabine|cytarabine|mesh-list
6250786|NCT02873338|Idarubicin|idarubicin|mesh-list
6250787|NCT02873338|Heparin|heparin|mesh-list
6250788|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6250789|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
6250790|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250791|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250792|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
6250793|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250794|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250795|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
6250796|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250797|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
6250798|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6250799|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6250800|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6250801|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6250802|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6250803|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250804|NCT02873377|Nicotine|nicotine|mesh-list
6250805|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6250806|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
6250807|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250808|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250809|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6250810|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6250811|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250812|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250813|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250814|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
6250815|NCT02873689|Lansoprazole|lansoprazole|mesh-list
6250816|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6250817|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6250818|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6250819|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250820|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250821|NCT02873702|Lansoprazole|lansoprazole|mesh-list
6250822|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
6250823|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6250824|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6250825|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6250826|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250827|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250828|NCT02873754|Bupropion|bupropion|mesh-list
6250829|NCT02873754|Nicotine|nicotine|mesh-list
6250830|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6250831|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
6250832|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6250833|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250834|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6250835|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6250836|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
6250837|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250838|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250839|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6250840|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
6250841|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6250842|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6250843|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6250844|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6250845|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
6250846|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6250847|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6250848|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250849|NCT02874092|Ticagrelor|ticagrelor|mesh-list
6250850|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6250851|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6250852|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6250853|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6250854|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
6250855|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250856|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250857|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250858|NCT02874794|Valsartan|valsartan|mesh-list
6250859|NCT02874794|Enalapril|enalapril|mesh-list
6250860|NCT02874794|Enalaprilat|enalaprilat|mesh-list
6250861|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6250862|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6250863|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6250864|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6250865|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250866|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6250867|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
6250868|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250869|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6250870|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6250871|NCT02874924|Sirolimus|sirolimus|mesh-list
6250872|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6250873|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250874|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6250875|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250876|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
6250877|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250878|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
6250879|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250880|NCT02875028|Vorapaxar|vorapaxar|mesh-list
6250881|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6250882|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
6250883|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
6250884|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250885|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250886|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250887|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
6250888|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
6250889|NCT02875340|Risperidone|risperidone|mesh-list
6250890|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6250891|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
6250892|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6250893|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250894|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250895|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6250896|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6250897|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6250898|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6250899|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6250900|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
6250901|NCT02875366|Ivacaftor|ivacaftor|mesh-list
6250902|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6250903|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6250904|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250905|NCT02875392|Fucoidan|fucoidan|mesh-list
6250906|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6250907|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6250908|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
6250909|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250910|NCT02875613|Avelumab|avelumab|mesh-list
6250911|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250912|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250913|NCT02876601|Defibrotide|defibrotide|mesh-list
6250914|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6250915|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6250916|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250917|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6250918|NCT02876900|Asenapine|asenapine|mesh-list
6250919|NCT02876900|Maleic acid|maleic acid|mesh-list
6250920|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250921|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250922|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6250923|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6250924|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6250925|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250926|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6250927|NCT02877082|Bortezomib|bortezomib|mesh-list
6250928|NCT02877082|Tacrolimus|tacrolimus|mesh-list
6250929|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
6250930|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
6250931|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250932|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
6250933|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250934|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6250935|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250936|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250937|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250938|NCT02877095|Furosemide|furosemide|mesh-list
6250939|NCT02877095|Diuretics|diuretics|mesh-ancestor
6250940|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
6250941|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250942|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
6250943|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6250944|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250945|NCT02877485|Triamcinolone|triamcinolone|mesh-list
6250946|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6250947|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6250948|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6250949|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6250950|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
6250951|NCT02877485|Hormones|hormones|mesh-ancestor
6250952|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6250953|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250954|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250955|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
6250956|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250957|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250958|NCT02877927|Linezolid|linezolid|mesh-list
6250959|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6250960|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250961|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6250962|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250963|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250964|NCT02878057|Apatinib|apatinib|mesh-list
6250965|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250966|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6250967|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250968|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250969|NCT02878382|Calcipotriene|calcipotriene|mesh-list
6250970|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
6250971|NCT02879318|Gemcitabine|gemcitabine|mesh-list
6250972|NCT02879318|Paclitaxel|paclitaxel|mesh-list
6250973|NCT02879318|Durvalumab|durvalumab|mesh-list
6250974|NCT02879318|Tremelimumab|tremelimumab|mesh-list
6250975|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6250976|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250977|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
6250978|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
6250979|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
6250980|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6250981|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6250982|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
6250983|NCT02879318|Antiviral Agents|antiviral agents|mesh-ancestor
6250984|NCT02879318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6250985|NCT02879318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6250986|NCT02879318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6250987|NCT02879318|Immunologic Factors|immunologic factors|mesh-ancestor
6250988|NCT02879318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6250989|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250990|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
6250991|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6250992|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6250993|NCT02880228|Dexamethasone|dexamethasone|mesh-list
6250994|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
6250995|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
6250996|NCT02880228|Lenalidomide|lenalidomide|mesh-list
6250997|NCT02880228|Ichthammol|ichthammol|mesh-list
6250998|NCT02880228|BB 1101|bb 1101|mesh-list
6250999|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251000|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
6251001|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
6251002|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251003|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251004|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6251005|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
6251006|NCT02880228|Hormones|hormones|mesh-ancestor
6251007|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6251008|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6251009|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251010|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251011|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
6251012|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6251013|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6251014|NCT02880228|Growth Substances|growth substances|mesh-ancestor
6251015|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
6251016|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
6251017|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251018|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251019|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
6251020|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
6251021|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251022|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
6251023|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6251024|NCT02880852|Belimumab|belimumab|mesh-list
6251025|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6251026|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
6251027|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251028|NCT02880865|Vaccines|vaccines|mesh-list
6251029|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
6251030|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251031|NCT02881008|Entecavir|entecavir|mesh-list
6251032|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
6251033|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6251034|NCT02881567|Daclizumab|daclizumab|mesh-list
6251035|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6251036|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
6251037|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251038|NCT02881957|Vitamin D|vitamin d|mesh-list
6251039|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
6251040|NCT02881957|Vitamins|vitamins|mesh-ancestor
6251041|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
6251042|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251043|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6251044|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6251045|NCT02881996|Acetaminophen|acetaminophen|mesh-list
6251046|NCT02881996|Ketorolac|ketorolac|mesh-list
6251047|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6251048|NCT02881996|Analgesics|analgesics|mesh-ancestor
6251049|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
6251050|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251051|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251052|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
6251053|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6251054|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251055|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251056|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6251057|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251058|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251059|NCT02882152|Morphine|morphine|mesh-list
6251060|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6251061|NCT02882152|Narcotics|narcotics|mesh-ancestor
6251062|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251063|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251064|NCT02882152|Analgesics|analgesics|mesh-ancestor
6251065|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
6251066|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251067|NCT02882633|Bupivacaine|bupivacaine|mesh-list
6251068|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
6251069|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
6251070|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251071|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251072|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
6251073|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251074|NCT02882711|Ketamine|ketamine|mesh-list
6251075|NCT02882711|Analgesics|analgesics|mesh-ancestor
6251076|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
6251077|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251078|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251079|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6251080|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6251081|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
6251082|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
6251083|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251084|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6251085|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6251086|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251087|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251088|NCT02882854|Guanfacine|guanfacine|mesh-list
6251089|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6251090|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6251091|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6251092|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6251093|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
6251094|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251095|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251096|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251097|NCT02883400|Spironolactone|spironolactone|mesh-list
6251098|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6251099|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
6251100|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6251101|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251102|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6251103|NCT02883400|Diuretics|diuretics|mesh-ancestor
6251104|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
6251105|NCT02883452|Infliximab|infliximab|mesh-list
6251106|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
6251107|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6251108|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251109|NCT02884089|Metformin|metformin|mesh-list
6251110|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6251111|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251112|NCT02885012|Ambrisentan|ambrisentan|mesh-list
6251113|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6251114|NCT02885025|Fluticasone|fluticasone|mesh-list
6251115|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251116|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6251117|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
6251118|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251119|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251120|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6251121|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
6251122|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
6251123|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6251124|NCT02885181|Methotrexate|methotrexate|mesh-list
6251125|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6251126|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
6251127|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6251128|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251129|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6251130|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
6251131|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251132|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251133|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
6251134|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251135|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6251136|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6251137|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
6251138|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251139|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6251140|NCT02885636|Albuterol|albuterol|mesh-list
6251141|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6251142|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
6251143|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251144|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251145|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6251146|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
6251147|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
6251148|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6251149|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6251150|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6251151|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6251152|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
6251153|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251154|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251155|NCT02886624|Grazoprevir|grazoprevir|mesh-list
6251156|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
6251157|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6251158|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
6251159|NCT02886702|Tazarotene|tazarotene|mesh-list
6251160|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
6251161|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
6251162|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
6251163|NCT02886702|Vitamins|vitamins|mesh-ancestor
6251164|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
6251165|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251166|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
6251167|NCT02886715|Tazarotene|tazarotene|mesh-list
6251168|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
6251169|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
6251170|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
6251171|NCT02886715|Vitamins|vitamins|mesh-ancestor
6251172|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
6251173|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251174|NCT02887183|Valsartan|valsartan|mesh-list
6251175|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6251176|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6251177|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6251178|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6251179|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251180|NCT02887404|Analgesics|analgesics|mesh-list
6251181|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
6251182|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251183|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251184|NCT02888106|Tenofovir|tenofovir|mesh-list
6251185|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6251186|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
6251187|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
6251188|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6251189|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6251190|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6251191|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251192|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251193|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6251194|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6251195|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251196|NCT02888665|Doxorubicin|doxorubicin|mesh-list
6251197|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
6251198|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
6251199|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6251200|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251201|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6251202|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6251203|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251204|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251205|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251206|NCT02889393|Teduglutide|teduglutide|mesh-list
6251207|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6251208|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6251209|NCT02889393|Protective Agents|protective agents|mesh-ancestor
6251210|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251211|NCT02889510|Liraglutide|liraglutide|mesh-list
6251212|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6251213|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251214|NCT02889510|Incretins|incretins|mesh-ancestor
6251215|NCT02889510|Hormones|hormones|mesh-ancestor
6251216|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6251217|NCT02889562|Warfarin|warfarin|mesh-list
6251218|NCT02889562|Apixaban|apixaban|mesh-list
6251219|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
6251220|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6251221|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
6251222|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6251223|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
6251224|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251225|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251226|NCT02889796|Adalimumab|adalimumab|mesh-list
6251227|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251228|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251229|NCT02889900|Olaparib|olaparib|mesh-list
6251230|NCT02889900|Cediranib|cediranib|mesh-list
6251231|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6251232|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251233|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251234|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251235|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6251236|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
6251237|NCT02890992|Niacin|niacin|mesh-list
6251238|NCT02890992|Niacinamide|niacinamide|mesh-list
6251239|NCT02890992|Ezetimibe|ezetimibe|mesh-list
6251240|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
6251241|NCT02890992|Fenofibrate|fenofibrate|mesh-list
6251242|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6251243|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6251244|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
6251245|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251246|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6251247|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
6251248|NCT02890992|Vitamins|vitamins|mesh-ancestor
6251249|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
6251250|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251251|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
6251252|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
6251253|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
6251254|NCT02891070|Coagulants|coagulants|mesh-ancestor
6251255|NCT02891174|Acetaminophen|acetaminophen|mesh-list
6251256|NCT02891174|Ibuprofen|ibuprofen|mesh-list
6251257|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6251258|NCT02891174|Analgesics|analgesics|mesh-ancestor
6251259|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
6251260|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251261|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251262|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
6251263|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6251264|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251265|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251266|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6251267|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251268|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251269|NCT02891408|Fenofibrate|fenofibrate|mesh-list
6251270|NCT02891408|Firsocostat|firsocostat|mesh-list
6251271|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6251272|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
6251273|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251274|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6251275|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251276|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
6251277|NCT02891850|Tadalafil|tadalafil|mesh-list
6251278|NCT02891850|Riociguat|riociguat|mesh-list
6251279|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
6251280|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6251281|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6251282|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251283|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251284|NCT02891850|Urological Agents|urological agents|mesh-ancestor
6251285|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
6251286|NCT02891915|Amoxicillin|amoxicillin|mesh-list
6251287|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
6251288|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
6251289|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6251290|NCT02891915|Cefdinir|cefdinir|mesh-list
6251291|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6251292|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6251293|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6251294|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251295|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251296|NCT02892110|Varenicline|varenicline|mesh-list
6251297|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6251298|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6251299|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
6251300|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251301|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251302|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251303|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
6251304|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251305|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
6251306|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6251307|NCT02892409|Amoxicillin|amoxicillin|mesh-list
6251308|NCT02892409|Clarithromycin|clarithromycin|mesh-list
6251309|NCT02892409|Lansoprazole|lansoprazole|mesh-list
6251310|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
6251311|NCT02892409|Bismuth|bismuth|mesh-list
6251312|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6251313|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6251314|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6251315|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251316|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251317|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6251318|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6251319|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6251320|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6251321|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6251322|NCT02892409|Antacids|antacids|mesh-ancestor
6251323|NCT02892734|Nivolumab|nivolumab|mesh-list
6251324|NCT02892734|Ipilimumab|ipilimumab|mesh-list
6251325|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251326|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251327|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6251328|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251329|NCT02895035|Ketorolac|ketorolac|mesh-list
6251330|NCT02895035|Phenylephrine|phenylephrine|mesh-list
6251331|NCT02895035|Epinephrine|epinephrine|mesh-list
6251332|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
6251333|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6251334|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6251335|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
6251336|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251337|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251338|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251339|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6251340|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6251341|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
6251342|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251343|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6251344|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
6251345|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
6251346|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
6251347|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6251348|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6251349|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6251350|NCT02895035|Analgesics|analgesics|mesh-ancestor
6251351|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
6251352|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251353|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251354|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6251355|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251356|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6251357|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
6251358|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6251359|NCT02895035|Protective Agents|protective agents|mesh-ancestor
6251360|NCT02895945|Factor VIII|factor viii|mesh-list
6251361|NCT02895945|Coagulants|coagulants|mesh-ancestor
6251362|NCT02896296|Buprenorphine|buprenorphine|mesh-list
6251363|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6251364|NCT02896296|Narcotics|narcotics|mesh-ancestor
6251365|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251366|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251367|NCT02896296|Analgesics|analgesics|mesh-ancestor
6251368|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
6251369|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251370|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6251371|NCT02896400|Nicotine|nicotine|mesh-list
6251372|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6251373|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
6251374|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251375|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251376|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6251377|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6251378|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
6251379|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251380|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251381|NCT02896595|Anesthetics|anesthetics|mesh-list
6251382|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251383|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251384|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
6251385|NCT02896907|Vitamins|vitamins|mesh-list
6251386|NCT02896907|Leucovorin|leucovorin|mesh-list
6251387|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
6251388|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
6251389|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
6251390|NCT02896907|Fluorouracil|fluorouracil|mesh-list
6251391|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
6251392|NCT02896907|Irinotecan|irinotecan|mesh-list
6251393|NCT02896907|Camptothecin|camptothecin|mesh-list
6251394|NCT02896907|Calcium|calcium|mesh-list
6251395|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
6251396|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
6251397|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251398|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6251399|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6251400|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
6251401|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251402|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6251403|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251404|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6251405|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
6251406|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6251407|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6251408|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251409|NCT02896907|Antidotes|antidotes|mesh-ancestor
6251410|NCT02896907|Protective Agents|protective agents|mesh-ancestor
6251411|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
6251412|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
6251413|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6251414|NCT02897115|Adalimumab|adalimumab|mesh-list
6251415|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6251416|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
6251417|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251418|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6251419|NCT02897115|Analgesics|analgesics|mesh-ancestor
6251420|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
6251421|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251422|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251423|NCT02897349|Linagliptin|linagliptin|mesh-list
6251424|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6251425|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251426|NCT02897349|Incretins|incretins|mesh-ancestor
6251427|NCT02897349|Hormones|hormones|mesh-ancestor
6251428|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6251429|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6251430|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
6251431|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251432|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251433|NCT02898077|Paclitaxel|paclitaxel|mesh-list
6251434|NCT02898077|Ramucirumab|ramucirumab|mesh-list
6251435|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6251436|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251437|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
6251438|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
6251439|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
6251440|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251441|NCT02898116|Durvalumab|durvalumab|mesh-list
6251442|NCT02898116|Ensartinib|ensartinib|mesh-list
6251443|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251444|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251445|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6251446|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251447|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251448|NCT02898259|Rituximab|rituximab|mesh-list
6251449|NCT02898259|Lenalidomide|lenalidomide|mesh-list
6251450|NCT02898259|Ixazomib|ixazomib|mesh-list
6251451|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251452|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251453|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
6251454|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251455|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251456|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6251457|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6251458|NCT02898259|Growth Substances|growth substances|mesh-ancestor
6251459|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
6251460|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
6251461|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251462|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251463|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
6251464|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251465|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
6251466|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6251467|NCT02899156|Flumazenil|flumazenil|mesh-list
6251468|NCT02899156|Antidotes|antidotes|mesh-ancestor
6251469|NCT02899156|Protective Agents|protective agents|mesh-ancestor
6251470|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251471|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
6251472|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
6251473|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251474|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251475|NCT02899195|Durvalumab|durvalumab|mesh-list
6251476|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251477|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251489|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6251490|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251491|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
6251492|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
6251493|NCT02899988|Mirikizumab|mirikizumab|mesh-list
6251494|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6251495|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6251496|NCT02899988|Analgesics|analgesics|mesh-ancestor
6251497|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
6251498|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251499|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251500|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251501|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251502|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6251503|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6251504|NCT02900092|Ganaxolone|ganaxolone|mesh-list
6251505|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
6251506|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251507|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251508|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251509|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
6251510|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
6251511|NCT02900378|Valsartan|valsartan|mesh-list
6251512|NCT02900378|Enalapril|enalapril|mesh-list
6251513|NCT02900378|Enalaprilat|enalaprilat|mesh-list
6251514|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6251515|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6251516|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6251517|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6251518|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251519|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6251520|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
6251521|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251522|NCT02901054|Ondansetron|ondansetron|mesh-list
6251523|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
6251524|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
6251525|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251526|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251527|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6251528|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
6251529|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
6251530|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6251531|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
6251532|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251533|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251534|NCT02901054|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6251535|NCT02901054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6251536|NCT02901054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251537|NCT02901054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6251538|NCT02901054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6251539|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
6251540|NCT02901249|Sertraline|sertraline|mesh-list
6251541|NCT02901249|Nortriptyline|nortriptyline|mesh-list
6251542|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
6251543|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6251544|NCT02901249|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6251545|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6251546|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6251547|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251548|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251549|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
6251550|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251551|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251552|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
6251553|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6251554|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251555|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6251556|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6251557|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
6251558|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
6251559|NCT02901899|Guadecitabine|guadecitabine|mesh-list
6251560|NCT02901899|Azacitidine|azacitidine|mesh-list
6251561|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251562|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251563|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6251564|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
6251565|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251566|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251567|NCT02902081|Cannabidiol|cannabidiol|mesh-list
6251568|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
6251569|NCT02902172|Acetaminophen|acetaminophen|mesh-list
6251570|NCT02902172|Ibuprofen|ibuprofen|mesh-list
6251571|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6251572|NCT02902172|Analgesics|analgesics|mesh-ancestor
6251573|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
6251574|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251575|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251576|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
6251577|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6251578|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251579|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251580|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6251581|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251582|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251583|NCT02902237|Thromboplastin|thromboplastin|mesh-list
6251584|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
6251585|NCT02902237|Coagulants|coagulants|mesh-ancestor
6251586|NCT02902770|Ketorolac|ketorolac|mesh-list
6251587|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
6251588|NCT02902770|Lidocaine|lidocaine|mesh-list
6251589|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
6251590|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
6251591|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251592|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251593|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
6251594|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251595|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6251596|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6251597|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6251598|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6251599|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251600|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6251601|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6251602|NCT02902770|Analgesics|analgesics|mesh-ancestor
6251603|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251604|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251605|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6251606|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251607|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6251608|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
6251609|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251610|NCT02902913|Ibuprofen|ibuprofen|mesh-list
6251611|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6251612|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6251613|NCT02902913|Analgesics|analgesics|mesh-ancestor
6251614|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
6251615|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251616|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251617|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251618|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251619|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6251620|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251621|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251622|NCT02902965|Dexamethasone|dexamethasone|mesh-list
6251623|NCT02902965|Bortezomib|bortezomib|mesh-list
6251624|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251625|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
6251626|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
6251627|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251628|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251629|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6251630|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
6251631|NCT02902965|Hormones|hormones|mesh-ancestor
6251632|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6251633|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6251634|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251635|NCT02903030|Silicon|silicon|mesh-list
6251636|NCT02903030|Trace Elements|trace elements|mesh-ancestor
6251637|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
6251638|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251639|NCT02903121|Tamoxifen|tamoxifen|mesh-list
6251640|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6251641|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
6251642|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6251643|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251644|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6251645|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251646|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6251647|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6251648|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6251649|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6251650|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6251651|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6251652|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6251653|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251654|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251655|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251656|NCT02903238|Analgesics|analgesics|mesh-ancestor
6251657|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
6251658|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251659|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
6251660|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6251661|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
6251662|NCT02903368|Prednisone|prednisone|mesh-list
6251663|NCT02903368|Leuprolide|leuprolide|mesh-list
6251664|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
6251665|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251666|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
6251667|NCT02903368|Hormones|hormones|mesh-ancestor
6251668|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6251669|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251670|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6251671|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251672|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6251673|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
6251674|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6251675|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6251676|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251677|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251678|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
6251679|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6251680|NCT02903407|Midazolam|midazolam|mesh-list
6251681|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
6251682|NCT02903407|Propofol|propofol|mesh-list
6251683|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6251684|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251685|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251686|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6251687|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
6251688|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
6251689|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6251690|NCT02903407|Analgesics|analgesics|mesh-ancestor
6251691|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
6251692|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251693|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6251694|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6251695|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6251696|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
6251697|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251698|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251699|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6251700|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6251701|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6251702|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6251703|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
6251704|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
6251705|NCT02903446|Denosumab|denosumab|mesh-list
6251706|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6251707|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251708|NCT02903511|Metformin|metformin|mesh-list
6251709|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6251710|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251711|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
6251712|NCT02903836|Nafithromycin|nafithromycin|mesh-list
6251713|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6251714|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6251715|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6251716|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6251717|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251718|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251719|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251720|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6251721|NCT02904096|Lidocaine|lidocaine|mesh-list
6251722|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
6251723|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
6251724|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251725|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251726|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
6251727|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251728|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6251729|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6251730|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6251731|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6251732|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251733|NCT02904200|Silicon|silicon|mesh-list
6251734|NCT02904200|Trace Elements|trace elements|mesh-ancestor
6251735|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
6251736|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251737|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
6251738|NCT02904226|Nivolumab|nivolumab|mesh-list
6251739|NCT02904226|Ipilimumab|ipilimumab|mesh-list
6251740|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251741|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251742|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6251743|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251744|NCT02904265|Acetazolamide|acetazolamide|mesh-list
6251745|NCT02904265|Diazepam|diazepam|mesh-list
6251746|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
6251747|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6251748|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251749|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251750|NCT02904265|Diuretics|diuretics|mesh-ancestor
6251751|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
6251752|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251753|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6251754|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
6251755|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
6251756|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251757|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6251758|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6251759|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251760|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6251761|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6251762|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6251763|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6251764|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6251765|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6251766|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
6251767|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
6251768|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
6251769|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
6251770|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251771|NCT02904902|Adalimumab|adalimumab|mesh-list
6251772|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6251773|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6251774|NCT02904915|Lidocaine|lidocaine|mesh-list
6251775|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
6251776|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
6251777|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251778|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251779|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
6251780|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251781|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6251782|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6251783|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6251784|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6251785|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251786|NCT02904954|Durvalumab|durvalumab|mesh-list
6251787|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6251788|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251789|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251790|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
6251791|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251792|NCT02905266|Nivolumab|nivolumab|mesh-list
6251793|NCT02905266|Ipilimumab|ipilimumab|mesh-list
6251794|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251795|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251796|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6251797|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251798|NCT02905981|Citric Acid|citric acid|mesh-list
6251799|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
6251800|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
6251801|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6251802|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
6251803|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
6251804|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251805|NCT02906566|Vitamin A|vitamin a|mesh-list
6251806|NCT02906566|Vitamins|vitamins|mesh-ancestor
6251807|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
6251808|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251809|NCT02906579|Praliciguat|praliciguat|mesh-list
6251810|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
6251811|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
6251812|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251813|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6251814|NCT02906644|Nicotine|nicotine|mesh-list
6251815|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6251816|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
6251817|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251818|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251819|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6251820|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6251821|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
6251822|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251823|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251824|NCT02906709|Insulin|insulin|mesh-list
6251825|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6251826|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251827|NCT02906917|Insulin|insulin|mesh-list
6251828|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6251829|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
6251830|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
6251831|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
6251832|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
6251833|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6251834|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251835|NCT02907177|Ponesimod|ponesimod|mesh-list
6251836|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6251837|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251838|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6251839|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
6251840|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251841|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6251842|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6251843|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6251844|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251845|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251846|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6251847|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6251848|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251849|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
6251850|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251851|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6251852|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
6251853|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6251854|NCT02907918|Trastuzumab|trastuzumab|mesh-list
6251855|NCT02907918|Letrozole|letrozole|mesh-list
6251856|NCT02907918|Palbociclib|palbociclib|mesh-list
6251857|NCT02907918|Goserelin|goserelin|mesh-list
6251858|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6251859|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251860|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6251861|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6251862|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251863|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251864|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6251865|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
6251866|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6251867|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251868|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6251869|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6251870|NCT02908269|Vaccines|vaccines|mesh-list
6251871|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
6251872|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251873|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
6251874|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
6251875|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6251876|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6251877|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251878|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251879|NCT02908490|Urological Agents|urological agents|mesh-ancestor
6251880|NCT02908529|Oxybutynin|oxybutynin|mesh-list
6251881|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
6251882|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6251883|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6251884|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6251885|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251886|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
6251887|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251888|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251889|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
6251890|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
6251891|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251892|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6251893|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6251894|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
6251895|NCT02908529|Urological Agents|urological agents|mesh-ancestor
6251896|NCT02908620|Anesthetics|anesthetics|mesh-list
6251897|NCT02908620|Tetracaine|tetracaine|mesh-list
6251898|NCT02908620|Benzocaine|benzocaine|mesh-list
6251899|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251900|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251901|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
6251902|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
6251903|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251904|NCT02909140|Lidocaine|lidocaine|mesh-list
6251905|NCT02909140|Phenylephrine|phenylephrine|mesh-list
6251906|NCT02909140|Epinephrine|epinephrine|mesh-list
6251907|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
6251908|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
6251909|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
6251910|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
6251911|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251912|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251913|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
6251914|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251915|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6251916|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6251917|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6251918|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6251919|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251920|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6251921|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6251922|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
6251923|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251924|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6251925|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6251926|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
6251927|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6251928|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
6251929|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
6251930|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
6251931|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6251932|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6251933|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
6251934|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6251935|NCT02909140|Protective Agents|protective agents|mesh-ancestor
6251936|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
6251937|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6251938|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6251939|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
6251940|NCT02909439|Neostigmine|neostigmine|mesh-list
6251941|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6251942|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251943|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251944|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
6251945|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251946|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251947|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6251948|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
6251949|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251950|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
6251951|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
6251952|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6251953|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6251954|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251955|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
6251956|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6251957|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6251958|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251959|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
6251960|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6251961|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6251962|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251963|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
6251964|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251965|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251966|NCT02909959|Sulforaphane|sulforaphane|mesh-list
6251967|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
6251968|NCT02909959|Protective Agents|protective agents|mesh-ancestor
6251969|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251970|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251971|NCT02910011|Doxycycline|doxycycline|mesh-list
6251972|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6251973|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6251974|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
6251975|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6251976|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6251977|NCT02910063|Blinatumomab|blinatumomab|mesh-list
6251978|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6251979|NCT02910167|Acetaminophen|acetaminophen|mesh-list
6251980|NCT02910167|Scopolamine|scopolamine|mesh-list
6251981|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6251982|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6251983|NCT02910167|Analgesics|analgesics|mesh-ancestor
6251984|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
6251985|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6251986|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6251987|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
6251988|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6251989|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
6251990|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
6251991|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6251992|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
6251993|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6251994|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
6251995|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6251996|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6251997|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6251998|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
6251999|NCT02911116|Ustekinumab|ustekinumab|mesh-list
6252000|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
6252001|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
6252002|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6252003|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
6252004|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6252005|NCT02911285|Expectorants|expectorants|mesh-ancestor
6252006|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
6252007|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6252008|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
6252009|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252010|NCT02911285|Protective Agents|protective agents|mesh-ancestor
6252011|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252012|NCT02911285|Antidotes|antidotes|mesh-ancestor
6252013|NCT02911324|Nabilone|nabilone|mesh-list
6252014|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
6252015|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
6252016|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252017|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252018|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6252019|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6252020|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6252021|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252022|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6252023|NCT02911688|Vitamin E|vitamin e|mesh-list
6252024|NCT02911688|Tocopherols|tocopherols|mesh-list
6252025|NCT02911688|Tocotrienols|tocotrienols|mesh-list
6252026|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
6252027|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
6252028|NCT02911688|Vitamins|vitamins|mesh-ancestor
6252029|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
6252030|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252031|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
6252032|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252033|NCT02911688|Protective Agents|protective agents|mesh-ancestor
6252034|NCT02911818|Liraglutide|liraglutide|mesh-list
6252035|NCT02911818|Phentermine|phentermine|mesh-list
6252036|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6252037|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252038|NCT02911818|Incretins|incretins|mesh-ancestor
6252039|NCT02911818|Hormones|hormones|mesh-ancestor
6252040|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252041|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6252042|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
6252043|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6252044|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
6252045|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
6252046|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252047|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
6252048|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252049|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252050|NCT02911844|Fulvestrant|fulvestrant|mesh-list
6252051|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6252052|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252053|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6252054|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6252055|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
6252056|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252057|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252058|NCT02911948|Insulin|insulin|mesh-list
6252059|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6252060|NCT02911948|Liraglutide|liraglutide|mesh-list
6252061|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
6252062|NCT02911948|Xultophy|xultophy|mesh-list
6252063|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6252064|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252065|NCT02911948|Incretins|incretins|mesh-ancestor
6252066|NCT02911948|Hormones|hormones|mesh-ancestor
6252067|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252068|NCT02912195|Lidocaine|lidocaine|mesh-list
6252069|NCT02912195|Morphine|morphine|mesh-list
6252070|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
6252071|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
6252072|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252073|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252074|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
6252075|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252076|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6252077|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6252078|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6252079|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6252080|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252081|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6252082|NCT02912195|Narcotics|narcotics|mesh-ancestor
6252083|NCT02912195|Analgesics|analgesics|mesh-ancestor
6252084|NCT02912364|Carbamazepine|carbamazepine|mesh-list
6252085|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
6252086|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
6252087|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
6252088|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6252089|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252090|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252091|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6252092|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6252093|NCT02912364|Analgesics|analgesics|mesh-ancestor
6252094|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
6252095|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252096|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6252097|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6252098|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252099|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6252100|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6252101|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6252102|NCT02912455|Canagliflozin|canagliflozin|mesh-list
6252103|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6252104|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252105|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6252106|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252107|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
6252108|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252109|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
6252110|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6252111|NCT02912650|Acetaminophen|acetaminophen|mesh-list
6252112|NCT02912650|Ibuprofen|ibuprofen|mesh-list
6252113|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6252114|NCT02912650|Analgesics|analgesics|mesh-ancestor
6252115|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
6252116|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252117|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252118|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
6252119|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6252120|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252121|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6252122|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6252123|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252124|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252125|NCT02913326|Warfarin|warfarin|mesh-list
6252126|NCT02913326|Dabigatran|dabigatran|mesh-list
6252127|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
6252128|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
6252129|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6252130|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
6252131|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252132|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252133|NCT02913521|Diclofenac|diclofenac|mesh-list
6252134|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6252135|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6252136|NCT02913521|Analgesics|analgesics|mesh-ancestor
6252137|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
6252138|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252139|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252140|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252141|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6252142|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6252143|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252144|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252145|NCT02913924|Clonazepam|clonazepam|mesh-list
6252146|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
6252147|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
6252148|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
6252149|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252150|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252151|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252152|NCT02914119|Rocuronium|rocuronium|mesh-list
6252153|NCT02914119|Mivacurium|mivacurium|mesh-list
6252154|NCT02914119|Cisatracurium|cisatracurium|mesh-list
6252155|NCT02914119|Succinylcholine|succinylcholine|mesh-list
6252156|NCT02914119|Neostigmine|neostigmine|mesh-list
6252157|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6252158|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6252159|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6252160|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252161|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252162|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6252163|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252164|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252165|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
6252166|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252167|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6252168|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
6252169|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
6252170|NCT02914275|Vaccines|vaccines|mesh-list
6252171|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
6252172|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252173|NCT02914509|Travoprost|travoprost|mesh-list
6252174|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6252175|NCT02915016|Vaccines|vaccines|mesh-list
6252176|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
6252177|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
6252178|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252179|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6252180|NCT02915159|Abatacept|abatacept|mesh-list
6252181|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6252182|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252183|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252184|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6252185|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
6252186|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252187|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6252188|NCT02915302|Vaccines|vaccines|mesh-list
6252189|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
6252190|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252191|NCT02915705|Vitamin D|vitamin d|mesh-list
6252192|NCT02915705|Vitamins|vitamins|mesh-ancestor
6252193|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
6252194|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252195|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6252196|NCT02915744|Gemcitabine|gemcitabine|mesh-list
6252197|NCT02915744|Paclitaxel|paclitaxel|mesh-list
6252198|NCT02915744|Vinorelbine|vinorelbine|mesh-list
6252199|NCT02915744|Docetaxel|docetaxel|mesh-list
6252200|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6252201|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
6252202|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6252203|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252204|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
6252205|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
6252206|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
6252207|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252208|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6252209|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
6252210|NCT02915744|Antiviral Agents|antiviral agents|mesh-ancestor
6252211|NCT02915744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6252212|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252213|NCT02915744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6252214|NCT02915744|Immunologic Factors|immunologic factors|mesh-ancestor
6252215|NCT02915744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252216|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6252217|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6252218|NCT02915835|Riociguat|riociguat|mesh-list
6252219|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
6252220|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252221|NCT02915978|Fentanyl|fentanyl|mesh-list
6252222|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6252223|NCT02915978|Narcotics|narcotics|mesh-ancestor
6252224|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252225|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252226|NCT02915978|Analgesics|analgesics|mesh-ancestor
6252227|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
6252228|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252229|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6252230|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6252231|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
6252232|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
6252233|NCT02916407|Sevoflurane|sevoflurane|mesh-list
6252234|NCT02916407|Desflurane|desflurane|mesh-list
6252235|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6252236|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6252237|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
6252238|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
6252239|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252240|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252241|NCT02916433|Octreotide|octreotide|mesh-list
6252242|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6252243|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6252244|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252245|NCT02916693|Mirabegron|mirabegron|mesh-list
6252246|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
6252247|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6252248|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6252249|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
6252250|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252251|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252252|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252253|NCT02916693|Urological Agents|urological agents|mesh-ancestor
6252254|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
6252255|NCT02916745|Trioxsalen|trioxsalen|mesh-list
6252256|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252257|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
6252258|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
6252259|NCT02916927|Ketamine|ketamine|mesh-list
6252260|NCT02916927|Analgesics|analgesics|mesh-ancestor
6252261|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
6252262|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252263|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252264|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6252265|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6252266|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
6252267|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
6252268|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252269|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6252270|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6252271|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252272|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252273|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6252274|NCT02917031|Saxagliptin|saxagliptin|mesh-list
6252275|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6252276|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252277|NCT02917031|Incretins|incretins|mesh-ancestor
6252278|NCT02917031|Hormones|hormones|mesh-ancestor
6252279|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252280|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6252281|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
6252282|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252283|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252284|NCT02917122|Sertraline|sertraline|mesh-list
6252285|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
6252286|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6252287|NCT02917122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6252288|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6252289|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6252290|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252291|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252292|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
6252293|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252294|NCT02917941|Dexamethasone|dexamethasone|mesh-list
6252295|NCT02917941|Lenalidomide|lenalidomide|mesh-list
6252296|NCT02917941|Ixazomib|ixazomib|mesh-list
6252297|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252298|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
6252299|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
6252300|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252301|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252302|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6252303|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
6252304|NCT02917941|Hormones|hormones|mesh-ancestor
6252305|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252306|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6252307|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252308|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
6252309|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6252310|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6252311|NCT02917941|Growth Substances|growth substances|mesh-ancestor
6252312|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
6252313|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
6252314|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252315|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252316|NCT02918071|Benralizumab|benralizumab|mesh-list
6252317|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6252318|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
6252319|NCT02918097|Risperidone|risperidone|mesh-list
6252320|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
6252321|NCT02918097|Sertraline|sertraline|mesh-list
6252322|NCT02918097|Nortriptyline|nortriptyline|mesh-list
6252323|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6252324|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
6252325|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252326|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252327|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252328|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6252329|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6252330|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252331|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6252332|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6252333|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
6252334|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
6252335|NCT02918097|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6252336|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6252337|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6252338|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252339|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
6252340|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
6252341|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6252342|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
6252343|NCT02918266|Scopolamine|scopolamine|mesh-list
6252344|NCT02918266|Donepezil|donepezil|mesh-list
6252345|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6252346|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6252347|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252348|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252349|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
6252350|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252351|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252352|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
6252353|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6252354|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
6252355|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
6252356|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252357|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6252358|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
6252359|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6252360|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6252361|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
6252362|NCT02918279|Liraglutide|liraglutide|mesh-list
6252363|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6252364|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252365|NCT02918279|Incretins|incretins|mesh-ancestor
6252366|NCT02918279|Hormones|hormones|mesh-ancestor
6252367|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252368|NCT02918318|Esketamine|esketamine|mesh-list
6252369|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
6252370|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6252371|NCT02918357|Edetic Acid|edetic acid|mesh-list
6252372|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
6252373|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
6252374|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252375|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
6252376|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6252377|NCT02918617|Fluorides|fluorides|mesh-list
6252378|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
6252379|NCT02918617|Protective Agents|protective agents|mesh-ancestor
6252380|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252381|NCT02918630|Nicotine|nicotine|mesh-list
6252382|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6252383|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
6252384|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252385|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252386|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6252387|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6252388|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
6252389|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252390|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252391|NCT02918721|Lidocaine|lidocaine|mesh-list
6252392|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
6252393|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
6252394|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
6252395|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252396|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252397|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
6252398|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252399|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6252400|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6252401|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6252402|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6252403|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252404|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6252405|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
6252406|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
6252407|NCT02918721|Protective Agents|protective agents|mesh-ancestor
6252408|NCT02918877|Propofol|propofol|mesh-list
6252409|NCT02918877|Sevoflurane|sevoflurane|mesh-list
6252410|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6252411|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252412|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252413|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6252414|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
6252415|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
6252416|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6252417|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6252418|NCT02918968|Flutamide|flutamide|mesh-list
6252419|NCT02918968|Androgens|androgens|mesh-list
6252420|NCT02918968|Hormones|hormones|mesh-ancestor
6252421|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252422|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252423|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
6252424|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
6252425|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6252426|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252427|NCT02919111|Edetic Acid|edetic acid|mesh-list
6252428|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
6252429|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
6252430|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252431|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
6252432|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6252433|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6252434|NCT02919761|Hormones|hormones|mesh-ancestor
6252435|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252436|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252437|NCT02920528|Ketamine|ketamine|mesh-list
6252438|NCT02920528|Analgesics|analgesics|mesh-ancestor
6252439|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
6252440|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252441|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252442|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6252443|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6252444|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
6252445|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
6252446|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252447|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6252448|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6252449|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252450|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252451|NCT02920749|Anesthetics|anesthetics|mesh-list
6252452|NCT02920749|Propofol|propofol|mesh-list
6252453|NCT02920749|Sevoflurane|sevoflurane|mesh-list
6252454|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252455|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252456|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6252457|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6252458|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
6252459|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6252460|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6252461|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6252462|NCT02920918|Canagliflozin|canagliflozin|mesh-list
6252463|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6252464|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252465|NCT02920918|Incretins|incretins|mesh-ancestor
6252466|NCT02920918|Hormones|hormones|mesh-ancestor
6252467|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252468|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6252469|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
6252470|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252471|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252472|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6252473|NCT02921061|Cytarabine|cytarabine|mesh-list
6252474|NCT02921061|Decitabine|decitabine|mesh-list
6252475|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
6252476|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
6252477|NCT02921061|Cladribine|cladribine|mesh-list
6252478|NCT02921061|Lenograstim|lenograstim|mesh-list
6252479|NCT02921061|Sargramostim|sargramostim|mesh-list
6252480|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6252481|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
6252482|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252483|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6252484|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
6252485|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252486|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252487|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
6252488|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6252489|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6252490|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252491|NCT02921061|Analgesics|analgesics|mesh-ancestor
6252492|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
6252493|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252494|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6252495|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6252496|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
6252497|NCT02921386|Testosterone|testosterone|mesh-list
6252498|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
6252499|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
6252500|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6252501|NCT02921386|Androgens|androgens|mesh-ancestor
6252502|NCT02921386|Hormones|hormones|mesh-ancestor
6252503|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252504|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252505|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6252506|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252507|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
6252508|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6252509|NCT02921750|Laxatives|laxatives|mesh-ancestor
6252510|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6252511|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
6252512|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6252513|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6252514|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252515|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
6252516|NCT02922582|Coagulants|coagulants|mesh-ancestor
6252517|NCT02922959|Naloxone|naloxone|mesh-list
6252518|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252519|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
6252520|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252521|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6252522|NCT02923115|Enoxaparin|enoxaparin|mesh-list
6252523|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
6252524|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6252525|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6252526|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252527|NCT02923895|Fluorides|fluorides|mesh-list
6252528|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
6252529|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
6252530|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
6252531|NCT02923895|Protective Agents|protective agents|mesh-ancestor
6252532|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252533|NCT02923921|Leucovorin|leucovorin|mesh-list
6252534|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
6252535|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252536|NCT02923921|Antidotes|antidotes|mesh-ancestor
6252537|NCT02923921|Protective Agents|protective agents|mesh-ancestor
6252538|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252539|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
6252540|NCT02923921|Vitamins|vitamins|mesh-ancestor
6252541|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
6252542|NCT02924350|Fluorides|fluorides|mesh-list
6252543|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
6252544|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
6252545|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
6252546|NCT02924350|Protective Agents|protective agents|mesh-ancestor
6252547|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252548|NCT02924688|Fluticasone|fluticasone|mesh-list
6252549|NCT02924688|Albuterol|albuterol|mesh-list
6252550|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6252551|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
6252552|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252553|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6252554|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
6252555|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252556|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252557|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6252558|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
6252559|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
6252560|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6252561|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6252562|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6252563|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6252564|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
6252565|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252566|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252567|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
6252568|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6252569|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
6252570|NCT02924688|Hormones|hormones|mesh-ancestor
6252571|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252572|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
6252573|NCT02924883|Trastuzumab|trastuzumab|mesh-list
6252574|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6252575|NCT02924883|Atezolizumab|atezolizumab|mesh-list
6252576|NCT02924883|Maytansine|maytansine|mesh-list
6252577|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6252578|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252579|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6252580|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
6252581|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
6252582|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
6252583|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252584|NCT02925117|Upadacitinib|upadacitinib|mesh-list
6252585|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6252586|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6252587|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252588|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252589|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6252590|NCT02925494|Norethindrone|norethindrone|mesh-list
6252591|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
6252592|NCT02925494|Estradiol|estradiol|mesh-list
6252593|NCT02925494|Estrogens|estrogens|mesh-ancestor
6252594|NCT02925494|Hormones|hormones|mesh-ancestor
6252595|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252596|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252597|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6252598|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
6252599|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6252600|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6252601|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6252602|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6252603|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6252604|NCT02925611|Desflurane|desflurane|mesh-list
6252605|NCT02925611|Isoflurane|isoflurane|mesh-list
6252606|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6252607|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
6252608|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
6252609|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252610|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252611|NCT02925858|Ketamine|ketamine|mesh-list
6252612|NCT02925858|Analgesics|analgesics|mesh-ancestor
6252613|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
6252614|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252615|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252616|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6252617|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6252618|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
6252619|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
6252620|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252621|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6252622|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6252623|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252624|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252625|NCT02925923|Clopidogrel|clopidogrel|mesh-list
6252626|NCT02925923|Ticagrelor|ticagrelor|mesh-list
6252627|NCT02925923|Eptifibatide|eptifibatide|mesh-list
6252628|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6252629|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6252630|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6252631|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6252632|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
6252633|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252634|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252635|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252636|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
6252637|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6252638|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6252639|NCT02926573|Gabapentin|gabapentin|mesh-list
6252640|NCT02926573|Analgesics|analgesics|mesh-ancestor
6252641|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
6252642|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252643|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252644|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
6252645|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6252646|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6252647|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252648|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6252649|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6252650|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6252651|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252652|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252653|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
6252654|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6252655|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6252656|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252657|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6252658|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252659|NCT02926950|Metformin|metformin|mesh-list
6252660|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6252661|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6252662|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252663|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6252664|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252665|NCT02927223|Atropine|atropine|mesh-list
6252666|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6252667|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6252668|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6252669|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
6252670|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252671|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252672|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6252673|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
6252674|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
6252675|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
6252676|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6252677|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6252678|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
6252679|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252680|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252681|NCT02927301|Atezolizumab|atezolizumab|mesh-list
6252682|NCT02927301|Antibodies|antibodies|mesh-list
6252683|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6252684|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
6252685|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252686|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252687|NCT02927431|Oseltamivir|oseltamivir|mesh-list
6252688|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
6252689|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6252690|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252691|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252692|NCT02927457|GSK2646264|gsk2646264|mesh-list
6252693|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6252694|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252695|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252696|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
6252697|NCT02927834|Prednisone|prednisone|mesh-list
6252698|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252699|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
6252700|NCT02927834|Hormones|hormones|mesh-ancestor
6252701|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252702|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252703|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6252704|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252705|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6252706|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6252707|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6252708|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252709|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252710|NCT02927873|Vaccines|vaccines|mesh-list
6252711|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
6252712|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252713|NCT02927925|Daratumumab|daratumumab|mesh-list
6252714|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252715|NCT02927938|Cytarabine|cytarabine|mesh-list
6252716|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6252717|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
6252718|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252719|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252720|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
6252721|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6252722|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6252723|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
6252724|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252725|NCT02928029|Dexamethasone|dexamethasone|mesh-list
6252726|NCT02928029|Bortezomib|bortezomib|mesh-list
6252727|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
6252728|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252729|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
6252730|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
6252731|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252732|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252733|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6252734|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
6252735|NCT02928029|Hormones|hormones|mesh-ancestor
6252736|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252737|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6252738|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252739|NCT02929498|Azacitidine|azacitidine|mesh-list
6252740|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6252741|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
6252742|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252743|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252744|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252745|NCT02929667|Fluoxetine|fluoxetine|mesh-list
6252746|NCT02929667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6252747|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6252748|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6252749|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252750|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252751|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
6252752|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252753|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6252754|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
6252755|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6252756|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6252757|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6252758|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252759|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6252760|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6252761|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
6252762|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
6252763|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
6252764|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6252765|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6252766|NCT02930005|Analgesics|analgesics|mesh-ancestor
6252767|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
6252768|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252769|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252770|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252771|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6252772|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6252773|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252774|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252775|NCT02930343|Folic Acid|folic acid|mesh-list
6252776|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
6252777|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
6252778|NCT02930343|Prednisolone|prednisolone|mesh-list
6252779|NCT02930343|Methotrexate|methotrexate|mesh-list
6252780|NCT02930343|Leflunomide|leflunomide|mesh-list
6252781|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
6252782|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6252783|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
6252784|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6252785|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252786|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6252787|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
6252788|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252789|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252790|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
6252791|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252792|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6252793|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6252794|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
6252795|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6252796|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6252797|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252798|NCT02930343|Hormones|hormones|mesh-ancestor
6252799|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252800|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6252801|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252802|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6252803|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
6252804|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6252805|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6252806|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6252807|NCT02930343|Hematinics|hematinics|mesh-ancestor
6252808|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
6252809|NCT02930343|Vitamins|vitamins|mesh-ancestor
6252810|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
6252811|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6252812|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6252813|NCT02930343|Analgesics|analgesics|mesh-ancestor
6252814|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
6252815|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
6252816|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6252817|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6252818|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252819|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
6252820|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6252821|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6252822|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252823|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
6252824|NCT02930941|Coagulants|coagulants|mesh-ancestor
6252825|NCT02931045|Clopidogrel|clopidogrel|mesh-list
6252826|NCT02931045|Ticagrelor|ticagrelor|mesh-list
6252827|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6252828|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6252829|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6252830|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6252831|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
6252832|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252833|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252834|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252835|NCT02931253|Metformin|metformin|mesh-list
6252836|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6252837|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252838|NCT02931539|Valganciclovir|valganciclovir|mesh-list
6252839|NCT02931539|Ganciclovir|ganciclovir|mesh-list
6252840|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
6252841|NCT02931539|Cidofovir|cidofovir|mesh-list
6252842|NCT02931539|Foscarnet|foscarnet|mesh-list
6252843|NCT02931539|Maribavir|maribavir|mesh-list
6252844|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
6252845|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6252846|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6252847|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252848|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252849|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6252850|NCT02931838|BMS-986165|bms-986165|mesh-list
6252851|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
6252852|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6252853|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252854|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252855|NCT02932267|Adapalene|adapalene|mesh-list
6252856|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6252857|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6252858|NCT02932267|Analgesics|analgesics|mesh-ancestor
6252859|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
6252860|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252861|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252862|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252863|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6252864|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
6252865|NCT02932904|Vortioxetine|vortioxetine|mesh-list
6252866|NCT02932904|Paroxetine|paroxetine|mesh-list
6252867|NCT02932904|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6252868|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6252869|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6252870|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252871|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252872|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
6252873|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252874|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6252875|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
6252876|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6252877|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6252878|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6252879|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252880|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6252881|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6252882|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252883|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6252884|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6252885|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6252886|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6252887|NCT02933034|Manganese|manganese|mesh-list
6252888|NCT02933034|Trace Elements|trace elements|mesh-ancestor
6252889|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
6252890|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252891|NCT02933320|Rituximab|rituximab|mesh-list
6252892|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6252893|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252894|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
6252895|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252896|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6252897|NCT02933372|Varenicline|varenicline|mesh-list
6252898|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6252899|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6252900|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
6252901|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252902|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252903|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252904|NCT02934191|Acetaminophen|acetaminophen|mesh-list
6252905|NCT02934191|Celecoxib|celecoxib|mesh-list
6252906|NCT02934191|Oxycodone|oxycodone|mesh-list
6252907|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
6252908|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252909|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6252910|NCT02934191|Analgesics|analgesics|mesh-ancestor
6252911|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
6252912|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252913|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
6252914|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6252915|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252916|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6252917|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6252918|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6252919|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252920|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252921|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6252922|NCT02934191|Narcotics|narcotics|mesh-ancestor
6252923|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252924|NCT02934191|Antacids|antacids|mesh-ancestor
6252925|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6252926|NCT02934698|Ivacaftor|ivacaftor|mesh-list
6252927|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6252928|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6252929|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252930|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
6252931|NCT02935699|Promethazine|promethazine|mesh-list
6252932|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6252933|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6252934|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6252935|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252936|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
6252937|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
6252938|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
6252939|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252940|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
6252941|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
6252942|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6252943|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6252944|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
6252945|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
6252946|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252947|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252948|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6252949|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
6252950|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
6252951|NCT02935738|Prednisolone|prednisolone|mesh-list
6252952|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252953|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
6252954|NCT02935738|Hormones|hormones|mesh-ancestor
6252955|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6252956|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252957|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6252958|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252959|NCT02935894|Ibuprofen|ibuprofen|mesh-list
6252960|NCT02935894|Pilocarpine|pilocarpine|mesh-list
6252961|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6252962|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6252963|NCT02935894|Analgesics|analgesics|mesh-ancestor
6252964|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
6252965|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6252966|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252967|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6252968|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6252969|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6252970|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6252971|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6252972|NCT02935894|Miotics|miotics|mesh-ancestor
6252973|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
6252974|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
6252975|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6252976|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
6252977|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6252978|NCT02936037|Biotin|biotin|mesh-list
6252979|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
6252980|NCT02936037|Vitamins|vitamins|mesh-ancestor
6252981|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
6252982|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252983|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
6252984|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
6252985|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6252986|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6252987|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
6252988|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6252989|NCT02937116|Gemcitabine|gemcitabine|mesh-list
6252990|NCT02937116|Cisplatin|cisplatin|mesh-list
6252991|NCT02937116|Capecitabine|capecitabine|mesh-list
6252992|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
6252993|NCT02937116|Irinotecan|irinotecan|mesh-list
6252994|NCT02937116|Etoposide|etoposide|mesh-list
6252995|NCT02937116|Pemetrexed|pemetrexed|mesh-list
6252996|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6252997|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6252998|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
6252999|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253000|NCT02937116|Antiviral Agents|antiviral agents|mesh-ancestor
6253001|NCT02937116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253002|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253003|NCT02937116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253004|NCT02937116|Immunologic Factors|immunologic factors|mesh-ancestor
6253005|NCT02937116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253006|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6253007|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6253008|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6253009|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6253010|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6253011|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6253012|NCT02937168|Reslizumab|reslizumab|mesh-list
6253013|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
6253014|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6253015|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253016|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6253017|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
6253018|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
6253019|NCT02937350|Calcifediol|calcifediol|mesh-list
6253020|NCT02937350|Vitamins|vitamins|mesh-ancestor
6253021|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
6253022|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253023|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6253024|NCT02937506|Fentanyl|fentanyl|mesh-list
6253025|NCT02937506|Midazolam|midazolam|mesh-list
6253026|NCT02937506|Propofol|propofol|mesh-list
6253027|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6253028|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253029|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253030|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6253031|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
6253032|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
6253033|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6253034|NCT02937506|Narcotics|narcotics|mesh-ancestor
6253035|NCT02937506|Analgesics|analgesics|mesh-ancestor
6253036|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
6253037|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253038|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6253039|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6253040|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6253041|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6253042|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
6253043|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
6253044|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253045|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253046|NCT02937558|Glucagon|glucagon|mesh-list
6253047|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6253048|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253049|NCT02937558|Hormones|hormones|mesh-ancestor
6253050|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253051|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253052|NCT02937558|Incretins|incretins|mesh-ancestor
6253053|NCT02937623|Calcium|calcium|mesh-list
6253054|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6253055|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253056|NCT02937636|Fluorides|fluorides|mesh-list
6253057|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
6253058|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
6253059|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
6253060|NCT02937636|Protective Agents|protective agents|mesh-ancestor
6253061|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253062|NCT02937701|Infliximab|infliximab|mesh-list
6253063|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
6253064|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253065|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6253066|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
6253067|NCT02937740|Testosterone|testosterone|mesh-list
6253068|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
6253069|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
6253070|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
6253071|NCT02937740|Androgens|androgens|mesh-ancestor
6253072|NCT02937740|Hormones|hormones|mesh-ancestor
6253073|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253074|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253075|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6253076|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253077|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
6253078|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6253079|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6253080|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6253081|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
6253082|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253083|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253084|NCT02937766|Progestins|progestins|mesh-ancestor
6253085|NCT02937766|Hormones|hormones|mesh-ancestor
6253086|NCT02938494|Tazarotene|tazarotene|mesh-list
6253087|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
6253088|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
6253089|NCT02938520|Rilpivirine|rilpivirine|mesh-list
6253090|NCT02938520|Cabotegravir|cabotegravir|mesh-list
6253091|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6253092|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6253093|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253094|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253095|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
6253096|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253097|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6253098|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6253099|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6253100|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6253101|NCT02938585|Factor VIII|factor viii|mesh-list
6253102|NCT02938585|Coagulants|coagulants|mesh-ancestor
6253103|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6253104|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6253105|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253106|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
6253107|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
6253108|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253109|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253110|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
6253111|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253112|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
6253113|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6253114|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253115|NCT02939937|Phenytoin|phenytoin|mesh-list
6253116|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
6253117|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6253118|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6253119|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6253120|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253121|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
6253122|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6253123|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
6253124|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
6253125|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6253126|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
6253127|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253128|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253129|NCT02940522|Progestins|progestins|mesh-ancestor
6253130|NCT02940522|Hormones|hormones|mesh-ancestor
6253131|NCT02940574|Oxytocin|oxytocin|mesh-list
6253132|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
6253133|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6253134|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253135|NCT02940691|Grazoprevir|grazoprevir|mesh-list
6253136|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
6253137|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253138|NCT02940730|Dalbavancin|dalbavancin|mesh-list
6253139|NCT02940730|Teicoplanin|teicoplanin|mesh-list
6253140|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6253141|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253142|NCT02940860|Iron|iron|mesh-list
6253143|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6253144|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6253145|NCT02940860|Trace Elements|trace elements|mesh-ancestor
6253146|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
6253147|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253148|NCT02940860|Hematinics|hematinics|mesh-ancestor
6253149|NCT02940886|Iron|iron|mesh-list
6253150|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
6253151|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6253152|NCT02940886|Trace Elements|trace elements|mesh-ancestor
6253153|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
6253154|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253155|NCT02940886|Hematinics|hematinics|mesh-ancestor
6253156|NCT02941523|Carboplatin|carboplatin|mesh-list
6253157|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253158|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6253159|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
6253160|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
6253161|NCT02941640|Hormones|hormones|mesh-ancestor
6253162|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253163|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253164|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253165|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253166|NCT02941692|Oxytocin|oxytocin|mesh-list
6253167|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
6253168|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6253169|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253170|NCT02942264|Temozolomide|temozolomide|mesh-list
6253171|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6253172|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
6253173|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253174|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253175|NCT02942407|Warfarin|warfarin|mesh-list
6253176|NCT02942407|Apixaban|apixaban|mesh-list
6253177|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
6253178|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6253179|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
6253180|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6253181|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
6253182|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253183|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253184|NCT02942485|Metronidazole|metronidazole|mesh-list
6253185|NCT02942485|Tinidazole|tinidazole|mesh-list
6253186|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253187|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6253188|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6253189|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6253190|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
6253191|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253192|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
6253193|NCT02942576|Warfarin|warfarin|mesh-list
6253194|NCT02942576|Edoxaban|edoxaban|mesh-list
6253195|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
6253196|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
6253197|NCT02942576|Fluindione|fluindione|mesh-list
6253198|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
6253199|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6253200|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
6253201|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6253202|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
6253203|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253204|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253205|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
6253206|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6253207|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253208|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
6253209|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
6253210|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
6253211|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253212|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253213|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253214|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6253215|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6253216|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253217|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6253218|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6253219|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
6253220|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253221|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253222|NCT02943668|Deferasirox|deferasirox|mesh-list
6253223|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6253224|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
6253225|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
6253226|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253227|NCT02944461|Dapsone|dapsone|mesh-list
6253228|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253229|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
6253230|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6253231|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6253232|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6253233|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253234|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253235|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
6253236|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6253237|NCT02944565|Daratumumab|daratumumab|mesh-list
6253238|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253239|NCT02944656|Gabapentin|gabapentin|mesh-list
6253240|NCT02944656|Analgesics|analgesics|mesh-ancestor
6253241|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
6253242|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253243|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253244|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
6253245|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6253246|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6253247|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253248|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6253249|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6253250|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6253251|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253252|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253253|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
6253254|NCT02945150|Grazoprevir|grazoprevir|mesh-list
6253255|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
6253256|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253257|NCT02945410|Vitamin D|vitamin d|mesh-list
6253258|NCT02945410|Calcium|calcium|mesh-list
6253259|NCT02945410|Vitamins|vitamins|mesh-ancestor
6253260|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
6253261|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253262|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6253263|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6253264|NCT02946034|Ribavirin|ribavirin|mesh-list
6253265|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
6253266|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253267|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
6253268|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253269|NCT02946073|Buprenorphine|buprenorphine|mesh-list
6253270|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6253271|NCT02946073|Narcotics|narcotics|mesh-ancestor
6253272|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253273|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253274|NCT02946073|Analgesics|analgesics|mesh-ancestor
6253275|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
6253276|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253277|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6253278|NCT02946385|Vaccines|vaccines|mesh-list
6253279|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
6253280|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253281|NCT02946463|Eculizumab|eculizumab|mesh-list
6253282|NCT02946463|Ravulizumab|ravulizumab|mesh-list
6253283|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6253284|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253285|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
6253286|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253287|NCT02946489|Ketamine|ketamine|mesh-list
6253288|NCT02946489|Analgesics|analgesics|mesh-ancestor
6253289|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
6253290|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253291|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253292|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6253293|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6253294|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
6253295|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
6253296|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253297|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6253298|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6253299|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253300|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253301|NCT02946580|Naloxegol|naloxegol|mesh-list
6253302|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6253303|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253304|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
6253305|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253306|NCT02946892|Carvedilol|carvedilol|mesh-list
6253307|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6253308|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6253309|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
6253310|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253311|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253312|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253313|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6253314|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
6253315|NCT02946892|Protective Agents|protective agents|mesh-ancestor
6253316|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6253317|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6253318|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6253319|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
6253320|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6253321|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6253322|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
6253323|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
6253324|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253325|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
6253326|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6253327|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6253328|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6253329|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6253330|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
6253331|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253332|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253333|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253334|NCT02948777|Evolocumab|evolocumab|mesh-list
6253335|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6253336|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6253337|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
6253338|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253339|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6253340|NCT02949011|Oseltamivir|oseltamivir|mesh-list
6253341|NCT02949011|Baloxavir|baloxavir|mesh-list
6253342|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
6253343|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253344|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253345|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253346|NCT02949024|Triamcinolone|triamcinolone|mesh-list
6253347|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6253348|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6253349|NCT02949024|Aflibercept|aflibercept|mesh-list
6253350|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6253351|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253352|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
6253353|NCT02949024|Hormones|hormones|mesh-ancestor
6253354|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253355|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253356|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253357|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
6253358|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253359|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253360|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6253361|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6253362|NCT02949024|Growth Substances|growth substances|mesh-ancestor
6253363|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
6253364|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253365|NCT02949128|Ravulizumab|ravulizumab|mesh-list
6253366|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6253367|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253368|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
6253369|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253370|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
6253371|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6253372|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253373|NCT02949271|Fentanyl|fentanyl|mesh-list
6253374|NCT02949271|Ropivacaine|ropivacaine|mesh-list
6253375|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
6253376|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
6253377|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253378|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253379|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
6253380|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253381|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6253382|NCT02949271|Narcotics|narcotics|mesh-ancestor
6253383|NCT02949271|Analgesics|analgesics|mesh-ancestor
6253384|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6253385|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6253386|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
6253387|NCT02949362|Teduglutide|teduglutide|mesh-list
6253388|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253389|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6253390|NCT02949362|Protective Agents|protective agents|mesh-ancestor
6253391|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253392|NCT02949674|Bupivacaine|bupivacaine|mesh-list
6253393|NCT02949674|Ropivacaine|ropivacaine|mesh-list
6253394|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
6253395|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
6253396|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253397|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253398|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
6253399|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253400|NCT02949921|Lidocaine|lidocaine|mesh-list
6253401|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
6253402|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
6253403|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253404|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253405|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
6253406|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253407|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6253408|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6253409|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6253410|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6253411|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253412|NCT02950467|Psilocybin|psilocybin|mesh-list
6253413|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
6253414|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
6253415|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253416|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6253417|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6253418|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
6253419|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253420|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253421|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6253422|NCT02950558|Ropivacaine|ropivacaine|mesh-list
6253423|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
6253424|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
6253425|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253426|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253427|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
6253428|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253429|NCT02951156|Gemcitabine|gemcitabine|mesh-list
6253430|NCT02951156|Rituximab|rituximab|mesh-list
6253431|NCT02951156|Avelumab|avelumab|mesh-list
6253432|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
6253433|NCT02951156|Azacitidine|azacitidine|mesh-list
6253434|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
6253435|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6253436|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253437|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
6253438|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253439|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6253440|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6253441|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
6253442|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253443|NCT02951156|Antiviral Agents|antiviral agents|mesh-ancestor
6253444|NCT02951156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253445|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253446|NCT02951156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253447|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6253448|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
6253449|NCT02951182|Ivacaftor|ivacaftor|mesh-list
6253450|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6253451|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6253452|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253453|NCT02951195|Ivacaftor|ivacaftor|mesh-list
6253454|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6253455|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6253456|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253457|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
6253458|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6253459|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6253460|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6253461|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6253462|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
6253463|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253464|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253465|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253466|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
6253467|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
6253468|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
6253469|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253470|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253471|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
6253472|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253473|NCT02951429|Pirfenidone|pirfenidone|mesh-list
6253474|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
6253475|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
6253476|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
6253477|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6253478|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253479|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253480|NCT02951429|Urological Agents|urological agents|mesh-ancestor
6253481|NCT02951429|Analgesics|analgesics|mesh-ancestor
6253482|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
6253483|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253484|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253485|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6253486|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6253487|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253488|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6253489|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253490|NCT02951702|Vancomycin|vancomycin|mesh-list
6253491|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6253492|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253493|NCT02951819|Dexamethasone|dexamethasone|mesh-list
6253494|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
6253495|NCT02951819|Bortezomib|bortezomib|mesh-list
6253496|NCT02951819|Daratumumab|daratumumab|mesh-list
6253497|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253498|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
6253499|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253500|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6253501|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6253502|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
6253503|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253504|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253505|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6253506|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253507|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
6253508|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
6253509|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253510|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253511|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
6253512|NCT02951819|Hormones|hormones|mesh-ancestor
6253513|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253514|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6253515|NCT02951884|Bupivacaine|bupivacaine|mesh-list
6253516|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
6253517|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
6253518|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253519|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253520|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
6253521|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253522|NCT02952001|Triamcinolone|triamcinolone|mesh-list
6253523|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6253524|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6253525|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6253526|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253527|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
6253528|NCT02952001|Hormones|hormones|mesh-ancestor
6253529|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253530|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253531|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253532|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
6253533|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253534|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253535|NCT02952586|Avelumab|avelumab|mesh-list
6253536|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6253537|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253538|NCT02952820|Lemborexant|lemborexant|mesh-list
6253539|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6253540|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253541|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253542|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6253543|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6253544|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253545|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253546|NCT02952898|Diclofenac|diclofenac|mesh-list
6253547|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6253548|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6253549|NCT02952898|Analgesics|analgesics|mesh-ancestor
6253550|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
6253551|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253552|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253553|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253554|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6253555|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6253556|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253557|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253558|NCT02953314|Ivacaftor|ivacaftor|mesh-list
6253559|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6253560|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6253561|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253562|NCT02953548|Cannabidiol|cannabidiol|mesh-list
6253563|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
6253564|NCT02953561|Azacitidine|azacitidine|mesh-list
6253565|NCT02953561|Avelumab|avelumab|mesh-list
6253566|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6253567|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6253568|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
6253569|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253570|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253571|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253572|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6253573|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
6253574|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253575|NCT02953678|Prednisone|prednisone|mesh-list
6253576|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
6253577|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6253578|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6253579|NCT02953678|Prednisolone|prednisolone|mesh-list
6253580|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
6253581|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6253582|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
6253583|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253584|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
6253585|NCT02953678|Hormones|hormones|mesh-ancestor
6253586|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253587|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253588|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6253589|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253590|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
6253591|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
6253592|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253593|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253594|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6253595|NCT02953678|Protective Agents|protective agents|mesh-ancestor
6253596|NCT02953782|Cetuximab|cetuximab|mesh-list
6253597|NCT02953782|Magrolimab|magrolimab|mesh-list
6253598|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6253599|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253600|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6253601|NCT02953821|Hormones|hormones|mesh-ancestor
6253602|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253603|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253604|NCT02953860|Fulvestrant|fulvestrant|mesh-list
6253605|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6253606|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253607|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6253608|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6253609|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
6253610|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253611|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253612|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
6253613|NCT02953873|Prednisone|prednisone|mesh-list
6253614|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
6253615|NCT02953873|Tacrolimus|tacrolimus|mesh-list
6253616|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253617|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
6253618|NCT02953873|Hormones|hormones|mesh-ancestor
6253619|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253620|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253621|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6253622|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253623|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253624|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
6253625|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6253626|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253627|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253628|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6253629|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6253630|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
6253631|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6253632|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253633|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
6253634|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
6253635|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253636|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253637|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6253638|NCT02953873|Protective Agents|protective agents|mesh-ancestor
6253639|NCT02953886|Fluorides|fluorides|mesh-list
6253640|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
6253641|NCT02953886|Protective Agents|protective agents|mesh-ancestor
6253642|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253643|NCT02953938|Ranibizumab|ranibizumab|mesh-list
6253644|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6253645|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6253646|NCT02953938|Growth Substances|growth substances|mesh-ancestor
6253647|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253648|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
6253649|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253650|NCT02954172|Paclitaxel|paclitaxel|mesh-list
6253651|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
6253652|NCT02954172|Bevacizumab|bevacizumab|mesh-list
6253653|NCT02954172|Carboplatin|carboplatin|mesh-list
6253654|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6253655|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253656|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
6253657|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
6253658|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
6253659|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253660|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6253661|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6253662|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6253663|NCT02954172|Growth Substances|growth substances|mesh-ancestor
6253664|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253665|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
6253666|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
6253667|NCT02954198|Prednisone|prednisone|mesh-list
6253668|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
6253669|NCT02954198|Everolimus|everolimus|mesh-list
6253670|NCT02954198|Tacrolimus|tacrolimus|mesh-list
6253671|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253672|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
6253673|NCT02954198|Hormones|hormones|mesh-ancestor
6253674|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253675|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253676|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6253677|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253678|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253679|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
6253680|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
6253681|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253682|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253683|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6253684|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6253685|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
6253686|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6253687|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253688|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
6253689|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
6253690|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253691|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253692|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6253693|NCT02954198|Protective Agents|protective agents|mesh-ancestor
6253694|NCT02954354|Oseltamivir|oseltamivir|mesh-list
6253695|NCT02954354|Baloxavir|baloxavir|mesh-list
6253696|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
6253697|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253698|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253699|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253700|NCT02954575|Factor VIII|factor viii|mesh-list
6253701|NCT02954575|Coagulants|coagulants|mesh-ancestor
6253702|NCT02954601|Insulin|insulin|mesh-list
6253703|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6253704|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6253705|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253706|NCT02954653|Cytarabine|cytarabine|mesh-list
6253707|NCT02954653|Azacitidine|azacitidine|mesh-list
6253708|NCT02954653|Decitabine|decitabine|mesh-list
6253709|NCT02954653|Daunorubicin|daunorubicin|mesh-list
6253710|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6253711|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
6253712|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253713|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253714|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
6253715|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253716|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253717|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
6253718|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253719|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253720|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6253721|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6253722|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6253723|NCT02954887|Cannabidiol|cannabidiol|mesh-list
6253724|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
6253725|NCT02955069|Spartalizumab|spartalizumab|mesh-list
6253726|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6253727|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253728|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253729|NCT02955147|Prednisone|prednisone|mesh-list
6253730|NCT02955147|Ustekinumab|ustekinumab|mesh-list
6253731|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253732|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
6253733|NCT02955147|Hormones|hormones|mesh-ancestor
6253734|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253735|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253736|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6253737|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253738|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
6253739|NCT02955186|Saracatinib|saracatinib|mesh-list
6253740|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253741|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253742|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253743|NCT02955212|Upadacitinib|upadacitinib|mesh-list
6253744|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
6253745|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6253746|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253747|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253748|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6253749|NCT02955329|Nicotine|nicotine|mesh-list
6253750|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6253751|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
6253752|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253753|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253754|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6253755|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6253756|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
6253757|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253758|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253759|NCT02955797|Vaccines|vaccines|mesh-list
6253760|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
6253761|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253762|NCT02956044|Metformin|metformin|mesh-list
6253763|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6253764|NCT02956044|Glimepiride|glimepiride|mesh-list
6253765|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
6253766|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6253767|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253768|NCT02956044|Incretins|incretins|mesh-ancestor
6253769|NCT02956044|Hormones|hormones|mesh-ancestor
6253770|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253771|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6253772|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
6253773|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253774|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253775|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6253776|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6253777|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
6253778|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
6253779|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
6253780|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
6253781|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253782|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
6253783|NCT02956057|Protective Agents|protective agents|mesh-ancestor
6253784|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253785|NCT02956057|Vitamins|vitamins|mesh-ancestor
6253786|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
6253787|NCT02956057|Cathartics|cathartics|mesh-ancestor
6253788|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253789|NCT02956070|Dexamethasone|dexamethasone|mesh-list
6253790|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
6253791|NCT02956070|BB 1101|bb 1101|mesh-list
6253792|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253793|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
6253794|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
6253795|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253796|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253797|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253798|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
6253799|NCT02956070|Hormones|hormones|mesh-ancestor
6253800|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253801|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6253802|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253803|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
6253804|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253805|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253806|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
6253807|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6253808|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6253809|NCT02956122|Prednisolone|prednisolone|mesh-list
6253810|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
6253811|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6253812|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
6253813|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6253814|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
6253815|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253816|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
6253817|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
6253818|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253819|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253820|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253821|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
6253822|NCT02956122|Hormones|hormones|mesh-ancestor
6253823|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253824|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6253825|NCT02956122|Protective Agents|protective agents|mesh-ancestor
6253826|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6253827|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253828|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6253829|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6253830|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253831|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253832|NCT02956278|Allopurinol|allopurinol|mesh-list
6253833|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
6253834|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253835|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253836|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
6253837|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6253838|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6253839|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
6253840|NCT02956278|Protective Agents|protective agents|mesh-ancestor
6253841|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253842|NCT02956616|Ketorolac|ketorolac|mesh-list
6253843|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6253844|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6253845|NCT02956616|Analgesics|analgesics|mesh-ancestor
6253846|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
6253847|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253848|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253849|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6253850|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6253851|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6253852|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253853|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253854|NCT02956629|Ribavirin|ribavirin|mesh-list
6253855|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
6253856|NCT02956629|Ruzasvir|ruzasvir|mesh-list
6253857|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
6253858|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253859|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
6253860|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253861|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
6253862|NCT02956746|Antibodies|antibodies|mesh-list
6253863|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
6253864|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
6253865|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
6253866|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
6253867|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253868|NCT02956837|Vaccines|vaccines|mesh-list
6253869|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
6253870|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253871|NCT02957305|Misoprostol|misoprostol|mesh-list
6253872|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6253873|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
6253874|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6253875|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253876|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6253877|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253878|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
6253879|NCT02957331|Propranolol|propranolol|mesh-list
6253880|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6253881|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6253882|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
6253883|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253884|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253885|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253886|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6253887|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6253888|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
6253889|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
6253890|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6253891|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
6253892|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253893|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
6253894|NCT02958267|Protective Agents|protective agents|mesh-ancestor
6253895|NCT02958345|Vaccines|vaccines|mesh-list
6253896|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
6253897|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253898|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
6253899|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6253900|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6253901|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6253902|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253903|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253904|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253905|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6253906|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
6253907|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6253908|NCT02958956|Pioglitazone|pioglitazone|mesh-list
6253909|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6253910|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253911|NCT02958969|Apixaban|apixaban|mesh-list
6253912|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6253913|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
6253914|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6253915|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
6253916|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253917|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253918|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
6253919|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
6253920|NCT02959437|Azacitidine|azacitidine|mesh-list
6253921|NCT02959437|INCB057643|incb057643|mesh-list
6253922|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6253923|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253924|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6253925|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
6253926|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253927|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253928|NCT02959840|Ondansetron|ondansetron|mesh-list
6253929|NCT02959840|Metoclopramide|metoclopramide|mesh-list
6253930|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
6253931|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
6253932|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253933|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253934|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253935|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
6253936|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
6253937|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6253938|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
6253939|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253940|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253941|NCT02959840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6253942|NCT02959840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6253943|NCT02959840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253944|NCT02959840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6253945|NCT02959840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6253946|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6253947|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6253948|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
6253949|NCT02959853|Anastrozole|anastrozole|mesh-list
6253950|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6253951|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6253952|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6253953|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6253954|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253955|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253956|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6253957|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
6253958|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6253959|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253960|NCT02959892|Amphetamine|amphetamine|mesh-list
6253961|NCT02959892|Naxagolide|naxagolide|mesh-list
6253962|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6253963|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253964|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
6253965|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
6253966|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253967|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
6253968|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6253969|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253970|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
6253971|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
6253972|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6253973|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6253974|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6253975|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
6253976|NCT02959970|Dapsone|dapsone|mesh-list
6253977|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6253978|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
6253979|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6253980|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6253981|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6253982|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6253983|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6253984|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
6253985|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6253986|NCT02959983|Eluxadoline|eluxadoline|mesh-list
6253987|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6253988|NCT02959996|Bupivacaine|bupivacaine|mesh-list
6253989|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
6253990|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
6253991|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6253992|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6253993|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
6253994|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6253995|NCT02960438|Quetmolimab|quetmolimab|mesh-list
6253996|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6253997|NCT02960490|Quetmolimab|quetmolimab|mesh-list
6253998|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6253999|NCT02960854|Nivolumab|nivolumab|mesh-list
6254000|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6254001|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254002|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6254003|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254004|NCT02960997|Sirolimus|sirolimus|mesh-list
6254005|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6254006|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254007|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6254008|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254009|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
6254010|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6254011|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
6254012|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254013|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
6254014|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254015|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6254016|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254017|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254018|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
6254019|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6254020|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254021|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6254022|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6254023|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254024|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254025|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254026|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6254027|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6254028|NCT02961764|Dalbavancin|dalbavancin|mesh-list
6254029|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6254030|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254031|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
6254032|NCT02961790|Oxybutynin|oxybutynin|mesh-list
6254033|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
6254034|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
6254035|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254036|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254037|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6254038|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6254039|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
6254040|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254041|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254042|NCT02961790|Urological Agents|urological agents|mesh-ancestor
6254043|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6254044|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254045|NCT02961790|Renal Agents|renal agents|mesh-ancestor
6254046|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
6254047|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
6254048|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
6254049|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
6254050|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
6254051|NCT02962284|Prednisolone|prednisolone|mesh-list
6254052|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
6254053|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
6254054|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
6254055|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
6254056|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6254057|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
6254058|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
6254059|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254060|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254061|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6254062|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
6254063|NCT02962284|Hormones|hormones|mesh-ancestor
6254064|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254065|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6254066|NCT02962284|Protective Agents|protective agents|mesh-ancestor
6254067|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6254068|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254069|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6254070|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254071|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254072|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
6254073|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6254074|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
6254075|NCT02962648|Hematinics|hematinics|mesh-ancestor
6254076|NCT02962739|Tenofovir|tenofovir|mesh-list
6254077|NCT02962739|Emtricitabine|emtricitabine|mesh-list
6254078|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
6254079|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254080|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6254081|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6254082|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254083|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254084|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6254085|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6254086|NCT02963701|Ibuprofen|ibuprofen|mesh-list
6254087|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
6254088|NCT02963701|Ephedrine|ephedrine|mesh-list
6254089|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6254090|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6254091|NCT02963701|Analgesics|analgesics|mesh-ancestor
6254092|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
6254093|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254094|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254095|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6254096|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6254097|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6254098|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254099|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254100|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6254101|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
6254102|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6254103|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
6254104|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
6254105|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6254106|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6254107|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
6254108|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
6254109|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254110|NCT02963922|Liraglutide|liraglutide|mesh-list
6254111|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6254112|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254113|NCT02963922|Incretins|incretins|mesh-ancestor
6254114|NCT02963922|Hormones|hormones|mesh-ancestor
6254115|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254116|NCT02963935|Liraglutide|liraglutide|mesh-list
6254117|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6254118|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254119|NCT02963935|Incretins|incretins|mesh-ancestor
6254120|NCT02963935|Hormones|hormones|mesh-ancestor
6254121|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254122|NCT02964247|Liraglutide|liraglutide|mesh-list
6254123|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6254124|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254125|NCT02964247|Incretins|incretins|mesh-ancestor
6254126|NCT02964247|Hormones|hormones|mesh-ancestor
6254127|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254128|NCT02964416|Tramadol|tramadol|mesh-list
6254129|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6254130|NCT02964416|Narcotics|narcotics|mesh-ancestor
6254131|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254132|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254133|NCT02964416|Analgesics|analgesics|mesh-ancestor
6254134|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
6254135|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254136|NCT02965378|Docetaxel|docetaxel|mesh-list
6254137|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254138|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
6254139|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
6254140|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
6254141|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254142|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
6254143|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6254144|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
6254145|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254146|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
6254147|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6254148|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
6254149|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254150|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6254151|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
6254152|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6254153|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6254154|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254155|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
6254156|NCT02965924|Phenylephrine|phenylephrine|mesh-list
6254157|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
6254158|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6254159|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
6254160|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
6254161|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254162|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254163|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
6254164|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6254165|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
6254166|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
6254167|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
6254168|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6254169|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6254170|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
6254171|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254172|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254173|NCT02965924|Protective Agents|protective agents|mesh-ancestor
6254174|NCT02966002|Aspirin|aspirin|mesh-list
6254175|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6254176|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6254177|NCT02966002|Analgesics|analgesics|mesh-ancestor
6254178|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
6254179|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254180|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254181|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6254182|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6254183|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6254184|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6254185|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254186|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6254187|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6254188|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254189|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
6254190|NCT02966275|Glucagon|glucagon|mesh-list
6254191|NCT02966275|Pancrelipase|pancrelipase|mesh-list
6254192|NCT02966275|Pancreatin|pancreatin|mesh-list
6254193|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6254194|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6254195|NCT02966275|Hormones|hormones|mesh-ancestor
6254196|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254197|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254198|NCT02966275|Incretins|incretins|mesh-ancestor
6254199|NCT02966314|Omalizumab|omalizumab|mesh-list
6254200|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6254201|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6254202|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
6254203|NCT02966340|Prazosin|prazosin|mesh-list
6254204|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6254205|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6254206|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6254207|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6254208|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
6254209|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254210|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254211|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254212|NCT02967354|Tryptophan|tryptophan|mesh-list
6254213|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
6254214|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6254215|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
6254216|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6254217|NCT02967679|Biotin|biotin|mesh-list
6254218|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
6254219|NCT02967679|Vitamins|vitamins|mesh-ancestor
6254220|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
6254221|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254222|NCT02968134|Posaconazole|posaconazole|mesh-list
6254223|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
6254224|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254225|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
6254226|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6254227|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6254228|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6254229|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6254230|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254231|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254232|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6254233|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
6254234|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254235|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254236|NCT02968173|Palivizumab|palivizumab|mesh-list
6254237|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
6254238|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254239|NCT02968368|Ferric maltol|ferric maltol|mesh-list
6254240|NCT02968368|Hematinics|hematinics|mesh-ancestor
6254241|NCT02968576|Tenofovir|tenofovir|mesh-list
6254242|NCT02968576|Emtricitabine|emtricitabine|mesh-list
6254243|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6254244|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
6254245|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254246|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6254247|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6254248|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254249|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254250|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6254251|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6254252|NCT02968914|Benralizumab|benralizumab|mesh-list
6254253|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6254254|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
6254255|NCT02969018|PF-06700841|pf-06700841|mesh-list
6254256|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6254257|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254258|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254259|NCT02969187|Bupivacaine|bupivacaine|mesh-list
6254260|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
6254261|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
6254262|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254263|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254264|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
6254265|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254266|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
6254267|NCT02969317|Olodaterol|olodaterol|mesh-list
6254268|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6254269|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
6254270|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254271|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254272|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6254273|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
6254274|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
6254275|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6254276|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
6254277|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254278|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254279|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
6254280|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6254281|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6254282|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6254283|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6254284|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254285|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
6254286|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254287|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254288|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6254289|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254290|NCT02969408|Albuterol|albuterol|mesh-list
6254291|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6254292|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
6254293|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254294|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254295|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6254296|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
6254297|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
6254298|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6254299|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6254300|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6254301|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6254302|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
6254303|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254304|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254305|NCT02969590|Leuprolide|leuprolide|mesh-list
6254306|NCT02969590|Norethindrone|norethindrone|mesh-list
6254307|NCT02969590|Estradiol|estradiol|mesh-list
6254308|NCT02969590|Estrogens|estrogens|mesh-list
6254309|NCT02969590|Progesterone|progesterone|mesh-list
6254310|NCT02969590|Progestins|progestins|mesh-list
6254311|NCT02969590|Hormones|hormones|mesh-ancestor
6254312|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254313|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254314|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6254315|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
6254316|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6254317|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6254318|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6254319|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
6254320|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6254321|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254322|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6254323|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6254324|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6254325|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
6254326|NCT02969655|Glycine|glycine|mesh-list
6254327|NCT02969655|Hematinics|hematinics|mesh-ancestor
6254328|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
6254329|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254330|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254331|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254332|NCT02969863|Pancrelipase|pancrelipase|mesh-list
6254333|NCT02969863|Pancreatin|pancreatin|mesh-list
6254334|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6254335|NCT02969876|Vortioxetine|vortioxetine|mesh-list
6254336|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
6254337|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6254338|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6254339|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6254340|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254341|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254342|NCT02969876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6254343|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6254344|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6254345|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254346|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254347|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
6254348|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6254349|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6254350|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6254351|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6254352|NCT02970032|Heparin|heparin|mesh-list
6254353|NCT02970032|Calcium heparin|calcium heparin|mesh-list
6254354|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
6254355|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6254356|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6254357|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254358|NCT02970162|Amifampridine|amifampridine|mesh-list
6254359|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6254360|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254361|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254362|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6254363|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6254364|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254365|NCT02970292|Pimavanserin|pimavanserin|mesh-list
6254366|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6254367|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6254368|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6254369|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6254370|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254371|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254372|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6254373|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6254374|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6254375|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
6254376|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254377|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254378|NCT02970305|Pimavanserin|pimavanserin|mesh-list
6254379|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6254380|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6254381|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6254382|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6254383|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254384|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254385|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6254386|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6254387|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6254388|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
6254389|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254390|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254391|NCT02970552|Progesterone|progesterone|mesh-list
6254392|NCT02970552|Progestins|progestins|mesh-ancestor
6254393|NCT02970552|Hormones|hormones|mesh-ancestor
6254394|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254395|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254396|NCT02970669|Valsartan|valsartan|mesh-list
6254397|NCT02970669|Enalapril|enalapril|mesh-list
6254398|NCT02970669|Enalaprilat|enalaprilat|mesh-list
6254399|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6254400|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6254401|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6254402|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6254403|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254404|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6254405|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
6254406|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254407|NCT02971007|Fluconazole|fluconazole|mesh-list
6254408|NCT02971007|Amphotericin B|amphotericin b|mesh-list
6254409|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
6254410|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
6254411|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254412|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6254413|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6254414|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254415|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254416|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6254417|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
6254418|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254419|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254420|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6254421|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6254422|NCT02971007|Amebicides|amebicides|mesh-ancestor
6254423|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6254424|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6254425|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6254426|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
6254427|NCT02971228|Glucagon|glucagon|mesh-list
6254428|NCT02971228|Pancrelipase|pancrelipase|mesh-list
6254429|NCT02971228|Pancreatin|pancreatin|mesh-list
6254430|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
6254431|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6254432|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254433|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6254434|NCT02971228|Hormones|hormones|mesh-ancestor
6254435|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254436|NCT02971228|Incretins|incretins|mesh-ancestor
6254437|NCT02971605|Psilocybin|psilocybin|mesh-list
6254438|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
6254439|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254440|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6254441|NCT02971683|Abatacept|abatacept|mesh-list
6254442|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6254443|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254444|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254445|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6254446|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
6254447|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254448|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6254449|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
6254450|NCT02972502|Promethazine|promethazine|mesh-list
6254451|NCT02972502|Haloperidol|haloperidol|mesh-list
6254452|NCT02972502|Metoclopramide|metoclopramide|mesh-list
6254453|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
6254454|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6254455|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6254456|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254457|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254458|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
6254459|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
6254460|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
6254461|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254462|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
6254463|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
6254464|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6254465|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6254466|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
6254467|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
6254468|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254469|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254470|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6254471|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
6254472|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
6254473|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6254474|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6254475|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6254476|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6254477|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
6254478|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6254479|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6254480|NCT02972554|Propranolol|propranolol|mesh-list
6254481|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6254482|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6254483|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
6254484|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254485|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254486|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254487|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6254488|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6254489|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
6254490|NCT02972632|Vortioxetine|vortioxetine|mesh-list
6254491|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
6254492|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6254493|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6254494|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6254495|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254496|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254497|NCT02972632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6254498|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6254499|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6254500|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254501|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254502|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
6254503|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6254504|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6254505|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6254506|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6254507|NCT02973048|Bupivacaine|bupivacaine|mesh-list
6254508|NCT02973048|Prilocaine|prilocaine|mesh-list
6254509|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
6254510|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
6254511|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254512|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254513|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
6254514|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254515|NCT02973087|Factor VIII|factor viii|mesh-list
6254516|NCT02973087|Coagulants|coagulants|mesh-ancestor
6254517|NCT02973100|Dulaglutide|dulaglutide|mesh-list
6254518|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6254519|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254520|NCT02973321|Metformin|metformin|mesh-list
6254521|NCT02973321|Liraglutide|liraglutide|mesh-list
6254522|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6254523|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254524|NCT02973321|Incretins|incretins|mesh-ancestor
6254525|NCT02973321|Hormones|hormones|mesh-ancestor
6254526|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254527|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
6254528|NCT02973477|Glimepiride|glimepiride|mesh-list
6254529|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6254530|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254531|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6254532|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254533|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6254534|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6254535|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
6254536|NCT02973503|Grazoprevir|grazoprevir|mesh-list
6254537|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
6254538|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254539|NCT02974010|Cycloserine|cycloserine|mesh-list
6254540|NCT02974010|Ketamine|ketamine|mesh-list
6254541|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
6254542|NCT02974010|Analgesics|analgesics|mesh-ancestor
6254543|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
6254544|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254545|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254546|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6254547|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6254548|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
6254549|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
6254550|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254551|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6254552|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6254553|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254554|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254555|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6254556|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254557|NCT02974010|Renal Agents|renal agents|mesh-ancestor
6254558|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6254559|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
6254560|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6254561|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
6254562|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6254563|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6254564|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6254565|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
6254566|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6254567|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6254568|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
6254569|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6254570|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6254571|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
6254572|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6254573|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6254574|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
6254575|NCT02974114|Acetaminophen|acetaminophen|mesh-list
6254576|NCT02974114|Caffeine|caffeine|mesh-list
6254577|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6254578|NCT02974114|Analgesics|analgesics|mesh-ancestor
6254579|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
6254580|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254581|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254582|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
6254583|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6254584|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6254585|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254586|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254587|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6254588|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6254589|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
6254590|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254591|NCT02974868|PF-06700841|pf-06700841|mesh-list
6254592|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6254593|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254594|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254595|NCT02975206|Serlopitant|serlopitant|mesh-list
6254596|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
6254597|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254598|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254599|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254600|NCT02975297|Exenatide|exenatide|mesh-list
6254601|NCT02975297|Nicotine|nicotine|mesh-list
6254602|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6254603|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
6254604|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254605|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254606|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6254607|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6254608|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
6254609|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254610|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254611|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6254612|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
6254613|NCT02975297|Incretins|incretins|mesh-ancestor
6254614|NCT02975297|Hormones|hormones|mesh-ancestor
6254615|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254616|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
6254617|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
6254618|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6254619|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
6254620|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254621|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6254622|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
6254623|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6254624|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6254625|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6254626|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6254627|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
6254628|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254629|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254630|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254631|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6254632|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6254633|NCT02976103|Analgesics|analgesics|mesh-list
6254634|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
6254635|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254636|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254637|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
6254638|NCT02977507|Hydroquinone|hydroquinone|mesh-list
6254639|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
6254640|NCT02977507|Protective Agents|protective agents|mesh-ancestor
6254641|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254642|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
6254643|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
6254644|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254645|NCT02978157|Amoxicillin|amoxicillin|mesh-list
6254646|NCT02978157|Levofloxacin|levofloxacin|mesh-list
6254647|NCT02978157|Ofloxacin|ofloxacin|mesh-list
6254648|NCT02978157|Tetracycline|tetracycline|mesh-list
6254649|NCT02978157|Esomeprazole|esomeprazole|mesh-list
6254650|NCT02978157|Bismuth|bismuth|mesh-list
6254651|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6254652|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254653|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6254654|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6254655|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6254656|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254657|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254658|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6254659|NCT02978157|Renal Agents|renal agents|mesh-ancestor
6254660|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6254661|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6254662|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254663|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
6254664|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6254665|NCT02978157|Antacids|antacids|mesh-ancestor
6254666|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6254667|NCT02978339|Curcumin|curcumin|mesh-list
6254668|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6254669|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6254670|NCT02978339|Analgesics|analgesics|mesh-ancestor
6254671|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
6254672|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254673|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254674|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6254675|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6254676|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254677|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254678|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254679|NCT02978417|Naltrexone|naltrexone|mesh-list
6254680|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6254681|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6254682|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254683|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
6254684|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254685|NCT02978508|Permethrin|permethrin|mesh-list
6254686|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254687|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254688|NCT02979197|Celecoxib|celecoxib|mesh-list
6254689|NCT02979197|Amlodipine|amlodipine|mesh-list
6254690|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6254691|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6254692|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6254693|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254694|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6254695|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254696|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
6254697|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6254698|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6254699|NCT02979197|Analgesics|analgesics|mesh-ancestor
6254700|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
6254701|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254702|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6254703|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6254704|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
6254705|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6254706|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254707|NCT02979301|Tamoxifen|tamoxifen|mesh-list
6254708|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6254709|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
6254710|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254711|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254712|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6254713|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254714|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6254715|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6254716|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6254717|NCT02979431|Gontivimab|gontivimab|mesh-list
6254718|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
6254719|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254720|NCT02979522|Doxorubicin|doxorubicin|mesh-list
6254721|NCT02979522|Dacarbazine|dacarbazine|mesh-list
6254722|NCT02979522|Vinblastine|vinblastine|mesh-list
6254723|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6254724|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6254725|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254726|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6254727|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6254728|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254729|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254730|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6254731|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
6254732|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6254733|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
6254734|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
6254735|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
6254736|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6254737|NCT02979535|Vaccines|vaccines|mesh-list
6254738|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
6254739|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254740|NCT02980042|Rituximab|rituximab|mesh-list
6254741|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
6254742|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6254743|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254744|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
6254745|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254746|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6254747|NCT02980133|Fluticasone|fluticasone|mesh-list
6254748|NCT02980133|Xhance|xhance|mesh-list
6254749|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6254750|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6254751|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6254752|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
6254753|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254754|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254755|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6254756|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
6254757|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
6254758|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6254759|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6254760|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6254761|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6254762|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
6254763|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254764|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254765|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
6254766|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
6254767|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
6254768|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
6254769|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
6254770|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6254771|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6254772|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254773|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6254774|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6254775|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254776|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254777|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254778|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254779|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6254780|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
6254781|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
6254782|NCT02980523|Protective Agents|protective agents|mesh-ancestor
6254783|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
6254784|NCT02980783|Lidocaine|lidocaine|mesh-list
6254785|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
6254786|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
6254787|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254788|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254789|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
6254790|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254791|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6254792|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6254793|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6254794|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6254795|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254796|NCT02980874|Triamcinolone|triamcinolone|mesh-list
6254797|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6254798|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6254799|NCT02980874|Aflibercept|aflibercept|mesh-list
6254800|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6254801|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6254802|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
6254803|NCT02980874|Hormones|hormones|mesh-ancestor
6254804|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254805|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254806|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6254807|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
6254808|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254809|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254810|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6254811|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6254812|NCT02980874|Growth Substances|growth substances|mesh-ancestor
6254813|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
6254814|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254815|NCT02981342|Gemcitabine|gemcitabine|mesh-list
6254816|NCT02981342|Capecitabine|capecitabine|mesh-list
6254817|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6254818|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
6254819|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254820|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254821|NCT02981342|Antiviral Agents|antiviral agents|mesh-ancestor
6254822|NCT02981342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254823|NCT02981342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254824|NCT02981342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6254825|NCT02981342|Immunologic Factors|immunologic factors|mesh-ancestor
6254826|NCT02981342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254827|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
6254828|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
6254829|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
6254830|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254831|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6254832|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6254833|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6254834|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
6254835|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254836|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254837|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6254838|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6254839|NCT02982590|Warfarin|warfarin|mesh-list
6254840|NCT02982590|Apixaban|apixaban|mesh-list
6254841|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
6254842|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6254843|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
6254844|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6254845|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
6254846|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254847|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254848|NCT02982772|Nicotine|nicotine|mesh-list
6254849|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6254850|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
6254851|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254852|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254853|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6254854|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6254855|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
6254856|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254857|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254858|NCT02982954|Nivolumab|nivolumab|mesh-list
6254859|NCT02982954|Ipilimumab|ipilimumab|mesh-list
6254860|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6254861|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254862|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6254863|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254864|NCT02983604|Fulvestrant|fulvestrant|mesh-list
6254865|NCT02983604|Exemestane|exemestane|mesh-list
6254866|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6254867|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254868|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6254869|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6254870|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
6254871|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254872|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254873|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6254874|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6254875|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254876|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254877|NCT02983981|Desoximetasone|desoximetasone|mesh-list
6254878|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6254879|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
6254880|NCT02983981|Hormones|hormones|mesh-ancestor
6254881|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254882|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254883|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
6254884|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6254885|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254886|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6254887|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254888|NCT02984982|Anticoagulants|anticoagulants|mesh-list
6254889|NCT02984982|Atorvastatin|atorvastatin|mesh-list
6254890|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6254891|NCT02984982|Ezetimibe|ezetimibe|mesh-list
6254892|NCT02984982|Fenofibrate|fenofibrate|mesh-list
6254893|NCT02984982|Bezafibrate|bezafibrate|mesh-list
6254894|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6254895|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6254896|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
6254897|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254898|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6254899|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6254900|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254901|NCT02985021|Carboplatin|carboplatin|mesh-list
6254902|NCT02985021|Docetaxel|docetaxel|mesh-list
6254903|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254904|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
6254905|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
6254906|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
6254907|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254908|NCT02985879|Tilavonemab|tilavonemab|mesh-list
6254909|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
6254910|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6254911|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
6254912|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6254913|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6254914|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254915|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254916|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
6254917|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6254918|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6254919|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6254920|NCT02986139|Etanercept|etanercept|mesh-list
6254921|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6254922|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6254923|NCT02986139|Analgesics|analgesics|mesh-ancestor
6254924|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
6254925|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254926|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254927|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6254928|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6254929|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6254930|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6254931|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
6254932|NCT02987543|Olaparib|olaparib|mesh-list
6254933|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
6254934|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6254935|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254936|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254937|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6254938|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6254939|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
6254940|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254941|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254942|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6254943|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
6254944|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
6254945|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
6254946|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6254947|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254948|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
6254949|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
6254950|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254951|NCT02988050|Lidocaine|lidocaine|mesh-list
6254952|NCT02988050|Epinephrine|epinephrine|mesh-list
6254953|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
6254954|NCT02988050|Remifentanil|remifentanil|mesh-list
6254955|NCT02988050|Bupivacaine|bupivacaine|mesh-list
6254956|NCT02988050|Propofol|propofol|mesh-list
6254957|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
6254958|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
6254959|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6254960|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254961|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
6254962|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6254963|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6254964|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6254965|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6254966|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6254967|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254968|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6254969|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6254970|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
6254971|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6254972|NCT02988050|Analgesics|analgesics|mesh-ancestor
6254973|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6254974|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6254975|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6254976|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
6254977|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6254978|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6254979|NCT02988050|Narcotics|narcotics|mesh-ancestor
6254980|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6254981|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6254982|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
6254983|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6254984|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
6254985|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
6254986|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
6254987|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6254988|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6254989|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6254990|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
6254991|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6254992|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6254993|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6254994|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6254995|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6254996|NCT02988219|Epinephrine|epinephrine|mesh-list
6254997|NCT02988219|Fentanyl|fentanyl|mesh-list
6254998|NCT02988219|Bupivacaine|bupivacaine|mesh-list
6254999|NCT02988219|Anesthetics|anesthetics|mesh-list
6255000|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
6255001|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255002|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255003|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
6255004|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255005|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6255006|NCT02988219|Narcotics|narcotics|mesh-ancestor
6255007|NCT02988219|Analgesics|analgesics|mesh-ancestor
6255008|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6255009|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6255010|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
6255011|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6255012|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6255013|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
6255014|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255015|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255016|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6255017|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6255018|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
6255019|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6255020|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
6255021|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
6255022|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
6255023|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6255024|NCT02988349|Listerine|listerine|mesh-list
6255025|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
6255026|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
6255027|NCT02988349|Protective Agents|protective agents|mesh-ancestor
6255028|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255029|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6255030|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255031|NCT02988843|Bevacizumab|bevacizumab|mesh-list
6255032|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
6255033|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6255034|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255035|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6255036|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6255037|NCT02988843|Growth Substances|growth substances|mesh-ancestor
6255038|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255039|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
6255040|NCT02988882|Dexamethasone|dexamethasone|mesh-list
6255041|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255042|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
6255043|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
6255044|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255045|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255046|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6255047|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
6255048|NCT02988882|Hormones|hormones|mesh-ancestor
6255049|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255050|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6255051|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255052|NCT02988986|Tamoxifen|tamoxifen|mesh-list
6255053|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6255054|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
6255055|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255056|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255057|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6255058|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255059|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6255060|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6255061|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6255062|NCT02989389|Itraconazole|itraconazole|mesh-list
6255063|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
6255064|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255065|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6255066|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6255067|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255068|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255069|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6255070|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
6255071|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255072|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255073|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6255074|NCT02989493|Doxazosin|doxazosin|mesh-list
6255075|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6255076|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
6255077|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
6255078|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6255079|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
6255080|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255081|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255082|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255083|NCT02989649|Metformin|metformin|mesh-list
6255084|NCT02989649|Pioglitazone|pioglitazone|mesh-list
6255085|NCT02989649|Alogliptin|alogliptin|mesh-list
6255086|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6255087|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255088|NCT02989649|Incretins|incretins|mesh-ancestor
6255089|NCT02989649|Hormones|hormones|mesh-ancestor
6255090|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255091|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6255092|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
6255093|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255094|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255095|NCT02989714|Nivolumab|nivolumab|mesh-list
6255096|NCT02989714|Interleukin-2|interleukin-2|mesh-list
6255097|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6255098|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255099|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6255100|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255101|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6255102|NCT02989714|Analgesics|analgesics|mesh-ancestor
6255103|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
6255104|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255105|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255106|NCT02989727|Lamotrigine|lamotrigine|mesh-list
6255107|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
6255108|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6255109|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6255110|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255111|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6255112|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255113|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6255114|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6255115|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255116|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6255117|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6255118|NCT02990338|Dexamethasone|dexamethasone|mesh-list
6255119|NCT02990338|Pomalidomide|pomalidomide|mesh-list
6255120|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255121|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
6255122|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
6255123|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255124|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255125|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6255126|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
6255127|NCT02990338|Hormones|hormones|mesh-ancestor
6255128|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255129|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6255130|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255131|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
6255132|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6255133|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6255134|NCT02990338|Growth Substances|growth substances|mesh-ancestor
6255135|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
6255136|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
6255137|NCT02990910|Narcotics|narcotics|mesh-ancestor
6255138|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255139|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255140|NCT02990910|Analgesics|analgesics|mesh-ancestor
6255141|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
6255142|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255143|NCT02991040|Lidocaine|lidocaine|mesh-list
6255144|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
6255145|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
6255146|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255147|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255148|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
6255149|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255150|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6255151|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6255152|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6255153|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6255154|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255155|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6255156|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6255157|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
6255158|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255159|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6255160|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255161|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6255162|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255163|NCT02991859|Fluticasone|fluticasone|mesh-list
6255164|NCT02991859|Xhance|xhance|mesh-list
6255165|NCT02991859|Budesonide|budesonide|mesh-list
6255166|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255167|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6255168|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
6255169|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255170|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255171|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6255172|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
6255173|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
6255174|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6255175|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
6255176|NCT02991859|Hormones|hormones|mesh-ancestor
6255177|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255178|NCT02992132|Pimavanserin|pimavanserin|mesh-list
6255179|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6255180|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6255181|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6255182|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6255183|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255184|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255185|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6255186|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6255187|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6255188|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
6255189|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255190|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255191|NCT02992418|Vaccines|vaccines|mesh-list
6255192|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
6255193|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255194|NCT02993224|Deferasirox|deferasirox|mesh-list
6255195|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
6255196|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
6255197|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
6255198|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255199|NCT02993250|Simeprevir|simeprevir|mesh-list
6255200|NCT02993250|Odalasvir|odalasvir|mesh-list
6255201|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
6255202|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255203|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
6255204|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255205|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255206|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
6255207|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
6255208|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6255209|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255210|NCT02993302|Vitamins|vitamins|mesh-ancestor
6255211|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
6255212|NCT02993471|Vitamin K|vitamin k|mesh-list
6255213|NCT02993471|Midazolam|midazolam|mesh-list
6255214|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
6255215|NCT02993471|Caffeine|caffeine|mesh-list
6255216|NCT02993471|Ixekizumab|ixekizumab|mesh-list
6255217|NCT02993471|Omeprazole|omeprazole|mesh-list
6255218|NCT02993471|Warfarin|warfarin|mesh-list
6255219|NCT02993471|Vitamins|vitamins|mesh-ancestor
6255220|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
6255221|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255222|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6255223|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6255224|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255225|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6255226|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6255227|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6255228|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6255229|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
6255230|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
6255231|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
6255232|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
6255233|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255234|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255235|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
6255236|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6255237|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6255238|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6255239|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255240|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6255241|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6255242|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6255243|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6255244|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
6255245|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
6255246|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6255247|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
6255248|NCT02993471|Coagulants|coagulants|mesh-ancestor
6255249|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
6255250|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
6255251|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6255252|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6255253|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
6255254|NCT02993731|Gemcitabine|gemcitabine|mesh-list
6255255|NCT02993731|Paclitaxel|paclitaxel|mesh-list
6255256|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6255257|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255258|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
6255259|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
6255260|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
6255261|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255262|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6255263|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
6255264|NCT02993731|Antiviral Agents|antiviral agents|mesh-ancestor
6255265|NCT02993731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255266|NCT02993731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255267|NCT02993731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6255268|NCT02993731|Immunologic Factors|immunologic factors|mesh-ancestor
6255269|NCT02993731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255270|NCT02993757|Vaccines|vaccines|mesh-list
6255271|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
6255272|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255273|NCT02993783|Vedolizumab|vedolizumab|mesh-list
6255274|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6255275|NCT02993926|Leuprolide|leuprolide|mesh-list
6255276|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6255277|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
6255278|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6255279|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255280|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6255281|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255282|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
6255283|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6255284|NCT02994056|Velpatasvir|velpatasvir|mesh-list
6255285|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
6255286|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255287|NCT02994394|Tolvaptan|tolvaptan|mesh-list
6255288|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6255289|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255290|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
6255291|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255292|NCT02994940|Acetaminophen|acetaminophen|mesh-list
6255293|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6255294|NCT02994940|Analgesics|analgesics|mesh-ancestor
6255295|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
6255296|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255297|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255298|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
6255299|NCT02995915|Bupropion|bupropion|mesh-list
6255300|NCT02995915|Nicotine|nicotine|mesh-list
6255301|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6255302|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
6255303|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255304|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255305|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6255306|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6255307|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
6255308|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255309|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255310|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6255311|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
6255312|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6255313|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6255314|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6255315|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6255316|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
6255317|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6255318|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6255319|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255320|NCT02996097|Triamcinolone|triamcinolone|mesh-list
6255321|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6255322|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6255323|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6255324|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255325|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
6255326|NCT02996097|Hormones|hormones|mesh-ancestor
6255327|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255328|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255329|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6255330|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
6255331|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255332|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255333|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
6255334|NCT02996474|Decitabine|decitabine|mesh-list
6255335|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6255336|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255337|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6255338|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
6255339|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255340|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255341|NCT02996500|Tofacitinib|tofacitinib|mesh-list
6255342|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6255343|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255344|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255345|NCT02996591|Dexamethasone|dexamethasone|mesh-list
6255346|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
6255347|NCT02996591|Midazolam|midazolam|mesh-list
6255348|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
6255349|NCT02996591|Ketamine|ketamine|mesh-list
6255350|NCT02996591|Bupivacaine|bupivacaine|mesh-list
6255351|NCT02996591|Mepivacaine|mepivacaine|mesh-list
6255352|NCT02996591|Anesthetics|anesthetics|mesh-list
6255353|NCT02996591|Propofol|propofol|mesh-list
6255354|NCT02996591|Sevoflurane|sevoflurane|mesh-list
6255355|NCT02996591|BB 1101|bb 1101|mesh-list
6255356|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255357|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
6255358|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
6255359|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255360|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255361|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6255362|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
6255363|NCT02996591|Hormones|hormones|mesh-ancestor
6255364|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255365|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6255366|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255367|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
6255368|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255369|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255370|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
6255371|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255372|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
6255373|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6255374|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6255375|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
6255376|NCT02996591|Analgesics|analgesics|mesh-ancestor
6255377|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6255378|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6255379|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6255380|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255381|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6255382|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6255383|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6255384|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6255385|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
6255386|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
6255387|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6255388|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6255389|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6255390|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6255391|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
6255392|NCT02996682|Ribavirin|ribavirin|mesh-list
6255393|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6255394|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
6255395|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255396|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
6255397|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255398|NCT02997163|Talazoparib|talazoparib|mesh-list
6255399|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6255400|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255401|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255402|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255403|NCT02997176|Talazoparib|talazoparib|mesh-list
6255404|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6255405|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255406|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255407|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255408|NCT02997722|Ketamine|ketamine|mesh-list
6255409|NCT02997722|Analgesics|analgesics|mesh-ancestor
6255410|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
6255411|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255412|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255413|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6255414|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6255415|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
6255416|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
6255417|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255418|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6255419|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6255420|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255421|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255422|NCT02998151|Minocycline|minocycline|mesh-list
6255423|NCT02998151|Acamprosate|acamprosate|mesh-list
6255424|NCT02998151|Baclofen|baclofen|mesh-list
6255425|NCT02998151|Lovastatin|lovastatin|mesh-list
6255426|NCT02998151|L 647318|l 647318|mesh-list
6255427|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
6255428|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6255429|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255430|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6255431|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255432|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6255433|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255434|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6255435|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
6255436|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
6255437|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255438|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255439|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6255440|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6255441|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
6255442|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6255443|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6255444|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255445|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6255446|NCT02998996|Endocine|endocine|mesh-list
6255447|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6255448|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
6255449|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255450|NCT02999100|Oxytocin|oxytocin|mesh-list
6255451|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
6255452|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6255453|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255454|NCT02999178|Nintedanib|nintedanib|mesh-list
6255455|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255456|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6255457|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255458|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255459|NCT02999633|Acetaminophen|acetaminophen|mesh-list
6255460|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
6255461|NCT02999633|Promethazine|promethazine|mesh-list
6255462|NCT02999633|Dexamethasone|dexamethasone|mesh-list
6255463|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
6255464|NCT02999633|Ranitidine|ranitidine|mesh-list
6255465|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
6255466|NCT02999633|BB 1101|bb 1101|mesh-list
6255467|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255468|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
6255469|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
6255470|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255471|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255472|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6255473|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
6255474|NCT02999633|Hormones|hormones|mesh-ancestor
6255475|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255476|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6255477|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255478|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
6255479|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255480|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255481|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6255482|NCT02999633|Analgesics|analgesics|mesh-ancestor
6255483|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
6255484|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
6255485|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6255486|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6255487|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255488|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
6255489|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
6255490|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6255491|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
6255492|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
6255493|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255494|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6255495|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
6255496|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
6255497|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6255498|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
6255499|NCT02999672|Trastuzumab|trastuzumab|mesh-list
6255500|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
6255501|NCT02999672|Maytansine|maytansine|mesh-list
6255502|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6255503|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255504|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6255505|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
6255506|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
6255507|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
6255508|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255509|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6255510|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
6255511|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255512|NCT03000283|Conivaptan|conivaptan|mesh-list
6255513|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6255514|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255515|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
6255516|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255517|NCT03000309|Apremilast|apremilast|mesh-list
6255518|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6255519|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6255520|NCT03000309|Analgesics|analgesics|mesh-ancestor
6255521|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
6255522|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255523|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255524|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255525|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6255526|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6255527|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6255528|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255529|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255530|NCT03000348|Cysteamine|cysteamine|mesh-list
6255531|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
6255532|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255533|NCT03000452|Durvalumab|durvalumab|mesh-list
6255534|NCT03000452|Daratumumab|daratumumab|mesh-list
6255535|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6255536|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255537|NCT03000673|Heparin|heparin|mesh-list
6255538|NCT03000673|Enoxaparin|enoxaparin|mesh-list
6255539|NCT03000673|Calcium heparin|calcium heparin|mesh-list
6255540|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
6255541|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6255542|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6255543|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255544|NCT03001011|Sevelamer|sevelamer|mesh-list
6255545|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
6255546|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
6255547|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255548|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6255549|NCT03001076|Ezetimibe|ezetimibe|mesh-list
6255550|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6255551|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6255552|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
6255553|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255554|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6255555|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255556|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6255557|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255558|NCT03001219|Methotrexate|methotrexate|mesh-list
6255559|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6255560|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
6255561|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6255562|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255563|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6255564|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
6255565|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255566|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255567|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
6255568|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255569|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6255570|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6255571|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
6255572|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6255573|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6255574|NCT03001453|Epinephrine|epinephrine|mesh-list
6255575|NCT03001453|Bupivacaine|bupivacaine|mesh-list
6255576|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
6255577|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
6255578|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255579|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255580|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
6255581|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255582|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6255583|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6255584|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
6255585|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255586|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255587|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6255588|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6255589|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
6255590|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6255591|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
6255592|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
6255593|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
6255594|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6255595|NCT03001557|Lemborexant|lemborexant|mesh-list
6255596|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6255597|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255598|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255599|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6255600|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6255601|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255602|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255603|NCT03001843|Ketamine|ketamine|mesh-list
6255604|NCT03001843|Narcotics|narcotics|mesh-list
6255605|NCT03001843|Analgesics|analgesics|mesh-ancestor
6255606|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
6255607|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255608|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255609|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6255610|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6255611|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
6255612|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
6255613|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255614|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6255615|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6255616|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255617|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255618|NCT03002012|Fluconazole|fluconazole|mesh-list
6255619|NCT03002012|Sertraline|sertraline|mesh-list
6255620|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
6255621|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6255622|NCT03002012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6255623|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6255624|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6255625|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255626|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255627|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
6255628|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255629|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
6255630|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255631|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6255632|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6255633|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255634|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6255635|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
6255636|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255637|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6255638|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6255639|NCT03002038|Rituximab|rituximab|mesh-list
6255640|NCT03002038|Azathioprine|azathioprine|mesh-list
6255641|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6255642|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255643|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
6255644|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255645|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6255646|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
6255647|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255648|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6255649|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6255650|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
6255651|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
6255652|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6255653|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255654|NCT03002506|Tazobactam|tazobactam|mesh-list
6255655|NCT03002506|Ceftolozane|ceftolozane|mesh-list
6255656|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
6255657|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6255658|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255659|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6255660|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255661|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255662|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6255663|NCT03002506|Renal Agents|renal agents|mesh-ancestor
6255664|NCT03002974|Triamcinolone|triamcinolone|mesh-list
6255665|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
6255666|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
6255667|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
6255668|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
6255669|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255670|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
6255671|NCT03002974|Hormones|hormones|mesh-ancestor
6255672|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255673|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255674|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6255675|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
6255676|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255677|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255678|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6255679|NCT03003000|Ibuprofen|ibuprofen|mesh-list
6255680|NCT03003000|Caffeine|caffeine|mesh-list
6255681|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6255682|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6255683|NCT03003000|Analgesics|analgesics|mesh-ancestor
6255684|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
6255685|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255686|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255687|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255688|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6255689|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6255690|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255691|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255692|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
6255693|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6255694|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
6255695|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6255696|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
6255697|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255698|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
6255699|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6255700|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
6255701|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255702|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
6255703|NCT03003130|Protective Agents|protective agents|mesh-ancestor
6255704|NCT03003390|Enoxaparin|enoxaparin|mesh-list
6255705|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
6255706|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6255707|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6255708|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255709|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
6255710|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
6255711|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6255712|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
6255713|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255714|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6255715|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6255716|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
6255717|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255718|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255719|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6255720|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6255721|NCT03003949|Estradiol|estradiol|mesh-list
6255722|NCT03003949|Progesterone|progesterone|mesh-list
6255723|NCT03003949|Estrogens|estrogens|mesh-ancestor
6255724|NCT03003949|Hormones|hormones|mesh-ancestor
6255725|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255726|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255727|NCT03003949|Progestins|progestins|mesh-ancestor
6255728|NCT03004469|Finasteride|finasteride|mesh-list
6255729|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
6255730|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6255731|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255732|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255733|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
6255734|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255735|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255736|NCT03004469|Urological Agents|urological agents|mesh-ancestor
6255737|NCT03006341|Telmisartan|telmisartan|mesh-list
6255738|NCT03006341|Warfarin|warfarin|mesh-list
6255739|NCT03006341|Dabigatran|dabigatran|mesh-list
6255740|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
6255741|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6255742|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6255743|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6255744|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255745|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
6255746|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6255747|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
6255748|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255749|NCT03006393|Infliximab|infliximab|mesh-list
6255750|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
6255751|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6255752|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6255753|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
6255754|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6255755|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255756|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6255757|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255758|NCT03006562|Heparin|heparin|mesh-list
6255759|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
6255760|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6255761|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6255762|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255763|NCT03006848|Avelumab|avelumab|mesh-list
6255764|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6255765|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255766|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
6255767|NCT03006887|Lenvatinib|lenvatinib|mesh-list
6255768|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6255769|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255770|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6255771|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255772|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255773|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
6255774|NCT03006926|Lenvatinib|lenvatinib|mesh-list
6255775|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6255776|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255777|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6255778|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255779|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255780|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
6255781|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
6255782|NCT03007225|Estrogens|estrogens|mesh-ancestor
6255783|NCT03007225|Hormones|hormones|mesh-ancestor
6255784|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255785|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255786|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6255787|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255788|NCT03007966|Clonidine|clonidine|mesh-list
6255789|NCT03007966|Epinephrine|epinephrine|mesh-list
6255790|NCT03007966|Bupivacaine|bupivacaine|mesh-list
6255791|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
6255792|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
6255793|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255794|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255795|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
6255796|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255797|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6255798|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6255799|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
6255800|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255801|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255802|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6255803|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6255804|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
6255805|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6255806|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
6255807|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
6255808|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
6255809|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6255810|NCT03007966|Analgesics|analgesics|mesh-ancestor
6255811|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6255812|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
6255813|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6255814|NCT03007979|Letrozole|letrozole|mesh-list
6255815|NCT03007979|Fulvestrant|fulvestrant|mesh-list
6255816|NCT03007979|Palbociclib|palbociclib|mesh-list
6255817|NCT03007979|Goserelin|goserelin|mesh-list
6255818|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255819|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
6255820|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6255821|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255822|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255823|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6255824|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
6255825|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255826|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255827|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6255828|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
6255829|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6255830|NCT03008213|Palonosetron|palonosetron|mesh-list
6255831|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
6255832|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
6255833|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255834|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255835|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6255836|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
6255837|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6255838|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
6255839|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255840|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255841|NCT03008590|Naltrexone|naltrexone|mesh-list
6255842|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6255843|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6255844|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255845|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
6255846|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255847|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
6255848|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
6255849|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
6255850|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255851|NCT03008889|Expectorants|expectorants|mesh-ancestor
6255852|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
6255853|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
6255854|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
6255855|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255856|NCT03008889|Protective Agents|protective agents|mesh-ancestor
6255857|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255858|NCT03008889|Antidotes|antidotes|mesh-ancestor
6255859|NCT03008915|Aspirin|aspirin|mesh-list
6255860|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
6255861|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
6255862|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6255863|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6255864|NCT03008915|Analgesics|analgesics|mesh-ancestor
6255865|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
6255866|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255867|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255868|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255869|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6255870|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6255871|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6255872|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255873|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6255874|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6255875|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255876|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
6255877|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
6255878|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6255879|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
6255880|NCT03009162|Lasmiditan|lasmiditan|mesh-list
6255881|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6255882|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
6255883|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255884|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255885|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255886|NCT03009396|Clarithromycin|clarithromycin|mesh-list
6255887|NCT03009396|Rifabutin|rifabutin|mesh-list
6255888|NCT03009396|Clofazimine|clofazimine|mesh-list
6255889|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6255890|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255891|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6255892|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255893|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255894|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6255895|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6255896|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6255897|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
6255898|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255899|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
6255900|NCT03010631|Lubiprostone|lubiprostone|mesh-list
6255901|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6255902|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6255903|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255904|NCT03010683|Metformin|metformin|mesh-list
6255905|NCT03010683|Liraglutide|liraglutide|mesh-list
6255906|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6255907|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255908|NCT03010683|Incretins|incretins|mesh-ancestor
6255909|NCT03010683|Hormones|hormones|mesh-ancestor
6255910|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255911|NCT03011333|Epinephrine|epinephrine|mesh-list
6255912|NCT03011333|Bupivacaine|bupivacaine|mesh-list
6255913|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
6255914|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
6255915|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255916|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255917|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
6255918|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255919|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6255920|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6255921|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
6255922|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255923|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255924|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6255925|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6255926|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
6255927|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6255928|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
6255929|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
6255930|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
6255931|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6255932|NCT03011892|Triamcinolone|triamcinolone|mesh-list
6255933|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255934|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
6255935|NCT03011892|Hormones|hormones|mesh-ancestor
6255936|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6255937|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255938|NCT03012061|Fluticasone|fluticasone|mesh-list
6255939|NCT03012061|Xhance|xhance|mesh-list
6255940|NCT03012061|Albuterol|albuterol|mesh-list
6255941|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6255942|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6255943|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
6255944|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6255945|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255946|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6255947|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
6255948|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
6255949|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6255950|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
6255951|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6255952|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6255953|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6255954|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6255955|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
6255956|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255957|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255958|NCT03012191|Gentamicins|gentamicins|mesh-list
6255959|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6255960|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255961|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6255962|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255963|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255964|NCT03012334|Alprazolam|alprazolam|mesh-list
6255965|NCT03012334|Lasmiditan|lasmiditan|mesh-list
6255966|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6255967|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6255968|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255969|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6255970|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6255971|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6255972|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
6255973|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
6255974|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6255975|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255976|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6255977|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
6255978|NCT03012477|Adavosertib|adavosertib|mesh-list
6255979|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6255980|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255981|NCT03012594|Lanreotide|lanreotide|mesh-list
6255982|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255983|NCT03012672|Cytarabine|cytarabine|mesh-list
6255984|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
6255985|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
6255986|NCT03012672|Cladribine|cladribine|mesh-list
6255987|NCT03012672|Lenograstim|lenograstim|mesh-list
6255988|NCT03012672|Sargramostim|sargramostim|mesh-list
6255989|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6255990|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
6255991|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6255992|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6255993|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
6255994|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6255995|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6255996|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
6255997|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6255998|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6255999|NCT03012672|Analgesics|analgesics|mesh-ancestor
6256000|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
6256001|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256002|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6256003|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6256004|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256005|NCT03012828|Moxidectin|moxidectin|mesh-list
6256006|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
6256007|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6256008|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256009|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
6256010|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
6256011|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
6256012|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6256013|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256014|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
6256015|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256016|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
6256017|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
6256018|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256019|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256020|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6256021|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256022|NCT03015220|Dulaglutide|dulaglutide|mesh-list
6256023|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6256024|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256025|NCT03015532|Bupivacaine|bupivacaine|mesh-list
6256026|NCT03015532|Ropivacaine|ropivacaine|mesh-list
6256027|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
6256028|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
6256029|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256030|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256031|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
6256032|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256033|NCT03015961|Bupivacaine|bupivacaine|mesh-list
6256034|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
6256035|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
6256036|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256037|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256038|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
6256039|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256040|NCT03016598|Oxytocin|oxytocin|mesh-list
6256041|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
6256042|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6256043|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256044|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
6256045|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
6256046|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
6256047|NCT03017235|Citric Acid|citric acid|mesh-list
6256048|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
6256049|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
6256050|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
6256051|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
6256052|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256053|NCT03017235|Cathartics|cathartics|mesh-ancestor
6256054|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256055|NCT03017235|Antacids|antacids|mesh-ancestor
6256056|NCT03017508|Riluzole|riluzole|mesh-list
6256057|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
6256058|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6256059|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6256060|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256061|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256062|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256063|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
6256064|NCT03017508|Protective Agents|protective agents|mesh-ancestor
6256065|NCT03017846|Cantharidin|cantharidin|mesh-list
6256066|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256067|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256068|NCT03018028|Liraglutide|liraglutide|mesh-list
6256069|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6256070|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256071|NCT03018028|Incretins|incretins|mesh-ancestor
6256072|NCT03018028|Hormones|hormones|mesh-ancestor
6256073|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256074|NCT03018106|Estrogens|estrogens|mesh-list
6256075|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
6256076|NCT03018106|Hormones|hormones|mesh-ancestor
6256077|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256078|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256079|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
6256080|NCT03018223|Sirolimus|sirolimus|mesh-list
6256081|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
6256082|NCT03018223|Busulfan|busulfan|mesh-list
6256083|NCT03018223|Fludarabine|fludarabine|mesh-list
6256084|NCT03018223|Lenograstim|lenograstim|mesh-list
6256085|NCT03018223|Sargramostim|sargramostim|mesh-list
6256086|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6256087|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
6256088|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256089|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6256090|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6256091|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
6256092|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256093|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256094|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6256095|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6256096|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6256097|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6256098|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
6256099|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6256100|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256101|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256102|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
6256103|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
6256104|NCT03018249|Entinostat|entinostat|mesh-list
6256105|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
6256106|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
6256107|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
6256108|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
6256109|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
6256110|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
6256111|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6256112|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256113|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
6256114|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
6256115|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
6256116|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6256117|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256118|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256119|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256120|NCT03018340|Pimavanserin|pimavanserin|mesh-list
6256121|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6256122|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6256123|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6256124|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6256125|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256126|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256127|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6256128|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6256129|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6256130|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
6256131|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256132|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256133|NCT03018925|Golimumab|golimumab|mesh-list
6256134|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
6256135|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256136|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6256137|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
6256138|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256139|NCT03018938|Insulin|insulin|mesh-list
6256140|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
6256141|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6256142|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256143|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6256144|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6256145|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6256146|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
6256147|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256148|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6256149|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6256150|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256151|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
6256152|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6256153|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6256154|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
6256155|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256156|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256157|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6256158|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6256159|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
6256160|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256161|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
6256162|NCT03019887|Haloperidol|haloperidol|mesh-list
6256163|NCT03019887|Olanzapine|olanzapine|mesh-list
6256164|NCT03019887|Risperidone|risperidone|mesh-list
6256165|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
6256166|NCT03019887|Aripiprazole|aripiprazole|mesh-list
6256167|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
6256168|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
6256169|NCT03019887|Perphenazine|perphenazine|mesh-list
6256170|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6256171|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
6256172|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256173|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256174|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256175|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6256176|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6256177|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256178|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6256179|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6256180|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
6256181|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
6256182|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
6256183|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256184|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256185|NCT03019887|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
6256186|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6256187|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6256188|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
6256189|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
6256190|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6256191|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6256192|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
6256193|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6256194|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6256195|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6256196|NCT03019887|Analgesics|analgesics|mesh-ancestor
6256197|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
6256198|NCT03019939|Isavuconazole|isavuconazole|mesh-list
6256199|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
6256200|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256201|NCT03019965|Meropenem|meropenem|mesh-list
6256202|NCT03019965|Tazobactam|tazobactam|mesh-list
6256203|NCT03019965|Piperacillin|piperacillin|mesh-list
6256204|NCT03019965|Imipenem|imipenem|mesh-list
6256205|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
6256206|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6256207|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256208|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
6256209|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256210|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256211|NCT03020004|Ritonavir|ritonavir|mesh-list
6256212|NCT03020004|Ribavirin|ribavirin|mesh-list
6256213|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6256214|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6256215|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6256216|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
6256217|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256218|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256219|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6256220|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6256221|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
6256222|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256223|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6256224|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6256225|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
6256226|NCT03020082|Ritonavir|ritonavir|mesh-list
6256227|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
6256228|NCT03020082|Ribavirin|ribavirin|mesh-list
6256229|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6256230|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6256231|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
6256232|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256233|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256234|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6256235|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6256236|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
6256237|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256238|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6256239|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6256240|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
6256241|NCT03020095|Ritonavir|ritonavir|mesh-list
6256242|NCT03020095|Ribavirin|ribavirin|mesh-list
6256243|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6256244|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6256245|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
6256246|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256247|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256248|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6256249|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6256250|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
6256251|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256252|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6256253|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6256254|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
6256255|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6256256|NCT03020407|Dopamine|dopamine|mesh-list
6256257|NCT03020407|Epinephrine|epinephrine|mesh-list
6256258|NCT03020407|Norepinephrine|norepinephrine|mesh-list
6256259|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
6256260|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256261|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6256262|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6256263|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
6256264|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256265|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256266|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256267|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6256268|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6256269|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
6256270|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256271|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6256272|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
6256273|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
6256274|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
6256275|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6256276|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
6256277|NCT03020407|Protective Agents|protective agents|mesh-ancestor
6256278|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
6256279|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256280|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
6256281|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256282|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256283|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6256284|NCT03020966|Acetaminophen|acetaminophen|mesh-list
6256285|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6256286|NCT03020966|Analgesics|analgesics|mesh-ancestor
6256287|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
6256288|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256289|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256290|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
6256291|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
6256292|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6256293|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
6256294|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256295|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6256296|NCT03021018|Lorazepam|lorazepam|mesh-list
6256297|NCT03021018|Brivaracetam|brivaracetam|mesh-list
6256298|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
6256299|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
6256300|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
6256301|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256302|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256303|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256304|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6256305|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256306|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6256307|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6256308|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6256309|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
6256310|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
6256311|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256312|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256313|NCT03021343|Colchicine|colchicine|mesh-list
6256314|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
6256315|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6256316|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
6256317|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
6256318|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
6256319|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256320|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256321|NCT03021642|Tepotinib|tepotinib|mesh-list
6256322|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256323|NCT03022526|Fentanyl|fentanyl|mesh-list
6256324|NCT03022526|Bupivacaine|bupivacaine|mesh-list
6256325|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
6256326|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
6256327|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256328|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256329|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
6256330|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256331|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6256332|NCT03022526|Narcotics|narcotics|mesh-ancestor
6256333|NCT03022526|Analgesics|analgesics|mesh-ancestor
6256334|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6256335|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6256336|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
6256337|NCT03022617|Apremilast|apremilast|mesh-list
6256338|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6256339|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6256340|NCT03022617|Analgesics|analgesics|mesh-ancestor
6256341|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
6256342|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256343|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256344|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256345|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6256346|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
6256347|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
6256348|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256349|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256350|NCT03022916|Efinaconazole|efinaconazole|mesh-list
6256351|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6256352|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
6256353|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256354|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
6256355|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6256356|NCT03022981|Velpatasvir|velpatasvir|mesh-list
6256357|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
6256358|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256359|NCT03023423|Atezolizumab|atezolizumab|mesh-list
6256360|NCT03023423|Daratumumab|daratumumab|mesh-list
6256361|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256362|NCT03023722|Maytansine|maytansine|mesh-list
6256363|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6256364|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256365|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
6256366|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
6256367|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
6256368|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256369|NCT03023878|Dexamethasone|dexamethasone|mesh-list
6256370|NCT03023878|Blinatumomab|blinatumomab|mesh-list
6256371|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256372|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
6256373|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
6256374|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256375|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256376|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256377|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
6256378|NCT03023878|Hormones|hormones|mesh-ancestor
6256379|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256380|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6256381|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256382|NCT03023891|Prednisone|prednisone|mesh-list
6256383|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256384|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
6256385|NCT03023891|Hormones|hormones|mesh-ancestor
6256386|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256387|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256388|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6256389|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256390|NCT03025945|Nepafenac|nepafenac|mesh-list
6256391|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6256392|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6256393|NCT03025945|Analgesics|analgesics|mesh-ancestor
6256394|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
6256395|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256396|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256397|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256398|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6256399|NCT03026088|Bisoprolol|bisoprolol|mesh-list
6256400|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6256401|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
6256402|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
6256403|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256404|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256405|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6256406|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6256407|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6256408|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
6256409|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256410|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256411|NCT03026166|Nivolumab|nivolumab|mesh-list
6256412|NCT03026166|Ipilimumab|ipilimumab|mesh-list
6256413|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6256414|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256415|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6256416|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256417|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
6256418|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
6256419|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
6256420|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6256421|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256422|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
6256423|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
6256424|NCT03026556|Apixaban|apixaban|mesh-list
6256425|NCT03026556|Dabigatran|dabigatran|mesh-list
6256426|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
6256427|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
6256428|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6256429|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
6256430|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256431|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256432|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
6256433|NCT03026803|Capecitabine|capecitabine|mesh-list
6256434|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
6256435|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6256436|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
6256437|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256438|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256439|NCT03027557|Denosumab|denosumab|mesh-list
6256440|NCT03027557|Cinacalcet|cinacalcet|mesh-list
6256441|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6256442|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256443|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6256444|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
6256445|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
6256446|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256447|NCT03027661|Bupivacaine|bupivacaine|mesh-list
6256448|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
6256449|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
6256450|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256451|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256452|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
6256453|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256454|NCT03028012|Dexamethasone|dexamethasone|mesh-list
6256455|NCT03028012|Ketorolac|ketorolac|mesh-list
6256456|NCT03028012|Lidocaine|lidocaine|mesh-list
6256457|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256458|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
6256459|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
6256460|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256461|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256462|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256463|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
6256464|NCT03028012|Hormones|hormones|mesh-ancestor
6256465|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256466|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6256467|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256468|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
6256469|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
6256470|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256471|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
6256472|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6256473|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6256474|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6256475|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6256476|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256477|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6256478|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6256479|NCT03028012|Analgesics|analgesics|mesh-ancestor
6256480|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6256481|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6256482|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256483|NCT03028025|Hemostatics|hemostatics|mesh-list
6256484|NCT03028025|Coagulants|coagulants|mesh-ancestor
6256485|NCT03028103|Repaglinide|repaglinide|mesh-list
6256486|NCT03028103|Fluconazole|fluconazole|mesh-list
6256487|NCT03028103|Omeprazole|omeprazole|mesh-list
6256488|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6256489|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256490|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6256491|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256492|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256493|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
6256494|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256495|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6256496|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6256497|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6256498|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
6256499|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256500|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256501|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
6256502|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
6256503|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6256504|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6256505|NCT03028129|Isoniazid|isoniazid|mesh-list
6256506|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256507|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
6256508|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
6256509|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6256510|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
6256511|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256512|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6256513|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
6256514|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6256515|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
6256516|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256517|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256518|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6256519|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
6256520|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
6256521|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6256522|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
6256523|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256524|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256525|NCT03028467|Folic Acid|folic acid|mesh-list
6256526|NCT03028467|Methotrexate|methotrexate|mesh-list
6256527|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6256528|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
6256529|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6256530|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256531|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6256532|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
6256533|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256534|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256535|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
6256536|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256537|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6256538|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6256539|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
6256540|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6256541|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6256542|NCT03028467|Hematinics|hematinics|mesh-ancestor
6256543|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
6256544|NCT03028467|Vitamins|vitamins|mesh-ancestor
6256545|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
6256546|NCT03028870|Naproxen|naproxen|mesh-list
6256547|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6256548|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6256549|NCT03028870|Analgesics|analgesics|mesh-ancestor
6256550|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
6256551|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256552|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256553|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256554|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6256555|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
6256556|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6256557|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256558|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256559|NCT03029091|Losartan|losartan|mesh-list
6256560|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6256561|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6256562|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6256563|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6256564|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256565|NCT03029143|Vedolizumab|vedolizumab|mesh-list
6256566|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256567|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
6256568|NCT03029208|Hematinics|hematinics|mesh-ancestor
6256569|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
6256570|NCT03029247|Hematinics|hematinics|mesh-ancestor
6256571|NCT03029650|Scopolamine|scopolamine|mesh-list
6256572|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
6256573|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6256574|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
6256575|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
6256576|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256577|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256578|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256579|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
6256580|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6256581|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
6256582|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256583|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256584|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6256585|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
6256586|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
6256587|NCT03029715|Remifentanil|remifentanil|mesh-list
6256588|NCT03029715|Propofol|propofol|mesh-list
6256589|NCT03029715|Desflurane|desflurane|mesh-list
6256590|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6256591|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256592|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256593|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6256594|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
6256595|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
6256596|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6256597|NCT03029715|Analgesics|analgesics|mesh-ancestor
6256598|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
6256599|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256600|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6256601|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6256602|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6256603|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
6256604|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256605|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256606|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6256607|NCT03029715|Narcotics|narcotics|mesh-ancestor
6256608|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6256609|NCT03029780|Nivolumab|nivolumab|mesh-list
6256610|NCT03029780|Ipilimumab|ipilimumab|mesh-list
6256611|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6256612|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256613|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6256614|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256615|NCT03029819|Nicotine|nicotine|mesh-list
6256616|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6256617|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
6256618|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256619|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256620|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6256621|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6256622|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
6256623|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256624|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256625|NCT03030638|Olodaterol|olodaterol|mesh-list
6256626|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6256627|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
6256628|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256629|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256630|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6256631|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
6256632|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
6256633|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
6256634|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6256635|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256636|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
6256637|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
6256638|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
6256639|NCT03031496|Amiloride|amiloride|mesh-list
6256640|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
6256641|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6256642|NCT03031496|Diuretics|diuretics|mesh-ancestor
6256643|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
6256644|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256645|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
6256646|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6256647|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256648|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
6256649|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6256650|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
6256651|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6256652|NCT03031795|Ketorolac|ketorolac|mesh-list
6256653|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6256654|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6256655|NCT03031795|Analgesics|analgesics|mesh-ancestor
6256656|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
6256657|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256658|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256659|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256660|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6256661|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6256662|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256663|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256664|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
6256665|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
6256666|NCT03031899|Coagulants|coagulants|mesh-ancestor
6256667|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
6256668|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256669|NCT03032380|Meropenem|meropenem|mesh-list
6256670|NCT03032380|Linezolid|linezolid|mesh-list
6256671|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6256672|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256673|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
6256674|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256675|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256676|NCT03032965|Adenosine|adenosine|mesh-list
6256677|NCT03032965|Isoproterenol|isoproterenol|mesh-list
6256678|NCT03032965|Analgesics|analgesics|mesh-ancestor
6256679|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
6256680|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256681|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256682|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6256683|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
6256684|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
6256685|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
6256686|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
6256687|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256688|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256689|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6256690|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6256691|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
6256692|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6256693|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
6256694|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6256695|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
6256696|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
6256697|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
6256698|NCT03032965|Protective Agents|protective agents|mesh-ancestor
6256699|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
6256700|NCT03033394|Penicillins|penicillins|mesh-list
6256701|NCT03033394|Lactams|lactams|mesh-list
6256702|NCT03033394|beta-Lactams|beta-lactams|mesh-list
6256703|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256704|NCT03033511|Dexamethasone|dexamethasone|mesh-list
6256705|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
6256706|NCT03033511|BB 1101|bb 1101|mesh-list
6256707|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
6256708|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256709|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
6256710|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
6256711|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256712|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256713|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256714|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
6256715|NCT03033511|Hormones|hormones|mesh-ancestor
6256716|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256717|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6256718|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256719|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
6256720|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256721|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256722|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
6256723|NCT03033784|Oxytocin|oxytocin|mesh-list
6256724|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
6256725|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6256726|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256727|NCT03034018|Suvorexant|suvorexant|mesh-list
6256728|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6256729|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6256730|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256731|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256732|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
6256733|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256734|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256735|NCT03034135|Copper|copper|mesh-list
6256736|NCT03034135|Temozolomide|temozolomide|mesh-list
6256737|NCT03034135|Disulfiram|disulfiram|mesh-list
6256738|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6256739|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
6256740|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256741|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256742|NCT03034135|Trace Elements|trace elements|mesh-ancestor
6256743|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
6256744|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256745|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6256746|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
6256747|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256748|NCT03034577|Neostigmine|neostigmine|mesh-list
6256749|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6256750|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256751|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256752|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
6256753|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256754|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256755|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
6256756|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
6256757|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256758|NCT03034772|Timolol|timolol|mesh-list
6256759|NCT03034772|Dorzolamide|dorzolamide|mesh-list
6256760|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
6256761|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6256762|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6256763|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
6256764|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256765|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256766|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256767|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6256768|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6256769|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6256770|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6256771|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
6256772|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256773|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6256774|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6256775|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
6256776|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256777|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256778|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6256779|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
6256780|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6256781|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6256782|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6256783|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
6256784|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256785|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256786|NCT03035032|Leuprolide|leuprolide|mesh-list
6256787|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
6256788|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
6256789|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6256790|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256791|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6256792|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256793|NCT03035708|Varenicline|varenicline|mesh-list
6256794|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6256795|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6256796|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
6256797|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256798|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256799|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256800|NCT03035760|Oxfendazole|oxfendazole|mesh-list
6256801|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
6256802|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6256803|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256804|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
6256805|NCT03035916|Anesthetics|anesthetics|mesh-list
6256806|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256807|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256808|NCT03035929|Dexamethasone|dexamethasone|mesh-list
6256809|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
6256810|NCT03035929|BB 1101|bb 1101|mesh-list
6256811|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256812|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
6256813|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
6256814|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256815|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256816|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256817|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
6256818|NCT03035929|Hormones|hormones|mesh-ancestor
6256819|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256820|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6256821|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256822|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
6256823|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6256824|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256825|NCT03035942|Dexamethasone|dexamethasone|mesh-list
6256826|NCT03035942|Ondansetron|ondansetron|mesh-list
6256827|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256828|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
6256829|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
6256830|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256831|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256832|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256833|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
6256834|NCT03035942|Hormones|hormones|mesh-ancestor
6256835|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256836|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6256837|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256838|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
6256839|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
6256840|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6256841|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
6256842|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256843|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256844|NCT03035942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6256845|NCT03035942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6256846|NCT03035942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256847|NCT03035942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6256848|NCT03035942|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6256849|NCT03035955|Azelaic acid|azelaic acid|mesh-list
6256850|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256851|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
6256852|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
6256853|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6256854|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256855|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6256856|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256857|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
6256858|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6256859|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256860|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6256861|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256862|NCT03036163|Macozinone|macozinone|mesh-list
6256863|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
6256864|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6256865|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256866|NCT03036384|Sufentanil|sufentanil|mesh-list
6256867|NCT03036384|Morphine|morphine|mesh-list
6256868|NCT03036384|Prilocaine|prilocaine|mesh-list
6256869|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6256870|NCT03036384|Narcotics|narcotics|mesh-ancestor
6256871|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256872|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256873|NCT03036384|Analgesics|analgesics|mesh-ancestor
6256874|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
6256875|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256876|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6256877|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6256878|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
6256879|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
6256880|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
6256881|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
6256882|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
6256883|NCT03036839|Ledipasvir|ledipasvir|mesh-list
6256884|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
6256885|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256886|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
6256887|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6256888|NCT03036852|Velpatasvir|velpatasvir|mesh-list
6256889|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
6256890|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6256891|NCT03037580|Treprostinil|treprostinil|mesh-list
6256892|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6256893|NCT03038308|Ropinirole|ropinirole|mesh-list
6256894|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6256895|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6256896|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
6256897|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
6256898|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256899|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256900|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256901|NCT03038620|Liraglutide|liraglutide|mesh-list
6256902|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6256903|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256904|NCT03038620|Incretins|incretins|mesh-ancestor
6256905|NCT03038620|Hormones|hormones|mesh-ancestor
6256906|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256907|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
6256908|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
6256909|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6256910|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6256911|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256912|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256913|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256914|NCT03038867|Analgesics|analgesics|mesh-ancestor
6256915|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
6256916|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256917|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
6256918|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6256919|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
6256920|NCT03038880|Ranibizumab|ranibizumab|mesh-list
6256921|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6256922|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6256923|NCT03038880|Growth Substances|growth substances|mesh-ancestor
6256924|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256925|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
6256926|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256927|NCT03039023|Choline|choline|mesh-list
6256928|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
6256929|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6256930|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
6256931|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256932|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256933|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6256934|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
6256935|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
6256936|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6256937|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
6256938|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256939|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256940|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256941|NCT03039192|Esketamine|esketamine|mesh-list
6256942|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
6256943|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6256944|NCT03039543|Rocuronium|rocuronium|mesh-list
6256945|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6256946|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6256947|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6256948|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256949|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256950|NCT03040011|Dexamethasone|dexamethasone|mesh-list
6256951|NCT03040011|Bupivacaine|bupivacaine|mesh-list
6256952|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6256953|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
6256954|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
6256955|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256956|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256957|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6256958|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
6256959|NCT03040011|Hormones|hormones|mesh-ancestor
6256960|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6256961|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6256962|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6256963|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
6256964|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
6256965|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256966|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
6256967|NCT03040024|Ketamine|ketamine|mesh-list
6256968|NCT03040024|Analgesics|analgesics|mesh-ancestor
6256969|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
6256970|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6256971|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256972|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6256973|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6256974|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
6256975|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
6256976|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6256977|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6256978|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6256979|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256980|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256981|NCT03040362|Lasmiditan|lasmiditan|mesh-list
6256982|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6256983|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
6256984|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256985|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256986|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256987|NCT03040479|Lasmiditan|lasmiditan|mesh-list
6256988|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6256989|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
6256990|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6256991|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6256992|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6256993|NCT03041181|Gemcitabine|gemcitabine|mesh-list
6256994|NCT03041181|Docetaxel|docetaxel|mesh-list
6256995|NCT03041181|Nivolumab|nivolumab|mesh-list
6256996|NCT03041181|Pemetrexed|pemetrexed|mesh-list
6256997|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6256998|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
6256999|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257000|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257001|NCT03041181|Antiviral Agents|antiviral agents|mesh-ancestor
6257002|NCT03041181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257003|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257004|NCT03041181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6257005|NCT03041181|Immunologic Factors|immunologic factors|mesh-ancestor
6257006|NCT03041181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257007|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
6257008|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
6257009|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
6257010|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257011|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6257012|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6257013|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6257014|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6257015|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
6257016|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
6257017|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257018|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
6257019|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6257020|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257021|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257022|NCT03041792|Liraglutide|liraglutide|mesh-list
6257023|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6257024|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257025|NCT03041792|Incretins|incretins|mesh-ancestor
6257026|NCT03041792|Hormones|hormones|mesh-ancestor
6257027|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6257028|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
6257029|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6257030|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6257031|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257032|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
6257033|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
6257034|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257035|NCT03042910|Talazoparib|talazoparib|mesh-list
6257036|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6257037|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257038|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257039|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257040|NCT03043105|Thalidomide|thalidomide|mesh-list
6257041|NCT03043105|Prednisone|prednisone|mesh-list
6257042|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
6257043|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6257044|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
6257045|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257046|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6257047|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6257048|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
6257049|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257050|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257051|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6257052|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257053|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
6257054|NCT03043105|Hormones|hormones|mesh-ancestor
6257055|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6257056|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6257057|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
6257058|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6257059|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257060|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6257061|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6257062|NCT03043105|Growth Substances|growth substances|mesh-ancestor
6257063|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
6257064|NCT03043274|Cangrelor|cangrelor|mesh-list
6257065|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6257066|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
6257067|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
6257068|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
6257069|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
6257070|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257071|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257072|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257073|NCT03043560|Ezogabine|ezogabine|mesh-list
6257074|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
6257075|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6257076|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257077|NCT03043651|Treprostinil|treprostinil|mesh-list
6257078|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6257079|NCT03043872|Carboplatin|carboplatin|mesh-list
6257080|NCT03043872|Etoposide|etoposide|mesh-list
6257081|NCT03043872|Durvalumab|durvalumab|mesh-list
6257082|NCT03043872|Tremelimumab|tremelimumab|mesh-list
6257083|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257084|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6257085|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6257086|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6257087|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257088|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257089|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257090|NCT03044418|Propofol|propofol|mesh-list
6257091|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
6257092|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257093|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257094|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6257095|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6257096|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
6257097|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
6257098|NCT03044730|Capecitabine|capecitabine|mesh-list
6257099|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257100|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257101|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6257102|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
6257103|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257104|NCT03044886|Vitamin D|vitamin d|mesh-list
6257105|NCT03044886|Vitamins|vitamins|mesh-ancestor
6257106|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
6257107|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257108|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6257109|NCT03045328|Venetoclax|venetoclax|mesh-list
6257110|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257111|NCT03045653|Tamoxifen|tamoxifen|mesh-list
6257112|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
6257113|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
6257114|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6257115|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257116|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6257117|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257118|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
6257119|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
6257120|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6257121|NCT03045861|Cobicistat|cobicistat|mesh-list
6257122|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
6257123|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6257124|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6257125|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
6257126|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257127|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6257128|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6257129|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257130|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257131|NCT03046446|FX006|fx006|mesh-list
6257132|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257133|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
6257134|NCT03046446|Hormones|hormones|mesh-ancestor
6257135|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6257136|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257137|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6257138|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
6257139|NCT03047980|Sirolimus|sirolimus|mesh-list
6257140|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6257141|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257142|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
6257143|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257144|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
6257145|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6257146|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
6257147|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257148|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
6257149|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
6257150|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
6257151|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257152|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
6257153|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6257154|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6257155|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6257156|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6257157|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
6257158|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257159|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257160|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257161|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6257162|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6257163|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6257164|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257165|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257166|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6257167|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6257168|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257169|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
6257170|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257171|NCT03048500|Metformin|metformin|mesh-list
6257172|NCT03048500|Nivolumab|nivolumab|mesh-list
6257173|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6257174|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257175|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257176|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257177|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6257178|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257179|NCT03048747|Tolvaptan|tolvaptan|mesh-list
6257180|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
6257181|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257182|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
6257183|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257184|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
6257185|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
6257186|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
6257187|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257188|NCT03049488|Antacids|antacids|mesh-ancestor
6257189|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257190|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6257191|NCT03050294|Desoximetasone|desoximetasone|mesh-list
6257192|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257193|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
6257194|NCT03050294|Hormones|hormones|mesh-ancestor
6257195|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6257196|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257197|NCT03050307|Lansoprazole|lansoprazole|mesh-list
6257198|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
6257199|NCT03050307|Bismuth|bismuth|mesh-list
6257200|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6257201|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6257202|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6257203|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257204|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257205|NCT03050307|Antacids|antacids|mesh-ancestor
6257206|NCT03050359|Lansoprazole|lansoprazole|mesh-list
6257207|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
6257208|NCT03050359|Bismuth|bismuth|mesh-list
6257209|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
6257210|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6257211|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
6257212|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257213|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257214|NCT03050359|Antacids|antacids|mesh-ancestor
6257215|NCT03050450|Lenalidomide|lenalidomide|mesh-list
6257216|NCT03050450|Vorinostat|vorinostat|mesh-list
6257217|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
6257218|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257219|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
6257220|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
6257221|NCT03050450|Growth Substances|growth substances|mesh-ancestor
6257222|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
6257223|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257224|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
6257225|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257226|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257227|NCT03050619|Empagliflozin|empagliflozin|mesh-list
6257228|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
6257229|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257230|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6257231|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257232|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6257233|NCT03051100|Atorvastatin|atorvastatin|mesh-list
6257234|NCT03051100|Ezetimibe|ezetimibe|mesh-list
6257235|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6257236|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6257237|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
6257238|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257239|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6257240|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6257241|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257242|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6257243|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257244|NCT03051256|Methadone|methadone|mesh-list
6257245|NCT03051256|D-methadone|d-methadone|mesh-list
6257246|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6257247|NCT03051256|Narcotics|narcotics|mesh-ancestor
6257248|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257249|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257250|NCT03051256|Analgesics|analgesics|mesh-ancestor
6257251|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
6257252|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257253|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
6257254|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
6257255|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6257256|NCT03051620|Alendronate|alendronate|mesh-list
6257257|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6257258|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257259|NCT03051646|Aspirin|aspirin|mesh-list
6257260|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6257261|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6257262|NCT03051646|Analgesics|analgesics|mesh-ancestor
6257263|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
6257264|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257265|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257266|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257267|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6257268|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
6257269|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
6257270|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257271|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
6257272|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6257273|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257274|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
6257275|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
6257276|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257277|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257278|NCT03052322|Adalimumab|adalimumab|mesh-list
6257279|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257280|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6257281|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
6257282|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
6257283|NCT03052517|Growth Substances|growth substances|mesh-ancestor
6257284|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257285|NCT03052725|Reslizumab|reslizumab|mesh-list
6257286|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6257287|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
6257288|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
6257289|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6257290|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
6257291|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257292|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
6257293|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
6257294|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
6257295|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
6257296|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6257297|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257298|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
6257299|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257300|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257301|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6257302|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257303|NCT03052816|Hydromorphone|hydromorphone|mesh-list
6257304|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6257305|NCT03052816|Narcotics|narcotics|mesh-ancestor
6257306|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257307|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257308|NCT03052816|Analgesics|analgesics|mesh-ancestor
6257309|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
6257310|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257311|NCT03053050|Selonsertib|selonsertib|mesh-list
6257312|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6257313|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257314|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257315|NCT03053063|Selonsertib|selonsertib|mesh-list
6257316|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
6257317|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257318|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257319|NCT03053401|Anesthetics|anesthetics|mesh-list
6257320|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
6257321|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257322|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257323|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
6257324|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257325|NCT03053427|Gabapentin|gabapentin|mesh-list
6257326|NCT03053427|Analgesics|analgesics|mesh-ancestor
6257327|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
6257328|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257329|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257330|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
6257331|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6257332|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6257333|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257334|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6257335|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6257336|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6257337|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257338|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257339|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
6257340|NCT03054103|Midazolam|midazolam|mesh-list
6257341|NCT03054103|Ketamine|ketamine|mesh-list
6257342|NCT03054103|Analgesics|analgesics|mesh-ancestor
6257343|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
6257344|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257345|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257346|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
6257347|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6257348|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
6257349|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
6257350|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257351|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
6257352|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
6257353|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257354|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257355|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6257356|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6257357|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6257358|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6257359|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6257360|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
6257361|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
6257362|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
6257363|NCT03054506|Laxatives|laxatives|mesh-ancestor
6257364|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6257365|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
6257366|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
6257367|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
6257368|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257369|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257370|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
6257371|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257372|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
6257373|NCT03054805|Antacids|antacids|mesh-ancestor
6257374|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257375|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6257376|NCT03054844|Lidocaine|lidocaine|mesh-list
6257377|NCT03054844|Midazolam|midazolam|mesh-list
6257378|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
6257379|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
6257380|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257381|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257382|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
6257383|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257384|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6257385|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6257386|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6257387|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6257388|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257389|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6257390|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6257391|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6257392|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6257393|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6257394|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6257395|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
6257396|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
6257397|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
6257398|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257399|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
6257400|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6257401|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257402|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257403|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6257404|NCT03054857|Analgesics|analgesics|mesh-ancestor
6257405|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
6257406|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257407|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6257408|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6257409|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6257410|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
6257411|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257412|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257413|NCT03054870|Xenon|xenon|mesh-list
6257414|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
6257415|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
6257416|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
6257417|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257418|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257419|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
6257420|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
6257421|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
6257422|NCT03055221|Treprostinil|treprostinil|mesh-list
6257423|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6257424|NCT03055338|Risperidone|risperidone|mesh-list
6257425|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6257426|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
6257427|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257428|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257429|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257430|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6257431|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6257432|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257433|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6257434|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6257435|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
6257436|NCT03055936|Levodopa|levodopa|mesh-list
6257437|NCT03055936|Carbidopa|carbidopa|mesh-list
6257438|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6257439|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6257440|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
6257441|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257442|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257443|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257444|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
6257445|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257446|NCT03055988|Fluticasone|fluticasone|mesh-list
6257447|NCT03055988|Xhance|xhance|mesh-list
6257448|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
6257449|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6257450|NCT03055988|Olodaterol|olodaterol|mesh-list
6257451|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257452|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6257453|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
6257454|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257455|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257456|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6257457|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
6257458|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
6257459|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6257460|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
6257461|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6257462|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
6257463|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257464|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257465|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6257466|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6257467|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6257468|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
6257469|NCT03056040|Eculizumab|eculizumab|mesh-list
6257470|NCT03056040|Ravulizumab|ravulizumab|mesh-list
6257471|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
6257472|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6257473|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
6257474|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257475|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
6257476|NCT03056352|Promethazine|promethazine|mesh-list
6257477|NCT03056352|Metoclopramide|metoclopramide|mesh-list
6257478|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
6257479|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6257480|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257481|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257482|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
6257483|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
6257484|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
6257485|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257486|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
6257487|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
6257488|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6257489|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
6257490|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
6257491|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
6257492|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257493|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257494|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6257495|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
6257496|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
6257497|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
6257498|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
6257499|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
6257500|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
6257501|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6257502|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257503|NCT03057132|Protective Agents|protective agents|mesh-list
6257504|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257505|NCT03057366|Paclitaxel|paclitaxel|mesh-list
6257506|NCT03057366|Docetaxel|docetaxel|mesh-list
6257507|NCT03057366|Carboplatin|carboplatin|mesh-list
6257508|NCT03057366|Pevonedistat|pevonedistat|mesh-list
6257509|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6257510|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257511|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
6257512|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
6257513|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
6257514|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257515|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257516|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
6257517|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257518|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257519|NCT03057704|Lidocaine|lidocaine|mesh-list
6257520|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
6257521|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
6257522|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257523|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257524|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
6257525|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257526|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6257527|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
6257528|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6257529|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6257530|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257531|NCT03057977|Empagliflozin|empagliflozin|mesh-list
6257532|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6257533|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257534|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6257535|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257536|NCT03058692|Vaccines|vaccines|mesh-list
6257537|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
6257538|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257539|NCT03060447|Vesatolimod|vesatolimod|mesh-list
6257540|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
6257541|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257542|NCT03060486|Hybenx|hybenx|mesh-list
6257543|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
6257544|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
6257545|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257546|NCT03060512|Naloxegol|naloxegol|mesh-list
6257547|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
6257548|NCT03060512|Laxatives|laxatives|mesh-ancestor
6257549|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6257550|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6257551|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257552|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
6257553|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257554|NCT03061188|Nivolumab|nivolumab|mesh-list
6257555|NCT03061188|Veliparib|veliparib|mesh-list
6257556|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257557|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257558|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6257559|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257560|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6257561|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257562|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
6257563|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6257564|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257565|NCT03061214|Incretins|incretins|mesh-ancestor
6257566|NCT03061214|Hormones|hormones|mesh-ancestor
6257567|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6257568|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
6257569|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
6257570|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257571|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257572|NCT03061331|Ivacaftor|ivacaftor|mesh-list
6257573|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6257574|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6257575|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257576|NCT03061812|Dexamethasone|dexamethasone|mesh-list
6257577|NCT03061812|Topotecan|topotecan|mesh-list
6257578|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257579|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
6257580|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
6257581|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257582|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257583|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6257584|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
6257585|NCT03061812|Hormones|hormones|mesh-ancestor
6257586|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6257587|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
6257588|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257589|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
6257590|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6257591|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257592|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257593|NCT03062488|Acetaminophen|acetaminophen|mesh-list
6257594|NCT03062488|Fentanyl|fentanyl|mesh-list
6257595|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6257596|NCT03062488|Narcotics|narcotics|mesh-ancestor
6257597|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257598|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257599|NCT03062488|Analgesics|analgesics|mesh-ancestor
6257600|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
6257601|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257602|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6257603|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6257604|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
6257605|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
6257606|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6257607|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
6257608|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
6257609|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
6257610|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257611|NCT03063086|Fluticasone|fluticasone|mesh-list
6257612|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
6257613|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257614|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6257615|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
6257616|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257617|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257618|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6257619|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
6257620|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
6257621|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
6257622|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6257623|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6257624|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6257625|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
6257626|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257627|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257628|NCT03063255|Anesthetics|anesthetics|mesh-list
6257629|NCT03063255|Mepivacaine|mepivacaine|mesh-list
6257630|NCT03063255|Rocuronium|rocuronium|mesh-list
6257631|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257632|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257633|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
6257634|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
6257635|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6257636|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257637|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
6257638|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
6257639|NCT03065179|Nivolumab|nivolumab|mesh-list
6257640|NCT03065179|Ipilimumab|ipilimumab|mesh-list
6257641|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257642|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257643|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6257644|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257645|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
6257646|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257647|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257648|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
6257649|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6257650|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257651|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257652|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6257653|NCT03065530|Analgesics|analgesics|mesh-ancestor
6257654|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
6257655|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257656|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6257657|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6257658|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6257659|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
6257660|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257661|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257662|NCT03066193|Palmidrol|palmidrol|mesh-list
6257663|NCT03066193|Dronabinol|dronabinol|mesh-list
6257664|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
6257665|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257666|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6257667|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6257668|NCT03066193|Analgesics|analgesics|mesh-ancestor
6257669|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
6257670|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257671|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
6257672|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
6257673|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257674|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257675|NCT03066193|Hormones|hormones|mesh-ancestor
6257676|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6257677|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6257678|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257679|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6257680|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
6257681|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257682|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
6257683|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
6257684|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257685|NCT03066778|Carboplatin|carboplatin|mesh-list
6257686|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
6257687|NCT03066778|Etoposide|etoposide|mesh-list
6257688|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257689|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257690|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6257691|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
6257692|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
6257693|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257694|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257695|NCT03066804|Valsartan|valsartan|mesh-list
6257696|NCT03066804|Enalapril|enalapril|mesh-list
6257697|NCT03066804|Enalaprilat|enalaprilat|mesh-list
6257698|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
6257699|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6257700|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
6257701|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
6257702|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257703|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
6257704|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
6257705|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257706|NCT03066830|Metformin|metformin|mesh-list
6257707|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
6257708|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6257709|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257710|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6257711|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257712|NCT03066947|Interferons|interferons|mesh-list
6257713|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
6257714|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
6257715|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
6257716|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6257717|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
6257718|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257719|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6257720|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6257721|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
6257722|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257723|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257724|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
6257725|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
6257726|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257727|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
6257728|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6257729|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
6257730|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257731|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6257732|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257733|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6257734|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257735|NCT03068312|Ivacaftor|ivacaftor|mesh-list
6257736|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
6257737|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6257738|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257739|NCT03068455|Nivolumab|nivolumab|mesh-list
6257740|NCT03068455|Ipilimumab|ipilimumab|mesh-list
6257741|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257742|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257743|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6257744|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257745|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
6257746|NCT03068754|Hormones|hormones|mesh-ancestor
6257747|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6257748|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257749|NCT03068767|Vitamin D|vitamin d|mesh-list
6257750|NCT03068767|Vitamins|vitamins|mesh-ancestor
6257751|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
6257752|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257753|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6257754|NCT03068897|Ibuprofen|ibuprofen|mesh-list
6257755|NCT03068897|Tizanidine|tizanidine|mesh-list
6257756|NCT03068897|Baclofen|baclofen|mesh-list
6257757|NCT03068897|Metaxalone|metaxalone|mesh-list
6257758|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6257759|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6257760|NCT03068897|Analgesics|analgesics|mesh-ancestor
6257761|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
6257762|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257763|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257764|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257765|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6257766|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6257767|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257768|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257769|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
6257770|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
6257771|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
6257772|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
6257773|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
6257774|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257775|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
6257776|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
6257777|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
6257778|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6257779|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6257780|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6257781|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
6257782|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
6257783|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
6257784|NCT03069313|Vitamins|vitamins|mesh-ancestor
6257785|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
6257786|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257787|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
6257788|NCT03069313|Hematinics|hematinics|mesh-ancestor
6257789|NCT03069352|Cytarabine|cytarabine|mesh-list
6257790|NCT03069352|Venetoclax|venetoclax|mesh-list
6257791|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6257792|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
6257793|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257794|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257795|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
6257796|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257797|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6257798|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
6257799|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257800|NCT03069482|Nicotine|nicotine|mesh-list
6257801|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
6257802|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
6257803|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257804|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257805|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
6257806|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
6257807|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
6257808|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257809|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257810|NCT03069677|Midazolam|midazolam|mesh-list
6257811|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6257812|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6257813|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257814|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257815|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6257816|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6257817|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6257818|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6257819|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
6257820|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
6257821|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
6257822|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
6257823|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257824|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257825|NCT03070171|Dabigatran|dabigatran|mesh-list
6257826|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
6257827|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
6257828|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
6257829|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257830|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257831|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
6257832|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
6257833|NCT03070392|Ipilimumab|ipilimumab|mesh-list
6257834|NCT03070392|Dacarbazine|dacarbazine|mesh-list
6257835|NCT03070392|Imidazole|imidazole|mesh-list
6257836|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257837|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257838|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6257839|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257840|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
6257841|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
6257842|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257843|NCT03070470|Ritonavir|ritonavir|mesh-list
6257844|NCT03070470|Lopinavir|lopinavir|mesh-list
6257845|NCT03070470|Chloroquine|chloroquine|mesh-list
6257846|NCT03070470|Verapamil|verapamil|mesh-list
6257847|NCT03070470|Dofetilide|dofetilide|mesh-list
6257848|NCT03070470|Diltiazem|diltiazem|mesh-list
6257849|NCT03070470|Ranolazine|ranolazine|mesh-list
6257850|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
6257851|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
6257852|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
6257853|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257854|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257855|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6257856|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6257857|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
6257858|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257859|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6257860|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6257861|NCT03070470|Amebicides|amebicides|mesh-ancestor
6257862|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6257863|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6257864|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
6257865|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6257866|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257867|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6257868|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
6257869|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6257870|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6257871|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
6257872|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6257873|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
6257874|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
6257875|NCT03070483|Vitamin D|vitamin d|mesh-list
6257876|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
6257877|NCT03070483|Vitamins|vitamins|mesh-ancestor
6257878|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
6257879|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257880|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
6257881|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
6257882|NCT03070548|Talazoparib|talazoparib|mesh-list
6257883|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6257884|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257885|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257886|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257887|NCT03070730|Atenolol|atenolol|mesh-list
6257888|NCT03070730|Droxidopa|droxidopa|mesh-list
6257889|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
6257890|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6257891|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
6257892|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
6257893|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257894|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257895|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
6257896|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
6257897|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
6257898|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
6257899|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257900|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257901|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
6257902|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6257903|NCT03071094|Nivolumab|nivolumab|mesh-list
6257904|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257905|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257906|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6257907|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257908|NCT03071263|Spironolactone|spironolactone|mesh-list
6257909|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
6257910|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
6257911|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6257912|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257913|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
6257914|NCT03071263|Diuretics|diuretics|mesh-ancestor
6257915|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
6257916|NCT03071276|Vidarabine|vidarabine|mesh-list
6257917|NCT03071276|Cytarabine|cytarabine|mesh-list
6257918|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
6257919|NCT03071276|Methotrexate|methotrexate|mesh-list
6257920|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
6257921|NCT03071276|Fludarabine|fludarabine|mesh-list
6257922|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
6257923|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
6257924|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6257925|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257926|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
6257927|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
6257928|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257929|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257930|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
6257931|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257932|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6257933|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6257934|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
6257935|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6257936|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6257937|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
6257938|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6257939|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257940|NCT03071744|Fentanyl|fentanyl|mesh-list
6257941|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6257942|NCT03071744|Narcotics|narcotics|mesh-ancestor
6257943|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6257944|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257945|NCT03071744|Analgesics|analgesics|mesh-ancestor
6257946|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
6257947|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257948|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6257949|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6257950|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
6257951|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
6257952|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
6257953|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6257954|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6257955|NCT03072719|Fluorides|fluorides|mesh-list
6257956|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
6257957|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
6257958|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
6257959|NCT03072719|Protective Agents|protective agents|mesh-ancestor
6257960|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257961|NCT03073200|Etanercept|etanercept|mesh-list
6257962|NCT03073200|Ixekizumab|ixekizumab|mesh-list
6257963|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6257964|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6257965|NCT03073200|Analgesics|analgesics|mesh-ancestor
6257966|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
6257967|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257968|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257969|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257970|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6257971|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6257972|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
6257973|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
6257974|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
6257975|NCT03073213|Ixekizumab|ixekizumab|mesh-list
6257976|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
6257977|NCT03073876|Donepezil|donepezil|mesh-list
6257978|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
6257979|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257980|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257981|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
6257982|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6257983|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257984|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
6257985|NCT03074162|Diclofenac|diclofenac|mesh-list
6257986|NCT03074162|Capsaicin|capsaicin|mesh-list
6257987|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
6257988|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6257989|NCT03074162|Analgesics|analgesics|mesh-ancestor
6257990|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
6257991|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6257992|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6257993|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6257994|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
6257995|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
6257996|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6257997|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6257998|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
6257999|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
6258000|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
6258001|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
6258002|NCT03074331|Velpatasvir|velpatasvir|mesh-list
6258003|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
6258004|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258005|NCT03074409|Oxytocin|oxytocin|mesh-list
6258006|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
6258007|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
6258008|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258009|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
6258010|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
6258011|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
6258012|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
6258013|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
6258014|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258015|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
6258016|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
6258017|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258018|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
6258019|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
6258020|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258021|NCT03075163|Ondansetron|ondansetron|mesh-list
6258022|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
6258023|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
6258024|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258025|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258026|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
6258027|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
6258028|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
6258029|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
6258030|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
6258031|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258032|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258033|NCT03075163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
6258034|NCT03075163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6258035|NCT03075163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258036|NCT03075163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6258037|NCT03075163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6258038|NCT03075267|Budesonide|budesonide|mesh-list
6258039|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
6258040|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
6258041|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
6258042|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
6258043|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
6258044|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258045|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258046|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
6258047|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
6258048|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
6258049|NCT03075267|Hormones|hormones|mesh-ancestor
6258050|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6258051|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
6258052|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
6258053|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6258054|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
6258055|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258056|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258057|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6258058|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
6258059|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
6258060|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
6258061|NCT03075410|GSK656|gsk656|mesh-list
6258062|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6258063|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258064|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
6258065|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258066|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258067|NCT03075527|Durvalumab|durvalumab|mesh-list
6258068|NCT03075527|Tremelimumab|tremelimumab|mesh-list
6258069|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258070|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258071|NCT03075553|Nivolumab|nivolumab|mesh-list
6258072|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
6258073|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258074|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
6258075|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258076|NCT03075891|Doxycycline|doxycycline|mesh-list
6258077|NCT03075891|Ivermectin|ivermectin|mesh-list
6258078|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6258079|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258080|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
6258081|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6258082|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6258083|NCT03076970|Sumatriptan|sumatriptan|mesh-list
6258084|NCT03076970|Lasmiditan|lasmiditan|mesh-list
6258085|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
6258086|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
6258087|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
6258088|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
6258089|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258090|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258091|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258092|NCT03077438|Vaccines|vaccines|mesh-list
6258093|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
6258094|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258095|NCT03077607|Itraconazole|itraconazole|mesh-list
6258096|NCT03077607|Rifampin|rifampin|mesh-list
6258097|NCT03077607|Talazoparib|talazoparib|mesh-list
6258098|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
6258099|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258100|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
6258101|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6258102|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258103|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258104|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
6258105|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
6258106|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
6258107|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258108|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
6258109|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
6258110|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
6258111|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6258112|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
6258113|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6258114|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
6258115|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
6258116|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
6258117|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
6258118|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
6258119|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
6258120|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
6258121|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258122|NCT03077659|Paclitaxel|paclitaxel|mesh-list
6258123|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
6258124|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
6258125|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
6258126|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
6258127|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
6258128|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258129|NCT03077711|Trimethoprim|trimethoprim|mesh-list
6258130|NCT03077711|Methenamine|methenamine|mesh-list
6258131|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
6258132|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
6258133|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
6258134|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258135|NCT03077711|Renal Agents|renal agents|mesh-ancestor
6258136|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
6258137|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
6258138|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
6258139|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
6258140|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258141|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258142|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
6258143|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
6258144|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6258145|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
6258146|NCT03077919|Ropivacaine|ropivacaine|mesh-list
6258147|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
6258148|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
6258149|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258150|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258151|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
6258152|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258153|NCT03078075|Naltrexone|naltrexone|mesh-list
6258154|NCT03078075|Bupropion|bupropion|mesh-list
6258155|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
6258156|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
6258157|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258158|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
6258159|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258160|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
6258161|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
6258162|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6258163|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
6258164|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
6258165|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
6258166|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258167|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
6258168|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258169|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
6258170|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
6258171|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258172|NCT03078556|Lamivudine|lamivudine|mesh-list
6258173|NCT03078556|Dolutegravir|dolutegravir|mesh-list
6258174|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
6258175|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
6258176|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
6258177|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258178|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
6258179|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
6258180|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
6258181|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
6258182|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
6258183|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
6258184|NCT03078907|Selexipag|selexipag|mesh-list
6258185|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
6258186|NCT03078946|Midazolam|midazolam|mesh-list
6258187|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
6258188|NCT03078946|Morphine|morphine|mesh-list
6258189|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
6258190|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258191|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258192|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
6258193|NCT03078946|Analgesics|analgesics|mesh-ancestor
6258194|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
6258195|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
6258196|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
6258197|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
6258198|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
6258199|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
6258200|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
6258201|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
6258202|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
6258203|NCT03078946|Narcotics|narcotics|mesh-ancestor
6258204|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
6258205|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
6258206|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
6258207|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
6258208|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
6258209|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
6258210|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
6258211|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
6258212|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
6258213|NCT03080142|Bupivacaine|bupivacaine|mesh-list
6258214|NCT03080142|Ropivacaine|ropivacaine|mesh-list
6258215|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
6258216|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
6258217|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
6258218|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
6258219|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
6258220|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
